data_2l19_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2l19 _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.4 ptt? . . . . . 0 N--CA 1.496 1.854 0 N-CA-C 111.776 0.287 . . . . 0.0 111.776 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 11.0 mtmm -59.91 128.4 36.71 Favored 'General case' 0 N--CA 1.475 0.8 0 N-CA-C 107.816 -1.179 . . . . 0.0 107.816 -178.872 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 66.0 mttt -103.14 136.12 43.52 Favored 'General case' 0 CA--C 1.513 -0.465 0 N-CA-C 107.745 -1.205 . . . . 0.0 107.745 171.528 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 3.7 t -113.73 152.73 15.38 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.622 0 C-N-CA 126.144 1.777 . . . . 0.0 107.111 -171.479 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 2.7 mtt -137.14 145.08 43.37 Favored 'General case' 0 C--N 1.323 -0.55 0 C-N-CA 126.433 1.893 . . . . 0.0 108.341 169.525 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 60.0 m-85 -128.6 89.01 2.82 Favored 'General case' 0 CA--C 1.528 0.109 0 N-CA-C 105.234 -2.136 . . . . 0.0 105.234 170.769 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 44.0 t -128.57 108.62 17.73 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.217 0 CA-C-O 121.409 0.623 . . . . 0.0 111.72 -168.741 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 33.9 t -101.64 164.57 11.68 Favored 'General case' 0 CA--C 1.543 0.682 0 N-CA-C 105.392 -2.077 . . . . 0.0 105.392 167.812 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 61.7 pttt -72.0 148.36 45.99 Favored 'General case' 0 CA--C 1.53 0.206 0 O-C-N 121.133 -0.979 . . . . 0.0 108.809 169.529 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 2.8 mpt_? 60.07 168.75 0.08 Allowed 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 125.63 1.572 . . . . 0.0 110.939 -170.443 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -138.4 -14.04 1.31 Allowed 'General case' 0 N--CA 1.468 0.433 0 N-CA-C 112.882 0.697 . . . . 0.0 112.882 -176.117 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 2.0 m -59.96 -30.71 69.28 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-N 118.681 0.673 . . . . 0.0 109.988 178.564 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 7.3 p -136.15 151.56 49.9 Favored 'General case' 0 N--CA 1.45 -0.455 0 C-N-CA 127.046 2.138 . . . . 0.0 105.652 168.738 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 2.0 mmm-85 58.77 176.12 0.07 Allowed 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 125.767 1.627 . . . . 0.0 110.026 -169.527 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 6.6 m 51.03 37.7 18.54 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 123.378 0.671 . . . . 0.0 111.557 -174.906 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 24.3 pt20 -143.21 155.09 44.45 Favored 'General case' 0 N--CA 1.444 -0.744 0 N-CA-C 106.476 -1.676 . . . . 0.0 106.476 174.401 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER 66.79 -39.58 0.35 Allowed 'General case' 0 C--N 1.326 -0.423 0 C-N-CA 127.091 2.156 . . . . 0.0 114.851 179.141 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -65.9 -48.14 72.45 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-N 120.834 1.652 . . . . 0.0 110.591 -176.315 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -64.37 -40.68 96.32 Favored 'General case' 0 C--N 1.324 -0.519 0 C-N-CA 123.651 0.78 . . . . 0.0 111.258 174.546 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -59.23 -45.44 95.37 Favored Glycine 0 CA--C 1.526 0.779 0 N-CA-C 111.622 -0.591 . . . . 0.0 111.622 176.476 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 1.5 m-85 -69.36 -33.44 73.08 Favored 'General case' 0 CA--C 1.51 -0.588 0 O-C-N 121.414 -1.051 . . . . 0.0 111.262 177.483 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -70.28 -37.83 74.94 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 119.098 0.863 . . . . 0.0 110.336 -178.105 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -53.06 -45.02 67.89 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 123.928 0.891 . . . . 0.0 109.146 169.55 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 14.7 m -70.48 -57.2 5.04 Favored 'General case' 0 N--CA 1.448 -0.562 0 C-N-CA 124.15 0.98 . . . . 0.0 111.279 -174.467 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 37.6 mt -74.65 -34.41 62.72 Favored 'General case' 0 C--N 1.332 -0.167 0 C-N-CA 125.108 1.363 . . . . 0.0 110.814 -171.71 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -92.05 1.21 73.64 Favored Glycine 0 CA--C 1.528 0.874 0 C-N-CA 125.162 1.363 . . . . 0.0 113.291 -175.898 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -49.27 127.81 15.58 Favored 'General case' 0 CA--C 1.534 0.335 0 CA-C-N 118.991 1.395 . . . . 0.0 110.565 -179.176 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 76.11 -9.8 17.67 Favored Glycine 0 CA--C 1.535 1.298 0 C-N-CA 124.412 1.006 . . . . 0.0 114.121 179.743 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 63.1 mttm -99.65 -47.51 5.06 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 119.177 1.489 . . . . 0.0 110.307 175.22 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 22.0 pt -144.0 155.38 15.63 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.26 0 C-N-CA 124.443 1.097 . . . . 0.0 110.819 -169.155 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -98.48 155.46 17.25 Favored 'General case' 0 C--O 1.224 -0.269 0 C-N-CA 125.344 1.458 . . . . 0.0 108.566 179.673 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 21.9 t -139.53 130.97 33.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 N-CA-C 106.969 -1.493 . . . . 0.0 106.969 -178.317 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 24.7 m -140.36 114.02 8.77 Favored 'General case' 0 N--CA 1.446 -0.664 0 N-CA-C 104.36 -2.459 . . . . 0.0 104.36 172.095 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 55.0 m -112.32 91.22 3.58 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 107.862 -1.162 . . . . 0.0 107.862 173.16 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 3.0 p -67.06 -59.12 3.73 Favored 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 126.478 1.911 . . . . 0.0 111.579 -174.372 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 107.15 164.49 22.08 Favored Glycine 0 CA--C 1.527 0.787 0 C-N-CA 124.463 1.03 . . . . 0.0 112.331 176.651 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 6.1 mt -131.86 138.85 48.61 Favored 'General case' 0 CA--C 1.508 -0.667 0 C-N-CA 127.362 2.265 . . . . 0.0 105.447 170.166 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 28.4 mt-10 53.72 20.46 2.24 Favored 'General case' 0 N--CA 1.48 1.029 0 CA-C-O 122.443 1.116 . . . . 0.0 111.735 179.178 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 3.7 p -78.13 165.41 24.0 Favored 'General case' 0 N--CA 1.435 -1.185 0 N-CA-C 116.481 2.03 . . . . 0.0 116.481 -166.854 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 37.3 p -147.07 -165.52 2.27 Favored 'General case' 0 N--CA 1.433 -1.278 0 C-N-CA 128.956 2.903 . . . . 0.0 106.289 -168.716 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -75.81 161.24 29.19 Favored 'General case' 0 N--CA 1.456 -0.153 0 CA-C-O 122.128 0.965 . . . . 0.0 109.182 169.343 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 2.3 m -66.87 173.28 0.63 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.709 0 CA-C-N 114.35 -1.295 . . . . 0.0 108.37 169.655 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 81.1 t60 -70.76 137.85 85.52 Favored Pre-proline 0 CA--C 1.544 0.73 0 O-C-N 121.187 -0.946 . . . . 0.0 110.4 -178.319 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 16.4 Cg_endo -56.44 -50.55 11.58 Favored 'Trans proline' 0 C--N 1.349 0.571 0 C-N-CA 123.077 2.518 . . . . 0.0 113.106 -177.433 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 23.5 m -69.35 -21.94 63.78 Favored 'General case' 0 CA--C 1.537 0.45 0 O-C-N 121.846 -0.534 . . . . 0.0 110.739 -177.296 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -61.18 -47.62 85.34 Favored 'General case' 0 CA--C 1.505 -0.774 0 N-CA-C 108.771 -0.825 . . . . 0.0 108.771 174.189 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 55.9 mt -58.7 -42.89 86.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 N-CA-C 108.345 -0.983 . . . . 0.0 108.345 -174.212 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -61.93 -47.43 84.92 Favored 'General case' 0 N--CA 1.453 -0.287 0 CA-C-N 118.395 0.543 . . . . 0.0 110.988 -179.898 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 27.4 mmt -66.5 -34.48 78.01 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-O 122.343 1.068 . . . . 0.0 110.7 179.853 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -78.36 -35.59 47.24 Favored 'General case' 0 N--CA 1.441 -0.875 0 N-CA-C 107.247 -1.39 . . . . 0.0 107.247 -172.924 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 33.9 mt-10 -70.42 -22.78 62.68 Favored 'General case' 0 N--CA 1.442 -0.851 0 C-N-CA 123.703 0.801 . . . . 0.0 110.229 171.757 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 14.7 mm-40 -69.23 -29.32 67.22 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-N 119.28 0.945 . . . . 0.0 110.62 171.448 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . 0.278 7.8 p -90.74 8.54 3.74 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.002 0 CA-C-N 118.768 0.713 . . . . 0.0 110.738 168.876 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 81.07 20.91 64.01 Favored Glycine 0 CA--C 1.532 1.114 0 C-N-CA 124.732 1.158 . . . . 0.0 114.055 173.463 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 16.7 mt -117.45 134.02 62.36 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.306 0 C-N-CA 124.49 1.116 . . . . 0.0 110.884 -172.251 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 3.3 t70 -89.4 139.11 30.84 Favored 'General case' 0 N--CA 1.464 0.258 0 N-CA-C 108.08 -1.082 . . . . 0.0 108.08 169.18 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 8.8 pt -129.92 -31.97 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.543 0 C-N-CA 124.587 1.155 . . . . 0.0 110.908 172.362 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -38.41 -42.52 0.74 Allowed 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 128.233 2.613 . . . . 0.0 113.698 169.388 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -70.58 1.63 20.41 Favored Glycine 0 CA--C 1.534 1.27 0 C-N-CA 124.518 1.056 . . . . 0.0 115.18 -174.121 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 16.6 mt-30 -60.46 -34.17 73.63 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 119.512 1.656 . . . . 0.0 114.457 -178.506 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -57.49 118.25 4.99 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-O 121.435 0.636 . . . . 0.0 110.765 -169.041 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 49.2 m -152.05 -167.63 2.83 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 127.857 2.463 . . . . 0.0 106.763 -169.537 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -59.52 153.21 51.57 Favored Pre-proline 0 CA--C 1.54 0.562 0 O-C-N 121.795 -0.566 . . . . 0.0 110.49 169.653 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -64.43 158.26 50.29 Favored 'Trans proline' 0 C--N 1.349 0.56 0 C-N-CA 123.13 2.553 . . . . 0.0 110.514 171.751 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 13.0 tt -59.72 -27.05 36.94 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.289 0 O-C-N 121.783 -0.573 . . . . 0.0 111.33 -178.762 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 15.7 mt-10 -65.98 -26.24 67.46 Favored 'General case' 0 C--O 1.234 0.24 0 C-N-CA 124.185 0.994 . . . . 0.0 110.409 -175.175 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 5.9 t-20 -66.48 -26.52 67.22 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 124.646 1.179 . . . . 0.0 111.769 177.13 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 96.3 m-85 -96.26 170.76 9.03 Favored 'General case' 0 C--O 1.235 0.32 0 C-N-CA 125.632 1.573 . . . . 0.0 110.927 -177.909 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 19.0 p-10 -116.79 137.43 52.2 Favored 'General case' 0 N--CA 1.436 -1.129 0 C-N-CA 125.075 1.35 . . . . 0.0 110.889 168.966 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -77.11 -22.18 53.09 Favored 'General case' 0 N--CA 1.433 -1.302 0 N-CA-C 109.82 -0.437 . . . . 0.0 109.82 -171.181 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -64.16 -21.92 66.74 Favored 'General case' 0 N--CA 1.443 -0.799 0 O-C-N 123.881 0.738 . . . . 0.0 111.79 -179.239 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 37.8 t70 -75.77 -27.72 58.14 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 122.973 0.509 . . . . 0.0 112.146 175.02 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 32.1 m-85 -85.93 170.11 12.63 Favored 'General case' 0 N--CA 1.451 -0.402 0 C-N-CA 126.271 1.828 . . . . 0.0 111.031 -179.319 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -119.01 -34.24 3.95 Favored 'General case' 0 N--CA 1.466 0.332 0 C-N-CA 123.117 0.567 . . . . 0.0 111.753 177.569 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -145.51 138.04 20.8 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.489 0 CA-C-O 121.324 0.583 . . . . 0.0 109.834 -170.216 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 95.5 t -144.87 126.09 8.51 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.515 0 N-CA-C 106.254 -1.758 . . . . 0.0 106.254 -173.782 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 4.5 mm -101.87 132.39 47.9 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.599 0 N-CA-C 105.803 -1.925 . . . . 0.0 105.803 173.609 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 55.8 m -93.04 -16.09 25.41 Favored 'General case' 0 CA--C 1.535 0.37 0 N-CA-C 113.288 0.848 . . . . 0.0 113.288 178.81 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 24.4 mt 57.06 -12.27 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.613 0 N-CA-C 118.218 2.673 . . . . 0.0 118.218 171.079 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 26.5 p -149.58 33.87 0.7 Allowed 'General case' 0 CA--C 1.537 0.454 0 CA-C-N 122.303 2.319 . . . . 0.0 112.816 -178.072 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 130.85 -165.49 22.9 Favored Glycine 0 CA--C 1.525 0.665 0 C-N-CA 125.498 1.523 . . . . 0.0 110.675 179.485 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 8.4 p -102.72 -53.39 2.87 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 124.762 1.225 . . . . 0.0 110.116 177.012 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -65.52 -53.93 29.13 Favored Glycine 0 C--N 1.341 0.84 0 N-CA-C 111.201 -0.76 . . . . 0.0 111.201 -175.394 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . 0.313 98.5 t 55.94 10.36 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.551 1.01 0 C-N-CA 126.749 2.02 . . . . 0.0 114.919 169.592 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 64.1 t30 53.38 44.57 29.86 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 124.839 1.256 . . . . 0.0 109.398 -169.592 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -126.31 142.63 43.39 Favored Pre-proline 0 CA--C 1.539 0.552 0 C-N-CA 127.242 2.217 . . . . 0.0 108.22 -169.317 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 30.1 Cg_exo -65.93 143.04 71.36 Favored 'Trans proline' 0 C--N 1.352 0.75 0 C-N-CA 121.396 1.397 . . . . 0.0 111.45 -178.749 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -65.4 -28.31 54.53 Favored 'Trans proline' 0 N--CA 1.462 -0.377 0 C-N-CA 122.054 1.836 . . . . 0.0 114.273 -169.191 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -58.09 -19.39 31.73 Favored 'General case' 0 CA--C 1.538 0.483 0 CA-C-N 119.436 1.016 . . . . 0.0 112.488 179.873 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 95.0 m95 -78.88 -40.62 31.88 Favored 'General case' 0 N--CA 1.446 -0.642 0 C-N-CA 123.52 0.728 . . . . 0.0 112.263 -177.15 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 2.9 m -71.25 -34.11 53.06 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.445 0 CA-C-O 118.722 -0.656 . . . . 0.0 110.117 174.29 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 76.6 p -81.99 23.69 0.68 Allowed 'General case' 0 C--O 1.236 0.356 0 CA-C-N 120.046 1.293 . . . . 0.0 113.893 -170.159 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 94.3 mm-40 -72.79 179.03 3.84 Favored 'General case' 0 N--CA 1.446 -0.634 0 O-C-N 121.703 -0.623 . . . . 0.0 110.319 172.343 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 30.7 mm-40 -62.3 -19.79 63.65 Favored 'General case' 0 CA--C 1.538 0.489 0 N-CA-C 112.829 0.677 . . . . 0.0 112.829 -169.398 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 2.1 tt -142.14 124.12 13.28 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.354 0 C-N-CA 126.338 1.855 . . . . 0.0 106.698 173.547 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 7.0 t80 -97.29 132.23 43.23 Favored 'General case' 0 CA--C 1.535 0.397 0 N-CA-C 105.158 -2.164 . . . . 0.0 105.158 169.022 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 7.9 mm-40 -138.46 160.27 39.98 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-O 121.792 0.806 . . . . 0.0 109.434 172.034 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 8.9 t70 -179.92 134.98 0.11 Allowed 'General case' 0 C--N 1.325 -0.482 0 C-N-CA 127.085 2.154 . . . . 0.0 106.509 -169.57 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 5.0 m-90 -145.58 154.23 41.94 Favored 'General case' 0 C--O 1.234 0.238 0 N-CA-C 109.325 -0.62 . . . . 0.0 109.325 -172.043 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 15.2 pt20 -79.58 50.24 1.11 Allowed 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 124.216 1.006 . . . . 0.0 110.118 171.474 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 1.1 mt -65.43 121.92 15.99 Favored 'General case' 0 C--N 1.34 0.181 0 N-CA-C 107.672 -1.232 . . . . 0.0 107.672 178.141 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 -73.02 160.35 32.21 Favored 'General case' 0 CA--C 1.537 0.465 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 173.826 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -137.26 137.21 21.95 Favored Pre-proline 0 C--O 1.237 0.413 0 C-N-CA 124.296 1.039 . . . . 0.0 109.835 -169.698 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 22.7 Cg_endo -88.66 6.16 4.84 Favored 'Trans proline' 0 CA--C 1.544 0.994 0 C-N-CA 122.817 2.344 . . . . 0.0 113.736 -170.517 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 4.6 t70 -47.01 111.53 0.41 Allowed 'General case' 0 C--O 1.236 0.389 0 CA-C-N 120.356 1.434 . . . . 0.0 111.857 -179.973 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 67.65 7.91 49.84 Favored Glycine 0 CA--C 1.535 1.307 0 C-N-CA 124.348 0.975 . . . . 0.0 114.3 177.853 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 6.7 mt-30 -91.2 173.6 7.84 Favored 'General case' 0 CA--C 1.541 0.626 0 CA-C-N 118.777 1.289 . . . . 0.0 110.518 -178.649 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 15.6 m -74.16 166.55 23.23 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 124.432 1.093 . . . . 0.0 111.555 179.978 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -57.35 -31.78 66.08 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 125.06 1.344 . . . . 0.0 112.084 -176.85 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 6.2 pt-20 -56.82 -35.17 68.48 Favored 'General case' 0 N--CA 1.463 0.196 0 C-N-CA 123.195 0.598 . . . . 0.0 111.377 176.404 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 15.6 t -76.9 -41.42 32.11 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.31 0 CA-C-O 118.412 -0.804 . . . . 0.0 109.416 -176.883 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 84.1 m-85 -57.25 -48.91 77.64 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-N 119.89 1.223 . . . . 0.0 110.413 171.606 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 94.9 mtt180 -60.81 -41.77 96.32 Favored 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 123.322 0.649 . . . . 0.0 110.972 179.766 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 5.2 m -63.5 -47.62 80.96 Favored 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 124.629 1.171 . . . . 0.0 110.196 176.25 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 73.1 t -68.92 -35.11 67.68 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.335 0 CA-C-O 117.955 -1.022 . . . . 0.0 109.7 -172.402 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 27.2 mtm105 -57.68 -48.24 80.08 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 120.205 1.366 . . . . 0.0 110.094 174.128 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -63.36 -48.84 75.24 Favored Glycine 0 CA--C 1.53 0.999 0 CA-C-N 118.38 0.536 . . . . 0.0 111.852 179.003 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 14.3 mm-40 -55.79 -54.1 48.56 Favored 'General case' 0 N--CA 1.464 0.259 0 C-N-CA 123.677 0.791 . . . . 0.0 109.93 179.556 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 95.6 t -65.34 -43.46 94.92 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-O 118.168 -0.92 . . . . 0.0 109.821 -173.559 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 61.5 tttm -53.45 -44.5 68.91 Favored 'General case' 0 C--O 1.225 -0.191 0 N-CA-C 108.828 -0.804 . . . . 0.0 108.828 178.479 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -69.53 -45.4 68.92 Favored 'General case' 0 N--CA 1.448 -0.575 0 CA-C-O 119.12 -0.467 . . . . 0.0 111.627 -176.394 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 1.5 mmt-85 -59.41 -44.85 92.77 Favored 'General case' 0 N--CA 1.478 0.969 0 CA-C-N 119.26 0.936 . . . . 0.0 110.257 176.487 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 88.6 t -68.63 -40.76 82.23 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.445 0 N-CA-C 109.193 -0.669 . . . . 0.0 109.193 -176.555 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 23.6 mt-10 -60.61 -40.45 91.9 Favored 'General case' 0 C--O 1.226 -0.151 0 CA-C-N 119.645 1.111 . . . . 0.0 110.21 176.129 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 25.0 t-20 -65.69 -43.2 89.95 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 123.082 0.553 . . . . 0.0 111.442 -179.579 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 1.4 tm? -58.75 -47.76 83.53 Favored 'General case' 0 C--O 1.225 -0.191 0 C-N-CA 126.112 1.765 . . . . 0.0 110.689 174.509 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 85.5 mt -65.91 -48.37 82.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 N-CA-C 108.697 -0.853 . . . . 0.0 108.697 179.16 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -56.54 -33.86 66.5 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-N 118.488 0.586 . . . . 0.0 112.264 -177.31 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 17.6 ptpt -80.4 -36.06 34.37 Favored 'General case' 0 C--N 1.342 0.279 0 CA-C-O 117.952 -1.023 . . . . 0.0 112.552 178.543 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 14.0 pt -85.22 -34.56 8.88 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.376 0 CA-C-N 119.973 1.261 . . . . 0.0 114.08 -177.353 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 75.1 m . . . . . 0 C--O 1.254 1.322 0 C-N-CA 125.706 1.602 . . . . 0.0 109.398 -169.884 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.497 1.882 0 N-CA-C 110.37 -0.233 . . . . 0.0 110.37 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 26.6 mttm -81.66 121.01 25.82 Favored 'General case' 0 N--CA 1.478 0.956 0 N-CA-C 106.776 -1.565 . . . . 0.0 106.776 173.501 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 37.0 ttmt -87.17 128.6 35.13 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 107.396 -1.335 . . . . 0.0 107.396 -179.366 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 1.7 t -117.17 150.8 19.12 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 C-N-CA 125.715 1.606 . . . . 0.0 109.61 -168.865 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 46.4 ttm -141.23 148.21 39.54 Favored 'General case' 0 C--N 1.329 -0.319 0 C-N-CA 125.474 1.51 . . . . 0.0 108.786 169.699 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 87.1 m-85 -136.29 128.7 30.25 Favored 'General case' 0 C--N 1.332 -0.175 0 N-CA-C 104.072 -2.566 . . . . 0.0 104.072 175.005 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 2.2 p -157.17 156.39 4.41 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.437 0 CA-C-N 119.147 0.885 . . . . 0.0 110.837 -168.947 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 48.0 t -140.63 177.58 7.93 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 126.966 2.106 . . . . 0.0 106.652 169.04 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 40.7 ttmt -49.86 -40.99 44.33 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 124.707 1.203 . . . . 0.0 111.742 -177.064 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 99.1 mtt180 -134.17 169.23 17.48 Favored 'General case' 0 N--CA 1.466 0.325 0 C-N-CA 125.478 1.511 . . . . 0.0 107.898 169.906 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 55.1 t-20 -70.8 -39.91 72.82 Favored 'General case' 0 N--CA 1.47 0.53 0 N-CA-C 109.702 -0.481 . . . . 0.0 109.702 173.405 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 3.6 m -51.85 139.15 22.56 Favored 'General case' 0 C--O 1.237 0.397 0 C-N-CA 124.849 1.26 . . . . 0.0 111.084 -178.339 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 4.6 m 60.99 17.13 7.63 Favored 'General case' 0 CA--C 1.542 0.648 0 N-CA-C 115.076 1.51 . . . . 0.0 115.076 171.852 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -156.13 -55.37 0.09 Allowed 'General case' 0 N--CA 1.471 0.605 0 CA-C-N 121.05 1.75 . . . . 0.0 114.886 169.842 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 3.3 m -77.92 15.6 0.85 Allowed 'General case' 0 N--CA 1.468 0.431 0 N-CA-C 115.654 1.724 . . . . 0.0 115.654 -168.254 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 6.0 pt20 -66.15 -43.26 87.54 Favored 'General case' 0 C--O 1.22 -0.453 0 CA-C-N 120.247 1.385 . . . . 0.0 113.302 -169.989 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 1.4 tpt -108.55 -19.83 13.31 Favored 'General case' 0 N--CA 1.47 0.526 0 N-CA-C 114.487 1.291 . . . . 0.0 114.487 -168.571 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -66.65 -50.29 63.41 Favored 'General case' 0 N--CA 1.475 0.792 0 CA-C-N 119.149 0.886 . . . . 0.0 111.846 -170.498 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -63.29 -32.42 73.83 Favored 'General case' 0 N--CA 1.467 0.38 0 N-CA-C 109.492 -0.559 . . . . 0.0 109.492 173.008 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -51.43 -65.7 2.98 Favored Glycine 0 C--N 1.345 1.03 0 C-N-CA 124.569 1.081 . . . . 0.0 111.347 174.471 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 13.6 m-85 -65.72 -29.38 69.9 Favored 'General case' 0 CA--C 1.506 -0.746 0 CA-C-N 118.588 1.194 . . . . 0.0 112.477 -176.882 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -67.45 -30.11 69.75 Favored 'General case' 0 N--CA 1.446 -0.638 0 CA-C-O 117.98 -1.01 . . . . 0.0 111.737 -177.624 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 2.1 ptmt -70.72 -27.89 64.31 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-N 120.248 1.385 . . . . 0.0 111.342 174.132 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 12.8 m -77.52 -57.16 3.97 Favored 'General case' 0 N--CA 1.448 -0.541 0 C-N-CA 125.538 1.535 . . . . 0.0 110.954 179.774 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 57.2 mt -72.84 -36.9 67.57 Favored 'General case' 0 N--CA 1.464 0.228 0 C-N-CA 124.019 0.927 . . . . 0.0 109.76 -175.703 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -81.21 0.74 87.08 Favored Glycine 0 CA--C 1.525 0.68 0 C-N-CA 124.812 1.196 . . . . 0.0 113.2 179.907 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -54.96 135.71 48.29 Favored 'General case' 0 C--O 1.236 0.372 0 CA-C-N 119.186 1.493 . . . . 0.0 109.395 179.172 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 72.49 5.81 64.44 Favored Glycine 0 CA--C 1.534 1.248 0 CA-C-O 118.332 -1.26 . . . . 0.0 114.597 178.393 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 9.2 ptpp? -137.81 -44.33 0.53 Allowed 'General case' 0 N--CA 1.475 0.777 0 CA-C-N 119.731 1.765 . . . . 0.0 112.937 -178.595 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 24.0 pt -138.49 152.81 25.44 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.794 0 CA-C-N 119.978 1.263 . . . . 0.0 110.138 -173.082 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -118.47 106.32 12.57 Favored 'General case' 0 C--O 1.227 -0.105 0 C-N-CA 124.62 1.168 . . . . 0.0 110.009 -169.738 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 4.6 t -79.62 134.4 27.74 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.399 0 N-CA-C 109.178 -0.675 . . . . 0.0 109.178 177.833 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 22.2 m -140.62 87.4 2.12 Favored 'General case' 0 N--CA 1.449 -0.5 0 N-CA-C 105.493 -2.04 . . . . 0.0 105.493 169.663 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 38.6 m -95.0 82.91 3.86 Favored 'General case' 0 N--CA 1.448 -0.557 0 CA-C-O 121.917 0.865 . . . . 0.0 111.223 -169.809 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -64.26 172.0 2.74 Favored 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 125.715 1.606 . . . . 0.0 110.3 169.874 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -157.75 -167.86 19.33 Favored Glycine 0 C--N 1.338 0.664 0 N-CA-C 108.575 -1.81 . . . . 0.0 108.575 -173.297 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 3.0 mt -136.96 131.27 32.75 Favored 'General case' 0 N--CA 1.44 -0.932 0 N-CA-C 104.468 -2.419 . . . . 0.0 104.468 -172.272 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 28.7 mt-10 65.47 -61.55 0.24 Allowed 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 126.754 2.022 . . . . 0.0 111.041 -169.714 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 75.4 m 65.31 158.63 0.1 Allowed 'General case' 0 N--CA 1.438 -1.026 0 C-N-CA 129.313 3.045 . . . . 0.0 115.917 171.133 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 49.7 p -161.9 170.94 18.53 Favored 'General case' 0 N--CA 1.431 -1.375 0 CA-C-N 111.039 -2.801 . . . . 0.0 106.932 -168.838 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 5.7 ttt180 -92.28 167.05 12.28 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.657 0.742 . . . . 0.0 109.31 175.721 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 18.8 m -73.07 171.88 1.13 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.622 0 CA-C-N 114.711 -1.131 . . . . 0.0 109.853 178.647 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 92.2 m-70 -82.99 150.28 61.2 Favored Pre-proline 0 CA--C 1.539 0.526 0 C-N-CA 123.416 0.687 . . . . 0.0 110.479 -176.889 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -62.7 -45.63 13.32 Favored 'Trans proline' 0 C--N 1.347 0.496 0 C-N-CA 122.982 2.455 . . . . 0.0 112.383 -172.675 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 6.1 m -68.49 -25.94 65.22 Favored 'General case' 0 CA--C 1.534 0.33 0 O-C-N 121.881 -0.512 . . . . 0.0 110.22 -179.146 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -58.51 -52.8 64.12 Favored 'General case' 0 CA--C 1.507 -0.691 0 N-CA-C 108.766 -0.827 . . . . 0.0 108.766 171.356 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 81.5 mt -59.27 -41.09 82.96 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.342 0 N-CA-C 108.471 -0.937 . . . . 0.0 108.471 -173.176 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -63.1 -49.75 73.21 Favored 'General case' 0 CA--C 1.534 0.363 0 CA-C-N 118.503 0.592 . . . . 0.0 111.331 179.718 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 29.4 mmt -65.89 -36.63 83.96 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-O 122.933 1.349 . . . . 0.0 111.106 -179.698 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -78.45 -30.44 47.46 Favored 'General case' 0 N--CA 1.439 -0.993 0 N-CA-C 106.803 -1.554 . . . . 0.0 106.803 -172.754 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 4.8 mm-40 -73.75 -20.51 60.48 Favored 'General case' 0 N--CA 1.445 -0.712 0 O-C-N 121.355 -0.841 . . . . 0.0 110.642 169.749 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 18.0 mm-40 -66.83 -30.67 70.91 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-N 119.713 1.142 . . . . 0.0 110.038 170.0 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 15.4 m -91.92 10.56 3.25 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.814 0 CA-C-N 118.703 0.683 . . . . 0.0 111.427 168.635 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 76.66 22.87 71.39 Favored Glycine 0 CA--C 1.531 1.059 0 C-N-CA 124.962 1.267 . . . . 0.0 113.554 172.24 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 8.1 mt -111.7 129.64 66.73 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.222 0 CA-C-N 118.485 1.142 . . . . 0.0 111.033 -173.659 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -86.31 126.09 34.08 Favored 'General case' 0 C--O 1.232 0.177 0 N-CA-C 107.371 -1.344 . . . . 0.0 107.371 168.822 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 6.5 pt -122.48 -22.22 3.17 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.645 0 C-N-CA 125.219 1.408 . . . . 0.0 109.894 169.659 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -36.86 -41.04 0.31 Allowed 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 129.367 3.067 . . . . 0.0 113.633 169.376 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -82.05 14.0 35.14 Favored Glycine 0 CA--C 1.532 1.119 0 C-N-CA 124.943 1.258 . . . . 0.0 114.801 -176.551 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -63.71 -30.18 71.31 Favored 'General case' 0 C--N 1.343 0.309 0 CA-C-N 119.667 1.733 . . . . 0.0 114.099 -170.533 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -61.91 122.88 16.55 Favored 'General case' 0 CA--C 1.535 0.379 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 -169.797 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 67.3 m -145.91 -175.28 4.68 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 125.92 1.688 . . . . 0.0 107.864 -169.261 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -57.3 155.22 19.0 Favored Pre-proline 0 CA--C 1.539 0.543 0 C-N-CA 124.162 0.985 . . . . 0.0 111.572 173.131 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -65.42 155.81 66.76 Favored 'Trans proline' 0 N--CA 1.456 -0.703 0 C-N-CA 122.529 2.152 . . . . 0.0 110.095 171.053 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 7.8 tt -58.97 -28.24 37.97 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.486 0 C-N-CA 124.02 0.928 . . . . 0.0 110.979 -178.713 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 14.5 mt-10 -68.08 -25.55 65.39 Favored 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 125.329 1.452 . . . . 0.0 110.399 -173.883 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 7.4 t-20 -62.04 -22.81 66.04 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 124.926 1.29 . . . . 0.0 111.969 177.149 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 88.7 m-85 -109.0 -176.71 3.11 Favored 'General case' 0 C--O 1.235 0.33 0 C-N-CA 125.697 1.599 . . . . 0.0 111.528 -172.109 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 55.2 t-20 -130.07 137.79 50.39 Favored 'General case' 0 N--CA 1.442 -0.866 0 N-CA-C 106.183 -1.784 . . . . 0.0 106.183 169.315 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -73.35 -24.5 60.35 Favored 'General case' 0 N--CA 1.432 -1.35 0 CA-C-N 118.539 0.609 . . . . 0.0 109.734 -178.826 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 35.8 t70 -63.94 -22.4 66.9 Favored 'General case' 0 N--CA 1.446 -0.636 0 O-C-N 123.627 0.579 . . . . 0.0 111.333 179.327 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -73.85 -29.77 62.3 Favored 'General case' 0 N--CA 1.452 -0.332 0 C-N-CA 123.762 0.825 . . . . 0.0 111.431 175.246 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 17.8 m-85 -79.33 159.53 27.14 Favored 'General case' 0 N--CA 1.446 -0.629 0 C-N-CA 124.518 1.127 . . . . 0.0 110.302 177.681 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 23.6 t70 -99.53 -38.61 8.7 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.241 171.218 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -139.26 137.6 41.21 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.359 0 C-N-CA 123.857 0.863 . . . . 0.0 109.634 -170.551 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 89.7 t -143.1 142.46 25.82 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.745 0 N-CA-C 106.435 -1.691 . . . . 0.0 106.435 -178.574 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 28.9 mm -137.09 132.7 47.06 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.568 0 N-CA-C 107.133 -1.432 . . . . 0.0 107.133 -171.32 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 57.8 m -95.92 166.36 11.82 Favored 'General case' 0 N--CA 1.445 -0.716 0 N-CA-C 108.146 -1.057 . . . . 0.0 108.146 168.691 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 53.6 mt -134.61 18.57 3.59 Favored 'General case' 0 CA--C 1.531 0.239 0 O-C-N 121.364 -0.835 . . . . 0.0 110.752 -178.638 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 25.1 p -168.86 -0.22 0.02 OUTLIER 'General case' 0 CA--C 1.543 0.674 0 N-CA-C 115.584 1.698 . . . . 0.0 115.584 -176.357 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 162.6 -175.12 39.04 Favored Glycine 0 CA--C 1.526 0.769 0 CA-C-N 120.89 1.677 . . . . 0.0 112.607 179.83 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 17.9 m -128.65 127.01 41.35 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 125.065 1.346 . . . . 0.0 107.888 -176.243 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 58.06 34.26 72.19 Favored Glycine 0 CA--C 1.533 1.2 0 N-CA-C 110.624 -0.99 . . . . 0.0 110.624 -170.414 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . 0.286 7.7 p -80.3 69.17 0.5 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.657 0 C-N-CA 125.332 1.453 . . . . 0.0 110.437 -169.263 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 56.2 t30 55.67 49.22 16.83 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 127.146 2.178 . . . . 0.0 109.103 -173.553 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -154.27 143.98 15.34 Favored Pre-proline 0 CA--C 1.541 0.611 0 C-N-CA 126.918 2.087 . . . . 0.0 106.596 -169.237 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_exo -69.56 145.86 59.64 Favored 'Trans proline' 0 C--N 1.352 0.737 0 CA-C-N 120.912 1.361 . . . . 0.0 113.059 -173.246 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -73.18 -22.52 19.04 Favored 'Trans proline' 0 N--CA 1.461 -0.391 0 C-N-CA 122.209 1.939 . . . . 0.0 113.795 -170.754 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -57.85 -23.48 53.02 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-N 120.072 1.305 . . . . 0.0 111.627 177.378 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 99.6 m95 -72.05 -43.48 64.87 Favored 'General case' 0 N--CA 1.449 -0.478 0 C-N-CA 123.493 0.717 . . . . 0.0 111.252 176.235 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 4.9 m -78.1 -1.33 3.95 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.627 0 N-CA-C 112.582 0.586 . . . . 0.0 112.582 -179.094 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 63.3 p -115.9 22.33 13.11 Favored 'General case' 0 CA--C 1.538 0.514 0 N-CA-C 115.462 1.652 . . . . 0.0 115.462 -178.412 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 92.3 mm-40 -71.03 179.46 2.75 Favored 'General case' 0 CA--C 1.54 0.573 0 O-C-N 121.27 -0.894 . . . . 0.0 111.875 175.015 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 30.1 mm-40 -54.84 -28.47 49.99 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 124.146 0.978 . . . . 0.0 112.733 -169.085 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 6.8 tt -135.12 139.66 46.66 Favored 'Isoleucine or valine' 0 C--O 1.238 0.497 0 N-CA-C 104.569 -2.382 . . . . 0.0 104.569 168.477 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 47.6 t80 -126.57 140.43 52.44 Favored 'General case' 0 N--CA 1.447 -0.608 0 N-CA-C 106.383 -1.71 . . . . 0.0 106.383 169.567 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 44.0 mm-40 -142.08 163.86 31.73 Favored 'General case' 0 C--O 1.235 0.336 0 N-CA-C 107.409 -1.33 . . . . 0.0 107.409 169.88 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -167.51 131.63 1.82 Allowed 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 125.443 1.497 . . . . 0.0 107.46 -173.65 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 4.3 m-90 -150.65 143.44 24.58 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 107.897 -1.149 . . . . 0.0 107.897 -169.598 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 24.8 tt0 -84.81 82.28 8.51 Favored 'General case' 0 CA--C 1.537 0.48 0 N-CA-C 107.689 -1.226 . . . . 0.0 107.689 173.44 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -69.34 140.98 54.34 Favored 'General case' 0 N--CA 1.464 0.234 0 N-CA-C 108.667 -0.864 . . . . 0.0 108.667 172.719 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -73.68 157.2 37.0 Favored 'General case' 0 CA--C 1.537 0.449 0 N-CA-C 107.036 -1.468 . . . . 0.0 107.036 168.683 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -129.45 130.68 23.31 Favored Pre-proline 0 C--O 1.236 0.386 0 C-N-CA 123.77 0.828 . . . . 0.0 109.095 176.886 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_endo -86.14 -8.39 7.73 Favored 'Trans proline' 0 CA--C 1.54 0.821 0 C-N-CA 123.17 2.58 . . . . 0.0 115.245 -169.992 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -50.03 -51.04 45.38 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-N 120.171 1.351 . . . . 0.0 113.723 -169.093 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -84.21 9.26 64.39 Favored Glycine 0 CA--C 1.531 1.038 0 CA-C-O 118.368 -1.24 . . . . 0.0 113.953 -172.725 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 25.9 pt20 -148.04 -164.19 1.95 Allowed 'General case' 0 CA--C 1.544 0.712 0 CA-C-N 119.385 1.592 . . . . 0.0 112.531 -169.585 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 1.5 m -69.01 159.09 33.48 Favored 'General case' 0 CA--C 1.535 0.372 0 N-CA-C 117.567 2.432 . . . . 0.0 117.567 -167.726 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 56.5 tp -54.44 -34.69 61.91 Favored 'General case' 0 N--CA 1.465 0.32 0 C-N-CA 126.94 2.096 . . . . 0.0 111.713 170.124 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -62.12 -32.34 72.91 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 122.819 0.448 . . . . 0.0 110.773 177.498 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 5.3 t -76.42 -37.74 31.29 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.362 0 CA-C-O 117.894 -1.051 . . . . 0.0 109.892 177.649 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 54.0 m-85 -57.01 -47.97 79.59 Favored 'General case' 0 N--CA 1.474 0.767 0 CA-C-N 120.728 1.604 . . . . 0.0 109.579 171.155 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 75.3 mtt180 -59.23 -43.96 92.33 Favored 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 123.333 0.653 . . . . 0.0 110.858 178.152 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 17.1 m -64.44 -48.89 73.62 Favored 'General case' 0 N--CA 1.446 -0.663 0 C-N-CA 124.192 0.997 . . . . 0.0 110.396 178.606 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 64.9 t -70.39 -29.9 40.84 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.301 0 CA-C-N 119.019 0.827 . . . . 0.0 109.945 -169.937 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 30.7 mtm105 -57.04 -47.91 79.8 Favored 'General case' 0 C--O 1.226 -0.181 0 CA-C-N 119.404 1.002 . . . . 0.0 109.583 169.859 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -62.06 -48.52 82.63 Favored Glycine 0 CA--C 1.529 0.961 0 CA-C-O 119.258 -0.745 . . . . 0.0 112.0 177.697 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 86.1 mt-30 -55.66 -52.93 62.17 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-O 122.017 0.913 . . . . 0.0 110.104 -178.83 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 98.1 t -67.5 -44.9 86.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 115.102 -0.954 . . . . 0.0 109.596 -175.32 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 62.6 tttm -55.04 -46.34 75.31 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 119.435 1.016 . . . . 0.0 109.197 -179.041 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -67.64 -43.44 80.35 Favored 'General case' 0 N--CA 1.449 -0.524 0 C-N-CA 122.873 0.469 . . . . 0.0 111.366 -176.271 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 44.9 mtt-85 -66.63 -42.23 87.08 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-N 118.867 0.758 . . . . 0.0 111.082 178.047 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 81.1 t -64.99 -41.48 92.23 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.532 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 177.736 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 21.2 mt-10 -59.69 -41.36 90.52 Favored 'General case' 0 C--N 1.34 0.162 0 CA-C-N 119.768 1.167 . . . . 0.0 110.641 176.971 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 29.1 t-20 -62.54 -45.01 94.92 Favored 'General case' 0 CA--C 1.534 0.336 0 CA-C-N 118.166 0.439 . . . . 0.0 111.139 -179.635 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 1.5 tm? -58.45 -49.49 77.12 Favored 'General case' 0 CA--C 1.53 0.192 0 C-N-CA 124.26 1.024 . . . . 0.0 110.277 177.091 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 94.8 mt -63.87 -43.02 97.69 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.276 0 C-N-CA 123.887 0.875 . . . . 0.0 108.86 -179.518 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -62.56 -28.14 69.67 Favored 'General case' 0 CA--C 1.534 0.355 0 CA-C-N 118.902 0.774 . . . . 0.0 112.074 179.956 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 89.7 mttt -69.57 -54.52 13.68 Favored 'General case' 0 C--N 1.341 0.235 0 CA-C-N 118.769 0.713 . . . . 0.0 110.358 172.646 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 19.3 pt -77.64 -38.19 25.34 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.362 0 N-CA-C 114.586 1.328 . . . . 0.0 114.586 -169.395 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 74.7 m . . . . . 0 C--O 1.252 1.209 0 C-N-CA 126.162 1.785 . . . . 0.0 109.629 -169.748 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 8.0 ptm . . . . . 0 N--CA 1.497 1.898 0 N-CA-C 110.468 -0.197 . . . . 0.0 110.468 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 15.7 mttm -74.64 128.46 35.62 Favored 'General case' 0 N--CA 1.478 0.971 0 N-CA-C 107.83 -1.174 . . . . 0.0 107.83 -174.912 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 72.9 mttt -97.4 138.1 35.37 Favored 'General case' 0 CA--C 1.511 -0.522 0 CA-C-N 120.198 1.363 . . . . 0.0 108.26 172.432 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 12.1 t -119.31 152.22 21.72 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.678 0 C-N-CA 126.231 1.812 . . . . 0.0 106.66 -169.995 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 15.8 mtt -135.27 146.45 48.57 Favored 'General case' 0 C--N 1.322 -0.623 0 C-N-CA 124.897 1.279 . . . . 0.0 108.167 168.792 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 86.5 m-85 -133.74 125.47 28.63 Favored 'General case' 0 CA--C 1.516 -0.361 0 N-CA-C 103.921 -2.622 . . . . 0.0 103.921 171.332 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 1.3 p -150.03 142.61 17.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 118.975 0.807 . . . . 0.0 110.382 -169.014 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 20.9 t -125.1 -174.96 3.17 Favored 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 127.379 2.272 . . . . 0.0 106.552 169.597 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 39.0 ttpt -60.45 -42.16 95.59 Favored 'General case' 0 N--CA 1.472 0.65 0 O-C-N 120.822 -1.174 . . . . 0.0 111.508 -177.33 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 94.0 mtt180 -123.79 163.92 20.22 Favored 'General case' 0 N--CA 1.467 0.423 0 C-N-CA 123.764 0.826 . . . . 0.0 109.48 176.421 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -77.01 -27.75 54.75 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 122.41 0.284 . . . . 0.0 111.28 -179.511 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 1.3 m -69.16 -23.58 63.96 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 124.133 0.973 . . . . 0.0 113.385 -169.657 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 6.8 t -128.55 136.3 50.56 Favored 'General case' 0 C--N 1.339 0.143 0 N-CA-C 108.274 -1.01 . . . . 0.0 108.274 -174.612 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 9.1 mpt_? 61.72 -42.94 0.15 Allowed 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 128.533 2.733 . . . . 0.0 114.45 -176.549 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -75.08 41.13 0.16 Allowed 'General case' 0 CA--C 1.542 0.635 0 CA-C-N 120.268 1.394 . . . . 0.0 111.463 177.286 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 20.2 pt20 -135.11 154.16 51.76 Favored 'General case' 0 N--CA 1.441 -0.892 0 C-N-CA 127.455 2.302 . . . . 0.0 104.819 169.593 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER 66.41 -33.91 0.2 Allowed 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 126.216 1.806 . . . . 0.0 114.681 -178.648 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -64.62 -49.97 68.96 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 121.514 1.961 . . . . 0.0 109.865 179.671 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 4.5 pm0 -61.53 -37.8 85.06 Favored 'General case' 0 N--CA 1.453 -0.293 0 C-N-CA 124.42 1.088 . . . . 0.0 110.74 172.445 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -60.54 -55.31 30.67 Favored Glycine 0 C--N 1.337 0.627 0 N-CA-C 109.457 -1.457 . . . . 0.0 109.457 -176.926 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 6.3 m-85 -63.65 -33.23 75.16 Favored 'General case' 0 CA--C 1.509 -0.634 0 O-C-N 122.143 -0.622 . . . . 0.0 111.887 177.417 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -67.49 -38.2 83.99 Favored 'General case' 0 N--CA 1.445 -0.706 0 C-N-CA 119.839 -0.744 . . . . 0.0 110.926 -178.08 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.06 -37.58 87.96 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-N 118.701 0.682 . . . . 0.0 110.077 173.45 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 13.0 m -66.99 -55.39 14.66 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 123.675 0.79 . . . . 0.0 112.244 179.887 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 40.1 mt -76.28 -35.68 58.78 Favored 'General case' 0 C--N 1.327 -0.376 0 C-N-CA 124.636 1.175 . . . . 0.0 110.09 -171.158 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -94.39 12.17 69.27 Favored Glycine 0 CA--C 1.525 0.666 0 C-N-CA 125.233 1.397 . . . . 0.0 112.848 -178.778 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -51.01 122.2 7.17 Favored 'General case' 0 CA--C 1.533 0.29 0 CA-C-N 119.011 1.406 . . . . 0.0 110.623 -173.813 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 78.89 -16.26 8.81 Favored Glycine 0 CA--C 1.535 1.313 0 C-N-CA 124.791 1.186 . . . . 0.0 114.21 -179.519 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 59.7 mttt -89.68 -42.5 11.32 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-N 119.398 1.599 . . . . 0.0 110.806 179.152 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 12.4 pt -140.71 149.97 20.95 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.33 0 C-N-CA 123.543 0.737 . . . . 0.0 111.263 -169.031 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -95.51 157.89 15.69 Favored 'General case' 0 C--O 1.224 -0.243 0 C-N-CA 125.6 1.56 . . . . 0.0 108.039 172.584 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 20.0 t -139.74 135.19 38.89 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 N-CA-C 107.189 -1.412 . . . . 0.0 107.189 -175.413 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 14.0 m -142.76 106.87 4.72 Favored 'General case' 0 N--CA 1.446 -0.663 0 N-CA-C 107.401 -1.333 . . . . 0.0 107.401 177.896 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 58.9 m -90.15 99.63 12.61 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 107.986 -1.116 . . . . 0.0 107.986 169.501 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 11.1 p -68.56 -63.03 1.14 Allowed 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 124.296 1.038 . . . . 0.0 110.461 -178.587 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 94.05 136.09 7.99 Favored Glycine 0 N--CA 1.446 -0.646 0 N-CA-C 107.713 -2.155 . . . . 0.0 107.713 -172.373 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 10.2 mt -68.74 -31.05 69.82 Favored 'General case' 0 CA--C 1.533 0.315 0 N-CA-C 108.538 -0.912 . . . . 0.0 108.538 170.183 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 26.6 mt-10 -137.25 156.1 48.7 Favored 'General case' 0 N--CA 1.444 -0.727 0 C-N-CA 129.119 2.968 . . . . 0.0 104.855 168.752 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 78.5 p -142.46 155.05 45.04 Favored 'General case' 0 N--CA 1.446 -0.646 0 N-CA-C 115.465 1.654 . . . . 0.0 115.465 -174.407 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 51.1 m -163.17 179.25 7.59 Favored 'General case' 0 N--CA 1.447 -0.577 0 C-N-CA 131.257 3.823 . . . . 0.0 104.796 -169.337 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 16.4 ttt180 -81.56 179.16 7.95 Favored 'General case' 0 N--CA 1.469 0.487 0 N-CA-C 108.411 -0.959 . . . . 0.0 108.411 169.486 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 4.1 m -81.16 176.4 0.68 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.575 0 C-N-CA 124.864 1.266 . . . . 0.0 109.445 176.805 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 76.1 t60 -78.59 140.97 59.91 Favored Pre-proline 0 CA--C 1.545 0.772 0 CA-C-O 118.58 -0.724 . . . . 0.0 110.104 -178.403 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 20.4 Cg_endo -60.59 -50.3 7.06 Favored 'Trans proline' 0 C--N 1.348 0.525 0 C-N-CA 123.084 2.523 . . . . 0.0 113.592 -173.787 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 23.1 m -65.91 -21.52 66.45 Favored 'General case' 0 CA--C 1.533 0.324 0 CA-C-N 118.807 0.731 . . . . 0.0 110.813 -178.29 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -58.79 -45.03 90.79 Favored 'General case' 0 C--O 1.215 -0.733 0 O-C-N 121.386 -0.821 . . . . 0.0 109.453 174.576 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 62.6 mt -60.51 -43.72 94.95 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 N-CA-C 108.303 -0.999 . . . . 0.0 108.303 -173.598 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -64.9 -44.47 89.48 Favored 'General case' 0 CA--C 1.536 0.442 0 CA-C-O 121.282 0.563 . . . . 0.0 110.857 -179.632 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 33.6 mmt -66.33 -39.3 89.14 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-O 123.455 1.598 . . . . 0.0 110.779 -179.972 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -76.21 -29.8 57.75 Favored 'General case' 0 N--CA 1.44 -0.952 0 N-CA-C 106.296 -1.742 . . . . 0.0 106.296 -174.882 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 -70.27 -20.48 63.04 Favored 'General case' 0 N--CA 1.444 -0.765 0 C-N-CA 123.91 0.884 . . . . 0.0 110.438 169.525 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 59.0 mt-10 -64.55 -38.03 89.59 Favored 'General case' 0 C--N 1.345 0.375 0 CA-C-N 120.237 1.381 . . . . 0.0 108.787 169.405 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . 0.311 5.3 p -84.92 8.21 1.65 Allowed 'Isoleucine or valine' 0 CA--C 1.548 0.87 0 N-CA-C 112.272 0.471 . . . . 0.0 112.272 171.442 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 75.05 16.68 80.45 Favored Glycine 0 CA--C 1.533 1.19 0 C-N-CA 124.493 1.044 . . . . 0.0 113.523 175.494 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 43.9 mt -108.85 137.62 39.89 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.229 0 C-N-CA 124.487 1.115 . . . . 0.0 108.921 -177.016 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 21.1 t0 -102.22 145.34 29.56 Favored 'General case' 0 N--CA 1.462 0.153 0 CA-C-O 121.103 0.478 . . . . 0.0 110.208 169.69 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 11.2 pt -138.36 -15.11 0.53 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.633 0 C-N-CA 127.548 2.339 . . . . 0.0 111.325 178.223 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 13.0 t -39.39 -43.12 1.16 Allowed 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 125.883 1.673 . . . . 0.0 113.527 171.584 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -76.37 6.13 39.35 Favored Glycine 0 CA--C 1.532 1.111 0 CA-C-O 118.635 -1.092 . . . . 0.0 114.36 -175.01 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -68.57 130.18 42.09 Favored 'General case' 0 N--CA 1.448 -0.559 0 CA-C-N 119.736 1.768 . . . . 0.0 110.203 -178.43 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 5.2 t -168.18 161.3 12.31 Favored 'General case' 0 N--CA 1.44 -0.95 0 N-CA-C 106.067 -1.827 . . . . 0.0 106.067 167.047 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 15.0 m -173.87 161.38 3.76 Favored 'General case' 0 C--N 1.322 -0.598 0 C-N-CA 127.438 2.295 . . . . 0.0 106.746 -178.396 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -65.91 161.49 53.99 Favored Pre-proline 0 CA--C 1.542 0.652 0 CA-C-N 115.184 -0.917 . . . . 0.0 108.854 169.002 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -59.39 150.6 74.08 Favored 'Trans proline' 0 N--CA 1.457 -0.627 0 C-N-CA 121.545 1.497 . . . . 0.0 109.802 172.444 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 16.8 tt -57.3 -26.34 25.67 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.278 0 C-N-CA 123.433 0.693 . . . . 0.0 112.181 -174.681 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 11.6 mt-10 -65.42 -27.71 68.72 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 123.212 0.605 . . . . 0.0 110.453 -176.637 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 10.0 t-20 -65.23 -30.04 70.89 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 125.484 1.514 . . . . 0.0 111.71 178.662 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 78.0 m-85 -88.47 176.51 7.14 Favored 'General case' 0 C--O 1.236 0.374 0 C-N-CA 125.012 1.325 . . . . 0.0 111.543 -173.962 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 51.9 t-20 -126.56 129.06 47.84 Favored 'General case' 0 N--CA 1.447 -0.621 0 N-CA-C 107.278 -1.379 . . . . 0.0 107.278 169.136 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -73.11 -21.23 60.78 Favored 'General case' 0 N--CA 1.436 -1.139 0 N-CA-C 109.936 -0.394 . . . . 0.0 109.936 -177.208 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 36.0 t70 -65.06 -25.76 67.95 Favored 'General case' 0 N--CA 1.441 -0.897 0 O-C-N 123.617 0.573 . . . . 0.0 111.583 -179.446 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -74.76 -28.37 60.73 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 122.976 0.51 . . . . 0.0 111.477 176.022 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 18.1 m-85 -84.43 163.58 19.4 Favored 'General case' 0 N--CA 1.45 -0.443 0 C-N-CA 125.784 1.634 . . . . 0.0 110.585 -179.419 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 19.8 t70 -108.01 -36.91 6.21 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.624 178.591 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -142.7 139.4 28.33 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.31 0 CA-C-O 121.657 0.741 . . . . 0.0 110.316 -170.797 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 96.9 t -141.15 140.68 32.0 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.407 0 N-CA-C 106.631 -1.618 . . . . 0.0 106.631 -175.634 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 45.3 mm -132.7 121.41 44.77 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.429 0 N-CA-C 106.619 -1.623 . . . . 0.0 106.619 -173.913 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 67.4 m -91.31 115.13 27.78 Favored 'General case' 0 N--CA 1.449 -0.5 0 N-CA-C 106.657 -1.608 . . . . 0.0 106.657 169.359 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 69.7 mt -77.04 -13.75 59.91 Favored 'General case' 0 N--CA 1.466 0.343 0 C-N-CA 124.245 1.018 . . . . 0.0 111.693 -177.536 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 65.2 m -140.87 88.64 2.2 Favored 'General case' 0 N--CA 1.452 -0.328 0 C-N-CA 125.288 1.435 . . . . 0.0 108.478 -169.724 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 63.66 -155.57 44.36 Favored Glycine 0 CA--C 1.528 0.893 0 N-CA-C 110.562 -1.015 . . . . 0.0 110.562 -175.852 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 4.7 p -150.82 148.56 28.64 Favored 'General case' 0 C--O 1.236 0.363 0 C-N-CA 124.527 1.131 . . . . 0.0 109.166 179.64 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 62.48 28.92 72.02 Favored Glycine 0 CA--C 1.532 1.153 0 CA-C-O 119.696 -0.502 . . . . 0.0 112.189 -179.495 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 12.7 m -80.06 67.59 0.44 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.587 0 C-N-CA 124.661 1.185 . . . . 0.0 110.63 -170.007 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 1.3 t30 58.0 56.06 4.89 Favored 'General case' 0 N--CA 1.468 0.432 0 C-N-CA 126.298 1.839 . . . . 0.0 108.201 -173.714 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -142.67 142.26 22.44 Favored Pre-proline 0 CA--C 1.541 0.613 0 C-N-CA 126.215 1.806 . . . . 0.0 108.425 -169.086 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_exo -67.46 146.43 74.41 Favored 'Trans proline' 0 CA--C 1.54 0.779 0 C-N-CA 121.693 1.595 . . . . 0.0 113.518 -176.95 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 69.8 Cg_endo -72.43 -18.46 26.13 Favored 'Trans proline' 0 N--CA 1.46 -0.451 0 C-N-CA 122.535 2.157 . . . . 0.0 113.751 -171.975 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -57.07 -24.78 56.36 Favored 'General case' 0 CA--C 1.538 0.491 0 CA-C-N 119.944 1.247 . . . . 0.0 111.19 173.98 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 95.1 m95 -81.8 -31.35 31.83 Favored 'General case' 0 N--CA 1.451 -0.389 0 C-N-CA 124.088 0.955 . . . . 0.0 112.251 178.546 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 2.7 m -80.83 -6.5 9.73 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.362 0 CA-C-N 118.748 0.704 . . . . 0.0 112.245 178.022 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 5.4 t -137.04 77.08 1.62 Allowed 'General case' 0 CA--C 1.542 0.654 0 CA-C-O 122.768 1.271 . . . . 0.0 111.655 -175.329 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 91.0 mm-40 -114.33 -171.68 1.96 Allowed 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 125.064 1.346 . . . . 0.0 108.115 168.694 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 35.1 mm-40 -58.76 -28.03 65.52 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-N 118.9 0.773 . . . . 0.0 111.194 -172.348 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 5.3 tt -141.37 143.63 27.44 Favored 'Isoleucine or valine' 0 C--O 1.24 0.567 0 N-CA-C 104.737 -2.32 . . . . 0.0 104.737 168.346 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 63.9 t80 -133.8 145.65 49.96 Favored 'General case' 0 N--CA 1.447 -0.581 0 N-CA-C 105.905 -1.887 . . . . 0.0 105.905 169.286 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 24.1 mm-40 -136.26 145.48 45.63 Favored 'General case' 0 C--O 1.237 0.434 0 N-CA-C 107.903 -1.147 . . . . 0.0 107.903 171.685 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -115.9 135.79 53.65 Favored 'General case' 0 C--O 1.238 0.451 0 N-CA-C 107.146 -1.428 . . . . 0.0 107.146 169.703 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 30.2 m95 -138.68 178.77 6.9 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 124.462 1.105 . . . . 0.0 108.796 178.963 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 30.6 tt0 -138.5 77.39 1.62 Allowed 'General case' 0 CA--C 1.532 0.285 0 N-CA-C 106.013 -1.847 . . . . 0.0 106.013 169.467 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -68.26 144.09 55.01 Favored 'General case' 0 N--CA 1.466 0.37 0 N-CA-C 108.656 -0.868 . . . . 0.0 108.656 177.877 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -81.18 166.66 20.43 Favored 'General case' 0 N--CA 1.452 -0.363 0 N-CA-C 107.576 -1.268 . . . . 0.0 107.576 169.457 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -142.32 135.23 13.92 Favored Pre-proline 0 CA--C 1.535 0.385 0 O-C-N 121.803 -0.56 . . . . 0.0 111.193 179.076 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -84.21 2.47 8.15 Favored 'Trans proline' 0 CA--C 1.545 1.042 0 C-N-CA 123.416 2.744 . . . . 0.0 114.958 -172.3 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 2.9 t70 -45.29 122.77 3.63 Favored 'General case' 0 C--O 1.238 0.484 0 CA-C-N 120.121 1.328 . . . . 0.0 111.521 176.634 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 70.9 13.73 72.54 Favored Glycine 0 CA--C 1.533 1.171 0 CA-C-O 118.335 -1.258 . . . . 0.0 114.724 170.18 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 29.6 pt20 -130.14 -172.32 2.75 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-N 119.444 1.622 . . . . 0.0 111.165 175.889 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 3.3 m -68.83 156.85 37.66 Favored 'General case' 0 CA--C 1.535 0.374 0 N-CA-C 116.25 1.944 . . . . 0.0 116.25 -168.0 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -63.73 -27.42 69.19 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 125.017 1.327 . . . . 0.0 111.155 179.645 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 7.7 tp10 -60.17 -35.12 74.63 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-N 118.171 0.442 . . . . 0.0 110.164 173.346 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 3.4 t -74.08 -42.62 52.08 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.301 0 CA-C-O 118.234 -0.889 . . . . 0.0 109.154 179.018 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 61.1 m-85 -53.78 -50.28 66.41 Favored 'General case' 0 N--CA 1.472 0.645 0 CA-C-N 120.042 1.292 . . . . 0.0 109.644 171.599 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 95.5 mtt180 -67.5 -34.97 78.21 Favored 'General case' 0 N--CA 1.465 0.296 0 O-C-N 121.795 -0.566 . . . . 0.0 111.237 -175.46 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 6.6 m -62.77 -49.9 73.15 Favored 'General case' 0 N--CA 1.448 -0.56 0 C-N-CA 123.984 0.913 . . . . 0.0 109.547 171.292 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 96.7 t -70.06 -26.72 30.38 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.296 0 CA-C-O 117.485 -1.245 . . . . 0.0 109.897 -171.092 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 85.4 mtm-85 -57.29 -48.41 78.97 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-N 120.407 1.458 . . . . 0.0 109.58 169.58 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -63.18 -48.67 77.71 Favored Glycine 0 CA--C 1.53 1.012 0 CA-C-N 118.464 0.575 . . . . 0.0 111.877 178.912 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 17.8 mt-30 -61.51 -46.69 88.94 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-N 118.073 0.937 . . . . 0.0 110.895 -178.3 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 67.4 t -64.89 -46.21 92.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-O 118.504 -0.76 . . . . 0.0 109.27 -179.585 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 87.4 tttt -54.23 -48.22 71.32 Favored 'General case' 0 C--O 1.22 -0.457 0 CA-C-N 118.921 0.782 . . . . 0.0 109.018 -178.462 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 40.4 tt0 -64.12 -42.62 96.77 Favored 'General case' 0 N--CA 1.45 -0.471 0 O-C-N 123.252 0.345 . . . . 0.0 110.865 -173.385 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 52.9 mtt-85 -67.34 -43.31 81.86 Favored 'General case' 0 N--CA 1.468 0.445 0 O-C-N 121.656 -0.653 . . . . 0.0 111.02 177.987 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 77.2 t -65.55 -41.15 90.15 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.395 0 N-CA-C 109.734 -0.469 . . . . 0.0 109.734 179.378 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 26.3 mt-10 -59.02 -44.82 91.77 Favored 'General case' 0 N--CA 1.455 -0.221 0 CA-C-N 119.17 0.895 . . . . 0.0 109.971 177.271 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 29.2 t-20 -62.06 -43.31 99.1 Favored 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 122.575 0.35 . . . . 0.0 110.933 -178.323 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 1.8 tm? -59.36 -49.04 79.34 Favored 'General case' 0 N--CA 1.455 -0.201 0 C-N-CA 124.042 0.937 . . . . 0.0 110.529 176.726 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 96.4 mt -64.91 -42.81 95.81 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.258 0 C-N-CA 124.108 0.963 . . . . 0.0 108.933 -178.844 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -61.5 -30.22 70.48 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 123.347 0.659 . . . . 0.0 111.639 177.951 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 91.5 mttt -69.25 -55.75 9.62 Favored 'General case' 0 C--N 1.343 0.313 0 CA-C-N 118.933 0.788 . . . . 0.0 110.229 172.862 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 20.8 pt -74.52 -41.26 49.09 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.291 0 N-CA-C 114.017 1.117 . . . . 0.0 114.017 -169.523 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 72.5 m . . . . . 0 C--O 1.253 1.268 0 C-N-CA 126.226 1.81 . . . . 0.0 108.995 -169.558 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 9.9 ptm . . . . . 0 N--CA 1.498 1.939 0 N-CA-C 110.64 -0.133 . . . . 0.0 110.64 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 33.8 mttm -74.62 119.76 19.24 Favored 'General case' 0 N--CA 1.479 0.985 0 O-C-N 121.127 -0.983 . . . . 0.0 108.397 -170.711 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 90.2 mttt -85.33 135.15 34.02 Favored 'General case' 0 CA--C 1.515 -0.403 0 N-CA-C 108.07 -1.085 . . . . 0.0 108.07 174.894 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 1.6 t -121.81 147.13 25.98 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 C-N-CA 125.529 1.532 . . . . 0.0 109.37 -168.849 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 13.3 mtt -134.66 146.39 49.47 Favored 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 125.659 1.584 . . . . 0.0 109.544 169.399 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 41.2 m-85 -135.58 113.51 11.14 Favored 'General case' 0 N--CA 1.454 -0.274 0 N-CA-C 106.339 -1.726 . . . . 0.0 106.339 169.41 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 3.2 p -157.25 146.36 10.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 N-CA-C 109.029 -0.73 . . . . 0.0 109.029 -169.963 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 25.5 t -157.73 145.75 18.87 Favored 'General case' 0 C--N 1.328 -0.326 0 N-CA-C 105.593 -2.003 . . . . 0.0 105.593 168.839 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 5.6 tmtt? 51.81 -85.58 0.01 OUTLIER 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 126.078 1.751 . . . . 0.0 112.145 178.552 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 11.8 ptp180 -142.17 -178.82 5.9 Favored 'General case' 0 C--O 1.225 -0.198 0 CA-C-N 119.589 1.086 . . . . 0.0 111.09 178.706 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 1.7 t30 -57.49 -35.26 69.98 Favored 'General case' 0 N--CA 1.467 0.412 0 C-N-CA 124.416 1.086 . . . . 0.0 111.666 -179.21 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -70.95 -23.45 62.23 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 124.456 1.102 . . . . 0.0 113.05 -175.194 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 3.8 m -70.4 -159.61 0.04 OUTLIER 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 126.272 1.829 . . . . 0.0 111.994 -169.673 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 2.8 mpp_? -51.8 -25.52 7.87 Favored 'General case' 0 N--CA 1.481 1.112 0 O-C-N 119.808 -1.808 . . . . 0.0 112.34 175.638 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 1.4 m -41.89 -29.44 0.21 Allowed 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 126.74 2.016 . . . . 0.0 112.856 169.622 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 5.1 pt20 -54.47 -35.87 63.52 Favored 'General case' 0 C--O 1.22 -0.497 0 CA-C-O 117.491 -1.242 . . . . 0.0 113.218 178.328 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -105.66 -51.64 2.96 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-N 120.678 1.581 . . . . 0.0 114.727 -168.592 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -63.72 -34.8 78.68 Favored 'General case' 0 N--CA 1.471 0.61 0 N-CA-C 114.248 1.203 . . . . 0.0 114.248 -168.456 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 2.4 pp20? -64.95 -34.13 77.69 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-N 119.003 0.82 . . . . 0.0 110.103 172.783 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -51.29 -62.79 5.14 Favored Glycine 0 C--N 1.338 0.652 0 C-N-CA 125.847 1.689 . . . . 0.0 110.419 174.287 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 9.2 m-85 -63.13 -33.31 75.18 Favored 'General case' 0 CA--C 1.507 -0.7 0 CA-C-N 118.684 1.242 . . . . 0.0 113.434 179.985 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -67.42 -30.47 70.23 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 119.592 1.087 . . . . 0.0 111.376 -173.644 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 1.1 ptmt -70.32 -20.92 62.97 Favored 'General case' 0 CA--C 1.539 0.522 0 CA-C-N 119.288 0.949 . . . . 0.0 111.784 174.366 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 2.9 m -85.37 -57.39 3.09 Favored 'General case' 0 N--CA 1.45 -0.475 0 C-N-CA 125.537 1.535 . . . . 0.0 110.633 176.931 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 75.3 mt -73.98 -36.76 64.59 Favored 'General case' 0 N--CA 1.463 0.224 0 C-N-CA 123.989 0.915 . . . . 0.0 110.297 -172.617 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -93.36 8.9 74.95 Favored Glycine 0 CA--C 1.525 0.662 0 CA-C-O 118.486 -1.174 . . . . 0.0 112.813 -177.202 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -51.33 123.69 10.2 Favored 'General case' 0 CA--C 1.534 0.327 0 C-N-CA 124.806 1.242 . . . . 0.0 110.507 -174.962 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 76.48 -9.81 19.9 Favored Glycine 0 CA--C 1.533 1.17 0 CA-C-O 118.721 -1.044 . . . . 0.0 114.274 179.906 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 85.4 mttt -97.19 -49.66 4.88 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-N 119.478 1.639 . . . . 0.0 110.518 178.666 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 39.8 pt -137.57 147.64 26.29 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.537 0 C-N-CA 124.056 0.942 . . . . 0.0 108.772 -169.881 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -107.47 102.6 11.86 Favored 'General case' 0 C--O 1.225 -0.193 0 C-N-CA 124.949 1.3 . . . . 0.0 110.065 -169.582 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 6.2 t -85.69 125.19 40.55 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 N-CA-C 108.619 -0.882 . . . . 0.0 108.619 -179.531 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 23.4 m -151.85 97.71 2.38 Favored 'General case' 0 N--CA 1.453 -0.321 0 N-CA-C 103.957 -2.608 . . . . 0.0 103.957 173.105 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 18.0 m -94.99 1.12 55.16 Favored 'General case' 0 CA--C 1.535 0.386 0 N-CA-C 115.019 1.489 . . . . 0.0 115.019 -169.153 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 1.5 m 52.88 -147.52 0.47 Allowed 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 123.747 0.819 . . . . 0.0 110.767 -179.663 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -164.27 167.15 38.08 Favored Glycine 0 CA--C 1.525 0.69 0 N-CA-C 109.7 -1.36 . . . . 0.0 109.7 169.973 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 3.2 mt -133.64 143.72 48.77 Favored 'General case' 0 N--CA 1.446 -0.657 0 C-N-CA 127.67 2.388 . . . . 0.0 104.952 170.02 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 50.7 mt-10 65.46 -59.78 0.27 Allowed 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 127.227 2.211 . . . . 0.0 111.293 -173.755 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 65.1 m 67.11 152.78 0.08 Allowed 'General case' 0 N--CA 1.44 -0.935 0 C-N-CA 129.463 3.105 . . . . 0.0 115.894 170.043 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 15.2 m -177.62 -173.75 0.43 Allowed 'General case' 0 CA--C 1.545 0.764 1 C-N-CA 132.107 4.163 . . . . 0.0 102.607 -169.457 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 7.5 ttt180 -105.53 169.02 8.71 Favored 'General case' 0 N--CA 1.469 0.515 0 O-C-N 120.584 -1.323 . . . . 0.0 108.663 169.678 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 11.4 m -69.68 165.62 2.47 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.71 0 CA-C-N 115.649 -0.705 . . . . 0.0 109.415 175.827 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 90.3 m-70 -79.12 151.62 75.91 Favored Pre-proline 0 CA--C 1.537 0.446 0 CA-C-O 119.314 -0.374 . . . . 0.0 111.511 -174.89 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 39.9 Cg_endo -62.21 -46.12 13.57 Favored 'Trans proline' 0 C--N 1.346 0.43 0 C-N-CA 123.175 2.583 . . . . 0.0 111.772 -174.583 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 4.4 m -66.93 -28.24 68.13 Favored 'General case' 0 CA--C 1.531 0.25 0 O-C-N 121.949 -0.47 . . . . 0.0 110.02 -179.953 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -57.62 -54.56 45.52 Favored 'General case' 0 CA--C 1.511 -0.545 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 173.03 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 63.4 mt -59.55 -40.05 80.96 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.357 0 N-CA-C 108.607 -0.886 . . . . 0.0 108.607 -174.987 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -61.65 -43.49 98.75 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-N 119.004 0.82 . . . . 0.0 111.633 179.8 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 38.0 mmt -75.48 -36.52 60.62 Favored 'General case' 0 C--O 1.235 0.315 0 CA-C-O 122.806 1.289 . . . . 0.0 110.488 -177.285 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -71.58 -28.89 64.13 Favored 'General case' 0 N--CA 1.446 -0.643 0 N-CA-C 107.509 -1.293 . . . . 0.0 107.509 178.604 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 41.2 tt0 -73.78 -19.18 60.84 Favored 'General case' 0 N--CA 1.446 -0.63 0 C-N-CA 125.069 1.347 . . . . 0.0 110.563 169.958 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 76.1 mt-10 -64.09 -34.71 78.65 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-N 120.234 1.379 . . . . 0.0 108.681 169.146 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . 0.302 10.0 p -89.8 10.11 2.57 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.931 0 N-CA-C 112.434 0.531 . . . . 0.0 112.434 169.582 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 71.89 15.77 76.22 Favored Glycine 0 CA--C 1.533 1.162 0 O-C-N 120.761 -1.212 . . . . 0.0 113.767 175.926 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 22.3 mt -96.07 142.46 13.79 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.288 0 CA-C-N 118.42 1.11 . . . . 0.0 110.462 -175.473 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 8.9 t70 -91.78 129.66 37.7 Favored 'General case' 0 C--O 1.236 0.392 0 N-CA-C 108.192 -1.04 . . . . 0.0 108.192 169.574 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 10.1 pt -124.91 -27.21 1.52 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.657 0 C-N-CA 124.567 1.147 . . . . 0.0 110.166 169.7 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -37.12 -40.92 0.34 Allowed 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 129.746 3.218 . . . . 0.0 113.909 169.11 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -83.2 13.04 47.52 Favored Glycine 0 CA--C 1.534 1.251 0 C-N-CA 125.443 1.497 . . . . 0.0 114.566 -177.47 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -60.98 -34.84 75.41 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 119.607 1.703 . . . . 0.0 113.026 -176.026 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -70.3 131.89 44.86 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 123.539 0.736 . . . . 0.0 109.142 -170.677 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 26.0 m -158.29 -61.17 0.08 Allowed 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 123.463 0.705 . . . . 0.0 110.568 -179.526 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -150.98 153.31 32.93 Favored Pre-proline 0 N--CA 1.467 0.422 0 C-N-CA 123.424 0.69 . . . . 0.0 109.815 -175.007 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 96.4 Cg_endo -66.94 155.59 70.11 Favored 'Trans proline' 0 N--CA 1.454 -0.819 0 C-N-CA 122.53 2.153 . . . . 0.0 110.008 171.588 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 7.1 tt -59.94 -26.0 34.42 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.513 0 C-N-CA 123.326 0.65 . . . . 0.0 111.324 -179.242 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 14.8 mt-10 -67.71 -25.25 65.57 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 124.867 1.267 . . . . 0.0 110.636 -175.096 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 7.0 t-20 -63.89 -22.72 67.05 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 124.69 1.196 . . . . 0.0 112.047 177.648 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 70.0 m-85 -105.75 -174.1 2.46 Favored 'General case' 0 C--O 1.234 0.269 0 C-N-CA 126.424 1.889 . . . . 0.0 109.923 -175.89 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 54.3 t-20 -137.69 140.86 41.02 Favored 'General case' 0 N--CA 1.446 -0.654 0 N-CA-C 107.667 -1.235 . . . . 0.0 107.667 169.407 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -74.07 -25.13 59.65 Favored 'General case' 0 N--CA 1.435 -1.181 0 N-CA-C 109.19 -0.67 . . . . 0.0 109.19 -178.559 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -63.01 -24.35 67.88 Favored 'General case' 0 N--CA 1.447 -0.584 0 O-C-N 123.441 0.463 . . . . 0.0 111.643 178.937 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -77.71 -27.69 50.72 Favored 'General case' 0 C--O 1.236 0.361 0 C-N-CA 123.808 0.843 . . . . 0.0 112.37 175.991 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 11.6 m-85 -81.02 172.21 14.02 Favored 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 125.853 1.661 . . . . 0.0 112.099 -177.47 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 24.1 t70 -120.98 -37.72 2.93 Favored 'General case' 0 N--CA 1.464 0.234 0 C-N-CA 123.68 0.792 . . . . 0.0 111.678 175.824 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -139.38 136.76 41.05 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.328 0 CA-C-N 118.432 0.56 . . . . 0.0 110.498 -170.144 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 77.2 t -147.5 128.81 5.96 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.537 0 N-CA-C 106.516 -1.661 . . . . 0.0 106.516 -176.062 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 12.0 mm -109.17 128.09 65.36 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.473 0 N-CA-C 106.862 -1.533 . . . . 0.0 106.862 177.732 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 60.5 m -94.71 101.24 13.08 Favored 'General case' 0 N--CA 1.446 -0.671 0 N-CA-C 104.508 -2.404 . . . . 0.0 104.508 169.292 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 30.0 mt -66.73 -4.94 10.15 Favored 'General case' 0 N--CA 1.471 0.576 0 N-CA-C 113.931 1.085 . . . . 0.0 113.931 -169.775 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -151.04 151.82 32.58 Favored 'General case' 0 N--CA 1.45 -0.46 0 N-CA-C 106.335 -1.728 . . . . 0.0 106.335 168.744 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 54.75 -140.77 37.28 Favored Glycine 0 CA--C 1.533 1.166 0 C-N-CA 123.851 0.738 . . . . 0.0 111.701 174.647 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 16.0 m -132.71 -76.65 0.49 Allowed 'General case' 0 CA--C 1.529 0.163 0 N-CA-C 108.603 -0.888 . . . . 0.0 108.603 175.783 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -78.34 -40.45 19.55 Favored Glycine 0 C--N 1.34 0.793 0 CA-C-O 118.85 -0.972 . . . . 0.0 112.05 -179.156 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . 0.351 16.2 m 47.48 -94.27 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.547 0.838 0 C-N-CA 125.56 1.544 . . . . 0.0 112.629 -178.757 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 58.7 t30 -141.82 45.07 1.7 Allowed 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 124.653 1.181 . . . . 0.0 109.365 171.557 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 1.2 tt -136.25 140.58 33.24 Favored Pre-proline 0 CA--C 1.547 0.837 0 C-N-CA 126.591 1.956 . . . . 0.0 109.384 -169.517 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -67.96 149.98 77.79 Favored 'Trans proline' 0 CA--C 1.541 0.873 0 C-N-CA 121.649 1.566 . . . . 0.0 113.668 -172.173 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -69.37 -27.66 28.07 Favored 'Trans proline' 0 N--CA 1.461 -0.423 0 C-N-CA 122.622 2.214 . . . . 0.0 115.502 -169.587 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 4.3 pm0 -61.91 -17.05 55.34 Favored 'General case' 0 CA--C 1.539 0.557 0 CA-C-N 121.432 1.924 . . . . 0.0 111.954 178.684 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 99.6 m95 -78.01 -42.04 33.86 Favored 'General case' 0 N--CA 1.447 -0.583 0 C-N-CA 123.8 0.84 . . . . 0.0 110.933 175.424 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 1.6 m -74.49 -7.72 10.46 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.26 0 C-N-CA 123.469 0.708 . . . . 0.0 111.97 -179.317 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 74.4 p -109.15 18.47 20.53 Favored 'General case' 0 C--O 1.238 0.49 0 N-CA-C 113.837 1.051 . . . . 0.0 113.837 -178.132 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 91.9 mm-40 -68.56 171.03 8.11 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-N 118.539 0.609 . . . . 0.0 111.644 176.912 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 32.8 mm-40 -56.03 -30.23 61.57 Favored 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 123.995 0.918 . . . . 0.0 112.929 -168.83 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 4.0 tt -130.54 114.73 29.04 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.345 0 N-CA-C 105.018 -2.216 . . . . 0.0 105.018 169.014 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 22.5 t80 -100.65 134.41 43.66 Favored 'General case' 0 C--O 1.236 0.392 0 N-CA-C 105.63 -1.989 . . . . 0.0 105.63 169.388 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 11.4 mm-40 -142.69 164.21 30.71 Favored 'General case' 0 C--N 1.329 -0.289 0 C-N-CA 124.451 1.1 . . . . 0.0 109.18 179.247 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 2.3 t70 -170.02 129.87 0.95 Allowed 'General case' 0 C--O 1.237 0.445 0 C-N-CA 128.192 2.597 . . . . 0.0 106.618 -169.954 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 10.0 m0 -140.8 147.91 39.79 Favored 'General case' 0 C--O 1.234 0.242 0 C-N-CA 123.33 0.652 . . . . 0.0 111.836 -169.814 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 18.4 mp0 -74.06 111.64 9.42 Favored 'General case' 0 C--O 1.234 0.285 0 N-CA-C 105.294 -2.114 . . . . 0.0 105.294 169.345 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 44.3 mt -146.03 128.34 15.83 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 104.323 -2.473 . . . . 0.0 104.323 178.604 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 61.4 mm-40 -76.99 156.07 32.16 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-N 119.197 0.908 . . . . 0.0 110.044 179.417 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 55.6 t0 -100.39 111.37 62.48 Favored Pre-proline 0 N--CA 1.448 -0.567 0 N-CA-C 105.612 -1.996 . . . . 0.0 105.612 168.882 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 96.3 Cg_endo -73.75 -0.08 8.92 Favored 'Trans proline' 0 CA--C 1.541 0.843 0 C-N-CA 122.913 2.408 . . . . 0.0 113.643 -175.834 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -47.61 128.96 13.37 Favored 'General case' 0 C--O 1.237 0.445 0 CA-C-N 119.468 1.031 . . . . 0.0 111.268 173.748 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 70.99 12.17 71.04 Favored Glycine 0 CA--C 1.53 1.017 0 CA-C-O 118.523 -1.154 . . . . 0.0 114.236 169.953 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 29.5 pt20 -133.15 -172.83 3.04 Favored 'General case' 0 CA--C 1.536 0.414 0 CA-C-N 119.029 1.415 . . . . 0.0 110.763 176.282 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 3.2 m -68.59 156.55 37.88 Favored 'General case' 0 CA--C 1.532 0.256 0 N-CA-C 116.161 1.912 . . . . 0.0 116.161 -167.964 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 48.7 mt -60.47 -28.49 68.38 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 125.05 1.34 . . . . 0.0 111.146 174.758 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 40.1 tt0 -58.19 -37.22 74.32 Favored 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 122.919 0.487 . . . . 0.0 110.34 173.168 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 3.5 t -75.12 -43.95 44.09 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.31 0 CA-C-O 117.866 -1.064 . . . . 0.0 109.34 179.195 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 59.9 m-85 -53.67 -47.45 70.38 Favored 'General case' 0 N--CA 1.474 0.759 0 CA-C-N 120.399 1.454 . . . . 0.0 110.404 172.873 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 92.5 mtt180 -72.88 -35.17 67.1 Favored 'General case' 0 N--CA 1.466 0.344 0 O-C-N 121.612 -0.68 . . . . 0.0 111.428 -175.785 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 4.0 m -60.77 -49.67 76.56 Favored 'General case' 0 N--CA 1.448 -0.551 0 N-CA-C 109.003 -0.74 . . . . 0.0 109.003 171.103 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 75.0 t -65.02 -38.4 82.68 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.415 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 -176.647 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 52.5 ttp85 -57.37 -44.88 84.79 Favored 'General case' 0 CA--C 1.539 0.528 0 CA-C-N 118.734 0.697 . . . . 0.0 110.234 176.244 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -65.65 -50.02 56.61 Favored Glycine 0 CA--C 1.532 1.146 0 CA-C-N 118.609 0.641 . . . . 0.0 112.143 174.915 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 40.8 mm-40 -58.69 -48.78 79.94 Favored 'General case' 0 N--CA 1.464 0.252 0 C-N-CA 123.776 0.83 . . . . 0.0 110.454 -176.215 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 87.7 t -66.27 -40.31 86.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-O 118.234 -0.889 . . . . 0.0 110.236 -175.724 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 57.2 tttm -54.28 -45.12 72.39 Favored 'General case' 0 N--CA 1.462 0.139 0 CA-C-N 119.374 0.988 . . . . 0.0 109.075 177.669 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -67.71 -43.03 81.02 Favored 'General case' 0 CA--C 1.54 0.595 0 CA-C-O 119.154 -0.451 . . . . 0.0 111.658 -177.631 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 29.0 mmt180 -58.53 -47.4 84.3 Favored 'General case' 0 N--CA 1.477 0.886 0 CA-C-N 119.31 0.959 . . . . 0.0 110.845 175.373 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 77.0 t -69.43 -37.59 75.5 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.536 0 CA-C-O 118.673 -0.679 . . . . 0.0 109.25 -176.361 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 28.4 mt-10 -59.0 -44.42 91.65 Favored 'General case' 0 C--N 1.339 0.149 0 CA-C-N 120.089 1.313 . . . . 0.0 110.047 173.315 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 29.1 t-20 -62.41 -44.32 96.72 Favored 'General case' 0 CA--C 1.53 0.174 0 C-N-CA 122.661 0.384 . . . . 0.0 110.918 -179.431 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 39.1 tp -57.91 -48.44 79.89 Favored 'General case' 0 N--CA 1.454 -0.25 0 C-N-CA 124.166 0.986 . . . . 0.0 110.944 176.76 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 62.4 mt -65.47 -45.15 93.66 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.266 0 N-CA-C 107.705 -1.22 . . . . 0.0 107.705 -178.407 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -59.27 -29.08 67.31 Favored 'General case' 0 CA--C 1.54 0.592 0 CA-C-O 118.855 -0.593 . . . . 0.0 112.124 177.114 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 94.5 mttt -70.05 -57.29 5.15 Favored 'General case' 0 C--N 1.343 0.321 0 CA-C-N 119.09 0.859 . . . . 0.0 110.604 172.379 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 9.5 pt -80.79 -42.84 20.8 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.334 0 N-CA-C 115.659 1.726 . . . . 0.0 115.659 -168.497 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 51.0 m . . . . . 0 C--O 1.251 1.184 0 C-N-CA 124.979 1.312 . . . . 0.0 110.387 -169.861 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 11.8 ptm . . . . . 0 N--CA 1.497 1.919 0 N-CA-C 110.57 -0.159 . . . . 0.0 110.57 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 25.3 mttm -75.55 120.84 21.52 Favored 'General case' 0 N--CA 1.479 1.018 0 N-CA-C 107.907 -1.145 . . . . 0.0 107.907 -171.806 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 89.8 mttt -89.38 134.85 33.9 Favored 'General case' 0 CA--C 1.515 -0.367 0 N-CA-C 108.069 -1.085 . . . . 0.0 108.069 177.548 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 1.5 t -119.69 149.59 22.3 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.619 0 C-N-CA 126.997 2.119 . . . . 0.0 108.789 -169.229 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 26.5 mtt -137.32 145.96 44.03 Favored 'General case' 0 C--N 1.325 -0.493 0 C-N-CA 124.849 1.26 . . . . 0.0 108.484 168.686 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 49.3 m-85 -138.12 132.48 32.05 Favored 'General case' 0 C--O 1.234 0.249 0 N-CA-C 105.661 -1.978 . . . . 0.0 105.661 171.132 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 2.1 p -163.13 143.86 2.62 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.189 0 CA-C-N 118.459 0.572 . . . . 0.0 111.035 -170.023 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 45.2 t -136.34 177.97 7.42 Favored 'General case' 0 CA--C 1.547 0.861 0 C-N-CA 127.758 2.423 . . . . 0.0 105.877 168.367 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 27.1 ttpp -59.58 -22.6 61.99 Favored 'General case' 0 N--CA 1.474 0.748 0 N-CA-C 113.874 1.064 . . . . 0.0 113.874 -169.804 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 84.9 mmt-85 -138.24 155.78 48.31 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-N 119.755 1.162 . . . . 0.0 107.871 169.886 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 46.6 t30 -71.09 -35.44 71.83 Favored 'General case' 0 CA--C 1.535 0.384 0 CA-C-O 121.279 0.561 . . . . 0.0 109.839 173.377 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 1.2 m -61.34 -25.26 67.02 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 125.012 1.325 . . . . 0.0 112.928 -174.993 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 14.2 m -138.37 125.28 21.17 Favored 'General case' 0 N--CA 1.455 -0.199 0 C-N-CA 123.46 0.704 . . . . 0.0 109.481 -172.73 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . 0.42 ' H ' ' CG ' ' A' ' 103' ' ' ASP 0.259 27.2 ttt180 59.57 31.05 20.72 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 126.878 2.071 . . . . 0.0 112.831 175.775 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 20.4 m -131.71 -122.18 0.2 Allowed 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 103.363 -2.829 . . . . 0.0 103.363 168.783 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . 0.352 17.7 pt20 54.79 -57.9 0.02 OUTLIER 'General case' 0 N--CA 1.452 -0.33 0 C-N-CA 129.507 3.123 . . . . 0.0 115.951 171.995 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 5.4 tpt -107.34 -16.79 14.3 Favored 'General case' 0 N--CA 1.45 -0.447 0 N-CA-C 116.588 2.07 . . . . 0.0 116.588 -169.659 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -65.63 -45.39 83.25 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 120.182 1.356 . . . . 0.0 109.027 174.189 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 2.8 pm0 -66.55 -37.25 84.57 Favored 'General case' 0 N--CA 1.45 -0.427 0 C-N-CA 124.818 1.247 . . . . 0.0 110.439 170.034 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -61.98 -45.35 96.31 Favored Glycine 0 C--N 1.339 0.746 0 C-N-CA 124.37 0.986 . . . . 0.0 111.997 -178.536 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 24.9 m-85 -73.82 -31.13 63.08 Favored 'General case' 0 CA--C 1.509 -0.597 0 CA-C-N 119.056 1.428 . . . . 0.0 113.717 170.981 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -65.49 -34.17 77.65 Favored 'General case' 0 C--O 1.225 -0.203 0 CA-C-N 120.531 1.514 . . . . 0.0 111.333 -172.493 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 17.1 ptpt -61.66 -27.72 68.88 Favored 'General case' 0 N--CA 1.475 0.795 0 CA-C-N 119.026 0.83 . . . . 0.0 112.392 170.945 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 2.1 m -84.27 -56.34 3.7 Favored 'General case' 0 N--CA 1.451 -0.382 0 C-N-CA 125.291 1.436 . . . . 0.0 109.817 -178.099 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 75.7 mt -72.72 -36.44 67.8 Favored 'General case' 0 CA--C 1.529 0.138 0 C-N-CA 124.068 0.947 . . . . 0.0 110.021 -173.232 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -96.7 9.26 66.32 Favored Glycine 0 CA--C 1.526 0.771 0 C-N-CA 125.159 1.361 . . . . 0.0 112.943 -175.737 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -48.83 122.88 6.16 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 124.989 1.316 . . . . 0.0 110.71 -175.41 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 77.33 -11.78 16.11 Favored Glycine 0 CA--C 1.533 1.203 0 C-N-CA 124.404 1.002 . . . . 0.0 114.589 178.953 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 63.7 mttm -96.68 -46.11 6.42 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-N 119.265 1.532 . . . . 0.0 110.571 179.908 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 29.6 pt -138.62 147.64 25.07 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.58 0 C-N-CA 123.547 0.739 . . . . 0.0 110.087 -169.577 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -107.77 107.82 18.76 Favored 'General case' 0 N--CA 1.467 0.389 0 C-N-CA 125.196 1.398 . . . . 0.0 109.679 -171.471 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 8.3 t -78.44 139.53 18.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 119.152 0.887 . . . . 0.0 109.117 176.385 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 4.2 m -139.79 115.78 10.32 Favored 'General case' 0 N--CA 1.436 -1.145 0 N-CA-C 105.176 -2.157 . . . . 0.0 105.176 169.899 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 4.5 m -90.34 45.3 1.25 Allowed 'General case' 0 C--N 1.32 -0.679 0 O-C-N 121.416 -0.803 . . . . 0.0 112.399 -170.831 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 2.6 m -67.15 165.35 16.16 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 124.484 1.114 . . . . 0.0 111.801 -178.577 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -177.1 -177.09 45.76 Favored Glycine 0 N--CA 1.444 -0.77 0 N-CA-C 106.081 -2.808 . . . . 0.0 106.081 -170.22 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 19.1 mt -104.76 -14.88 15.4 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 117.754 0.777 . . . . 0.0 111.152 179.047 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -144.12 155.26 43.87 Favored 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 128.227 2.611 . . . . 0.0 105.388 168.984 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 1.9 m -164.25 169.8 17.1 Favored 'General case' 0 N--CA 1.449 -0.485 0 CA-C-O 122.277 1.037 . . . . 0.0 110.994 175.379 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 62.7 p -153.14 -172.37 4.22 Favored 'General case' 0 N--CA 1.439 -1.023 0 C-N-CA 126.385 1.874 . . . . 0.0 107.304 -169.182 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 7.5 ttt180 -91.62 168.98 11.11 Favored 'General case' 0 C--N 1.331 -0.237 0 O-C-N 121.19 -0.943 . . . . 0.0 109.587 170.473 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 19.8 m -71.28 170.55 1.27 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.805 0 C-N-CA 123.543 0.737 . . . . 0.0 109.585 -178.824 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 74.1 t60 -71.44 138.71 83.8 Favored Pre-proline 0 CA--C 1.546 0.818 0 CA-C-O 118.391 -0.814 . . . . 0.0 109.274 172.989 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -59.29 -49.46 10.76 Favored 'Trans proline' 0 C--N 1.349 0.556 0 C-N-CA 123.231 2.621 . . . . 0.0 113.899 -173.654 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 22.6 m -66.13 -17.18 64.55 Favored 'General case' 0 CA--C 1.539 0.521 0 CA-C-N 118.842 0.746 . . . . 0.0 111.168 -178.471 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -60.62 -49.0 79.3 Favored 'General case' 0 C--O 1.215 -0.715 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 173.253 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 52.4 mt -58.49 -41.05 80.69 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 N-CA-C 108.288 -1.005 . . . . 0.0 108.288 -173.44 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -66.27 -50.76 62.6 Favored 'General case' 0 N--CA 1.45 -0.434 0 CA-C-N 118.229 0.468 . . . . 0.0 111.597 -179.99 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 31.9 mmt -69.15 -34.2 74.62 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-O 122.825 1.297 . . . . 0.0 111.087 -177.047 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 20.8 mmt -77.81 -28.66 50.42 Favored 'General case' 0 N--CA 1.441 -0.899 0 O-C-N 120.784 -1.197 . . . . 0.0 108.277 -177.355 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 -70.87 -23.32 62.28 Favored 'General case' 0 N--CA 1.449 -0.479 0 O-C-N 121.372 -0.83 . . . . 0.0 109.692 169.652 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 18.2 mm-40 -68.14 -30.66 69.85 Favored 'General case' 0 CA--C 1.531 0.242 0 CA-C-N 119.203 0.91 . . . . 0.0 110.443 170.984 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . 0.286 3.1 p -87.64 9.43 2.04 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.918 0 CA-C-N 118.807 0.73 . . . . 0.0 111.264 169.205 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 81.41 17.69 70.66 Favored Glycine 0 CA--C 1.531 1.057 0 C-N-CA 124.667 1.127 . . . . 0.0 113.75 172.449 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 39.5 mt -116.28 139.35 43.39 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.295 0 CA-C-N 119.107 1.453 . . . . 0.0 110.625 -176.618 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -100.73 136.16 41.04 Favored 'General case' 0 C--O 1.235 0.319 0 N-CA-C 109.236 -0.653 . . . . 0.0 109.236 169.141 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 15.8 pt -128.36 -13.43 3.01 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.499 0 C-N-CA 125.439 1.496 . . . . 0.0 112.414 176.172 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 93.2 p -44.38 -38.21 3.84 Favored 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 125.467 1.507 . . . . 0.0 114.552 176.143 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -87.12 2.86 87.05 Favored Glycine 0 CA--C 1.529 0.912 0 CA-C-O 118.81 -0.995 . . . . 0.0 114.091 -172.92 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 26.8 mt-30 -75.81 120.11 20.73 Favored 'General case' 0 CA--C 1.514 -0.44 0 CA-C-N 119.615 1.708 . . . . 0.0 111.28 -170.182 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 7.7 t -162.13 167.0 24.95 Favored 'General case' 0 N--CA 1.436 -1.132 0 N-CA-C 106.671 -1.603 . . . . 0.0 106.671 167.391 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 40.4 m -154.32 164.38 38.67 Favored 'General case' 0 N--CA 1.448 -0.558 0 C-N-CA 126.195 1.798 . . . . 0.0 107.236 -177.548 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -60.18 163.25 8.53 Favored Pre-proline 0 CA--C 1.54 0.586 0 C-N-CA 124.514 1.125 . . . . 0.0 110.704 169.973 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -61.36 151.19 81.12 Favored 'Trans proline' 0 N--CA 1.456 -0.692 0 C-N-CA 121.584 1.523 . . . . 0.0 109.478 172.565 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 5.6 tt -61.59 -24.23 33.22 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.536 0 O-C-N 121.648 -0.658 . . . . 0.0 111.254 -173.289 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 12.3 mt-10 -67.59 -25.52 65.81 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 125.352 1.461 . . . . 0.0 110.803 -177.064 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 12.2 t-20 -63.07 -26.12 68.69 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 125.006 1.322 . . . . 0.0 111.904 178.612 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 39.2 m-85 -105.07 -169.68 1.64 Allowed 'General case' 0 C--O 1.236 0.37 0 C-N-CA 126.464 1.906 . . . . 0.0 109.762 -176.357 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 55.3 t-20 -135.98 138.81 42.66 Favored 'General case' 0 N--CA 1.445 -0.688 0 N-CA-C 106.526 -1.657 . . . . 0.0 106.526 168.753 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -72.18 -27.16 62.39 Favored 'General case' 0 N--CA 1.431 -1.379 0 N-CA-C 108.576 -0.898 . . . . 0.0 108.576 -178.768 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 35.8 t70 -67.04 -20.93 65.92 Favored 'General case' 0 N--CA 1.443 -0.778 0 C-N-CA 120.728 -0.389 . . . . 0.0 111.388 -177.55 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 35.2 t70 -80.13 -29.74 38.93 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 124.278 1.031 . . . . 0.0 111.697 173.672 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 11.2 m-85 -77.51 168.59 19.74 Favored 'General case' 0 C--O 1.237 0.446 0 C-N-CA 125.176 1.39 . . . . 0.0 110.926 177.551 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -119.29 -38.56 3.01 Favored 'General case' 0 C--O 1.235 0.309 0 C-N-CA 123.098 0.559 . . . . 0.0 111.491 178.728 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -139.32 134.62 40.44 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.494 0 CA-C-O 121.565 0.698 . . . . 0.0 110.196 -169.921 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 57.0 t -142.5 139.66 28.86 Favored 'Isoleucine or valine' 0 C--O 1.236 0.369 0 N-CA-C 106.082 -1.822 . . . . 0.0 106.082 -179.85 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 23.8 mm -125.63 122.07 61.51 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.572 0 N-CA-C 105.859 -1.904 . . . . 0.0 105.859 -177.388 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 36.0 m -95.4 97.06 9.54 Favored 'General case' 0 N--CA 1.447 -0.586 0 N-CA-C 106.019 -1.845 . . . . 0.0 106.019 169.731 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 67.6 mt -63.04 -18.6 63.53 Favored 'General case' 0 N--CA 1.463 0.207 0 C-N-CA 122.756 0.422 . . . . 0.0 111.092 -178.629 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 14.3 p -152.78 166.55 31.87 Favored 'General case' 0 N--CA 1.448 -0.54 0 N-CA-C 106.7 -1.593 . . . . 0.0 106.7 168.847 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 73.36 -165.52 54.79 Favored Glycine 0 CA--C 1.533 1.194 0 CA-C-O 121.381 0.434 . . . . 0.0 113.053 172.764 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 34.9 p -151.88 -168.21 3.01 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 125.548 1.539 . . . . 0.0 109.318 -169.873 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -73.36 60.74 1.91 Allowed Glycine 0 CA--C 1.534 1.277 0 C-N-CA 124.449 1.023 . . . . 0.0 110.644 170.743 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 7.3 p -72.66 -55.11 14.09 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.398 0 C-N-CA 124.987 1.315 . . . . 0.0 110.823 -169.87 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 36.7 p-10 -135.99 24.93 3.32 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 127.12 2.168 . . . . 0.0 108.6 170.053 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 2.8 tt -116.15 135.52 22.82 Favored Pre-proline 0 CA--C 1.537 0.446 0 C-N-CA 127.076 2.15 . . . . 0.0 107.881 -169.491 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -63.55 141.96 82.33 Favored 'Trans proline' 0 CA--C 1.541 0.84 0 CA-C-N 120.518 1.221 . . . . 0.0 114.78 -169.313 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 75.4 Cg_exo -60.33 -33.97 93.96 Favored 'Trans proline' 0 C--N 1.35 0.614 0 C-N-CA 122.1 1.867 . . . . 0.0 115.106 -171.425 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 4.0 pm0 -62.41 -13.62 31.6 Favored 'General case' 0 CA--C 1.536 0.435 0 CA-C-N 119.817 1.189 . . . . 0.0 112.349 -177.721 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 99.1 m95 -80.51 -32.31 36.95 Favored 'General case' 0 CA--C 1.53 0.191 0 CA-C-N 118.61 0.641 . . . . 0.0 111.825 173.83 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 25.1 m -96.3 -3.52 10.27 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.472 0 C-N-CA 124.913 1.285 . . . . 0.0 112.822 -179.309 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . 0.263 6.5 t -130.99 65.54 1.55 Allowed 'General case' 0 CA--C 1.541 0.604 0 CA-C-O 123.465 1.602 . . . . 0.0 108.132 169.634 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 32.9 mm-40 -80.56 -175.85 5.43 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 125.668 1.587 . . . . 0.0 109.603 169.516 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 36.4 mm-40 -63.06 -28.25 69.96 Favored 'General case' 0 CA--C 1.54 0.563 0 O-C-N 121.869 -0.52 . . . . 0.0 110.118 175.121 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 3.8 tt -141.01 134.58 31.89 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.358 0 C-N-CA 126.69 1.996 . . . . 0.0 105.675 169.319 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 57.0 t80 -126.11 137.57 53.61 Favored 'General case' 0 N--CA 1.448 -0.543 0 N-CA-C 107.556 -1.276 . . . . 0.0 107.556 169.789 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 8.5 mm-40 -138.11 167.03 22.67 Favored 'General case' 0 C--O 1.236 0.372 0 CA-C-O 122.248 1.023 . . . . 0.0 109.223 175.186 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -168.74 133.0 1.51 Allowed 'General case' 0 C--N 1.325 -0.488 0 C-N-CA 129.267 3.027 . . . . 0.0 105.606 -170.121 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 8.2 m0 -142.87 147.66 35.72 Favored 'General case' 0 C--O 1.232 0.18 0 C-N-CA 123.126 0.57 . . . . 0.0 110.136 -169.833 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 84.6 mt-30 -83.59 52.69 2.31 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 124.301 1.041 . . . . 0.0 108.914 172.362 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 16.3 mt -70.59 123.42 21.8 Favored 'General case' 0 C--N 1.339 0.113 0 N-CA-C 107.546 -1.279 . . . . 0.0 107.546 176.328 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 5.6 pt-20 -71.87 163.6 27.55 Favored 'General case' 0 CA--C 1.54 0.564 0 N-CA-C 109.139 -0.689 . . . . 0.0 109.139 169.759 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . 0.42 ' CG ' ' H ' ' A' ' 14' ' ' ARG . 13.7 t70 -138.66 139.61 24.92 Favored Pre-proline 0 CA--C 1.538 0.489 0 C-N-CA 124.132 0.973 . . . . 0.0 110.158 -173.198 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 39.5 Cg_endo -86.68 0.01 7.95 Favored 'Trans proline' 0 CA--C 1.543 0.96 0 C-N-CA 122.716 2.277 . . . . 0.0 114.651 -170.436 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -48.59 118.96 2.77 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-N 120.43 1.468 . . . . 0.0 111.221 -177.903 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 72.21 14.15 76.63 Favored Glycine 0 CA--C 1.534 1.249 0 CA-C-O 118.193 -1.337 . . . . 0.0 114.544 172.538 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 16.6 pt20 -128.23 172.26 11.19 Favored 'General case' 0 CA--C 1.541 0.605 0 CA-C-N 119.455 1.628 . . . . 0.0 111.827 176.448 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 9.9 m -65.78 165.18 13.25 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 125.851 1.66 . . . . 0.0 115.133 -168.644 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -60.68 -26.68 67.28 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 125.678 1.591 . . . . 0.0 112.614 -173.993 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 -56.07 -35.14 66.65 Favored 'General case' 0 N--CA 1.461 0.113 0 CA-C-N 118.687 0.676 . . . . 0.0 111.105 173.054 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 4.1 t -77.18 -40.98 30.41 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.558 0 CA-C-O 118.214 -0.898 . . . . 0.0 109.733 -178.036 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 83.6 m-85 -57.5 -46.44 83.75 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-N 120.29 1.404 . . . . 0.0 109.93 171.926 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 91.4 mtt180 -62.94 -41.35 99.46 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 123.274 0.629 . . . . 0.0 110.915 -179.906 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 8.7 m -63.13 -48.56 77.98 Favored 'General case' 0 N--CA 1.449 -0.522 0 C-N-CA 124.704 1.202 . . . . 0.0 110.178 175.525 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 75.4 t -68.72 -31.65 51.73 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.28 0 CA-C-O 118.481 -0.771 . . . . 0.0 109.703 -172.679 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 34.7 mtm105 -57.7 -50.16 74.11 Favored 'General case' 0 C--O 1.226 -0.15 0 CA-C-N 119.521 1.055 . . . . 0.0 110.497 171.399 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -60.74 -51.48 58.35 Favored Glycine 0 CA--C 1.529 0.955 0 N-CA-C 111.22 -0.752 . . . . 0.0 111.22 178.755 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 15.1 mm-40 -58.24 -52.15 66.76 Favored 'General case' 0 N--CA 1.464 0.235 0 C-N-CA 123.911 0.885 . . . . 0.0 110.658 -176.269 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 69.4 t -74.47 -39.48 47.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-O 118.357 -0.83 . . . . 0.0 110.339 -171.91 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 59.8 tttm -54.79 -44.7 73.99 Favored 'General case' 0 CA--C 1.517 -0.29 0 CA-C-N 119.134 0.879 . . . . 0.0 108.871 175.798 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 45.1 tt0 -64.79 -42.99 94.64 Favored 'General case' 0 CA--C 1.542 0.642 0 CA-C-O 118.75 -0.643 . . . . 0.0 111.363 -177.862 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 63.2 mmt-85 -62.87 -47.63 82.51 Favored 'General case' 0 N--CA 1.478 0.972 0 CA-C-N 119.967 1.258 . . . . 0.0 110.822 176.161 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 60.2 t -69.09 -37.44 76.79 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.438 0 N-CA-C 108.774 -0.824 . . . . 0.0 108.774 -174.675 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 15.8 mt-10 -61.07 -45.22 95.63 Favored 'General case' 0 CA--C 1.52 -0.185 0 CA-C-N 119.269 0.941 . . . . 0.0 110.076 174.111 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 28.4 t-20 -64.22 -40.97 97.14 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 123.008 0.523 . . . . 0.0 111.218 -178.332 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 53.0 tp -58.86 -49.94 75.86 Favored 'General case' 0 C--O 1.226 -0.14 0 C-N-CA 125.285 1.434 . . . . 0.0 110.909 173.77 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 56.7 mt -64.59 -46.87 91.23 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 N-CA-C 107.997 -1.112 . . . . 0.0 107.997 -178.748 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -58.65 -32.45 69.09 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 123.424 0.69 . . . . 0.0 112.102 -178.151 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 18.6 ptpt -81.53 -36.56 29.01 Favored 'General case' 0 C--N 1.345 0.37 0 CA-C-O 117.824 -1.084 . . . . 0.0 112.596 177.105 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 10.4 pt -84.81 -41.27 15.76 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.322 0 CA-C-N 120.124 1.329 . . . . 0.0 113.741 -176.225 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 67.4 m . . . . . 0 C--O 1.254 1.302 0 C-N-CA 126.065 1.746 . . . . 0.0 109.873 -169.927 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 8.5 ptm . . . . . 0 N--CA 1.498 1.965 0 N-CA-C 110.523 -0.177 . . . . 0.0 110.523 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 23.4 mttm -74.62 125.07 27.87 Favored 'General case' 0 N--CA 1.479 1.005 0 N-CA-C 107.103 -1.443 . . . . 0.0 107.103 -174.516 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 70.0 mttt -97.97 136.4 38.31 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-N 120.236 1.38 . . . . 0.0 108.027 173.771 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 11.6 t -116.31 152.47 18.03 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.551 0 C-N-CA 127.233 2.213 . . . . 0.0 108.199 -169.56 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 17.7 mtt -137.19 144.11 42.7 Favored 'General case' 0 C--N 1.324 -0.541 0 C-N-CA 124.926 1.29 . . . . 0.0 108.057 168.67 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 92.1 m-85 -125.26 113.89 18.22 Favored 'General case' 0 CA--C 1.516 -0.329 0 N-CA-C 102.839 -3.023 . . . . 0.0 102.839 170.05 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 1.2 p -141.0 137.21 34.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 121.289 0.566 . . . . 0.0 111.531 -168.051 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 44.0 t -165.82 152.93 10.08 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 128.639 2.775 . . . . 0.0 104.94 171.767 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 40.2 mtmt -75.47 163.3 27.55 Favored 'General case' 0 N--CA 1.47 0.569 0 O-C-N 121.655 -0.653 . . . . 0.0 111.421 -170.038 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 28.5 mmt85 53.41 70.39 0.6 Allowed 'General case' 0 N--CA 1.465 0.285 0 C-N-CA 126.801 2.041 . . . . 0.0 110.888 -176.28 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 2.4 t-20 -44.4 -20.07 0.03 OUTLIER 'General case' 0 N--CA 1.487 1.386 0 C-N-CA 127.839 2.455 . . . . 0.0 114.955 176.828 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 3.3 m -50.47 -27.82 7.23 Favored 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 124.269 1.028 . . . . 0.0 111.407 168.954 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 10.3 m -131.63 140.32 49.35 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 126.876 2.071 . . . . 0.0 107.889 172.078 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 5.5 mpt_? 59.16 165.2 0.05 OUTLIER 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 126.536 1.934 . . . . 0.0 112.631 -173.022 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 54.7 m 52.2 39.65 27.31 Favored 'General case' 0 CA--C 1.536 0.42 0 CA-C-N 115.207 -0.906 . . . . 0.0 110.334 -169.525 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 26.1 pt20 -135.48 33.07 3.03 Favored 'General case' 0 C--O 1.223 -0.294 0 O-C-N 120.543 -1.348 . . . . 0.0 109.636 174.414 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -163.88 -50.2 0.03 OUTLIER 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 124.149 0.979 . . . . 0.0 109.848 -177.762 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -67.73 -45.21 75.68 Favored 'General case' 0 C--N 1.343 0.285 0 N-CA-C 112.584 0.586 . . . . 0.0 112.584 -169.465 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . 0.471 ' H ' ' CD ' ' A' ' 19' ' ' GLU . 0.7 OUTLIER -66.86 -34.88 78.78 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 109.489 -0.56 . . . . 0.0 109.489 174.516 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -47.97 -66.71 1.87 Allowed Glycine 0 CA--C 1.527 0.791 0 N-CA-C 110.094 -1.202 . . . . 0.0 110.094 169.909 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 3.7 m-85 -59.62 -34.36 72.68 Favored 'General case' 0 CA--C 1.509 -0.602 0 O-C-N 121.547 -0.973 . . . . 0.0 113.444 178.091 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -66.63 -32.57 73.99 Favored 'General case' 0 N--CA 1.447 -0.61 0 C-N-CA 119.943 -0.703 . . . . 0.0 109.954 -174.032 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -65.9 -33.73 76.5 Favored 'General case' 0 CA--C 1.533 0.327 0 CA-C-N 118.395 0.543 . . . . 0.0 110.675 174.797 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 7.4 m -75.06 -55.69 5.49 Favored 'General case' 0 N--CA 1.448 -0.528 0 C-N-CA 125.453 1.501 . . . . 0.0 110.354 -176.752 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 40.1 mt -75.08 -38.63 61.2 Favored 'General case' 0 C--N 1.331 -0.22 0 C-N-CA 124.302 1.041 . . . . 0.0 109.467 -174.025 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -84.97 5.16 83.8 Favored Glycine 0 CA--C 1.526 0.78 0 C-N-CA 125.487 1.518 . . . . 0.0 113.629 -177.959 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -53.24 128.56 28.48 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-N 118.807 1.303 . . . . 0.0 109.802 -178.983 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 74.2 6.63 75.24 Favored Glycine 0 CA--C 1.536 1.35 0 C-N-CA 124.567 1.08 . . . . 0.0 114.313 -178.388 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 42.7 mttp -124.94 -50.42 1.7 Allowed 'General case' 0 N--CA 1.47 0.534 0 CA-C-N 118.927 1.364 . . . . 0.0 110.986 -175.0 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 19.3 pt -139.25 147.58 24.39 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.497 0 C-N-CA 123.642 0.777 . . . . 0.0 110.278 -169.244 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -96.01 159.48 14.95 Favored 'General case' 0 C--O 1.221 -0.417 0 C-N-CA 125.833 1.653 . . . . 0.0 108.109 175.578 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 12.2 t -142.44 135.68 27.43 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 N-CA-C 107.961 -1.125 . . . . 0.0 107.961 -173.416 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 4.1 m -148.38 103.04 3.39 Favored 'General case' 0 N--CA 1.446 -0.65 0 C-N-CA 124.665 1.186 . . . . 0.0 107.952 -177.218 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 60.2 m -89.6 71.43 7.87 Favored 'General case' 0 C--O 1.234 0.247 0 O-C-N 120.942 -1.099 . . . . 0.0 111.92 177.608 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 2.1 m -69.14 176.6 3.14 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 124.819 1.248 . . . . 0.0 110.696 170.763 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -167.07 -167.85 28.38 Favored Glycine 0 C--N 1.339 0.698 0 N-CA-C 108.082 -2.007 . . . . 0.0 108.082 179.691 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 18.2 mt -124.44 2.59 8.39 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 124.607 1.163 . . . . 0.0 111.691 -179.755 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 -145.36 -155.5 0.62 Allowed 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 129.185 2.994 . . . . 0.0 105.463 174.969 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 5.8 m 70.4 176.69 0.28 Allowed 'General case' 0 C--O 1.235 0.338 0 C-N-CA 125.38 1.472 . . . . 0.0 114.891 169.41 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 17.1 m -143.9 -72.87 0.28 Allowed 'General case' 0 N--CA 1.452 -0.354 0 CA-C-N 113.491 -1.686 . . . . 0.0 109.769 -169.236 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 6.0 ttt180 -152.3 172.1 16.96 Favored 'General case' 0 N--CA 1.467 0.415 0 C-N-CA 123.952 0.901 . . . . 0.0 111.15 -175.406 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 3.5 m -73.5 168.7 1.85 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.57 0 C-N-CA 124.534 1.134 . . . . 0.0 109.842 176.657 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -94.23 160.03 32.87 Favored Pre-proline 0 CA--C 1.544 0.718 0 N-CA-C 112.697 0.629 . . . . 0.0 112.697 -177.815 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -61.26 -53.55 2.37 Favored 'Trans proline' 0 C--N 1.352 0.742 0 C-N-CA 124.018 3.145 . . . . 0.0 113.777 -169.261 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 4.9 m -66.06 -26.6 67.58 Favored 'General case' 0 CA--C 1.532 0.278 0 O-C-N 121.893 -0.505 . . . . 0.0 110.358 -174.324 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -54.27 -53.19 56.97 Favored 'General case' 0 CA--C 1.509 -0.609 0 N-CA-C 108.75 -0.834 . . . . 0.0 108.75 174.745 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 58.9 mt -60.79 -41.08 87.2 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.468 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 -171.482 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -62.58 -40.97 98.59 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-N 118.431 0.56 . . . . 0.0 110.802 -179.009 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' MET . . . . . 0.415 ' HG3' ' CG ' ' A' ' 112' ' ' PHE . 38.4 mmt -74.06 -35.9 64.31 Favored 'General case' 0 C--O 1.235 0.321 0 CA-C-O 122.388 1.089 . . . . 0.0 110.338 -178.853 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -73.02 -31.33 64.39 Favored 'General case' 0 N--CA 1.442 -0.863 0 N-CA-C 106.806 -1.553 . . . . 0.0 106.806 -178.916 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 -70.52 -21.08 62.77 Favored 'General case' 0 N--CA 1.445 -0.719 0 C-N-CA 124.703 1.201 . . . . 0.0 111.061 170.273 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 77.7 mt-10 -63.84 -37.88 89.04 Favored 'General case' 0 C--N 1.344 0.361 0 CA-C-N 120.137 1.335 . . . . 0.0 109.107 169.457 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . 0.303 7.7 p -88.28 12.68 1.34 Allowed 'Isoleucine or valine' 0 CA--C 1.548 0.897 0 CA-C-O 121.082 0.468 . . . . 0.0 112.204 171.076 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 72.02 17.24 76.98 Favored Glycine 0 CA--C 1.533 1.212 0 O-C-N 120.723 -1.235 . . . . 0.0 113.869 174.791 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 5.7 mt -100.36 145.57 10.7 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.191 0 C-N-CA 125.154 1.382 . . . . 0.0 111.494 -174.221 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -96.77 137.13 36.32 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 125.297 1.439 . . . . 0.0 108.874 169.625 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 4.6 pt -134.0 -28.83 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.46 0 C-N-CA 125.441 1.496 . . . . 0.0 109.382 169.529 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -39.86 -37.67 0.58 Allowed 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 128.475 2.71 . . . . 0.0 113.509 169.563 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -66.72 -12.25 59.01 Favored Glycine 0 CA--C 1.537 1.423 0 C-N-CA 124.481 1.039 . . . . 0.0 114.379 179.213 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 28.7 mt-30 -70.73 156.43 39.51 Favored 'General case' 0 N--CA 1.45 -0.438 0 CA-C-N 118.965 1.382 . . . . 0.0 110.297 174.382 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 1.4 p -150.31 151.07 32.34 Favored 'General case' 0 N--CA 1.431 -1.421 0 N-CA-C 104.717 -2.327 . . . . 0.0 104.717 168.448 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 63.2 m -92.47 75.82 5.15 Favored 'General case' 0 N--CA 1.45 -0.44 0 N-CA-C 107.831 -1.174 . . . . 0.0 107.831 -174.117 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -62.96 153.13 81.67 Favored Pre-proline 0 C--O 1.241 0.642 0 N-CA-C 108.947 -0.761 . . . . 0.0 108.947 171.161 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 26.4 Cg_exo -57.55 134.36 62.78 Favored 'Trans proline' 0 N--CA 1.447 -1.209 0 N-CA-C 107.841 -1.638 . . . . 0.0 107.841 169.376 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 8.3 tt -61.22 -23.8 31.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 O-C-N 121.482 -0.762 . . . . 0.0 109.596 171.021 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 21.5 tt0 -69.61 -22.9 63.46 Favored 'General case' 0 N--CA 1.434 -1.273 0 C-N-CA 127.375 2.27 . . . . 0.0 110.789 -179.995 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 8.2 t-20 -60.32 -17.59 43.92 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 124.665 1.186 . . . . 0.0 111.68 174.313 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 4.4 m-85 -128.31 178.34 6.32 Favored 'General case' 0 C--O 1.235 0.34 0 C-N-CA 127.115 2.166 . . . . 0.0 108.54 -179.873 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 13.9 p-10 -128.32 143.61 51.04 Favored 'General case' 0 N--CA 1.438 -1.035 0 C-N-CA 124.716 1.206 . . . . 0.0 110.428 169.236 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -77.36 -25.27 50.85 Favored 'General case' 0 N--CA 1.432 -1.347 0 N-CA-C 109.143 -0.688 . . . . 0.0 109.143 -170.712 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 35.6 t70 -64.61 -19.79 65.89 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 120.41 -0.516 . . . . 0.0 111.214 -178.903 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -83.96 -31.04 25.77 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 124.427 1.091 . . . . 0.0 112.321 172.215 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 11.1 m-85 -72.85 170.31 14.98 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 124.89 1.276 . . . . 0.0 110.287 173.23 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -120.43 -35.85 3.33 Favored 'General case' 0 C--O 1.236 0.39 0 C-N-CA 123.047 0.539 . . . . 0.0 111.67 179.905 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -141.51 135.31 30.82 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.691 0 CA-C-O 121.839 0.828 . . . . 0.0 110.454 -169.705 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 76.3 t -143.0 138.38 27.16 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.278 0 N-CA-C 106.629 -1.619 . . . . 0.0 106.629 -177.496 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 41.6 mm -127.16 117.28 46.96 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.581 0 N-CA-C 106.12 -1.807 . . . . 0.0 106.12 -170.516 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 67.1 m -94.96 91.61 6.47 Favored 'General case' 0 N--CA 1.449 -0.519 0 N-CA-C 105.546 -2.02 . . . . 0.0 105.546 169.445 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . 0.251 0.3 OUTLIER -75.3 -6.55 50.44 Favored 'General case' 0 CA--C 1.536 0.442 0 CA-C-N 115.605 -0.725 . . . . 0.0 112.908 -175.267 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 6.4 p -166.14 167.38 16.34 Favored 'General case' 0 C--O 1.236 0.344 0 C-N-CA 127.398 2.279 . . . . 0.0 107.549 168.247 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 77.79 -81.3 1.27 Allowed Glycine 0 CA--C 1.526 0.746 0 N-CA-C 110.632 -0.987 . . . . 0.0 110.632 174.573 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 4.9 m 67.79 -53.2 0.51 Allowed 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 127.659 2.383 . . . . 0.0 113.738 178.429 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -81.47 57.79 4.89 Favored Glycine 0 CA--C 1.528 0.902 0 C-N-CA 124.774 1.178 . . . . 0.0 110.511 170.741 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 27.7 m -99.5 14.71 4.51 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.71 0 C-N-CA 124.082 0.953 . . . . 0.0 113.068 -169.881 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 47.4 t30 58.64 69.65 0.71 Allowed 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 126.1 1.76 . . . . 0.0 109.258 -175.865 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -139.36 148.61 57.36 Favored Pre-proline 0 CA--C 1.546 0.81 0 C-N-CA 126.146 1.778 . . . . 0.0 109.276 -168.949 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo -62.99 149.43 91.61 Favored 'Trans proline' 0 C--N 1.356 0.957 0 C-N-CA 121.47 1.447 . . . . 0.0 114.501 -169.643 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_endo -66.83 -34.9 29.17 Favored 'Trans proline' 0 N--CA 1.459 -0.522 0 C-N-CA 122.649 2.232 . . . . 0.0 114.583 -169.212 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -64.16 -11.91 35.0 Favored 'General case' 0 CA--C 1.54 0.57 0 CA-C-N 119.85 1.205 . . . . 0.0 112.157 -176.62 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 98.0 m95 -80.96 -35.53 32.07 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 123.481 0.712 . . . . 0.0 111.941 173.932 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 18.8 m -92.34 -4.59 10.78 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.551 0 C-N-CA 125.047 1.339 . . . . 0.0 112.697 -179.694 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 4.0 t -132.92 85.61 2.24 Favored 'General case' 0 CA--C 1.539 0.54 0 CA-C-O 123.24 1.495 . . . . 0.0 107.159 169.725 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 30.4 mm-40 -103.02 -174.11 2.47 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 127.806 2.442 . . . . 0.0 108.943 173.889 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 38.3 mm-40 -64.55 -28.62 69.77 Favored 'General case' 0 CA--C 1.539 0.544 0 O-C-N 121.82 -0.55 . . . . 0.0 110.036 172.653 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 4.0 tt -142.39 130.21 20.38 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.409 0 N-CA-C 105.692 -1.966 . . . . 0.0 105.692 169.338 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 70.3 t80 -122.87 142.37 50.85 Favored 'General case' 0 N--CA 1.448 -0.537 0 N-CA-C 105.868 -1.901 . . . . 0.0 105.868 169.062 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 10.5 mm-40 -132.77 138.9 47.31 Favored 'General case' 0 C--O 1.236 0.369 0 N-CA-C 107.809 -1.182 . . . . 0.0 107.809 174.025 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 8.0 t70 -108.36 118.91 37.99 Favored 'General case' 0 N--CA 1.45 -0.443 0 N-CA-C 106.455 -1.683 . . . . 0.0 106.455 169.855 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 10.5 m95 -115.68 170.44 8.44 Favored 'General case' 0 CA--C 1.533 0.318 0 N-CA-C 108.73 -0.841 . . . . 0.0 108.73 170.308 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 47.8 mt-30 -129.76 57.99 1.66 Allowed 'General case' 0 CA--C 1.534 0.362 0 N-CA-C 106.823 -1.547 . . . . 0.0 106.823 169.86 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 4.5 mt -67.76 139.48 56.66 Favored 'General case' 0 N--CA 1.463 0.217 0 N-CA-C 108.197 -1.038 . . . . 0.0 108.197 -179.694 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -74.65 170.61 15.46 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 125.056 1.343 . . . . 0.0 109.083 174.408 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -143.0 138.01 15.43 Favored Pre-proline 0 N--CA 1.452 -0.35 0 C-N-CA 123.199 0.599 . . . . 0.0 110.833 176.856 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 29.2 Cg_endo -86.35 -2.88 8.59 Favored 'Trans proline' 0 CA--C 1.54 0.807 0 C-N-CA 123.302 2.668 . . . . 0.0 115.318 -172.586 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -56.78 130.88 47.51 Favored 'General case' 0 C--O 1.237 0.432 0 CA-C-N 120.356 1.435 . . . . 0.0 110.571 -174.209 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 72.41 9.4 73.16 Favored Glycine 0 CA--C 1.534 1.233 0 CA-C-O 118.399 -1.223 . . . . 0.0 114.146 174.215 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 30.0 pt20 -126.44 -167.65 1.75 Allowed 'General case' 0 CA--C 1.537 0.453 0 CA-C-N 119.253 1.526 . . . . 0.0 110.799 172.326 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 1.9 m -66.93 154.74 40.3 Favored 'General case' 0 CA--C 1.532 0.268 0 N-CA-C 116.144 1.905 . . . . 0.0 116.144 -167.96 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 9.0 tp -57.61 -34.61 69.45 Favored 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 126.255 1.822 . . . . 0.0 111.201 177.487 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 -59.22 -34.66 72.45 Favored 'General case' 0 CA--C 1.531 0.213 0 C-N-CA 124.297 1.039 . . . . 0.0 110.721 175.839 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 3.5 t -73.18 -40.46 57.82 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.283 0 CA-C-O 118.207 -0.901 . . . . 0.0 109.456 -178.477 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . 0.415 ' CG ' ' HG3' ' A' ' 49' ' ' MET . 81.1 m-85 -56.56 -50.01 73.17 Favored 'General case' 0 N--CA 1.471 0.612 0 CA-C-N 120.248 1.385 . . . . 0.0 109.376 172.482 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 91.6 mtt180 -66.25 -33.19 75.18 Favored 'General case' 0 CA--C 1.535 0.378 0 CA-C-O 119.348 -0.358 . . . . 0.0 111.515 -177.009 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 6.2 m -67.37 -49.86 62.18 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 124.224 1.01 . . . . 0.0 109.971 173.107 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 80.1 t -69.8 -26.89 31.39 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.232 0 CA-C-O 117.675 -1.155 . . . . 0.0 109.399 -170.938 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 31.5 mtm105 -56.63 -47.5 79.57 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-N 120.31 1.414 . . . . 0.0 109.746 169.791 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -63.48 -49.12 72.24 Favored Glycine 0 CA--C 1.532 1.135 0 CA-C-N 118.949 0.795 . . . . 0.0 112.241 179.445 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 16.8 mt-30 -57.78 -46.37 84.69 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-N 117.565 0.682 . . . . 0.0 110.67 179.277 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 65.8 t -70.42 -41.2 78.29 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.474 0 CA-C-O 118.585 -0.722 . . . . 0.0 110.405 -176.675 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 57.7 tttm -54.54 -46.48 73.61 Favored 'General case' 0 CA--C 1.517 -0.301 0 CA-C-N 119.381 0.991 . . . . 0.0 109.178 179.917 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -64.19 -42.79 96.51 Favored 'General case' 0 N--CA 1.448 -0.539 0 C-N-CA 123.002 0.521 . . . . 0.0 110.68 -176.758 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 37.8 mmt180 -63.16 -46.54 86.69 Favored 'General case' 0 N--CA 1.47 0.541 0 O-C-N 121.808 -0.557 . . . . 0.0 110.824 178.047 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 86.1 t -70.02 -39.03 76.86 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.436 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 -176.834 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 17.2 mt-10 -60.82 -43.8 97.75 Favored 'General case' 0 C--O 1.227 -0.105 0 CA-C-N 119.392 0.996 . . . . 0.0 110.316 175.509 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 28.8 t-20 -63.71 -43.68 95.88 Favored 'General case' 0 CA--C 1.53 0.206 0 C-N-CA 122.968 0.507 . . . . 0.0 111.115 -178.011 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 45.7 tp -58.09 -49.47 76.81 Favored 'General case' 0 N--CA 1.453 -0.322 0 C-N-CA 125.525 1.53 . . . . 0.0 111.151 174.374 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 73.1 mt -64.58 -46.03 93.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 N-CA-C 108.261 -1.014 . . . . 0.0 108.261 -178.895 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -59.74 -30.8 69.08 Favored 'General case' 0 CA--C 1.536 0.438 0 CA-C-O 118.734 -0.651 . . . . 0.0 112.157 -178.084 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 19.1 ptpt -82.45 -37.65 25.11 Favored 'General case' 0 C--N 1.344 0.35 0 CA-C-O 118.033 -0.984 . . . . 0.0 112.346 176.797 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 12.7 pt -81.69 -41.68 18.77 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.328 0 CA-C-N 120.072 1.305 . . . . 0.0 113.354 -176.737 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 74.5 m . . . . . 0 C--O 1.252 1.232 0 C-N-CA 125.882 1.673 . . . . 0.0 109.607 -169.848 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 11.6 ptm . . . . . 0 N--CA 1.497 1.897 0 N-CA-C 110.744 -0.095 . . . . 0.0 110.744 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 26.1 mttm -76.08 118.71 19.12 Favored 'General case' 0 N--CA 1.48 1.064 0 O-C-N 120.875 -1.141 . . . . 0.0 108.196 -170.262 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 90.9 mttt -86.08 136.03 33.39 Favored 'General case' 0 CA--C 1.513 -0.454 0 N-CA-C 107.935 -1.135 . . . . 0.0 107.935 177.223 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 1.8 t -122.45 150.82 26.16 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 C-N-CA 125.752 1.621 . . . . 0.0 109.45 -168.936 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 13.6 mtt -139.35 147.52 41.65 Favored 'General case' 0 C--N 1.327 -0.376 0 C-N-CA 125.677 1.591 . . . . 0.0 108.462 168.963 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 70.2 m-85 -134.51 121.98 21.78 Favored 'General case' 0 N--CA 1.456 -0.161 0 N-CA-C 105.246 -2.131 . . . . 0.0 105.246 170.502 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 1.5 p -152.35 146.28 15.33 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.244 0 CA-C-N 118.954 0.797 . . . . 0.0 111.422 -168.932 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 43.7 t -132.99 -175.73 3.88 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 126.709 2.004 . . . . 0.0 106.226 169.225 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 20.2 ptpt -58.53 -25.44 62.45 Favored 'General case' 0 N--CA 1.471 0.601 0 N-CA-C 114.104 1.15 . . . . 0.0 114.104 -171.308 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 48.3 ttt85 -140.39 159.29 42.52 Favored 'General case' 0 N--CA 1.467 0.417 0 C-N-CA 124.264 1.026 . . . . 0.0 109.054 176.428 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 6.4 t30 -72.06 -34.86 69.06 Favored 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 123.779 0.832 . . . . 0.0 112.963 -176.556 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -64.75 -55.95 16.68 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 123.197 0.599 . . . . 0.0 111.215 -169.116 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 11.1 m -88.73 146.48 25.01 Favored 'General case' 0 N--CA 1.455 -0.196 0 C-N-CA 123.549 0.74 . . . . 0.0 109.624 -176.652 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 6.4 mmm180 68.33 -57.49 0.48 Allowed 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 127.424 2.29 . . . . 0.0 111.488 176.993 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 2.5 m -69.62 -9.95 56.25 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 124.702 1.201 . . . . 0.0 113.97 -172.146 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 29.3 pt20 -64.9 -42.67 94.56 Favored 'General case' 0 C--O 1.223 -0.332 0 CA-C-O 117.732 -1.127 . . . . 0.0 113.587 -175.292 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 2.2 tpt -94.72 -36.26 11.8 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-N 120.046 1.294 . . . . 0.0 114.102 -169.199 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -62.78 -42.97 99.94 Favored 'General case' 0 N--CA 1.474 0.737 0 N-CA-C 113.526 0.936 . . . . 0.0 113.526 -168.929 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -64.46 -33.49 76.0 Favored 'General case' 0 N--CA 1.472 0.645 0 CA-C-N 118.674 0.67 . . . . 0.0 109.366 175.6 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -51.94 -57.57 12.5 Favored Glycine 0 C--N 1.342 0.888 0 C-N-CA 125.422 1.487 . . . . 0.0 110.439 175.647 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 13.5 m-85 -70.8 -31.89 68.79 Favored 'General case' 0 CA--C 1.505 -0.757 0 O-C-N 121.647 -0.914 . . . . 0.0 112.724 -179.172 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -68.94 -34.41 75.31 Favored 'General case' 0 N--CA 1.449 -0.521 0 C-N-CA 119.305 -0.958 . . . . 0.0 111.155 -174.761 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 2.4 ptmt -65.39 -25.88 67.75 Favored 'General case' 0 N--CA 1.471 0.621 0 CA-C-N 119.085 0.857 . . . . 0.0 111.717 172.952 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 8.8 m -83.21 -57.07 3.42 Favored 'General case' 0 N--CA 1.444 -0.728 0 C-N-CA 125.198 1.399 . . . . 0.0 109.538 -173.96 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 55.5 mt -74.9 -36.34 62.23 Favored 'General case' 0 C--N 1.331 -0.204 0 C-N-CA 124.753 1.221 . . . . 0.0 110.213 -175.005 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -93.34 9.4 74.49 Favored Glycine 0 C--N 1.338 0.675 0 C-N-CA 124.988 1.28 . . . . 0.0 113.068 -176.161 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -50.89 122.73 7.85 Favored 'General case' 0 CA--C 1.534 0.327 0 C-N-CA 124.841 1.257 . . . . 0.0 110.524 -175.257 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 76.54 -8.76 25.29 Favored Glycine 0 CA--C 1.534 1.264 0 C-N-CA 124.371 0.986 . . . . 0.0 114.426 179.652 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 60.2 mttm -98.67 -46.67 5.61 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 119.19 1.495 . . . . 0.0 110.403 179.254 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 24.3 pt -139.24 149.25 23.14 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.585 0 C-N-CA 123.632 0.773 . . . . 0.0 109.388 -169.76 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -113.09 106.41 14.64 Favored 'General case' 0 N--CA 1.463 0.187 0 C-N-CA 125.132 1.373 . . . . 0.0 109.272 -169.899 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 2.5 t -84.64 137.68 20.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 119.316 0.962 . . . . 0.0 109.742 -179.449 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 14.5 m -145.32 91.7 2.16 Favored 'General case' 0 N--CA 1.446 -0.669 0 N-CA-C 106.037 -1.838 . . . . 0.0 106.037 170.368 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 45.0 m -89.28 68.93 8.13 Favored 'General case' 0 CA--C 1.532 0.273 0 O-C-N 121.287 -0.883 . . . . 0.0 111.017 -171.363 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 11.9 m -61.89 164.72 6.1 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 125.895 1.678 . . . . 0.0 110.715 170.198 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -158.6 -167.64 19.67 Favored Glycine 0 C--N 1.337 0.638 0 N-CA-C 107.752 -2.139 . . . . 0.0 107.752 -170.057 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 17.3 mt -123.96 -3.72 8.1 Favored 'General case' 0 C--N 1.327 -0.376 0 C-N-CA 124.113 0.965 . . . . 0.0 111.592 -179.405 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 36.7 mt-10 -142.63 154.15 44.12 Favored 'General case' 0 C--O 1.238 0.499 0 C-N-CA 128.052 2.541 . . . . 0.0 106.511 169.297 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 60.7 p -148.53 160.78 42.75 Favored 'General case' 0 N--CA 1.446 -0.66 0 CA-C-O 122.555 1.169 . . . . 0.0 113.795 -179.693 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 93.0 p -164.45 -144.45 0.08 Allowed 'General case' 0 N--CA 1.443 -0.817 0 CA-C-N 112.531 -2.122 . . . . 0.0 105.94 -168.841 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 9.2 ttt180 -136.31 173.0 12.18 Favored 'General case' 0 C--O 1.232 0.134 0 N-CA-C 106.311 -1.737 . . . . 0.0 106.311 168.368 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 5.6 m -81.89 175.16 0.77 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.609 0 C-N-CA 122.918 0.487 . . . . 0.0 110.038 -178.845 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 97.0 m-70 -90.98 150.33 41.66 Favored Pre-proline 0 CA--C 1.542 0.669 0 CA-C-O 119.3 -0.381 . . . . 0.0 111.686 -174.916 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -63.4 -45.64 11.37 Favored 'Trans proline' 0 C--N 1.349 0.59 0 C-N-CA 122.76 2.306 . . . . 0.0 113.31 -171.216 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 5.8 m -69.0 -22.74 64.06 Favored 'General case' 0 CA--C 1.54 0.558 0 O-C-N 121.681 -0.637 . . . . 0.0 110.364 -178.321 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -61.11 -56.68 18.1 Favored 'General case' 0 CA--C 1.509 -0.632 0 N-CA-C 108.197 -1.038 . . . . 0.0 108.197 169.85 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 75.9 mt -56.8 -38.76 60.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 N-CA-C 108.427 -0.953 . . . . 0.0 108.427 -175.229 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -62.47 -50.48 71.27 Favored 'General case' 0 N--CA 1.452 -0.332 0 CA-C-N 118.87 0.759 . . . . 0.0 111.827 -178.845 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 35.9 mmt -72.18 -31.78 66.23 Favored 'General case' 0 N--CA 1.472 0.648 0 CA-C-O 122.584 1.183 . . . . 0.0 110.806 -179.112 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -72.21 -33.13 67.37 Favored 'General case' 0 N--CA 1.443 -0.801 0 N-CA-C 106.855 -1.535 . . . . 0.0 106.855 -177.911 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 41.3 tt0 -74.7 -19.94 60.05 Favored 'General case' 0 N--CA 1.446 -0.67 0 O-C-N 120.925 -1.109 . . . . 0.0 110.525 172.441 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 20.3 mm-40 -64.49 -33.33 75.63 Favored 'General case' 0 CA--C 1.532 0.265 0 CA-C-N 119.576 1.08 . . . . 0.0 109.982 169.771 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 16.4 m -91.17 12.31 2.17 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.736 0 N-CA-C 112.275 0.472 . . . . 0.0 112.275 169.192 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 73.08 13.67 79.25 Favored Glycine 0 CA--C 1.531 1.089 0 C-N-CA 124.53 1.062 . . . . 0.0 113.695 174.675 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 17.2 mt -91.23 143.95 10.17 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.239 0 C-N-CA 124.438 1.095 . . . . 0.0 110.001 -177.476 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 7.2 t70 -104.49 124.6 49.56 Favored 'General case' 0 C--O 1.235 0.298 0 N-CA-C 106.628 -1.619 . . . . 0.0 106.628 168.902 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 5.8 pt -120.06 -21.81 4.02 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.697 0 C-N-CA 124.686 1.195 . . . . 0.0 109.526 169.073 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -38.67 -35.91 0.22 Allowed 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 129.252 3.021 . . . . 0.0 113.778 169.326 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -72.46 -9.75 74.0 Favored Glycine 0 CA--C 1.535 1.321 0 C-N-CA 124.649 1.118 . . . . 0.0 114.229 179.963 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 26.2 mt-30 -68.1 140.08 56.21 Favored 'General case' 0 N--CA 1.451 -0.401 0 CA-C-N 119.753 1.777 . . . . 0.0 110.265 176.764 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 1.2 m -155.94 -51.88 0.08 Allowed 'General case' 0 N--CA 1.438 -1.046 0 N-CA-C 104.119 -2.548 . . . . 0.0 104.119 168.412 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 3.9 m 68.9 160.03 0.18 Allowed 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 126.677 1.991 . . . . 0.0 114.071 169.095 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -95.32 163.61 21.23 Favored Pre-proline 0 C--O 1.241 0.621 0 C-N-CA 124.968 1.307 . . . . 0.0 109.754 -172.833 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -62.05 136.24 59.77 Favored 'Trans proline' 0 N--CA 1.449 -1.095 0 N-CA-C 108.203 -1.499 . . . . 0.0 108.203 169.762 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 8.1 tt -61.6 -19.15 20.3 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.498 0 C-N-CA 124.248 1.019 . . . . 0.0 111.03 -177.958 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 12.1 mt-10 -67.29 -25.48 66.06 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 125.533 1.533 . . . . 0.0 110.391 -179.748 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 15.4 t-20 -71.82 1.29 7.21 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 124.702 1.201 . . . . 0.0 113.112 -179.632 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 42.5 m-85 -130.74 -174.18 3.29 Favored 'General case' 0 C--O 1.236 0.388 0 C-N-CA 126.585 1.954 . . . . 0.0 109.136 -177.707 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 57.1 t-20 -135.05 140.19 45.38 Favored 'General case' 0 N--CA 1.446 -0.628 0 N-CA-C 107.397 -1.335 . . . . 0.0 107.397 169.382 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -72.22 -25.13 61.53 Favored 'General case' 0 N--CA 1.435 -1.207 0 N-CA-C 109.08 -0.711 . . . . 0.0 109.08 -178.157 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 35.1 t70 -63.71 -24.76 67.91 Favored 'General case' 0 N--CA 1.447 -0.609 0 O-C-N 123.254 0.346 . . . . 0.0 111.868 -179.132 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -78.08 -28.32 48.73 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 123.52 0.728 . . . . 0.0 111.925 176.036 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 14.7 m-85 -80.38 170.96 15.67 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 125.805 1.642 . . . . 0.0 111.695 -178.568 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 22.9 t70 -119.63 -39.07 2.9 Favored 'General case' 0 N--CA 1.464 0.272 0 C-N-CA 123.185 0.594 . . . . 0.0 111.599 177.318 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -139.32 133.96 39.73 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.494 0 CA-C-O 121.98 0.895 . . . . 0.0 110.639 -170.204 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 70.4 t -142.69 133.45 23.77 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.632 0 N-CA-C 105.746 -1.946 . . . . 0.0 105.746 -176.382 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 33.6 mm -124.94 122.09 62.59 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.527 0 N-CA-C 106.448 -1.686 . . . . 0.0 106.448 -171.603 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 58.7 m -87.09 122.59 31.12 Favored 'General case' 0 N--CA 1.441 -0.884 0 N-CA-C 105.204 -2.147 . . . . 0.0 105.204 169.0 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 69.3 mt -83.92 3.39 34.25 Favored 'General case' 0 C--N 1.327 -0.37 0 O-C-N 121.711 -0.618 . . . . 0.0 110.341 175.153 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 29.7 p -160.82 141.57 11.56 Favored 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 124.838 1.255 . . . . 0.0 108.249 169.728 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 57.97 -162.2 9.71 Favored Glycine 0 CA--C 1.534 1.223 0 C-N-CA 124.581 1.086 . . . . 0.0 114.523 170.26 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 10.9 p -152.17 147.75 26.8 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 125.367 1.467 . . . . 0.0 107.536 170.303 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 59.1 44.2 96.5 Favored Glycine 0 CA--C 1.533 1.176 0 N-CA-C 111.145 -0.782 . . . . 0.0 111.145 -178.107 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 29.8 m -79.8 52.53 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.545 0.775 0 C-N-CA 124.845 1.258 . . . . 0.0 112.799 -169.589 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 17.5 t-20 56.06 53.09 9.51 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 126.295 1.838 . . . . 0.0 108.827 -175.275 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -147.74 147.17 26.5 Favored Pre-proline 0 CA--C 1.54 0.579 0 C-N-CA 126.913 2.085 . . . . 0.0 107.34 -169.28 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_exo -64.24 138.34 60.68 Favored 'Trans proline' 0 CA--C 1.542 0.892 0 CA-C-N 120.692 1.283 . . . . 0.0 112.693 -171.878 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -67.15 -28.37 40.77 Favored 'Trans proline' 0 N--CA 1.458 -0.567 0 C-N-CA 122.667 2.245 . . . . 0.0 114.425 -169.393 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 5.1 pm0 -62.13 -15.92 48.95 Favored 'General case' 0 CA--C 1.536 0.42 0 CA-C-N 120.404 1.456 . . . . 0.0 112.53 -178.275 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 96.4 m95 -73.38 -49.36 27.62 Favored 'General case' 0 N--CA 1.451 -0.394 0 C-N-CA 123.242 0.617 . . . . 0.0 110.848 174.371 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 28.6 m -79.87 -0.29 3.79 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.359 0 C-N-CA 123.615 0.766 . . . . 0.0 112.717 -178.446 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 57.7 p -113.33 25.32 11.42 Favored 'General case' 0 C--O 1.237 0.409 0 CA-C-N 119.547 1.067 . . . . 0.0 113.155 174.033 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 76.2 mm-40 -66.57 174.22 2.94 Favored 'General case' 0 CA--C 1.539 0.528 0 CA-C-N 118.611 0.641 . . . . 0.0 112.084 176.251 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 32.7 mm-40 -54.57 -29.44 51.25 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 124.038 0.935 . . . . 0.0 111.723 -169.765 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 3.3 tt -133.7 130.63 56.36 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.672 0 N-CA-C 104.041 -2.577 . . . . 0.0 104.041 168.388 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 44.1 t80 -120.86 142.03 50.03 Favored 'General case' 0 N--CA 1.448 -0.546 0 N-CA-C 105.921 -1.881 . . . . 0.0 105.921 169.221 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 20.6 mm-40 -139.79 144.49 37.39 Favored 'General case' 0 C--O 1.236 0.373 0 N-CA-C 107.624 -1.25 . . . . 0.0 107.624 170.112 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 6.0 t0 -110.56 107.69 17.39 Favored 'General case' 0 C--O 1.238 0.484 0 N-CA-C 105.168 -2.16 . . . . 0.0 105.168 169.093 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -99.53 125.37 45.29 Favored 'General case' 0 N--CA 1.454 -0.269 0 C-N-CA 123.377 0.671 . . . . 0.0 109.546 -173.301 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 34.2 mm-40 -89.05 116.98 27.73 Favored 'General case' 0 N--CA 1.456 -0.163 0 N-CA-C 105.416 -2.068 . . . . 0.0 105.416 168.823 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 28.9 mt -142.95 127.69 18.17 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 104.638 -2.356 . . . . 0.0 104.638 -179.738 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 26.5 mm-40 -63.48 157.77 22.59 Favored 'General case' 0 CA--C 1.534 0.333 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 172.722 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -117.13 135.03 22.98 Favored Pre-proline 0 N--CA 1.45 -0.426 0 C-N-CA 124.526 1.13 . . . . 0.0 108.105 169.687 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -89.09 -8.68 4.72 Favored 'Trans proline' 0 N--CA 1.453 -0.882 0 C-N-CA 122.285 1.99 . . . . 0.0 114.674 -170.138 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -50.7 -51.4 49.97 Favored 'General case' 0 N--CA 1.472 0.672 0 CA-C-N 120.554 1.525 . . . . 0.0 113.14 -169.31 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -84.31 11.84 56.93 Favored Glycine 0 CA--C 1.532 1.147 0 CA-C-O 118.702 -1.055 . . . . 0.0 113.396 -176.49 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 9.8 mt-30 -130.98 176.45 8.23 Favored 'General case' 0 CA--C 1.542 0.664 0 CA-C-N 118.847 1.324 . . . . 0.0 110.654 -169.683 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 13.9 m -78.23 169.7 17.83 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 124.604 1.161 . . . . 0.0 112.242 -173.592 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 34.4 tp -55.19 -33.93 63.45 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 125.86 1.664 . . . . 0.0 113.058 -178.11 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 5.9 pt-20 -56.99 -34.71 68.41 Favored 'General case' 0 N--CA 1.463 0.208 0 C-N-CA 123.483 0.713 . . . . 0.0 111.608 174.782 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 16.0 t -76.63 -38.52 30.96 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.525 0 CA-C-O 118.02 -0.991 . . . . 0.0 109.801 -176.874 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 85.2 m-85 -57.02 -48.13 79.23 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-N 120.377 1.444 . . . . 0.0 109.547 171.545 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 85.6 mtt180 -63.72 -39.46 94.35 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 122.916 0.486 . . . . 0.0 111.247 -179.613 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 5.7 m -67.34 -49.6 63.37 Favored 'General case' 0 N--CA 1.452 -0.339 0 C-N-CA 124.203 1.001 . . . . 0.0 110.226 177.975 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 59.2 t -65.56 -35.13 74.52 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.306 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 -173.697 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 58.7 ttp85 -56.42 -45.18 80.84 Favored 'General case' 0 CA--C 1.537 0.475 0 CA-C-N 118.499 0.59 . . . . 0.0 109.76 174.077 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -64.18 -51.63 51.24 Favored Glycine 0 CA--C 1.53 1.006 0 CA-C-N 118.346 0.521 . . . . 0.0 112.208 175.922 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 9.4 mt-30 -61.52 -43.21 99.27 Favored 'General case' 0 N--CA 1.468 0.428 0 CA-C-N 118.258 1.029 . . . . 0.0 110.713 -175.364 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 95.6 t -70.58 -40.66 77.48 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.377 0 CA-C-O 118.399 -0.81 . . . . 0.0 109.265 -176.011 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 58.2 tttm -54.94 -45.85 74.88 Favored 'General case' 0 CA--C 1.518 -0.276 0 CA-C-N 119.275 0.943 . . . . 0.0 109.093 174.906 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 41.5 tt0 -66.84 -43.16 84.43 Favored 'General case' 0 N--CA 1.45 -0.446 0 C-N-CA 122.761 0.424 . . . . 0.0 111.043 -173.794 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 36.3 mtt-85 -66.21 -40.75 90.56 Favored 'General case' 0 N--CA 1.471 0.599 0 O-C-N 121.413 -0.804 . . . . 0.0 111.722 176.857 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 90.2 t -68.77 -37.61 77.7 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.499 0 N-CA-C 108.952 -0.758 . . . . 0.0 108.952 179.289 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 13.4 mt-10 -60.01 -43.8 94.99 Favored 'General case' 0 C--O 1.226 -0.174 0 CA-C-N 119.308 0.958 . . . . 0.0 110.064 174.13 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 29.2 t-20 -63.02 -45.27 93.13 Favored 'General case' 0 CA--C 1.53 0.204 0 CA-C-N 118.124 0.42 . . . . 0.0 111.103 -179.489 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 38.6 tp -57.75 -49.11 77.66 Favored 'General case' 0 N--CA 1.452 -0.364 0 C-N-CA 124.684 1.194 . . . . 0.0 110.489 176.715 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 70.0 mt -63.49 -46.78 94.23 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 N-CA-C 108.12 -1.067 . . . . 0.0 108.12 -179.408 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -59.13 -29.64 67.54 Favored 'General case' 0 CA--C 1.535 0.377 0 CA-C-O 118.325 -0.845 . . . . 0.0 112.251 -178.426 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . 0.25 19.3 ptpt -83.17 -39.05 21.52 Favored 'General case' 0 C--N 1.343 0.323 0 CA-C-O 117.863 -1.065 . . . . 0.0 112.616 175.421 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 12.6 pt -82.46 -40.19 16.72 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.362 0 CA-C-N 120.207 1.367 . . . . 0.0 113.497 -175.166 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 70.8 m . . . . . 0 C--O 1.253 1.24 0 C-N-CA 125.692 1.597 . . . . 0.0 109.848 -170.05 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 9.8 ptm . . . . . 0 N--CA 1.496 1.872 0 N-CA-C 110.622 -0.14 . . . . 0.0 110.622 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 27.5 mttm -75.09 121.25 21.75 Favored 'General case' 0 N--CA 1.48 1.045 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 -171.24 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 91.6 mttt -88.15 134.75 33.69 Favored 'General case' 0 CA--C 1.512 -0.491 0 N-CA-C 108.075 -1.083 . . . . 0.0 108.075 177.201 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 1.9 t -123.35 147.93 27.49 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.648 0 C-N-CA 126.574 1.95 . . . . 0.0 108.89 -168.994 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 34.3 mtt -137.02 150.5 48.14 Favored 'General case' 0 C--N 1.325 -0.493 0 C-N-CA 124.671 1.189 . . . . 0.0 108.215 168.049 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 35.7 m-85 -129.29 129.54 45.03 Favored 'General case' 0 CA--C 1.515 -0.397 0 N-CA-C 103.833 -2.654 . . . . 0.0 103.833 169.715 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 1.1 p -152.78 136.39 8.17 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.366 0 CA-C-O 121.352 0.596 . . . . 0.0 109.587 -169.276 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 49.9 t -122.08 174.66 6.79 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 127.317 2.247 . . . . 0.0 107.182 169.661 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 51.5 tttm -63.78 -32.28 73.73 Favored 'General case' 0 CA--C 1.539 0.531 0 O-C-N 121.226 -0.921 . . . . 0.0 111.303 179.275 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 74.4 mtm-85 -108.63 162.94 13.68 Favored 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 124.815 1.246 . . . . 0.0 108.003 169.615 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 7.3 t30 -70.55 -54.77 10.8 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-O 121.366 0.603 . . . . 0.0 110.296 172.625 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 12.4 m -89.75 46.39 1.36 Allowed 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 123.499 0.72 . . . . 0.0 111.454 -168.953 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 50.6 m -139.78 118.17 12.12 Favored 'General case' 0 N--CA 1.448 -0.548 0 N-CA-C 106.81 -1.552 . . . . 0.0 106.81 170.073 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 79.2 mtt180 64.96 -26.88 0.09 Allowed 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 129.02 2.928 . . . . 0.0 115.218 176.537 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 1.2 m -76.67 -140.79 0.02 OUTLIER 'General case' 0 CA--C 1.549 0.916 0 N-CA-C 104.658 -2.349 . . . . 0.0 104.658 168.036 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 22.5 pt20 49.43 26.44 1.65 Allowed 'General case' 0 N--CA 1.475 0.813 0 CA-C-N 121.047 1.749 . . . . 0.0 112.455 178.311 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -171.42 -49.34 0.02 OUTLIER 'General case' 0 N--CA 1.446 -0.663 0 C-N-CA 127.748 2.419 . . . . 0.0 108.515 -175.102 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -71.88 -45.94 59.53 Favored 'General case' 0 C--N 1.343 0.321 0 C-N-CA 123.448 0.699 . . . . 0.0 112.749 -169.562 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -63.71 -35.58 81.02 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 169.493 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -49.75 -66.06 2.5 Favored Glycine 0 C--N 1.341 0.811 0 C-N-CA 126.021 1.772 . . . . 0.0 110.745 174.851 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 2.5 m-85 -59.75 -27.67 66.7 Favored 'General case' 0 CA--C 1.512 -0.497 0 O-C-N 121.103 -1.234 . . . . 0.0 112.519 178.492 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -71.65 -32.8 68.31 Favored 'General case' 0 N--CA 1.447 -0.599 0 CA-C-O 117.71 -1.138 . . . . 0.0 112.117 -176.526 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.29 -30.44 70.3 Favored 'General case' 0 N--CA 1.476 0.848 0 CA-C-N 120.517 1.508 . . . . 0.0 110.903 172.065 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 18.8 m -75.92 -56.63 4.49 Favored 'General case' 0 N--CA 1.448 -0.54 0 C-N-CA 124.638 1.175 . . . . 0.0 111.078 -176.864 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 71.9 mt -78.56 -38.06 41.25 Favored 'General case' 0 C--N 1.33 -0.267 0 C-N-CA 124.3 1.04 . . . . 0.0 109.807 -173.771 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -80.54 2.75 76.98 Favored Glycine 0 CA--C 1.527 0.811 0 C-N-CA 124.838 1.209 . . . . 0.0 112.971 179.929 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -53.35 129.74 32.85 Favored 'General case' 0 C--O 1.236 0.389 0 CA-C-N 118.462 1.131 . . . . 0.0 109.301 179.809 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 75.44 5.32 77.33 Favored Glycine 0 CA--C 1.536 1.397 0 C-N-CA 124.378 0.99 . . . . 0.0 114.464 -178.606 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 41.0 mttp -128.23 -52.32 1.29 Allowed 'General case' 0 N--CA 1.472 0.671 0 CA-C-N 119.087 1.444 . . . . 0.0 111.373 -172.375 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 29.5 pt -140.02 147.43 23.67 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.502 0 C-N-CA 123.57 0.748 . . . . 0.0 109.59 -169.407 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -105.32 104.85 14.66 Favored 'General case' 0 N--CA 1.464 0.261 0 C-N-CA 124.889 1.275 . . . . 0.0 109.035 -172.825 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 9.8 p -80.24 137.47 21.48 Favored 'Isoleucine or valine' 0 C--O 1.236 0.357 0 CA-C-N 119.126 0.876 . . . . 0.0 109.431 173.86 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 6.6 m -134.56 117.9 16.67 Favored 'General case' 0 N--CA 1.434 -1.264 0 N-CA-C 104.686 -2.339 . . . . 0.0 104.686 173.766 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 2.4 m -89.74 39.62 0.96 Allowed 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 113.01 0.744 . . . . 0.0 113.01 -169.643 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 1.5 m -65.19 159.68 23.05 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 124.515 1.126 . . . . 0.0 111.077 178.549 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -177.64 -165.85 33.35 Favored Glycine 0 C--N 1.337 0.618 0 N-CA-C 108.678 -1.769 . . . . 0.0 108.678 -175.542 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 12.4 mt -132.49 160.59 36.04 Favored 'General case' 0 N--CA 1.445 -0.679 0 C-N-CA 126.547 1.939 . . . . 0.0 107.773 177.473 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 21.5 mt-10 56.13 18.04 3.02 Favored 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 124.627 1.171 . . . . 0.0 112.885 178.639 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 13.7 p -76.35 163.53 26.91 Favored 'General case' 0 N--CA 1.435 -1.179 0 N-CA-C 115.054 1.501 . . . . 0.0 115.054 -167.841 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 8.0 m -153.82 177.21 11.25 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 129.15 2.98 . . . . 0.0 105.98 -169.735 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 53.6 ttt180 -88.9 153.13 21.29 Favored 'General case' 0 CA--C 1.533 0.297 0 O-C-N 121.07 -1.019 . . . . 0.0 109.737 -177.505 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 1.9 p -44.72 149.54 0.25 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.439 0 C-N-CA 128.035 2.534 . . . . 0.0 112.568 169.987 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 23.0 m170 -88.69 152.81 49.59 Favored Pre-proline 0 CA--C 1.543 0.7 0 C-N-CA 123.274 0.63 . . . . 0.0 111.2 -179.563 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -59.08 -52.98 4.1 Favored 'Trans proline' 0 C--N 1.351 0.665 0 C-N-CA 124.149 3.233 . . . . 0.0 114.204 -169.091 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 7.3 m -67.37 -24.58 65.71 Favored 'General case' 0 CA--C 1.537 0.445 0 CA-C-O 119.215 -0.421 . . . . 0.0 110.651 -171.407 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -56.8 -53.8 53.7 Favored 'General case' 0 CA--C 1.511 -0.548 0 N-CA-C 109.177 -0.675 . . . . 0.0 109.177 173.231 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 52.1 mt -60.6 -38.59 78.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 -170.424 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -62.92 -49.13 75.98 Favored 'General case' 0 N--CA 1.454 -0.243 0 CA-C-N 118.595 0.634 . . . . 0.0 111.244 178.957 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 30.2 mmt -67.46 -37.14 82.48 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-O 122.779 1.276 . . . . 0.0 110.968 179.964 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -74.3 -31.61 62.55 Favored 'General case' 0 N--CA 1.443 -0.779 0 N-CA-C 107.2 -1.408 . . . . 0.0 107.2 -176.08 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 40.2 tt0 -72.07 -20.84 61.6 Favored 'General case' 0 N--CA 1.449 -0.52 0 O-C-N 121.211 -0.931 . . . . 0.0 110.788 170.699 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 20.6 mm-40 -66.01 -32.23 73.59 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-N 119.571 1.078 . . . . 0.0 109.89 169.912 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 15.7 m -91.97 13.63 1.98 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.835 0 CA-C-N 118.361 0.528 . . . . 0.0 112.036 169.037 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 75.82 15.97 80.97 Favored Glycine 0 CA--C 1.532 1.123 0 C-N-CA 124.99 1.281 . . . . 0.0 113.981 173.006 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 3.5 mt -99.54 140.8 18.04 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.113 0 C-N-CA 124.588 1.155 . . . . 0.0 111.201 -171.613 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 3.0 t70 -97.04 130.72 44.31 Favored 'General case' 0 CA--C 1.528 0.12 0 C-N-CA 125.421 1.489 . . . . 0.0 108.886 169.857 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 6.5 pt -132.58 -31.27 0.55 Allowed 'Isoleucine or valine' 0 C--O 1.216 -0.689 0 C-N-CA 125.78 1.632 . . . . 0.0 109.501 169.673 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -15.76 -36.37 0.0 OUTLIER 'General case' 0 CA--C 1.545 0.763 1 C-N-CA 131.768 4.027 . . . . 0.0 118.5 169.992 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -110.25 37.2 3.86 Favored Glycine 0 CA--C 1.534 1.251 0 C-N-CA 125.921 1.724 . . . . 0.0 113.858 -179.507 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 6.3 mt-30 -59.88 -30.48 69.02 Favored 'General case' 0 N--CA 1.474 0.75 0 CA-C-N 119.63 1.715 . . . . 0.0 114.232 -174.719 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -57.8 123.73 16.74 Favored 'General case' 0 C--O 1.236 0.342 0 C-N-CA 124.043 0.937 . . . . 0.0 109.135 -169.421 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 75.2 m -145.96 177.28 9.06 Favored 'General case' 0 N--CA 1.443 -0.802 0 C-N-CA 126.452 1.901 . . . . 0.0 107.019 -169.369 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -59.26 153.95 44.48 Favored Pre-proline 0 C--O 1.239 0.543 0 C-N-CA 123.691 0.796 . . . . 0.0 111.49 175.756 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -63.48 154.16 70.34 Favored 'Trans proline' 0 N--CA 1.454 -0.826 0 C-N-CA 122.49 2.127 . . . . 0.0 109.84 170.879 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 3.2 tt -61.95 -24.41 34.32 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.522 0 O-C-N 121.701 -0.624 . . . . 0.0 111.212 -175.764 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 12.6 mt-10 -65.96 -26.23 67.48 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 124.751 1.22 . . . . 0.0 110.81 -177.377 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 7.6 t-20 -63.12 -23.89 67.65 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 124.673 1.189 . . . . 0.0 111.942 179.085 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 75.0 m-85 -104.62 -174.68 2.59 Favored 'General case' 0 C--O 1.236 0.367 0 C-N-CA 126.19 1.796 . . . . 0.0 110.357 -174.819 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 56.3 t-20 -135.82 132.83 37.16 Favored 'General case' 0 N--CA 1.443 -0.819 0 N-CA-C 106.176 -1.787 . . . . 0.0 106.176 168.855 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -75.0 -19.75 59.95 Favored 'General case' 0 N--CA 1.431 -1.38 0 C-N-CA 120.125 -0.63 . . . . 0.0 109.389 -176.585 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 35.5 t70 -65.03 -24.71 67.57 Favored 'General case' 0 N--CA 1.442 -0.829 0 O-C-N 122.211 -0.305 . . . . 0.0 111.235 179.127 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -77.0 -28.81 55.18 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 123.773 0.829 . . . . 0.0 111.779 173.872 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 11.6 m-85 -77.35 168.21 20.41 Favored 'General case' 0 N--CA 1.451 -0.42 0 C-N-CA 125.261 1.424 . . . . 0.0 111.342 178.863 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -117.28 -39.21 3.22 Favored 'General case' 0 C--O 1.234 0.266 0 C-N-CA 123.213 0.605 . . . . 0.0 111.249 177.256 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -138.2 135.02 44.73 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.693 0 CA-C-O 122.021 0.915 . . . . 0.0 109.943 -169.887 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 75.6 t -142.09 133.89 26.65 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.451 0 N-CA-C 105.905 -1.887 . . . . 0.0 105.905 176.708 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 39.7 mm -117.78 102.82 13.89 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.78 0 N-CA-C 105.253 -2.129 . . . . 0.0 105.253 -170.437 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 47.2 m -101.34 70.61 1.32 Allowed 'General case' 0 N--CA 1.439 -1.014 0 N-CA-C 106.458 -1.682 . . . . 0.0 106.458 -172.947 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -71.22 23.33 0.04 OUTLIER 'General case' 0 CA--C 1.542 0.655 0 N-CA-C 114.136 1.162 . . . . 0.0 114.136 -170.075 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 74.9 m -146.3 55.64 1.16 Allowed 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 125.823 1.649 . . . . 0.0 109.996 172.33 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 81.34 -167.0 48.55 Favored Glycine 0 CA--C 1.531 1.034 0 O-C-N 121.363 -0.835 . . . . 0.0 112.663 176.981 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 15.0 p -151.68 150.19 29.96 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 123.649 0.779 . . . . 0.0 110.375 -169.952 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 61.26 28.25 68.91 Favored Glycine 0 CA--C 1.531 1.036 0 C-N-CA 123.208 0.433 . . . . 0.0 112.081 -179.014 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 32.8 m -71.45 -34.43 53.25 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.612 0 CA-C-N 117.479 0.64 . . . . 0.0 111.719 -169.303 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 21.2 t-20 -178.13 -43.02 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 128.792 2.837 . . . . 0.0 106.14 174.318 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 3.0 tt -44.09 139.68 3.03 Favored Pre-proline 0 CA--C 1.547 0.859 0 C-N-CA 128.202 2.601 . . . . 0.0 111.295 169.659 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_exo -65.17 150.98 86.99 Favored 'Trans proline' 0 C--N 1.356 0.936 0 C-N-CA 121.974 1.782 . . . . 0.0 115.658 -169.727 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -64.51 -30.47 61.63 Favored 'Trans proline' 0 C--N 1.349 0.594 0 C-N-CA 122.491 2.127 . . . . 0.0 114.972 -174.661 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -56.35 -21.05 22.05 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-N 119.49 1.041 . . . . 0.0 112.739 -177.026 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 99.4 m95 -80.06 -28.75 39.16 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 124.948 1.299 . . . . 0.0 112.188 -179.56 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 16.1 m -100.67 -4.35 9.29 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.41 0 C-N-CA 124.946 1.299 . . . . 0.0 112.019 179.623 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 59.8 p -103.27 30.37 4.95 Favored 'General case' 0 CA--C 1.535 0.39 0 CA-C-N 119.325 0.966 . . . . 0.0 112.449 175.644 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 46.1 mm-40 -72.33 175.06 6.47 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 123.344 0.658 . . . . 0.0 111.275 -175.354 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 36.2 mm-40 -61.54 -26.05 67.69 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-O 120.832 0.348 . . . . 0.0 110.513 179.758 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 4.1 tt -136.54 124.49 34.3 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.523 0 N-CA-C 104.997 -2.223 . . . . 0.0 104.997 169.169 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 20.9 t80 -103.49 135.01 45.89 Favored 'General case' 0 CA--C 1.538 0.49 0 N-CA-C 105.755 -1.943 . . . . 0.0 105.755 169.581 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 15.6 mm-40 -136.26 162.25 33.51 Favored 'General case' 0 C--O 1.235 0.291 0 N-CA-C 108.552 -0.907 . . . . 0.0 108.552 170.294 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 5.2 t0 -178.79 126.95 0.1 Allowed 'General case' 0 C--N 1.326 -0.439 0 C-N-CA 126.869 2.068 . . . . 0.0 105.643 -169.519 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 6.6 m0 -143.42 149.0 37.01 Favored 'General case' 0 C--N 1.333 -0.136 0 C-N-CA 122.616 0.366 . . . . 0.0 110.788 -170.933 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 1.9 tp-100 -82.73 54.04 2.56 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 124.338 1.055 . . . . 0.0 109.508 175.909 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 1.1 mp -64.28 147.13 53.16 Favored 'General case' 0 C--N 1.34 0.184 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 178.209 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 69.2 mm-40 -77.8 166.4 22.97 Favored 'General case' 0 CA--C 1.536 0.413 0 N-CA-C 108.229 -1.026 . . . . 0.0 108.229 169.496 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -135.08 137.74 27.69 Favored Pre-proline 0 CA--C 1.536 0.426 0 C-N-CA 124.161 0.984 . . . . 0.0 109.334 171.86 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 21.4 Cg_endo -92.94 3.77 3.43 Favored 'Trans proline' 0 N--CA 1.452 -0.944 0 C-N-CA 122.318 2.012 . . . . 0.0 114.781 -171.661 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -55.81 120.88 8.04 Favored 'General case' 0 C--O 1.237 0.399 0 CA-C-N 120.398 1.454 . . . . 0.0 110.841 -174.571 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 68.65 5.48 45.04 Favored Glycine 0 CA--C 1.534 1.274 0 CA-C-O 118.873 -0.96 . . . . 0.0 114.151 179.902 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 7.0 mt-30 -97.12 167.74 10.87 Favored 'General case' 0 CA--C 1.537 0.47 0 CA-C-N 118.882 1.341 . . . . 0.0 109.864 179.428 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 15.6 m -69.95 165.98 20.57 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 124.097 0.959 . . . . 0.0 111.754 179.762 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 64.7 mt -60.29 -26.77 66.76 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 123.924 0.89 . . . . 0.0 112.452 -175.594 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 5.8 pt-20 -56.29 -35.27 67.32 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 118.773 0.715 . . . . 0.0 111.162 173.934 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 11.9 t -77.27 -41.09 30.14 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.309 0 CA-C-O 118.203 -0.903 . . . . 0.0 109.823 -178.951 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 62.7 m-85 -57.21 -45.67 83.6 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-N 120.323 1.419 . . . . 0.0 109.596 172.091 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 92.4 mtt180 -63.77 -44.11 94.41 Favored 'General case' 0 N--CA 1.468 0.455 0 C-N-CA 123.395 0.678 . . . . 0.0 110.8 -179.789 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 5.3 m -60.9 -46.76 89.37 Favored 'General case' 0 N--CA 1.449 -0.475 0 C-N-CA 124.642 1.177 . . . . 0.0 109.998 176.281 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 69.4 t -70.09 -37.86 73.33 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.494 0 CA-C-O 117.704 -1.141 . . . . 0.0 109.116 -173.39 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 41.1 mtm105 -57.22 -43.36 82.75 Favored 'General case' 0 C--O 1.224 -0.275 0 CA-C-N 120.113 1.324 . . . . 0.0 110.131 172.859 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -63.67 -54.35 31.99 Favored Glycine 0 CA--C 1.53 1.022 0 CA-C-N 118.672 0.669 . . . . 0.0 111.766 179.128 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 49.8 mm-40 -52.69 -51.23 61.2 Favored 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 124.696 1.198 . . . . 0.0 110.049 177.838 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 59.6 t -63.8 -50.22 78.64 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.666 0 CA-C-O 118.397 -0.811 . . . . 0.0 109.782 -176.172 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 86.7 tttt -56.38 -46.81 79.91 Favored 'General case' 0 CA--C 1.512 -0.483 0 N-CA-C 108.219 -1.03 . . . . 0.0 108.219 -175.059 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 40.2 tt0 -64.11 -42.88 96.71 Favored 'General case' 0 N--CA 1.446 -0.668 0 C-N-CA 122.945 0.498 . . . . 0.0 111.112 -175.561 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 25.4 mtt180 -74.61 -38.73 62.5 Favored 'General case' 0 N--CA 1.467 0.395 0 O-C-N 121.047 -1.033 . . . . 0.0 111.666 -178.046 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 85.2 t -65.29 -40.33 88.2 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.634 0 N-CA-C 108.441 -0.948 . . . . 0.0 108.441 174.676 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 4.2 mm-40 -60.54 -46.74 89.07 Favored 'General case' 0 C--O 1.227 -0.125 0 CA-C-N 119.489 1.041 . . . . 0.0 109.798 176.028 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 27.7 t-20 -64.36 -40.64 96.25 Favored 'General case' 0 CA--C 1.529 0.17 0 C-N-CA 123.039 0.536 . . . . 0.0 110.952 -176.471 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 24.2 tp -58.19 -50.13 74.6 Favored 'General case' 0 N--CA 1.451 -0.399 0 C-N-CA 124.875 1.27 . . . . 0.0 110.784 173.186 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 75.3 mt -66.12 -44.89 91.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 N-CA-C 107.808 -1.182 . . . . 0.0 107.808 -177.081 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -58.92 -33.93 71.13 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 123.315 0.646 . . . . 0.0 112.182 -179.796 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 17.8 ptpt -79.73 -38.95 32.21 Favored 'General case' 0 C--N 1.345 0.4 0 CA-C-O 117.926 -1.035 . . . . 0.0 112.101 177.634 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 11.1 pt -83.98 -40.6 15.82 Favored 'Isoleucine or valine' 0 C--O 1.234 0.271 0 CA-C-N 119.997 1.271 . . . . 0.0 113.699 -174.794 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 67.7 m . . . . . 0 C--O 1.254 1.333 0 C-N-CA 125.436 1.494 . . . . 0.0 110.06 -169.807 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 9.9 ptm . . . . . 0 N--CA 1.497 1.902 0 N-CA-C 110.837 -0.06 . . . . 0.0 110.837 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 20.9 mttm -73.95 122.76 23.08 Favored 'General case' 0 N--CA 1.478 0.967 0 O-C-N 120.961 -1.087 . . . . 0.0 108.329 -171.083 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 93.7 mttt -89.23 134.92 33.84 Favored 'General case' 0 CA--C 1.515 -0.371 0 N-CA-C 108.156 -1.053 . . . . 0.0 108.156 176.403 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 1.9 t -122.26 149.98 25.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 C-N-CA 125.764 1.626 . . . . 0.0 109.655 -169.021 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 28.3 mtt -141.02 148.31 40.06 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 125.548 1.539 . . . . 0.0 108.31 168.667 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 65.4 m-85 -132.21 113.02 12.77 Favored 'General case' 0 N--CA 1.453 -0.318 0 N-CA-C 103.919 -2.623 . . . . 0.0 103.919 169.983 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 19.7 t -140.69 127.02 20.95 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 N-CA-C 107.07 -1.455 . . . . 0.0 107.07 -169.248 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 44.3 t -91.7 -152.07 0.29 Allowed 'General case' 0 CA--C 1.546 0.814 0 N-CA-C 105.621 -1.992 . . . . 0.0 105.621 169.239 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 64.0 tttp -58.95 -35.24 72.8 Favored 'General case' 0 N--CA 1.473 0.693 0 O-C-N 119.852 -1.78 . . . . 0.0 109.187 169.348 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 79.7 mtt180 -134.06 176.93 8.14 Favored 'General case' 0 N--CA 1.465 0.302 0 C-N-CA 125.462 1.505 . . . . 0.0 108.999 177.662 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 51.5 t30 -70.64 -15.35 62.73 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 123.387 0.675 . . . . 0.0 111.296 169.651 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 1.8 m -57.04 169.68 0.51 Allowed 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 126.682 1.993 . . . . 0.0 112.443 174.72 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 5.1 m 62.51 -92.51 0.03 OUTLIER 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 125.974 1.71 . . . . 0.0 113.885 169.549 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -92.68 -36.65 12.83 Favored 'General case' 0 N--CA 1.476 0.855 0 CA-C-N 119.851 1.205 . . . . 0.0 112.34 -174.247 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 1.2 m -59.72 -37.28 78.46 Favored 'General case' 0 N--CA 1.47 0.574 0 O-C-N 121.516 -0.74 . . . . 0.0 112.344 -169.659 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 22.2 pt20 -47.82 -46.09 30.5 Favored 'General case' 0 C--N 1.341 0.212 0 C-N-CA 125.008 1.323 . . . . 0.0 111.299 176.028 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -84.45 -38.59 19.97 Favored 'General case' 0 C--O 1.226 -0.183 0 CA-C-N 118.999 0.818 . . . . 0.0 111.139 -175.685 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -61.66 -47.88 83.36 Favored 'General case' 0 C--N 1.332 -0.16 0 C-N-CA 122.126 0.171 . . . . 0.0 111.307 -174.421 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 1.2 pp20? -71.01 -29.37 65.29 Favored 'General case' 0 C--O 1.235 0.309 0 C-N-CA 119.928 -0.709 . . . . 0.0 109.928 176.113 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -49.01 -62.54 4.54 Favored Glycine 0 C--N 1.34 0.805 0 C-N-CA 126.418 1.961 . . . . 0.0 110.457 173.917 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 9.7 m-85 -65.84 -31.21 72.03 Favored 'General case' 0 CA--C 1.512 -0.491 0 CA-C-N 119.35 1.575 . . . . 0.0 114.14 175.922 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -65.22 -33.05 75.09 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 119.56 1.073 . . . . 0.0 111.918 -169.823 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 5.9 ptpt -63.22 -33.79 76.25 Favored 'General case' 0 N--CA 1.476 0.846 0 CA-C-N 119.561 1.073 . . . . 0.0 111.646 173.312 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 6.6 m -75.31 -54.71 6.62 Favored 'General case' 0 N--CA 1.448 -0.528 0 C-N-CA 125.179 1.392 . . . . 0.0 110.002 -177.672 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 87.8 mt -73.41 -35.95 65.92 Favored 'General case' 0 CA--C 1.53 0.205 0 C-N-CA 123.667 0.787 . . . . 0.0 110.533 -173.509 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -93.43 6.27 74.77 Favored Glycine 0 CA--C 1.526 0.762 0 C-N-CA 125.117 1.342 . . . . 0.0 113.499 -175.757 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -48.72 123.92 7.61 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 125.06 1.344 . . . . 0.0 110.94 -173.389 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 77.9 -14.62 9.99 Favored Glycine 0 CA--C 1.536 1.368 0 C-N-CA 124.655 1.122 . . . . 0.0 114.472 178.406 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 61.9 mttm -95.39 -45.04 7.29 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-N 119.372 1.586 . . . . 0.0 110.48 179.655 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 25.7 pt -140.29 153.14 21.87 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.37 0 C-N-CA 123.776 0.83 . . . . 0.0 110.215 -169.534 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -113.15 104.98 12.9 Favored 'General case' 0 C--O 1.226 -0.162 0 C-N-CA 125.209 1.404 . . . . 0.0 108.611 -173.258 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 14.9 p -88.97 133.01 32.32 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.307 0 CA-C-N 118.988 0.813 . . . . 0.0 109.248 175.756 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 15.1 m -152.36 95.54 2.05 Favored 'General case' 0 N--CA 1.456 -0.157 0 N-CA-C 105.302 -2.111 . . . . 0.0 105.302 172.351 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 48.3 m -92.31 72.39 5.3 Favored 'General case' 0 C--O 1.232 0.184 0 CA-C-O 121.741 0.781 . . . . 0.0 111.03 -169.844 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 3.7 m -60.31 165.74 3.39 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 125.482 1.513 . . . . 0.0 109.925 170.066 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -161.1 -160.73 10.96 Favored Glycine 0 C--N 1.337 0.622 0 N-CA-C 109.209 -1.557 . . . . 0.0 109.209 -169.686 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 10.6 mt -133.56 -62.23 0.79 Allowed 'General case' 0 N--CA 1.45 -0.455 0 C-N-CA 123.329 0.651 . . . . 0.0 110.13 -169.731 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -80.44 -21.01 42.55 Favored 'General case' 0 CA--C 1.537 0.481 0 C-N-CA 124.013 0.925 . . . . 0.0 111.382 174.825 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 43.0 m -60.82 166.18 3.54 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 128.196 2.598 . . . . 0.0 116.086 -169.306 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 60.9 p -145.69 -96.68 0.09 Allowed 'General case' 0 N--CA 1.448 -0.529 0 CA-C-N 113.439 -1.71 . . . . 0.0 111.685 -168.604 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 6.4 ttt180 -140.97 179.67 6.59 Favored 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 125.366 1.466 . . . . 0.0 109.316 178.052 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 3.5 m -85.68 178.72 0.53 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.788 0 C-N-CA 123.701 0.8 . . . . 0.0 110.234 -174.442 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 18.4 m-70 -89.05 153.85 49.33 Favored Pre-proline 0 CA--C 1.546 0.801 0 C-N-CA 123.505 0.722 . . . . 0.0 110.825 -177.974 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 33.1 Cg_endo -65.72 -54.29 0.59 Allowed 'Trans proline' 0 C--N 1.349 0.554 0 C-N-CA 123.109 2.539 . . . . 0.0 113.033 -174.004 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 8.7 m -67.74 -24.46 65.36 Favored 'General case' 0 CA--C 1.535 0.381 0 O-C-N 121.97 -0.456 . . . . 0.0 110.337 -176.702 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -55.56 -52.03 65.11 Favored 'General case' 0 CA--C 1.509 -0.623 0 CA-C-O 119.198 -0.429 . . . . 0.0 109.862 173.266 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 37.3 mt -58.87 -42.32 85.4 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 N-CA-C 108.466 -0.939 . . . . 0.0 108.466 -172.778 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -62.21 -47.13 85.82 Favored 'General case' 0 N--CA 1.448 -0.534 0 CA-C-N 118.23 0.468 . . . . 0.0 110.724 -179.443 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 30.7 mmt -72.56 -33.7 66.99 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-O 122.251 1.024 . . . . 0.0 111.415 -177.144 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -74.49 -31.52 62.22 Favored 'General case' 0 N--CA 1.443 -0.821 0 N-CA-C 107.316 -1.364 . . . . 0.0 107.316 -179.144 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 41.6 tt0 -72.91 -22.77 60.68 Favored 'General case' 0 N--CA 1.444 -0.73 0 O-C-N 121.341 -0.849 . . . . 0.0 110.087 172.418 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 16.9 mm-40 -67.32 -29.71 69.36 Favored 'General case' 0 CA--C 1.532 0.28 0 CA-C-N 119.179 0.9 . . . . 0.0 110.334 171.392 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . 0.279 5.3 p -90.83 11.17 2.49 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.927 0 CA-C-N 118.552 0.615 . . . . 0.0 111.289 169.183 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 77.82 17.64 78.34 Favored Glycine 0 CA--C 1.531 1.034 0 C-N-CA 124.677 1.132 . . . . 0.0 113.65 173.773 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 6.9 mt -108.9 138.11 37.63 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.186 0 CA-C-N 118.723 1.262 . . . . 0.0 110.454 -175.374 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 4.3 t70 -90.07 138.36 31.57 Favored 'General case' 0 C--O 1.234 0.275 0 C-N-CA 123.929 0.891 . . . . 0.0 108.773 169.301 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 13.7 pt -130.5 -30.38 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.438 0 C-N-CA 124.67 1.188 . . . . 0.0 110.182 169.492 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -42.18 -35.87 1.06 Allowed 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 127.471 2.308 . . . . 0.0 114.253 169.035 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -65.55 -13.54 58.77 Favored Glycine 0 CA--C 1.53 1.02 0 C-N-CA 124.031 0.824 . . . . 0.0 113.506 -179.862 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 28.0 mt-30 -72.28 154.33 41.04 Favored 'General case' 0 N--CA 1.442 -0.84 0 CA-C-N 118.753 1.276 . . . . 0.0 111.372 172.589 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 2.4 p -152.11 161.7 42.23 Favored 'General case' 0 N--CA 1.433 -1.312 0 C-N-CA 129.826 3.25 . . . . 0.0 103.605 167.702 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 49.9 m -112.72 97.01 6.29 Favored 'General case' 0 C--O 1.234 0.287 0 N-CA-C 108.76 -0.83 . . . . 0.0 108.76 -170.444 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -68.84 152.85 96.56 Favored Pre-proline 0 C--O 1.241 0.646 0 N-CA-C 107.558 -1.275 . . . . 0.0 107.558 169.183 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -59.78 135.74 65.71 Favored 'Trans proline' 0 N--CA 1.449 -1.129 0 C-N-CA 121.531 1.487 . . . . 0.0 108.447 170.168 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 2.1 tt -61.77 -19.13 20.59 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.622 0 C-N-CA 123.703 0.801 . . . . 0.0 110.767 -179.445 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 12.8 mt-10 -66.32 -24.37 66.52 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 126.089 1.756 . . . . 0.0 110.669 179.418 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 13.3 t-20 -69.25 -0.45 6.16 Favored 'General case' 0 CA--C 1.546 0.798 0 C-N-CA 124.822 1.249 . . . . 0.0 112.603 176.346 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 14.0 m-85 -137.22 -170.95 2.84 Favored 'General case' 0 C--O 1.236 0.392 0 C-N-CA 127.604 2.362 . . . . 0.0 108.245 -179.155 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 57.0 t-20 -141.08 141.87 34.21 Favored 'General case' 0 N--CA 1.45 -0.46 0 N-CA-C 107.657 -1.238 . . . . 0.0 107.657 169.577 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -71.8 -28.85 63.88 Favored 'General case' 0 N--CA 1.434 -1.267 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 178.98 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 36.6 t70 -65.86 -20.98 66.42 Favored 'General case' 0 CA--C 1.546 0.799 0 C-N-CA 120.582 -0.447 . . . . 0.0 111.015 -177.806 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -80.18 -28.91 38.64 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 124.677 1.191 . . . . 0.0 111.79 173.999 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 8.0 m-85 -77.57 169.84 17.61 Favored 'General case' 0 C--O 1.238 0.465 0 C-N-CA 125.152 1.381 . . . . 0.0 111.8 179.956 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 23.5 t70 -118.3 -39.98 2.99 Favored 'General case' 0 C--O 1.235 0.33 0 C-N-CA 123.437 0.695 . . . . 0.0 111.606 178.593 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -139.44 134.49 39.73 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.395 0 CA-C-O 121.393 0.616 . . . . 0.0 110.113 -170.111 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 70.5 t -145.52 129.7 11.81 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.495 0 N-CA-C 105.554 -2.017 . . . . 0.0 105.554 179.424 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 11.6 mm -104.85 130.55 55.7 Favored 'Isoleucine or valine' 0 C--O 1.236 0.392 0 N-CA-C 106.759 -1.571 . . . . 0.0 106.759 176.484 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 37.5 m -96.87 91.2 5.53 Favored 'General case' 0 N--CA 1.446 -0.672 0 N-CA-C 104.677 -2.342 . . . . 0.0 104.677 169.028 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 33.9 mt -61.62 -12.86 17.8 Favored 'General case' 0 N--CA 1.465 0.314 0 C-N-CA 123.399 0.68 . . . . 0.0 112.748 -175.368 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 56.7 m -143.54 134.65 25.67 Favored 'General case' 0 N--CA 1.445 -0.696 0 N-CA-C 106.075 -1.824 . . . . 0.0 106.075 179.194 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 57.03 -146.3 36.17 Favored Glycine 0 CA--C 1.533 1.195 0 C-N-CA 123.452 0.548 . . . . 0.0 111.826 178.929 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 19.6 p -127.23 -93.56 0.47 Allowed 'General case' 0 CA--C 1.529 0.172 0 C-N-CA 124.052 0.941 . . . . 0.0 108.822 174.163 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -72.85 -27.5 68.81 Favored Glycine 0 C--N 1.337 0.602 0 CA-C-O 118.898 -0.945 . . . . 0.0 112.482 -178.442 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.422 HG23 ' H ' ' A' ' 85' ' ' ASN 0.325 16.0 m 47.18 -94.04 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.545 0.754 0 C-N-CA 126.404 1.882 . . . . 0.0 112.602 179.452 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . 0.422 ' H ' HG23 ' A' ' 84' ' ' VAL . 53.0 t30 -142.91 45.4 1.58 Allowed 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 126.105 1.762 . . . . 0.0 108.068 178.408 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -143.14 147.08 39.4 Favored Pre-proline 0 CA--C 1.548 0.88 0 C-N-CA 125.408 1.483 . . . . 0.0 110.624 -168.89 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_exo -64.67 150.3 88.4 Favored 'Trans proline' 0 C--N 1.357 1.005 0 C-N-CA 122.08 1.853 . . . . 0.0 114.498 -170.973 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -67.19 -33.52 30.79 Favored 'Trans proline' 0 N--CA 1.458 -0.616 0 C-N-CA 122.795 2.33 . . . . 0.0 116.014 -169.204 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 3.1 pm0 -63.33 -15.26 56.84 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-N 121.573 1.988 . . . . 0.0 112.045 -178.719 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 98.2 m95 -76.51 -22.95 53.76 Favored 'General case' 0 N--CA 1.452 -0.341 0 CA-C-O 118.835 -0.602 . . . . 0.0 111.953 174.597 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 28.3 m -104.46 -6.85 9.63 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.488 0 C-N-CA 124.832 1.253 . . . . 0.0 113.163 178.023 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . 0.271 9.3 t -112.73 70.62 0.72 Allowed 'General case' 0 CA--C 1.537 0.454 0 CA-C-O 123.441 1.591 . . . . 0.0 107.539 168.899 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 60.4 mm-40 -100.67 179.46 4.41 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 126.545 1.938 . . . . 0.0 109.084 175.067 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 37.7 mm-40 -64.95 -24.18 67.44 Favored 'General case' 0 CA--C 1.539 0.543 0 O-C-N 121.743 -0.598 . . . . 0.0 110.94 179.892 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 6.9 tt -139.63 130.08 31.33 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.354 0 N-CA-C 105.807 -1.923 . . . . 0.0 105.807 169.329 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 36.8 t80 -113.36 135.54 53.75 Favored 'General case' 0 CA--C 1.536 0.41 0 N-CA-C 105.713 -1.958 . . . . 0.0 105.713 169.643 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 11.1 mm-40 -142.44 163.29 33.23 Favored 'General case' 0 C--O 1.232 0.165 0 C-N-CA 124.311 1.044 . . . . 0.0 109.524 179.666 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 2.7 t70 -172.46 129.64 0.56 Allowed 'General case' 0 C--O 1.237 0.422 0 C-N-CA 127.594 2.358 . . . . 0.0 107.07 -169.366 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 5.9 m0 -144.58 153.5 41.87 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-O 120.99 0.424 . . . . 0.0 111.936 -170.637 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 2.3 mp0 -87.48 51.87 2.34 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 124.527 1.131 . . . . 0.0 109.456 175.789 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -67.42 134.59 51.7 Favored 'General case' 0 C--N 1.339 0.136 0 N-CA-C 106.5 -1.667 . . . . 0.0 106.5 169.823 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 6.4 pt-20 -83.18 171.55 13.56 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 123.488 0.715 . . . . 0.0 110.192 175.448 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -131.6 133.27 24.1 Favored Pre-proline 0 C--O 1.238 0.459 0 C-N-CA 125.849 1.66 . . . . 0.0 109.804 -169.805 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 10.6 Cg_endo -97.93 2.5 1.41 Allowed 'Trans proline' 0 N--CA 1.451 -1.004 0 C-N-CA 123.003 2.469 . . . . 0.0 113.538 -174.799 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 8.0 t70 -50.61 115.84 1.66 Allowed 'General case' 0 CA--C 1.538 0.518 0 CA-C-N 120.486 1.494 . . . . 0.0 110.787 -174.113 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 67.47 5.5 36.68 Favored Glycine 0 CA--C 1.537 1.434 0 CA-C-O 119.014 -0.881 . . . . 0.0 114.61 178.172 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 5.6 mt-30 -87.32 172.46 9.84 Favored 'General case' 0 CA--C 1.54 0.583 0 CA-C-N 118.998 1.399 . . . . 0.0 109.869 178.495 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 15.5 m -68.95 161.19 29.37 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 123.854 0.862 . . . . 0.0 110.559 176.897 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 28.1 mt -63.36 -24.42 67.84 Favored 'General case' 0 N--CA 1.47 0.561 0 O-C-N 121.491 -0.756 . . . . 0.0 112.499 -173.02 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 6.0 pt-20 -55.19 -35.49 64.89 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 118.875 0.761 . . . . 0.0 111.189 172.346 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 10.9 t -76.82 -42.08 33.02 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.398 0 CA-C-O 118.433 -0.794 . . . . 0.0 109.189 -178.811 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 55.4 m-85 -57.24 -45.36 83.99 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-N 120.222 1.374 . . . . 0.0 110.296 172.529 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 90.9 mtt180 -63.27 -43.82 96.86 Favored 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 123.327 0.651 . . . . 0.0 110.584 179.548 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 4.2 m -62.14 -45.6 92.7 Favored 'General case' 0 N--CA 1.448 -0.542 0 C-N-CA 124.518 1.127 . . . . 0.0 110.275 177.168 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 60.2 t -67.21 -39.34 82.82 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.404 0 CA-C-O 118.593 -0.718 . . . . 0.0 109.25 -174.892 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 44.0 mtm105 -57.41 -42.89 83.2 Favored 'General case' 0 CA--C 1.536 0.431 0 CA-C-N 119.31 0.959 . . . . 0.0 110.397 174.913 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -63.37 -54.13 34.4 Favored Glycine 0 CA--C 1.533 1.158 0 CA-C-O 119.576 -0.569 . . . . 0.0 112.08 177.548 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 13.3 mm-40 -51.65 -51.52 55.11 Favored 'General case' 0 N--CA 1.468 0.47 0 C-N-CA 124.66 1.184 . . . . 0.0 110.204 178.215 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 86.1 t -67.74 -48.17 76.95 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 115.186 -0.916 . . . . 0.0 109.684 -173.114 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 62.0 tttm -55.06 -47.51 74.74 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 119.388 0.995 . . . . 0.0 109.711 -175.033 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -64.68 -43.32 93.93 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 122.917 0.487 . . . . 0.0 111.214 -175.469 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 20.8 mtt180 -75.1 -33.97 61.67 Favored 'General case' 0 N--CA 1.469 0.511 0 O-C-N 121.277 -0.889 . . . . 0.0 111.623 -178.179 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 59.5 t -67.34 -39.8 83.51 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.419 0 N-CA-C 108.62 -0.882 . . . . 0.0 108.62 173.674 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 22.8 mt-10 -59.45 -43.05 93.27 Favored 'General case' 0 N--CA 1.462 0.157 0 CA-C-N 119.938 1.245 . . . . 0.0 110.403 174.112 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 29.2 t-20 -63.55 -43.39 97.19 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 123.151 0.58 . . . . 0.0 111.371 -178.918 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 1.9 tm? -59.1 -47.22 86.06 Favored 'General case' 0 N--CA 1.456 -0.152 0 C-N-CA 125.063 1.345 . . . . 0.0 110.947 175.253 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 84.8 mt -65.17 -46.09 92.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 N-CA-C 108.302 -0.999 . . . . 0.0 108.302 179.985 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -59.23 -29.62 67.65 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 123.431 0.692 . . . . 0.0 112.073 177.099 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 69.1 mttt -69.09 -55.21 11.43 Favored 'General case' 0 C--N 1.343 0.311 0 CA-C-N 119.033 0.833 . . . . 0.0 110.385 172.707 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 17.1 pt -78.7 -36.76 19.87 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.335 0 N-CA-C 114.854 1.427 . . . . 0.0 114.854 -169.609 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 75.3 m . . . . . 0 C--O 1.253 1.26 0 C-N-CA 126.185 1.794 . . . . 0.0 109.117 -169.898 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 12.3 ptm . . . . . 0 N--CA 1.497 1.877 0 CA-C-O 120.17 0.033 . . . . 0.0 110.987 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 26.7 mttm -71.08 127.49 32.75 Favored 'General case' 0 N--CA 1.478 0.945 0 N-CA-C 107.682 -1.229 . . . . 0.0 107.682 -174.496 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 72.7 mttt -97.91 133.71 42.03 Favored 'General case' 0 CA--C 1.512 -0.502 0 CA-C-N 119.785 1.175 . . . . 0.0 108.059 172.199 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 11.7 t -113.21 151.21 15.12 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.605 0 C-N-CA 127.237 2.215 . . . . 0.0 106.568 -170.916 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 52.3 ttm -146.43 141.94 27.65 Favored 'General case' 0 C--N 1.32 -0.676 0 C-N-CA 125.544 1.538 . . . . 0.0 108.708 174.751 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 47.4 m-85 -131.63 103.72 6.54 Favored 'General case' 0 CA--C 1.519 -0.233 0 N-CA-C 106.088 -1.819 . . . . 0.0 106.088 175.216 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 11.0 t -134.83 137.84 50.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 118.629 0.65 . . . . 0.0 110.812 -168.912 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 44.8 t -121.08 -171.66 2.24 Favored 'General case' 0 CA--C 1.548 0.875 0 N-CA-C 104.594 -2.373 . . . . 0.0 104.594 168.53 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 60.2 mtpt -57.18 -67.62 0.3 Allowed 'General case' 0 N--CA 1.471 0.617 0 CA-C-N 120.007 1.276 . . . . 0.0 111.365 -171.191 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 29.3 ttm-85 -111.8 132.83 54.41 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-N 119.47 1.032 . . . . 0.0 108.221 -178.759 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 12.6 t30 -54.56 -34.84 62.53 Favored 'General case' 0 N--CA 1.478 0.943 0 N-CA-C 114.177 1.177 . . . . 0.0 114.177 -169.665 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 5.7 m -57.94 -20.56 38.5 Favored 'General case' 0 CA--C 1.537 0.464 0 N-CA-C 114.242 1.201 . . . . 0.0 114.242 -170.373 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 21.2 m -134.13 151.79 51.53 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 124.513 1.125 . . . . 0.0 109.652 176.828 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 90.5 mtm-85 55.01 40.78 32.15 Favored 'General case' 0 N--CA 1.467 0.414 0 C-N-CA 126.024 1.729 . . . . 0.0 112.346 175.845 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 13.6 m -136.43 -73.78 0.44 Allowed 'General case' 0 CA--C 1.534 0.353 0 N-CA-C 104.052 -2.573 . . . . 0.0 104.052 169.044 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER 40.89 -109.81 0.11 Allowed 'General case' 0 N--CA 1.454 -0.244 0 C-N-CA 127.607 2.363 . . . . 0.0 112.135 168.017 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -76.54 -14.55 60.01 Favored 'General case' 0 CA--C 1.518 -0.261 0 N-CA-C 113.819 1.044 . . . . 0.0 113.819 -169.964 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -63.86 -50.58 68.27 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 119.608 1.094 . . . . 0.0 111.415 -169.135 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -66.82 -38.07 85.74 Favored 'General case' 0 N--CA 1.467 0.405 0 N-CA-C 109.573 -0.529 . . . . 0.0 109.573 173.39 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -55.69 -55.71 27.43 Favored Glycine 0 C--N 1.338 0.645 0 N-CA-C 110.881 -0.888 . . . . 0.0 110.881 -176.959 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 4.8 m-85 -65.9 -32.17 73.52 Favored 'General case' 0 CA--C 1.506 -0.718 0 CA-C-O 118.587 -0.72 . . . . 0.0 111.787 178.484 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -68.84 -32.92 72.95 Favored 'General case' 0 N--CA 1.446 -0.674 0 CA-C-N 118.965 0.802 . . . . 0.0 110.72 -178.051 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.74 -36.97 86.03 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-N 119.504 1.047 . . . . 0.0 110.066 172.256 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 19.0 m -70.09 -56.89 5.76 Favored 'General case' 0 N--CA 1.45 -0.429 0 C-N-CA 124.236 1.014 . . . . 0.0 112.26 -179.939 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 41.7 mt -75.19 -38.23 60.89 Favored 'General case' 0 N--CA 1.466 0.359 0 C-N-CA 124.809 1.244 . . . . 0.0 109.891 -173.513 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -82.51 4.13 79.38 Favored Glycine 0 CA--C 1.526 0.756 0 C-N-CA 125.585 1.564 . . . . 0.0 113.19 179.796 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -53.79 133.22 42.41 Favored 'General case' 0 C--O 1.236 0.358 0 CA-C-N 118.793 1.297 . . . . 0.0 109.279 178.913 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 70.19 8.57 62.18 Favored Glycine 0 CA--C 1.533 1.196 0 CA-C-O 118.444 -1.198 . . . . 0.0 114.969 177.837 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 9.8 ptpp? -137.01 -36.59 0.67 Allowed 'General case' 0 N--CA 1.473 0.724 0 CA-C-N 119.744 1.772 . . . . 0.0 113.079 179.727 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 17.6 pt -141.22 148.73 21.06 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.568 0 CA-C-N 119.807 1.185 . . . . 0.0 109.723 -177.477 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -95.26 158.22 15.55 Favored 'General case' 0 N--CA 1.467 0.412 0 C-N-CA 125.322 1.449 . . . . 0.0 108.181 176.81 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 21.7 t -141.34 134.19 30.0 Favored 'Isoleucine or valine' 0 C--O 1.236 0.374 0 N-CA-C 107.872 -1.159 . . . . 0.0 107.872 -176.421 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 26.7 m -147.23 113.41 5.86 Favored 'General case' 0 N--CA 1.44 -0.964 0 N-CA-C 106.751 -1.574 . . . . 0.0 106.751 171.711 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 50.3 m -99.65 97.8 8.72 Favored 'General case' 0 N--CA 1.449 -0.516 0 N-CA-C 108.423 -0.955 . . . . 0.0 108.423 169.578 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 7.7 p -68.07 -66.46 0.56 Allowed 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 125.566 1.546 . . . . 0.0 111.322 -175.952 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 110.17 135.07 6.96 Favored Glycine 0 CA--C 1.523 0.581 0 N-CA-C 108.428 -1.869 . . . . 0.0 108.428 -171.436 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 5.9 mt -70.71 -36.96 73.48 Favored 'General case' 0 CA--C 1.529 0.15 0 N-CA-C 109.003 -0.74 . . . . 0.0 109.003 171.31 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 34.4 mt-10 -126.77 160.97 29.3 Favored 'General case' 0 N--CA 1.445 -0.702 0 C-N-CA 129.624 3.17 . . . . 0.0 105.691 169.259 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 54.6 p -150.86 145.51 25.72 Favored 'General case' 0 N--CA 1.445 -0.715 0 N-CA-C 114.003 1.112 . . . . 0.0 114.003 -173.192 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 3.1 m -147.3 -82.94 0.12 Allowed 'General case' 0 N--CA 1.452 -0.351 0 CA-C-N 113.117 -1.856 . . . . 0.0 108.271 -173.119 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 5.8 ttp180 -159.22 -154.01 0.39 Allowed 'General case' 0 N--CA 1.466 0.339 0 N-CA-C 109.33 -0.619 . . . . 0.0 109.33 -179.29 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 2.9 p -133.12 148.79 31.19 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.7 0 C-N-CA 128.2 2.6 . . . . 0.0 105.529 177.988 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 81.5 t60 -73.38 136.97 78.16 Favored Pre-proline 0 CA--C 1.544 0.725 0 CA-C-O 118.646 -0.692 . . . . 0.0 110.5 -169.759 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 28.6 Cg_endo -60.75 -49.1 9.23 Favored 'Trans proline' 0 C--N 1.35 0.626 0 C-N-CA 123.181 2.587 . . . . 0.0 112.962 -172.918 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 18.5 m -67.05 -20.13 65.79 Favored 'General case' 0 CA--C 1.536 0.416 0 O-C-N 121.95 -0.469 . . . . 0.0 110.526 -177.881 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -59.52 -52.32 66.08 Favored 'General case' 0 CA--C 1.506 -0.737 0 N-CA-C 108.838 -0.801 . . . . 0.0 108.838 173.87 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 60.0 mt -56.89 -42.27 78.05 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 N-CA-C 108.729 -0.841 . . . . 0.0 108.729 -171.621 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -64.23 -47.95 77.7 Favored 'General case' 0 N--CA 1.45 -0.429 0 CA-C-N 117.826 0.285 . . . . 0.0 111.509 -179.798 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 38.9 mmt -69.26 -35.37 76.02 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-O 122.747 1.261 . . . . 0.0 110.76 -178.521 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -73.26 -33.05 65.06 Favored 'General case' 0 N--CA 1.443 -0.82 0 N-CA-C 106.887 -1.523 . . . . 0.0 106.887 -177.662 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 6.6 tp10 -70.24 -20.29 63.08 Favored 'General case' 0 N--CA 1.449 -0.522 0 C-N-CA 123.645 0.778 . . . . 0.0 110.775 170.807 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 81.5 mt-10 -64.26 -38.65 91.8 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-N 119.773 1.17 . . . . 0.0 109.353 169.666 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . 0.306 9.7 p -83.43 7.35 1.55 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.771 0 CA-C-O 120.805 0.336 . . . . 0.0 111.81 171.252 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 74.45 23.57 75.15 Favored Glycine 0 CA--C 1.531 1.071 0 O-C-N 120.838 -1.164 . . . . 0.0 113.028 175.981 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 38.4 mt -117.12 131.88 68.52 Favored 'Isoleucine or valine' 0 C--N 1.338 0.068 0 C-N-CA 124.831 1.252 . . . . 0.0 108.584 -176.552 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 34.6 t0 -101.59 146.39 27.75 Favored 'General case' 0 C--O 1.235 0.318 0 CA-C-O 121.028 0.442 . . . . 0.0 110.238 170.794 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 12.2 pt -135.98 -9.6 0.84 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.461 0 C-N-CA 127.081 2.152 . . . . 0.0 110.836 176.145 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 7.7 t -43.31 131.82 4.6 Favored 'General case' 0 CA--C 1.542 0.663 0 CA-C-N 120.249 1.386 . . . . 0.0 109.325 168.971 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 71.92 38.37 60.24 Favored Glycine 0 CA--C 1.532 1.114 0 CA-C-O 118.917 -0.935 . . . . 0.0 113.082 -177.299 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 29.9 mt-30 -56.25 -40.94 74.95 Favored 'General case' 0 N--CA 1.473 0.679 0 CA-C-N 118.888 1.344 . . . . 0.0 110.478 169.995 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -66.17 134.59 53.06 Favored 'General case' 0 N--CA 1.447 -0.592 0 C-N-CA 124.177 0.991 . . . . 0.0 109.413 -170.0 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 2.9 p -140.2 -68.77 0.41 Allowed 'General case' 0 C--O 1.233 0.226 0 C-N-CA 124.018 0.927 . . . . 0.0 108.929 -169.657 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -148.54 154.6 41.45 Favored Pre-proline 0 C--O 1.238 0.484 0 C-N-CA 126.021 1.728 . . . . 0.0 107.478 174.595 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -62.71 151.81 81.7 Favored 'Trans proline' 0 N--CA 1.456 -0.734 0 C-N-CA 121.831 1.687 . . . . 0.0 109.34 170.027 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 18.2 tt -56.19 -28.78 26.17 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.439 0 C-N-CA 123.25 0.62 . . . . 0.0 111.741 -178.687 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 11.4 mt-10 -66.72 -26.69 67.12 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 124.563 1.145 . . . . 0.0 110.689 -174.83 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 11.2 t-20 -63.6 -30.97 72.0 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 124.833 1.253 . . . . 0.0 111.611 178.424 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 94.1 m-85 -92.12 -178.11 4.88 Favored 'General case' 0 C--O 1.235 0.328 0 C-N-CA 125.269 1.428 . . . . 0.0 111.139 -176.61 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 54.6 t-20 -124.11 137.77 54.52 Favored 'General case' 0 N--CA 1.443 -0.79 0 N-CA-C 106.756 -1.572 . . . . 0.0 106.756 168.654 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -73.58 -24.4 60.07 Favored 'General case' 0 N--CA 1.433 -1.29 0 N-CA-C 109.187 -0.671 . . . . 0.0 109.187 -178.048 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 36.1 t70 -67.32 -20.56 65.62 Favored 'General case' 0 N--CA 1.447 -0.618 0 C-N-CA 121.221 -0.192 . . . . 0.0 111.474 -178.611 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 37.1 t70 -75.75 -29.07 58.73 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 123.526 0.73 . . . . 0.0 111.61 175.186 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 33.0 m-85 -80.17 167.24 20.6 Favored 'General case' 0 N--CA 1.45 -0.433 0 C-N-CA 125.058 1.343 . . . . 0.0 110.613 176.558 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 24.2 t70 -117.29 -35.4 4.04 Favored 'General case' 0 C--O 1.237 0.401 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.169 175.241 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -140.04 134.77 36.99 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.697 0 CA-C-O 121.922 0.868 . . . . 0.0 108.676 -173.399 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 88.7 t -143.36 137.72 25.9 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.604 0 N-CA-C 105.786 -1.931 . . . . 0.0 105.786 178.929 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 20.6 mm -112.75 127.3 70.06 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.727 0 N-CA-C 105.781 -1.933 . . . . 0.0 105.781 177.188 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 70.6 m -89.32 99.83 12.74 Favored 'General case' 0 N--CA 1.441 -0.918 0 N-CA-C 104.196 -2.52 . . . . 0.0 104.196 169.225 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 38.3 mt -69.56 -2.04 10.38 Favored 'General case' 0 N--CA 1.464 0.244 0 O-C-N 121.484 -0.76 . . . . 0.0 112.386 -178.578 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 85.4 m -139.58 135.05 32.96 Favored 'General case' 0 N--CA 1.441 -0.887 0 N-CA-C 106.988 -1.486 . . . . 0.0 106.988 170.149 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 48.43 -142.18 8.59 Favored Glycine 0 CA--C 1.535 1.301 0 C-N-CA 125.148 1.356 . . . . 0.0 113.148 175.123 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 13.2 m -127.48 -85.64 0.59 Allowed 'General case' 0 CA--C 1.529 0.165 0 N-CA-C 107.585 -1.265 . . . . 0.0 107.585 175.993 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -84.55 66.66 3.84 Favored Glycine 0 C--N 1.338 0.694 0 N-CA-C 110.145 -1.182 . . . . 0.0 110.145 175.226 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 6.5 m -77.78 65.28 0.26 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.575 0 C-N-CA 124.071 0.948 . . . . 0.0 110.891 -178.094 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 52.1 t30 54.36 54.05 10.0 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 126.4 1.88 . . . . 0.0 108.249 -172.611 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -133.14 142.32 44.03 Favored Pre-proline 0 CA--C 1.539 0.544 0 C-N-CA 126.604 1.962 . . . . 0.0 108.506 -168.867 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -66.97 135.38 37.53 Favored 'Trans proline' 0 CA--C 1.541 0.857 0 C-N-CA 121.798 1.665 . . . . 0.0 110.611 176.6 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 42.1 Cg_endo -63.24 -23.99 72.4 Favored 'Trans proline' 0 N--CA 1.461 -0.439 0 C-N-CA 122.746 2.297 . . . . 0.0 114.315 -169.721 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 5.7 pm0 -56.21 -21.67 24.67 Favored 'General case' 0 CA--C 1.539 0.521 0 CA-C-N 119.529 1.059 . . . . 0.0 112.133 175.95 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 99.3 m95 -82.64 -21.78 34.91 Favored 'General case' 0 N--CA 1.454 -0.251 0 N-CA-C 113.13 0.789 . . . . 0.0 113.13 179.979 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 5.5 m -92.94 -34.86 6.19 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.351 0 CA-C-N 120.117 1.326 . . . . 0.0 110.998 172.518 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . 0.266 6.3 t -87.22 46.01 1.33 Allowed 'General case' 0 CA--C 1.548 0.869 0 CA-C-O 123.409 1.576 . . . . 0.0 110.497 -174.85 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 68.6 mm-40 -79.0 -178.81 6.3 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 126.851 2.061 . . . . 0.0 109.218 171.338 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 35.1 mm-40 -67.22 -18.38 65.21 Favored 'General case' 0 CA--C 1.539 0.554 0 O-C-N 121.572 -0.705 . . . . 0.0 111.87 -178.629 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 7.4 tt -143.2 135.03 24.02 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.381 0 C-N-CA 125.642 1.577 . . . . 0.0 106.88 170.035 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 32.4 t80 -110.21 135.26 51.25 Favored 'General case' 0 CA--C 1.535 0.373 0 N-CA-C 106.186 -1.783 . . . . 0.0 106.186 169.386 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 31.2 mm-40 -144.73 164.09 32.04 Favored 'General case' 0 C--O 1.238 0.452 0 C-N-CA 123.971 0.908 . . . . 0.0 108.689 170.21 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -169.87 130.67 1.02 Allowed 'General case' 0 N--CA 1.45 -0.458 0 C-N-CA 127.969 2.508 . . . . 0.0 106.889 -170.585 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 5.1 m-90 -150.14 141.21 23.01 Favored 'General case' 0 N--CA 1.453 -0.315 0 N-CA-C 107.947 -1.131 . . . . 0.0 107.947 -171.231 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 63.0 tt0 -82.26 77.98 8.99 Favored 'General case' 0 CA--C 1.536 0.416 0 N-CA-C 108.219 -1.03 . . . . 0.0 108.219 179.095 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 10.1 mp -71.51 119.1 15.18 Favored 'General case' 0 N--CA 1.462 0.157 0 N-CA-C 107.023 -1.473 . . . . 0.0 107.023 171.056 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -79.35 112.91 17.05 Favored 'General case' 0 N--CA 1.449 -0.524 0 N-CA-C 106.085 -1.821 . . . . 0.0 106.085 170.069 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 11.2 t70 -76.32 133.99 70.87 Favored Pre-proline 0 C--O 1.239 0.501 0 CA-C-O 118.928 -0.558 . . . . 0.0 109.833 -177.021 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -78.7 3.13 7.55 Favored 'Trans proline' 0 CA--C 1.545 1.071 0 C-N-CA 123.01 2.473 . . . . 0.0 113.971 -177.435 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 2.1 t70 -36.7 112.68 0.2 Allowed 'General case' 0 C--O 1.239 0.538 0 C-N-CA 126.196 1.798 . . . . 0.0 111.778 171.876 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 68.58 5.31 43.64 Favored Glycine 0 CA--C 1.537 1.462 0 CA-C-O 118.813 -0.993 . . . . 0.0 115.038 175.172 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 33.7 mm-40 -80.47 174.37 11.67 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-N 119.41 1.605 . . . . 0.0 110.45 178.412 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 15.3 m -68.96 156.9 37.77 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 123.729 0.811 . . . . 0.0 109.9 169.683 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -65.15 -26.25 68.09 Favored 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 123.429 0.692 . . . . 0.0 111.641 -172.29 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 6.9 pt-20 -56.33 -34.85 66.95 Favored 'General case' 0 N--CA 1.462 0.164 0 C-N-CA 123.29 0.636 . . . . 0.0 111.279 173.072 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 13.2 t -76.89 -45.59 31.05 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.362 0 CA-C-O 118.27 -0.871 . . . . 0.0 108.987 -176.724 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 67.2 m-85 -50.62 -50.45 54.15 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-N 119.691 1.132 . . . . 0.0 110.211 169.643 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 94.5 mtt180 -69.4 -34.6 74.74 Favored 'General case' 0 N--CA 1.466 0.349 0 O-C-N 121.887 -0.508 . . . . 0.0 110.901 -173.291 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 2.7 m -61.56 -49.64 75.86 Favored 'General case' 0 N--CA 1.45 -0.452 0 C-N-CA 124.162 0.985 . . . . 0.0 109.407 169.947 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 81.7 t -70.35 -27.18 30.83 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.182 0 CA-C-O 118.417 -0.801 . . . . 0.0 109.761 -170.972 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 14.2 mtm105 -56.72 -48.98 76.54 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-N 119.644 1.111 . . . . 0.0 109.646 169.956 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -63.02 -48.18 82.56 Favored Glycine 0 CA--C 1.527 0.784 0 N-CA-C 111.614 -0.594 . . . . 0.0 111.614 179.235 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 9.9 mt-30 -62.29 -45.41 93.37 Favored 'General case' 0 C--N 1.342 0.24 0 CA-C-N 117.676 0.738 . . . . 0.0 110.952 -177.209 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 86.9 t -67.75 -42.32 86.09 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.189 0 CA-C-O 118.229 -0.891 . . . . 0.0 110.557 -178.911 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 59.1 tttm -53.81 -46.6 71.15 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 119.307 0.958 . . . . 0.0 109.337 179.908 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -65.19 -43.52 91.37 Favored 'General case' 0 N--CA 1.45 -0.464 0 C-N-CA 122.964 0.506 . . . . 0.0 111.139 -175.97 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 49.4 mtt-85 -65.5 -44.54 86.7 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-N 118.719 0.69 . . . . 0.0 111.303 178.554 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 98.0 t -66.15 -40.19 86.41 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.472 0 N-CA-C 109.204 -0.665 . . . . 0.0 109.204 179.024 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 16.6 mt-10 -60.25 -42.52 95.5 Favored 'General case' 0 N--CA 1.46 0.047 0 CA-C-N 119.751 1.16 . . . . 0.0 110.488 176.153 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 29.0 t-20 -62.68 -44.67 95.66 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 122.712 0.405 . . . . 0.0 110.998 178.977 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 34.8 tp -58.08 -49.2 77.75 Favored 'General case' 0 N--CA 1.455 -0.208 0 C-N-CA 124.26 1.024 . . . . 0.0 110.772 176.992 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 89.8 mt -63.55 -44.62 98.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 N-CA-C 108.043 -1.095 . . . . 0.0 108.043 -179.524 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -61.07 -28.37 69.03 Favored 'General case' 0 CA--C 1.54 0.58 0 CA-C-N 118.654 0.661 . . . . 0.0 112.19 177.545 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 93.5 mttt -70.03 -56.13 7.76 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-N 119.391 0.996 . . . . 0.0 110.69 171.183 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 14.9 pt -78.13 -44.41 27.59 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.424 0 N-CA-C 114.969 1.47 . . . . 0.0 114.969 -168.925 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 69.8 m . . . . . 0 C--O 1.252 1.217 0 C-N-CA 126.011 1.724 . . . . 0.0 109.945 -169.772 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.497 1.906 0 N-CA-C 110.365 -0.235 . . . . 0.0 110.365 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 31.2 mttm -79.1 118.64 21.25 Favored 'General case' 0 N--CA 1.474 0.742 0 N-CA-C 105.787 -1.931 . . . . 0.0 105.787 171.84 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 89.2 mttt -86.06 134.11 33.85 Favored 'General case' 0 CA--C 1.513 -0.464 0 N-CA-C 107.69 -1.226 . . . . 0.0 107.69 178.465 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 1.5 t -119.8 148.82 22.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 C-N-CA 125.535 1.534 . . . . 0.0 109.0 -169.006 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 3.2 mtt -135.88 146.82 47.81 Favored 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 125.872 1.669 . . . . 0.0 108.434 169.255 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 90.6 m-85 -132.5 95.42 3.62 Favored 'General case' 0 N--CA 1.457 -0.099 0 N-CA-C 105.165 -2.161 . . . . 0.0 105.165 171.495 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 42.3 t -131.29 129.98 62.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 N-CA-C 109.675 -0.491 . . . . 0.0 109.675 -169.049 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 41.1 t -99.07 -177.76 3.72 Favored 'General case' 0 CA--C 1.547 0.857 0 C-N-CA 125.754 1.622 . . . . 0.0 106.922 169.101 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -56.48 -39.2 72.82 Favored 'General case' 0 N--CA 1.478 0.932 0 O-C-N 120.587 -1.32 . . . . 0.0 111.292 -176.532 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 79.1 mtp180 -119.89 168.65 10.9 Favored 'General case' 0 N--CA 1.465 0.308 0 N-CA-C 107.106 -1.442 . . . . 0.0 107.106 169.156 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 29.1 t30 -65.13 -28.61 69.55 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 120.563 -0.455 . . . . 0.0 110.784 169.601 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 1.5 m -56.15 124.15 16.9 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 125.165 1.386 . . . . 0.0 110.548 179.644 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 8.5 m 65.72 150.2 0.05 OUTLIER 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 126.256 1.822 . . . . 0.0 113.302 178.872 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 1.5 mmm180 68.34 -58.33 0.47 Allowed 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 127.455 2.302 . . . . 0.0 111.869 177.12 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 1.7 m -63.83 -17.15 62.83 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 125.436 1.495 . . . . 0.0 112.719 -175.214 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 21.7 pt20 -62.17 -63.01 1.38 Allowed 'General case' 0 C--N 1.343 0.289 0 CA-C-N 119.285 0.948 . . . . 0.0 111.585 176.7 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 1.1 tpt -78.56 -32.57 47.85 Favored 'General case' 0 N--CA 1.465 0.291 0 O-C-N 121.56 -0.713 . . . . 0.0 112.209 -169.61 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -64.58 -51.38 63.03 Favored 'General case' 0 N--CA 1.469 0.488 0 N-CA-C 112.346 0.499 . . . . 0.0 112.346 -170.955 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -65.68 -31.45 72.47 Favored 'General case' 0 N--CA 1.469 0.491 0 O-C-N 121.505 -0.747 . . . . 0.0 110.198 172.811 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -49.12 -55.42 12.14 Favored Glycine 0 C--N 1.342 0.895 0 C-N-CA 125.89 1.709 . . . . 0.0 110.518 175.149 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 8.8 m-85 -73.99 -29.74 62.13 Favored 'General case' 0 CA--C 1.508 -0.655 0 CA-C-N 119.072 1.436 . . . . 0.0 113.811 178.806 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -67.85 -31.7 71.71 Favored 'General case' 0 N--CA 1.451 -0.408 0 C-N-CA 119.459 -0.896 . . . . 0.0 111.318 -169.989 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 6.7 ptpt -62.06 -34.35 76.1 Favored 'General case' 0 N--CA 1.476 0.835 0 CA-C-N 119.252 0.933 . . . . 0.0 111.498 172.108 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 12.2 m -76.46 -55.42 5.55 Favored 'General case' 0 N--CA 1.447 -0.601 0 C-N-CA 125.373 1.469 . . . . 0.0 110.183 -175.939 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 75.3 mt -74.74 -35.63 62.63 Favored 'General case' 0 CA--C 1.531 0.213 0 C-N-CA 123.455 0.702 . . . . 0.0 110.328 -174.022 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -93.04 6.81 76.45 Favored Glycine 0 CA--C 1.526 0.722 0 C-N-CA 125.118 1.342 . . . . 0.0 113.285 -175.317 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -49.67 125.45 11.57 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 125.113 1.365 . . . . 0.0 110.881 -175.105 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 76.33 -8.1 27.35 Favored Glycine 0 CA--C 1.535 1.343 0 C-N-CA 124.452 1.025 . . . . 0.0 114.287 178.801 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 64.3 mttm -102.83 -49.93 3.67 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-N 119.421 1.61 . . . . 0.0 110.384 -179.711 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 25.3 pt -136.2 149.09 27.27 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.385 0 C-N-CA 123.669 0.788 . . . . 0.0 110.34 -169.37 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -111.58 104.47 12.87 Favored 'General case' 0 C--O 1.227 -0.123 0 C-N-CA 124.962 1.305 . . . . 0.0 109.844 -169.332 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 6.5 t -87.02 132.08 33.33 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 C-N-CA 123.471 0.708 . . . . 0.0 109.669 -175.957 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 20.5 m -144.96 110.81 5.42 Favored 'General case' 0 N--CA 1.446 -0.658 0 N-CA-C 104.623 -2.362 . . . . 0.0 104.623 169.963 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 51.8 m -107.18 81.53 1.55 Allowed 'General case' 0 N--CA 1.463 0.205 0 CA-C-N 119.611 1.096 . . . . 0.0 108.233 179.661 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 3.8 m -61.16 -39.79 91.43 Favored 'General case' 0 CA--C 1.532 0.274 0 N-CA-C 114.289 1.218 . . . . 0.0 114.289 -169.261 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 92.91 137.81 8.36 Favored Glycine 0 C--N 1.338 0.671 0 N-CA-C 109.107 -1.597 . . . . 0.0 109.107 176.912 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 15.5 mt -74.51 -34.01 62.94 Favored 'General case' 0 C--N 1.331 -0.199 0 C-N-CA 124.108 0.963 . . . . 0.0 108.794 176.774 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 26.3 mt-10 -141.33 156.79 45.81 Favored 'General case' 0 N--CA 1.443 -0.805 0 C-N-CA 128.28 2.632 . . . . 0.0 105.984 168.926 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 60.9 p -109.79 148.33 31.66 Favored 'General case' 0 N--CA 1.441 -0.922 0 CA-C-O 123.106 1.431 . . . . 0.0 112.937 -175.116 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 17.1 m -170.35 162.13 8.34 Favored 'General case' 0 N--CA 1.447 -0.608 0 C-N-CA 129.389 3.076 . . . . 0.0 103.752 -169.856 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . 0.422 ' HG3' ' H ' ' A' ' 42' ' ' VAL . 6.9 tpt180 -92.14 -155.93 0.44 Allowed 'General case' 0 N--CA 1.467 0.416 0 O-C-N 121.053 -1.029 . . . . 0.0 109.656 -173.039 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.422 ' H ' ' HG3' ' A' ' 41' ' ' ARG . 0.6 OUTLIER -131.87 156.67 42.75 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 C-N-CA 129.009 2.924 . . . . 0.0 107.064 -169.446 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 62.4 m80 -85.79 144.53 39.71 Favored Pre-proline 0 N--CA 1.468 0.459 0 N-CA-C 112.317 0.488 . . . . 0.0 112.317 -169.071 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -65.06 -45.07 8.44 Favored 'Trans proline' 0 C--N 1.348 0.546 0 C-N-CA 122.904 2.403 . . . . 0.0 111.834 -176.172 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 6.5 m -69.57 -28.06 65.66 Favored 'General case' 0 CA--C 1.531 0.233 0 CA-C-O 118.977 -0.535 . . . . 0.0 110.002 179.575 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -60.46 -54.33 46.86 Favored 'General case' 0 CA--C 1.507 -0.691 0 N-CA-C 107.882 -1.155 . . . . 0.0 107.882 171.183 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 56.7 mt -58.1 -40.21 76.11 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 N-CA-C 108.657 -0.868 . . . . 0.0 108.657 -173.828 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -63.37 -49.3 74.39 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-N 118.555 0.616 . . . . 0.0 111.61 179.046 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 28.1 mmt -66.23 -36.5 83.2 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-O 122.98 1.371 . . . . 0.0 110.895 -179.712 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -78.25 -30.82 48.85 Favored 'General case' 0 N--CA 1.441 -0.875 0 N-CA-C 107.416 -1.327 . . . . 0.0 107.416 -173.335 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 41.2 tt0 -71.95 -22.14 61.5 Favored 'General case' 0 N--CA 1.447 -0.598 0 C-N-CA 123.815 0.846 . . . . 0.0 110.228 169.986 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 16.8 mm-40 -68.19 -30.73 69.89 Favored 'General case' 0 CA--C 1.534 0.361 0 CA-C-N 119.487 1.039 . . . . 0.0 110.23 171.62 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . 0.276 9.3 p -89.34 10.0 2.43 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.035 0 CA-C-N 118.514 0.597 . . . . 0.0 111.114 168.914 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 78.18 16.28 79.89 Favored Glycine 0 CA--C 1.532 1.121 0 C-N-CA 124.956 1.265 . . . . 0.0 113.76 173.8 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 13.5 mt -102.2 141.35 18.57 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.237 0 C-N-CA 124.453 1.101 . . . . 0.0 110.555 -173.574 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -94.71 137.29 33.99 Favored 'General case' 0 C--O 1.235 0.312 0 C-N-CA 124.417 1.087 . . . . 0.0 108.26 169.817 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 7.0 pt -138.04 -30.0 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.544 0 C-N-CA 124.543 1.137 . . . . 0.0 110.538 170.095 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -23.53 -38.32 0.0 OUTLIER 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 130.054 3.341 . . . . 0.0 117.045 169.563 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -98.64 31.26 8.32 Favored Glycine 0 CA--C 1.536 1.383 0 C-N-CA 125.543 1.544 . . . . 0.0 115.349 -175.205 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 12.7 mt-30 -62.0 -31.42 71.79 Favored 'General case' 0 N--CA 1.476 0.846 0 CA-C-N 120.088 1.944 . . . . 0.0 113.956 -174.336 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -70.34 122.16 19.04 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 123.059 0.544 . . . . 0.0 110.517 -169.158 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 74.9 m -151.91 -167.9 2.91 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 127.03 2.132 . . . . 0.0 107.417 -171.292 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -51.58 143.55 20.0 Favored Pre-proline 0 CA--C 1.539 0.528 0 C-N-CA 123.967 0.907 . . . . 0.0 110.402 170.51 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 84.5 Cg_endo -70.92 160.73 48.43 Favored 'Trans proline' 0 N--CA 1.456 -0.683 0 C-N-CA 122.883 2.389 . . . . 0.0 110.326 172.941 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 11.9 tt -60.86 -20.45 21.74 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.447 0 C-N-CA 123.889 0.876 . . . . 0.0 112.246 -179.878 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 25.9 tt0 -66.5 -28.6 68.69 Favored 'General case' 0 N--CA 1.434 -1.256 0 C-N-CA 124.768 1.227 . . . . 0.0 110.516 -176.558 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 74.9 m-20 -80.54 -1.44 41.96 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 124.305 1.042 . . . . 0.0 112.387 179.115 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 85.5 m-85 -110.76 177.19 4.75 Favored 'General case' 0 C--O 1.234 0.278 0 C-N-CA 125.698 1.599 . . . . 0.0 110.925 179.204 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 50.4 t-20 -128.66 135.76 49.72 Favored 'General case' 0 N--CA 1.448 -0.532 0 N-CA-C 108.175 -1.046 . . . . 0.0 108.175 169.297 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -73.28 -24.63 60.45 Favored 'General case' 0 N--CA 1.435 -1.184 0 N-CA-C 109.25 -0.648 . . . . 0.0 109.25 -178.473 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 35.5 t70 -66.2 -21.78 66.32 Favored 'General case' 0 N--CA 1.445 -0.696 0 C-N-CA 120.644 -0.422 . . . . 0.0 111.091 -177.59 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 35.2 t70 -77.42 -27.95 52.48 Favored 'General case' 0 C--N 1.345 0.393 0 C-N-CA 123.617 0.767 . . . . 0.0 111.584 174.144 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 14.1 m-85 -80.17 167.55 20.21 Favored 'General case' 0 C--O 1.239 0.53 0 C-N-CA 125.39 1.476 . . . . 0.0 111.392 -179.552 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -117.03 -39.18 3.26 Favored 'General case' 0 C--O 1.235 0.312 0 C-N-CA 123.338 0.655 . . . . 0.0 111.668 177.953 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -138.01 133.56 44.38 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.406 0 C-N-CA 123.866 0.866 . . . . 0.0 109.881 -170.871 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 66.6 t -140.79 125.63 18.55 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.402 0 N-CA-C 105.72 -1.956 . . . . 0.0 105.72 178.306 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 7.5 mm -96.24 125.26 49.15 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.545 0 N-CA-C 105.333 -2.099 . . . . 0.0 105.333 170.071 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 59.6 m -93.36 91.81 7.37 Favored 'General case' 0 N--CA 1.443 -0.811 0 N-CA-C 104.123 -2.547 . . . . 0.0 104.123 169.662 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 23.0 mt -63.08 -12.68 28.54 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-O 118.321 -0.847 . . . . 0.0 112.771 -173.206 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 39.3 m -142.94 126.53 16.88 Favored 'General case' 0 N--CA 1.445 -0.684 0 N-CA-C 106.634 -1.617 . . . . 0.0 106.634 174.43 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 58.44 -148.55 37.51 Favored Glycine 0 CA--C 1.534 1.227 0 C-N-CA 123.613 0.625 . . . . 0.0 112.183 177.488 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 14.0 p -139.2 -79.11 0.33 Allowed 'General case' 0 CA--C 1.529 0.165 0 C-N-CA 124.173 0.989 . . . . 0.0 108.727 175.865 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -79.24 53.24 4.16 Favored Glycine 0 CA--C 1.526 0.756 0 C-N-CA 125.498 1.523 . . . . 0.0 112.096 -178.429 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 16.3 m -81.21 60.83 0.2 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.71 0 C-N-CA 124.868 1.267 . . . . 0.0 110.802 -173.984 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 50.1 t30 56.2 59.74 3.54 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 125.944 1.698 . . . . 0.0 108.374 -172.41 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -136.69 143.14 41.63 Favored Pre-proline 0 CA--C 1.544 0.729 0 C-N-CA 126.223 1.809 . . . . 0.0 108.845 -168.925 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_exo -67.13 136.77 41.89 Favored 'Trans proline' 0 CA--C 1.542 0.909 0 C-N-CA 122.555 2.17 . . . . 0.0 111.353 172.973 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 42.4 Cg_endo -63.66 -25.84 69.0 Favored 'Trans proline' 0 N--CA 1.46 -0.474 0 C-N-CA 122.778 2.319 . . . . 0.0 114.821 -169.663 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 6.4 pm0 -57.42 -20.61 31.19 Favored 'General case' 0 CA--C 1.539 0.528 0 CA-C-N 120.149 1.341 . . . . 0.0 112.272 177.345 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 99.9 m95 -79.28 -23.41 43.61 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-O 118.726 -0.654 . . . . 0.0 112.629 178.657 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 6.5 m -104.67 -8.87 9.77 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.156 0 C-N-CA 124.669 1.188 . . . . 0.0 113.03 -179.818 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . 0.266 6.6 t -111.57 45.58 1.2 Allowed 'General case' 0 CA--C 1.544 0.713 0 CA-C-O 123.142 1.448 . . . . 0.0 110.104 172.299 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 56.2 mm-40 -73.47 177.42 5.3 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 124.919 1.288 . . . . 0.0 109.73 169.936 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 34.9 mm-40 -65.49 -21.73 66.66 Favored 'General case' 0 CA--C 1.538 0.503 0 O-C-N 121.844 -0.535 . . . . 0.0 111.225 -179.626 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 4.6 tt -140.26 131.14 30.33 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.334 0 C-N-CA 126.241 1.816 . . . . 0.0 106.439 169.871 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 35.2 t80 -109.57 136.36 49.07 Favored 'General case' 0 CA--C 1.539 0.528 0 N-CA-C 106.272 -1.751 . . . . 0.0 106.272 169.487 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 10.7 mm-40 -142.2 162.55 35.18 Favored 'General case' 0 C--O 1.234 0.287 0 C-N-CA 124.429 1.091 . . . . 0.0 108.871 175.83 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 2.5 t70 -175.27 129.62 0.28 Allowed 'General case' 0 C--O 1.236 0.368 0 C-N-CA 127.014 2.126 . . . . 0.0 106.918 -169.802 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 6.5 m0 -143.69 140.47 30.05 Favored 'General case' 0 CA--C 1.522 -0.119 0 C-N-CA 122.826 0.45 . . . . 0.0 110.057 -171.853 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 31.3 mm-40 -84.57 59.79 5.69 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-O 121.653 0.739 . . . . 0.0 109.159 171.786 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 16.6 mt -64.68 138.67 58.53 Favored 'General case' 0 CA--C 1.529 0.14 0 N-CA-C 108.233 -1.025 . . . . 0.0 108.233 172.471 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 34.3 mm-40 -68.65 161.15 28.78 Favored 'General case' 0 N--CA 1.451 -0.397 0 N-CA-C 108.265 -1.013 . . . . 0.0 108.265 168.901 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -130.97 131.45 23.24 Favored Pre-proline 0 N--CA 1.45 -0.456 0 N-CA-C 107.341 -1.355 . . . . 0.0 107.341 169.352 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 67.9 Cg_endo -78.9 -3.9 13.57 Favored 'Trans proline' 0 CA--C 1.545 1.043 0 C-N-CA 122.125 1.883 . . . . 0.0 114.729 -169.867 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -51.26 129.38 24.5 Favored 'General case' 0 CA--C 1.537 0.443 0 CA-C-N 119.996 1.271 . . . . 0.0 111.05 177.606 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 72.71 11.1 77.39 Favored Glycine 0 CA--C 1.533 1.206 0 CA-C-O 118.758 -1.023 . . . . 0.0 114.127 171.942 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 29.7 pt20 -136.66 -171.12 2.84 Favored 'General case' 0 CA--C 1.542 0.659 0 CA-C-N 118.991 1.395 . . . . 0.0 111.302 176.245 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 1.9 m -68.34 158.3 33.8 Favored 'General case' 0 CA--C 1.533 0.327 0 N-CA-C 117.641 2.46 . . . . 0.0 117.641 -167.563 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 55.7 tp -54.42 -34.16 60.83 Favored 'General case' 0 C--N 1.344 0.33 0 C-N-CA 126.917 2.087 . . . . 0.0 111.451 170.144 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 29.5 tp10 -64.73 -29.32 70.3 Favored 'General case' 0 C--N 1.331 -0.235 0 O-C-N 122.028 -0.42 . . . . 0.0 110.796 177.491 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 4.1 t -76.83 -37.1 27.25 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.385 0 CA-C-O 117.866 -1.064 . . . . 0.0 110.21 175.471 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 59.3 m-85 -56.21 -49.36 74.31 Favored 'General case' 0 N--CA 1.474 0.727 0 CA-C-N 120.738 1.608 . . . . 0.0 109.656 170.121 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 77.0 mtt180 -58.99 -44.07 91.54 Favored 'General case' 0 N--CA 1.468 0.432 0 C-N-CA 123.501 0.72 . . . . 0.0 110.691 178.319 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 18.5 m -65.5 -49.24 69.76 Favored 'General case' 0 N--CA 1.445 -0.714 0 C-N-CA 124.261 1.025 . . . . 0.0 110.07 -179.962 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 63.8 t -67.69 -35.84 74.06 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.191 0 CA-C-N 119.42 1.009 . . . . 0.0 109.353 -172.128 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 45.8 ttp85 -58.23 -39.9 80.28 Favored 'General case' 0 CA--C 1.539 0.553 0 CA-C-N 118.405 0.548 . . . . 0.0 109.808 173.585 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -66.81 -53.41 27.51 Favored Glycine 0 CA--C 1.533 1.218 0 C-N-CA 123.698 0.666 . . . . 0.0 112.566 172.809 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 72.2 mt-30 -55.08 -48.35 73.64 Favored 'General case' 0 N--CA 1.469 0.5 0 CA-C-O 122.184 0.992 . . . . 0.0 110.0 -176.137 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 97.0 t -74.48 -37.01 43.45 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.439 0 CA-C-O 117.738 -1.125 . . . . 0.0 109.786 -171.563 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -55.47 -46.58 76.83 Favored 'General case' 0 C--O 1.224 -0.288 0 CA-C-N 120.112 1.324 . . . . 0.0 108.585 172.198 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 41.5 tt0 -66.43 -43.04 86.79 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 122.458 0.303 . . . . 0.0 111.205 -175.121 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 38.5 mmt180 -62.44 -45.55 92.58 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-N 119.069 0.85 . . . . 0.0 111.01 176.18 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 97.2 t -69.14 -37.68 76.92 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.578 0 N-CA-C 109.196 -0.668 . . . . 0.0 109.196 -177.219 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 20.2 mt-10 -59.85 -44.79 93.92 Favored 'General case' 0 N--CA 1.457 -0.12 0 CA-C-N 119.346 0.975 . . . . 0.0 110.09 173.556 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 25.9 t-20 -65.02 -42.24 94.57 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 123.169 0.588 . . . . 0.0 111.641 -178.487 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 1.6 tm? -58.31 -48.39 80.67 Favored 'General case' 0 C--O 1.228 -0.068 0 C-N-CA 126.323 1.849 . . . . 0.0 110.752 174.035 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 63.4 mt -66.04 -47.75 83.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 N-CA-C 108.658 -0.867 . . . . 0.0 108.658 179.598 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -58.52 -31.21 67.7 Favored 'General case' 0 CA--C 1.535 0.381 0 CA-C-O 118.849 -0.596 . . . . 0.0 112.145 -176.851 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 17.3 ptpt -81.59 -39.62 24.26 Favored 'General case' 0 C--N 1.344 0.364 0 CA-C-O 117.786 -1.102 . . . . 0.0 112.486 176.53 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 11.8 pt -81.67 -37.42 15.24 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.287 0 CA-C-N 119.931 1.242 . . . . 0.0 113.725 -176.039 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 72.4 m . . . . . 0 C--O 1.253 1.288 0 C-N-CA 125.638 1.575 . . . . 0.0 109.764 -169.985 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.499 1.985 0 N-CA-C 110.411 -0.218 . . . . 0.0 110.411 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 32.9 mttm -81.43 118.92 23.09 Favored 'General case' 0 N--CA 1.476 0.849 0 N-CA-C 106.541 -1.652 . . . . 0.0 106.541 173.348 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 93.0 mttt -80.86 133.84 35.65 Favored 'General case' 0 CA--C 1.507 -0.692 0 CA-C-N 119.785 1.175 . . . . 0.0 108.398 175.691 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 1.5 t -118.36 145.48 24.27 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.589 0 C-N-CA 125.914 1.686 . . . . 0.0 106.796 -172.843 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 26.6 ttm -136.53 145.1 44.66 Favored 'General case' 0 C--N 1.318 -0.777 0 C-N-CA 125.143 1.377 . . . . 0.0 108.265 169.764 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 91.5 m-85 -137.93 121.62 17.46 Favored 'General case' 0 CA--C 1.516 -0.339 0 N-CA-C 104.673 -2.343 . . . . 0.0 104.673 177.445 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 2.6 p -153.58 154.16 7.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-O 122.338 1.066 . . . . 0.0 111.745 -169.178 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 42.7 t -144.77 165.18 28.82 Favored 'General case' 0 CA--C 1.538 0.486 0 N-CA-C 104.506 -2.405 . . . . 0.0 104.506 168.981 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 22.9 pttp -61.47 130.17 44.73 Favored 'General case' 0 N--CA 1.467 0.378 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 172.515 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 59.2 136.58 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 128.211 2.604 . . . . 0.0 114.114 -170.373 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 20.4 t30 -56.05 -35.0 66.43 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 125.106 1.362 . . . . 0.0 111.885 176.526 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 1.6 p -70.3 -8.06 47.41 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 125.398 1.479 . . . . 0.0 113.243 -175.802 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 38.5 m -76.01 -88.15 0.04 OUTLIER 'General case' 0 CA--C 1.54 0.568 0 CA-C-N 119.292 0.951 . . . . 0.0 110.259 178.638 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 10.6 mpt_? -115.5 6.83 14.79 Favored 'General case' 0 N--CA 1.475 0.801 0 CA-C-N 120.349 1.431 . . . . 0.0 113.041 179.227 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 1.4 m -91.92 47.44 1.35 Allowed 'General case' 0 CA--C 1.541 0.601 0 O-C-N 121.327 -0.858 . . . . 0.0 110.918 -175.449 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -118.37 9.01 12.31 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 125.967 1.707 . . . . 0.0 112.596 170.941 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 1.1 tpt -159.87 -39.48 0.05 Allowed 'General case' 0 N--CA 1.457 -0.119 0 N-CA-C 115.443 1.646 . . . . 0.0 115.443 -176.916 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -69.55 -46.72 65.77 Favored 'General case' 0 N--CA 1.471 0.597 0 CA-C-N 120.947 1.703 . . . . 0.0 111.703 -169.482 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -57.35 -42.28 81.69 Favored 'General case' 0 C--N 1.325 -0.473 0 C-N-CA 124.321 1.049 . . . . 0.0 110.731 170.837 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -61.59 -45.59 96.02 Favored Glycine 0 CA--C 1.524 0.653 0 C-N-CA 123.84 0.733 . . . . 0.0 111.798 176.924 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -66.85 -35.93 81.17 Favored 'General case' 0 CA--C 1.514 -0.431 0 O-C-N 121.216 -1.167 . . . . 0.0 111.918 178.278 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -70.86 -36.3 72.77 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 119.662 1.119 . . . . 0.0 110.555 179.688 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -52.52 -42.66 64.54 Favored 'General case' 0 N--CA 1.467 0.392 0 C-N-CA 123.864 0.866 . . . . 0.0 109.009 169.207 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 22.4 m -75.15 -59.29 2.81 Favored 'General case' 0 N--CA 1.446 -0.653 0 C-N-CA 124.303 1.041 . . . . 0.0 111.397 -173.872 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 34.6 mt -73.82 -33.87 64.35 Favored 'General case' 0 C--N 1.332 -0.191 0 C-N-CA 125.083 1.353 . . . . 0.0 110.949 -170.567 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -102.76 6.77 52.43 Favored Glycine 0 CA--C 1.525 0.668 0 CA-C-O 117.901 -1.5 . . . . 0.0 113.521 -172.585 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -41.15 -52.77 3.25 Favored 'General case' 0 N--CA 1.466 0.363 0 C-N-CA 126.254 1.821 . . . . 0.0 114.819 -169.714 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -88.81 7.12 82.83 Favored Glycine 0 CA--C 1.531 1.048 0 CA-C-O 119.186 -0.785 . . . . 0.0 113.573 -175.547 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 70.0 mttt -124.73 -49.35 1.76 Allowed 'General case' 0 N--CA 1.467 0.395 0 CA-C-N 118.511 1.155 . . . . 0.0 111.937 -169.27 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 27.1 pt -137.96 150.93 25.07 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.401 0 C-N-CA 124.732 1.213 . . . . 0.0 110.415 -168.911 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -111.17 105.77 14.58 Favored 'General case' 0 C--O 1.226 -0.146 0 C-N-CA 125.013 1.325 . . . . 0.0 109.971 -169.526 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 11.4 t -78.93 127.9 38.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 177.374 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 18.7 m -144.31 92.94 2.37 Favored 'General case' 0 N--CA 1.449 -0.503 0 N-CA-C 103.615 -2.735 . . . . 0.0 103.615 169.677 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 58.1 m -89.33 -1.32 58.02 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 115.764 1.764 . . . . 0.0 115.764 -168.759 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 28.4 p 49.05 -130.08 1.92 Allowed 'General case' 0 CA--C 1.546 0.815 0 C-N-CA 124.451 1.1 . . . . 0.0 111.333 -178.842 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 173.5 153.98 10.17 Favored Glycine 0 CA--C 1.53 0.978 0 C-N-CA 124.951 1.262 . . . . 0.0 111.027 170.06 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 4.3 mt -111.89 103.95 12.21 Favored 'General case' 0 N--CA 1.444 -0.755 1 N-CA-C 100.071 -4.048 . . . . 0.0 100.071 169.16 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 35.2 mt-10 64.05 170.36 0.17 Allowed 'General case' 0 C--O 1.238 0.458 0 O-C-N 125.371 1.669 . . . . 0.0 110.241 -167.583 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 59.1 p -146.9 158.79 44.01 Favored 'General case' 0 N--CA 1.448 -0.558 0 CA-C-O 122.628 1.204 . . . . 0.0 113.701 -178.457 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 4.1 m -170.81 166.96 7.72 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 129.801 3.24 . . . . 0.0 104.222 -171.892 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -87.94 -159.61 0.55 Allowed 'General case' 0 N--CA 1.468 0.459 0 O-C-N 120.845 -1.159 . . . . 0.0 108.72 176.209 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 1.5 p -127.17 157.84 38.51 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.782 0 C-N-CA 126.418 1.887 . . . . 0.0 107.73 179.933 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -85.84 153.04 57.48 Favored Pre-proline 0 CA--C 1.538 0.517 0 C-N-CA 124.67 1.188 . . . . 0.0 111.366 -169.452 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 55.1 Cg_endo -63.84 -41.34 24.26 Favored 'Trans proline' 0 C--N 1.347 0.495 0 C-N-CA 123.474 2.783 . . . . 0.0 112.415 -174.039 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 7.3 m -69.79 -29.63 66.98 Favored 'General case' 0 CA--C 1.53 0.188 0 CA-C-O 118.649 -0.691 . . . . 0.0 110.319 -176.839 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -62.99 -50.6 70.13 Favored 'General case' 0 C--O 1.215 -0.712 0 CA-C-N 119.659 1.118 . . . . 0.0 108.413 171.094 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 75.1 mt -58.38 -40.09 76.89 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.447 0 CA-C-N 118.982 0.81 . . . . 0.0 108.851 -176.462 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -64.7 -49.63 70.15 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-N 118.915 0.779 . . . . 0.0 112.354 178.255 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 38.6 mmt -69.35 -36.48 76.92 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-O 122.739 1.257 . . . . 0.0 110.543 -177.564 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -71.69 -32.05 67.41 Favored 'General case' 0 N--CA 1.444 -0.763 0 N-CA-C 106.369 -1.715 . . . . 0.0 106.369 -178.761 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 40.5 tt0 -72.02 -19.57 61.83 Favored 'General case' 0 CA--C 1.54 0.572 0 O-C-N 121.122 -0.986 . . . . 0.0 110.999 169.882 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 75.5 mt-10 -64.19 -37.11 86.31 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-N 120.176 1.353 . . . . 0.0 109.859 169.605 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 11.9 m -85.94 12.12 1.05 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.675 0 N-CA-C 112.759 0.651 . . . . 0.0 112.759 169.968 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 72.4 14.23 77.2 Favored Glycine 0 CA--C 1.532 1.155 0 C-N-CA 124.488 1.042 . . . . 0.0 113.476 176.154 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 10.5 mt -93.35 137.73 21.88 Favored 'Isoleucine or valine' 0 C--O 1.233 0.199 0 CA-C-N 118.498 1.149 . . . . 0.0 109.613 -177.053 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 12.9 t0 -101.87 132.93 47.37 Favored 'General case' 0 C--O 1.233 0.236 0 N-CA-C 107.566 -1.272 . . . . 0.0 107.566 169.343 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -118.72 -70.64 0.78 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.37 0 C-N-CA 125.528 1.531 . . . . 0.0 107.319 177.321 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 97.2 p 40.33 -97.78 0.02 OUTLIER 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 127.169 2.187 . . . . 0.0 114.349 170.152 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -74.79 58.0 2.6 Favored Glycine 0 CA--C 1.531 1.067 0 C-N-CA 126.99 2.233 . . . . 0.0 111.705 178.947 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 12.5 mm100 -66.89 -30.31 70.43 Favored 'General case' 0 C--O 1.233 0.232 0 C-N-CA 125.051 1.34 . . . . 0.0 111.69 -179.868 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 1.1 p -62.68 133.66 55.17 Favored 'General case' 0 N--CA 1.444 -0.746 0 C-N-CA 124.934 1.294 . . . . 0.0 109.435 -169.369 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 57.7 m -146.14 -179.21 6.57 Favored 'General case' 0 N--CA 1.446 -0.666 0 C-N-CA 125.999 1.72 . . . . 0.0 107.493 -169.307 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -56.61 152.74 24.19 Favored Pre-proline 0 CA--C 1.536 0.427 0 C-N-CA 123.87 0.868 . . . . 0.0 111.446 175.064 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 89.3 Cg_endo -65.59 158.24 54.25 Favored 'Trans proline' 0 N--CA 1.453 -0.856 0 C-N-CA 122.574 2.183 . . . . 0.0 110.345 172.965 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 14.0 tt -58.52 -26.81 31.97 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.411 0 C-N-CA 124.013 0.925 . . . . 0.0 111.622 179.133 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 15.1 mt-10 -67.94 -26.55 66.02 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 124.255 1.022 . . . . 0.0 110.356 -174.524 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 5.4 t-20 -64.31 -22.16 66.86 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 125.197 1.399 . . . . 0.0 112.208 177.728 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -108.67 178.57 4.44 Favored 'General case' 0 C--O 1.235 0.339 0 C-N-CA 126.024 1.729 . . . . 0.0 111.209 -173.797 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 57.5 t-20 -133.25 137.36 46.05 Favored 'General case' 0 N--CA 1.444 -0.745 0 N-CA-C 107.144 -1.428 . . . . 0.0 107.144 168.988 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -74.86 -23.84 58.48 Favored 'General case' 0 N--CA 1.437 -1.112 0 N-CA-C 109.456 -0.572 . . . . 0.0 109.456 -176.985 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -61.62 -24.74 66.9 Favored 'General case' 0 N--CA 1.447 -0.604 0 O-C-N 123.331 0.395 . . . . 0.0 111.579 178.831 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -76.57 -27.64 55.93 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 123.578 0.751 . . . . 0.0 112.081 177.133 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 11.7 m-85 -78.75 164.01 24.91 Favored 'General case' 0 N--CA 1.45 -0.442 0 C-N-CA 125.187 1.395 . . . . 0.0 111.465 -177.043 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -105.4 -39.29 6.19 Favored 'General case' 0 N--CA 1.462 0.13 0 CA-C-N 115.557 -0.747 . . . . 0.0 110.41 171.436 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -139.19 138.91 40.57 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.441 0 CA-C-O 122.449 1.118 . . . . 0.0 110.188 -171.333 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 42.6 t -140.21 145.03 26.75 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.855 0 N-CA-C 106.411 -1.7 . . . . 0.0 106.411 179.936 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 24.1 mm -141.71 137.36 31.65 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.865 0 N-CA-C 106.496 -1.668 . . . . 0.0 106.496 -170.69 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 50.3 m -101.43 163.84 12.07 Favored 'General case' 0 N--CA 1.445 -0.691 0 N-CA-C 107.625 -1.25 . . . . 0.0 107.625 168.861 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 51.3 mt -132.66 18.84 4.26 Favored 'General case' 0 CA--C 1.533 0.292 0 O-C-N 121.14 -0.975 . . . . 0.0 111.048 -174.53 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 28.1 p -169.21 -5.12 0.02 OUTLIER 'General case' 0 CA--C 1.541 0.603 0 N-CA-C 115.433 1.642 . . . . 0.0 115.433 -173.986 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 167.78 175.0 37.24 Favored Glycine 0 CA--C 1.529 0.927 0 CA-C-N 120.54 1.518 . . . . 0.0 111.292 -177.081 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 40.2 m -117.31 124.34 48.73 Favored 'General case' 0 C--O 1.233 0.229 0 C-N-CA 124.444 1.098 . . . . 0.0 108.101 -177.046 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 62.55 28.74 71.83 Favored Glycine 0 CA--C 1.531 1.044 0 N-CA-C 111.343 -0.703 . . . . 0.0 111.343 -174.822 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . 0.267 7.2 p -80.2 74.41 0.74 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.512 0 C-N-CA 125.006 1.322 . . . . 0.0 109.988 -169.459 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 1.1 t30 60.07 54.08 4.3 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 126.711 2.005 . . . . 0.0 108.012 -176.476 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -152.12 138.4 11.79 Favored Pre-proline 0 CA--C 1.539 0.55 0 C-N-CA 125.803 1.641 . . . . 0.0 107.621 -169.341 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_exo -69.84 146.6 60.2 Favored 'Trans proline' 0 CA--C 1.546 1.08 0 C-N-CA 121.494 1.463 . . . . 0.0 114.139 -175.77 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_exo -63.7 -25.95 68.65 Favored 'Trans proline' 0 C--N 1.349 0.581 0 C-N-CA 122.667 2.244 . . . . 0.0 115.945 -174.085 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 5.7 pm0 -61.53 -14.84 32.85 Favored 'General case' 0 CA--C 1.543 0.707 0 CA-C-N 121.024 1.738 . . . . 0.0 111.809 175.982 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 90.8 m95 -91.81 -21.7 20.53 Favored 'General case' 0 N--CA 1.451 -0.409 0 C-N-CA 124.509 1.123 . . . . 0.0 113.07 173.793 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 2.9 m -78.64 -5.01 7.39 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.36 0 CA-C-N 120.129 1.331 . . . . 0.0 111.326 171.377 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 60.3 p -107.95 -118.14 0.26 Allowed 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 123.081 0.552 . . . . 0.0 111.492 -176.747 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 70.5 mm-40 55.96 -171.13 0.07 Allowed 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 125.563 1.545 . . . . 0.0 111.47 -168.787 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 37.0 mm-40 -70.25 -23.11 62.85 Favored 'General case' 0 CA--C 1.537 0.474 0 O-C-N 121.479 -0.763 . . . . 0.0 112.316 -169.466 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 9.5 tt -147.83 141.64 19.3 Favored 'Isoleucine or valine' 0 C--O 1.238 0.46 0 C-N-CA 125.103 1.361 . . . . 0.0 107.607 169.761 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 73.3 t80 -128.22 139.41 52.47 Favored 'General case' 0 N--CA 1.446 -0.661 0 N-CA-C 106.277 -1.749 . . . . 0.0 106.277 168.867 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 29.3 mm-40 -139.32 166.26 25.02 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 107.246 -1.39 . . . . 0.0 107.246 170.003 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -165.33 137.29 4.17 Favored 'General case' 0 C--N 1.323 -0.568 0 C-N-CA 126.074 1.75 . . . . 0.0 106.334 -176.642 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 6.9 m0 -143.12 144.77 32.35 Favored 'General case' 0 N--CA 1.451 -0.377 0 C-N-CA 122.875 0.47 . . . . 0.0 110.201 -169.332 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 20.0 tt0 -83.33 57.42 3.98 Favored 'General case' 0 CA--C 1.537 0.451 0 N-CA-C 108.179 -1.045 . . . . 0.0 108.179 171.054 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 19.4 mt -65.74 138.47 57.97 Favored 'General case' 0 C--O 1.235 0.321 0 N-CA-C 107.155 -1.424 . . . . 0.0 107.155 173.459 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 23.5 mm-40 -67.22 151.52 47.38 Favored 'General case' 0 N--CA 1.451 -0.41 0 CA-C-O 121.574 0.702 . . . . 0.0 109.511 172.033 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -112.41 117.97 46.33 Favored Pre-proline 0 N--CA 1.45 -0.468 0 N-CA-C 106.098 -1.816 . . . . 0.0 106.098 170.447 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_endo -80.82 -1.52 11.29 Favored 'Trans proline' 0 N--CA 1.448 -1.183 0 C-N-CA 122.98 2.453 . . . . 0.0 113.412 -173.217 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -53.4 120.07 5.61 Favored 'General case' 0 CA--C 1.536 0.429 0 CA-C-N 120.473 1.488 . . . . 0.0 110.864 -175.917 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 70.2 0.65 30.08 Favored Glycine 0 CA--C 1.534 1.245 0 CA-C-O 118.765 -1.019 . . . . 0.0 114.562 179.518 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 12.9 mt-30 -85.3 171.89 11.54 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-N 119.156 1.478 . . . . 0.0 109.638 174.096 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 15.0 m -69.2 162.33 27.32 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 123.91 0.884 . . . . 0.0 111.322 178.71 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 13.3 tp -59.04 -30.93 68.4 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 124.615 1.166 . . . . 0.0 112.43 -173.779 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 5.3 pt-20 -56.57 -34.92 67.61 Favored 'General case' 0 C--O 1.226 -0.166 0 C-N-CA 124.768 1.227 . . . . 0.0 111.775 174.778 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 32.2 t -75.03 -42.19 45.54 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.422 0 CA-C-O 117.813 -1.089 . . . . 0.0 109.164 -176.798 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 89.7 m-85 -56.52 -49.94 73.27 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-N 120.329 1.422 . . . . 0.0 109.666 172.621 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 86.8 mtt180 -66.84 -34.6 78.17 Favored 'General case' 0 N--CA 1.467 0.409 0 O-C-N 122.037 -0.414 . . . . 0.0 111.761 -176.358 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 3.5 m -62.24 -48.59 79.29 Favored 'General case' 0 N--CA 1.451 -0.404 0 C-N-CA 124.681 1.192 . . . . 0.0 109.413 170.357 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 45.7 t -63.62 -33.44 61.63 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.243 0 CA-C-O 118.265 -0.874 . . . . 0.0 110.0 -174.627 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 13.1 mtm105 -56.58 -49.8 73.83 Favored 'General case' 0 C--O 1.225 -0.226 0 CA-C-N 119.303 0.956 . . . . 0.0 110.071 172.188 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -62.3 -48.55 81.69 Favored Glycine 0 CA--C 1.526 0.731 0 CA-C-O 119.103 -0.832 . . . . 0.0 111.216 179.55 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 69.8 mt-30 -55.24 -53.23 58.63 Favored 'General case' 0 C--N 1.343 0.296 0 CA-C-O 122.091 0.948 . . . . 0.0 109.364 -179.802 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 73.8 t -71.44 -39.97 71.91 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-O 117.875 -1.06 . . . . 0.0 110.605 -170.608 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 87.2 tttt -55.6 -47.46 76.47 Favored 'General case' 0 C--O 1.223 -0.321 0 CA-C-N 119.411 1.005 . . . . 0.0 108.316 176.792 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -66.22 -43.01 87.89 Favored 'General case' 0 N--CA 1.45 -0.465 0 C-N-CA 122.438 0.295 . . . . 0.0 111.078 -174.838 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 40.2 mmt180 -63.02 -46.6 86.85 Favored 'General case' 0 N--CA 1.471 0.611 0 O-C-N 121.563 -0.711 . . . . 0.0 110.837 177.831 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 78.2 t -67.31 -41.73 86.81 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.665 0 C-N-CA 123.08 0.552 . . . . 0.0 109.618 -178.897 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 31.3 mt-10 -60.23 -43.74 95.81 Favored 'General case' 0 CA--C 1.52 -0.191 0 CA-C-N 119.595 1.089 . . . . 0.0 110.011 177.651 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 29.0 t-20 -62.38 -45.03 94.97 Favored 'General case' 0 N--CA 1.454 -0.243 0 C-N-CA 122.776 0.43 . . . . 0.0 110.668 179.789 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 28.5 tp -59.44 -47.69 84.49 Favored 'General case' 0 N--CA 1.453 -0.277 0 C-N-CA 123.859 0.864 . . . . 0.0 111.102 177.579 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 85.0 mt -63.09 -46.59 95.71 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.175 0 N-CA-C 107.845 -1.169 . . . . 0.0 107.845 179.504 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -59.79 -28.8 67.74 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-N 118.457 0.571 . . . . 0.0 112.335 178.682 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 92.1 mttt -69.37 -57.17 5.63 Favored 'General case' 0 C--N 1.344 0.349 0 CA-C-N 119.219 0.918 . . . . 0.0 110.629 171.751 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 13.6 pt -77.29 -38.46 27.03 Favored 'Isoleucine or valine' 0 C--O 1.235 0.305 0 N-CA-C 115.095 1.517 . . . . 0.0 115.095 -168.823 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 69.5 m . . . . . 0 C--O 1.252 1.219 0 C-N-CA 125.694 1.597 . . . . 0.0 109.334 -169.79 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.496 1.839 0 N-CA-C 110.535 -0.172 . . . . 0.0 110.535 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 30.8 mttm -80.18 116.65 20.39 Favored 'General case' 0 N--CA 1.475 0.799 0 N-CA-C 106.109 -1.811 . . . . 0.0 106.109 173.66 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 92.2 mttt -81.89 131.88 35.26 Favored 'General case' 0 CA--C 1.505 -0.777 0 CA-C-N 119.566 1.075 . . . . 0.0 108.399 177.45 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 1.4 t -116.61 146.82 20.53 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 O-C-N 125.515 1.76 . . . . 0.0 107.131 -170.821 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 35.3 ttm -138.27 147.27 43.47 Favored 'General case' 0 C--N 1.32 -0.676 0 C-N-CA 125.194 1.398 . . . . 0.0 107.864 170.709 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 67.2 m-85 -136.26 119.82 17.07 Favored 'General case' 0 CA--C 1.516 -0.339 0 N-CA-C 105.509 -2.034 . . . . 0.0 105.509 177.526 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 2.0 p -151.45 129.81 2.75 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.386 0 N-CA-C 108.656 -0.868 . . . . 0.0 108.656 -169.427 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -110.77 -178.58 3.52 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 125.764 1.626 . . . . 0.0 106.921 169.754 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 85.1 tttt -70.88 -26.98 63.48 Favored 'General case' 0 N--CA 1.472 0.659 0 O-C-N 121.131 -0.981 . . . . 0.0 112.306 -171.821 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 37.8 ttp180 -136.47 160.7 37.98 Favored 'General case' 0 N--CA 1.467 0.392 0 C-N-CA 124.269 1.028 . . . . 0.0 109.077 -169.545 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -68.96 -38.82 79.64 Favored 'General case' 0 N--CA 1.47 0.571 0 CA-C-N 118.613 0.642 . . . . 0.0 110.596 175.748 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 2.9 p -84.13 66.87 9.49 Favored 'General case' 0 C--O 1.234 0.284 0 C-N-CA 125.863 1.665 . . . . 0.0 108.565 -177.863 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 40.6 p -155.15 -167.02 2.43 Favored 'General case' 0 N--CA 1.451 -0.382 0 CA-C-O 121.789 0.804 . . . . 0.0 109.903 -172.946 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 76.0 mtt180 -54.17 -23.29 13.81 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 126.033 1.733 . . . . 0.0 111.986 169.987 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 28.7 m -51.01 -26.05 5.58 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-N 119.84 1.2 . . . . 0.0 112.991 178.1 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 6.5 pt20 -69.1 -26.99 65.19 Favored 'General case' 0 C--O 1.221 -0.432 0 N-CA-C 114.925 1.454 . . . . 0.0 114.925 -172.554 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 2.1 tpt -115.43 -32.26 5.65 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-N 120.72 1.6 . . . . 0.0 115.033 -169.31 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -68.48 -43.7 76.35 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-N 119.723 1.147 . . . . 0.0 113.083 -169.204 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 1.5 pp20? -63.75 -34.07 77.07 Favored 'General case' 0 N--CA 1.473 0.688 0 CA-C-N 119.267 0.94 . . . . 0.0 109.541 171.997 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -50.8 -49.66 40.44 Favored Glycine 0 C--O 1.219 -0.839 0 C-N-CA 125.259 1.409 . . . . 0.0 111.011 176.057 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 5.6 m-85 -75.98 -31.76 59.14 Favored 'General case' 0 CA--C 1.511 -0.541 0 CA-C-N 118.928 1.364 . . . . 0.0 113.899 178.258 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -68.03 -32.8 73.42 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 119.421 1.009 . . . . 0.0 111.58 -170.174 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 4.7 ptpt -61.07 -29.21 69.61 Favored 'General case' 0 N--CA 1.473 0.697 0 CA-C-N 118.546 0.612 . . . . 0.0 111.643 172.407 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 15.1 m -82.66 -56.93 3.56 Favored 'General case' 0 N--CA 1.443 -0.793 0 C-N-CA 124.965 1.306 . . . . 0.0 109.819 -177.399 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 76.3 mt -73.49 -36.58 65.8 Favored 'General case' 0 C--N 1.331 -0.207 0 C-N-CA 123.35 0.66 . . . . 0.0 110.947 -170.359 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -103.87 13.16 53.17 Favored Glycine 0 CA--C 1.525 0.687 0 CA-C-O 118.068 -1.407 . . . . 0.0 113.044 -174.072 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -41.66 -53.95 3.41 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 126.345 1.858 . . . . 0.0 114.707 -169.229 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -91.31 10.08 75.78 Favored Glycine 0 CA--C 1.53 1.027 0 CA-C-O 119.216 -0.769 . . . . 0.0 113.525 -176.201 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 50.5 mttm -124.13 -50.86 1.79 Allowed 'General case' 0 N--CA 1.467 0.411 0 CA-C-N 118.435 1.117 . . . . 0.0 112.028 -169.21 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 28.3 pt -136.54 150.36 27.32 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.338 0 C-N-CA 124.222 1.009 . . . . 0.0 110.137 -169.011 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -110.27 102.48 11.14 Favored 'General case' 0 C--O 1.228 -0.048 0 C-N-CA 124.911 1.284 . . . . 0.0 109.47 -169.549 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 9.6 p -84.93 130.28 36.32 Favored 'Isoleucine or valine' 0 C--O 1.235 0.309 0 CA-C-N 118.686 0.675 . . . . 0.0 109.658 -179.982 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 19.1 m -145.14 115.46 7.55 Favored 'General case' 0 N--CA 1.448 -0.548 0 N-CA-C 104.342 -2.466 . . . . 0.0 104.342 170.519 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 48.2 m -112.47 8.0 19.22 Favored 'General case' 0 N--CA 1.466 0.325 0 N-CA-C 115.434 1.642 . . . . 0.0 115.434 -174.391 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 1.5 m 52.96 -133.73 1.78 Allowed 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 123.568 0.747 . . . . 0.0 111.114 169.679 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -171.14 154.7 23.08 Favored Glycine 0 N--CA 1.444 -0.777 0 N-CA-C 108.16 -1.976 . . . . 0.0 108.16 170.047 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 55.8 mt -103.08 -51.02 3.35 Favored 'General case' 0 N--CA 1.451 -0.404 0 C-N-CA 124.057 0.943 . . . . 0.0 108.864 171.755 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 25.7 mt-10 -130.58 72.0 1.48 Allowed 'General case' 0 CA--C 1.514 -0.428 0 CA-C-O 124.124 1.916 . . . . 0.0 107.069 169.663 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 10.7 m 57.33 -31.39 0.03 OUTLIER 'General case' 0 C--N 1.321 -0.649 0 C-N-CA 131.446 3.898 . . . . 0.0 117.422 -174.976 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 60.9 m 60.67 23.25 13.09 Favored 'General case' 0 CA--C 1.54 0.573 0 N-CA-C 115.9 1.815 . . . . 0.0 115.9 168.35 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 11.3 ttt180 -71.86 -178.98 2.5 Favored 'General case' 0 CA--C 1.539 0.519 0 N-CA-C 107.558 -1.275 . . . . 0.0 107.558 169.017 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 11.5 m -123.95 -172.32 0.75 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.642 0 C-N-CA 124.437 1.095 . . . . 0.0 111.279 -169.187 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 96.1 m-70 -112.45 156.32 42.41 Favored Pre-proline 0 CA--C 1.536 0.422 0 C-N-CA 125.184 1.394 . . . . 0.0 111.009 -171.984 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -57.2 -48.49 17.65 Favored 'Trans proline' 0 C--N 1.347 0.49 0 C-N-CA 124.012 3.141 . . . . 0.0 112.628 -174.014 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 2.7 m -67.9 -29.64 68.79 Favored 'General case' 0 CA--C 1.531 0.227 0 CA-C-O 118.849 -0.596 . . . . 0.0 110.156 -176.876 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -59.61 -56.09 26.33 Favored 'General case' 0 CA--C 1.505 -0.763 0 N-CA-C 108.137 -1.06 . . . . 0.0 108.137 171.164 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 56.2 mt -59.61 -39.07 78.51 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.396 0 N-CA-C 108.52 -0.918 . . . . 0.0 108.52 -173.043 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -62.32 -49.58 75.05 Favored 'General case' 0 N--CA 1.452 -0.358 0 CA-C-N 119.181 0.9 . . . . 0.0 111.138 -179.838 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 38.9 mmt -71.46 -34.25 70.06 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-O 122.756 1.265 . . . . 0.0 110.161 -177.226 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -73.31 -31.27 63.92 Favored 'General case' 0 N--CA 1.44 -0.925 0 N-CA-C 107.393 -1.336 . . . . 0.0 107.393 -178.634 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 4.9 mm-40 -72.88 -17.5 61.52 Favored 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 124.101 0.96 . . . . 0.0 110.985 169.704 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 78.5 mt-10 -65.11 -36.84 85.55 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 119.844 1.202 . . . . 0.0 108.762 168.932 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . 0.302 8.5 p -86.46 7.5 2.33 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.991 0 CA-C-O 120.789 0.328 . . . . 0.0 111.608 169.742 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 71.41 23.31 78.2 Favored Glycine 0 CA--C 1.532 1.147 0 C-N-CA 124.994 1.283 . . . . 0.0 113.266 175.773 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 5.4 mt -103.7 136.65 35.71 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.226 0 C-N-CA 124.273 1.029 . . . . 0.0 111.975 -172.225 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -78.11 137.28 38.12 Favored 'General case' 0 CA--C 1.529 0.155 0 CA-C-N 114.507 -1.224 . . . . 0.0 109.043 168.972 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 8.1 pt -143.35 -27.56 0.17 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.39 0 C-N-CA 125.062 1.345 . . . . 0.0 108.951 168.209 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -40.21 -41.17 1.25 Allowed 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 129.459 3.104 . . . . 0.0 113.113 169.443 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -87.25 20.52 25.68 Favored Glycine 0 CA--C 1.533 1.171 0 C-N-CA 125.225 1.393 . . . . 0.0 114.38 -177.422 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -60.08 -35.14 74.54 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-N 119.812 1.806 . . . . 0.0 112.489 -178.161 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -66.97 133.01 49.12 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 123.981 0.912 . . . . 0.0 109.817 -171.067 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 13.7 p -151.23 -68.97 0.18 Allowed 'General case' 0 C--O 1.235 0.307 0 C-N-CA 123.356 0.663 . . . . 0.0 109.962 -177.761 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -151.3 155.77 34.74 Favored Pre-proline 0 C--O 1.236 0.376 0 C-N-CA 125.807 1.643 . . . . 0.0 108.57 -177.126 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -64.39 156.3 60.98 Favored 'Trans proline' 0 N--CA 1.456 -0.686 0 C-N-CA 122.234 1.956 . . . . 0.0 110.208 171.46 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 11.3 tt -57.55 -28.41 31.59 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.499 0 C-N-CA 123.137 0.575 . . . . 0.0 111.536 178.826 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 23.1 tt0 -66.04 -25.23 66.95 Favored 'General case' 0 N--CA 1.437 -1.083 0 C-N-CA 126.335 1.854 . . . . 0.0 110.715 -175.588 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 6.1 t-20 -64.11 -21.22 66.45 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 124.287 1.035 . . . . 0.0 112.126 176.82 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 77.6 m-85 -110.88 -176.0 2.86 Favored 'General case' 0 C--O 1.235 0.306 0 C-N-CA 126.025 1.73 . . . . 0.0 110.802 -174.487 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 61.5 t-20 -136.68 141.2 43.12 Favored 'General case' 0 N--CA 1.445 -0.697 0 N-CA-C 107.206 -1.405 . . . . 0.0 107.206 169.366 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -72.2 -25.2 61.58 Favored 'General case' 0 N--CA 1.433 -1.295 0 CA-C-N 118.44 0.564 . . . . 0.0 109.701 -178.901 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 35.6 t70 -63.04 -24.16 67.78 Favored 'General case' 0 N--CA 1.447 -0.607 0 O-C-N 123.549 0.531 . . . . 0.0 111.634 -179.417 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -74.94 -28.11 60.46 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 123.159 0.584 . . . . 0.0 111.868 175.626 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 12.3 m-85 -81.51 164.47 21.96 Favored 'General case' 0 N--CA 1.448 -0.556 0 C-N-CA 125.353 1.461 . . . . 0.0 111.357 -177.21 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -107.16 -37.9 6.15 Favored 'General case' 0 N--CA 1.462 0.138 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.776 173.583 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -139.28 138.71 40.39 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.504 0 CA-C-O 121.731 0.776 . . . . 0.0 110.17 -170.615 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 57.9 t -141.42 130.6 24.15 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.659 0 N-CA-C 106.22 -1.77 . . . . 0.0 106.22 178.033 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 27.4 mm -106.0 128.12 60.57 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.76 0 N-CA-C 105.325 -2.102 . . . . 0.0 105.325 176.537 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 28.9 m -109.93 75.72 0.95 Allowed 'General case' 0 N--CA 1.437 -1.112 0 N-CA-C 105.455 -2.054 . . . . 0.0 105.455 -176.336 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 59.9 mt -53.03 -17.06 1.27 Allowed 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 125.768 1.627 . . . . 0.0 115.102 -169.1 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 12.7 m -112.14 -7.92 14.03 Favored 'General case' 0 CA--C 1.541 0.597 0 CA-C-N 119.866 1.212 . . . . 0.0 114.2 -177.477 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 142.89 -132.91 5.28 Favored Glycine 0 C--N 1.338 0.692 0 CA-C-N 120.635 1.562 . . . . 0.0 111.543 -178.041 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 13.0 m -125.15 -28.13 3.45 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 123.554 0.742 . . . . 0.0 112.314 -169.901 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -76.14 -62.93 2.5 Favored Glycine 0 C--N 1.343 0.925 0 N-CA-C 109.45 -1.46 . . . . 0.0 109.45 173.171 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . 0.321 10.9 t 56.81 18.96 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.55 0.962 0 C-N-CA 125.39 1.476 . . . . 0.0 112.693 170.602 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 64.9 t30 45.33 37.79 3.1 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 125.56 1.544 . . . . 0.0 112.385 -172.089 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -136.45 158.73 72.82 Favored Pre-proline 0 CA--C 1.541 0.62 0 C-N-CA 123.63 0.772 . . . . 0.0 111.849 179.766 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 80.4 Cg_exo -54.99 131.14 44.64 Favored 'Trans proline' 0 C--N 1.352 0.732 0 C-N-CA 123.22 2.613 . . . . 0.0 110.953 175.04 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 49.3 Cg_endo -62.06 -19.45 66.33 Favored 'Trans proline' 0 C--N 1.348 0.512 0 C-N-CA 122.089 1.86 . . . . 0.0 112.138 -177.997 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 2.2 pt-20 -51.13 -26.56 6.81 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 126.136 1.775 . . . . 0.0 112.569 172.739 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 83.4 m95 -74.52 -40.9 61.47 Favored 'General case' 0 N--CA 1.455 -0.2 0 C-N-CA 123.803 0.841 . . . . 0.0 111.844 175.371 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 14.0 t -66.15 -37.12 79.06 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.5 0 C-N-CA 123.901 0.88 . . . . 0.0 108.931 179.374 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 68.8 p -84.39 25.52 0.86 Allowed 'General case' 0 C--O 1.237 0.438 0 N-CA-C 114.851 1.426 . . . . 0.0 114.851 -168.826 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 91.3 mm-40 -74.44 -179.12 3.83 Favored 'General case' 0 CA--C 1.54 0.583 0 CA-C-N 118.385 0.539 . . . . 0.0 110.877 171.706 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 25.6 mm-40 -61.73 -17.87 57.48 Favored 'General case' 0 CA--C 1.54 0.566 0 N-CA-C 113.421 0.897 . . . . 0.0 113.421 -169.027 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 4.6 tt -140.6 133.61 32.59 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.513 0 N-CA-C 106.849 -1.537 . . . . 0.0 106.849 170.026 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -109.57 135.4 50.62 Favored 'General case' 0 CA--C 1.537 0.467 0 N-CA-C 105.04 -2.208 . . . . 0.0 105.04 169.149 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 12.8 mm-40 -138.67 163.6 31.69 Favored 'General case' 0 C--O 1.233 0.185 0 C-N-CA 124.542 1.137 . . . . 0.0 107.982 171.26 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -173.57 127.96 0.42 Allowed 'General case' 0 C--O 1.238 0.482 0 C-N-CA 126.944 2.098 . . . . 0.0 105.374 -169.571 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 7.5 m0 -143.13 142.48 31.5 Favored 'General case' 0 N--CA 1.469 0.519 0 N-CA-C 112.751 0.648 . . . . 0.0 112.751 -169.669 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 7.3 pt20 -81.52 50.5 1.49 Allowed 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 125.107 1.363 . . . . 0.0 111.183 174.66 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 41.7 mt -64.51 140.91 58.92 Favored 'General case' 0 N--CA 1.464 0.269 0 N-CA-C 107.707 -1.22 . . . . 0.0 107.707 172.856 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 27.8 mm-40 -67.15 142.01 57.18 Favored 'General case' 0 CA--C 1.533 0.324 0 CA-C-N 119.681 1.128 . . . . 0.0 109.035 169.938 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 1.5 t0 -97.35 116.07 65.85 Favored Pre-proline 0 N--CA 1.448 -0.526 0 N-CA-C 105.435 -2.061 . . . . 0.0 105.435 169.224 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 49.7 Cg_endo -83.94 -5.4 10.53 Favored 'Trans proline' 0 N--CA 1.451 -1.004 0 C-N-CA 122.815 2.344 . . . . 0.0 112.963 -174.949 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -58.86 127.42 32.12 Favored 'General case' 0 C--O 1.236 0.384 0 CA-C-N 120.204 1.366 . . . . 0.0 109.742 -178.882 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 74.4 0.4 57.7 Favored Glycine 0 CA--C 1.537 1.414 0 CA-C-O 118.618 -1.101 . . . . 0.0 114.013 -178.687 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 13.0 mt-30 -97.3 169.14 9.97 Favored 'General case' 0 CA--C 1.54 0.581 0 CA-C-N 119.09 1.445 . . . . 0.0 109.841 173.386 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 15.0 m -70.64 164.85 24.1 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 124.442 1.097 . . . . 0.0 111.554 -179.608 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 38.2 mt -61.93 -27.04 68.55 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 123.596 0.758 . . . . 0.0 112.115 -175.654 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 5.0 pt-20 -56.76 -36.09 69.38 Favored 'General case' 0 CA--C 1.53 0.198 0 C-N-CA 123.274 0.63 . . . . 0.0 111.228 173.413 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 24.8 t -76.44 -44.37 35.21 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.298 0 CA-C-O 117.786 -1.102 . . . . 0.0 108.837 -178.73 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 59.1 m-85 -55.05 -47.88 74.22 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-N 120.488 1.495 . . . . 0.0 110.364 173.272 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 93.7 mtt180 -70.01 -35.22 74.2 Favored 'General case' 0 CA--C 1.534 0.337 0 O-C-N 121.705 -0.622 . . . . 0.0 110.97 -175.801 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 2.6 m -60.81 -47.35 86.73 Favored 'General case' 0 N--CA 1.454 -0.262 0 C-N-CA 123.922 0.889 . . . . 0.0 109.175 169.812 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 44.4 t -65.31 -31.66 54.86 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.263 0 CA-C-O 118.481 -0.771 . . . . 0.0 109.867 -174.211 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 19.2 mtm105 -57.31 -46.37 83.26 Favored 'General case' 0 CA--C 1.535 0.382 0 CA-C-N 119.41 1.004 . . . . 0.0 110.375 172.507 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -62.57 -50.69 62.07 Favored Glycine 0 CA--C 1.529 0.907 0 CA-C-O 119.543 -0.587 . . . . 0.0 111.636 175.649 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 70.7 mt-30 -57.03 -49.63 75.23 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-O 121.889 0.852 . . . . 0.0 110.414 -176.865 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 58.4 t -74.89 -37.74 42.31 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-O 117.998 -1.001 . . . . 0.0 110.336 -172.062 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -54.77 -45.19 74.21 Favored 'General case' 0 C--O 1.224 -0.247 0 CA-C-N 119.892 1.224 . . . . 0.0 108.839 173.617 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 40.6 tt0 -67.16 -42.81 83.69 Favored 'General case' 0 N--CA 1.448 -0.571 0 C-N-CA 122.977 0.511 . . . . 0.0 111.267 -175.425 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 35.3 mmt180 -63.89 -45.69 88.24 Favored 'General case' 0 N--CA 1.473 0.689 0 CA-C-N 119.084 0.856 . . . . 0.0 111.304 176.881 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 77.5 t -68.37 -37.48 77.96 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.828 0 N-CA-C 108.71 -0.848 . . . . 0.0 108.71 -177.981 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 4.8 mm-40 -59.22 -46.26 88.93 Favored 'General case' 0 C--N 1.34 0.18 0 CA-C-N 119.426 1.012 . . . . 0.0 110.429 172.647 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 27.1 t-20 -64.89 -40.16 94.66 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 123.143 0.577 . . . . 0.0 111.182 -176.87 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 27.9 tp -58.99 -49.83 76.41 Favored 'General case' 0 CA--C 1.53 0.176 0 C-N-CA 125.105 1.362 . . . . 0.0 110.906 172.901 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 51.7 mt -64.57 -46.13 93.47 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 N-CA-C 107.829 -1.175 . . . . 0.0 107.829 -178.059 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -58.98 -30.96 68.35 Favored 'General case' 0 N--CA 1.452 -0.364 0 CA-C-O 118.52 -0.753 . . . . 0.0 112.284 -178.557 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 17.6 ptpt -84.25 -39.81 18.82 Favored 'General case' 0 C--N 1.345 0.375 0 CA-C-O 117.845 -1.074 . . . . 0.0 112.561 177.003 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 11.8 pt -82.55 -35.94 13.09 Favored 'Isoleucine or valine' 0 C--O 1.235 0.309 0 CA-C-N 120.094 1.315 . . . . 0.0 113.814 -175.133 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 65.1 m . . . . . 0 C--O 1.253 1.243 0 C-N-CA 125.134 1.374 . . . . 0.0 109.732 -169.814 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.0 mmt . . . . . 0 N--CA 1.495 1.805 0 N-CA-C 111.195 0.072 . . . . 0.0 111.195 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 30.0 mttm -83.75 112.34 19.99 Favored 'General case' 0 N--CA 1.475 0.818 0 N-CA-C 105.044 -2.206 . . . . 0.0 105.044 169.495 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 91.9 mttt -82.46 133.87 35.21 Favored 'General case' 0 CA--C 1.512 -0.481 0 CA-C-N 119.869 1.213 . . . . 0.0 107.94 179.758 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 1.8 t -120.05 147.14 23.93 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 C-N-CA 125.512 1.525 . . . . 0.0 108.867 -169.077 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 11.1 mtt -134.55 147.22 50.23 Favored 'General case' 0 C--N 1.326 -0.423 0 C-N-CA 125.731 1.613 . . . . 0.0 109.856 169.432 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 62.0 m-85 -135.54 116.72 14.45 Favored 'General case' 0 C--N 1.334 -0.084 0 N-CA-C 105.878 -1.897 . . . . 0.0 105.878 169.684 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 2.6 p -155.04 157.12 4.42 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.367 0 CA-C-O 121.127 0.489 . . . . 0.0 110.269 -168.991 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 52.3 t -152.43 174.89 13.3 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 127.482 2.313 . . . . 0.0 105.932 169.547 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 65.7 pttt -62.7 144.46 56.34 Favored 'General case' 0 N--CA 1.469 0.488 0 O-C-N 121.213 -0.93 . . . . 0.0 109.867 171.598 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 62.8 mtp85 57.78 170.34 0.05 OUTLIER 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 126.468 1.907 . . . . 0.0 113.171 -173.501 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -118.53 0.21 11.52 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 124.066 0.946 . . . . 0.0 111.462 170.113 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 1.4 m -64.19 -37.78 88.69 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 124.137 0.975 . . . . 0.0 110.147 -174.328 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 24.1 p -136.8 153.38 50.83 Favored 'General case' 0 C--O 1.236 0.391 0 C-N-CA 126.657 1.983 . . . . 0.0 106.532 169.718 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 8.0 mpt_? 56.68 -176.05 0.06 Allowed 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 125.391 1.476 . . . . 0.0 110.003 -169.288 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 3.9 m 48.45 46.44 20.64 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 124.069 0.948 . . . . 0.0 110.245 -169.756 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 21.4 pt20 -151.93 157.28 41.58 Favored 'General case' 0 N--CA 1.444 -0.732 0 N-CA-C 106.175 -1.787 . . . . 0.0 106.175 169.997 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER 64.47 -36.07 0.18 Allowed 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 128.124 2.569 . . . . 0.0 115.746 179.326 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -71.51 -48.76 46.8 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-N 121.431 1.923 . . . . 0.0 110.141 -176.827 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -62.66 -39.0 92.53 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 123.113 0.565 . . . . 0.0 110.447 170.012 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -55.73 -43.43 86.67 Favored Glycine 0 C--N 1.343 0.918 0 C-N-CA 123.924 0.773 . . . . 0.0 112.543 174.822 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 2.1 m-85 -74.72 -32.31 62.11 Favored 'General case' 0 CA--C 1.51 -0.573 0 CA-C-N 119.599 1.7 . . . . 0.0 112.227 177.253 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -67.37 -34.19 76.78 Favored 'General case' 0 N--CA 1.453 -0.313 0 CA-C-N 118.839 0.745 . . . . 0.0 111.257 -172.853 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 17.9 ptpt -62.71 -28.16 69.76 Favored 'General case' 0 N--CA 1.475 0.794 0 CA-C-N 119.224 0.92 . . . . 0.0 111.975 170.827 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 2.1 m -83.78 -56.16 3.86 Favored 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 124.573 1.149 . . . . 0.0 110.369 -177.483 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 72.4 mt -73.33 -34.34 65.61 Favored 'General case' 0 C--N 1.331 -0.206 0 C-N-CA 123.861 0.864 . . . . 0.0 110.186 -173.856 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -97.98 11.34 64.14 Favored Glycine 0 CA--C 1.525 0.667 0 C-N-CA 125.487 1.518 . . . . 0.0 112.82 -177.112 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -50.25 122.8 7.37 Favored 'General case' 0 CA--C 1.535 0.391 0 CA-C-N 118.754 1.277 . . . . 0.0 110.406 -177.121 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 74.67 -2.85 46.23 Favored Glycine 0 CA--C 1.536 1.348 0 CA-C-O 118.764 -1.02 . . . . 0.0 114.39 179.216 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 64.4 mttm -103.89 -42.23 5.65 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-N 119.316 1.558 . . . . 0.0 111.319 178.918 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 17.2 pt -141.97 152.84 18.68 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.657 0 C-N-CA 125.068 1.347 . . . . 0.0 109.671 -171.012 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -113.69 103.42 11.21 Favored 'General case' 0 N--CA 1.467 0.4 0 C-N-CA 125.242 1.417 . . . . 0.0 109.877 -170.752 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 3.8 t -86.22 127.9 39.87 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 O-C-N 121.299 -0.875 . . . . 0.0 108.695 -178.517 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 24.6 m -151.46 98.67 2.54 Favored 'General case' 0 C--O 1.223 -0.341 0 N-CA-C 104.843 -2.28 . . . . 0.0 104.843 173.659 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 20.2 m -97.53 5.06 50.13 Favored 'General case' 0 N--CA 1.467 0.388 0 N-CA-C 114.7 1.37 . . . . 0.0 114.7 -169.693 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 4.6 m 53.12 -133.95 1.74 Allowed 'General case' 0 CA--C 1.548 0.873 0 C-N-CA 124.02 0.928 . . . . 0.0 111.458 175.318 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -177.75 170.79 43.27 Favored Glycine 0 CA--C 1.526 0.728 0 N-CA-C 107.121 -2.392 . . . . 0.0 107.121 179.447 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 24.8 mt -113.34 -43.17 3.38 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 118.481 1.14 . . . . 0.0 109.707 179.327 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -141.83 -59.51 0.47 Allowed 'General case' 0 C--N 1.332 -0.175 0 N-CA-C 102.404 -3.184 . . . . 0.0 102.404 169.743 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 15.9 m 58.93 175.58 0.07 Allowed 'General case' 0 N--CA 1.446 -0.649 0 C-N-CA 127.167 2.187 . . . . 0.0 115.772 167.553 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 4.4 m -165.75 178.98 6.23 Favored 'General case' 0 C--O 1.238 0.499 0 C-N-CA 129.464 3.105 . . . . 0.0 104.442 -169.645 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -65.9 163.17 17.55 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-O 122.491 1.139 . . . . 0.0 110.581 172.26 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 4.3 m -67.34 175.32 0.51 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.71 0 CA-C-N 113.305 -1.771 . . . . 0.0 109.3 169.849 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 49.8 t-80 -72.62 139.55 80.91 Favored Pre-proline 0 CA--C 1.545 0.786 0 CA-C-O 118.474 -0.774 . . . . 0.0 109.549 -176.638 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 21.8 Cg_endo -60.74 -48.1 11.72 Favored 'Trans proline' 0 C--N 1.348 0.552 0 C-N-CA 122.645 2.23 . . . . 0.0 113.019 -172.301 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 4.9 m -65.47 -23.41 66.9 Favored 'General case' 0 CA--C 1.536 0.425 0 O-C-N 121.727 -0.608 . . . . 0.0 110.899 179.374 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -58.89 -46.52 87.64 Favored 'General case' 0 C--O 1.216 -0.707 0 CA-C-N 119.146 0.884 . . . . 0.0 108.723 176.835 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 38.6 mt -61.11 -40.18 84.87 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 N-CA-C 108.89 -0.781 . . . . 0.0 108.89 -174.489 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -65.71 -45.1 84.01 Favored 'General case' 0 CA--C 1.534 0.338 0 CA-C-N 118.39 0.541 . . . . 0.0 110.946 -179.864 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 33.0 mmt -68.25 -36.77 79.95 Favored 'General case' 0 CA--C 1.536 0.414 0 CA-C-O 123.295 1.522 . . . . 0.0 110.006 -179.106 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -76.96 -30.39 56.0 Favored 'General case' 0 N--CA 1.44 -0.933 0 N-CA-C 106.632 -1.618 . . . . 0.0 106.632 -175.675 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 40.6 tt0 -69.69 -21.13 63.53 Favored 'General case' 0 N--CA 1.445 -0.686 0 C-N-CA 124.1 0.96 . . . . 0.0 110.049 169.672 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 54.8 mt-10 -63.65 -39.02 93.3 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-N 119.85 1.205 . . . . 0.0 108.963 169.206 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . 0.32 6.2 p -84.7 8.42 1.56 Allowed 'Isoleucine or valine' 0 CA--C 1.549 0.922 0 N-CA-C 112.005 0.372 . . . . 0.0 112.005 171.628 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 79.46 20.15 69.79 Favored Glycine 0 CA--C 1.53 1.01 0 C-N-CA 125.009 1.29 . . . . 0.0 113.563 174.318 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 22.8 mt -116.54 145.97 21.58 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.261 0 C-N-CA 124.861 1.265 . . . . 0.0 110.547 -171.528 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -116.73 149.02 40.56 Favored 'General case' 0 N--CA 1.463 0.214 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 168.94 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 3.3 pt -138.34 -18.78 0.47 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.376 0 C-N-CA 128.058 2.543 . . . . 0.0 111.197 -174.529 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 1.6 t -47.2 -39.87 14.89 Favored 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 124.11 0.964 . . . . 0.0 112.023 169.929 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -68.97 6.26 4.0 Favored Glycine 0 CA--C 1.535 1.306 0 C-N-CA 124.958 1.266 . . . . 0.0 115.318 -176.977 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 2.2 mt-30 -61.33 -33.35 73.47 Favored 'General case' 0 C--N 1.342 0.24 0 CA-C-N 119.605 1.702 . . . . 0.0 113.355 179.191 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -59.77 119.75 8.25 Favored 'General case' 0 C--O 1.236 0.385 0 C-N-CA 123.596 0.758 . . . . 0.0 109.736 -169.412 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 56.1 m -148.84 -169.71 3.44 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 126.358 1.863 . . . . 0.0 108.229 -169.149 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -54.75 154.6 9.1 Favored Pre-proline 0 C--O 1.239 0.524 0 C-N-CA 124.407 1.083 . . . . 0.0 111.613 169.925 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 98.2 Cg_endo -66.08 157.06 61.55 Favored 'Trans proline' 0 N--CA 1.454 -0.82 0 C-N-CA 122.328 2.018 . . . . 0.0 110.225 171.175 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 14.0 tt -61.19 -26.46 39.31 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.328 0 C-N-CA 124.229 1.011 . . . . 0.0 110.979 -178.789 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 13.6 mt-10 -68.03 -24.93 65.15 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 124.556 1.142 . . . . 0.0 110.619 -175.673 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 6.8 t-20 -62.93 -19.14 63.95 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 124.821 1.249 . . . . 0.0 112.153 177.477 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 13.3 m-85 -120.8 174.01 6.87 Favored 'General case' 0 C--O 1.237 0.412 0 C-N-CA 126.484 1.914 . . . . 0.0 109.318 -178.286 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 29.9 p-10 -125.09 149.29 47.99 Favored 'General case' 0 N--CA 1.437 -1.124 0 C-N-CA 124.681 1.192 . . . . 0.0 110.942 168.936 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -75.64 -22.23 56.97 Favored 'General case' 0 N--CA 1.435 -1.223 0 N-CA-C 109.603 -0.518 . . . . 0.0 109.603 -169.901 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 34.7 t70 -64.7 -23.66 67.32 Favored 'General case' 0 N--CA 1.444 -0.774 0 O-C-N 123.666 0.603 . . . . 0.0 111.804 -178.828 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -76.61 -29.44 56.5 Favored 'General case' 0 CA--C 1.533 0.323 0 O-C-N 121.893 -0.505 . . . . 0.0 111.928 173.993 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 21.0 m-85 -78.7 167.73 20.79 Favored 'General case' 0 N--CA 1.448 -0.532 0 C-N-CA 125.116 1.366 . . . . 0.0 110.949 179.597 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -115.63 -40.06 3.43 Favored 'General case' 0 N--CA 1.466 0.353 0 C-N-CA 122.893 0.477 . . . . 0.0 111.223 178.962 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -138.04 136.16 45.03 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.497 0 CA-C-O 121.8 0.81 . . . . 0.0 109.315 -171.324 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 72.1 t -143.84 136.56 23.75 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.68 0 N-CA-C 106.126 -1.805 . . . . 0.0 106.126 -176.869 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 40.9 mm -129.18 127.3 65.45 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.609 0 N-CA-C 107.325 -1.361 . . . . 0.0 107.325 -169.916 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 15.0 m -87.37 131.19 34.37 Favored 'General case' 0 N--CA 1.436 -1.159 0 N-CA-C 105.96 -1.867 . . . . 0.0 105.96 168.235 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 90.6 mt -88.71 -11.67 44.5 Favored 'General case' 0 C--N 1.331 -0.208 0 O-C-N 122.026 -0.421 . . . . 0.0 110.617 172.004 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -167.23 148.85 5.81 Favored 'General case' 0 N--CA 1.447 -0.618 0 C-N-CA 126.633 1.973 . . . . 0.0 107.339 168.385 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 72.37 167.79 10.51 Favored Glycine 0 CA--C 1.535 1.338 0 C-N-CA 124.849 1.214 . . . . 0.0 114.452 174.009 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 41.9 m -141.38 111.09 6.51 Favored 'General case' 0 CA--C 1.532 0.262 0 N-CA-C 107.454 -1.313 . . . . 0.0 107.454 178.936 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 60.23 30.94 71.96 Favored Glycine 0 CA--C 1.535 1.304 0 N-CA-C 111.567 -0.613 . . . . 0.0 111.567 -174.747 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 10.4 p -67.4 -51.71 49.52 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.563 0 C-N-CA 123.882 0.873 . . . . 0.0 111.493 -169.182 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 16.1 t-20 -154.4 41.61 0.49 Allowed 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 125.32 1.448 . . . . 0.0 107.128 173.04 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 2.3 tt -147.59 141.12 15.39 Favored Pre-proline 0 CA--C 1.542 0.641 0 C-N-CA 125.934 1.693 . . . . 0.0 107.85 -169.351 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 32.9 Cg_exo -68.18 149.94 76.57 Favored 'Trans proline' 0 C--N 1.355 0.885 0 CA-C-N 120.742 1.301 . . . . 0.0 114.272 -169.837 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -69.53 -29.05 25.58 Favored 'Trans proline' 0 C--N 1.347 0.455 0 C-N-CA 122.464 2.11 . . . . 0.0 114.292 -169.873 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -61.22 -18.36 57.93 Favored 'General case' 0 CA--C 1.538 0.492 0 CA-C-N 119.738 1.154 . . . . 0.0 112.081 -178.866 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 97.9 m95 -75.83 -49.37 18.2 Favored 'General case' 0 N--CA 1.449 -0.522 0 C-N-CA 123.628 0.771 . . . . 0.0 110.583 177.739 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 33.5 m -77.02 1.07 2.2 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.44 0 C-N-CA 123.13 0.572 . . . . 0.0 112.421 -178.647 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 81.3 p -111.47 19.57 18.06 Favored 'General case' 0 CA--C 1.537 0.458 0 N-CA-C 114.302 1.223 . . . . 0.0 114.302 175.464 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 87.4 mm-40 -67.54 174.61 3.33 Favored 'General case' 0 CA--C 1.539 0.544 0 CA-C-N 119.16 0.891 . . . . 0.0 112.445 178.158 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 29.7 mm-40 -51.91 -32.23 31.87 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 124.711 1.204 . . . . 0.0 112.334 -169.056 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 5.3 tt -131.71 130.85 62.24 Favored 'Isoleucine or valine' 0 C--O 1.24 0.557 0 N-CA-C 103.92 -2.622 . . . . 0.0 103.92 168.017 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 40.9 t80 -120.47 141.18 50.42 Favored 'General case' 0 N--CA 1.444 -0.738 0 N-CA-C 106.061 -1.829 . . . . 0.0 106.061 169.27 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 31.2 mm-40 -139.68 144.8 37.76 Favored 'General case' 0 C--O 1.237 0.408 0 N-CA-C 106.204 -1.776 . . . . 0.0 106.204 169.632 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 7.1 t0 -119.8 103.45 9.37 Favored 'General case' 0 C--O 1.237 0.443 0 N-CA-C 104.746 -2.316 . . . . 0.0 104.746 169.247 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 4.2 m95 -86.15 134.22 33.81 Favored 'General case' 0 N--CA 1.453 -0.278 0 CA-C-O 120.683 0.278 . . . . 0.0 110.928 -169.62 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 66.5 tt0 -81.89 99.71 9.21 Favored 'General case' 0 C--O 1.236 0.383 0 N-CA-C 103.568 -2.753 . . . . 0.0 103.568 168.712 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 11.1 mt -129.62 133.17 46.99 Favored 'General case' 0 CA--C 1.52 -0.196 0 N-CA-C 107.477 -1.305 . . . . 0.0 107.477 178.622 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 -76.74 165.0 25.33 Favored 'General case' 0 N--CA 1.452 -0.366 0 C-N-CA 124.902 1.281 . . . . 0.0 108.323 169.803 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 15.3 t70 -140.66 139.72 20.71 Favored Pre-proline 0 CA--C 1.536 0.439 0 C-N-CA 123.872 0.869 . . . . 0.0 110.142 -177.511 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 42.4 Cg_endo -84.83 0.92 8.82 Favored 'Trans proline' 0 CA--C 1.544 0.977 0 C-N-CA 123.149 2.566 . . . . 0.0 114.405 -172.8 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 3.2 t70 -48.76 120.0 3.52 Favored 'General case' 0 N--CA 1.468 0.428 0 CA-C-N 120.517 1.508 . . . . 0.0 110.926 177.623 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 67.87 4.73 35.49 Favored Glycine 0 CA--C 1.536 1.383 0 CA-C-O 118.723 -1.043 . . . . 0.0 114.777 179.076 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 6.3 mt-30 -94.45 171.14 8.99 Favored 'General case' 0 CA--C 1.538 0.509 0 CA-C-N 119.31 1.555 . . . . 0.0 110.424 -178.612 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 14.6 m -68.47 159.61 31.36 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 124.321 1.048 . . . . 0.0 110.599 178.083 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 13.8 tp -60.06 -32.0 70.52 Favored 'General case' 0 N--CA 1.467 0.417 0 C-N-CA 123.888 0.875 . . . . 0.0 112.127 -170.055 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 5.3 pt-20 -53.85 -35.76 61.86 Favored 'General case' 0 N--CA 1.467 0.418 0 C-N-CA 126.016 1.726 . . . . 0.0 112.137 176.095 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 38.3 t -70.81 -37.86 70.37 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.258 0 N-CA-C 109.083 -0.71 . . . . 0.0 109.083 -174.008 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 91.8 m-85 -56.74 -50.35 72.5 Favored 'General case' 0 N--CA 1.462 0.126 0 CA-C-N 119.346 0.975 . . . . 0.0 110.806 172.563 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -66.34 -38.09 86.86 Favored 'General case' 0 N--CA 1.473 0.699 0 N-CA-C 109.766 -0.457 . . . . 0.0 109.766 -174.992 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 4.0 m -60.85 -49.64 76.66 Favored 'General case' 0 N--CA 1.451 -0.42 0 C-N-CA 124.704 1.201 . . . . 0.0 109.984 173.681 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 76.7 t -69.59 -25.84 29.62 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.229 0 CA-C-O 117.812 -1.089 . . . . 0.0 109.944 -171.829 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 11.9 mtm105 -57.15 -49.07 77.07 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 120.142 1.337 . . . . 0.0 109.729 169.839 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -63.35 -48.47 78.54 Favored Glycine 0 CA--C 1.527 0.84 0 CA-C-N 118.608 0.64 . . . . 0.0 111.951 -179.52 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 12.8 mt-30 -60.74 -46.15 91.52 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-N 117.719 0.759 . . . . 0.0 110.77 -179.188 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 82.6 t -70.68 -40.67 77.27 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-O 118.424 -0.798 . . . . 0.0 110.297 -175.84 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 85.9 tttt -52.69 -47.26 67.33 Favored 'General case' 0 C--O 1.223 -0.322 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 175.688 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 40.2 tt0 -64.58 -42.63 95.49 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-O 119.245 -0.407 . . . . 0.0 111.253 -175.134 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 35.3 mmt180 -60.21 -47.46 85.86 Favored 'General case' 0 N--CA 1.472 0.635 0 CA-C-N 118.882 0.765 . . . . 0.0 110.434 175.893 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 89.8 t -69.94 -37.78 73.7 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.525 0 N-CA-C 109.563 -0.532 . . . . 0.0 109.563 -175.274 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 35.4 mt-10 -59.96 -44.44 94.42 Favored 'General case' 0 C--O 1.227 -0.097 0 CA-C-N 119.657 1.117 . . . . 0.0 110.049 174.165 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 28.7 t-20 -63.26 -44.55 94.84 Favored 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 122.693 0.397 . . . . 0.0 110.834 -178.564 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 41.8 tp -58.73 -48.53 80.85 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 124.335 1.054 . . . . 0.0 111.104 175.97 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 65.4 mt -62.79 -47.1 94.48 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.149 0 N-CA-C 107.865 -1.161 . . . . 0.0 107.865 -179.999 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -58.85 -27.65 65.34 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 123.095 0.558 . . . . 0.0 112.436 178.11 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 89.4 mttt -72.03 -57.43 4.29 Favored 'General case' 0 C--N 1.343 0.325 0 CA-C-N 119.153 0.888 . . . . 0.0 110.616 171.604 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 13.2 pt -76.14 -36.23 30.31 Favored 'Isoleucine or valine' 0 C--O 1.235 0.293 0 N-CA-C 115.184 1.55 . . . . 0.0 115.184 -168.943 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 69.2 m . . . . . 0 C--O 1.252 1.229 0 C-N-CA 125.707 1.603 . . . . 0.0 109.606 -169.881 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 19.5 mmm . . . . . 0 N--CA 1.499 1.997 0 N-CA-C 110.936 -0.024 . . . . 0.0 110.936 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 31.0 mttm -79.43 117.81 20.73 Favored 'General case' 0 N--CA 1.477 0.895 0 N-CA-C 105.407 -2.071 . . . . 0.0 105.407 169.545 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 74.5 mttt -83.43 133.67 34.91 Favored 'General case' 0 CA--C 1.514 -0.414 0 CA-C-N 120.252 1.387 . . . . 0.0 107.997 179.324 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 1.5 t -118.78 147.94 21.98 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.583 0 C-N-CA 126.725 2.01 . . . . 0.0 106.711 -169.635 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 49.7 ttm -142.8 142.04 31.78 Favored 'General case' 0 C--N 1.325 -0.484 0 C-N-CA 123.71 0.804 . . . . 0.0 109.343 172.191 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 97.0 m-85 -132.64 122.06 24.12 Favored 'General case' 0 CA--C 1.511 -0.551 0 N-CA-C 104.987 -2.227 . . . . 0.0 104.987 179.855 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 1.6 p -154.07 119.78 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.397 0 C-N-CA 119.566 -0.854 . . . . 0.0 109.412 -169.515 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 51.1 t -98.75 178.43 4.98 Favored 'General case' 0 CA--C 1.541 0.623 0 N-CA-C 106.971 -1.492 . . . . 0.0 106.971 168.915 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -52.4 -42.19 63.83 Favored 'General case' 0 N--CA 1.473 0.707 0 O-C-N 121.624 -0.673 . . . . 0.0 110.803 178.662 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 66.2 mtp180 -108.94 145.45 35.41 Favored 'General case' 0 CA--C 1.521 -0.156 0 N-CA-C 108.978 -0.749 . . . . 0.0 108.978 169.852 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 7.4 t30 -55.04 -38.01 67.42 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 124.363 1.065 . . . . 0.0 111.112 169.372 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 1.4 m -68.71 -15.0 63.38 Favored 'General case' 0 CA--C 1.533 0.307 0 N-CA-C 114.667 1.358 . . . . 0.0 114.667 -169.557 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 52.3 m -124.69 139.43 53.86 Favored 'General case' 0 C--O 1.223 -0.309 0 C-N-CA 123.97 0.908 . . . . 0.0 110.311 -169.09 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 6.4 mpt_? 59.14 -60.97 0.04 OUTLIER 'General case' 0 N--CA 1.481 1.112 0 C-N-CA 127.605 2.362 . . . . 0.0 114.066 -174.737 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -44.72 -36.91 3.39 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 126.499 1.919 . . . . 0.0 109.624 170.001 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 23.8 tt0 -25.63 -61.91 0.07 Allowed 'General case' 0 C--O 1.22 -0.486 0 C-N-CA 130.686 3.595 . . . . 0.0 111.772 168.848 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -98.68 -29.87 12.78 Favored 'General case' 0 CA--C 1.516 -0.345 0 CA-C-N 119.719 1.145 . . . . 0.0 113.434 177.501 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -61.09 -48.55 81.18 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 111.993 0.368 . . . . 0.0 111.993 -169.321 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -68.74 -30.62 69.28 Favored 'General case' 0 N--CA 1.463 0.177 0 C-N-CA 120.237 -0.585 . . . . 0.0 109.645 176.767 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -54.81 -57.3 18.55 Favored Glycine 0 C--N 1.34 0.781 0 C-N-CA 125.405 1.478 . . . . 0.0 110.099 176.812 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 8.7 m-85 -67.89 -32.18 72.48 Favored 'General case' 0 CA--C 1.503 -0.835 0 O-C-N 121.659 -0.906 . . . . 0.0 111.981 179.982 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -65.82 -34.74 78.85 Favored 'General case' 0 N--CA 1.447 -0.585 0 C-N-CA 119.431 -0.908 . . . . 0.0 111.141 -175.452 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -68.1 -24.23 65.01 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-N 119.436 1.016 . . . . 0.0 112.036 175.037 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 2.1 m -82.11 -56.12 4.13 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 125.223 1.409 . . . . 0.0 110.438 -179.993 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 72.3 mt -76.37 -34.97 58.91 Favored 'General case' 0 C--N 1.329 -0.283 0 C-N-CA 124.631 1.172 . . . . 0.0 110.258 -172.529 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -92.57 7.13 77.69 Favored Glycine 0 CA--C 1.526 0.758 0 C-N-CA 125.282 1.42 . . . . 0.0 113.198 -177.292 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -52.52 124.18 12.93 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 124.448 1.099 . . . . 0.0 110.002 -176.01 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 75.44 1.95 66.74 Favored Glycine 0 CA--C 1.535 1.288 0 CA-C-O 118.835 -0.981 . . . . 0.0 114.406 179.074 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 64.0 mttm -113.36 -43.06 3.39 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-N 119.294 1.547 . . . . 0.0 111.359 178.828 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 20.4 pt -140.94 151.41 20.2 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.604 0 C-N-CA 123.805 0.842 . . . . 0.0 110.388 -169.36 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -108.66 103.25 12.31 Favored 'General case' 0 N--CA 1.467 0.393 0 C-N-CA 125.37 1.468 . . . . 0.0 109.646 -173.209 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 20.8 t -81.31 135.84 24.28 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 179.604 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 4.8 m -140.68 111.51 6.99 Favored 'General case' 0 N--CA 1.445 -0.678 0 N-CA-C 104.492 -2.41 . . . . 0.0 104.492 169.513 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 75.0 m -114.31 91.97 3.81 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 107.64 -1.245 . . . . 0.0 107.64 178.739 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 5.0 p -63.69 -62.38 1.7 Allowed 'General case' 0 C--O 1.233 0.215 0 C-N-CA 126.408 1.883 . . . . 0.0 112.044 -173.071 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 107.88 137.63 8.36 Favored Glycine 0 CA--C 1.527 0.786 0 N-CA-C 109.157 -1.577 . . . . 0.0 109.157 -174.425 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 12.8 mt -80.08 -40.44 27.6 Favored 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 124.395 1.078 . . . . 0.0 108.874 170.207 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 33.5 mt-10 -139.87 170.16 16.38 Favored 'General case' 0 C--O 1.239 0.523 0 C-N-CA 128.143 2.577 . . . . 0.0 107.629 172.914 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 13.2 m 64.75 -168.17 0.21 Allowed 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 124.837 1.255 . . . . 0.0 112.315 -177.487 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 36.8 p -162.55 -47.66 0.04 OUTLIER 'General case' 0 C--O 1.232 0.184 0 N-CA-C 112.442 0.534 . . . . 0.0 112.442 -167.067 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 2.0 ttp-105 -108.87 -167.5 1.23 Allowed 'General case' 0 CA--C 1.52 -0.19 0 C-N-CA 125.498 1.519 . . . . 0.0 109.227 177.766 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 34.2 m -127.32 168.94 19.53 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 C-N-CA 125.506 1.523 . . . . 0.0 109.838 -171.757 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 37.4 m80 -71.59 148.1 92.67 Favored Pre-proline 0 CA--C 1.548 0.889 0 C-N-CA 123.313 0.645 . . . . 0.0 109.694 177.975 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -62.39 -50.74 4.14 Favored 'Trans proline' 0 C--N 1.348 0.529 0 C-N-CA 123.818 3.012 . . . . 0.0 114.806 -168.632 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 11.5 m -63.88 -22.69 67.03 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-N 118.211 0.459 . . . . 0.0 110.61 -175.678 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -55.12 -55.33 32.32 Favored 'General case' 0 CA--C 1.511 -0.546 0 C-N-CA 122.765 0.426 . . . . 0.0 109.911 174.152 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 56.3 mt -60.54 -38.04 76.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 N-CA-C 108.554 -0.906 . . . . 0.0 108.554 -170.635 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -62.94 -48.19 79.98 Favored 'General case' 0 N--CA 1.451 -0.379 0 CA-C-N 118.471 0.578 . . . . 0.0 111.07 177.778 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 27.8 mmt -66.73 -36.54 82.71 Favored 'General case' 0 C--O 1.238 0.488 0 CA-C-O 122.78 1.276 . . . . 0.0 111.071 -179.748 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -75.98 -31.23 58.88 Favored 'General case' 0 N--CA 1.441 -0.878 0 N-CA-C 107.183 -1.414 . . . . 0.0 107.183 -174.777 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 41.0 tt0 -71.28 -21.77 62.04 Favored 'General case' 0 N--CA 1.446 -0.63 0 C-N-CA 124.138 0.975 . . . . 0.0 110.426 171.031 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 20.0 mm-40 -67.57 -31.0 70.77 Favored 'General case' 0 CA--C 1.534 0.359 0 CA-C-N 119.508 1.049 . . . . 0.0 110.141 170.814 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . 0.28 7.2 p -90.39 8.62 3.53 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.983 0 CA-C-N 118.633 0.652 . . . . 0.0 111.482 169.062 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 75.73 18.59 79.6 Favored Glycine 0 CA--C 1.533 1.162 0 C-N-CA 124.678 1.133 . . . . 0.0 113.746 174.908 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 21.6 mt -111.35 134.81 52.5 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.23 0 C-N-CA 124.559 1.143 . . . . 0.0 109.379 -177.234 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 28.7 t0 -99.52 141.53 32.19 Favored 'General case' 0 C--O 1.235 0.323 0 N-CA-C 108.288 -1.005 . . . . 0.0 108.288 168.952 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 8.8 pt -131.15 -15.67 1.58 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.503 0 C-N-CA 126.335 1.854 . . . . 0.0 111.298 -174.135 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 1.2 t -57.2 163.48 2.14 Favored 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 124.544 1.138 . . . . 0.0 109.86 168.342 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 57.73 32.6 65.82 Favored Glycine 0 CA--C 1.532 1.106 0 C-N-CA 123.543 0.592 . . . . 0.0 112.129 179.177 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 4.3 tt0 -65.5 -39.41 91.82 Favored 'General case' 0 C--N 1.341 0.214 0 N-CA-C 113.957 1.095 . . . . 0.0 113.957 -169.135 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 7.0 t -76.19 177.82 6.9 Favored 'General case' 0 N--CA 1.449 -0.518 0 CA-C-O 122.557 1.17 . . . . 0.0 110.555 -169.646 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 13.3 p -155.72 -54.1 0.09 Allowed 'General case' 0 C--N 1.324 -0.515 0 C-N-CA 125.213 1.405 . . . . 0.0 108.327 -171.25 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -151.88 155.89 33.95 Favored Pre-proline 0 C--O 1.239 0.521 0 C-N-CA 127.628 2.371 . . . . 0.0 106.173 169.955 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -59.84 148.81 86.85 Favored 'Trans proline' 0 N--CA 1.457 -0.654 0 C-N-CA 121.801 1.668 . . . . 0.0 108.991 169.411 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 20.6 tt -55.24 -29.62 23.44 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.352 0 C-N-CA 123.12 0.568 . . . . 0.0 112.364 -174.181 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 9.0 mt-10 -65.73 -29.62 70.17 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 123.233 0.613 . . . . 0.0 111.026 -173.234 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 88.3 m-20 -77.93 -8.98 58.84 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 124.002 0.921 . . . . 0.0 112.273 -177.796 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 61.8 m-85 -95.53 162.24 13.72 Favored 'General case' 0 C--O 1.236 0.352 0 C-N-CA 124.286 1.034 . . . . 0.0 111.321 176.836 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 40.9 t-20 -99.47 127.32 45.52 Favored 'General case' 0 N--CA 1.447 -0.62 0 N-CA-C 107.431 -1.322 . . . . 0.0 107.431 168.875 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -73.3 -26.28 61.01 Favored 'General case' 0 N--CA 1.434 -1.266 0 N-CA-C 109.466 -0.568 . . . . 0.0 109.466 -178.252 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -63.85 -22.47 66.93 Favored 'General case' 0 N--CA 1.443 -0.798 0 CA-C-N 116.528 -0.306 . . . . 0.0 111.582 -178.347 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -74.02 -24.64 59.58 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 123.058 0.543 . . . . 0.0 111.991 178.851 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 34.4 m-85 -85.85 145.67 27.09 Favored 'General case' 0 N--CA 1.451 -0.394 0 C-N-CA 124.974 1.31 . . . . 0.0 111.5 -176.534 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 27.3 t70 -98.66 -32.69 11.28 Favored 'General case' 0 N--CA 1.466 0.357 0 C-N-CA 123.506 0.722 . . . . 0.0 111.032 -179.844 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -140.19 134.66 36.13 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.393 0 C-N-CA 124.376 1.071 . . . . 0.0 109.119 -175.792 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 94.2 t -144.1 139.49 24.77 Favored 'Isoleucine or valine' 0 C--O 1.237 0.396 0 N-CA-C 107.165 -1.42 . . . . 0.0 107.165 -178.822 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 19.0 mm -123.06 124.4 70.11 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.601 0 N-CA-C 106.589 -1.634 . . . . 0.0 106.589 -179.357 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 28.2 m -95.4 105.87 17.88 Favored 'General case' 0 N--CA 1.448 -0.555 0 N-CA-C 103.66 -2.718 . . . . 0.0 103.66 169.321 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 29.4 mt -76.21 -4.76 43.58 Favored 'General case' 0 N--CA 1.463 0.219 0 N-CA-C 114.273 1.212 . . . . 0.0 114.273 -169.364 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 73.2 m -146.13 71.77 1.27 Allowed 'General case' 0 N--CA 1.451 -0.391 0 CA-C-N 118.795 0.725 . . . . 0.0 109.168 -169.761 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 91.05 178.79 43.18 Favored Glycine 0 CA--C 1.53 0.979 0 C-N-CA 124.484 1.04 . . . . 0.0 111.031 -177.009 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 15.0 p -89.79 -92.95 0.12 Allowed 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 123.643 0.777 . . . . 0.0 111.087 -169.533 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -79.52 -41.67 12.85 Favored Glycine 0 C--N 1.338 0.665 0 CA-C-O 119.058 -0.856 . . . . 0.0 111.06 176.885 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . 0.317 4.7 m 44.13 -94.41 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.543 0.698 0 C-N-CA 126.063 1.745 . . . . 0.0 113.704 174.833 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 57.3 t30 -141.13 43.42 1.79 Allowed 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 125.129 1.372 . . . . 0.0 109.111 177.131 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -133.72 139.27 33.1 Favored Pre-proline 0 CA--C 1.541 0.623 0 C-N-CA 127.247 2.219 . . . . 0.0 107.316 -171.642 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 39.6 Cg_exo -65.36 137.84 52.91 Favored 'Trans proline' 0 CA--C 1.539 0.748 0 C-N-CA 121.386 1.391 . . . . 0.0 111.965 -176.124 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 65.1 Cg_endo -68.88 -15.53 40.44 Favored 'Trans proline' 0 N--CA 1.46 -0.472 0 C-N-CA 122.616 2.211 . . . . 0.0 113.513 -173.644 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -59.54 -14.74 14.21 Favored 'General case' 0 CA--C 1.541 0.625 0 CA-C-N 120.315 1.416 . . . . 0.0 111.966 170.425 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 99.8 m95 -96.56 -11.36 25.49 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 125.215 1.406 . . . . 0.0 113.563 174.683 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 3.9 m -92.42 0.75 9.42 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.355 0 CA-C-N 120.261 1.392 . . . . 0.0 111.477 174.745 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 63.6 p -117.88 15.66 14.32 Favored 'General case' 0 C--O 1.237 0.406 0 N-CA-C 116.872 2.175 . . . . 0.0 116.872 -169.455 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 17.6 mp0 -66.51 173.87 3.1 Favored 'General case' 0 CA--C 1.54 0.587 0 CA-C-N 118.852 0.751 . . . . 0.0 111.016 176.284 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 33.3 mm-40 -56.67 -27.06 57.98 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 123.691 0.796 . . . . 0.0 111.268 -172.353 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 5.0 tt -133.8 131.24 56.41 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.528 0 N-CA-C 104.958 -2.238 . . . . 0.0 104.958 168.361 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 40.5 t80 -117.99 135.99 53.81 Favored 'General case' 0 N--CA 1.449 -0.486 0 N-CA-C 106.706 -1.59 . . . . 0.0 106.706 169.739 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 16.4 mm-40 -142.09 165.81 26.44 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-O 121.963 0.887 . . . . 0.0 110.116 174.881 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 3.7 t0 -168.1 134.16 1.95 Allowed 'General case' 0 C--O 1.239 0.516 0 C-N-CA 129.71 3.204 . . . . 0.0 106.108 -172.76 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 6.2 m-90 -144.8 149.04 34.77 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 123.847 0.859 . . . . 0.0 109.72 -171.269 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 7.4 tp-100 -82.56 57.36 3.69 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-O 121.809 0.814 . . . . 0.0 109.589 177.889 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 66.6 mt -79.22 152.66 30.5 Favored 'General case' 0 CA--C 1.53 0.179 0 N-CA-C 106.526 -1.657 . . . . 0.0 106.526 169.62 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 5.6 pt-20 -119.24 164.55 15.46 Favored 'General case' 0 N--CA 1.456 -0.141 0 C-N-CA 124.936 1.294 . . . . 0.0 110.436 178.623 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 64.4 t0 -97.42 121.28 58.91 Favored Pre-proline 0 CA--C 1.539 0.542 0 C-N-CA 123.739 0.815 . . . . 0.0 108.842 171.375 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 90.2 Cg_endo -70.48 -5.0 15.65 Favored 'Trans proline' 0 CA--C 1.544 1.02 0 C-N-CA 123.792 2.995 . . . . 0.0 113.765 176.18 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -43.28 123.23 2.85 Favored 'General case' 0 C--O 1.238 0.453 0 C-N-CA 126.249 1.82 . . . . 0.0 111.367 -179.506 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 69.5 2.79 36.89 Favored Glycine 0 CA--C 1.533 1.19 0 CA-C-O 118.612 -1.105 . . . . 0.0 114.98 169.759 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 28.8 pt20 -111.62 -167.06 1.13 Allowed 'General case' 0 CA--C 1.536 0.433 0 CA-C-N 119.021 1.41 . . . . 0.0 109.737 171.928 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 2.3 m -68.45 154.43 41.84 Favored 'General case' 0 N--CA 1.453 -0.303 0 N-CA-C 115.699 1.74 . . . . 0.0 115.699 -168.261 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 36.0 tp -55.76 -33.39 64.27 Favored 'General case' 0 N--CA 1.465 0.317 0 C-N-CA 126.349 1.86 . . . . 0.0 111.784 173.722 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -58.12 -34.67 70.47 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 123.544 0.738 . . . . 0.0 110.529 174.711 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 2.8 t -76.47 -40.52 34.53 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.299 0 CA-C-O 118.284 -0.865 . . . . 0.0 109.96 -178.912 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 61.9 m-85 -56.47 -47.27 79.55 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-N 120.122 1.328 . . . . 0.0 109.538 171.4 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 86.7 mtt180 -62.99 -43.16 99.55 Favored 'General case' 0 N--CA 1.466 0.351 0 C-N-CA 122.982 0.513 . . . . 0.0 110.972 179.43 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 6.9 m -64.25 -50.12 69.19 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 124.266 1.027 . . . . 0.0 109.955 179.347 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 75.8 t -68.68 -37.46 77.59 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.365 0 CA-C-N 118.796 0.725 . . . . 0.0 109.056 -173.564 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 46.1 ttp85 -58.22 -44.39 88.17 Favored 'General case' 0 CA--C 1.538 0.483 0 CA-C-N 119.117 0.871 . . . . 0.0 110.329 174.706 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -64.83 -50.24 59.34 Favored Glycine 0 CA--C 1.531 1.07 0 CA-C-N 118.543 0.611 . . . . 0.0 112.204 176.137 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 39.1 mm-40 -58.02 -50.99 71.51 Favored 'General case' 0 N--CA 1.465 0.324 0 C-N-CA 124.213 1.005 . . . . 0.0 110.278 -177.838 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 98.3 t -67.56 -38.38 80.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-O 118.211 -0.899 . . . . 0.0 110.344 -174.054 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 57.1 tttm -55.0 -44.75 74.8 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 119.451 1.023 . . . . 0.0 109.338 175.551 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -68.48 -43.33 77.16 Favored 'General case' 0 N--CA 1.447 -0.621 0 CA-C-O 119.053 -0.498 . . . . 0.0 111.293 -176.204 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 1.8 mmt-85 -60.34 -46.83 88.51 Favored 'General case' 0 N--CA 1.476 0.841 0 CA-C-N 119.363 0.983 . . . . 0.0 110.604 176.262 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 98.4 t -69.41 -38.57 77.43 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.487 0 N-CA-C 109.101 -0.703 . . . . 0.0 109.101 -177.172 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 15.3 mt-10 -60.38 -45.63 92.86 Favored 'General case' 0 CA--C 1.52 -0.202 0 CA-C-N 119.884 1.22 . . . . 0.0 110.122 175.022 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 29.4 t-20 -62.53 -41.51 98.91 Favored 'General case' 0 CA--C 1.531 0.223 0 C-N-CA 123.25 0.62 . . . . 0.0 110.712 -179.85 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 58.7 tp -60.78 -48.45 81.73 Favored 'General case' 0 N--CA 1.456 -0.148 0 C-N-CA 123.819 0.848 . . . . 0.0 111.261 176.424 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 76.1 mt -63.49 -45.72 97.09 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.292 0 N-CA-C 107.646 -1.242 . . . . 0.0 107.646 179.91 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -59.19 -28.31 66.51 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 123.135 0.574 . . . . 0.0 112.405 177.009 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 72.3 mttt -71.87 -54.22 10.77 Favored 'General case' 0 C--N 1.343 0.309 0 CA-C-N 119.129 0.877 . . . . 0.0 110.726 172.772 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 14.1 pt -79.44 -38.43 19.74 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.332 0 N-CA-C 114.667 1.358 . . . . 0.0 114.667 -169.215 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 73.3 m . . . . . 0 C--O 1.253 1.266 0 C-N-CA 125.967 1.707 . . . . 0.0 109.742 -169.982 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.496 1.834 0 N-CA-C 110.234 -0.284 . . . . 0.0 110.234 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 34.3 mttm -76.56 117.16 17.92 Favored 'General case' 0 N--CA 1.477 0.883 0 N-CA-C 106.021 -1.844 . . . . 0.0 106.021 172.295 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 88.8 mttt -84.92 135.11 34.2 Favored 'General case' 0 CA--C 1.515 -0.387 0 N-CA-C 107.695 -1.224 . . . . 0.0 107.695 179.47 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 1.8 t -120.81 149.51 23.69 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 C-N-CA 125.9 1.68 . . . . 0.0 109.511 -168.493 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 25.9 mtt -139.57 147.47 41.2 Favored 'General case' 0 C--N 1.324 -0.523 0 C-N-CA 124.534 1.133 . . . . 0.0 109.111 169.27 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 72.0 m-85 -133.06 114.33 13.81 Favored 'General case' 0 CA--C 1.517 -0.32 0 N-CA-C 104.343 -2.465 . . . . 0.0 104.343 172.133 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 2.4 p -151.39 137.2 11.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 118.563 0.62 . . . . 0.0 109.758 -169.352 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 19.9 t -117.24 178.43 4.37 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 126.225 1.81 . . . . 0.0 106.323 169.6 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 39.7 ttpt -55.05 -35.08 64.11 Favored 'General case' 0 N--CA 1.475 0.819 0 O-C-N 121.148 -0.97 . . . . 0.0 111.479 179.638 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 33.3 ptt180 -123.55 160.27 27.38 Favored 'General case' 0 N--CA 1.463 0.212 0 C-N-CA 124.868 1.267 . . . . 0.0 108.294 169.628 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 47.6 t30 -71.75 -42.66 66.97 Favored 'General case' 0 N--CA 1.471 0.578 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 170.864 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 1.1 m -52.02 141.45 18.07 Favored 'General case' 0 N--CA 1.453 -0.319 0 C-N-CA 125.696 1.598 . . . . 0.0 110.616 -171.331 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 3.9 m 66.91 -66.65 0.18 Allowed 'General case' 0 C--N 1.327 -0.383 0 C-N-CA 126.315 1.846 . . . . 0.0 114.525 -173.459 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 8.9 tpp180 -82.78 -46.93 12.51 Favored 'General case' 0 N--CA 1.471 0.576 0 N-CA-C 116.464 2.024 . . . . 0.0 116.464 -167.59 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 3.6 m -89.78 4.69 48.95 Favored 'General case' 0 N--CA 1.471 0.596 0 N-CA-C 114.81 1.411 . . . . 0.0 114.81 -169.051 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 28.2 pt20 -68.83 -47.64 65.54 Favored 'General case' 0 C--O 1.224 -0.289 0 O-C-N 120.959 -1.088 . . . . 0.0 113.364 -171.035 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 2.4 tpt -88.06 -34.63 17.9 Favored 'General case' 0 N--CA 1.47 0.527 0 N-CA-C 113.659 0.985 . . . . 0.0 113.659 -169.309 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -61.03 -44.95 96.64 Favored 'General case' 0 N--CA 1.471 0.605 0 N-CA-C 112.88 0.696 . . . . 0.0 112.88 -169.082 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . 0.417 ' CD ' ' HZ2' ' A' ' 23' ' ' LYS . 1.9 pp20? -64.96 -34.51 78.59 Favored 'General case' 0 N--CA 1.464 0.255 0 O-C-N 121.96 -0.463 . . . . 0.0 109.834 176.522 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -52.11 -56.47 16.64 Favored Glycine 0 C--N 1.34 0.753 0 C-N-CA 125.182 1.372 . . . . 0.0 110.623 175.539 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 13.5 m-85 -68.52 -29.89 68.58 Favored 'General case' 0 CA--C 1.508 -0.657 0 O-C-N 121.521 -0.987 . . . . 0.0 112.512 -179.964 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -69.73 -31.93 70.19 Favored 'General case' 0 N--CA 1.452 -0.341 0 CA-C-N 119.52 1.055 . . . . 0.0 111.603 -174.766 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.417 ' HZ2' ' CD ' ' A' ' 19' ' ' GLU . 0.4 OUTLIER -68.19 -25.56 65.3 Favored 'General case' 0 N--CA 1.474 0.758 0 CA-C-N 119.541 1.064 . . . . 0.0 111.651 172.566 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 3.2 m -82.42 -56.46 3.87 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 124.959 1.304 . . . . 0.0 110.139 -177.592 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 70.7 mt -75.33 -36.42 61.05 Favored 'General case' 0 C--N 1.331 -0.215 0 C-N-CA 124.298 1.039 . . . . 0.0 110.055 -173.83 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -89.96 6.12 82.92 Favored Glycine 0 C--N 1.339 0.715 0 C-N-CA 124.855 1.217 . . . . 0.0 113.152 -177.017 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -50.74 125.28 12.86 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 124.739 1.215 . . . . 0.0 110.321 -175.635 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 76.54 -5.41 45.38 Favored Glycine 0 CA--C 1.534 1.229 0 CA-C-O 118.782 -1.01 . . . . 0.0 114.437 179.41 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 63.2 mttm -107.5 -51.89 2.84 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-N 119.322 1.561 . . . . 0.0 110.226 -179.762 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 26.1 pt -136.36 147.74 27.66 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.295 0 C-N-CA 123.913 0.885 . . . . 0.0 110.066 -169.31 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -109.89 104.26 13.16 Favored 'General case' 0 N--CA 1.463 0.198 0 C-N-CA 125.082 1.353 . . . . 0.0 108.885 -169.871 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 14.6 p -81.09 142.02 14.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 119.51 1.05 . . . . 0.0 109.192 177.003 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 11.6 m -132.15 -49.63 0.94 Allowed 'General case' 0 N--CA 1.455 -0.212 0 C-N-CA 124.216 1.006 . . . . 0.0 110.22 175.633 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 48.1 m 62.69 -27.03 0.06 Allowed 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 127.439 2.296 . . . . 0.0 117.14 176.49 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 5.6 m 54.37 -135.78 1.4 Allowed 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 124.765 1.226 . . . . 0.0 110.804 169.752 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -172.65 170.25 43.35 Favored Glycine 0 C--N 1.336 0.574 0 N-CA-C 108.331 -1.907 . . . . 0.0 108.331 178.289 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 34.2 mt -118.28 -43.31 2.73 Favored 'General case' 0 N--CA 1.451 -0.398 0 C-N-CA 125.353 1.461 . . . . 0.0 109.084 179.833 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 36.6 mt-10 -140.45 -59.3 0.53 Allowed 'General case' 0 C--O 1.233 0.192 0 N-CA-C 101.687 -3.449 . . . . 0.0 101.687 169.605 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 17.1 m 57.39 177.88 0.05 OUTLIER 'General case' 0 N--CA 1.447 -0.582 0 C-N-CA 127.291 2.236 . . . . 0.0 116.702 167.263 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 4.4 m -162.51 175.38 11.52 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 128.233 2.613 . . . . 0.0 106.089 -169.491 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 11.4 ptt180 -91.72 174.08 7.54 Favored 'General case' 0 N--CA 1.469 0.503 0 O-C-N 121.022 -1.049 . . . . 0.0 109.607 178.618 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 15.9 m -74.94 176.11 0.67 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.64 0 C-N-CA 123.701 0.8 . . . . 0.0 111.219 -176.415 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 26.0 m-70 -88.02 152.2 50.47 Favored Pre-proline 0 CA--C 1.54 0.596 0 C-N-CA 123.8 0.84 . . . . 0.0 109.995 -175.999 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -63.47 -47.29 7.79 Favored 'Trans proline' 0 C--N 1.347 0.49 0 C-N-CA 122.956 2.438 . . . . 0.0 112.612 -172.636 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 4.4 m -68.21 -25.83 65.41 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-O 119.247 -0.406 . . . . 0.0 110.3 -178.391 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -56.91 -53.4 58.37 Favored 'General case' 0 CA--C 1.51 -0.595 0 N-CA-C 108.99 -0.744 . . . . 0.0 108.99 175.048 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 63.9 mt -60.51 -38.09 76.99 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 N-CA-C 109.054 -0.721 . . . . 0.0 109.054 -172.562 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -63.86 -46.74 83.63 Favored 'General case' 0 CA--C 1.536 0.425 0 CA-C-N 119.041 0.837 . . . . 0.0 111.007 179.869 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 37.6 mmt -71.18 -34.7 71.16 Favored 'General case' 0 CA--C 1.539 0.523 0 CA-C-O 123.546 1.641 . . . . 0.0 110.366 -178.376 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -74.82 -31.61 61.73 Favored 'General case' 0 N--CA 1.443 -0.825 0 N-CA-C 106.886 -1.524 . . . . 0.0 106.886 -177.796 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 -70.76 -20.41 62.63 Favored 'General case' 0 N--CA 1.45 -0.453 0 C-N-CA 124.347 1.059 . . . . 0.0 110.305 169.661 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 77.3 mt-10 -62.55 -38.76 91.28 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-N 119.958 1.254 . . . . 0.0 109.306 169.244 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 17.1 m -86.92 10.25 1.6 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.724 0 N-CA-C 113.168 0.803 . . . . 0.0 113.168 169.933 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 70.55 15.48 73.17 Favored Glycine 0 CA--C 1.532 1.114 0 C-N-CA 124.621 1.105 . . . . 0.0 113.803 177.115 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 4.8 mt -91.6 143.54 11.08 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.259 0 C-N-CA 124.425 1.09 . . . . 0.0 111.372 -172.707 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 3.4 t70 -90.84 131.84 36.24 Favored 'General case' 0 C--O 1.234 0.247 0 C-N-CA 126.04 1.736 . . . . 0.0 108.851 169.352 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 7.2 pt -140.41 -27.03 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.874 0 C-N-CA 124.661 1.184 . . . . 0.0 110.371 168.863 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -38.78 138.26 0.55 Allowed 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 128.31 2.644 . . . . 0.0 111.453 168.964 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 62.72 34.67 90.34 Favored Glycine 0 CA--C 1.533 1.21 0 CA-C-O 119.661 -0.522 . . . . 0.0 112.655 175.002 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 5.4 tt0 -57.24 -35.74 70.07 Favored 'General case' 0 C--N 1.344 0.346 0 C-N-CA 123.781 0.832 . . . . 0.0 112.83 -175.422 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -69.07 139.34 54.84 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 124.56 1.144 . . . . 0.0 110.518 -169.611 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 9.9 p -141.43 -67.78 0.4 Allowed 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 123.605 0.762 . . . . 0.0 110.624 -170.622 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -147.33 155.93 46.17 Favored Pre-proline 0 C--O 1.239 0.513 0 C-N-CA 125.484 1.513 . . . . 0.0 108.798 -176.852 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -66.06 152.54 81.03 Favored 'Trans proline' 0 N--CA 1.455 -0.782 0 C-N-CA 121.991 1.794 . . . . 0.0 109.617 171.224 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 3.8 tt -62.58 -23.57 32.92 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.545 0 C-N-CA 123.745 0.818 . . . . 0.0 110.811 -177.626 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 24.0 tt0 -67.7 -25.08 65.49 Favored 'General case' 0 N--CA 1.438 -1.075 0 C-N-CA 126.546 1.938 . . . . 0.0 110.658 -179.111 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 9.0 t-20 -63.43 -23.64 67.49 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 124.567 1.147 . . . . 0.0 112.103 176.385 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 40.5 m-85 -106.03 -168.39 1.43 Allowed 'General case' 0 C--O 1.236 0.363 0 C-N-CA 126.573 1.949 . . . . 0.0 109.305 -176.394 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 55.5 t-20 -139.44 139.74 37.13 Favored 'General case' 0 N--CA 1.447 -0.616 0 N-CA-C 106.836 -1.542 . . . . 0.0 106.836 169.251 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -71.45 -25.31 62.25 Favored 'General case' 0 N--CA 1.434 -1.236 0 C-N-CA 119.749 -0.78 . . . . 0.0 109.516 -178.821 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 35.5 t70 -64.8 -24.84 67.68 Favored 'General case' 0 N--CA 1.445 -0.686 0 O-C-N 123.505 0.503 . . . . 0.0 112.022 -179.575 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -78.05 -29.01 49.08 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 123.38 0.672 . . . . 0.0 111.426 174.411 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 13.1 m-85 -79.24 166.06 22.57 Favored 'General case' 0 N--CA 1.451 -0.394 0 C-N-CA 125.582 1.553 . . . . 0.0 111.126 178.855 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -118.25 -34.41 4.09 Favored 'General case' 0 N--CA 1.466 0.348 0 C-N-CA 123.022 0.529 . . . . 0.0 111.446 -179.985 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -143.35 136.02 24.57 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.595 0 CA-C-O 121.865 0.841 . . . . 0.0 110.234 -172.151 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 98.9 t -144.02 126.36 11.17 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.593 0 N-CA-C 106.249 -1.76 . . . . 0.0 106.249 -178.583 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 12.6 mm -104.6 124.37 59.13 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.521 0 N-CA-C 105.846 -1.909 . . . . 0.0 105.846 176.108 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 37.0 m -93.46 98.25 11.08 Favored 'General case' 0 N--CA 1.443 -0.807 0 N-CA-C 105.057 -2.201 . . . . 0.0 105.057 169.576 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 85.8 mt -68.54 -2.97 10.03 Favored 'General case' 0 N--CA 1.467 0.391 0 O-C-N 121.51 -0.744 . . . . 0.0 112.283 -176.709 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 64.0 m -138.65 128.4 24.99 Favored 'General case' 0 N--CA 1.443 -0.812 0 N-CA-C 106.134 -1.802 . . . . 0.0 106.134 169.397 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 50.71 -144.4 11.96 Favored Glycine 0 CA--C 1.532 1.133 0 C-N-CA 125.272 1.415 . . . . 0.0 113.515 173.425 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 16.2 m -112.23 -111.52 0.34 Allowed 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 124.652 1.181 . . . . 0.0 107.993 178.832 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -80.61 69.37 3.2 Favored Glycine 0 CA--C 1.527 0.83 0 N-CA-C 109.682 -1.367 . . . . 0.0 109.682 171.087 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 1.3 m -60.04 -50.51 79.9 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.598 0 CA-C-N 117.528 0.664 . . . . 0.0 111.688 -171.689 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 1.5 t30 -154.69 52.48 0.64 Allowed 'General case' 0 N--CA 1.467 0.404 0 N-CA-C 103.845 -2.65 . . . . 0.0 103.845 169.327 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -147.42 139.6 14.09 Favored Pre-proline 0 CA--C 1.536 0.442 0 C-N-CA 125.622 1.569 . . . . 0.0 108.297 -168.36 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -65.96 144.21 75.6 Favored 'Trans proline' 0 C--N 1.351 0.692 0 C-N-CA 121.338 1.358 . . . . 0.0 112.577 -174.669 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_endo -66.48 -26.09 47.71 Favored 'Trans proline' 0 N--CA 1.461 -0.405 0 C-N-CA 122.314 2.009 . . . . 0.0 113.242 -169.848 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 -55.91 -22.46 25.96 Favored 'General case' 0 CA--C 1.537 0.474 0 CA-C-N 118.898 0.772 . . . . 0.0 111.926 178.426 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 85.5 m95 -74.67 -43.64 54.24 Favored 'General case' 0 N--CA 1.445 -0.687 0 C-N-CA 123.504 0.722 . . . . 0.0 112.179 -179.339 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 15.2 m -70.46 -32.98 51.84 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.438 0 CA-C-O 118.398 -0.81 . . . . 0.0 110.109 176.854 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 82.3 p -82.06 29.83 0.4 Allowed 'General case' 0 CA--C 1.538 0.504 0 CA-C-N 120.23 1.377 . . . . 0.0 114.019 -170.01 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 93.0 mm-40 -79.09 -173.78 3.76 Favored 'General case' 0 CA--C 1.539 0.52 0 O-C-N 121.731 -0.605 . . . . 0.0 110.543 172.107 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 29.0 mm-40 -65.04 -14.71 61.12 Favored 'General case' 0 CA--C 1.54 0.577 0 N-CA-C 112.531 0.567 . . . . 0.0 112.531 -169.757 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 6.4 tt -143.72 137.36 24.74 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.496 0 C-N-CA 125.664 1.586 . . . . 0.0 107.177 170.934 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 16.2 t80 -116.98 132.32 56.73 Favored 'General case' 0 CA--C 1.535 0.399 0 N-CA-C 105.385 -2.08 . . . . 0.0 105.385 169.381 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 11.6 mm-40 -142.13 162.83 34.49 Favored 'General case' 0 C--O 1.237 0.418 0 C-N-CA 124.546 1.139 . . . . 0.0 108.522 176.288 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 3.0 t70 -173.96 127.9 0.38 Allowed 'General case' 0 C--O 1.236 0.393 0 C-N-CA 127.11 2.164 . . . . 0.0 107.758 -169.255 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 5.4 m0 -148.65 142.58 25.79 Favored 'General case' 0 N--CA 1.456 -0.133 0 C-N-CA 123.571 0.749 . . . . 0.0 109.019 -170.488 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 86.4 mt-30 -84.21 83.24 8.04 Favored 'General case' 0 CA--C 1.533 0.3 0 N-CA-C 108.399 -0.963 . . . . 0.0 108.399 174.46 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 9.6 mp -67.42 129.05 38.67 Favored 'General case' 0 N--CA 1.466 0.352 0 N-CA-C 106.148 -1.797 . . . . 0.0 106.148 171.132 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 32.4 mt-10 -71.29 -20.83 62.16 Favored 'General case' 0 CA--C 1.536 0.417 0 N-CA-C 113.563 0.949 . . . . 0.0 113.563 -169.279 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 1.6 t70 62.29 124.09 0.02 OUTLIER Pre-proline 0 CA--C 1.552 1.047 0 C-N-CA 127.039 2.136 . . . . 0.0 114.212 -179.7 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 23.7 Cg_endo -88.48 -3.67 6.64 Favored 'Trans proline' 0 N--CA 1.454 -0.809 0 C-N-CA 122.689 2.259 . . . . 0.0 114.488 -178.93 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -53.42 126.51 21.61 Favored 'General case' 0 C--O 1.238 0.457 0 CA-C-N 120.793 1.633 . . . . 0.0 111.152 -172.374 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 71.74 -1.64 28.98 Favored Glycine 0 CA--C 1.534 1.271 0 CA-C-O 118.918 -0.934 . . . . 0.0 113.729 177.238 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 8.2 mt-30 -89.7 171.51 9.6 Favored 'General case' 0 CA--C 1.543 0.689 0 CA-C-N 118.807 1.304 . . . . 0.0 109.159 174.796 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 15.6 m -69.11 163.52 24.61 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 123.658 0.783 . . . . 0.0 111.063 -179.301 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 43.2 mt -63.88 -26.37 68.58 Favored 'General case' 0 N--CA 1.472 0.638 0 O-C-N 121.231 -0.918 . . . . 0.0 112.019 -175.026 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 5.4 pt-20 -56.41 -34.85 67.15 Favored 'General case' 0 N--CA 1.461 0.12 0 C-N-CA 123.322 0.649 . . . . 0.0 111.26 171.935 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 21.4 t -76.82 -41.77 32.9 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.395 0 CA-C-O 118.28 -0.866 . . . . 0.0 109.066 -178.139 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 61.8 m-85 -55.02 -49.6 71.15 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-N 120.002 1.274 . . . . 0.0 109.66 170.384 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 96.2 mtt180 -67.67 -33.14 74.34 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 123.056 0.542 . . . . 0.0 111.214 -175.778 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 3.2 m -65.55 -50.16 66.19 Favored 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 124.222 1.009 . . . . 0.0 109.712 170.977 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 90.1 t -70.25 -26.9 30.24 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.309 0 CA-C-O 118.426 -0.797 . . . . 0.0 109.109 -171.442 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 20.5 mtm105 -56.5 -50.15 72.63 Favored 'General case' 0 C--O 1.223 -0.309 0 CA-C-N 119.462 1.028 . . . . 0.0 109.239 169.569 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -62.09 -46.59 93.7 Favored Glycine 0 CA--C 1.528 0.884 0 CA-C-O 119.539 -0.59 . . . . 0.0 111.898 178.676 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 89.8 mt-30 -57.14 -51.69 68.28 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-N 117.854 0.827 . . . . 0.0 110.268 -179.784 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 95.9 t -68.68 -42.35 83.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-O 118.445 -0.788 . . . . 0.0 109.615 -175.574 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -54.51 -47.24 73.31 Favored 'General case' 0 C--O 1.223 -0.341 0 N-CA-C 108.62 -0.881 . . . . 0.0 108.62 178.355 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 39.9 tt0 -64.91 -42.49 94.7 Favored 'General case' 0 N--CA 1.449 -0.523 0 C-N-CA 122.953 0.501 . . . . 0.0 111.325 -176.358 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 44.4 mtt-85 -65.64 -45.61 82.35 Favored 'General case' 0 N--CA 1.469 0.485 0 O-C-N 121.302 -0.874 . . . . 0.0 111.766 177.19 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 61.3 t -64.94 -37.23 79.7 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.723 0 N-CA-C 109.143 -0.688 . . . . 0.0 109.143 178.092 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 20.9 mt-10 -60.66 -44.58 96.28 Favored 'General case' 0 C--O 1.226 -0.182 0 O-C-N 120.743 -1.223 . . . . 0.0 109.857 174.911 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 27.8 t-20 -65.12 -40.54 94.63 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 123.021 0.528 . . . . 0.0 111.054 -177.925 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 29.3 tp -58.7 -49.58 77.07 Favored 'General case' 0 CA--C 1.53 0.195 0 C-N-CA 124.864 1.266 . . . . 0.0 110.85 173.292 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 63.6 mt -64.72 -46.66 91.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 N-CA-C 107.925 -1.139 . . . . 0.0 107.925 -177.969 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -58.17 -31.82 67.63 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 123.436 0.695 . . . . 0.0 112.109 -178.882 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . 0.258 18.5 ptpt -82.51 -37.89 24.61 Favored 'General case' 0 C--N 1.344 0.341 0 CA-C-O 117.782 -1.104 . . . . 0.0 112.512 177.099 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 12.1 pt -84.08 -38.74 14.15 Favored 'Isoleucine or valine' 0 C--O 1.236 0.35 0 CA-C-N 120.373 1.442 . . . . 0.0 113.967 -176.261 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 68.2 m . . . . . 0 C--O 1.252 1.219 0 C-N-CA 125.644 1.578 . . . . 0.0 110.141 -169.876 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.498 1.964 0 N-CA-C 110.583 -0.155 . . . . 0.0 110.583 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 26.1 mttm -79.77 117.48 20.7 Favored 'General case' 0 N--CA 1.474 0.749 0 N-CA-C 105.71 -1.959 . . . . 0.0 105.71 171.53 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 85.0 mttt -81.84 143.4 31.76 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-N 119.935 1.243 . . . . 0.0 108.499 176.904 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 2.2 t -132.54 145.07 35.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 O-C-N 124.347 1.029 . . . . 0.0 111.058 -169.341 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 12.4 mtt -137.06 145.33 43.85 Favored 'General case' 0 C--N 1.329 -0.291 0 C-N-CA 125.327 1.451 . . . . 0.0 108.957 168.48 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 54.5 m-85 -133.91 117.46 16.8 Favored 'General case' 0 CA--C 1.518 -0.281 0 N-CA-C 104.903 -2.258 . . . . 0.0 104.903 169.915 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 2.2 p -151.67 155.26 7.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-O 121.248 0.547 . . . . 0.0 109.842 -168.848 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 39.9 t -140.94 159.32 42.45 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 105.119 -2.178 . . . . 0.0 105.119 169.266 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 64.8 pttt -56.68 143.92 34.37 Favored 'General case' 0 N--CA 1.467 0.394 0 N-CA-C 109.036 -0.727 . . . . 0.0 109.036 171.838 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 96.6 mtt180 51.44 73.9 0.28 Allowed 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 124.665 1.186 . . . . 0.0 110.136 -169.824 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 10.4 t30 -31.63 -46.41 0.11 Allowed 'General case' 0 N--CA 1.482 1.141 0 C-N-CA 127.523 2.329 . . . . 0.0 115.33 -172.4 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 2.1 m -50.96 -37.79 46.71 Favored 'General case' 0 N--CA 1.45 -0.447 0 C-N-CA 124.164 0.985 . . . . 0.0 111.419 -175.515 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 21.9 m -72.17 122.15 20.52 Favored 'General case' 0 N--CA 1.449 -0.51 0 CA-C-N 119.094 0.861 . . . . 0.0 109.767 173.906 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . 0.334 0.1 OUTLIER 56.01 -24.02 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 130.914 3.686 . . . . 0.0 117.248 177.182 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -74.92 -11.53 60.15 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-N 121.102 1.774 . . . . 0.0 111.417 175.416 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 25.2 pt20 -75.04 30.47 0.09 Allowed 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 125.756 1.622 . . . . 0.0 113.725 174.856 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' MET . . . . . 0.425 ' SD ' ' CD2' ' A' ' 21' ' ' PHE . 0.0 OUTLIER -152.62 -54.24 0.12 Allowed 'General case' 0 C--N 1.329 -0.284 0 O-C-N 120.29 -1.506 . . . . 0.0 112.06 174.837 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -59.44 -47.77 84.21 Favored 'General case' 0 N--CA 1.474 0.725 0 N-CA-C 114.313 1.227 . . . . 0.0 114.313 -169.009 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -65.05 -30.99 71.99 Favored 'General case' 0 N--CA 1.463 0.182 0 O-C-N 121.88 -0.512 . . . . 0.0 110.058 177.7 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -55.15 -59.13 10.93 Favored Glycine 0 C--N 1.337 0.605 0 C-N-CA 125.312 1.434 . . . . 0.0 110.588 173.222 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . 0.425 ' CD2' ' SD ' ' A' ' 17' ' ' MET . 3.3 m-85 -61.98 -32.54 73.0 Favored 'General case' 0 CA--C 1.511 -0.532 0 CA-C-N 118.377 1.088 . . . . 0.0 112.906 175.806 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -63.91 -36.47 84.05 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 119.146 0.884 . . . . 0.0 111.123 -172.418 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -69.03 -24.43 64.19 Favored 'General case' 0 N--CA 1.47 0.571 0 CA-C-N 119.164 0.893 . . . . 0.0 112.274 176.803 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 1.5 m -80.15 -53.22 6.89 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 125.305 1.442 . . . . 0.0 110.45 177.733 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 80.9 mt -74.24 -37.82 63.68 Favored 'General case' 0 N--CA 1.464 0.249 0 C-N-CA 123.648 0.779 . . . . 0.0 110.266 -173.124 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -96.39 14.07 64.81 Favored Glycine 0 CA--C 1.527 0.815 0 C-N-CA 125.175 1.369 . . . . 0.0 112.98 -176.767 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -51.52 123.57 10.18 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 124.743 1.217 . . . . 0.0 110.49 -174.809 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 76.11 -7.89 26.97 Favored Glycine 0 CA--C 1.536 1.356 0 C-N-CA 124.293 0.949 . . . . 0.0 114.382 179.797 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 62.9 mttm -97.62 -49.19 4.96 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-N 119.283 1.541 . . . . 0.0 110.298 179.854 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 17.1 pt -137.28 152.52 27.83 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.328 0 C-N-CA 124.137 0.975 . . . . 0.0 110.067 -169.264 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -112.02 98.66 7.5 Favored 'General case' 0 CA--C 1.521 -0.153 0 C-N-CA 124.584 1.153 . . . . 0.0 109.187 -169.738 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 13.0 p -87.8 134.4 28.0 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.487 0 O-C-N 121.823 -0.548 . . . . 0.0 109.666 178.966 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 20.1 m -150.51 92.45 1.85 Allowed 'General case' 0 N--CA 1.456 -0.143 0 N-CA-C 105.19 -2.152 . . . . 0.0 105.19 172.413 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 53.4 m -95.49 87.01 4.63 Favored 'General case' 0 C--O 1.237 0.396 0 C-N-CA 120.066 -0.654 . . . . 0.0 110.63 -170.057 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 58.8 m -61.19 165.85 4.14 Favored 'General case' 0 CA--C 1.539 0.522 0 CA-C-N 115.322 -0.854 . . . . 0.0 110.07 169.018 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -138.96 -173.84 13.18 Favored Glycine 0 CA--C 1.525 0.702 0 N-CA-C 106.807 -2.517 . . . . 0.0 106.807 -177.721 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 6.4 mt -123.71 -83.51 0.65 Allowed 'General case' 0 N--CA 1.45 -0.465 0 C-N-CA 124.298 1.039 . . . . 0.0 109.048 -169.952 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 3.3 tt0 -69.02 -27.17 65.44 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 122.823 0.449 . . . . 0.0 111.574 176.673 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 1.3 m -144.18 179.45 7.21 Favored 'General case' 0 N--CA 1.463 0.176 0 C-N-CA 126.187 1.795 . . . . 0.0 107.747 177.032 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 3.7 m -166.05 -18.66 0.02 OUTLIER 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 125.301 1.44 . . . . 0.0 112.145 -169.725 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 7.8 ttt180 -100.37 -162.1 0.92 Allowed 'General case' 0 N--CA 1.473 0.709 0 CA-C-N 119.637 1.108 . . . . 0.0 110.207 176.046 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 27.4 m -134.95 173.68 14.1 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.449 0 C-N-CA 125.421 1.489 . . . . 0.0 111.376 -169.988 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 96.7 m-70 -83.65 156.45 65.01 Favored Pre-proline 0 CA--C 1.543 0.698 0 C-N-CA 124.804 1.242 . . . . 0.0 110.299 173.816 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -62.16 -51.47 3.58 Favored 'Trans proline' 0 C--N 1.349 0.575 0 C-N-CA 123.845 3.03 . . . . 0.0 113.426 -173.425 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 6.8 m -65.85 -24.95 66.99 Favored 'General case' 0 CA--C 1.534 0.328 0 O-C-N 121.902 -0.499 . . . . 0.0 110.936 -172.845 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -55.52 -53.31 57.95 Favored 'General case' 0 CA--C 1.508 -0.672 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 173.261 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 69.8 mt -59.83 -40.71 83.43 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.369 0 N-CA-C 108.475 -0.935 . . . . 0.0 108.475 -170.352 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -62.75 -46.76 86.58 Favored 'General case' 0 N--CA 1.449 -0.518 0 CA-C-N 118.488 0.586 . . . . 0.0 111.004 179.924 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 27.9 mmt -67.64 -39.78 84.61 Favored 'General case' 0 C--O 1.238 0.473 0 CA-C-O 122.789 1.281 . . . . 0.0 110.839 -178.65 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 1.2 mmt -74.31 -35.2 63.66 Favored 'General case' 0 N--CA 1.444 -0.772 0 N-CA-C 106.711 -1.588 . . . . 0.0 106.711 -174.875 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 41.7 tt0 -69.98 -23.94 63.24 Favored 'General case' 0 N--CA 1.447 -0.583 0 O-C-N 121.179 -0.951 . . . . 0.0 110.219 173.672 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 10.2 mm-40 -65.74 -29.49 70.01 Favored 'General case' 0 N--CA 1.452 -0.341 0 CA-C-N 118.762 0.71 . . . . 0.0 110.241 173.251 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . 0.29 9.0 m -98.22 16.95 2.85 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.858 0 N-CA-C 112.758 0.651 . . . . 0.0 112.758 169.35 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 84.33 16.21 67.27 Favored Glycine 0 CA--C 1.534 1.275 0 C-N-CA 125.366 1.46 . . . . 0.0 114.636 169.935 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 8.2 mm -97.52 151.59 4.25 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.329 0 C-N-CA 124.736 1.214 . . . . 0.0 111.121 -170.52 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -112.52 126.95 55.89 Favored 'General case' 0 C--O 1.233 0.189 0 N-CA-C 106.051 -1.833 . . . . 0.0 106.051 168.222 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 3.6 pt -128.93 -24.51 1.24 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.481 0 C-N-CA 125.751 1.62 . . . . 0.0 110.353 170.312 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -39.51 -40.38 0.84 Allowed 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 128.177 2.591 . . . . 0.0 112.789 169.163 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -91.24 19.62 45.63 Favored Glycine 0 CA--C 1.531 1.069 0 C-N-CA 125.446 1.498 . . . . 0.0 113.763 -179.166 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 21.2 mt-30 -61.84 -27.62 68.91 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-N 120.152 1.976 . . . . 0.0 112.84 179.78 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -61.92 129.39 40.72 Favored 'General case' 0 N--CA 1.445 -0.678 0 N-CA-C 109.683 -0.488 . . . . 0.0 109.683 -171.562 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 8.5 p -141.61 -70.44 0.36 Allowed 'General case' 0 C--O 1.235 0.31 0 C-N-CA 123.817 0.847 . . . . 0.0 109.452 -173.269 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -157.66 161.34 29.26 Favored Pre-proline 0 CA--C 1.552 1.037 0 C-N-CA 124.952 1.301 . . . . 0.0 109.913 -174.66 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -67.84 28.92 0.13 Allowed 'Trans proline' 0 CA--C 1.552 1.381 0 C-N-CA 125.247 3.964 . . . . 0.0 116.694 173.126 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . 0.256 1.1 tt 64.43 -26.21 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.541 0.619 0 C-N-CA 129.529 3.132 . . . . 0.0 113.989 -169.583 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -68.79 -30.19 68.72 Favored 'General case' 0 N--CA 1.429 -1.516 0 C-N-CA 128.005 2.522 . . . . 0.0 115.407 -169.304 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 26.0 m-80 -68.72 -17.44 64.06 Favored 'General case' 0 C--O 1.236 0.35 0 CA-C-N 118.359 0.527 . . . . 0.0 112.192 -176.419 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 69.8 m-85 -104.76 160.98 14.55 Favored 'General case' 0 CA--C 1.513 -0.447 0 C-N-CA 124.726 1.211 . . . . 0.0 112.015 -176.854 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 48.1 t-20 -95.65 134.13 38.92 Favored 'General case' 0 N--CA 1.439 -0.989 0 N-CA-C 106.107 -1.812 . . . . 0.0 106.107 168.156 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -72.57 -27.67 62.34 Favored 'General case' 0 N--CA 1.436 -1.172 0 N-CA-C 108.845 -0.798 . . . . 0.0 108.845 179.629 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 36.6 t70 -67.0 -21.04 65.97 Favored 'General case' 0 N--CA 1.447 -0.585 0 N-CA-C 111.73 0.27 . . . . 0.0 111.73 -179.168 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 35.7 t70 -72.63 -29.24 63.3 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 122.974 0.509 . . . . 0.0 111.611 175.782 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 17.2 m-85 -77.27 144.51 38.1 Favored 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 123.981 0.912 . . . . 0.0 110.316 179.18 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -93.93 -32.1 14.02 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.724 177.555 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 21.7 t -137.34 130.8 44.15 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.467 0 C-N-CA 123.824 0.85 . . . . 0.0 109.841 -171.307 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 53.7 t -145.48 139.58 21.84 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.419 0 N-CA-C 106.28 -1.748 . . . . 0.0 106.28 174.851 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 36.6 mm -130.63 123.62 55.26 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.537 0 N-CA-C 107.238 -1.393 . . . . 0.0 107.238 -169.859 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 55.3 m -90.49 115.37 27.59 Favored 'General case' 0 N--CA 1.444 -0.732 0 N-CA-C 106.562 -1.644 . . . . 0.0 106.562 169.225 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 68.7 mt -77.72 -7.54 56.66 Favored 'General case' 0 C--N 1.332 -0.191 0 C-N-CA 123.769 0.827 . . . . 0.0 111.418 179.88 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 31.9 p -139.72 132.75 29.5 Favored 'General case' 0 N--CA 1.443 -0.817 0 N-CA-C 106.81 -1.552 . . . . 0.0 106.81 169.632 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 50.68 -155.85 2.84 Favored Glycine 0 CA--C 1.539 1.547 0 C-N-CA 125.579 1.561 . . . . 0.0 115.713 170.067 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 17.4 m -134.52 139.24 45.29 Favored 'General case' 0 C--O 1.235 0.306 0 C-N-CA 125.897 1.679 . . . . 0.0 107.153 177.232 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 74.36 -75.44 1.18 Allowed Glycine 0 C--N 1.335 0.517 0 N-CA-C 110.324 -1.11 . . . . 0.0 110.324 -174.28 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . 0.299 34.7 m 48.12 36.22 0.27 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.792 0 C-N-CA 125.973 1.709 . . . . 0.0 113.401 176.647 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 10.6 t-20 69.99 -0.15 2.86 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 127.679 2.392 . . . . 0.0 113.318 179.061 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -77.03 148.09 78.01 Favored Pre-proline 0 CA--C 1.548 0.882 0 N-CA-C 107.749 -1.204 . . . . 0.0 107.749 169.524 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 34.1 Cg_exo -65.99 142.17 67.38 Favored 'Trans proline' 0 CA--C 1.544 1.013 0 C-N-CA 121.452 1.435 . . . . 0.0 113.0 -174.165 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -67.33 -20.17 49.03 Favored 'Trans proline' 0 C--N 1.344 0.336 0 C-N-CA 123.379 2.719 . . . . 0.0 114.267 -170.592 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 5.4 pm0 -63.04 -18.77 63.71 Favored 'General case' 0 CA--C 1.54 0.562 0 CA-C-N 121.371 1.896 . . . . 0.0 111.547 174.75 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 97.8 m95 -88.33 -5.93 58.03 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 125.414 1.486 . . . . 0.0 112.799 173.728 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 39.9 t -94.23 -9.03 9.66 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.62 0 C-N-CA 124.769 1.228 . . . . 0.0 109.137 173.325 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 73.3 p -119.77 36.94 4.34 Favored 'General case' 0 C--O 1.237 0.404 0 N-CA-C 116.134 1.901 . . . . 0.0 116.134 -169.305 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 12.2 mp0 -71.42 173.71 7.53 Favored 'General case' 0 CA--C 1.535 0.384 0 O-C-N 121.718 -0.614 . . . . 0.0 111.568 173.852 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 33.9 mm-40 -59.93 -28.81 67.93 Favored 'General case' 0 CA--C 1.536 0.432 0 N-CA-C 109.807 -0.442 . . . . 0.0 109.807 177.012 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 4.3 tt -133.62 116.98 25.65 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.56 0 N-CA-C 105.489 -2.041 . . . . 0.0 105.489 168.729 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 62.1 t80 -108.98 145.3 35.73 Favored 'General case' 0 C--O 1.237 0.443 0 N-CA-C 104.534 -2.395 . . . . 0.0 104.534 168.28 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 21.7 mm-40 -134.86 139.74 45.28 Favored 'General case' 0 C--O 1.236 0.379 0 CA-C-N 119.161 0.891 . . . . 0.0 108.691 169.859 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -106.93 113.29 26.69 Favored 'General case' 0 C--O 1.239 0.551 0 N-CA-C 105.609 -1.997 . . . . 0.0 105.609 169.883 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 9.2 m95 -117.47 166.52 12.24 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 124.405 1.082 . . . . 0.0 108.118 169.756 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 24.0 mm-40 -128.33 78.1 1.81 Allowed 'General case' 0 CA--C 1.534 0.36 0 N-CA-C 107.257 -1.386 . . . . 0.0 107.257 174.326 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -77.04 148.46 36.15 Favored 'General case' 0 N--CA 1.467 0.399 0 N-CA-C 109.192 -0.67 . . . . 0.0 109.192 -179.505 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -81.09 168.25 18.83 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 124.514 1.126 . . . . 0.0 108.724 169.765 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -134.14 133.71 22.18 Favored Pre-proline 0 CA--C 1.534 0.334 0 C-N-CA 124.022 0.929 . . . . 0.0 110.975 178.085 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 40.2 Cg_endo -89.87 -2.41 5.65 Favored 'Trans proline' 0 CA--C 1.539 0.772 0 C-N-CA 122.911 2.407 . . . . 0.0 115.22 -174.349 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 24.4 t70 -60.25 128.32 36.14 Favored 'General case' 0 C--O 1.238 0.484 0 CA-C-N 121.347 1.885 . . . . 0.0 110.357 -177.861 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 72.94 -0.3 46.61 Favored Glycine 0 CA--C 1.533 1.163 0 CA-C-O 119.216 -0.769 . . . . 0.0 113.605 179.474 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 17.1 mm-40 -86.2 172.82 10.23 Favored 'General case' 0 C--O 1.238 0.454 0 CA-C-N 118.65 1.225 . . . . 0.0 109.738 174.335 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 16.0 m -69.17 159.53 32.81 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 123.768 0.827 . . . . 0.0 110.868 171.778 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 33.1 tp -56.61 -30.58 63.41 Favored 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 126.153 1.781 . . . . 0.0 113.071 -176.302 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 6.7 pt-20 -56.49 -34.28 66.79 Favored 'General case' 0 CA--C 1.528 0.106 0 C-N-CA 123.817 0.847 . . . . 0.0 111.331 175.563 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 5.1 t -77.61 -39.81 27.44 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.39 0 CA-C-O 118.125 -0.941 . . . . 0.0 110.414 -174.987 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 63.9 m-85 -56.5 -47.98 78.15 Favored 'General case' 0 N--CA 1.473 0.708 0 CA-C-N 120.368 1.44 . . . . 0.0 109.454 170.152 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 86.3 mtt180 -60.87 -42.69 98.38 Favored 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 123.259 0.624 . . . . 0.0 110.909 179.794 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 6.0 m -67.51 -49.42 63.51 Favored 'General case' 0 N--CA 1.447 -0.595 0 C-N-CA 124.696 1.199 . . . . 0.0 110.311 -179.865 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 73.0 t -68.96 -30.02 45.34 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.234 0 CA-C-O 117.813 -1.089 . . . . 0.0 110.223 -169.787 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 32.5 mtm105 -56.84 -47.1 81.11 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-N 120.011 1.278 . . . . 0.0 110.357 169.89 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -62.94 -49.05 75.63 Favored Glycine 0 CA--C 1.527 0.816 0 CA-C-N 118.438 0.563 . . . . 0.0 111.773 179.272 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 17.5 mt-30 -62.01 -44.18 97.27 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-N 117.698 0.749 . . . . 0.0 110.22 -177.914 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 54.6 t -66.19 -45.15 90.88 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.245 0 CA-C-O 118.183 -0.913 . . . . 0.0 109.684 -177.96 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -52.74 -47.79 67.16 Favored 'General case' 0 CA--C 1.516 -0.361 0 CA-C-N 119.094 0.861 . . . . 0.0 109.013 -177.957 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 39.9 tt0 -62.72 -42.79 99.83 Favored 'General case' 0 N--CA 1.447 -0.584 0 O-C-N 123.569 0.543 . . . . 0.0 111.029 -176.052 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 44.7 mtt-85 -67.06 -41.45 86.42 Favored 'General case' 0 N--CA 1.468 0.455 0 O-C-N 121.381 -0.824 . . . . 0.0 111.57 177.85 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 54.0 t -68.92 -38.46 78.61 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.429 0 N-CA-C 109.372 -0.603 . . . . 0.0 109.372 179.463 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 22.1 mt-10 -60.06 -42.09 93.74 Favored 'General case' 0 C--O 1.226 -0.166 0 O-C-N 121.414 -0.804 . . . . 0.0 110.247 174.923 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 29.1 t-20 -64.56 -45.25 87.88 Favored 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 122.735 0.414 . . . . 0.0 111.145 -179.7 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 2.1 tm? -57.19 -49.28 76.49 Favored 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 124.625 1.17 . . . . 0.0 109.992 175.815 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 75.8 mt -63.21 -47.71 91.0 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.141 0 N-CA-C 108.558 -0.904 . . . . 0.0 108.558 -179.797 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -58.61 -28.74 65.9 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 123.254 0.621 . . . . 0.0 112.411 178.908 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 88.9 mttt -70.18 -55.39 9.46 Favored 'General case' 0 C--O 1.234 0.243 0 CA-C-N 119.257 0.935 . . . . 0.0 110.567 172.495 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 16.2 pt -77.03 -38.28 27.71 Favored 'Isoleucine or valine' 0 C--O 1.234 0.25 0 N-CA-C 114.91 1.448 . . . . 0.0 114.91 -169.085 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 74.5 m . . . . . 0 C--O 1.254 1.296 0 C-N-CA 125.882 1.673 . . . . 0.0 109.52 -169.774 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 19.8 ptm . . . . . 0 N--CA 1.497 1.924 0 N-CA-C 110.821 -0.066 . . . . 0.0 110.821 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 16.3 mttm -73.59 125.96 29.18 Favored 'General case' 0 N--CA 1.482 1.131 0 N-CA-C 107.88 -1.156 . . . . 0.0 107.88 -172.006 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 69.6 mttt -94.13 137.26 33.52 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-N 120.062 1.301 . . . . 0.0 108.376 174.087 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 15.0 t -119.84 151.28 22.39 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 C-N-CA 127.121 2.169 . . . . 0.0 106.473 -169.939 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 31.9 mtt -134.65 147.14 50.09 Favored 'General case' 0 C--N 1.321 -0.64 0 C-N-CA 124.164 0.986 . . . . 0.0 108.705 168.782 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 45.6 m-85 -131.67 122.85 26.64 Favored 'General case' 0 CA--C 1.516 -0.336 0 N-CA-C 102.218 -3.252 . . . . 0.0 102.218 169.226 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 1.3 p -148.4 141.81 18.74 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.263 0 CA-C-O 121.764 0.793 . . . . 0.0 112.151 -168.41 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 46.3 t -136.29 173.86 11.25 Favored 'General case' 0 CA--C 1.547 0.846 0 C-N-CA 127.807 2.443 . . . . 0.0 105.269 169.019 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 87.6 tttt -51.59 -46.92 63.71 Favored 'General case' 0 N--CA 1.475 0.813 0 O-C-N 120.975 -1.078 . . . . 0.0 113.433 -169.368 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 19.6 ttt180 -130.11 147.47 51.85 Favored 'General case' 0 N--CA 1.468 0.461 0 CA-C-N 118.995 0.816 . . . . 0.0 109.118 -178.319 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 64.3 t30 -58.94 -30.33 67.79 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 123.964 0.906 . . . . 0.0 113.354 -175.589 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -56.31 -55.27 35.46 Favored 'General case' 0 C--O 1.236 0.378 0 C-N-CA 124.069 0.948 . . . . 0.0 109.992 -171.428 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 9.2 m -91.02 151.2 21.13 Favored 'General case' 0 N--CA 1.452 -0.37 0 C-N-CA 123.659 0.784 . . . . 0.0 110.797 -176.353 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 5.4 mmm180 67.32 -50.5 0.49 Allowed 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 128.462 2.705 . . . . 0.0 113.323 170.228 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 7.3 m -76.92 49.94 0.68 Allowed 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 125.677 1.591 . . . . 0.0 111.704 -179.351 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 4.5 pt20 -123.52 12.73 9.36 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 126.109 1.763 . . . . 0.0 112.148 -175.669 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -160.96 -40.37 0.05 OUTLIER 'General case' 0 C--O 1.224 -0.265 0 N-CA-C 113.973 1.101 . . . . 0.0 113.973 176.935 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -66.62 -52.45 44.99 Favored 'General case' 0 N--CA 1.475 0.797 0 CA-C-N 120.657 1.571 . . . . 0.0 112.164 -169.56 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -56.42 -38.3 71.39 Favored 'General case' 0 N--CA 1.446 -0.653 0 C-N-CA 124.029 0.931 . . . . 0.0 110.645 169.942 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -57.11 -52.6 50.4 Favored Glycine 0 CA--C 1.526 0.754 0 C-N-CA 124.722 1.153 . . . . 0.0 111.209 175.902 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 1.3 m-85 -65.0 -32.07 73.61 Favored 'General case' 0 CA--C 1.51 -0.582 0 O-C-N 120.94 -1.329 . . . . 0.0 111.907 175.723 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -71.05 -41.23 71.04 Favored 'General case' 0 N--CA 1.445 -0.688 0 CA-C-O 118.156 -0.926 . . . . 0.0 110.739 -174.607 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.15 -33.3 75.18 Favored 'General case' 0 N--CA 1.471 0.582 0 CA-C-N 119.617 1.099 . . . . 0.0 109.886 173.591 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 10.6 m -68.9 -54.05 17.66 Favored 'General case' 0 N--CA 1.442 -0.842 0 C-N-CA 123.171 0.588 . . . . 0.0 110.364 -175.046 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 39.9 mt -77.8 -37.3 49.06 Favored 'General case' 0 C--N 1.329 -0.285 0 C-N-CA 124.946 1.298 . . . . 0.0 111.034 -172.941 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -101.08 8.29 57.42 Favored Glycine 0 CA--C 1.526 0.761 0 CA-C-O 118.033 -1.426 . . . . 0.0 114.303 -169.734 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -40.92 -48.91 3.21 Favored 'General case' 0 N--CA 1.468 0.437 0 C-N-CA 125.798 1.639 . . . . 0.0 114.882 -169.443 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -89.94 -2.09 75.47 Favored Glycine 0 CA--C 1.531 1.074 0 CA-C-O 118.836 -0.98 . . . . 0.0 114.469 -173.506 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 13.8 ptpt -124.88 -28.29 3.51 Favored 'General case' 0 N--CA 1.472 0.651 0 CA-C-N 118.915 1.357 . . . . 0.0 113.145 -173.626 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 14.8 pt -143.65 150.15 17.47 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.437 0 CA-C-N 119.657 1.117 . . . . 0.0 111.47 -174.218 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -98.54 158.17 15.77 Favored 'General case' 0 N--CA 1.465 0.302 0 C-N-CA 125.575 1.55 . . . . 0.0 108.543 172.182 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 22.6 t -139.66 133.35 37.23 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 N-CA-C 107.547 -1.279 . . . . 0.0 107.547 -175.976 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 34.5 m -138.49 107.42 5.99 Favored 'General case' 0 N--CA 1.447 -0.594 0 N-CA-C 106.042 -1.836 . . . . 0.0 106.042 175.345 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 2.4 p -80.65 99.48 8.18 Favored 'General case' 0 C--N 1.327 -0.386 0 C-N-CA 119.843 -0.743 . . . . 0.0 109.064 174.501 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 25.7 p -72.16 -177.47 2.11 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 123.956 0.903 . . . . 0.0 110.827 175.254 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -173.17 171.88 44.76 Favored Glycine 0 CA--C 1.522 0.504 0 N-CA-C 106.457 -2.657 . . . . 0.0 106.457 -179.297 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 18.4 mt -106.43 -20.05 13.5 Favored 'General case' 0 C--N 1.325 -0.489 0 C-N-CA 124.804 1.241 . . . . 0.0 110.072 174.633 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 36.9 mt-10 -131.87 162.84 29.64 Favored 'General case' 0 N--CA 1.448 -0.538 0 C-N-CA 127.683 2.393 . . . . 0.0 106.948 169.207 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 78.9 p -145.2 155.99 43.59 Favored 'General case' 0 N--CA 1.451 -0.409 0 CA-C-O 122.844 1.307 . . . . 0.0 114.499 179.615 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 4.3 m -168.89 -179.85 3.86 Favored 'General case' 0 N--CA 1.451 -0.41 0 C-N-CA 131.118 3.767 . . . . 0.0 103.966 -170.028 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 25.6 ttp180 -86.9 171.69 10.62 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 107.079 -1.452 . . . . 0.0 107.079 169.142 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 11.2 m -68.58 165.47 2.3 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.808 0 CA-C-N 115.796 -0.638 . . . . 0.0 109.973 178.409 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 55.1 m170 -62.96 152.43 83.51 Favored Pre-proline 0 CA--C 1.549 0.917 0 C-N-CA 123.161 0.584 . . . . 0.0 112.537 177.675 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -70.45 -55.62 0.15 Allowed 'Trans proline' 0 C--N 1.352 0.711 0 C-N-CA 123.382 2.722 . . . . 0.0 114.388 -169.909 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 26.9 m -65.8 -22.75 66.59 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-N 119.256 0.934 . . . . 0.0 110.071 -175.973 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -52.41 -52.3 54.52 Favored 'General case' 0 CA--C 1.509 -0.603 0 CA-C-O 118.815 -0.612 . . . . 0.0 110.585 169.957 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 85.3 mt -58.69 -41.32 81.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 -172.292 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -63.96 -49.32 72.99 Favored 'General case' 0 N--CA 1.45 -0.455 0 CA-C-N 118.079 0.399 . . . . 0.0 111.113 178.477 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' MET . . . . . 0.431 ' HG3' ' CG ' ' A' ' 112' ' ' PHE . 24.3 mmt -65.33 -35.81 82.12 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-O 122.638 1.208 . . . . 0.0 111.445 -178.627 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -79.22 -33.09 44.01 Favored 'General case' 0 N--CA 1.44 -0.944 0 N-CA-C 107.584 -1.265 . . . . 0.0 107.584 -173.47 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 42.0 tt0 -68.25 -26.76 65.84 Favored 'General case' 0 N--CA 1.445 -0.713 0 C-N-CA 123.307 0.643 . . . . 0.0 109.86 170.614 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 14.7 mm-40 -68.25 -28.57 67.33 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-N 118.816 0.734 . . . . 0.0 110.654 174.241 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . 0.276 4.6 p -93.07 11.81 3.14 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.907 0 CA-C-N 118.658 0.663 . . . . 0.0 111.375 169.201 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 77.33 17.53 79.23 Favored Glycine 0 CA--C 1.53 1.029 0 C-N-CA 124.516 1.055 . . . . 0.0 114.003 173.071 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 12.5 mt -109.58 131.3 60.85 Favored 'Isoleucine or valine' 0 C--O 1.232 0.134 0 CA-C-N 118.884 1.342 . . . . 0.0 109.921 -177.947 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 8.1 t70 -87.28 121.04 29.19 Favored 'General case' 0 C--O 1.236 0.375 0 N-CA-C 106.783 -1.562 . . . . 0.0 106.783 169.061 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 10.1 pt -110.39 -26.68 3.09 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.487 0 C-N-CA 123.097 0.559 . . . . 0.0 110.105 169.126 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -32.67 -46.42 0.14 Allowed 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 130.146 3.378 . . . . 0.0 114.279 173.073 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -73.75 -3.59 63.85 Favored Glycine 0 CA--C 1.534 1.221 0 CA-C-O 118.82 -0.989 . . . . 0.0 114.126 -176.27 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 13.3 mt-30 -79.25 114.53 18.26 Favored 'General case' 0 CA--C 1.511 -0.55 0 CA-C-N 119.353 1.577 . . . . 0.0 111.468 -176.216 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -150.22 148.33 28.77 Favored 'General case' 0 N--CA 1.434 -1.248 0 N-CA-C 105.257 -2.127 . . . . 0.0 105.257 167.328 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 18.8 m -150.81 156.7 41.78 Favored 'General case' 0 N--CA 1.447 -0.607 0 N-CA-C 108.373 -0.973 . . . . 0.0 108.373 -169.677 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -67.98 163.45 50.4 Favored Pre-proline 0 CA--C 1.542 0.646 0 C-N-CA 124.682 1.193 . . . . 0.0 109.464 169.422 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -60.73 151.65 75.08 Favored 'Trans proline' 0 N--CA 1.456 -0.685 0 C-N-CA 122.043 1.829 . . . . 0.0 110.31 172.126 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 13.9 tt -58.61 -26.24 30.69 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.453 0 C-N-CA 124.031 0.932 . . . . 0.0 112.212 -174.475 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 23.1 tt0 -67.21 -25.34 66.07 Favored 'General case' 0 N--CA 1.434 -1.241 0 C-N-CA 125.68 1.592 . . . . 0.0 110.682 -177.052 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 12.9 t-20 -63.21 -31.51 72.67 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 124.984 1.314 . . . . 0.0 112.221 -178.888 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 8.5 m-85 -96.69 -167.69 1.6 Allowed 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 124.904 1.281 . . . . 0.0 110.333 -175.46 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 54.9 t-20 -137.35 136.95 38.39 Favored 'General case' 0 CA--C 1.515 -0.402 0 N-CA-C 107.27 -1.382 . . . . 0.0 107.27 169.188 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -73.54 -24.91 60.19 Favored 'General case' 0 N--CA 1.436 -1.128 0 N-CA-C 109.408 -0.59 . . . . 0.0 109.408 -176.547 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 36.0 t70 -66.34 -23.97 66.44 Favored 'General case' 0 N--CA 1.443 -0.804 0 O-C-N 123.751 0.657 . . . . 0.0 111.82 -179.618 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -75.96 -28.82 58.05 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 123.097 0.559 . . . . 0.0 111.348 175.541 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 18.8 m-85 -83.58 168.61 16.22 Favored 'General case' 0 N--CA 1.45 -0.47 0 C-N-CA 125.897 1.679 . . . . 0.0 110.368 177.939 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -114.97 -36.26 4.5 Favored 'General case' 0 N--CA 1.465 0.321 0 C-N-CA 123.126 0.57 . . . . 0.0 111.281 178.595 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -140.58 139.09 35.57 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.361 0 C-N-CA 123.42 0.688 . . . . 0.0 109.621 -171.499 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 83.4 t -140.48 140.0 34.72 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.319 0 N-CA-C 106.381 -1.711 . . . . 0.0 106.381 -177.692 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 37.3 mm -131.41 127.86 60.44 Favored 'Isoleucine or valine' 0 C--O 1.237 0.441 0 N-CA-C 106.743 -1.577 . . . . 0.0 106.743 -174.921 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 13.6 m -86.59 130.83 34.34 Favored 'General case' 0 N--CA 1.441 -0.905 0 N-CA-C 106.647 -1.612 . . . . 0.0 106.647 168.927 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 85.0 mt -93.94 -7.25 43.53 Favored 'General case' 0 C--N 1.331 -0.226 0 C-N-CA 123.465 0.706 . . . . 0.0 109.726 169.751 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 18.0 p -161.58 158.67 26.65 Favored 'General case' 0 N--CA 1.444 -0.73 0 C-N-CA 124.881 1.272 . . . . 0.0 108.768 169.454 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 65.76 -161.39 43.4 Favored Glycine 0 CA--C 1.535 1.285 0 N-CA-C 115.178 0.831 . . . . 0.0 115.178 169.345 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 15.1 m -142.59 -161.2 1.2 Allowed 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 126.841 2.057 . . . . 0.0 107.626 -172.39 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -72.76 61.41 1.64 Allowed Glycine 0 CA--C 1.535 1.315 0 O-C-N 120.921 -1.112 . . . . 0.0 111.667 172.28 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 6.7 m -78.21 -55.86 9.03 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.508 0 C-N-CA 124.235 1.014 . . . . 0.0 110.82 -170.001 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 46.4 t30 -143.9 48.85 1.39 Allowed 'General case' 0 N--CA 1.467 0.383 0 N-CA-C 104.416 -2.438 . . . . 0.0 104.416 169.551 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 6.0 tt -144.15 119.33 6.09 Favored Pre-proline 0 CA--C 1.535 0.386 0 N-CA-C 104.75 -2.315 . . . . 0.0 104.75 -168.443 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 76.4 Cg_exo -60.13 138.07 79.35 Favored 'Trans proline' 0 C--N 1.349 0.579 0 C-N-CA 121.823 1.682 . . . . 0.0 112.316 -170.194 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 66.9 Cg_endo -68.85 -14.57 39.16 Favored 'Trans proline' 0 N--CA 1.459 -0.516 0 C-N-CA 122.0 1.8 . . . . 0.0 113.084 -174.776 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 14.0 tt0 -58.08 -25.48 61.34 Favored 'General case' 0 N--CA 1.439 -1.019 0 C-N-CA 125.713 1.605 . . . . 0.0 110.887 171.565 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 99.7 m95 -78.87 -41.38 30.02 Favored 'General case' 0 N--CA 1.456 -0.134 0 C-N-CA 123.722 0.809 . . . . 0.0 111.804 173.035 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 2.0 m -79.46 0.02 3.47 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.638 0 C-N-CA 123.321 0.648 . . . . 0.0 112.326 -175.153 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . 0.254 1.4 t -133.11 34.98 3.53 Favored 'General case' 0 CA--C 1.546 0.797 0 O-C-N 121.519 -0.738 . . . . 0.0 112.565 -175.731 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 89.4 mm-40 -71.66 -178.66 2.3 Favored 'General case' 0 CA--C 1.543 0.703 0 O-C-N 121.208 -0.933 . . . . 0.0 110.052 169.199 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 31.1 mm-40 -57.22 -28.83 63.23 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 123.181 0.592 . . . . 0.0 111.923 -169.348 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 5.3 tt -136.72 138.63 46.06 Favored 'Isoleucine or valine' 0 C--O 1.239 0.519 0 N-CA-C 104.383 -2.451 . . . . 0.0 104.383 168.406 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 70.9 t80 -132.33 142.46 49.35 Favored 'General case' 0 N--CA 1.448 -0.564 0 N-CA-C 106.407 -1.701 . . . . 0.0 106.407 169.491 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 19.9 mm-40 -141.64 152.1 43.66 Favored 'General case' 0 C--O 1.237 0.397 0 N-CA-C 106.652 -1.61 . . . . 0.0 106.652 171.351 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -125.4 127.66 46.92 Favored 'General case' 0 C--O 1.239 0.5 0 N-CA-C 107.244 -1.391 . . . . 0.0 107.244 169.204 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 4.6 m95 -116.05 158.17 23.56 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 124.192 0.997 . . . . 0.0 110.452 -173.328 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 19.9 pt20 -122.06 39.56 3.85 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 124.553 1.141 . . . . 0.0 111.258 -177.054 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -64.36 133.08 51.91 Favored 'General case' 0 N--CA 1.466 0.359 0 N-CA-C 107.764 -1.199 . . . . 0.0 107.764 173.492 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 3.2 mp0 -64.59 152.09 42.95 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 123.943 0.897 . . . . 0.0 110.037 173.049 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -91.01 113.64 58.85 Favored Pre-proline 0 C--O 1.236 0.377 0 N-CA-C 105.603 -1.999 . . . . 0.0 105.603 168.349 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 78.6 Cg_endo -76.25 -8.73 18.78 Favored 'Trans proline' 0 N--CA 1.453 -0.868 0 C-N-CA 121.804 1.669 . . . . 0.0 114.189 -172.819 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -66.79 -41.2 88.01 Favored 'General case' 0 C--O 1.235 0.299 0 CA-C-N 120.45 1.477 . . . . 0.0 113.293 -169.309 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -79.3 6.96 55.65 Favored Glycine 0 CA--C 1.533 1.179 0 CA-C-O 118.823 -0.987 . . . . 0.0 113.663 -176.082 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 24.3 pt20 -148.53 -165.59 2.32 Favored 'General case' 0 CA--C 1.54 0.582 0 CA-C-N 118.932 1.366 . . . . 0.0 111.141 -169.874 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 2.1 m -69.3 156.65 38.42 Favored 'General case' 0 CA--C 1.533 0.324 0 N-CA-C 116.164 1.912 . . . . 0.0 116.164 -168.365 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 35.0 tp -57.33 -30.34 64.71 Favored 'General case' 0 N--CA 1.465 0.305 0 C-N-CA 126.28 1.832 . . . . 0.0 112.475 173.544 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 40.4 tt0 -58.62 -34.92 71.71 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 123.601 0.76 . . . . 0.0 110.62 173.978 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 3.4 t -76.0 -38.23 35.2 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.378 0 CA-C-O 118.12 -0.943 . . . . 0.0 109.676 -178.939 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . 0.431 ' CG ' ' HG3' ' A' ' 49' ' ' MET . 27.0 m-85 -57.03 -50.14 73.66 Favored 'General case' 0 N--CA 1.475 0.793 0 CA-C-N 120.733 1.606 . . . . 0.0 110.256 169.904 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 85.7 mtt180 -60.5 -39.54 88.07 Favored 'General case' 0 N--CA 1.468 0.457 0 C-N-CA 123.358 0.663 . . . . 0.0 110.849 -179.161 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 16.3 m -68.28 -50.58 52.73 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 124.657 1.183 . . . . 0.0 110.726 176.565 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 55.2 t -67.6 -33.87 64.69 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.197 0 CA-C-O 117.498 -1.239 . . . . 0.0 110.856 -169.423 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 31.1 mtm105 -57.54 -41.77 81.62 Favored 'General case' 0 CA--C 1.539 0.534 0 CA-C-N 120.335 1.425 . . . . 0.0 110.273 173.598 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -67.02 -50.34 47.27 Favored Glycine 0 CA--C 1.529 0.92 0 C-N-CA 123.926 0.774 . . . . 0.0 111.878 177.577 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 25.4 mt-30 -54.95 -47.59 74.3 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-N 117.752 0.776 . . . . 0.0 110.211 178.377 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 53.7 t -64.83 -48.79 82.96 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.432 0 CA-C-O 118.329 -0.843 . . . . 0.0 109.967 -177.101 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 62.6 tttm -55.96 -45.65 78.83 Favored 'General case' 0 CA--C 1.519 -0.22 0 CA-C-N 119.114 0.87 . . . . 0.0 109.107 -174.429 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -64.88 -43.93 91.31 Favored 'General case' 0 N--CA 1.443 -0.781 0 C-N-CA 123.019 0.528 . . . . 0.0 110.776 -177.12 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 57.8 mtt-85 -68.0 -42.94 79.95 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-N 118.639 0.654 . . . . 0.0 111.695 179.578 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 98.5 t -66.55 -44.11 90.29 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.374 0 N-CA-C 108.433 -0.951 . . . . 0.0 108.433 179.406 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 21.3 mt-10 -61.39 -42.73 99.19 Favored 'General case' 0 C--N 1.338 0.092 0 CA-C-N 119.892 1.224 . . . . 0.0 110.39 178.861 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 29.6 t-20 -62.22 -44.56 96.29 Favored 'General case' 0 C--O 1.225 -0.189 0 C-N-CA 122.861 0.464 . . . . 0.0 110.827 178.239 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 45.7 tp -60.1 -47.24 86.74 Favored 'General case' 0 N--CA 1.454 -0.246 0 C-N-CA 124.239 1.016 . . . . 0.0 111.052 177.5 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 79.7 mt -61.69 -45.83 97.83 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.256 0 N-CA-C 108.026 -1.101 . . . . 0.0 108.026 178.191 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -62.04 -29.3 70.19 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 123.262 0.625 . . . . 0.0 112.239 178.28 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 89.9 mttt -68.59 -56.55 7.89 Favored 'General case' 0 C--N 1.342 0.248 0 CA-C-N 119.16 0.891 . . . . 0.0 110.096 171.711 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 15.8 pt -73.93 -40.35 52.51 Favored 'Isoleucine or valine' 0 C--O 1.235 0.338 0 N-CA-C 114.213 1.19 . . . . 0.0 114.213 -169.308 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 75.0 m . . . . . 0 C--O 1.253 1.262 0 C-N-CA 126.144 1.777 . . . . 0.0 109.408 -169.74 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 9.7 ptm . . . . . 0 N--CA 1.497 1.913 0 N-CA-C 110.711 -0.107 . . . . 0.0 110.711 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 18.1 mttm -76.06 124.0 26.7 Favored 'General case' 0 N--CA 1.481 1.095 0 N-CA-C 107.701 -1.222 . . . . 0.0 107.701 -172.499 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 87.1 mttt -92.64 135.01 34.46 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-N 119.689 1.131 . . . . 0.0 108.343 176.692 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 1.7 t -118.81 150.31 21.11 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 C-N-CA 126.852 2.061 . . . . 0.0 108.848 -169.161 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 6.2 mtt -139.41 148.15 42.4 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 125.617 1.567 . . . . 0.0 109.286 169.352 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 91.0 m-85 -132.78 105.75 7.34 Favored 'General case' 0 C--O 1.225 -0.193 0 N-CA-C 104.769 -2.308 . . . . 0.0 104.769 172.131 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 22.1 t -131.82 138.88 51.76 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.221 0 CA-C-O 121.898 0.856 . . . . 0.0 111.211 -168.745 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 37.9 t -154.41 156.08 36.17 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 127.47 2.308 . . . . 0.0 105.236 169.27 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 65.6 pttt -65.37 -21.74 66.72 Favored 'General case' 0 N--CA 1.472 0.64 0 N-CA-C 114.69 1.367 . . . . 0.0 114.69 -170.427 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 7.9 tpp180 -126.94 78.05 1.77 Allowed 'General case' 0 N--CA 1.47 0.54 0 CA-C-N 119.814 1.188 . . . . 0.0 110.058 -173.9 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 34.9 t30 -43.18 -48.33 6.44 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 125.159 1.384 . . . . 0.0 112.222 176.379 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -51.53 -32.14 26.76 Favored 'General case' 0 C--O 1.232 0.147 0 C-N-CA 126.617 1.967 . . . . 0.0 112.998 -175.66 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 8.8 m -125.01 17.52 8.5 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 123.795 0.838 . . . . 0.0 111.805 -173.198 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 10.2 tpt180 -151.81 -55.86 0.14 Allowed 'General case' 0 C--N 1.348 0.528 0 N-CA-C 115.727 1.751 . . . . 0.0 115.727 179.33 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 3.3 m -65.66 -55.01 19.78 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 119.61 1.095 . . . . 0.0 112.195 -168.509 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER 43.8 -111.12 0.19 Allowed 'General case' 0 N--CA 1.452 -0.368 0 C-N-CA 126.328 1.851 . . . . 0.0 111.453 169.106 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -78.53 -8.38 58.51 Favored 'General case' 0 C--O 1.224 -0.246 0 N-CA-C 114.29 1.218 . . . . 0.0 114.29 -170.629 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -62.78 -58.95 5.66 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-N 120.131 1.332 . . . . 0.0 111.138 -169.751 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -68.11 -32.1 72.16 Favored 'General case' 0 CA--C 1.541 0.597 0 O-C-N 121.722 -0.611 . . . . 0.0 109.542 175.627 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -48.63 -56.65 9.35 Favored Glycine 0 C--N 1.346 1.113 0 C-N-CA 125.38 1.467 . . . . 0.0 111.637 176.23 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 13.9 m-85 -74.54 -28.3 60.9 Favored 'General case' 0 CA--C 1.508 -0.663 0 CA-C-N 118.77 1.285 . . . . 0.0 112.928 179.322 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -66.25 -31.0 71.55 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 119.323 0.965 . . . . 0.0 111.554 -172.451 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 7.5 ptpt -63.5 -33.06 74.75 Favored 'General case' 0 N--CA 1.477 0.908 0 CA-C-N 119.432 1.015 . . . . 0.0 112.036 171.067 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 5.9 m -78.72 -55.17 5.38 Favored 'General case' 0 N--CA 1.446 -0.626 0 C-N-CA 125.187 1.395 . . . . 0.0 110.245 -175.202 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 79.3 mt -73.4 -34.32 65.45 Favored 'General case' 0 C--N 1.33 -0.248 0 C-N-CA 123.971 0.909 . . . . 0.0 110.339 -174.753 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -91.08 2.85 79.88 Favored Glycine 0 CA--C 1.527 0.822 0 CA-C-O 118.362 -1.243 . . . . 0.0 113.709 -176.494 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -49.92 123.0 7.31 Favored 'General case' 0 CA--C 1.533 0.31 0 CA-C-N 118.796 1.298 . . . . 0.0 110.904 -172.074 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 76.78 -14.11 7.73 Favored Glycine 0 CA--C 1.533 1.195 0 C-N-CA 124.676 1.132 . . . . 0.0 114.353 179.631 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 53.6 mttm -94.15 -46.41 7.12 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-N 119.212 1.506 . . . . 0.0 110.393 178.918 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 24.7 pt -142.15 152.39 18.41 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.427 0 C-N-CA 124.301 1.04 . . . . 0.0 109.95 -169.408 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -112.87 109.01 18.19 Favored 'General case' 0 N--CA 1.464 0.235 0 C-N-CA 125.035 1.334 . . . . 0.0 108.694 -174.036 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 11.1 p -86.27 139.16 17.79 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.401 0 CA-C-N 119.702 1.137 . . . . 0.0 109.867 177.71 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 3.9 m -144.55 107.7 4.55 Favored 'General case' 0 N--CA 1.445 -0.69 0 N-CA-C 104.77 -2.308 . . . . 0.0 104.77 172.191 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 66.2 m -105.63 75.47 1.14 Allowed 'General case' 0 C--N 1.329 -0.32 0 O-C-N 120.933 -1.105 . . . . 0.0 108.827 178.48 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 2.0 m -60.46 -45.55 93.29 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 125.388 1.475 . . . . 0.0 112.054 -169.891 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 89.65 161.73 37.74 Favored Glycine 0 C--N 1.335 0.508 0 CA-C-O 122.038 0.799 . . . . 0.0 112.159 170.905 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 5.6 mt -131.49 142.67 50.01 Favored 'General case' 0 N--CA 1.442 -0.845 0 C-N-CA 128.079 2.552 . . . . 0.0 104.548 174.533 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 33.2 mt-10 57.42 -89.77 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.385 0 N-CA-C 108.134 -1.061 . . . . 0.0 108.134 -169.516 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 69.3 m 64.52 169.63 0.18 Allowed 'General case' 0 N--CA 1.445 -0.721 0 C-N-CA 127.269 2.228 . . . . 0.0 115.615 169.184 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 59.9 m -157.47 177.29 11.59 Favored 'General case' 0 N--CA 1.446 -0.646 0 C-N-CA 128.269 2.627 . . . . 0.0 105.984 -168.847 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 14.4 ttt85 -82.12 -178.77 7.15 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 107.963 -1.125 . . . . 0.0 107.963 169.377 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 17.6 m -81.41 170.17 1.48 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.729 0 C-N-CA 123.789 0.836 . . . . 0.0 109.766 -178.675 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 74.0 t60 -73.0 139.22 79.59 Favored Pre-proline 0 CA--C 1.545 0.763 0 CA-C-O 118.163 -0.922 . . . . 0.0 108.631 172.207 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -58.35 -48.3 16.16 Favored 'Trans proline' 0 C--N 1.348 0.507 0 C-N-CA 123.093 2.529 . . . . 0.0 113.833 -174.193 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 25.2 m -65.58 -18.82 65.6 Favored 'General case' 0 CA--C 1.535 0.387 0 CA-C-N 118.258 0.481 . . . . 0.0 110.937 -179.294 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -60.28 -50.64 72.82 Favored 'General case' 0 CA--C 1.51 -0.562 0 O-C-N 121.458 -0.776 . . . . 0.0 108.996 175.018 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 72.5 mt -57.98 -41.57 80.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 N-CA-C 108.352 -0.981 . . . . 0.0 108.352 -173.112 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -63.56 -46.48 85.72 Favored 'General case' 0 N--CA 1.452 -0.352 0 CA-C-N 117.631 0.196 . . . . 0.0 110.856 -179.05 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 28.4 mmt -68.02 -36.38 79.85 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-O 122.439 1.114 . . . . 0.0 110.841 -179.819 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -74.6 -31.93 62.19 Favored 'General case' 0 N--CA 1.444 -0.753 0 N-CA-C 106.887 -1.523 . . . . 0.0 106.887 -175.698 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 40.8 tt0 -72.3 -21.89 61.28 Favored 'General case' 0 N--CA 1.446 -0.651 0 C-N-CA 124.311 1.045 . . . . 0.0 110.157 172.495 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 21.6 mm-40 -67.53 -30.63 70.34 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-N 119.272 0.942 . . . . 0.0 110.017 169.962 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . 0.291 5.5 p -89.86 8.74 3.21 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.993 0 CA-C-N 118.802 0.728 . . . . 0.0 111.467 168.839 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 77.29 21.75 72.36 Favored Glycine 0 CA--C 1.532 1.11 0 O-C-N 120.818 -1.176 . . . . 0.0 113.799 174.953 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 25.2 mt -118.71 144.71 26.17 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.239 0 C-N-CA 125.314 1.445 . . . . 0.0 110.005 -174.15 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 20.6 t70 -108.03 147.59 30.93 Favored 'General case' 0 C--O 1.234 0.282 0 N-CA-C 108.375 -0.972 . . . . 0.0 108.375 168.74 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 13.5 pt -132.29 -12.57 1.48 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.707 0 C-N-CA 125.895 1.678 . . . . 0.0 111.529 170.565 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 5.4 t -45.77 -46.73 15.42 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-N 120.333 1.424 . . . . 0.0 111.688 170.845 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -78.51 29.51 1.99 Allowed Glycine 0 CA--C 1.533 1.207 0 C-N-CA 124.966 1.269 . . . . 0.0 114.147 -177.621 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 1.7 tt0 -63.5 -37.37 87.04 Favored 'General case' 0 C--N 1.344 0.36 0 CA-C-N 119.728 1.764 . . . . 0.0 113.213 -175.046 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 12.4 t -81.22 161.36 24.01 Favored 'General case' 0 C--O 1.238 0.451 0 CA-C-O 122.047 0.927 . . . . 0.0 110.352 -169.534 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 4.2 m -168.34 -51.42 0.02 OUTLIER 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 125.919 1.687 . . . . 0.0 109.175 178.197 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -154.39 154.97 30.32 Favored Pre-proline 0 C--O 1.237 0.41 0 C-N-CA 124.988 1.315 . . . . 0.0 108.208 -179.672 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 98.9 Cg_endo -66.86 159.13 53.07 Favored 'Trans proline' 0 N--CA 1.457 -0.659 0 C-N-CA 123.111 2.541 . . . . 0.0 110.508 171.421 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 5.6 tt -60.11 -26.01 35.01 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.477 0 O-C-N 121.577 -0.702 . . . . 0.0 111.63 179.681 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 15.8 mt-10 -65.66 -25.46 67.36 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 124.555 1.142 . . . . 0.0 110.593 -175.121 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 4.4 t-20 -65.84 -20.96 66.43 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 124.666 1.186 . . . . 0.0 112.459 177.985 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 77.0 m-85 -106.42 -173.49 2.31 Favored 'General case' 0 C--O 1.236 0.356 0 C-N-CA 126.37 1.868 . . . . 0.0 110.1 -174.95 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 53.2 t-20 -135.78 139.71 43.72 Favored 'General case' 0 N--CA 1.448 -0.542 0 N-CA-C 107.857 -1.164 . . . . 0.0 107.857 169.123 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -72.44 -26.16 61.73 Favored 'General case' 0 N--CA 1.433 -1.31 0 N-CA-C 109.283 -0.636 . . . . 0.0 109.283 -178.102 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -65.56 -24.39 67.08 Favored 'General case' 0 N--CA 1.447 -0.596 0 O-C-N 123.639 0.587 . . . . 0.0 112.002 -179.652 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -78.42 -28.43 46.79 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 123.297 0.639 . . . . 0.0 111.635 174.848 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 11.4 m-85 -81.13 167.44 19.68 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 125.536 1.534 . . . . 0.0 111.151 179.877 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -116.86 -39.98 3.21 Favored 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 123.099 0.56 . . . . 0.0 111.243 -179.081 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -136.13 133.62 50.28 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.453 0 CA-C-O 121.841 0.829 . . . . 0.0 109.498 -172.43 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 70.5 t -142.01 130.0 21.32 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.585 0 N-CA-C 106.199 -1.778 . . . . 0.0 106.199 -177.83 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 38.0 mm -118.9 125.42 74.46 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.575 0 N-CA-C 106.387 -1.708 . . . . 0.0 106.387 -173.233 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 56.0 m -84.0 145.06 28.72 Favored 'General case' 0 N--CA 1.446 -0.655 0 N-CA-C 106.061 -1.829 . . . . 0.0 106.061 168.601 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 93.1 mt -111.61 5.35 19.3 Favored 'General case' 0 C--N 1.328 -0.344 0 O-C-N 121.637 -0.664 . . . . 0.0 110.785 171.74 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 10.8 p -155.47 147.25 23.22 Favored 'General case' 0 N--CA 1.447 -0.584 0 C-N-CA 124.537 1.135 . . . . 0.0 108.566 168.898 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 53.4 -156.56 5.5 Favored Glycine 0 CA--C 1.537 1.426 0 C-N-CA 125.204 1.383 . . . . 0.0 115.22 169.604 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 48.0 m -145.83 127.12 14.85 Favored 'General case' 0 CA--C 1.532 0.271 0 N-CA-C 105.902 -1.888 . . . . 0.0 105.902 174.913 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 58.59 44.43 95.55 Favored Glycine 0 CA--C 1.53 1.013 0 N-CA-C 109.711 -1.356 . . . . 0.0 109.711 -171.378 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . 0.279 4.0 p -75.37 64.46 0.16 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.842 0 C-N-CA 125.916 1.686 . . . . 0.0 112.213 -168.834 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 56.5 t30 56.84 52.89 8.81 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 125.874 1.67 . . . . 0.0 107.83 -169.569 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -143.83 138.59 15.29 Favored Pre-proline 0 CA--C 1.538 0.489 0 C-N-CA 126.102 1.761 . . . . 0.0 108.743 -168.748 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 33.2 Cg_exo -64.93 139.47 62.05 Favored 'Trans proline' 0 CA--C 1.54 0.81 0 C-N-CA 122.221 1.947 . . . . 0.0 111.576 176.463 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -66.21 -24.9 50.72 Favored 'Trans proline' 0 N--CA 1.457 -0.657 0 C-N-CA 122.585 2.19 . . . . 0.0 114.476 -169.649 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 5.0 pm0 -61.46 -18.08 57.36 Favored 'General case' 0 CA--C 1.537 0.453 0 CA-C-N 121.251 1.841 . . . . 0.0 111.898 178.413 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 99.4 m95 -77.91 -38.84 44.71 Favored 'General case' 0 N--CA 1.451 -0.393 0 O-C-N 121.702 -0.624 . . . . 0.0 111.396 174.093 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -79.33 -5.12 7.72 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.456 0 O-C-N 121.869 -0.519 . . . . 0.0 111.672 -177.827 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 81.5 p -114.39 18.42 16.9 Favored 'General case' 0 C--O 1.238 0.453 0 N-CA-C 114.411 1.264 . . . . 0.0 114.411 -175.633 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 91.6 mm-40 -68.18 173.99 4.27 Favored 'General case' 0 CA--C 1.541 0.628 0 CA-C-N 119.025 0.83 . . . . 0.0 111.858 179.324 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 28.7 mm-40 -53.22 -31.57 43.79 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 124.362 1.065 . . . . 0.0 112.735 -169.0 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 4.8 tt -131.35 124.83 55.77 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.51 0 N-CA-C 104.305 -2.48 . . . . 0.0 104.305 168.39 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 4.1 t80 -113.55 133.39 55.28 Favored 'General case' 0 C--O 1.237 0.444 0 N-CA-C 104.722 -2.325 . . . . 0.0 104.722 169.186 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 14.4 mm-40 -137.66 152.07 48.93 Favored 'General case' 0 C--O 1.238 0.495 0 N-CA-C 106.57 -1.641 . . . . 0.0 106.57 169.723 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -130.94 134.82 47.1 Favored 'General case' 0 C--O 1.237 0.419 0 N-CA-C 107.411 -1.329 . . . . 0.0 107.411 169.263 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 6.6 m95 -121.08 138.95 53.94 Favored 'General case' 0 C--O 1.234 0.25 0 C-N-CA 123.059 0.543 . . . . 0.0 109.767 -174.82 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 4.8 tp-100 -82.72 63.33 6.79 Favored 'General case' 0 CA--C 1.535 0.395 0 N-CA-C 107.361 -1.348 . . . . 0.0 107.361 169.907 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 1.6 tp -67.38 127.53 33.03 Favored 'General case' 0 C--N 1.34 0.165 0 N-CA-C 108.955 -0.757 . . . . 0.0 108.955 -173.352 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -76.89 159.05 30.33 Favored 'General case' 0 N--CA 1.449 -0.508 0 N-CA-C 107.045 -1.465 . . . . 0.0 107.045 169.572 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 20.0 t70 -149.07 137.65 11.96 Favored Pre-proline 0 CA--C 1.536 0.419 0 CA-C-O 118.596 -0.716 . . . . 0.0 111.209 -171.584 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 20.8 Cg_endo -91.7 9.53 2.82 Favored 'Trans proline' 0 CA--C 1.548 1.217 0 C-N-CA 123.424 2.749 . . . . 0.0 114.808 -172.193 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -53.27 128.44 28.16 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-N 120.596 1.544 . . . . 0.0 111.361 177.811 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 64.0 25.16 69.18 Favored Glycine 0 CA--C 1.532 1.126 0 CA-C-O 118.741 -1.033 . . . . 0.0 115.458 169.223 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 6.9 pt20 -142.1 -168.48 2.71 Favored 'General case' 0 CA--C 1.536 0.434 0 CA-C-N 118.891 1.345 . . . . 0.0 111.343 -177.911 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 2.6 m -68.51 156.0 38.84 Favored 'General case' 0 CA--C 1.532 0.274 0 N-CA-C 116.149 1.907 . . . . 0.0 116.149 -168.401 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 42.9 tp -54.97 -33.68 62.63 Favored 'General case' 0 N--CA 1.465 0.307 0 C-N-CA 126.997 2.119 . . . . 0.0 111.785 175.211 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 40.8 tt0 -58.49 -35.43 72.2 Favored 'General case' 0 CA--C 1.529 0.172 0 C-N-CA 123.806 0.843 . . . . 0.0 110.702 176.399 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 4.2 t -74.98 -40.47 45.39 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.291 0 CA-C-O 118.434 -0.793 . . . . 0.0 109.652 -177.216 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 89.9 m-85 -57.12 -49.64 75.29 Favored 'General case' 0 N--CA 1.471 0.621 0 CA-C-N 119.927 1.24 . . . . 0.0 109.568 171.837 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 89.4 mtt180 -61.61 -40.0 93.27 Favored 'General case' 0 N--CA 1.467 0.385 0 C-N-CA 122.871 0.468 . . . . 0.0 110.993 -178.592 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 7.6 m -66.32 -56.27 11.96 Favored 'General case' 0 N--CA 1.447 -0.608 0 C-N-CA 124.507 1.123 . . . . 0.0 109.514 177.996 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 83.8 t -68.33 -34.06 63.92 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.343 0 CA-C-O 118.683 -0.675 . . . . 0.0 110.057 -169.643 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 47.1 ttp85 -57.82 -43.23 85.59 Favored 'General case' 0 CA--C 1.538 0.489 0 CA-C-N 119.275 0.943 . . . . 0.0 109.883 173.173 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -64.54 -53.4 35.62 Favored Glycine 0 CA--C 1.53 0.987 0 CA-C-N 118.318 0.508 . . . . 0.0 111.842 175.273 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 12.6 mt-30 -61.01 -43.34 99.03 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-N 117.884 0.842 . . . . 0.0 110.837 -174.859 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 76.8 t -70.5 -38.85 75.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 118.085 -0.959 . . . . 0.0 109.966 -174.951 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 84.0 tttt -54.73 -46.81 74.29 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 119.279 0.945 . . . . 0.0 108.673 175.789 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -65.98 -42.51 89.75 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 122.933 0.493 . . . . 0.0 111.398 -176.604 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 43.6 mtt-85 -61.49 -46.62 89.22 Favored 'General case' 0 N--CA 1.472 0.635 0 O-C-N 121.336 -0.852 . . . . 0.0 111.514 176.524 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 98.4 t -65.28 -39.87 86.77 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.637 0 N-CA-C 109.08 -0.711 . . . . 0.0 109.08 179.354 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 29.7 mt-10 -59.42 -44.48 92.87 Favored 'General case' 0 N--CA 1.462 0.172 0 CA-C-N 119.789 1.177 . . . . 0.0 110.787 176.667 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 46.7 t30 -62.98 -45.2 93.54 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 123.329 0.652 . . . . 0.0 110.551 -177.649 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 22.0 tp -58.0 -47.91 81.61 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 124.112 0.965 . . . . 0.0 111.006 175.382 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 81.0 mt -63.09 -46.09 96.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 N-CA-C 108.329 -0.989 . . . . 0.0 108.329 179.664 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -59.91 -27.83 67.08 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 123.25 0.62 . . . . 0.0 112.214 177.901 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 90.5 mttt -69.72 -56.99 5.69 Favored 'General case' 0 C--N 1.343 0.284 0 CA-C-N 119.322 0.964 . . . . 0.0 110.184 171.706 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 18.2 pt -75.71 -38.44 37.66 Favored 'Isoleucine or valine' 0 C--O 1.235 0.326 0 N-CA-C 114.645 1.35 . . . . 0.0 114.645 -169.283 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 73.7 m . . . . . 0 C--O 1.252 1.237 0 C-N-CA 126.199 1.799 . . . . 0.0 109.128 -169.805 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 6.3 ptm . . . . . 0 N--CA 1.497 1.878 0 N-CA-C 110.807 -0.071 . . . . 0.0 110.807 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 10.6 mtmm -71.69 130.14 40.41 Favored 'General case' 0 N--CA 1.476 0.874 0 N-CA-C 107.507 -1.294 . . . . 0.0 107.507 -178.936 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 66.7 mttt -103.74 138.32 40.53 Favored 'General case' 0 CA--C 1.511 -0.526 0 N-CA-C 107.912 -1.144 . . . . 0.0 107.912 171.046 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 4.0 t -116.25 152.84 17.93 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.787 0 C-N-CA 126.522 1.929 . . . . 0.0 108.169 -169.878 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 5.1 mtt -135.78 148.17 48.66 Favored 'General case' 0 C--N 1.323 -0.562 0 C-N-CA 126.512 1.925 . . . . 0.0 107.951 168.88 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -135.19 109.22 8.2 Favored 'General case' 0 CA--C 1.512 -0.51 0 N-CA-C 104.161 -2.533 . . . . 0.0 104.161 175.909 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 72.4 t -132.73 149.52 32.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-O 121.378 0.608 . . . . 0.0 110.0 -168.454 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 32.7 t -135.85 -174.43 3.66 Favored 'General case' 0 CA--C 1.548 0.866 0 C-N-CA 128.134 2.573 . . . . 0.0 105.952 172.814 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 64.3 tttp -54.45 -39.93 67.88 Favored 'General case' 0 N--CA 1.479 1.008 0 O-C-N 121.26 -0.9 . . . . 0.0 111.505 177.777 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 33.3 mtp85 -132.3 158.35 42.1 Favored 'General case' 0 N--CA 1.468 0.47 0 C-N-CA 124.644 1.177 . . . . 0.0 108.449 174.6 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -63.27 -24.97 68.1 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 122.948 0.499 . . . . 0.0 112.093 170.212 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -48.93 -44.46 40.51 Favored 'General case' 0 CA--C 1.53 0.197 0 C-N-CA 126.105 1.762 . . . . 0.0 113.627 -169.31 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 13.5 m -120.03 144.36 47.59 Favored 'General case' 0 N--CA 1.454 -0.27 0 C-N-CA 123.111 0.564 . . . . 0.0 109.733 -169.386 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . 0.37 0.0 OUTLIER 56.32 -40.68 0.03 OUTLIER 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 130.3 3.44 . . . . 0.0 115.061 -178.746 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 2.0 m -61.8 -24.19 66.7 Favored 'General case' 0 CA--C 1.539 0.524 0 O-C-N 120.358 -1.464 . . . . 0.0 109.663 169.293 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 22.0 pt20 -67.18 10.81 0.13 Allowed 'General case' 0 CA--C 1.546 0.823 0 C-N-CA 125.638 1.575 . . . . 0.0 113.401 169.414 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -139.18 -51.64 0.54 Allowed 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 125.158 1.383 . . . . 0.0 111.577 173.599 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -57.8 -47.43 82.6 Favored 'General case' 0 N--CA 1.472 0.669 0 N-CA-C 114.934 1.457 . . . . 0.0 114.934 -169.003 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 1.9 pp20? -63.5 -30.61 71.71 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-N 117.981 0.355 . . . . 0.0 110.109 178.36 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -51.81 -67.32 2.07 Favored Glycine 0 C--N 1.34 0.805 0 C-N-CA 126.399 1.952 . . . . 0.0 110.885 173.376 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 12.8 m-85 -62.53 -31.01 71.71 Favored 'General case' 0 N--CA 1.469 0.514 0 CA-C-N 118.25 1.025 . . . . 0.0 113.294 179.67 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -67.36 -35.79 80.07 Favored 'General case' 0 N--CA 1.45 -0.454 0 CA-C-N 119.07 0.85 . . . . 0.0 111.549 -176.226 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -67.35 -27.28 67.0 Favored 'General case' 0 CA--C 1.541 0.624 0 CA-C-N 119.426 1.012 . . . . 0.0 111.431 174.201 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 2.8 m -77.2 -56.17 4.8 Favored 'General case' 0 N--CA 1.451 -0.397 0 C-N-CA 125.443 1.497 . . . . 0.0 110.571 -178.601 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 54.9 mt -75.54 -38.35 59.37 Favored 'General case' 0 C--N 1.33 -0.245 0 C-N-CA 124.098 0.959 . . . . 0.0 109.497 -174.484 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -82.24 3.78 79.68 Favored Glycine 0 CA--C 1.524 0.628 0 C-N-CA 125.154 1.359 . . . . 0.0 113.447 -179.65 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -54.39 127.28 26.73 Favored 'General case' 0 CA--C 1.531 0.219 0 CA-C-N 118.881 1.34 . . . . 0.0 109.691 -177.328 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 73.38 5.41 67.18 Favored Glycine 0 CA--C 1.533 1.168 0 CA-C-O 118.775 -1.014 . . . . 0.0 114.273 -178.8 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 46.3 mttp -121.22 -51.32 2.1 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-N 119.104 1.452 . . . . 0.0 110.943 -176.508 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 19.2 pt -139.71 148.12 23.39 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.453 0 C-N-CA 123.88 0.872 . . . . 0.0 109.567 -169.495 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -94.67 158.75 15.38 Favored 'General case' 0 C--O 1.224 -0.266 0 C-N-CA 124.851 1.26 . . . . 0.0 108.522 178.06 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 21.7 t -140.54 130.71 28.07 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 N-CA-C 107.172 -1.418 . . . . 0.0 107.172 -176.474 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 24.4 m -141.0 109.77 6.04 Favored 'General case' 0 N--CA 1.446 -0.645 0 N-CA-C 105.122 -2.177 . . . . 0.0 105.122 172.684 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 69.3 m -110.81 85.0 2.03 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.869 0.842 . . . . 0.0 110.079 -177.439 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 4.8 m -72.48 -170.09 0.61 Allowed 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 126.651 1.98 . . . . 0.0 110.748 176.749 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -165.74 -168.2 27.53 Favored Glycine 0 C--N 1.337 0.604 0 N-CA-C 108.01 -2.036 . . . . 0.0 108.01 177.949 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 16.9 mt -127.25 -8.41 5.86 Favored 'General case' 0 C--N 1.332 -0.177 0 C-N-CA 124.657 1.183 . . . . 0.0 112.773 -171.946 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 20.9 mt-10 -142.52 -71.53 0.32 Allowed 'General case' 0 CA--C 1.535 0.366 0 N-CA-C 107.427 -1.323 . . . . 0.0 107.427 -178.023 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . 0.25 53.8 m 63.17 158.58 0.07 Allowed 'General case' 0 N--CA 1.465 0.296 0 C-N-CA 127.259 2.223 . . . . 0.0 116.586 169.675 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 69.6 m -152.74 1.62 0.3 Allowed 'General case' 0 CA--C 1.538 0.484 0 N-CA-C 115.747 1.758 . . . . 0.0 115.747 -167.532 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 1.5 ttt180 66.51 168.51 0.23 Allowed 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 125.251 1.42 . . . . 0.0 109.802 -167.439 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 5.1 m -83.79 172.33 1.07 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.315 0 C-N-CA 123.528 0.731 . . . . 0.0 110.978 -169.19 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 91.1 m-70 -88.65 150.55 46.36 Favored Pre-proline 0 CA--C 1.537 0.443 0 C-N-CA 123.188 0.595 . . . . 0.0 109.949 178.133 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 39.5 Cg_endo -63.72 -46.44 8.95 Favored 'Trans proline' 0 C--N 1.347 0.485 0 C-N-CA 122.855 2.37 . . . . 0.0 112.341 -170.338 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 6.0 m -66.17 -25.94 67.19 Favored 'General case' 0 CA--C 1.531 0.242 0 CA-C-O 119.016 -0.516 . . . . 0.0 110.256 -179.112 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -58.69 -54.12 50.61 Favored 'General case' 0 CA--C 1.51 -0.581 0 CA-C-N 119.086 0.857 . . . . 0.0 109.109 176.27 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 38.1 mt -59.7 -42.8 89.78 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.427 0 N-CA-C 108.193 -1.04 . . . . 0.0 108.193 -174.654 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -59.23 -44.86 92.31 Favored 'General case' 0 CA--C 1.532 0.269 0 CA-C-N 118.421 0.555 . . . . 0.0 110.623 -178.775 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 26.4 mmt -70.9 -37.58 72.98 Favored 'General case' 0 C--O 1.239 0.503 0 CA-C-O 122.158 0.98 . . . . 0.0 111.128 -179.161 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -69.91 -32.96 71.54 Favored 'General case' 0 N--CA 1.443 -0.778 0 N-CA-C 106.649 -1.612 . . . . 0.0 106.649 179.781 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 18.6 mm-40 -73.29 -16.59 61.38 Favored 'General case' 0 N--CA 1.444 -0.752 0 O-C-N 120.79 -1.194 . . . . 0.0 111.278 171.757 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 22.6 mm-40 -66.28 -35.1 79.53 Favored 'General case' 0 C--N 1.341 0.221 0 CA-C-N 119.847 1.203 . . . . 0.0 109.095 169.552 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 16.8 m -90.07 11.59 2.09 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.766 0 N-CA-C 112.2 0.445 . . . . 0.0 112.2 169.311 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 73.21 23.52 77.36 Favored Glycine 0 CA--C 1.534 1.234 0 C-N-CA 124.487 1.042 . . . . 0.0 113.345 174.67 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 8.6 mt -107.83 135.53 46.19 Favored 'Isoleucine or valine' 0 C--O 1.232 0.152 0 C-N-CA 125.419 1.488 . . . . 0.0 110.197 -174.994 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -95.57 140.01 31.02 Favored 'General case' 0 C--O 1.236 0.365 0 C-N-CA 123.508 0.723 . . . . 0.0 109.514 169.791 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.49 HG13 ' H ' ' A' ' 58' ' ' SER . 3.6 pt -119.72 -66.94 1.2 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.607 0 C-N-CA 124.773 1.229 . . . . 0.0 108.393 171.043 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' SER . . . . . 0.49 ' H ' HG13 ' A' ' 57' ' ' ILE . 95.2 p 30.59 -98.54 0.01 OUTLIER 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 128.961 2.905 . . . . 0.0 114.225 174.897 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -76.35 53.96 3.16 Favored Glycine 0 CA--C 1.528 0.876 0 C-N-CA 127.273 2.368 . . . . 0.0 112.703 -175.773 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 5.6 mt-30 -65.44 -29.9 70.63 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 123.203 0.601 . . . . 0.0 110.297 169.744 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -60.28 128.19 35.52 Favored 'General case' 0 N--CA 1.446 -0.639 0 C-N-CA 126.037 1.735 . . . . 0.0 109.19 -169.795 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 75.5 m -147.63 -169.94 3.44 Favored 'General case' 0 N--CA 1.447 -0.587 0 C-N-CA 126.332 1.853 . . . . 0.0 106.605 -169.635 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -57.38 154.59 22.24 Favored Pre-proline 0 C--O 1.241 0.613 0 O-C-N 121.854 -0.529 . . . . 0.0 109.903 169.355 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 64.4 Cg_endo -61.2 152.61 70.77 Favored 'Trans proline' 0 N--CA 1.456 -0.691 0 C-N-CA 121.918 1.745 . . . . 0.0 109.488 171.613 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 7.9 tt -60.09 -26.53 36.48 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.497 0 O-C-N 121.794 -0.566 . . . . 0.0 111.015 -176.682 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 25.4 tt0 -67.52 -26.33 66.28 Favored 'General case' 0 N--CA 1.435 -1.215 0 C-N-CA 125.398 1.479 . . . . 0.0 110.65 -176.625 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 11.3 t-20 -64.72 -31.16 72.26 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 124.416 1.087 . . . . 0.0 111.731 176.945 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 79.4 m-85 -86.58 168.13 13.94 Favored 'General case' 0 C--O 1.237 0.429 0 C-N-CA 124.946 1.298 . . . . 0.0 111.612 -174.695 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 46.4 t-20 -106.26 132.05 52.77 Favored 'General case' 0 N--CA 1.444 -0.738 0 N-CA-C 107.298 -1.371 . . . . 0.0 107.298 168.676 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -73.6 -24.69 60.08 Favored 'General case' 0 N--CA 1.437 -1.092 0 N-CA-C 109.339 -0.615 . . . . 0.0 109.339 -178.77 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 36.1 t70 -65.85 -21.76 66.49 Favored 'General case' 0 N--CA 1.447 -0.595 0 O-C-N 123.477 0.486 . . . . 0.0 112.096 -179.617 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -73.29 -29.31 62.63 Favored 'General case' 0 C--N 1.344 0.367 0 CA-C-O 121.222 0.534 . . . . 0.0 111.795 176.164 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 32.7 m-85 -84.25 165.84 18.0 Favored 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 125.744 1.618 . . . . 0.0 110.166 179.703 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 20.4 t70 -113.13 -35.84 5.25 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.72 176.903 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -142.24 135.94 28.5 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.826 0 CA-C-O 121.792 0.806 . . . . 0.0 110.496 -169.305 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 73.3 t -142.16 131.07 22.32 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.729 0 N-CA-C 106.178 -1.786 . . . . 0.0 106.178 -174.097 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 41.4 mm -117.93 125.5 74.23 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.443 0 N-CA-C 106.387 -1.709 . . . . 0.0 106.387 -171.712 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 41.3 m -95.19 108.69 20.83 Favored 'General case' 0 N--CA 1.447 -0.597 0 N-CA-C 106.675 -1.602 . . . . 0.0 106.675 169.889 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 90.0 mt -74.63 -13.37 60.63 Favored 'General case' 0 N--CA 1.464 0.254 0 C-N-CA 123.175 0.59 . . . . 0.0 111.661 -178.943 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 45.4 m -142.19 89.89 2.21 Favored 'General case' 0 N--CA 1.452 -0.367 0 C-N-CA 124.981 1.312 . . . . 0.0 109.073 -169.824 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 64.33 -154.7 47.51 Favored Glycine 0 CA--C 1.534 1.221 0 N-CA-C 111.585 -0.606 . . . . 0.0 111.585 178.418 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 2.9 p -161.77 152.81 18.11 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 124.587 1.155 . . . . 0.0 109.651 179.365 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 61.43 31.0 75.85 Favored Glycine 0 CA--C 1.531 1.069 0 N-CA-C 111.619 -0.592 . . . . 0.0 111.619 -178.534 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 28.5 m -70.69 -38.76 74.34 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.543 0 C-N-CA 123.087 0.555 . . . . 0.0 112.118 -169.366 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 21.4 t-20 179.66 -40.86 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 127.795 2.438 . . . . 0.0 107.573 176.712 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 3.6 tt -37.59 137.93 0.64 Allowed Pre-proline 0 CA--C 1.548 0.878 0 C-N-CA 128.788 2.835 . . . . 0.0 112.562 170.963 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_exo -65.32 148.83 88.7 Favored 'Trans proline' 0 C--N 1.355 0.886 0 C-N-CA 121.734 1.623 . . . . 0.0 115.635 -169.399 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -64.04 -33.44 62.26 Favored 'Trans proline' 0 C--N 1.351 0.672 0 C-N-CA 122.394 2.062 . . . . 0.0 115.788 -170.981 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 5.1 pm0 -61.45 -14.41 28.34 Favored 'General case' 0 CA--C 1.538 0.49 0 CA-C-N 120.27 1.395 . . . . 0.0 112.46 -175.876 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 98.0 m95 -79.67 -45.94 18.08 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 124.008 0.923 . . . . 0.0 110.904 176.711 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 16.1 m -80.18 -1.32 4.58 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.366 0 C-N-CA 123.955 0.902 . . . . 0.0 112.25 179.975 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 74.9 p -109.62 18.76 19.94 Favored 'General case' 0 C--O 1.238 0.454 0 CA-C-N 119.672 1.124 . . . . 0.0 113.655 175.544 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 88.0 mm-40 -66.66 172.24 4.41 Favored 'General case' 0 CA--C 1.542 0.635 0 CA-C-N 118.842 0.746 . . . . 0.0 111.783 177.0 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 31.7 mm-40 -54.85 -31.97 60.14 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 123.869 0.868 . . . . 0.0 112.272 -169.033 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 1.9 tt -129.0 126.32 64.37 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.543 0 N-CA-C 103.817 -2.66 . . . . 0.0 103.817 168.412 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 7.3 t80 -110.47 139.04 46.08 Favored 'General case' 0 N--CA 1.448 -0.549 0 N-CA-C 105.955 -1.869 . . . . 0.0 105.955 170.104 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 12.8 mm-40 -134.8 145.09 48.03 Favored 'General case' 0 C--O 1.237 0.435 0 N-CA-C 107.137 -1.431 . . . . 0.0 107.137 169.774 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -129.11 125.78 37.9 Favored 'General case' 0 C--O 1.239 0.515 0 C-N-CA 126.375 1.87 . . . . 0.0 106.235 178.117 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 34.6 m95 -135.43 179.31 6.41 Favored 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 124.585 1.154 . . . . 0.0 108.865 179.987 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 6.4 tp-100 -141.24 72.22 1.38 Allowed 'General case' 0 CA--C 1.535 0.376 0 N-CA-C 106.274 -1.75 . . . . 0.0 106.274 169.643 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -67.03 146.01 54.78 Favored 'General case' 0 N--CA 1.469 0.488 0 N-CA-C 108.448 -0.945 . . . . 0.0 108.448 178.506 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 34.4 mt-10 -78.66 169.68 17.85 Favored 'General case' 0 C--N 1.328 -0.369 0 C-N-CA 123.975 0.91 . . . . 0.0 109.318 170.891 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -141.35 138.59 17.76 Favored Pre-proline 0 CA--C 1.539 0.549 0 C-N-CA 124.331 1.052 . . . . 0.0 110.27 179.27 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_endo -85.47 0.58 8.57 Favored 'Trans proline' 0 CA--C 1.543 0.927 0 C-N-CA 123.248 2.632 . . . . 0.0 115.771 -174.063 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 7.1 t70 -53.66 124.0 13.86 Favored 'General case' 0 C--O 1.237 0.416 0 CA-C-N 121.077 1.762 . . . . 0.0 110.849 -179.063 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 72.33 4.71 61.02 Favored Glycine 0 CA--C 1.533 1.168 0 CA-C-O 118.961 -0.911 . . . . 0.0 113.749 178.188 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 7.1 mt-30 -103.0 167.25 9.96 Favored 'General case' 0 CA--C 1.539 0.557 0 CA-C-N 118.658 1.229 . . . . 0.0 110.014 178.594 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 16.4 m -71.91 167.38 20.18 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 124.09 0.956 . . . . 0.0 111.636 -178.928 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 73.8 mt -59.62 -26.51 65.54 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 124.379 1.072 . . . . 0.0 112.402 -176.454 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 5.9 pt-20 -56.25 -34.93 66.84 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-N 118.738 0.699 . . . . 0.0 111.11 174.184 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 14.0 t -77.93 -42.51 28.31 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.316 0 CA-C-O 118.664 -0.684 . . . . 0.0 109.913 -177.238 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 68.3 m-85 -56.84 -43.5 81.19 Favored 'General case' 0 N--CA 1.474 0.77 0 CA-C-N 119.639 1.109 . . . . 0.0 109.569 171.07 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 94.1 mtt180 -66.25 -42.33 88.7 Favored 'General case' 0 N--CA 1.472 0.655 0 O-C-N 121.305 -0.872 . . . . 0.0 110.804 179.485 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 4.1 m -65.75 -49.72 67.36 Favored 'General case' 0 N--CA 1.45 -0.427 0 C-N-CA 124.606 1.162 . . . . 0.0 110.312 179.394 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 77.2 t -70.43 -30.58 43.46 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.202 0 CA-C-O 117.807 -1.092 . . . . 0.0 110.587 -169.501 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 74.5 mtm-85 -59.09 -45.36 91.05 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 120.192 1.36 . . . . 0.0 109.799 170.508 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -62.16 -51.68 55.05 Favored Glycine 0 CA--C 1.528 0.88 0 CA-C-N 118.946 0.794 . . . . 0.0 112.1 178.093 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 15.7 mt-30 -58.94 -45.4 90.53 Favored 'General case' 0 N--CA 1.469 0.475 0 CA-C-N 117.936 0.868 . . . . 0.0 110.779 -178.852 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 55.3 t -67.04 -47.22 82.72 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.344 0 N-CA-C 109.202 -0.666 . . . . 0.0 109.202 -177.987 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 84.3 tttt -55.52 -45.67 77.11 Favored 'General case' 0 C--O 1.224 -0.262 0 N-CA-C 109.185 -0.672 . . . . 0.0 109.185 -176.635 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 10.1 tp10 -62.83 -44.2 96.79 Favored 'General case' 0 N--CA 1.45 -0.427 0 C-N-CA 123.145 0.578 . . . . 0.0 110.757 -176.268 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 48.6 mtt-85 -68.51 -42.97 77.81 Favored 'General case' 0 N--CA 1.468 0.443 0 O-C-N 121.32 -0.863 . . . . 0.0 111.025 178.987 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 95.4 t -64.17 -38.98 83.87 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.513 0 CA-C-O 119.138 -0.458 . . . . 0.0 109.884 178.305 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 27.8 mt-10 -61.72 -44.85 96.13 Favored 'General case' 0 C--O 1.227 -0.128 0 CA-C-N 119.993 1.27 . . . . 0.0 110.177 176.014 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 28.3 t-20 -63.02 -42.12 99.71 Favored 'General case' 0 CA--C 1.53 0.208 0 C-N-CA 122.915 0.486 . . . . 0.0 111.049 -177.801 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 28.7 tp -58.04 -49.63 76.21 Favored 'General case' 0 N--CA 1.451 -0.399 0 C-N-CA 125.203 1.401 . . . . 0.0 110.742 174.17 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 81.6 mt -66.41 -43.99 90.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 N-CA-C 108.146 -1.057 . . . . 0.0 108.146 -177.057 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -59.23 -32.92 70.41 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 123.198 0.599 . . . . 0.0 112.098 -179.486 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 18.6 ptpt -80.87 -37.79 29.25 Favored 'General case' 0 C--N 1.344 0.351 0 CA-C-O 117.929 -1.034 . . . . 0.0 112.32 177.344 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 13.1 pt -84.85 -34.38 9.05 Favored 'Isoleucine or valine' 0 C--O 1.236 0.356 0 CA-C-N 119.962 1.255 . . . . 0.0 114.045 -175.184 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 74.3 m . . . . . 0 C--O 1.252 1.195 0 C-N-CA 125.372 1.469 . . . . 0.0 109.462 -169.837 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.4 ptt? . . . . . 0 N--CA 1.496 1.854 0 N-CA-C 111.776 0.287 . . . . 0.0 111.776 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 11.0 mtmm -59.91 128.4 36.71 Favored 'General case' 0 N--CA 1.475 0.8 0 N-CA-C 107.816 -1.179 . . . . 0.0 107.816 -178.872 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 66.0 mttt -103.14 136.12 43.52 Favored 'General case' 0 CA--C 1.513 -0.465 0 N-CA-C 107.745 -1.205 . . . . 0.0 107.745 171.528 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 3.7 t -113.73 152.73 15.38 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.622 0 C-N-CA 126.144 1.777 . . . . 0.0 107.111 -171.479 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 2.7 mtt -137.14 145.08 43.37 Favored 'General case' 0 C--N 1.323 -0.55 0 C-N-CA 126.433 1.893 . . . . 0.0 108.341 169.525 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 60.0 m-85 -128.6 89.01 2.82 Favored 'General case' 0 CA--C 1.528 0.109 0 N-CA-C 105.234 -2.136 . . . . 0.0 105.234 170.769 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 44.0 t -128.57 108.62 17.73 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.217 0 CA-C-O 121.409 0.623 . . . . 0.0 111.72 -168.741 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 33.9 t -101.64 164.57 11.68 Favored 'General case' 0 CA--C 1.543 0.682 0 N-CA-C 105.392 -2.077 . . . . 0.0 105.392 167.812 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 61.7 pttt -72.0 148.36 45.99 Favored 'General case' 0 CA--C 1.53 0.206 0 O-C-N 121.133 -0.979 . . . . 0.0 108.809 169.529 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 2.8 mpt_? 60.07 168.75 0.08 Allowed 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 125.63 1.572 . . . . 0.0 110.939 -170.443 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -138.4 -14.04 1.31 Allowed 'General case' 0 N--CA 1.468 0.433 0 N-CA-C 112.882 0.697 . . . . 0.0 112.882 -176.117 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 2.0 m -59.96 -30.71 69.28 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-N 118.681 0.673 . . . . 0.0 109.988 178.564 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 7.3 p -136.15 151.56 49.9 Favored 'General case' 0 N--CA 1.45 -0.455 0 C-N-CA 127.046 2.138 . . . . 0.0 105.652 168.738 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 2.0 mmm-85 58.77 176.12 0.07 Allowed 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 125.767 1.627 . . . . 0.0 110.026 -169.527 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 6.6 m 51.03 37.7 18.54 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 123.378 0.671 . . . . 0.0 111.557 -174.906 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 24.3 pt20 -143.21 155.09 44.45 Favored 'General case' 0 N--CA 1.444 -0.744 0 N-CA-C 106.476 -1.676 . . . . 0.0 106.476 174.401 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER 66.79 -39.58 0.35 Allowed 'General case' 0 C--N 1.326 -0.423 0 C-N-CA 127.091 2.156 . . . . 0.0 114.851 179.141 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -65.9 -48.14 72.45 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-N 120.834 1.652 . . . . 0.0 110.591 -176.315 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -64.37 -40.68 96.32 Favored 'General case' 0 C--N 1.324 -0.519 0 C-N-CA 123.651 0.78 . . . . 0.0 111.258 174.546 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -59.23 -45.44 95.37 Favored Glycine 0 CA--C 1.526 0.779 0 N-CA-C 111.622 -0.591 . . . . 0.0 111.622 176.476 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 1.5 m-85 -69.36 -33.44 73.08 Favored 'General case' 0 CA--C 1.51 -0.588 0 O-C-N 121.414 -1.051 . . . . 0.0 111.262 177.483 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -70.28 -37.83 74.94 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 119.098 0.863 . . . . 0.0 110.336 -178.105 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -53.06 -45.02 67.89 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 123.928 0.891 . . . . 0.0 109.146 169.55 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 14.7 m -70.48 -57.2 5.04 Favored 'General case' 0 N--CA 1.448 -0.562 0 C-N-CA 124.15 0.98 . . . . 0.0 111.279 -174.467 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 37.6 mt -74.65 -34.41 62.72 Favored 'General case' 0 C--N 1.332 -0.167 0 C-N-CA 125.108 1.363 . . . . 0.0 110.814 -171.71 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -92.05 1.21 73.64 Favored Glycine 0 CA--C 1.528 0.874 0 C-N-CA 125.162 1.363 . . . . 0.0 113.291 -175.898 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -49.27 127.81 15.58 Favored 'General case' 0 CA--C 1.534 0.335 0 CA-C-N 118.991 1.395 . . . . 0.0 110.565 -179.176 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 76.11 -9.8 17.67 Favored Glycine 0 CA--C 1.535 1.298 0 C-N-CA 124.412 1.006 . . . . 0.0 114.121 179.743 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 63.1 mttm -99.65 -47.51 5.06 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 119.177 1.489 . . . . 0.0 110.307 175.22 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 22.0 pt -144.0 155.38 15.63 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.26 0 C-N-CA 124.443 1.097 . . . . 0.0 110.819 -169.155 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -98.48 155.46 17.25 Favored 'General case' 0 C--O 1.224 -0.269 0 C-N-CA 125.344 1.458 . . . . 0.0 108.566 179.673 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 21.9 t -139.53 130.97 33.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 N-CA-C 106.969 -1.493 . . . . 0.0 106.969 -178.317 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 24.7 m -140.36 114.02 8.77 Favored 'General case' 0 N--CA 1.446 -0.664 0 N-CA-C 104.36 -2.459 . . . . 0.0 104.36 172.095 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 55.0 m -112.32 91.22 3.58 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 107.862 -1.162 . . . . 0.0 107.862 173.16 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 3.0 p -67.06 -59.12 3.73 Favored 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 126.478 1.911 . . . . 0.0 111.579 -174.372 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 107.15 164.49 22.08 Favored Glycine 0 CA--C 1.527 0.787 0 C-N-CA 124.463 1.03 . . . . 0.0 112.331 176.651 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 6.1 mt -131.86 138.85 48.61 Favored 'General case' 0 CA--C 1.508 -0.667 0 C-N-CA 127.362 2.265 . . . . 0.0 105.447 170.166 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 28.4 mt-10 53.72 20.46 2.24 Favored 'General case' 0 N--CA 1.48 1.029 0 CA-C-O 122.443 1.116 . . . . 0.0 111.735 179.178 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 3.7 p -78.13 165.41 24.0 Favored 'General case' 0 N--CA 1.435 -1.185 0 N-CA-C 116.481 2.03 . . . . 0.0 116.481 -166.854 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 37.3 p -147.07 -165.52 2.27 Favored 'General case' 0 N--CA 1.433 -1.278 0 C-N-CA 128.956 2.903 . . . . 0.0 106.289 -168.716 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -75.81 161.24 29.19 Favored 'General case' 0 N--CA 1.456 -0.153 0 CA-C-O 122.128 0.965 . . . . 0.0 109.182 169.343 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 2.3 m -66.87 173.28 0.63 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.709 0 CA-C-N 114.35 -1.295 . . . . 0.0 108.37 169.655 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 81.1 t60 -70.76 137.85 85.52 Favored Pre-proline 0 CA--C 1.544 0.73 0 O-C-N 121.187 -0.946 . . . . 0.0 110.4 -178.319 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 16.4 Cg_endo -56.44 -50.55 11.58 Favored 'Trans proline' 0 C--N 1.349 0.571 0 C-N-CA 123.077 2.518 . . . . 0.0 113.106 -177.433 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 23.5 m -69.35 -21.94 63.78 Favored 'General case' 0 CA--C 1.537 0.45 0 O-C-N 121.846 -0.534 . . . . 0.0 110.739 -177.296 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -61.18 -47.62 85.34 Favored 'General case' 0 CA--C 1.505 -0.774 0 N-CA-C 108.771 -0.825 . . . . 0.0 108.771 174.189 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 55.9 mt -58.7 -42.89 86.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 N-CA-C 108.345 -0.983 . . . . 0.0 108.345 -174.212 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -61.93 -47.43 84.92 Favored 'General case' 0 N--CA 1.453 -0.287 0 CA-C-N 118.395 0.543 . . . . 0.0 110.988 -179.898 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 27.4 mmt -66.5 -34.48 78.01 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-O 122.343 1.068 . . . . 0.0 110.7 179.853 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -78.36 -35.59 47.24 Favored 'General case' 0 N--CA 1.441 -0.875 0 N-CA-C 107.247 -1.39 . . . . 0.0 107.247 -172.924 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 33.9 mt-10 -70.42 -22.78 62.68 Favored 'General case' 0 N--CA 1.442 -0.851 0 C-N-CA 123.703 0.801 . . . . 0.0 110.229 171.757 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 14.7 mm-40 -69.23 -29.32 67.22 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-N 119.28 0.945 . . . . 0.0 110.62 171.448 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . 0.278 7.8 p -90.74 8.54 3.74 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.002 0 CA-C-N 118.768 0.713 . . . . 0.0 110.738 168.876 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 81.07 20.91 64.01 Favored Glycine 0 CA--C 1.532 1.114 0 C-N-CA 124.732 1.158 . . . . 0.0 114.055 173.463 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 16.7 mt -117.45 134.02 62.36 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.306 0 C-N-CA 124.49 1.116 . . . . 0.0 110.884 -172.251 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 3.3 t70 -89.4 139.11 30.84 Favored 'General case' 0 N--CA 1.464 0.258 0 N-CA-C 108.08 -1.082 . . . . 0.0 108.08 169.18 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 8.8 pt -129.92 -31.97 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.543 0 C-N-CA 124.587 1.155 . . . . 0.0 110.908 172.362 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -38.41 -42.52 0.74 Allowed 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 128.233 2.613 . . . . 0.0 113.698 169.388 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -70.58 1.63 20.41 Favored Glycine 0 CA--C 1.534 1.27 0 C-N-CA 124.518 1.056 . . . . 0.0 115.18 -174.121 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 16.6 mt-30 -60.46 -34.17 73.63 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 119.512 1.656 . . . . 0.0 114.457 -178.506 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -57.49 118.25 4.99 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-O 121.435 0.636 . . . . 0.0 110.765 -169.041 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 49.2 m -152.05 -167.63 2.83 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 127.857 2.463 . . . . 0.0 106.763 -169.537 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -59.52 153.21 51.57 Favored Pre-proline 0 CA--C 1.54 0.562 0 O-C-N 121.795 -0.566 . . . . 0.0 110.49 169.653 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -64.43 158.26 50.29 Favored 'Trans proline' 0 C--N 1.349 0.56 0 C-N-CA 123.13 2.553 . . . . 0.0 110.514 171.751 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 13.0 tt -59.72 -27.05 36.94 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.289 0 O-C-N 121.783 -0.573 . . . . 0.0 111.33 -178.762 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 15.7 mt-10 -65.98 -26.24 67.46 Favored 'General case' 0 C--O 1.234 0.24 0 C-N-CA 124.185 0.994 . . . . 0.0 110.409 -175.175 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 5.9 t-20 -66.48 -26.52 67.22 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 124.646 1.179 . . . . 0.0 111.769 177.13 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 96.3 m-85 -96.26 170.76 9.03 Favored 'General case' 0 C--O 1.235 0.32 0 C-N-CA 125.632 1.573 . . . . 0.0 110.927 -177.909 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 19.0 p-10 -116.79 137.43 52.2 Favored 'General case' 0 N--CA 1.436 -1.129 0 C-N-CA 125.075 1.35 . . . . 0.0 110.889 168.966 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -77.11 -22.18 53.09 Favored 'General case' 0 N--CA 1.433 -1.302 0 N-CA-C 109.82 -0.437 . . . . 0.0 109.82 -171.181 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -64.16 -21.92 66.74 Favored 'General case' 0 N--CA 1.443 -0.799 0 O-C-N 123.881 0.738 . . . . 0.0 111.79 -179.239 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 37.8 t70 -75.77 -27.72 58.14 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 122.973 0.509 . . . . 0.0 112.146 175.02 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 32.1 m-85 -85.93 170.11 12.63 Favored 'General case' 0 N--CA 1.451 -0.402 0 C-N-CA 126.271 1.828 . . . . 0.0 111.031 -179.319 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -119.01 -34.24 3.95 Favored 'General case' 0 N--CA 1.466 0.332 0 C-N-CA 123.117 0.567 . . . . 0.0 111.753 177.569 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -145.51 138.04 20.8 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.489 0 CA-C-O 121.324 0.583 . . . . 0.0 109.834 -170.216 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 95.5 t -144.87 126.09 8.51 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.515 0 N-CA-C 106.254 -1.758 . . . . 0.0 106.254 -173.782 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 4.5 mm -101.87 132.39 47.9 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.599 0 N-CA-C 105.803 -1.925 . . . . 0.0 105.803 173.609 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 55.8 m -93.04 -16.09 25.41 Favored 'General case' 0 CA--C 1.535 0.37 0 N-CA-C 113.288 0.848 . . . . 0.0 113.288 178.81 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 24.4 mt 57.06 -12.27 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.613 0 N-CA-C 118.218 2.673 . . . . 0.0 118.218 171.079 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 26.5 p -149.58 33.87 0.7 Allowed 'General case' 0 CA--C 1.537 0.454 0 CA-C-N 122.303 2.319 . . . . 0.0 112.816 -178.072 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 130.85 -165.49 22.9 Favored Glycine 0 CA--C 1.525 0.665 0 C-N-CA 125.498 1.523 . . . . 0.0 110.675 179.485 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 8.4 p -102.72 -53.39 2.87 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 124.762 1.225 . . . . 0.0 110.116 177.012 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -65.52 -53.93 29.13 Favored Glycine 0 C--N 1.341 0.84 0 N-CA-C 111.201 -0.76 . . . . 0.0 111.201 -175.394 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . 0.313 98.5 t 55.94 10.36 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.551 1.01 0 C-N-CA 126.749 2.02 . . . . 0.0 114.919 169.592 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 64.1 t30 53.38 44.57 29.86 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 124.839 1.256 . . . . 0.0 109.398 -169.592 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -126.31 142.63 43.39 Favored Pre-proline 0 CA--C 1.539 0.552 0 C-N-CA 127.242 2.217 . . . . 0.0 108.22 -169.317 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 30.1 Cg_exo -65.93 143.04 71.36 Favored 'Trans proline' 0 C--N 1.352 0.75 0 C-N-CA 121.396 1.397 . . . . 0.0 111.45 -178.749 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -65.4 -28.31 54.53 Favored 'Trans proline' 0 N--CA 1.462 -0.377 0 C-N-CA 122.054 1.836 . . . . 0.0 114.273 -169.191 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -58.09 -19.39 31.73 Favored 'General case' 0 CA--C 1.538 0.483 0 CA-C-N 119.436 1.016 . . . . 0.0 112.488 179.873 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 95.0 m95 -78.88 -40.62 31.88 Favored 'General case' 0 N--CA 1.446 -0.642 0 C-N-CA 123.52 0.728 . . . . 0.0 112.263 -177.15 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 2.9 m -71.25 -34.11 53.06 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.445 0 CA-C-O 118.722 -0.656 . . . . 0.0 110.117 174.29 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 76.6 p -81.99 23.69 0.68 Allowed 'General case' 0 C--O 1.236 0.356 0 CA-C-N 120.046 1.293 . . . . 0.0 113.893 -170.159 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 94.3 mm-40 -72.79 179.03 3.84 Favored 'General case' 0 N--CA 1.446 -0.634 0 O-C-N 121.703 -0.623 . . . . 0.0 110.319 172.343 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 30.7 mm-40 -62.3 -19.79 63.65 Favored 'General case' 0 CA--C 1.538 0.489 0 N-CA-C 112.829 0.677 . . . . 0.0 112.829 -169.398 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 2.1 tt -142.14 124.12 13.28 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.354 0 C-N-CA 126.338 1.855 . . . . 0.0 106.698 173.547 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 7.0 t80 -97.29 132.23 43.23 Favored 'General case' 0 CA--C 1.535 0.397 0 N-CA-C 105.158 -2.164 . . . . 0.0 105.158 169.022 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 7.9 mm-40 -138.46 160.27 39.98 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-O 121.792 0.806 . . . . 0.0 109.434 172.034 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 8.9 t70 -179.92 134.98 0.11 Allowed 'General case' 0 C--N 1.325 -0.482 0 C-N-CA 127.085 2.154 . . . . 0.0 106.509 -169.57 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 5.0 m-90 -145.58 154.23 41.94 Favored 'General case' 0 C--O 1.234 0.238 0 N-CA-C 109.325 -0.62 . . . . 0.0 109.325 -172.043 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 15.2 pt20 -79.58 50.24 1.11 Allowed 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 124.216 1.006 . . . . 0.0 110.118 171.474 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 1.1 mt -65.43 121.92 15.99 Favored 'General case' 0 C--N 1.34 0.181 0 N-CA-C 107.672 -1.232 . . . . 0.0 107.672 178.141 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 -73.02 160.35 32.21 Favored 'General case' 0 CA--C 1.537 0.465 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 173.826 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -137.26 137.21 21.95 Favored Pre-proline 0 C--O 1.237 0.413 0 C-N-CA 124.296 1.039 . . . . 0.0 109.835 -169.698 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 22.7 Cg_endo -88.66 6.16 4.84 Favored 'Trans proline' 0 CA--C 1.544 0.994 0 C-N-CA 122.817 2.344 . . . . 0.0 113.736 -170.517 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 4.6 t70 -47.01 111.53 0.41 Allowed 'General case' 0 C--O 1.236 0.389 0 CA-C-N 120.356 1.434 . . . . 0.0 111.857 -179.973 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 67.65 7.91 49.84 Favored Glycine 0 CA--C 1.535 1.307 0 C-N-CA 124.348 0.975 . . . . 0.0 114.3 177.853 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 6.7 mt-30 -91.2 173.6 7.84 Favored 'General case' 0 CA--C 1.541 0.626 0 CA-C-N 118.777 1.289 . . . . 0.0 110.518 -178.649 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 15.6 m -74.16 166.55 23.23 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 124.432 1.093 . . . . 0.0 111.555 179.978 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -57.35 -31.78 66.08 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 125.06 1.344 . . . . 0.0 112.084 -176.85 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 6.2 pt-20 -56.82 -35.17 68.48 Favored 'General case' 0 N--CA 1.463 0.196 0 C-N-CA 123.195 0.598 . . . . 0.0 111.377 176.404 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 15.6 t -76.9 -41.42 32.11 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.31 0 CA-C-O 118.412 -0.804 . . . . 0.0 109.416 -176.883 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 84.1 m-85 -57.25 -48.91 77.64 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-N 119.89 1.223 . . . . 0.0 110.413 171.606 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 94.9 mtt180 -60.81 -41.77 96.32 Favored 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 123.322 0.649 . . . . 0.0 110.972 179.766 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 5.2 m -63.5 -47.62 80.96 Favored 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 124.629 1.171 . . . . 0.0 110.196 176.25 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 73.1 t -68.92 -35.11 67.68 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.335 0 CA-C-O 117.955 -1.022 . . . . 0.0 109.7 -172.402 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 27.2 mtm105 -57.68 -48.24 80.08 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 120.205 1.366 . . . . 0.0 110.094 174.128 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -63.36 -48.84 75.24 Favored Glycine 0 CA--C 1.53 0.999 0 CA-C-N 118.38 0.536 . . . . 0.0 111.852 179.003 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 14.3 mm-40 -55.79 -54.1 48.56 Favored 'General case' 0 N--CA 1.464 0.259 0 C-N-CA 123.677 0.791 . . . . 0.0 109.93 179.556 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 95.6 t -65.34 -43.46 94.92 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-O 118.168 -0.92 . . . . 0.0 109.821 -173.559 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 61.5 tttm -53.45 -44.5 68.91 Favored 'General case' 0 C--O 1.225 -0.191 0 N-CA-C 108.828 -0.804 . . . . 0.0 108.828 178.479 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -69.53 -45.4 68.92 Favored 'General case' 0 N--CA 1.448 -0.575 0 CA-C-O 119.12 -0.467 . . . . 0.0 111.627 -176.394 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 1.5 mmt-85 -59.41 -44.85 92.77 Favored 'General case' 0 N--CA 1.478 0.969 0 CA-C-N 119.26 0.936 . . . . 0.0 110.257 176.487 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 88.6 t -68.63 -40.76 82.23 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.445 0 N-CA-C 109.193 -0.669 . . . . 0.0 109.193 -176.555 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 23.6 mt-10 -60.61 -40.45 91.9 Favored 'General case' 0 C--O 1.226 -0.151 0 CA-C-N 119.645 1.111 . . . . 0.0 110.21 176.129 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 25.0 t-20 -65.69 -43.2 89.95 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 123.082 0.553 . . . . 0.0 111.442 -179.579 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 1.4 tm? -58.75 -47.76 83.53 Favored 'General case' 0 C--O 1.225 -0.191 0 C-N-CA 126.112 1.765 . . . . 0.0 110.689 174.509 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 85.5 mt -65.91 -48.37 82.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 N-CA-C 108.697 -0.853 . . . . 0.0 108.697 179.16 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -56.54 -33.86 66.5 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-N 118.488 0.586 . . . . 0.0 112.264 -177.31 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 17.6 ptpt -80.4 -36.06 34.37 Favored 'General case' 0 C--N 1.342 0.279 0 CA-C-O 117.952 -1.023 . . . . 0.0 112.552 178.543 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 14.0 pt -85.22 -34.56 8.88 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.376 0 CA-C-N 119.973 1.261 . . . . 0.0 114.08 -177.353 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 75.1 m . . . . . 0 C--O 1.254 1.322 0 C-N-CA 125.706 1.602 . . . . 0.0 109.398 -169.884 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.497 1.882 0 N-CA-C 110.37 -0.233 . . . . 0.0 110.37 . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 26.6 mttm -81.66 121.01 25.82 Favored 'General case' 0 N--CA 1.478 0.956 0 N-CA-C 106.776 -1.565 . . . . 0.0 106.776 173.501 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 37.0 ttmt -87.17 128.6 35.13 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 107.396 -1.335 . . . . 0.0 107.396 -179.366 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 1.7 t -117.17 150.8 19.12 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 C-N-CA 125.715 1.606 . . . . 0.0 109.61 -168.865 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 46.4 ttm -141.23 148.21 39.54 Favored 'General case' 0 C--N 1.329 -0.319 0 C-N-CA 125.474 1.51 . . . . 0.0 108.786 169.699 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 87.1 m-85 -136.29 128.7 30.25 Favored 'General case' 0 C--N 1.332 -0.175 0 N-CA-C 104.072 -2.566 . . . . 0.0 104.072 175.005 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 2.2 p -157.17 156.39 4.41 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.437 0 CA-C-N 119.147 0.885 . . . . 0.0 110.837 -168.947 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 48.0 t -140.63 177.58 7.93 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 126.966 2.106 . . . . 0.0 106.652 169.04 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 40.7 ttmt -49.86 -40.99 44.33 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 124.707 1.203 . . . . 0.0 111.742 -177.064 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 99.1 mtt180 -134.17 169.23 17.48 Favored 'General case' 0 N--CA 1.466 0.325 0 C-N-CA 125.478 1.511 . . . . 0.0 107.898 169.906 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 55.1 t-20 -70.8 -39.91 72.82 Favored 'General case' 0 N--CA 1.47 0.53 0 N-CA-C 109.702 -0.481 . . . . 0.0 109.702 173.405 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 3.6 m -51.85 139.15 22.56 Favored 'General case' 0 C--O 1.237 0.397 0 C-N-CA 124.849 1.26 . . . . 0.0 111.084 -178.339 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 4.6 m 60.99 17.13 7.63 Favored 'General case' 0 CA--C 1.542 0.648 0 N-CA-C 115.076 1.51 . . . . 0.0 115.076 171.852 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -156.13 -55.37 0.09 Allowed 'General case' 0 N--CA 1.471 0.605 0 CA-C-N 121.05 1.75 . . . . 0.0 114.886 169.842 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 3.3 m -77.92 15.6 0.85 Allowed 'General case' 0 N--CA 1.468 0.431 0 N-CA-C 115.654 1.724 . . . . 0.0 115.654 -168.254 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 6.0 pt20 -66.15 -43.26 87.54 Favored 'General case' 0 C--O 1.22 -0.453 0 CA-C-N 120.247 1.385 . . . . 0.0 113.302 -169.989 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 1.4 tpt -108.55 -19.83 13.31 Favored 'General case' 0 N--CA 1.47 0.526 0 N-CA-C 114.487 1.291 . . . . 0.0 114.487 -168.571 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -66.65 -50.29 63.41 Favored 'General case' 0 N--CA 1.475 0.792 0 CA-C-N 119.149 0.886 . . . . 0.0 111.846 -170.498 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -63.29 -32.42 73.83 Favored 'General case' 0 N--CA 1.467 0.38 0 N-CA-C 109.492 -0.559 . . . . 0.0 109.492 173.008 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -51.43 -65.7 2.98 Favored Glycine 0 C--N 1.345 1.03 0 C-N-CA 124.569 1.081 . . . . 0.0 111.347 174.471 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 13.6 m-85 -65.72 -29.38 69.9 Favored 'General case' 0 CA--C 1.506 -0.746 0 CA-C-N 118.588 1.194 . . . . 0.0 112.477 -176.882 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -67.45 -30.11 69.75 Favored 'General case' 0 N--CA 1.446 -0.638 0 CA-C-O 117.98 -1.01 . . . . 0.0 111.737 -177.624 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 2.1 ptmt -70.72 -27.89 64.31 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-N 120.248 1.385 . . . . 0.0 111.342 174.132 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 12.8 m -77.52 -57.16 3.97 Favored 'General case' 0 N--CA 1.448 -0.541 0 C-N-CA 125.538 1.535 . . . . 0.0 110.954 179.774 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 57.2 mt -72.84 -36.9 67.57 Favored 'General case' 0 N--CA 1.464 0.228 0 C-N-CA 124.019 0.927 . . . . 0.0 109.76 -175.703 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -81.21 0.74 87.08 Favored Glycine 0 CA--C 1.525 0.68 0 C-N-CA 124.812 1.196 . . . . 0.0 113.2 179.907 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -54.96 135.71 48.29 Favored 'General case' 0 C--O 1.236 0.372 0 CA-C-N 119.186 1.493 . . . . 0.0 109.395 179.172 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 72.49 5.81 64.44 Favored Glycine 0 CA--C 1.534 1.248 0 CA-C-O 118.332 -1.26 . . . . 0.0 114.597 178.393 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 9.2 ptpp? -137.81 -44.33 0.53 Allowed 'General case' 0 N--CA 1.475 0.777 0 CA-C-N 119.731 1.765 . . . . 0.0 112.937 -178.595 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 24.0 pt -138.49 152.81 25.44 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.794 0 CA-C-N 119.978 1.263 . . . . 0.0 110.138 -173.082 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -118.47 106.32 12.57 Favored 'General case' 0 C--O 1.227 -0.105 0 C-N-CA 124.62 1.168 . . . . 0.0 110.009 -169.738 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 4.6 t -79.62 134.4 27.74 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.399 0 N-CA-C 109.178 -0.675 . . . . 0.0 109.178 177.833 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 22.2 m -140.62 87.4 2.12 Favored 'General case' 0 N--CA 1.449 -0.5 0 N-CA-C 105.493 -2.04 . . . . 0.0 105.493 169.663 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 38.6 m -95.0 82.91 3.86 Favored 'General case' 0 N--CA 1.448 -0.557 0 CA-C-O 121.917 0.865 . . . . 0.0 111.223 -169.809 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -64.26 172.0 2.74 Favored 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 125.715 1.606 . . . . 0.0 110.3 169.874 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -157.75 -167.86 19.33 Favored Glycine 0 C--N 1.338 0.664 0 N-CA-C 108.575 -1.81 . . . . 0.0 108.575 -173.297 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 3.0 mt -136.96 131.27 32.75 Favored 'General case' 0 N--CA 1.44 -0.932 0 N-CA-C 104.468 -2.419 . . . . 0.0 104.468 -172.272 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 28.7 mt-10 65.47 -61.55 0.24 Allowed 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 126.754 2.022 . . . . 0.0 111.041 -169.714 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 75.4 m 65.31 158.63 0.1 Allowed 'General case' 0 N--CA 1.438 -1.026 0 C-N-CA 129.313 3.045 . . . . 0.0 115.917 171.133 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 49.7 p -161.9 170.94 18.53 Favored 'General case' 0 N--CA 1.431 -1.375 0 CA-C-N 111.039 -2.801 . . . . 0.0 106.932 -168.838 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 5.7 ttt180 -92.28 167.05 12.28 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.657 0.742 . . . . 0.0 109.31 175.721 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 18.8 m -73.07 171.88 1.13 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.622 0 CA-C-N 114.711 -1.131 . . . . 0.0 109.853 178.647 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 92.2 m-70 -82.99 150.28 61.2 Favored Pre-proline 0 CA--C 1.539 0.526 0 C-N-CA 123.416 0.687 . . . . 0.0 110.479 -176.889 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -62.7 -45.63 13.32 Favored 'Trans proline' 0 C--N 1.347 0.496 0 C-N-CA 122.982 2.455 . . . . 0.0 112.383 -172.675 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 6.1 m -68.49 -25.94 65.22 Favored 'General case' 0 CA--C 1.534 0.33 0 O-C-N 121.881 -0.512 . . . . 0.0 110.22 -179.146 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -58.51 -52.8 64.12 Favored 'General case' 0 CA--C 1.507 -0.691 0 N-CA-C 108.766 -0.827 . . . . 0.0 108.766 171.356 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 81.5 mt -59.27 -41.09 82.96 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.342 0 N-CA-C 108.471 -0.937 . . . . 0.0 108.471 -173.176 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -63.1 -49.75 73.21 Favored 'General case' 0 CA--C 1.534 0.363 0 CA-C-N 118.503 0.592 . . . . 0.0 111.331 179.718 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 29.4 mmt -65.89 -36.63 83.96 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-O 122.933 1.349 . . . . 0.0 111.106 -179.698 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -78.45 -30.44 47.46 Favored 'General case' 0 N--CA 1.439 -0.993 0 N-CA-C 106.803 -1.554 . . . . 0.0 106.803 -172.754 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 4.8 mm-40 -73.75 -20.51 60.48 Favored 'General case' 0 N--CA 1.445 -0.712 0 O-C-N 121.355 -0.841 . . . . 0.0 110.642 169.749 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 18.0 mm-40 -66.83 -30.67 70.91 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-N 119.713 1.142 . . . . 0.0 110.038 170.0 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 15.4 m -91.92 10.56 3.25 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.814 0 CA-C-N 118.703 0.683 . . . . 0.0 111.427 168.635 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 76.66 22.87 71.39 Favored Glycine 0 CA--C 1.531 1.059 0 C-N-CA 124.962 1.267 . . . . 0.0 113.554 172.24 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 8.1 mt -111.7 129.64 66.73 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.222 0 CA-C-N 118.485 1.142 . . . . 0.0 111.033 -173.659 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -86.31 126.09 34.08 Favored 'General case' 0 C--O 1.232 0.177 0 N-CA-C 107.371 -1.344 . . . . 0.0 107.371 168.822 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 6.5 pt -122.48 -22.22 3.17 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.645 0 C-N-CA 125.219 1.408 . . . . 0.0 109.894 169.659 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -36.86 -41.04 0.31 Allowed 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 129.367 3.067 . . . . 0.0 113.633 169.376 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -82.05 14.0 35.14 Favored Glycine 0 CA--C 1.532 1.119 0 C-N-CA 124.943 1.258 . . . . 0.0 114.801 -176.551 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -63.71 -30.18 71.31 Favored 'General case' 0 C--N 1.343 0.309 0 CA-C-N 119.667 1.733 . . . . 0.0 114.099 -170.533 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -61.91 122.88 16.55 Favored 'General case' 0 CA--C 1.535 0.379 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 -169.797 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 67.3 m -145.91 -175.28 4.68 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 125.92 1.688 . . . . 0.0 107.864 -169.261 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -57.3 155.22 19.0 Favored Pre-proline 0 CA--C 1.539 0.543 0 C-N-CA 124.162 0.985 . . . . 0.0 111.572 173.131 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -65.42 155.81 66.76 Favored 'Trans proline' 0 N--CA 1.456 -0.703 0 C-N-CA 122.529 2.152 . . . . 0.0 110.095 171.053 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 7.8 tt -58.97 -28.24 37.97 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.486 0 C-N-CA 124.02 0.928 . . . . 0.0 110.979 -178.713 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 14.5 mt-10 -68.08 -25.55 65.39 Favored 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 125.329 1.452 . . . . 0.0 110.399 -173.883 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 7.4 t-20 -62.04 -22.81 66.04 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 124.926 1.29 . . . . 0.0 111.969 177.149 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 88.7 m-85 -109.0 -176.71 3.11 Favored 'General case' 0 C--O 1.235 0.33 0 C-N-CA 125.697 1.599 . . . . 0.0 111.528 -172.109 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 55.2 t-20 -130.07 137.79 50.39 Favored 'General case' 0 N--CA 1.442 -0.866 0 N-CA-C 106.183 -1.784 . . . . 0.0 106.183 169.315 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -73.35 -24.5 60.35 Favored 'General case' 0 N--CA 1.432 -1.35 0 CA-C-N 118.539 0.609 . . . . 0.0 109.734 -178.826 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 35.8 t70 -63.94 -22.4 66.9 Favored 'General case' 0 N--CA 1.446 -0.636 0 O-C-N 123.627 0.579 . . . . 0.0 111.333 179.327 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -73.85 -29.77 62.3 Favored 'General case' 0 N--CA 1.452 -0.332 0 C-N-CA 123.762 0.825 . . . . 0.0 111.431 175.246 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 17.8 m-85 -79.33 159.53 27.14 Favored 'General case' 0 N--CA 1.446 -0.629 0 C-N-CA 124.518 1.127 . . . . 0.0 110.302 177.681 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 23.6 t70 -99.53 -38.61 8.7 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.241 171.218 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -139.26 137.6 41.21 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.359 0 C-N-CA 123.857 0.863 . . . . 0.0 109.634 -170.551 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 89.7 t -143.1 142.46 25.82 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.745 0 N-CA-C 106.435 -1.691 . . . . 0.0 106.435 -178.574 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 28.9 mm -137.09 132.7 47.06 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.568 0 N-CA-C 107.133 -1.432 . . . . 0.0 107.133 -171.32 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 57.8 m -95.92 166.36 11.82 Favored 'General case' 0 N--CA 1.445 -0.716 0 N-CA-C 108.146 -1.057 . . . . 0.0 108.146 168.691 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 53.6 mt -134.61 18.57 3.59 Favored 'General case' 0 CA--C 1.531 0.239 0 O-C-N 121.364 -0.835 . . . . 0.0 110.752 -178.638 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 25.1 p -168.86 -0.22 0.02 OUTLIER 'General case' 0 CA--C 1.543 0.674 0 N-CA-C 115.584 1.698 . . . . 0.0 115.584 -176.357 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 162.6 -175.12 39.04 Favored Glycine 0 CA--C 1.526 0.769 0 CA-C-N 120.89 1.677 . . . . 0.0 112.607 179.83 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 17.9 m -128.65 127.01 41.35 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 125.065 1.346 . . . . 0.0 107.888 -176.243 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 58.06 34.26 72.19 Favored Glycine 0 CA--C 1.533 1.2 0 N-CA-C 110.624 -0.99 . . . . 0.0 110.624 -170.414 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . 0.286 7.7 p -80.3 69.17 0.5 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.657 0 C-N-CA 125.332 1.453 . . . . 0.0 110.437 -169.263 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 56.2 t30 55.67 49.22 16.83 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 127.146 2.178 . . . . 0.0 109.103 -173.553 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -154.27 143.98 15.34 Favored Pre-proline 0 CA--C 1.541 0.611 0 C-N-CA 126.918 2.087 . . . . 0.0 106.596 -169.237 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_exo -69.56 145.86 59.64 Favored 'Trans proline' 0 C--N 1.352 0.737 0 CA-C-N 120.912 1.361 . . . . 0.0 113.059 -173.246 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -73.18 -22.52 19.04 Favored 'Trans proline' 0 N--CA 1.461 -0.391 0 C-N-CA 122.209 1.939 . . . . 0.0 113.795 -170.754 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -57.85 -23.48 53.02 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-N 120.072 1.305 . . . . 0.0 111.627 177.378 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 99.6 m95 -72.05 -43.48 64.87 Favored 'General case' 0 N--CA 1.449 -0.478 0 C-N-CA 123.493 0.717 . . . . 0.0 111.252 176.235 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 4.9 m -78.1 -1.33 3.95 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.627 0 N-CA-C 112.582 0.586 . . . . 0.0 112.582 -179.094 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 63.3 p -115.9 22.33 13.11 Favored 'General case' 0 CA--C 1.538 0.514 0 N-CA-C 115.462 1.652 . . . . 0.0 115.462 -178.412 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 92.3 mm-40 -71.03 179.46 2.75 Favored 'General case' 0 CA--C 1.54 0.573 0 O-C-N 121.27 -0.894 . . . . 0.0 111.875 175.015 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 30.1 mm-40 -54.84 -28.47 49.99 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 124.146 0.978 . . . . 0.0 112.733 -169.085 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 6.8 tt -135.12 139.66 46.66 Favored 'Isoleucine or valine' 0 C--O 1.238 0.497 0 N-CA-C 104.569 -2.382 . . . . 0.0 104.569 168.477 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 47.6 t80 -126.57 140.43 52.44 Favored 'General case' 0 N--CA 1.447 -0.608 0 N-CA-C 106.383 -1.71 . . . . 0.0 106.383 169.567 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 44.0 mm-40 -142.08 163.86 31.73 Favored 'General case' 0 C--O 1.235 0.336 0 N-CA-C 107.409 -1.33 . . . . 0.0 107.409 169.88 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -167.51 131.63 1.82 Allowed 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 125.443 1.497 . . . . 0.0 107.46 -173.65 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 4.3 m-90 -150.65 143.44 24.58 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 107.897 -1.149 . . . . 0.0 107.897 -169.598 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 24.8 tt0 -84.81 82.28 8.51 Favored 'General case' 0 CA--C 1.537 0.48 0 N-CA-C 107.689 -1.226 . . . . 0.0 107.689 173.44 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -69.34 140.98 54.34 Favored 'General case' 0 N--CA 1.464 0.234 0 N-CA-C 108.667 -0.864 . . . . 0.0 108.667 172.719 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -73.68 157.2 37.0 Favored 'General case' 0 CA--C 1.537 0.449 0 N-CA-C 107.036 -1.468 . . . . 0.0 107.036 168.683 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -129.45 130.68 23.31 Favored Pre-proline 0 C--O 1.236 0.386 0 C-N-CA 123.77 0.828 . . . . 0.0 109.095 176.886 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_endo -86.14 -8.39 7.73 Favored 'Trans proline' 0 CA--C 1.54 0.821 0 C-N-CA 123.17 2.58 . . . . 0.0 115.245 -169.992 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -50.03 -51.04 45.38 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-N 120.171 1.351 . . . . 0.0 113.723 -169.093 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -84.21 9.26 64.39 Favored Glycine 0 CA--C 1.531 1.038 0 CA-C-O 118.368 -1.24 . . . . 0.0 113.953 -172.725 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 25.9 pt20 -148.04 -164.19 1.95 Allowed 'General case' 0 CA--C 1.544 0.712 0 CA-C-N 119.385 1.592 . . . . 0.0 112.531 -169.585 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 1.5 m -69.01 159.09 33.48 Favored 'General case' 0 CA--C 1.535 0.372 0 N-CA-C 117.567 2.432 . . . . 0.0 117.567 -167.726 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 56.5 tp -54.44 -34.69 61.91 Favored 'General case' 0 N--CA 1.465 0.32 0 C-N-CA 126.94 2.096 . . . . 0.0 111.713 170.124 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -62.12 -32.34 72.91 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 122.819 0.448 . . . . 0.0 110.773 177.498 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 5.3 t -76.42 -37.74 31.29 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.362 0 CA-C-O 117.894 -1.051 . . . . 0.0 109.892 177.649 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 54.0 m-85 -57.01 -47.97 79.59 Favored 'General case' 0 N--CA 1.474 0.767 0 CA-C-N 120.728 1.604 . . . . 0.0 109.579 171.155 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 75.3 mtt180 -59.23 -43.96 92.33 Favored 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 123.333 0.653 . . . . 0.0 110.858 178.152 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 17.1 m -64.44 -48.89 73.62 Favored 'General case' 0 N--CA 1.446 -0.663 0 C-N-CA 124.192 0.997 . . . . 0.0 110.396 178.606 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 64.9 t -70.39 -29.9 40.84 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.301 0 CA-C-N 119.019 0.827 . . . . 0.0 109.945 -169.937 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 30.7 mtm105 -57.04 -47.91 79.8 Favored 'General case' 0 C--O 1.226 -0.181 0 CA-C-N 119.404 1.002 . . . . 0.0 109.583 169.859 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -62.06 -48.52 82.63 Favored Glycine 0 CA--C 1.529 0.961 0 CA-C-O 119.258 -0.745 . . . . 0.0 112.0 177.697 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 86.1 mt-30 -55.66 -52.93 62.17 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-O 122.017 0.913 . . . . 0.0 110.104 -178.83 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 98.1 t -67.5 -44.9 86.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 115.102 -0.954 . . . . 0.0 109.596 -175.32 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 62.6 tttm -55.04 -46.34 75.31 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 119.435 1.016 . . . . 0.0 109.197 -179.041 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -67.64 -43.44 80.35 Favored 'General case' 0 N--CA 1.449 -0.524 0 C-N-CA 122.873 0.469 . . . . 0.0 111.366 -176.271 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 44.9 mtt-85 -66.63 -42.23 87.08 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-N 118.867 0.758 . . . . 0.0 111.082 178.047 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 81.1 t -64.99 -41.48 92.23 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.532 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 177.736 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 21.2 mt-10 -59.69 -41.36 90.52 Favored 'General case' 0 C--N 1.34 0.162 0 CA-C-N 119.768 1.167 . . . . 0.0 110.641 176.971 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 29.1 t-20 -62.54 -45.01 94.92 Favored 'General case' 0 CA--C 1.534 0.336 0 CA-C-N 118.166 0.439 . . . . 0.0 111.139 -179.635 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 1.5 tm? -58.45 -49.49 77.12 Favored 'General case' 0 CA--C 1.53 0.192 0 C-N-CA 124.26 1.024 . . . . 0.0 110.277 177.091 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 94.8 mt -63.87 -43.02 97.69 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.276 0 C-N-CA 123.887 0.875 . . . . 0.0 108.86 -179.518 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -62.56 -28.14 69.67 Favored 'General case' 0 CA--C 1.534 0.355 0 CA-C-N 118.902 0.774 . . . . 0.0 112.074 179.956 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 89.7 mttt -69.57 -54.52 13.68 Favored 'General case' 0 C--N 1.341 0.235 0 CA-C-N 118.769 0.713 . . . . 0.0 110.358 172.646 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 19.3 pt -77.64 -38.19 25.34 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.362 0 N-CA-C 114.586 1.328 . . . . 0.0 114.586 -169.395 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 74.7 m . . . . . 0 C--O 1.252 1.209 0 C-N-CA 126.162 1.785 . . . . 0.0 109.629 -169.748 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 8.0 ptm . . . . . 0 N--CA 1.497 1.898 0 N-CA-C 110.468 -0.197 . . . . 0.0 110.468 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 15.7 mttm -74.64 128.46 35.62 Favored 'General case' 0 N--CA 1.478 0.971 0 N-CA-C 107.83 -1.174 . . . . 0.0 107.83 -174.912 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 72.9 mttt -97.4 138.1 35.37 Favored 'General case' 0 CA--C 1.511 -0.522 0 CA-C-N 120.198 1.363 . . . . 0.0 108.26 172.432 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 12.1 t -119.31 152.22 21.72 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.678 0 C-N-CA 126.231 1.812 . . . . 0.0 106.66 -169.995 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 15.8 mtt -135.27 146.45 48.57 Favored 'General case' 0 C--N 1.322 -0.623 0 C-N-CA 124.897 1.279 . . . . 0.0 108.167 168.792 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 86.5 m-85 -133.74 125.47 28.63 Favored 'General case' 0 CA--C 1.516 -0.361 0 N-CA-C 103.921 -2.622 . . . . 0.0 103.921 171.332 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 1.3 p -150.03 142.61 17.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 118.975 0.807 . . . . 0.0 110.382 -169.014 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 20.9 t -125.1 -174.96 3.17 Favored 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 127.379 2.272 . . . . 0.0 106.552 169.597 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 39.0 ttpt -60.45 -42.16 95.59 Favored 'General case' 0 N--CA 1.472 0.65 0 O-C-N 120.822 -1.174 . . . . 0.0 111.508 -177.33 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 94.0 mtt180 -123.79 163.92 20.22 Favored 'General case' 0 N--CA 1.467 0.423 0 C-N-CA 123.764 0.826 . . . . 0.0 109.48 176.421 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -77.01 -27.75 54.75 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 122.41 0.284 . . . . 0.0 111.28 -179.511 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 1.3 m -69.16 -23.58 63.96 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 124.133 0.973 . . . . 0.0 113.385 -169.657 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 6.8 t -128.55 136.3 50.56 Favored 'General case' 0 C--N 1.339 0.143 0 N-CA-C 108.274 -1.01 . . . . 0.0 108.274 -174.612 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 9.1 mpt_? 61.72 -42.94 0.15 Allowed 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 128.533 2.733 . . . . 0.0 114.45 -176.549 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -75.08 41.13 0.16 Allowed 'General case' 0 CA--C 1.542 0.635 0 CA-C-N 120.268 1.394 . . . . 0.0 111.463 177.286 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 20.2 pt20 -135.11 154.16 51.76 Favored 'General case' 0 N--CA 1.441 -0.892 0 C-N-CA 127.455 2.302 . . . . 0.0 104.819 169.593 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER 66.41 -33.91 0.2 Allowed 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 126.216 1.806 . . . . 0.0 114.681 -178.648 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -64.62 -49.97 68.96 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 121.514 1.961 . . . . 0.0 109.865 179.671 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 4.5 pm0 -61.53 -37.8 85.06 Favored 'General case' 0 N--CA 1.453 -0.293 0 C-N-CA 124.42 1.088 . . . . 0.0 110.74 172.445 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -60.54 -55.31 30.67 Favored Glycine 0 C--N 1.337 0.627 0 N-CA-C 109.457 -1.457 . . . . 0.0 109.457 -176.926 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 6.3 m-85 -63.65 -33.23 75.16 Favored 'General case' 0 CA--C 1.509 -0.634 0 O-C-N 122.143 -0.622 . . . . 0.0 111.887 177.417 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -67.49 -38.2 83.99 Favored 'General case' 0 N--CA 1.445 -0.706 0 C-N-CA 119.839 -0.744 . . . . 0.0 110.926 -178.08 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.06 -37.58 87.96 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-N 118.701 0.682 . . . . 0.0 110.077 173.45 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 13.0 m -66.99 -55.39 14.66 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 123.675 0.79 . . . . 0.0 112.244 179.887 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 40.1 mt -76.28 -35.68 58.78 Favored 'General case' 0 C--N 1.327 -0.376 0 C-N-CA 124.636 1.175 . . . . 0.0 110.09 -171.158 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -94.39 12.17 69.27 Favored Glycine 0 CA--C 1.525 0.666 0 C-N-CA 125.233 1.397 . . . . 0.0 112.848 -178.778 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -51.01 122.2 7.17 Favored 'General case' 0 CA--C 1.533 0.29 0 CA-C-N 119.011 1.406 . . . . 0.0 110.623 -173.813 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 78.89 -16.26 8.81 Favored Glycine 0 CA--C 1.535 1.313 0 C-N-CA 124.791 1.186 . . . . 0.0 114.21 -179.519 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 59.7 mttt -89.68 -42.5 11.32 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-N 119.398 1.599 . . . . 0.0 110.806 179.152 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 12.4 pt -140.71 149.97 20.95 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.33 0 C-N-CA 123.543 0.737 . . . . 0.0 111.263 -169.031 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -95.51 157.89 15.69 Favored 'General case' 0 C--O 1.224 -0.243 0 C-N-CA 125.6 1.56 . . . . 0.0 108.039 172.584 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 20.0 t -139.74 135.19 38.89 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 N-CA-C 107.189 -1.412 . . . . 0.0 107.189 -175.413 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 14.0 m -142.76 106.87 4.72 Favored 'General case' 0 N--CA 1.446 -0.663 0 N-CA-C 107.401 -1.333 . . . . 0.0 107.401 177.896 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 58.9 m -90.15 99.63 12.61 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 107.986 -1.116 . . . . 0.0 107.986 169.501 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 11.1 p -68.56 -63.03 1.14 Allowed 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 124.296 1.038 . . . . 0.0 110.461 -178.587 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 94.05 136.09 7.99 Favored Glycine 0 N--CA 1.446 -0.646 0 N-CA-C 107.713 -2.155 . . . . 0.0 107.713 -172.373 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 10.2 mt -68.74 -31.05 69.82 Favored 'General case' 0 CA--C 1.533 0.315 0 N-CA-C 108.538 -0.912 . . . . 0.0 108.538 170.183 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 26.6 mt-10 -137.25 156.1 48.7 Favored 'General case' 0 N--CA 1.444 -0.727 0 C-N-CA 129.119 2.968 . . . . 0.0 104.855 168.752 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 78.5 p -142.46 155.05 45.04 Favored 'General case' 0 N--CA 1.446 -0.646 0 N-CA-C 115.465 1.654 . . . . 0.0 115.465 -174.407 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 51.1 m -163.17 179.25 7.59 Favored 'General case' 0 N--CA 1.447 -0.577 0 C-N-CA 131.257 3.823 . . . . 0.0 104.796 -169.337 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 16.4 ttt180 -81.56 179.16 7.95 Favored 'General case' 0 N--CA 1.469 0.487 0 N-CA-C 108.411 -0.959 . . . . 0.0 108.411 169.486 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 4.1 m -81.16 176.4 0.68 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.575 0 C-N-CA 124.864 1.266 . . . . 0.0 109.445 176.805 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 76.1 t60 -78.59 140.97 59.91 Favored Pre-proline 0 CA--C 1.545 0.772 0 CA-C-O 118.58 -0.724 . . . . 0.0 110.104 -178.403 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 20.4 Cg_endo -60.59 -50.3 7.06 Favored 'Trans proline' 0 C--N 1.348 0.525 0 C-N-CA 123.084 2.523 . . . . 0.0 113.592 -173.787 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 23.1 m -65.91 -21.52 66.45 Favored 'General case' 0 CA--C 1.533 0.324 0 CA-C-N 118.807 0.731 . . . . 0.0 110.813 -178.29 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -58.79 -45.03 90.79 Favored 'General case' 0 C--O 1.215 -0.733 0 O-C-N 121.386 -0.821 . . . . 0.0 109.453 174.576 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 62.6 mt -60.51 -43.72 94.95 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 N-CA-C 108.303 -0.999 . . . . 0.0 108.303 -173.598 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -64.9 -44.47 89.48 Favored 'General case' 0 CA--C 1.536 0.442 0 CA-C-O 121.282 0.563 . . . . 0.0 110.857 -179.632 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 33.6 mmt -66.33 -39.3 89.14 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-O 123.455 1.598 . . . . 0.0 110.779 -179.972 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -76.21 -29.8 57.75 Favored 'General case' 0 N--CA 1.44 -0.952 0 N-CA-C 106.296 -1.742 . . . . 0.0 106.296 -174.882 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 -70.27 -20.48 63.04 Favored 'General case' 0 N--CA 1.444 -0.765 0 C-N-CA 123.91 0.884 . . . . 0.0 110.438 169.525 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 59.0 mt-10 -64.55 -38.03 89.59 Favored 'General case' 0 C--N 1.345 0.375 0 CA-C-N 120.237 1.381 . . . . 0.0 108.787 169.405 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . 0.311 5.3 p -84.92 8.21 1.65 Allowed 'Isoleucine or valine' 0 CA--C 1.548 0.87 0 N-CA-C 112.272 0.471 . . . . 0.0 112.272 171.442 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 75.05 16.68 80.45 Favored Glycine 0 CA--C 1.533 1.19 0 C-N-CA 124.493 1.044 . . . . 0.0 113.523 175.494 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 43.9 mt -108.85 137.62 39.89 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.229 0 C-N-CA 124.487 1.115 . . . . 0.0 108.921 -177.016 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 21.1 t0 -102.22 145.34 29.56 Favored 'General case' 0 N--CA 1.462 0.153 0 CA-C-O 121.103 0.478 . . . . 0.0 110.208 169.69 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 11.2 pt -138.36 -15.11 0.53 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.633 0 C-N-CA 127.548 2.339 . . . . 0.0 111.325 178.223 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 13.0 t -39.39 -43.12 1.16 Allowed 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 125.883 1.673 . . . . 0.0 113.527 171.584 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -76.37 6.13 39.35 Favored Glycine 0 CA--C 1.532 1.111 0 CA-C-O 118.635 -1.092 . . . . 0.0 114.36 -175.01 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -68.57 130.18 42.09 Favored 'General case' 0 N--CA 1.448 -0.559 0 CA-C-N 119.736 1.768 . . . . 0.0 110.203 -178.43 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 5.2 t -168.18 161.3 12.31 Favored 'General case' 0 N--CA 1.44 -0.95 0 N-CA-C 106.067 -1.827 . . . . 0.0 106.067 167.047 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 15.0 m -173.87 161.38 3.76 Favored 'General case' 0 C--N 1.322 -0.598 0 C-N-CA 127.438 2.295 . . . . 0.0 106.746 -178.396 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -65.91 161.49 53.99 Favored Pre-proline 0 CA--C 1.542 0.652 0 CA-C-N 115.184 -0.917 . . . . 0.0 108.854 169.002 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -59.39 150.6 74.08 Favored 'Trans proline' 0 N--CA 1.457 -0.627 0 C-N-CA 121.545 1.497 . . . . 0.0 109.802 172.444 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 16.8 tt -57.3 -26.34 25.67 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.278 0 C-N-CA 123.433 0.693 . . . . 0.0 112.181 -174.681 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 11.6 mt-10 -65.42 -27.71 68.72 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 123.212 0.605 . . . . 0.0 110.453 -176.637 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 10.0 t-20 -65.23 -30.04 70.89 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 125.484 1.514 . . . . 0.0 111.71 178.662 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 78.0 m-85 -88.47 176.51 7.14 Favored 'General case' 0 C--O 1.236 0.374 0 C-N-CA 125.012 1.325 . . . . 0.0 111.543 -173.962 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 51.9 t-20 -126.56 129.06 47.84 Favored 'General case' 0 N--CA 1.447 -0.621 0 N-CA-C 107.278 -1.379 . . . . 0.0 107.278 169.136 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -73.11 -21.23 60.78 Favored 'General case' 0 N--CA 1.436 -1.139 0 N-CA-C 109.936 -0.394 . . . . 0.0 109.936 -177.208 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 36.0 t70 -65.06 -25.76 67.95 Favored 'General case' 0 N--CA 1.441 -0.897 0 O-C-N 123.617 0.573 . . . . 0.0 111.583 -179.446 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -74.76 -28.37 60.73 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 122.976 0.51 . . . . 0.0 111.477 176.022 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 18.1 m-85 -84.43 163.58 19.4 Favored 'General case' 0 N--CA 1.45 -0.443 0 C-N-CA 125.784 1.634 . . . . 0.0 110.585 -179.419 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 19.8 t70 -108.01 -36.91 6.21 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.624 178.591 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -142.7 139.4 28.33 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.31 0 CA-C-O 121.657 0.741 . . . . 0.0 110.316 -170.797 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 96.9 t -141.15 140.68 32.0 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.407 0 N-CA-C 106.631 -1.618 . . . . 0.0 106.631 -175.634 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 45.3 mm -132.7 121.41 44.77 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.429 0 N-CA-C 106.619 -1.623 . . . . 0.0 106.619 -173.913 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 67.4 m -91.31 115.13 27.78 Favored 'General case' 0 N--CA 1.449 -0.5 0 N-CA-C 106.657 -1.608 . . . . 0.0 106.657 169.359 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 69.7 mt -77.04 -13.75 59.91 Favored 'General case' 0 N--CA 1.466 0.343 0 C-N-CA 124.245 1.018 . . . . 0.0 111.693 -177.536 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 65.2 m -140.87 88.64 2.2 Favored 'General case' 0 N--CA 1.452 -0.328 0 C-N-CA 125.288 1.435 . . . . 0.0 108.478 -169.724 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 63.66 -155.57 44.36 Favored Glycine 0 CA--C 1.528 0.893 0 N-CA-C 110.562 -1.015 . . . . 0.0 110.562 -175.852 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 4.7 p -150.82 148.56 28.64 Favored 'General case' 0 C--O 1.236 0.363 0 C-N-CA 124.527 1.131 . . . . 0.0 109.166 179.64 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 62.48 28.92 72.02 Favored Glycine 0 CA--C 1.532 1.153 0 CA-C-O 119.696 -0.502 . . . . 0.0 112.189 -179.495 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 12.7 m -80.06 67.59 0.44 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.587 0 C-N-CA 124.661 1.185 . . . . 0.0 110.63 -170.007 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 1.3 t30 58.0 56.06 4.89 Favored 'General case' 0 N--CA 1.468 0.432 0 C-N-CA 126.298 1.839 . . . . 0.0 108.201 -173.714 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -142.67 142.26 22.44 Favored Pre-proline 0 CA--C 1.541 0.613 0 C-N-CA 126.215 1.806 . . . . 0.0 108.425 -169.086 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_exo -67.46 146.43 74.41 Favored 'Trans proline' 0 CA--C 1.54 0.779 0 C-N-CA 121.693 1.595 . . . . 0.0 113.518 -176.95 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 69.8 Cg_endo -72.43 -18.46 26.13 Favored 'Trans proline' 0 N--CA 1.46 -0.451 0 C-N-CA 122.535 2.157 . . . . 0.0 113.751 -171.975 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -57.07 -24.78 56.36 Favored 'General case' 0 CA--C 1.538 0.491 0 CA-C-N 119.944 1.247 . . . . 0.0 111.19 173.98 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 95.1 m95 -81.8 -31.35 31.83 Favored 'General case' 0 N--CA 1.451 -0.389 0 C-N-CA 124.088 0.955 . . . . 0.0 112.251 178.546 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 2.7 m -80.83 -6.5 9.73 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.362 0 CA-C-N 118.748 0.704 . . . . 0.0 112.245 178.022 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 5.4 t -137.04 77.08 1.62 Allowed 'General case' 0 CA--C 1.542 0.654 0 CA-C-O 122.768 1.271 . . . . 0.0 111.655 -175.329 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 91.0 mm-40 -114.33 -171.68 1.96 Allowed 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 125.064 1.346 . . . . 0.0 108.115 168.694 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 35.1 mm-40 -58.76 -28.03 65.52 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-N 118.9 0.773 . . . . 0.0 111.194 -172.348 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 5.3 tt -141.37 143.63 27.44 Favored 'Isoleucine or valine' 0 C--O 1.24 0.567 0 N-CA-C 104.737 -2.32 . . . . 0.0 104.737 168.346 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 63.9 t80 -133.8 145.65 49.96 Favored 'General case' 0 N--CA 1.447 -0.581 0 N-CA-C 105.905 -1.887 . . . . 0.0 105.905 169.286 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 24.1 mm-40 -136.26 145.48 45.63 Favored 'General case' 0 C--O 1.237 0.434 0 N-CA-C 107.903 -1.147 . . . . 0.0 107.903 171.685 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -115.9 135.79 53.65 Favored 'General case' 0 C--O 1.238 0.451 0 N-CA-C 107.146 -1.428 . . . . 0.0 107.146 169.703 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 30.2 m95 -138.68 178.77 6.9 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 124.462 1.105 . . . . 0.0 108.796 178.963 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 30.6 tt0 -138.5 77.39 1.62 Allowed 'General case' 0 CA--C 1.532 0.285 0 N-CA-C 106.013 -1.847 . . . . 0.0 106.013 169.467 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -68.26 144.09 55.01 Favored 'General case' 0 N--CA 1.466 0.37 0 N-CA-C 108.656 -0.868 . . . . 0.0 108.656 177.877 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -81.18 166.66 20.43 Favored 'General case' 0 N--CA 1.452 -0.363 0 N-CA-C 107.576 -1.268 . . . . 0.0 107.576 169.457 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -142.32 135.23 13.92 Favored Pre-proline 0 CA--C 1.535 0.385 0 O-C-N 121.803 -0.56 . . . . 0.0 111.193 179.076 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -84.21 2.47 8.15 Favored 'Trans proline' 0 CA--C 1.545 1.042 0 C-N-CA 123.416 2.744 . . . . 0.0 114.958 -172.3 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 2.9 t70 -45.29 122.77 3.63 Favored 'General case' 0 C--O 1.238 0.484 0 CA-C-N 120.121 1.328 . . . . 0.0 111.521 176.634 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 70.9 13.73 72.54 Favored Glycine 0 CA--C 1.533 1.171 0 CA-C-O 118.335 -1.258 . . . . 0.0 114.724 170.18 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 29.6 pt20 -130.14 -172.32 2.75 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-N 119.444 1.622 . . . . 0.0 111.165 175.889 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 3.3 m -68.83 156.85 37.66 Favored 'General case' 0 CA--C 1.535 0.374 0 N-CA-C 116.25 1.944 . . . . 0.0 116.25 -168.0 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -63.73 -27.42 69.19 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 125.017 1.327 . . . . 0.0 111.155 179.645 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 7.7 tp10 -60.17 -35.12 74.63 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-N 118.171 0.442 . . . . 0.0 110.164 173.346 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 3.4 t -74.08 -42.62 52.08 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.301 0 CA-C-O 118.234 -0.889 . . . . 0.0 109.154 179.018 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 61.1 m-85 -53.78 -50.28 66.41 Favored 'General case' 0 N--CA 1.472 0.645 0 CA-C-N 120.042 1.292 . . . . 0.0 109.644 171.599 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 95.5 mtt180 -67.5 -34.97 78.21 Favored 'General case' 0 N--CA 1.465 0.296 0 O-C-N 121.795 -0.566 . . . . 0.0 111.237 -175.46 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 6.6 m -62.77 -49.9 73.15 Favored 'General case' 0 N--CA 1.448 -0.56 0 C-N-CA 123.984 0.913 . . . . 0.0 109.547 171.292 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 96.7 t -70.06 -26.72 30.38 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.296 0 CA-C-O 117.485 -1.245 . . . . 0.0 109.897 -171.092 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 85.4 mtm-85 -57.29 -48.41 78.97 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-N 120.407 1.458 . . . . 0.0 109.58 169.58 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -63.18 -48.67 77.71 Favored Glycine 0 CA--C 1.53 1.012 0 CA-C-N 118.464 0.575 . . . . 0.0 111.877 178.912 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 17.8 mt-30 -61.51 -46.69 88.94 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-N 118.073 0.937 . . . . 0.0 110.895 -178.3 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 67.4 t -64.89 -46.21 92.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-O 118.504 -0.76 . . . . 0.0 109.27 -179.585 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 87.4 tttt -54.23 -48.22 71.32 Favored 'General case' 0 C--O 1.22 -0.457 0 CA-C-N 118.921 0.782 . . . . 0.0 109.018 -178.462 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 40.4 tt0 -64.12 -42.62 96.77 Favored 'General case' 0 N--CA 1.45 -0.471 0 O-C-N 123.252 0.345 . . . . 0.0 110.865 -173.385 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 52.9 mtt-85 -67.34 -43.31 81.86 Favored 'General case' 0 N--CA 1.468 0.445 0 O-C-N 121.656 -0.653 . . . . 0.0 111.02 177.987 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 77.2 t -65.55 -41.15 90.15 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.395 0 N-CA-C 109.734 -0.469 . . . . 0.0 109.734 179.378 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 26.3 mt-10 -59.02 -44.82 91.77 Favored 'General case' 0 N--CA 1.455 -0.221 0 CA-C-N 119.17 0.895 . . . . 0.0 109.971 177.271 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 29.2 t-20 -62.06 -43.31 99.1 Favored 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 122.575 0.35 . . . . 0.0 110.933 -178.323 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 1.8 tm? -59.36 -49.04 79.34 Favored 'General case' 0 N--CA 1.455 -0.201 0 C-N-CA 124.042 0.937 . . . . 0.0 110.529 176.726 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 96.4 mt -64.91 -42.81 95.81 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.258 0 C-N-CA 124.108 0.963 . . . . 0.0 108.933 -178.844 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -61.5 -30.22 70.48 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 123.347 0.659 . . . . 0.0 111.639 177.951 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 91.5 mttt -69.25 -55.75 9.62 Favored 'General case' 0 C--N 1.343 0.313 0 CA-C-N 118.933 0.788 . . . . 0.0 110.229 172.862 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 20.8 pt -74.52 -41.26 49.09 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.291 0 N-CA-C 114.017 1.117 . . . . 0.0 114.017 -169.523 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 72.5 m . . . . . 0 C--O 1.253 1.268 0 C-N-CA 126.226 1.81 . . . . 0.0 108.995 -169.558 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 9.9 ptm . . . . . 0 N--CA 1.498 1.939 0 N-CA-C 110.64 -0.133 . . . . 0.0 110.64 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 33.8 mttm -74.62 119.76 19.24 Favored 'General case' 0 N--CA 1.479 0.985 0 O-C-N 121.127 -0.983 . . . . 0.0 108.397 -170.711 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 90.2 mttt -85.33 135.15 34.02 Favored 'General case' 0 CA--C 1.515 -0.403 0 N-CA-C 108.07 -1.085 . . . . 0.0 108.07 174.894 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 1.6 t -121.81 147.13 25.98 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 C-N-CA 125.529 1.532 . . . . 0.0 109.37 -168.849 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 13.3 mtt -134.66 146.39 49.47 Favored 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 125.659 1.584 . . . . 0.0 109.544 169.399 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 41.2 m-85 -135.58 113.51 11.14 Favored 'General case' 0 N--CA 1.454 -0.274 0 N-CA-C 106.339 -1.726 . . . . 0.0 106.339 169.41 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 3.2 p -157.25 146.36 10.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 N-CA-C 109.029 -0.73 . . . . 0.0 109.029 -169.963 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 25.5 t -157.73 145.75 18.87 Favored 'General case' 0 C--N 1.328 -0.326 0 N-CA-C 105.593 -2.003 . . . . 0.0 105.593 168.839 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 5.6 tmtt? 51.81 -85.58 0.01 OUTLIER 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 126.078 1.751 . . . . 0.0 112.145 178.552 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 11.8 ptp180 -142.17 -178.82 5.9 Favored 'General case' 0 C--O 1.225 -0.198 0 CA-C-N 119.589 1.086 . . . . 0.0 111.09 178.706 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 1.7 t30 -57.49 -35.26 69.98 Favored 'General case' 0 N--CA 1.467 0.412 0 C-N-CA 124.416 1.086 . . . . 0.0 111.666 -179.21 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -70.95 -23.45 62.23 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 124.456 1.102 . . . . 0.0 113.05 -175.194 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 3.8 m -70.4 -159.61 0.04 OUTLIER 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 126.272 1.829 . . . . 0.0 111.994 -169.673 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 2.8 mpp_? -51.8 -25.52 7.87 Favored 'General case' 0 N--CA 1.481 1.112 0 O-C-N 119.808 -1.808 . . . . 0.0 112.34 175.638 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 1.4 m -41.89 -29.44 0.21 Allowed 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 126.74 2.016 . . . . 0.0 112.856 169.622 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 5.1 pt20 -54.47 -35.87 63.52 Favored 'General case' 0 C--O 1.22 -0.497 0 CA-C-O 117.491 -1.242 . . . . 0.0 113.218 178.328 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -105.66 -51.64 2.96 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-N 120.678 1.581 . . . . 0.0 114.727 -168.592 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -63.72 -34.8 78.68 Favored 'General case' 0 N--CA 1.471 0.61 0 N-CA-C 114.248 1.203 . . . . 0.0 114.248 -168.456 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 2.4 pp20? -64.95 -34.13 77.69 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-N 119.003 0.82 . . . . 0.0 110.103 172.783 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -51.29 -62.79 5.14 Favored Glycine 0 C--N 1.338 0.652 0 C-N-CA 125.847 1.689 . . . . 0.0 110.419 174.287 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 9.2 m-85 -63.13 -33.31 75.18 Favored 'General case' 0 CA--C 1.507 -0.7 0 CA-C-N 118.684 1.242 . . . . 0.0 113.434 179.985 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -67.42 -30.47 70.23 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 119.592 1.087 . . . . 0.0 111.376 -173.644 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 1.1 ptmt -70.32 -20.92 62.97 Favored 'General case' 0 CA--C 1.539 0.522 0 CA-C-N 119.288 0.949 . . . . 0.0 111.784 174.366 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 2.9 m -85.37 -57.39 3.09 Favored 'General case' 0 N--CA 1.45 -0.475 0 C-N-CA 125.537 1.535 . . . . 0.0 110.633 176.931 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 75.3 mt -73.98 -36.76 64.59 Favored 'General case' 0 N--CA 1.463 0.224 0 C-N-CA 123.989 0.915 . . . . 0.0 110.297 -172.617 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -93.36 8.9 74.95 Favored Glycine 0 CA--C 1.525 0.662 0 CA-C-O 118.486 -1.174 . . . . 0.0 112.813 -177.202 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -51.33 123.69 10.2 Favored 'General case' 0 CA--C 1.534 0.327 0 C-N-CA 124.806 1.242 . . . . 0.0 110.507 -174.962 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 76.48 -9.81 19.9 Favored Glycine 0 CA--C 1.533 1.17 0 CA-C-O 118.721 -1.044 . . . . 0.0 114.274 179.906 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 85.4 mttt -97.19 -49.66 4.88 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-N 119.478 1.639 . . . . 0.0 110.518 178.666 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 39.8 pt -137.57 147.64 26.29 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.537 0 C-N-CA 124.056 0.942 . . . . 0.0 108.772 -169.881 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -107.47 102.6 11.86 Favored 'General case' 0 C--O 1.225 -0.193 0 C-N-CA 124.949 1.3 . . . . 0.0 110.065 -169.582 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 6.2 t -85.69 125.19 40.55 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 N-CA-C 108.619 -0.882 . . . . 0.0 108.619 -179.531 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 23.4 m -151.85 97.71 2.38 Favored 'General case' 0 N--CA 1.453 -0.321 0 N-CA-C 103.957 -2.608 . . . . 0.0 103.957 173.105 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 18.0 m -94.99 1.12 55.16 Favored 'General case' 0 CA--C 1.535 0.386 0 N-CA-C 115.019 1.489 . . . . 0.0 115.019 -169.153 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 1.5 m 52.88 -147.52 0.47 Allowed 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 123.747 0.819 . . . . 0.0 110.767 -179.663 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -164.27 167.15 38.08 Favored Glycine 0 CA--C 1.525 0.69 0 N-CA-C 109.7 -1.36 . . . . 0.0 109.7 169.973 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 3.2 mt -133.64 143.72 48.77 Favored 'General case' 0 N--CA 1.446 -0.657 0 C-N-CA 127.67 2.388 . . . . 0.0 104.952 170.02 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 50.7 mt-10 65.46 -59.78 0.27 Allowed 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 127.227 2.211 . . . . 0.0 111.293 -173.755 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 65.1 m 67.11 152.78 0.08 Allowed 'General case' 0 N--CA 1.44 -0.935 0 C-N-CA 129.463 3.105 . . . . 0.0 115.894 170.043 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 15.2 m -177.62 -173.75 0.43 Allowed 'General case' 0 CA--C 1.545 0.764 1 C-N-CA 132.107 4.163 . . . . 0.0 102.607 -169.457 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 7.5 ttt180 -105.53 169.02 8.71 Favored 'General case' 0 N--CA 1.469 0.515 0 O-C-N 120.584 -1.323 . . . . 0.0 108.663 169.678 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 11.4 m -69.68 165.62 2.47 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.71 0 CA-C-N 115.649 -0.705 . . . . 0.0 109.415 175.827 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 90.3 m-70 -79.12 151.62 75.91 Favored Pre-proline 0 CA--C 1.537 0.446 0 CA-C-O 119.314 -0.374 . . . . 0.0 111.511 -174.89 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 39.9 Cg_endo -62.21 -46.12 13.57 Favored 'Trans proline' 0 C--N 1.346 0.43 0 C-N-CA 123.175 2.583 . . . . 0.0 111.772 -174.583 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 4.4 m -66.93 -28.24 68.13 Favored 'General case' 0 CA--C 1.531 0.25 0 O-C-N 121.949 -0.47 . . . . 0.0 110.02 -179.953 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -57.62 -54.56 45.52 Favored 'General case' 0 CA--C 1.511 -0.545 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 173.03 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 63.4 mt -59.55 -40.05 80.96 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.357 0 N-CA-C 108.607 -0.886 . . . . 0.0 108.607 -174.987 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -61.65 -43.49 98.75 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-N 119.004 0.82 . . . . 0.0 111.633 179.8 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 38.0 mmt -75.48 -36.52 60.62 Favored 'General case' 0 C--O 1.235 0.315 0 CA-C-O 122.806 1.289 . . . . 0.0 110.488 -177.285 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -71.58 -28.89 64.13 Favored 'General case' 0 N--CA 1.446 -0.643 0 N-CA-C 107.509 -1.293 . . . . 0.0 107.509 178.604 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 41.2 tt0 -73.78 -19.18 60.84 Favored 'General case' 0 N--CA 1.446 -0.63 0 C-N-CA 125.069 1.347 . . . . 0.0 110.563 169.958 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 76.1 mt-10 -64.09 -34.71 78.65 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-N 120.234 1.379 . . . . 0.0 108.681 169.146 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . 0.302 10.0 p -89.8 10.11 2.57 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.931 0 N-CA-C 112.434 0.531 . . . . 0.0 112.434 169.582 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 71.89 15.77 76.22 Favored Glycine 0 CA--C 1.533 1.162 0 O-C-N 120.761 -1.212 . . . . 0.0 113.767 175.926 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 22.3 mt -96.07 142.46 13.79 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.288 0 CA-C-N 118.42 1.11 . . . . 0.0 110.462 -175.473 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 8.9 t70 -91.78 129.66 37.7 Favored 'General case' 0 C--O 1.236 0.392 0 N-CA-C 108.192 -1.04 . . . . 0.0 108.192 169.574 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 10.1 pt -124.91 -27.21 1.52 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.657 0 C-N-CA 124.567 1.147 . . . . 0.0 110.166 169.7 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -37.12 -40.92 0.34 Allowed 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 129.746 3.218 . . . . 0.0 113.909 169.11 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -83.2 13.04 47.52 Favored Glycine 0 CA--C 1.534 1.251 0 C-N-CA 125.443 1.497 . . . . 0.0 114.566 -177.47 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -60.98 -34.84 75.41 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 119.607 1.703 . . . . 0.0 113.026 -176.026 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -70.3 131.89 44.86 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 123.539 0.736 . . . . 0.0 109.142 -170.677 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 26.0 m -158.29 -61.17 0.08 Allowed 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 123.463 0.705 . . . . 0.0 110.568 -179.526 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -150.98 153.31 32.93 Favored Pre-proline 0 N--CA 1.467 0.422 0 C-N-CA 123.424 0.69 . . . . 0.0 109.815 -175.007 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 96.4 Cg_endo -66.94 155.59 70.11 Favored 'Trans proline' 0 N--CA 1.454 -0.819 0 C-N-CA 122.53 2.153 . . . . 0.0 110.008 171.588 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 7.1 tt -59.94 -26.0 34.42 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.513 0 C-N-CA 123.326 0.65 . . . . 0.0 111.324 -179.242 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 14.8 mt-10 -67.71 -25.25 65.57 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 124.867 1.267 . . . . 0.0 110.636 -175.096 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 7.0 t-20 -63.89 -22.72 67.05 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 124.69 1.196 . . . . 0.0 112.047 177.648 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 70.0 m-85 -105.75 -174.1 2.46 Favored 'General case' 0 C--O 1.234 0.269 0 C-N-CA 126.424 1.889 . . . . 0.0 109.923 -175.89 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 54.3 t-20 -137.69 140.86 41.02 Favored 'General case' 0 N--CA 1.446 -0.654 0 N-CA-C 107.667 -1.235 . . . . 0.0 107.667 169.407 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -74.07 -25.13 59.65 Favored 'General case' 0 N--CA 1.435 -1.181 0 N-CA-C 109.19 -0.67 . . . . 0.0 109.19 -178.559 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -63.01 -24.35 67.88 Favored 'General case' 0 N--CA 1.447 -0.584 0 O-C-N 123.441 0.463 . . . . 0.0 111.643 178.937 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -77.71 -27.69 50.72 Favored 'General case' 0 C--O 1.236 0.361 0 C-N-CA 123.808 0.843 . . . . 0.0 112.37 175.991 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 11.6 m-85 -81.02 172.21 14.02 Favored 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 125.853 1.661 . . . . 0.0 112.099 -177.47 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 24.1 t70 -120.98 -37.72 2.93 Favored 'General case' 0 N--CA 1.464 0.234 0 C-N-CA 123.68 0.792 . . . . 0.0 111.678 175.824 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -139.38 136.76 41.05 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.328 0 CA-C-N 118.432 0.56 . . . . 0.0 110.498 -170.144 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 77.2 t -147.5 128.81 5.96 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.537 0 N-CA-C 106.516 -1.661 . . . . 0.0 106.516 -176.062 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 12.0 mm -109.17 128.09 65.36 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.473 0 N-CA-C 106.862 -1.533 . . . . 0.0 106.862 177.732 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 60.5 m -94.71 101.24 13.08 Favored 'General case' 0 N--CA 1.446 -0.671 0 N-CA-C 104.508 -2.404 . . . . 0.0 104.508 169.292 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 30.0 mt -66.73 -4.94 10.15 Favored 'General case' 0 N--CA 1.471 0.576 0 N-CA-C 113.931 1.085 . . . . 0.0 113.931 -169.775 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -151.04 151.82 32.58 Favored 'General case' 0 N--CA 1.45 -0.46 0 N-CA-C 106.335 -1.728 . . . . 0.0 106.335 168.744 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 54.75 -140.77 37.28 Favored Glycine 0 CA--C 1.533 1.166 0 C-N-CA 123.851 0.738 . . . . 0.0 111.701 174.647 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 16.0 m -132.71 -76.65 0.49 Allowed 'General case' 0 CA--C 1.529 0.163 0 N-CA-C 108.603 -0.888 . . . . 0.0 108.603 175.783 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -78.34 -40.45 19.55 Favored Glycine 0 C--N 1.34 0.793 0 CA-C-O 118.85 -0.972 . . . . 0.0 112.05 -179.156 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . 0.351 16.2 m 47.48 -94.27 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.547 0.838 0 C-N-CA 125.56 1.544 . . . . 0.0 112.629 -178.757 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 58.7 t30 -141.82 45.07 1.7 Allowed 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 124.653 1.181 . . . . 0.0 109.365 171.557 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 1.2 tt -136.25 140.58 33.24 Favored Pre-proline 0 CA--C 1.547 0.837 0 C-N-CA 126.591 1.956 . . . . 0.0 109.384 -169.517 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -67.96 149.98 77.79 Favored 'Trans proline' 0 CA--C 1.541 0.873 0 C-N-CA 121.649 1.566 . . . . 0.0 113.668 -172.173 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -69.37 -27.66 28.07 Favored 'Trans proline' 0 N--CA 1.461 -0.423 0 C-N-CA 122.622 2.214 . . . . 0.0 115.502 -169.587 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 4.3 pm0 -61.91 -17.05 55.34 Favored 'General case' 0 CA--C 1.539 0.557 0 CA-C-N 121.432 1.924 . . . . 0.0 111.954 178.684 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 99.6 m95 -78.01 -42.04 33.86 Favored 'General case' 0 N--CA 1.447 -0.583 0 C-N-CA 123.8 0.84 . . . . 0.0 110.933 175.424 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 1.6 m -74.49 -7.72 10.46 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.26 0 C-N-CA 123.469 0.708 . . . . 0.0 111.97 -179.317 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 74.4 p -109.15 18.47 20.53 Favored 'General case' 0 C--O 1.238 0.49 0 N-CA-C 113.837 1.051 . . . . 0.0 113.837 -178.132 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 91.9 mm-40 -68.56 171.03 8.11 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-N 118.539 0.609 . . . . 0.0 111.644 176.912 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 32.8 mm-40 -56.03 -30.23 61.57 Favored 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 123.995 0.918 . . . . 0.0 112.929 -168.83 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 4.0 tt -130.54 114.73 29.04 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.345 0 N-CA-C 105.018 -2.216 . . . . 0.0 105.018 169.014 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 22.5 t80 -100.65 134.41 43.66 Favored 'General case' 0 C--O 1.236 0.392 0 N-CA-C 105.63 -1.989 . . . . 0.0 105.63 169.388 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 11.4 mm-40 -142.69 164.21 30.71 Favored 'General case' 0 C--N 1.329 -0.289 0 C-N-CA 124.451 1.1 . . . . 0.0 109.18 179.247 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 2.3 t70 -170.02 129.87 0.95 Allowed 'General case' 0 C--O 1.237 0.445 0 C-N-CA 128.192 2.597 . . . . 0.0 106.618 -169.954 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 10.0 m0 -140.8 147.91 39.79 Favored 'General case' 0 C--O 1.234 0.242 0 C-N-CA 123.33 0.652 . . . . 0.0 111.836 -169.814 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 18.4 mp0 -74.06 111.64 9.42 Favored 'General case' 0 C--O 1.234 0.285 0 N-CA-C 105.294 -2.114 . . . . 0.0 105.294 169.345 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 44.3 mt -146.03 128.34 15.83 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 104.323 -2.473 . . . . 0.0 104.323 178.604 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 61.4 mm-40 -76.99 156.07 32.16 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-N 119.197 0.908 . . . . 0.0 110.044 179.417 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 55.6 t0 -100.39 111.37 62.48 Favored Pre-proline 0 N--CA 1.448 -0.567 0 N-CA-C 105.612 -1.996 . . . . 0.0 105.612 168.882 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 96.3 Cg_endo -73.75 -0.08 8.92 Favored 'Trans proline' 0 CA--C 1.541 0.843 0 C-N-CA 122.913 2.408 . . . . 0.0 113.643 -175.834 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -47.61 128.96 13.37 Favored 'General case' 0 C--O 1.237 0.445 0 CA-C-N 119.468 1.031 . . . . 0.0 111.268 173.748 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 70.99 12.17 71.04 Favored Glycine 0 CA--C 1.53 1.017 0 CA-C-O 118.523 -1.154 . . . . 0.0 114.236 169.953 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 29.5 pt20 -133.15 -172.83 3.04 Favored 'General case' 0 CA--C 1.536 0.414 0 CA-C-N 119.029 1.415 . . . . 0.0 110.763 176.282 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 3.2 m -68.59 156.55 37.88 Favored 'General case' 0 CA--C 1.532 0.256 0 N-CA-C 116.161 1.912 . . . . 0.0 116.161 -167.964 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 48.7 mt -60.47 -28.49 68.38 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 125.05 1.34 . . . . 0.0 111.146 174.758 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 40.1 tt0 -58.19 -37.22 74.32 Favored 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 122.919 0.487 . . . . 0.0 110.34 173.168 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 3.5 t -75.12 -43.95 44.09 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.31 0 CA-C-O 117.866 -1.064 . . . . 0.0 109.34 179.195 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 59.9 m-85 -53.67 -47.45 70.38 Favored 'General case' 0 N--CA 1.474 0.759 0 CA-C-N 120.399 1.454 . . . . 0.0 110.404 172.873 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 92.5 mtt180 -72.88 -35.17 67.1 Favored 'General case' 0 N--CA 1.466 0.344 0 O-C-N 121.612 -0.68 . . . . 0.0 111.428 -175.785 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 4.0 m -60.77 -49.67 76.56 Favored 'General case' 0 N--CA 1.448 -0.551 0 N-CA-C 109.003 -0.74 . . . . 0.0 109.003 171.103 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 75.0 t -65.02 -38.4 82.68 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.415 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 -176.647 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 52.5 ttp85 -57.37 -44.88 84.79 Favored 'General case' 0 CA--C 1.539 0.528 0 CA-C-N 118.734 0.697 . . . . 0.0 110.234 176.244 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -65.65 -50.02 56.61 Favored Glycine 0 CA--C 1.532 1.146 0 CA-C-N 118.609 0.641 . . . . 0.0 112.143 174.915 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 40.8 mm-40 -58.69 -48.78 79.94 Favored 'General case' 0 N--CA 1.464 0.252 0 C-N-CA 123.776 0.83 . . . . 0.0 110.454 -176.215 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 87.7 t -66.27 -40.31 86.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-O 118.234 -0.889 . . . . 0.0 110.236 -175.724 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 57.2 tttm -54.28 -45.12 72.39 Favored 'General case' 0 N--CA 1.462 0.139 0 CA-C-N 119.374 0.988 . . . . 0.0 109.075 177.669 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -67.71 -43.03 81.02 Favored 'General case' 0 CA--C 1.54 0.595 0 CA-C-O 119.154 -0.451 . . . . 0.0 111.658 -177.631 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 29.0 mmt180 -58.53 -47.4 84.3 Favored 'General case' 0 N--CA 1.477 0.886 0 CA-C-N 119.31 0.959 . . . . 0.0 110.845 175.373 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 77.0 t -69.43 -37.59 75.5 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.536 0 CA-C-O 118.673 -0.679 . . . . 0.0 109.25 -176.361 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 28.4 mt-10 -59.0 -44.42 91.65 Favored 'General case' 0 C--N 1.339 0.149 0 CA-C-N 120.089 1.313 . . . . 0.0 110.047 173.315 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 29.1 t-20 -62.41 -44.32 96.72 Favored 'General case' 0 CA--C 1.53 0.174 0 C-N-CA 122.661 0.384 . . . . 0.0 110.918 -179.431 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 39.1 tp -57.91 -48.44 79.89 Favored 'General case' 0 N--CA 1.454 -0.25 0 C-N-CA 124.166 0.986 . . . . 0.0 110.944 176.76 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 62.4 mt -65.47 -45.15 93.66 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.266 0 N-CA-C 107.705 -1.22 . . . . 0.0 107.705 -178.407 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -59.27 -29.08 67.31 Favored 'General case' 0 CA--C 1.54 0.592 0 CA-C-O 118.855 -0.593 . . . . 0.0 112.124 177.114 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 94.5 mttt -70.05 -57.29 5.15 Favored 'General case' 0 C--N 1.343 0.321 0 CA-C-N 119.09 0.859 . . . . 0.0 110.604 172.379 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 9.5 pt -80.79 -42.84 20.8 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.334 0 N-CA-C 115.659 1.726 . . . . 0.0 115.659 -168.497 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 51.0 m . . . . . 0 C--O 1.251 1.184 0 C-N-CA 124.979 1.312 . . . . 0.0 110.387 -169.861 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 11.8 ptm . . . . . 0 N--CA 1.497 1.919 0 N-CA-C 110.57 -0.159 . . . . 0.0 110.57 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 25.3 mttm -75.55 120.84 21.52 Favored 'General case' 0 N--CA 1.479 1.018 0 N-CA-C 107.907 -1.145 . . . . 0.0 107.907 -171.806 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 89.8 mttt -89.38 134.85 33.9 Favored 'General case' 0 CA--C 1.515 -0.367 0 N-CA-C 108.069 -1.085 . . . . 0.0 108.069 177.548 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 1.5 t -119.69 149.59 22.3 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.619 0 C-N-CA 126.997 2.119 . . . . 0.0 108.789 -169.229 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 26.5 mtt -137.32 145.96 44.03 Favored 'General case' 0 C--N 1.325 -0.493 0 C-N-CA 124.849 1.26 . . . . 0.0 108.484 168.686 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 49.3 m-85 -138.12 132.48 32.05 Favored 'General case' 0 C--O 1.234 0.249 0 N-CA-C 105.661 -1.978 . . . . 0.0 105.661 171.132 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 2.1 p -163.13 143.86 2.62 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.189 0 CA-C-N 118.459 0.572 . . . . 0.0 111.035 -170.023 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 45.2 t -136.34 177.97 7.42 Favored 'General case' 0 CA--C 1.547 0.861 0 C-N-CA 127.758 2.423 . . . . 0.0 105.877 168.367 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 27.1 ttpp -59.58 -22.6 61.99 Favored 'General case' 0 N--CA 1.474 0.748 0 N-CA-C 113.874 1.064 . . . . 0.0 113.874 -169.804 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 84.9 mmt-85 -138.24 155.78 48.31 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-N 119.755 1.162 . . . . 0.0 107.871 169.886 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 46.6 t30 -71.09 -35.44 71.83 Favored 'General case' 0 CA--C 1.535 0.384 0 CA-C-O 121.279 0.561 . . . . 0.0 109.839 173.377 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 1.2 m -61.34 -25.26 67.02 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 125.012 1.325 . . . . 0.0 112.928 -174.993 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 14.2 m -138.37 125.28 21.17 Favored 'General case' 0 N--CA 1.455 -0.199 0 C-N-CA 123.46 0.704 . . . . 0.0 109.481 -172.73 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . 0.42 ' H ' ' CG ' ' A' ' 103' ' ' ASP 0.259 27.2 ttt180 59.57 31.05 20.72 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 126.878 2.071 . . . . 0.0 112.831 175.775 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 20.4 m -131.71 -122.18 0.2 Allowed 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 103.363 -2.829 . . . . 0.0 103.363 168.783 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . 0.352 17.7 pt20 54.79 -57.9 0.02 OUTLIER 'General case' 0 N--CA 1.452 -0.33 0 C-N-CA 129.507 3.123 . . . . 0.0 115.951 171.995 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 5.4 tpt -107.34 -16.79 14.3 Favored 'General case' 0 N--CA 1.45 -0.447 0 N-CA-C 116.588 2.07 . . . . 0.0 116.588 -169.659 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -65.63 -45.39 83.25 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 120.182 1.356 . . . . 0.0 109.027 174.189 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 2.8 pm0 -66.55 -37.25 84.57 Favored 'General case' 0 N--CA 1.45 -0.427 0 C-N-CA 124.818 1.247 . . . . 0.0 110.439 170.034 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -61.98 -45.35 96.31 Favored Glycine 0 C--N 1.339 0.746 0 C-N-CA 124.37 0.986 . . . . 0.0 111.997 -178.536 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 24.9 m-85 -73.82 -31.13 63.08 Favored 'General case' 0 CA--C 1.509 -0.597 0 CA-C-N 119.056 1.428 . . . . 0.0 113.717 170.981 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -65.49 -34.17 77.65 Favored 'General case' 0 C--O 1.225 -0.203 0 CA-C-N 120.531 1.514 . . . . 0.0 111.333 -172.493 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 17.1 ptpt -61.66 -27.72 68.88 Favored 'General case' 0 N--CA 1.475 0.795 0 CA-C-N 119.026 0.83 . . . . 0.0 112.392 170.945 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 2.1 m -84.27 -56.34 3.7 Favored 'General case' 0 N--CA 1.451 -0.382 0 C-N-CA 125.291 1.436 . . . . 0.0 109.817 -178.099 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 75.7 mt -72.72 -36.44 67.8 Favored 'General case' 0 CA--C 1.529 0.138 0 C-N-CA 124.068 0.947 . . . . 0.0 110.021 -173.232 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -96.7 9.26 66.32 Favored Glycine 0 CA--C 1.526 0.771 0 C-N-CA 125.159 1.361 . . . . 0.0 112.943 -175.737 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -48.83 122.88 6.16 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 124.989 1.316 . . . . 0.0 110.71 -175.41 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 77.33 -11.78 16.11 Favored Glycine 0 CA--C 1.533 1.203 0 C-N-CA 124.404 1.002 . . . . 0.0 114.589 178.953 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 63.7 mttm -96.68 -46.11 6.42 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-N 119.265 1.532 . . . . 0.0 110.571 179.908 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 29.6 pt -138.62 147.64 25.07 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.58 0 C-N-CA 123.547 0.739 . . . . 0.0 110.087 -169.577 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -107.77 107.82 18.76 Favored 'General case' 0 N--CA 1.467 0.389 0 C-N-CA 125.196 1.398 . . . . 0.0 109.679 -171.471 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 8.3 t -78.44 139.53 18.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 119.152 0.887 . . . . 0.0 109.117 176.385 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 4.2 m -139.79 115.78 10.32 Favored 'General case' 0 N--CA 1.436 -1.145 0 N-CA-C 105.176 -2.157 . . . . 0.0 105.176 169.899 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 4.5 m -90.34 45.3 1.25 Allowed 'General case' 0 C--N 1.32 -0.679 0 O-C-N 121.416 -0.803 . . . . 0.0 112.399 -170.831 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 2.6 m -67.15 165.35 16.16 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 124.484 1.114 . . . . 0.0 111.801 -178.577 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -177.1 -177.09 45.76 Favored Glycine 0 N--CA 1.444 -0.77 0 N-CA-C 106.081 -2.808 . . . . 0.0 106.081 -170.22 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 19.1 mt -104.76 -14.88 15.4 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 117.754 0.777 . . . . 0.0 111.152 179.047 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -144.12 155.26 43.87 Favored 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 128.227 2.611 . . . . 0.0 105.388 168.984 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 1.9 m -164.25 169.8 17.1 Favored 'General case' 0 N--CA 1.449 -0.485 0 CA-C-O 122.277 1.037 . . . . 0.0 110.994 175.379 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 62.7 p -153.14 -172.37 4.22 Favored 'General case' 0 N--CA 1.439 -1.023 0 C-N-CA 126.385 1.874 . . . . 0.0 107.304 -169.182 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 7.5 ttt180 -91.62 168.98 11.11 Favored 'General case' 0 C--N 1.331 -0.237 0 O-C-N 121.19 -0.943 . . . . 0.0 109.587 170.473 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 19.8 m -71.28 170.55 1.27 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.805 0 C-N-CA 123.543 0.737 . . . . 0.0 109.585 -178.824 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 74.1 t60 -71.44 138.71 83.8 Favored Pre-proline 0 CA--C 1.546 0.818 0 CA-C-O 118.391 -0.814 . . . . 0.0 109.274 172.989 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -59.29 -49.46 10.76 Favored 'Trans proline' 0 C--N 1.349 0.556 0 C-N-CA 123.231 2.621 . . . . 0.0 113.899 -173.654 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 22.6 m -66.13 -17.18 64.55 Favored 'General case' 0 CA--C 1.539 0.521 0 CA-C-N 118.842 0.746 . . . . 0.0 111.168 -178.471 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -60.62 -49.0 79.3 Favored 'General case' 0 C--O 1.215 -0.715 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 173.253 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 52.4 mt -58.49 -41.05 80.69 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 N-CA-C 108.288 -1.005 . . . . 0.0 108.288 -173.44 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -66.27 -50.76 62.6 Favored 'General case' 0 N--CA 1.45 -0.434 0 CA-C-N 118.229 0.468 . . . . 0.0 111.597 -179.99 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 31.9 mmt -69.15 -34.2 74.62 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-O 122.825 1.297 . . . . 0.0 111.087 -177.047 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 20.8 mmt -77.81 -28.66 50.42 Favored 'General case' 0 N--CA 1.441 -0.899 0 O-C-N 120.784 -1.197 . . . . 0.0 108.277 -177.355 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 -70.87 -23.32 62.28 Favored 'General case' 0 N--CA 1.449 -0.479 0 O-C-N 121.372 -0.83 . . . . 0.0 109.692 169.652 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 18.2 mm-40 -68.14 -30.66 69.85 Favored 'General case' 0 CA--C 1.531 0.242 0 CA-C-N 119.203 0.91 . . . . 0.0 110.443 170.984 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . 0.286 3.1 p -87.64 9.43 2.04 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.918 0 CA-C-N 118.807 0.73 . . . . 0.0 111.264 169.205 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 81.41 17.69 70.66 Favored Glycine 0 CA--C 1.531 1.057 0 C-N-CA 124.667 1.127 . . . . 0.0 113.75 172.449 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 39.5 mt -116.28 139.35 43.39 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.295 0 CA-C-N 119.107 1.453 . . . . 0.0 110.625 -176.618 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -100.73 136.16 41.04 Favored 'General case' 0 C--O 1.235 0.319 0 N-CA-C 109.236 -0.653 . . . . 0.0 109.236 169.141 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 15.8 pt -128.36 -13.43 3.01 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.499 0 C-N-CA 125.439 1.496 . . . . 0.0 112.414 176.172 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 93.2 p -44.38 -38.21 3.84 Favored 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 125.467 1.507 . . . . 0.0 114.552 176.143 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -87.12 2.86 87.05 Favored Glycine 0 CA--C 1.529 0.912 0 CA-C-O 118.81 -0.995 . . . . 0.0 114.091 -172.92 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 26.8 mt-30 -75.81 120.11 20.73 Favored 'General case' 0 CA--C 1.514 -0.44 0 CA-C-N 119.615 1.708 . . . . 0.0 111.28 -170.182 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 7.7 t -162.13 167.0 24.95 Favored 'General case' 0 N--CA 1.436 -1.132 0 N-CA-C 106.671 -1.603 . . . . 0.0 106.671 167.391 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 40.4 m -154.32 164.38 38.67 Favored 'General case' 0 N--CA 1.448 -0.558 0 C-N-CA 126.195 1.798 . . . . 0.0 107.236 -177.548 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -60.18 163.25 8.53 Favored Pre-proline 0 CA--C 1.54 0.586 0 C-N-CA 124.514 1.125 . . . . 0.0 110.704 169.973 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -61.36 151.19 81.12 Favored 'Trans proline' 0 N--CA 1.456 -0.692 0 C-N-CA 121.584 1.523 . . . . 0.0 109.478 172.565 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 5.6 tt -61.59 -24.23 33.22 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.536 0 O-C-N 121.648 -0.658 . . . . 0.0 111.254 -173.289 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 12.3 mt-10 -67.59 -25.52 65.81 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 125.352 1.461 . . . . 0.0 110.803 -177.064 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 12.2 t-20 -63.07 -26.12 68.69 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 125.006 1.322 . . . . 0.0 111.904 178.612 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 39.2 m-85 -105.07 -169.68 1.64 Allowed 'General case' 0 C--O 1.236 0.37 0 C-N-CA 126.464 1.906 . . . . 0.0 109.762 -176.357 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 55.3 t-20 -135.98 138.81 42.66 Favored 'General case' 0 N--CA 1.445 -0.688 0 N-CA-C 106.526 -1.657 . . . . 0.0 106.526 168.753 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -72.18 -27.16 62.39 Favored 'General case' 0 N--CA 1.431 -1.379 0 N-CA-C 108.576 -0.898 . . . . 0.0 108.576 -178.768 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 35.8 t70 -67.04 -20.93 65.92 Favored 'General case' 0 N--CA 1.443 -0.778 0 C-N-CA 120.728 -0.389 . . . . 0.0 111.388 -177.55 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 35.2 t70 -80.13 -29.74 38.93 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 124.278 1.031 . . . . 0.0 111.697 173.672 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 11.2 m-85 -77.51 168.59 19.74 Favored 'General case' 0 C--O 1.237 0.446 0 C-N-CA 125.176 1.39 . . . . 0.0 110.926 177.551 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -119.29 -38.56 3.01 Favored 'General case' 0 C--O 1.235 0.309 0 C-N-CA 123.098 0.559 . . . . 0.0 111.491 178.728 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -139.32 134.62 40.44 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.494 0 CA-C-O 121.565 0.698 . . . . 0.0 110.196 -169.921 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 57.0 t -142.5 139.66 28.86 Favored 'Isoleucine or valine' 0 C--O 1.236 0.369 0 N-CA-C 106.082 -1.822 . . . . 0.0 106.082 -179.85 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 23.8 mm -125.63 122.07 61.51 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.572 0 N-CA-C 105.859 -1.904 . . . . 0.0 105.859 -177.388 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 36.0 m -95.4 97.06 9.54 Favored 'General case' 0 N--CA 1.447 -0.586 0 N-CA-C 106.019 -1.845 . . . . 0.0 106.019 169.731 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 67.6 mt -63.04 -18.6 63.53 Favored 'General case' 0 N--CA 1.463 0.207 0 C-N-CA 122.756 0.422 . . . . 0.0 111.092 -178.629 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 14.3 p -152.78 166.55 31.87 Favored 'General case' 0 N--CA 1.448 -0.54 0 N-CA-C 106.7 -1.593 . . . . 0.0 106.7 168.847 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 73.36 -165.52 54.79 Favored Glycine 0 CA--C 1.533 1.194 0 CA-C-O 121.381 0.434 . . . . 0.0 113.053 172.764 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 34.9 p -151.88 -168.21 3.01 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 125.548 1.539 . . . . 0.0 109.318 -169.873 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -73.36 60.74 1.91 Allowed Glycine 0 CA--C 1.534 1.277 0 C-N-CA 124.449 1.023 . . . . 0.0 110.644 170.743 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 7.3 p -72.66 -55.11 14.09 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.398 0 C-N-CA 124.987 1.315 . . . . 0.0 110.823 -169.87 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 36.7 p-10 -135.99 24.93 3.32 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 127.12 2.168 . . . . 0.0 108.6 170.053 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 2.8 tt -116.15 135.52 22.82 Favored Pre-proline 0 CA--C 1.537 0.446 0 C-N-CA 127.076 2.15 . . . . 0.0 107.881 -169.491 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -63.55 141.96 82.33 Favored 'Trans proline' 0 CA--C 1.541 0.84 0 CA-C-N 120.518 1.221 . . . . 0.0 114.78 -169.313 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 75.4 Cg_exo -60.33 -33.97 93.96 Favored 'Trans proline' 0 C--N 1.35 0.614 0 C-N-CA 122.1 1.867 . . . . 0.0 115.106 -171.425 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 4.0 pm0 -62.41 -13.62 31.6 Favored 'General case' 0 CA--C 1.536 0.435 0 CA-C-N 119.817 1.189 . . . . 0.0 112.349 -177.721 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 99.1 m95 -80.51 -32.31 36.95 Favored 'General case' 0 CA--C 1.53 0.191 0 CA-C-N 118.61 0.641 . . . . 0.0 111.825 173.83 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 25.1 m -96.3 -3.52 10.27 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.472 0 C-N-CA 124.913 1.285 . . . . 0.0 112.822 -179.309 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . 0.263 6.5 t -130.99 65.54 1.55 Allowed 'General case' 0 CA--C 1.541 0.604 0 CA-C-O 123.465 1.602 . . . . 0.0 108.132 169.634 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 32.9 mm-40 -80.56 -175.85 5.43 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 125.668 1.587 . . . . 0.0 109.603 169.516 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 36.4 mm-40 -63.06 -28.25 69.96 Favored 'General case' 0 CA--C 1.54 0.563 0 O-C-N 121.869 -0.52 . . . . 0.0 110.118 175.121 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 3.8 tt -141.01 134.58 31.89 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.358 0 C-N-CA 126.69 1.996 . . . . 0.0 105.675 169.319 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 57.0 t80 -126.11 137.57 53.61 Favored 'General case' 0 N--CA 1.448 -0.543 0 N-CA-C 107.556 -1.276 . . . . 0.0 107.556 169.789 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 8.5 mm-40 -138.11 167.03 22.67 Favored 'General case' 0 C--O 1.236 0.372 0 CA-C-O 122.248 1.023 . . . . 0.0 109.223 175.186 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -168.74 133.0 1.51 Allowed 'General case' 0 C--N 1.325 -0.488 0 C-N-CA 129.267 3.027 . . . . 0.0 105.606 -170.121 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 8.2 m0 -142.87 147.66 35.72 Favored 'General case' 0 C--O 1.232 0.18 0 C-N-CA 123.126 0.57 . . . . 0.0 110.136 -169.833 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 84.6 mt-30 -83.59 52.69 2.31 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 124.301 1.041 . . . . 0.0 108.914 172.362 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 16.3 mt -70.59 123.42 21.8 Favored 'General case' 0 C--N 1.339 0.113 0 N-CA-C 107.546 -1.279 . . . . 0.0 107.546 176.328 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 5.6 pt-20 -71.87 163.6 27.55 Favored 'General case' 0 CA--C 1.54 0.564 0 N-CA-C 109.139 -0.689 . . . . 0.0 109.139 169.759 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . 0.42 ' CG ' ' H ' ' A' ' 14' ' ' ARG . 13.7 t70 -138.66 139.61 24.92 Favored Pre-proline 0 CA--C 1.538 0.489 0 C-N-CA 124.132 0.973 . . . . 0.0 110.158 -173.198 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 39.5 Cg_endo -86.68 0.01 7.95 Favored 'Trans proline' 0 CA--C 1.543 0.96 0 C-N-CA 122.716 2.277 . . . . 0.0 114.651 -170.436 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -48.59 118.96 2.77 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-N 120.43 1.468 . . . . 0.0 111.221 -177.903 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 72.21 14.15 76.63 Favored Glycine 0 CA--C 1.534 1.249 0 CA-C-O 118.193 -1.337 . . . . 0.0 114.544 172.538 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 16.6 pt20 -128.23 172.26 11.19 Favored 'General case' 0 CA--C 1.541 0.605 0 CA-C-N 119.455 1.628 . . . . 0.0 111.827 176.448 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 9.9 m -65.78 165.18 13.25 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 125.851 1.66 . . . . 0.0 115.133 -168.644 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -60.68 -26.68 67.28 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 125.678 1.591 . . . . 0.0 112.614 -173.993 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 -56.07 -35.14 66.65 Favored 'General case' 0 N--CA 1.461 0.113 0 CA-C-N 118.687 0.676 . . . . 0.0 111.105 173.054 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 4.1 t -77.18 -40.98 30.41 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.558 0 CA-C-O 118.214 -0.898 . . . . 0.0 109.733 -178.036 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 83.6 m-85 -57.5 -46.44 83.75 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-N 120.29 1.404 . . . . 0.0 109.93 171.926 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 91.4 mtt180 -62.94 -41.35 99.46 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 123.274 0.629 . . . . 0.0 110.915 -179.906 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 8.7 m -63.13 -48.56 77.98 Favored 'General case' 0 N--CA 1.449 -0.522 0 C-N-CA 124.704 1.202 . . . . 0.0 110.178 175.525 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 75.4 t -68.72 -31.65 51.73 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.28 0 CA-C-O 118.481 -0.771 . . . . 0.0 109.703 -172.679 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 34.7 mtm105 -57.7 -50.16 74.11 Favored 'General case' 0 C--O 1.226 -0.15 0 CA-C-N 119.521 1.055 . . . . 0.0 110.497 171.399 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -60.74 -51.48 58.35 Favored Glycine 0 CA--C 1.529 0.955 0 N-CA-C 111.22 -0.752 . . . . 0.0 111.22 178.755 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 15.1 mm-40 -58.24 -52.15 66.76 Favored 'General case' 0 N--CA 1.464 0.235 0 C-N-CA 123.911 0.885 . . . . 0.0 110.658 -176.269 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 69.4 t -74.47 -39.48 47.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-O 118.357 -0.83 . . . . 0.0 110.339 -171.91 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 59.8 tttm -54.79 -44.7 73.99 Favored 'General case' 0 CA--C 1.517 -0.29 0 CA-C-N 119.134 0.879 . . . . 0.0 108.871 175.798 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 45.1 tt0 -64.79 -42.99 94.64 Favored 'General case' 0 CA--C 1.542 0.642 0 CA-C-O 118.75 -0.643 . . . . 0.0 111.363 -177.862 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 63.2 mmt-85 -62.87 -47.63 82.51 Favored 'General case' 0 N--CA 1.478 0.972 0 CA-C-N 119.967 1.258 . . . . 0.0 110.822 176.161 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 60.2 t -69.09 -37.44 76.79 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.438 0 N-CA-C 108.774 -0.824 . . . . 0.0 108.774 -174.675 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 15.8 mt-10 -61.07 -45.22 95.63 Favored 'General case' 0 CA--C 1.52 -0.185 0 CA-C-N 119.269 0.941 . . . . 0.0 110.076 174.111 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 28.4 t-20 -64.22 -40.97 97.14 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 123.008 0.523 . . . . 0.0 111.218 -178.332 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 53.0 tp -58.86 -49.94 75.86 Favored 'General case' 0 C--O 1.226 -0.14 0 C-N-CA 125.285 1.434 . . . . 0.0 110.909 173.77 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 56.7 mt -64.59 -46.87 91.23 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 N-CA-C 107.997 -1.112 . . . . 0.0 107.997 -178.748 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -58.65 -32.45 69.09 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 123.424 0.69 . . . . 0.0 112.102 -178.151 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 18.6 ptpt -81.53 -36.56 29.01 Favored 'General case' 0 C--N 1.345 0.37 0 CA-C-O 117.824 -1.084 . . . . 0.0 112.596 177.105 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 10.4 pt -84.81 -41.27 15.76 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.322 0 CA-C-N 120.124 1.329 . . . . 0.0 113.741 -176.225 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 67.4 m . . . . . 0 C--O 1.254 1.302 0 C-N-CA 126.065 1.746 . . . . 0.0 109.873 -169.927 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 8.5 ptm . . . . . 0 N--CA 1.498 1.965 0 N-CA-C 110.523 -0.177 . . . . 0.0 110.523 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 23.4 mttm -74.62 125.07 27.87 Favored 'General case' 0 N--CA 1.479 1.005 0 N-CA-C 107.103 -1.443 . . . . 0.0 107.103 -174.516 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 70.0 mttt -97.97 136.4 38.31 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-N 120.236 1.38 . . . . 0.0 108.027 173.771 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 11.6 t -116.31 152.47 18.03 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.551 0 C-N-CA 127.233 2.213 . . . . 0.0 108.199 -169.56 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 17.7 mtt -137.19 144.11 42.7 Favored 'General case' 0 C--N 1.324 -0.541 0 C-N-CA 124.926 1.29 . . . . 0.0 108.057 168.67 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 92.1 m-85 -125.26 113.89 18.22 Favored 'General case' 0 CA--C 1.516 -0.329 0 N-CA-C 102.839 -3.023 . . . . 0.0 102.839 170.05 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 1.2 p -141.0 137.21 34.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 121.289 0.566 . . . . 0.0 111.531 -168.051 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 44.0 t -165.82 152.93 10.08 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 128.639 2.775 . . . . 0.0 104.94 171.767 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 40.2 mtmt -75.47 163.3 27.55 Favored 'General case' 0 N--CA 1.47 0.569 0 O-C-N 121.655 -0.653 . . . . 0.0 111.421 -170.038 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 28.5 mmt85 53.41 70.39 0.6 Allowed 'General case' 0 N--CA 1.465 0.285 0 C-N-CA 126.801 2.041 . . . . 0.0 110.888 -176.28 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 2.4 t-20 -44.4 -20.07 0.03 OUTLIER 'General case' 0 N--CA 1.487 1.386 0 C-N-CA 127.839 2.455 . . . . 0.0 114.955 176.828 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 3.3 m -50.47 -27.82 7.23 Favored 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 124.269 1.028 . . . . 0.0 111.407 168.954 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 10.3 m -131.63 140.32 49.35 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 126.876 2.071 . . . . 0.0 107.889 172.078 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 5.5 mpt_? 59.16 165.2 0.05 OUTLIER 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 126.536 1.934 . . . . 0.0 112.631 -173.022 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 54.7 m 52.2 39.65 27.31 Favored 'General case' 0 CA--C 1.536 0.42 0 CA-C-N 115.207 -0.906 . . . . 0.0 110.334 -169.525 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 26.1 pt20 -135.48 33.07 3.03 Favored 'General case' 0 C--O 1.223 -0.294 0 O-C-N 120.543 -1.348 . . . . 0.0 109.636 174.414 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -163.88 -50.2 0.03 OUTLIER 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 124.149 0.979 . . . . 0.0 109.848 -177.762 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -67.73 -45.21 75.68 Favored 'General case' 0 C--N 1.343 0.285 0 N-CA-C 112.584 0.586 . . . . 0.0 112.584 -169.465 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . 0.471 ' H ' ' CD ' ' A' ' 19' ' ' GLU . 0.7 OUTLIER -66.86 -34.88 78.78 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 109.489 -0.56 . . . . 0.0 109.489 174.516 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -47.97 -66.71 1.87 Allowed Glycine 0 CA--C 1.527 0.791 0 N-CA-C 110.094 -1.202 . . . . 0.0 110.094 169.909 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 3.7 m-85 -59.62 -34.36 72.68 Favored 'General case' 0 CA--C 1.509 -0.602 0 O-C-N 121.547 -0.973 . . . . 0.0 113.444 178.091 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -66.63 -32.57 73.99 Favored 'General case' 0 N--CA 1.447 -0.61 0 C-N-CA 119.943 -0.703 . . . . 0.0 109.954 -174.032 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -65.9 -33.73 76.5 Favored 'General case' 0 CA--C 1.533 0.327 0 CA-C-N 118.395 0.543 . . . . 0.0 110.675 174.797 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 7.4 m -75.06 -55.69 5.49 Favored 'General case' 0 N--CA 1.448 -0.528 0 C-N-CA 125.453 1.501 . . . . 0.0 110.354 -176.752 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 40.1 mt -75.08 -38.63 61.2 Favored 'General case' 0 C--N 1.331 -0.22 0 C-N-CA 124.302 1.041 . . . . 0.0 109.467 -174.025 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -84.97 5.16 83.8 Favored Glycine 0 CA--C 1.526 0.78 0 C-N-CA 125.487 1.518 . . . . 0.0 113.629 -177.959 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -53.24 128.56 28.48 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-N 118.807 1.303 . . . . 0.0 109.802 -178.983 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 74.2 6.63 75.24 Favored Glycine 0 CA--C 1.536 1.35 0 C-N-CA 124.567 1.08 . . . . 0.0 114.313 -178.388 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 42.7 mttp -124.94 -50.42 1.7 Allowed 'General case' 0 N--CA 1.47 0.534 0 CA-C-N 118.927 1.364 . . . . 0.0 110.986 -175.0 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 19.3 pt -139.25 147.58 24.39 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.497 0 C-N-CA 123.642 0.777 . . . . 0.0 110.278 -169.244 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -96.01 159.48 14.95 Favored 'General case' 0 C--O 1.221 -0.417 0 C-N-CA 125.833 1.653 . . . . 0.0 108.109 175.578 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 12.2 t -142.44 135.68 27.43 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 N-CA-C 107.961 -1.125 . . . . 0.0 107.961 -173.416 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 4.1 m -148.38 103.04 3.39 Favored 'General case' 0 N--CA 1.446 -0.65 0 C-N-CA 124.665 1.186 . . . . 0.0 107.952 -177.218 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 60.2 m -89.6 71.43 7.87 Favored 'General case' 0 C--O 1.234 0.247 0 O-C-N 120.942 -1.099 . . . . 0.0 111.92 177.608 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 2.1 m -69.14 176.6 3.14 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 124.819 1.248 . . . . 0.0 110.696 170.763 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -167.07 -167.85 28.38 Favored Glycine 0 C--N 1.339 0.698 0 N-CA-C 108.082 -2.007 . . . . 0.0 108.082 179.691 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 18.2 mt -124.44 2.59 8.39 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 124.607 1.163 . . . . 0.0 111.691 -179.755 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 -145.36 -155.5 0.62 Allowed 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 129.185 2.994 . . . . 0.0 105.463 174.969 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 5.8 m 70.4 176.69 0.28 Allowed 'General case' 0 C--O 1.235 0.338 0 C-N-CA 125.38 1.472 . . . . 0.0 114.891 169.41 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 17.1 m -143.9 -72.87 0.28 Allowed 'General case' 0 N--CA 1.452 -0.354 0 CA-C-N 113.491 -1.686 . . . . 0.0 109.769 -169.236 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 6.0 ttt180 -152.3 172.1 16.96 Favored 'General case' 0 N--CA 1.467 0.415 0 C-N-CA 123.952 0.901 . . . . 0.0 111.15 -175.406 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 3.5 m -73.5 168.7 1.85 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.57 0 C-N-CA 124.534 1.134 . . . . 0.0 109.842 176.657 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -94.23 160.03 32.87 Favored Pre-proline 0 CA--C 1.544 0.718 0 N-CA-C 112.697 0.629 . . . . 0.0 112.697 -177.815 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -61.26 -53.55 2.37 Favored 'Trans proline' 0 C--N 1.352 0.742 0 C-N-CA 124.018 3.145 . . . . 0.0 113.777 -169.261 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 4.9 m -66.06 -26.6 67.58 Favored 'General case' 0 CA--C 1.532 0.278 0 O-C-N 121.893 -0.505 . . . . 0.0 110.358 -174.324 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -54.27 -53.19 56.97 Favored 'General case' 0 CA--C 1.509 -0.609 0 N-CA-C 108.75 -0.834 . . . . 0.0 108.75 174.745 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 58.9 mt -60.79 -41.08 87.2 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.468 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 -171.482 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -62.58 -40.97 98.59 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-N 118.431 0.56 . . . . 0.0 110.802 -179.009 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' MET . . . . . 0.415 ' HG3' ' CG ' ' A' ' 112' ' ' PHE . 38.4 mmt -74.06 -35.9 64.31 Favored 'General case' 0 C--O 1.235 0.321 0 CA-C-O 122.388 1.089 . . . . 0.0 110.338 -178.853 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -73.02 -31.33 64.39 Favored 'General case' 0 N--CA 1.442 -0.863 0 N-CA-C 106.806 -1.553 . . . . 0.0 106.806 -178.916 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 -70.52 -21.08 62.77 Favored 'General case' 0 N--CA 1.445 -0.719 0 C-N-CA 124.703 1.201 . . . . 0.0 111.061 170.273 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 77.7 mt-10 -63.84 -37.88 89.04 Favored 'General case' 0 C--N 1.344 0.361 0 CA-C-N 120.137 1.335 . . . . 0.0 109.107 169.457 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . 0.303 7.7 p -88.28 12.68 1.34 Allowed 'Isoleucine or valine' 0 CA--C 1.548 0.897 0 CA-C-O 121.082 0.468 . . . . 0.0 112.204 171.076 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 72.02 17.24 76.98 Favored Glycine 0 CA--C 1.533 1.212 0 O-C-N 120.723 -1.235 . . . . 0.0 113.869 174.791 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 5.7 mt -100.36 145.57 10.7 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.191 0 C-N-CA 125.154 1.382 . . . . 0.0 111.494 -174.221 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -96.77 137.13 36.32 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 125.297 1.439 . . . . 0.0 108.874 169.625 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 4.6 pt -134.0 -28.83 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.46 0 C-N-CA 125.441 1.496 . . . . 0.0 109.382 169.529 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -39.86 -37.67 0.58 Allowed 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 128.475 2.71 . . . . 0.0 113.509 169.563 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -66.72 -12.25 59.01 Favored Glycine 0 CA--C 1.537 1.423 0 C-N-CA 124.481 1.039 . . . . 0.0 114.379 179.213 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 28.7 mt-30 -70.73 156.43 39.51 Favored 'General case' 0 N--CA 1.45 -0.438 0 CA-C-N 118.965 1.382 . . . . 0.0 110.297 174.382 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 1.4 p -150.31 151.07 32.34 Favored 'General case' 0 N--CA 1.431 -1.421 0 N-CA-C 104.717 -2.327 . . . . 0.0 104.717 168.448 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 63.2 m -92.47 75.82 5.15 Favored 'General case' 0 N--CA 1.45 -0.44 0 N-CA-C 107.831 -1.174 . . . . 0.0 107.831 -174.117 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -62.96 153.13 81.67 Favored Pre-proline 0 C--O 1.241 0.642 0 N-CA-C 108.947 -0.761 . . . . 0.0 108.947 171.161 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 26.4 Cg_exo -57.55 134.36 62.78 Favored 'Trans proline' 0 N--CA 1.447 -1.209 0 N-CA-C 107.841 -1.638 . . . . 0.0 107.841 169.376 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 8.3 tt -61.22 -23.8 31.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 O-C-N 121.482 -0.762 . . . . 0.0 109.596 171.021 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 21.5 tt0 -69.61 -22.9 63.46 Favored 'General case' 0 N--CA 1.434 -1.273 0 C-N-CA 127.375 2.27 . . . . 0.0 110.789 -179.995 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 8.2 t-20 -60.32 -17.59 43.92 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 124.665 1.186 . . . . 0.0 111.68 174.313 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 4.4 m-85 -128.31 178.34 6.32 Favored 'General case' 0 C--O 1.235 0.34 0 C-N-CA 127.115 2.166 . . . . 0.0 108.54 -179.873 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 13.9 p-10 -128.32 143.61 51.04 Favored 'General case' 0 N--CA 1.438 -1.035 0 C-N-CA 124.716 1.206 . . . . 0.0 110.428 169.236 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -77.36 -25.27 50.85 Favored 'General case' 0 N--CA 1.432 -1.347 0 N-CA-C 109.143 -0.688 . . . . 0.0 109.143 -170.712 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 35.6 t70 -64.61 -19.79 65.89 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 120.41 -0.516 . . . . 0.0 111.214 -178.903 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -83.96 -31.04 25.77 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 124.427 1.091 . . . . 0.0 112.321 172.215 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 11.1 m-85 -72.85 170.31 14.98 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 124.89 1.276 . . . . 0.0 110.287 173.23 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -120.43 -35.85 3.33 Favored 'General case' 0 C--O 1.236 0.39 0 C-N-CA 123.047 0.539 . . . . 0.0 111.67 179.905 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -141.51 135.31 30.82 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.691 0 CA-C-O 121.839 0.828 . . . . 0.0 110.454 -169.705 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 76.3 t -143.0 138.38 27.16 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.278 0 N-CA-C 106.629 -1.619 . . . . 0.0 106.629 -177.496 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 41.6 mm -127.16 117.28 46.96 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.581 0 N-CA-C 106.12 -1.807 . . . . 0.0 106.12 -170.516 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 67.1 m -94.96 91.61 6.47 Favored 'General case' 0 N--CA 1.449 -0.519 0 N-CA-C 105.546 -2.02 . . . . 0.0 105.546 169.445 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . 0.251 0.3 OUTLIER -75.3 -6.55 50.44 Favored 'General case' 0 CA--C 1.536 0.442 0 CA-C-N 115.605 -0.725 . . . . 0.0 112.908 -175.267 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 6.4 p -166.14 167.38 16.34 Favored 'General case' 0 C--O 1.236 0.344 0 C-N-CA 127.398 2.279 . . . . 0.0 107.549 168.247 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 77.79 -81.3 1.27 Allowed Glycine 0 CA--C 1.526 0.746 0 N-CA-C 110.632 -0.987 . . . . 0.0 110.632 174.573 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 4.9 m 67.79 -53.2 0.51 Allowed 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 127.659 2.383 . . . . 0.0 113.738 178.429 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -81.47 57.79 4.89 Favored Glycine 0 CA--C 1.528 0.902 0 C-N-CA 124.774 1.178 . . . . 0.0 110.511 170.741 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 27.7 m -99.5 14.71 4.51 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.71 0 C-N-CA 124.082 0.953 . . . . 0.0 113.068 -169.881 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 47.4 t30 58.64 69.65 0.71 Allowed 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 126.1 1.76 . . . . 0.0 109.258 -175.865 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -139.36 148.61 57.36 Favored Pre-proline 0 CA--C 1.546 0.81 0 C-N-CA 126.146 1.778 . . . . 0.0 109.276 -168.949 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo -62.99 149.43 91.61 Favored 'Trans proline' 0 C--N 1.356 0.957 0 C-N-CA 121.47 1.447 . . . . 0.0 114.501 -169.643 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_endo -66.83 -34.9 29.17 Favored 'Trans proline' 0 N--CA 1.459 -0.522 0 C-N-CA 122.649 2.232 . . . . 0.0 114.583 -169.212 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -64.16 -11.91 35.0 Favored 'General case' 0 CA--C 1.54 0.57 0 CA-C-N 119.85 1.205 . . . . 0.0 112.157 -176.62 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 98.0 m95 -80.96 -35.53 32.07 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 123.481 0.712 . . . . 0.0 111.941 173.932 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 18.8 m -92.34 -4.59 10.78 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.551 0 C-N-CA 125.047 1.339 . . . . 0.0 112.697 -179.694 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 4.0 t -132.92 85.61 2.24 Favored 'General case' 0 CA--C 1.539 0.54 0 CA-C-O 123.24 1.495 . . . . 0.0 107.159 169.725 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 30.4 mm-40 -103.02 -174.11 2.47 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 127.806 2.442 . . . . 0.0 108.943 173.889 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 38.3 mm-40 -64.55 -28.62 69.77 Favored 'General case' 0 CA--C 1.539 0.544 0 O-C-N 121.82 -0.55 . . . . 0.0 110.036 172.653 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 4.0 tt -142.39 130.21 20.38 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.409 0 N-CA-C 105.692 -1.966 . . . . 0.0 105.692 169.338 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 70.3 t80 -122.87 142.37 50.85 Favored 'General case' 0 N--CA 1.448 -0.537 0 N-CA-C 105.868 -1.901 . . . . 0.0 105.868 169.062 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 10.5 mm-40 -132.77 138.9 47.31 Favored 'General case' 0 C--O 1.236 0.369 0 N-CA-C 107.809 -1.182 . . . . 0.0 107.809 174.025 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 8.0 t70 -108.36 118.91 37.99 Favored 'General case' 0 N--CA 1.45 -0.443 0 N-CA-C 106.455 -1.683 . . . . 0.0 106.455 169.855 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 10.5 m95 -115.68 170.44 8.44 Favored 'General case' 0 CA--C 1.533 0.318 0 N-CA-C 108.73 -0.841 . . . . 0.0 108.73 170.308 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 47.8 mt-30 -129.76 57.99 1.66 Allowed 'General case' 0 CA--C 1.534 0.362 0 N-CA-C 106.823 -1.547 . . . . 0.0 106.823 169.86 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 4.5 mt -67.76 139.48 56.66 Favored 'General case' 0 N--CA 1.463 0.217 0 N-CA-C 108.197 -1.038 . . . . 0.0 108.197 -179.694 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -74.65 170.61 15.46 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 125.056 1.343 . . . . 0.0 109.083 174.408 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -143.0 138.01 15.43 Favored Pre-proline 0 N--CA 1.452 -0.35 0 C-N-CA 123.199 0.599 . . . . 0.0 110.833 176.856 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 29.2 Cg_endo -86.35 -2.88 8.59 Favored 'Trans proline' 0 CA--C 1.54 0.807 0 C-N-CA 123.302 2.668 . . . . 0.0 115.318 -172.586 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -56.78 130.88 47.51 Favored 'General case' 0 C--O 1.237 0.432 0 CA-C-N 120.356 1.435 . . . . 0.0 110.571 -174.209 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 72.41 9.4 73.16 Favored Glycine 0 CA--C 1.534 1.233 0 CA-C-O 118.399 -1.223 . . . . 0.0 114.146 174.215 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 30.0 pt20 -126.44 -167.65 1.75 Allowed 'General case' 0 CA--C 1.537 0.453 0 CA-C-N 119.253 1.526 . . . . 0.0 110.799 172.326 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 1.9 m -66.93 154.74 40.3 Favored 'General case' 0 CA--C 1.532 0.268 0 N-CA-C 116.144 1.905 . . . . 0.0 116.144 -167.96 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 9.0 tp -57.61 -34.61 69.45 Favored 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 126.255 1.822 . . . . 0.0 111.201 177.487 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 -59.22 -34.66 72.45 Favored 'General case' 0 CA--C 1.531 0.213 0 C-N-CA 124.297 1.039 . . . . 0.0 110.721 175.839 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 3.5 t -73.18 -40.46 57.82 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.283 0 CA-C-O 118.207 -0.901 . . . . 0.0 109.456 -178.477 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . 0.415 ' CG ' ' HG3' ' A' ' 49' ' ' MET . 81.1 m-85 -56.56 -50.01 73.17 Favored 'General case' 0 N--CA 1.471 0.612 0 CA-C-N 120.248 1.385 . . . . 0.0 109.376 172.482 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 91.6 mtt180 -66.25 -33.19 75.18 Favored 'General case' 0 CA--C 1.535 0.378 0 CA-C-O 119.348 -0.358 . . . . 0.0 111.515 -177.009 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 6.2 m -67.37 -49.86 62.18 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 124.224 1.01 . . . . 0.0 109.971 173.107 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 80.1 t -69.8 -26.89 31.39 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.232 0 CA-C-O 117.675 -1.155 . . . . 0.0 109.399 -170.938 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 31.5 mtm105 -56.63 -47.5 79.57 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-N 120.31 1.414 . . . . 0.0 109.746 169.791 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -63.48 -49.12 72.24 Favored Glycine 0 CA--C 1.532 1.135 0 CA-C-N 118.949 0.795 . . . . 0.0 112.241 179.445 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 16.8 mt-30 -57.78 -46.37 84.69 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-N 117.565 0.682 . . . . 0.0 110.67 179.277 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 65.8 t -70.42 -41.2 78.29 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.474 0 CA-C-O 118.585 -0.722 . . . . 0.0 110.405 -176.675 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 57.7 tttm -54.54 -46.48 73.61 Favored 'General case' 0 CA--C 1.517 -0.301 0 CA-C-N 119.381 0.991 . . . . 0.0 109.178 179.917 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -64.19 -42.79 96.51 Favored 'General case' 0 N--CA 1.448 -0.539 0 C-N-CA 123.002 0.521 . . . . 0.0 110.68 -176.758 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 37.8 mmt180 -63.16 -46.54 86.69 Favored 'General case' 0 N--CA 1.47 0.541 0 O-C-N 121.808 -0.557 . . . . 0.0 110.824 178.047 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 86.1 t -70.02 -39.03 76.86 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.436 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 -176.834 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 17.2 mt-10 -60.82 -43.8 97.75 Favored 'General case' 0 C--O 1.227 -0.105 0 CA-C-N 119.392 0.996 . . . . 0.0 110.316 175.509 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 28.8 t-20 -63.71 -43.68 95.88 Favored 'General case' 0 CA--C 1.53 0.206 0 C-N-CA 122.968 0.507 . . . . 0.0 111.115 -178.011 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 45.7 tp -58.09 -49.47 76.81 Favored 'General case' 0 N--CA 1.453 -0.322 0 C-N-CA 125.525 1.53 . . . . 0.0 111.151 174.374 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 73.1 mt -64.58 -46.03 93.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 N-CA-C 108.261 -1.014 . . . . 0.0 108.261 -178.895 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -59.74 -30.8 69.08 Favored 'General case' 0 CA--C 1.536 0.438 0 CA-C-O 118.734 -0.651 . . . . 0.0 112.157 -178.084 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 19.1 ptpt -82.45 -37.65 25.11 Favored 'General case' 0 C--N 1.344 0.35 0 CA-C-O 118.033 -0.984 . . . . 0.0 112.346 176.797 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 12.7 pt -81.69 -41.68 18.77 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.328 0 CA-C-N 120.072 1.305 . . . . 0.0 113.354 -176.737 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 74.5 m . . . . . 0 C--O 1.252 1.232 0 C-N-CA 125.882 1.673 . . . . 0.0 109.607 -169.848 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 11.6 ptm . . . . . 0 N--CA 1.497 1.897 0 N-CA-C 110.744 -0.095 . . . . 0.0 110.744 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 26.1 mttm -76.08 118.71 19.12 Favored 'General case' 0 N--CA 1.48 1.064 0 O-C-N 120.875 -1.141 . . . . 0.0 108.196 -170.262 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 90.9 mttt -86.08 136.03 33.39 Favored 'General case' 0 CA--C 1.513 -0.454 0 N-CA-C 107.935 -1.135 . . . . 0.0 107.935 177.223 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 1.8 t -122.45 150.82 26.16 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 C-N-CA 125.752 1.621 . . . . 0.0 109.45 -168.936 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 13.6 mtt -139.35 147.52 41.65 Favored 'General case' 0 C--N 1.327 -0.376 0 C-N-CA 125.677 1.591 . . . . 0.0 108.462 168.963 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 70.2 m-85 -134.51 121.98 21.78 Favored 'General case' 0 N--CA 1.456 -0.161 0 N-CA-C 105.246 -2.131 . . . . 0.0 105.246 170.502 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 1.5 p -152.35 146.28 15.33 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.244 0 CA-C-N 118.954 0.797 . . . . 0.0 111.422 -168.932 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 43.7 t -132.99 -175.73 3.88 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 126.709 2.004 . . . . 0.0 106.226 169.225 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 20.2 ptpt -58.53 -25.44 62.45 Favored 'General case' 0 N--CA 1.471 0.601 0 N-CA-C 114.104 1.15 . . . . 0.0 114.104 -171.308 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 48.3 ttt85 -140.39 159.29 42.52 Favored 'General case' 0 N--CA 1.467 0.417 0 C-N-CA 124.264 1.026 . . . . 0.0 109.054 176.428 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 6.4 t30 -72.06 -34.86 69.06 Favored 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 123.779 0.832 . . . . 0.0 112.963 -176.556 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -64.75 -55.95 16.68 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 123.197 0.599 . . . . 0.0 111.215 -169.116 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 11.1 m -88.73 146.48 25.01 Favored 'General case' 0 N--CA 1.455 -0.196 0 C-N-CA 123.549 0.74 . . . . 0.0 109.624 -176.652 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 6.4 mmm180 68.33 -57.49 0.48 Allowed 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 127.424 2.29 . . . . 0.0 111.488 176.993 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 2.5 m -69.62 -9.95 56.25 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 124.702 1.201 . . . . 0.0 113.97 -172.146 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 29.3 pt20 -64.9 -42.67 94.56 Favored 'General case' 0 C--O 1.223 -0.332 0 CA-C-O 117.732 -1.127 . . . . 0.0 113.587 -175.292 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 2.2 tpt -94.72 -36.26 11.8 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-N 120.046 1.294 . . . . 0.0 114.102 -169.199 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -62.78 -42.97 99.94 Favored 'General case' 0 N--CA 1.474 0.737 0 N-CA-C 113.526 0.936 . . . . 0.0 113.526 -168.929 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -64.46 -33.49 76.0 Favored 'General case' 0 N--CA 1.472 0.645 0 CA-C-N 118.674 0.67 . . . . 0.0 109.366 175.6 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -51.94 -57.57 12.5 Favored Glycine 0 C--N 1.342 0.888 0 C-N-CA 125.422 1.487 . . . . 0.0 110.439 175.647 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 13.5 m-85 -70.8 -31.89 68.79 Favored 'General case' 0 CA--C 1.505 -0.757 0 O-C-N 121.647 -0.914 . . . . 0.0 112.724 -179.172 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -68.94 -34.41 75.31 Favored 'General case' 0 N--CA 1.449 -0.521 0 C-N-CA 119.305 -0.958 . . . . 0.0 111.155 -174.761 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 2.4 ptmt -65.39 -25.88 67.75 Favored 'General case' 0 N--CA 1.471 0.621 0 CA-C-N 119.085 0.857 . . . . 0.0 111.717 172.952 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 8.8 m -83.21 -57.07 3.42 Favored 'General case' 0 N--CA 1.444 -0.728 0 C-N-CA 125.198 1.399 . . . . 0.0 109.538 -173.96 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 55.5 mt -74.9 -36.34 62.23 Favored 'General case' 0 C--N 1.331 -0.204 0 C-N-CA 124.753 1.221 . . . . 0.0 110.213 -175.005 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -93.34 9.4 74.49 Favored Glycine 0 C--N 1.338 0.675 0 C-N-CA 124.988 1.28 . . . . 0.0 113.068 -176.161 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -50.89 122.73 7.85 Favored 'General case' 0 CA--C 1.534 0.327 0 C-N-CA 124.841 1.257 . . . . 0.0 110.524 -175.257 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 76.54 -8.76 25.29 Favored Glycine 0 CA--C 1.534 1.264 0 C-N-CA 124.371 0.986 . . . . 0.0 114.426 179.652 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 60.2 mttm -98.67 -46.67 5.61 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 119.19 1.495 . . . . 0.0 110.403 179.254 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 24.3 pt -139.24 149.25 23.14 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.585 0 C-N-CA 123.632 0.773 . . . . 0.0 109.388 -169.76 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -113.09 106.41 14.64 Favored 'General case' 0 N--CA 1.463 0.187 0 C-N-CA 125.132 1.373 . . . . 0.0 109.272 -169.899 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 2.5 t -84.64 137.68 20.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 119.316 0.962 . . . . 0.0 109.742 -179.449 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 14.5 m -145.32 91.7 2.16 Favored 'General case' 0 N--CA 1.446 -0.669 0 N-CA-C 106.037 -1.838 . . . . 0.0 106.037 170.368 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 45.0 m -89.28 68.93 8.13 Favored 'General case' 0 CA--C 1.532 0.273 0 O-C-N 121.287 -0.883 . . . . 0.0 111.017 -171.363 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 11.9 m -61.89 164.72 6.1 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 125.895 1.678 . . . . 0.0 110.715 170.198 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -158.6 -167.64 19.67 Favored Glycine 0 C--N 1.337 0.638 0 N-CA-C 107.752 -2.139 . . . . 0.0 107.752 -170.057 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 17.3 mt -123.96 -3.72 8.1 Favored 'General case' 0 C--N 1.327 -0.376 0 C-N-CA 124.113 0.965 . . . . 0.0 111.592 -179.405 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 36.7 mt-10 -142.63 154.15 44.12 Favored 'General case' 0 C--O 1.238 0.499 0 C-N-CA 128.052 2.541 . . . . 0.0 106.511 169.297 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 60.7 p -148.53 160.78 42.75 Favored 'General case' 0 N--CA 1.446 -0.66 0 CA-C-O 122.555 1.169 . . . . 0.0 113.795 -179.693 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 93.0 p -164.45 -144.45 0.08 Allowed 'General case' 0 N--CA 1.443 -0.817 0 CA-C-N 112.531 -2.122 . . . . 0.0 105.94 -168.841 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 9.2 ttt180 -136.31 173.0 12.18 Favored 'General case' 0 C--O 1.232 0.134 0 N-CA-C 106.311 -1.737 . . . . 0.0 106.311 168.368 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 5.6 m -81.89 175.16 0.77 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.609 0 C-N-CA 122.918 0.487 . . . . 0.0 110.038 -178.845 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 97.0 m-70 -90.98 150.33 41.66 Favored Pre-proline 0 CA--C 1.542 0.669 0 CA-C-O 119.3 -0.381 . . . . 0.0 111.686 -174.916 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -63.4 -45.64 11.37 Favored 'Trans proline' 0 C--N 1.349 0.59 0 C-N-CA 122.76 2.306 . . . . 0.0 113.31 -171.216 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 5.8 m -69.0 -22.74 64.06 Favored 'General case' 0 CA--C 1.54 0.558 0 O-C-N 121.681 -0.637 . . . . 0.0 110.364 -178.321 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -61.11 -56.68 18.1 Favored 'General case' 0 CA--C 1.509 -0.632 0 N-CA-C 108.197 -1.038 . . . . 0.0 108.197 169.85 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 75.9 mt -56.8 -38.76 60.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 N-CA-C 108.427 -0.953 . . . . 0.0 108.427 -175.229 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -62.47 -50.48 71.27 Favored 'General case' 0 N--CA 1.452 -0.332 0 CA-C-N 118.87 0.759 . . . . 0.0 111.827 -178.845 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 35.9 mmt -72.18 -31.78 66.23 Favored 'General case' 0 N--CA 1.472 0.648 0 CA-C-O 122.584 1.183 . . . . 0.0 110.806 -179.112 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -72.21 -33.13 67.37 Favored 'General case' 0 N--CA 1.443 -0.801 0 N-CA-C 106.855 -1.535 . . . . 0.0 106.855 -177.911 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 41.3 tt0 -74.7 -19.94 60.05 Favored 'General case' 0 N--CA 1.446 -0.67 0 O-C-N 120.925 -1.109 . . . . 0.0 110.525 172.441 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 20.3 mm-40 -64.49 -33.33 75.63 Favored 'General case' 0 CA--C 1.532 0.265 0 CA-C-N 119.576 1.08 . . . . 0.0 109.982 169.771 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 16.4 m -91.17 12.31 2.17 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.736 0 N-CA-C 112.275 0.472 . . . . 0.0 112.275 169.192 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 73.08 13.67 79.25 Favored Glycine 0 CA--C 1.531 1.089 0 C-N-CA 124.53 1.062 . . . . 0.0 113.695 174.675 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 17.2 mt -91.23 143.95 10.17 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.239 0 C-N-CA 124.438 1.095 . . . . 0.0 110.001 -177.476 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 7.2 t70 -104.49 124.6 49.56 Favored 'General case' 0 C--O 1.235 0.298 0 N-CA-C 106.628 -1.619 . . . . 0.0 106.628 168.902 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 5.8 pt -120.06 -21.81 4.02 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.697 0 C-N-CA 124.686 1.195 . . . . 0.0 109.526 169.073 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -38.67 -35.91 0.22 Allowed 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 129.252 3.021 . . . . 0.0 113.778 169.326 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -72.46 -9.75 74.0 Favored Glycine 0 CA--C 1.535 1.321 0 C-N-CA 124.649 1.118 . . . . 0.0 114.229 179.963 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 26.2 mt-30 -68.1 140.08 56.21 Favored 'General case' 0 N--CA 1.451 -0.401 0 CA-C-N 119.753 1.777 . . . . 0.0 110.265 176.764 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 1.2 m -155.94 -51.88 0.08 Allowed 'General case' 0 N--CA 1.438 -1.046 0 N-CA-C 104.119 -2.548 . . . . 0.0 104.119 168.412 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 3.9 m 68.9 160.03 0.18 Allowed 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 126.677 1.991 . . . . 0.0 114.071 169.095 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -95.32 163.61 21.23 Favored Pre-proline 0 C--O 1.241 0.621 0 C-N-CA 124.968 1.307 . . . . 0.0 109.754 -172.833 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -62.05 136.24 59.77 Favored 'Trans proline' 0 N--CA 1.449 -1.095 0 N-CA-C 108.203 -1.499 . . . . 0.0 108.203 169.762 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 8.1 tt -61.6 -19.15 20.3 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.498 0 C-N-CA 124.248 1.019 . . . . 0.0 111.03 -177.958 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 12.1 mt-10 -67.29 -25.48 66.06 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 125.533 1.533 . . . . 0.0 110.391 -179.748 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 15.4 t-20 -71.82 1.29 7.21 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 124.702 1.201 . . . . 0.0 113.112 -179.632 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 42.5 m-85 -130.74 -174.18 3.29 Favored 'General case' 0 C--O 1.236 0.388 0 C-N-CA 126.585 1.954 . . . . 0.0 109.136 -177.707 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 57.1 t-20 -135.05 140.19 45.38 Favored 'General case' 0 N--CA 1.446 -0.628 0 N-CA-C 107.397 -1.335 . . . . 0.0 107.397 169.382 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -72.22 -25.13 61.53 Favored 'General case' 0 N--CA 1.435 -1.207 0 N-CA-C 109.08 -0.711 . . . . 0.0 109.08 -178.157 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 35.1 t70 -63.71 -24.76 67.91 Favored 'General case' 0 N--CA 1.447 -0.609 0 O-C-N 123.254 0.346 . . . . 0.0 111.868 -179.132 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -78.08 -28.32 48.73 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 123.52 0.728 . . . . 0.0 111.925 176.036 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 14.7 m-85 -80.38 170.96 15.67 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 125.805 1.642 . . . . 0.0 111.695 -178.568 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 22.9 t70 -119.63 -39.07 2.9 Favored 'General case' 0 N--CA 1.464 0.272 0 C-N-CA 123.185 0.594 . . . . 0.0 111.599 177.318 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -139.32 133.96 39.73 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.494 0 CA-C-O 121.98 0.895 . . . . 0.0 110.639 -170.204 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 70.4 t -142.69 133.45 23.77 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.632 0 N-CA-C 105.746 -1.946 . . . . 0.0 105.746 -176.382 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 33.6 mm -124.94 122.09 62.59 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.527 0 N-CA-C 106.448 -1.686 . . . . 0.0 106.448 -171.603 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 58.7 m -87.09 122.59 31.12 Favored 'General case' 0 N--CA 1.441 -0.884 0 N-CA-C 105.204 -2.147 . . . . 0.0 105.204 169.0 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 69.3 mt -83.92 3.39 34.25 Favored 'General case' 0 C--N 1.327 -0.37 0 O-C-N 121.711 -0.618 . . . . 0.0 110.341 175.153 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 29.7 p -160.82 141.57 11.56 Favored 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 124.838 1.255 . . . . 0.0 108.249 169.728 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 57.97 -162.2 9.71 Favored Glycine 0 CA--C 1.534 1.223 0 C-N-CA 124.581 1.086 . . . . 0.0 114.523 170.26 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 10.9 p -152.17 147.75 26.8 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 125.367 1.467 . . . . 0.0 107.536 170.303 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 59.1 44.2 96.5 Favored Glycine 0 CA--C 1.533 1.176 0 N-CA-C 111.145 -0.782 . . . . 0.0 111.145 -178.107 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 29.8 m -79.8 52.53 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.545 0.775 0 C-N-CA 124.845 1.258 . . . . 0.0 112.799 -169.589 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 17.5 t-20 56.06 53.09 9.51 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 126.295 1.838 . . . . 0.0 108.827 -175.275 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -147.74 147.17 26.5 Favored Pre-proline 0 CA--C 1.54 0.579 0 C-N-CA 126.913 2.085 . . . . 0.0 107.34 -169.28 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_exo -64.24 138.34 60.68 Favored 'Trans proline' 0 CA--C 1.542 0.892 0 CA-C-N 120.692 1.283 . . . . 0.0 112.693 -171.878 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -67.15 -28.37 40.77 Favored 'Trans proline' 0 N--CA 1.458 -0.567 0 C-N-CA 122.667 2.245 . . . . 0.0 114.425 -169.393 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 5.1 pm0 -62.13 -15.92 48.95 Favored 'General case' 0 CA--C 1.536 0.42 0 CA-C-N 120.404 1.456 . . . . 0.0 112.53 -178.275 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 96.4 m95 -73.38 -49.36 27.62 Favored 'General case' 0 N--CA 1.451 -0.394 0 C-N-CA 123.242 0.617 . . . . 0.0 110.848 174.371 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 28.6 m -79.87 -0.29 3.79 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.359 0 C-N-CA 123.615 0.766 . . . . 0.0 112.717 -178.446 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 57.7 p -113.33 25.32 11.42 Favored 'General case' 0 C--O 1.237 0.409 0 CA-C-N 119.547 1.067 . . . . 0.0 113.155 174.033 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 76.2 mm-40 -66.57 174.22 2.94 Favored 'General case' 0 CA--C 1.539 0.528 0 CA-C-N 118.611 0.641 . . . . 0.0 112.084 176.251 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 32.7 mm-40 -54.57 -29.44 51.25 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 124.038 0.935 . . . . 0.0 111.723 -169.765 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 3.3 tt -133.7 130.63 56.36 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.672 0 N-CA-C 104.041 -2.577 . . . . 0.0 104.041 168.388 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 44.1 t80 -120.86 142.03 50.03 Favored 'General case' 0 N--CA 1.448 -0.546 0 N-CA-C 105.921 -1.881 . . . . 0.0 105.921 169.221 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 20.6 mm-40 -139.79 144.49 37.39 Favored 'General case' 0 C--O 1.236 0.373 0 N-CA-C 107.624 -1.25 . . . . 0.0 107.624 170.112 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 6.0 t0 -110.56 107.69 17.39 Favored 'General case' 0 C--O 1.238 0.484 0 N-CA-C 105.168 -2.16 . . . . 0.0 105.168 169.093 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -99.53 125.37 45.29 Favored 'General case' 0 N--CA 1.454 -0.269 0 C-N-CA 123.377 0.671 . . . . 0.0 109.546 -173.301 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 34.2 mm-40 -89.05 116.98 27.73 Favored 'General case' 0 N--CA 1.456 -0.163 0 N-CA-C 105.416 -2.068 . . . . 0.0 105.416 168.823 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 28.9 mt -142.95 127.69 18.17 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 104.638 -2.356 . . . . 0.0 104.638 -179.738 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 26.5 mm-40 -63.48 157.77 22.59 Favored 'General case' 0 CA--C 1.534 0.333 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 172.722 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -117.13 135.03 22.98 Favored Pre-proline 0 N--CA 1.45 -0.426 0 C-N-CA 124.526 1.13 . . . . 0.0 108.105 169.687 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -89.09 -8.68 4.72 Favored 'Trans proline' 0 N--CA 1.453 -0.882 0 C-N-CA 122.285 1.99 . . . . 0.0 114.674 -170.138 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -50.7 -51.4 49.97 Favored 'General case' 0 N--CA 1.472 0.672 0 CA-C-N 120.554 1.525 . . . . 0.0 113.14 -169.31 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -84.31 11.84 56.93 Favored Glycine 0 CA--C 1.532 1.147 0 CA-C-O 118.702 -1.055 . . . . 0.0 113.396 -176.49 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 9.8 mt-30 -130.98 176.45 8.23 Favored 'General case' 0 CA--C 1.542 0.664 0 CA-C-N 118.847 1.324 . . . . 0.0 110.654 -169.683 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 13.9 m -78.23 169.7 17.83 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 124.604 1.161 . . . . 0.0 112.242 -173.592 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 34.4 tp -55.19 -33.93 63.45 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 125.86 1.664 . . . . 0.0 113.058 -178.11 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 5.9 pt-20 -56.99 -34.71 68.41 Favored 'General case' 0 N--CA 1.463 0.208 0 C-N-CA 123.483 0.713 . . . . 0.0 111.608 174.782 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 16.0 t -76.63 -38.52 30.96 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.525 0 CA-C-O 118.02 -0.991 . . . . 0.0 109.801 -176.874 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 85.2 m-85 -57.02 -48.13 79.23 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-N 120.377 1.444 . . . . 0.0 109.547 171.545 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 85.6 mtt180 -63.72 -39.46 94.35 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 122.916 0.486 . . . . 0.0 111.247 -179.613 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 5.7 m -67.34 -49.6 63.37 Favored 'General case' 0 N--CA 1.452 -0.339 0 C-N-CA 124.203 1.001 . . . . 0.0 110.226 177.975 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 59.2 t -65.56 -35.13 74.52 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.306 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 -173.697 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 58.7 ttp85 -56.42 -45.18 80.84 Favored 'General case' 0 CA--C 1.537 0.475 0 CA-C-N 118.499 0.59 . . . . 0.0 109.76 174.077 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -64.18 -51.63 51.24 Favored Glycine 0 CA--C 1.53 1.006 0 CA-C-N 118.346 0.521 . . . . 0.0 112.208 175.922 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 9.4 mt-30 -61.52 -43.21 99.27 Favored 'General case' 0 N--CA 1.468 0.428 0 CA-C-N 118.258 1.029 . . . . 0.0 110.713 -175.364 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 95.6 t -70.58 -40.66 77.48 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.377 0 CA-C-O 118.399 -0.81 . . . . 0.0 109.265 -176.011 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 58.2 tttm -54.94 -45.85 74.88 Favored 'General case' 0 CA--C 1.518 -0.276 0 CA-C-N 119.275 0.943 . . . . 0.0 109.093 174.906 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 41.5 tt0 -66.84 -43.16 84.43 Favored 'General case' 0 N--CA 1.45 -0.446 0 C-N-CA 122.761 0.424 . . . . 0.0 111.043 -173.794 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 36.3 mtt-85 -66.21 -40.75 90.56 Favored 'General case' 0 N--CA 1.471 0.599 0 O-C-N 121.413 -0.804 . . . . 0.0 111.722 176.857 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 90.2 t -68.77 -37.61 77.7 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.499 0 N-CA-C 108.952 -0.758 . . . . 0.0 108.952 179.289 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 13.4 mt-10 -60.01 -43.8 94.99 Favored 'General case' 0 C--O 1.226 -0.174 0 CA-C-N 119.308 0.958 . . . . 0.0 110.064 174.13 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 29.2 t-20 -63.02 -45.27 93.13 Favored 'General case' 0 CA--C 1.53 0.204 0 CA-C-N 118.124 0.42 . . . . 0.0 111.103 -179.489 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 38.6 tp -57.75 -49.11 77.66 Favored 'General case' 0 N--CA 1.452 -0.364 0 C-N-CA 124.684 1.194 . . . . 0.0 110.489 176.715 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 70.0 mt -63.49 -46.78 94.23 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 N-CA-C 108.12 -1.067 . . . . 0.0 108.12 -179.408 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -59.13 -29.64 67.54 Favored 'General case' 0 CA--C 1.535 0.377 0 CA-C-O 118.325 -0.845 . . . . 0.0 112.251 -178.426 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . 0.25 19.3 ptpt -83.17 -39.05 21.52 Favored 'General case' 0 C--N 1.343 0.323 0 CA-C-O 117.863 -1.065 . . . . 0.0 112.616 175.421 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 12.6 pt -82.46 -40.19 16.72 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.362 0 CA-C-N 120.207 1.367 . . . . 0.0 113.497 -175.166 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 70.8 m . . . . . 0 C--O 1.253 1.24 0 C-N-CA 125.692 1.597 . . . . 0.0 109.848 -170.05 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 9.8 ptm . . . . . 0 N--CA 1.496 1.872 0 N-CA-C 110.622 -0.14 . . . . 0.0 110.622 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 27.5 mttm -75.09 121.25 21.75 Favored 'General case' 0 N--CA 1.48 1.045 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 -171.24 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 91.6 mttt -88.15 134.75 33.69 Favored 'General case' 0 CA--C 1.512 -0.491 0 N-CA-C 108.075 -1.083 . . . . 0.0 108.075 177.201 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 1.9 t -123.35 147.93 27.49 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.648 0 C-N-CA 126.574 1.95 . . . . 0.0 108.89 -168.994 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 34.3 mtt -137.02 150.5 48.14 Favored 'General case' 0 C--N 1.325 -0.493 0 C-N-CA 124.671 1.189 . . . . 0.0 108.215 168.049 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 35.7 m-85 -129.29 129.54 45.03 Favored 'General case' 0 CA--C 1.515 -0.397 0 N-CA-C 103.833 -2.654 . . . . 0.0 103.833 169.715 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 1.1 p -152.78 136.39 8.17 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.366 0 CA-C-O 121.352 0.596 . . . . 0.0 109.587 -169.276 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 49.9 t -122.08 174.66 6.79 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 127.317 2.247 . . . . 0.0 107.182 169.661 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 51.5 tttm -63.78 -32.28 73.73 Favored 'General case' 0 CA--C 1.539 0.531 0 O-C-N 121.226 -0.921 . . . . 0.0 111.303 179.275 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 74.4 mtm-85 -108.63 162.94 13.68 Favored 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 124.815 1.246 . . . . 0.0 108.003 169.615 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 7.3 t30 -70.55 -54.77 10.8 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-O 121.366 0.603 . . . . 0.0 110.296 172.625 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 12.4 m -89.75 46.39 1.36 Allowed 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 123.499 0.72 . . . . 0.0 111.454 -168.953 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 50.6 m -139.78 118.17 12.12 Favored 'General case' 0 N--CA 1.448 -0.548 0 N-CA-C 106.81 -1.552 . . . . 0.0 106.81 170.073 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 79.2 mtt180 64.96 -26.88 0.09 Allowed 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 129.02 2.928 . . . . 0.0 115.218 176.537 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 1.2 m -76.67 -140.79 0.02 OUTLIER 'General case' 0 CA--C 1.549 0.916 0 N-CA-C 104.658 -2.349 . . . . 0.0 104.658 168.036 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 22.5 pt20 49.43 26.44 1.65 Allowed 'General case' 0 N--CA 1.475 0.813 0 CA-C-N 121.047 1.749 . . . . 0.0 112.455 178.311 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -171.42 -49.34 0.02 OUTLIER 'General case' 0 N--CA 1.446 -0.663 0 C-N-CA 127.748 2.419 . . . . 0.0 108.515 -175.102 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -71.88 -45.94 59.53 Favored 'General case' 0 C--N 1.343 0.321 0 C-N-CA 123.448 0.699 . . . . 0.0 112.749 -169.562 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -63.71 -35.58 81.02 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 169.493 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -49.75 -66.06 2.5 Favored Glycine 0 C--N 1.341 0.811 0 C-N-CA 126.021 1.772 . . . . 0.0 110.745 174.851 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 2.5 m-85 -59.75 -27.67 66.7 Favored 'General case' 0 CA--C 1.512 -0.497 0 O-C-N 121.103 -1.234 . . . . 0.0 112.519 178.492 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -71.65 -32.8 68.31 Favored 'General case' 0 N--CA 1.447 -0.599 0 CA-C-O 117.71 -1.138 . . . . 0.0 112.117 -176.526 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.29 -30.44 70.3 Favored 'General case' 0 N--CA 1.476 0.848 0 CA-C-N 120.517 1.508 . . . . 0.0 110.903 172.065 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 18.8 m -75.92 -56.63 4.49 Favored 'General case' 0 N--CA 1.448 -0.54 0 C-N-CA 124.638 1.175 . . . . 0.0 111.078 -176.864 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 71.9 mt -78.56 -38.06 41.25 Favored 'General case' 0 C--N 1.33 -0.267 0 C-N-CA 124.3 1.04 . . . . 0.0 109.807 -173.771 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -80.54 2.75 76.98 Favored Glycine 0 CA--C 1.527 0.811 0 C-N-CA 124.838 1.209 . . . . 0.0 112.971 179.929 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -53.35 129.74 32.85 Favored 'General case' 0 C--O 1.236 0.389 0 CA-C-N 118.462 1.131 . . . . 0.0 109.301 179.809 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 75.44 5.32 77.33 Favored Glycine 0 CA--C 1.536 1.397 0 C-N-CA 124.378 0.99 . . . . 0.0 114.464 -178.606 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 41.0 mttp -128.23 -52.32 1.29 Allowed 'General case' 0 N--CA 1.472 0.671 0 CA-C-N 119.087 1.444 . . . . 0.0 111.373 -172.375 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 29.5 pt -140.02 147.43 23.67 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.502 0 C-N-CA 123.57 0.748 . . . . 0.0 109.59 -169.407 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -105.32 104.85 14.66 Favored 'General case' 0 N--CA 1.464 0.261 0 C-N-CA 124.889 1.275 . . . . 0.0 109.035 -172.825 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 9.8 p -80.24 137.47 21.48 Favored 'Isoleucine or valine' 0 C--O 1.236 0.357 0 CA-C-N 119.126 0.876 . . . . 0.0 109.431 173.86 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 6.6 m -134.56 117.9 16.67 Favored 'General case' 0 N--CA 1.434 -1.264 0 N-CA-C 104.686 -2.339 . . . . 0.0 104.686 173.766 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 2.4 m -89.74 39.62 0.96 Allowed 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 113.01 0.744 . . . . 0.0 113.01 -169.643 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 1.5 m -65.19 159.68 23.05 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 124.515 1.126 . . . . 0.0 111.077 178.549 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -177.64 -165.85 33.35 Favored Glycine 0 C--N 1.337 0.618 0 N-CA-C 108.678 -1.769 . . . . 0.0 108.678 -175.542 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 12.4 mt -132.49 160.59 36.04 Favored 'General case' 0 N--CA 1.445 -0.679 0 C-N-CA 126.547 1.939 . . . . 0.0 107.773 177.473 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 21.5 mt-10 56.13 18.04 3.02 Favored 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 124.627 1.171 . . . . 0.0 112.885 178.639 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 13.7 p -76.35 163.53 26.91 Favored 'General case' 0 N--CA 1.435 -1.179 0 N-CA-C 115.054 1.501 . . . . 0.0 115.054 -167.841 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 8.0 m -153.82 177.21 11.25 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 129.15 2.98 . . . . 0.0 105.98 -169.735 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 53.6 ttt180 -88.9 153.13 21.29 Favored 'General case' 0 CA--C 1.533 0.297 0 O-C-N 121.07 -1.019 . . . . 0.0 109.737 -177.505 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 1.9 p -44.72 149.54 0.25 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.439 0 C-N-CA 128.035 2.534 . . . . 0.0 112.568 169.987 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 23.0 m170 -88.69 152.81 49.59 Favored Pre-proline 0 CA--C 1.543 0.7 0 C-N-CA 123.274 0.63 . . . . 0.0 111.2 -179.563 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -59.08 -52.98 4.1 Favored 'Trans proline' 0 C--N 1.351 0.665 0 C-N-CA 124.149 3.233 . . . . 0.0 114.204 -169.091 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 7.3 m -67.37 -24.58 65.71 Favored 'General case' 0 CA--C 1.537 0.445 0 CA-C-O 119.215 -0.421 . . . . 0.0 110.651 -171.407 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -56.8 -53.8 53.7 Favored 'General case' 0 CA--C 1.511 -0.548 0 N-CA-C 109.177 -0.675 . . . . 0.0 109.177 173.231 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 52.1 mt -60.6 -38.59 78.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 -170.424 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -62.92 -49.13 75.98 Favored 'General case' 0 N--CA 1.454 -0.243 0 CA-C-N 118.595 0.634 . . . . 0.0 111.244 178.957 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 30.2 mmt -67.46 -37.14 82.48 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-O 122.779 1.276 . . . . 0.0 110.968 179.964 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -74.3 -31.61 62.55 Favored 'General case' 0 N--CA 1.443 -0.779 0 N-CA-C 107.2 -1.408 . . . . 0.0 107.2 -176.08 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 40.2 tt0 -72.07 -20.84 61.6 Favored 'General case' 0 N--CA 1.449 -0.52 0 O-C-N 121.211 -0.931 . . . . 0.0 110.788 170.699 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 20.6 mm-40 -66.01 -32.23 73.59 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-N 119.571 1.078 . . . . 0.0 109.89 169.912 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 15.7 m -91.97 13.63 1.98 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.835 0 CA-C-N 118.361 0.528 . . . . 0.0 112.036 169.037 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 75.82 15.97 80.97 Favored Glycine 0 CA--C 1.532 1.123 0 C-N-CA 124.99 1.281 . . . . 0.0 113.981 173.006 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 3.5 mt -99.54 140.8 18.04 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.113 0 C-N-CA 124.588 1.155 . . . . 0.0 111.201 -171.613 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 3.0 t70 -97.04 130.72 44.31 Favored 'General case' 0 CA--C 1.528 0.12 0 C-N-CA 125.421 1.489 . . . . 0.0 108.886 169.857 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 6.5 pt -132.58 -31.27 0.55 Allowed 'Isoleucine or valine' 0 C--O 1.216 -0.689 0 C-N-CA 125.78 1.632 . . . . 0.0 109.501 169.673 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -15.76 -36.37 0.0 OUTLIER 'General case' 0 CA--C 1.545 0.763 1 C-N-CA 131.768 4.027 . . . . 0.0 118.5 169.992 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -110.25 37.2 3.86 Favored Glycine 0 CA--C 1.534 1.251 0 C-N-CA 125.921 1.724 . . . . 0.0 113.858 -179.507 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 6.3 mt-30 -59.88 -30.48 69.02 Favored 'General case' 0 N--CA 1.474 0.75 0 CA-C-N 119.63 1.715 . . . . 0.0 114.232 -174.719 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -57.8 123.73 16.74 Favored 'General case' 0 C--O 1.236 0.342 0 C-N-CA 124.043 0.937 . . . . 0.0 109.135 -169.421 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 75.2 m -145.96 177.28 9.06 Favored 'General case' 0 N--CA 1.443 -0.802 0 C-N-CA 126.452 1.901 . . . . 0.0 107.019 -169.369 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -59.26 153.95 44.48 Favored Pre-proline 0 C--O 1.239 0.543 0 C-N-CA 123.691 0.796 . . . . 0.0 111.49 175.756 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -63.48 154.16 70.34 Favored 'Trans proline' 0 N--CA 1.454 -0.826 0 C-N-CA 122.49 2.127 . . . . 0.0 109.84 170.879 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 3.2 tt -61.95 -24.41 34.32 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.522 0 O-C-N 121.701 -0.624 . . . . 0.0 111.212 -175.764 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 12.6 mt-10 -65.96 -26.23 67.48 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 124.751 1.22 . . . . 0.0 110.81 -177.377 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 7.6 t-20 -63.12 -23.89 67.65 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 124.673 1.189 . . . . 0.0 111.942 179.085 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 75.0 m-85 -104.62 -174.68 2.59 Favored 'General case' 0 C--O 1.236 0.367 0 C-N-CA 126.19 1.796 . . . . 0.0 110.357 -174.819 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 56.3 t-20 -135.82 132.83 37.16 Favored 'General case' 0 N--CA 1.443 -0.819 0 N-CA-C 106.176 -1.787 . . . . 0.0 106.176 168.855 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -75.0 -19.75 59.95 Favored 'General case' 0 N--CA 1.431 -1.38 0 C-N-CA 120.125 -0.63 . . . . 0.0 109.389 -176.585 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 35.5 t70 -65.03 -24.71 67.57 Favored 'General case' 0 N--CA 1.442 -0.829 0 O-C-N 122.211 -0.305 . . . . 0.0 111.235 179.127 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -77.0 -28.81 55.18 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 123.773 0.829 . . . . 0.0 111.779 173.872 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 11.6 m-85 -77.35 168.21 20.41 Favored 'General case' 0 N--CA 1.451 -0.42 0 C-N-CA 125.261 1.424 . . . . 0.0 111.342 178.863 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -117.28 -39.21 3.22 Favored 'General case' 0 C--O 1.234 0.266 0 C-N-CA 123.213 0.605 . . . . 0.0 111.249 177.256 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -138.2 135.02 44.73 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.693 0 CA-C-O 122.021 0.915 . . . . 0.0 109.943 -169.887 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 75.6 t -142.09 133.89 26.65 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.451 0 N-CA-C 105.905 -1.887 . . . . 0.0 105.905 176.708 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 39.7 mm -117.78 102.82 13.89 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.78 0 N-CA-C 105.253 -2.129 . . . . 0.0 105.253 -170.437 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 47.2 m -101.34 70.61 1.32 Allowed 'General case' 0 N--CA 1.439 -1.014 0 N-CA-C 106.458 -1.682 . . . . 0.0 106.458 -172.947 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -71.22 23.33 0.04 OUTLIER 'General case' 0 CA--C 1.542 0.655 0 N-CA-C 114.136 1.162 . . . . 0.0 114.136 -170.075 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 74.9 m -146.3 55.64 1.16 Allowed 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 125.823 1.649 . . . . 0.0 109.996 172.33 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 81.34 -167.0 48.55 Favored Glycine 0 CA--C 1.531 1.034 0 O-C-N 121.363 -0.835 . . . . 0.0 112.663 176.981 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 15.0 p -151.68 150.19 29.96 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 123.649 0.779 . . . . 0.0 110.375 -169.952 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 61.26 28.25 68.91 Favored Glycine 0 CA--C 1.531 1.036 0 C-N-CA 123.208 0.433 . . . . 0.0 112.081 -179.014 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 32.8 m -71.45 -34.43 53.25 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.612 0 CA-C-N 117.479 0.64 . . . . 0.0 111.719 -169.303 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 21.2 t-20 -178.13 -43.02 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 128.792 2.837 . . . . 0.0 106.14 174.318 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 3.0 tt -44.09 139.68 3.03 Favored Pre-proline 0 CA--C 1.547 0.859 0 C-N-CA 128.202 2.601 . . . . 0.0 111.295 169.659 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_exo -65.17 150.98 86.99 Favored 'Trans proline' 0 C--N 1.356 0.936 0 C-N-CA 121.974 1.782 . . . . 0.0 115.658 -169.727 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -64.51 -30.47 61.63 Favored 'Trans proline' 0 C--N 1.349 0.594 0 C-N-CA 122.491 2.127 . . . . 0.0 114.972 -174.661 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -56.35 -21.05 22.05 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-N 119.49 1.041 . . . . 0.0 112.739 -177.026 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 99.4 m95 -80.06 -28.75 39.16 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 124.948 1.299 . . . . 0.0 112.188 -179.56 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 16.1 m -100.67 -4.35 9.29 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.41 0 C-N-CA 124.946 1.299 . . . . 0.0 112.019 179.623 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 59.8 p -103.27 30.37 4.95 Favored 'General case' 0 CA--C 1.535 0.39 0 CA-C-N 119.325 0.966 . . . . 0.0 112.449 175.644 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 46.1 mm-40 -72.33 175.06 6.47 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 123.344 0.658 . . . . 0.0 111.275 -175.354 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 36.2 mm-40 -61.54 -26.05 67.69 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-O 120.832 0.348 . . . . 0.0 110.513 179.758 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 4.1 tt -136.54 124.49 34.3 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.523 0 N-CA-C 104.997 -2.223 . . . . 0.0 104.997 169.169 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 20.9 t80 -103.49 135.01 45.89 Favored 'General case' 0 CA--C 1.538 0.49 0 N-CA-C 105.755 -1.943 . . . . 0.0 105.755 169.581 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 15.6 mm-40 -136.26 162.25 33.51 Favored 'General case' 0 C--O 1.235 0.291 0 N-CA-C 108.552 -0.907 . . . . 0.0 108.552 170.294 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 5.2 t0 -178.79 126.95 0.1 Allowed 'General case' 0 C--N 1.326 -0.439 0 C-N-CA 126.869 2.068 . . . . 0.0 105.643 -169.519 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 6.6 m0 -143.42 149.0 37.01 Favored 'General case' 0 C--N 1.333 -0.136 0 C-N-CA 122.616 0.366 . . . . 0.0 110.788 -170.933 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 1.9 tp-100 -82.73 54.04 2.56 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 124.338 1.055 . . . . 0.0 109.508 175.909 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 1.1 mp -64.28 147.13 53.16 Favored 'General case' 0 C--N 1.34 0.184 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 178.209 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 69.2 mm-40 -77.8 166.4 22.97 Favored 'General case' 0 CA--C 1.536 0.413 0 N-CA-C 108.229 -1.026 . . . . 0.0 108.229 169.496 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -135.08 137.74 27.69 Favored Pre-proline 0 CA--C 1.536 0.426 0 C-N-CA 124.161 0.984 . . . . 0.0 109.334 171.86 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 21.4 Cg_endo -92.94 3.77 3.43 Favored 'Trans proline' 0 N--CA 1.452 -0.944 0 C-N-CA 122.318 2.012 . . . . 0.0 114.781 -171.661 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -55.81 120.88 8.04 Favored 'General case' 0 C--O 1.237 0.399 0 CA-C-N 120.398 1.454 . . . . 0.0 110.841 -174.571 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 68.65 5.48 45.04 Favored Glycine 0 CA--C 1.534 1.274 0 CA-C-O 118.873 -0.96 . . . . 0.0 114.151 179.902 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 7.0 mt-30 -97.12 167.74 10.87 Favored 'General case' 0 CA--C 1.537 0.47 0 CA-C-N 118.882 1.341 . . . . 0.0 109.864 179.428 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 15.6 m -69.95 165.98 20.57 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 124.097 0.959 . . . . 0.0 111.754 179.762 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 64.7 mt -60.29 -26.77 66.76 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 123.924 0.89 . . . . 0.0 112.452 -175.594 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 5.8 pt-20 -56.29 -35.27 67.32 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 118.773 0.715 . . . . 0.0 111.162 173.934 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 11.9 t -77.27 -41.09 30.14 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.309 0 CA-C-O 118.203 -0.903 . . . . 0.0 109.823 -178.951 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 62.7 m-85 -57.21 -45.67 83.6 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-N 120.323 1.419 . . . . 0.0 109.596 172.091 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 92.4 mtt180 -63.77 -44.11 94.41 Favored 'General case' 0 N--CA 1.468 0.455 0 C-N-CA 123.395 0.678 . . . . 0.0 110.8 -179.789 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 5.3 m -60.9 -46.76 89.37 Favored 'General case' 0 N--CA 1.449 -0.475 0 C-N-CA 124.642 1.177 . . . . 0.0 109.998 176.281 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 69.4 t -70.09 -37.86 73.33 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.494 0 CA-C-O 117.704 -1.141 . . . . 0.0 109.116 -173.39 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 41.1 mtm105 -57.22 -43.36 82.75 Favored 'General case' 0 C--O 1.224 -0.275 0 CA-C-N 120.113 1.324 . . . . 0.0 110.131 172.859 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -63.67 -54.35 31.99 Favored Glycine 0 CA--C 1.53 1.022 0 CA-C-N 118.672 0.669 . . . . 0.0 111.766 179.128 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 49.8 mm-40 -52.69 -51.23 61.2 Favored 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 124.696 1.198 . . . . 0.0 110.049 177.838 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 59.6 t -63.8 -50.22 78.64 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.666 0 CA-C-O 118.397 -0.811 . . . . 0.0 109.782 -176.172 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 86.7 tttt -56.38 -46.81 79.91 Favored 'General case' 0 CA--C 1.512 -0.483 0 N-CA-C 108.219 -1.03 . . . . 0.0 108.219 -175.059 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 40.2 tt0 -64.11 -42.88 96.71 Favored 'General case' 0 N--CA 1.446 -0.668 0 C-N-CA 122.945 0.498 . . . . 0.0 111.112 -175.561 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 25.4 mtt180 -74.61 -38.73 62.5 Favored 'General case' 0 N--CA 1.467 0.395 0 O-C-N 121.047 -1.033 . . . . 0.0 111.666 -178.046 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 85.2 t -65.29 -40.33 88.2 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.634 0 N-CA-C 108.441 -0.948 . . . . 0.0 108.441 174.676 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 4.2 mm-40 -60.54 -46.74 89.07 Favored 'General case' 0 C--O 1.227 -0.125 0 CA-C-N 119.489 1.041 . . . . 0.0 109.798 176.028 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 27.7 t-20 -64.36 -40.64 96.25 Favored 'General case' 0 CA--C 1.529 0.17 0 C-N-CA 123.039 0.536 . . . . 0.0 110.952 -176.471 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 24.2 tp -58.19 -50.13 74.6 Favored 'General case' 0 N--CA 1.451 -0.399 0 C-N-CA 124.875 1.27 . . . . 0.0 110.784 173.186 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 75.3 mt -66.12 -44.89 91.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 N-CA-C 107.808 -1.182 . . . . 0.0 107.808 -177.081 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -58.92 -33.93 71.13 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 123.315 0.646 . . . . 0.0 112.182 -179.796 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 17.8 ptpt -79.73 -38.95 32.21 Favored 'General case' 0 C--N 1.345 0.4 0 CA-C-O 117.926 -1.035 . . . . 0.0 112.101 177.634 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 11.1 pt -83.98 -40.6 15.82 Favored 'Isoleucine or valine' 0 C--O 1.234 0.271 0 CA-C-N 119.997 1.271 . . . . 0.0 113.699 -174.794 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 67.7 m . . . . . 0 C--O 1.254 1.333 0 C-N-CA 125.436 1.494 . . . . 0.0 110.06 -169.807 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 9.9 ptm . . . . . 0 N--CA 1.497 1.902 0 N-CA-C 110.837 -0.06 . . . . 0.0 110.837 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 20.9 mttm -73.95 122.76 23.08 Favored 'General case' 0 N--CA 1.478 0.967 0 O-C-N 120.961 -1.087 . . . . 0.0 108.329 -171.083 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 93.7 mttt -89.23 134.92 33.84 Favored 'General case' 0 CA--C 1.515 -0.371 0 N-CA-C 108.156 -1.053 . . . . 0.0 108.156 176.403 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 1.9 t -122.26 149.98 25.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 C-N-CA 125.764 1.626 . . . . 0.0 109.655 -169.021 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 28.3 mtt -141.02 148.31 40.06 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 125.548 1.539 . . . . 0.0 108.31 168.667 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 65.4 m-85 -132.21 113.02 12.77 Favored 'General case' 0 N--CA 1.453 -0.318 0 N-CA-C 103.919 -2.623 . . . . 0.0 103.919 169.983 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 19.7 t -140.69 127.02 20.95 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 N-CA-C 107.07 -1.455 . . . . 0.0 107.07 -169.248 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 44.3 t -91.7 -152.07 0.29 Allowed 'General case' 0 CA--C 1.546 0.814 0 N-CA-C 105.621 -1.992 . . . . 0.0 105.621 169.239 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 64.0 tttp -58.95 -35.24 72.8 Favored 'General case' 0 N--CA 1.473 0.693 0 O-C-N 119.852 -1.78 . . . . 0.0 109.187 169.348 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 79.7 mtt180 -134.06 176.93 8.14 Favored 'General case' 0 N--CA 1.465 0.302 0 C-N-CA 125.462 1.505 . . . . 0.0 108.999 177.662 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 51.5 t30 -70.64 -15.35 62.73 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 123.387 0.675 . . . . 0.0 111.296 169.651 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 1.8 m -57.04 169.68 0.51 Allowed 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 126.682 1.993 . . . . 0.0 112.443 174.72 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 5.1 m 62.51 -92.51 0.03 OUTLIER 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 125.974 1.71 . . . . 0.0 113.885 169.549 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -92.68 -36.65 12.83 Favored 'General case' 0 N--CA 1.476 0.855 0 CA-C-N 119.851 1.205 . . . . 0.0 112.34 -174.247 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 1.2 m -59.72 -37.28 78.46 Favored 'General case' 0 N--CA 1.47 0.574 0 O-C-N 121.516 -0.74 . . . . 0.0 112.344 -169.659 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 22.2 pt20 -47.82 -46.09 30.5 Favored 'General case' 0 C--N 1.341 0.212 0 C-N-CA 125.008 1.323 . . . . 0.0 111.299 176.028 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -84.45 -38.59 19.97 Favored 'General case' 0 C--O 1.226 -0.183 0 CA-C-N 118.999 0.818 . . . . 0.0 111.139 -175.685 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -61.66 -47.88 83.36 Favored 'General case' 0 C--N 1.332 -0.16 0 C-N-CA 122.126 0.171 . . . . 0.0 111.307 -174.421 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 1.2 pp20? -71.01 -29.37 65.29 Favored 'General case' 0 C--O 1.235 0.309 0 C-N-CA 119.928 -0.709 . . . . 0.0 109.928 176.113 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -49.01 -62.54 4.54 Favored Glycine 0 C--N 1.34 0.805 0 C-N-CA 126.418 1.961 . . . . 0.0 110.457 173.917 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 9.7 m-85 -65.84 -31.21 72.03 Favored 'General case' 0 CA--C 1.512 -0.491 0 CA-C-N 119.35 1.575 . . . . 0.0 114.14 175.922 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -65.22 -33.05 75.09 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 119.56 1.073 . . . . 0.0 111.918 -169.823 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 5.9 ptpt -63.22 -33.79 76.25 Favored 'General case' 0 N--CA 1.476 0.846 0 CA-C-N 119.561 1.073 . . . . 0.0 111.646 173.312 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 6.6 m -75.31 -54.71 6.62 Favored 'General case' 0 N--CA 1.448 -0.528 0 C-N-CA 125.179 1.392 . . . . 0.0 110.002 -177.672 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 87.8 mt -73.41 -35.95 65.92 Favored 'General case' 0 CA--C 1.53 0.205 0 C-N-CA 123.667 0.787 . . . . 0.0 110.533 -173.509 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -93.43 6.27 74.77 Favored Glycine 0 CA--C 1.526 0.762 0 C-N-CA 125.117 1.342 . . . . 0.0 113.499 -175.757 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -48.72 123.92 7.61 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 125.06 1.344 . . . . 0.0 110.94 -173.389 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 77.9 -14.62 9.99 Favored Glycine 0 CA--C 1.536 1.368 0 C-N-CA 124.655 1.122 . . . . 0.0 114.472 178.406 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 61.9 mttm -95.39 -45.04 7.29 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-N 119.372 1.586 . . . . 0.0 110.48 179.655 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 25.7 pt -140.29 153.14 21.87 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.37 0 C-N-CA 123.776 0.83 . . . . 0.0 110.215 -169.534 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -113.15 104.98 12.9 Favored 'General case' 0 C--O 1.226 -0.162 0 C-N-CA 125.209 1.404 . . . . 0.0 108.611 -173.258 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 14.9 p -88.97 133.01 32.32 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.307 0 CA-C-N 118.988 0.813 . . . . 0.0 109.248 175.756 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 15.1 m -152.36 95.54 2.05 Favored 'General case' 0 N--CA 1.456 -0.157 0 N-CA-C 105.302 -2.111 . . . . 0.0 105.302 172.351 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 48.3 m -92.31 72.39 5.3 Favored 'General case' 0 C--O 1.232 0.184 0 CA-C-O 121.741 0.781 . . . . 0.0 111.03 -169.844 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 3.7 m -60.31 165.74 3.39 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 125.482 1.513 . . . . 0.0 109.925 170.066 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -161.1 -160.73 10.96 Favored Glycine 0 C--N 1.337 0.622 0 N-CA-C 109.209 -1.557 . . . . 0.0 109.209 -169.686 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 10.6 mt -133.56 -62.23 0.79 Allowed 'General case' 0 N--CA 1.45 -0.455 0 C-N-CA 123.329 0.651 . . . . 0.0 110.13 -169.731 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -80.44 -21.01 42.55 Favored 'General case' 0 CA--C 1.537 0.481 0 C-N-CA 124.013 0.925 . . . . 0.0 111.382 174.825 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 43.0 m -60.82 166.18 3.54 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 128.196 2.598 . . . . 0.0 116.086 -169.306 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 60.9 p -145.69 -96.68 0.09 Allowed 'General case' 0 N--CA 1.448 -0.529 0 CA-C-N 113.439 -1.71 . . . . 0.0 111.685 -168.604 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 6.4 ttt180 -140.97 179.67 6.59 Favored 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 125.366 1.466 . . . . 0.0 109.316 178.052 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 3.5 m -85.68 178.72 0.53 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.788 0 C-N-CA 123.701 0.8 . . . . 0.0 110.234 -174.442 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 18.4 m-70 -89.05 153.85 49.33 Favored Pre-proline 0 CA--C 1.546 0.801 0 C-N-CA 123.505 0.722 . . . . 0.0 110.825 -177.974 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 33.1 Cg_endo -65.72 -54.29 0.59 Allowed 'Trans proline' 0 C--N 1.349 0.554 0 C-N-CA 123.109 2.539 . . . . 0.0 113.033 -174.004 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 8.7 m -67.74 -24.46 65.36 Favored 'General case' 0 CA--C 1.535 0.381 0 O-C-N 121.97 -0.456 . . . . 0.0 110.337 -176.702 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -55.56 -52.03 65.11 Favored 'General case' 0 CA--C 1.509 -0.623 0 CA-C-O 119.198 -0.429 . . . . 0.0 109.862 173.266 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 37.3 mt -58.87 -42.32 85.4 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 N-CA-C 108.466 -0.939 . . . . 0.0 108.466 -172.778 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -62.21 -47.13 85.82 Favored 'General case' 0 N--CA 1.448 -0.534 0 CA-C-N 118.23 0.468 . . . . 0.0 110.724 -179.443 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 30.7 mmt -72.56 -33.7 66.99 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-O 122.251 1.024 . . . . 0.0 111.415 -177.144 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -74.49 -31.52 62.22 Favored 'General case' 0 N--CA 1.443 -0.821 0 N-CA-C 107.316 -1.364 . . . . 0.0 107.316 -179.144 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 41.6 tt0 -72.91 -22.77 60.68 Favored 'General case' 0 N--CA 1.444 -0.73 0 O-C-N 121.341 -0.849 . . . . 0.0 110.087 172.418 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 16.9 mm-40 -67.32 -29.71 69.36 Favored 'General case' 0 CA--C 1.532 0.28 0 CA-C-N 119.179 0.9 . . . . 0.0 110.334 171.392 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . 0.279 5.3 p -90.83 11.17 2.49 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.927 0 CA-C-N 118.552 0.615 . . . . 0.0 111.289 169.183 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 77.82 17.64 78.34 Favored Glycine 0 CA--C 1.531 1.034 0 C-N-CA 124.677 1.132 . . . . 0.0 113.65 173.773 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 6.9 mt -108.9 138.11 37.63 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.186 0 CA-C-N 118.723 1.262 . . . . 0.0 110.454 -175.374 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 4.3 t70 -90.07 138.36 31.57 Favored 'General case' 0 C--O 1.234 0.275 0 C-N-CA 123.929 0.891 . . . . 0.0 108.773 169.301 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 13.7 pt -130.5 -30.38 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.438 0 C-N-CA 124.67 1.188 . . . . 0.0 110.182 169.492 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -42.18 -35.87 1.06 Allowed 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 127.471 2.308 . . . . 0.0 114.253 169.035 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -65.55 -13.54 58.77 Favored Glycine 0 CA--C 1.53 1.02 0 C-N-CA 124.031 0.824 . . . . 0.0 113.506 -179.862 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 28.0 mt-30 -72.28 154.33 41.04 Favored 'General case' 0 N--CA 1.442 -0.84 0 CA-C-N 118.753 1.276 . . . . 0.0 111.372 172.589 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 2.4 p -152.11 161.7 42.23 Favored 'General case' 0 N--CA 1.433 -1.312 0 C-N-CA 129.826 3.25 . . . . 0.0 103.605 167.702 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 49.9 m -112.72 97.01 6.29 Favored 'General case' 0 C--O 1.234 0.287 0 N-CA-C 108.76 -0.83 . . . . 0.0 108.76 -170.444 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -68.84 152.85 96.56 Favored Pre-proline 0 C--O 1.241 0.646 0 N-CA-C 107.558 -1.275 . . . . 0.0 107.558 169.183 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -59.78 135.74 65.71 Favored 'Trans proline' 0 N--CA 1.449 -1.129 0 C-N-CA 121.531 1.487 . . . . 0.0 108.447 170.168 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 2.1 tt -61.77 -19.13 20.59 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.622 0 C-N-CA 123.703 0.801 . . . . 0.0 110.767 -179.445 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 12.8 mt-10 -66.32 -24.37 66.52 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 126.089 1.756 . . . . 0.0 110.669 179.418 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 13.3 t-20 -69.25 -0.45 6.16 Favored 'General case' 0 CA--C 1.546 0.798 0 C-N-CA 124.822 1.249 . . . . 0.0 112.603 176.346 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 14.0 m-85 -137.22 -170.95 2.84 Favored 'General case' 0 C--O 1.236 0.392 0 C-N-CA 127.604 2.362 . . . . 0.0 108.245 -179.155 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 57.0 t-20 -141.08 141.87 34.21 Favored 'General case' 0 N--CA 1.45 -0.46 0 N-CA-C 107.657 -1.238 . . . . 0.0 107.657 169.577 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -71.8 -28.85 63.88 Favored 'General case' 0 N--CA 1.434 -1.267 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 178.98 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 36.6 t70 -65.86 -20.98 66.42 Favored 'General case' 0 CA--C 1.546 0.799 0 C-N-CA 120.582 -0.447 . . . . 0.0 111.015 -177.806 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -80.18 -28.91 38.64 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 124.677 1.191 . . . . 0.0 111.79 173.999 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 8.0 m-85 -77.57 169.84 17.61 Favored 'General case' 0 C--O 1.238 0.465 0 C-N-CA 125.152 1.381 . . . . 0.0 111.8 179.956 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 23.5 t70 -118.3 -39.98 2.99 Favored 'General case' 0 C--O 1.235 0.33 0 C-N-CA 123.437 0.695 . . . . 0.0 111.606 178.593 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -139.44 134.49 39.73 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.395 0 CA-C-O 121.393 0.616 . . . . 0.0 110.113 -170.111 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 70.5 t -145.52 129.7 11.81 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.495 0 N-CA-C 105.554 -2.017 . . . . 0.0 105.554 179.424 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 11.6 mm -104.85 130.55 55.7 Favored 'Isoleucine or valine' 0 C--O 1.236 0.392 0 N-CA-C 106.759 -1.571 . . . . 0.0 106.759 176.484 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 37.5 m -96.87 91.2 5.53 Favored 'General case' 0 N--CA 1.446 -0.672 0 N-CA-C 104.677 -2.342 . . . . 0.0 104.677 169.028 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 33.9 mt -61.62 -12.86 17.8 Favored 'General case' 0 N--CA 1.465 0.314 0 C-N-CA 123.399 0.68 . . . . 0.0 112.748 -175.368 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 56.7 m -143.54 134.65 25.67 Favored 'General case' 0 N--CA 1.445 -0.696 0 N-CA-C 106.075 -1.824 . . . . 0.0 106.075 179.194 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 57.03 -146.3 36.17 Favored Glycine 0 CA--C 1.533 1.195 0 C-N-CA 123.452 0.548 . . . . 0.0 111.826 178.929 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 19.6 p -127.23 -93.56 0.47 Allowed 'General case' 0 CA--C 1.529 0.172 0 C-N-CA 124.052 0.941 . . . . 0.0 108.822 174.163 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -72.85 -27.5 68.81 Favored Glycine 0 C--N 1.337 0.602 0 CA-C-O 118.898 -0.945 . . . . 0.0 112.482 -178.442 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.422 HG23 ' H ' ' A' ' 85' ' ' ASN 0.325 16.0 m 47.18 -94.04 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.545 0.754 0 C-N-CA 126.404 1.882 . . . . 0.0 112.602 179.452 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . 0.422 ' H ' HG23 ' A' ' 84' ' ' VAL . 53.0 t30 -142.91 45.4 1.58 Allowed 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 126.105 1.762 . . . . 0.0 108.068 178.408 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -143.14 147.08 39.4 Favored Pre-proline 0 CA--C 1.548 0.88 0 C-N-CA 125.408 1.483 . . . . 0.0 110.624 -168.89 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_exo -64.67 150.3 88.4 Favored 'Trans proline' 0 C--N 1.357 1.005 0 C-N-CA 122.08 1.853 . . . . 0.0 114.498 -170.973 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -67.19 -33.52 30.79 Favored 'Trans proline' 0 N--CA 1.458 -0.616 0 C-N-CA 122.795 2.33 . . . . 0.0 116.014 -169.204 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 3.1 pm0 -63.33 -15.26 56.84 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-N 121.573 1.988 . . . . 0.0 112.045 -178.719 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 98.2 m95 -76.51 -22.95 53.76 Favored 'General case' 0 N--CA 1.452 -0.341 0 CA-C-O 118.835 -0.602 . . . . 0.0 111.953 174.597 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 28.3 m -104.46 -6.85 9.63 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.488 0 C-N-CA 124.832 1.253 . . . . 0.0 113.163 178.023 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . 0.271 9.3 t -112.73 70.62 0.72 Allowed 'General case' 0 CA--C 1.537 0.454 0 CA-C-O 123.441 1.591 . . . . 0.0 107.539 168.899 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 60.4 mm-40 -100.67 179.46 4.41 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 126.545 1.938 . . . . 0.0 109.084 175.067 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 37.7 mm-40 -64.95 -24.18 67.44 Favored 'General case' 0 CA--C 1.539 0.543 0 O-C-N 121.743 -0.598 . . . . 0.0 110.94 179.892 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 6.9 tt -139.63 130.08 31.33 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.354 0 N-CA-C 105.807 -1.923 . . . . 0.0 105.807 169.329 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 36.8 t80 -113.36 135.54 53.75 Favored 'General case' 0 CA--C 1.536 0.41 0 N-CA-C 105.713 -1.958 . . . . 0.0 105.713 169.643 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 11.1 mm-40 -142.44 163.29 33.23 Favored 'General case' 0 C--O 1.232 0.165 0 C-N-CA 124.311 1.044 . . . . 0.0 109.524 179.666 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 2.7 t70 -172.46 129.64 0.56 Allowed 'General case' 0 C--O 1.237 0.422 0 C-N-CA 127.594 2.358 . . . . 0.0 107.07 -169.366 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 5.9 m0 -144.58 153.5 41.87 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-O 120.99 0.424 . . . . 0.0 111.936 -170.637 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 2.3 mp0 -87.48 51.87 2.34 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 124.527 1.131 . . . . 0.0 109.456 175.789 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -67.42 134.59 51.7 Favored 'General case' 0 C--N 1.339 0.136 0 N-CA-C 106.5 -1.667 . . . . 0.0 106.5 169.823 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 6.4 pt-20 -83.18 171.55 13.56 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 123.488 0.715 . . . . 0.0 110.192 175.448 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -131.6 133.27 24.1 Favored Pre-proline 0 C--O 1.238 0.459 0 C-N-CA 125.849 1.66 . . . . 0.0 109.804 -169.805 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 10.6 Cg_endo -97.93 2.5 1.41 Allowed 'Trans proline' 0 N--CA 1.451 -1.004 0 C-N-CA 123.003 2.469 . . . . 0.0 113.538 -174.799 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 8.0 t70 -50.61 115.84 1.66 Allowed 'General case' 0 CA--C 1.538 0.518 0 CA-C-N 120.486 1.494 . . . . 0.0 110.787 -174.113 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 67.47 5.5 36.68 Favored Glycine 0 CA--C 1.537 1.434 0 CA-C-O 119.014 -0.881 . . . . 0.0 114.61 178.172 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 5.6 mt-30 -87.32 172.46 9.84 Favored 'General case' 0 CA--C 1.54 0.583 0 CA-C-N 118.998 1.399 . . . . 0.0 109.869 178.495 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 15.5 m -68.95 161.19 29.37 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 123.854 0.862 . . . . 0.0 110.559 176.897 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 28.1 mt -63.36 -24.42 67.84 Favored 'General case' 0 N--CA 1.47 0.561 0 O-C-N 121.491 -0.756 . . . . 0.0 112.499 -173.02 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 6.0 pt-20 -55.19 -35.49 64.89 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 118.875 0.761 . . . . 0.0 111.189 172.346 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 10.9 t -76.82 -42.08 33.02 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.398 0 CA-C-O 118.433 -0.794 . . . . 0.0 109.189 -178.811 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 55.4 m-85 -57.24 -45.36 83.99 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-N 120.222 1.374 . . . . 0.0 110.296 172.529 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 90.9 mtt180 -63.27 -43.82 96.86 Favored 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 123.327 0.651 . . . . 0.0 110.584 179.548 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 4.2 m -62.14 -45.6 92.7 Favored 'General case' 0 N--CA 1.448 -0.542 0 C-N-CA 124.518 1.127 . . . . 0.0 110.275 177.168 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 60.2 t -67.21 -39.34 82.82 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.404 0 CA-C-O 118.593 -0.718 . . . . 0.0 109.25 -174.892 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 44.0 mtm105 -57.41 -42.89 83.2 Favored 'General case' 0 CA--C 1.536 0.431 0 CA-C-N 119.31 0.959 . . . . 0.0 110.397 174.913 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -63.37 -54.13 34.4 Favored Glycine 0 CA--C 1.533 1.158 0 CA-C-O 119.576 -0.569 . . . . 0.0 112.08 177.548 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 13.3 mm-40 -51.65 -51.52 55.11 Favored 'General case' 0 N--CA 1.468 0.47 0 C-N-CA 124.66 1.184 . . . . 0.0 110.204 178.215 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 86.1 t -67.74 -48.17 76.95 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 115.186 -0.916 . . . . 0.0 109.684 -173.114 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 62.0 tttm -55.06 -47.51 74.74 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 119.388 0.995 . . . . 0.0 109.711 -175.033 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -64.68 -43.32 93.93 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 122.917 0.487 . . . . 0.0 111.214 -175.469 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 20.8 mtt180 -75.1 -33.97 61.67 Favored 'General case' 0 N--CA 1.469 0.511 0 O-C-N 121.277 -0.889 . . . . 0.0 111.623 -178.179 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 59.5 t -67.34 -39.8 83.51 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.419 0 N-CA-C 108.62 -0.882 . . . . 0.0 108.62 173.674 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 22.8 mt-10 -59.45 -43.05 93.27 Favored 'General case' 0 N--CA 1.462 0.157 0 CA-C-N 119.938 1.245 . . . . 0.0 110.403 174.112 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 29.2 t-20 -63.55 -43.39 97.19 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 123.151 0.58 . . . . 0.0 111.371 -178.918 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 1.9 tm? -59.1 -47.22 86.06 Favored 'General case' 0 N--CA 1.456 -0.152 0 C-N-CA 125.063 1.345 . . . . 0.0 110.947 175.253 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 84.8 mt -65.17 -46.09 92.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 N-CA-C 108.302 -0.999 . . . . 0.0 108.302 179.985 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -59.23 -29.62 67.65 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 123.431 0.692 . . . . 0.0 112.073 177.099 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 69.1 mttt -69.09 -55.21 11.43 Favored 'General case' 0 C--N 1.343 0.311 0 CA-C-N 119.033 0.833 . . . . 0.0 110.385 172.707 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 17.1 pt -78.7 -36.76 19.87 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.335 0 N-CA-C 114.854 1.427 . . . . 0.0 114.854 -169.609 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 75.3 m . . . . . 0 C--O 1.253 1.26 0 C-N-CA 126.185 1.794 . . . . 0.0 109.117 -169.898 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 12.3 ptm . . . . . 0 N--CA 1.497 1.877 0 CA-C-O 120.17 0.033 . . . . 0.0 110.987 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 26.7 mttm -71.08 127.49 32.75 Favored 'General case' 0 N--CA 1.478 0.945 0 N-CA-C 107.682 -1.229 . . . . 0.0 107.682 -174.496 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 72.7 mttt -97.91 133.71 42.03 Favored 'General case' 0 CA--C 1.512 -0.502 0 CA-C-N 119.785 1.175 . . . . 0.0 108.059 172.199 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 11.7 t -113.21 151.21 15.12 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.605 0 C-N-CA 127.237 2.215 . . . . 0.0 106.568 -170.916 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 52.3 ttm -146.43 141.94 27.65 Favored 'General case' 0 C--N 1.32 -0.676 0 C-N-CA 125.544 1.538 . . . . 0.0 108.708 174.751 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 47.4 m-85 -131.63 103.72 6.54 Favored 'General case' 0 CA--C 1.519 -0.233 0 N-CA-C 106.088 -1.819 . . . . 0.0 106.088 175.216 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 11.0 t -134.83 137.84 50.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 118.629 0.65 . . . . 0.0 110.812 -168.912 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 44.8 t -121.08 -171.66 2.24 Favored 'General case' 0 CA--C 1.548 0.875 0 N-CA-C 104.594 -2.373 . . . . 0.0 104.594 168.53 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 60.2 mtpt -57.18 -67.62 0.3 Allowed 'General case' 0 N--CA 1.471 0.617 0 CA-C-N 120.007 1.276 . . . . 0.0 111.365 -171.191 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 29.3 ttm-85 -111.8 132.83 54.41 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-N 119.47 1.032 . . . . 0.0 108.221 -178.759 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 12.6 t30 -54.56 -34.84 62.53 Favored 'General case' 0 N--CA 1.478 0.943 0 N-CA-C 114.177 1.177 . . . . 0.0 114.177 -169.665 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 5.7 m -57.94 -20.56 38.5 Favored 'General case' 0 CA--C 1.537 0.464 0 N-CA-C 114.242 1.201 . . . . 0.0 114.242 -170.373 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 21.2 m -134.13 151.79 51.53 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 124.513 1.125 . . . . 0.0 109.652 176.828 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 90.5 mtm-85 55.01 40.78 32.15 Favored 'General case' 0 N--CA 1.467 0.414 0 C-N-CA 126.024 1.729 . . . . 0.0 112.346 175.845 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 13.6 m -136.43 -73.78 0.44 Allowed 'General case' 0 CA--C 1.534 0.353 0 N-CA-C 104.052 -2.573 . . . . 0.0 104.052 169.044 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER 40.89 -109.81 0.11 Allowed 'General case' 0 N--CA 1.454 -0.244 0 C-N-CA 127.607 2.363 . . . . 0.0 112.135 168.017 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -76.54 -14.55 60.01 Favored 'General case' 0 CA--C 1.518 -0.261 0 N-CA-C 113.819 1.044 . . . . 0.0 113.819 -169.964 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -63.86 -50.58 68.27 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 119.608 1.094 . . . . 0.0 111.415 -169.135 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -66.82 -38.07 85.74 Favored 'General case' 0 N--CA 1.467 0.405 0 N-CA-C 109.573 -0.529 . . . . 0.0 109.573 173.39 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -55.69 -55.71 27.43 Favored Glycine 0 C--N 1.338 0.645 0 N-CA-C 110.881 -0.888 . . . . 0.0 110.881 -176.959 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 4.8 m-85 -65.9 -32.17 73.52 Favored 'General case' 0 CA--C 1.506 -0.718 0 CA-C-O 118.587 -0.72 . . . . 0.0 111.787 178.484 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -68.84 -32.92 72.95 Favored 'General case' 0 N--CA 1.446 -0.674 0 CA-C-N 118.965 0.802 . . . . 0.0 110.72 -178.051 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.74 -36.97 86.03 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-N 119.504 1.047 . . . . 0.0 110.066 172.256 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 19.0 m -70.09 -56.89 5.76 Favored 'General case' 0 N--CA 1.45 -0.429 0 C-N-CA 124.236 1.014 . . . . 0.0 112.26 -179.939 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 41.7 mt -75.19 -38.23 60.89 Favored 'General case' 0 N--CA 1.466 0.359 0 C-N-CA 124.809 1.244 . . . . 0.0 109.891 -173.513 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -82.51 4.13 79.38 Favored Glycine 0 CA--C 1.526 0.756 0 C-N-CA 125.585 1.564 . . . . 0.0 113.19 179.796 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -53.79 133.22 42.41 Favored 'General case' 0 C--O 1.236 0.358 0 CA-C-N 118.793 1.297 . . . . 0.0 109.279 178.913 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 70.19 8.57 62.18 Favored Glycine 0 CA--C 1.533 1.196 0 CA-C-O 118.444 -1.198 . . . . 0.0 114.969 177.837 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 9.8 ptpp? -137.01 -36.59 0.67 Allowed 'General case' 0 N--CA 1.473 0.724 0 CA-C-N 119.744 1.772 . . . . 0.0 113.079 179.727 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 17.6 pt -141.22 148.73 21.06 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.568 0 CA-C-N 119.807 1.185 . . . . 0.0 109.723 -177.477 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -95.26 158.22 15.55 Favored 'General case' 0 N--CA 1.467 0.412 0 C-N-CA 125.322 1.449 . . . . 0.0 108.181 176.81 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 21.7 t -141.34 134.19 30.0 Favored 'Isoleucine or valine' 0 C--O 1.236 0.374 0 N-CA-C 107.872 -1.159 . . . . 0.0 107.872 -176.421 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 26.7 m -147.23 113.41 5.86 Favored 'General case' 0 N--CA 1.44 -0.964 0 N-CA-C 106.751 -1.574 . . . . 0.0 106.751 171.711 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 50.3 m -99.65 97.8 8.72 Favored 'General case' 0 N--CA 1.449 -0.516 0 N-CA-C 108.423 -0.955 . . . . 0.0 108.423 169.578 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 7.7 p -68.07 -66.46 0.56 Allowed 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 125.566 1.546 . . . . 0.0 111.322 -175.952 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 110.17 135.07 6.96 Favored Glycine 0 CA--C 1.523 0.581 0 N-CA-C 108.428 -1.869 . . . . 0.0 108.428 -171.436 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 5.9 mt -70.71 -36.96 73.48 Favored 'General case' 0 CA--C 1.529 0.15 0 N-CA-C 109.003 -0.74 . . . . 0.0 109.003 171.31 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 34.4 mt-10 -126.77 160.97 29.3 Favored 'General case' 0 N--CA 1.445 -0.702 0 C-N-CA 129.624 3.17 . . . . 0.0 105.691 169.259 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 54.6 p -150.86 145.51 25.72 Favored 'General case' 0 N--CA 1.445 -0.715 0 N-CA-C 114.003 1.112 . . . . 0.0 114.003 -173.192 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 3.1 m -147.3 -82.94 0.12 Allowed 'General case' 0 N--CA 1.452 -0.351 0 CA-C-N 113.117 -1.856 . . . . 0.0 108.271 -173.119 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 5.8 ttp180 -159.22 -154.01 0.39 Allowed 'General case' 0 N--CA 1.466 0.339 0 N-CA-C 109.33 -0.619 . . . . 0.0 109.33 -179.29 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 2.9 p -133.12 148.79 31.19 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.7 0 C-N-CA 128.2 2.6 . . . . 0.0 105.529 177.988 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 81.5 t60 -73.38 136.97 78.16 Favored Pre-proline 0 CA--C 1.544 0.725 0 CA-C-O 118.646 -0.692 . . . . 0.0 110.5 -169.759 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 28.6 Cg_endo -60.75 -49.1 9.23 Favored 'Trans proline' 0 C--N 1.35 0.626 0 C-N-CA 123.181 2.587 . . . . 0.0 112.962 -172.918 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 18.5 m -67.05 -20.13 65.79 Favored 'General case' 0 CA--C 1.536 0.416 0 O-C-N 121.95 -0.469 . . . . 0.0 110.526 -177.881 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -59.52 -52.32 66.08 Favored 'General case' 0 CA--C 1.506 -0.737 0 N-CA-C 108.838 -0.801 . . . . 0.0 108.838 173.87 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 60.0 mt -56.89 -42.27 78.05 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 N-CA-C 108.729 -0.841 . . . . 0.0 108.729 -171.621 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -64.23 -47.95 77.7 Favored 'General case' 0 N--CA 1.45 -0.429 0 CA-C-N 117.826 0.285 . . . . 0.0 111.509 -179.798 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 38.9 mmt -69.26 -35.37 76.02 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-O 122.747 1.261 . . . . 0.0 110.76 -178.521 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -73.26 -33.05 65.06 Favored 'General case' 0 N--CA 1.443 -0.82 0 N-CA-C 106.887 -1.523 . . . . 0.0 106.887 -177.662 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 6.6 tp10 -70.24 -20.29 63.08 Favored 'General case' 0 N--CA 1.449 -0.522 0 C-N-CA 123.645 0.778 . . . . 0.0 110.775 170.807 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 81.5 mt-10 -64.26 -38.65 91.8 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-N 119.773 1.17 . . . . 0.0 109.353 169.666 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . 0.306 9.7 p -83.43 7.35 1.55 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.771 0 CA-C-O 120.805 0.336 . . . . 0.0 111.81 171.252 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 74.45 23.57 75.15 Favored Glycine 0 CA--C 1.531 1.071 0 O-C-N 120.838 -1.164 . . . . 0.0 113.028 175.981 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 38.4 mt -117.12 131.88 68.52 Favored 'Isoleucine or valine' 0 C--N 1.338 0.068 0 C-N-CA 124.831 1.252 . . . . 0.0 108.584 -176.552 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 34.6 t0 -101.59 146.39 27.75 Favored 'General case' 0 C--O 1.235 0.318 0 CA-C-O 121.028 0.442 . . . . 0.0 110.238 170.794 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 12.2 pt -135.98 -9.6 0.84 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.461 0 C-N-CA 127.081 2.152 . . . . 0.0 110.836 176.145 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 7.7 t -43.31 131.82 4.6 Favored 'General case' 0 CA--C 1.542 0.663 0 CA-C-N 120.249 1.386 . . . . 0.0 109.325 168.971 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 71.92 38.37 60.24 Favored Glycine 0 CA--C 1.532 1.114 0 CA-C-O 118.917 -0.935 . . . . 0.0 113.082 -177.299 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 29.9 mt-30 -56.25 -40.94 74.95 Favored 'General case' 0 N--CA 1.473 0.679 0 CA-C-N 118.888 1.344 . . . . 0.0 110.478 169.995 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -66.17 134.59 53.06 Favored 'General case' 0 N--CA 1.447 -0.592 0 C-N-CA 124.177 0.991 . . . . 0.0 109.413 -170.0 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 2.9 p -140.2 -68.77 0.41 Allowed 'General case' 0 C--O 1.233 0.226 0 C-N-CA 124.018 0.927 . . . . 0.0 108.929 -169.657 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -148.54 154.6 41.45 Favored Pre-proline 0 C--O 1.238 0.484 0 C-N-CA 126.021 1.728 . . . . 0.0 107.478 174.595 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -62.71 151.81 81.7 Favored 'Trans proline' 0 N--CA 1.456 -0.734 0 C-N-CA 121.831 1.687 . . . . 0.0 109.34 170.027 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 18.2 tt -56.19 -28.78 26.17 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.439 0 C-N-CA 123.25 0.62 . . . . 0.0 111.741 -178.687 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 11.4 mt-10 -66.72 -26.69 67.12 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 124.563 1.145 . . . . 0.0 110.689 -174.83 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 11.2 t-20 -63.6 -30.97 72.0 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 124.833 1.253 . . . . 0.0 111.611 178.424 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 94.1 m-85 -92.12 -178.11 4.88 Favored 'General case' 0 C--O 1.235 0.328 0 C-N-CA 125.269 1.428 . . . . 0.0 111.139 -176.61 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 54.6 t-20 -124.11 137.77 54.52 Favored 'General case' 0 N--CA 1.443 -0.79 0 N-CA-C 106.756 -1.572 . . . . 0.0 106.756 168.654 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -73.58 -24.4 60.07 Favored 'General case' 0 N--CA 1.433 -1.29 0 N-CA-C 109.187 -0.671 . . . . 0.0 109.187 -178.048 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 36.1 t70 -67.32 -20.56 65.62 Favored 'General case' 0 N--CA 1.447 -0.618 0 C-N-CA 121.221 -0.192 . . . . 0.0 111.474 -178.611 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 37.1 t70 -75.75 -29.07 58.73 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 123.526 0.73 . . . . 0.0 111.61 175.186 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 33.0 m-85 -80.17 167.24 20.6 Favored 'General case' 0 N--CA 1.45 -0.433 0 C-N-CA 125.058 1.343 . . . . 0.0 110.613 176.558 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 24.2 t70 -117.29 -35.4 4.04 Favored 'General case' 0 C--O 1.237 0.401 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.169 175.241 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -140.04 134.77 36.99 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.697 0 CA-C-O 121.922 0.868 . . . . 0.0 108.676 -173.399 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 88.7 t -143.36 137.72 25.9 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.604 0 N-CA-C 105.786 -1.931 . . . . 0.0 105.786 178.929 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 20.6 mm -112.75 127.3 70.06 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.727 0 N-CA-C 105.781 -1.933 . . . . 0.0 105.781 177.188 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 70.6 m -89.32 99.83 12.74 Favored 'General case' 0 N--CA 1.441 -0.918 0 N-CA-C 104.196 -2.52 . . . . 0.0 104.196 169.225 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 38.3 mt -69.56 -2.04 10.38 Favored 'General case' 0 N--CA 1.464 0.244 0 O-C-N 121.484 -0.76 . . . . 0.0 112.386 -178.578 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 85.4 m -139.58 135.05 32.96 Favored 'General case' 0 N--CA 1.441 -0.887 0 N-CA-C 106.988 -1.486 . . . . 0.0 106.988 170.149 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 48.43 -142.18 8.59 Favored Glycine 0 CA--C 1.535 1.301 0 C-N-CA 125.148 1.356 . . . . 0.0 113.148 175.123 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 13.2 m -127.48 -85.64 0.59 Allowed 'General case' 0 CA--C 1.529 0.165 0 N-CA-C 107.585 -1.265 . . . . 0.0 107.585 175.993 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -84.55 66.66 3.84 Favored Glycine 0 C--N 1.338 0.694 0 N-CA-C 110.145 -1.182 . . . . 0.0 110.145 175.226 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 6.5 m -77.78 65.28 0.26 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.575 0 C-N-CA 124.071 0.948 . . . . 0.0 110.891 -178.094 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 52.1 t30 54.36 54.05 10.0 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 126.4 1.88 . . . . 0.0 108.249 -172.611 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -133.14 142.32 44.03 Favored Pre-proline 0 CA--C 1.539 0.544 0 C-N-CA 126.604 1.962 . . . . 0.0 108.506 -168.867 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -66.97 135.38 37.53 Favored 'Trans proline' 0 CA--C 1.541 0.857 0 C-N-CA 121.798 1.665 . . . . 0.0 110.611 176.6 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 42.1 Cg_endo -63.24 -23.99 72.4 Favored 'Trans proline' 0 N--CA 1.461 -0.439 0 C-N-CA 122.746 2.297 . . . . 0.0 114.315 -169.721 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 5.7 pm0 -56.21 -21.67 24.67 Favored 'General case' 0 CA--C 1.539 0.521 0 CA-C-N 119.529 1.059 . . . . 0.0 112.133 175.95 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 99.3 m95 -82.64 -21.78 34.91 Favored 'General case' 0 N--CA 1.454 -0.251 0 N-CA-C 113.13 0.789 . . . . 0.0 113.13 179.979 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 5.5 m -92.94 -34.86 6.19 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.351 0 CA-C-N 120.117 1.326 . . . . 0.0 110.998 172.518 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . 0.266 6.3 t -87.22 46.01 1.33 Allowed 'General case' 0 CA--C 1.548 0.869 0 CA-C-O 123.409 1.576 . . . . 0.0 110.497 -174.85 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 68.6 mm-40 -79.0 -178.81 6.3 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 126.851 2.061 . . . . 0.0 109.218 171.338 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 35.1 mm-40 -67.22 -18.38 65.21 Favored 'General case' 0 CA--C 1.539 0.554 0 O-C-N 121.572 -0.705 . . . . 0.0 111.87 -178.629 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 7.4 tt -143.2 135.03 24.02 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.381 0 C-N-CA 125.642 1.577 . . . . 0.0 106.88 170.035 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 32.4 t80 -110.21 135.26 51.25 Favored 'General case' 0 CA--C 1.535 0.373 0 N-CA-C 106.186 -1.783 . . . . 0.0 106.186 169.386 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 31.2 mm-40 -144.73 164.09 32.04 Favored 'General case' 0 C--O 1.238 0.452 0 C-N-CA 123.971 0.908 . . . . 0.0 108.689 170.21 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -169.87 130.67 1.02 Allowed 'General case' 0 N--CA 1.45 -0.458 0 C-N-CA 127.969 2.508 . . . . 0.0 106.889 -170.585 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 5.1 m-90 -150.14 141.21 23.01 Favored 'General case' 0 N--CA 1.453 -0.315 0 N-CA-C 107.947 -1.131 . . . . 0.0 107.947 -171.231 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 63.0 tt0 -82.26 77.98 8.99 Favored 'General case' 0 CA--C 1.536 0.416 0 N-CA-C 108.219 -1.03 . . . . 0.0 108.219 179.095 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 10.1 mp -71.51 119.1 15.18 Favored 'General case' 0 N--CA 1.462 0.157 0 N-CA-C 107.023 -1.473 . . . . 0.0 107.023 171.056 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -79.35 112.91 17.05 Favored 'General case' 0 N--CA 1.449 -0.524 0 N-CA-C 106.085 -1.821 . . . . 0.0 106.085 170.069 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 11.2 t70 -76.32 133.99 70.87 Favored Pre-proline 0 C--O 1.239 0.501 0 CA-C-O 118.928 -0.558 . . . . 0.0 109.833 -177.021 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -78.7 3.13 7.55 Favored 'Trans proline' 0 CA--C 1.545 1.071 0 C-N-CA 123.01 2.473 . . . . 0.0 113.971 -177.435 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 2.1 t70 -36.7 112.68 0.2 Allowed 'General case' 0 C--O 1.239 0.538 0 C-N-CA 126.196 1.798 . . . . 0.0 111.778 171.876 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 68.58 5.31 43.64 Favored Glycine 0 CA--C 1.537 1.462 0 CA-C-O 118.813 -0.993 . . . . 0.0 115.038 175.172 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 33.7 mm-40 -80.47 174.37 11.67 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-N 119.41 1.605 . . . . 0.0 110.45 178.412 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 15.3 m -68.96 156.9 37.77 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 123.729 0.811 . . . . 0.0 109.9 169.683 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -65.15 -26.25 68.09 Favored 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 123.429 0.692 . . . . 0.0 111.641 -172.29 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 6.9 pt-20 -56.33 -34.85 66.95 Favored 'General case' 0 N--CA 1.462 0.164 0 C-N-CA 123.29 0.636 . . . . 0.0 111.279 173.072 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 13.2 t -76.89 -45.59 31.05 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.362 0 CA-C-O 118.27 -0.871 . . . . 0.0 108.987 -176.724 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 67.2 m-85 -50.62 -50.45 54.15 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-N 119.691 1.132 . . . . 0.0 110.211 169.643 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 94.5 mtt180 -69.4 -34.6 74.74 Favored 'General case' 0 N--CA 1.466 0.349 0 O-C-N 121.887 -0.508 . . . . 0.0 110.901 -173.291 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 2.7 m -61.56 -49.64 75.86 Favored 'General case' 0 N--CA 1.45 -0.452 0 C-N-CA 124.162 0.985 . . . . 0.0 109.407 169.947 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 81.7 t -70.35 -27.18 30.83 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.182 0 CA-C-O 118.417 -0.801 . . . . 0.0 109.761 -170.972 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 14.2 mtm105 -56.72 -48.98 76.54 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-N 119.644 1.111 . . . . 0.0 109.646 169.956 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -63.02 -48.18 82.56 Favored Glycine 0 CA--C 1.527 0.784 0 N-CA-C 111.614 -0.594 . . . . 0.0 111.614 179.235 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 9.9 mt-30 -62.29 -45.41 93.37 Favored 'General case' 0 C--N 1.342 0.24 0 CA-C-N 117.676 0.738 . . . . 0.0 110.952 -177.209 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 86.9 t -67.75 -42.32 86.09 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.189 0 CA-C-O 118.229 -0.891 . . . . 0.0 110.557 -178.911 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 59.1 tttm -53.81 -46.6 71.15 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 119.307 0.958 . . . . 0.0 109.337 179.908 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -65.19 -43.52 91.37 Favored 'General case' 0 N--CA 1.45 -0.464 0 C-N-CA 122.964 0.506 . . . . 0.0 111.139 -175.97 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 49.4 mtt-85 -65.5 -44.54 86.7 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-N 118.719 0.69 . . . . 0.0 111.303 178.554 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 98.0 t -66.15 -40.19 86.41 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.472 0 N-CA-C 109.204 -0.665 . . . . 0.0 109.204 179.024 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 16.6 mt-10 -60.25 -42.52 95.5 Favored 'General case' 0 N--CA 1.46 0.047 0 CA-C-N 119.751 1.16 . . . . 0.0 110.488 176.153 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 29.0 t-20 -62.68 -44.67 95.66 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 122.712 0.405 . . . . 0.0 110.998 178.977 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 34.8 tp -58.08 -49.2 77.75 Favored 'General case' 0 N--CA 1.455 -0.208 0 C-N-CA 124.26 1.024 . . . . 0.0 110.772 176.992 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 89.8 mt -63.55 -44.62 98.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 N-CA-C 108.043 -1.095 . . . . 0.0 108.043 -179.524 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -61.07 -28.37 69.03 Favored 'General case' 0 CA--C 1.54 0.58 0 CA-C-N 118.654 0.661 . . . . 0.0 112.19 177.545 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 93.5 mttt -70.03 -56.13 7.76 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-N 119.391 0.996 . . . . 0.0 110.69 171.183 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 14.9 pt -78.13 -44.41 27.59 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.424 0 N-CA-C 114.969 1.47 . . . . 0.0 114.969 -168.925 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 69.8 m . . . . . 0 C--O 1.252 1.217 0 C-N-CA 126.011 1.724 . . . . 0.0 109.945 -169.772 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.497 1.906 0 N-CA-C 110.365 -0.235 . . . . 0.0 110.365 . . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 31.2 mttm -79.1 118.64 21.25 Favored 'General case' 0 N--CA 1.474 0.742 0 N-CA-C 105.787 -1.931 . . . . 0.0 105.787 171.84 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 89.2 mttt -86.06 134.11 33.85 Favored 'General case' 0 CA--C 1.513 -0.464 0 N-CA-C 107.69 -1.226 . . . . 0.0 107.69 178.465 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 1.5 t -119.8 148.82 22.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 C-N-CA 125.535 1.534 . . . . 0.0 109.0 -169.006 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 3.2 mtt -135.88 146.82 47.81 Favored 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 125.872 1.669 . . . . 0.0 108.434 169.255 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 90.6 m-85 -132.5 95.42 3.62 Favored 'General case' 0 N--CA 1.457 -0.099 0 N-CA-C 105.165 -2.161 . . . . 0.0 105.165 171.495 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 42.3 t -131.29 129.98 62.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 N-CA-C 109.675 -0.491 . . . . 0.0 109.675 -169.049 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 41.1 t -99.07 -177.76 3.72 Favored 'General case' 0 CA--C 1.547 0.857 0 C-N-CA 125.754 1.622 . . . . 0.0 106.922 169.101 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -56.48 -39.2 72.82 Favored 'General case' 0 N--CA 1.478 0.932 0 O-C-N 120.587 -1.32 . . . . 0.0 111.292 -176.532 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 79.1 mtp180 -119.89 168.65 10.9 Favored 'General case' 0 N--CA 1.465 0.308 0 N-CA-C 107.106 -1.442 . . . . 0.0 107.106 169.156 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 29.1 t30 -65.13 -28.61 69.55 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 120.563 -0.455 . . . . 0.0 110.784 169.601 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 1.5 m -56.15 124.15 16.9 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 125.165 1.386 . . . . 0.0 110.548 179.644 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 8.5 m 65.72 150.2 0.05 OUTLIER 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 126.256 1.822 . . . . 0.0 113.302 178.872 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 1.5 mmm180 68.34 -58.33 0.47 Allowed 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 127.455 2.302 . . . . 0.0 111.869 177.12 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 1.7 m -63.83 -17.15 62.83 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 125.436 1.495 . . . . 0.0 112.719 -175.214 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 21.7 pt20 -62.17 -63.01 1.38 Allowed 'General case' 0 C--N 1.343 0.289 0 CA-C-N 119.285 0.948 . . . . 0.0 111.585 176.7 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 1.1 tpt -78.56 -32.57 47.85 Favored 'General case' 0 N--CA 1.465 0.291 0 O-C-N 121.56 -0.713 . . . . 0.0 112.209 -169.61 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -64.58 -51.38 63.03 Favored 'General case' 0 N--CA 1.469 0.488 0 N-CA-C 112.346 0.499 . . . . 0.0 112.346 -170.955 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -65.68 -31.45 72.47 Favored 'General case' 0 N--CA 1.469 0.491 0 O-C-N 121.505 -0.747 . . . . 0.0 110.198 172.811 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -49.12 -55.42 12.14 Favored Glycine 0 C--N 1.342 0.895 0 C-N-CA 125.89 1.709 . . . . 0.0 110.518 175.149 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 8.8 m-85 -73.99 -29.74 62.13 Favored 'General case' 0 CA--C 1.508 -0.655 0 CA-C-N 119.072 1.436 . . . . 0.0 113.811 178.806 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -67.85 -31.7 71.71 Favored 'General case' 0 N--CA 1.451 -0.408 0 C-N-CA 119.459 -0.896 . . . . 0.0 111.318 -169.989 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 6.7 ptpt -62.06 -34.35 76.1 Favored 'General case' 0 N--CA 1.476 0.835 0 CA-C-N 119.252 0.933 . . . . 0.0 111.498 172.108 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 12.2 m -76.46 -55.42 5.55 Favored 'General case' 0 N--CA 1.447 -0.601 0 C-N-CA 125.373 1.469 . . . . 0.0 110.183 -175.939 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 75.3 mt -74.74 -35.63 62.63 Favored 'General case' 0 CA--C 1.531 0.213 0 C-N-CA 123.455 0.702 . . . . 0.0 110.328 -174.022 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -93.04 6.81 76.45 Favored Glycine 0 CA--C 1.526 0.722 0 C-N-CA 125.118 1.342 . . . . 0.0 113.285 -175.317 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -49.67 125.45 11.57 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 125.113 1.365 . . . . 0.0 110.881 -175.105 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 76.33 -8.1 27.35 Favored Glycine 0 CA--C 1.535 1.343 0 C-N-CA 124.452 1.025 . . . . 0.0 114.287 178.801 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 64.3 mttm -102.83 -49.93 3.67 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-N 119.421 1.61 . . . . 0.0 110.384 -179.711 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 25.3 pt -136.2 149.09 27.27 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.385 0 C-N-CA 123.669 0.788 . . . . 0.0 110.34 -169.37 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -111.58 104.47 12.87 Favored 'General case' 0 C--O 1.227 -0.123 0 C-N-CA 124.962 1.305 . . . . 0.0 109.844 -169.332 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 6.5 t -87.02 132.08 33.33 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 C-N-CA 123.471 0.708 . . . . 0.0 109.669 -175.957 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 20.5 m -144.96 110.81 5.42 Favored 'General case' 0 N--CA 1.446 -0.658 0 N-CA-C 104.623 -2.362 . . . . 0.0 104.623 169.963 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 51.8 m -107.18 81.53 1.55 Allowed 'General case' 0 N--CA 1.463 0.205 0 CA-C-N 119.611 1.096 . . . . 0.0 108.233 179.661 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 3.8 m -61.16 -39.79 91.43 Favored 'General case' 0 CA--C 1.532 0.274 0 N-CA-C 114.289 1.218 . . . . 0.0 114.289 -169.261 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 92.91 137.81 8.36 Favored Glycine 0 C--N 1.338 0.671 0 N-CA-C 109.107 -1.597 . . . . 0.0 109.107 176.912 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 15.5 mt -74.51 -34.01 62.94 Favored 'General case' 0 C--N 1.331 -0.199 0 C-N-CA 124.108 0.963 . . . . 0.0 108.794 176.774 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 26.3 mt-10 -141.33 156.79 45.81 Favored 'General case' 0 N--CA 1.443 -0.805 0 C-N-CA 128.28 2.632 . . . . 0.0 105.984 168.926 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 60.9 p -109.79 148.33 31.66 Favored 'General case' 0 N--CA 1.441 -0.922 0 CA-C-O 123.106 1.431 . . . . 0.0 112.937 -175.116 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 17.1 m -170.35 162.13 8.34 Favored 'General case' 0 N--CA 1.447 -0.608 0 C-N-CA 129.389 3.076 . . . . 0.0 103.752 -169.856 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . 0.422 ' HG3' ' H ' ' A' ' 42' ' ' VAL . 6.9 tpt180 -92.14 -155.93 0.44 Allowed 'General case' 0 N--CA 1.467 0.416 0 O-C-N 121.053 -1.029 . . . . 0.0 109.656 -173.039 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.422 ' H ' ' HG3' ' A' ' 41' ' ' ARG . 0.6 OUTLIER -131.87 156.67 42.75 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 C-N-CA 129.009 2.924 . . . . 0.0 107.064 -169.446 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 62.4 m80 -85.79 144.53 39.71 Favored Pre-proline 0 N--CA 1.468 0.459 0 N-CA-C 112.317 0.488 . . . . 0.0 112.317 -169.071 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -65.06 -45.07 8.44 Favored 'Trans proline' 0 C--N 1.348 0.546 0 C-N-CA 122.904 2.403 . . . . 0.0 111.834 -176.172 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 6.5 m -69.57 -28.06 65.66 Favored 'General case' 0 CA--C 1.531 0.233 0 CA-C-O 118.977 -0.535 . . . . 0.0 110.002 179.575 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -60.46 -54.33 46.86 Favored 'General case' 0 CA--C 1.507 -0.691 0 N-CA-C 107.882 -1.155 . . . . 0.0 107.882 171.183 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 56.7 mt -58.1 -40.21 76.11 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 N-CA-C 108.657 -0.868 . . . . 0.0 108.657 -173.828 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -63.37 -49.3 74.39 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-N 118.555 0.616 . . . . 0.0 111.61 179.046 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 28.1 mmt -66.23 -36.5 83.2 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-O 122.98 1.371 . . . . 0.0 110.895 -179.712 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -78.25 -30.82 48.85 Favored 'General case' 0 N--CA 1.441 -0.875 0 N-CA-C 107.416 -1.327 . . . . 0.0 107.416 -173.335 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 41.2 tt0 -71.95 -22.14 61.5 Favored 'General case' 0 N--CA 1.447 -0.598 0 C-N-CA 123.815 0.846 . . . . 0.0 110.228 169.986 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 16.8 mm-40 -68.19 -30.73 69.89 Favored 'General case' 0 CA--C 1.534 0.361 0 CA-C-N 119.487 1.039 . . . . 0.0 110.23 171.62 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . 0.276 9.3 p -89.34 10.0 2.43 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.035 0 CA-C-N 118.514 0.597 . . . . 0.0 111.114 168.914 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 78.18 16.28 79.89 Favored Glycine 0 CA--C 1.532 1.121 0 C-N-CA 124.956 1.265 . . . . 0.0 113.76 173.8 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 13.5 mt -102.2 141.35 18.57 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.237 0 C-N-CA 124.453 1.101 . . . . 0.0 110.555 -173.574 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -94.71 137.29 33.99 Favored 'General case' 0 C--O 1.235 0.312 0 C-N-CA 124.417 1.087 . . . . 0.0 108.26 169.817 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 7.0 pt -138.04 -30.0 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.544 0 C-N-CA 124.543 1.137 . . . . 0.0 110.538 170.095 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -23.53 -38.32 0.0 OUTLIER 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 130.054 3.341 . . . . 0.0 117.045 169.563 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -98.64 31.26 8.32 Favored Glycine 0 CA--C 1.536 1.383 0 C-N-CA 125.543 1.544 . . . . 0.0 115.349 -175.205 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 12.7 mt-30 -62.0 -31.42 71.79 Favored 'General case' 0 N--CA 1.476 0.846 0 CA-C-N 120.088 1.944 . . . . 0.0 113.956 -174.336 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -70.34 122.16 19.04 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 123.059 0.544 . . . . 0.0 110.517 -169.158 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 74.9 m -151.91 -167.9 2.91 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 127.03 2.132 . . . . 0.0 107.417 -171.292 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -51.58 143.55 20.0 Favored Pre-proline 0 CA--C 1.539 0.528 0 C-N-CA 123.967 0.907 . . . . 0.0 110.402 170.51 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 84.5 Cg_endo -70.92 160.73 48.43 Favored 'Trans proline' 0 N--CA 1.456 -0.683 0 C-N-CA 122.883 2.389 . . . . 0.0 110.326 172.941 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 11.9 tt -60.86 -20.45 21.74 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.447 0 C-N-CA 123.889 0.876 . . . . 0.0 112.246 -179.878 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 25.9 tt0 -66.5 -28.6 68.69 Favored 'General case' 0 N--CA 1.434 -1.256 0 C-N-CA 124.768 1.227 . . . . 0.0 110.516 -176.558 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 74.9 m-20 -80.54 -1.44 41.96 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 124.305 1.042 . . . . 0.0 112.387 179.115 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 85.5 m-85 -110.76 177.19 4.75 Favored 'General case' 0 C--O 1.234 0.278 0 C-N-CA 125.698 1.599 . . . . 0.0 110.925 179.204 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 50.4 t-20 -128.66 135.76 49.72 Favored 'General case' 0 N--CA 1.448 -0.532 0 N-CA-C 108.175 -1.046 . . . . 0.0 108.175 169.297 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -73.28 -24.63 60.45 Favored 'General case' 0 N--CA 1.435 -1.184 0 N-CA-C 109.25 -0.648 . . . . 0.0 109.25 -178.473 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 35.5 t70 -66.2 -21.78 66.32 Favored 'General case' 0 N--CA 1.445 -0.696 0 C-N-CA 120.644 -0.422 . . . . 0.0 111.091 -177.59 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 35.2 t70 -77.42 -27.95 52.48 Favored 'General case' 0 C--N 1.345 0.393 0 C-N-CA 123.617 0.767 . . . . 0.0 111.584 174.144 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 14.1 m-85 -80.17 167.55 20.21 Favored 'General case' 0 C--O 1.239 0.53 0 C-N-CA 125.39 1.476 . . . . 0.0 111.392 -179.552 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -117.03 -39.18 3.26 Favored 'General case' 0 C--O 1.235 0.312 0 C-N-CA 123.338 0.655 . . . . 0.0 111.668 177.953 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -138.01 133.56 44.38 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.406 0 C-N-CA 123.866 0.866 . . . . 0.0 109.881 -170.871 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 66.6 t -140.79 125.63 18.55 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.402 0 N-CA-C 105.72 -1.956 . . . . 0.0 105.72 178.306 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 7.5 mm -96.24 125.26 49.15 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.545 0 N-CA-C 105.333 -2.099 . . . . 0.0 105.333 170.071 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 59.6 m -93.36 91.81 7.37 Favored 'General case' 0 N--CA 1.443 -0.811 0 N-CA-C 104.123 -2.547 . . . . 0.0 104.123 169.662 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 23.0 mt -63.08 -12.68 28.54 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-O 118.321 -0.847 . . . . 0.0 112.771 -173.206 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 39.3 m -142.94 126.53 16.88 Favored 'General case' 0 N--CA 1.445 -0.684 0 N-CA-C 106.634 -1.617 . . . . 0.0 106.634 174.43 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 58.44 -148.55 37.51 Favored Glycine 0 CA--C 1.534 1.227 0 C-N-CA 123.613 0.625 . . . . 0.0 112.183 177.488 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 14.0 p -139.2 -79.11 0.33 Allowed 'General case' 0 CA--C 1.529 0.165 0 C-N-CA 124.173 0.989 . . . . 0.0 108.727 175.865 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -79.24 53.24 4.16 Favored Glycine 0 CA--C 1.526 0.756 0 C-N-CA 125.498 1.523 . . . . 0.0 112.096 -178.429 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 16.3 m -81.21 60.83 0.2 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.71 0 C-N-CA 124.868 1.267 . . . . 0.0 110.802 -173.984 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 50.1 t30 56.2 59.74 3.54 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 125.944 1.698 . . . . 0.0 108.374 -172.41 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -136.69 143.14 41.63 Favored Pre-proline 0 CA--C 1.544 0.729 0 C-N-CA 126.223 1.809 . . . . 0.0 108.845 -168.925 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_exo -67.13 136.77 41.89 Favored 'Trans proline' 0 CA--C 1.542 0.909 0 C-N-CA 122.555 2.17 . . . . 0.0 111.353 172.973 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 42.4 Cg_endo -63.66 -25.84 69.0 Favored 'Trans proline' 0 N--CA 1.46 -0.474 0 C-N-CA 122.778 2.319 . . . . 0.0 114.821 -169.663 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 6.4 pm0 -57.42 -20.61 31.19 Favored 'General case' 0 CA--C 1.539 0.528 0 CA-C-N 120.149 1.341 . . . . 0.0 112.272 177.345 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 99.9 m95 -79.28 -23.41 43.61 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-O 118.726 -0.654 . . . . 0.0 112.629 178.657 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 6.5 m -104.67 -8.87 9.77 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.156 0 C-N-CA 124.669 1.188 . . . . 0.0 113.03 -179.818 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . 0.266 6.6 t -111.57 45.58 1.2 Allowed 'General case' 0 CA--C 1.544 0.713 0 CA-C-O 123.142 1.448 . . . . 0.0 110.104 172.299 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 56.2 mm-40 -73.47 177.42 5.3 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 124.919 1.288 . . . . 0.0 109.73 169.936 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 34.9 mm-40 -65.49 -21.73 66.66 Favored 'General case' 0 CA--C 1.538 0.503 0 O-C-N 121.844 -0.535 . . . . 0.0 111.225 -179.626 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 4.6 tt -140.26 131.14 30.33 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.334 0 C-N-CA 126.241 1.816 . . . . 0.0 106.439 169.871 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 35.2 t80 -109.57 136.36 49.07 Favored 'General case' 0 CA--C 1.539 0.528 0 N-CA-C 106.272 -1.751 . . . . 0.0 106.272 169.487 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 10.7 mm-40 -142.2 162.55 35.18 Favored 'General case' 0 C--O 1.234 0.287 0 C-N-CA 124.429 1.091 . . . . 0.0 108.871 175.83 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 2.5 t70 -175.27 129.62 0.28 Allowed 'General case' 0 C--O 1.236 0.368 0 C-N-CA 127.014 2.126 . . . . 0.0 106.918 -169.802 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 6.5 m0 -143.69 140.47 30.05 Favored 'General case' 0 CA--C 1.522 -0.119 0 C-N-CA 122.826 0.45 . . . . 0.0 110.057 -171.853 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 31.3 mm-40 -84.57 59.79 5.69 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-O 121.653 0.739 . . . . 0.0 109.159 171.786 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 16.6 mt -64.68 138.67 58.53 Favored 'General case' 0 CA--C 1.529 0.14 0 N-CA-C 108.233 -1.025 . . . . 0.0 108.233 172.471 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 34.3 mm-40 -68.65 161.15 28.78 Favored 'General case' 0 N--CA 1.451 -0.397 0 N-CA-C 108.265 -1.013 . . . . 0.0 108.265 168.901 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -130.97 131.45 23.24 Favored Pre-proline 0 N--CA 1.45 -0.456 0 N-CA-C 107.341 -1.355 . . . . 0.0 107.341 169.352 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 67.9 Cg_endo -78.9 -3.9 13.57 Favored 'Trans proline' 0 CA--C 1.545 1.043 0 C-N-CA 122.125 1.883 . . . . 0.0 114.729 -169.867 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -51.26 129.38 24.5 Favored 'General case' 0 CA--C 1.537 0.443 0 CA-C-N 119.996 1.271 . . . . 0.0 111.05 177.606 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 72.71 11.1 77.39 Favored Glycine 0 CA--C 1.533 1.206 0 CA-C-O 118.758 -1.023 . . . . 0.0 114.127 171.942 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 29.7 pt20 -136.66 -171.12 2.84 Favored 'General case' 0 CA--C 1.542 0.659 0 CA-C-N 118.991 1.395 . . . . 0.0 111.302 176.245 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 1.9 m -68.34 158.3 33.8 Favored 'General case' 0 CA--C 1.533 0.327 0 N-CA-C 117.641 2.46 . . . . 0.0 117.641 -167.563 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 55.7 tp -54.42 -34.16 60.83 Favored 'General case' 0 C--N 1.344 0.33 0 C-N-CA 126.917 2.087 . . . . 0.0 111.451 170.144 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 29.5 tp10 -64.73 -29.32 70.3 Favored 'General case' 0 C--N 1.331 -0.235 0 O-C-N 122.028 -0.42 . . . . 0.0 110.796 177.491 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 4.1 t -76.83 -37.1 27.25 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.385 0 CA-C-O 117.866 -1.064 . . . . 0.0 110.21 175.471 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 59.3 m-85 -56.21 -49.36 74.31 Favored 'General case' 0 N--CA 1.474 0.727 0 CA-C-N 120.738 1.608 . . . . 0.0 109.656 170.121 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 77.0 mtt180 -58.99 -44.07 91.54 Favored 'General case' 0 N--CA 1.468 0.432 0 C-N-CA 123.501 0.72 . . . . 0.0 110.691 178.319 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 18.5 m -65.5 -49.24 69.76 Favored 'General case' 0 N--CA 1.445 -0.714 0 C-N-CA 124.261 1.025 . . . . 0.0 110.07 -179.962 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 63.8 t -67.69 -35.84 74.06 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.191 0 CA-C-N 119.42 1.009 . . . . 0.0 109.353 -172.128 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 45.8 ttp85 -58.23 -39.9 80.28 Favored 'General case' 0 CA--C 1.539 0.553 0 CA-C-N 118.405 0.548 . . . . 0.0 109.808 173.585 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -66.81 -53.41 27.51 Favored Glycine 0 CA--C 1.533 1.218 0 C-N-CA 123.698 0.666 . . . . 0.0 112.566 172.809 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 72.2 mt-30 -55.08 -48.35 73.64 Favored 'General case' 0 N--CA 1.469 0.5 0 CA-C-O 122.184 0.992 . . . . 0.0 110.0 -176.137 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 97.0 t -74.48 -37.01 43.45 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.439 0 CA-C-O 117.738 -1.125 . . . . 0.0 109.786 -171.563 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -55.47 -46.58 76.83 Favored 'General case' 0 C--O 1.224 -0.288 0 CA-C-N 120.112 1.324 . . . . 0.0 108.585 172.198 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 41.5 tt0 -66.43 -43.04 86.79 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 122.458 0.303 . . . . 0.0 111.205 -175.121 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 38.5 mmt180 -62.44 -45.55 92.58 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-N 119.069 0.85 . . . . 0.0 111.01 176.18 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 97.2 t -69.14 -37.68 76.92 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.578 0 N-CA-C 109.196 -0.668 . . . . 0.0 109.196 -177.219 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 20.2 mt-10 -59.85 -44.79 93.92 Favored 'General case' 0 N--CA 1.457 -0.12 0 CA-C-N 119.346 0.975 . . . . 0.0 110.09 173.556 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 25.9 t-20 -65.02 -42.24 94.57 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 123.169 0.588 . . . . 0.0 111.641 -178.487 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 1.6 tm? -58.31 -48.39 80.67 Favored 'General case' 0 C--O 1.228 -0.068 0 C-N-CA 126.323 1.849 . . . . 0.0 110.752 174.035 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 63.4 mt -66.04 -47.75 83.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 N-CA-C 108.658 -0.867 . . . . 0.0 108.658 179.598 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -58.52 -31.21 67.7 Favored 'General case' 0 CA--C 1.535 0.381 0 CA-C-O 118.849 -0.596 . . . . 0.0 112.145 -176.851 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 17.3 ptpt -81.59 -39.62 24.26 Favored 'General case' 0 C--N 1.344 0.364 0 CA-C-O 117.786 -1.102 . . . . 0.0 112.486 176.53 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 11.8 pt -81.67 -37.42 15.24 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.287 0 CA-C-N 119.931 1.242 . . . . 0.0 113.725 -176.039 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 72.4 m . . . . . 0 C--O 1.253 1.288 0 C-N-CA 125.638 1.575 . . . . 0.0 109.764 -169.985 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.499 1.985 0 N-CA-C 110.411 -0.218 . . . . 0.0 110.411 . . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 32.9 mttm -81.43 118.92 23.09 Favored 'General case' 0 N--CA 1.476 0.849 0 N-CA-C 106.541 -1.652 . . . . 0.0 106.541 173.348 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 93.0 mttt -80.86 133.84 35.65 Favored 'General case' 0 CA--C 1.507 -0.692 0 CA-C-N 119.785 1.175 . . . . 0.0 108.398 175.691 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 1.5 t -118.36 145.48 24.27 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.589 0 C-N-CA 125.914 1.686 . . . . 0.0 106.796 -172.843 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 26.6 ttm -136.53 145.1 44.66 Favored 'General case' 0 C--N 1.318 -0.777 0 C-N-CA 125.143 1.377 . . . . 0.0 108.265 169.764 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 91.5 m-85 -137.93 121.62 17.46 Favored 'General case' 0 CA--C 1.516 -0.339 0 N-CA-C 104.673 -2.343 . . . . 0.0 104.673 177.445 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 2.6 p -153.58 154.16 7.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-O 122.338 1.066 . . . . 0.0 111.745 -169.178 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 42.7 t -144.77 165.18 28.82 Favored 'General case' 0 CA--C 1.538 0.486 0 N-CA-C 104.506 -2.405 . . . . 0.0 104.506 168.981 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 22.9 pttp -61.47 130.17 44.73 Favored 'General case' 0 N--CA 1.467 0.378 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 172.515 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 59.2 136.58 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 128.211 2.604 . . . . 0.0 114.114 -170.373 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 20.4 t30 -56.05 -35.0 66.43 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 125.106 1.362 . . . . 0.0 111.885 176.526 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 1.6 p -70.3 -8.06 47.41 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 125.398 1.479 . . . . 0.0 113.243 -175.802 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 38.5 m -76.01 -88.15 0.04 OUTLIER 'General case' 0 CA--C 1.54 0.568 0 CA-C-N 119.292 0.951 . . . . 0.0 110.259 178.638 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 10.6 mpt_? -115.5 6.83 14.79 Favored 'General case' 0 N--CA 1.475 0.801 0 CA-C-N 120.349 1.431 . . . . 0.0 113.041 179.227 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 1.4 m -91.92 47.44 1.35 Allowed 'General case' 0 CA--C 1.541 0.601 0 O-C-N 121.327 -0.858 . . . . 0.0 110.918 -175.449 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -118.37 9.01 12.31 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 125.967 1.707 . . . . 0.0 112.596 170.941 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 1.1 tpt -159.87 -39.48 0.05 Allowed 'General case' 0 N--CA 1.457 -0.119 0 N-CA-C 115.443 1.646 . . . . 0.0 115.443 -176.916 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -69.55 -46.72 65.77 Favored 'General case' 0 N--CA 1.471 0.597 0 CA-C-N 120.947 1.703 . . . . 0.0 111.703 -169.482 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -57.35 -42.28 81.69 Favored 'General case' 0 C--N 1.325 -0.473 0 C-N-CA 124.321 1.049 . . . . 0.0 110.731 170.837 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -61.59 -45.59 96.02 Favored Glycine 0 CA--C 1.524 0.653 0 C-N-CA 123.84 0.733 . . . . 0.0 111.798 176.924 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -66.85 -35.93 81.17 Favored 'General case' 0 CA--C 1.514 -0.431 0 O-C-N 121.216 -1.167 . . . . 0.0 111.918 178.278 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -70.86 -36.3 72.77 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 119.662 1.119 . . . . 0.0 110.555 179.688 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -52.52 -42.66 64.54 Favored 'General case' 0 N--CA 1.467 0.392 0 C-N-CA 123.864 0.866 . . . . 0.0 109.009 169.207 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 22.4 m -75.15 -59.29 2.81 Favored 'General case' 0 N--CA 1.446 -0.653 0 C-N-CA 124.303 1.041 . . . . 0.0 111.397 -173.872 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 34.6 mt -73.82 -33.87 64.35 Favored 'General case' 0 C--N 1.332 -0.191 0 C-N-CA 125.083 1.353 . . . . 0.0 110.949 -170.567 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -102.76 6.77 52.43 Favored Glycine 0 CA--C 1.525 0.668 0 CA-C-O 117.901 -1.5 . . . . 0.0 113.521 -172.585 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -41.15 -52.77 3.25 Favored 'General case' 0 N--CA 1.466 0.363 0 C-N-CA 126.254 1.821 . . . . 0.0 114.819 -169.714 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -88.81 7.12 82.83 Favored Glycine 0 CA--C 1.531 1.048 0 CA-C-O 119.186 -0.785 . . . . 0.0 113.573 -175.547 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 70.0 mttt -124.73 -49.35 1.76 Allowed 'General case' 0 N--CA 1.467 0.395 0 CA-C-N 118.511 1.155 . . . . 0.0 111.937 -169.27 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 27.1 pt -137.96 150.93 25.07 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.401 0 C-N-CA 124.732 1.213 . . . . 0.0 110.415 -168.911 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -111.17 105.77 14.58 Favored 'General case' 0 C--O 1.226 -0.146 0 C-N-CA 125.013 1.325 . . . . 0.0 109.971 -169.526 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 11.4 t -78.93 127.9 38.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 177.374 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 18.7 m -144.31 92.94 2.37 Favored 'General case' 0 N--CA 1.449 -0.503 0 N-CA-C 103.615 -2.735 . . . . 0.0 103.615 169.677 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 58.1 m -89.33 -1.32 58.02 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 115.764 1.764 . . . . 0.0 115.764 -168.759 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 28.4 p 49.05 -130.08 1.92 Allowed 'General case' 0 CA--C 1.546 0.815 0 C-N-CA 124.451 1.1 . . . . 0.0 111.333 -178.842 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 173.5 153.98 10.17 Favored Glycine 0 CA--C 1.53 0.978 0 C-N-CA 124.951 1.262 . . . . 0.0 111.027 170.06 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 4.3 mt -111.89 103.95 12.21 Favored 'General case' 0 N--CA 1.444 -0.755 1 N-CA-C 100.071 -4.048 . . . . 0.0 100.071 169.16 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 35.2 mt-10 64.05 170.36 0.17 Allowed 'General case' 0 C--O 1.238 0.458 0 O-C-N 125.371 1.669 . . . . 0.0 110.241 -167.583 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 59.1 p -146.9 158.79 44.01 Favored 'General case' 0 N--CA 1.448 -0.558 0 CA-C-O 122.628 1.204 . . . . 0.0 113.701 -178.457 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 4.1 m -170.81 166.96 7.72 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 129.801 3.24 . . . . 0.0 104.222 -171.892 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -87.94 -159.61 0.55 Allowed 'General case' 0 N--CA 1.468 0.459 0 O-C-N 120.845 -1.159 . . . . 0.0 108.72 176.209 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 1.5 p -127.17 157.84 38.51 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.782 0 C-N-CA 126.418 1.887 . . . . 0.0 107.73 179.933 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -85.84 153.04 57.48 Favored Pre-proline 0 CA--C 1.538 0.517 0 C-N-CA 124.67 1.188 . . . . 0.0 111.366 -169.452 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 55.1 Cg_endo -63.84 -41.34 24.26 Favored 'Trans proline' 0 C--N 1.347 0.495 0 C-N-CA 123.474 2.783 . . . . 0.0 112.415 -174.039 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 7.3 m -69.79 -29.63 66.98 Favored 'General case' 0 CA--C 1.53 0.188 0 CA-C-O 118.649 -0.691 . . . . 0.0 110.319 -176.839 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -62.99 -50.6 70.13 Favored 'General case' 0 C--O 1.215 -0.712 0 CA-C-N 119.659 1.118 . . . . 0.0 108.413 171.094 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 75.1 mt -58.38 -40.09 76.89 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.447 0 CA-C-N 118.982 0.81 . . . . 0.0 108.851 -176.462 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -64.7 -49.63 70.15 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-N 118.915 0.779 . . . . 0.0 112.354 178.255 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 38.6 mmt -69.35 -36.48 76.92 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-O 122.739 1.257 . . . . 0.0 110.543 -177.564 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -71.69 -32.05 67.41 Favored 'General case' 0 N--CA 1.444 -0.763 0 N-CA-C 106.369 -1.715 . . . . 0.0 106.369 -178.761 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 40.5 tt0 -72.02 -19.57 61.83 Favored 'General case' 0 CA--C 1.54 0.572 0 O-C-N 121.122 -0.986 . . . . 0.0 110.999 169.882 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 75.5 mt-10 -64.19 -37.11 86.31 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-N 120.176 1.353 . . . . 0.0 109.859 169.605 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 11.9 m -85.94 12.12 1.05 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.675 0 N-CA-C 112.759 0.651 . . . . 0.0 112.759 169.968 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 72.4 14.23 77.2 Favored Glycine 0 CA--C 1.532 1.155 0 C-N-CA 124.488 1.042 . . . . 0.0 113.476 176.154 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 10.5 mt -93.35 137.73 21.88 Favored 'Isoleucine or valine' 0 C--O 1.233 0.199 0 CA-C-N 118.498 1.149 . . . . 0.0 109.613 -177.053 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 12.9 t0 -101.87 132.93 47.37 Favored 'General case' 0 C--O 1.233 0.236 0 N-CA-C 107.566 -1.272 . . . . 0.0 107.566 169.343 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -118.72 -70.64 0.78 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.37 0 C-N-CA 125.528 1.531 . . . . 0.0 107.319 177.321 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 97.2 p 40.33 -97.78 0.02 OUTLIER 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 127.169 2.187 . . . . 0.0 114.349 170.152 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -74.79 58.0 2.6 Favored Glycine 0 CA--C 1.531 1.067 0 C-N-CA 126.99 2.233 . . . . 0.0 111.705 178.947 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 12.5 mm100 -66.89 -30.31 70.43 Favored 'General case' 0 C--O 1.233 0.232 0 C-N-CA 125.051 1.34 . . . . 0.0 111.69 -179.868 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 1.1 p -62.68 133.66 55.17 Favored 'General case' 0 N--CA 1.444 -0.746 0 C-N-CA 124.934 1.294 . . . . 0.0 109.435 -169.369 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 57.7 m -146.14 -179.21 6.57 Favored 'General case' 0 N--CA 1.446 -0.666 0 C-N-CA 125.999 1.72 . . . . 0.0 107.493 -169.307 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -56.61 152.74 24.19 Favored Pre-proline 0 CA--C 1.536 0.427 0 C-N-CA 123.87 0.868 . . . . 0.0 111.446 175.064 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 89.3 Cg_endo -65.59 158.24 54.25 Favored 'Trans proline' 0 N--CA 1.453 -0.856 0 C-N-CA 122.574 2.183 . . . . 0.0 110.345 172.965 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 14.0 tt -58.52 -26.81 31.97 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.411 0 C-N-CA 124.013 0.925 . . . . 0.0 111.622 179.133 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 15.1 mt-10 -67.94 -26.55 66.02 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 124.255 1.022 . . . . 0.0 110.356 -174.524 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 5.4 t-20 -64.31 -22.16 66.86 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 125.197 1.399 . . . . 0.0 112.208 177.728 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -108.67 178.57 4.44 Favored 'General case' 0 C--O 1.235 0.339 0 C-N-CA 126.024 1.729 . . . . 0.0 111.209 -173.797 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 57.5 t-20 -133.25 137.36 46.05 Favored 'General case' 0 N--CA 1.444 -0.745 0 N-CA-C 107.144 -1.428 . . . . 0.0 107.144 168.988 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -74.86 -23.84 58.48 Favored 'General case' 0 N--CA 1.437 -1.112 0 N-CA-C 109.456 -0.572 . . . . 0.0 109.456 -176.985 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -61.62 -24.74 66.9 Favored 'General case' 0 N--CA 1.447 -0.604 0 O-C-N 123.331 0.395 . . . . 0.0 111.579 178.831 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -76.57 -27.64 55.93 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 123.578 0.751 . . . . 0.0 112.081 177.133 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 11.7 m-85 -78.75 164.01 24.91 Favored 'General case' 0 N--CA 1.45 -0.442 0 C-N-CA 125.187 1.395 . . . . 0.0 111.465 -177.043 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -105.4 -39.29 6.19 Favored 'General case' 0 N--CA 1.462 0.13 0 CA-C-N 115.557 -0.747 . . . . 0.0 110.41 171.436 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -139.19 138.91 40.57 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.441 0 CA-C-O 122.449 1.118 . . . . 0.0 110.188 -171.333 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 42.6 t -140.21 145.03 26.75 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.855 0 N-CA-C 106.411 -1.7 . . . . 0.0 106.411 179.936 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 24.1 mm -141.71 137.36 31.65 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.865 0 N-CA-C 106.496 -1.668 . . . . 0.0 106.496 -170.69 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 50.3 m -101.43 163.84 12.07 Favored 'General case' 0 N--CA 1.445 -0.691 0 N-CA-C 107.625 -1.25 . . . . 0.0 107.625 168.861 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 51.3 mt -132.66 18.84 4.26 Favored 'General case' 0 CA--C 1.533 0.292 0 O-C-N 121.14 -0.975 . . . . 0.0 111.048 -174.53 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 28.1 p -169.21 -5.12 0.02 OUTLIER 'General case' 0 CA--C 1.541 0.603 0 N-CA-C 115.433 1.642 . . . . 0.0 115.433 -173.986 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 167.78 175.0 37.24 Favored Glycine 0 CA--C 1.529 0.927 0 CA-C-N 120.54 1.518 . . . . 0.0 111.292 -177.081 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 40.2 m -117.31 124.34 48.73 Favored 'General case' 0 C--O 1.233 0.229 0 C-N-CA 124.444 1.098 . . . . 0.0 108.101 -177.046 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 62.55 28.74 71.83 Favored Glycine 0 CA--C 1.531 1.044 0 N-CA-C 111.343 -0.703 . . . . 0.0 111.343 -174.822 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . 0.267 7.2 p -80.2 74.41 0.74 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.512 0 C-N-CA 125.006 1.322 . . . . 0.0 109.988 -169.459 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 1.1 t30 60.07 54.08 4.3 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 126.711 2.005 . . . . 0.0 108.012 -176.476 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -152.12 138.4 11.79 Favored Pre-proline 0 CA--C 1.539 0.55 0 C-N-CA 125.803 1.641 . . . . 0.0 107.621 -169.341 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_exo -69.84 146.6 60.2 Favored 'Trans proline' 0 CA--C 1.546 1.08 0 C-N-CA 121.494 1.463 . . . . 0.0 114.139 -175.77 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_exo -63.7 -25.95 68.65 Favored 'Trans proline' 0 C--N 1.349 0.581 0 C-N-CA 122.667 2.244 . . . . 0.0 115.945 -174.085 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 5.7 pm0 -61.53 -14.84 32.85 Favored 'General case' 0 CA--C 1.543 0.707 0 CA-C-N 121.024 1.738 . . . . 0.0 111.809 175.982 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 90.8 m95 -91.81 -21.7 20.53 Favored 'General case' 0 N--CA 1.451 -0.409 0 C-N-CA 124.509 1.123 . . . . 0.0 113.07 173.793 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 2.9 m -78.64 -5.01 7.39 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.36 0 CA-C-N 120.129 1.331 . . . . 0.0 111.326 171.377 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 60.3 p -107.95 -118.14 0.26 Allowed 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 123.081 0.552 . . . . 0.0 111.492 -176.747 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 70.5 mm-40 55.96 -171.13 0.07 Allowed 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 125.563 1.545 . . . . 0.0 111.47 -168.787 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 37.0 mm-40 -70.25 -23.11 62.85 Favored 'General case' 0 CA--C 1.537 0.474 0 O-C-N 121.479 -0.763 . . . . 0.0 112.316 -169.466 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 9.5 tt -147.83 141.64 19.3 Favored 'Isoleucine or valine' 0 C--O 1.238 0.46 0 C-N-CA 125.103 1.361 . . . . 0.0 107.607 169.761 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 73.3 t80 -128.22 139.41 52.47 Favored 'General case' 0 N--CA 1.446 -0.661 0 N-CA-C 106.277 -1.749 . . . . 0.0 106.277 168.867 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 29.3 mm-40 -139.32 166.26 25.02 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 107.246 -1.39 . . . . 0.0 107.246 170.003 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -165.33 137.29 4.17 Favored 'General case' 0 C--N 1.323 -0.568 0 C-N-CA 126.074 1.75 . . . . 0.0 106.334 -176.642 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 6.9 m0 -143.12 144.77 32.35 Favored 'General case' 0 N--CA 1.451 -0.377 0 C-N-CA 122.875 0.47 . . . . 0.0 110.201 -169.332 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 20.0 tt0 -83.33 57.42 3.98 Favored 'General case' 0 CA--C 1.537 0.451 0 N-CA-C 108.179 -1.045 . . . . 0.0 108.179 171.054 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 19.4 mt -65.74 138.47 57.97 Favored 'General case' 0 C--O 1.235 0.321 0 N-CA-C 107.155 -1.424 . . . . 0.0 107.155 173.459 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 23.5 mm-40 -67.22 151.52 47.38 Favored 'General case' 0 N--CA 1.451 -0.41 0 CA-C-O 121.574 0.702 . . . . 0.0 109.511 172.033 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -112.41 117.97 46.33 Favored Pre-proline 0 N--CA 1.45 -0.468 0 N-CA-C 106.098 -1.816 . . . . 0.0 106.098 170.447 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_endo -80.82 -1.52 11.29 Favored 'Trans proline' 0 N--CA 1.448 -1.183 0 C-N-CA 122.98 2.453 . . . . 0.0 113.412 -173.217 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -53.4 120.07 5.61 Favored 'General case' 0 CA--C 1.536 0.429 0 CA-C-N 120.473 1.488 . . . . 0.0 110.864 -175.917 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 70.2 0.65 30.08 Favored Glycine 0 CA--C 1.534 1.245 0 CA-C-O 118.765 -1.019 . . . . 0.0 114.562 179.518 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 12.9 mt-30 -85.3 171.89 11.54 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-N 119.156 1.478 . . . . 0.0 109.638 174.096 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 15.0 m -69.2 162.33 27.32 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 123.91 0.884 . . . . 0.0 111.322 178.71 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 13.3 tp -59.04 -30.93 68.4 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 124.615 1.166 . . . . 0.0 112.43 -173.779 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 5.3 pt-20 -56.57 -34.92 67.61 Favored 'General case' 0 C--O 1.226 -0.166 0 C-N-CA 124.768 1.227 . . . . 0.0 111.775 174.778 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 32.2 t -75.03 -42.19 45.54 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.422 0 CA-C-O 117.813 -1.089 . . . . 0.0 109.164 -176.798 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 89.7 m-85 -56.52 -49.94 73.27 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-N 120.329 1.422 . . . . 0.0 109.666 172.621 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 86.8 mtt180 -66.84 -34.6 78.17 Favored 'General case' 0 N--CA 1.467 0.409 0 O-C-N 122.037 -0.414 . . . . 0.0 111.761 -176.358 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 3.5 m -62.24 -48.59 79.29 Favored 'General case' 0 N--CA 1.451 -0.404 0 C-N-CA 124.681 1.192 . . . . 0.0 109.413 170.357 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 45.7 t -63.62 -33.44 61.63 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.243 0 CA-C-O 118.265 -0.874 . . . . 0.0 110.0 -174.627 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 13.1 mtm105 -56.58 -49.8 73.83 Favored 'General case' 0 C--O 1.225 -0.226 0 CA-C-N 119.303 0.956 . . . . 0.0 110.071 172.188 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -62.3 -48.55 81.69 Favored Glycine 0 CA--C 1.526 0.731 0 CA-C-O 119.103 -0.832 . . . . 0.0 111.216 179.55 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 69.8 mt-30 -55.24 -53.23 58.63 Favored 'General case' 0 C--N 1.343 0.296 0 CA-C-O 122.091 0.948 . . . . 0.0 109.364 -179.802 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 73.8 t -71.44 -39.97 71.91 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-O 117.875 -1.06 . . . . 0.0 110.605 -170.608 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 87.2 tttt -55.6 -47.46 76.47 Favored 'General case' 0 C--O 1.223 -0.321 0 CA-C-N 119.411 1.005 . . . . 0.0 108.316 176.792 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -66.22 -43.01 87.89 Favored 'General case' 0 N--CA 1.45 -0.465 0 C-N-CA 122.438 0.295 . . . . 0.0 111.078 -174.838 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 40.2 mmt180 -63.02 -46.6 86.85 Favored 'General case' 0 N--CA 1.471 0.611 0 O-C-N 121.563 -0.711 . . . . 0.0 110.837 177.831 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 78.2 t -67.31 -41.73 86.81 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.665 0 C-N-CA 123.08 0.552 . . . . 0.0 109.618 -178.897 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 31.3 mt-10 -60.23 -43.74 95.81 Favored 'General case' 0 CA--C 1.52 -0.191 0 CA-C-N 119.595 1.089 . . . . 0.0 110.011 177.651 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 29.0 t-20 -62.38 -45.03 94.97 Favored 'General case' 0 N--CA 1.454 -0.243 0 C-N-CA 122.776 0.43 . . . . 0.0 110.668 179.789 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 28.5 tp -59.44 -47.69 84.49 Favored 'General case' 0 N--CA 1.453 -0.277 0 C-N-CA 123.859 0.864 . . . . 0.0 111.102 177.579 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 85.0 mt -63.09 -46.59 95.71 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.175 0 N-CA-C 107.845 -1.169 . . . . 0.0 107.845 179.504 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -59.79 -28.8 67.74 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-N 118.457 0.571 . . . . 0.0 112.335 178.682 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 92.1 mttt -69.37 -57.17 5.63 Favored 'General case' 0 C--N 1.344 0.349 0 CA-C-N 119.219 0.918 . . . . 0.0 110.629 171.751 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 13.6 pt -77.29 -38.46 27.03 Favored 'Isoleucine or valine' 0 C--O 1.235 0.305 0 N-CA-C 115.095 1.517 . . . . 0.0 115.095 -168.823 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 69.5 m . . . . . 0 C--O 1.252 1.219 0 C-N-CA 125.694 1.597 . . . . 0.0 109.334 -169.79 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.496 1.839 0 N-CA-C 110.535 -0.172 . . . . 0.0 110.535 . . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 30.8 mttm -80.18 116.65 20.39 Favored 'General case' 0 N--CA 1.475 0.799 0 N-CA-C 106.109 -1.811 . . . . 0.0 106.109 173.66 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 92.2 mttt -81.89 131.88 35.26 Favored 'General case' 0 CA--C 1.505 -0.777 0 CA-C-N 119.566 1.075 . . . . 0.0 108.399 177.45 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 1.4 t -116.61 146.82 20.53 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 O-C-N 125.515 1.76 . . . . 0.0 107.131 -170.821 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 35.3 ttm -138.27 147.27 43.47 Favored 'General case' 0 C--N 1.32 -0.676 0 C-N-CA 125.194 1.398 . . . . 0.0 107.864 170.709 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 67.2 m-85 -136.26 119.82 17.07 Favored 'General case' 0 CA--C 1.516 -0.339 0 N-CA-C 105.509 -2.034 . . . . 0.0 105.509 177.526 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 2.0 p -151.45 129.81 2.75 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.386 0 N-CA-C 108.656 -0.868 . . . . 0.0 108.656 -169.427 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -110.77 -178.58 3.52 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 125.764 1.626 . . . . 0.0 106.921 169.754 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 85.1 tttt -70.88 -26.98 63.48 Favored 'General case' 0 N--CA 1.472 0.659 0 O-C-N 121.131 -0.981 . . . . 0.0 112.306 -171.821 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 37.8 ttp180 -136.47 160.7 37.98 Favored 'General case' 0 N--CA 1.467 0.392 0 C-N-CA 124.269 1.028 . . . . 0.0 109.077 -169.545 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -68.96 -38.82 79.64 Favored 'General case' 0 N--CA 1.47 0.571 0 CA-C-N 118.613 0.642 . . . . 0.0 110.596 175.748 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 2.9 p -84.13 66.87 9.49 Favored 'General case' 0 C--O 1.234 0.284 0 C-N-CA 125.863 1.665 . . . . 0.0 108.565 -177.863 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 40.6 p -155.15 -167.02 2.43 Favored 'General case' 0 N--CA 1.451 -0.382 0 CA-C-O 121.789 0.804 . . . . 0.0 109.903 -172.946 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 76.0 mtt180 -54.17 -23.29 13.81 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 126.033 1.733 . . . . 0.0 111.986 169.987 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 28.7 m -51.01 -26.05 5.58 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-N 119.84 1.2 . . . . 0.0 112.991 178.1 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 6.5 pt20 -69.1 -26.99 65.19 Favored 'General case' 0 C--O 1.221 -0.432 0 N-CA-C 114.925 1.454 . . . . 0.0 114.925 -172.554 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 2.1 tpt -115.43 -32.26 5.65 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-N 120.72 1.6 . . . . 0.0 115.033 -169.31 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -68.48 -43.7 76.35 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-N 119.723 1.147 . . . . 0.0 113.083 -169.204 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 1.5 pp20? -63.75 -34.07 77.07 Favored 'General case' 0 N--CA 1.473 0.688 0 CA-C-N 119.267 0.94 . . . . 0.0 109.541 171.997 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -50.8 -49.66 40.44 Favored Glycine 0 C--O 1.219 -0.839 0 C-N-CA 125.259 1.409 . . . . 0.0 111.011 176.057 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 5.6 m-85 -75.98 -31.76 59.14 Favored 'General case' 0 CA--C 1.511 -0.541 0 CA-C-N 118.928 1.364 . . . . 0.0 113.899 178.258 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -68.03 -32.8 73.42 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 119.421 1.009 . . . . 0.0 111.58 -170.174 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 4.7 ptpt -61.07 -29.21 69.61 Favored 'General case' 0 N--CA 1.473 0.697 0 CA-C-N 118.546 0.612 . . . . 0.0 111.643 172.407 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 15.1 m -82.66 -56.93 3.56 Favored 'General case' 0 N--CA 1.443 -0.793 0 C-N-CA 124.965 1.306 . . . . 0.0 109.819 -177.399 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 76.3 mt -73.49 -36.58 65.8 Favored 'General case' 0 C--N 1.331 -0.207 0 C-N-CA 123.35 0.66 . . . . 0.0 110.947 -170.359 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -103.87 13.16 53.17 Favored Glycine 0 CA--C 1.525 0.687 0 CA-C-O 118.068 -1.407 . . . . 0.0 113.044 -174.072 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -41.66 -53.95 3.41 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 126.345 1.858 . . . . 0.0 114.707 -169.229 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -91.31 10.08 75.78 Favored Glycine 0 CA--C 1.53 1.027 0 CA-C-O 119.216 -0.769 . . . . 0.0 113.525 -176.201 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 50.5 mttm -124.13 -50.86 1.79 Allowed 'General case' 0 N--CA 1.467 0.411 0 CA-C-N 118.435 1.117 . . . . 0.0 112.028 -169.21 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 28.3 pt -136.54 150.36 27.32 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.338 0 C-N-CA 124.222 1.009 . . . . 0.0 110.137 -169.011 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -110.27 102.48 11.14 Favored 'General case' 0 C--O 1.228 -0.048 0 C-N-CA 124.911 1.284 . . . . 0.0 109.47 -169.549 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 9.6 p -84.93 130.28 36.32 Favored 'Isoleucine or valine' 0 C--O 1.235 0.309 0 CA-C-N 118.686 0.675 . . . . 0.0 109.658 -179.982 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 19.1 m -145.14 115.46 7.55 Favored 'General case' 0 N--CA 1.448 -0.548 0 N-CA-C 104.342 -2.466 . . . . 0.0 104.342 170.519 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 48.2 m -112.47 8.0 19.22 Favored 'General case' 0 N--CA 1.466 0.325 0 N-CA-C 115.434 1.642 . . . . 0.0 115.434 -174.391 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 1.5 m 52.96 -133.73 1.78 Allowed 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 123.568 0.747 . . . . 0.0 111.114 169.679 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -171.14 154.7 23.08 Favored Glycine 0 N--CA 1.444 -0.777 0 N-CA-C 108.16 -1.976 . . . . 0.0 108.16 170.047 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 55.8 mt -103.08 -51.02 3.35 Favored 'General case' 0 N--CA 1.451 -0.404 0 C-N-CA 124.057 0.943 . . . . 0.0 108.864 171.755 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 25.7 mt-10 -130.58 72.0 1.48 Allowed 'General case' 0 CA--C 1.514 -0.428 0 CA-C-O 124.124 1.916 . . . . 0.0 107.069 169.663 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 10.7 m 57.33 -31.39 0.03 OUTLIER 'General case' 0 C--N 1.321 -0.649 0 C-N-CA 131.446 3.898 . . . . 0.0 117.422 -174.976 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 60.9 m 60.67 23.25 13.09 Favored 'General case' 0 CA--C 1.54 0.573 0 N-CA-C 115.9 1.815 . . . . 0.0 115.9 168.35 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 11.3 ttt180 -71.86 -178.98 2.5 Favored 'General case' 0 CA--C 1.539 0.519 0 N-CA-C 107.558 -1.275 . . . . 0.0 107.558 169.017 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 11.5 m -123.95 -172.32 0.75 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.642 0 C-N-CA 124.437 1.095 . . . . 0.0 111.279 -169.187 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 96.1 m-70 -112.45 156.32 42.41 Favored Pre-proline 0 CA--C 1.536 0.422 0 C-N-CA 125.184 1.394 . . . . 0.0 111.009 -171.984 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -57.2 -48.49 17.65 Favored 'Trans proline' 0 C--N 1.347 0.49 0 C-N-CA 124.012 3.141 . . . . 0.0 112.628 -174.014 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 2.7 m -67.9 -29.64 68.79 Favored 'General case' 0 CA--C 1.531 0.227 0 CA-C-O 118.849 -0.596 . . . . 0.0 110.156 -176.876 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -59.61 -56.09 26.33 Favored 'General case' 0 CA--C 1.505 -0.763 0 N-CA-C 108.137 -1.06 . . . . 0.0 108.137 171.164 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 56.2 mt -59.61 -39.07 78.51 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.396 0 N-CA-C 108.52 -0.918 . . . . 0.0 108.52 -173.043 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -62.32 -49.58 75.05 Favored 'General case' 0 N--CA 1.452 -0.358 0 CA-C-N 119.181 0.9 . . . . 0.0 111.138 -179.838 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 38.9 mmt -71.46 -34.25 70.06 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-O 122.756 1.265 . . . . 0.0 110.161 -177.226 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -73.31 -31.27 63.92 Favored 'General case' 0 N--CA 1.44 -0.925 0 N-CA-C 107.393 -1.336 . . . . 0.0 107.393 -178.634 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 4.9 mm-40 -72.88 -17.5 61.52 Favored 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 124.101 0.96 . . . . 0.0 110.985 169.704 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 78.5 mt-10 -65.11 -36.84 85.55 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 119.844 1.202 . . . . 0.0 108.762 168.932 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . 0.302 8.5 p -86.46 7.5 2.33 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.991 0 CA-C-O 120.789 0.328 . . . . 0.0 111.608 169.742 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 71.41 23.31 78.2 Favored Glycine 0 CA--C 1.532 1.147 0 C-N-CA 124.994 1.283 . . . . 0.0 113.266 175.773 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 5.4 mt -103.7 136.65 35.71 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.226 0 C-N-CA 124.273 1.029 . . . . 0.0 111.975 -172.225 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -78.11 137.28 38.12 Favored 'General case' 0 CA--C 1.529 0.155 0 CA-C-N 114.507 -1.224 . . . . 0.0 109.043 168.972 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 8.1 pt -143.35 -27.56 0.17 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.39 0 C-N-CA 125.062 1.345 . . . . 0.0 108.951 168.209 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -40.21 -41.17 1.25 Allowed 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 129.459 3.104 . . . . 0.0 113.113 169.443 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -87.25 20.52 25.68 Favored Glycine 0 CA--C 1.533 1.171 0 C-N-CA 125.225 1.393 . . . . 0.0 114.38 -177.422 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -60.08 -35.14 74.54 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-N 119.812 1.806 . . . . 0.0 112.489 -178.161 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -66.97 133.01 49.12 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 123.981 0.912 . . . . 0.0 109.817 -171.067 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 13.7 p -151.23 -68.97 0.18 Allowed 'General case' 0 C--O 1.235 0.307 0 C-N-CA 123.356 0.663 . . . . 0.0 109.962 -177.761 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -151.3 155.77 34.74 Favored Pre-proline 0 C--O 1.236 0.376 0 C-N-CA 125.807 1.643 . . . . 0.0 108.57 -177.126 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -64.39 156.3 60.98 Favored 'Trans proline' 0 N--CA 1.456 -0.686 0 C-N-CA 122.234 1.956 . . . . 0.0 110.208 171.46 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 11.3 tt -57.55 -28.41 31.59 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.499 0 C-N-CA 123.137 0.575 . . . . 0.0 111.536 178.826 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 23.1 tt0 -66.04 -25.23 66.95 Favored 'General case' 0 N--CA 1.437 -1.083 0 C-N-CA 126.335 1.854 . . . . 0.0 110.715 -175.588 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 6.1 t-20 -64.11 -21.22 66.45 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 124.287 1.035 . . . . 0.0 112.126 176.82 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 77.6 m-85 -110.88 -176.0 2.86 Favored 'General case' 0 C--O 1.235 0.306 0 C-N-CA 126.025 1.73 . . . . 0.0 110.802 -174.487 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 61.5 t-20 -136.68 141.2 43.12 Favored 'General case' 0 N--CA 1.445 -0.697 0 N-CA-C 107.206 -1.405 . . . . 0.0 107.206 169.366 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -72.2 -25.2 61.58 Favored 'General case' 0 N--CA 1.433 -1.295 0 CA-C-N 118.44 0.564 . . . . 0.0 109.701 -178.901 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 35.6 t70 -63.04 -24.16 67.78 Favored 'General case' 0 N--CA 1.447 -0.607 0 O-C-N 123.549 0.531 . . . . 0.0 111.634 -179.417 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -74.94 -28.11 60.46 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 123.159 0.584 . . . . 0.0 111.868 175.626 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 12.3 m-85 -81.51 164.47 21.96 Favored 'General case' 0 N--CA 1.448 -0.556 0 C-N-CA 125.353 1.461 . . . . 0.0 111.357 -177.21 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -107.16 -37.9 6.15 Favored 'General case' 0 N--CA 1.462 0.138 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.776 173.583 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -139.28 138.71 40.39 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.504 0 CA-C-O 121.731 0.776 . . . . 0.0 110.17 -170.615 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 57.9 t -141.42 130.6 24.15 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.659 0 N-CA-C 106.22 -1.77 . . . . 0.0 106.22 178.033 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 27.4 mm -106.0 128.12 60.57 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.76 0 N-CA-C 105.325 -2.102 . . . . 0.0 105.325 176.537 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 28.9 m -109.93 75.72 0.95 Allowed 'General case' 0 N--CA 1.437 -1.112 0 N-CA-C 105.455 -2.054 . . . . 0.0 105.455 -176.336 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 59.9 mt -53.03 -17.06 1.27 Allowed 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 125.768 1.627 . . . . 0.0 115.102 -169.1 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 12.7 m -112.14 -7.92 14.03 Favored 'General case' 0 CA--C 1.541 0.597 0 CA-C-N 119.866 1.212 . . . . 0.0 114.2 -177.477 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 142.89 -132.91 5.28 Favored Glycine 0 C--N 1.338 0.692 0 CA-C-N 120.635 1.562 . . . . 0.0 111.543 -178.041 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 13.0 m -125.15 -28.13 3.45 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 123.554 0.742 . . . . 0.0 112.314 -169.901 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -76.14 -62.93 2.5 Favored Glycine 0 C--N 1.343 0.925 0 N-CA-C 109.45 -1.46 . . . . 0.0 109.45 173.171 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . 0.321 10.9 t 56.81 18.96 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.55 0.962 0 C-N-CA 125.39 1.476 . . . . 0.0 112.693 170.602 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 64.9 t30 45.33 37.79 3.1 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 125.56 1.544 . . . . 0.0 112.385 -172.089 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -136.45 158.73 72.82 Favored Pre-proline 0 CA--C 1.541 0.62 0 C-N-CA 123.63 0.772 . . . . 0.0 111.849 179.766 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 80.4 Cg_exo -54.99 131.14 44.64 Favored 'Trans proline' 0 C--N 1.352 0.732 0 C-N-CA 123.22 2.613 . . . . 0.0 110.953 175.04 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 49.3 Cg_endo -62.06 -19.45 66.33 Favored 'Trans proline' 0 C--N 1.348 0.512 0 C-N-CA 122.089 1.86 . . . . 0.0 112.138 -177.997 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 2.2 pt-20 -51.13 -26.56 6.81 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 126.136 1.775 . . . . 0.0 112.569 172.739 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 83.4 m95 -74.52 -40.9 61.47 Favored 'General case' 0 N--CA 1.455 -0.2 0 C-N-CA 123.803 0.841 . . . . 0.0 111.844 175.371 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 14.0 t -66.15 -37.12 79.06 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.5 0 C-N-CA 123.901 0.88 . . . . 0.0 108.931 179.374 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 68.8 p -84.39 25.52 0.86 Allowed 'General case' 0 C--O 1.237 0.438 0 N-CA-C 114.851 1.426 . . . . 0.0 114.851 -168.826 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 91.3 mm-40 -74.44 -179.12 3.83 Favored 'General case' 0 CA--C 1.54 0.583 0 CA-C-N 118.385 0.539 . . . . 0.0 110.877 171.706 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 25.6 mm-40 -61.73 -17.87 57.48 Favored 'General case' 0 CA--C 1.54 0.566 0 N-CA-C 113.421 0.897 . . . . 0.0 113.421 -169.027 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 4.6 tt -140.6 133.61 32.59 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.513 0 N-CA-C 106.849 -1.537 . . . . 0.0 106.849 170.026 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -109.57 135.4 50.62 Favored 'General case' 0 CA--C 1.537 0.467 0 N-CA-C 105.04 -2.208 . . . . 0.0 105.04 169.149 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 12.8 mm-40 -138.67 163.6 31.69 Favored 'General case' 0 C--O 1.233 0.185 0 C-N-CA 124.542 1.137 . . . . 0.0 107.982 171.26 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -173.57 127.96 0.42 Allowed 'General case' 0 C--O 1.238 0.482 0 C-N-CA 126.944 2.098 . . . . 0.0 105.374 -169.571 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 7.5 m0 -143.13 142.48 31.5 Favored 'General case' 0 N--CA 1.469 0.519 0 N-CA-C 112.751 0.648 . . . . 0.0 112.751 -169.669 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 7.3 pt20 -81.52 50.5 1.49 Allowed 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 125.107 1.363 . . . . 0.0 111.183 174.66 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 41.7 mt -64.51 140.91 58.92 Favored 'General case' 0 N--CA 1.464 0.269 0 N-CA-C 107.707 -1.22 . . . . 0.0 107.707 172.856 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 27.8 mm-40 -67.15 142.01 57.18 Favored 'General case' 0 CA--C 1.533 0.324 0 CA-C-N 119.681 1.128 . . . . 0.0 109.035 169.938 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 1.5 t0 -97.35 116.07 65.85 Favored Pre-proline 0 N--CA 1.448 -0.526 0 N-CA-C 105.435 -2.061 . . . . 0.0 105.435 169.224 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 49.7 Cg_endo -83.94 -5.4 10.53 Favored 'Trans proline' 0 N--CA 1.451 -1.004 0 C-N-CA 122.815 2.344 . . . . 0.0 112.963 -174.949 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -58.86 127.42 32.12 Favored 'General case' 0 C--O 1.236 0.384 0 CA-C-N 120.204 1.366 . . . . 0.0 109.742 -178.882 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 74.4 0.4 57.7 Favored Glycine 0 CA--C 1.537 1.414 0 CA-C-O 118.618 -1.101 . . . . 0.0 114.013 -178.687 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 13.0 mt-30 -97.3 169.14 9.97 Favored 'General case' 0 CA--C 1.54 0.581 0 CA-C-N 119.09 1.445 . . . . 0.0 109.841 173.386 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 15.0 m -70.64 164.85 24.1 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 124.442 1.097 . . . . 0.0 111.554 -179.608 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 38.2 mt -61.93 -27.04 68.55 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 123.596 0.758 . . . . 0.0 112.115 -175.654 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 5.0 pt-20 -56.76 -36.09 69.38 Favored 'General case' 0 CA--C 1.53 0.198 0 C-N-CA 123.274 0.63 . . . . 0.0 111.228 173.413 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 24.8 t -76.44 -44.37 35.21 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.298 0 CA-C-O 117.786 -1.102 . . . . 0.0 108.837 -178.73 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 59.1 m-85 -55.05 -47.88 74.22 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-N 120.488 1.495 . . . . 0.0 110.364 173.272 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 93.7 mtt180 -70.01 -35.22 74.2 Favored 'General case' 0 CA--C 1.534 0.337 0 O-C-N 121.705 -0.622 . . . . 0.0 110.97 -175.801 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 2.6 m -60.81 -47.35 86.73 Favored 'General case' 0 N--CA 1.454 -0.262 0 C-N-CA 123.922 0.889 . . . . 0.0 109.175 169.812 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 44.4 t -65.31 -31.66 54.86 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.263 0 CA-C-O 118.481 -0.771 . . . . 0.0 109.867 -174.211 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 19.2 mtm105 -57.31 -46.37 83.26 Favored 'General case' 0 CA--C 1.535 0.382 0 CA-C-N 119.41 1.004 . . . . 0.0 110.375 172.507 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -62.57 -50.69 62.07 Favored Glycine 0 CA--C 1.529 0.907 0 CA-C-O 119.543 -0.587 . . . . 0.0 111.636 175.649 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 70.7 mt-30 -57.03 -49.63 75.23 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-O 121.889 0.852 . . . . 0.0 110.414 -176.865 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 58.4 t -74.89 -37.74 42.31 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-O 117.998 -1.001 . . . . 0.0 110.336 -172.062 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -54.77 -45.19 74.21 Favored 'General case' 0 C--O 1.224 -0.247 0 CA-C-N 119.892 1.224 . . . . 0.0 108.839 173.617 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 40.6 tt0 -67.16 -42.81 83.69 Favored 'General case' 0 N--CA 1.448 -0.571 0 C-N-CA 122.977 0.511 . . . . 0.0 111.267 -175.425 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 35.3 mmt180 -63.89 -45.69 88.24 Favored 'General case' 0 N--CA 1.473 0.689 0 CA-C-N 119.084 0.856 . . . . 0.0 111.304 176.881 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 77.5 t -68.37 -37.48 77.96 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.828 0 N-CA-C 108.71 -0.848 . . . . 0.0 108.71 -177.981 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 4.8 mm-40 -59.22 -46.26 88.93 Favored 'General case' 0 C--N 1.34 0.18 0 CA-C-N 119.426 1.012 . . . . 0.0 110.429 172.647 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 27.1 t-20 -64.89 -40.16 94.66 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 123.143 0.577 . . . . 0.0 111.182 -176.87 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 27.9 tp -58.99 -49.83 76.41 Favored 'General case' 0 CA--C 1.53 0.176 0 C-N-CA 125.105 1.362 . . . . 0.0 110.906 172.901 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 51.7 mt -64.57 -46.13 93.47 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 N-CA-C 107.829 -1.175 . . . . 0.0 107.829 -178.059 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -58.98 -30.96 68.35 Favored 'General case' 0 N--CA 1.452 -0.364 0 CA-C-O 118.52 -0.753 . . . . 0.0 112.284 -178.557 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 17.6 ptpt -84.25 -39.81 18.82 Favored 'General case' 0 C--N 1.345 0.375 0 CA-C-O 117.845 -1.074 . . . . 0.0 112.561 177.003 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 11.8 pt -82.55 -35.94 13.09 Favored 'Isoleucine or valine' 0 C--O 1.235 0.309 0 CA-C-N 120.094 1.315 . . . . 0.0 113.814 -175.133 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 65.1 m . . . . . 0 C--O 1.253 1.243 0 C-N-CA 125.134 1.374 . . . . 0.0 109.732 -169.814 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.0 mmt . . . . . 0 N--CA 1.495 1.805 0 N-CA-C 111.195 0.072 . . . . 0.0 111.195 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 30.0 mttm -83.75 112.34 19.99 Favored 'General case' 0 N--CA 1.475 0.818 0 N-CA-C 105.044 -2.206 . . . . 0.0 105.044 169.495 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 91.9 mttt -82.46 133.87 35.21 Favored 'General case' 0 CA--C 1.512 -0.481 0 CA-C-N 119.869 1.213 . . . . 0.0 107.94 179.758 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 1.8 t -120.05 147.14 23.93 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 C-N-CA 125.512 1.525 . . . . 0.0 108.867 -169.077 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 11.1 mtt -134.55 147.22 50.23 Favored 'General case' 0 C--N 1.326 -0.423 0 C-N-CA 125.731 1.613 . . . . 0.0 109.856 169.432 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 62.0 m-85 -135.54 116.72 14.45 Favored 'General case' 0 C--N 1.334 -0.084 0 N-CA-C 105.878 -1.897 . . . . 0.0 105.878 169.684 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 2.6 p -155.04 157.12 4.42 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.367 0 CA-C-O 121.127 0.489 . . . . 0.0 110.269 -168.991 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 52.3 t -152.43 174.89 13.3 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 127.482 2.313 . . . . 0.0 105.932 169.547 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 65.7 pttt -62.7 144.46 56.34 Favored 'General case' 0 N--CA 1.469 0.488 0 O-C-N 121.213 -0.93 . . . . 0.0 109.867 171.598 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 62.8 mtp85 57.78 170.34 0.05 OUTLIER 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 126.468 1.907 . . . . 0.0 113.171 -173.501 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -118.53 0.21 11.52 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 124.066 0.946 . . . . 0.0 111.462 170.113 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 1.4 m -64.19 -37.78 88.69 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 124.137 0.975 . . . . 0.0 110.147 -174.328 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 24.1 p -136.8 153.38 50.83 Favored 'General case' 0 C--O 1.236 0.391 0 C-N-CA 126.657 1.983 . . . . 0.0 106.532 169.718 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 8.0 mpt_? 56.68 -176.05 0.06 Allowed 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 125.391 1.476 . . . . 0.0 110.003 -169.288 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 3.9 m 48.45 46.44 20.64 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 124.069 0.948 . . . . 0.0 110.245 -169.756 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 21.4 pt20 -151.93 157.28 41.58 Favored 'General case' 0 N--CA 1.444 -0.732 0 N-CA-C 106.175 -1.787 . . . . 0.0 106.175 169.997 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER 64.47 -36.07 0.18 Allowed 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 128.124 2.569 . . . . 0.0 115.746 179.326 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -71.51 -48.76 46.8 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-N 121.431 1.923 . . . . 0.0 110.141 -176.827 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -62.66 -39.0 92.53 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 123.113 0.565 . . . . 0.0 110.447 170.012 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -55.73 -43.43 86.67 Favored Glycine 0 C--N 1.343 0.918 0 C-N-CA 123.924 0.773 . . . . 0.0 112.543 174.822 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 2.1 m-85 -74.72 -32.31 62.11 Favored 'General case' 0 CA--C 1.51 -0.573 0 CA-C-N 119.599 1.7 . . . . 0.0 112.227 177.253 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -67.37 -34.19 76.78 Favored 'General case' 0 N--CA 1.453 -0.313 0 CA-C-N 118.839 0.745 . . . . 0.0 111.257 -172.853 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 17.9 ptpt -62.71 -28.16 69.76 Favored 'General case' 0 N--CA 1.475 0.794 0 CA-C-N 119.224 0.92 . . . . 0.0 111.975 170.827 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 2.1 m -83.78 -56.16 3.86 Favored 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 124.573 1.149 . . . . 0.0 110.369 -177.483 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 72.4 mt -73.33 -34.34 65.61 Favored 'General case' 0 C--N 1.331 -0.206 0 C-N-CA 123.861 0.864 . . . . 0.0 110.186 -173.856 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -97.98 11.34 64.14 Favored Glycine 0 CA--C 1.525 0.667 0 C-N-CA 125.487 1.518 . . . . 0.0 112.82 -177.112 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -50.25 122.8 7.37 Favored 'General case' 0 CA--C 1.535 0.391 0 CA-C-N 118.754 1.277 . . . . 0.0 110.406 -177.121 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 74.67 -2.85 46.23 Favored Glycine 0 CA--C 1.536 1.348 0 CA-C-O 118.764 -1.02 . . . . 0.0 114.39 179.216 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 64.4 mttm -103.89 -42.23 5.65 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-N 119.316 1.558 . . . . 0.0 111.319 178.918 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 17.2 pt -141.97 152.84 18.68 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.657 0 C-N-CA 125.068 1.347 . . . . 0.0 109.671 -171.012 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -113.69 103.42 11.21 Favored 'General case' 0 N--CA 1.467 0.4 0 C-N-CA 125.242 1.417 . . . . 0.0 109.877 -170.752 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 3.8 t -86.22 127.9 39.87 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 O-C-N 121.299 -0.875 . . . . 0.0 108.695 -178.517 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 24.6 m -151.46 98.67 2.54 Favored 'General case' 0 C--O 1.223 -0.341 0 N-CA-C 104.843 -2.28 . . . . 0.0 104.843 173.659 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 20.2 m -97.53 5.06 50.13 Favored 'General case' 0 N--CA 1.467 0.388 0 N-CA-C 114.7 1.37 . . . . 0.0 114.7 -169.693 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 4.6 m 53.12 -133.95 1.74 Allowed 'General case' 0 CA--C 1.548 0.873 0 C-N-CA 124.02 0.928 . . . . 0.0 111.458 175.318 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -177.75 170.79 43.27 Favored Glycine 0 CA--C 1.526 0.728 0 N-CA-C 107.121 -2.392 . . . . 0.0 107.121 179.447 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 24.8 mt -113.34 -43.17 3.38 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 118.481 1.14 . . . . 0.0 109.707 179.327 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -141.83 -59.51 0.47 Allowed 'General case' 0 C--N 1.332 -0.175 0 N-CA-C 102.404 -3.184 . . . . 0.0 102.404 169.743 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 15.9 m 58.93 175.58 0.07 Allowed 'General case' 0 N--CA 1.446 -0.649 0 C-N-CA 127.167 2.187 . . . . 0.0 115.772 167.553 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 4.4 m -165.75 178.98 6.23 Favored 'General case' 0 C--O 1.238 0.499 0 C-N-CA 129.464 3.105 . . . . 0.0 104.442 -169.645 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -65.9 163.17 17.55 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-O 122.491 1.139 . . . . 0.0 110.581 172.26 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 4.3 m -67.34 175.32 0.51 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.71 0 CA-C-N 113.305 -1.771 . . . . 0.0 109.3 169.849 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 49.8 t-80 -72.62 139.55 80.91 Favored Pre-proline 0 CA--C 1.545 0.786 0 CA-C-O 118.474 -0.774 . . . . 0.0 109.549 -176.638 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 21.8 Cg_endo -60.74 -48.1 11.72 Favored 'Trans proline' 0 C--N 1.348 0.552 0 C-N-CA 122.645 2.23 . . . . 0.0 113.019 -172.301 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 4.9 m -65.47 -23.41 66.9 Favored 'General case' 0 CA--C 1.536 0.425 0 O-C-N 121.727 -0.608 . . . . 0.0 110.899 179.374 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -58.89 -46.52 87.64 Favored 'General case' 0 C--O 1.216 -0.707 0 CA-C-N 119.146 0.884 . . . . 0.0 108.723 176.835 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 38.6 mt -61.11 -40.18 84.87 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 N-CA-C 108.89 -0.781 . . . . 0.0 108.89 -174.489 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -65.71 -45.1 84.01 Favored 'General case' 0 CA--C 1.534 0.338 0 CA-C-N 118.39 0.541 . . . . 0.0 110.946 -179.864 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 33.0 mmt -68.25 -36.77 79.95 Favored 'General case' 0 CA--C 1.536 0.414 0 CA-C-O 123.295 1.522 . . . . 0.0 110.006 -179.106 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -76.96 -30.39 56.0 Favored 'General case' 0 N--CA 1.44 -0.933 0 N-CA-C 106.632 -1.618 . . . . 0.0 106.632 -175.675 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 40.6 tt0 -69.69 -21.13 63.53 Favored 'General case' 0 N--CA 1.445 -0.686 0 C-N-CA 124.1 0.96 . . . . 0.0 110.049 169.672 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 54.8 mt-10 -63.65 -39.02 93.3 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-N 119.85 1.205 . . . . 0.0 108.963 169.206 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . 0.32 6.2 p -84.7 8.42 1.56 Allowed 'Isoleucine or valine' 0 CA--C 1.549 0.922 0 N-CA-C 112.005 0.372 . . . . 0.0 112.005 171.628 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 79.46 20.15 69.79 Favored Glycine 0 CA--C 1.53 1.01 0 C-N-CA 125.009 1.29 . . . . 0.0 113.563 174.318 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 22.8 mt -116.54 145.97 21.58 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.261 0 C-N-CA 124.861 1.265 . . . . 0.0 110.547 -171.528 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -116.73 149.02 40.56 Favored 'General case' 0 N--CA 1.463 0.214 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 168.94 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 3.3 pt -138.34 -18.78 0.47 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.376 0 C-N-CA 128.058 2.543 . . . . 0.0 111.197 -174.529 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 1.6 t -47.2 -39.87 14.89 Favored 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 124.11 0.964 . . . . 0.0 112.023 169.929 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -68.97 6.26 4.0 Favored Glycine 0 CA--C 1.535 1.306 0 C-N-CA 124.958 1.266 . . . . 0.0 115.318 -176.977 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 2.2 mt-30 -61.33 -33.35 73.47 Favored 'General case' 0 C--N 1.342 0.24 0 CA-C-N 119.605 1.702 . . . . 0.0 113.355 179.191 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -59.77 119.75 8.25 Favored 'General case' 0 C--O 1.236 0.385 0 C-N-CA 123.596 0.758 . . . . 0.0 109.736 -169.412 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 56.1 m -148.84 -169.71 3.44 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 126.358 1.863 . . . . 0.0 108.229 -169.149 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -54.75 154.6 9.1 Favored Pre-proline 0 C--O 1.239 0.524 0 C-N-CA 124.407 1.083 . . . . 0.0 111.613 169.925 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 98.2 Cg_endo -66.08 157.06 61.55 Favored 'Trans proline' 0 N--CA 1.454 -0.82 0 C-N-CA 122.328 2.018 . . . . 0.0 110.225 171.175 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 14.0 tt -61.19 -26.46 39.31 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.328 0 C-N-CA 124.229 1.011 . . . . 0.0 110.979 -178.789 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 13.6 mt-10 -68.03 -24.93 65.15 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 124.556 1.142 . . . . 0.0 110.619 -175.673 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 6.8 t-20 -62.93 -19.14 63.95 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 124.821 1.249 . . . . 0.0 112.153 177.477 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 13.3 m-85 -120.8 174.01 6.87 Favored 'General case' 0 C--O 1.237 0.412 0 C-N-CA 126.484 1.914 . . . . 0.0 109.318 -178.286 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 29.9 p-10 -125.09 149.29 47.99 Favored 'General case' 0 N--CA 1.437 -1.124 0 C-N-CA 124.681 1.192 . . . . 0.0 110.942 168.936 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -75.64 -22.23 56.97 Favored 'General case' 0 N--CA 1.435 -1.223 0 N-CA-C 109.603 -0.518 . . . . 0.0 109.603 -169.901 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 34.7 t70 -64.7 -23.66 67.32 Favored 'General case' 0 N--CA 1.444 -0.774 0 O-C-N 123.666 0.603 . . . . 0.0 111.804 -178.828 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -76.61 -29.44 56.5 Favored 'General case' 0 CA--C 1.533 0.323 0 O-C-N 121.893 -0.505 . . . . 0.0 111.928 173.993 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 21.0 m-85 -78.7 167.73 20.79 Favored 'General case' 0 N--CA 1.448 -0.532 0 C-N-CA 125.116 1.366 . . . . 0.0 110.949 179.597 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -115.63 -40.06 3.43 Favored 'General case' 0 N--CA 1.466 0.353 0 C-N-CA 122.893 0.477 . . . . 0.0 111.223 178.962 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -138.04 136.16 45.03 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.497 0 CA-C-O 121.8 0.81 . . . . 0.0 109.315 -171.324 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 72.1 t -143.84 136.56 23.75 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.68 0 N-CA-C 106.126 -1.805 . . . . 0.0 106.126 -176.869 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 40.9 mm -129.18 127.3 65.45 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.609 0 N-CA-C 107.325 -1.361 . . . . 0.0 107.325 -169.916 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 15.0 m -87.37 131.19 34.37 Favored 'General case' 0 N--CA 1.436 -1.159 0 N-CA-C 105.96 -1.867 . . . . 0.0 105.96 168.235 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 90.6 mt -88.71 -11.67 44.5 Favored 'General case' 0 C--N 1.331 -0.208 0 O-C-N 122.026 -0.421 . . . . 0.0 110.617 172.004 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -167.23 148.85 5.81 Favored 'General case' 0 N--CA 1.447 -0.618 0 C-N-CA 126.633 1.973 . . . . 0.0 107.339 168.385 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 72.37 167.79 10.51 Favored Glycine 0 CA--C 1.535 1.338 0 C-N-CA 124.849 1.214 . . . . 0.0 114.452 174.009 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 41.9 m -141.38 111.09 6.51 Favored 'General case' 0 CA--C 1.532 0.262 0 N-CA-C 107.454 -1.313 . . . . 0.0 107.454 178.936 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 60.23 30.94 71.96 Favored Glycine 0 CA--C 1.535 1.304 0 N-CA-C 111.567 -0.613 . . . . 0.0 111.567 -174.747 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 10.4 p -67.4 -51.71 49.52 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.563 0 C-N-CA 123.882 0.873 . . . . 0.0 111.493 -169.182 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 16.1 t-20 -154.4 41.61 0.49 Allowed 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 125.32 1.448 . . . . 0.0 107.128 173.04 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 2.3 tt -147.59 141.12 15.39 Favored Pre-proline 0 CA--C 1.542 0.641 0 C-N-CA 125.934 1.693 . . . . 0.0 107.85 -169.351 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 32.9 Cg_exo -68.18 149.94 76.57 Favored 'Trans proline' 0 C--N 1.355 0.885 0 CA-C-N 120.742 1.301 . . . . 0.0 114.272 -169.837 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -69.53 -29.05 25.58 Favored 'Trans proline' 0 C--N 1.347 0.455 0 C-N-CA 122.464 2.11 . . . . 0.0 114.292 -169.873 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -61.22 -18.36 57.93 Favored 'General case' 0 CA--C 1.538 0.492 0 CA-C-N 119.738 1.154 . . . . 0.0 112.081 -178.866 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 97.9 m95 -75.83 -49.37 18.2 Favored 'General case' 0 N--CA 1.449 -0.522 0 C-N-CA 123.628 0.771 . . . . 0.0 110.583 177.739 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 33.5 m -77.02 1.07 2.2 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.44 0 C-N-CA 123.13 0.572 . . . . 0.0 112.421 -178.647 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 81.3 p -111.47 19.57 18.06 Favored 'General case' 0 CA--C 1.537 0.458 0 N-CA-C 114.302 1.223 . . . . 0.0 114.302 175.464 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 87.4 mm-40 -67.54 174.61 3.33 Favored 'General case' 0 CA--C 1.539 0.544 0 CA-C-N 119.16 0.891 . . . . 0.0 112.445 178.158 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 29.7 mm-40 -51.91 -32.23 31.87 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 124.711 1.204 . . . . 0.0 112.334 -169.056 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 5.3 tt -131.71 130.85 62.24 Favored 'Isoleucine or valine' 0 C--O 1.24 0.557 0 N-CA-C 103.92 -2.622 . . . . 0.0 103.92 168.017 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 40.9 t80 -120.47 141.18 50.42 Favored 'General case' 0 N--CA 1.444 -0.738 0 N-CA-C 106.061 -1.829 . . . . 0.0 106.061 169.27 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 31.2 mm-40 -139.68 144.8 37.76 Favored 'General case' 0 C--O 1.237 0.408 0 N-CA-C 106.204 -1.776 . . . . 0.0 106.204 169.632 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 7.1 t0 -119.8 103.45 9.37 Favored 'General case' 0 C--O 1.237 0.443 0 N-CA-C 104.746 -2.316 . . . . 0.0 104.746 169.247 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 4.2 m95 -86.15 134.22 33.81 Favored 'General case' 0 N--CA 1.453 -0.278 0 CA-C-O 120.683 0.278 . . . . 0.0 110.928 -169.62 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 66.5 tt0 -81.89 99.71 9.21 Favored 'General case' 0 C--O 1.236 0.383 0 N-CA-C 103.568 -2.753 . . . . 0.0 103.568 168.712 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 11.1 mt -129.62 133.17 46.99 Favored 'General case' 0 CA--C 1.52 -0.196 0 N-CA-C 107.477 -1.305 . . . . 0.0 107.477 178.622 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 -76.74 165.0 25.33 Favored 'General case' 0 N--CA 1.452 -0.366 0 C-N-CA 124.902 1.281 . . . . 0.0 108.323 169.803 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 15.3 t70 -140.66 139.72 20.71 Favored Pre-proline 0 CA--C 1.536 0.439 0 C-N-CA 123.872 0.869 . . . . 0.0 110.142 -177.511 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 42.4 Cg_endo -84.83 0.92 8.82 Favored 'Trans proline' 0 CA--C 1.544 0.977 0 C-N-CA 123.149 2.566 . . . . 0.0 114.405 -172.8 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 3.2 t70 -48.76 120.0 3.52 Favored 'General case' 0 N--CA 1.468 0.428 0 CA-C-N 120.517 1.508 . . . . 0.0 110.926 177.623 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 67.87 4.73 35.49 Favored Glycine 0 CA--C 1.536 1.383 0 CA-C-O 118.723 -1.043 . . . . 0.0 114.777 179.076 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 6.3 mt-30 -94.45 171.14 8.99 Favored 'General case' 0 CA--C 1.538 0.509 0 CA-C-N 119.31 1.555 . . . . 0.0 110.424 -178.612 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 14.6 m -68.47 159.61 31.36 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 124.321 1.048 . . . . 0.0 110.599 178.083 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 13.8 tp -60.06 -32.0 70.52 Favored 'General case' 0 N--CA 1.467 0.417 0 C-N-CA 123.888 0.875 . . . . 0.0 112.127 -170.055 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 5.3 pt-20 -53.85 -35.76 61.86 Favored 'General case' 0 N--CA 1.467 0.418 0 C-N-CA 126.016 1.726 . . . . 0.0 112.137 176.095 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 38.3 t -70.81 -37.86 70.37 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.258 0 N-CA-C 109.083 -0.71 . . . . 0.0 109.083 -174.008 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 91.8 m-85 -56.74 -50.35 72.5 Favored 'General case' 0 N--CA 1.462 0.126 0 CA-C-N 119.346 0.975 . . . . 0.0 110.806 172.563 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -66.34 -38.09 86.86 Favored 'General case' 0 N--CA 1.473 0.699 0 N-CA-C 109.766 -0.457 . . . . 0.0 109.766 -174.992 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 4.0 m -60.85 -49.64 76.66 Favored 'General case' 0 N--CA 1.451 -0.42 0 C-N-CA 124.704 1.201 . . . . 0.0 109.984 173.681 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 76.7 t -69.59 -25.84 29.62 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.229 0 CA-C-O 117.812 -1.089 . . . . 0.0 109.944 -171.829 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 11.9 mtm105 -57.15 -49.07 77.07 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 120.142 1.337 . . . . 0.0 109.729 169.839 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -63.35 -48.47 78.54 Favored Glycine 0 CA--C 1.527 0.84 0 CA-C-N 118.608 0.64 . . . . 0.0 111.951 -179.52 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 12.8 mt-30 -60.74 -46.15 91.52 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-N 117.719 0.759 . . . . 0.0 110.77 -179.188 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 82.6 t -70.68 -40.67 77.27 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-O 118.424 -0.798 . . . . 0.0 110.297 -175.84 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 85.9 tttt -52.69 -47.26 67.33 Favored 'General case' 0 C--O 1.223 -0.322 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 175.688 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 40.2 tt0 -64.58 -42.63 95.49 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-O 119.245 -0.407 . . . . 0.0 111.253 -175.134 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 35.3 mmt180 -60.21 -47.46 85.86 Favored 'General case' 0 N--CA 1.472 0.635 0 CA-C-N 118.882 0.765 . . . . 0.0 110.434 175.893 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 89.8 t -69.94 -37.78 73.7 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.525 0 N-CA-C 109.563 -0.532 . . . . 0.0 109.563 -175.274 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 35.4 mt-10 -59.96 -44.44 94.42 Favored 'General case' 0 C--O 1.227 -0.097 0 CA-C-N 119.657 1.117 . . . . 0.0 110.049 174.165 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 28.7 t-20 -63.26 -44.55 94.84 Favored 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 122.693 0.397 . . . . 0.0 110.834 -178.564 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 41.8 tp -58.73 -48.53 80.85 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 124.335 1.054 . . . . 0.0 111.104 175.97 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 65.4 mt -62.79 -47.1 94.48 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.149 0 N-CA-C 107.865 -1.161 . . . . 0.0 107.865 -179.999 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -58.85 -27.65 65.34 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 123.095 0.558 . . . . 0.0 112.436 178.11 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 89.4 mttt -72.03 -57.43 4.29 Favored 'General case' 0 C--N 1.343 0.325 0 CA-C-N 119.153 0.888 . . . . 0.0 110.616 171.604 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 13.2 pt -76.14 -36.23 30.31 Favored 'Isoleucine or valine' 0 C--O 1.235 0.293 0 N-CA-C 115.184 1.55 . . . . 0.0 115.184 -168.943 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 69.2 m . . . . . 0 C--O 1.252 1.229 0 C-N-CA 125.707 1.603 . . . . 0.0 109.606 -169.881 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 19.5 mmm . . . . . 0 N--CA 1.499 1.997 0 N-CA-C 110.936 -0.024 . . . . 0.0 110.936 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 31.0 mttm -79.43 117.81 20.73 Favored 'General case' 0 N--CA 1.477 0.895 0 N-CA-C 105.407 -2.071 . . . . 0.0 105.407 169.545 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 74.5 mttt -83.43 133.67 34.91 Favored 'General case' 0 CA--C 1.514 -0.414 0 CA-C-N 120.252 1.387 . . . . 0.0 107.997 179.324 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 1.5 t -118.78 147.94 21.98 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.583 0 C-N-CA 126.725 2.01 . . . . 0.0 106.711 -169.635 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 49.7 ttm -142.8 142.04 31.78 Favored 'General case' 0 C--N 1.325 -0.484 0 C-N-CA 123.71 0.804 . . . . 0.0 109.343 172.191 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 97.0 m-85 -132.64 122.06 24.12 Favored 'General case' 0 CA--C 1.511 -0.551 0 N-CA-C 104.987 -2.227 . . . . 0.0 104.987 179.855 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 1.6 p -154.07 119.78 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.397 0 C-N-CA 119.566 -0.854 . . . . 0.0 109.412 -169.515 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 51.1 t -98.75 178.43 4.98 Favored 'General case' 0 CA--C 1.541 0.623 0 N-CA-C 106.971 -1.492 . . . . 0.0 106.971 168.915 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -52.4 -42.19 63.83 Favored 'General case' 0 N--CA 1.473 0.707 0 O-C-N 121.624 -0.673 . . . . 0.0 110.803 178.662 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 66.2 mtp180 -108.94 145.45 35.41 Favored 'General case' 0 CA--C 1.521 -0.156 0 N-CA-C 108.978 -0.749 . . . . 0.0 108.978 169.852 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 7.4 t30 -55.04 -38.01 67.42 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 124.363 1.065 . . . . 0.0 111.112 169.372 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 1.4 m -68.71 -15.0 63.38 Favored 'General case' 0 CA--C 1.533 0.307 0 N-CA-C 114.667 1.358 . . . . 0.0 114.667 -169.557 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 52.3 m -124.69 139.43 53.86 Favored 'General case' 0 C--O 1.223 -0.309 0 C-N-CA 123.97 0.908 . . . . 0.0 110.311 -169.09 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 6.4 mpt_? 59.14 -60.97 0.04 OUTLIER 'General case' 0 N--CA 1.481 1.112 0 C-N-CA 127.605 2.362 . . . . 0.0 114.066 -174.737 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -44.72 -36.91 3.39 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 126.499 1.919 . . . . 0.0 109.624 170.001 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 23.8 tt0 -25.63 -61.91 0.07 Allowed 'General case' 0 C--O 1.22 -0.486 0 C-N-CA 130.686 3.595 . . . . 0.0 111.772 168.848 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -98.68 -29.87 12.78 Favored 'General case' 0 CA--C 1.516 -0.345 0 CA-C-N 119.719 1.145 . . . . 0.0 113.434 177.501 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -61.09 -48.55 81.18 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 111.993 0.368 . . . . 0.0 111.993 -169.321 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -68.74 -30.62 69.28 Favored 'General case' 0 N--CA 1.463 0.177 0 C-N-CA 120.237 -0.585 . . . . 0.0 109.645 176.767 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -54.81 -57.3 18.55 Favored Glycine 0 C--N 1.34 0.781 0 C-N-CA 125.405 1.478 . . . . 0.0 110.099 176.812 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 8.7 m-85 -67.89 -32.18 72.48 Favored 'General case' 0 CA--C 1.503 -0.835 0 O-C-N 121.659 -0.906 . . . . 0.0 111.981 179.982 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -65.82 -34.74 78.85 Favored 'General case' 0 N--CA 1.447 -0.585 0 C-N-CA 119.431 -0.908 . . . . 0.0 111.141 -175.452 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -68.1 -24.23 65.01 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-N 119.436 1.016 . . . . 0.0 112.036 175.037 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 2.1 m -82.11 -56.12 4.13 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 125.223 1.409 . . . . 0.0 110.438 -179.993 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 72.3 mt -76.37 -34.97 58.91 Favored 'General case' 0 C--N 1.329 -0.283 0 C-N-CA 124.631 1.172 . . . . 0.0 110.258 -172.529 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -92.57 7.13 77.69 Favored Glycine 0 CA--C 1.526 0.758 0 C-N-CA 125.282 1.42 . . . . 0.0 113.198 -177.292 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -52.52 124.18 12.93 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 124.448 1.099 . . . . 0.0 110.002 -176.01 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 75.44 1.95 66.74 Favored Glycine 0 CA--C 1.535 1.288 0 CA-C-O 118.835 -0.981 . . . . 0.0 114.406 179.074 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 64.0 mttm -113.36 -43.06 3.39 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-N 119.294 1.547 . . . . 0.0 111.359 178.828 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 20.4 pt -140.94 151.41 20.2 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.604 0 C-N-CA 123.805 0.842 . . . . 0.0 110.388 -169.36 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -108.66 103.25 12.31 Favored 'General case' 0 N--CA 1.467 0.393 0 C-N-CA 125.37 1.468 . . . . 0.0 109.646 -173.209 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 20.8 t -81.31 135.84 24.28 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 179.604 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 4.8 m -140.68 111.51 6.99 Favored 'General case' 0 N--CA 1.445 -0.678 0 N-CA-C 104.492 -2.41 . . . . 0.0 104.492 169.513 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 75.0 m -114.31 91.97 3.81 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 107.64 -1.245 . . . . 0.0 107.64 178.739 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 5.0 p -63.69 -62.38 1.7 Allowed 'General case' 0 C--O 1.233 0.215 0 C-N-CA 126.408 1.883 . . . . 0.0 112.044 -173.071 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 107.88 137.63 8.36 Favored Glycine 0 CA--C 1.527 0.786 0 N-CA-C 109.157 -1.577 . . . . 0.0 109.157 -174.425 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 12.8 mt -80.08 -40.44 27.6 Favored 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 124.395 1.078 . . . . 0.0 108.874 170.207 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 33.5 mt-10 -139.87 170.16 16.38 Favored 'General case' 0 C--O 1.239 0.523 0 C-N-CA 128.143 2.577 . . . . 0.0 107.629 172.914 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 13.2 m 64.75 -168.17 0.21 Allowed 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 124.837 1.255 . . . . 0.0 112.315 -177.487 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 36.8 p -162.55 -47.66 0.04 OUTLIER 'General case' 0 C--O 1.232 0.184 0 N-CA-C 112.442 0.534 . . . . 0.0 112.442 -167.067 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 2.0 ttp-105 -108.87 -167.5 1.23 Allowed 'General case' 0 CA--C 1.52 -0.19 0 C-N-CA 125.498 1.519 . . . . 0.0 109.227 177.766 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 34.2 m -127.32 168.94 19.53 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 C-N-CA 125.506 1.523 . . . . 0.0 109.838 -171.757 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 37.4 m80 -71.59 148.1 92.67 Favored Pre-proline 0 CA--C 1.548 0.889 0 C-N-CA 123.313 0.645 . . . . 0.0 109.694 177.975 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -62.39 -50.74 4.14 Favored 'Trans proline' 0 C--N 1.348 0.529 0 C-N-CA 123.818 3.012 . . . . 0.0 114.806 -168.632 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 11.5 m -63.88 -22.69 67.03 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-N 118.211 0.459 . . . . 0.0 110.61 -175.678 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -55.12 -55.33 32.32 Favored 'General case' 0 CA--C 1.511 -0.546 0 C-N-CA 122.765 0.426 . . . . 0.0 109.911 174.152 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 56.3 mt -60.54 -38.04 76.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 N-CA-C 108.554 -0.906 . . . . 0.0 108.554 -170.635 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -62.94 -48.19 79.98 Favored 'General case' 0 N--CA 1.451 -0.379 0 CA-C-N 118.471 0.578 . . . . 0.0 111.07 177.778 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 27.8 mmt -66.73 -36.54 82.71 Favored 'General case' 0 C--O 1.238 0.488 0 CA-C-O 122.78 1.276 . . . . 0.0 111.071 -179.748 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -75.98 -31.23 58.88 Favored 'General case' 0 N--CA 1.441 -0.878 0 N-CA-C 107.183 -1.414 . . . . 0.0 107.183 -174.777 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 41.0 tt0 -71.28 -21.77 62.04 Favored 'General case' 0 N--CA 1.446 -0.63 0 C-N-CA 124.138 0.975 . . . . 0.0 110.426 171.031 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 20.0 mm-40 -67.57 -31.0 70.77 Favored 'General case' 0 CA--C 1.534 0.359 0 CA-C-N 119.508 1.049 . . . . 0.0 110.141 170.814 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . 0.28 7.2 p -90.39 8.62 3.53 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.983 0 CA-C-N 118.633 0.652 . . . . 0.0 111.482 169.062 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 75.73 18.59 79.6 Favored Glycine 0 CA--C 1.533 1.162 0 C-N-CA 124.678 1.133 . . . . 0.0 113.746 174.908 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 21.6 mt -111.35 134.81 52.5 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.23 0 C-N-CA 124.559 1.143 . . . . 0.0 109.379 -177.234 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 28.7 t0 -99.52 141.53 32.19 Favored 'General case' 0 C--O 1.235 0.323 0 N-CA-C 108.288 -1.005 . . . . 0.0 108.288 168.952 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 8.8 pt -131.15 -15.67 1.58 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.503 0 C-N-CA 126.335 1.854 . . . . 0.0 111.298 -174.135 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 1.2 t -57.2 163.48 2.14 Favored 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 124.544 1.138 . . . . 0.0 109.86 168.342 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 57.73 32.6 65.82 Favored Glycine 0 CA--C 1.532 1.106 0 C-N-CA 123.543 0.592 . . . . 0.0 112.129 179.177 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 4.3 tt0 -65.5 -39.41 91.82 Favored 'General case' 0 C--N 1.341 0.214 0 N-CA-C 113.957 1.095 . . . . 0.0 113.957 -169.135 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 7.0 t -76.19 177.82 6.9 Favored 'General case' 0 N--CA 1.449 -0.518 0 CA-C-O 122.557 1.17 . . . . 0.0 110.555 -169.646 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 13.3 p -155.72 -54.1 0.09 Allowed 'General case' 0 C--N 1.324 -0.515 0 C-N-CA 125.213 1.405 . . . . 0.0 108.327 -171.25 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -151.88 155.89 33.95 Favored Pre-proline 0 C--O 1.239 0.521 0 C-N-CA 127.628 2.371 . . . . 0.0 106.173 169.955 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -59.84 148.81 86.85 Favored 'Trans proline' 0 N--CA 1.457 -0.654 0 C-N-CA 121.801 1.668 . . . . 0.0 108.991 169.411 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 20.6 tt -55.24 -29.62 23.44 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.352 0 C-N-CA 123.12 0.568 . . . . 0.0 112.364 -174.181 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 9.0 mt-10 -65.73 -29.62 70.17 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 123.233 0.613 . . . . 0.0 111.026 -173.234 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 88.3 m-20 -77.93 -8.98 58.84 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 124.002 0.921 . . . . 0.0 112.273 -177.796 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 61.8 m-85 -95.53 162.24 13.72 Favored 'General case' 0 C--O 1.236 0.352 0 C-N-CA 124.286 1.034 . . . . 0.0 111.321 176.836 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 40.9 t-20 -99.47 127.32 45.52 Favored 'General case' 0 N--CA 1.447 -0.62 0 N-CA-C 107.431 -1.322 . . . . 0.0 107.431 168.875 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -73.3 -26.28 61.01 Favored 'General case' 0 N--CA 1.434 -1.266 0 N-CA-C 109.466 -0.568 . . . . 0.0 109.466 -178.252 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -63.85 -22.47 66.93 Favored 'General case' 0 N--CA 1.443 -0.798 0 CA-C-N 116.528 -0.306 . . . . 0.0 111.582 -178.347 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -74.02 -24.64 59.58 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 123.058 0.543 . . . . 0.0 111.991 178.851 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 34.4 m-85 -85.85 145.67 27.09 Favored 'General case' 0 N--CA 1.451 -0.394 0 C-N-CA 124.974 1.31 . . . . 0.0 111.5 -176.534 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 27.3 t70 -98.66 -32.69 11.28 Favored 'General case' 0 N--CA 1.466 0.357 0 C-N-CA 123.506 0.722 . . . . 0.0 111.032 -179.844 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -140.19 134.66 36.13 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.393 0 C-N-CA 124.376 1.071 . . . . 0.0 109.119 -175.792 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 94.2 t -144.1 139.49 24.77 Favored 'Isoleucine or valine' 0 C--O 1.237 0.396 0 N-CA-C 107.165 -1.42 . . . . 0.0 107.165 -178.822 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 19.0 mm -123.06 124.4 70.11 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.601 0 N-CA-C 106.589 -1.634 . . . . 0.0 106.589 -179.357 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 28.2 m -95.4 105.87 17.88 Favored 'General case' 0 N--CA 1.448 -0.555 0 N-CA-C 103.66 -2.718 . . . . 0.0 103.66 169.321 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 29.4 mt -76.21 -4.76 43.58 Favored 'General case' 0 N--CA 1.463 0.219 0 N-CA-C 114.273 1.212 . . . . 0.0 114.273 -169.364 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 73.2 m -146.13 71.77 1.27 Allowed 'General case' 0 N--CA 1.451 -0.391 0 CA-C-N 118.795 0.725 . . . . 0.0 109.168 -169.761 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 91.05 178.79 43.18 Favored Glycine 0 CA--C 1.53 0.979 0 C-N-CA 124.484 1.04 . . . . 0.0 111.031 -177.009 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 15.0 p -89.79 -92.95 0.12 Allowed 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 123.643 0.777 . . . . 0.0 111.087 -169.533 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -79.52 -41.67 12.85 Favored Glycine 0 C--N 1.338 0.665 0 CA-C-O 119.058 -0.856 . . . . 0.0 111.06 176.885 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . 0.317 4.7 m 44.13 -94.41 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.543 0.698 0 C-N-CA 126.063 1.745 . . . . 0.0 113.704 174.833 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 57.3 t30 -141.13 43.42 1.79 Allowed 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 125.129 1.372 . . . . 0.0 109.111 177.131 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -133.72 139.27 33.1 Favored Pre-proline 0 CA--C 1.541 0.623 0 C-N-CA 127.247 2.219 . . . . 0.0 107.316 -171.642 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 39.6 Cg_exo -65.36 137.84 52.91 Favored 'Trans proline' 0 CA--C 1.539 0.748 0 C-N-CA 121.386 1.391 . . . . 0.0 111.965 -176.124 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 65.1 Cg_endo -68.88 -15.53 40.44 Favored 'Trans proline' 0 N--CA 1.46 -0.472 0 C-N-CA 122.616 2.211 . . . . 0.0 113.513 -173.644 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -59.54 -14.74 14.21 Favored 'General case' 0 CA--C 1.541 0.625 0 CA-C-N 120.315 1.416 . . . . 0.0 111.966 170.425 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 99.8 m95 -96.56 -11.36 25.49 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 125.215 1.406 . . . . 0.0 113.563 174.683 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 3.9 m -92.42 0.75 9.42 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.355 0 CA-C-N 120.261 1.392 . . . . 0.0 111.477 174.745 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 63.6 p -117.88 15.66 14.32 Favored 'General case' 0 C--O 1.237 0.406 0 N-CA-C 116.872 2.175 . . . . 0.0 116.872 -169.455 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 17.6 mp0 -66.51 173.87 3.1 Favored 'General case' 0 CA--C 1.54 0.587 0 CA-C-N 118.852 0.751 . . . . 0.0 111.016 176.284 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 33.3 mm-40 -56.67 -27.06 57.98 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 123.691 0.796 . . . . 0.0 111.268 -172.353 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 5.0 tt -133.8 131.24 56.41 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.528 0 N-CA-C 104.958 -2.238 . . . . 0.0 104.958 168.361 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 40.5 t80 -117.99 135.99 53.81 Favored 'General case' 0 N--CA 1.449 -0.486 0 N-CA-C 106.706 -1.59 . . . . 0.0 106.706 169.739 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 16.4 mm-40 -142.09 165.81 26.44 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-O 121.963 0.887 . . . . 0.0 110.116 174.881 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 3.7 t0 -168.1 134.16 1.95 Allowed 'General case' 0 C--O 1.239 0.516 0 C-N-CA 129.71 3.204 . . . . 0.0 106.108 -172.76 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 6.2 m-90 -144.8 149.04 34.77 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 123.847 0.859 . . . . 0.0 109.72 -171.269 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 7.4 tp-100 -82.56 57.36 3.69 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-O 121.809 0.814 . . . . 0.0 109.589 177.889 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 66.6 mt -79.22 152.66 30.5 Favored 'General case' 0 CA--C 1.53 0.179 0 N-CA-C 106.526 -1.657 . . . . 0.0 106.526 169.62 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 5.6 pt-20 -119.24 164.55 15.46 Favored 'General case' 0 N--CA 1.456 -0.141 0 C-N-CA 124.936 1.294 . . . . 0.0 110.436 178.623 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 64.4 t0 -97.42 121.28 58.91 Favored Pre-proline 0 CA--C 1.539 0.542 0 C-N-CA 123.739 0.815 . . . . 0.0 108.842 171.375 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 90.2 Cg_endo -70.48 -5.0 15.65 Favored 'Trans proline' 0 CA--C 1.544 1.02 0 C-N-CA 123.792 2.995 . . . . 0.0 113.765 176.18 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -43.28 123.23 2.85 Favored 'General case' 0 C--O 1.238 0.453 0 C-N-CA 126.249 1.82 . . . . 0.0 111.367 -179.506 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 69.5 2.79 36.89 Favored Glycine 0 CA--C 1.533 1.19 0 CA-C-O 118.612 -1.105 . . . . 0.0 114.98 169.759 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 28.8 pt20 -111.62 -167.06 1.13 Allowed 'General case' 0 CA--C 1.536 0.433 0 CA-C-N 119.021 1.41 . . . . 0.0 109.737 171.928 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 2.3 m -68.45 154.43 41.84 Favored 'General case' 0 N--CA 1.453 -0.303 0 N-CA-C 115.699 1.74 . . . . 0.0 115.699 -168.261 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 36.0 tp -55.76 -33.39 64.27 Favored 'General case' 0 N--CA 1.465 0.317 0 C-N-CA 126.349 1.86 . . . . 0.0 111.784 173.722 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -58.12 -34.67 70.47 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 123.544 0.738 . . . . 0.0 110.529 174.711 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 2.8 t -76.47 -40.52 34.53 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.299 0 CA-C-O 118.284 -0.865 . . . . 0.0 109.96 -178.912 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 61.9 m-85 -56.47 -47.27 79.55 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-N 120.122 1.328 . . . . 0.0 109.538 171.4 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 86.7 mtt180 -62.99 -43.16 99.55 Favored 'General case' 0 N--CA 1.466 0.351 0 C-N-CA 122.982 0.513 . . . . 0.0 110.972 179.43 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 6.9 m -64.25 -50.12 69.19 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 124.266 1.027 . . . . 0.0 109.955 179.347 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 75.8 t -68.68 -37.46 77.59 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.365 0 CA-C-N 118.796 0.725 . . . . 0.0 109.056 -173.564 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 46.1 ttp85 -58.22 -44.39 88.17 Favored 'General case' 0 CA--C 1.538 0.483 0 CA-C-N 119.117 0.871 . . . . 0.0 110.329 174.706 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -64.83 -50.24 59.34 Favored Glycine 0 CA--C 1.531 1.07 0 CA-C-N 118.543 0.611 . . . . 0.0 112.204 176.137 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 39.1 mm-40 -58.02 -50.99 71.51 Favored 'General case' 0 N--CA 1.465 0.324 0 C-N-CA 124.213 1.005 . . . . 0.0 110.278 -177.838 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 98.3 t -67.56 -38.38 80.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-O 118.211 -0.899 . . . . 0.0 110.344 -174.054 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 57.1 tttm -55.0 -44.75 74.8 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 119.451 1.023 . . . . 0.0 109.338 175.551 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -68.48 -43.33 77.16 Favored 'General case' 0 N--CA 1.447 -0.621 0 CA-C-O 119.053 -0.498 . . . . 0.0 111.293 -176.204 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 1.8 mmt-85 -60.34 -46.83 88.51 Favored 'General case' 0 N--CA 1.476 0.841 0 CA-C-N 119.363 0.983 . . . . 0.0 110.604 176.262 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 98.4 t -69.41 -38.57 77.43 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.487 0 N-CA-C 109.101 -0.703 . . . . 0.0 109.101 -177.172 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 15.3 mt-10 -60.38 -45.63 92.86 Favored 'General case' 0 CA--C 1.52 -0.202 0 CA-C-N 119.884 1.22 . . . . 0.0 110.122 175.022 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 29.4 t-20 -62.53 -41.51 98.91 Favored 'General case' 0 CA--C 1.531 0.223 0 C-N-CA 123.25 0.62 . . . . 0.0 110.712 -179.85 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 58.7 tp -60.78 -48.45 81.73 Favored 'General case' 0 N--CA 1.456 -0.148 0 C-N-CA 123.819 0.848 . . . . 0.0 111.261 176.424 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 76.1 mt -63.49 -45.72 97.09 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.292 0 N-CA-C 107.646 -1.242 . . . . 0.0 107.646 179.91 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -59.19 -28.31 66.51 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 123.135 0.574 . . . . 0.0 112.405 177.009 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 72.3 mttt -71.87 -54.22 10.77 Favored 'General case' 0 C--N 1.343 0.309 0 CA-C-N 119.129 0.877 . . . . 0.0 110.726 172.772 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 14.1 pt -79.44 -38.43 19.74 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.332 0 N-CA-C 114.667 1.358 . . . . 0.0 114.667 -169.215 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 73.3 m . . . . . 0 C--O 1.253 1.266 0 C-N-CA 125.967 1.707 . . . . 0.0 109.742 -169.982 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.496 1.834 0 N-CA-C 110.234 -0.284 . . . . 0.0 110.234 . . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 34.3 mttm -76.56 117.16 17.92 Favored 'General case' 0 N--CA 1.477 0.883 0 N-CA-C 106.021 -1.844 . . . . 0.0 106.021 172.295 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 88.8 mttt -84.92 135.11 34.2 Favored 'General case' 0 CA--C 1.515 -0.387 0 N-CA-C 107.695 -1.224 . . . . 0.0 107.695 179.47 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 1.8 t -120.81 149.51 23.69 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 C-N-CA 125.9 1.68 . . . . 0.0 109.511 -168.493 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 25.9 mtt -139.57 147.47 41.2 Favored 'General case' 0 C--N 1.324 -0.523 0 C-N-CA 124.534 1.133 . . . . 0.0 109.111 169.27 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 72.0 m-85 -133.06 114.33 13.81 Favored 'General case' 0 CA--C 1.517 -0.32 0 N-CA-C 104.343 -2.465 . . . . 0.0 104.343 172.133 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 2.4 p -151.39 137.2 11.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 118.563 0.62 . . . . 0.0 109.758 -169.352 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 19.9 t -117.24 178.43 4.37 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 126.225 1.81 . . . . 0.0 106.323 169.6 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 39.7 ttpt -55.05 -35.08 64.11 Favored 'General case' 0 N--CA 1.475 0.819 0 O-C-N 121.148 -0.97 . . . . 0.0 111.479 179.638 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 33.3 ptt180 -123.55 160.27 27.38 Favored 'General case' 0 N--CA 1.463 0.212 0 C-N-CA 124.868 1.267 . . . . 0.0 108.294 169.628 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 47.6 t30 -71.75 -42.66 66.97 Favored 'General case' 0 N--CA 1.471 0.578 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 170.864 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 1.1 m -52.02 141.45 18.07 Favored 'General case' 0 N--CA 1.453 -0.319 0 C-N-CA 125.696 1.598 . . . . 0.0 110.616 -171.331 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 3.9 m 66.91 -66.65 0.18 Allowed 'General case' 0 C--N 1.327 -0.383 0 C-N-CA 126.315 1.846 . . . . 0.0 114.525 -173.459 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 8.9 tpp180 -82.78 -46.93 12.51 Favored 'General case' 0 N--CA 1.471 0.576 0 N-CA-C 116.464 2.024 . . . . 0.0 116.464 -167.59 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 3.6 m -89.78 4.69 48.95 Favored 'General case' 0 N--CA 1.471 0.596 0 N-CA-C 114.81 1.411 . . . . 0.0 114.81 -169.051 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 28.2 pt20 -68.83 -47.64 65.54 Favored 'General case' 0 C--O 1.224 -0.289 0 O-C-N 120.959 -1.088 . . . . 0.0 113.364 -171.035 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 2.4 tpt -88.06 -34.63 17.9 Favored 'General case' 0 N--CA 1.47 0.527 0 N-CA-C 113.659 0.985 . . . . 0.0 113.659 -169.309 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -61.03 -44.95 96.64 Favored 'General case' 0 N--CA 1.471 0.605 0 N-CA-C 112.88 0.696 . . . . 0.0 112.88 -169.082 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . 0.417 ' CD ' ' HZ2' ' A' ' 23' ' ' LYS . 1.9 pp20? -64.96 -34.51 78.59 Favored 'General case' 0 N--CA 1.464 0.255 0 O-C-N 121.96 -0.463 . . . . 0.0 109.834 176.522 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -52.11 -56.47 16.64 Favored Glycine 0 C--N 1.34 0.753 0 C-N-CA 125.182 1.372 . . . . 0.0 110.623 175.539 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 13.5 m-85 -68.52 -29.89 68.58 Favored 'General case' 0 CA--C 1.508 -0.657 0 O-C-N 121.521 -0.987 . . . . 0.0 112.512 -179.964 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -69.73 -31.93 70.19 Favored 'General case' 0 N--CA 1.452 -0.341 0 CA-C-N 119.52 1.055 . . . . 0.0 111.603 -174.766 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.417 ' HZ2' ' CD ' ' A' ' 19' ' ' GLU . 0.4 OUTLIER -68.19 -25.56 65.3 Favored 'General case' 0 N--CA 1.474 0.758 0 CA-C-N 119.541 1.064 . . . . 0.0 111.651 172.566 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 3.2 m -82.42 -56.46 3.87 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 124.959 1.304 . . . . 0.0 110.139 -177.592 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 70.7 mt -75.33 -36.42 61.05 Favored 'General case' 0 C--N 1.331 -0.215 0 C-N-CA 124.298 1.039 . . . . 0.0 110.055 -173.83 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -89.96 6.12 82.92 Favored Glycine 0 C--N 1.339 0.715 0 C-N-CA 124.855 1.217 . . . . 0.0 113.152 -177.017 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -50.74 125.28 12.86 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 124.739 1.215 . . . . 0.0 110.321 -175.635 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 76.54 -5.41 45.38 Favored Glycine 0 CA--C 1.534 1.229 0 CA-C-O 118.782 -1.01 . . . . 0.0 114.437 179.41 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 63.2 mttm -107.5 -51.89 2.84 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-N 119.322 1.561 . . . . 0.0 110.226 -179.762 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 26.1 pt -136.36 147.74 27.66 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.295 0 C-N-CA 123.913 0.885 . . . . 0.0 110.066 -169.31 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -109.89 104.26 13.16 Favored 'General case' 0 N--CA 1.463 0.198 0 C-N-CA 125.082 1.353 . . . . 0.0 108.885 -169.871 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 14.6 p -81.09 142.02 14.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 119.51 1.05 . . . . 0.0 109.192 177.003 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 11.6 m -132.15 -49.63 0.94 Allowed 'General case' 0 N--CA 1.455 -0.212 0 C-N-CA 124.216 1.006 . . . . 0.0 110.22 175.633 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 48.1 m 62.69 -27.03 0.06 Allowed 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 127.439 2.296 . . . . 0.0 117.14 176.49 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 5.6 m 54.37 -135.78 1.4 Allowed 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 124.765 1.226 . . . . 0.0 110.804 169.752 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -172.65 170.25 43.35 Favored Glycine 0 C--N 1.336 0.574 0 N-CA-C 108.331 -1.907 . . . . 0.0 108.331 178.289 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 34.2 mt -118.28 -43.31 2.73 Favored 'General case' 0 N--CA 1.451 -0.398 0 C-N-CA 125.353 1.461 . . . . 0.0 109.084 179.833 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 36.6 mt-10 -140.45 -59.3 0.53 Allowed 'General case' 0 C--O 1.233 0.192 0 N-CA-C 101.687 -3.449 . . . . 0.0 101.687 169.605 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 17.1 m 57.39 177.88 0.05 OUTLIER 'General case' 0 N--CA 1.447 -0.582 0 C-N-CA 127.291 2.236 . . . . 0.0 116.702 167.263 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 4.4 m -162.51 175.38 11.52 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 128.233 2.613 . . . . 0.0 106.089 -169.491 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 11.4 ptt180 -91.72 174.08 7.54 Favored 'General case' 0 N--CA 1.469 0.503 0 O-C-N 121.022 -1.049 . . . . 0.0 109.607 178.618 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 15.9 m -74.94 176.11 0.67 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.64 0 C-N-CA 123.701 0.8 . . . . 0.0 111.219 -176.415 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 26.0 m-70 -88.02 152.2 50.47 Favored Pre-proline 0 CA--C 1.54 0.596 0 C-N-CA 123.8 0.84 . . . . 0.0 109.995 -175.999 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -63.47 -47.29 7.79 Favored 'Trans proline' 0 C--N 1.347 0.49 0 C-N-CA 122.956 2.438 . . . . 0.0 112.612 -172.636 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 4.4 m -68.21 -25.83 65.41 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-O 119.247 -0.406 . . . . 0.0 110.3 -178.391 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -56.91 -53.4 58.37 Favored 'General case' 0 CA--C 1.51 -0.595 0 N-CA-C 108.99 -0.744 . . . . 0.0 108.99 175.048 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 63.9 mt -60.51 -38.09 76.99 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 N-CA-C 109.054 -0.721 . . . . 0.0 109.054 -172.562 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -63.86 -46.74 83.63 Favored 'General case' 0 CA--C 1.536 0.425 0 CA-C-N 119.041 0.837 . . . . 0.0 111.007 179.869 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 37.6 mmt -71.18 -34.7 71.16 Favored 'General case' 0 CA--C 1.539 0.523 0 CA-C-O 123.546 1.641 . . . . 0.0 110.366 -178.376 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -74.82 -31.61 61.73 Favored 'General case' 0 N--CA 1.443 -0.825 0 N-CA-C 106.886 -1.524 . . . . 0.0 106.886 -177.796 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 -70.76 -20.41 62.63 Favored 'General case' 0 N--CA 1.45 -0.453 0 C-N-CA 124.347 1.059 . . . . 0.0 110.305 169.661 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 77.3 mt-10 -62.55 -38.76 91.28 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-N 119.958 1.254 . . . . 0.0 109.306 169.244 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 17.1 m -86.92 10.25 1.6 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.724 0 N-CA-C 113.168 0.803 . . . . 0.0 113.168 169.933 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 70.55 15.48 73.17 Favored Glycine 0 CA--C 1.532 1.114 0 C-N-CA 124.621 1.105 . . . . 0.0 113.803 177.115 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 4.8 mt -91.6 143.54 11.08 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.259 0 C-N-CA 124.425 1.09 . . . . 0.0 111.372 -172.707 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 3.4 t70 -90.84 131.84 36.24 Favored 'General case' 0 C--O 1.234 0.247 0 C-N-CA 126.04 1.736 . . . . 0.0 108.851 169.352 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 7.2 pt -140.41 -27.03 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.874 0 C-N-CA 124.661 1.184 . . . . 0.0 110.371 168.863 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -38.78 138.26 0.55 Allowed 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 128.31 2.644 . . . . 0.0 111.453 168.964 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 62.72 34.67 90.34 Favored Glycine 0 CA--C 1.533 1.21 0 CA-C-O 119.661 -0.522 . . . . 0.0 112.655 175.002 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 5.4 tt0 -57.24 -35.74 70.07 Favored 'General case' 0 C--N 1.344 0.346 0 C-N-CA 123.781 0.832 . . . . 0.0 112.83 -175.422 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -69.07 139.34 54.84 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 124.56 1.144 . . . . 0.0 110.518 -169.611 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 9.9 p -141.43 -67.78 0.4 Allowed 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 123.605 0.762 . . . . 0.0 110.624 -170.622 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -147.33 155.93 46.17 Favored Pre-proline 0 C--O 1.239 0.513 0 C-N-CA 125.484 1.513 . . . . 0.0 108.798 -176.852 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -66.06 152.54 81.03 Favored 'Trans proline' 0 N--CA 1.455 -0.782 0 C-N-CA 121.991 1.794 . . . . 0.0 109.617 171.224 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 3.8 tt -62.58 -23.57 32.92 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.545 0 C-N-CA 123.745 0.818 . . . . 0.0 110.811 -177.626 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 24.0 tt0 -67.7 -25.08 65.49 Favored 'General case' 0 N--CA 1.438 -1.075 0 C-N-CA 126.546 1.938 . . . . 0.0 110.658 -179.111 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 9.0 t-20 -63.43 -23.64 67.49 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 124.567 1.147 . . . . 0.0 112.103 176.385 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 40.5 m-85 -106.03 -168.39 1.43 Allowed 'General case' 0 C--O 1.236 0.363 0 C-N-CA 126.573 1.949 . . . . 0.0 109.305 -176.394 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 55.5 t-20 -139.44 139.74 37.13 Favored 'General case' 0 N--CA 1.447 -0.616 0 N-CA-C 106.836 -1.542 . . . . 0.0 106.836 169.251 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -71.45 -25.31 62.25 Favored 'General case' 0 N--CA 1.434 -1.236 0 C-N-CA 119.749 -0.78 . . . . 0.0 109.516 -178.821 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 35.5 t70 -64.8 -24.84 67.68 Favored 'General case' 0 N--CA 1.445 -0.686 0 O-C-N 123.505 0.503 . . . . 0.0 112.022 -179.575 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -78.05 -29.01 49.08 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 123.38 0.672 . . . . 0.0 111.426 174.411 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 13.1 m-85 -79.24 166.06 22.57 Favored 'General case' 0 N--CA 1.451 -0.394 0 C-N-CA 125.582 1.553 . . . . 0.0 111.126 178.855 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -118.25 -34.41 4.09 Favored 'General case' 0 N--CA 1.466 0.348 0 C-N-CA 123.022 0.529 . . . . 0.0 111.446 -179.985 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -143.35 136.02 24.57 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.595 0 CA-C-O 121.865 0.841 . . . . 0.0 110.234 -172.151 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 98.9 t -144.02 126.36 11.17 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.593 0 N-CA-C 106.249 -1.76 . . . . 0.0 106.249 -178.583 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 12.6 mm -104.6 124.37 59.13 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.521 0 N-CA-C 105.846 -1.909 . . . . 0.0 105.846 176.108 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 37.0 m -93.46 98.25 11.08 Favored 'General case' 0 N--CA 1.443 -0.807 0 N-CA-C 105.057 -2.201 . . . . 0.0 105.057 169.576 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 85.8 mt -68.54 -2.97 10.03 Favored 'General case' 0 N--CA 1.467 0.391 0 O-C-N 121.51 -0.744 . . . . 0.0 112.283 -176.709 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 64.0 m -138.65 128.4 24.99 Favored 'General case' 0 N--CA 1.443 -0.812 0 N-CA-C 106.134 -1.802 . . . . 0.0 106.134 169.397 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 50.71 -144.4 11.96 Favored Glycine 0 CA--C 1.532 1.133 0 C-N-CA 125.272 1.415 . . . . 0.0 113.515 173.425 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 16.2 m -112.23 -111.52 0.34 Allowed 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 124.652 1.181 . . . . 0.0 107.993 178.832 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -80.61 69.37 3.2 Favored Glycine 0 CA--C 1.527 0.83 0 N-CA-C 109.682 -1.367 . . . . 0.0 109.682 171.087 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 1.3 m -60.04 -50.51 79.9 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.598 0 CA-C-N 117.528 0.664 . . . . 0.0 111.688 -171.689 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 1.5 t30 -154.69 52.48 0.64 Allowed 'General case' 0 N--CA 1.467 0.404 0 N-CA-C 103.845 -2.65 . . . . 0.0 103.845 169.327 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -147.42 139.6 14.09 Favored Pre-proline 0 CA--C 1.536 0.442 0 C-N-CA 125.622 1.569 . . . . 0.0 108.297 -168.36 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -65.96 144.21 75.6 Favored 'Trans proline' 0 C--N 1.351 0.692 0 C-N-CA 121.338 1.358 . . . . 0.0 112.577 -174.669 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_endo -66.48 -26.09 47.71 Favored 'Trans proline' 0 N--CA 1.461 -0.405 0 C-N-CA 122.314 2.009 . . . . 0.0 113.242 -169.848 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 -55.91 -22.46 25.96 Favored 'General case' 0 CA--C 1.537 0.474 0 CA-C-N 118.898 0.772 . . . . 0.0 111.926 178.426 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 85.5 m95 -74.67 -43.64 54.24 Favored 'General case' 0 N--CA 1.445 -0.687 0 C-N-CA 123.504 0.722 . . . . 0.0 112.179 -179.339 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 15.2 m -70.46 -32.98 51.84 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.438 0 CA-C-O 118.398 -0.81 . . . . 0.0 110.109 176.854 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 82.3 p -82.06 29.83 0.4 Allowed 'General case' 0 CA--C 1.538 0.504 0 CA-C-N 120.23 1.377 . . . . 0.0 114.019 -170.01 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 93.0 mm-40 -79.09 -173.78 3.76 Favored 'General case' 0 CA--C 1.539 0.52 0 O-C-N 121.731 -0.605 . . . . 0.0 110.543 172.107 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 29.0 mm-40 -65.04 -14.71 61.12 Favored 'General case' 0 CA--C 1.54 0.577 0 N-CA-C 112.531 0.567 . . . . 0.0 112.531 -169.757 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 6.4 tt -143.72 137.36 24.74 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.496 0 C-N-CA 125.664 1.586 . . . . 0.0 107.177 170.934 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 16.2 t80 -116.98 132.32 56.73 Favored 'General case' 0 CA--C 1.535 0.399 0 N-CA-C 105.385 -2.08 . . . . 0.0 105.385 169.381 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 11.6 mm-40 -142.13 162.83 34.49 Favored 'General case' 0 C--O 1.237 0.418 0 C-N-CA 124.546 1.139 . . . . 0.0 108.522 176.288 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 3.0 t70 -173.96 127.9 0.38 Allowed 'General case' 0 C--O 1.236 0.393 0 C-N-CA 127.11 2.164 . . . . 0.0 107.758 -169.255 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 5.4 m0 -148.65 142.58 25.79 Favored 'General case' 0 N--CA 1.456 -0.133 0 C-N-CA 123.571 0.749 . . . . 0.0 109.019 -170.488 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 86.4 mt-30 -84.21 83.24 8.04 Favored 'General case' 0 CA--C 1.533 0.3 0 N-CA-C 108.399 -0.963 . . . . 0.0 108.399 174.46 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 9.6 mp -67.42 129.05 38.67 Favored 'General case' 0 N--CA 1.466 0.352 0 N-CA-C 106.148 -1.797 . . . . 0.0 106.148 171.132 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 32.4 mt-10 -71.29 -20.83 62.16 Favored 'General case' 0 CA--C 1.536 0.417 0 N-CA-C 113.563 0.949 . . . . 0.0 113.563 -169.279 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 1.6 t70 62.29 124.09 0.02 OUTLIER Pre-proline 0 CA--C 1.552 1.047 0 C-N-CA 127.039 2.136 . . . . 0.0 114.212 -179.7 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 23.7 Cg_endo -88.48 -3.67 6.64 Favored 'Trans proline' 0 N--CA 1.454 -0.809 0 C-N-CA 122.689 2.259 . . . . 0.0 114.488 -178.93 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -53.42 126.51 21.61 Favored 'General case' 0 C--O 1.238 0.457 0 CA-C-N 120.793 1.633 . . . . 0.0 111.152 -172.374 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 71.74 -1.64 28.98 Favored Glycine 0 CA--C 1.534 1.271 0 CA-C-O 118.918 -0.934 . . . . 0.0 113.729 177.238 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 8.2 mt-30 -89.7 171.51 9.6 Favored 'General case' 0 CA--C 1.543 0.689 0 CA-C-N 118.807 1.304 . . . . 0.0 109.159 174.796 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 15.6 m -69.11 163.52 24.61 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 123.658 0.783 . . . . 0.0 111.063 -179.301 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 43.2 mt -63.88 -26.37 68.58 Favored 'General case' 0 N--CA 1.472 0.638 0 O-C-N 121.231 -0.918 . . . . 0.0 112.019 -175.026 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 5.4 pt-20 -56.41 -34.85 67.15 Favored 'General case' 0 N--CA 1.461 0.12 0 C-N-CA 123.322 0.649 . . . . 0.0 111.26 171.935 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 21.4 t -76.82 -41.77 32.9 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.395 0 CA-C-O 118.28 -0.866 . . . . 0.0 109.066 -178.139 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 61.8 m-85 -55.02 -49.6 71.15 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-N 120.002 1.274 . . . . 0.0 109.66 170.384 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 96.2 mtt180 -67.67 -33.14 74.34 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 123.056 0.542 . . . . 0.0 111.214 -175.778 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 3.2 m -65.55 -50.16 66.19 Favored 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 124.222 1.009 . . . . 0.0 109.712 170.977 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 90.1 t -70.25 -26.9 30.24 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.309 0 CA-C-O 118.426 -0.797 . . . . 0.0 109.109 -171.442 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 20.5 mtm105 -56.5 -50.15 72.63 Favored 'General case' 0 C--O 1.223 -0.309 0 CA-C-N 119.462 1.028 . . . . 0.0 109.239 169.569 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -62.09 -46.59 93.7 Favored Glycine 0 CA--C 1.528 0.884 0 CA-C-O 119.539 -0.59 . . . . 0.0 111.898 178.676 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 89.8 mt-30 -57.14 -51.69 68.28 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-N 117.854 0.827 . . . . 0.0 110.268 -179.784 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 95.9 t -68.68 -42.35 83.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-O 118.445 -0.788 . . . . 0.0 109.615 -175.574 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -54.51 -47.24 73.31 Favored 'General case' 0 C--O 1.223 -0.341 0 N-CA-C 108.62 -0.881 . . . . 0.0 108.62 178.355 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 39.9 tt0 -64.91 -42.49 94.7 Favored 'General case' 0 N--CA 1.449 -0.523 0 C-N-CA 122.953 0.501 . . . . 0.0 111.325 -176.358 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 44.4 mtt-85 -65.64 -45.61 82.35 Favored 'General case' 0 N--CA 1.469 0.485 0 O-C-N 121.302 -0.874 . . . . 0.0 111.766 177.19 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 61.3 t -64.94 -37.23 79.7 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.723 0 N-CA-C 109.143 -0.688 . . . . 0.0 109.143 178.092 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 20.9 mt-10 -60.66 -44.58 96.28 Favored 'General case' 0 C--O 1.226 -0.182 0 O-C-N 120.743 -1.223 . . . . 0.0 109.857 174.911 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 27.8 t-20 -65.12 -40.54 94.63 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 123.021 0.528 . . . . 0.0 111.054 -177.925 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 29.3 tp -58.7 -49.58 77.07 Favored 'General case' 0 CA--C 1.53 0.195 0 C-N-CA 124.864 1.266 . . . . 0.0 110.85 173.292 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 63.6 mt -64.72 -46.66 91.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 N-CA-C 107.925 -1.139 . . . . 0.0 107.925 -177.969 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -58.17 -31.82 67.63 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 123.436 0.695 . . . . 0.0 112.109 -178.882 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . 0.258 18.5 ptpt -82.51 -37.89 24.61 Favored 'General case' 0 C--N 1.344 0.341 0 CA-C-O 117.782 -1.104 . . . . 0.0 112.512 177.099 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 12.1 pt -84.08 -38.74 14.15 Favored 'Isoleucine or valine' 0 C--O 1.236 0.35 0 CA-C-N 120.373 1.442 . . . . 0.0 113.967 -176.261 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 68.2 m . . . . . 0 C--O 1.252 1.219 0 C-N-CA 125.644 1.578 . . . . 0.0 110.141 -169.876 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.498 1.964 0 N-CA-C 110.583 -0.155 . . . . 0.0 110.583 . . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 26.1 mttm -79.77 117.48 20.7 Favored 'General case' 0 N--CA 1.474 0.749 0 N-CA-C 105.71 -1.959 . . . . 0.0 105.71 171.53 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 85.0 mttt -81.84 143.4 31.76 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-N 119.935 1.243 . . . . 0.0 108.499 176.904 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 2.2 t -132.54 145.07 35.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 O-C-N 124.347 1.029 . . . . 0.0 111.058 -169.341 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 12.4 mtt -137.06 145.33 43.85 Favored 'General case' 0 C--N 1.329 -0.291 0 C-N-CA 125.327 1.451 . . . . 0.0 108.957 168.48 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 54.5 m-85 -133.91 117.46 16.8 Favored 'General case' 0 CA--C 1.518 -0.281 0 N-CA-C 104.903 -2.258 . . . . 0.0 104.903 169.915 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 2.2 p -151.67 155.26 7.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-O 121.248 0.547 . . . . 0.0 109.842 -168.848 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 39.9 t -140.94 159.32 42.45 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 105.119 -2.178 . . . . 0.0 105.119 169.266 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 64.8 pttt -56.68 143.92 34.37 Favored 'General case' 0 N--CA 1.467 0.394 0 N-CA-C 109.036 -0.727 . . . . 0.0 109.036 171.838 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 96.6 mtt180 51.44 73.9 0.28 Allowed 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 124.665 1.186 . . . . 0.0 110.136 -169.824 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 10.4 t30 -31.63 -46.41 0.11 Allowed 'General case' 0 N--CA 1.482 1.141 0 C-N-CA 127.523 2.329 . . . . 0.0 115.33 -172.4 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 2.1 m -50.96 -37.79 46.71 Favored 'General case' 0 N--CA 1.45 -0.447 0 C-N-CA 124.164 0.985 . . . . 0.0 111.419 -175.515 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 21.9 m -72.17 122.15 20.52 Favored 'General case' 0 N--CA 1.449 -0.51 0 CA-C-N 119.094 0.861 . . . . 0.0 109.767 173.906 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . 0.334 0.1 OUTLIER 56.01 -24.02 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 130.914 3.686 . . . . 0.0 117.248 177.182 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -74.92 -11.53 60.15 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-N 121.102 1.774 . . . . 0.0 111.417 175.416 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 25.2 pt20 -75.04 30.47 0.09 Allowed 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 125.756 1.622 . . . . 0.0 113.725 174.856 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' MET . . . . . 0.425 ' SD ' ' CD2' ' A' ' 21' ' ' PHE . 0.0 OUTLIER -152.62 -54.24 0.12 Allowed 'General case' 0 C--N 1.329 -0.284 0 O-C-N 120.29 -1.506 . . . . 0.0 112.06 174.837 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -59.44 -47.77 84.21 Favored 'General case' 0 N--CA 1.474 0.725 0 N-CA-C 114.313 1.227 . . . . 0.0 114.313 -169.009 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -65.05 -30.99 71.99 Favored 'General case' 0 N--CA 1.463 0.182 0 O-C-N 121.88 -0.512 . . . . 0.0 110.058 177.7 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -55.15 -59.13 10.93 Favored Glycine 0 C--N 1.337 0.605 0 C-N-CA 125.312 1.434 . . . . 0.0 110.588 173.222 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . 0.425 ' CD2' ' SD ' ' A' ' 17' ' ' MET . 3.3 m-85 -61.98 -32.54 73.0 Favored 'General case' 0 CA--C 1.511 -0.532 0 CA-C-N 118.377 1.088 . . . . 0.0 112.906 175.806 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -63.91 -36.47 84.05 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 119.146 0.884 . . . . 0.0 111.123 -172.418 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -69.03 -24.43 64.19 Favored 'General case' 0 N--CA 1.47 0.571 0 CA-C-N 119.164 0.893 . . . . 0.0 112.274 176.803 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 1.5 m -80.15 -53.22 6.89 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 125.305 1.442 . . . . 0.0 110.45 177.733 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 80.9 mt -74.24 -37.82 63.68 Favored 'General case' 0 N--CA 1.464 0.249 0 C-N-CA 123.648 0.779 . . . . 0.0 110.266 -173.124 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -96.39 14.07 64.81 Favored Glycine 0 CA--C 1.527 0.815 0 C-N-CA 125.175 1.369 . . . . 0.0 112.98 -176.767 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -51.52 123.57 10.18 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 124.743 1.217 . . . . 0.0 110.49 -174.809 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 76.11 -7.89 26.97 Favored Glycine 0 CA--C 1.536 1.356 0 C-N-CA 124.293 0.949 . . . . 0.0 114.382 179.797 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 62.9 mttm -97.62 -49.19 4.96 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-N 119.283 1.541 . . . . 0.0 110.298 179.854 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 17.1 pt -137.28 152.52 27.83 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.328 0 C-N-CA 124.137 0.975 . . . . 0.0 110.067 -169.264 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -112.02 98.66 7.5 Favored 'General case' 0 CA--C 1.521 -0.153 0 C-N-CA 124.584 1.153 . . . . 0.0 109.187 -169.738 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 13.0 p -87.8 134.4 28.0 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.487 0 O-C-N 121.823 -0.548 . . . . 0.0 109.666 178.966 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 20.1 m -150.51 92.45 1.85 Allowed 'General case' 0 N--CA 1.456 -0.143 0 N-CA-C 105.19 -2.152 . . . . 0.0 105.19 172.413 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 53.4 m -95.49 87.01 4.63 Favored 'General case' 0 C--O 1.237 0.396 0 C-N-CA 120.066 -0.654 . . . . 0.0 110.63 -170.057 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 58.8 m -61.19 165.85 4.14 Favored 'General case' 0 CA--C 1.539 0.522 0 CA-C-N 115.322 -0.854 . . . . 0.0 110.07 169.018 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -138.96 -173.84 13.18 Favored Glycine 0 CA--C 1.525 0.702 0 N-CA-C 106.807 -2.517 . . . . 0.0 106.807 -177.721 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 6.4 mt -123.71 -83.51 0.65 Allowed 'General case' 0 N--CA 1.45 -0.465 0 C-N-CA 124.298 1.039 . . . . 0.0 109.048 -169.952 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 3.3 tt0 -69.02 -27.17 65.44 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 122.823 0.449 . . . . 0.0 111.574 176.673 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 1.3 m -144.18 179.45 7.21 Favored 'General case' 0 N--CA 1.463 0.176 0 C-N-CA 126.187 1.795 . . . . 0.0 107.747 177.032 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 3.7 m -166.05 -18.66 0.02 OUTLIER 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 125.301 1.44 . . . . 0.0 112.145 -169.725 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 7.8 ttt180 -100.37 -162.1 0.92 Allowed 'General case' 0 N--CA 1.473 0.709 0 CA-C-N 119.637 1.108 . . . . 0.0 110.207 176.046 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 27.4 m -134.95 173.68 14.1 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.449 0 C-N-CA 125.421 1.489 . . . . 0.0 111.376 -169.988 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 96.7 m-70 -83.65 156.45 65.01 Favored Pre-proline 0 CA--C 1.543 0.698 0 C-N-CA 124.804 1.242 . . . . 0.0 110.299 173.816 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -62.16 -51.47 3.58 Favored 'Trans proline' 0 C--N 1.349 0.575 0 C-N-CA 123.845 3.03 . . . . 0.0 113.426 -173.425 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 6.8 m -65.85 -24.95 66.99 Favored 'General case' 0 CA--C 1.534 0.328 0 O-C-N 121.902 -0.499 . . . . 0.0 110.936 -172.845 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -55.52 -53.31 57.95 Favored 'General case' 0 CA--C 1.508 -0.672 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 173.261 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 69.8 mt -59.83 -40.71 83.43 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.369 0 N-CA-C 108.475 -0.935 . . . . 0.0 108.475 -170.352 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -62.75 -46.76 86.58 Favored 'General case' 0 N--CA 1.449 -0.518 0 CA-C-N 118.488 0.586 . . . . 0.0 111.004 179.924 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 27.9 mmt -67.64 -39.78 84.61 Favored 'General case' 0 C--O 1.238 0.473 0 CA-C-O 122.789 1.281 . . . . 0.0 110.839 -178.65 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 1.2 mmt -74.31 -35.2 63.66 Favored 'General case' 0 N--CA 1.444 -0.772 0 N-CA-C 106.711 -1.588 . . . . 0.0 106.711 -174.875 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 41.7 tt0 -69.98 -23.94 63.24 Favored 'General case' 0 N--CA 1.447 -0.583 0 O-C-N 121.179 -0.951 . . . . 0.0 110.219 173.672 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 10.2 mm-40 -65.74 -29.49 70.01 Favored 'General case' 0 N--CA 1.452 -0.341 0 CA-C-N 118.762 0.71 . . . . 0.0 110.241 173.251 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . 0.29 9.0 m -98.22 16.95 2.85 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.858 0 N-CA-C 112.758 0.651 . . . . 0.0 112.758 169.35 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 84.33 16.21 67.27 Favored Glycine 0 CA--C 1.534 1.275 0 C-N-CA 125.366 1.46 . . . . 0.0 114.636 169.935 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 8.2 mm -97.52 151.59 4.25 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.329 0 C-N-CA 124.736 1.214 . . . . 0.0 111.121 -170.52 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -112.52 126.95 55.89 Favored 'General case' 0 C--O 1.233 0.189 0 N-CA-C 106.051 -1.833 . . . . 0.0 106.051 168.222 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 3.6 pt -128.93 -24.51 1.24 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.481 0 C-N-CA 125.751 1.62 . . . . 0.0 110.353 170.312 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -39.51 -40.38 0.84 Allowed 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 128.177 2.591 . . . . 0.0 112.789 169.163 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -91.24 19.62 45.63 Favored Glycine 0 CA--C 1.531 1.069 0 C-N-CA 125.446 1.498 . . . . 0.0 113.763 -179.166 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 21.2 mt-30 -61.84 -27.62 68.91 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-N 120.152 1.976 . . . . 0.0 112.84 179.78 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -61.92 129.39 40.72 Favored 'General case' 0 N--CA 1.445 -0.678 0 N-CA-C 109.683 -0.488 . . . . 0.0 109.683 -171.562 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 8.5 p -141.61 -70.44 0.36 Allowed 'General case' 0 C--O 1.235 0.31 0 C-N-CA 123.817 0.847 . . . . 0.0 109.452 -173.269 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -157.66 161.34 29.26 Favored Pre-proline 0 CA--C 1.552 1.037 0 C-N-CA 124.952 1.301 . . . . 0.0 109.913 -174.66 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -67.84 28.92 0.13 Allowed 'Trans proline' 0 CA--C 1.552 1.381 0 C-N-CA 125.247 3.964 . . . . 0.0 116.694 173.126 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . 0.256 1.1 tt 64.43 -26.21 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.541 0.619 0 C-N-CA 129.529 3.132 . . . . 0.0 113.989 -169.583 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -68.79 -30.19 68.72 Favored 'General case' 0 N--CA 1.429 -1.516 0 C-N-CA 128.005 2.522 . . . . 0.0 115.407 -169.304 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 26.0 m-80 -68.72 -17.44 64.06 Favored 'General case' 0 C--O 1.236 0.35 0 CA-C-N 118.359 0.527 . . . . 0.0 112.192 -176.419 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 69.8 m-85 -104.76 160.98 14.55 Favored 'General case' 0 CA--C 1.513 -0.447 0 C-N-CA 124.726 1.211 . . . . 0.0 112.015 -176.854 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 48.1 t-20 -95.65 134.13 38.92 Favored 'General case' 0 N--CA 1.439 -0.989 0 N-CA-C 106.107 -1.812 . . . . 0.0 106.107 168.156 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -72.57 -27.67 62.34 Favored 'General case' 0 N--CA 1.436 -1.172 0 N-CA-C 108.845 -0.798 . . . . 0.0 108.845 179.629 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 36.6 t70 -67.0 -21.04 65.97 Favored 'General case' 0 N--CA 1.447 -0.585 0 N-CA-C 111.73 0.27 . . . . 0.0 111.73 -179.168 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 35.7 t70 -72.63 -29.24 63.3 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 122.974 0.509 . . . . 0.0 111.611 175.782 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 17.2 m-85 -77.27 144.51 38.1 Favored 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 123.981 0.912 . . . . 0.0 110.316 179.18 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -93.93 -32.1 14.02 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.724 177.555 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 21.7 t -137.34 130.8 44.15 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.467 0 C-N-CA 123.824 0.85 . . . . 0.0 109.841 -171.307 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 53.7 t -145.48 139.58 21.84 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.419 0 N-CA-C 106.28 -1.748 . . . . 0.0 106.28 174.851 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 36.6 mm -130.63 123.62 55.26 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.537 0 N-CA-C 107.238 -1.393 . . . . 0.0 107.238 -169.859 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 55.3 m -90.49 115.37 27.59 Favored 'General case' 0 N--CA 1.444 -0.732 0 N-CA-C 106.562 -1.644 . . . . 0.0 106.562 169.225 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 68.7 mt -77.72 -7.54 56.66 Favored 'General case' 0 C--N 1.332 -0.191 0 C-N-CA 123.769 0.827 . . . . 0.0 111.418 179.88 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 31.9 p -139.72 132.75 29.5 Favored 'General case' 0 N--CA 1.443 -0.817 0 N-CA-C 106.81 -1.552 . . . . 0.0 106.81 169.632 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 50.68 -155.85 2.84 Favored Glycine 0 CA--C 1.539 1.547 0 C-N-CA 125.579 1.561 . . . . 0.0 115.713 170.067 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 17.4 m -134.52 139.24 45.29 Favored 'General case' 0 C--O 1.235 0.306 0 C-N-CA 125.897 1.679 . . . . 0.0 107.153 177.232 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 74.36 -75.44 1.18 Allowed Glycine 0 C--N 1.335 0.517 0 N-CA-C 110.324 -1.11 . . . . 0.0 110.324 -174.28 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . 0.299 34.7 m 48.12 36.22 0.27 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.792 0 C-N-CA 125.973 1.709 . . . . 0.0 113.401 176.647 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 10.6 t-20 69.99 -0.15 2.86 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 127.679 2.392 . . . . 0.0 113.318 179.061 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -77.03 148.09 78.01 Favored Pre-proline 0 CA--C 1.548 0.882 0 N-CA-C 107.749 -1.204 . . . . 0.0 107.749 169.524 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 34.1 Cg_exo -65.99 142.17 67.38 Favored 'Trans proline' 0 CA--C 1.544 1.013 0 C-N-CA 121.452 1.435 . . . . 0.0 113.0 -174.165 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -67.33 -20.17 49.03 Favored 'Trans proline' 0 C--N 1.344 0.336 0 C-N-CA 123.379 2.719 . . . . 0.0 114.267 -170.592 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 5.4 pm0 -63.04 -18.77 63.71 Favored 'General case' 0 CA--C 1.54 0.562 0 CA-C-N 121.371 1.896 . . . . 0.0 111.547 174.75 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 97.8 m95 -88.33 -5.93 58.03 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 125.414 1.486 . . . . 0.0 112.799 173.728 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 39.9 t -94.23 -9.03 9.66 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.62 0 C-N-CA 124.769 1.228 . . . . 0.0 109.137 173.325 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 73.3 p -119.77 36.94 4.34 Favored 'General case' 0 C--O 1.237 0.404 0 N-CA-C 116.134 1.901 . . . . 0.0 116.134 -169.305 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 12.2 mp0 -71.42 173.71 7.53 Favored 'General case' 0 CA--C 1.535 0.384 0 O-C-N 121.718 -0.614 . . . . 0.0 111.568 173.852 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 33.9 mm-40 -59.93 -28.81 67.93 Favored 'General case' 0 CA--C 1.536 0.432 0 N-CA-C 109.807 -0.442 . . . . 0.0 109.807 177.012 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 4.3 tt -133.62 116.98 25.65 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.56 0 N-CA-C 105.489 -2.041 . . . . 0.0 105.489 168.729 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 62.1 t80 -108.98 145.3 35.73 Favored 'General case' 0 C--O 1.237 0.443 0 N-CA-C 104.534 -2.395 . . . . 0.0 104.534 168.28 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 21.7 mm-40 -134.86 139.74 45.28 Favored 'General case' 0 C--O 1.236 0.379 0 CA-C-N 119.161 0.891 . . . . 0.0 108.691 169.859 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -106.93 113.29 26.69 Favored 'General case' 0 C--O 1.239 0.551 0 N-CA-C 105.609 -1.997 . . . . 0.0 105.609 169.883 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 9.2 m95 -117.47 166.52 12.24 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 124.405 1.082 . . . . 0.0 108.118 169.756 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 24.0 mm-40 -128.33 78.1 1.81 Allowed 'General case' 0 CA--C 1.534 0.36 0 N-CA-C 107.257 -1.386 . . . . 0.0 107.257 174.326 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -77.04 148.46 36.15 Favored 'General case' 0 N--CA 1.467 0.399 0 N-CA-C 109.192 -0.67 . . . . 0.0 109.192 -179.505 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -81.09 168.25 18.83 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 124.514 1.126 . . . . 0.0 108.724 169.765 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -134.14 133.71 22.18 Favored Pre-proline 0 CA--C 1.534 0.334 0 C-N-CA 124.022 0.929 . . . . 0.0 110.975 178.085 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 40.2 Cg_endo -89.87 -2.41 5.65 Favored 'Trans proline' 0 CA--C 1.539 0.772 0 C-N-CA 122.911 2.407 . . . . 0.0 115.22 -174.349 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 24.4 t70 -60.25 128.32 36.14 Favored 'General case' 0 C--O 1.238 0.484 0 CA-C-N 121.347 1.885 . . . . 0.0 110.357 -177.861 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 72.94 -0.3 46.61 Favored Glycine 0 CA--C 1.533 1.163 0 CA-C-O 119.216 -0.769 . . . . 0.0 113.605 179.474 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 17.1 mm-40 -86.2 172.82 10.23 Favored 'General case' 0 C--O 1.238 0.454 0 CA-C-N 118.65 1.225 . . . . 0.0 109.738 174.335 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 16.0 m -69.17 159.53 32.81 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 123.768 0.827 . . . . 0.0 110.868 171.778 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 33.1 tp -56.61 -30.58 63.41 Favored 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 126.153 1.781 . . . . 0.0 113.071 -176.302 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 6.7 pt-20 -56.49 -34.28 66.79 Favored 'General case' 0 CA--C 1.528 0.106 0 C-N-CA 123.817 0.847 . . . . 0.0 111.331 175.563 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 5.1 t -77.61 -39.81 27.44 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.39 0 CA-C-O 118.125 -0.941 . . . . 0.0 110.414 -174.987 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 63.9 m-85 -56.5 -47.98 78.15 Favored 'General case' 0 N--CA 1.473 0.708 0 CA-C-N 120.368 1.44 . . . . 0.0 109.454 170.152 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 86.3 mtt180 -60.87 -42.69 98.38 Favored 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 123.259 0.624 . . . . 0.0 110.909 179.794 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 6.0 m -67.51 -49.42 63.51 Favored 'General case' 0 N--CA 1.447 -0.595 0 C-N-CA 124.696 1.199 . . . . 0.0 110.311 -179.865 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 73.0 t -68.96 -30.02 45.34 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.234 0 CA-C-O 117.813 -1.089 . . . . 0.0 110.223 -169.787 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 32.5 mtm105 -56.84 -47.1 81.11 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-N 120.011 1.278 . . . . 0.0 110.357 169.89 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -62.94 -49.05 75.63 Favored Glycine 0 CA--C 1.527 0.816 0 CA-C-N 118.438 0.563 . . . . 0.0 111.773 179.272 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 17.5 mt-30 -62.01 -44.18 97.27 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-N 117.698 0.749 . . . . 0.0 110.22 -177.914 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 54.6 t -66.19 -45.15 90.88 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.245 0 CA-C-O 118.183 -0.913 . . . . 0.0 109.684 -177.96 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -52.74 -47.79 67.16 Favored 'General case' 0 CA--C 1.516 -0.361 0 CA-C-N 119.094 0.861 . . . . 0.0 109.013 -177.957 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 39.9 tt0 -62.72 -42.79 99.83 Favored 'General case' 0 N--CA 1.447 -0.584 0 O-C-N 123.569 0.543 . . . . 0.0 111.029 -176.052 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 44.7 mtt-85 -67.06 -41.45 86.42 Favored 'General case' 0 N--CA 1.468 0.455 0 O-C-N 121.381 -0.824 . . . . 0.0 111.57 177.85 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 54.0 t -68.92 -38.46 78.61 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.429 0 N-CA-C 109.372 -0.603 . . . . 0.0 109.372 179.463 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 22.1 mt-10 -60.06 -42.09 93.74 Favored 'General case' 0 C--O 1.226 -0.166 0 O-C-N 121.414 -0.804 . . . . 0.0 110.247 174.923 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 29.1 t-20 -64.56 -45.25 87.88 Favored 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 122.735 0.414 . . . . 0.0 111.145 -179.7 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 2.1 tm? -57.19 -49.28 76.49 Favored 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 124.625 1.17 . . . . 0.0 109.992 175.815 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 75.8 mt -63.21 -47.71 91.0 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.141 0 N-CA-C 108.558 -0.904 . . . . 0.0 108.558 -179.797 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -58.61 -28.74 65.9 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 123.254 0.621 . . . . 0.0 112.411 178.908 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 88.9 mttt -70.18 -55.39 9.46 Favored 'General case' 0 C--O 1.234 0.243 0 CA-C-N 119.257 0.935 . . . . 0.0 110.567 172.495 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 16.2 pt -77.03 -38.28 27.71 Favored 'Isoleucine or valine' 0 C--O 1.234 0.25 0 N-CA-C 114.91 1.448 . . . . 0.0 114.91 -169.085 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 74.5 m . . . . . 0 C--O 1.254 1.296 0 C-N-CA 125.882 1.673 . . . . 0.0 109.52 -169.774 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 19.8 ptm . . . . . 0 N--CA 1.497 1.924 0 N-CA-C 110.821 -0.066 . . . . 0.0 110.821 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 16.3 mttm -73.59 125.96 29.18 Favored 'General case' 0 N--CA 1.482 1.131 0 N-CA-C 107.88 -1.156 . . . . 0.0 107.88 -172.006 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 69.6 mttt -94.13 137.26 33.52 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-N 120.062 1.301 . . . . 0.0 108.376 174.087 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 15.0 t -119.84 151.28 22.39 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 C-N-CA 127.121 2.169 . . . . 0.0 106.473 -169.939 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 31.9 mtt -134.65 147.14 50.09 Favored 'General case' 0 C--N 1.321 -0.64 0 C-N-CA 124.164 0.986 . . . . 0.0 108.705 168.782 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 45.6 m-85 -131.67 122.85 26.64 Favored 'General case' 0 CA--C 1.516 -0.336 0 N-CA-C 102.218 -3.252 . . . . 0.0 102.218 169.226 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 1.3 p -148.4 141.81 18.74 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.263 0 CA-C-O 121.764 0.793 . . . . 0.0 112.151 -168.41 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 46.3 t -136.29 173.86 11.25 Favored 'General case' 0 CA--C 1.547 0.846 0 C-N-CA 127.807 2.443 . . . . 0.0 105.269 169.019 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 87.6 tttt -51.59 -46.92 63.71 Favored 'General case' 0 N--CA 1.475 0.813 0 O-C-N 120.975 -1.078 . . . . 0.0 113.433 -169.368 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 19.6 ttt180 -130.11 147.47 51.85 Favored 'General case' 0 N--CA 1.468 0.461 0 CA-C-N 118.995 0.816 . . . . 0.0 109.118 -178.319 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 64.3 t30 -58.94 -30.33 67.79 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 123.964 0.906 . . . . 0.0 113.354 -175.589 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -56.31 -55.27 35.46 Favored 'General case' 0 C--O 1.236 0.378 0 C-N-CA 124.069 0.948 . . . . 0.0 109.992 -171.428 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 9.2 m -91.02 151.2 21.13 Favored 'General case' 0 N--CA 1.452 -0.37 0 C-N-CA 123.659 0.784 . . . . 0.0 110.797 -176.353 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 5.4 mmm180 67.32 -50.5 0.49 Allowed 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 128.462 2.705 . . . . 0.0 113.323 170.228 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 7.3 m -76.92 49.94 0.68 Allowed 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 125.677 1.591 . . . . 0.0 111.704 -179.351 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 4.5 pt20 -123.52 12.73 9.36 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 126.109 1.763 . . . . 0.0 112.148 -175.669 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -160.96 -40.37 0.05 OUTLIER 'General case' 0 C--O 1.224 -0.265 0 N-CA-C 113.973 1.101 . . . . 0.0 113.973 176.935 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -66.62 -52.45 44.99 Favored 'General case' 0 N--CA 1.475 0.797 0 CA-C-N 120.657 1.571 . . . . 0.0 112.164 -169.56 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -56.42 -38.3 71.39 Favored 'General case' 0 N--CA 1.446 -0.653 0 C-N-CA 124.029 0.931 . . . . 0.0 110.645 169.942 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -57.11 -52.6 50.4 Favored Glycine 0 CA--C 1.526 0.754 0 C-N-CA 124.722 1.153 . . . . 0.0 111.209 175.902 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 1.3 m-85 -65.0 -32.07 73.61 Favored 'General case' 0 CA--C 1.51 -0.582 0 O-C-N 120.94 -1.329 . . . . 0.0 111.907 175.723 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -71.05 -41.23 71.04 Favored 'General case' 0 N--CA 1.445 -0.688 0 CA-C-O 118.156 -0.926 . . . . 0.0 110.739 -174.607 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.15 -33.3 75.18 Favored 'General case' 0 N--CA 1.471 0.582 0 CA-C-N 119.617 1.099 . . . . 0.0 109.886 173.591 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 10.6 m -68.9 -54.05 17.66 Favored 'General case' 0 N--CA 1.442 -0.842 0 C-N-CA 123.171 0.588 . . . . 0.0 110.364 -175.046 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 39.9 mt -77.8 -37.3 49.06 Favored 'General case' 0 C--N 1.329 -0.285 0 C-N-CA 124.946 1.298 . . . . 0.0 111.034 -172.941 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -101.08 8.29 57.42 Favored Glycine 0 CA--C 1.526 0.761 0 CA-C-O 118.033 -1.426 . . . . 0.0 114.303 -169.734 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -40.92 -48.91 3.21 Favored 'General case' 0 N--CA 1.468 0.437 0 C-N-CA 125.798 1.639 . . . . 0.0 114.882 -169.443 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -89.94 -2.09 75.47 Favored Glycine 0 CA--C 1.531 1.074 0 CA-C-O 118.836 -0.98 . . . . 0.0 114.469 -173.506 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 13.8 ptpt -124.88 -28.29 3.51 Favored 'General case' 0 N--CA 1.472 0.651 0 CA-C-N 118.915 1.357 . . . . 0.0 113.145 -173.626 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 14.8 pt -143.65 150.15 17.47 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.437 0 CA-C-N 119.657 1.117 . . . . 0.0 111.47 -174.218 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -98.54 158.17 15.77 Favored 'General case' 0 N--CA 1.465 0.302 0 C-N-CA 125.575 1.55 . . . . 0.0 108.543 172.182 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 22.6 t -139.66 133.35 37.23 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 N-CA-C 107.547 -1.279 . . . . 0.0 107.547 -175.976 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 34.5 m -138.49 107.42 5.99 Favored 'General case' 0 N--CA 1.447 -0.594 0 N-CA-C 106.042 -1.836 . . . . 0.0 106.042 175.345 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 2.4 p -80.65 99.48 8.18 Favored 'General case' 0 C--N 1.327 -0.386 0 C-N-CA 119.843 -0.743 . . . . 0.0 109.064 174.501 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 25.7 p -72.16 -177.47 2.11 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 123.956 0.903 . . . . 0.0 110.827 175.254 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -173.17 171.88 44.76 Favored Glycine 0 CA--C 1.522 0.504 0 N-CA-C 106.457 -2.657 . . . . 0.0 106.457 -179.297 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 18.4 mt -106.43 -20.05 13.5 Favored 'General case' 0 C--N 1.325 -0.489 0 C-N-CA 124.804 1.241 . . . . 0.0 110.072 174.633 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 36.9 mt-10 -131.87 162.84 29.64 Favored 'General case' 0 N--CA 1.448 -0.538 0 C-N-CA 127.683 2.393 . . . . 0.0 106.948 169.207 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 78.9 p -145.2 155.99 43.59 Favored 'General case' 0 N--CA 1.451 -0.409 0 CA-C-O 122.844 1.307 . . . . 0.0 114.499 179.615 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 4.3 m -168.89 -179.85 3.86 Favored 'General case' 0 N--CA 1.451 -0.41 0 C-N-CA 131.118 3.767 . . . . 0.0 103.966 -170.028 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 25.6 ttp180 -86.9 171.69 10.62 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 107.079 -1.452 . . . . 0.0 107.079 169.142 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 11.2 m -68.58 165.47 2.3 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.808 0 CA-C-N 115.796 -0.638 . . . . 0.0 109.973 178.409 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 55.1 m170 -62.96 152.43 83.51 Favored Pre-proline 0 CA--C 1.549 0.917 0 C-N-CA 123.161 0.584 . . . . 0.0 112.537 177.675 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -70.45 -55.62 0.15 Allowed 'Trans proline' 0 C--N 1.352 0.711 0 C-N-CA 123.382 2.722 . . . . 0.0 114.388 -169.909 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 26.9 m -65.8 -22.75 66.59 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-N 119.256 0.934 . . . . 0.0 110.071 -175.973 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -52.41 -52.3 54.52 Favored 'General case' 0 CA--C 1.509 -0.603 0 CA-C-O 118.815 -0.612 . . . . 0.0 110.585 169.957 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 85.3 mt -58.69 -41.32 81.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 -172.292 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -63.96 -49.32 72.99 Favored 'General case' 0 N--CA 1.45 -0.455 0 CA-C-N 118.079 0.399 . . . . 0.0 111.113 178.477 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' MET . . . . . 0.431 ' HG3' ' CG ' ' A' ' 112' ' ' PHE . 24.3 mmt -65.33 -35.81 82.12 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-O 122.638 1.208 . . . . 0.0 111.445 -178.627 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -79.22 -33.09 44.01 Favored 'General case' 0 N--CA 1.44 -0.944 0 N-CA-C 107.584 -1.265 . . . . 0.0 107.584 -173.47 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 42.0 tt0 -68.25 -26.76 65.84 Favored 'General case' 0 N--CA 1.445 -0.713 0 C-N-CA 123.307 0.643 . . . . 0.0 109.86 170.614 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 14.7 mm-40 -68.25 -28.57 67.33 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-N 118.816 0.734 . . . . 0.0 110.654 174.241 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . 0.276 4.6 p -93.07 11.81 3.14 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.907 0 CA-C-N 118.658 0.663 . . . . 0.0 111.375 169.201 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 77.33 17.53 79.23 Favored Glycine 0 CA--C 1.53 1.029 0 C-N-CA 124.516 1.055 . . . . 0.0 114.003 173.071 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 12.5 mt -109.58 131.3 60.85 Favored 'Isoleucine or valine' 0 C--O 1.232 0.134 0 CA-C-N 118.884 1.342 . . . . 0.0 109.921 -177.947 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 8.1 t70 -87.28 121.04 29.19 Favored 'General case' 0 C--O 1.236 0.375 0 N-CA-C 106.783 -1.562 . . . . 0.0 106.783 169.061 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 10.1 pt -110.39 -26.68 3.09 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.487 0 C-N-CA 123.097 0.559 . . . . 0.0 110.105 169.126 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -32.67 -46.42 0.14 Allowed 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 130.146 3.378 . . . . 0.0 114.279 173.073 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -73.75 -3.59 63.85 Favored Glycine 0 CA--C 1.534 1.221 0 CA-C-O 118.82 -0.989 . . . . 0.0 114.126 -176.27 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 13.3 mt-30 -79.25 114.53 18.26 Favored 'General case' 0 CA--C 1.511 -0.55 0 CA-C-N 119.353 1.577 . . . . 0.0 111.468 -176.216 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -150.22 148.33 28.77 Favored 'General case' 0 N--CA 1.434 -1.248 0 N-CA-C 105.257 -2.127 . . . . 0.0 105.257 167.328 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 18.8 m -150.81 156.7 41.78 Favored 'General case' 0 N--CA 1.447 -0.607 0 N-CA-C 108.373 -0.973 . . . . 0.0 108.373 -169.677 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -67.98 163.45 50.4 Favored Pre-proline 0 CA--C 1.542 0.646 0 C-N-CA 124.682 1.193 . . . . 0.0 109.464 169.422 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -60.73 151.65 75.08 Favored 'Trans proline' 0 N--CA 1.456 -0.685 0 C-N-CA 122.043 1.829 . . . . 0.0 110.31 172.126 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 13.9 tt -58.61 -26.24 30.69 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.453 0 C-N-CA 124.031 0.932 . . . . 0.0 112.212 -174.475 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 23.1 tt0 -67.21 -25.34 66.07 Favored 'General case' 0 N--CA 1.434 -1.241 0 C-N-CA 125.68 1.592 . . . . 0.0 110.682 -177.052 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 12.9 t-20 -63.21 -31.51 72.67 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 124.984 1.314 . . . . 0.0 112.221 -178.888 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 8.5 m-85 -96.69 -167.69 1.6 Allowed 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 124.904 1.281 . . . . 0.0 110.333 -175.46 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 54.9 t-20 -137.35 136.95 38.39 Favored 'General case' 0 CA--C 1.515 -0.402 0 N-CA-C 107.27 -1.382 . . . . 0.0 107.27 169.188 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -73.54 -24.91 60.19 Favored 'General case' 0 N--CA 1.436 -1.128 0 N-CA-C 109.408 -0.59 . . . . 0.0 109.408 -176.547 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 36.0 t70 -66.34 -23.97 66.44 Favored 'General case' 0 N--CA 1.443 -0.804 0 O-C-N 123.751 0.657 . . . . 0.0 111.82 -179.618 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -75.96 -28.82 58.05 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 123.097 0.559 . . . . 0.0 111.348 175.541 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 18.8 m-85 -83.58 168.61 16.22 Favored 'General case' 0 N--CA 1.45 -0.47 0 C-N-CA 125.897 1.679 . . . . 0.0 110.368 177.939 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -114.97 -36.26 4.5 Favored 'General case' 0 N--CA 1.465 0.321 0 C-N-CA 123.126 0.57 . . . . 0.0 111.281 178.595 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -140.58 139.09 35.57 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.361 0 C-N-CA 123.42 0.688 . . . . 0.0 109.621 -171.499 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 83.4 t -140.48 140.0 34.72 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.319 0 N-CA-C 106.381 -1.711 . . . . 0.0 106.381 -177.692 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 37.3 mm -131.41 127.86 60.44 Favored 'Isoleucine or valine' 0 C--O 1.237 0.441 0 N-CA-C 106.743 -1.577 . . . . 0.0 106.743 -174.921 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 13.6 m -86.59 130.83 34.34 Favored 'General case' 0 N--CA 1.441 -0.905 0 N-CA-C 106.647 -1.612 . . . . 0.0 106.647 168.927 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 85.0 mt -93.94 -7.25 43.53 Favored 'General case' 0 C--N 1.331 -0.226 0 C-N-CA 123.465 0.706 . . . . 0.0 109.726 169.751 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 18.0 p -161.58 158.67 26.65 Favored 'General case' 0 N--CA 1.444 -0.73 0 C-N-CA 124.881 1.272 . . . . 0.0 108.768 169.454 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 65.76 -161.39 43.4 Favored Glycine 0 CA--C 1.535 1.285 0 N-CA-C 115.178 0.831 . . . . 0.0 115.178 169.345 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 15.1 m -142.59 -161.2 1.2 Allowed 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 126.841 2.057 . . . . 0.0 107.626 -172.39 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -72.76 61.41 1.64 Allowed Glycine 0 CA--C 1.535 1.315 0 O-C-N 120.921 -1.112 . . . . 0.0 111.667 172.28 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 6.7 m -78.21 -55.86 9.03 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.508 0 C-N-CA 124.235 1.014 . . . . 0.0 110.82 -170.001 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 46.4 t30 -143.9 48.85 1.39 Allowed 'General case' 0 N--CA 1.467 0.383 0 N-CA-C 104.416 -2.438 . . . . 0.0 104.416 169.551 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 6.0 tt -144.15 119.33 6.09 Favored Pre-proline 0 CA--C 1.535 0.386 0 N-CA-C 104.75 -2.315 . . . . 0.0 104.75 -168.443 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 76.4 Cg_exo -60.13 138.07 79.35 Favored 'Trans proline' 0 C--N 1.349 0.579 0 C-N-CA 121.823 1.682 . . . . 0.0 112.316 -170.194 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 66.9 Cg_endo -68.85 -14.57 39.16 Favored 'Trans proline' 0 N--CA 1.459 -0.516 0 C-N-CA 122.0 1.8 . . . . 0.0 113.084 -174.776 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 14.0 tt0 -58.08 -25.48 61.34 Favored 'General case' 0 N--CA 1.439 -1.019 0 C-N-CA 125.713 1.605 . . . . 0.0 110.887 171.565 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 99.7 m95 -78.87 -41.38 30.02 Favored 'General case' 0 N--CA 1.456 -0.134 0 C-N-CA 123.722 0.809 . . . . 0.0 111.804 173.035 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 2.0 m -79.46 0.02 3.47 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.638 0 C-N-CA 123.321 0.648 . . . . 0.0 112.326 -175.153 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . 0.254 1.4 t -133.11 34.98 3.53 Favored 'General case' 0 CA--C 1.546 0.797 0 O-C-N 121.519 -0.738 . . . . 0.0 112.565 -175.731 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 89.4 mm-40 -71.66 -178.66 2.3 Favored 'General case' 0 CA--C 1.543 0.703 0 O-C-N 121.208 -0.933 . . . . 0.0 110.052 169.199 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 31.1 mm-40 -57.22 -28.83 63.23 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 123.181 0.592 . . . . 0.0 111.923 -169.348 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 5.3 tt -136.72 138.63 46.06 Favored 'Isoleucine or valine' 0 C--O 1.239 0.519 0 N-CA-C 104.383 -2.451 . . . . 0.0 104.383 168.406 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 70.9 t80 -132.33 142.46 49.35 Favored 'General case' 0 N--CA 1.448 -0.564 0 N-CA-C 106.407 -1.701 . . . . 0.0 106.407 169.491 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 19.9 mm-40 -141.64 152.1 43.66 Favored 'General case' 0 C--O 1.237 0.397 0 N-CA-C 106.652 -1.61 . . . . 0.0 106.652 171.351 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -125.4 127.66 46.92 Favored 'General case' 0 C--O 1.239 0.5 0 N-CA-C 107.244 -1.391 . . . . 0.0 107.244 169.204 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 4.6 m95 -116.05 158.17 23.56 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 124.192 0.997 . . . . 0.0 110.452 -173.328 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 19.9 pt20 -122.06 39.56 3.85 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 124.553 1.141 . . . . 0.0 111.258 -177.054 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -64.36 133.08 51.91 Favored 'General case' 0 N--CA 1.466 0.359 0 N-CA-C 107.764 -1.199 . . . . 0.0 107.764 173.492 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 3.2 mp0 -64.59 152.09 42.95 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 123.943 0.897 . . . . 0.0 110.037 173.049 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -91.01 113.64 58.85 Favored Pre-proline 0 C--O 1.236 0.377 0 N-CA-C 105.603 -1.999 . . . . 0.0 105.603 168.349 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 78.6 Cg_endo -76.25 -8.73 18.78 Favored 'Trans proline' 0 N--CA 1.453 -0.868 0 C-N-CA 121.804 1.669 . . . . 0.0 114.189 -172.819 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -66.79 -41.2 88.01 Favored 'General case' 0 C--O 1.235 0.299 0 CA-C-N 120.45 1.477 . . . . 0.0 113.293 -169.309 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -79.3 6.96 55.65 Favored Glycine 0 CA--C 1.533 1.179 0 CA-C-O 118.823 -0.987 . . . . 0.0 113.663 -176.082 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 24.3 pt20 -148.53 -165.59 2.32 Favored 'General case' 0 CA--C 1.54 0.582 0 CA-C-N 118.932 1.366 . . . . 0.0 111.141 -169.874 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 2.1 m -69.3 156.65 38.42 Favored 'General case' 0 CA--C 1.533 0.324 0 N-CA-C 116.164 1.912 . . . . 0.0 116.164 -168.365 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 35.0 tp -57.33 -30.34 64.71 Favored 'General case' 0 N--CA 1.465 0.305 0 C-N-CA 126.28 1.832 . . . . 0.0 112.475 173.544 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 40.4 tt0 -58.62 -34.92 71.71 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 123.601 0.76 . . . . 0.0 110.62 173.978 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 3.4 t -76.0 -38.23 35.2 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.378 0 CA-C-O 118.12 -0.943 . . . . 0.0 109.676 -178.939 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . 0.431 ' CG ' ' HG3' ' A' ' 49' ' ' MET . 27.0 m-85 -57.03 -50.14 73.66 Favored 'General case' 0 N--CA 1.475 0.793 0 CA-C-N 120.733 1.606 . . . . 0.0 110.256 169.904 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 85.7 mtt180 -60.5 -39.54 88.07 Favored 'General case' 0 N--CA 1.468 0.457 0 C-N-CA 123.358 0.663 . . . . 0.0 110.849 -179.161 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 16.3 m -68.28 -50.58 52.73 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 124.657 1.183 . . . . 0.0 110.726 176.565 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 55.2 t -67.6 -33.87 64.69 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.197 0 CA-C-O 117.498 -1.239 . . . . 0.0 110.856 -169.423 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 31.1 mtm105 -57.54 -41.77 81.62 Favored 'General case' 0 CA--C 1.539 0.534 0 CA-C-N 120.335 1.425 . . . . 0.0 110.273 173.598 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -67.02 -50.34 47.27 Favored Glycine 0 CA--C 1.529 0.92 0 C-N-CA 123.926 0.774 . . . . 0.0 111.878 177.577 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 25.4 mt-30 -54.95 -47.59 74.3 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-N 117.752 0.776 . . . . 0.0 110.211 178.377 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 53.7 t -64.83 -48.79 82.96 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.432 0 CA-C-O 118.329 -0.843 . . . . 0.0 109.967 -177.101 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 62.6 tttm -55.96 -45.65 78.83 Favored 'General case' 0 CA--C 1.519 -0.22 0 CA-C-N 119.114 0.87 . . . . 0.0 109.107 -174.429 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -64.88 -43.93 91.31 Favored 'General case' 0 N--CA 1.443 -0.781 0 C-N-CA 123.019 0.528 . . . . 0.0 110.776 -177.12 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 57.8 mtt-85 -68.0 -42.94 79.95 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-N 118.639 0.654 . . . . 0.0 111.695 179.578 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 98.5 t -66.55 -44.11 90.29 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.374 0 N-CA-C 108.433 -0.951 . . . . 0.0 108.433 179.406 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 21.3 mt-10 -61.39 -42.73 99.19 Favored 'General case' 0 C--N 1.338 0.092 0 CA-C-N 119.892 1.224 . . . . 0.0 110.39 178.861 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 29.6 t-20 -62.22 -44.56 96.29 Favored 'General case' 0 C--O 1.225 -0.189 0 C-N-CA 122.861 0.464 . . . . 0.0 110.827 178.239 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 45.7 tp -60.1 -47.24 86.74 Favored 'General case' 0 N--CA 1.454 -0.246 0 C-N-CA 124.239 1.016 . . . . 0.0 111.052 177.5 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 79.7 mt -61.69 -45.83 97.83 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.256 0 N-CA-C 108.026 -1.101 . . . . 0.0 108.026 178.191 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -62.04 -29.3 70.19 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 123.262 0.625 . . . . 0.0 112.239 178.28 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 89.9 mttt -68.59 -56.55 7.89 Favored 'General case' 0 C--N 1.342 0.248 0 CA-C-N 119.16 0.891 . . . . 0.0 110.096 171.711 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 15.8 pt -73.93 -40.35 52.51 Favored 'Isoleucine or valine' 0 C--O 1.235 0.338 0 N-CA-C 114.213 1.19 . . . . 0.0 114.213 -169.308 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 75.0 m . . . . . 0 C--O 1.253 1.262 0 C-N-CA 126.144 1.777 . . . . 0.0 109.408 -169.74 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 9.7 ptm . . . . . 0 N--CA 1.497 1.913 0 N-CA-C 110.711 -0.107 . . . . 0.0 110.711 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 18.1 mttm -76.06 124.0 26.7 Favored 'General case' 0 N--CA 1.481 1.095 0 N-CA-C 107.701 -1.222 . . . . 0.0 107.701 -172.499 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 87.1 mttt -92.64 135.01 34.46 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-N 119.689 1.131 . . . . 0.0 108.343 176.692 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 1.7 t -118.81 150.31 21.11 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 C-N-CA 126.852 2.061 . . . . 0.0 108.848 -169.161 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 6.2 mtt -139.41 148.15 42.4 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 125.617 1.567 . . . . 0.0 109.286 169.352 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 91.0 m-85 -132.78 105.75 7.34 Favored 'General case' 0 C--O 1.225 -0.193 0 N-CA-C 104.769 -2.308 . . . . 0.0 104.769 172.131 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 22.1 t -131.82 138.88 51.76 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.221 0 CA-C-O 121.898 0.856 . . . . 0.0 111.211 -168.745 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 37.9 t -154.41 156.08 36.17 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 127.47 2.308 . . . . 0.0 105.236 169.27 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 65.6 pttt -65.37 -21.74 66.72 Favored 'General case' 0 N--CA 1.472 0.64 0 N-CA-C 114.69 1.367 . . . . 0.0 114.69 -170.427 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 7.9 tpp180 -126.94 78.05 1.77 Allowed 'General case' 0 N--CA 1.47 0.54 0 CA-C-N 119.814 1.188 . . . . 0.0 110.058 -173.9 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 34.9 t30 -43.18 -48.33 6.44 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 125.159 1.384 . . . . 0.0 112.222 176.379 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -51.53 -32.14 26.76 Favored 'General case' 0 C--O 1.232 0.147 0 C-N-CA 126.617 1.967 . . . . 0.0 112.998 -175.66 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 8.8 m -125.01 17.52 8.5 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 123.795 0.838 . . . . 0.0 111.805 -173.198 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 10.2 tpt180 -151.81 -55.86 0.14 Allowed 'General case' 0 C--N 1.348 0.528 0 N-CA-C 115.727 1.751 . . . . 0.0 115.727 179.33 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 3.3 m -65.66 -55.01 19.78 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 119.61 1.095 . . . . 0.0 112.195 -168.509 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER 43.8 -111.12 0.19 Allowed 'General case' 0 N--CA 1.452 -0.368 0 C-N-CA 126.328 1.851 . . . . 0.0 111.453 169.106 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -78.53 -8.38 58.51 Favored 'General case' 0 C--O 1.224 -0.246 0 N-CA-C 114.29 1.218 . . . . 0.0 114.29 -170.629 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -62.78 -58.95 5.66 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-N 120.131 1.332 . . . . 0.0 111.138 -169.751 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -68.11 -32.1 72.16 Favored 'General case' 0 CA--C 1.541 0.597 0 O-C-N 121.722 -0.611 . . . . 0.0 109.542 175.627 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -48.63 -56.65 9.35 Favored Glycine 0 C--N 1.346 1.113 0 C-N-CA 125.38 1.467 . . . . 0.0 111.637 176.23 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 13.9 m-85 -74.54 -28.3 60.9 Favored 'General case' 0 CA--C 1.508 -0.663 0 CA-C-N 118.77 1.285 . . . . 0.0 112.928 179.322 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -66.25 -31.0 71.55 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 119.323 0.965 . . . . 0.0 111.554 -172.451 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 7.5 ptpt -63.5 -33.06 74.75 Favored 'General case' 0 N--CA 1.477 0.908 0 CA-C-N 119.432 1.015 . . . . 0.0 112.036 171.067 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 5.9 m -78.72 -55.17 5.38 Favored 'General case' 0 N--CA 1.446 -0.626 0 C-N-CA 125.187 1.395 . . . . 0.0 110.245 -175.202 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 79.3 mt -73.4 -34.32 65.45 Favored 'General case' 0 C--N 1.33 -0.248 0 C-N-CA 123.971 0.909 . . . . 0.0 110.339 -174.753 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -91.08 2.85 79.88 Favored Glycine 0 CA--C 1.527 0.822 0 CA-C-O 118.362 -1.243 . . . . 0.0 113.709 -176.494 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -49.92 123.0 7.31 Favored 'General case' 0 CA--C 1.533 0.31 0 CA-C-N 118.796 1.298 . . . . 0.0 110.904 -172.074 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 76.78 -14.11 7.73 Favored Glycine 0 CA--C 1.533 1.195 0 C-N-CA 124.676 1.132 . . . . 0.0 114.353 179.631 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 53.6 mttm -94.15 -46.41 7.12 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-N 119.212 1.506 . . . . 0.0 110.393 178.918 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 24.7 pt -142.15 152.39 18.41 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.427 0 C-N-CA 124.301 1.04 . . . . 0.0 109.95 -169.408 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -112.87 109.01 18.19 Favored 'General case' 0 N--CA 1.464 0.235 0 C-N-CA 125.035 1.334 . . . . 0.0 108.694 -174.036 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 11.1 p -86.27 139.16 17.79 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.401 0 CA-C-N 119.702 1.137 . . . . 0.0 109.867 177.71 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 3.9 m -144.55 107.7 4.55 Favored 'General case' 0 N--CA 1.445 -0.69 0 N-CA-C 104.77 -2.308 . . . . 0.0 104.77 172.191 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 66.2 m -105.63 75.47 1.14 Allowed 'General case' 0 C--N 1.329 -0.32 0 O-C-N 120.933 -1.105 . . . . 0.0 108.827 178.48 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 2.0 m -60.46 -45.55 93.29 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 125.388 1.475 . . . . 0.0 112.054 -169.891 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 89.65 161.73 37.74 Favored Glycine 0 C--N 1.335 0.508 0 CA-C-O 122.038 0.799 . . . . 0.0 112.159 170.905 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 5.6 mt -131.49 142.67 50.01 Favored 'General case' 0 N--CA 1.442 -0.845 0 C-N-CA 128.079 2.552 . . . . 0.0 104.548 174.533 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 33.2 mt-10 57.42 -89.77 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.385 0 N-CA-C 108.134 -1.061 . . . . 0.0 108.134 -169.516 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 69.3 m 64.52 169.63 0.18 Allowed 'General case' 0 N--CA 1.445 -0.721 0 C-N-CA 127.269 2.228 . . . . 0.0 115.615 169.184 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 59.9 m -157.47 177.29 11.59 Favored 'General case' 0 N--CA 1.446 -0.646 0 C-N-CA 128.269 2.627 . . . . 0.0 105.984 -168.847 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 14.4 ttt85 -82.12 -178.77 7.15 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 107.963 -1.125 . . . . 0.0 107.963 169.377 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 17.6 m -81.41 170.17 1.48 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.729 0 C-N-CA 123.789 0.836 . . . . 0.0 109.766 -178.675 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 74.0 t60 -73.0 139.22 79.59 Favored Pre-proline 0 CA--C 1.545 0.763 0 CA-C-O 118.163 -0.922 . . . . 0.0 108.631 172.207 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -58.35 -48.3 16.16 Favored 'Trans proline' 0 C--N 1.348 0.507 0 C-N-CA 123.093 2.529 . . . . 0.0 113.833 -174.193 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 25.2 m -65.58 -18.82 65.6 Favored 'General case' 0 CA--C 1.535 0.387 0 CA-C-N 118.258 0.481 . . . . 0.0 110.937 -179.294 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -60.28 -50.64 72.82 Favored 'General case' 0 CA--C 1.51 -0.562 0 O-C-N 121.458 -0.776 . . . . 0.0 108.996 175.018 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 72.5 mt -57.98 -41.57 80.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 N-CA-C 108.352 -0.981 . . . . 0.0 108.352 -173.112 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -63.56 -46.48 85.72 Favored 'General case' 0 N--CA 1.452 -0.352 0 CA-C-N 117.631 0.196 . . . . 0.0 110.856 -179.05 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 28.4 mmt -68.02 -36.38 79.85 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-O 122.439 1.114 . . . . 0.0 110.841 -179.819 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -74.6 -31.93 62.19 Favored 'General case' 0 N--CA 1.444 -0.753 0 N-CA-C 106.887 -1.523 . . . . 0.0 106.887 -175.698 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 40.8 tt0 -72.3 -21.89 61.28 Favored 'General case' 0 N--CA 1.446 -0.651 0 C-N-CA 124.311 1.045 . . . . 0.0 110.157 172.495 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 21.6 mm-40 -67.53 -30.63 70.34 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-N 119.272 0.942 . . . . 0.0 110.017 169.962 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . 0.291 5.5 p -89.86 8.74 3.21 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.993 0 CA-C-N 118.802 0.728 . . . . 0.0 111.467 168.839 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 77.29 21.75 72.36 Favored Glycine 0 CA--C 1.532 1.11 0 O-C-N 120.818 -1.176 . . . . 0.0 113.799 174.953 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 25.2 mt -118.71 144.71 26.17 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.239 0 C-N-CA 125.314 1.445 . . . . 0.0 110.005 -174.15 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 20.6 t70 -108.03 147.59 30.93 Favored 'General case' 0 C--O 1.234 0.282 0 N-CA-C 108.375 -0.972 . . . . 0.0 108.375 168.74 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 13.5 pt -132.29 -12.57 1.48 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.707 0 C-N-CA 125.895 1.678 . . . . 0.0 111.529 170.565 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 5.4 t -45.77 -46.73 15.42 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-N 120.333 1.424 . . . . 0.0 111.688 170.845 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -78.51 29.51 1.99 Allowed Glycine 0 CA--C 1.533 1.207 0 C-N-CA 124.966 1.269 . . . . 0.0 114.147 -177.621 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 1.7 tt0 -63.5 -37.37 87.04 Favored 'General case' 0 C--N 1.344 0.36 0 CA-C-N 119.728 1.764 . . . . 0.0 113.213 -175.046 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 12.4 t -81.22 161.36 24.01 Favored 'General case' 0 C--O 1.238 0.451 0 CA-C-O 122.047 0.927 . . . . 0.0 110.352 -169.534 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 4.2 m -168.34 -51.42 0.02 OUTLIER 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 125.919 1.687 . . . . 0.0 109.175 178.197 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -154.39 154.97 30.32 Favored Pre-proline 0 C--O 1.237 0.41 0 C-N-CA 124.988 1.315 . . . . 0.0 108.208 -179.672 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 98.9 Cg_endo -66.86 159.13 53.07 Favored 'Trans proline' 0 N--CA 1.457 -0.659 0 C-N-CA 123.111 2.541 . . . . 0.0 110.508 171.421 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 5.6 tt -60.11 -26.01 35.01 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.477 0 O-C-N 121.577 -0.702 . . . . 0.0 111.63 179.681 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 15.8 mt-10 -65.66 -25.46 67.36 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 124.555 1.142 . . . . 0.0 110.593 -175.121 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 4.4 t-20 -65.84 -20.96 66.43 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 124.666 1.186 . . . . 0.0 112.459 177.985 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 77.0 m-85 -106.42 -173.49 2.31 Favored 'General case' 0 C--O 1.236 0.356 0 C-N-CA 126.37 1.868 . . . . 0.0 110.1 -174.95 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 53.2 t-20 -135.78 139.71 43.72 Favored 'General case' 0 N--CA 1.448 -0.542 0 N-CA-C 107.857 -1.164 . . . . 0.0 107.857 169.123 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -72.44 -26.16 61.73 Favored 'General case' 0 N--CA 1.433 -1.31 0 N-CA-C 109.283 -0.636 . . . . 0.0 109.283 -178.102 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -65.56 -24.39 67.08 Favored 'General case' 0 N--CA 1.447 -0.596 0 O-C-N 123.639 0.587 . . . . 0.0 112.002 -179.652 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -78.42 -28.43 46.79 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 123.297 0.639 . . . . 0.0 111.635 174.848 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 11.4 m-85 -81.13 167.44 19.68 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 125.536 1.534 . . . . 0.0 111.151 179.877 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -116.86 -39.98 3.21 Favored 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 123.099 0.56 . . . . 0.0 111.243 -179.081 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -136.13 133.62 50.28 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.453 0 CA-C-O 121.841 0.829 . . . . 0.0 109.498 -172.43 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 70.5 t -142.01 130.0 21.32 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.585 0 N-CA-C 106.199 -1.778 . . . . 0.0 106.199 -177.83 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 38.0 mm -118.9 125.42 74.46 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.575 0 N-CA-C 106.387 -1.708 . . . . 0.0 106.387 -173.233 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 56.0 m -84.0 145.06 28.72 Favored 'General case' 0 N--CA 1.446 -0.655 0 N-CA-C 106.061 -1.829 . . . . 0.0 106.061 168.601 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 93.1 mt -111.61 5.35 19.3 Favored 'General case' 0 C--N 1.328 -0.344 0 O-C-N 121.637 -0.664 . . . . 0.0 110.785 171.74 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 10.8 p -155.47 147.25 23.22 Favored 'General case' 0 N--CA 1.447 -0.584 0 C-N-CA 124.537 1.135 . . . . 0.0 108.566 168.898 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 53.4 -156.56 5.5 Favored Glycine 0 CA--C 1.537 1.426 0 C-N-CA 125.204 1.383 . . . . 0.0 115.22 169.604 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 48.0 m -145.83 127.12 14.85 Favored 'General case' 0 CA--C 1.532 0.271 0 N-CA-C 105.902 -1.888 . . . . 0.0 105.902 174.913 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 58.59 44.43 95.55 Favored Glycine 0 CA--C 1.53 1.013 0 N-CA-C 109.711 -1.356 . . . . 0.0 109.711 -171.378 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . 0.279 4.0 p -75.37 64.46 0.16 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.842 0 C-N-CA 125.916 1.686 . . . . 0.0 112.213 -168.834 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 56.5 t30 56.84 52.89 8.81 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 125.874 1.67 . . . . 0.0 107.83 -169.569 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -143.83 138.59 15.29 Favored Pre-proline 0 CA--C 1.538 0.489 0 C-N-CA 126.102 1.761 . . . . 0.0 108.743 -168.748 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 33.2 Cg_exo -64.93 139.47 62.05 Favored 'Trans proline' 0 CA--C 1.54 0.81 0 C-N-CA 122.221 1.947 . . . . 0.0 111.576 176.463 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -66.21 -24.9 50.72 Favored 'Trans proline' 0 N--CA 1.457 -0.657 0 C-N-CA 122.585 2.19 . . . . 0.0 114.476 -169.649 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 5.0 pm0 -61.46 -18.08 57.36 Favored 'General case' 0 CA--C 1.537 0.453 0 CA-C-N 121.251 1.841 . . . . 0.0 111.898 178.413 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 99.4 m95 -77.91 -38.84 44.71 Favored 'General case' 0 N--CA 1.451 -0.393 0 O-C-N 121.702 -0.624 . . . . 0.0 111.396 174.093 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -79.33 -5.12 7.72 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.456 0 O-C-N 121.869 -0.519 . . . . 0.0 111.672 -177.827 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 81.5 p -114.39 18.42 16.9 Favored 'General case' 0 C--O 1.238 0.453 0 N-CA-C 114.411 1.264 . . . . 0.0 114.411 -175.633 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 91.6 mm-40 -68.18 173.99 4.27 Favored 'General case' 0 CA--C 1.541 0.628 0 CA-C-N 119.025 0.83 . . . . 0.0 111.858 179.324 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 28.7 mm-40 -53.22 -31.57 43.79 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 124.362 1.065 . . . . 0.0 112.735 -169.0 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 4.8 tt -131.35 124.83 55.77 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.51 0 N-CA-C 104.305 -2.48 . . . . 0.0 104.305 168.39 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 4.1 t80 -113.55 133.39 55.28 Favored 'General case' 0 C--O 1.237 0.444 0 N-CA-C 104.722 -2.325 . . . . 0.0 104.722 169.186 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 14.4 mm-40 -137.66 152.07 48.93 Favored 'General case' 0 C--O 1.238 0.495 0 N-CA-C 106.57 -1.641 . . . . 0.0 106.57 169.723 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -130.94 134.82 47.1 Favored 'General case' 0 C--O 1.237 0.419 0 N-CA-C 107.411 -1.329 . . . . 0.0 107.411 169.263 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 6.6 m95 -121.08 138.95 53.94 Favored 'General case' 0 C--O 1.234 0.25 0 C-N-CA 123.059 0.543 . . . . 0.0 109.767 -174.82 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 4.8 tp-100 -82.72 63.33 6.79 Favored 'General case' 0 CA--C 1.535 0.395 0 N-CA-C 107.361 -1.348 . . . . 0.0 107.361 169.907 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 1.6 tp -67.38 127.53 33.03 Favored 'General case' 0 C--N 1.34 0.165 0 N-CA-C 108.955 -0.757 . . . . 0.0 108.955 -173.352 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -76.89 159.05 30.33 Favored 'General case' 0 N--CA 1.449 -0.508 0 N-CA-C 107.045 -1.465 . . . . 0.0 107.045 169.572 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 20.0 t70 -149.07 137.65 11.96 Favored Pre-proline 0 CA--C 1.536 0.419 0 CA-C-O 118.596 -0.716 . . . . 0.0 111.209 -171.584 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 20.8 Cg_endo -91.7 9.53 2.82 Favored 'Trans proline' 0 CA--C 1.548 1.217 0 C-N-CA 123.424 2.749 . . . . 0.0 114.808 -172.193 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -53.27 128.44 28.16 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-N 120.596 1.544 . . . . 0.0 111.361 177.811 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 64.0 25.16 69.18 Favored Glycine 0 CA--C 1.532 1.126 0 CA-C-O 118.741 -1.033 . . . . 0.0 115.458 169.223 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 6.9 pt20 -142.1 -168.48 2.71 Favored 'General case' 0 CA--C 1.536 0.434 0 CA-C-N 118.891 1.345 . . . . 0.0 111.343 -177.911 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 2.6 m -68.51 156.0 38.84 Favored 'General case' 0 CA--C 1.532 0.274 0 N-CA-C 116.149 1.907 . . . . 0.0 116.149 -168.401 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 42.9 tp -54.97 -33.68 62.63 Favored 'General case' 0 N--CA 1.465 0.307 0 C-N-CA 126.997 2.119 . . . . 0.0 111.785 175.211 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 40.8 tt0 -58.49 -35.43 72.2 Favored 'General case' 0 CA--C 1.529 0.172 0 C-N-CA 123.806 0.843 . . . . 0.0 110.702 176.399 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 4.2 t -74.98 -40.47 45.39 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.291 0 CA-C-O 118.434 -0.793 . . . . 0.0 109.652 -177.216 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 89.9 m-85 -57.12 -49.64 75.29 Favored 'General case' 0 N--CA 1.471 0.621 0 CA-C-N 119.927 1.24 . . . . 0.0 109.568 171.837 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 89.4 mtt180 -61.61 -40.0 93.27 Favored 'General case' 0 N--CA 1.467 0.385 0 C-N-CA 122.871 0.468 . . . . 0.0 110.993 -178.592 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 7.6 m -66.32 -56.27 11.96 Favored 'General case' 0 N--CA 1.447 -0.608 0 C-N-CA 124.507 1.123 . . . . 0.0 109.514 177.996 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 83.8 t -68.33 -34.06 63.92 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.343 0 CA-C-O 118.683 -0.675 . . . . 0.0 110.057 -169.643 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 47.1 ttp85 -57.82 -43.23 85.59 Favored 'General case' 0 CA--C 1.538 0.489 0 CA-C-N 119.275 0.943 . . . . 0.0 109.883 173.173 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -64.54 -53.4 35.62 Favored Glycine 0 CA--C 1.53 0.987 0 CA-C-N 118.318 0.508 . . . . 0.0 111.842 175.273 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 12.6 mt-30 -61.01 -43.34 99.03 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-N 117.884 0.842 . . . . 0.0 110.837 -174.859 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 76.8 t -70.5 -38.85 75.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 118.085 -0.959 . . . . 0.0 109.966 -174.951 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 84.0 tttt -54.73 -46.81 74.29 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 119.279 0.945 . . . . 0.0 108.673 175.789 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -65.98 -42.51 89.75 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 122.933 0.493 . . . . 0.0 111.398 -176.604 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 43.6 mtt-85 -61.49 -46.62 89.22 Favored 'General case' 0 N--CA 1.472 0.635 0 O-C-N 121.336 -0.852 . . . . 0.0 111.514 176.524 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 98.4 t -65.28 -39.87 86.77 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.637 0 N-CA-C 109.08 -0.711 . . . . 0.0 109.08 179.354 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 29.7 mt-10 -59.42 -44.48 92.87 Favored 'General case' 0 N--CA 1.462 0.172 0 CA-C-N 119.789 1.177 . . . . 0.0 110.787 176.667 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 46.7 t30 -62.98 -45.2 93.54 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 123.329 0.652 . . . . 0.0 110.551 -177.649 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 22.0 tp -58.0 -47.91 81.61 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 124.112 0.965 . . . . 0.0 111.006 175.382 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 81.0 mt -63.09 -46.09 96.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 N-CA-C 108.329 -0.989 . . . . 0.0 108.329 179.664 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -59.91 -27.83 67.08 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 123.25 0.62 . . . . 0.0 112.214 177.901 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 90.5 mttt -69.72 -56.99 5.69 Favored 'General case' 0 C--N 1.343 0.284 0 CA-C-N 119.322 0.964 . . . . 0.0 110.184 171.706 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 18.2 pt -75.71 -38.44 37.66 Favored 'Isoleucine or valine' 0 C--O 1.235 0.326 0 N-CA-C 114.645 1.35 . . . . 0.0 114.645 -169.283 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 73.7 m . . . . . 0 C--O 1.252 1.237 0 C-N-CA 126.199 1.799 . . . . 0.0 109.128 -169.805 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 6.3 ptm . . . . . 0 N--CA 1.497 1.878 0 N-CA-C 110.807 -0.071 . . . . 0.0 110.807 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 10.6 mtmm -71.69 130.14 40.41 Favored 'General case' 0 N--CA 1.476 0.874 0 N-CA-C 107.507 -1.294 . . . . 0.0 107.507 -178.936 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 66.7 mttt -103.74 138.32 40.53 Favored 'General case' 0 CA--C 1.511 -0.526 0 N-CA-C 107.912 -1.144 . . . . 0.0 107.912 171.046 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 4.0 t -116.25 152.84 17.93 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.787 0 C-N-CA 126.522 1.929 . . . . 0.0 108.169 -169.878 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 5.1 mtt -135.78 148.17 48.66 Favored 'General case' 0 C--N 1.323 -0.562 0 C-N-CA 126.512 1.925 . . . . 0.0 107.951 168.88 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -135.19 109.22 8.2 Favored 'General case' 0 CA--C 1.512 -0.51 0 N-CA-C 104.161 -2.533 . . . . 0.0 104.161 175.909 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 72.4 t -132.73 149.52 32.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-O 121.378 0.608 . . . . 0.0 110.0 -168.454 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 32.7 t -135.85 -174.43 3.66 Favored 'General case' 0 CA--C 1.548 0.866 0 C-N-CA 128.134 2.573 . . . . 0.0 105.952 172.814 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 64.3 tttp -54.45 -39.93 67.88 Favored 'General case' 0 N--CA 1.479 1.008 0 O-C-N 121.26 -0.9 . . . . 0.0 111.505 177.777 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 33.3 mtp85 -132.3 158.35 42.1 Favored 'General case' 0 N--CA 1.468 0.47 0 C-N-CA 124.644 1.177 . . . . 0.0 108.449 174.6 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -63.27 -24.97 68.1 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 122.948 0.499 . . . . 0.0 112.093 170.212 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -48.93 -44.46 40.51 Favored 'General case' 0 CA--C 1.53 0.197 0 C-N-CA 126.105 1.762 . . . . 0.0 113.627 -169.31 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 13.5 m -120.03 144.36 47.59 Favored 'General case' 0 N--CA 1.454 -0.27 0 C-N-CA 123.111 0.564 . . . . 0.0 109.733 -169.386 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . 0.37 0.0 OUTLIER 56.32 -40.68 0.03 OUTLIER 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 130.3 3.44 . . . . 0.0 115.061 -178.746 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 2.0 m -61.8 -24.19 66.7 Favored 'General case' 0 CA--C 1.539 0.524 0 O-C-N 120.358 -1.464 . . . . 0.0 109.663 169.293 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 22.0 pt20 -67.18 10.81 0.13 Allowed 'General case' 0 CA--C 1.546 0.823 0 C-N-CA 125.638 1.575 . . . . 0.0 113.401 169.414 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -139.18 -51.64 0.54 Allowed 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 125.158 1.383 . . . . 0.0 111.577 173.599 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -57.8 -47.43 82.6 Favored 'General case' 0 N--CA 1.472 0.669 0 N-CA-C 114.934 1.457 . . . . 0.0 114.934 -169.003 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 1.9 pp20? -63.5 -30.61 71.71 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-N 117.981 0.355 . . . . 0.0 110.109 178.36 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -51.81 -67.32 2.07 Favored Glycine 0 C--N 1.34 0.805 0 C-N-CA 126.399 1.952 . . . . 0.0 110.885 173.376 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 12.8 m-85 -62.53 -31.01 71.71 Favored 'General case' 0 N--CA 1.469 0.514 0 CA-C-N 118.25 1.025 . . . . 0.0 113.294 179.67 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -67.36 -35.79 80.07 Favored 'General case' 0 N--CA 1.45 -0.454 0 CA-C-N 119.07 0.85 . . . . 0.0 111.549 -176.226 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -67.35 -27.28 67.0 Favored 'General case' 0 CA--C 1.541 0.624 0 CA-C-N 119.426 1.012 . . . . 0.0 111.431 174.201 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 2.8 m -77.2 -56.17 4.8 Favored 'General case' 0 N--CA 1.451 -0.397 0 C-N-CA 125.443 1.497 . . . . 0.0 110.571 -178.601 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 54.9 mt -75.54 -38.35 59.37 Favored 'General case' 0 C--N 1.33 -0.245 0 C-N-CA 124.098 0.959 . . . . 0.0 109.497 -174.484 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -82.24 3.78 79.68 Favored Glycine 0 CA--C 1.524 0.628 0 C-N-CA 125.154 1.359 . . . . 0.0 113.447 -179.65 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -54.39 127.28 26.73 Favored 'General case' 0 CA--C 1.531 0.219 0 CA-C-N 118.881 1.34 . . . . 0.0 109.691 -177.328 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 73.38 5.41 67.18 Favored Glycine 0 CA--C 1.533 1.168 0 CA-C-O 118.775 -1.014 . . . . 0.0 114.273 -178.8 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 46.3 mttp -121.22 -51.32 2.1 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-N 119.104 1.452 . . . . 0.0 110.943 -176.508 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 19.2 pt -139.71 148.12 23.39 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.453 0 C-N-CA 123.88 0.872 . . . . 0.0 109.567 -169.495 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -94.67 158.75 15.38 Favored 'General case' 0 C--O 1.224 -0.266 0 C-N-CA 124.851 1.26 . . . . 0.0 108.522 178.06 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 21.7 t -140.54 130.71 28.07 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 N-CA-C 107.172 -1.418 . . . . 0.0 107.172 -176.474 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 24.4 m -141.0 109.77 6.04 Favored 'General case' 0 N--CA 1.446 -0.645 0 N-CA-C 105.122 -2.177 . . . . 0.0 105.122 172.684 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 69.3 m -110.81 85.0 2.03 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.869 0.842 . . . . 0.0 110.079 -177.439 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 4.8 m -72.48 -170.09 0.61 Allowed 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 126.651 1.98 . . . . 0.0 110.748 176.749 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -165.74 -168.2 27.53 Favored Glycine 0 C--N 1.337 0.604 0 N-CA-C 108.01 -2.036 . . . . 0.0 108.01 177.949 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 16.9 mt -127.25 -8.41 5.86 Favored 'General case' 0 C--N 1.332 -0.177 0 C-N-CA 124.657 1.183 . . . . 0.0 112.773 -171.946 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 20.9 mt-10 -142.52 -71.53 0.32 Allowed 'General case' 0 CA--C 1.535 0.366 0 N-CA-C 107.427 -1.323 . . . . 0.0 107.427 -178.023 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . 0.25 53.8 m 63.17 158.58 0.07 Allowed 'General case' 0 N--CA 1.465 0.296 0 C-N-CA 127.259 2.223 . . . . 0.0 116.586 169.675 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 69.6 m -152.74 1.62 0.3 Allowed 'General case' 0 CA--C 1.538 0.484 0 N-CA-C 115.747 1.758 . . . . 0.0 115.747 -167.532 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 1.5 ttt180 66.51 168.51 0.23 Allowed 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 125.251 1.42 . . . . 0.0 109.802 -167.439 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 5.1 m -83.79 172.33 1.07 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.315 0 C-N-CA 123.528 0.731 . . . . 0.0 110.978 -169.19 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 91.1 m-70 -88.65 150.55 46.36 Favored Pre-proline 0 CA--C 1.537 0.443 0 C-N-CA 123.188 0.595 . . . . 0.0 109.949 178.133 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 39.5 Cg_endo -63.72 -46.44 8.95 Favored 'Trans proline' 0 C--N 1.347 0.485 0 C-N-CA 122.855 2.37 . . . . 0.0 112.341 -170.338 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 6.0 m -66.17 -25.94 67.19 Favored 'General case' 0 CA--C 1.531 0.242 0 CA-C-O 119.016 -0.516 . . . . 0.0 110.256 -179.112 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -58.69 -54.12 50.61 Favored 'General case' 0 CA--C 1.51 -0.581 0 CA-C-N 119.086 0.857 . . . . 0.0 109.109 176.27 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 38.1 mt -59.7 -42.8 89.78 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.427 0 N-CA-C 108.193 -1.04 . . . . 0.0 108.193 -174.654 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -59.23 -44.86 92.31 Favored 'General case' 0 CA--C 1.532 0.269 0 CA-C-N 118.421 0.555 . . . . 0.0 110.623 -178.775 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 26.4 mmt -70.9 -37.58 72.98 Favored 'General case' 0 C--O 1.239 0.503 0 CA-C-O 122.158 0.98 . . . . 0.0 111.128 -179.161 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -69.91 -32.96 71.54 Favored 'General case' 0 N--CA 1.443 -0.778 0 N-CA-C 106.649 -1.612 . . . . 0.0 106.649 179.781 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 18.6 mm-40 -73.29 -16.59 61.38 Favored 'General case' 0 N--CA 1.444 -0.752 0 O-C-N 120.79 -1.194 . . . . 0.0 111.278 171.757 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 22.6 mm-40 -66.28 -35.1 79.53 Favored 'General case' 0 C--N 1.341 0.221 0 CA-C-N 119.847 1.203 . . . . 0.0 109.095 169.552 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 16.8 m -90.07 11.59 2.09 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.766 0 N-CA-C 112.2 0.445 . . . . 0.0 112.2 169.311 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 73.21 23.52 77.36 Favored Glycine 0 CA--C 1.534 1.234 0 C-N-CA 124.487 1.042 . . . . 0.0 113.345 174.67 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 8.6 mt -107.83 135.53 46.19 Favored 'Isoleucine or valine' 0 C--O 1.232 0.152 0 C-N-CA 125.419 1.488 . . . . 0.0 110.197 -174.994 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -95.57 140.01 31.02 Favored 'General case' 0 C--O 1.236 0.365 0 C-N-CA 123.508 0.723 . . . . 0.0 109.514 169.791 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.49 HG13 ' H ' ' A' ' 58' ' ' SER . 3.6 pt -119.72 -66.94 1.2 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.607 0 C-N-CA 124.773 1.229 . . . . 0.0 108.393 171.043 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' SER . . . . . 0.49 ' H ' HG13 ' A' ' 57' ' ' ILE . 95.2 p 30.59 -98.54 0.01 OUTLIER 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 128.961 2.905 . . . . 0.0 114.225 174.897 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -76.35 53.96 3.16 Favored Glycine 0 CA--C 1.528 0.876 0 C-N-CA 127.273 2.368 . . . . 0.0 112.703 -175.773 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 5.6 mt-30 -65.44 -29.9 70.63 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 123.203 0.601 . . . . 0.0 110.297 169.744 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -60.28 128.19 35.52 Favored 'General case' 0 N--CA 1.446 -0.639 0 C-N-CA 126.037 1.735 . . . . 0.0 109.19 -169.795 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 75.5 m -147.63 -169.94 3.44 Favored 'General case' 0 N--CA 1.447 -0.587 0 C-N-CA 126.332 1.853 . . . . 0.0 106.605 -169.635 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -57.38 154.59 22.24 Favored Pre-proline 0 C--O 1.241 0.613 0 O-C-N 121.854 -0.529 . . . . 0.0 109.903 169.355 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 64.4 Cg_endo -61.2 152.61 70.77 Favored 'Trans proline' 0 N--CA 1.456 -0.691 0 C-N-CA 121.918 1.745 . . . . 0.0 109.488 171.613 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 7.9 tt -60.09 -26.53 36.48 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.497 0 O-C-N 121.794 -0.566 . . . . 0.0 111.015 -176.682 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 25.4 tt0 -67.52 -26.33 66.28 Favored 'General case' 0 N--CA 1.435 -1.215 0 C-N-CA 125.398 1.479 . . . . 0.0 110.65 -176.625 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 11.3 t-20 -64.72 -31.16 72.26 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 124.416 1.087 . . . . 0.0 111.731 176.945 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 79.4 m-85 -86.58 168.13 13.94 Favored 'General case' 0 C--O 1.237 0.429 0 C-N-CA 124.946 1.298 . . . . 0.0 111.612 -174.695 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 46.4 t-20 -106.26 132.05 52.77 Favored 'General case' 0 N--CA 1.444 -0.738 0 N-CA-C 107.298 -1.371 . . . . 0.0 107.298 168.676 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -73.6 -24.69 60.08 Favored 'General case' 0 N--CA 1.437 -1.092 0 N-CA-C 109.339 -0.615 . . . . 0.0 109.339 -178.77 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 36.1 t70 -65.85 -21.76 66.49 Favored 'General case' 0 N--CA 1.447 -0.595 0 O-C-N 123.477 0.486 . . . . 0.0 112.096 -179.617 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -73.29 -29.31 62.63 Favored 'General case' 0 C--N 1.344 0.367 0 CA-C-O 121.222 0.534 . . . . 0.0 111.795 176.164 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 32.7 m-85 -84.25 165.84 18.0 Favored 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 125.744 1.618 . . . . 0.0 110.166 179.703 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 20.4 t70 -113.13 -35.84 5.25 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.72 176.903 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -142.24 135.94 28.5 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.826 0 CA-C-O 121.792 0.806 . . . . 0.0 110.496 -169.305 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 73.3 t -142.16 131.07 22.32 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.729 0 N-CA-C 106.178 -1.786 . . . . 0.0 106.178 -174.097 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 41.4 mm -117.93 125.5 74.23 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.443 0 N-CA-C 106.387 -1.709 . . . . 0.0 106.387 -171.712 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 41.3 m -95.19 108.69 20.83 Favored 'General case' 0 N--CA 1.447 -0.597 0 N-CA-C 106.675 -1.602 . . . . 0.0 106.675 169.889 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 90.0 mt -74.63 -13.37 60.63 Favored 'General case' 0 N--CA 1.464 0.254 0 C-N-CA 123.175 0.59 . . . . 0.0 111.661 -178.943 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 45.4 m -142.19 89.89 2.21 Favored 'General case' 0 N--CA 1.452 -0.367 0 C-N-CA 124.981 1.312 . . . . 0.0 109.073 -169.824 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 64.33 -154.7 47.51 Favored Glycine 0 CA--C 1.534 1.221 0 N-CA-C 111.585 -0.606 . . . . 0.0 111.585 178.418 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 2.9 p -161.77 152.81 18.11 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 124.587 1.155 . . . . 0.0 109.651 179.365 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 61.43 31.0 75.85 Favored Glycine 0 CA--C 1.531 1.069 0 N-CA-C 111.619 -0.592 . . . . 0.0 111.619 -178.534 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 28.5 m -70.69 -38.76 74.34 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.543 0 C-N-CA 123.087 0.555 . . . . 0.0 112.118 -169.366 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 21.4 t-20 179.66 -40.86 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 127.795 2.438 . . . . 0.0 107.573 176.712 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 3.6 tt -37.59 137.93 0.64 Allowed Pre-proline 0 CA--C 1.548 0.878 0 C-N-CA 128.788 2.835 . . . . 0.0 112.562 170.963 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_exo -65.32 148.83 88.7 Favored 'Trans proline' 0 C--N 1.355 0.886 0 C-N-CA 121.734 1.623 . . . . 0.0 115.635 -169.399 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -64.04 -33.44 62.26 Favored 'Trans proline' 0 C--N 1.351 0.672 0 C-N-CA 122.394 2.062 . . . . 0.0 115.788 -170.981 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 5.1 pm0 -61.45 -14.41 28.34 Favored 'General case' 0 CA--C 1.538 0.49 0 CA-C-N 120.27 1.395 . . . . 0.0 112.46 -175.876 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 98.0 m95 -79.67 -45.94 18.08 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 124.008 0.923 . . . . 0.0 110.904 176.711 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 16.1 m -80.18 -1.32 4.58 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.366 0 C-N-CA 123.955 0.902 . . . . 0.0 112.25 179.975 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 74.9 p -109.62 18.76 19.94 Favored 'General case' 0 C--O 1.238 0.454 0 CA-C-N 119.672 1.124 . . . . 0.0 113.655 175.544 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 88.0 mm-40 -66.66 172.24 4.41 Favored 'General case' 0 CA--C 1.542 0.635 0 CA-C-N 118.842 0.746 . . . . 0.0 111.783 177.0 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 31.7 mm-40 -54.85 -31.97 60.14 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 123.869 0.868 . . . . 0.0 112.272 -169.033 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 1.9 tt -129.0 126.32 64.37 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.543 0 N-CA-C 103.817 -2.66 . . . . 0.0 103.817 168.412 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 7.3 t80 -110.47 139.04 46.08 Favored 'General case' 0 N--CA 1.448 -0.549 0 N-CA-C 105.955 -1.869 . . . . 0.0 105.955 170.104 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 12.8 mm-40 -134.8 145.09 48.03 Favored 'General case' 0 C--O 1.237 0.435 0 N-CA-C 107.137 -1.431 . . . . 0.0 107.137 169.774 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -129.11 125.78 37.9 Favored 'General case' 0 C--O 1.239 0.515 0 C-N-CA 126.375 1.87 . . . . 0.0 106.235 178.117 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 34.6 m95 -135.43 179.31 6.41 Favored 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 124.585 1.154 . . . . 0.0 108.865 179.987 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 6.4 tp-100 -141.24 72.22 1.38 Allowed 'General case' 0 CA--C 1.535 0.376 0 N-CA-C 106.274 -1.75 . . . . 0.0 106.274 169.643 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -67.03 146.01 54.78 Favored 'General case' 0 N--CA 1.469 0.488 0 N-CA-C 108.448 -0.945 . . . . 0.0 108.448 178.506 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 34.4 mt-10 -78.66 169.68 17.85 Favored 'General case' 0 C--N 1.328 -0.369 0 C-N-CA 123.975 0.91 . . . . 0.0 109.318 170.891 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -141.35 138.59 17.76 Favored Pre-proline 0 CA--C 1.539 0.549 0 C-N-CA 124.331 1.052 . . . . 0.0 110.27 179.27 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_endo -85.47 0.58 8.57 Favored 'Trans proline' 0 CA--C 1.543 0.927 0 C-N-CA 123.248 2.632 . . . . 0.0 115.771 -174.063 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 7.1 t70 -53.66 124.0 13.86 Favored 'General case' 0 C--O 1.237 0.416 0 CA-C-N 121.077 1.762 . . . . 0.0 110.849 -179.063 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 72.33 4.71 61.02 Favored Glycine 0 CA--C 1.533 1.168 0 CA-C-O 118.961 -0.911 . . . . 0.0 113.749 178.188 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 7.1 mt-30 -103.0 167.25 9.96 Favored 'General case' 0 CA--C 1.539 0.557 0 CA-C-N 118.658 1.229 . . . . 0.0 110.014 178.594 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 16.4 m -71.91 167.38 20.18 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 124.09 0.956 . . . . 0.0 111.636 -178.928 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 73.8 mt -59.62 -26.51 65.54 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 124.379 1.072 . . . . 0.0 112.402 -176.454 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 5.9 pt-20 -56.25 -34.93 66.84 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-N 118.738 0.699 . . . . 0.0 111.11 174.184 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 14.0 t -77.93 -42.51 28.31 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.316 0 CA-C-O 118.664 -0.684 . . . . 0.0 109.913 -177.238 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 68.3 m-85 -56.84 -43.5 81.19 Favored 'General case' 0 N--CA 1.474 0.77 0 CA-C-N 119.639 1.109 . . . . 0.0 109.569 171.07 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 94.1 mtt180 -66.25 -42.33 88.7 Favored 'General case' 0 N--CA 1.472 0.655 0 O-C-N 121.305 -0.872 . . . . 0.0 110.804 179.485 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 4.1 m -65.75 -49.72 67.36 Favored 'General case' 0 N--CA 1.45 -0.427 0 C-N-CA 124.606 1.162 . . . . 0.0 110.312 179.394 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 77.2 t -70.43 -30.58 43.46 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.202 0 CA-C-O 117.807 -1.092 . . . . 0.0 110.587 -169.501 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 74.5 mtm-85 -59.09 -45.36 91.05 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 120.192 1.36 . . . . 0.0 109.799 170.508 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -62.16 -51.68 55.05 Favored Glycine 0 CA--C 1.528 0.88 0 CA-C-N 118.946 0.794 . . . . 0.0 112.1 178.093 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 15.7 mt-30 -58.94 -45.4 90.53 Favored 'General case' 0 N--CA 1.469 0.475 0 CA-C-N 117.936 0.868 . . . . 0.0 110.779 -178.852 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 55.3 t -67.04 -47.22 82.72 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.344 0 N-CA-C 109.202 -0.666 . . . . 0.0 109.202 -177.987 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 84.3 tttt -55.52 -45.67 77.11 Favored 'General case' 0 C--O 1.224 -0.262 0 N-CA-C 109.185 -0.672 . . . . 0.0 109.185 -176.635 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 10.1 tp10 -62.83 -44.2 96.79 Favored 'General case' 0 N--CA 1.45 -0.427 0 C-N-CA 123.145 0.578 . . . . 0.0 110.757 -176.268 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 48.6 mtt-85 -68.51 -42.97 77.81 Favored 'General case' 0 N--CA 1.468 0.443 0 O-C-N 121.32 -0.863 . . . . 0.0 111.025 178.987 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 95.4 t -64.17 -38.98 83.87 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.513 0 CA-C-O 119.138 -0.458 . . . . 0.0 109.884 178.305 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 27.8 mt-10 -61.72 -44.85 96.13 Favored 'General case' 0 C--O 1.227 -0.128 0 CA-C-N 119.993 1.27 . . . . 0.0 110.177 176.014 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 28.3 t-20 -63.02 -42.12 99.71 Favored 'General case' 0 CA--C 1.53 0.208 0 C-N-CA 122.915 0.486 . . . . 0.0 111.049 -177.801 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 28.7 tp -58.04 -49.63 76.21 Favored 'General case' 0 N--CA 1.451 -0.399 0 C-N-CA 125.203 1.401 . . . . 0.0 110.742 174.17 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 81.6 mt -66.41 -43.99 90.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 N-CA-C 108.146 -1.057 . . . . 0.0 108.146 -177.057 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -59.23 -32.92 70.41 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 123.198 0.599 . . . . 0.0 112.098 -179.486 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 18.6 ptpt -80.87 -37.79 29.25 Favored 'General case' 0 C--N 1.344 0.351 0 CA-C-O 117.929 -1.034 . . . . 0.0 112.32 177.344 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 13.1 pt -84.85 -34.38 9.05 Favored 'Isoleucine or valine' 0 C--O 1.236 0.356 0 CA-C-N 119.962 1.255 . . . . 0.0 114.045 -175.184 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 74.3 m . . . . . 0 C--O 1.252 1.195 0 C-N-CA 125.372 1.469 . . . . 0.0 109.462 -169.837 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.4 ptt? . . . . . 0 N--CA 1.496 1.854 0 N-CA-C 111.776 0.287 . . . . 0.0 111.776 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 2' ' ' LYS . . . . . 0.426 ' HB2' HG22 ' A' ' 30' ' ' ILE . 11.0 mtmm -59.91 128.4 36.71 Favored 'General case' 0 N--CA 1.475 0.8 0 N-CA-C 107.816 -1.179 . . . . 0.0 107.816 -178.872 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 66.0 mttt -103.14 136.12 43.52 Favored 'General case' 0 CA--C 1.513 -0.465 0 N-CA-C 107.745 -1.205 . . . . 0.0 107.745 171.528 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.44 HG21 HD12 ' A' ' 30' ' ' ILE . 3.7 t -113.73 152.73 15.38 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.622 0 C-N-CA 126.144 1.777 . . . . 0.0 107.111 -171.479 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 2.7 mtt -137.14 145.08 43.37 Favored 'General case' 0 C--N 1.323 -0.55 0 C-N-CA 126.433 1.893 . . . . 0.0 108.341 169.525 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 60.0 m-85 -128.6 89.01 2.82 Favored 'General case' 0 CA--C 1.528 0.109 0 N-CA-C 105.234 -2.136 . . . . 0.0 105.234 170.769 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 44.0 t -128.57 108.62 17.73 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.217 0 CA-C-O 121.409 0.623 . . . . 0.0 111.72 -168.741 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 33.9 t -101.64 164.57 11.68 Favored 'General case' 0 CA--C 1.543 0.682 0 N-CA-C 105.392 -2.077 . . . . 0.0 105.392 167.812 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 61.7 pttt -72.0 148.36 45.99 Favored 'General case' 0 CA--C 1.53 0.206 0 O-C-N 121.133 -0.979 . . . . 0.0 108.809 169.529 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 2.8 mpt_? 60.07 168.75 0.08 Allowed 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 125.63 1.572 . . . . 0.0 110.939 -170.443 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -138.4 -14.04 1.31 Allowed 'General case' 0 N--CA 1.468 0.433 0 N-CA-C 112.882 0.697 . . . . 0.0 112.882 -176.117 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 2.0 m -59.96 -30.71 69.28 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-N 118.681 0.673 . . . . 0.0 109.988 178.564 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 7.3 p -136.15 151.56 49.9 Favored 'General case' 0 N--CA 1.45 -0.455 0 C-N-CA 127.046 2.138 . . . . 0.0 105.652 168.738 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 2.0 mmm-85 58.77 176.12 0.07 Allowed 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 125.767 1.627 . . . . 0.0 110.026 -169.527 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 6.6 m 51.03 37.7 18.54 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 123.378 0.671 . . . . 0.0 111.557 -174.906 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 24.3 pt20 -143.21 155.09 44.45 Favored 'General case' 0 N--CA 1.444 -0.744 0 N-CA-C 106.476 -1.676 . . . . 0.0 106.476 174.401 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER 66.79 -39.58 0.35 Allowed 'General case' 0 C--N 1.326 -0.423 0 C-N-CA 127.091 2.156 . . . . 0.0 114.851 179.141 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -65.9 -48.14 72.45 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-N 120.834 1.652 . . . . 0.0 110.591 -176.315 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -64.37 -40.68 96.32 Favored 'General case' 0 C--N 1.324 -0.519 0 C-N-CA 123.651 0.78 . . . . 0.0 111.258 174.546 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -59.23 -45.44 95.37 Favored Glycine 0 CA--C 1.526 0.779 0 N-CA-C 111.622 -0.591 . . . . 0.0 111.622 176.476 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 1.5 m-85 -69.36 -33.44 73.08 Favored 'General case' 0 CA--C 1.51 -0.588 0 O-C-N 121.414 -1.051 . . . . 0.0 111.262 177.483 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -70.28 -37.83 74.94 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 119.098 0.863 . . . . 0.0 110.336 -178.105 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -53.06 -45.02 67.89 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 123.928 0.891 . . . . 0.0 109.146 169.55 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 14.7 m -70.48 -57.2 5.04 Favored 'General case' 0 N--CA 1.448 -0.562 0 C-N-CA 124.15 0.98 . . . . 0.0 111.279 -174.467 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 37.6 mt -74.65 -34.41 62.72 Favored 'General case' 0 C--N 1.332 -0.167 0 C-N-CA 125.108 1.363 . . . . 0.0 110.814 -171.71 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -92.05 1.21 73.64 Favored Glycine 0 CA--C 1.528 0.874 0 C-N-CA 125.162 1.363 . . . . 0.0 113.291 -175.898 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -49.27 127.81 15.58 Favored 'General case' 0 CA--C 1.534 0.335 0 CA-C-N 118.991 1.395 . . . . 0.0 110.565 -179.176 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 76.11 -9.8 17.67 Favored Glycine 0 CA--C 1.535 1.298 0 C-N-CA 124.412 1.006 . . . . 0.0 114.121 179.743 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 63.1 mttm -99.65 -47.51 5.06 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 119.177 1.489 . . . . 0.0 110.307 175.22 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.44 HD12 HG21 ' A' ' 4' ' ' VAL . 22.0 pt -144.0 155.38 15.63 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.26 0 C-N-CA 124.443 1.097 . . . . 0.0 110.819 -169.155 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -98.48 155.46 17.25 Favored 'General case' 0 C--O 1.224 -0.269 0 C-N-CA 125.344 1.458 . . . . 0.0 108.566 179.673 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 21.9 t -139.53 130.97 33.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 N-CA-C 106.969 -1.493 . . . . 0.0 106.969 -178.317 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 24.7 m -140.36 114.02 8.77 Favored 'General case' 0 N--CA 1.446 -0.664 0 N-CA-C 104.36 -2.459 . . . . 0.0 104.36 172.095 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 55.0 m -112.32 91.22 3.58 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 107.862 -1.162 . . . . 0.0 107.862 173.16 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 3.0 p -67.06 -59.12 3.73 Favored 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 126.478 1.911 . . . . 0.0 111.579 -174.372 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 107.15 164.49 22.08 Favored Glycine 0 CA--C 1.527 0.787 0 C-N-CA 124.463 1.03 . . . . 0.0 112.331 176.651 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 6.1 mt -131.86 138.85 48.61 Favored 'General case' 0 CA--C 1.508 -0.667 0 C-N-CA 127.362 2.265 . . . . 0.0 105.447 170.166 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 28.4 mt-10 53.72 20.46 2.24 Favored 'General case' 0 N--CA 1.48 1.029 0 CA-C-O 122.443 1.116 . . . . 0.0 111.735 179.178 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 3.7 p -78.13 165.41 24.0 Favored 'General case' 0 N--CA 1.435 -1.185 0 N-CA-C 116.481 2.03 . . . . 0.0 116.481 -166.854 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 37.3 p -147.07 -165.52 2.27 Favored 'General case' 0 N--CA 1.433 -1.278 0 C-N-CA 128.956 2.903 . . . . 0.0 106.289 -168.716 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -75.81 161.24 29.19 Favored 'General case' 0 N--CA 1.456 -0.153 0 CA-C-O 122.128 0.965 . . . . 0.0 109.182 169.343 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 2.3 m -66.87 173.28 0.63 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.709 0 CA-C-N 114.35 -1.295 . . . . 0.0 108.37 169.655 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 81.1 t60 -70.76 137.85 85.52 Favored Pre-proline 0 CA--C 1.544 0.73 0 O-C-N 121.187 -0.946 . . . . 0.0 110.4 -178.319 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 16.4 Cg_endo -56.44 -50.55 11.58 Favored 'Trans proline' 0 C--N 1.349 0.571 0 C-N-CA 123.077 2.518 . . . . 0.0 113.106 -177.433 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 23.5 m -69.35 -21.94 63.78 Favored 'General case' 0 CA--C 1.537 0.45 0 O-C-N 121.846 -0.534 . . . . 0.0 110.739 -177.296 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -61.18 -47.62 85.34 Favored 'General case' 0 CA--C 1.505 -0.774 0 N-CA-C 108.771 -0.825 . . . . 0.0 108.771 174.189 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 55.9 mt -58.7 -42.89 86.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 N-CA-C 108.345 -0.983 . . . . 0.0 108.345 -174.212 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -61.93 -47.43 84.92 Favored 'General case' 0 N--CA 1.453 -0.287 0 CA-C-N 118.395 0.543 . . . . 0.0 110.988 -179.898 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 27.4 mmt -66.5 -34.48 78.01 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-O 122.343 1.068 . . . . 0.0 110.7 179.853 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -78.36 -35.59 47.24 Favored 'General case' 0 N--CA 1.441 -0.875 0 N-CA-C 107.247 -1.39 . . . . 0.0 107.247 -172.924 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 33.9 mt-10 -70.42 -22.78 62.68 Favored 'General case' 0 N--CA 1.442 -0.851 0 C-N-CA 123.703 0.801 . . . . 0.0 110.229 171.757 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 14.7 mm-40 -69.23 -29.32 67.22 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-N 119.28 0.945 . . . . 0.0 110.62 171.448 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . 0.278 7.8 p -90.74 8.54 3.74 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.002 0 CA-C-N 118.768 0.713 . . . . 0.0 110.738 168.876 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 81.07 20.91 64.01 Favored Glycine 0 CA--C 1.532 1.114 0 C-N-CA 124.732 1.158 . . . . 0.0 114.055 173.463 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 16.7 mt -117.45 134.02 62.36 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.306 0 C-N-CA 124.49 1.116 . . . . 0.0 110.884 -172.251 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 3.3 t70 -89.4 139.11 30.84 Favored 'General case' 0 N--CA 1.464 0.258 0 N-CA-C 108.08 -1.082 . . . . 0.0 108.08 169.18 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 8.8 pt -129.92 -31.97 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.543 0 C-N-CA 124.587 1.155 . . . . 0.0 110.908 172.362 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -38.41 -42.52 0.74 Allowed 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 128.233 2.613 . . . . 0.0 113.698 169.388 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -70.58 1.63 20.41 Favored Glycine 0 CA--C 1.534 1.27 0 C-N-CA 124.518 1.056 . . . . 0.0 115.18 -174.121 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 16.6 mt-30 -60.46 -34.17 73.63 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 119.512 1.656 . . . . 0.0 114.457 -178.506 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -57.49 118.25 4.99 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-O 121.435 0.636 . . . . 0.0 110.765 -169.041 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 49.2 m -152.05 -167.63 2.83 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 127.857 2.463 . . . . 0.0 106.763 -169.537 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -59.52 153.21 51.57 Favored Pre-proline 0 CA--C 1.54 0.562 0 O-C-N 121.795 -0.566 . . . . 0.0 110.49 169.653 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -64.43 158.26 50.29 Favored 'Trans proline' 0 C--N 1.349 0.56 0 C-N-CA 123.13 2.553 . . . . 0.0 110.514 171.751 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 13.0 tt -59.72 -27.05 36.94 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.289 0 O-C-N 121.783 -0.573 . . . . 0.0 111.33 -178.762 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 15.7 mt-10 -65.98 -26.24 67.46 Favored 'General case' 0 C--O 1.234 0.24 0 C-N-CA 124.185 0.994 . . . . 0.0 110.409 -175.175 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 5.9 t-20 -66.48 -26.52 67.22 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 124.646 1.179 . . . . 0.0 111.769 177.13 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 96.3 m-85 -96.26 170.76 9.03 Favored 'General case' 0 C--O 1.235 0.32 0 C-N-CA 125.632 1.573 . . . . 0.0 110.927 -177.909 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 19.0 p-10 -116.79 137.43 52.2 Favored 'General case' 0 N--CA 1.436 -1.129 0 C-N-CA 125.075 1.35 . . . . 0.0 110.889 168.966 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -77.11 -22.18 53.09 Favored 'General case' 0 N--CA 1.433 -1.302 0 N-CA-C 109.82 -0.437 . . . . 0.0 109.82 -171.181 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -64.16 -21.92 66.74 Favored 'General case' 0 N--CA 1.443 -0.799 0 O-C-N 123.881 0.738 . . . . 0.0 111.79 -179.239 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 37.8 t70 -75.77 -27.72 58.14 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 122.973 0.509 . . . . 0.0 112.146 175.02 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 32.1 m-85 -85.93 170.11 12.63 Favored 'General case' 0 N--CA 1.451 -0.402 0 C-N-CA 126.271 1.828 . . . . 0.0 111.031 -179.319 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -119.01 -34.24 3.95 Favored 'General case' 0 N--CA 1.466 0.332 0 C-N-CA 123.117 0.567 . . . . 0.0 111.753 177.569 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -145.51 138.04 20.8 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.489 0 CA-C-O 121.324 0.583 . . . . 0.0 109.834 -170.216 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 95.5 t -144.87 126.09 8.51 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.515 0 N-CA-C 106.254 -1.758 . . . . 0.0 106.254 -173.782 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.518 HD12 ' HB2' ' A' ' 97' ' ' GLU . 4.5 mm -101.87 132.39 47.9 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.599 0 N-CA-C 105.803 -1.925 . . . . 0.0 105.803 173.609 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 55.8 m -93.04 -16.09 25.41 Favored 'General case' 0 CA--C 1.535 0.37 0 N-CA-C 113.288 0.848 . . . . 0.0 113.288 178.81 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 24.4 mt 57.06 -12.27 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.613 0 N-CA-C 118.218 2.673 . . . . 0.0 118.218 171.079 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 26.5 p -149.58 33.87 0.7 Allowed 'General case' 0 CA--C 1.537 0.454 0 CA-C-N 122.303 2.319 . . . . 0.0 112.816 -178.072 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 130.85 -165.49 22.9 Favored Glycine 0 CA--C 1.525 0.665 0 C-N-CA 125.498 1.523 . . . . 0.0 110.675 179.485 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 8.4 p -102.72 -53.39 2.87 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 124.762 1.225 . . . . 0.0 110.116 177.012 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -65.52 -53.93 29.13 Favored Glycine 0 C--N 1.341 0.84 0 N-CA-C 111.201 -0.76 . . . . 0.0 111.201 -175.394 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . 0.313 98.5 t 55.94 10.36 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.551 1.01 0 C-N-CA 126.749 2.02 . . . . 0.0 114.919 169.592 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 64.1 t30 53.38 44.57 29.86 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 124.839 1.256 . . . . 0.0 109.398 -169.592 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -126.31 142.63 43.39 Favored Pre-proline 0 CA--C 1.539 0.552 0 C-N-CA 127.242 2.217 . . . . 0.0 108.22 -169.317 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 30.1 Cg_exo -65.93 143.04 71.36 Favored 'Trans proline' 0 C--N 1.352 0.75 0 C-N-CA 121.396 1.397 . . . . 0.0 111.45 -178.749 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -65.4 -28.31 54.53 Favored 'Trans proline' 0 N--CA 1.462 -0.377 0 C-N-CA 122.054 1.836 . . . . 0.0 114.273 -169.191 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -58.09 -19.39 31.73 Favored 'General case' 0 CA--C 1.538 0.483 0 CA-C-N 119.436 1.016 . . . . 0.0 112.488 179.873 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 95.0 m95 -78.88 -40.62 31.88 Favored 'General case' 0 N--CA 1.446 -0.642 0 C-N-CA 123.52 0.728 . . . . 0.0 112.263 -177.15 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 2.9 m -71.25 -34.11 53.06 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.445 0 CA-C-O 118.722 -0.656 . . . . 0.0 110.117 174.29 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 76.6 p -81.99 23.69 0.68 Allowed 'General case' 0 C--O 1.236 0.356 0 CA-C-N 120.046 1.293 . . . . 0.0 113.893 -170.159 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 94.3 mm-40 -72.79 179.03 3.84 Favored 'General case' 0 N--CA 1.446 -0.634 0 O-C-N 121.703 -0.623 . . . . 0.0 110.319 172.343 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 30.7 mm-40 -62.3 -19.79 63.65 Favored 'General case' 0 CA--C 1.538 0.489 0 N-CA-C 112.829 0.677 . . . . 0.0 112.829 -169.398 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 2.1 tt -142.14 124.12 13.28 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.354 0 C-N-CA 126.338 1.855 . . . . 0.0 106.698 173.547 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 7.0 t80 -97.29 132.23 43.23 Favored 'General case' 0 CA--C 1.535 0.397 0 N-CA-C 105.158 -2.164 . . . . 0.0 105.158 169.022 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 97' ' ' GLU . . . . . 0.518 ' HB2' HD12 ' A' ' 77' ' ' ILE . 7.9 mm-40 -138.46 160.27 39.98 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-O 121.792 0.806 . . . . 0.0 109.434 172.034 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 8.9 t70 -179.92 134.98 0.11 Allowed 'General case' 0 C--N 1.325 -0.482 0 C-N-CA 127.085 2.154 . . . . 0.0 106.509 -169.57 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 99' ' ' TRP . . . . . 0.465 ' CZ3' HG21 ' A' ' 77' ' ' ILE . 5.0 m-90 -145.58 154.23 41.94 Favored 'General case' 0 C--O 1.234 0.238 0 N-CA-C 109.325 -0.62 . . . . 0.0 109.325 -172.043 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 15.2 pt20 -79.58 50.24 1.11 Allowed 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 124.216 1.006 . . . . 0.0 110.118 171.474 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 1.1 mt -65.43 121.92 15.99 Favored 'General case' 0 C--N 1.34 0.181 0 N-CA-C 107.672 -1.232 . . . . 0.0 107.672 178.141 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 -73.02 160.35 32.21 Favored 'General case' 0 CA--C 1.537 0.465 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 173.826 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -137.26 137.21 21.95 Favored Pre-proline 0 C--O 1.237 0.413 0 C-N-CA 124.296 1.039 . . . . 0.0 109.835 -169.698 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 22.7 Cg_endo -88.66 6.16 4.84 Favored 'Trans proline' 0 CA--C 1.544 0.994 0 C-N-CA 122.817 2.344 . . . . 0.0 113.736 -170.517 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 4.6 t70 -47.01 111.53 0.41 Allowed 'General case' 0 C--O 1.236 0.389 0 CA-C-N 120.356 1.434 . . . . 0.0 111.857 -179.973 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 67.65 7.91 49.84 Favored Glycine 0 CA--C 1.535 1.307 0 C-N-CA 124.348 0.975 . . . . 0.0 114.3 177.853 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 6.7 mt-30 -91.2 173.6 7.84 Favored 'General case' 0 CA--C 1.541 0.626 0 CA-C-N 118.777 1.289 . . . . 0.0 110.518 -178.649 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 15.6 m -74.16 166.55 23.23 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 124.432 1.093 . . . . 0.0 111.555 179.978 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -57.35 -31.78 66.08 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 125.06 1.344 . . . . 0.0 112.084 -176.85 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 6.2 pt-20 -56.82 -35.17 68.48 Favored 'General case' 0 N--CA 1.463 0.196 0 C-N-CA 123.195 0.598 . . . . 0.0 111.377 176.404 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 15.6 t -76.9 -41.42 32.11 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.31 0 CA-C-O 118.412 -0.804 . . . . 0.0 109.416 -176.883 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 84.1 m-85 -57.25 -48.91 77.64 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-N 119.89 1.223 . . . . 0.0 110.413 171.606 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 94.9 mtt180 -60.81 -41.77 96.32 Favored 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 123.322 0.649 . . . . 0.0 110.972 179.766 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 5.2 m -63.5 -47.62 80.96 Favored 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 124.629 1.171 . . . . 0.0 110.196 176.25 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 73.1 t -68.92 -35.11 67.68 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.335 0 CA-C-O 117.955 -1.022 . . . . 0.0 109.7 -172.402 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 27.2 mtm105 -57.68 -48.24 80.08 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 120.205 1.366 . . . . 0.0 110.094 174.128 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -63.36 -48.84 75.24 Favored Glycine 0 CA--C 1.53 0.999 0 CA-C-N 118.38 0.536 . . . . 0.0 111.852 179.003 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 14.3 mm-40 -55.79 -54.1 48.56 Favored 'General case' 0 N--CA 1.464 0.259 0 C-N-CA 123.677 0.791 . . . . 0.0 109.93 179.556 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 95.6 t -65.34 -43.46 94.92 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-O 118.168 -0.92 . . . . 0.0 109.821 -173.559 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 61.5 tttm -53.45 -44.5 68.91 Favored 'General case' 0 C--O 1.225 -0.191 0 N-CA-C 108.828 -0.804 . . . . 0.0 108.828 178.479 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -69.53 -45.4 68.92 Favored 'General case' 0 N--CA 1.448 -0.575 0 CA-C-O 119.12 -0.467 . . . . 0.0 111.627 -176.394 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 1.5 mmt-85 -59.41 -44.85 92.77 Favored 'General case' 0 N--CA 1.478 0.969 0 CA-C-N 119.26 0.936 . . . . 0.0 110.257 176.487 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 88.6 t -68.63 -40.76 82.23 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.445 0 N-CA-C 109.193 -0.669 . . . . 0.0 109.193 -176.555 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 23.6 mt-10 -60.61 -40.45 91.9 Favored 'General case' 0 C--O 1.226 -0.151 0 CA-C-N 119.645 1.111 . . . . 0.0 110.21 176.129 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 25.0 t-20 -65.69 -43.2 89.95 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 123.082 0.553 . . . . 0.0 111.442 -179.579 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 1.4 tm? -58.75 -47.76 83.53 Favored 'General case' 0 C--O 1.225 -0.191 0 C-N-CA 126.112 1.765 . . . . 0.0 110.689 174.509 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 85.5 mt -65.91 -48.37 82.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 N-CA-C 108.697 -0.853 . . . . 0.0 108.697 179.16 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -56.54 -33.86 66.5 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-N 118.488 0.586 . . . . 0.0 112.264 -177.31 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 17.6 ptpt -80.4 -36.06 34.37 Favored 'General case' 0 C--N 1.342 0.279 0 CA-C-O 117.952 -1.023 . . . . 0.0 112.552 178.543 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 14.0 pt -85.22 -34.56 8.88 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.376 0 CA-C-N 119.973 1.261 . . . . 0.0 114.08 -177.353 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 75.1 m . . . . . 0 C--O 1.254 1.322 0 C-N-CA 125.706 1.602 . . . . 0.0 109.398 -169.884 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.497 1.882 0 N-CA-C 110.37 -0.233 . . . . 0.0 110.37 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 26.6 mttm -81.66 121.01 25.82 Favored 'General case' 0 N--CA 1.478 0.956 0 N-CA-C 106.776 -1.565 . . . . 0.0 106.776 173.501 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 37.0 ttmt -87.17 128.6 35.13 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 107.396 -1.335 . . . . 0.0 107.396 -179.366 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 1.7 t -117.17 150.8 19.12 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 C-N-CA 125.715 1.606 . . . . 0.0 109.61 -168.865 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 46.4 ttm -141.23 148.21 39.54 Favored 'General case' 0 C--N 1.329 -0.319 0 C-N-CA 125.474 1.51 . . . . 0.0 108.786 169.699 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 87.1 m-85 -136.29 128.7 30.25 Favored 'General case' 0 C--N 1.332 -0.175 0 N-CA-C 104.072 -2.566 . . . . 0.0 104.072 175.005 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 2.2 p -157.17 156.39 4.41 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.437 0 CA-C-N 119.147 0.885 . . . . 0.0 110.837 -168.947 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 48.0 t -140.63 177.58 7.93 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 126.966 2.106 . . . . 0.0 106.652 169.04 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 40.7 ttmt -49.86 -40.99 44.33 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 124.707 1.203 . . . . 0.0 111.742 -177.064 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 99.1 mtt180 -134.17 169.23 17.48 Favored 'General case' 0 N--CA 1.466 0.325 0 C-N-CA 125.478 1.511 . . . . 0.0 107.898 169.906 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 55.1 t-20 -70.8 -39.91 72.82 Favored 'General case' 0 N--CA 1.47 0.53 0 N-CA-C 109.702 -0.481 . . . . 0.0 109.702 173.405 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 3.6 m -51.85 139.15 22.56 Favored 'General case' 0 C--O 1.237 0.397 0 C-N-CA 124.849 1.26 . . . . 0.0 111.084 -178.339 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 4.6 m 60.99 17.13 7.63 Favored 'General case' 0 CA--C 1.542 0.648 0 N-CA-C 115.076 1.51 . . . . 0.0 115.076 171.852 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -156.13 -55.37 0.09 Allowed 'General case' 0 N--CA 1.471 0.605 0 CA-C-N 121.05 1.75 . . . . 0.0 114.886 169.842 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 3.3 m -77.92 15.6 0.85 Allowed 'General case' 0 N--CA 1.468 0.431 0 N-CA-C 115.654 1.724 . . . . 0.0 115.654 -168.254 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 6.0 pt20 -66.15 -43.26 87.54 Favored 'General case' 0 C--O 1.22 -0.453 0 CA-C-N 120.247 1.385 . . . . 0.0 113.302 -169.989 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 1.4 tpt -108.55 -19.83 13.31 Favored 'General case' 0 N--CA 1.47 0.526 0 N-CA-C 114.487 1.291 . . . . 0.0 114.487 -168.571 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -66.65 -50.29 63.41 Favored 'General case' 0 N--CA 1.475 0.792 0 CA-C-N 119.149 0.886 . . . . 0.0 111.846 -170.498 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -63.29 -32.42 73.83 Favored 'General case' 0 N--CA 1.467 0.38 0 N-CA-C 109.492 -0.559 . . . . 0.0 109.492 173.008 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -51.43 -65.7 2.98 Favored Glycine 0 C--N 1.345 1.03 0 C-N-CA 124.569 1.081 . . . . 0.0 111.347 174.471 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 13.6 m-85 -65.72 -29.38 69.9 Favored 'General case' 0 CA--C 1.506 -0.746 0 CA-C-N 118.588 1.194 . . . . 0.0 112.477 -176.882 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -67.45 -30.11 69.75 Favored 'General case' 0 N--CA 1.446 -0.638 0 CA-C-O 117.98 -1.01 . . . . 0.0 111.737 -177.624 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 2.1 ptmt -70.72 -27.89 64.31 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-N 120.248 1.385 . . . . 0.0 111.342 174.132 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 12.8 m -77.52 -57.16 3.97 Favored 'General case' 0 N--CA 1.448 -0.541 0 C-N-CA 125.538 1.535 . . . . 0.0 110.954 179.774 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 57.2 mt -72.84 -36.9 67.57 Favored 'General case' 0 N--CA 1.464 0.228 0 C-N-CA 124.019 0.927 . . . . 0.0 109.76 -175.703 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -81.21 0.74 87.08 Favored Glycine 0 CA--C 1.525 0.68 0 C-N-CA 124.812 1.196 . . . . 0.0 113.2 179.907 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -54.96 135.71 48.29 Favored 'General case' 0 C--O 1.236 0.372 0 CA-C-N 119.186 1.493 . . . . 0.0 109.395 179.172 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 72.49 5.81 64.44 Favored Glycine 0 CA--C 1.534 1.248 0 CA-C-O 118.332 -1.26 . . . . 0.0 114.597 178.393 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 9.2 ptpp? -137.81 -44.33 0.53 Allowed 'General case' 0 N--CA 1.475 0.777 0 CA-C-N 119.731 1.765 . . . . 0.0 112.937 -178.595 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 24.0 pt -138.49 152.81 25.44 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.794 0 CA-C-N 119.978 1.263 . . . . 0.0 110.138 -173.082 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -118.47 106.32 12.57 Favored 'General case' 0 C--O 1.227 -0.105 0 C-N-CA 124.62 1.168 . . . . 0.0 110.009 -169.738 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 4.6 t -79.62 134.4 27.74 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.399 0 N-CA-C 109.178 -0.675 . . . . 0.0 109.178 177.833 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 22.2 m -140.62 87.4 2.12 Favored 'General case' 0 N--CA 1.449 -0.5 0 N-CA-C 105.493 -2.04 . . . . 0.0 105.493 169.663 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 38.6 m -95.0 82.91 3.86 Favored 'General case' 0 N--CA 1.448 -0.557 0 CA-C-O 121.917 0.865 . . . . 0.0 111.223 -169.809 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -64.26 172.0 2.74 Favored 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 125.715 1.606 . . . . 0.0 110.3 169.874 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -157.75 -167.86 19.33 Favored Glycine 0 C--N 1.338 0.664 0 N-CA-C 108.575 -1.81 . . . . 0.0 108.575 -173.297 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 3.0 mt -136.96 131.27 32.75 Favored 'General case' 0 N--CA 1.44 -0.932 0 N-CA-C 104.468 -2.419 . . . . 0.0 104.468 -172.272 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 28.7 mt-10 65.47 -61.55 0.24 Allowed 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 126.754 2.022 . . . . 0.0 111.041 -169.714 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 75.4 m 65.31 158.63 0.1 Allowed 'General case' 0 N--CA 1.438 -1.026 0 C-N-CA 129.313 3.045 . . . . 0.0 115.917 171.133 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 49.7 p -161.9 170.94 18.53 Favored 'General case' 0 N--CA 1.431 -1.375 0 CA-C-N 111.039 -2.801 . . . . 0.0 106.932 -168.838 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 5.7 ttt180 -92.28 167.05 12.28 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.657 0.742 . . . . 0.0 109.31 175.721 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 18.8 m -73.07 171.88 1.13 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.622 0 CA-C-N 114.711 -1.131 . . . . 0.0 109.853 178.647 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 92.2 m-70 -82.99 150.28 61.2 Favored Pre-proline 0 CA--C 1.539 0.526 0 C-N-CA 123.416 0.687 . . . . 0.0 110.479 -176.889 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -62.7 -45.63 13.32 Favored 'Trans proline' 0 C--N 1.347 0.496 0 C-N-CA 122.982 2.455 . . . . 0.0 112.383 -172.675 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 6.1 m -68.49 -25.94 65.22 Favored 'General case' 0 CA--C 1.534 0.33 0 O-C-N 121.881 -0.512 . . . . 0.0 110.22 -179.146 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -58.51 -52.8 64.12 Favored 'General case' 0 CA--C 1.507 -0.691 0 N-CA-C 108.766 -0.827 . . . . 0.0 108.766 171.356 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 81.5 mt -59.27 -41.09 82.96 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.342 0 N-CA-C 108.471 -0.937 . . . . 0.0 108.471 -173.176 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -63.1 -49.75 73.21 Favored 'General case' 0 CA--C 1.534 0.363 0 CA-C-N 118.503 0.592 . . . . 0.0 111.331 179.718 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 29.4 mmt -65.89 -36.63 83.96 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-O 122.933 1.349 . . . . 0.0 111.106 -179.698 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -78.45 -30.44 47.46 Favored 'General case' 0 N--CA 1.439 -0.993 0 N-CA-C 106.803 -1.554 . . . . 0.0 106.803 -172.754 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 4.8 mm-40 -73.75 -20.51 60.48 Favored 'General case' 0 N--CA 1.445 -0.712 0 O-C-N 121.355 -0.841 . . . . 0.0 110.642 169.749 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 18.0 mm-40 -66.83 -30.67 70.91 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-N 119.713 1.142 . . . . 0.0 110.038 170.0 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 15.4 m -91.92 10.56 3.25 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.814 0 CA-C-N 118.703 0.683 . . . . 0.0 111.427 168.635 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 76.66 22.87 71.39 Favored Glycine 0 CA--C 1.531 1.059 0 C-N-CA 124.962 1.267 . . . . 0.0 113.554 172.24 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 8.1 mt -111.7 129.64 66.73 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.222 0 CA-C-N 118.485 1.142 . . . . 0.0 111.033 -173.659 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -86.31 126.09 34.08 Favored 'General case' 0 C--O 1.232 0.177 0 N-CA-C 107.371 -1.344 . . . . 0.0 107.371 168.822 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 6.5 pt -122.48 -22.22 3.17 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.645 0 C-N-CA 125.219 1.408 . . . . 0.0 109.894 169.659 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -36.86 -41.04 0.31 Allowed 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 129.367 3.067 . . . . 0.0 113.633 169.376 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -82.05 14.0 35.14 Favored Glycine 0 CA--C 1.532 1.119 0 C-N-CA 124.943 1.258 . . . . 0.0 114.801 -176.551 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -63.71 -30.18 71.31 Favored 'General case' 0 C--N 1.343 0.309 0 CA-C-N 119.667 1.733 . . . . 0.0 114.099 -170.533 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -61.91 122.88 16.55 Favored 'General case' 0 CA--C 1.535 0.379 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 -169.797 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 67.3 m -145.91 -175.28 4.68 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 125.92 1.688 . . . . 0.0 107.864 -169.261 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -57.3 155.22 19.0 Favored Pre-proline 0 CA--C 1.539 0.543 0 C-N-CA 124.162 0.985 . . . . 0.0 111.572 173.131 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -65.42 155.81 66.76 Favored 'Trans proline' 0 N--CA 1.456 -0.703 0 C-N-CA 122.529 2.152 . . . . 0.0 110.095 171.053 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 7.8 tt -58.97 -28.24 37.97 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.486 0 C-N-CA 124.02 0.928 . . . . 0.0 110.979 -178.713 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 14.5 mt-10 -68.08 -25.55 65.39 Favored 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 125.329 1.452 . . . . 0.0 110.399 -173.883 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 7.4 t-20 -62.04 -22.81 66.04 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 124.926 1.29 . . . . 0.0 111.969 177.149 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 88.7 m-85 -109.0 -176.71 3.11 Favored 'General case' 0 C--O 1.235 0.33 0 C-N-CA 125.697 1.599 . . . . 0.0 111.528 -172.109 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 55.2 t-20 -130.07 137.79 50.39 Favored 'General case' 0 N--CA 1.442 -0.866 0 N-CA-C 106.183 -1.784 . . . . 0.0 106.183 169.315 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -73.35 -24.5 60.35 Favored 'General case' 0 N--CA 1.432 -1.35 0 CA-C-N 118.539 0.609 . . . . 0.0 109.734 -178.826 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 35.8 t70 -63.94 -22.4 66.9 Favored 'General case' 0 N--CA 1.446 -0.636 0 O-C-N 123.627 0.579 . . . . 0.0 111.333 179.327 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -73.85 -29.77 62.3 Favored 'General case' 0 N--CA 1.452 -0.332 0 C-N-CA 123.762 0.825 . . . . 0.0 111.431 175.246 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 17.8 m-85 -79.33 159.53 27.14 Favored 'General case' 0 N--CA 1.446 -0.629 0 C-N-CA 124.518 1.127 . . . . 0.0 110.302 177.681 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 23.6 t70 -99.53 -38.61 8.7 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.241 171.218 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -139.26 137.6 41.21 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.359 0 C-N-CA 123.857 0.863 . . . . 0.0 109.634 -170.551 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 89.7 t -143.1 142.46 25.82 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.745 0 N-CA-C 106.435 -1.691 . . . . 0.0 106.435 -178.574 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.526 HD12 ' HB2' ' A' ' 97' ' ' GLU . 28.9 mm -137.09 132.7 47.06 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.568 0 N-CA-C 107.133 -1.432 . . . . 0.0 107.133 -171.32 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 57.8 m -95.92 166.36 11.82 Favored 'General case' 0 N--CA 1.445 -0.716 0 N-CA-C 108.146 -1.057 . . . . 0.0 108.146 168.691 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 53.6 mt -134.61 18.57 3.59 Favored 'General case' 0 CA--C 1.531 0.239 0 O-C-N 121.364 -0.835 . . . . 0.0 110.752 -178.638 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 25.1 p -168.86 -0.22 0.02 OUTLIER 'General case' 0 CA--C 1.543 0.674 0 N-CA-C 115.584 1.698 . . . . 0.0 115.584 -176.357 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 162.6 -175.12 39.04 Favored Glycine 0 CA--C 1.526 0.769 0 CA-C-N 120.89 1.677 . . . . 0.0 112.607 179.83 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 17.9 m -128.65 127.01 41.35 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 125.065 1.346 . . . . 0.0 107.888 -176.243 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 83' ' ' GLY . . . . . 0.409 ' H ' HG11 ' A' ' 91' ' ' VAL . . . 58.06 34.26 72.19 Favored Glycine 0 CA--C 1.533 1.2 0 N-CA-C 110.624 -0.99 . . . . 0.0 110.624 -170.414 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . 0.286 7.7 p -80.3 69.17 0.5 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.657 0 C-N-CA 125.332 1.453 . . . . 0.0 110.437 -169.263 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 56.2 t30 55.67 49.22 16.83 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 127.146 2.178 . . . . 0.0 109.103 -173.553 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -154.27 143.98 15.34 Favored Pre-proline 0 CA--C 1.541 0.611 0 C-N-CA 126.918 2.087 . . . . 0.0 106.596 -169.237 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_exo -69.56 145.86 59.64 Favored 'Trans proline' 0 C--N 1.352 0.737 0 CA-C-N 120.912 1.361 . . . . 0.0 113.059 -173.246 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -73.18 -22.52 19.04 Favored 'Trans proline' 0 N--CA 1.461 -0.391 0 C-N-CA 122.209 1.939 . . . . 0.0 113.795 -170.754 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -57.85 -23.48 53.02 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-N 120.072 1.305 . . . . 0.0 111.627 177.378 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 99.6 m95 -72.05 -43.48 64.87 Favored 'General case' 0 N--CA 1.449 -0.478 0 C-N-CA 123.493 0.717 . . . . 0.0 111.252 176.235 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.409 HG11 ' H ' ' A' ' 83' ' ' GLY . 4.9 m -78.1 -1.33 3.95 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.627 0 N-CA-C 112.582 0.586 . . . . 0.0 112.582 -179.094 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 63.3 p -115.9 22.33 13.11 Favored 'General case' 0 CA--C 1.538 0.514 0 N-CA-C 115.462 1.652 . . . . 0.0 115.462 -178.412 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 92.3 mm-40 -71.03 179.46 2.75 Favored 'General case' 0 CA--C 1.54 0.573 0 O-C-N 121.27 -0.894 . . . . 0.0 111.875 175.015 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 30.1 mm-40 -54.84 -28.47 49.99 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 124.146 0.978 . . . . 0.0 112.733 -169.085 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 6.8 tt -135.12 139.66 46.66 Favored 'Isoleucine or valine' 0 C--O 1.238 0.497 0 N-CA-C 104.569 -2.382 . . . . 0.0 104.569 168.477 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 47.6 t80 -126.57 140.43 52.44 Favored 'General case' 0 N--CA 1.447 -0.608 0 N-CA-C 106.383 -1.71 . . . . 0.0 106.383 169.567 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 97' ' ' GLU . . . . . 0.526 ' HB2' HD12 ' A' ' 77' ' ' ILE . 44.0 mm-40 -142.08 163.86 31.73 Favored 'General case' 0 C--O 1.235 0.336 0 N-CA-C 107.409 -1.33 . . . . 0.0 107.409 169.88 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -167.51 131.63 1.82 Allowed 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 125.443 1.497 . . . . 0.0 107.46 -173.65 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 4.3 m-90 -150.65 143.44 24.58 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 107.897 -1.149 . . . . 0.0 107.897 -169.598 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 24.8 tt0 -84.81 82.28 8.51 Favored 'General case' 0 CA--C 1.537 0.48 0 N-CA-C 107.689 -1.226 . . . . 0.0 107.689 173.44 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -69.34 140.98 54.34 Favored 'General case' 0 N--CA 1.464 0.234 0 N-CA-C 108.667 -0.864 . . . . 0.0 108.667 172.719 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -73.68 157.2 37.0 Favored 'General case' 0 CA--C 1.537 0.449 0 N-CA-C 107.036 -1.468 . . . . 0.0 107.036 168.683 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -129.45 130.68 23.31 Favored Pre-proline 0 C--O 1.236 0.386 0 C-N-CA 123.77 0.828 . . . . 0.0 109.095 176.886 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_endo -86.14 -8.39 7.73 Favored 'Trans proline' 0 CA--C 1.54 0.821 0 C-N-CA 123.17 2.58 . . . . 0.0 115.245 -169.992 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -50.03 -51.04 45.38 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-N 120.171 1.351 . . . . 0.0 113.723 -169.093 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -84.21 9.26 64.39 Favored Glycine 0 CA--C 1.531 1.038 0 CA-C-O 118.368 -1.24 . . . . 0.0 113.953 -172.725 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 25.9 pt20 -148.04 -164.19 1.95 Allowed 'General case' 0 CA--C 1.544 0.712 0 CA-C-N 119.385 1.592 . . . . 0.0 112.531 -169.585 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 1.5 m -69.01 159.09 33.48 Favored 'General case' 0 CA--C 1.535 0.372 0 N-CA-C 117.567 2.432 . . . . 0.0 117.567 -167.726 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 56.5 tp -54.44 -34.69 61.91 Favored 'General case' 0 N--CA 1.465 0.32 0 C-N-CA 126.94 2.096 . . . . 0.0 111.713 170.124 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -62.12 -32.34 72.91 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 122.819 0.448 . . . . 0.0 110.773 177.498 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 5.3 t -76.42 -37.74 31.29 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.362 0 CA-C-O 117.894 -1.051 . . . . 0.0 109.892 177.649 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 54.0 m-85 -57.01 -47.97 79.59 Favored 'General case' 0 N--CA 1.474 0.767 0 CA-C-N 120.728 1.604 . . . . 0.0 109.579 171.155 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 75.3 mtt180 -59.23 -43.96 92.33 Favored 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 123.333 0.653 . . . . 0.0 110.858 178.152 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 17.1 m -64.44 -48.89 73.62 Favored 'General case' 0 N--CA 1.446 -0.663 0 C-N-CA 124.192 0.997 . . . . 0.0 110.396 178.606 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 64.9 t -70.39 -29.9 40.84 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.301 0 CA-C-N 119.019 0.827 . . . . 0.0 109.945 -169.937 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 30.7 mtm105 -57.04 -47.91 79.8 Favored 'General case' 0 C--O 1.226 -0.181 0 CA-C-N 119.404 1.002 . . . . 0.0 109.583 169.859 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -62.06 -48.52 82.63 Favored Glycine 0 CA--C 1.529 0.961 0 CA-C-O 119.258 -0.745 . . . . 0.0 112.0 177.697 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 86.1 mt-30 -55.66 -52.93 62.17 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-O 122.017 0.913 . . . . 0.0 110.104 -178.83 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 98.1 t -67.5 -44.9 86.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 115.102 -0.954 . . . . 0.0 109.596 -175.32 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 62.6 tttm -55.04 -46.34 75.31 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 119.435 1.016 . . . . 0.0 109.197 -179.041 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -67.64 -43.44 80.35 Favored 'General case' 0 N--CA 1.449 -0.524 0 C-N-CA 122.873 0.469 . . . . 0.0 111.366 -176.271 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 44.9 mtt-85 -66.63 -42.23 87.08 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-N 118.867 0.758 . . . . 0.0 111.082 178.047 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 81.1 t -64.99 -41.48 92.23 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.532 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 177.736 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 21.2 mt-10 -59.69 -41.36 90.52 Favored 'General case' 0 C--N 1.34 0.162 0 CA-C-N 119.768 1.167 . . . . 0.0 110.641 176.971 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 29.1 t-20 -62.54 -45.01 94.92 Favored 'General case' 0 CA--C 1.534 0.336 0 CA-C-N 118.166 0.439 . . . . 0.0 111.139 -179.635 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 1.5 tm? -58.45 -49.49 77.12 Favored 'General case' 0 CA--C 1.53 0.192 0 C-N-CA 124.26 1.024 . . . . 0.0 110.277 177.091 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 94.8 mt -63.87 -43.02 97.69 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.276 0 C-N-CA 123.887 0.875 . . . . 0.0 108.86 -179.518 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -62.56 -28.14 69.67 Favored 'General case' 0 CA--C 1.534 0.355 0 CA-C-N 118.902 0.774 . . . . 0.0 112.074 179.956 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 89.7 mttt -69.57 -54.52 13.68 Favored 'General case' 0 C--N 1.341 0.235 0 CA-C-N 118.769 0.713 . . . . 0.0 110.358 172.646 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 19.3 pt -77.64 -38.19 25.34 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.362 0 N-CA-C 114.586 1.328 . . . . 0.0 114.586 -169.395 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 74.7 m . . . . . 0 C--O 1.252 1.209 0 C-N-CA 126.162 1.785 . . . . 0.0 109.629 -169.748 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 8.0 ptm . . . . . 0 N--CA 1.497 1.898 0 N-CA-C 110.468 -0.197 . . . . 0.0 110.468 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 2' ' ' LYS . . . . . 0.455 ' HB2' HG22 ' A' ' 30' ' ' ILE . 15.7 mttm -74.64 128.46 35.62 Favored 'General case' 0 N--CA 1.478 0.971 0 N-CA-C 107.83 -1.174 . . . . 0.0 107.83 -174.912 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 72.9 mttt -97.4 138.1 35.37 Favored 'General case' 0 CA--C 1.511 -0.522 0 CA-C-N 120.198 1.363 . . . . 0.0 108.26 172.432 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.461 HG21 HD12 ' A' ' 30' ' ' ILE . 12.1 t -119.31 152.22 21.72 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.678 0 C-N-CA 126.231 1.812 . . . . 0.0 106.66 -169.995 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 15.8 mtt -135.27 146.45 48.57 Favored 'General case' 0 C--N 1.322 -0.623 0 C-N-CA 124.897 1.279 . . . . 0.0 108.167 168.792 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 86.5 m-85 -133.74 125.47 28.63 Favored 'General case' 0 CA--C 1.516 -0.361 0 N-CA-C 103.921 -2.622 . . . . 0.0 103.921 171.332 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 1.3 p -150.03 142.61 17.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 118.975 0.807 . . . . 0.0 110.382 -169.014 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 20.9 t -125.1 -174.96 3.17 Favored 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 127.379 2.272 . . . . 0.0 106.552 169.597 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 39.0 ttpt -60.45 -42.16 95.59 Favored 'General case' 0 N--CA 1.472 0.65 0 O-C-N 120.822 -1.174 . . . . 0.0 111.508 -177.33 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 94.0 mtt180 -123.79 163.92 20.22 Favored 'General case' 0 N--CA 1.467 0.423 0 C-N-CA 123.764 0.826 . . . . 0.0 109.48 176.421 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -77.01 -27.75 54.75 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 122.41 0.284 . . . . 0.0 111.28 -179.511 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 1.3 m -69.16 -23.58 63.96 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 124.133 0.973 . . . . 0.0 113.385 -169.657 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 6.8 t -128.55 136.3 50.56 Favored 'General case' 0 C--N 1.339 0.143 0 N-CA-C 108.274 -1.01 . . . . 0.0 108.274 -174.612 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 9.1 mpt_? 61.72 -42.94 0.15 Allowed 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 128.533 2.733 . . . . 0.0 114.45 -176.549 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -75.08 41.13 0.16 Allowed 'General case' 0 CA--C 1.542 0.635 0 CA-C-N 120.268 1.394 . . . . 0.0 111.463 177.286 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 20.2 pt20 -135.11 154.16 51.76 Favored 'General case' 0 N--CA 1.441 -0.892 0 C-N-CA 127.455 2.302 . . . . 0.0 104.819 169.593 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER 66.41 -33.91 0.2 Allowed 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 126.216 1.806 . . . . 0.0 114.681 -178.648 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -64.62 -49.97 68.96 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 121.514 1.961 . . . . 0.0 109.865 179.671 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 4.5 pm0 -61.53 -37.8 85.06 Favored 'General case' 0 N--CA 1.453 -0.293 0 C-N-CA 124.42 1.088 . . . . 0.0 110.74 172.445 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -60.54 -55.31 30.67 Favored Glycine 0 C--N 1.337 0.627 0 N-CA-C 109.457 -1.457 . . . . 0.0 109.457 -176.926 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 6.3 m-85 -63.65 -33.23 75.16 Favored 'General case' 0 CA--C 1.509 -0.634 0 O-C-N 122.143 -0.622 . . . . 0.0 111.887 177.417 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -67.49 -38.2 83.99 Favored 'General case' 0 N--CA 1.445 -0.706 0 C-N-CA 119.839 -0.744 . . . . 0.0 110.926 -178.08 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.06 -37.58 87.96 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-N 118.701 0.682 . . . . 0.0 110.077 173.45 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 13.0 m -66.99 -55.39 14.66 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 123.675 0.79 . . . . 0.0 112.244 179.887 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 40.1 mt -76.28 -35.68 58.78 Favored 'General case' 0 C--N 1.327 -0.376 0 C-N-CA 124.636 1.175 . . . . 0.0 110.09 -171.158 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -94.39 12.17 69.27 Favored Glycine 0 CA--C 1.525 0.666 0 C-N-CA 125.233 1.397 . . . . 0.0 112.848 -178.778 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -51.01 122.2 7.17 Favored 'General case' 0 CA--C 1.533 0.29 0 CA-C-N 119.011 1.406 . . . . 0.0 110.623 -173.813 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 78.89 -16.26 8.81 Favored Glycine 0 CA--C 1.535 1.313 0 C-N-CA 124.791 1.186 . . . . 0.0 114.21 -179.519 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 59.7 mttt -89.68 -42.5 11.32 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-N 119.398 1.599 . . . . 0.0 110.806 179.152 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.461 HD12 HG21 ' A' ' 4' ' ' VAL . 12.4 pt -140.71 149.97 20.95 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.33 0 C-N-CA 123.543 0.737 . . . . 0.0 111.263 -169.031 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -95.51 157.89 15.69 Favored 'General case' 0 C--O 1.224 -0.243 0 C-N-CA 125.6 1.56 . . . . 0.0 108.039 172.584 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 20.0 t -139.74 135.19 38.89 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 N-CA-C 107.189 -1.412 . . . . 0.0 107.189 -175.413 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 14.0 m -142.76 106.87 4.72 Favored 'General case' 0 N--CA 1.446 -0.663 0 N-CA-C 107.401 -1.333 . . . . 0.0 107.401 177.896 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 58.9 m -90.15 99.63 12.61 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 107.986 -1.116 . . . . 0.0 107.986 169.501 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 11.1 p -68.56 -63.03 1.14 Allowed 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 124.296 1.038 . . . . 0.0 110.461 -178.587 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 94.05 136.09 7.99 Favored Glycine 0 N--CA 1.446 -0.646 0 N-CA-C 107.713 -2.155 . . . . 0.0 107.713 -172.373 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 10.2 mt -68.74 -31.05 69.82 Favored 'General case' 0 CA--C 1.533 0.315 0 N-CA-C 108.538 -0.912 . . . . 0.0 108.538 170.183 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 26.6 mt-10 -137.25 156.1 48.7 Favored 'General case' 0 N--CA 1.444 -0.727 0 C-N-CA 129.119 2.968 . . . . 0.0 104.855 168.752 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 78.5 p -142.46 155.05 45.04 Favored 'General case' 0 N--CA 1.446 -0.646 0 N-CA-C 115.465 1.654 . . . . 0.0 115.465 -174.407 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 51.1 m -163.17 179.25 7.59 Favored 'General case' 0 N--CA 1.447 -0.577 0 C-N-CA 131.257 3.823 . . . . 0.0 104.796 -169.337 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 16.4 ttt180 -81.56 179.16 7.95 Favored 'General case' 0 N--CA 1.469 0.487 0 N-CA-C 108.411 -0.959 . . . . 0.0 108.411 169.486 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 4.1 m -81.16 176.4 0.68 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.575 0 C-N-CA 124.864 1.266 . . . . 0.0 109.445 176.805 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 76.1 t60 -78.59 140.97 59.91 Favored Pre-proline 0 CA--C 1.545 0.772 0 CA-C-O 118.58 -0.724 . . . . 0.0 110.104 -178.403 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 20.4 Cg_endo -60.59 -50.3 7.06 Favored 'Trans proline' 0 C--N 1.348 0.525 0 C-N-CA 123.084 2.523 . . . . 0.0 113.592 -173.787 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 23.1 m -65.91 -21.52 66.45 Favored 'General case' 0 CA--C 1.533 0.324 0 CA-C-N 118.807 0.731 . . . . 0.0 110.813 -178.29 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -58.79 -45.03 90.79 Favored 'General case' 0 C--O 1.215 -0.733 0 O-C-N 121.386 -0.821 . . . . 0.0 109.453 174.576 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 62.6 mt -60.51 -43.72 94.95 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 N-CA-C 108.303 -0.999 . . . . 0.0 108.303 -173.598 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -64.9 -44.47 89.48 Favored 'General case' 0 CA--C 1.536 0.442 0 CA-C-O 121.282 0.563 . . . . 0.0 110.857 -179.632 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 33.6 mmt -66.33 -39.3 89.14 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-O 123.455 1.598 . . . . 0.0 110.779 -179.972 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -76.21 -29.8 57.75 Favored 'General case' 0 N--CA 1.44 -0.952 0 N-CA-C 106.296 -1.742 . . . . 0.0 106.296 -174.882 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 -70.27 -20.48 63.04 Favored 'General case' 0 N--CA 1.444 -0.765 0 C-N-CA 123.91 0.884 . . . . 0.0 110.438 169.525 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 59.0 mt-10 -64.55 -38.03 89.59 Favored 'General case' 0 C--N 1.345 0.375 0 CA-C-N 120.237 1.381 . . . . 0.0 108.787 169.405 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . 0.311 5.3 p -84.92 8.21 1.65 Allowed 'Isoleucine or valine' 0 CA--C 1.548 0.87 0 N-CA-C 112.272 0.471 . . . . 0.0 112.272 171.442 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 75.05 16.68 80.45 Favored Glycine 0 CA--C 1.533 1.19 0 C-N-CA 124.493 1.044 . . . . 0.0 113.523 175.494 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 43.9 mt -108.85 137.62 39.89 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.229 0 C-N-CA 124.487 1.115 . . . . 0.0 108.921 -177.016 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 21.1 t0 -102.22 145.34 29.56 Favored 'General case' 0 N--CA 1.462 0.153 0 CA-C-O 121.103 0.478 . . . . 0.0 110.208 169.69 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 11.2 pt -138.36 -15.11 0.53 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.633 0 C-N-CA 127.548 2.339 . . . . 0.0 111.325 178.223 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 13.0 t -39.39 -43.12 1.16 Allowed 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 125.883 1.673 . . . . 0.0 113.527 171.584 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -76.37 6.13 39.35 Favored Glycine 0 CA--C 1.532 1.111 0 CA-C-O 118.635 -1.092 . . . . 0.0 114.36 -175.01 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -68.57 130.18 42.09 Favored 'General case' 0 N--CA 1.448 -0.559 0 CA-C-N 119.736 1.768 . . . . 0.0 110.203 -178.43 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 5.2 t -168.18 161.3 12.31 Favored 'General case' 0 N--CA 1.44 -0.95 0 N-CA-C 106.067 -1.827 . . . . 0.0 106.067 167.047 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 15.0 m -173.87 161.38 3.76 Favored 'General case' 0 C--N 1.322 -0.598 0 C-N-CA 127.438 2.295 . . . . 0.0 106.746 -178.396 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -65.91 161.49 53.99 Favored Pre-proline 0 CA--C 1.542 0.652 0 CA-C-N 115.184 -0.917 . . . . 0.0 108.854 169.002 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -59.39 150.6 74.08 Favored 'Trans proline' 0 N--CA 1.457 -0.627 0 C-N-CA 121.545 1.497 . . . . 0.0 109.802 172.444 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 16.8 tt -57.3 -26.34 25.67 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.278 0 C-N-CA 123.433 0.693 . . . . 0.0 112.181 -174.681 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 11.6 mt-10 -65.42 -27.71 68.72 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 123.212 0.605 . . . . 0.0 110.453 -176.637 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 10.0 t-20 -65.23 -30.04 70.89 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 125.484 1.514 . . . . 0.0 111.71 178.662 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 78.0 m-85 -88.47 176.51 7.14 Favored 'General case' 0 C--O 1.236 0.374 0 C-N-CA 125.012 1.325 . . . . 0.0 111.543 -173.962 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 51.9 t-20 -126.56 129.06 47.84 Favored 'General case' 0 N--CA 1.447 -0.621 0 N-CA-C 107.278 -1.379 . . . . 0.0 107.278 169.136 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -73.11 -21.23 60.78 Favored 'General case' 0 N--CA 1.436 -1.139 0 N-CA-C 109.936 -0.394 . . . . 0.0 109.936 -177.208 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 36.0 t70 -65.06 -25.76 67.95 Favored 'General case' 0 N--CA 1.441 -0.897 0 O-C-N 123.617 0.573 . . . . 0.0 111.583 -179.446 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -74.76 -28.37 60.73 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 122.976 0.51 . . . . 0.0 111.477 176.022 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 18.1 m-85 -84.43 163.58 19.4 Favored 'General case' 0 N--CA 1.45 -0.443 0 C-N-CA 125.784 1.634 . . . . 0.0 110.585 -179.419 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 19.8 t70 -108.01 -36.91 6.21 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.624 178.591 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -142.7 139.4 28.33 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.31 0 CA-C-O 121.657 0.741 . . . . 0.0 110.316 -170.797 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 96.9 t -141.15 140.68 32.0 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.407 0 N-CA-C 106.631 -1.618 . . . . 0.0 106.631 -175.634 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 45.3 mm -132.7 121.41 44.77 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.429 0 N-CA-C 106.619 -1.623 . . . . 0.0 106.619 -173.913 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 67.4 m -91.31 115.13 27.78 Favored 'General case' 0 N--CA 1.449 -0.5 0 N-CA-C 106.657 -1.608 . . . . 0.0 106.657 169.359 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 69.7 mt -77.04 -13.75 59.91 Favored 'General case' 0 N--CA 1.466 0.343 0 C-N-CA 124.245 1.018 . . . . 0.0 111.693 -177.536 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 65.2 m -140.87 88.64 2.2 Favored 'General case' 0 N--CA 1.452 -0.328 0 C-N-CA 125.288 1.435 . . . . 0.0 108.478 -169.724 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 63.66 -155.57 44.36 Favored Glycine 0 CA--C 1.528 0.893 0 N-CA-C 110.562 -1.015 . . . . 0.0 110.562 -175.852 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 4.7 p -150.82 148.56 28.64 Favored 'General case' 0 C--O 1.236 0.363 0 C-N-CA 124.527 1.131 . . . . 0.0 109.166 179.64 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 62.48 28.92 72.02 Favored Glycine 0 CA--C 1.532 1.153 0 CA-C-O 119.696 -0.502 . . . . 0.0 112.189 -179.495 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 12.7 m -80.06 67.59 0.44 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.587 0 C-N-CA 124.661 1.185 . . . . 0.0 110.63 -170.007 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 1.3 t30 58.0 56.06 4.89 Favored 'General case' 0 N--CA 1.468 0.432 0 C-N-CA 126.298 1.839 . . . . 0.0 108.201 -173.714 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.407 ' HA ' ' HD3' ' A' ' 87' ' ' PRO . 0.4 OUTLIER -142.67 142.26 22.44 Favored Pre-proline 0 CA--C 1.541 0.613 0 C-N-CA 126.215 1.806 . . . . 0.0 108.425 -169.086 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 87' ' ' PRO . . . . . 0.407 ' HD3' ' HA ' ' A' ' 86' ' ' LEU . 35.2 Cg_exo -67.46 146.43 74.41 Favored 'Trans proline' 0 CA--C 1.54 0.779 0 C-N-CA 121.693 1.595 . . . . 0.0 113.518 -176.95 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 88' ' ' PRO . . . . . 0.432 ' O ' HG22 ' A' ' 92' ' ' THR . 69.8 Cg_endo -72.43 -18.46 26.13 Favored 'Trans proline' 0 N--CA 1.46 -0.451 0 C-N-CA 122.535 2.157 . . . . 0.0 113.751 -171.975 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -57.07 -24.78 56.36 Favored 'General case' 0 CA--C 1.538 0.491 0 CA-C-N 119.944 1.247 . . . . 0.0 111.19 173.98 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 95.1 m95 -81.8 -31.35 31.83 Favored 'General case' 0 N--CA 1.451 -0.389 0 C-N-CA 124.088 0.955 . . . . 0.0 112.251 178.546 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 2.7 m -80.83 -6.5 9.73 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.362 0 CA-C-N 118.748 0.704 . . . . 0.0 112.245 178.022 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 92' ' ' THR . . . . . 0.432 HG22 ' O ' ' A' ' 88' ' ' PRO . 5.4 t -137.04 77.08 1.62 Allowed 'General case' 0 CA--C 1.542 0.654 0 CA-C-O 122.768 1.271 . . . . 0.0 111.655 -175.329 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 91.0 mm-40 -114.33 -171.68 1.96 Allowed 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 125.064 1.346 . . . . 0.0 108.115 168.694 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 35.1 mm-40 -58.76 -28.03 65.52 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-N 118.9 0.773 . . . . 0.0 111.194 -172.348 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 5.3 tt -141.37 143.63 27.44 Favored 'Isoleucine or valine' 0 C--O 1.24 0.567 0 N-CA-C 104.737 -2.32 . . . . 0.0 104.737 168.346 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 63.9 t80 -133.8 145.65 49.96 Favored 'General case' 0 N--CA 1.447 -0.581 0 N-CA-C 105.905 -1.887 . . . . 0.0 105.905 169.286 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 24.1 mm-40 -136.26 145.48 45.63 Favored 'General case' 0 C--O 1.237 0.434 0 N-CA-C 107.903 -1.147 . . . . 0.0 107.903 171.685 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -115.9 135.79 53.65 Favored 'General case' 0 C--O 1.238 0.451 0 N-CA-C 107.146 -1.428 . . . . 0.0 107.146 169.703 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 30.2 m95 -138.68 178.77 6.9 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 124.462 1.105 . . . . 0.0 108.796 178.963 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 30.6 tt0 -138.5 77.39 1.62 Allowed 'General case' 0 CA--C 1.532 0.285 0 N-CA-C 106.013 -1.847 . . . . 0.0 106.013 169.467 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -68.26 144.09 55.01 Favored 'General case' 0 N--CA 1.466 0.37 0 N-CA-C 108.656 -0.868 . . . . 0.0 108.656 177.877 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -81.18 166.66 20.43 Favored 'General case' 0 N--CA 1.452 -0.363 0 N-CA-C 107.576 -1.268 . . . . 0.0 107.576 169.457 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -142.32 135.23 13.92 Favored Pre-proline 0 CA--C 1.535 0.385 0 O-C-N 121.803 -0.56 . . . . 0.0 111.193 179.076 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -84.21 2.47 8.15 Favored 'Trans proline' 0 CA--C 1.545 1.042 0 C-N-CA 123.416 2.744 . . . . 0.0 114.958 -172.3 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 2.9 t70 -45.29 122.77 3.63 Favored 'General case' 0 C--O 1.238 0.484 0 CA-C-N 120.121 1.328 . . . . 0.0 111.521 176.634 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 70.9 13.73 72.54 Favored Glycine 0 CA--C 1.533 1.171 0 CA-C-O 118.335 -1.258 . . . . 0.0 114.724 170.18 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 29.6 pt20 -130.14 -172.32 2.75 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-N 119.444 1.622 . . . . 0.0 111.165 175.889 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 3.3 m -68.83 156.85 37.66 Favored 'General case' 0 CA--C 1.535 0.374 0 N-CA-C 116.25 1.944 . . . . 0.0 116.25 -168.0 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -63.73 -27.42 69.19 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 125.017 1.327 . . . . 0.0 111.155 179.645 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 7.7 tp10 -60.17 -35.12 74.63 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-N 118.171 0.442 . . . . 0.0 110.164 173.346 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 3.4 t -74.08 -42.62 52.08 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.301 0 CA-C-O 118.234 -0.889 . . . . 0.0 109.154 179.018 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 61.1 m-85 -53.78 -50.28 66.41 Favored 'General case' 0 N--CA 1.472 0.645 0 CA-C-N 120.042 1.292 . . . . 0.0 109.644 171.599 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 95.5 mtt180 -67.5 -34.97 78.21 Favored 'General case' 0 N--CA 1.465 0.296 0 O-C-N 121.795 -0.566 . . . . 0.0 111.237 -175.46 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 6.6 m -62.77 -49.9 73.15 Favored 'General case' 0 N--CA 1.448 -0.56 0 C-N-CA 123.984 0.913 . . . . 0.0 109.547 171.292 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 96.7 t -70.06 -26.72 30.38 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.296 0 CA-C-O 117.485 -1.245 . . . . 0.0 109.897 -171.092 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 85.4 mtm-85 -57.29 -48.41 78.97 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-N 120.407 1.458 . . . . 0.0 109.58 169.58 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -63.18 -48.67 77.71 Favored Glycine 0 CA--C 1.53 1.012 0 CA-C-N 118.464 0.575 . . . . 0.0 111.877 178.912 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 17.8 mt-30 -61.51 -46.69 88.94 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-N 118.073 0.937 . . . . 0.0 110.895 -178.3 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 67.4 t -64.89 -46.21 92.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-O 118.504 -0.76 . . . . 0.0 109.27 -179.585 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 87.4 tttt -54.23 -48.22 71.32 Favored 'General case' 0 C--O 1.22 -0.457 0 CA-C-N 118.921 0.782 . . . . 0.0 109.018 -178.462 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 40.4 tt0 -64.12 -42.62 96.77 Favored 'General case' 0 N--CA 1.45 -0.471 0 O-C-N 123.252 0.345 . . . . 0.0 110.865 -173.385 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 52.9 mtt-85 -67.34 -43.31 81.86 Favored 'General case' 0 N--CA 1.468 0.445 0 O-C-N 121.656 -0.653 . . . . 0.0 111.02 177.987 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 77.2 t -65.55 -41.15 90.15 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.395 0 N-CA-C 109.734 -0.469 . . . . 0.0 109.734 179.378 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 26.3 mt-10 -59.02 -44.82 91.77 Favored 'General case' 0 N--CA 1.455 -0.221 0 CA-C-N 119.17 0.895 . . . . 0.0 109.971 177.271 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 29.2 t-20 -62.06 -43.31 99.1 Favored 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 122.575 0.35 . . . . 0.0 110.933 -178.323 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 1.8 tm? -59.36 -49.04 79.34 Favored 'General case' 0 N--CA 1.455 -0.201 0 C-N-CA 124.042 0.937 . . . . 0.0 110.529 176.726 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 96.4 mt -64.91 -42.81 95.81 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.258 0 C-N-CA 124.108 0.963 . . . . 0.0 108.933 -178.844 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -61.5 -30.22 70.48 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 123.347 0.659 . . . . 0.0 111.639 177.951 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 91.5 mttt -69.25 -55.75 9.62 Favored 'General case' 0 C--N 1.343 0.313 0 CA-C-N 118.933 0.788 . . . . 0.0 110.229 172.862 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 20.8 pt -74.52 -41.26 49.09 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.291 0 N-CA-C 114.017 1.117 . . . . 0.0 114.017 -169.523 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 72.5 m . . . . . 0 C--O 1.253 1.268 0 C-N-CA 126.226 1.81 . . . . 0.0 108.995 -169.558 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 9.9 ptm . . . . . 0 N--CA 1.498 1.939 0 N-CA-C 110.64 -0.133 . . . . 0.0 110.64 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 33.8 mttm -74.62 119.76 19.24 Favored 'General case' 0 N--CA 1.479 0.985 0 O-C-N 121.127 -0.983 . . . . 0.0 108.397 -170.711 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 90.2 mttt -85.33 135.15 34.02 Favored 'General case' 0 CA--C 1.515 -0.403 0 N-CA-C 108.07 -1.085 . . . . 0.0 108.07 174.894 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 1.6 t -121.81 147.13 25.98 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 C-N-CA 125.529 1.532 . . . . 0.0 109.37 -168.849 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 13.3 mtt -134.66 146.39 49.47 Favored 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 125.659 1.584 . . . . 0.0 109.544 169.399 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 41.2 m-85 -135.58 113.51 11.14 Favored 'General case' 0 N--CA 1.454 -0.274 0 N-CA-C 106.339 -1.726 . . . . 0.0 106.339 169.41 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 3.2 p -157.25 146.36 10.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 N-CA-C 109.029 -0.73 . . . . 0.0 109.029 -169.963 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 25.5 t -157.73 145.75 18.87 Favored 'General case' 0 C--N 1.328 -0.326 0 N-CA-C 105.593 -2.003 . . . . 0.0 105.593 168.839 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 5.6 tmtt? 51.81 -85.58 0.01 OUTLIER 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 126.078 1.751 . . . . 0.0 112.145 178.552 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 11.8 ptp180 -142.17 -178.82 5.9 Favored 'General case' 0 C--O 1.225 -0.198 0 CA-C-N 119.589 1.086 . . . . 0.0 111.09 178.706 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 1.7 t30 -57.49 -35.26 69.98 Favored 'General case' 0 N--CA 1.467 0.412 0 C-N-CA 124.416 1.086 . . . . 0.0 111.666 -179.21 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -70.95 -23.45 62.23 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 124.456 1.102 . . . . 0.0 113.05 -175.194 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 3.8 m -70.4 -159.61 0.04 OUTLIER 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 126.272 1.829 . . . . 0.0 111.994 -169.673 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 2.8 mpp_? -51.8 -25.52 7.87 Favored 'General case' 0 N--CA 1.481 1.112 0 O-C-N 119.808 -1.808 . . . . 0.0 112.34 175.638 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 1.4 m -41.89 -29.44 0.21 Allowed 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 126.74 2.016 . . . . 0.0 112.856 169.622 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 5.1 pt20 -54.47 -35.87 63.52 Favored 'General case' 0 C--O 1.22 -0.497 0 CA-C-O 117.491 -1.242 . . . . 0.0 113.218 178.328 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -105.66 -51.64 2.96 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-N 120.678 1.581 . . . . 0.0 114.727 -168.592 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -63.72 -34.8 78.68 Favored 'General case' 0 N--CA 1.471 0.61 0 N-CA-C 114.248 1.203 . . . . 0.0 114.248 -168.456 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 2.4 pp20? -64.95 -34.13 77.69 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-N 119.003 0.82 . . . . 0.0 110.103 172.783 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -51.29 -62.79 5.14 Favored Glycine 0 C--N 1.338 0.652 0 C-N-CA 125.847 1.689 . . . . 0.0 110.419 174.287 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 9.2 m-85 -63.13 -33.31 75.18 Favored 'General case' 0 CA--C 1.507 -0.7 0 CA-C-N 118.684 1.242 . . . . 0.0 113.434 179.985 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -67.42 -30.47 70.23 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 119.592 1.087 . . . . 0.0 111.376 -173.644 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 1.1 ptmt -70.32 -20.92 62.97 Favored 'General case' 0 CA--C 1.539 0.522 0 CA-C-N 119.288 0.949 . . . . 0.0 111.784 174.366 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 2.9 m -85.37 -57.39 3.09 Favored 'General case' 0 N--CA 1.45 -0.475 0 C-N-CA 125.537 1.535 . . . . 0.0 110.633 176.931 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 75.3 mt -73.98 -36.76 64.59 Favored 'General case' 0 N--CA 1.463 0.224 0 C-N-CA 123.989 0.915 . . . . 0.0 110.297 -172.617 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -93.36 8.9 74.95 Favored Glycine 0 CA--C 1.525 0.662 0 CA-C-O 118.486 -1.174 . . . . 0.0 112.813 -177.202 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -51.33 123.69 10.2 Favored 'General case' 0 CA--C 1.534 0.327 0 C-N-CA 124.806 1.242 . . . . 0.0 110.507 -174.962 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 76.48 -9.81 19.9 Favored Glycine 0 CA--C 1.533 1.17 0 CA-C-O 118.721 -1.044 . . . . 0.0 114.274 179.906 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 85.4 mttt -97.19 -49.66 4.88 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-N 119.478 1.639 . . . . 0.0 110.518 178.666 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 39.8 pt -137.57 147.64 26.29 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.537 0 C-N-CA 124.056 0.942 . . . . 0.0 108.772 -169.881 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -107.47 102.6 11.86 Favored 'General case' 0 C--O 1.225 -0.193 0 C-N-CA 124.949 1.3 . . . . 0.0 110.065 -169.582 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 6.2 t -85.69 125.19 40.55 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 N-CA-C 108.619 -0.882 . . . . 0.0 108.619 -179.531 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 23.4 m -151.85 97.71 2.38 Favored 'General case' 0 N--CA 1.453 -0.321 0 N-CA-C 103.957 -2.608 . . . . 0.0 103.957 173.105 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 18.0 m -94.99 1.12 55.16 Favored 'General case' 0 CA--C 1.535 0.386 0 N-CA-C 115.019 1.489 . . . . 0.0 115.019 -169.153 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 1.5 m 52.88 -147.52 0.47 Allowed 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 123.747 0.819 . . . . 0.0 110.767 -179.663 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -164.27 167.15 38.08 Favored Glycine 0 CA--C 1.525 0.69 0 N-CA-C 109.7 -1.36 . . . . 0.0 109.7 169.973 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 3.2 mt -133.64 143.72 48.77 Favored 'General case' 0 N--CA 1.446 -0.657 0 C-N-CA 127.67 2.388 . . . . 0.0 104.952 170.02 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 50.7 mt-10 65.46 -59.78 0.27 Allowed 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 127.227 2.211 . . . . 0.0 111.293 -173.755 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 65.1 m 67.11 152.78 0.08 Allowed 'General case' 0 N--CA 1.44 -0.935 0 C-N-CA 129.463 3.105 . . . . 0.0 115.894 170.043 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 15.2 m -177.62 -173.75 0.43 Allowed 'General case' 0 CA--C 1.545 0.764 1 C-N-CA 132.107 4.163 . . . . 0.0 102.607 -169.457 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 7.5 ttt180 -105.53 169.02 8.71 Favored 'General case' 0 N--CA 1.469 0.515 0 O-C-N 120.584 -1.323 . . . . 0.0 108.663 169.678 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 11.4 m -69.68 165.62 2.47 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.71 0 CA-C-N 115.649 -0.705 . . . . 0.0 109.415 175.827 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 90.3 m-70 -79.12 151.62 75.91 Favored Pre-proline 0 CA--C 1.537 0.446 0 CA-C-O 119.314 -0.374 . . . . 0.0 111.511 -174.89 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 39.9 Cg_endo -62.21 -46.12 13.57 Favored 'Trans proline' 0 C--N 1.346 0.43 0 C-N-CA 123.175 2.583 . . . . 0.0 111.772 -174.583 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 4.4 m -66.93 -28.24 68.13 Favored 'General case' 0 CA--C 1.531 0.25 0 O-C-N 121.949 -0.47 . . . . 0.0 110.02 -179.953 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -57.62 -54.56 45.52 Favored 'General case' 0 CA--C 1.511 -0.545 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 173.03 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 63.4 mt -59.55 -40.05 80.96 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.357 0 N-CA-C 108.607 -0.886 . . . . 0.0 108.607 -174.987 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -61.65 -43.49 98.75 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-N 119.004 0.82 . . . . 0.0 111.633 179.8 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 38.0 mmt -75.48 -36.52 60.62 Favored 'General case' 0 C--O 1.235 0.315 0 CA-C-O 122.806 1.289 . . . . 0.0 110.488 -177.285 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -71.58 -28.89 64.13 Favored 'General case' 0 N--CA 1.446 -0.643 0 N-CA-C 107.509 -1.293 . . . . 0.0 107.509 178.604 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 41.2 tt0 -73.78 -19.18 60.84 Favored 'General case' 0 N--CA 1.446 -0.63 0 C-N-CA 125.069 1.347 . . . . 0.0 110.563 169.958 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 76.1 mt-10 -64.09 -34.71 78.65 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-N 120.234 1.379 . . . . 0.0 108.681 169.146 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . 0.302 10.0 p -89.8 10.11 2.57 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.931 0 N-CA-C 112.434 0.531 . . . . 0.0 112.434 169.582 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 71.89 15.77 76.22 Favored Glycine 0 CA--C 1.533 1.162 0 O-C-N 120.761 -1.212 . . . . 0.0 113.767 175.926 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 22.3 mt -96.07 142.46 13.79 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.288 0 CA-C-N 118.42 1.11 . . . . 0.0 110.462 -175.473 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 8.9 t70 -91.78 129.66 37.7 Favored 'General case' 0 C--O 1.236 0.392 0 N-CA-C 108.192 -1.04 . . . . 0.0 108.192 169.574 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 10.1 pt -124.91 -27.21 1.52 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.657 0 C-N-CA 124.567 1.147 . . . . 0.0 110.166 169.7 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -37.12 -40.92 0.34 Allowed 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 129.746 3.218 . . . . 0.0 113.909 169.11 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -83.2 13.04 47.52 Favored Glycine 0 CA--C 1.534 1.251 0 C-N-CA 125.443 1.497 . . . . 0.0 114.566 -177.47 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 1.2 mt-30 -60.98 -34.84 75.41 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 119.607 1.703 . . . . 0.0 113.026 -176.026 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -70.3 131.89 44.86 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 123.539 0.736 . . . . 0.0 109.142 -170.677 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 26.0 m -158.29 -61.17 0.08 Allowed 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 123.463 0.705 . . . . 0.0 110.568 -179.526 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -150.98 153.31 32.93 Favored Pre-proline 0 N--CA 1.467 0.422 0 C-N-CA 123.424 0.69 . . . . 0.0 109.815 -175.007 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 96.4 Cg_endo -66.94 155.59 70.11 Favored 'Trans proline' 0 N--CA 1.454 -0.819 0 C-N-CA 122.53 2.153 . . . . 0.0 110.008 171.588 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 7.1 tt -59.94 -26.0 34.42 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.513 0 C-N-CA 123.326 0.65 . . . . 0.0 111.324 -179.242 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 14.8 mt-10 -67.71 -25.25 65.57 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 124.867 1.267 . . . . 0.0 110.636 -175.096 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 7.0 t-20 -63.89 -22.72 67.05 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 124.69 1.196 . . . . 0.0 112.047 177.648 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 70.0 m-85 -105.75 -174.1 2.46 Favored 'General case' 0 C--O 1.234 0.269 0 C-N-CA 126.424 1.889 . . . . 0.0 109.923 -175.89 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 54.3 t-20 -137.69 140.86 41.02 Favored 'General case' 0 N--CA 1.446 -0.654 0 N-CA-C 107.667 -1.235 . . . . 0.0 107.667 169.407 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -74.07 -25.13 59.65 Favored 'General case' 0 N--CA 1.435 -1.181 0 N-CA-C 109.19 -0.67 . . . . 0.0 109.19 -178.559 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -63.01 -24.35 67.88 Favored 'General case' 0 N--CA 1.447 -0.584 0 O-C-N 123.441 0.463 . . . . 0.0 111.643 178.937 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -77.71 -27.69 50.72 Favored 'General case' 0 C--O 1.236 0.361 0 C-N-CA 123.808 0.843 . . . . 0.0 112.37 175.991 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 11.6 m-85 -81.02 172.21 14.02 Favored 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 125.853 1.661 . . . . 0.0 112.099 -177.47 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 24.1 t70 -120.98 -37.72 2.93 Favored 'General case' 0 N--CA 1.464 0.234 0 C-N-CA 123.68 0.792 . . . . 0.0 111.678 175.824 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -139.38 136.76 41.05 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.328 0 CA-C-N 118.432 0.56 . . . . 0.0 110.498 -170.144 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 77.2 t -147.5 128.81 5.96 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.537 0 N-CA-C 106.516 -1.661 . . . . 0.0 106.516 -176.062 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.597 HD12 ' HB2' ' A' ' 97' ' ' GLU . 12.0 mm -109.17 128.09 65.36 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.473 0 N-CA-C 106.862 -1.533 . . . . 0.0 106.862 177.732 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 60.5 m -94.71 101.24 13.08 Favored 'General case' 0 N--CA 1.446 -0.671 0 N-CA-C 104.508 -2.404 . . . . 0.0 104.508 169.292 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 30.0 mt -66.73 -4.94 10.15 Favored 'General case' 0 N--CA 1.471 0.576 0 N-CA-C 113.931 1.085 . . . . 0.0 113.931 -169.775 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -151.04 151.82 32.58 Favored 'General case' 0 N--CA 1.45 -0.46 0 N-CA-C 106.335 -1.728 . . . . 0.0 106.335 168.744 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 54.75 -140.77 37.28 Favored Glycine 0 CA--C 1.533 1.166 0 C-N-CA 123.851 0.738 . . . . 0.0 111.701 174.647 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 16.0 m -132.71 -76.65 0.49 Allowed 'General case' 0 CA--C 1.529 0.163 0 N-CA-C 108.603 -0.888 . . . . 0.0 108.603 175.783 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -78.34 -40.45 19.55 Favored Glycine 0 C--N 1.34 0.793 0 CA-C-O 118.85 -0.972 . . . . 0.0 112.05 -179.156 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . 0.351 16.2 m 47.48 -94.27 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.547 0.838 0 C-N-CA 125.56 1.544 . . . . 0.0 112.629 -178.757 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 58.7 t30 -141.82 45.07 1.7 Allowed 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 124.653 1.181 . . . . 0.0 109.365 171.557 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 1.2 tt -136.25 140.58 33.24 Favored Pre-proline 0 CA--C 1.547 0.837 0 C-N-CA 126.591 1.956 . . . . 0.0 109.384 -169.517 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -67.96 149.98 77.79 Favored 'Trans proline' 0 CA--C 1.541 0.873 0 C-N-CA 121.649 1.566 . . . . 0.0 113.668 -172.173 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -69.37 -27.66 28.07 Favored 'Trans proline' 0 N--CA 1.461 -0.423 0 C-N-CA 122.622 2.214 . . . . 0.0 115.502 -169.587 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 4.3 pm0 -61.91 -17.05 55.34 Favored 'General case' 0 CA--C 1.539 0.557 0 CA-C-N 121.432 1.924 . . . . 0.0 111.954 178.684 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 99.6 m95 -78.01 -42.04 33.86 Favored 'General case' 0 N--CA 1.447 -0.583 0 C-N-CA 123.8 0.84 . . . . 0.0 110.933 175.424 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 1.6 m -74.49 -7.72 10.46 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.26 0 C-N-CA 123.469 0.708 . . . . 0.0 111.97 -179.317 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 74.4 p -109.15 18.47 20.53 Favored 'General case' 0 C--O 1.238 0.49 0 N-CA-C 113.837 1.051 . . . . 0.0 113.837 -178.132 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 91.9 mm-40 -68.56 171.03 8.11 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-N 118.539 0.609 . . . . 0.0 111.644 176.912 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 32.8 mm-40 -56.03 -30.23 61.57 Favored 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 123.995 0.918 . . . . 0.0 112.929 -168.83 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 4.0 tt -130.54 114.73 29.04 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.345 0 N-CA-C 105.018 -2.216 . . . . 0.0 105.018 169.014 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 22.5 t80 -100.65 134.41 43.66 Favored 'General case' 0 C--O 1.236 0.392 0 N-CA-C 105.63 -1.989 . . . . 0.0 105.63 169.388 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 97' ' ' GLU . . . . . 0.597 ' HB2' HD12 ' A' ' 77' ' ' ILE . 11.4 mm-40 -142.69 164.21 30.71 Favored 'General case' 0 C--N 1.329 -0.289 0 C-N-CA 124.451 1.1 . . . . 0.0 109.18 179.247 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 2.3 t70 -170.02 129.87 0.95 Allowed 'General case' 0 C--O 1.237 0.445 0 C-N-CA 128.192 2.597 . . . . 0.0 106.618 -169.954 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 99' ' ' TRP . . . . . 0.465 ' CZ3' HG21 ' A' ' 77' ' ' ILE . 10.0 m0 -140.8 147.91 39.79 Favored 'General case' 0 C--O 1.234 0.242 0 C-N-CA 123.33 0.652 . . . . 0.0 111.836 -169.814 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 18.4 mp0 -74.06 111.64 9.42 Favored 'General case' 0 C--O 1.234 0.285 0 N-CA-C 105.294 -2.114 . . . . 0.0 105.294 169.345 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.464 HD13 HG22 ' A' ' 119' ' ' VAL . 44.3 mt -146.03 128.34 15.83 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 104.323 -2.473 . . . . 0.0 104.323 178.604 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 61.4 mm-40 -76.99 156.07 32.16 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-N 119.197 0.908 . . . . 0.0 110.044 179.417 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 55.6 t0 -100.39 111.37 62.48 Favored Pre-proline 0 N--CA 1.448 -0.567 0 N-CA-C 105.612 -1.996 . . . . 0.0 105.612 168.882 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 96.3 Cg_endo -73.75 -0.08 8.92 Favored 'Trans proline' 0 CA--C 1.541 0.843 0 C-N-CA 122.913 2.408 . . . . 0.0 113.643 -175.834 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -47.61 128.96 13.37 Favored 'General case' 0 C--O 1.237 0.445 0 CA-C-N 119.468 1.031 . . . . 0.0 111.268 173.748 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 70.99 12.17 71.04 Favored Glycine 0 CA--C 1.53 1.017 0 CA-C-O 118.523 -1.154 . . . . 0.0 114.236 169.953 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 29.5 pt20 -133.15 -172.83 3.04 Favored 'General case' 0 CA--C 1.536 0.414 0 CA-C-N 119.029 1.415 . . . . 0.0 110.763 176.282 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 3.2 m -68.59 156.55 37.88 Favored 'General case' 0 CA--C 1.532 0.256 0 N-CA-C 116.161 1.912 . . . . 0.0 116.161 -167.964 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 48.7 mt -60.47 -28.49 68.38 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 125.05 1.34 . . . . 0.0 111.146 174.758 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 40.1 tt0 -58.19 -37.22 74.32 Favored 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 122.919 0.487 . . . . 0.0 110.34 173.168 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 3.5 t -75.12 -43.95 44.09 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.31 0 CA-C-O 117.866 -1.064 . . . . 0.0 109.34 179.195 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 59.9 m-85 -53.67 -47.45 70.38 Favored 'General case' 0 N--CA 1.474 0.759 0 CA-C-N 120.399 1.454 . . . . 0.0 110.404 172.873 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 92.5 mtt180 -72.88 -35.17 67.1 Favored 'General case' 0 N--CA 1.466 0.344 0 O-C-N 121.612 -0.68 . . . . 0.0 111.428 -175.785 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 4.0 m -60.77 -49.67 76.56 Favored 'General case' 0 N--CA 1.448 -0.551 0 N-CA-C 109.003 -0.74 . . . . 0.0 109.003 171.103 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 75.0 t -65.02 -38.4 82.68 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.415 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 -176.647 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 52.5 ttp85 -57.37 -44.88 84.79 Favored 'General case' 0 CA--C 1.539 0.528 0 CA-C-N 118.734 0.697 . . . . 0.0 110.234 176.244 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -65.65 -50.02 56.61 Favored Glycine 0 CA--C 1.532 1.146 0 CA-C-N 118.609 0.641 . . . . 0.0 112.143 174.915 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 40.8 mm-40 -58.69 -48.78 79.94 Favored 'General case' 0 N--CA 1.464 0.252 0 C-N-CA 123.776 0.83 . . . . 0.0 110.454 -176.215 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 119' ' ' VAL . . . . . 0.464 HG22 HD13 ' A' ' 101' ' ' LEU . 87.7 t -66.27 -40.31 86.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-O 118.234 -0.889 . . . . 0.0 110.236 -175.724 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 57.2 tttm -54.28 -45.12 72.39 Favored 'General case' 0 N--CA 1.462 0.139 0 CA-C-N 119.374 0.988 . . . . 0.0 109.075 177.669 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -67.71 -43.03 81.02 Favored 'General case' 0 CA--C 1.54 0.595 0 CA-C-O 119.154 -0.451 . . . . 0.0 111.658 -177.631 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 29.0 mmt180 -58.53 -47.4 84.3 Favored 'General case' 0 N--CA 1.477 0.886 0 CA-C-N 119.31 0.959 . . . . 0.0 110.845 175.373 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 77.0 t -69.43 -37.59 75.5 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.536 0 CA-C-O 118.673 -0.679 . . . . 0.0 109.25 -176.361 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 28.4 mt-10 -59.0 -44.42 91.65 Favored 'General case' 0 C--N 1.339 0.149 0 CA-C-N 120.089 1.313 . . . . 0.0 110.047 173.315 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 29.1 t-20 -62.41 -44.32 96.72 Favored 'General case' 0 CA--C 1.53 0.174 0 C-N-CA 122.661 0.384 . . . . 0.0 110.918 -179.431 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 39.1 tp -57.91 -48.44 79.89 Favored 'General case' 0 N--CA 1.454 -0.25 0 C-N-CA 124.166 0.986 . . . . 0.0 110.944 176.76 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 62.4 mt -65.47 -45.15 93.66 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.266 0 N-CA-C 107.705 -1.22 . . . . 0.0 107.705 -178.407 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -59.27 -29.08 67.31 Favored 'General case' 0 CA--C 1.54 0.592 0 CA-C-O 118.855 -0.593 . . . . 0.0 112.124 177.114 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 94.5 mttt -70.05 -57.29 5.15 Favored 'General case' 0 C--N 1.343 0.321 0 CA-C-N 119.09 0.859 . . . . 0.0 110.604 172.379 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 9.5 pt -80.79 -42.84 20.8 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.334 0 N-CA-C 115.659 1.726 . . . . 0.0 115.659 -168.497 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 51.0 m . . . . . 0 C--O 1.251 1.184 0 C-N-CA 124.979 1.312 . . . . 0.0 110.387 -169.861 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 11.8 ptm . . . . . 0 N--CA 1.497 1.919 0 N-CA-C 110.57 -0.159 . . . . 0.0 110.57 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 2' ' ' LYS . . . . . 0.416 ' HB2' HG22 ' A' ' 30' ' ' ILE . 25.3 mttm -75.55 120.84 21.52 Favored 'General case' 0 N--CA 1.479 1.018 0 N-CA-C 107.907 -1.145 . . . . 0.0 107.907 -171.806 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 89.8 mttt -89.38 134.85 33.9 Favored 'General case' 0 CA--C 1.515 -0.367 0 N-CA-C 108.069 -1.085 . . . . 0.0 108.069 177.548 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 1.5 t -119.69 149.59 22.3 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.619 0 C-N-CA 126.997 2.119 . . . . 0.0 108.789 -169.229 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 26.5 mtt -137.32 145.96 44.03 Favored 'General case' 0 C--N 1.325 -0.493 0 C-N-CA 124.849 1.26 . . . . 0.0 108.484 168.686 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 49.3 m-85 -138.12 132.48 32.05 Favored 'General case' 0 C--O 1.234 0.249 0 N-CA-C 105.661 -1.978 . . . . 0.0 105.661 171.132 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 2.1 p -163.13 143.86 2.62 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.189 0 CA-C-N 118.459 0.572 . . . . 0.0 111.035 -170.023 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 45.2 t -136.34 177.97 7.42 Favored 'General case' 0 CA--C 1.547 0.861 0 C-N-CA 127.758 2.423 . . . . 0.0 105.877 168.367 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 27.1 ttpp -59.58 -22.6 61.99 Favored 'General case' 0 N--CA 1.474 0.748 0 N-CA-C 113.874 1.064 . . . . 0.0 113.874 -169.804 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 84.9 mmt-85 -138.24 155.78 48.31 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-N 119.755 1.162 . . . . 0.0 107.871 169.886 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 46.6 t30 -71.09 -35.44 71.83 Favored 'General case' 0 CA--C 1.535 0.384 0 CA-C-O 121.279 0.561 . . . . 0.0 109.839 173.377 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 1.2 m -61.34 -25.26 67.02 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 125.012 1.325 . . . . 0.0 112.928 -174.993 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 14.2 m -138.37 125.28 21.17 Favored 'General case' 0 N--CA 1.455 -0.199 0 C-N-CA 123.46 0.704 . . . . 0.0 109.481 -172.73 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 14' ' ' ARG . . . . . 0.449 ' H ' ' CG ' ' A' ' 103' ' ' ASP 0.259 27.2 ttt180 59.57 31.05 20.72 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 126.878 2.071 . . . . 0.0 112.831 175.775 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 20.4 m -131.71 -122.18 0.2 Allowed 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 103.363 -2.829 . . . . 0.0 103.363 168.783 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . 0.352 17.7 pt20 54.79 -57.9 0.02 OUTLIER 'General case' 0 N--CA 1.452 -0.33 0 C-N-CA 129.507 3.123 . . . . 0.0 115.951 171.995 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 5.4 tpt -107.34 -16.79 14.3 Favored 'General case' 0 N--CA 1.45 -0.447 0 N-CA-C 116.588 2.07 . . . . 0.0 116.588 -169.659 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -65.63 -45.39 83.25 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 120.182 1.356 . . . . 0.0 109.027 174.189 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 2.8 pm0 -66.55 -37.25 84.57 Favored 'General case' 0 N--CA 1.45 -0.427 0 C-N-CA 124.818 1.247 . . . . 0.0 110.439 170.034 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -61.98 -45.35 96.31 Favored Glycine 0 C--N 1.339 0.746 0 C-N-CA 124.37 0.986 . . . . 0.0 111.997 -178.536 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 24.9 m-85 -73.82 -31.13 63.08 Favored 'General case' 0 CA--C 1.509 -0.597 0 CA-C-N 119.056 1.428 . . . . 0.0 113.717 170.981 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -65.49 -34.17 77.65 Favored 'General case' 0 C--O 1.225 -0.203 0 CA-C-N 120.531 1.514 . . . . 0.0 111.333 -172.493 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 17.1 ptpt -61.66 -27.72 68.88 Favored 'General case' 0 N--CA 1.475 0.795 0 CA-C-N 119.026 0.83 . . . . 0.0 112.392 170.945 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 2.1 m -84.27 -56.34 3.7 Favored 'General case' 0 N--CA 1.451 -0.382 0 C-N-CA 125.291 1.436 . . . . 0.0 109.817 -178.099 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 75.7 mt -72.72 -36.44 67.8 Favored 'General case' 0 CA--C 1.529 0.138 0 C-N-CA 124.068 0.947 . . . . 0.0 110.021 -173.232 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -96.7 9.26 66.32 Favored Glycine 0 CA--C 1.526 0.771 0 C-N-CA 125.159 1.361 . . . . 0.0 112.943 -175.737 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -48.83 122.88 6.16 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 124.989 1.316 . . . . 0.0 110.71 -175.41 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 77.33 -11.78 16.11 Favored Glycine 0 CA--C 1.533 1.203 0 C-N-CA 124.404 1.002 . . . . 0.0 114.589 178.953 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 63.7 mttm -96.68 -46.11 6.42 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-N 119.265 1.532 . . . . 0.0 110.571 179.908 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.416 HG22 ' HB2' ' A' ' 2' ' ' LYS . 29.6 pt -138.62 147.64 25.07 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.58 0 C-N-CA 123.547 0.739 . . . . 0.0 110.087 -169.577 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -107.77 107.82 18.76 Favored 'General case' 0 N--CA 1.467 0.389 0 C-N-CA 125.196 1.398 . . . . 0.0 109.679 -171.471 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 8.3 t -78.44 139.53 18.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 119.152 0.887 . . . . 0.0 109.117 176.385 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 4.2 m -139.79 115.78 10.32 Favored 'General case' 0 N--CA 1.436 -1.145 0 N-CA-C 105.176 -2.157 . . . . 0.0 105.176 169.899 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 4.5 m -90.34 45.3 1.25 Allowed 'General case' 0 C--N 1.32 -0.679 0 O-C-N 121.416 -0.803 . . . . 0.0 112.399 -170.831 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 2.6 m -67.15 165.35 16.16 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 124.484 1.114 . . . . 0.0 111.801 -178.577 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -177.1 -177.09 45.76 Favored Glycine 0 N--CA 1.444 -0.77 0 N-CA-C 106.081 -2.808 . . . . 0.0 106.081 -170.22 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 19.1 mt -104.76 -14.88 15.4 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 117.754 0.777 . . . . 0.0 111.152 179.047 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -144.12 155.26 43.87 Favored 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 128.227 2.611 . . . . 0.0 105.388 168.984 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 1.9 m -164.25 169.8 17.1 Favored 'General case' 0 N--CA 1.449 -0.485 0 CA-C-O 122.277 1.037 . . . . 0.0 110.994 175.379 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 62.7 p -153.14 -172.37 4.22 Favored 'General case' 0 N--CA 1.439 -1.023 0 C-N-CA 126.385 1.874 . . . . 0.0 107.304 -169.182 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 7.5 ttt180 -91.62 168.98 11.11 Favored 'General case' 0 C--N 1.331 -0.237 0 O-C-N 121.19 -0.943 . . . . 0.0 109.587 170.473 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 19.8 m -71.28 170.55 1.27 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.805 0 C-N-CA 123.543 0.737 . . . . 0.0 109.585 -178.824 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 74.1 t60 -71.44 138.71 83.8 Favored Pre-proline 0 CA--C 1.546 0.818 0 CA-C-O 118.391 -0.814 . . . . 0.0 109.274 172.989 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -59.29 -49.46 10.76 Favored 'Trans proline' 0 C--N 1.349 0.556 0 C-N-CA 123.231 2.621 . . . . 0.0 113.899 -173.654 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 22.6 m -66.13 -17.18 64.55 Favored 'General case' 0 CA--C 1.539 0.521 0 CA-C-N 118.842 0.746 . . . . 0.0 111.168 -178.471 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.472 ' HB1' HD11 ' A' ' 57' ' ' ILE . . . -60.62 -49.0 79.3 Favored 'General case' 0 C--O 1.215 -0.715 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 173.253 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 52.4 mt -58.49 -41.05 80.69 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 N-CA-C 108.288 -1.005 . . . . 0.0 108.288 -173.44 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -66.27 -50.76 62.6 Favored 'General case' 0 N--CA 1.45 -0.434 0 CA-C-N 118.229 0.468 . . . . 0.0 111.597 -179.99 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 31.9 mmt -69.15 -34.2 74.62 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-O 122.825 1.297 . . . . 0.0 111.087 -177.047 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 20.8 mmt -77.81 -28.66 50.42 Favored 'General case' 0 N--CA 1.441 -0.899 0 O-C-N 120.784 -1.197 . . . . 0.0 108.277 -177.355 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 -70.87 -23.32 62.28 Favored 'General case' 0 N--CA 1.449 -0.479 0 O-C-N 121.372 -0.83 . . . . 0.0 109.692 169.652 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 18.2 mm-40 -68.14 -30.66 69.85 Favored 'General case' 0 CA--C 1.531 0.242 0 CA-C-N 119.203 0.91 . . . . 0.0 110.443 170.984 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . 0.286 3.1 p -87.64 9.43 2.04 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.918 0 CA-C-N 118.807 0.73 . . . . 0.0 111.264 169.205 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 81.41 17.69 70.66 Favored Glycine 0 CA--C 1.531 1.057 0 C-N-CA 124.667 1.127 . . . . 0.0 113.75 172.449 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 39.5 mt -116.28 139.35 43.39 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.295 0 CA-C-N 119.107 1.453 . . . . 0.0 110.625 -176.618 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -100.73 136.16 41.04 Favored 'General case' 0 C--O 1.235 0.319 0 N-CA-C 109.236 -0.653 . . . . 0.0 109.236 169.141 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.472 HD11 ' HB1' ' A' ' 46' ' ' ALA . 15.8 pt -128.36 -13.43 3.01 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.499 0 C-N-CA 125.439 1.496 . . . . 0.0 112.414 176.172 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 93.2 p -44.38 -38.21 3.84 Favored 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 125.467 1.507 . . . . 0.0 114.552 176.143 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -87.12 2.86 87.05 Favored Glycine 0 CA--C 1.529 0.912 0 CA-C-O 118.81 -0.995 . . . . 0.0 114.091 -172.92 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 26.8 mt-30 -75.81 120.11 20.73 Favored 'General case' 0 CA--C 1.514 -0.44 0 CA-C-N 119.615 1.708 . . . . 0.0 111.28 -170.182 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 7.7 t -162.13 167.0 24.95 Favored 'General case' 0 N--CA 1.436 -1.132 0 N-CA-C 106.671 -1.603 . . . . 0.0 106.671 167.391 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 40.4 m -154.32 164.38 38.67 Favored 'General case' 0 N--CA 1.448 -0.558 0 C-N-CA 126.195 1.798 . . . . 0.0 107.236 -177.548 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -60.18 163.25 8.53 Favored Pre-proline 0 CA--C 1.54 0.586 0 C-N-CA 124.514 1.125 . . . . 0.0 110.704 169.973 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -61.36 151.19 81.12 Favored 'Trans proline' 0 N--CA 1.456 -0.692 0 C-N-CA 121.584 1.523 . . . . 0.0 109.478 172.565 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 5.6 tt -61.59 -24.23 33.22 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.536 0 O-C-N 121.648 -0.658 . . . . 0.0 111.254 -173.289 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 12.3 mt-10 -67.59 -25.52 65.81 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 125.352 1.461 . . . . 0.0 110.803 -177.064 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 12.2 t-20 -63.07 -26.12 68.69 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 125.006 1.322 . . . . 0.0 111.904 178.612 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 39.2 m-85 -105.07 -169.68 1.64 Allowed 'General case' 0 C--O 1.236 0.37 0 C-N-CA 126.464 1.906 . . . . 0.0 109.762 -176.357 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 55.3 t-20 -135.98 138.81 42.66 Favored 'General case' 0 N--CA 1.445 -0.688 0 N-CA-C 106.526 -1.657 . . . . 0.0 106.526 168.753 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.536 ' HB2' ' CD2' ' A' ' 90' ' ' TRP . . . -72.18 -27.16 62.39 Favored 'General case' 0 N--CA 1.431 -1.379 0 N-CA-C 108.576 -0.898 . . . . 0.0 108.576 -178.768 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 35.8 t70 -67.04 -20.93 65.92 Favored 'General case' 0 N--CA 1.443 -0.778 0 C-N-CA 120.728 -0.389 . . . . 0.0 111.388 -177.55 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 35.2 t70 -80.13 -29.74 38.93 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 124.278 1.031 . . . . 0.0 111.697 173.672 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 11.2 m-85 -77.51 168.59 19.74 Favored 'General case' 0 C--O 1.237 0.446 0 C-N-CA 125.176 1.39 . . . . 0.0 110.926 177.551 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -119.29 -38.56 3.01 Favored 'General case' 0 C--O 1.235 0.309 0 C-N-CA 123.098 0.559 . . . . 0.0 111.491 178.728 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -139.32 134.62 40.44 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.494 0 CA-C-O 121.565 0.698 . . . . 0.0 110.196 -169.921 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 57.0 t -142.5 139.66 28.86 Favored 'Isoleucine or valine' 0 C--O 1.236 0.369 0 N-CA-C 106.082 -1.822 . . . . 0.0 106.082 -179.85 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.533 HD12 ' HB2' ' A' ' 97' ' ' GLU . 23.8 mm -125.63 122.07 61.51 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.572 0 N-CA-C 105.859 -1.904 . . . . 0.0 105.859 -177.388 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 36.0 m -95.4 97.06 9.54 Favored 'General case' 0 N--CA 1.447 -0.586 0 N-CA-C 106.019 -1.845 . . . . 0.0 106.019 169.731 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 67.6 mt -63.04 -18.6 63.53 Favored 'General case' 0 N--CA 1.463 0.207 0 C-N-CA 122.756 0.422 . . . . 0.0 111.092 -178.629 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 14.3 p -152.78 166.55 31.87 Favored 'General case' 0 N--CA 1.448 -0.54 0 N-CA-C 106.7 -1.593 . . . . 0.0 106.7 168.847 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 73.36 -165.52 54.79 Favored Glycine 0 CA--C 1.533 1.194 0 CA-C-O 121.381 0.434 . . . . 0.0 113.053 172.764 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 34.9 p -151.88 -168.21 3.01 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 125.548 1.539 . . . . 0.0 109.318 -169.873 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -73.36 60.74 1.91 Allowed Glycine 0 CA--C 1.534 1.277 0 C-N-CA 124.449 1.023 . . . . 0.0 110.644 170.743 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 7.3 p -72.66 -55.11 14.09 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.398 0 C-N-CA 124.987 1.315 . . . . 0.0 110.823 -169.87 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 36.7 p-10 -135.99 24.93 3.32 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 127.12 2.168 . . . . 0.0 108.6 170.053 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 2.8 tt -116.15 135.52 22.82 Favored Pre-proline 0 CA--C 1.537 0.446 0 C-N-CA 127.076 2.15 . . . . 0.0 107.881 -169.491 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 87' ' ' PRO . . . . . 0.45 ' HA ' ' HD3' ' A' ' 88' ' ' PRO . 51.4 Cg_exo -63.55 141.96 82.33 Favored 'Trans proline' 0 CA--C 1.541 0.84 0 CA-C-N 120.518 1.221 . . . . 0.0 114.78 -169.313 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 88' ' ' PRO . . . . . 0.45 ' HD3' ' HA ' ' A' ' 87' ' ' PRO . 75.4 Cg_exo -60.33 -33.97 93.96 Favored 'Trans proline' 0 C--N 1.35 0.614 0 C-N-CA 122.1 1.867 . . . . 0.0 115.106 -171.425 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 4.0 pm0 -62.41 -13.62 31.6 Favored 'General case' 0 CA--C 1.536 0.435 0 CA-C-N 119.817 1.189 . . . . 0.0 112.349 -177.721 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 90' ' ' TRP . . . . . 0.536 ' CD2' ' HB2' ' A' ' 70' ' ' ALA . 99.1 m95 -80.51 -32.31 36.95 Favored 'General case' 0 CA--C 1.53 0.191 0 CA-C-N 118.61 0.641 . . . . 0.0 111.825 173.83 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 25.1 m -96.3 -3.52 10.27 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.472 0 C-N-CA 124.913 1.285 . . . . 0.0 112.822 -179.309 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . 0.263 6.5 t -130.99 65.54 1.55 Allowed 'General case' 0 CA--C 1.541 0.604 0 CA-C-O 123.465 1.602 . . . . 0.0 108.132 169.634 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 32.9 mm-40 -80.56 -175.85 5.43 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 125.668 1.587 . . . . 0.0 109.603 169.516 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 36.4 mm-40 -63.06 -28.25 69.96 Favored 'General case' 0 CA--C 1.54 0.563 0 O-C-N 121.869 -0.52 . . . . 0.0 110.118 175.121 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 3.8 tt -141.01 134.58 31.89 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.358 0 C-N-CA 126.69 1.996 . . . . 0.0 105.675 169.319 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 57.0 t80 -126.11 137.57 53.61 Favored 'General case' 0 N--CA 1.448 -0.543 0 N-CA-C 107.556 -1.276 . . . . 0.0 107.556 169.789 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 97' ' ' GLU . . . . . 0.533 ' HB2' HD12 ' A' ' 77' ' ' ILE . 8.5 mm-40 -138.11 167.03 22.67 Favored 'General case' 0 C--O 1.236 0.372 0 CA-C-O 122.248 1.023 . . . . 0.0 109.223 175.186 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -168.74 133.0 1.51 Allowed 'General case' 0 C--N 1.325 -0.488 0 C-N-CA 129.267 3.027 . . . . 0.0 105.606 -170.121 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 8.2 m0 -142.87 147.66 35.72 Favored 'General case' 0 C--O 1.232 0.18 0 C-N-CA 123.126 0.57 . . . . 0.0 110.136 -169.833 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 84.6 mt-30 -83.59 52.69 2.31 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 124.301 1.041 . . . . 0.0 108.914 172.362 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.454 HD13 HG22 ' A' ' 119' ' ' VAL . 16.3 mt -70.59 123.42 21.8 Favored 'General case' 0 C--N 1.339 0.113 0 N-CA-C 107.546 -1.279 . . . . 0.0 107.546 176.328 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 5.6 pt-20 -71.87 163.6 27.55 Favored 'General case' 0 CA--C 1.54 0.564 0 N-CA-C 109.139 -0.689 . . . . 0.0 109.139 169.759 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 103' ' ' ASP . . . . . 0.449 ' CG ' ' H ' ' A' ' 14' ' ' ARG . 13.7 t70 -138.66 139.61 24.92 Favored Pre-proline 0 CA--C 1.538 0.489 0 C-N-CA 124.132 0.973 . . . . 0.0 110.158 -173.198 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 39.5 Cg_endo -86.68 0.01 7.95 Favored 'Trans proline' 0 CA--C 1.543 0.96 0 C-N-CA 122.716 2.277 . . . . 0.0 114.651 -170.436 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -48.59 118.96 2.77 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-N 120.43 1.468 . . . . 0.0 111.221 -177.903 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 72.21 14.15 76.63 Favored Glycine 0 CA--C 1.534 1.249 0 CA-C-O 118.193 -1.337 . . . . 0.0 114.544 172.538 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 16.6 pt20 -128.23 172.26 11.19 Favored 'General case' 0 CA--C 1.541 0.605 0 CA-C-N 119.455 1.628 . . . . 0.0 111.827 176.448 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 9.9 m -65.78 165.18 13.25 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 125.851 1.66 . . . . 0.0 115.133 -168.644 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -60.68 -26.68 67.28 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 125.678 1.591 . . . . 0.0 112.614 -173.993 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 -56.07 -35.14 66.65 Favored 'General case' 0 N--CA 1.461 0.113 0 CA-C-N 118.687 0.676 . . . . 0.0 111.105 173.054 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 4.1 t -77.18 -40.98 30.41 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.558 0 CA-C-O 118.214 -0.898 . . . . 0.0 109.733 -178.036 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 83.6 m-85 -57.5 -46.44 83.75 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-N 120.29 1.404 . . . . 0.0 109.93 171.926 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 91.4 mtt180 -62.94 -41.35 99.46 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 123.274 0.629 . . . . 0.0 110.915 -179.906 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 8.7 m -63.13 -48.56 77.98 Favored 'General case' 0 N--CA 1.449 -0.522 0 C-N-CA 124.704 1.202 . . . . 0.0 110.178 175.525 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 75.4 t -68.72 -31.65 51.73 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.28 0 CA-C-O 118.481 -0.771 . . . . 0.0 109.703 -172.679 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 34.7 mtm105 -57.7 -50.16 74.11 Favored 'General case' 0 C--O 1.226 -0.15 0 CA-C-N 119.521 1.055 . . . . 0.0 110.497 171.399 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -60.74 -51.48 58.35 Favored Glycine 0 CA--C 1.529 0.955 0 N-CA-C 111.22 -0.752 . . . . 0.0 111.22 178.755 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 15.1 mm-40 -58.24 -52.15 66.76 Favored 'General case' 0 N--CA 1.464 0.235 0 C-N-CA 123.911 0.885 . . . . 0.0 110.658 -176.269 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 119' ' ' VAL . . . . . 0.454 HG22 HD13 ' A' ' 101' ' ' LEU . 69.4 t -74.47 -39.48 47.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-O 118.357 -0.83 . . . . 0.0 110.339 -171.91 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 59.8 tttm -54.79 -44.7 73.99 Favored 'General case' 0 CA--C 1.517 -0.29 0 CA-C-N 119.134 0.879 . . . . 0.0 108.871 175.798 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 45.1 tt0 -64.79 -42.99 94.64 Favored 'General case' 0 CA--C 1.542 0.642 0 CA-C-O 118.75 -0.643 . . . . 0.0 111.363 -177.862 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 63.2 mmt-85 -62.87 -47.63 82.51 Favored 'General case' 0 N--CA 1.478 0.972 0 CA-C-N 119.967 1.258 . . . . 0.0 110.822 176.161 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 60.2 t -69.09 -37.44 76.79 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.438 0 N-CA-C 108.774 -0.824 . . . . 0.0 108.774 -174.675 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 15.8 mt-10 -61.07 -45.22 95.63 Favored 'General case' 0 CA--C 1.52 -0.185 0 CA-C-N 119.269 0.941 . . . . 0.0 110.076 174.111 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 28.4 t-20 -64.22 -40.97 97.14 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 123.008 0.523 . . . . 0.0 111.218 -178.332 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 53.0 tp -58.86 -49.94 75.86 Favored 'General case' 0 C--O 1.226 -0.14 0 C-N-CA 125.285 1.434 . . . . 0.0 110.909 173.77 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 56.7 mt -64.59 -46.87 91.23 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 N-CA-C 107.997 -1.112 . . . . 0.0 107.997 -178.748 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -58.65 -32.45 69.09 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 123.424 0.69 . . . . 0.0 112.102 -178.151 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 18.6 ptpt -81.53 -36.56 29.01 Favored 'General case' 0 C--N 1.345 0.37 0 CA-C-O 117.824 -1.084 . . . . 0.0 112.596 177.105 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 10.4 pt -84.81 -41.27 15.76 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.322 0 CA-C-N 120.124 1.329 . . . . 0.0 113.741 -176.225 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 67.4 m . . . . . 0 C--O 1.254 1.302 0 C-N-CA 126.065 1.746 . . . . 0.0 109.873 -169.927 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 8.5 ptm . . . . . 0 N--CA 1.498 1.965 0 N-CA-C 110.523 -0.177 . . . . 0.0 110.523 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 2' ' ' LYS . . . . . 0.41 ' HB2' HG22 ' A' ' 30' ' ' ILE . 23.4 mttm -74.62 125.07 27.87 Favored 'General case' 0 N--CA 1.479 1.005 0 N-CA-C 107.103 -1.443 . . . . 0.0 107.103 -174.516 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 70.0 mttt -97.97 136.4 38.31 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-N 120.236 1.38 . . . . 0.0 108.027 173.771 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.428 HG21 HD12 ' A' ' 30' ' ' ILE . 11.6 t -116.31 152.47 18.03 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.551 0 C-N-CA 127.233 2.213 . . . . 0.0 108.199 -169.56 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 17.7 mtt -137.19 144.11 42.7 Favored 'General case' 0 C--N 1.324 -0.541 0 C-N-CA 124.926 1.29 . . . . 0.0 108.057 168.67 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 92.1 m-85 -125.26 113.89 18.22 Favored 'General case' 0 CA--C 1.516 -0.329 0 N-CA-C 102.839 -3.023 . . . . 0.0 102.839 170.05 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 1.2 p -141.0 137.21 34.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 121.289 0.566 . . . . 0.0 111.531 -168.051 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 44.0 t -165.82 152.93 10.08 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 128.639 2.775 . . . . 0.0 104.94 171.767 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 40.2 mtmt -75.47 163.3 27.55 Favored 'General case' 0 N--CA 1.47 0.569 0 O-C-N 121.655 -0.653 . . . . 0.0 111.421 -170.038 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 28.5 mmt85 53.41 70.39 0.6 Allowed 'General case' 0 N--CA 1.465 0.285 0 C-N-CA 126.801 2.041 . . . . 0.0 110.888 -176.28 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 2.4 t-20 -44.4 -20.07 0.03 OUTLIER 'General case' 0 N--CA 1.487 1.386 0 C-N-CA 127.839 2.455 . . . . 0.0 114.955 176.828 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 3.3 m -50.47 -27.82 7.23 Favored 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 124.269 1.028 . . . . 0.0 111.407 168.954 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 10.3 m -131.63 140.32 49.35 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 126.876 2.071 . . . . 0.0 107.889 172.078 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 5.5 mpt_? 59.16 165.2 0.05 OUTLIER 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 126.536 1.934 . . . . 0.0 112.631 -173.022 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 54.7 m 52.2 39.65 27.31 Favored 'General case' 0 CA--C 1.536 0.42 0 CA-C-N 115.207 -0.906 . . . . 0.0 110.334 -169.525 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 26.1 pt20 -135.48 33.07 3.03 Favored 'General case' 0 C--O 1.223 -0.294 0 O-C-N 120.543 -1.348 . . . . 0.0 109.636 174.414 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' MET . . . . . 0.405 ' HE2' ' HG3' ' A' ' 50' ' ' MET . 0.0 OUTLIER -163.88 -50.2 0.03 OUTLIER 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 124.149 0.979 . . . . 0.0 109.848 -177.762 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -67.73 -45.21 75.68 Favored 'General case' 0 C--N 1.343 0.285 0 N-CA-C 112.584 0.586 . . . . 0.0 112.584 -169.465 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 19' ' ' GLU . . . . . 0.518 ' H ' ' CD ' ' A' ' 19' ' ' GLU . 0.7 OUTLIER -66.86 -34.88 78.78 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 109.489 -0.56 . . . . 0.0 109.489 174.516 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -47.97 -66.71 1.87 Allowed Glycine 0 CA--C 1.527 0.791 0 N-CA-C 110.094 -1.202 . . . . 0.0 110.094 169.909 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 3.7 m-85 -59.62 -34.36 72.68 Favored 'General case' 0 CA--C 1.509 -0.602 0 O-C-N 121.547 -0.973 . . . . 0.0 113.444 178.091 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -66.63 -32.57 73.99 Favored 'General case' 0 N--CA 1.447 -0.61 0 C-N-CA 119.943 -0.703 . . . . 0.0 109.954 -174.032 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -65.9 -33.73 76.5 Favored 'General case' 0 CA--C 1.533 0.327 0 CA-C-N 118.395 0.543 . . . . 0.0 110.675 174.797 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 7.4 m -75.06 -55.69 5.49 Favored 'General case' 0 N--CA 1.448 -0.528 0 C-N-CA 125.453 1.501 . . . . 0.0 110.354 -176.752 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 40.1 mt -75.08 -38.63 61.2 Favored 'General case' 0 C--N 1.331 -0.22 0 C-N-CA 124.302 1.041 . . . . 0.0 109.467 -174.025 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -84.97 5.16 83.8 Favored Glycine 0 CA--C 1.526 0.78 0 C-N-CA 125.487 1.518 . . . . 0.0 113.629 -177.959 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -53.24 128.56 28.48 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-N 118.807 1.303 . . . . 0.0 109.802 -178.983 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 74.2 6.63 75.24 Favored Glycine 0 CA--C 1.536 1.35 0 C-N-CA 124.567 1.08 . . . . 0.0 114.313 -178.388 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 42.7 mttp -124.94 -50.42 1.7 Allowed 'General case' 0 N--CA 1.47 0.534 0 CA-C-N 118.927 1.364 . . . . 0.0 110.986 -175.0 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.428 HD12 HG21 ' A' ' 4' ' ' VAL . 19.3 pt -139.25 147.58 24.39 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.497 0 C-N-CA 123.642 0.777 . . . . 0.0 110.278 -169.244 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -96.01 159.48 14.95 Favored 'General case' 0 C--O 1.221 -0.417 0 C-N-CA 125.833 1.653 . . . . 0.0 108.109 175.578 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 12.2 t -142.44 135.68 27.43 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 N-CA-C 107.961 -1.125 . . . . 0.0 107.961 -173.416 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 4.1 m -148.38 103.04 3.39 Favored 'General case' 0 N--CA 1.446 -0.65 0 C-N-CA 124.665 1.186 . . . . 0.0 107.952 -177.218 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 60.2 m -89.6 71.43 7.87 Favored 'General case' 0 C--O 1.234 0.247 0 O-C-N 120.942 -1.099 . . . . 0.0 111.92 177.608 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 2.1 m -69.14 176.6 3.14 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 124.819 1.248 . . . . 0.0 110.696 170.763 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -167.07 -167.85 28.38 Favored Glycine 0 C--N 1.339 0.698 0 N-CA-C 108.082 -2.007 . . . . 0.0 108.082 179.691 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 18.2 mt -124.44 2.59 8.39 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 124.607 1.163 . . . . 0.0 111.691 -179.755 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 -145.36 -155.5 0.62 Allowed 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 129.185 2.994 . . . . 0.0 105.463 174.969 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 5.8 m 70.4 176.69 0.28 Allowed 'General case' 0 C--O 1.235 0.338 0 C-N-CA 125.38 1.472 . . . . 0.0 114.891 169.41 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 17.1 m -143.9 -72.87 0.28 Allowed 'General case' 0 N--CA 1.452 -0.354 0 CA-C-N 113.491 -1.686 . . . . 0.0 109.769 -169.236 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 6.0 ttt180 -152.3 172.1 16.96 Favored 'General case' 0 N--CA 1.467 0.415 0 C-N-CA 123.952 0.901 . . . . 0.0 111.15 -175.406 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 3.5 m -73.5 168.7 1.85 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.57 0 C-N-CA 124.534 1.134 . . . . 0.0 109.842 176.657 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -94.23 160.03 32.87 Favored Pre-proline 0 CA--C 1.544 0.718 0 N-CA-C 112.697 0.629 . . . . 0.0 112.697 -177.815 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -61.26 -53.55 2.37 Favored 'Trans proline' 0 C--N 1.352 0.742 0 C-N-CA 124.018 3.145 . . . . 0.0 113.777 -169.261 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 4.9 m -66.06 -26.6 67.58 Favored 'General case' 0 CA--C 1.532 0.278 0 O-C-N 121.893 -0.505 . . . . 0.0 110.358 -174.324 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -54.27 -53.19 56.97 Favored 'General case' 0 CA--C 1.509 -0.609 0 N-CA-C 108.75 -0.834 . . . . 0.0 108.75 174.745 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 58.9 mt -60.79 -41.08 87.2 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.468 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 -171.482 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -62.58 -40.97 98.59 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-N 118.431 0.56 . . . . 0.0 110.802 -179.009 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 49' ' ' MET . . . . . 0.426 ' HG3' ' CG ' ' A' ' 112' ' ' PHE . 38.4 mmt -74.06 -35.9 64.31 Favored 'General case' 0 C--O 1.235 0.321 0 CA-C-O 122.388 1.089 . . . . 0.0 110.338 -178.853 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 50' ' ' MET . . . . . 0.405 ' HG3' ' HE2' ' A' ' 17' ' ' MET . 0.2 OUTLIER -73.02 -31.33 64.39 Favored 'General case' 0 N--CA 1.442 -0.863 0 N-CA-C 106.806 -1.553 . . . . 0.0 106.806 -178.916 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 -70.52 -21.08 62.77 Favored 'General case' 0 N--CA 1.445 -0.719 0 C-N-CA 124.703 1.201 . . . . 0.0 111.061 170.273 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 77.7 mt-10 -63.84 -37.88 89.04 Favored 'General case' 0 C--N 1.344 0.361 0 CA-C-N 120.137 1.335 . . . . 0.0 109.107 169.457 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . 0.303 7.7 p -88.28 12.68 1.34 Allowed 'Isoleucine or valine' 0 CA--C 1.548 0.897 0 CA-C-O 121.082 0.468 . . . . 0.0 112.204 171.076 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 72.02 17.24 76.98 Favored Glycine 0 CA--C 1.533 1.212 0 O-C-N 120.723 -1.235 . . . . 0.0 113.869 174.791 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 5.7 mt -100.36 145.57 10.7 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.191 0 C-N-CA 125.154 1.382 . . . . 0.0 111.494 -174.221 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -96.77 137.13 36.32 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 125.297 1.439 . . . . 0.0 108.874 169.625 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 4.6 pt -134.0 -28.83 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.46 0 C-N-CA 125.441 1.496 . . . . 0.0 109.382 169.529 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -39.86 -37.67 0.58 Allowed 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 128.475 2.71 . . . . 0.0 113.509 169.563 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -66.72 -12.25 59.01 Favored Glycine 0 CA--C 1.537 1.423 0 C-N-CA 124.481 1.039 . . . . 0.0 114.379 179.213 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 28.7 mt-30 -70.73 156.43 39.51 Favored 'General case' 0 N--CA 1.45 -0.438 0 CA-C-N 118.965 1.382 . . . . 0.0 110.297 174.382 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 1.4 p -150.31 151.07 32.34 Favored 'General case' 0 N--CA 1.431 -1.421 0 N-CA-C 104.717 -2.327 . . . . 0.0 104.717 168.448 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 63.2 m -92.47 75.82 5.15 Favored 'General case' 0 N--CA 1.45 -0.44 0 N-CA-C 107.831 -1.174 . . . . 0.0 107.831 -174.117 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -62.96 153.13 81.67 Favored Pre-proline 0 C--O 1.241 0.642 0 N-CA-C 108.947 -0.761 . . . . 0.0 108.947 171.161 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 26.4 Cg_exo -57.55 134.36 62.78 Favored 'Trans proline' 0 N--CA 1.447 -1.209 0 N-CA-C 107.841 -1.638 . . . . 0.0 107.841 169.376 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 8.3 tt -61.22 -23.8 31.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 O-C-N 121.482 -0.762 . . . . 0.0 109.596 171.021 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 21.5 tt0 -69.61 -22.9 63.46 Favored 'General case' 0 N--CA 1.434 -1.273 0 C-N-CA 127.375 2.27 . . . . 0.0 110.789 -179.995 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 8.2 t-20 -60.32 -17.59 43.92 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 124.665 1.186 . . . . 0.0 111.68 174.313 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 4.4 m-85 -128.31 178.34 6.32 Favored 'General case' 0 C--O 1.235 0.34 0 C-N-CA 127.115 2.166 . . . . 0.0 108.54 -179.873 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 13.9 p-10 -128.32 143.61 51.04 Favored 'General case' 0 N--CA 1.438 -1.035 0 C-N-CA 124.716 1.206 . . . . 0.0 110.428 169.236 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.575 ' HB2' ' CD2' ' A' ' 90' ' ' TRP . . . -77.36 -25.27 50.85 Favored 'General case' 0 N--CA 1.432 -1.347 0 N-CA-C 109.143 -0.688 . . . . 0.0 109.143 -170.712 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 35.6 t70 -64.61 -19.79 65.89 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 120.41 -0.516 . . . . 0.0 111.214 -178.903 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -83.96 -31.04 25.77 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 124.427 1.091 . . . . 0.0 112.321 172.215 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 11.1 m-85 -72.85 170.31 14.98 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 124.89 1.276 . . . . 0.0 110.287 173.23 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -120.43 -35.85 3.33 Favored 'General case' 0 C--O 1.236 0.39 0 C-N-CA 123.047 0.539 . . . . 0.0 111.67 179.905 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -141.51 135.31 30.82 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.691 0 CA-C-O 121.839 0.828 . . . . 0.0 110.454 -169.705 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 76.3 t -143.0 138.38 27.16 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.278 0 N-CA-C 106.629 -1.619 . . . . 0.0 106.629 -177.496 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 41.6 mm -127.16 117.28 46.96 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.581 0 N-CA-C 106.12 -1.807 . . . . 0.0 106.12 -170.516 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 67.1 m -94.96 91.61 6.47 Favored 'General case' 0 N--CA 1.449 -0.519 0 N-CA-C 105.546 -2.02 . . . . 0.0 105.546 169.445 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . 0.251 0.3 OUTLIER -75.3 -6.55 50.44 Favored 'General case' 0 CA--C 1.536 0.442 0 CA-C-N 115.605 -0.725 . . . . 0.0 112.908 -175.267 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 6.4 p -166.14 167.38 16.34 Favored 'General case' 0 C--O 1.236 0.344 0 C-N-CA 127.398 2.279 . . . . 0.0 107.549 168.247 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 77.79 -81.3 1.27 Allowed Glycine 0 CA--C 1.526 0.746 0 N-CA-C 110.632 -0.987 . . . . 0.0 110.632 174.573 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 4.9 m 67.79 -53.2 0.51 Allowed 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 127.659 2.383 . . . . 0.0 113.738 178.429 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -81.47 57.79 4.89 Favored Glycine 0 CA--C 1.528 0.902 0 C-N-CA 124.774 1.178 . . . . 0.0 110.511 170.741 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 27.7 m -99.5 14.71 4.51 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.71 0 C-N-CA 124.082 0.953 . . . . 0.0 113.068 -169.881 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 47.4 t30 58.64 69.65 0.71 Allowed 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 126.1 1.76 . . . . 0.0 109.258 -175.865 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.405 ' HA ' ' HD3' ' A' ' 87' ' ' PRO . 0.3 OUTLIER -139.36 148.61 57.36 Favored Pre-proline 0 CA--C 1.546 0.81 0 C-N-CA 126.146 1.778 . . . . 0.0 109.276 -168.949 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 87' ' ' PRO . . . . . 0.405 ' HD3' ' HA ' ' A' ' 86' ' ' LEU . 51.7 Cg_exo -62.99 149.43 91.61 Favored 'Trans proline' 0 C--N 1.356 0.957 0 C-N-CA 121.47 1.447 . . . . 0.0 114.501 -169.643 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_endo -66.83 -34.9 29.17 Favored 'Trans proline' 0 N--CA 1.459 -0.522 0 C-N-CA 122.649 2.232 . . . . 0.0 114.583 -169.212 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 89' ' ' GLU . . . . . 0.446 ' HG3' ' HB3' ' A' ' 70' ' ' ALA . 11.8 pt-20 -64.16 -11.91 35.0 Favored 'General case' 0 CA--C 1.54 0.57 0 CA-C-N 119.85 1.205 . . . . 0.0 112.157 -176.62 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 90' ' ' TRP . . . . . 0.575 ' CD2' ' HB2' ' A' ' 70' ' ' ALA . 98.0 m95 -80.96 -35.53 32.07 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 123.481 0.712 . . . . 0.0 111.941 173.932 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 18.8 m -92.34 -4.59 10.78 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.551 0 C-N-CA 125.047 1.339 . . . . 0.0 112.697 -179.694 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 4.0 t -132.92 85.61 2.24 Favored 'General case' 0 CA--C 1.539 0.54 0 CA-C-O 123.24 1.495 . . . . 0.0 107.159 169.725 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 30.4 mm-40 -103.02 -174.11 2.47 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 127.806 2.442 . . . . 0.0 108.943 173.889 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 38.3 mm-40 -64.55 -28.62 69.77 Favored 'General case' 0 CA--C 1.539 0.544 0 O-C-N 121.82 -0.55 . . . . 0.0 110.036 172.653 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 4.0 tt -142.39 130.21 20.38 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.409 0 N-CA-C 105.692 -1.966 . . . . 0.0 105.692 169.338 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 70.3 t80 -122.87 142.37 50.85 Favored 'General case' 0 N--CA 1.448 -0.537 0 N-CA-C 105.868 -1.901 . . . . 0.0 105.868 169.062 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 10.5 mm-40 -132.77 138.9 47.31 Favored 'General case' 0 C--O 1.236 0.369 0 N-CA-C 107.809 -1.182 . . . . 0.0 107.809 174.025 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 8.0 t70 -108.36 118.91 37.99 Favored 'General case' 0 N--CA 1.45 -0.443 0 N-CA-C 106.455 -1.683 . . . . 0.0 106.455 169.855 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 10.5 m95 -115.68 170.44 8.44 Favored 'General case' 0 CA--C 1.533 0.318 0 N-CA-C 108.73 -0.841 . . . . 0.0 108.73 170.308 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 47.8 mt-30 -129.76 57.99 1.66 Allowed 'General case' 0 CA--C 1.534 0.362 0 N-CA-C 106.823 -1.547 . . . . 0.0 106.823 169.86 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.423 HD13 HG22 ' A' ' 119' ' ' VAL . 4.5 mt -67.76 139.48 56.66 Favored 'General case' 0 N--CA 1.463 0.217 0 N-CA-C 108.197 -1.038 . . . . 0.0 108.197 -179.694 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -74.65 170.61 15.46 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 125.056 1.343 . . . . 0.0 109.083 174.408 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -143.0 138.01 15.43 Favored Pre-proline 0 N--CA 1.452 -0.35 0 C-N-CA 123.199 0.599 . . . . 0.0 110.833 176.856 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 29.2 Cg_endo -86.35 -2.88 8.59 Favored 'Trans proline' 0 CA--C 1.54 0.807 0 C-N-CA 123.302 2.668 . . . . 0.0 115.318 -172.586 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -56.78 130.88 47.51 Favored 'General case' 0 C--O 1.237 0.432 0 CA-C-N 120.356 1.435 . . . . 0.0 110.571 -174.209 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 72.41 9.4 73.16 Favored Glycine 0 CA--C 1.534 1.233 0 CA-C-O 118.399 -1.223 . . . . 0.0 114.146 174.215 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 30.0 pt20 -126.44 -167.65 1.75 Allowed 'General case' 0 CA--C 1.537 0.453 0 CA-C-N 119.253 1.526 . . . . 0.0 110.799 172.326 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 1.9 m -66.93 154.74 40.3 Favored 'General case' 0 CA--C 1.532 0.268 0 N-CA-C 116.144 1.905 . . . . 0.0 116.144 -167.96 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 9.0 tp -57.61 -34.61 69.45 Favored 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 126.255 1.822 . . . . 0.0 111.201 177.487 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 -59.22 -34.66 72.45 Favored 'General case' 0 CA--C 1.531 0.213 0 C-N-CA 124.297 1.039 . . . . 0.0 110.721 175.839 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 3.5 t -73.18 -40.46 57.82 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.283 0 CA-C-O 118.207 -0.901 . . . . 0.0 109.456 -178.477 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 112' ' ' PHE . . . . . 0.426 ' CG ' ' HG3' ' A' ' 49' ' ' MET . 81.1 m-85 -56.56 -50.01 73.17 Favored 'General case' 0 N--CA 1.471 0.612 0 CA-C-N 120.248 1.385 . . . . 0.0 109.376 172.482 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 91.6 mtt180 -66.25 -33.19 75.18 Favored 'General case' 0 CA--C 1.535 0.378 0 CA-C-O 119.348 -0.358 . . . . 0.0 111.515 -177.009 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 6.2 m -67.37 -49.86 62.18 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 124.224 1.01 . . . . 0.0 109.971 173.107 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 80.1 t -69.8 -26.89 31.39 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.232 0 CA-C-O 117.675 -1.155 . . . . 0.0 109.399 -170.938 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 31.5 mtm105 -56.63 -47.5 79.57 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-N 120.31 1.414 . . . . 0.0 109.746 169.791 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -63.48 -49.12 72.24 Favored Glycine 0 CA--C 1.532 1.135 0 CA-C-N 118.949 0.795 . . . . 0.0 112.241 179.445 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 16.8 mt-30 -57.78 -46.37 84.69 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-N 117.565 0.682 . . . . 0.0 110.67 179.277 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 119' ' ' VAL . . . . . 0.423 HG22 HD13 ' A' ' 101' ' ' LEU . 65.8 t -70.42 -41.2 78.29 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.474 0 CA-C-O 118.585 -0.722 . . . . 0.0 110.405 -176.675 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 57.7 tttm -54.54 -46.48 73.61 Favored 'General case' 0 CA--C 1.517 -0.301 0 CA-C-N 119.381 0.991 . . . . 0.0 109.178 179.917 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -64.19 -42.79 96.51 Favored 'General case' 0 N--CA 1.448 -0.539 0 C-N-CA 123.002 0.521 . . . . 0.0 110.68 -176.758 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 37.8 mmt180 -63.16 -46.54 86.69 Favored 'General case' 0 N--CA 1.47 0.541 0 O-C-N 121.808 -0.557 . . . . 0.0 110.824 178.047 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 86.1 t -70.02 -39.03 76.86 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.436 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 -176.834 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 17.2 mt-10 -60.82 -43.8 97.75 Favored 'General case' 0 C--O 1.227 -0.105 0 CA-C-N 119.392 0.996 . . . . 0.0 110.316 175.509 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 28.8 t-20 -63.71 -43.68 95.88 Favored 'General case' 0 CA--C 1.53 0.206 0 C-N-CA 122.968 0.507 . . . . 0.0 111.115 -178.011 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 45.7 tp -58.09 -49.47 76.81 Favored 'General case' 0 N--CA 1.453 -0.322 0 C-N-CA 125.525 1.53 . . . . 0.0 111.151 174.374 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 73.1 mt -64.58 -46.03 93.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 N-CA-C 108.261 -1.014 . . . . 0.0 108.261 -178.895 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -59.74 -30.8 69.08 Favored 'General case' 0 CA--C 1.536 0.438 0 CA-C-O 118.734 -0.651 . . . . 0.0 112.157 -178.084 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 19.1 ptpt -82.45 -37.65 25.11 Favored 'General case' 0 C--N 1.344 0.35 0 CA-C-O 118.033 -0.984 . . . . 0.0 112.346 176.797 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 12.7 pt -81.69 -41.68 18.77 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.328 0 CA-C-N 120.072 1.305 . . . . 0.0 113.354 -176.737 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 74.5 m . . . . . 0 C--O 1.252 1.232 0 C-N-CA 125.882 1.673 . . . . 0.0 109.607 -169.848 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 11.6 ptm . . . . . 0 N--CA 1.497 1.897 0 N-CA-C 110.744 -0.095 . . . . 0.0 110.744 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 2' ' ' LYS . . . . . 0.402 ' HB2' HG22 ' A' ' 30' ' ' ILE . 26.1 mttm -76.08 118.71 19.12 Favored 'General case' 0 N--CA 1.48 1.064 0 O-C-N 120.875 -1.141 . . . . 0.0 108.196 -170.262 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 90.9 mttt -86.08 136.03 33.39 Favored 'General case' 0 CA--C 1.513 -0.454 0 N-CA-C 107.935 -1.135 . . . . 0.0 107.935 177.223 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 1.8 t -122.45 150.82 26.16 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 C-N-CA 125.752 1.621 . . . . 0.0 109.45 -168.936 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 13.6 mtt -139.35 147.52 41.65 Favored 'General case' 0 C--N 1.327 -0.376 0 C-N-CA 125.677 1.591 . . . . 0.0 108.462 168.963 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 70.2 m-85 -134.51 121.98 21.78 Favored 'General case' 0 N--CA 1.456 -0.161 0 N-CA-C 105.246 -2.131 . . . . 0.0 105.246 170.502 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 1.5 p -152.35 146.28 15.33 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.244 0 CA-C-N 118.954 0.797 . . . . 0.0 111.422 -168.932 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 43.7 t -132.99 -175.73 3.88 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 126.709 2.004 . . . . 0.0 106.226 169.225 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 20.2 ptpt -58.53 -25.44 62.45 Favored 'General case' 0 N--CA 1.471 0.601 0 N-CA-C 114.104 1.15 . . . . 0.0 114.104 -171.308 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 48.3 ttt85 -140.39 159.29 42.52 Favored 'General case' 0 N--CA 1.467 0.417 0 C-N-CA 124.264 1.026 . . . . 0.0 109.054 176.428 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 6.4 t30 -72.06 -34.86 69.06 Favored 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 123.779 0.832 . . . . 0.0 112.963 -176.556 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -64.75 -55.95 16.68 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 123.197 0.599 . . . . 0.0 111.215 -169.116 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 11.1 m -88.73 146.48 25.01 Favored 'General case' 0 N--CA 1.455 -0.196 0 C-N-CA 123.549 0.74 . . . . 0.0 109.624 -176.652 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 6.4 mmm180 68.33 -57.49 0.48 Allowed 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 127.424 2.29 . . . . 0.0 111.488 176.993 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 2.5 m -69.62 -9.95 56.25 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 124.702 1.201 . . . . 0.0 113.97 -172.146 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 29.3 pt20 -64.9 -42.67 94.56 Favored 'General case' 0 C--O 1.223 -0.332 0 CA-C-O 117.732 -1.127 . . . . 0.0 113.587 -175.292 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 2.2 tpt -94.72 -36.26 11.8 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-N 120.046 1.294 . . . . 0.0 114.102 -169.199 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -62.78 -42.97 99.94 Favored 'General case' 0 N--CA 1.474 0.737 0 N-CA-C 113.526 0.936 . . . . 0.0 113.526 -168.929 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -64.46 -33.49 76.0 Favored 'General case' 0 N--CA 1.472 0.645 0 CA-C-N 118.674 0.67 . . . . 0.0 109.366 175.6 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -51.94 -57.57 12.5 Favored Glycine 0 C--N 1.342 0.888 0 C-N-CA 125.422 1.487 . . . . 0.0 110.439 175.647 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 13.5 m-85 -70.8 -31.89 68.79 Favored 'General case' 0 CA--C 1.505 -0.757 0 O-C-N 121.647 -0.914 . . . . 0.0 112.724 -179.172 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -68.94 -34.41 75.31 Favored 'General case' 0 N--CA 1.449 -0.521 0 C-N-CA 119.305 -0.958 . . . . 0.0 111.155 -174.761 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 2.4 ptmt -65.39 -25.88 67.75 Favored 'General case' 0 N--CA 1.471 0.621 0 CA-C-N 119.085 0.857 . . . . 0.0 111.717 172.952 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 8.8 m -83.21 -57.07 3.42 Favored 'General case' 0 N--CA 1.444 -0.728 0 C-N-CA 125.198 1.399 . . . . 0.0 109.538 -173.96 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 55.5 mt -74.9 -36.34 62.23 Favored 'General case' 0 C--N 1.331 -0.204 0 C-N-CA 124.753 1.221 . . . . 0.0 110.213 -175.005 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -93.34 9.4 74.49 Favored Glycine 0 C--N 1.338 0.675 0 C-N-CA 124.988 1.28 . . . . 0.0 113.068 -176.161 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -50.89 122.73 7.85 Favored 'General case' 0 CA--C 1.534 0.327 0 C-N-CA 124.841 1.257 . . . . 0.0 110.524 -175.257 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 76.54 -8.76 25.29 Favored Glycine 0 CA--C 1.534 1.264 0 C-N-CA 124.371 0.986 . . . . 0.0 114.426 179.652 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 60.2 mttm -98.67 -46.67 5.61 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 119.19 1.495 . . . . 0.0 110.403 179.254 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.402 HG22 ' HB2' ' A' ' 2' ' ' LYS . 24.3 pt -139.24 149.25 23.14 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.585 0 C-N-CA 123.632 0.773 . . . . 0.0 109.388 -169.76 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -113.09 106.41 14.64 Favored 'General case' 0 N--CA 1.463 0.187 0 C-N-CA 125.132 1.373 . . . . 0.0 109.272 -169.899 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 2.5 t -84.64 137.68 20.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 119.316 0.962 . . . . 0.0 109.742 -179.449 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 14.5 m -145.32 91.7 2.16 Favored 'General case' 0 N--CA 1.446 -0.669 0 N-CA-C 106.037 -1.838 . . . . 0.0 106.037 170.368 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 45.0 m -89.28 68.93 8.13 Favored 'General case' 0 CA--C 1.532 0.273 0 O-C-N 121.287 -0.883 . . . . 0.0 111.017 -171.363 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 11.9 m -61.89 164.72 6.1 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 125.895 1.678 . . . . 0.0 110.715 170.198 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -158.6 -167.64 19.67 Favored Glycine 0 C--N 1.337 0.638 0 N-CA-C 107.752 -2.139 . . . . 0.0 107.752 -170.057 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 17.3 mt -123.96 -3.72 8.1 Favored 'General case' 0 C--N 1.327 -0.376 0 C-N-CA 124.113 0.965 . . . . 0.0 111.592 -179.405 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 36.7 mt-10 -142.63 154.15 44.12 Favored 'General case' 0 C--O 1.238 0.499 0 C-N-CA 128.052 2.541 . . . . 0.0 106.511 169.297 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 60.7 p -148.53 160.78 42.75 Favored 'General case' 0 N--CA 1.446 -0.66 0 CA-C-O 122.555 1.169 . . . . 0.0 113.795 -179.693 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 93.0 p -164.45 -144.45 0.08 Allowed 'General case' 0 N--CA 1.443 -0.817 0 CA-C-N 112.531 -2.122 . . . . 0.0 105.94 -168.841 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 9.2 ttt180 -136.31 173.0 12.18 Favored 'General case' 0 C--O 1.232 0.134 0 N-CA-C 106.311 -1.737 . . . . 0.0 106.311 168.368 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 5.6 m -81.89 175.16 0.77 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.609 0 C-N-CA 122.918 0.487 . . . . 0.0 110.038 -178.845 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 97.0 m-70 -90.98 150.33 41.66 Favored Pre-proline 0 CA--C 1.542 0.669 0 CA-C-O 119.3 -0.381 . . . . 0.0 111.686 -174.916 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -63.4 -45.64 11.37 Favored 'Trans proline' 0 C--N 1.349 0.59 0 C-N-CA 122.76 2.306 . . . . 0.0 113.31 -171.216 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 45' ' ' THR . . . . . 0.407 ' HB ' ' CZ ' ' A' ' 112' ' ' PHE . 5.8 m -69.0 -22.74 64.06 Favored 'General case' 0 CA--C 1.54 0.558 0 O-C-N 121.681 -0.637 . . . . 0.0 110.364 -178.321 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -61.11 -56.68 18.1 Favored 'General case' 0 CA--C 1.509 -0.632 0 N-CA-C 108.197 -1.038 . . . . 0.0 108.197 169.85 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 75.9 mt -56.8 -38.76 60.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 N-CA-C 108.427 -0.953 . . . . 0.0 108.427 -175.229 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -62.47 -50.48 71.27 Favored 'General case' 0 N--CA 1.452 -0.332 0 CA-C-N 118.87 0.759 . . . . 0.0 111.827 -178.845 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 35.9 mmt -72.18 -31.78 66.23 Favored 'General case' 0 N--CA 1.472 0.648 0 CA-C-O 122.584 1.183 . . . . 0.0 110.806 -179.112 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -72.21 -33.13 67.37 Favored 'General case' 0 N--CA 1.443 -0.801 0 N-CA-C 106.855 -1.535 . . . . 0.0 106.855 -177.911 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 41.3 tt0 -74.7 -19.94 60.05 Favored 'General case' 0 N--CA 1.446 -0.67 0 O-C-N 120.925 -1.109 . . . . 0.0 110.525 172.441 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 20.3 mm-40 -64.49 -33.33 75.63 Favored 'General case' 0 CA--C 1.532 0.265 0 CA-C-N 119.576 1.08 . . . . 0.0 109.982 169.771 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 16.4 m -91.17 12.31 2.17 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.736 0 N-CA-C 112.275 0.472 . . . . 0.0 112.275 169.192 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 73.08 13.67 79.25 Favored Glycine 0 CA--C 1.531 1.089 0 C-N-CA 124.53 1.062 . . . . 0.0 113.695 174.675 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 17.2 mt -91.23 143.95 10.17 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.239 0 C-N-CA 124.438 1.095 . . . . 0.0 110.001 -177.476 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 7.2 t70 -104.49 124.6 49.56 Favored 'General case' 0 C--O 1.235 0.298 0 N-CA-C 106.628 -1.619 . . . . 0.0 106.628 168.902 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 5.8 pt -120.06 -21.81 4.02 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.697 0 C-N-CA 124.686 1.195 . . . . 0.0 109.526 169.073 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -38.67 -35.91 0.22 Allowed 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 129.252 3.021 . . . . 0.0 113.778 169.326 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -72.46 -9.75 74.0 Favored Glycine 0 CA--C 1.535 1.321 0 C-N-CA 124.649 1.118 . . . . 0.0 114.229 179.963 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 26.2 mt-30 -68.1 140.08 56.21 Favored 'General case' 0 N--CA 1.451 -0.401 0 CA-C-N 119.753 1.777 . . . . 0.0 110.265 176.764 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 1.2 m -155.94 -51.88 0.08 Allowed 'General case' 0 N--CA 1.438 -1.046 0 N-CA-C 104.119 -2.548 . . . . 0.0 104.119 168.412 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 3.9 m 68.9 160.03 0.18 Allowed 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 126.677 1.991 . . . . 0.0 114.071 169.095 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -95.32 163.61 21.23 Favored Pre-proline 0 C--O 1.241 0.621 0 C-N-CA 124.968 1.307 . . . . 0.0 109.754 -172.833 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -62.05 136.24 59.77 Favored 'Trans proline' 0 N--CA 1.449 -1.095 0 N-CA-C 108.203 -1.499 . . . . 0.0 108.203 169.762 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 8.1 tt -61.6 -19.15 20.3 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.498 0 C-N-CA 124.248 1.019 . . . . 0.0 111.03 -177.958 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 12.1 mt-10 -67.29 -25.48 66.06 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 125.533 1.533 . . . . 0.0 110.391 -179.748 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 15.4 t-20 -71.82 1.29 7.21 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 124.702 1.201 . . . . 0.0 113.112 -179.632 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 42.5 m-85 -130.74 -174.18 3.29 Favored 'General case' 0 C--O 1.236 0.388 0 C-N-CA 126.585 1.954 . . . . 0.0 109.136 -177.707 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 57.1 t-20 -135.05 140.19 45.38 Favored 'General case' 0 N--CA 1.446 -0.628 0 N-CA-C 107.397 -1.335 . . . . 0.0 107.397 169.382 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -72.22 -25.13 61.53 Favored 'General case' 0 N--CA 1.435 -1.207 0 N-CA-C 109.08 -0.711 . . . . 0.0 109.08 -178.157 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 35.1 t70 -63.71 -24.76 67.91 Favored 'General case' 0 N--CA 1.447 -0.609 0 O-C-N 123.254 0.346 . . . . 0.0 111.868 -179.132 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -78.08 -28.32 48.73 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 123.52 0.728 . . . . 0.0 111.925 176.036 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 14.7 m-85 -80.38 170.96 15.67 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 125.805 1.642 . . . . 0.0 111.695 -178.568 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 22.9 t70 -119.63 -39.07 2.9 Favored 'General case' 0 N--CA 1.464 0.272 0 C-N-CA 123.185 0.594 . . . . 0.0 111.599 177.318 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -139.32 133.96 39.73 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.494 0 CA-C-O 121.98 0.895 . . . . 0.0 110.639 -170.204 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 70.4 t -142.69 133.45 23.77 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.632 0 N-CA-C 105.746 -1.946 . . . . 0.0 105.746 -176.382 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 33.6 mm -124.94 122.09 62.59 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.527 0 N-CA-C 106.448 -1.686 . . . . 0.0 106.448 -171.603 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 58.7 m -87.09 122.59 31.12 Favored 'General case' 0 N--CA 1.441 -0.884 0 N-CA-C 105.204 -2.147 . . . . 0.0 105.204 169.0 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 69.3 mt -83.92 3.39 34.25 Favored 'General case' 0 C--N 1.327 -0.37 0 O-C-N 121.711 -0.618 . . . . 0.0 110.341 175.153 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 29.7 p -160.82 141.57 11.56 Favored 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 124.838 1.255 . . . . 0.0 108.249 169.728 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 57.97 -162.2 9.71 Favored Glycine 0 CA--C 1.534 1.223 0 C-N-CA 124.581 1.086 . . . . 0.0 114.523 170.26 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 10.9 p -152.17 147.75 26.8 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 125.367 1.467 . . . . 0.0 107.536 170.303 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 59.1 44.2 96.5 Favored Glycine 0 CA--C 1.533 1.176 0 N-CA-C 111.145 -0.782 . . . . 0.0 111.145 -178.107 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 29.8 m -79.8 52.53 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.545 0.775 0 C-N-CA 124.845 1.258 . . . . 0.0 112.799 -169.589 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 17.5 t-20 56.06 53.09 9.51 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 126.295 1.838 . . . . 0.0 108.827 -175.275 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -147.74 147.17 26.5 Favored Pre-proline 0 CA--C 1.54 0.579 0 C-N-CA 126.913 2.085 . . . . 0.0 107.34 -169.28 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_exo -64.24 138.34 60.68 Favored 'Trans proline' 0 CA--C 1.542 0.892 0 CA-C-N 120.692 1.283 . . . . 0.0 112.693 -171.878 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -67.15 -28.37 40.77 Favored 'Trans proline' 0 N--CA 1.458 -0.567 0 C-N-CA 122.667 2.245 . . . . 0.0 114.425 -169.393 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 5.1 pm0 -62.13 -15.92 48.95 Favored 'General case' 0 CA--C 1.536 0.42 0 CA-C-N 120.404 1.456 . . . . 0.0 112.53 -178.275 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 96.4 m95 -73.38 -49.36 27.62 Favored 'General case' 0 N--CA 1.451 -0.394 0 C-N-CA 123.242 0.617 . . . . 0.0 110.848 174.371 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 28.6 m -79.87 -0.29 3.79 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.359 0 C-N-CA 123.615 0.766 . . . . 0.0 112.717 -178.446 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 57.7 p -113.33 25.32 11.42 Favored 'General case' 0 C--O 1.237 0.409 0 CA-C-N 119.547 1.067 . . . . 0.0 113.155 174.033 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 76.2 mm-40 -66.57 174.22 2.94 Favored 'General case' 0 CA--C 1.539 0.528 0 CA-C-N 118.611 0.641 . . . . 0.0 112.084 176.251 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 32.7 mm-40 -54.57 -29.44 51.25 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 124.038 0.935 . . . . 0.0 111.723 -169.765 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 3.3 tt -133.7 130.63 56.36 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.672 0 N-CA-C 104.041 -2.577 . . . . 0.0 104.041 168.388 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 44.1 t80 -120.86 142.03 50.03 Favored 'General case' 0 N--CA 1.448 -0.546 0 N-CA-C 105.921 -1.881 . . . . 0.0 105.921 169.221 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 20.6 mm-40 -139.79 144.49 37.39 Favored 'General case' 0 C--O 1.236 0.373 0 N-CA-C 107.624 -1.25 . . . . 0.0 107.624 170.112 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 6.0 t0 -110.56 107.69 17.39 Favored 'General case' 0 C--O 1.238 0.484 0 N-CA-C 105.168 -2.16 . . . . 0.0 105.168 169.093 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -99.53 125.37 45.29 Favored 'General case' 0 N--CA 1.454 -0.269 0 C-N-CA 123.377 0.671 . . . . 0.0 109.546 -173.301 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 34.2 mm-40 -89.05 116.98 27.73 Favored 'General case' 0 N--CA 1.456 -0.163 0 N-CA-C 105.416 -2.068 . . . . 0.0 105.416 168.823 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.517 HD13 HG22 ' A' ' 119' ' ' VAL . 28.9 mt -142.95 127.69 18.17 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 104.638 -2.356 . . . . 0.0 104.638 -179.738 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 26.5 mm-40 -63.48 157.77 22.59 Favored 'General case' 0 CA--C 1.534 0.333 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 172.722 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -117.13 135.03 22.98 Favored Pre-proline 0 N--CA 1.45 -0.426 0 C-N-CA 124.526 1.13 . . . . 0.0 108.105 169.687 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -89.09 -8.68 4.72 Favored 'Trans proline' 0 N--CA 1.453 -0.882 0 C-N-CA 122.285 1.99 . . . . 0.0 114.674 -170.138 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -50.7 -51.4 49.97 Favored 'General case' 0 N--CA 1.472 0.672 0 CA-C-N 120.554 1.525 . . . . 0.0 113.14 -169.31 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -84.31 11.84 56.93 Favored Glycine 0 CA--C 1.532 1.147 0 CA-C-O 118.702 -1.055 . . . . 0.0 113.396 -176.49 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 9.8 mt-30 -130.98 176.45 8.23 Favored 'General case' 0 CA--C 1.542 0.664 0 CA-C-N 118.847 1.324 . . . . 0.0 110.654 -169.683 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 13.9 m -78.23 169.7 17.83 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 124.604 1.161 . . . . 0.0 112.242 -173.592 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 34.4 tp -55.19 -33.93 63.45 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 125.86 1.664 . . . . 0.0 113.058 -178.11 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 5.9 pt-20 -56.99 -34.71 68.41 Favored 'General case' 0 N--CA 1.463 0.208 0 C-N-CA 123.483 0.713 . . . . 0.0 111.608 174.782 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 16.0 t -76.63 -38.52 30.96 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.525 0 CA-C-O 118.02 -0.991 . . . . 0.0 109.801 -176.874 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 112' ' ' PHE . . . . . 0.407 ' CZ ' ' HB ' ' A' ' 45' ' ' THR . 85.2 m-85 -57.02 -48.13 79.23 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-N 120.377 1.444 . . . . 0.0 109.547 171.545 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 85.6 mtt180 -63.72 -39.46 94.35 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 122.916 0.486 . . . . 0.0 111.247 -179.613 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 5.7 m -67.34 -49.6 63.37 Favored 'General case' 0 N--CA 1.452 -0.339 0 C-N-CA 124.203 1.001 . . . . 0.0 110.226 177.975 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 59.2 t -65.56 -35.13 74.52 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.306 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 -173.697 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 58.7 ttp85 -56.42 -45.18 80.84 Favored 'General case' 0 CA--C 1.537 0.475 0 CA-C-N 118.499 0.59 . . . . 0.0 109.76 174.077 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -64.18 -51.63 51.24 Favored Glycine 0 CA--C 1.53 1.006 0 CA-C-N 118.346 0.521 . . . . 0.0 112.208 175.922 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 9.4 mt-30 -61.52 -43.21 99.27 Favored 'General case' 0 N--CA 1.468 0.428 0 CA-C-N 118.258 1.029 . . . . 0.0 110.713 -175.364 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 119' ' ' VAL . . . . . 0.517 HG22 HD13 ' A' ' 101' ' ' LEU . 95.6 t -70.58 -40.66 77.48 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.377 0 CA-C-O 118.399 -0.81 . . . . 0.0 109.265 -176.011 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 58.2 tttm -54.94 -45.85 74.88 Favored 'General case' 0 CA--C 1.518 -0.276 0 CA-C-N 119.275 0.943 . . . . 0.0 109.093 174.906 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 41.5 tt0 -66.84 -43.16 84.43 Favored 'General case' 0 N--CA 1.45 -0.446 0 C-N-CA 122.761 0.424 . . . . 0.0 111.043 -173.794 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 36.3 mtt-85 -66.21 -40.75 90.56 Favored 'General case' 0 N--CA 1.471 0.599 0 O-C-N 121.413 -0.804 . . . . 0.0 111.722 176.857 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 90.2 t -68.77 -37.61 77.7 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.499 0 N-CA-C 108.952 -0.758 . . . . 0.0 108.952 179.289 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 13.4 mt-10 -60.01 -43.8 94.99 Favored 'General case' 0 C--O 1.226 -0.174 0 CA-C-N 119.308 0.958 . . . . 0.0 110.064 174.13 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 29.2 t-20 -63.02 -45.27 93.13 Favored 'General case' 0 CA--C 1.53 0.204 0 CA-C-N 118.124 0.42 . . . . 0.0 111.103 -179.489 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 38.6 tp -57.75 -49.11 77.66 Favored 'General case' 0 N--CA 1.452 -0.364 0 C-N-CA 124.684 1.194 . . . . 0.0 110.489 176.715 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 70.0 mt -63.49 -46.78 94.23 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 N-CA-C 108.12 -1.067 . . . . 0.0 108.12 -179.408 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -59.13 -29.64 67.54 Favored 'General case' 0 CA--C 1.535 0.377 0 CA-C-O 118.325 -0.845 . . . . 0.0 112.251 -178.426 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . 0.25 19.3 ptpt -83.17 -39.05 21.52 Favored 'General case' 0 C--N 1.343 0.323 0 CA-C-O 117.863 -1.065 . . . . 0.0 112.616 175.421 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 12.6 pt -82.46 -40.19 16.72 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.362 0 CA-C-N 120.207 1.367 . . . . 0.0 113.497 -175.166 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 70.8 m . . . . . 0 C--O 1.253 1.24 0 C-N-CA 125.692 1.597 . . . . 0.0 109.848 -170.05 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 9.8 ptm . . . . . 0 N--CA 1.496 1.872 0 N-CA-C 110.622 -0.14 . . . . 0.0 110.622 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 27.5 mttm -75.09 121.25 21.75 Favored 'General case' 0 N--CA 1.48 1.045 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 -171.24 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 91.6 mttt -88.15 134.75 33.69 Favored 'General case' 0 CA--C 1.512 -0.491 0 N-CA-C 108.075 -1.083 . . . . 0.0 108.075 177.201 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 1.9 t -123.35 147.93 27.49 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.648 0 C-N-CA 126.574 1.95 . . . . 0.0 108.89 -168.994 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 34.3 mtt -137.02 150.5 48.14 Favored 'General case' 0 C--N 1.325 -0.493 0 C-N-CA 124.671 1.189 . . . . 0.0 108.215 168.049 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 35.7 m-85 -129.29 129.54 45.03 Favored 'General case' 0 CA--C 1.515 -0.397 0 N-CA-C 103.833 -2.654 . . . . 0.0 103.833 169.715 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 1.1 p -152.78 136.39 8.17 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.366 0 CA-C-O 121.352 0.596 . . . . 0.0 109.587 -169.276 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 49.9 t -122.08 174.66 6.79 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 127.317 2.247 . . . . 0.0 107.182 169.661 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 51.5 tttm -63.78 -32.28 73.73 Favored 'General case' 0 CA--C 1.539 0.531 0 O-C-N 121.226 -0.921 . . . . 0.0 111.303 179.275 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 74.4 mtm-85 -108.63 162.94 13.68 Favored 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 124.815 1.246 . . . . 0.0 108.003 169.615 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 7.3 t30 -70.55 -54.77 10.8 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-O 121.366 0.603 . . . . 0.0 110.296 172.625 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 12.4 m -89.75 46.39 1.36 Allowed 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 123.499 0.72 . . . . 0.0 111.454 -168.953 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 50.6 m -139.78 118.17 12.12 Favored 'General case' 0 N--CA 1.448 -0.548 0 N-CA-C 106.81 -1.552 . . . . 0.0 106.81 170.073 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 79.2 mtt180 64.96 -26.88 0.09 Allowed 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 129.02 2.928 . . . . 0.0 115.218 176.537 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 1.2 m -76.67 -140.79 0.02 OUTLIER 'General case' 0 CA--C 1.549 0.916 0 N-CA-C 104.658 -2.349 . . . . 0.0 104.658 168.036 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 22.5 pt20 49.43 26.44 1.65 Allowed 'General case' 0 N--CA 1.475 0.813 0 CA-C-N 121.047 1.749 . . . . 0.0 112.455 178.311 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' MET . . . . . 0.428 ' HG2' ' CE ' ' A' ' 50' ' ' MET . 0.0 OUTLIER -171.42 -49.34 0.02 OUTLIER 'General case' 0 N--CA 1.446 -0.663 0 C-N-CA 127.748 2.419 . . . . 0.0 108.515 -175.102 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 18' ' ' ALA . . . . . 0.407 ' HA ' ' CG1' ' A' ' 119' ' ' VAL . . . -71.88 -45.94 59.53 Favored 'General case' 0 C--N 1.343 0.321 0 C-N-CA 123.448 0.699 . . . . 0.0 112.749 -169.562 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -63.71 -35.58 81.02 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 169.493 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -49.75 -66.06 2.5 Favored Glycine 0 C--N 1.341 0.811 0 C-N-CA 126.021 1.772 . . . . 0.0 110.745 174.851 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 2.5 m-85 -59.75 -27.67 66.7 Favored 'General case' 0 CA--C 1.512 -0.497 0 O-C-N 121.103 -1.234 . . . . 0.0 112.519 178.492 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -71.65 -32.8 68.31 Favored 'General case' 0 N--CA 1.447 -0.599 0 CA-C-O 117.71 -1.138 . . . . 0.0 112.117 -176.526 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.29 -30.44 70.3 Favored 'General case' 0 N--CA 1.476 0.848 0 CA-C-N 120.517 1.508 . . . . 0.0 110.903 172.065 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 18.8 m -75.92 -56.63 4.49 Favored 'General case' 0 N--CA 1.448 -0.54 0 C-N-CA 124.638 1.175 . . . . 0.0 111.078 -176.864 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 71.9 mt -78.56 -38.06 41.25 Favored 'General case' 0 C--N 1.33 -0.267 0 C-N-CA 124.3 1.04 . . . . 0.0 109.807 -173.771 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -80.54 2.75 76.98 Favored Glycine 0 CA--C 1.527 0.811 0 C-N-CA 124.838 1.209 . . . . 0.0 112.971 179.929 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -53.35 129.74 32.85 Favored 'General case' 0 C--O 1.236 0.389 0 CA-C-N 118.462 1.131 . . . . 0.0 109.301 179.809 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 75.44 5.32 77.33 Favored Glycine 0 CA--C 1.536 1.397 0 C-N-CA 124.378 0.99 . . . . 0.0 114.464 -178.606 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 41.0 mttp -128.23 -52.32 1.29 Allowed 'General case' 0 N--CA 1.472 0.671 0 CA-C-N 119.087 1.444 . . . . 0.0 111.373 -172.375 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 29.5 pt -140.02 147.43 23.67 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.502 0 C-N-CA 123.57 0.748 . . . . 0.0 109.59 -169.407 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -105.32 104.85 14.66 Favored 'General case' 0 N--CA 1.464 0.261 0 C-N-CA 124.889 1.275 . . . . 0.0 109.035 -172.825 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 9.8 p -80.24 137.47 21.48 Favored 'Isoleucine or valine' 0 C--O 1.236 0.357 0 CA-C-N 119.126 0.876 . . . . 0.0 109.431 173.86 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 6.6 m -134.56 117.9 16.67 Favored 'General case' 0 N--CA 1.434 -1.264 0 N-CA-C 104.686 -2.339 . . . . 0.0 104.686 173.766 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 2.4 m -89.74 39.62 0.96 Allowed 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 113.01 0.744 . . . . 0.0 113.01 -169.643 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 1.5 m -65.19 159.68 23.05 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 124.515 1.126 . . . . 0.0 111.077 178.549 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -177.64 -165.85 33.35 Favored Glycine 0 C--N 1.337 0.618 0 N-CA-C 108.678 -1.769 . . . . 0.0 108.678 -175.542 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 12.4 mt -132.49 160.59 36.04 Favored 'General case' 0 N--CA 1.445 -0.679 0 C-N-CA 126.547 1.939 . . . . 0.0 107.773 177.473 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 21.5 mt-10 56.13 18.04 3.02 Favored 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 124.627 1.171 . . . . 0.0 112.885 178.639 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 13.7 p -76.35 163.53 26.91 Favored 'General case' 0 N--CA 1.435 -1.179 0 N-CA-C 115.054 1.501 . . . . 0.0 115.054 -167.841 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 8.0 m -153.82 177.21 11.25 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 129.15 2.98 . . . . 0.0 105.98 -169.735 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 53.6 ttt180 -88.9 153.13 21.29 Favored 'General case' 0 CA--C 1.533 0.297 0 O-C-N 121.07 -1.019 . . . . 0.0 109.737 -177.505 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 1.9 p -44.72 149.54 0.25 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.439 0 C-N-CA 128.035 2.534 . . . . 0.0 112.568 169.987 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 23.0 m170 -88.69 152.81 49.59 Favored Pre-proline 0 CA--C 1.543 0.7 0 C-N-CA 123.274 0.63 . . . . 0.0 111.2 -179.563 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -59.08 -52.98 4.1 Favored 'Trans proline' 0 C--N 1.351 0.665 0 C-N-CA 124.149 3.233 . . . . 0.0 114.204 -169.091 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 7.3 m -67.37 -24.58 65.71 Favored 'General case' 0 CA--C 1.537 0.445 0 CA-C-O 119.215 -0.421 . . . . 0.0 110.651 -171.407 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -56.8 -53.8 53.7 Favored 'General case' 0 CA--C 1.511 -0.548 0 N-CA-C 109.177 -0.675 . . . . 0.0 109.177 173.231 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 52.1 mt -60.6 -38.59 78.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 -170.424 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -62.92 -49.13 75.98 Favored 'General case' 0 N--CA 1.454 -0.243 0 CA-C-N 118.595 0.634 . . . . 0.0 111.244 178.957 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 30.2 mmt -67.46 -37.14 82.48 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-O 122.779 1.276 . . . . 0.0 110.968 179.964 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 50' ' ' MET . . . . . 0.428 ' CE ' ' HG2' ' A' ' 17' ' ' MET . 0.0 OUTLIER -74.3 -31.61 62.55 Favored 'General case' 0 N--CA 1.443 -0.779 0 N-CA-C 107.2 -1.408 . . . . 0.0 107.2 -176.08 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 40.2 tt0 -72.07 -20.84 61.6 Favored 'General case' 0 N--CA 1.449 -0.52 0 O-C-N 121.211 -0.931 . . . . 0.0 110.788 170.699 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 20.6 mm-40 -66.01 -32.23 73.59 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-N 119.571 1.078 . . . . 0.0 109.89 169.912 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 15.7 m -91.97 13.63 1.98 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.835 0 CA-C-N 118.361 0.528 . . . . 0.0 112.036 169.037 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 75.82 15.97 80.97 Favored Glycine 0 CA--C 1.532 1.123 0 C-N-CA 124.99 1.281 . . . . 0.0 113.981 173.006 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 3.5 mt -99.54 140.8 18.04 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.113 0 C-N-CA 124.588 1.155 . . . . 0.0 111.201 -171.613 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 3.0 t70 -97.04 130.72 44.31 Favored 'General case' 0 CA--C 1.528 0.12 0 C-N-CA 125.421 1.489 . . . . 0.0 108.886 169.857 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 6.5 pt -132.58 -31.27 0.55 Allowed 'Isoleucine or valine' 0 C--O 1.216 -0.689 0 C-N-CA 125.78 1.632 . . . . 0.0 109.501 169.673 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -15.76 -36.37 0.0 OUTLIER 'General case' 0 CA--C 1.545 0.763 1 C-N-CA 131.768 4.027 . . . . 0.0 118.5 169.992 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -110.25 37.2 3.86 Favored Glycine 0 CA--C 1.534 1.251 0 C-N-CA 125.921 1.724 . . . . 0.0 113.858 -179.507 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 6.3 mt-30 -59.88 -30.48 69.02 Favored 'General case' 0 N--CA 1.474 0.75 0 CA-C-N 119.63 1.715 . . . . 0.0 114.232 -174.719 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -57.8 123.73 16.74 Favored 'General case' 0 C--O 1.236 0.342 0 C-N-CA 124.043 0.937 . . . . 0.0 109.135 -169.421 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 75.2 m -145.96 177.28 9.06 Favored 'General case' 0 N--CA 1.443 -0.802 0 C-N-CA 126.452 1.901 . . . . 0.0 107.019 -169.369 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -59.26 153.95 44.48 Favored Pre-proline 0 C--O 1.239 0.543 0 C-N-CA 123.691 0.796 . . . . 0.0 111.49 175.756 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -63.48 154.16 70.34 Favored 'Trans proline' 0 N--CA 1.454 -0.826 0 C-N-CA 122.49 2.127 . . . . 0.0 109.84 170.879 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 3.2 tt -61.95 -24.41 34.32 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.522 0 O-C-N 121.701 -0.624 . . . . 0.0 111.212 -175.764 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 12.6 mt-10 -65.96 -26.23 67.48 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 124.751 1.22 . . . . 0.0 110.81 -177.377 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 7.6 t-20 -63.12 -23.89 67.65 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 124.673 1.189 . . . . 0.0 111.942 179.085 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 75.0 m-85 -104.62 -174.68 2.59 Favored 'General case' 0 C--O 1.236 0.367 0 C-N-CA 126.19 1.796 . . . . 0.0 110.357 -174.819 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 56.3 t-20 -135.82 132.83 37.16 Favored 'General case' 0 N--CA 1.443 -0.819 0 N-CA-C 106.176 -1.787 . . . . 0.0 106.176 168.855 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -75.0 -19.75 59.95 Favored 'General case' 0 N--CA 1.431 -1.38 0 C-N-CA 120.125 -0.63 . . . . 0.0 109.389 -176.585 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 35.5 t70 -65.03 -24.71 67.57 Favored 'General case' 0 N--CA 1.442 -0.829 0 O-C-N 122.211 -0.305 . . . . 0.0 111.235 179.127 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -77.0 -28.81 55.18 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 123.773 0.829 . . . . 0.0 111.779 173.872 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 11.6 m-85 -77.35 168.21 20.41 Favored 'General case' 0 N--CA 1.451 -0.42 0 C-N-CA 125.261 1.424 . . . . 0.0 111.342 178.863 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -117.28 -39.21 3.22 Favored 'General case' 0 C--O 1.234 0.266 0 C-N-CA 123.213 0.605 . . . . 0.0 111.249 177.256 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -138.2 135.02 44.73 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.693 0 CA-C-O 122.021 0.915 . . . . 0.0 109.943 -169.887 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 75.6 t -142.09 133.89 26.65 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.451 0 N-CA-C 105.905 -1.887 . . . . 0.0 105.905 176.708 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 39.7 mm -117.78 102.82 13.89 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.78 0 N-CA-C 105.253 -2.129 . . . . 0.0 105.253 -170.437 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 47.2 m -101.34 70.61 1.32 Allowed 'General case' 0 N--CA 1.439 -1.014 0 N-CA-C 106.458 -1.682 . . . . 0.0 106.458 -172.947 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -71.22 23.33 0.04 OUTLIER 'General case' 0 CA--C 1.542 0.655 0 N-CA-C 114.136 1.162 . . . . 0.0 114.136 -170.075 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 74.9 m -146.3 55.64 1.16 Allowed 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 125.823 1.649 . . . . 0.0 109.996 172.33 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 81.34 -167.0 48.55 Favored Glycine 0 CA--C 1.531 1.034 0 O-C-N 121.363 -0.835 . . . . 0.0 112.663 176.981 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 15.0 p -151.68 150.19 29.96 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 123.649 0.779 . . . . 0.0 110.375 -169.952 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 61.26 28.25 68.91 Favored Glycine 0 CA--C 1.531 1.036 0 C-N-CA 123.208 0.433 . . . . 0.0 112.081 -179.014 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 32.8 m -71.45 -34.43 53.25 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.612 0 CA-C-N 117.479 0.64 . . . . 0.0 111.719 -169.303 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 21.2 t-20 -178.13 -43.02 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 128.792 2.837 . . . . 0.0 106.14 174.318 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.437 ' HA ' ' HD3' ' A' ' 87' ' ' PRO . 3.0 tt -44.09 139.68 3.03 Favored Pre-proline 0 CA--C 1.547 0.859 0 C-N-CA 128.202 2.601 . . . . 0.0 111.295 169.659 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 87' ' ' PRO . . . . . 0.437 ' HD3' ' HA ' ' A' ' 86' ' ' LEU . 51.8 Cg_exo -65.17 150.98 86.99 Favored 'Trans proline' 0 C--N 1.356 0.936 0 C-N-CA 121.974 1.782 . . . . 0.0 115.658 -169.727 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 88' ' ' PRO . . . . . 0.431 ' HD3' ' HA ' ' A' ' 87' ' ' PRO . 51.2 Cg_exo -64.51 -30.47 61.63 Favored 'Trans proline' 0 C--N 1.349 0.594 0 C-N-CA 122.491 2.127 . . . . 0.0 114.972 -174.661 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -56.35 -21.05 22.05 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-N 119.49 1.041 . . . . 0.0 112.739 -177.026 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 99.4 m95 -80.06 -28.75 39.16 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 124.948 1.299 . . . . 0.0 112.188 -179.56 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 16.1 m -100.67 -4.35 9.29 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.41 0 C-N-CA 124.946 1.299 . . . . 0.0 112.019 179.623 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 59.8 p -103.27 30.37 4.95 Favored 'General case' 0 CA--C 1.535 0.39 0 CA-C-N 119.325 0.966 . . . . 0.0 112.449 175.644 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 46.1 mm-40 -72.33 175.06 6.47 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 123.344 0.658 . . . . 0.0 111.275 -175.354 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 36.2 mm-40 -61.54 -26.05 67.69 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-O 120.832 0.348 . . . . 0.0 110.513 179.758 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 4.1 tt -136.54 124.49 34.3 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.523 0 N-CA-C 104.997 -2.223 . . . . 0.0 104.997 169.169 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 20.9 t80 -103.49 135.01 45.89 Favored 'General case' 0 CA--C 1.538 0.49 0 N-CA-C 105.755 -1.943 . . . . 0.0 105.755 169.581 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 15.6 mm-40 -136.26 162.25 33.51 Favored 'General case' 0 C--O 1.235 0.291 0 N-CA-C 108.552 -0.907 . . . . 0.0 108.552 170.294 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 5.2 t0 -178.79 126.95 0.1 Allowed 'General case' 0 C--N 1.326 -0.439 0 C-N-CA 126.869 2.068 . . . . 0.0 105.643 -169.519 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 6.6 m0 -143.42 149.0 37.01 Favored 'General case' 0 C--N 1.333 -0.136 0 C-N-CA 122.616 0.366 . . . . 0.0 110.788 -170.933 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 1.9 tp-100 -82.73 54.04 2.56 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 124.338 1.055 . . . . 0.0 109.508 175.909 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 1.1 mp -64.28 147.13 53.16 Favored 'General case' 0 C--N 1.34 0.184 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 178.209 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 69.2 mm-40 -77.8 166.4 22.97 Favored 'General case' 0 CA--C 1.536 0.413 0 N-CA-C 108.229 -1.026 . . . . 0.0 108.229 169.496 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -135.08 137.74 27.69 Favored Pre-proline 0 CA--C 1.536 0.426 0 C-N-CA 124.161 0.984 . . . . 0.0 109.334 171.86 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 21.4 Cg_endo -92.94 3.77 3.43 Favored 'Trans proline' 0 N--CA 1.452 -0.944 0 C-N-CA 122.318 2.012 . . . . 0.0 114.781 -171.661 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -55.81 120.88 8.04 Favored 'General case' 0 C--O 1.237 0.399 0 CA-C-N 120.398 1.454 . . . . 0.0 110.841 -174.571 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 68.65 5.48 45.04 Favored Glycine 0 CA--C 1.534 1.274 0 CA-C-O 118.873 -0.96 . . . . 0.0 114.151 179.902 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 7.0 mt-30 -97.12 167.74 10.87 Favored 'General case' 0 CA--C 1.537 0.47 0 CA-C-N 118.882 1.341 . . . . 0.0 109.864 179.428 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 15.6 m -69.95 165.98 20.57 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 124.097 0.959 . . . . 0.0 111.754 179.762 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 64.7 mt -60.29 -26.77 66.76 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 123.924 0.89 . . . . 0.0 112.452 -175.594 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 5.8 pt-20 -56.29 -35.27 67.32 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 118.773 0.715 . . . . 0.0 111.162 173.934 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 11.9 t -77.27 -41.09 30.14 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.309 0 CA-C-O 118.203 -0.903 . . . . 0.0 109.823 -178.951 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 62.7 m-85 -57.21 -45.67 83.6 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-N 120.323 1.419 . . . . 0.0 109.596 172.091 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 92.4 mtt180 -63.77 -44.11 94.41 Favored 'General case' 0 N--CA 1.468 0.455 0 C-N-CA 123.395 0.678 . . . . 0.0 110.8 -179.789 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 5.3 m -60.9 -46.76 89.37 Favored 'General case' 0 N--CA 1.449 -0.475 0 C-N-CA 124.642 1.177 . . . . 0.0 109.998 176.281 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 69.4 t -70.09 -37.86 73.33 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.494 0 CA-C-O 117.704 -1.141 . . . . 0.0 109.116 -173.39 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 41.1 mtm105 -57.22 -43.36 82.75 Favored 'General case' 0 C--O 1.224 -0.275 0 CA-C-N 120.113 1.324 . . . . 0.0 110.131 172.859 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -63.67 -54.35 31.99 Favored Glycine 0 CA--C 1.53 1.022 0 CA-C-N 118.672 0.669 . . . . 0.0 111.766 179.128 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 49.8 mm-40 -52.69 -51.23 61.2 Favored 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 124.696 1.198 . . . . 0.0 110.049 177.838 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 119' ' ' VAL . . . . . 0.407 ' CG1' ' HA ' ' A' ' 18' ' ' ALA . 59.6 t -63.8 -50.22 78.64 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.666 0 CA-C-O 118.397 -0.811 . . . . 0.0 109.782 -176.172 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 86.7 tttt -56.38 -46.81 79.91 Favored 'General case' 0 CA--C 1.512 -0.483 0 N-CA-C 108.219 -1.03 . . . . 0.0 108.219 -175.059 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 40.2 tt0 -64.11 -42.88 96.71 Favored 'General case' 0 N--CA 1.446 -0.668 0 C-N-CA 122.945 0.498 . . . . 0.0 111.112 -175.561 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 25.4 mtt180 -74.61 -38.73 62.5 Favored 'General case' 0 N--CA 1.467 0.395 0 O-C-N 121.047 -1.033 . . . . 0.0 111.666 -178.046 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 85.2 t -65.29 -40.33 88.2 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.634 0 N-CA-C 108.441 -0.948 . . . . 0.0 108.441 174.676 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 4.2 mm-40 -60.54 -46.74 89.07 Favored 'General case' 0 C--O 1.227 -0.125 0 CA-C-N 119.489 1.041 . . . . 0.0 109.798 176.028 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 27.7 t-20 -64.36 -40.64 96.25 Favored 'General case' 0 CA--C 1.529 0.17 0 C-N-CA 123.039 0.536 . . . . 0.0 110.952 -176.471 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 24.2 tp -58.19 -50.13 74.6 Favored 'General case' 0 N--CA 1.451 -0.399 0 C-N-CA 124.875 1.27 . . . . 0.0 110.784 173.186 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 75.3 mt -66.12 -44.89 91.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 N-CA-C 107.808 -1.182 . . . . 0.0 107.808 -177.081 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -58.92 -33.93 71.13 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 123.315 0.646 . . . . 0.0 112.182 -179.796 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 17.8 ptpt -79.73 -38.95 32.21 Favored 'General case' 0 C--N 1.345 0.4 0 CA-C-O 117.926 -1.035 . . . . 0.0 112.101 177.634 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 11.1 pt -83.98 -40.6 15.82 Favored 'Isoleucine or valine' 0 C--O 1.234 0.271 0 CA-C-N 119.997 1.271 . . . . 0.0 113.699 -174.794 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 67.7 m . . . . . 0 C--O 1.254 1.333 0 C-N-CA 125.436 1.494 . . . . 0.0 110.06 -169.807 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 9.9 ptm . . . . . 0 N--CA 1.497 1.902 0 N-CA-C 110.837 -0.06 . . . . 0.0 110.837 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 2' ' ' LYS . . . . . 0.43 ' HB2' HG22 ' A' ' 30' ' ' ILE . 20.9 mttm -73.95 122.76 23.08 Favored 'General case' 0 N--CA 1.478 0.967 0 O-C-N 120.961 -1.087 . . . . 0.0 108.329 -171.083 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 93.7 mttt -89.23 134.92 33.84 Favored 'General case' 0 CA--C 1.515 -0.371 0 N-CA-C 108.156 -1.053 . . . . 0.0 108.156 176.403 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 1.9 t -122.26 149.98 25.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 C-N-CA 125.764 1.626 . . . . 0.0 109.655 -169.021 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 28.3 mtt -141.02 148.31 40.06 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 125.548 1.539 . . . . 0.0 108.31 168.667 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 65.4 m-85 -132.21 113.02 12.77 Favored 'General case' 0 N--CA 1.453 -0.318 0 N-CA-C 103.919 -2.623 . . . . 0.0 103.919 169.983 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 19.7 t -140.69 127.02 20.95 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 N-CA-C 107.07 -1.455 . . . . 0.0 107.07 -169.248 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 44.3 t -91.7 -152.07 0.29 Allowed 'General case' 0 CA--C 1.546 0.814 0 N-CA-C 105.621 -1.992 . . . . 0.0 105.621 169.239 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 64.0 tttp -58.95 -35.24 72.8 Favored 'General case' 0 N--CA 1.473 0.693 0 O-C-N 119.852 -1.78 . . . . 0.0 109.187 169.348 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 79.7 mtt180 -134.06 176.93 8.14 Favored 'General case' 0 N--CA 1.465 0.302 0 C-N-CA 125.462 1.505 . . . . 0.0 108.999 177.662 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 51.5 t30 -70.64 -15.35 62.73 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 123.387 0.675 . . . . 0.0 111.296 169.651 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 1.8 m -57.04 169.68 0.51 Allowed 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 126.682 1.993 . . . . 0.0 112.443 174.72 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 5.1 m 62.51 -92.51 0.03 OUTLIER 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 125.974 1.71 . . . . 0.0 113.885 169.549 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -92.68 -36.65 12.83 Favored 'General case' 0 N--CA 1.476 0.855 0 CA-C-N 119.851 1.205 . . . . 0.0 112.34 -174.247 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 1.2 m -59.72 -37.28 78.46 Favored 'General case' 0 N--CA 1.47 0.574 0 O-C-N 121.516 -0.74 . . . . 0.0 112.344 -169.659 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 22.2 pt20 -47.82 -46.09 30.5 Favored 'General case' 0 C--N 1.341 0.212 0 C-N-CA 125.008 1.323 . . . . 0.0 111.299 176.028 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -84.45 -38.59 19.97 Favored 'General case' 0 C--O 1.226 -0.183 0 CA-C-N 118.999 0.818 . . . . 0.0 111.139 -175.685 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -61.66 -47.88 83.36 Favored 'General case' 0 C--N 1.332 -0.16 0 C-N-CA 122.126 0.171 . . . . 0.0 111.307 -174.421 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 1.2 pp20? -71.01 -29.37 65.29 Favored 'General case' 0 C--O 1.235 0.309 0 C-N-CA 119.928 -0.709 . . . . 0.0 109.928 176.113 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -49.01 -62.54 4.54 Favored Glycine 0 C--N 1.34 0.805 0 C-N-CA 126.418 1.961 . . . . 0.0 110.457 173.917 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 9.7 m-85 -65.84 -31.21 72.03 Favored 'General case' 0 CA--C 1.512 -0.491 0 CA-C-N 119.35 1.575 . . . . 0.0 114.14 175.922 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -65.22 -33.05 75.09 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 119.56 1.073 . . . . 0.0 111.918 -169.823 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 5.9 ptpt -63.22 -33.79 76.25 Favored 'General case' 0 N--CA 1.476 0.846 0 CA-C-N 119.561 1.073 . . . . 0.0 111.646 173.312 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 6.6 m -75.31 -54.71 6.62 Favored 'General case' 0 N--CA 1.448 -0.528 0 C-N-CA 125.179 1.392 . . . . 0.0 110.002 -177.672 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 87.8 mt -73.41 -35.95 65.92 Favored 'General case' 0 CA--C 1.53 0.205 0 C-N-CA 123.667 0.787 . . . . 0.0 110.533 -173.509 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -93.43 6.27 74.77 Favored Glycine 0 CA--C 1.526 0.762 0 C-N-CA 125.117 1.342 . . . . 0.0 113.499 -175.757 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -48.72 123.92 7.61 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 125.06 1.344 . . . . 0.0 110.94 -173.389 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 77.9 -14.62 9.99 Favored Glycine 0 CA--C 1.536 1.368 0 C-N-CA 124.655 1.122 . . . . 0.0 114.472 178.406 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 61.9 mttm -95.39 -45.04 7.29 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-N 119.372 1.586 . . . . 0.0 110.48 179.655 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.43 HG22 ' HB2' ' A' ' 2' ' ' LYS . 25.7 pt -140.29 153.14 21.87 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.37 0 C-N-CA 123.776 0.83 . . . . 0.0 110.215 -169.534 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -113.15 104.98 12.9 Favored 'General case' 0 C--O 1.226 -0.162 0 C-N-CA 125.209 1.404 . . . . 0.0 108.611 -173.258 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 14.9 p -88.97 133.01 32.32 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.307 0 CA-C-N 118.988 0.813 . . . . 0.0 109.248 175.756 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 15.1 m -152.36 95.54 2.05 Favored 'General case' 0 N--CA 1.456 -0.157 0 N-CA-C 105.302 -2.111 . . . . 0.0 105.302 172.351 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 48.3 m -92.31 72.39 5.3 Favored 'General case' 0 C--O 1.232 0.184 0 CA-C-O 121.741 0.781 . . . . 0.0 111.03 -169.844 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 3.7 m -60.31 165.74 3.39 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 125.482 1.513 . . . . 0.0 109.925 170.066 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -161.1 -160.73 10.96 Favored Glycine 0 C--N 1.337 0.622 0 N-CA-C 109.209 -1.557 . . . . 0.0 109.209 -169.686 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 10.6 mt -133.56 -62.23 0.79 Allowed 'General case' 0 N--CA 1.45 -0.455 0 C-N-CA 123.329 0.651 . . . . 0.0 110.13 -169.731 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -80.44 -21.01 42.55 Favored 'General case' 0 CA--C 1.537 0.481 0 C-N-CA 124.013 0.925 . . . . 0.0 111.382 174.825 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 43.0 m -60.82 166.18 3.54 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 128.196 2.598 . . . . 0.0 116.086 -169.306 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 60.9 p -145.69 -96.68 0.09 Allowed 'General case' 0 N--CA 1.448 -0.529 0 CA-C-N 113.439 -1.71 . . . . 0.0 111.685 -168.604 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 6.4 ttt180 -140.97 179.67 6.59 Favored 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 125.366 1.466 . . . . 0.0 109.316 178.052 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 3.5 m -85.68 178.72 0.53 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.788 0 C-N-CA 123.701 0.8 . . . . 0.0 110.234 -174.442 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 18.4 m-70 -89.05 153.85 49.33 Favored Pre-proline 0 CA--C 1.546 0.801 0 C-N-CA 123.505 0.722 . . . . 0.0 110.825 -177.974 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 33.1 Cg_endo -65.72 -54.29 0.59 Allowed 'Trans proline' 0 C--N 1.349 0.554 0 C-N-CA 123.109 2.539 . . . . 0.0 113.033 -174.004 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 8.7 m -67.74 -24.46 65.36 Favored 'General case' 0 CA--C 1.535 0.381 0 O-C-N 121.97 -0.456 . . . . 0.0 110.337 -176.702 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -55.56 -52.03 65.11 Favored 'General case' 0 CA--C 1.509 -0.623 0 CA-C-O 119.198 -0.429 . . . . 0.0 109.862 173.266 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 37.3 mt -58.87 -42.32 85.4 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 N-CA-C 108.466 -0.939 . . . . 0.0 108.466 -172.778 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -62.21 -47.13 85.82 Favored 'General case' 0 N--CA 1.448 -0.534 0 CA-C-N 118.23 0.468 . . . . 0.0 110.724 -179.443 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 49' ' ' MET . . . . . 0.4 ' HG3' ' CG ' ' A' ' 112' ' ' PHE . 30.7 mmt -72.56 -33.7 66.99 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-O 122.251 1.024 . . . . 0.0 111.415 -177.144 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -74.49 -31.52 62.22 Favored 'General case' 0 N--CA 1.443 -0.821 0 N-CA-C 107.316 -1.364 . . . . 0.0 107.316 -179.144 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 41.6 tt0 -72.91 -22.77 60.68 Favored 'General case' 0 N--CA 1.444 -0.73 0 O-C-N 121.341 -0.849 . . . . 0.0 110.087 172.418 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 16.9 mm-40 -67.32 -29.71 69.36 Favored 'General case' 0 CA--C 1.532 0.28 0 CA-C-N 119.179 0.9 . . . . 0.0 110.334 171.392 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . 0.279 5.3 p -90.83 11.17 2.49 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.927 0 CA-C-N 118.552 0.615 . . . . 0.0 111.289 169.183 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 77.82 17.64 78.34 Favored Glycine 0 CA--C 1.531 1.034 0 C-N-CA 124.677 1.132 . . . . 0.0 113.65 173.773 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 6.9 mt -108.9 138.11 37.63 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.186 0 CA-C-N 118.723 1.262 . . . . 0.0 110.454 -175.374 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 4.3 t70 -90.07 138.36 31.57 Favored 'General case' 0 C--O 1.234 0.275 0 C-N-CA 123.929 0.891 . . . . 0.0 108.773 169.301 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 13.7 pt -130.5 -30.38 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.438 0 C-N-CA 124.67 1.188 . . . . 0.0 110.182 169.492 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -42.18 -35.87 1.06 Allowed 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 127.471 2.308 . . . . 0.0 114.253 169.035 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -65.55 -13.54 58.77 Favored Glycine 0 CA--C 1.53 1.02 0 C-N-CA 124.031 0.824 . . . . 0.0 113.506 -179.862 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 28.0 mt-30 -72.28 154.33 41.04 Favored 'General case' 0 N--CA 1.442 -0.84 0 CA-C-N 118.753 1.276 . . . . 0.0 111.372 172.589 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 2.4 p -152.11 161.7 42.23 Favored 'General case' 0 N--CA 1.433 -1.312 0 C-N-CA 129.826 3.25 . . . . 0.0 103.605 167.702 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 49.9 m -112.72 97.01 6.29 Favored 'General case' 0 C--O 1.234 0.287 0 N-CA-C 108.76 -0.83 . . . . 0.0 108.76 -170.444 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -68.84 152.85 96.56 Favored Pre-proline 0 C--O 1.241 0.646 0 N-CA-C 107.558 -1.275 . . . . 0.0 107.558 169.183 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -59.78 135.74 65.71 Favored 'Trans proline' 0 N--CA 1.449 -1.129 0 C-N-CA 121.531 1.487 . . . . 0.0 108.447 170.168 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 2.1 tt -61.77 -19.13 20.59 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.622 0 C-N-CA 123.703 0.801 . . . . 0.0 110.767 -179.445 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 12.8 mt-10 -66.32 -24.37 66.52 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 126.089 1.756 . . . . 0.0 110.669 179.418 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 13.3 t-20 -69.25 -0.45 6.16 Favored 'General case' 0 CA--C 1.546 0.798 0 C-N-CA 124.822 1.249 . . . . 0.0 112.603 176.346 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 14.0 m-85 -137.22 -170.95 2.84 Favored 'General case' 0 C--O 1.236 0.392 0 C-N-CA 127.604 2.362 . . . . 0.0 108.245 -179.155 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 57.0 t-20 -141.08 141.87 34.21 Favored 'General case' 0 N--CA 1.45 -0.46 0 N-CA-C 107.657 -1.238 . . . . 0.0 107.657 169.577 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.544 ' HB2' ' CD2' ' A' ' 90' ' ' TRP . . . -71.8 -28.85 63.88 Favored 'General case' 0 N--CA 1.434 -1.267 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 178.98 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 36.6 t70 -65.86 -20.98 66.42 Favored 'General case' 0 CA--C 1.546 0.799 0 C-N-CA 120.582 -0.447 . . . . 0.0 111.015 -177.806 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -80.18 -28.91 38.64 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 124.677 1.191 . . . . 0.0 111.79 173.999 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 8.0 m-85 -77.57 169.84 17.61 Favored 'General case' 0 C--O 1.238 0.465 0 C-N-CA 125.152 1.381 . . . . 0.0 111.8 179.956 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 23.5 t70 -118.3 -39.98 2.99 Favored 'General case' 0 C--O 1.235 0.33 0 C-N-CA 123.437 0.695 . . . . 0.0 111.606 178.593 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -139.44 134.49 39.73 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.395 0 CA-C-O 121.393 0.616 . . . . 0.0 110.113 -170.111 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 70.5 t -145.52 129.7 11.81 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.495 0 N-CA-C 105.554 -2.017 . . . . 0.0 105.554 179.424 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.615 HD12 ' HB2' ' A' ' 97' ' ' GLU . 11.6 mm -104.85 130.55 55.7 Favored 'Isoleucine or valine' 0 C--O 1.236 0.392 0 N-CA-C 106.759 -1.571 . . . . 0.0 106.759 176.484 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 37.5 m -96.87 91.2 5.53 Favored 'General case' 0 N--CA 1.446 -0.672 0 N-CA-C 104.677 -2.342 . . . . 0.0 104.677 169.028 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 33.9 mt -61.62 -12.86 17.8 Favored 'General case' 0 N--CA 1.465 0.314 0 C-N-CA 123.399 0.68 . . . . 0.0 112.748 -175.368 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 56.7 m -143.54 134.65 25.67 Favored 'General case' 0 N--CA 1.445 -0.696 0 N-CA-C 106.075 -1.824 . . . . 0.0 106.075 179.194 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 57.03 -146.3 36.17 Favored Glycine 0 CA--C 1.533 1.195 0 C-N-CA 123.452 0.548 . . . . 0.0 111.826 178.929 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 19.6 p -127.23 -93.56 0.47 Allowed 'General case' 0 CA--C 1.529 0.172 0 C-N-CA 124.052 0.941 . . . . 0.0 108.822 174.163 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -72.85 -27.5 68.81 Favored Glycine 0 C--N 1.337 0.602 0 CA-C-O 118.898 -0.945 . . . . 0.0 112.482 -178.442 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.441 HG23 ' H ' ' A' ' 85' ' ' ASN 0.325 16.0 m 47.18 -94.04 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.545 0.754 0 C-N-CA 126.404 1.882 . . . . 0.0 112.602 179.452 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 85' ' ' ASN . . . . . 0.441 ' H ' HG23 ' A' ' 84' ' ' VAL . 53.0 t30 -142.91 45.4 1.58 Allowed 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 126.105 1.762 . . . . 0.0 108.068 178.408 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.412 ' HA ' ' HD3' ' A' ' 87' ' ' PRO . 0.3 OUTLIER -143.14 147.08 39.4 Favored Pre-proline 0 CA--C 1.548 0.88 0 C-N-CA 125.408 1.483 . . . . 0.0 110.624 -168.89 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 87' ' ' PRO . . . . . 0.412 ' HD3' ' HA ' ' A' ' 86' ' ' LEU . 51.8 Cg_exo -64.67 150.3 88.4 Favored 'Trans proline' 0 C--N 1.357 1.005 0 C-N-CA 122.08 1.853 . . . . 0.0 114.498 -170.973 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -67.19 -33.52 30.79 Favored 'Trans proline' 0 N--CA 1.458 -0.616 0 C-N-CA 122.795 2.33 . . . . 0.0 116.014 -169.204 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 3.1 pm0 -63.33 -15.26 56.84 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-N 121.573 1.988 . . . . 0.0 112.045 -178.719 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 90' ' ' TRP . . . . . 0.544 ' CD2' ' HB2' ' A' ' 70' ' ' ALA . 98.2 m95 -76.51 -22.95 53.76 Favored 'General case' 0 N--CA 1.452 -0.341 0 CA-C-O 118.835 -0.602 . . . . 0.0 111.953 174.597 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 28.3 m -104.46 -6.85 9.63 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.488 0 C-N-CA 124.832 1.253 . . . . 0.0 113.163 178.023 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . 0.271 9.3 t -112.73 70.62 0.72 Allowed 'General case' 0 CA--C 1.537 0.454 0 CA-C-O 123.441 1.591 . . . . 0.0 107.539 168.899 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 60.4 mm-40 -100.67 179.46 4.41 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 126.545 1.938 . . . . 0.0 109.084 175.067 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 37.7 mm-40 -64.95 -24.18 67.44 Favored 'General case' 0 CA--C 1.539 0.543 0 O-C-N 121.743 -0.598 . . . . 0.0 110.94 179.892 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 6.9 tt -139.63 130.08 31.33 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.354 0 N-CA-C 105.807 -1.923 . . . . 0.0 105.807 169.329 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 36.8 t80 -113.36 135.54 53.75 Favored 'General case' 0 CA--C 1.536 0.41 0 N-CA-C 105.713 -1.958 . . . . 0.0 105.713 169.643 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 97' ' ' GLU . . . . . 0.615 ' HB2' HD12 ' A' ' 77' ' ' ILE . 11.1 mm-40 -142.44 163.29 33.23 Favored 'General case' 0 C--O 1.232 0.165 0 C-N-CA 124.311 1.044 . . . . 0.0 109.524 179.666 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 2.7 t70 -172.46 129.64 0.56 Allowed 'General case' 0 C--O 1.237 0.422 0 C-N-CA 127.594 2.358 . . . . 0.0 107.07 -169.366 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 99' ' ' TRP . . . . . 0.523 ' CZ3' HG21 ' A' ' 77' ' ' ILE . 5.9 m0 -144.58 153.5 41.87 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-O 120.99 0.424 . . . . 0.0 111.936 -170.637 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 2.3 mp0 -87.48 51.87 2.34 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 124.527 1.131 . . . . 0.0 109.456 175.789 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -67.42 134.59 51.7 Favored 'General case' 0 C--N 1.339 0.136 0 N-CA-C 106.5 -1.667 . . . . 0.0 106.5 169.823 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 6.4 pt-20 -83.18 171.55 13.56 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 123.488 0.715 . . . . 0.0 110.192 175.448 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -131.6 133.27 24.1 Favored Pre-proline 0 C--O 1.238 0.459 0 C-N-CA 125.849 1.66 . . . . 0.0 109.804 -169.805 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 10.6 Cg_endo -97.93 2.5 1.41 Allowed 'Trans proline' 0 N--CA 1.451 -1.004 0 C-N-CA 123.003 2.469 . . . . 0.0 113.538 -174.799 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 8.0 t70 -50.61 115.84 1.66 Allowed 'General case' 0 CA--C 1.538 0.518 0 CA-C-N 120.486 1.494 . . . . 0.0 110.787 -174.113 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 67.47 5.5 36.68 Favored Glycine 0 CA--C 1.537 1.434 0 CA-C-O 119.014 -0.881 . . . . 0.0 114.61 178.172 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 5.6 mt-30 -87.32 172.46 9.84 Favored 'General case' 0 CA--C 1.54 0.583 0 CA-C-N 118.998 1.399 . . . . 0.0 109.869 178.495 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 15.5 m -68.95 161.19 29.37 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 123.854 0.862 . . . . 0.0 110.559 176.897 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 28.1 mt -63.36 -24.42 67.84 Favored 'General case' 0 N--CA 1.47 0.561 0 O-C-N 121.491 -0.756 . . . . 0.0 112.499 -173.02 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 6.0 pt-20 -55.19 -35.49 64.89 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 118.875 0.761 . . . . 0.0 111.189 172.346 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 10.9 t -76.82 -42.08 33.02 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.398 0 CA-C-O 118.433 -0.794 . . . . 0.0 109.189 -178.811 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 112' ' ' PHE . . . . . 0.4 ' CG ' ' HG3' ' A' ' 49' ' ' MET . 55.4 m-85 -57.24 -45.36 83.99 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-N 120.222 1.374 . . . . 0.0 110.296 172.529 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 90.9 mtt180 -63.27 -43.82 96.86 Favored 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 123.327 0.651 . . . . 0.0 110.584 179.548 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 4.2 m -62.14 -45.6 92.7 Favored 'General case' 0 N--CA 1.448 -0.542 0 C-N-CA 124.518 1.127 . . . . 0.0 110.275 177.168 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 60.2 t -67.21 -39.34 82.82 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.404 0 CA-C-O 118.593 -0.718 . . . . 0.0 109.25 -174.892 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 44.0 mtm105 -57.41 -42.89 83.2 Favored 'General case' 0 CA--C 1.536 0.431 0 CA-C-N 119.31 0.959 . . . . 0.0 110.397 174.913 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -63.37 -54.13 34.4 Favored Glycine 0 CA--C 1.533 1.158 0 CA-C-O 119.576 -0.569 . . . . 0.0 112.08 177.548 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 13.3 mm-40 -51.65 -51.52 55.11 Favored 'General case' 0 N--CA 1.468 0.47 0 C-N-CA 124.66 1.184 . . . . 0.0 110.204 178.215 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 86.1 t -67.74 -48.17 76.95 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 115.186 -0.916 . . . . 0.0 109.684 -173.114 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 62.0 tttm -55.06 -47.51 74.74 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 119.388 0.995 . . . . 0.0 109.711 -175.033 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -64.68 -43.32 93.93 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 122.917 0.487 . . . . 0.0 111.214 -175.469 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 20.8 mtt180 -75.1 -33.97 61.67 Favored 'General case' 0 N--CA 1.469 0.511 0 O-C-N 121.277 -0.889 . . . . 0.0 111.623 -178.179 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 59.5 t -67.34 -39.8 83.51 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.419 0 N-CA-C 108.62 -0.882 . . . . 0.0 108.62 173.674 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 22.8 mt-10 -59.45 -43.05 93.27 Favored 'General case' 0 N--CA 1.462 0.157 0 CA-C-N 119.938 1.245 . . . . 0.0 110.403 174.112 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 29.2 t-20 -63.55 -43.39 97.19 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 123.151 0.58 . . . . 0.0 111.371 -178.918 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 1.9 tm? -59.1 -47.22 86.06 Favored 'General case' 0 N--CA 1.456 -0.152 0 C-N-CA 125.063 1.345 . . . . 0.0 110.947 175.253 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 84.8 mt -65.17 -46.09 92.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 N-CA-C 108.302 -0.999 . . . . 0.0 108.302 179.985 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -59.23 -29.62 67.65 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 123.431 0.692 . . . . 0.0 112.073 177.099 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 69.1 mttt -69.09 -55.21 11.43 Favored 'General case' 0 C--N 1.343 0.311 0 CA-C-N 119.033 0.833 . . . . 0.0 110.385 172.707 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 17.1 pt -78.7 -36.76 19.87 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.335 0 N-CA-C 114.854 1.427 . . . . 0.0 114.854 -169.609 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 75.3 m . . . . . 0 C--O 1.253 1.26 0 C-N-CA 126.185 1.794 . . . . 0.0 109.117 -169.898 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 12.3 ptm . . . . . 0 N--CA 1.497 1.877 0 CA-C-O 120.17 0.033 . . . . 0.0 110.987 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 26.7 mttm -71.08 127.49 32.75 Favored 'General case' 0 N--CA 1.478 0.945 0 N-CA-C 107.682 -1.229 . . . . 0.0 107.682 -174.496 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 72.7 mttt -97.91 133.71 42.03 Favored 'General case' 0 CA--C 1.512 -0.502 0 CA-C-N 119.785 1.175 . . . . 0.0 108.059 172.199 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.474 HG21 HD12 ' A' ' 30' ' ' ILE . 11.7 t -113.21 151.21 15.12 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.605 0 C-N-CA 127.237 2.215 . . . . 0.0 106.568 -170.916 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 52.3 ttm -146.43 141.94 27.65 Favored 'General case' 0 C--N 1.32 -0.676 0 C-N-CA 125.544 1.538 . . . . 0.0 108.708 174.751 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 47.4 m-85 -131.63 103.72 6.54 Favored 'General case' 0 CA--C 1.519 -0.233 0 N-CA-C 106.088 -1.819 . . . . 0.0 106.088 175.216 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 11.0 t -134.83 137.84 50.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 118.629 0.65 . . . . 0.0 110.812 -168.912 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 44.8 t -121.08 -171.66 2.24 Favored 'General case' 0 CA--C 1.548 0.875 0 N-CA-C 104.594 -2.373 . . . . 0.0 104.594 168.53 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 60.2 mtpt -57.18 -67.62 0.3 Allowed 'General case' 0 N--CA 1.471 0.617 0 CA-C-N 120.007 1.276 . . . . 0.0 111.365 -171.191 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 29.3 ttm-85 -111.8 132.83 54.41 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-N 119.47 1.032 . . . . 0.0 108.221 -178.759 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 12.6 t30 -54.56 -34.84 62.53 Favored 'General case' 0 N--CA 1.478 0.943 0 N-CA-C 114.177 1.177 . . . . 0.0 114.177 -169.665 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 5.7 m -57.94 -20.56 38.5 Favored 'General case' 0 CA--C 1.537 0.464 0 N-CA-C 114.242 1.201 . . . . 0.0 114.242 -170.373 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 21.2 m -134.13 151.79 51.53 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 124.513 1.125 . . . . 0.0 109.652 176.828 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 90.5 mtm-85 55.01 40.78 32.15 Favored 'General case' 0 N--CA 1.467 0.414 0 C-N-CA 126.024 1.729 . . . . 0.0 112.346 175.845 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 13.6 m -136.43 -73.78 0.44 Allowed 'General case' 0 CA--C 1.534 0.353 0 N-CA-C 104.052 -2.573 . . . . 0.0 104.052 169.044 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER 40.89 -109.81 0.11 Allowed 'General case' 0 N--CA 1.454 -0.244 0 C-N-CA 127.607 2.363 . . . . 0.0 112.135 168.017 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -76.54 -14.55 60.01 Favored 'General case' 0 CA--C 1.518 -0.261 0 N-CA-C 113.819 1.044 . . . . 0.0 113.819 -169.964 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -63.86 -50.58 68.27 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 119.608 1.094 . . . . 0.0 111.415 -169.135 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -66.82 -38.07 85.74 Favored 'General case' 0 N--CA 1.467 0.405 0 N-CA-C 109.573 -0.529 . . . . 0.0 109.573 173.39 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -55.69 -55.71 27.43 Favored Glycine 0 C--N 1.338 0.645 0 N-CA-C 110.881 -0.888 . . . . 0.0 110.881 -176.959 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 4.8 m-85 -65.9 -32.17 73.52 Favored 'General case' 0 CA--C 1.506 -0.718 0 CA-C-O 118.587 -0.72 . . . . 0.0 111.787 178.484 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -68.84 -32.92 72.95 Favored 'General case' 0 N--CA 1.446 -0.674 0 CA-C-N 118.965 0.802 . . . . 0.0 110.72 -178.051 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.74 -36.97 86.03 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-N 119.504 1.047 . . . . 0.0 110.066 172.256 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 19.0 m -70.09 -56.89 5.76 Favored 'General case' 0 N--CA 1.45 -0.429 0 C-N-CA 124.236 1.014 . . . . 0.0 112.26 -179.939 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 41.7 mt -75.19 -38.23 60.89 Favored 'General case' 0 N--CA 1.466 0.359 0 C-N-CA 124.809 1.244 . . . . 0.0 109.891 -173.513 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -82.51 4.13 79.38 Favored Glycine 0 CA--C 1.526 0.756 0 C-N-CA 125.585 1.564 . . . . 0.0 113.19 179.796 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -53.79 133.22 42.41 Favored 'General case' 0 C--O 1.236 0.358 0 CA-C-N 118.793 1.297 . . . . 0.0 109.279 178.913 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 70.19 8.57 62.18 Favored Glycine 0 CA--C 1.533 1.196 0 CA-C-O 118.444 -1.198 . . . . 0.0 114.969 177.837 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 9.8 ptpp? -137.01 -36.59 0.67 Allowed 'General case' 0 N--CA 1.473 0.724 0 CA-C-N 119.744 1.772 . . . . 0.0 113.079 179.727 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.474 HD12 HG21 ' A' ' 4' ' ' VAL . 17.6 pt -141.22 148.73 21.06 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.568 0 CA-C-N 119.807 1.185 . . . . 0.0 109.723 -177.477 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -95.26 158.22 15.55 Favored 'General case' 0 N--CA 1.467 0.412 0 C-N-CA 125.322 1.449 . . . . 0.0 108.181 176.81 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 21.7 t -141.34 134.19 30.0 Favored 'Isoleucine or valine' 0 C--O 1.236 0.374 0 N-CA-C 107.872 -1.159 . . . . 0.0 107.872 -176.421 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 26.7 m -147.23 113.41 5.86 Favored 'General case' 0 N--CA 1.44 -0.964 0 N-CA-C 106.751 -1.574 . . . . 0.0 106.751 171.711 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 50.3 m -99.65 97.8 8.72 Favored 'General case' 0 N--CA 1.449 -0.516 0 N-CA-C 108.423 -0.955 . . . . 0.0 108.423 169.578 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 7.7 p -68.07 -66.46 0.56 Allowed 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 125.566 1.546 . . . . 0.0 111.322 -175.952 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 110.17 135.07 6.96 Favored Glycine 0 CA--C 1.523 0.581 0 N-CA-C 108.428 -1.869 . . . . 0.0 108.428 -171.436 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 5.9 mt -70.71 -36.96 73.48 Favored 'General case' 0 CA--C 1.529 0.15 0 N-CA-C 109.003 -0.74 . . . . 0.0 109.003 171.31 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 34.4 mt-10 -126.77 160.97 29.3 Favored 'General case' 0 N--CA 1.445 -0.702 0 C-N-CA 129.624 3.17 . . . . 0.0 105.691 169.259 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 54.6 p -150.86 145.51 25.72 Favored 'General case' 0 N--CA 1.445 -0.715 0 N-CA-C 114.003 1.112 . . . . 0.0 114.003 -173.192 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 3.1 m -147.3 -82.94 0.12 Allowed 'General case' 0 N--CA 1.452 -0.351 0 CA-C-N 113.117 -1.856 . . . . 0.0 108.271 -173.119 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 5.8 ttp180 -159.22 -154.01 0.39 Allowed 'General case' 0 N--CA 1.466 0.339 0 N-CA-C 109.33 -0.619 . . . . 0.0 109.33 -179.29 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 2.9 p -133.12 148.79 31.19 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.7 0 C-N-CA 128.2 2.6 . . . . 0.0 105.529 177.988 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 81.5 t60 -73.38 136.97 78.16 Favored Pre-proline 0 CA--C 1.544 0.725 0 CA-C-O 118.646 -0.692 . . . . 0.0 110.5 -169.759 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 28.6 Cg_endo -60.75 -49.1 9.23 Favored 'Trans proline' 0 C--N 1.35 0.626 0 C-N-CA 123.181 2.587 . . . . 0.0 112.962 -172.918 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 18.5 m -67.05 -20.13 65.79 Favored 'General case' 0 CA--C 1.536 0.416 0 O-C-N 121.95 -0.469 . . . . 0.0 110.526 -177.881 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -59.52 -52.32 66.08 Favored 'General case' 0 CA--C 1.506 -0.737 0 N-CA-C 108.838 -0.801 . . . . 0.0 108.838 173.87 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 60.0 mt -56.89 -42.27 78.05 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 N-CA-C 108.729 -0.841 . . . . 0.0 108.729 -171.621 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -64.23 -47.95 77.7 Favored 'General case' 0 N--CA 1.45 -0.429 0 CA-C-N 117.826 0.285 . . . . 0.0 111.509 -179.798 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 38.9 mmt -69.26 -35.37 76.02 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-O 122.747 1.261 . . . . 0.0 110.76 -178.521 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -73.26 -33.05 65.06 Favored 'General case' 0 N--CA 1.443 -0.82 0 N-CA-C 106.887 -1.523 . . . . 0.0 106.887 -177.662 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 6.6 tp10 -70.24 -20.29 63.08 Favored 'General case' 0 N--CA 1.449 -0.522 0 C-N-CA 123.645 0.778 . . . . 0.0 110.775 170.807 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 81.5 mt-10 -64.26 -38.65 91.8 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-N 119.773 1.17 . . . . 0.0 109.353 169.666 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . 0.306 9.7 p -83.43 7.35 1.55 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.771 0 CA-C-O 120.805 0.336 . . . . 0.0 111.81 171.252 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 74.45 23.57 75.15 Favored Glycine 0 CA--C 1.531 1.071 0 O-C-N 120.838 -1.164 . . . . 0.0 113.028 175.981 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 38.4 mt -117.12 131.88 68.52 Favored 'Isoleucine or valine' 0 C--N 1.338 0.068 0 C-N-CA 124.831 1.252 . . . . 0.0 108.584 -176.552 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 34.6 t0 -101.59 146.39 27.75 Favored 'General case' 0 C--O 1.235 0.318 0 CA-C-O 121.028 0.442 . . . . 0.0 110.238 170.794 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 12.2 pt -135.98 -9.6 0.84 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.461 0 C-N-CA 127.081 2.152 . . . . 0.0 110.836 176.145 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 7.7 t -43.31 131.82 4.6 Favored 'General case' 0 CA--C 1.542 0.663 0 CA-C-N 120.249 1.386 . . . . 0.0 109.325 168.971 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 71.92 38.37 60.24 Favored Glycine 0 CA--C 1.532 1.114 0 CA-C-O 118.917 -0.935 . . . . 0.0 113.082 -177.299 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 29.9 mt-30 -56.25 -40.94 74.95 Favored 'General case' 0 N--CA 1.473 0.679 0 CA-C-N 118.888 1.344 . . . . 0.0 110.478 169.995 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -66.17 134.59 53.06 Favored 'General case' 0 N--CA 1.447 -0.592 0 C-N-CA 124.177 0.991 . . . . 0.0 109.413 -170.0 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 2.9 p -140.2 -68.77 0.41 Allowed 'General case' 0 C--O 1.233 0.226 0 C-N-CA 124.018 0.927 . . . . 0.0 108.929 -169.657 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -148.54 154.6 41.45 Favored Pre-proline 0 C--O 1.238 0.484 0 C-N-CA 126.021 1.728 . . . . 0.0 107.478 174.595 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -62.71 151.81 81.7 Favored 'Trans proline' 0 N--CA 1.456 -0.734 0 C-N-CA 121.831 1.687 . . . . 0.0 109.34 170.027 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 18.2 tt -56.19 -28.78 26.17 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.439 0 C-N-CA 123.25 0.62 . . . . 0.0 111.741 -178.687 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 11.4 mt-10 -66.72 -26.69 67.12 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 124.563 1.145 . . . . 0.0 110.689 -174.83 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 11.2 t-20 -63.6 -30.97 72.0 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 124.833 1.253 . . . . 0.0 111.611 178.424 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 94.1 m-85 -92.12 -178.11 4.88 Favored 'General case' 0 C--O 1.235 0.328 0 C-N-CA 125.269 1.428 . . . . 0.0 111.139 -176.61 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 54.6 t-20 -124.11 137.77 54.52 Favored 'General case' 0 N--CA 1.443 -0.79 0 N-CA-C 106.756 -1.572 . . . . 0.0 106.756 168.654 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.457 ' HB2' ' CD2' ' A' ' 90' ' ' TRP . . . -73.58 -24.4 60.07 Favored 'General case' 0 N--CA 1.433 -1.29 0 N-CA-C 109.187 -0.671 . . . . 0.0 109.187 -178.048 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 36.1 t70 -67.32 -20.56 65.62 Favored 'General case' 0 N--CA 1.447 -0.618 0 C-N-CA 121.221 -0.192 . . . . 0.0 111.474 -178.611 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 37.1 t70 -75.75 -29.07 58.73 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 123.526 0.73 . . . . 0.0 111.61 175.186 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 33.0 m-85 -80.17 167.24 20.6 Favored 'General case' 0 N--CA 1.45 -0.433 0 C-N-CA 125.058 1.343 . . . . 0.0 110.613 176.558 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 24.2 t70 -117.29 -35.4 4.04 Favored 'General case' 0 C--O 1.237 0.401 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.169 175.241 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -140.04 134.77 36.99 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.697 0 CA-C-O 121.922 0.868 . . . . 0.0 108.676 -173.399 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 88.7 t -143.36 137.72 25.9 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.604 0 N-CA-C 105.786 -1.931 . . . . 0.0 105.786 178.929 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.658 HD12 ' HB2' ' A' ' 97' ' ' GLU . 20.6 mm -112.75 127.3 70.06 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.727 0 N-CA-C 105.781 -1.933 . . . . 0.0 105.781 177.188 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 70.6 m -89.32 99.83 12.74 Favored 'General case' 0 N--CA 1.441 -0.918 0 N-CA-C 104.196 -2.52 . . . . 0.0 104.196 169.225 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 38.3 mt -69.56 -2.04 10.38 Favored 'General case' 0 N--CA 1.464 0.244 0 O-C-N 121.484 -0.76 . . . . 0.0 112.386 -178.578 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 85.4 m -139.58 135.05 32.96 Favored 'General case' 0 N--CA 1.441 -0.887 0 N-CA-C 106.988 -1.486 . . . . 0.0 106.988 170.149 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 48.43 -142.18 8.59 Favored Glycine 0 CA--C 1.535 1.301 0 C-N-CA 125.148 1.356 . . . . 0.0 113.148 175.123 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 13.2 m -127.48 -85.64 0.59 Allowed 'General case' 0 CA--C 1.529 0.165 0 N-CA-C 107.585 -1.265 . . . . 0.0 107.585 175.993 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -84.55 66.66 3.84 Favored Glycine 0 C--N 1.338 0.694 0 N-CA-C 110.145 -1.182 . . . . 0.0 110.145 175.226 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 6.5 m -77.78 65.28 0.26 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.575 0 C-N-CA 124.071 0.948 . . . . 0.0 110.891 -178.094 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 52.1 t30 54.36 54.05 10.0 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 126.4 1.88 . . . . 0.0 108.249 -172.611 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -133.14 142.32 44.03 Favored Pre-proline 0 CA--C 1.539 0.544 0 C-N-CA 126.604 1.962 . . . . 0.0 108.506 -168.867 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -66.97 135.38 37.53 Favored 'Trans proline' 0 CA--C 1.541 0.857 0 C-N-CA 121.798 1.665 . . . . 0.0 110.611 176.6 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 42.1 Cg_endo -63.24 -23.99 72.4 Favored 'Trans proline' 0 N--CA 1.461 -0.439 0 C-N-CA 122.746 2.297 . . . . 0.0 114.315 -169.721 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 5.7 pm0 -56.21 -21.67 24.67 Favored 'General case' 0 CA--C 1.539 0.521 0 CA-C-N 119.529 1.059 . . . . 0.0 112.133 175.95 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 90' ' ' TRP . . . . . 0.457 ' CD2' ' HB2' ' A' ' 70' ' ' ALA . 99.3 m95 -82.64 -21.78 34.91 Favored 'General case' 0 N--CA 1.454 -0.251 0 N-CA-C 113.13 0.789 . . . . 0.0 113.13 179.979 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 5.5 m -92.94 -34.86 6.19 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.351 0 CA-C-N 120.117 1.326 . . . . 0.0 110.998 172.518 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . 0.266 6.3 t -87.22 46.01 1.33 Allowed 'General case' 0 CA--C 1.548 0.869 0 CA-C-O 123.409 1.576 . . . . 0.0 110.497 -174.85 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 68.6 mm-40 -79.0 -178.81 6.3 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 126.851 2.061 . . . . 0.0 109.218 171.338 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 35.1 mm-40 -67.22 -18.38 65.21 Favored 'General case' 0 CA--C 1.539 0.554 0 O-C-N 121.572 -0.705 . . . . 0.0 111.87 -178.629 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 7.4 tt -143.2 135.03 24.02 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.381 0 C-N-CA 125.642 1.577 . . . . 0.0 106.88 170.035 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 32.4 t80 -110.21 135.26 51.25 Favored 'General case' 0 CA--C 1.535 0.373 0 N-CA-C 106.186 -1.783 . . . . 0.0 106.186 169.386 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 97' ' ' GLU . . . . . 0.658 ' HB2' HD12 ' A' ' 77' ' ' ILE . 31.2 mm-40 -144.73 164.09 32.04 Favored 'General case' 0 C--O 1.238 0.452 0 C-N-CA 123.971 0.908 . . . . 0.0 108.689 170.21 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -169.87 130.67 1.02 Allowed 'General case' 0 N--CA 1.45 -0.458 0 C-N-CA 127.969 2.508 . . . . 0.0 106.889 -170.585 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 99' ' ' TRP . . . . . 0.411 ' CZ3' HG21 ' A' ' 77' ' ' ILE . 5.1 m-90 -150.14 141.21 23.01 Favored 'General case' 0 N--CA 1.453 -0.315 0 N-CA-C 107.947 -1.131 . . . . 0.0 107.947 -171.231 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 63.0 tt0 -82.26 77.98 8.99 Favored 'General case' 0 CA--C 1.536 0.416 0 N-CA-C 108.219 -1.03 . . . . 0.0 108.219 179.095 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 10.1 mp -71.51 119.1 15.18 Favored 'General case' 0 N--CA 1.462 0.157 0 N-CA-C 107.023 -1.473 . . . . 0.0 107.023 171.056 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -79.35 112.91 17.05 Favored 'General case' 0 N--CA 1.449 -0.524 0 N-CA-C 106.085 -1.821 . . . . 0.0 106.085 170.069 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 11.2 t70 -76.32 133.99 70.87 Favored Pre-proline 0 C--O 1.239 0.501 0 CA-C-O 118.928 -0.558 . . . . 0.0 109.833 -177.021 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -78.7 3.13 7.55 Favored 'Trans proline' 0 CA--C 1.545 1.071 0 C-N-CA 123.01 2.473 . . . . 0.0 113.971 -177.435 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 2.1 t70 -36.7 112.68 0.2 Allowed 'General case' 0 C--O 1.239 0.538 0 C-N-CA 126.196 1.798 . . . . 0.0 111.778 171.876 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 68.58 5.31 43.64 Favored Glycine 0 CA--C 1.537 1.462 0 CA-C-O 118.813 -0.993 . . . . 0.0 115.038 175.172 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 33.7 mm-40 -80.47 174.37 11.67 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-N 119.41 1.605 . . . . 0.0 110.45 178.412 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 15.3 m -68.96 156.9 37.77 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 123.729 0.811 . . . . 0.0 109.9 169.683 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -65.15 -26.25 68.09 Favored 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 123.429 0.692 . . . . 0.0 111.641 -172.29 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 6.9 pt-20 -56.33 -34.85 66.95 Favored 'General case' 0 N--CA 1.462 0.164 0 C-N-CA 123.29 0.636 . . . . 0.0 111.279 173.072 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 13.2 t -76.89 -45.59 31.05 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.362 0 CA-C-O 118.27 -0.871 . . . . 0.0 108.987 -176.724 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 67.2 m-85 -50.62 -50.45 54.15 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-N 119.691 1.132 . . . . 0.0 110.211 169.643 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 94.5 mtt180 -69.4 -34.6 74.74 Favored 'General case' 0 N--CA 1.466 0.349 0 O-C-N 121.887 -0.508 . . . . 0.0 110.901 -173.291 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 2.7 m -61.56 -49.64 75.86 Favored 'General case' 0 N--CA 1.45 -0.452 0 C-N-CA 124.162 0.985 . . . . 0.0 109.407 169.947 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 81.7 t -70.35 -27.18 30.83 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.182 0 CA-C-O 118.417 -0.801 . . . . 0.0 109.761 -170.972 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 14.2 mtm105 -56.72 -48.98 76.54 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-N 119.644 1.111 . . . . 0.0 109.646 169.956 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -63.02 -48.18 82.56 Favored Glycine 0 CA--C 1.527 0.784 0 N-CA-C 111.614 -0.594 . . . . 0.0 111.614 179.235 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 9.9 mt-30 -62.29 -45.41 93.37 Favored 'General case' 0 C--N 1.342 0.24 0 CA-C-N 117.676 0.738 . . . . 0.0 110.952 -177.209 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 86.9 t -67.75 -42.32 86.09 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.189 0 CA-C-O 118.229 -0.891 . . . . 0.0 110.557 -178.911 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 59.1 tttm -53.81 -46.6 71.15 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 119.307 0.958 . . . . 0.0 109.337 179.908 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -65.19 -43.52 91.37 Favored 'General case' 0 N--CA 1.45 -0.464 0 C-N-CA 122.964 0.506 . . . . 0.0 111.139 -175.97 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 49.4 mtt-85 -65.5 -44.54 86.7 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-N 118.719 0.69 . . . . 0.0 111.303 178.554 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 98.0 t -66.15 -40.19 86.41 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.472 0 N-CA-C 109.204 -0.665 . . . . 0.0 109.204 179.024 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 16.6 mt-10 -60.25 -42.52 95.5 Favored 'General case' 0 N--CA 1.46 0.047 0 CA-C-N 119.751 1.16 . . . . 0.0 110.488 176.153 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 29.0 t-20 -62.68 -44.67 95.66 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 122.712 0.405 . . . . 0.0 110.998 178.977 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 34.8 tp -58.08 -49.2 77.75 Favored 'General case' 0 N--CA 1.455 -0.208 0 C-N-CA 124.26 1.024 . . . . 0.0 110.772 176.992 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 89.8 mt -63.55 -44.62 98.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 N-CA-C 108.043 -1.095 . . . . 0.0 108.043 -179.524 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -61.07 -28.37 69.03 Favored 'General case' 0 CA--C 1.54 0.58 0 CA-C-N 118.654 0.661 . . . . 0.0 112.19 177.545 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 93.5 mttt -70.03 -56.13 7.76 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-N 119.391 0.996 . . . . 0.0 110.69 171.183 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 14.9 pt -78.13 -44.41 27.59 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.424 0 N-CA-C 114.969 1.47 . . . . 0.0 114.969 -168.925 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 69.8 m . . . . . 0 C--O 1.252 1.217 0 C-N-CA 126.011 1.724 . . . . 0.0 109.945 -169.772 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.497 1.906 0 N-CA-C 110.365 -0.235 . . . . 0.0 110.365 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 31.2 mttm -79.1 118.64 21.25 Favored 'General case' 0 N--CA 1.474 0.742 0 N-CA-C 105.787 -1.931 . . . . 0.0 105.787 171.84 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 89.2 mttt -86.06 134.11 33.85 Favored 'General case' 0 CA--C 1.513 -0.464 0 N-CA-C 107.69 -1.226 . . . . 0.0 107.69 178.465 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 1.5 t -119.8 148.82 22.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 C-N-CA 125.535 1.534 . . . . 0.0 109.0 -169.006 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 3.2 mtt -135.88 146.82 47.81 Favored 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 125.872 1.669 . . . . 0.0 108.434 169.255 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 90.6 m-85 -132.5 95.42 3.62 Favored 'General case' 0 N--CA 1.457 -0.099 0 N-CA-C 105.165 -2.161 . . . . 0.0 105.165 171.495 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 42.3 t -131.29 129.98 62.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 N-CA-C 109.675 -0.491 . . . . 0.0 109.675 -169.049 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 41.1 t -99.07 -177.76 3.72 Favored 'General case' 0 CA--C 1.547 0.857 0 C-N-CA 125.754 1.622 . . . . 0.0 106.922 169.101 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -56.48 -39.2 72.82 Favored 'General case' 0 N--CA 1.478 0.932 0 O-C-N 120.587 -1.32 . . . . 0.0 111.292 -176.532 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 79.1 mtp180 -119.89 168.65 10.9 Favored 'General case' 0 N--CA 1.465 0.308 0 N-CA-C 107.106 -1.442 . . . . 0.0 107.106 169.156 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 29.1 t30 -65.13 -28.61 69.55 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 120.563 -0.455 . . . . 0.0 110.784 169.601 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 1.5 m -56.15 124.15 16.9 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 125.165 1.386 . . . . 0.0 110.548 179.644 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 8.5 m 65.72 150.2 0.05 OUTLIER 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 126.256 1.822 . . . . 0.0 113.302 178.872 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 1.5 mmm180 68.34 -58.33 0.47 Allowed 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 127.455 2.302 . . . . 0.0 111.869 177.12 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 1.7 m -63.83 -17.15 62.83 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 125.436 1.495 . . . . 0.0 112.719 -175.214 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 21.7 pt20 -62.17 -63.01 1.38 Allowed 'General case' 0 C--N 1.343 0.289 0 CA-C-N 119.285 0.948 . . . . 0.0 111.585 176.7 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 1.1 tpt -78.56 -32.57 47.85 Favored 'General case' 0 N--CA 1.465 0.291 0 O-C-N 121.56 -0.713 . . . . 0.0 112.209 -169.61 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -64.58 -51.38 63.03 Favored 'General case' 0 N--CA 1.469 0.488 0 N-CA-C 112.346 0.499 . . . . 0.0 112.346 -170.955 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -65.68 -31.45 72.47 Favored 'General case' 0 N--CA 1.469 0.491 0 O-C-N 121.505 -0.747 . . . . 0.0 110.198 172.811 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -49.12 -55.42 12.14 Favored Glycine 0 C--N 1.342 0.895 0 C-N-CA 125.89 1.709 . . . . 0.0 110.518 175.149 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 8.8 m-85 -73.99 -29.74 62.13 Favored 'General case' 0 CA--C 1.508 -0.655 0 CA-C-N 119.072 1.436 . . . . 0.0 113.811 178.806 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -67.85 -31.7 71.71 Favored 'General case' 0 N--CA 1.451 -0.408 0 C-N-CA 119.459 -0.896 . . . . 0.0 111.318 -169.989 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 6.7 ptpt -62.06 -34.35 76.1 Favored 'General case' 0 N--CA 1.476 0.835 0 CA-C-N 119.252 0.933 . . . . 0.0 111.498 172.108 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 12.2 m -76.46 -55.42 5.55 Favored 'General case' 0 N--CA 1.447 -0.601 0 C-N-CA 125.373 1.469 . . . . 0.0 110.183 -175.939 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 75.3 mt -74.74 -35.63 62.63 Favored 'General case' 0 CA--C 1.531 0.213 0 C-N-CA 123.455 0.702 . . . . 0.0 110.328 -174.022 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -93.04 6.81 76.45 Favored Glycine 0 CA--C 1.526 0.722 0 C-N-CA 125.118 1.342 . . . . 0.0 113.285 -175.317 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -49.67 125.45 11.57 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 125.113 1.365 . . . . 0.0 110.881 -175.105 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 76.33 -8.1 27.35 Favored Glycine 0 CA--C 1.535 1.343 0 C-N-CA 124.452 1.025 . . . . 0.0 114.287 178.801 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 64.3 mttm -102.83 -49.93 3.67 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-N 119.421 1.61 . . . . 0.0 110.384 -179.711 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 25.3 pt -136.2 149.09 27.27 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.385 0 C-N-CA 123.669 0.788 . . . . 0.0 110.34 -169.37 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -111.58 104.47 12.87 Favored 'General case' 0 C--O 1.227 -0.123 0 C-N-CA 124.962 1.305 . . . . 0.0 109.844 -169.332 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 6.5 t -87.02 132.08 33.33 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 C-N-CA 123.471 0.708 . . . . 0.0 109.669 -175.957 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 20.5 m -144.96 110.81 5.42 Favored 'General case' 0 N--CA 1.446 -0.658 0 N-CA-C 104.623 -2.362 . . . . 0.0 104.623 169.963 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 51.8 m -107.18 81.53 1.55 Allowed 'General case' 0 N--CA 1.463 0.205 0 CA-C-N 119.611 1.096 . . . . 0.0 108.233 179.661 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 3.8 m -61.16 -39.79 91.43 Favored 'General case' 0 CA--C 1.532 0.274 0 N-CA-C 114.289 1.218 . . . . 0.0 114.289 -169.261 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 92.91 137.81 8.36 Favored Glycine 0 C--N 1.338 0.671 0 N-CA-C 109.107 -1.597 . . . . 0.0 109.107 176.912 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 15.5 mt -74.51 -34.01 62.94 Favored 'General case' 0 C--N 1.331 -0.199 0 C-N-CA 124.108 0.963 . . . . 0.0 108.794 176.774 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 26.3 mt-10 -141.33 156.79 45.81 Favored 'General case' 0 N--CA 1.443 -0.805 0 C-N-CA 128.28 2.632 . . . . 0.0 105.984 168.926 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 60.9 p -109.79 148.33 31.66 Favored 'General case' 0 N--CA 1.441 -0.922 0 CA-C-O 123.106 1.431 . . . . 0.0 112.937 -175.116 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 17.1 m -170.35 162.13 8.34 Favored 'General case' 0 N--CA 1.447 -0.608 0 C-N-CA 129.389 3.076 . . . . 0.0 103.752 -169.856 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 41' ' ' ARG . . . . . 0.433 ' HG3' ' H ' ' A' ' 42' ' ' VAL . 6.9 tpt180 -92.14 -155.93 0.44 Allowed 'General case' 0 N--CA 1.467 0.416 0 O-C-N 121.053 -1.029 . . . . 0.0 109.656 -173.039 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.433 ' H ' ' HG3' ' A' ' 41' ' ' ARG . 0.6 OUTLIER -131.87 156.67 42.75 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 C-N-CA 129.009 2.924 . . . . 0.0 107.064 -169.446 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 62.4 m80 -85.79 144.53 39.71 Favored Pre-proline 0 N--CA 1.468 0.459 0 N-CA-C 112.317 0.488 . . . . 0.0 112.317 -169.071 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -65.06 -45.07 8.44 Favored 'Trans proline' 0 C--N 1.348 0.546 0 C-N-CA 122.904 2.403 . . . . 0.0 111.834 -176.172 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 6.5 m -69.57 -28.06 65.66 Favored 'General case' 0 CA--C 1.531 0.233 0 CA-C-O 118.977 -0.535 . . . . 0.0 110.002 179.575 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -60.46 -54.33 46.86 Favored 'General case' 0 CA--C 1.507 -0.691 0 N-CA-C 107.882 -1.155 . . . . 0.0 107.882 171.183 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 56.7 mt -58.1 -40.21 76.11 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 N-CA-C 108.657 -0.868 . . . . 0.0 108.657 -173.828 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -63.37 -49.3 74.39 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-N 118.555 0.616 . . . . 0.0 111.61 179.046 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 28.1 mmt -66.23 -36.5 83.2 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-O 122.98 1.371 . . . . 0.0 110.895 -179.712 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -78.25 -30.82 48.85 Favored 'General case' 0 N--CA 1.441 -0.875 0 N-CA-C 107.416 -1.327 . . . . 0.0 107.416 -173.335 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 41.2 tt0 -71.95 -22.14 61.5 Favored 'General case' 0 N--CA 1.447 -0.598 0 C-N-CA 123.815 0.846 . . . . 0.0 110.228 169.986 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 16.8 mm-40 -68.19 -30.73 69.89 Favored 'General case' 0 CA--C 1.534 0.361 0 CA-C-N 119.487 1.039 . . . . 0.0 110.23 171.62 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . 0.276 9.3 p -89.34 10.0 2.43 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.035 0 CA-C-N 118.514 0.597 . . . . 0.0 111.114 168.914 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 78.18 16.28 79.89 Favored Glycine 0 CA--C 1.532 1.121 0 C-N-CA 124.956 1.265 . . . . 0.0 113.76 173.8 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 13.5 mt -102.2 141.35 18.57 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.237 0 C-N-CA 124.453 1.101 . . . . 0.0 110.555 -173.574 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -94.71 137.29 33.99 Favored 'General case' 0 C--O 1.235 0.312 0 C-N-CA 124.417 1.087 . . . . 0.0 108.26 169.817 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 7.0 pt -138.04 -30.0 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.544 0 C-N-CA 124.543 1.137 . . . . 0.0 110.538 170.095 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -23.53 -38.32 0.0 OUTLIER 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 130.054 3.341 . . . . 0.0 117.045 169.563 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -98.64 31.26 8.32 Favored Glycine 0 CA--C 1.536 1.383 0 C-N-CA 125.543 1.544 . . . . 0.0 115.349 -175.205 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 12.7 mt-30 -62.0 -31.42 71.79 Favored 'General case' 0 N--CA 1.476 0.846 0 CA-C-N 120.088 1.944 . . . . 0.0 113.956 -174.336 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -70.34 122.16 19.04 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 123.059 0.544 . . . . 0.0 110.517 -169.158 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 74.9 m -151.91 -167.9 2.91 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 127.03 2.132 . . . . 0.0 107.417 -171.292 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -51.58 143.55 20.0 Favored Pre-proline 0 CA--C 1.539 0.528 0 C-N-CA 123.967 0.907 . . . . 0.0 110.402 170.51 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 84.5 Cg_endo -70.92 160.73 48.43 Favored 'Trans proline' 0 N--CA 1.456 -0.683 0 C-N-CA 122.883 2.389 . . . . 0.0 110.326 172.941 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 11.9 tt -60.86 -20.45 21.74 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.447 0 C-N-CA 123.889 0.876 . . . . 0.0 112.246 -179.878 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 25.9 tt0 -66.5 -28.6 68.69 Favored 'General case' 0 N--CA 1.434 -1.256 0 C-N-CA 124.768 1.227 . . . . 0.0 110.516 -176.558 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 74.9 m-20 -80.54 -1.44 41.96 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 124.305 1.042 . . . . 0.0 112.387 179.115 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 85.5 m-85 -110.76 177.19 4.75 Favored 'General case' 0 C--O 1.234 0.278 0 C-N-CA 125.698 1.599 . . . . 0.0 110.925 179.204 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 50.4 t-20 -128.66 135.76 49.72 Favored 'General case' 0 N--CA 1.448 -0.532 0 N-CA-C 108.175 -1.046 . . . . 0.0 108.175 169.297 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.589 ' HB2' ' CD2' ' A' ' 90' ' ' TRP . . . -73.28 -24.63 60.45 Favored 'General case' 0 N--CA 1.435 -1.184 0 N-CA-C 109.25 -0.648 . . . . 0.0 109.25 -178.473 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 35.5 t70 -66.2 -21.78 66.32 Favored 'General case' 0 N--CA 1.445 -0.696 0 C-N-CA 120.644 -0.422 . . . . 0.0 111.091 -177.59 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 35.2 t70 -77.42 -27.95 52.48 Favored 'General case' 0 C--N 1.345 0.393 0 C-N-CA 123.617 0.767 . . . . 0.0 111.584 174.144 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 14.1 m-85 -80.17 167.55 20.21 Favored 'General case' 0 C--O 1.239 0.53 0 C-N-CA 125.39 1.476 . . . . 0.0 111.392 -179.552 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -117.03 -39.18 3.26 Favored 'General case' 0 C--O 1.235 0.312 0 C-N-CA 123.338 0.655 . . . . 0.0 111.668 177.953 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -138.01 133.56 44.38 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.406 0 C-N-CA 123.866 0.866 . . . . 0.0 109.881 -170.871 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 66.6 t -140.79 125.63 18.55 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.402 0 N-CA-C 105.72 -1.956 . . . . 0.0 105.72 178.306 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.557 HD12 ' HB2' ' A' ' 97' ' ' GLU . 7.5 mm -96.24 125.26 49.15 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.545 0 N-CA-C 105.333 -2.099 . . . . 0.0 105.333 170.071 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 59.6 m -93.36 91.81 7.37 Favored 'General case' 0 N--CA 1.443 -0.811 0 N-CA-C 104.123 -2.547 . . . . 0.0 104.123 169.662 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 23.0 mt -63.08 -12.68 28.54 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-O 118.321 -0.847 . . . . 0.0 112.771 -173.206 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 39.3 m -142.94 126.53 16.88 Favored 'General case' 0 N--CA 1.445 -0.684 0 N-CA-C 106.634 -1.617 . . . . 0.0 106.634 174.43 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 58.44 -148.55 37.51 Favored Glycine 0 CA--C 1.534 1.227 0 C-N-CA 123.613 0.625 . . . . 0.0 112.183 177.488 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 14.0 p -139.2 -79.11 0.33 Allowed 'General case' 0 CA--C 1.529 0.165 0 C-N-CA 124.173 0.989 . . . . 0.0 108.727 175.865 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -79.24 53.24 4.16 Favored Glycine 0 CA--C 1.526 0.756 0 C-N-CA 125.498 1.523 . . . . 0.0 112.096 -178.429 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 16.3 m -81.21 60.83 0.2 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.71 0 C-N-CA 124.868 1.267 . . . . 0.0 110.802 -173.984 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 50.1 t30 56.2 59.74 3.54 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 125.944 1.698 . . . . 0.0 108.374 -172.41 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -136.69 143.14 41.63 Favored Pre-proline 0 CA--C 1.544 0.729 0 C-N-CA 126.223 1.809 . . . . 0.0 108.845 -168.925 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_exo -67.13 136.77 41.89 Favored 'Trans proline' 0 CA--C 1.542 0.909 0 C-N-CA 122.555 2.17 . . . . 0.0 111.353 172.973 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 42.4 Cg_endo -63.66 -25.84 69.0 Favored 'Trans proline' 0 N--CA 1.46 -0.474 0 C-N-CA 122.778 2.319 . . . . 0.0 114.821 -169.663 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 6.4 pm0 -57.42 -20.61 31.19 Favored 'General case' 0 CA--C 1.539 0.528 0 CA-C-N 120.149 1.341 . . . . 0.0 112.272 177.345 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 90' ' ' TRP . . . . . 0.589 ' CD2' ' HB2' ' A' ' 70' ' ' ALA . 99.9 m95 -79.28 -23.41 43.61 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-O 118.726 -0.654 . . . . 0.0 112.629 178.657 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 6.5 m -104.67 -8.87 9.77 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.156 0 C-N-CA 124.669 1.188 . . . . 0.0 113.03 -179.818 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . 0.266 6.6 t -111.57 45.58 1.2 Allowed 'General case' 0 CA--C 1.544 0.713 0 CA-C-O 123.142 1.448 . . . . 0.0 110.104 172.299 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 56.2 mm-40 -73.47 177.42 5.3 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 124.919 1.288 . . . . 0.0 109.73 169.936 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 34.9 mm-40 -65.49 -21.73 66.66 Favored 'General case' 0 CA--C 1.538 0.503 0 O-C-N 121.844 -0.535 . . . . 0.0 111.225 -179.626 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 4.6 tt -140.26 131.14 30.33 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.334 0 C-N-CA 126.241 1.816 . . . . 0.0 106.439 169.871 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 35.2 t80 -109.57 136.36 49.07 Favored 'General case' 0 CA--C 1.539 0.528 0 N-CA-C 106.272 -1.751 . . . . 0.0 106.272 169.487 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 97' ' ' GLU . . . . . 0.557 ' HB2' HD12 ' A' ' 77' ' ' ILE . 10.7 mm-40 -142.2 162.55 35.18 Favored 'General case' 0 C--O 1.234 0.287 0 C-N-CA 124.429 1.091 . . . . 0.0 108.871 175.83 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 2.5 t70 -175.27 129.62 0.28 Allowed 'General case' 0 C--O 1.236 0.368 0 C-N-CA 127.014 2.126 . . . . 0.0 106.918 -169.802 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 99' ' ' TRP . . . . . 0.53 ' CZ3' HG21 ' A' ' 77' ' ' ILE . 6.5 m0 -143.69 140.47 30.05 Favored 'General case' 0 CA--C 1.522 -0.119 0 C-N-CA 122.826 0.45 . . . . 0.0 110.057 -171.853 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 31.3 mm-40 -84.57 59.79 5.69 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-O 121.653 0.739 . . . . 0.0 109.159 171.786 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.47 HD13 HG22 ' A' ' 119' ' ' VAL . 16.6 mt -64.68 138.67 58.53 Favored 'General case' 0 CA--C 1.529 0.14 0 N-CA-C 108.233 -1.025 . . . . 0.0 108.233 172.471 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 34.3 mm-40 -68.65 161.15 28.78 Favored 'General case' 0 N--CA 1.451 -0.397 0 N-CA-C 108.265 -1.013 . . . . 0.0 108.265 168.901 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -130.97 131.45 23.24 Favored Pre-proline 0 N--CA 1.45 -0.456 0 N-CA-C 107.341 -1.355 . . . . 0.0 107.341 169.352 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 67.9 Cg_endo -78.9 -3.9 13.57 Favored 'Trans proline' 0 CA--C 1.545 1.043 0 C-N-CA 122.125 1.883 . . . . 0.0 114.729 -169.867 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -51.26 129.38 24.5 Favored 'General case' 0 CA--C 1.537 0.443 0 CA-C-N 119.996 1.271 . . . . 0.0 111.05 177.606 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 72.71 11.1 77.39 Favored Glycine 0 CA--C 1.533 1.206 0 CA-C-O 118.758 -1.023 . . . . 0.0 114.127 171.942 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 29.7 pt20 -136.66 -171.12 2.84 Favored 'General case' 0 CA--C 1.542 0.659 0 CA-C-N 118.991 1.395 . . . . 0.0 111.302 176.245 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 1.9 m -68.34 158.3 33.8 Favored 'General case' 0 CA--C 1.533 0.327 0 N-CA-C 117.641 2.46 . . . . 0.0 117.641 -167.563 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 55.7 tp -54.42 -34.16 60.83 Favored 'General case' 0 C--N 1.344 0.33 0 C-N-CA 126.917 2.087 . . . . 0.0 111.451 170.144 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 29.5 tp10 -64.73 -29.32 70.3 Favored 'General case' 0 C--N 1.331 -0.235 0 O-C-N 122.028 -0.42 . . . . 0.0 110.796 177.491 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 4.1 t -76.83 -37.1 27.25 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.385 0 CA-C-O 117.866 -1.064 . . . . 0.0 110.21 175.471 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 59.3 m-85 -56.21 -49.36 74.31 Favored 'General case' 0 N--CA 1.474 0.727 0 CA-C-N 120.738 1.608 . . . . 0.0 109.656 170.121 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 77.0 mtt180 -58.99 -44.07 91.54 Favored 'General case' 0 N--CA 1.468 0.432 0 C-N-CA 123.501 0.72 . . . . 0.0 110.691 178.319 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 18.5 m -65.5 -49.24 69.76 Favored 'General case' 0 N--CA 1.445 -0.714 0 C-N-CA 124.261 1.025 . . . . 0.0 110.07 -179.962 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 63.8 t -67.69 -35.84 74.06 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.191 0 CA-C-N 119.42 1.009 . . . . 0.0 109.353 -172.128 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 45.8 ttp85 -58.23 -39.9 80.28 Favored 'General case' 0 CA--C 1.539 0.553 0 CA-C-N 118.405 0.548 . . . . 0.0 109.808 173.585 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -66.81 -53.41 27.51 Favored Glycine 0 CA--C 1.533 1.218 0 C-N-CA 123.698 0.666 . . . . 0.0 112.566 172.809 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 72.2 mt-30 -55.08 -48.35 73.64 Favored 'General case' 0 N--CA 1.469 0.5 0 CA-C-O 122.184 0.992 . . . . 0.0 110.0 -176.137 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 119' ' ' VAL . . . . . 0.47 HG22 HD13 ' A' ' 101' ' ' LEU . 97.0 t -74.48 -37.01 43.45 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.439 0 CA-C-O 117.738 -1.125 . . . . 0.0 109.786 -171.563 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -55.47 -46.58 76.83 Favored 'General case' 0 C--O 1.224 -0.288 0 CA-C-N 120.112 1.324 . . . . 0.0 108.585 172.198 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 41.5 tt0 -66.43 -43.04 86.79 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 122.458 0.303 . . . . 0.0 111.205 -175.121 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 38.5 mmt180 -62.44 -45.55 92.58 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-N 119.069 0.85 . . . . 0.0 111.01 176.18 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 97.2 t -69.14 -37.68 76.92 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.578 0 N-CA-C 109.196 -0.668 . . . . 0.0 109.196 -177.219 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 20.2 mt-10 -59.85 -44.79 93.92 Favored 'General case' 0 N--CA 1.457 -0.12 0 CA-C-N 119.346 0.975 . . . . 0.0 110.09 173.556 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 25.9 t-20 -65.02 -42.24 94.57 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 123.169 0.588 . . . . 0.0 111.641 -178.487 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 1.6 tm? -58.31 -48.39 80.67 Favored 'General case' 0 C--O 1.228 -0.068 0 C-N-CA 126.323 1.849 . . . . 0.0 110.752 174.035 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 63.4 mt -66.04 -47.75 83.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 N-CA-C 108.658 -0.867 . . . . 0.0 108.658 179.598 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -58.52 -31.21 67.7 Favored 'General case' 0 CA--C 1.535 0.381 0 CA-C-O 118.849 -0.596 . . . . 0.0 112.145 -176.851 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 17.3 ptpt -81.59 -39.62 24.26 Favored 'General case' 0 C--N 1.344 0.364 0 CA-C-O 117.786 -1.102 . . . . 0.0 112.486 176.53 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 11.8 pt -81.67 -37.42 15.24 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.287 0 CA-C-N 119.931 1.242 . . . . 0.0 113.725 -176.039 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 72.4 m . . . . . 0 C--O 1.253 1.288 0 C-N-CA 125.638 1.575 . . . . 0.0 109.764 -169.985 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.499 1.985 0 N-CA-C 110.411 -0.218 . . . . 0.0 110.411 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 32.9 mttm -81.43 118.92 23.09 Favored 'General case' 0 N--CA 1.476 0.849 0 N-CA-C 106.541 -1.652 . . . . 0.0 106.541 173.348 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 93.0 mttt -80.86 133.84 35.65 Favored 'General case' 0 CA--C 1.507 -0.692 0 CA-C-N 119.785 1.175 . . . . 0.0 108.398 175.691 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 1.5 t -118.36 145.48 24.27 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.589 0 C-N-CA 125.914 1.686 . . . . 0.0 106.796 -172.843 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 26.6 ttm -136.53 145.1 44.66 Favored 'General case' 0 C--N 1.318 -0.777 0 C-N-CA 125.143 1.377 . . . . 0.0 108.265 169.764 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 91.5 m-85 -137.93 121.62 17.46 Favored 'General case' 0 CA--C 1.516 -0.339 0 N-CA-C 104.673 -2.343 . . . . 0.0 104.673 177.445 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 2.6 p -153.58 154.16 7.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-O 122.338 1.066 . . . . 0.0 111.745 -169.178 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 42.7 t -144.77 165.18 28.82 Favored 'General case' 0 CA--C 1.538 0.486 0 N-CA-C 104.506 -2.405 . . . . 0.0 104.506 168.981 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 22.9 pttp -61.47 130.17 44.73 Favored 'General case' 0 N--CA 1.467 0.378 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 172.515 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 59.2 136.58 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 128.211 2.604 . . . . 0.0 114.114 -170.373 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 20.4 t30 -56.05 -35.0 66.43 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 125.106 1.362 . . . . 0.0 111.885 176.526 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 1.6 p -70.3 -8.06 47.41 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 125.398 1.479 . . . . 0.0 113.243 -175.802 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 38.5 m -76.01 -88.15 0.04 OUTLIER 'General case' 0 CA--C 1.54 0.568 0 CA-C-N 119.292 0.951 . . . . 0.0 110.259 178.638 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 10.6 mpt_? -115.5 6.83 14.79 Favored 'General case' 0 N--CA 1.475 0.801 0 CA-C-N 120.349 1.431 . . . . 0.0 113.041 179.227 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 1.4 m -91.92 47.44 1.35 Allowed 'General case' 0 CA--C 1.541 0.601 0 O-C-N 121.327 -0.858 . . . . 0.0 110.918 -175.449 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -118.37 9.01 12.31 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 125.967 1.707 . . . . 0.0 112.596 170.941 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 1.1 tpt -159.87 -39.48 0.05 Allowed 'General case' 0 N--CA 1.457 -0.119 0 N-CA-C 115.443 1.646 . . . . 0.0 115.443 -176.916 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -69.55 -46.72 65.77 Favored 'General case' 0 N--CA 1.471 0.597 0 CA-C-N 120.947 1.703 . . . . 0.0 111.703 -169.482 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 19' ' ' GLU . . . . . 0.45 ' CD ' HE22 ' A' ' 60' ' ' GLN . 0.0 OUTLIER -57.35 -42.28 81.69 Favored 'General case' 0 C--N 1.325 -0.473 0 C-N-CA 124.321 1.049 . . . . 0.0 110.731 170.837 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -61.59 -45.59 96.02 Favored Glycine 0 CA--C 1.524 0.653 0 C-N-CA 123.84 0.733 . . . . 0.0 111.798 176.924 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -66.85 -35.93 81.17 Favored 'General case' 0 CA--C 1.514 -0.431 0 O-C-N 121.216 -1.167 . . . . 0.0 111.918 178.278 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -70.86 -36.3 72.77 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 119.662 1.119 . . . . 0.0 110.555 179.688 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -52.52 -42.66 64.54 Favored 'General case' 0 N--CA 1.467 0.392 0 C-N-CA 123.864 0.866 . . . . 0.0 109.009 169.207 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 22.4 m -75.15 -59.29 2.81 Favored 'General case' 0 N--CA 1.446 -0.653 0 C-N-CA 124.303 1.041 . . . . 0.0 111.397 -173.872 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 34.6 mt -73.82 -33.87 64.35 Favored 'General case' 0 C--N 1.332 -0.191 0 C-N-CA 125.083 1.353 . . . . 0.0 110.949 -170.567 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -102.76 6.77 52.43 Favored Glycine 0 CA--C 1.525 0.668 0 CA-C-O 117.901 -1.5 . . . . 0.0 113.521 -172.585 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -41.15 -52.77 3.25 Favored 'General case' 0 N--CA 1.466 0.363 0 C-N-CA 126.254 1.821 . . . . 0.0 114.819 -169.714 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -88.81 7.12 82.83 Favored Glycine 0 CA--C 1.531 1.048 0 CA-C-O 119.186 -0.785 . . . . 0.0 113.573 -175.547 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 70.0 mttt -124.73 -49.35 1.76 Allowed 'General case' 0 N--CA 1.467 0.395 0 CA-C-N 118.511 1.155 . . . . 0.0 111.937 -169.27 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 27.1 pt -137.96 150.93 25.07 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.401 0 C-N-CA 124.732 1.213 . . . . 0.0 110.415 -168.911 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -111.17 105.77 14.58 Favored 'General case' 0 C--O 1.226 -0.146 0 C-N-CA 125.013 1.325 . . . . 0.0 109.971 -169.526 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 11.4 t -78.93 127.9 38.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 177.374 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 18.7 m -144.31 92.94 2.37 Favored 'General case' 0 N--CA 1.449 -0.503 0 N-CA-C 103.615 -2.735 . . . . 0.0 103.615 169.677 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 58.1 m -89.33 -1.32 58.02 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 115.764 1.764 . . . . 0.0 115.764 -168.759 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 28.4 p 49.05 -130.08 1.92 Allowed 'General case' 0 CA--C 1.546 0.815 0 C-N-CA 124.451 1.1 . . . . 0.0 111.333 -178.842 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 173.5 153.98 10.17 Favored Glycine 0 CA--C 1.53 0.978 0 C-N-CA 124.951 1.262 . . . . 0.0 111.027 170.06 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 4.3 mt -111.89 103.95 12.21 Favored 'General case' 0 N--CA 1.444 -0.755 1 N-CA-C 100.071 -4.048 . . . . 0.0 100.071 169.16 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 35.2 mt-10 64.05 170.36 0.17 Allowed 'General case' 0 C--O 1.238 0.458 0 O-C-N 125.371 1.669 . . . . 0.0 110.241 -167.583 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 59.1 p -146.9 158.79 44.01 Favored 'General case' 0 N--CA 1.448 -0.558 0 CA-C-O 122.628 1.204 . . . . 0.0 113.701 -178.457 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 4.1 m -170.81 166.96 7.72 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 129.801 3.24 . . . . 0.0 104.222 -171.892 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -87.94 -159.61 0.55 Allowed 'General case' 0 N--CA 1.468 0.459 0 O-C-N 120.845 -1.159 . . . . 0.0 108.72 176.209 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.517 HG21 HD12 ' A' ' 57' ' ' ILE . 1.5 p -127.17 157.84 38.51 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.782 0 C-N-CA 126.418 1.887 . . . . 0.0 107.73 179.933 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -85.84 153.04 57.48 Favored Pre-proline 0 CA--C 1.538 0.517 0 C-N-CA 124.67 1.188 . . . . 0.0 111.366 -169.452 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 55.1 Cg_endo -63.84 -41.34 24.26 Favored 'Trans proline' 0 C--N 1.347 0.495 0 C-N-CA 123.474 2.783 . . . . 0.0 112.415 -174.039 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 7.3 m -69.79 -29.63 66.98 Favored 'General case' 0 CA--C 1.53 0.188 0 CA-C-O 118.649 -0.691 . . . . 0.0 110.319 -176.839 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -62.99 -50.6 70.13 Favored 'General case' 0 C--O 1.215 -0.712 0 CA-C-N 119.659 1.118 . . . . 0.0 108.413 171.094 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 75.1 mt -58.38 -40.09 76.89 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.447 0 CA-C-N 118.982 0.81 . . . . 0.0 108.851 -176.462 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -64.7 -49.63 70.15 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-N 118.915 0.779 . . . . 0.0 112.354 178.255 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 38.6 mmt -69.35 -36.48 76.92 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-O 122.739 1.257 . . . . 0.0 110.543 -177.564 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -71.69 -32.05 67.41 Favored 'General case' 0 N--CA 1.444 -0.763 0 N-CA-C 106.369 -1.715 . . . . 0.0 106.369 -178.761 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 40.5 tt0 -72.02 -19.57 61.83 Favored 'General case' 0 CA--C 1.54 0.572 0 O-C-N 121.122 -0.986 . . . . 0.0 110.999 169.882 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 75.5 mt-10 -64.19 -37.11 86.31 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-N 120.176 1.353 . . . . 0.0 109.859 169.605 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 11.9 m -85.94 12.12 1.05 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.675 0 N-CA-C 112.759 0.651 . . . . 0.0 112.759 169.968 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 72.4 14.23 77.2 Favored Glycine 0 CA--C 1.532 1.155 0 C-N-CA 124.488 1.042 . . . . 0.0 113.476 176.154 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 10.5 mt -93.35 137.73 21.88 Favored 'Isoleucine or valine' 0 C--O 1.233 0.199 0 CA-C-N 118.498 1.149 . . . . 0.0 109.613 -177.053 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 12.9 t0 -101.87 132.93 47.37 Favored 'General case' 0 C--O 1.233 0.236 0 N-CA-C 107.566 -1.272 . . . . 0.0 107.566 169.343 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.517 HD12 HG21 ' A' ' 42' ' ' VAL . 0.6 OUTLIER -118.72 -70.64 0.78 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.37 0 C-N-CA 125.528 1.531 . . . . 0.0 107.319 177.321 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 97.2 p 40.33 -97.78 0.02 OUTLIER 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 127.169 2.187 . . . . 0.0 114.349 170.152 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -74.79 58.0 2.6 Favored Glycine 0 CA--C 1.531 1.067 0 C-N-CA 126.99 2.233 . . . . 0.0 111.705 178.947 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 60' ' ' GLN . . . . . 0.45 HE22 ' CD ' ' A' ' 19' ' ' GLU . 12.5 mm100 -66.89 -30.31 70.43 Favored 'General case' 0 C--O 1.233 0.232 0 C-N-CA 125.051 1.34 . . . . 0.0 111.69 -179.868 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 1.1 p -62.68 133.66 55.17 Favored 'General case' 0 N--CA 1.444 -0.746 0 C-N-CA 124.934 1.294 . . . . 0.0 109.435 -169.369 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 57.7 m -146.14 -179.21 6.57 Favored 'General case' 0 N--CA 1.446 -0.666 0 C-N-CA 125.999 1.72 . . . . 0.0 107.493 -169.307 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -56.61 152.74 24.19 Favored Pre-proline 0 CA--C 1.536 0.427 0 C-N-CA 123.87 0.868 . . . . 0.0 111.446 175.064 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 89.3 Cg_endo -65.59 158.24 54.25 Favored 'Trans proline' 0 N--CA 1.453 -0.856 0 C-N-CA 122.574 2.183 . . . . 0.0 110.345 172.965 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 14.0 tt -58.52 -26.81 31.97 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.411 0 C-N-CA 124.013 0.925 . . . . 0.0 111.622 179.133 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 15.1 mt-10 -67.94 -26.55 66.02 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 124.255 1.022 . . . . 0.0 110.356 -174.524 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 5.4 t-20 -64.31 -22.16 66.86 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 125.197 1.399 . . . . 0.0 112.208 177.728 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -108.67 178.57 4.44 Favored 'General case' 0 C--O 1.235 0.339 0 C-N-CA 126.024 1.729 . . . . 0.0 111.209 -173.797 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 57.5 t-20 -133.25 137.36 46.05 Favored 'General case' 0 N--CA 1.444 -0.745 0 N-CA-C 107.144 -1.428 . . . . 0.0 107.144 168.988 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -74.86 -23.84 58.48 Favored 'General case' 0 N--CA 1.437 -1.112 0 N-CA-C 109.456 -0.572 . . . . 0.0 109.456 -176.985 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -61.62 -24.74 66.9 Favored 'General case' 0 N--CA 1.447 -0.604 0 O-C-N 123.331 0.395 . . . . 0.0 111.579 178.831 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -76.57 -27.64 55.93 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 123.578 0.751 . . . . 0.0 112.081 177.133 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 11.7 m-85 -78.75 164.01 24.91 Favored 'General case' 0 N--CA 1.45 -0.442 0 C-N-CA 125.187 1.395 . . . . 0.0 111.465 -177.043 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -105.4 -39.29 6.19 Favored 'General case' 0 N--CA 1.462 0.13 0 CA-C-N 115.557 -0.747 . . . . 0.0 110.41 171.436 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -139.19 138.91 40.57 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.441 0 CA-C-O 122.449 1.118 . . . . 0.0 110.188 -171.333 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 42.6 t -140.21 145.03 26.75 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.855 0 N-CA-C 106.411 -1.7 . . . . 0.0 106.411 179.936 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.435 HD12 ' HB2' ' A' ' 97' ' ' GLU . 24.1 mm -141.71 137.36 31.65 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.865 0 N-CA-C 106.496 -1.668 . . . . 0.0 106.496 -170.69 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 50.3 m -101.43 163.84 12.07 Favored 'General case' 0 N--CA 1.445 -0.691 0 N-CA-C 107.625 -1.25 . . . . 0.0 107.625 168.861 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 51.3 mt -132.66 18.84 4.26 Favored 'General case' 0 CA--C 1.533 0.292 0 O-C-N 121.14 -0.975 . . . . 0.0 111.048 -174.53 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 28.1 p -169.21 -5.12 0.02 OUTLIER 'General case' 0 CA--C 1.541 0.603 0 N-CA-C 115.433 1.642 . . . . 0.0 115.433 -173.986 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 167.78 175.0 37.24 Favored Glycine 0 CA--C 1.529 0.927 0 CA-C-N 120.54 1.518 . . . . 0.0 111.292 -177.081 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 40.2 m -117.31 124.34 48.73 Favored 'General case' 0 C--O 1.233 0.229 0 C-N-CA 124.444 1.098 . . . . 0.0 108.101 -177.046 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 62.55 28.74 71.83 Favored Glycine 0 CA--C 1.531 1.044 0 N-CA-C 111.343 -0.703 . . . . 0.0 111.343 -174.822 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . 0.267 7.2 p -80.2 74.41 0.74 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.512 0 C-N-CA 125.006 1.322 . . . . 0.0 109.988 -169.459 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 1.1 t30 60.07 54.08 4.3 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 126.711 2.005 . . . . 0.0 108.012 -176.476 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.409 ' HA ' ' HD3' ' A' ' 87' ' ' PRO . 0.9 OUTLIER -152.12 138.4 11.79 Favored Pre-proline 0 CA--C 1.539 0.55 0 C-N-CA 125.803 1.641 . . . . 0.0 107.621 -169.341 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 87' ' ' PRO . . . . . 0.417 ' HA ' ' HD3' ' A' ' 88' ' ' PRO . 31.8 Cg_exo -69.84 146.6 60.2 Favored 'Trans proline' 0 CA--C 1.546 1.08 0 C-N-CA 121.494 1.463 . . . . 0.0 114.139 -175.77 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 88' ' ' PRO . . . . . 0.417 ' HD3' ' HA ' ' A' ' 87' ' ' PRO . 51.8 Cg_exo -63.7 -25.95 68.65 Favored 'Trans proline' 0 C--N 1.349 0.581 0 C-N-CA 122.667 2.244 . . . . 0.0 115.945 -174.085 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 5.7 pm0 -61.53 -14.84 32.85 Favored 'General case' 0 CA--C 1.543 0.707 0 CA-C-N 121.024 1.738 . . . . 0.0 111.809 175.982 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 90.8 m95 -91.81 -21.7 20.53 Favored 'General case' 0 N--CA 1.451 -0.409 0 C-N-CA 124.509 1.123 . . . . 0.0 113.07 173.793 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 2.9 m -78.64 -5.01 7.39 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.36 0 CA-C-N 120.129 1.331 . . . . 0.0 111.326 171.377 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 60.3 p -107.95 -118.14 0.26 Allowed 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 123.081 0.552 . . . . 0.0 111.492 -176.747 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 70.5 mm-40 55.96 -171.13 0.07 Allowed 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 125.563 1.545 . . . . 0.0 111.47 -168.787 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 37.0 mm-40 -70.25 -23.11 62.85 Favored 'General case' 0 CA--C 1.537 0.474 0 O-C-N 121.479 -0.763 . . . . 0.0 112.316 -169.466 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 9.5 tt -147.83 141.64 19.3 Favored 'Isoleucine or valine' 0 C--O 1.238 0.46 0 C-N-CA 125.103 1.361 . . . . 0.0 107.607 169.761 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 73.3 t80 -128.22 139.41 52.47 Favored 'General case' 0 N--CA 1.446 -0.661 0 N-CA-C 106.277 -1.749 . . . . 0.0 106.277 168.867 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 97' ' ' GLU . . . . . 0.435 ' HB2' HD12 ' A' ' 77' ' ' ILE . 29.3 mm-40 -139.32 166.26 25.02 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 107.246 -1.39 . . . . 0.0 107.246 170.003 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -165.33 137.29 4.17 Favored 'General case' 0 C--N 1.323 -0.568 0 C-N-CA 126.074 1.75 . . . . 0.0 106.334 -176.642 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 6.9 m0 -143.12 144.77 32.35 Favored 'General case' 0 N--CA 1.451 -0.377 0 C-N-CA 122.875 0.47 . . . . 0.0 110.201 -169.332 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 20.0 tt0 -83.33 57.42 3.98 Favored 'General case' 0 CA--C 1.537 0.451 0 N-CA-C 108.179 -1.045 . . . . 0.0 108.179 171.054 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.455 HD13 HG22 ' A' ' 119' ' ' VAL . 19.4 mt -65.74 138.47 57.97 Favored 'General case' 0 C--O 1.235 0.321 0 N-CA-C 107.155 -1.424 . . . . 0.0 107.155 173.459 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 23.5 mm-40 -67.22 151.52 47.38 Favored 'General case' 0 N--CA 1.451 -0.41 0 CA-C-O 121.574 0.702 . . . . 0.0 109.511 172.033 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -112.41 117.97 46.33 Favored Pre-proline 0 N--CA 1.45 -0.468 0 N-CA-C 106.098 -1.816 . . . . 0.0 106.098 170.447 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_endo -80.82 -1.52 11.29 Favored 'Trans proline' 0 N--CA 1.448 -1.183 0 C-N-CA 122.98 2.453 . . . . 0.0 113.412 -173.217 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -53.4 120.07 5.61 Favored 'General case' 0 CA--C 1.536 0.429 0 CA-C-N 120.473 1.488 . . . . 0.0 110.864 -175.917 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 70.2 0.65 30.08 Favored Glycine 0 CA--C 1.534 1.245 0 CA-C-O 118.765 -1.019 . . . . 0.0 114.562 179.518 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 12.9 mt-30 -85.3 171.89 11.54 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-N 119.156 1.478 . . . . 0.0 109.638 174.096 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 15.0 m -69.2 162.33 27.32 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 123.91 0.884 . . . . 0.0 111.322 178.71 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 13.3 tp -59.04 -30.93 68.4 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 124.615 1.166 . . . . 0.0 112.43 -173.779 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 5.3 pt-20 -56.57 -34.92 67.61 Favored 'General case' 0 C--O 1.226 -0.166 0 C-N-CA 124.768 1.227 . . . . 0.0 111.775 174.778 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 32.2 t -75.03 -42.19 45.54 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.422 0 CA-C-O 117.813 -1.089 . . . . 0.0 109.164 -176.798 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 89.7 m-85 -56.52 -49.94 73.27 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-N 120.329 1.422 . . . . 0.0 109.666 172.621 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 86.8 mtt180 -66.84 -34.6 78.17 Favored 'General case' 0 N--CA 1.467 0.409 0 O-C-N 122.037 -0.414 . . . . 0.0 111.761 -176.358 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 3.5 m -62.24 -48.59 79.29 Favored 'General case' 0 N--CA 1.451 -0.404 0 C-N-CA 124.681 1.192 . . . . 0.0 109.413 170.357 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 45.7 t -63.62 -33.44 61.63 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.243 0 CA-C-O 118.265 -0.874 . . . . 0.0 110.0 -174.627 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 13.1 mtm105 -56.58 -49.8 73.83 Favored 'General case' 0 C--O 1.225 -0.226 0 CA-C-N 119.303 0.956 . . . . 0.0 110.071 172.188 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -62.3 -48.55 81.69 Favored Glycine 0 CA--C 1.526 0.731 0 CA-C-O 119.103 -0.832 . . . . 0.0 111.216 179.55 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 69.8 mt-30 -55.24 -53.23 58.63 Favored 'General case' 0 C--N 1.343 0.296 0 CA-C-O 122.091 0.948 . . . . 0.0 109.364 -179.802 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 119' ' ' VAL . . . . . 0.455 HG22 HD13 ' A' ' 101' ' ' LEU . 73.8 t -71.44 -39.97 71.91 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-O 117.875 -1.06 . . . . 0.0 110.605 -170.608 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 87.2 tttt -55.6 -47.46 76.47 Favored 'General case' 0 C--O 1.223 -0.321 0 CA-C-N 119.411 1.005 . . . . 0.0 108.316 176.792 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -66.22 -43.01 87.89 Favored 'General case' 0 N--CA 1.45 -0.465 0 C-N-CA 122.438 0.295 . . . . 0.0 111.078 -174.838 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 40.2 mmt180 -63.02 -46.6 86.85 Favored 'General case' 0 N--CA 1.471 0.611 0 O-C-N 121.563 -0.711 . . . . 0.0 110.837 177.831 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 78.2 t -67.31 -41.73 86.81 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.665 0 C-N-CA 123.08 0.552 . . . . 0.0 109.618 -178.897 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 31.3 mt-10 -60.23 -43.74 95.81 Favored 'General case' 0 CA--C 1.52 -0.191 0 CA-C-N 119.595 1.089 . . . . 0.0 110.011 177.651 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 29.0 t-20 -62.38 -45.03 94.97 Favored 'General case' 0 N--CA 1.454 -0.243 0 C-N-CA 122.776 0.43 . . . . 0.0 110.668 179.789 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 28.5 tp -59.44 -47.69 84.49 Favored 'General case' 0 N--CA 1.453 -0.277 0 C-N-CA 123.859 0.864 . . . . 0.0 111.102 177.579 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 85.0 mt -63.09 -46.59 95.71 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.175 0 N-CA-C 107.845 -1.169 . . . . 0.0 107.845 179.504 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -59.79 -28.8 67.74 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-N 118.457 0.571 . . . . 0.0 112.335 178.682 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 92.1 mttt -69.37 -57.17 5.63 Favored 'General case' 0 C--N 1.344 0.349 0 CA-C-N 119.219 0.918 . . . . 0.0 110.629 171.751 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 13.6 pt -77.29 -38.46 27.03 Favored 'Isoleucine or valine' 0 C--O 1.235 0.305 0 N-CA-C 115.095 1.517 . . . . 0.0 115.095 -168.823 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 69.5 m . . . . . 0 C--O 1.252 1.219 0 C-N-CA 125.694 1.597 . . . . 0.0 109.334 -169.79 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.496 1.839 0 N-CA-C 110.535 -0.172 . . . . 0.0 110.535 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 30.8 mttm -80.18 116.65 20.39 Favored 'General case' 0 N--CA 1.475 0.799 0 N-CA-C 106.109 -1.811 . . . . 0.0 106.109 173.66 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 92.2 mttt -81.89 131.88 35.26 Favored 'General case' 0 CA--C 1.505 -0.777 0 CA-C-N 119.566 1.075 . . . . 0.0 108.399 177.45 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 1.4 t -116.61 146.82 20.53 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 O-C-N 125.515 1.76 . . . . 0.0 107.131 -170.821 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 35.3 ttm -138.27 147.27 43.47 Favored 'General case' 0 C--N 1.32 -0.676 0 C-N-CA 125.194 1.398 . . . . 0.0 107.864 170.709 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 6' ' ' PHE . . . . . 0.403 ' CE2' HG13 ' A' ' 77' ' ' ILE . 67.2 m-85 -136.26 119.82 17.07 Favored 'General case' 0 CA--C 1.516 -0.339 0 N-CA-C 105.509 -2.034 . . . . 0.0 105.509 177.526 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 2.0 p -151.45 129.81 2.75 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.386 0 N-CA-C 108.656 -0.868 . . . . 0.0 108.656 -169.427 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -110.77 -178.58 3.52 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 125.764 1.626 . . . . 0.0 106.921 169.754 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 85.1 tttt -70.88 -26.98 63.48 Favored 'General case' 0 N--CA 1.472 0.659 0 O-C-N 121.131 -0.981 . . . . 0.0 112.306 -171.821 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 37.8 ttp180 -136.47 160.7 37.98 Favored 'General case' 0 N--CA 1.467 0.392 0 C-N-CA 124.269 1.028 . . . . 0.0 109.077 -169.545 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -68.96 -38.82 79.64 Favored 'General case' 0 N--CA 1.47 0.571 0 CA-C-N 118.613 0.642 . . . . 0.0 110.596 175.748 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 2.9 p -84.13 66.87 9.49 Favored 'General case' 0 C--O 1.234 0.284 0 C-N-CA 125.863 1.665 . . . . 0.0 108.565 -177.863 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 40.6 p -155.15 -167.02 2.43 Favored 'General case' 0 N--CA 1.451 -0.382 0 CA-C-O 121.789 0.804 . . . . 0.0 109.903 -172.946 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 76.0 mtt180 -54.17 -23.29 13.81 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 126.033 1.733 . . . . 0.0 111.986 169.987 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 28.7 m -51.01 -26.05 5.58 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-N 119.84 1.2 . . . . 0.0 112.991 178.1 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 6.5 pt20 -69.1 -26.99 65.19 Favored 'General case' 0 C--O 1.221 -0.432 0 N-CA-C 114.925 1.454 . . . . 0.0 114.925 -172.554 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 2.1 tpt -115.43 -32.26 5.65 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-N 120.72 1.6 . . . . 0.0 115.033 -169.31 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -68.48 -43.7 76.35 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-N 119.723 1.147 . . . . 0.0 113.083 -169.204 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 1.5 pp20? -63.75 -34.07 77.07 Favored 'General case' 0 N--CA 1.473 0.688 0 CA-C-N 119.267 0.94 . . . . 0.0 109.541 171.997 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -50.8 -49.66 40.44 Favored Glycine 0 C--O 1.219 -0.839 0 C-N-CA 125.259 1.409 . . . . 0.0 111.011 176.057 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 5.6 m-85 -75.98 -31.76 59.14 Favored 'General case' 0 CA--C 1.511 -0.541 0 CA-C-N 118.928 1.364 . . . . 0.0 113.899 178.258 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -68.03 -32.8 73.42 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 119.421 1.009 . . . . 0.0 111.58 -170.174 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 4.7 ptpt -61.07 -29.21 69.61 Favored 'General case' 0 N--CA 1.473 0.697 0 CA-C-N 118.546 0.612 . . . . 0.0 111.643 172.407 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 15.1 m -82.66 -56.93 3.56 Favored 'General case' 0 N--CA 1.443 -0.793 0 C-N-CA 124.965 1.306 . . . . 0.0 109.819 -177.399 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 76.3 mt -73.49 -36.58 65.8 Favored 'General case' 0 C--N 1.331 -0.207 0 C-N-CA 123.35 0.66 . . . . 0.0 110.947 -170.359 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -103.87 13.16 53.17 Favored Glycine 0 CA--C 1.525 0.687 0 CA-C-O 118.068 -1.407 . . . . 0.0 113.044 -174.072 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -41.66 -53.95 3.41 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 126.345 1.858 . . . . 0.0 114.707 -169.229 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -91.31 10.08 75.78 Favored Glycine 0 CA--C 1.53 1.027 0 CA-C-O 119.216 -0.769 . . . . 0.0 113.525 -176.201 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 50.5 mttm -124.13 -50.86 1.79 Allowed 'General case' 0 N--CA 1.467 0.411 0 CA-C-N 118.435 1.117 . . . . 0.0 112.028 -169.21 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 28.3 pt -136.54 150.36 27.32 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.338 0 C-N-CA 124.222 1.009 . . . . 0.0 110.137 -169.011 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -110.27 102.48 11.14 Favored 'General case' 0 C--O 1.228 -0.048 0 C-N-CA 124.911 1.284 . . . . 0.0 109.47 -169.549 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 9.6 p -84.93 130.28 36.32 Favored 'Isoleucine or valine' 0 C--O 1.235 0.309 0 CA-C-N 118.686 0.675 . . . . 0.0 109.658 -179.982 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 19.1 m -145.14 115.46 7.55 Favored 'General case' 0 N--CA 1.448 -0.548 0 N-CA-C 104.342 -2.466 . . . . 0.0 104.342 170.519 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 48.2 m -112.47 8.0 19.22 Favored 'General case' 0 N--CA 1.466 0.325 0 N-CA-C 115.434 1.642 . . . . 0.0 115.434 -174.391 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 1.5 m 52.96 -133.73 1.78 Allowed 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 123.568 0.747 . . . . 0.0 111.114 169.679 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -171.14 154.7 23.08 Favored Glycine 0 N--CA 1.444 -0.777 0 N-CA-C 108.16 -1.976 . . . . 0.0 108.16 170.047 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 55.8 mt -103.08 -51.02 3.35 Favored 'General case' 0 N--CA 1.451 -0.404 0 C-N-CA 124.057 0.943 . . . . 0.0 108.864 171.755 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 25.7 mt-10 -130.58 72.0 1.48 Allowed 'General case' 0 CA--C 1.514 -0.428 0 CA-C-O 124.124 1.916 . . . . 0.0 107.069 169.663 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 10.7 m 57.33 -31.39 0.03 OUTLIER 'General case' 0 C--N 1.321 -0.649 0 C-N-CA 131.446 3.898 . . . . 0.0 117.422 -174.976 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 60.9 m 60.67 23.25 13.09 Favored 'General case' 0 CA--C 1.54 0.573 0 N-CA-C 115.9 1.815 . . . . 0.0 115.9 168.35 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 11.3 ttt180 -71.86 -178.98 2.5 Favored 'General case' 0 CA--C 1.539 0.519 0 N-CA-C 107.558 -1.275 . . . . 0.0 107.558 169.017 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 11.5 m -123.95 -172.32 0.75 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.642 0 C-N-CA 124.437 1.095 . . . . 0.0 111.279 -169.187 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 96.1 m-70 -112.45 156.32 42.41 Favored Pre-proline 0 CA--C 1.536 0.422 0 C-N-CA 125.184 1.394 . . . . 0.0 111.009 -171.984 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -57.2 -48.49 17.65 Favored 'Trans proline' 0 C--N 1.347 0.49 0 C-N-CA 124.012 3.141 . . . . 0.0 112.628 -174.014 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 2.7 m -67.9 -29.64 68.79 Favored 'General case' 0 CA--C 1.531 0.227 0 CA-C-O 118.849 -0.596 . . . . 0.0 110.156 -176.876 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -59.61 -56.09 26.33 Favored 'General case' 0 CA--C 1.505 -0.763 0 N-CA-C 108.137 -1.06 . . . . 0.0 108.137 171.164 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 56.2 mt -59.61 -39.07 78.51 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.396 0 N-CA-C 108.52 -0.918 . . . . 0.0 108.52 -173.043 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -62.32 -49.58 75.05 Favored 'General case' 0 N--CA 1.452 -0.358 0 CA-C-N 119.181 0.9 . . . . 0.0 111.138 -179.838 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 38.9 mmt -71.46 -34.25 70.06 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-O 122.756 1.265 . . . . 0.0 110.161 -177.226 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -73.31 -31.27 63.92 Favored 'General case' 0 N--CA 1.44 -0.925 0 N-CA-C 107.393 -1.336 . . . . 0.0 107.393 -178.634 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 4.9 mm-40 -72.88 -17.5 61.52 Favored 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 124.101 0.96 . . . . 0.0 110.985 169.704 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 78.5 mt-10 -65.11 -36.84 85.55 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 119.844 1.202 . . . . 0.0 108.762 168.932 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . 0.302 8.5 p -86.46 7.5 2.33 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.991 0 CA-C-O 120.789 0.328 . . . . 0.0 111.608 169.742 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 71.41 23.31 78.2 Favored Glycine 0 CA--C 1.532 1.147 0 C-N-CA 124.994 1.283 . . . . 0.0 113.266 175.773 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 5.4 mt -103.7 136.65 35.71 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.226 0 C-N-CA 124.273 1.029 . . . . 0.0 111.975 -172.225 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -78.11 137.28 38.12 Favored 'General case' 0 CA--C 1.529 0.155 0 CA-C-N 114.507 -1.224 . . . . 0.0 109.043 168.972 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 8.1 pt -143.35 -27.56 0.17 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.39 0 C-N-CA 125.062 1.345 . . . . 0.0 108.951 168.209 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -40.21 -41.17 1.25 Allowed 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 129.459 3.104 . . . . 0.0 113.113 169.443 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -87.25 20.52 25.68 Favored Glycine 0 CA--C 1.533 1.171 0 C-N-CA 125.225 1.393 . . . . 0.0 114.38 -177.422 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -60.08 -35.14 74.54 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-N 119.812 1.806 . . . . 0.0 112.489 -178.161 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -66.97 133.01 49.12 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 123.981 0.912 . . . . 0.0 109.817 -171.067 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 13.7 p -151.23 -68.97 0.18 Allowed 'General case' 0 C--O 1.235 0.307 0 C-N-CA 123.356 0.663 . . . . 0.0 109.962 -177.761 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -151.3 155.77 34.74 Favored Pre-proline 0 C--O 1.236 0.376 0 C-N-CA 125.807 1.643 . . . . 0.0 108.57 -177.126 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -64.39 156.3 60.98 Favored 'Trans proline' 0 N--CA 1.456 -0.686 0 C-N-CA 122.234 1.956 . . . . 0.0 110.208 171.46 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 11.3 tt -57.55 -28.41 31.59 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.499 0 C-N-CA 123.137 0.575 . . . . 0.0 111.536 178.826 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 23.1 tt0 -66.04 -25.23 66.95 Favored 'General case' 0 N--CA 1.437 -1.083 0 C-N-CA 126.335 1.854 . . . . 0.0 110.715 -175.588 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 6.1 t-20 -64.11 -21.22 66.45 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 124.287 1.035 . . . . 0.0 112.126 176.82 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 77.6 m-85 -110.88 -176.0 2.86 Favored 'General case' 0 C--O 1.235 0.306 0 C-N-CA 126.025 1.73 . . . . 0.0 110.802 -174.487 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 61.5 t-20 -136.68 141.2 43.12 Favored 'General case' 0 N--CA 1.445 -0.697 0 N-CA-C 107.206 -1.405 . . . . 0.0 107.206 169.366 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -72.2 -25.2 61.58 Favored 'General case' 0 N--CA 1.433 -1.295 0 CA-C-N 118.44 0.564 . . . . 0.0 109.701 -178.901 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 35.6 t70 -63.04 -24.16 67.78 Favored 'General case' 0 N--CA 1.447 -0.607 0 O-C-N 123.549 0.531 . . . . 0.0 111.634 -179.417 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -74.94 -28.11 60.46 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 123.159 0.584 . . . . 0.0 111.868 175.626 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 12.3 m-85 -81.51 164.47 21.96 Favored 'General case' 0 N--CA 1.448 -0.556 0 C-N-CA 125.353 1.461 . . . . 0.0 111.357 -177.21 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -107.16 -37.9 6.15 Favored 'General case' 0 N--CA 1.462 0.138 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.776 173.583 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -139.28 138.71 40.39 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.504 0 CA-C-O 121.731 0.776 . . . . 0.0 110.17 -170.615 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 57.9 t -141.42 130.6 24.15 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.659 0 N-CA-C 106.22 -1.77 . . . . 0.0 106.22 178.033 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.538 HD12 ' HB2' ' A' ' 97' ' ' GLU . 27.4 mm -106.0 128.12 60.57 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.76 0 N-CA-C 105.325 -2.102 . . . . 0.0 105.325 176.537 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 28.9 m -109.93 75.72 0.95 Allowed 'General case' 0 N--CA 1.437 -1.112 0 N-CA-C 105.455 -2.054 . . . . 0.0 105.455 -176.336 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 59.9 mt -53.03 -17.06 1.27 Allowed 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 125.768 1.627 . . . . 0.0 115.102 -169.1 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 12.7 m -112.14 -7.92 14.03 Favored 'General case' 0 CA--C 1.541 0.597 0 CA-C-N 119.866 1.212 . . . . 0.0 114.2 -177.477 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 142.89 -132.91 5.28 Favored Glycine 0 C--N 1.338 0.692 0 CA-C-N 120.635 1.562 . . . . 0.0 111.543 -178.041 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 13.0 m -125.15 -28.13 3.45 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 123.554 0.742 . . . . 0.0 112.314 -169.901 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -76.14 -62.93 2.5 Favored Glycine 0 C--N 1.343 0.925 0 N-CA-C 109.45 -1.46 . . . . 0.0 109.45 173.171 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . 0.321 10.9 t 56.81 18.96 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.55 0.962 0 C-N-CA 125.39 1.476 . . . . 0.0 112.693 170.602 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 64.9 t30 45.33 37.79 3.1 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 125.56 1.544 . . . . 0.0 112.385 -172.089 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -136.45 158.73 72.82 Favored Pre-proline 0 CA--C 1.541 0.62 0 C-N-CA 123.63 0.772 . . . . 0.0 111.849 179.766 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 80.4 Cg_exo -54.99 131.14 44.64 Favored 'Trans proline' 0 C--N 1.352 0.732 0 C-N-CA 123.22 2.613 . . . . 0.0 110.953 175.04 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 49.3 Cg_endo -62.06 -19.45 66.33 Favored 'Trans proline' 0 C--N 1.348 0.512 0 C-N-CA 122.089 1.86 . . . . 0.0 112.138 -177.997 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 2.2 pt-20 -51.13 -26.56 6.81 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 126.136 1.775 . . . . 0.0 112.569 172.739 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 83.4 m95 -74.52 -40.9 61.47 Favored 'General case' 0 N--CA 1.455 -0.2 0 C-N-CA 123.803 0.841 . . . . 0.0 111.844 175.371 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 14.0 t -66.15 -37.12 79.06 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.5 0 C-N-CA 123.901 0.88 . . . . 0.0 108.931 179.374 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 68.8 p -84.39 25.52 0.86 Allowed 'General case' 0 C--O 1.237 0.438 0 N-CA-C 114.851 1.426 . . . . 0.0 114.851 -168.826 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 91.3 mm-40 -74.44 -179.12 3.83 Favored 'General case' 0 CA--C 1.54 0.583 0 CA-C-N 118.385 0.539 . . . . 0.0 110.877 171.706 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 25.6 mm-40 -61.73 -17.87 57.48 Favored 'General case' 0 CA--C 1.54 0.566 0 N-CA-C 113.421 0.897 . . . . 0.0 113.421 -169.027 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 4.6 tt -140.6 133.61 32.59 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.513 0 N-CA-C 106.849 -1.537 . . . . 0.0 106.849 170.026 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -109.57 135.4 50.62 Favored 'General case' 0 CA--C 1.537 0.467 0 N-CA-C 105.04 -2.208 . . . . 0.0 105.04 169.149 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 97' ' ' GLU . . . . . 0.538 ' HB2' HD12 ' A' ' 77' ' ' ILE . 12.8 mm-40 -138.67 163.6 31.69 Favored 'General case' 0 C--O 1.233 0.185 0 C-N-CA 124.542 1.137 . . . . 0.0 107.982 171.26 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -173.57 127.96 0.42 Allowed 'General case' 0 C--O 1.238 0.482 0 C-N-CA 126.944 2.098 . . . . 0.0 105.374 -169.571 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 99' ' ' TRP . . . . . 0.402 ' CZ3' HG21 ' A' ' 77' ' ' ILE . 7.5 m0 -143.13 142.48 31.5 Favored 'General case' 0 N--CA 1.469 0.519 0 N-CA-C 112.751 0.648 . . . . 0.0 112.751 -169.669 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 7.3 pt20 -81.52 50.5 1.49 Allowed 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 125.107 1.363 . . . . 0.0 111.183 174.66 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.497 HD13 HG22 ' A' ' 119' ' ' VAL . 41.7 mt -64.51 140.91 58.92 Favored 'General case' 0 N--CA 1.464 0.269 0 N-CA-C 107.707 -1.22 . . . . 0.0 107.707 172.856 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 27.8 mm-40 -67.15 142.01 57.18 Favored 'General case' 0 CA--C 1.533 0.324 0 CA-C-N 119.681 1.128 . . . . 0.0 109.035 169.938 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 1.5 t0 -97.35 116.07 65.85 Favored Pre-proline 0 N--CA 1.448 -0.526 0 N-CA-C 105.435 -2.061 . . . . 0.0 105.435 169.224 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 49.7 Cg_endo -83.94 -5.4 10.53 Favored 'Trans proline' 0 N--CA 1.451 -1.004 0 C-N-CA 122.815 2.344 . . . . 0.0 112.963 -174.949 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -58.86 127.42 32.12 Favored 'General case' 0 C--O 1.236 0.384 0 CA-C-N 120.204 1.366 . . . . 0.0 109.742 -178.882 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 74.4 0.4 57.7 Favored Glycine 0 CA--C 1.537 1.414 0 CA-C-O 118.618 -1.101 . . . . 0.0 114.013 -178.687 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 13.0 mt-30 -97.3 169.14 9.97 Favored 'General case' 0 CA--C 1.54 0.581 0 CA-C-N 119.09 1.445 . . . . 0.0 109.841 173.386 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 15.0 m -70.64 164.85 24.1 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 124.442 1.097 . . . . 0.0 111.554 -179.608 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 38.2 mt -61.93 -27.04 68.55 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 123.596 0.758 . . . . 0.0 112.115 -175.654 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 5.0 pt-20 -56.76 -36.09 69.38 Favored 'General case' 0 CA--C 1.53 0.198 0 C-N-CA 123.274 0.63 . . . . 0.0 111.228 173.413 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 24.8 t -76.44 -44.37 35.21 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.298 0 CA-C-O 117.786 -1.102 . . . . 0.0 108.837 -178.73 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 59.1 m-85 -55.05 -47.88 74.22 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-N 120.488 1.495 . . . . 0.0 110.364 173.272 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 93.7 mtt180 -70.01 -35.22 74.2 Favored 'General case' 0 CA--C 1.534 0.337 0 O-C-N 121.705 -0.622 . . . . 0.0 110.97 -175.801 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 2.6 m -60.81 -47.35 86.73 Favored 'General case' 0 N--CA 1.454 -0.262 0 C-N-CA 123.922 0.889 . . . . 0.0 109.175 169.812 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 44.4 t -65.31 -31.66 54.86 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.263 0 CA-C-O 118.481 -0.771 . . . . 0.0 109.867 -174.211 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 19.2 mtm105 -57.31 -46.37 83.26 Favored 'General case' 0 CA--C 1.535 0.382 0 CA-C-N 119.41 1.004 . . . . 0.0 110.375 172.507 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -62.57 -50.69 62.07 Favored Glycine 0 CA--C 1.529 0.907 0 CA-C-O 119.543 -0.587 . . . . 0.0 111.636 175.649 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 70.7 mt-30 -57.03 -49.63 75.23 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-O 121.889 0.852 . . . . 0.0 110.414 -176.865 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 119' ' ' VAL . . . . . 0.497 HG22 HD13 ' A' ' 101' ' ' LEU . 58.4 t -74.89 -37.74 42.31 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-O 117.998 -1.001 . . . . 0.0 110.336 -172.062 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -54.77 -45.19 74.21 Favored 'General case' 0 C--O 1.224 -0.247 0 CA-C-N 119.892 1.224 . . . . 0.0 108.839 173.617 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 40.6 tt0 -67.16 -42.81 83.69 Favored 'General case' 0 N--CA 1.448 -0.571 0 C-N-CA 122.977 0.511 . . . . 0.0 111.267 -175.425 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 35.3 mmt180 -63.89 -45.69 88.24 Favored 'General case' 0 N--CA 1.473 0.689 0 CA-C-N 119.084 0.856 . . . . 0.0 111.304 176.881 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 77.5 t -68.37 -37.48 77.96 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.828 0 N-CA-C 108.71 -0.848 . . . . 0.0 108.71 -177.981 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 4.8 mm-40 -59.22 -46.26 88.93 Favored 'General case' 0 C--N 1.34 0.18 0 CA-C-N 119.426 1.012 . . . . 0.0 110.429 172.647 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 27.1 t-20 -64.89 -40.16 94.66 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 123.143 0.577 . . . . 0.0 111.182 -176.87 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 27.9 tp -58.99 -49.83 76.41 Favored 'General case' 0 CA--C 1.53 0.176 0 C-N-CA 125.105 1.362 . . . . 0.0 110.906 172.901 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 51.7 mt -64.57 -46.13 93.47 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 N-CA-C 107.829 -1.175 . . . . 0.0 107.829 -178.059 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -58.98 -30.96 68.35 Favored 'General case' 0 N--CA 1.452 -0.364 0 CA-C-O 118.52 -0.753 . . . . 0.0 112.284 -178.557 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 17.6 ptpt -84.25 -39.81 18.82 Favored 'General case' 0 C--N 1.345 0.375 0 CA-C-O 117.845 -1.074 . . . . 0.0 112.561 177.003 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 11.8 pt -82.55 -35.94 13.09 Favored 'Isoleucine or valine' 0 C--O 1.235 0.309 0 CA-C-N 120.094 1.315 . . . . 0.0 113.814 -175.133 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 65.1 m . . . . . 0 C--O 1.253 1.243 0 C-N-CA 125.134 1.374 . . . . 0.0 109.732 -169.814 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.0 mmt . . . . . 0 N--CA 1.495 1.805 0 N-CA-C 111.195 0.072 . . . . 0.0 111.195 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 30.0 mttm -83.75 112.34 19.99 Favored 'General case' 0 N--CA 1.475 0.818 0 N-CA-C 105.044 -2.206 . . . . 0.0 105.044 169.495 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 91.9 mttt -82.46 133.87 35.21 Favored 'General case' 0 CA--C 1.512 -0.481 0 CA-C-N 119.869 1.213 . . . . 0.0 107.94 179.758 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 1.8 t -120.05 147.14 23.93 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 C-N-CA 125.512 1.525 . . . . 0.0 108.867 -169.077 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 11.1 mtt -134.55 147.22 50.23 Favored 'General case' 0 C--N 1.326 -0.423 0 C-N-CA 125.731 1.613 . . . . 0.0 109.856 169.432 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 62.0 m-85 -135.54 116.72 14.45 Favored 'General case' 0 C--N 1.334 -0.084 0 N-CA-C 105.878 -1.897 . . . . 0.0 105.878 169.684 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 2.6 p -155.04 157.12 4.42 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.367 0 CA-C-O 121.127 0.489 . . . . 0.0 110.269 -168.991 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 52.3 t -152.43 174.89 13.3 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 127.482 2.313 . . . . 0.0 105.932 169.547 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 65.7 pttt -62.7 144.46 56.34 Favored 'General case' 0 N--CA 1.469 0.488 0 O-C-N 121.213 -0.93 . . . . 0.0 109.867 171.598 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 62.8 mtp85 57.78 170.34 0.05 OUTLIER 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 126.468 1.907 . . . . 0.0 113.171 -173.501 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -118.53 0.21 11.52 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 124.066 0.946 . . . . 0.0 111.462 170.113 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 1.4 m -64.19 -37.78 88.69 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 124.137 0.975 . . . . 0.0 110.147 -174.328 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 24.1 p -136.8 153.38 50.83 Favored 'General case' 0 C--O 1.236 0.391 0 C-N-CA 126.657 1.983 . . . . 0.0 106.532 169.718 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 8.0 mpt_? 56.68 -176.05 0.06 Allowed 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 125.391 1.476 . . . . 0.0 110.003 -169.288 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 3.9 m 48.45 46.44 20.64 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 124.069 0.948 . . . . 0.0 110.245 -169.756 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 21.4 pt20 -151.93 157.28 41.58 Favored 'General case' 0 N--CA 1.444 -0.732 0 N-CA-C 106.175 -1.787 . . . . 0.0 106.175 169.997 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER 64.47 -36.07 0.18 Allowed 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 128.124 2.569 . . . . 0.0 115.746 179.326 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -71.51 -48.76 46.8 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-N 121.431 1.923 . . . . 0.0 110.141 -176.827 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -62.66 -39.0 92.53 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 123.113 0.565 . . . . 0.0 110.447 170.012 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -55.73 -43.43 86.67 Favored Glycine 0 C--N 1.343 0.918 0 C-N-CA 123.924 0.773 . . . . 0.0 112.543 174.822 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 2.1 m-85 -74.72 -32.31 62.11 Favored 'General case' 0 CA--C 1.51 -0.573 0 CA-C-N 119.599 1.7 . . . . 0.0 112.227 177.253 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -67.37 -34.19 76.78 Favored 'General case' 0 N--CA 1.453 -0.313 0 CA-C-N 118.839 0.745 . . . . 0.0 111.257 -172.853 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 17.9 ptpt -62.71 -28.16 69.76 Favored 'General case' 0 N--CA 1.475 0.794 0 CA-C-N 119.224 0.92 . . . . 0.0 111.975 170.827 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 2.1 m -83.78 -56.16 3.86 Favored 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 124.573 1.149 . . . . 0.0 110.369 -177.483 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 72.4 mt -73.33 -34.34 65.61 Favored 'General case' 0 C--N 1.331 -0.206 0 C-N-CA 123.861 0.864 . . . . 0.0 110.186 -173.856 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -97.98 11.34 64.14 Favored Glycine 0 CA--C 1.525 0.667 0 C-N-CA 125.487 1.518 . . . . 0.0 112.82 -177.112 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -50.25 122.8 7.37 Favored 'General case' 0 CA--C 1.535 0.391 0 CA-C-N 118.754 1.277 . . . . 0.0 110.406 -177.121 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 74.67 -2.85 46.23 Favored Glycine 0 CA--C 1.536 1.348 0 CA-C-O 118.764 -1.02 . . . . 0.0 114.39 179.216 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 64.4 mttm -103.89 -42.23 5.65 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-N 119.316 1.558 . . . . 0.0 111.319 178.918 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 17.2 pt -141.97 152.84 18.68 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.657 0 C-N-CA 125.068 1.347 . . . . 0.0 109.671 -171.012 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -113.69 103.42 11.21 Favored 'General case' 0 N--CA 1.467 0.4 0 C-N-CA 125.242 1.417 . . . . 0.0 109.877 -170.752 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 3.8 t -86.22 127.9 39.87 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 O-C-N 121.299 -0.875 . . . . 0.0 108.695 -178.517 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 24.6 m -151.46 98.67 2.54 Favored 'General case' 0 C--O 1.223 -0.341 0 N-CA-C 104.843 -2.28 . . . . 0.0 104.843 173.659 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 20.2 m -97.53 5.06 50.13 Favored 'General case' 0 N--CA 1.467 0.388 0 N-CA-C 114.7 1.37 . . . . 0.0 114.7 -169.693 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 4.6 m 53.12 -133.95 1.74 Allowed 'General case' 0 CA--C 1.548 0.873 0 C-N-CA 124.02 0.928 . . . . 0.0 111.458 175.318 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -177.75 170.79 43.27 Favored Glycine 0 CA--C 1.526 0.728 0 N-CA-C 107.121 -2.392 . . . . 0.0 107.121 179.447 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 24.8 mt -113.34 -43.17 3.38 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 118.481 1.14 . . . . 0.0 109.707 179.327 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -141.83 -59.51 0.47 Allowed 'General case' 0 C--N 1.332 -0.175 0 N-CA-C 102.404 -3.184 . . . . 0.0 102.404 169.743 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 15.9 m 58.93 175.58 0.07 Allowed 'General case' 0 N--CA 1.446 -0.649 0 C-N-CA 127.167 2.187 . . . . 0.0 115.772 167.553 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 4.4 m -165.75 178.98 6.23 Favored 'General case' 0 C--O 1.238 0.499 0 C-N-CA 129.464 3.105 . . . . 0.0 104.442 -169.645 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -65.9 163.17 17.55 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-O 122.491 1.139 . . . . 0.0 110.581 172.26 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 4.3 m -67.34 175.32 0.51 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.71 0 CA-C-N 113.305 -1.771 . . . . 0.0 109.3 169.849 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 49.8 t-80 -72.62 139.55 80.91 Favored Pre-proline 0 CA--C 1.545 0.786 0 CA-C-O 118.474 -0.774 . . . . 0.0 109.549 -176.638 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 21.8 Cg_endo -60.74 -48.1 11.72 Favored 'Trans proline' 0 C--N 1.348 0.552 0 C-N-CA 122.645 2.23 . . . . 0.0 113.019 -172.301 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 4.9 m -65.47 -23.41 66.9 Favored 'General case' 0 CA--C 1.536 0.425 0 O-C-N 121.727 -0.608 . . . . 0.0 110.899 179.374 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -58.89 -46.52 87.64 Favored 'General case' 0 C--O 1.216 -0.707 0 CA-C-N 119.146 0.884 . . . . 0.0 108.723 176.835 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 38.6 mt -61.11 -40.18 84.87 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 N-CA-C 108.89 -0.781 . . . . 0.0 108.89 -174.489 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -65.71 -45.1 84.01 Favored 'General case' 0 CA--C 1.534 0.338 0 CA-C-N 118.39 0.541 . . . . 0.0 110.946 -179.864 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 33.0 mmt -68.25 -36.77 79.95 Favored 'General case' 0 CA--C 1.536 0.414 0 CA-C-O 123.295 1.522 . . . . 0.0 110.006 -179.106 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -76.96 -30.39 56.0 Favored 'General case' 0 N--CA 1.44 -0.933 0 N-CA-C 106.632 -1.618 . . . . 0.0 106.632 -175.675 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 40.6 tt0 -69.69 -21.13 63.53 Favored 'General case' 0 N--CA 1.445 -0.686 0 C-N-CA 124.1 0.96 . . . . 0.0 110.049 169.672 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 54.8 mt-10 -63.65 -39.02 93.3 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-N 119.85 1.205 . . . . 0.0 108.963 169.206 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . 0.32 6.2 p -84.7 8.42 1.56 Allowed 'Isoleucine or valine' 0 CA--C 1.549 0.922 0 N-CA-C 112.005 0.372 . . . . 0.0 112.005 171.628 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 79.46 20.15 69.79 Favored Glycine 0 CA--C 1.53 1.01 0 C-N-CA 125.009 1.29 . . . . 0.0 113.563 174.318 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 22.8 mt -116.54 145.97 21.58 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.261 0 C-N-CA 124.861 1.265 . . . . 0.0 110.547 -171.528 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -116.73 149.02 40.56 Favored 'General case' 0 N--CA 1.463 0.214 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 168.94 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 3.3 pt -138.34 -18.78 0.47 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.376 0 C-N-CA 128.058 2.543 . . . . 0.0 111.197 -174.529 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 1.6 t -47.2 -39.87 14.89 Favored 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 124.11 0.964 . . . . 0.0 112.023 169.929 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -68.97 6.26 4.0 Favored Glycine 0 CA--C 1.535 1.306 0 C-N-CA 124.958 1.266 . . . . 0.0 115.318 -176.977 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 2.2 mt-30 -61.33 -33.35 73.47 Favored 'General case' 0 C--N 1.342 0.24 0 CA-C-N 119.605 1.702 . . . . 0.0 113.355 179.191 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -59.77 119.75 8.25 Favored 'General case' 0 C--O 1.236 0.385 0 C-N-CA 123.596 0.758 . . . . 0.0 109.736 -169.412 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 56.1 m -148.84 -169.71 3.44 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 126.358 1.863 . . . . 0.0 108.229 -169.149 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -54.75 154.6 9.1 Favored Pre-proline 0 C--O 1.239 0.524 0 C-N-CA 124.407 1.083 . . . . 0.0 111.613 169.925 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 98.2 Cg_endo -66.08 157.06 61.55 Favored 'Trans proline' 0 N--CA 1.454 -0.82 0 C-N-CA 122.328 2.018 . . . . 0.0 110.225 171.175 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 14.0 tt -61.19 -26.46 39.31 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.328 0 C-N-CA 124.229 1.011 . . . . 0.0 110.979 -178.789 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 13.6 mt-10 -68.03 -24.93 65.15 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 124.556 1.142 . . . . 0.0 110.619 -175.673 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 6.8 t-20 -62.93 -19.14 63.95 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 124.821 1.249 . . . . 0.0 112.153 177.477 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 13.3 m-85 -120.8 174.01 6.87 Favored 'General case' 0 C--O 1.237 0.412 0 C-N-CA 126.484 1.914 . . . . 0.0 109.318 -178.286 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 29.9 p-10 -125.09 149.29 47.99 Favored 'General case' 0 N--CA 1.437 -1.124 0 C-N-CA 124.681 1.192 . . . . 0.0 110.942 168.936 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -75.64 -22.23 56.97 Favored 'General case' 0 N--CA 1.435 -1.223 0 N-CA-C 109.603 -0.518 . . . . 0.0 109.603 -169.901 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 34.7 t70 -64.7 -23.66 67.32 Favored 'General case' 0 N--CA 1.444 -0.774 0 O-C-N 123.666 0.603 . . . . 0.0 111.804 -178.828 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -76.61 -29.44 56.5 Favored 'General case' 0 CA--C 1.533 0.323 0 O-C-N 121.893 -0.505 . . . . 0.0 111.928 173.993 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 21.0 m-85 -78.7 167.73 20.79 Favored 'General case' 0 N--CA 1.448 -0.532 0 C-N-CA 125.116 1.366 . . . . 0.0 110.949 179.597 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -115.63 -40.06 3.43 Favored 'General case' 0 N--CA 1.466 0.353 0 C-N-CA 122.893 0.477 . . . . 0.0 111.223 178.962 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -138.04 136.16 45.03 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.497 0 CA-C-O 121.8 0.81 . . . . 0.0 109.315 -171.324 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 72.1 t -143.84 136.56 23.75 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.68 0 N-CA-C 106.126 -1.805 . . . . 0.0 106.126 -176.869 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 40.9 mm -129.18 127.3 65.45 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.609 0 N-CA-C 107.325 -1.361 . . . . 0.0 107.325 -169.916 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 15.0 m -87.37 131.19 34.37 Favored 'General case' 0 N--CA 1.436 -1.159 0 N-CA-C 105.96 -1.867 . . . . 0.0 105.96 168.235 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 90.6 mt -88.71 -11.67 44.5 Favored 'General case' 0 C--N 1.331 -0.208 0 O-C-N 122.026 -0.421 . . . . 0.0 110.617 172.004 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -167.23 148.85 5.81 Favored 'General case' 0 N--CA 1.447 -0.618 0 C-N-CA 126.633 1.973 . . . . 0.0 107.339 168.385 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 72.37 167.79 10.51 Favored Glycine 0 CA--C 1.535 1.338 0 C-N-CA 124.849 1.214 . . . . 0.0 114.452 174.009 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 41.9 m -141.38 111.09 6.51 Favored 'General case' 0 CA--C 1.532 0.262 0 N-CA-C 107.454 -1.313 . . . . 0.0 107.454 178.936 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 60.23 30.94 71.96 Favored Glycine 0 CA--C 1.535 1.304 0 N-CA-C 111.567 -0.613 . . . . 0.0 111.567 -174.747 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 10.4 p -67.4 -51.71 49.52 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.563 0 C-N-CA 123.882 0.873 . . . . 0.0 111.493 -169.182 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 16.1 t-20 -154.4 41.61 0.49 Allowed 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 125.32 1.448 . . . . 0.0 107.128 173.04 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 2.3 tt -147.59 141.12 15.39 Favored Pre-proline 0 CA--C 1.542 0.641 0 C-N-CA 125.934 1.693 . . . . 0.0 107.85 -169.351 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 32.9 Cg_exo -68.18 149.94 76.57 Favored 'Trans proline' 0 C--N 1.355 0.885 0 CA-C-N 120.742 1.301 . . . . 0.0 114.272 -169.837 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -69.53 -29.05 25.58 Favored 'Trans proline' 0 C--N 1.347 0.455 0 C-N-CA 122.464 2.11 . . . . 0.0 114.292 -169.873 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -61.22 -18.36 57.93 Favored 'General case' 0 CA--C 1.538 0.492 0 CA-C-N 119.738 1.154 . . . . 0.0 112.081 -178.866 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 97.9 m95 -75.83 -49.37 18.2 Favored 'General case' 0 N--CA 1.449 -0.522 0 C-N-CA 123.628 0.771 . . . . 0.0 110.583 177.739 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 33.5 m -77.02 1.07 2.2 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.44 0 C-N-CA 123.13 0.572 . . . . 0.0 112.421 -178.647 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 81.3 p -111.47 19.57 18.06 Favored 'General case' 0 CA--C 1.537 0.458 0 N-CA-C 114.302 1.223 . . . . 0.0 114.302 175.464 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 87.4 mm-40 -67.54 174.61 3.33 Favored 'General case' 0 CA--C 1.539 0.544 0 CA-C-N 119.16 0.891 . . . . 0.0 112.445 178.158 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 29.7 mm-40 -51.91 -32.23 31.87 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 124.711 1.204 . . . . 0.0 112.334 -169.056 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 5.3 tt -131.71 130.85 62.24 Favored 'Isoleucine or valine' 0 C--O 1.24 0.557 0 N-CA-C 103.92 -2.622 . . . . 0.0 103.92 168.017 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 40.9 t80 -120.47 141.18 50.42 Favored 'General case' 0 N--CA 1.444 -0.738 0 N-CA-C 106.061 -1.829 . . . . 0.0 106.061 169.27 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 31.2 mm-40 -139.68 144.8 37.76 Favored 'General case' 0 C--O 1.237 0.408 0 N-CA-C 106.204 -1.776 . . . . 0.0 106.204 169.632 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 7.1 t0 -119.8 103.45 9.37 Favored 'General case' 0 C--O 1.237 0.443 0 N-CA-C 104.746 -2.316 . . . . 0.0 104.746 169.247 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 4.2 m95 -86.15 134.22 33.81 Favored 'General case' 0 N--CA 1.453 -0.278 0 CA-C-O 120.683 0.278 . . . . 0.0 110.928 -169.62 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 66.5 tt0 -81.89 99.71 9.21 Favored 'General case' 0 C--O 1.236 0.383 0 N-CA-C 103.568 -2.753 . . . . 0.0 103.568 168.712 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.401 HD13 HG22 ' A' ' 119' ' ' VAL . 11.1 mt -129.62 133.17 46.99 Favored 'General case' 0 CA--C 1.52 -0.196 0 N-CA-C 107.477 -1.305 . . . . 0.0 107.477 178.622 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 -76.74 165.0 25.33 Favored 'General case' 0 N--CA 1.452 -0.366 0 C-N-CA 124.902 1.281 . . . . 0.0 108.323 169.803 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 15.3 t70 -140.66 139.72 20.71 Favored Pre-proline 0 CA--C 1.536 0.439 0 C-N-CA 123.872 0.869 . . . . 0.0 110.142 -177.511 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 42.4 Cg_endo -84.83 0.92 8.82 Favored 'Trans proline' 0 CA--C 1.544 0.977 0 C-N-CA 123.149 2.566 . . . . 0.0 114.405 -172.8 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 3.2 t70 -48.76 120.0 3.52 Favored 'General case' 0 N--CA 1.468 0.428 0 CA-C-N 120.517 1.508 . . . . 0.0 110.926 177.623 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 67.87 4.73 35.49 Favored Glycine 0 CA--C 1.536 1.383 0 CA-C-O 118.723 -1.043 . . . . 0.0 114.777 179.076 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 6.3 mt-30 -94.45 171.14 8.99 Favored 'General case' 0 CA--C 1.538 0.509 0 CA-C-N 119.31 1.555 . . . . 0.0 110.424 -178.612 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 14.6 m -68.47 159.61 31.36 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 124.321 1.048 . . . . 0.0 110.599 178.083 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 13.8 tp -60.06 -32.0 70.52 Favored 'General case' 0 N--CA 1.467 0.417 0 C-N-CA 123.888 0.875 . . . . 0.0 112.127 -170.055 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 5.3 pt-20 -53.85 -35.76 61.86 Favored 'General case' 0 N--CA 1.467 0.418 0 C-N-CA 126.016 1.726 . . . . 0.0 112.137 176.095 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 38.3 t -70.81 -37.86 70.37 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.258 0 N-CA-C 109.083 -0.71 . . . . 0.0 109.083 -174.008 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 91.8 m-85 -56.74 -50.35 72.5 Favored 'General case' 0 N--CA 1.462 0.126 0 CA-C-N 119.346 0.975 . . . . 0.0 110.806 172.563 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -66.34 -38.09 86.86 Favored 'General case' 0 N--CA 1.473 0.699 0 N-CA-C 109.766 -0.457 . . . . 0.0 109.766 -174.992 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 4.0 m -60.85 -49.64 76.66 Favored 'General case' 0 N--CA 1.451 -0.42 0 C-N-CA 124.704 1.201 . . . . 0.0 109.984 173.681 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 76.7 t -69.59 -25.84 29.62 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.229 0 CA-C-O 117.812 -1.089 . . . . 0.0 109.944 -171.829 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 11.9 mtm105 -57.15 -49.07 77.07 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 120.142 1.337 . . . . 0.0 109.729 169.839 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -63.35 -48.47 78.54 Favored Glycine 0 CA--C 1.527 0.84 0 CA-C-N 118.608 0.64 . . . . 0.0 111.951 -179.52 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 12.8 mt-30 -60.74 -46.15 91.52 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-N 117.719 0.759 . . . . 0.0 110.77 -179.188 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 119' ' ' VAL . . . . . 0.401 HG22 HD13 ' A' ' 101' ' ' LEU . 82.6 t -70.68 -40.67 77.27 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-O 118.424 -0.798 . . . . 0.0 110.297 -175.84 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 85.9 tttt -52.69 -47.26 67.33 Favored 'General case' 0 C--O 1.223 -0.322 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 175.688 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 40.2 tt0 -64.58 -42.63 95.49 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-O 119.245 -0.407 . . . . 0.0 111.253 -175.134 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 35.3 mmt180 -60.21 -47.46 85.86 Favored 'General case' 0 N--CA 1.472 0.635 0 CA-C-N 118.882 0.765 . . . . 0.0 110.434 175.893 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 89.8 t -69.94 -37.78 73.7 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.525 0 N-CA-C 109.563 -0.532 . . . . 0.0 109.563 -175.274 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 35.4 mt-10 -59.96 -44.44 94.42 Favored 'General case' 0 C--O 1.227 -0.097 0 CA-C-N 119.657 1.117 . . . . 0.0 110.049 174.165 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 28.7 t-20 -63.26 -44.55 94.84 Favored 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 122.693 0.397 . . . . 0.0 110.834 -178.564 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 41.8 tp -58.73 -48.53 80.85 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 124.335 1.054 . . . . 0.0 111.104 175.97 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 65.4 mt -62.79 -47.1 94.48 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.149 0 N-CA-C 107.865 -1.161 . . . . 0.0 107.865 -179.999 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -58.85 -27.65 65.34 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 123.095 0.558 . . . . 0.0 112.436 178.11 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 89.4 mttt -72.03 -57.43 4.29 Favored 'General case' 0 C--N 1.343 0.325 0 CA-C-N 119.153 0.888 . . . . 0.0 110.616 171.604 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 13.2 pt -76.14 -36.23 30.31 Favored 'Isoleucine or valine' 0 C--O 1.235 0.293 0 N-CA-C 115.184 1.55 . . . . 0.0 115.184 -168.943 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 69.2 m . . . . . 0 C--O 1.252 1.229 0 C-N-CA 125.707 1.603 . . . . 0.0 109.606 -169.881 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 19.5 mmm . . . . . 0 N--CA 1.499 1.997 0 N-CA-C 110.936 -0.024 . . . . 0.0 110.936 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 31.0 mttm -79.43 117.81 20.73 Favored 'General case' 0 N--CA 1.477 0.895 0 N-CA-C 105.407 -2.071 . . . . 0.0 105.407 169.545 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 74.5 mttt -83.43 133.67 34.91 Favored 'General case' 0 CA--C 1.514 -0.414 0 CA-C-N 120.252 1.387 . . . . 0.0 107.997 179.324 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 1.5 t -118.78 147.94 21.98 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.583 0 C-N-CA 126.725 2.01 . . . . 0.0 106.711 -169.635 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 49.7 ttm -142.8 142.04 31.78 Favored 'General case' 0 C--N 1.325 -0.484 0 C-N-CA 123.71 0.804 . . . . 0.0 109.343 172.191 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 97.0 m-85 -132.64 122.06 24.12 Favored 'General case' 0 CA--C 1.511 -0.551 0 N-CA-C 104.987 -2.227 . . . . 0.0 104.987 179.855 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 1.6 p -154.07 119.78 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.397 0 C-N-CA 119.566 -0.854 . . . . 0.0 109.412 -169.515 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 51.1 t -98.75 178.43 4.98 Favored 'General case' 0 CA--C 1.541 0.623 0 N-CA-C 106.971 -1.492 . . . . 0.0 106.971 168.915 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -52.4 -42.19 63.83 Favored 'General case' 0 N--CA 1.473 0.707 0 O-C-N 121.624 -0.673 . . . . 0.0 110.803 178.662 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 66.2 mtp180 -108.94 145.45 35.41 Favored 'General case' 0 CA--C 1.521 -0.156 0 N-CA-C 108.978 -0.749 . . . . 0.0 108.978 169.852 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 7.4 t30 -55.04 -38.01 67.42 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 124.363 1.065 . . . . 0.0 111.112 169.372 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 1.4 m -68.71 -15.0 63.38 Favored 'General case' 0 CA--C 1.533 0.307 0 N-CA-C 114.667 1.358 . . . . 0.0 114.667 -169.557 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 52.3 m -124.69 139.43 53.86 Favored 'General case' 0 C--O 1.223 -0.309 0 C-N-CA 123.97 0.908 . . . . 0.0 110.311 -169.09 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 6.4 mpt_? 59.14 -60.97 0.04 OUTLIER 'General case' 0 N--CA 1.481 1.112 0 C-N-CA 127.605 2.362 . . . . 0.0 114.066 -174.737 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -44.72 -36.91 3.39 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 126.499 1.919 . . . . 0.0 109.624 170.001 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 23.8 tt0 -25.63 -61.91 0.07 Allowed 'General case' 0 C--O 1.22 -0.486 0 C-N-CA 130.686 3.595 . . . . 0.0 111.772 168.848 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -98.68 -29.87 12.78 Favored 'General case' 0 CA--C 1.516 -0.345 0 CA-C-N 119.719 1.145 . . . . 0.0 113.434 177.501 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -61.09 -48.55 81.18 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 111.993 0.368 . . . . 0.0 111.993 -169.321 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -68.74 -30.62 69.28 Favored 'General case' 0 N--CA 1.463 0.177 0 C-N-CA 120.237 -0.585 . . . . 0.0 109.645 176.767 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -54.81 -57.3 18.55 Favored Glycine 0 C--N 1.34 0.781 0 C-N-CA 125.405 1.478 . . . . 0.0 110.099 176.812 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 8.7 m-85 -67.89 -32.18 72.48 Favored 'General case' 0 CA--C 1.503 -0.835 0 O-C-N 121.659 -0.906 . . . . 0.0 111.981 179.982 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -65.82 -34.74 78.85 Favored 'General case' 0 N--CA 1.447 -0.585 0 C-N-CA 119.431 -0.908 . . . . 0.0 111.141 -175.452 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -68.1 -24.23 65.01 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-N 119.436 1.016 . . . . 0.0 112.036 175.037 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 2.1 m -82.11 -56.12 4.13 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 125.223 1.409 . . . . 0.0 110.438 -179.993 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 72.3 mt -76.37 -34.97 58.91 Favored 'General case' 0 C--N 1.329 -0.283 0 C-N-CA 124.631 1.172 . . . . 0.0 110.258 -172.529 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -92.57 7.13 77.69 Favored Glycine 0 CA--C 1.526 0.758 0 C-N-CA 125.282 1.42 . . . . 0.0 113.198 -177.292 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -52.52 124.18 12.93 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 124.448 1.099 . . . . 0.0 110.002 -176.01 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 75.44 1.95 66.74 Favored Glycine 0 CA--C 1.535 1.288 0 CA-C-O 118.835 -0.981 . . . . 0.0 114.406 179.074 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 64.0 mttm -113.36 -43.06 3.39 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-N 119.294 1.547 . . . . 0.0 111.359 178.828 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 20.4 pt -140.94 151.41 20.2 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.604 0 C-N-CA 123.805 0.842 . . . . 0.0 110.388 -169.36 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -108.66 103.25 12.31 Favored 'General case' 0 N--CA 1.467 0.393 0 C-N-CA 125.37 1.468 . . . . 0.0 109.646 -173.209 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 20.8 t -81.31 135.84 24.28 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 179.604 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 4.8 m -140.68 111.51 6.99 Favored 'General case' 0 N--CA 1.445 -0.678 0 N-CA-C 104.492 -2.41 . . . . 0.0 104.492 169.513 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 75.0 m -114.31 91.97 3.81 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 107.64 -1.245 . . . . 0.0 107.64 178.739 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 5.0 p -63.69 -62.38 1.7 Allowed 'General case' 0 C--O 1.233 0.215 0 C-N-CA 126.408 1.883 . . . . 0.0 112.044 -173.071 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 107.88 137.63 8.36 Favored Glycine 0 CA--C 1.527 0.786 0 N-CA-C 109.157 -1.577 . . . . 0.0 109.157 -174.425 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 12.8 mt -80.08 -40.44 27.6 Favored 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 124.395 1.078 . . . . 0.0 108.874 170.207 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 33.5 mt-10 -139.87 170.16 16.38 Favored 'General case' 0 C--O 1.239 0.523 0 C-N-CA 128.143 2.577 . . . . 0.0 107.629 172.914 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 13.2 m 64.75 -168.17 0.21 Allowed 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 124.837 1.255 . . . . 0.0 112.315 -177.487 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 36.8 p -162.55 -47.66 0.04 OUTLIER 'General case' 0 C--O 1.232 0.184 0 N-CA-C 112.442 0.534 . . . . 0.0 112.442 -167.067 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 2.0 ttp-105 -108.87 -167.5 1.23 Allowed 'General case' 0 CA--C 1.52 -0.19 0 C-N-CA 125.498 1.519 . . . . 0.0 109.227 177.766 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 34.2 m -127.32 168.94 19.53 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 C-N-CA 125.506 1.523 . . . . 0.0 109.838 -171.757 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 37.4 m80 -71.59 148.1 92.67 Favored Pre-proline 0 CA--C 1.548 0.889 0 C-N-CA 123.313 0.645 . . . . 0.0 109.694 177.975 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -62.39 -50.74 4.14 Favored 'Trans proline' 0 C--N 1.348 0.529 0 C-N-CA 123.818 3.012 . . . . 0.0 114.806 -168.632 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 11.5 m -63.88 -22.69 67.03 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-N 118.211 0.459 . . . . 0.0 110.61 -175.678 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.415 ' HB1' HD11 ' A' ' 57' ' ' ILE . . . -55.12 -55.33 32.32 Favored 'General case' 0 CA--C 1.511 -0.546 0 C-N-CA 122.765 0.426 . . . . 0.0 109.911 174.152 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 56.3 mt -60.54 -38.04 76.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 N-CA-C 108.554 -0.906 . . . . 0.0 108.554 -170.635 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -62.94 -48.19 79.98 Favored 'General case' 0 N--CA 1.451 -0.379 0 CA-C-N 118.471 0.578 . . . . 0.0 111.07 177.778 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 27.8 mmt -66.73 -36.54 82.71 Favored 'General case' 0 C--O 1.238 0.488 0 CA-C-O 122.78 1.276 . . . . 0.0 111.071 -179.748 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -75.98 -31.23 58.88 Favored 'General case' 0 N--CA 1.441 -0.878 0 N-CA-C 107.183 -1.414 . . . . 0.0 107.183 -174.777 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 41.0 tt0 -71.28 -21.77 62.04 Favored 'General case' 0 N--CA 1.446 -0.63 0 C-N-CA 124.138 0.975 . . . . 0.0 110.426 171.031 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 20.0 mm-40 -67.57 -31.0 70.77 Favored 'General case' 0 CA--C 1.534 0.359 0 CA-C-N 119.508 1.049 . . . . 0.0 110.141 170.814 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . 0.28 7.2 p -90.39 8.62 3.53 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.983 0 CA-C-N 118.633 0.652 . . . . 0.0 111.482 169.062 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 75.73 18.59 79.6 Favored Glycine 0 CA--C 1.533 1.162 0 C-N-CA 124.678 1.133 . . . . 0.0 113.746 174.908 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 21.6 mt -111.35 134.81 52.5 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.23 0 C-N-CA 124.559 1.143 . . . . 0.0 109.379 -177.234 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 28.7 t0 -99.52 141.53 32.19 Favored 'General case' 0 C--O 1.235 0.323 0 N-CA-C 108.288 -1.005 . . . . 0.0 108.288 168.952 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.415 HD11 ' HB1' ' A' ' 46' ' ' ALA . 8.8 pt -131.15 -15.67 1.58 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.503 0 C-N-CA 126.335 1.854 . . . . 0.0 111.298 -174.135 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 1.2 t -57.2 163.48 2.14 Favored 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 124.544 1.138 . . . . 0.0 109.86 168.342 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 57.73 32.6 65.82 Favored Glycine 0 CA--C 1.532 1.106 0 C-N-CA 123.543 0.592 . . . . 0.0 112.129 179.177 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 4.3 tt0 -65.5 -39.41 91.82 Favored 'General case' 0 C--N 1.341 0.214 0 N-CA-C 113.957 1.095 . . . . 0.0 113.957 -169.135 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 7.0 t -76.19 177.82 6.9 Favored 'General case' 0 N--CA 1.449 -0.518 0 CA-C-O 122.557 1.17 . . . . 0.0 110.555 -169.646 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 13.3 p -155.72 -54.1 0.09 Allowed 'General case' 0 C--N 1.324 -0.515 0 C-N-CA 125.213 1.405 . . . . 0.0 108.327 -171.25 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -151.88 155.89 33.95 Favored Pre-proline 0 C--O 1.239 0.521 0 C-N-CA 127.628 2.371 . . . . 0.0 106.173 169.955 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -59.84 148.81 86.85 Favored 'Trans proline' 0 N--CA 1.457 -0.654 0 C-N-CA 121.801 1.668 . . . . 0.0 108.991 169.411 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 20.6 tt -55.24 -29.62 23.44 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.352 0 C-N-CA 123.12 0.568 . . . . 0.0 112.364 -174.181 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 9.0 mt-10 -65.73 -29.62 70.17 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 123.233 0.613 . . . . 0.0 111.026 -173.234 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 88.3 m-20 -77.93 -8.98 58.84 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 124.002 0.921 . . . . 0.0 112.273 -177.796 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 61.8 m-85 -95.53 162.24 13.72 Favored 'General case' 0 C--O 1.236 0.352 0 C-N-CA 124.286 1.034 . . . . 0.0 111.321 176.836 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 40.9 t-20 -99.47 127.32 45.52 Favored 'General case' 0 N--CA 1.447 -0.62 0 N-CA-C 107.431 -1.322 . . . . 0.0 107.431 168.875 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.415 ' HB2' ' CE2' ' A' ' 90' ' ' TRP . . . -73.3 -26.28 61.01 Favored 'General case' 0 N--CA 1.434 -1.266 0 N-CA-C 109.466 -0.568 . . . . 0.0 109.466 -178.252 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -63.85 -22.47 66.93 Favored 'General case' 0 N--CA 1.443 -0.798 0 CA-C-N 116.528 -0.306 . . . . 0.0 111.582 -178.347 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -74.02 -24.64 59.58 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 123.058 0.543 . . . . 0.0 111.991 178.851 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 34.4 m-85 -85.85 145.67 27.09 Favored 'General case' 0 N--CA 1.451 -0.394 0 C-N-CA 124.974 1.31 . . . . 0.0 111.5 -176.534 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 27.3 t70 -98.66 -32.69 11.28 Favored 'General case' 0 N--CA 1.466 0.357 0 C-N-CA 123.506 0.722 . . . . 0.0 111.032 -179.844 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -140.19 134.66 36.13 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.393 0 C-N-CA 124.376 1.071 . . . . 0.0 109.119 -175.792 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 94.2 t -144.1 139.49 24.77 Favored 'Isoleucine or valine' 0 C--O 1.237 0.396 0 N-CA-C 107.165 -1.42 . . . . 0.0 107.165 -178.822 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.598 HD12 ' HB2' ' A' ' 97' ' ' GLU . 19.0 mm -123.06 124.4 70.11 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.601 0 N-CA-C 106.589 -1.634 . . . . 0.0 106.589 -179.357 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 28.2 m -95.4 105.87 17.88 Favored 'General case' 0 N--CA 1.448 -0.555 0 N-CA-C 103.66 -2.718 . . . . 0.0 103.66 169.321 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 29.4 mt -76.21 -4.76 43.58 Favored 'General case' 0 N--CA 1.463 0.219 0 N-CA-C 114.273 1.212 . . . . 0.0 114.273 -169.364 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 73.2 m -146.13 71.77 1.27 Allowed 'General case' 0 N--CA 1.451 -0.391 0 CA-C-N 118.795 0.725 . . . . 0.0 109.168 -169.761 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 91.05 178.79 43.18 Favored Glycine 0 CA--C 1.53 0.979 0 C-N-CA 124.484 1.04 . . . . 0.0 111.031 -177.009 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 15.0 p -89.79 -92.95 0.12 Allowed 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 123.643 0.777 . . . . 0.0 111.087 -169.533 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -79.52 -41.67 12.85 Favored Glycine 0 C--N 1.338 0.665 0 CA-C-O 119.058 -0.856 . . . . 0.0 111.06 176.885 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . 0.317 4.7 m 44.13 -94.41 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.543 0.698 0 C-N-CA 126.063 1.745 . . . . 0.0 113.704 174.833 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 57.3 t30 -141.13 43.42 1.79 Allowed 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 125.129 1.372 . . . . 0.0 109.111 177.131 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -133.72 139.27 33.1 Favored Pre-proline 0 CA--C 1.541 0.623 0 C-N-CA 127.247 2.219 . . . . 0.0 107.316 -171.642 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 39.6 Cg_exo -65.36 137.84 52.91 Favored 'Trans proline' 0 CA--C 1.539 0.748 0 C-N-CA 121.386 1.391 . . . . 0.0 111.965 -176.124 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 65.1 Cg_endo -68.88 -15.53 40.44 Favored 'Trans proline' 0 N--CA 1.46 -0.472 0 C-N-CA 122.616 2.211 . . . . 0.0 113.513 -173.644 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -59.54 -14.74 14.21 Favored 'General case' 0 CA--C 1.541 0.625 0 CA-C-N 120.315 1.416 . . . . 0.0 111.966 170.425 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 90' ' ' TRP . . . . . 0.415 ' CE2' ' HB2' ' A' ' 70' ' ' ALA . 99.8 m95 -96.56 -11.36 25.49 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 125.215 1.406 . . . . 0.0 113.563 174.683 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.403 ' HA ' ' CD1' ' A' ' 96' ' ' PHE . 3.9 m -92.42 0.75 9.42 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.355 0 CA-C-N 120.261 1.392 . . . . 0.0 111.477 174.745 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 63.6 p -117.88 15.66 14.32 Favored 'General case' 0 C--O 1.237 0.406 0 N-CA-C 116.872 2.175 . . . . 0.0 116.872 -169.455 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 17.6 mp0 -66.51 173.87 3.1 Favored 'General case' 0 CA--C 1.54 0.587 0 CA-C-N 118.852 0.751 . . . . 0.0 111.016 176.284 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 33.3 mm-40 -56.67 -27.06 57.98 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 123.691 0.796 . . . . 0.0 111.268 -172.353 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 5.0 tt -133.8 131.24 56.41 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.528 0 N-CA-C 104.958 -2.238 . . . . 0.0 104.958 168.361 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 96' ' ' PHE . . . . . 0.403 ' CD1' ' HA ' ' A' ' 91' ' ' VAL . 40.5 t80 -117.99 135.99 53.81 Favored 'General case' 0 N--CA 1.449 -0.486 0 N-CA-C 106.706 -1.59 . . . . 0.0 106.706 169.739 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 97' ' ' GLU . . . . . 0.598 ' HB2' HD12 ' A' ' 77' ' ' ILE . 16.4 mm-40 -142.09 165.81 26.44 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-O 121.963 0.887 . . . . 0.0 110.116 174.881 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 3.7 t0 -168.1 134.16 1.95 Allowed 'General case' 0 C--O 1.239 0.516 0 C-N-CA 129.71 3.204 . . . . 0.0 106.108 -172.76 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 6.2 m-90 -144.8 149.04 34.77 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 123.847 0.859 . . . . 0.0 109.72 -171.269 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 7.4 tp-100 -82.56 57.36 3.69 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-O 121.809 0.814 . . . . 0.0 109.589 177.889 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.515 HD13 HG22 ' A' ' 119' ' ' VAL . 66.6 mt -79.22 152.66 30.5 Favored 'General case' 0 CA--C 1.53 0.179 0 N-CA-C 106.526 -1.657 . . . . 0.0 106.526 169.62 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 5.6 pt-20 -119.24 164.55 15.46 Favored 'General case' 0 N--CA 1.456 -0.141 0 C-N-CA 124.936 1.294 . . . . 0.0 110.436 178.623 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 64.4 t0 -97.42 121.28 58.91 Favored Pre-proline 0 CA--C 1.539 0.542 0 C-N-CA 123.739 0.815 . . . . 0.0 108.842 171.375 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 90.2 Cg_endo -70.48 -5.0 15.65 Favored 'Trans proline' 0 CA--C 1.544 1.02 0 C-N-CA 123.792 2.995 . . . . 0.0 113.765 176.18 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -43.28 123.23 2.85 Favored 'General case' 0 C--O 1.238 0.453 0 C-N-CA 126.249 1.82 . . . . 0.0 111.367 -179.506 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 69.5 2.79 36.89 Favored Glycine 0 CA--C 1.533 1.19 0 CA-C-O 118.612 -1.105 . . . . 0.0 114.98 169.759 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 28.8 pt20 -111.62 -167.06 1.13 Allowed 'General case' 0 CA--C 1.536 0.433 0 CA-C-N 119.021 1.41 . . . . 0.0 109.737 171.928 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 2.3 m -68.45 154.43 41.84 Favored 'General case' 0 N--CA 1.453 -0.303 0 N-CA-C 115.699 1.74 . . . . 0.0 115.699 -168.261 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 36.0 tp -55.76 -33.39 64.27 Favored 'General case' 0 N--CA 1.465 0.317 0 C-N-CA 126.349 1.86 . . . . 0.0 111.784 173.722 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -58.12 -34.67 70.47 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 123.544 0.738 . . . . 0.0 110.529 174.711 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 2.8 t -76.47 -40.52 34.53 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.299 0 CA-C-O 118.284 -0.865 . . . . 0.0 109.96 -178.912 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 61.9 m-85 -56.47 -47.27 79.55 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-N 120.122 1.328 . . . . 0.0 109.538 171.4 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 86.7 mtt180 -62.99 -43.16 99.55 Favored 'General case' 0 N--CA 1.466 0.351 0 C-N-CA 122.982 0.513 . . . . 0.0 110.972 179.43 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 6.9 m -64.25 -50.12 69.19 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 124.266 1.027 . . . . 0.0 109.955 179.347 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 75.8 t -68.68 -37.46 77.59 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.365 0 CA-C-N 118.796 0.725 . . . . 0.0 109.056 -173.564 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 46.1 ttp85 -58.22 -44.39 88.17 Favored 'General case' 0 CA--C 1.538 0.483 0 CA-C-N 119.117 0.871 . . . . 0.0 110.329 174.706 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -64.83 -50.24 59.34 Favored Glycine 0 CA--C 1.531 1.07 0 CA-C-N 118.543 0.611 . . . . 0.0 112.204 176.137 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 39.1 mm-40 -58.02 -50.99 71.51 Favored 'General case' 0 N--CA 1.465 0.324 0 C-N-CA 124.213 1.005 . . . . 0.0 110.278 -177.838 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 119' ' ' VAL . . . . . 0.515 HG22 HD13 ' A' ' 101' ' ' LEU . 98.3 t -67.56 -38.38 80.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-O 118.211 -0.899 . . . . 0.0 110.344 -174.054 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 57.1 tttm -55.0 -44.75 74.8 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 119.451 1.023 . . . . 0.0 109.338 175.551 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -68.48 -43.33 77.16 Favored 'General case' 0 N--CA 1.447 -0.621 0 CA-C-O 119.053 -0.498 . . . . 0.0 111.293 -176.204 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 1.8 mmt-85 -60.34 -46.83 88.51 Favored 'General case' 0 N--CA 1.476 0.841 0 CA-C-N 119.363 0.983 . . . . 0.0 110.604 176.262 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 98.4 t -69.41 -38.57 77.43 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.487 0 N-CA-C 109.101 -0.703 . . . . 0.0 109.101 -177.172 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 15.3 mt-10 -60.38 -45.63 92.86 Favored 'General case' 0 CA--C 1.52 -0.202 0 CA-C-N 119.884 1.22 . . . . 0.0 110.122 175.022 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 29.4 t-20 -62.53 -41.51 98.91 Favored 'General case' 0 CA--C 1.531 0.223 0 C-N-CA 123.25 0.62 . . . . 0.0 110.712 -179.85 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 58.7 tp -60.78 -48.45 81.73 Favored 'General case' 0 N--CA 1.456 -0.148 0 C-N-CA 123.819 0.848 . . . . 0.0 111.261 176.424 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 76.1 mt -63.49 -45.72 97.09 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.292 0 N-CA-C 107.646 -1.242 . . . . 0.0 107.646 179.91 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -59.19 -28.31 66.51 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 123.135 0.574 . . . . 0.0 112.405 177.009 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 72.3 mttt -71.87 -54.22 10.77 Favored 'General case' 0 C--N 1.343 0.309 0 CA-C-N 119.129 0.877 . . . . 0.0 110.726 172.772 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 14.1 pt -79.44 -38.43 19.74 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.332 0 N-CA-C 114.667 1.358 . . . . 0.0 114.667 -169.215 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 73.3 m . . . . . 0 C--O 1.253 1.266 0 C-N-CA 125.967 1.707 . . . . 0.0 109.742 -169.982 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.496 1.834 0 N-CA-C 110.234 -0.284 . . . . 0.0 110.234 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 34.3 mttm -76.56 117.16 17.92 Favored 'General case' 0 N--CA 1.477 0.883 0 N-CA-C 106.021 -1.844 . . . . 0.0 106.021 172.295 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 88.8 mttt -84.92 135.11 34.2 Favored 'General case' 0 CA--C 1.515 -0.387 0 N-CA-C 107.695 -1.224 . . . . 0.0 107.695 179.47 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 1.8 t -120.81 149.51 23.69 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 C-N-CA 125.9 1.68 . . . . 0.0 109.511 -168.493 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 25.9 mtt -139.57 147.47 41.2 Favored 'General case' 0 C--N 1.324 -0.523 0 C-N-CA 124.534 1.133 . . . . 0.0 109.111 169.27 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 72.0 m-85 -133.06 114.33 13.81 Favored 'General case' 0 CA--C 1.517 -0.32 0 N-CA-C 104.343 -2.465 . . . . 0.0 104.343 172.133 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 2.4 p -151.39 137.2 11.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 118.563 0.62 . . . . 0.0 109.758 -169.352 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 19.9 t -117.24 178.43 4.37 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 126.225 1.81 . . . . 0.0 106.323 169.6 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 39.7 ttpt -55.05 -35.08 64.11 Favored 'General case' 0 N--CA 1.475 0.819 0 O-C-N 121.148 -0.97 . . . . 0.0 111.479 179.638 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 33.3 ptt180 -123.55 160.27 27.38 Favored 'General case' 0 N--CA 1.463 0.212 0 C-N-CA 124.868 1.267 . . . . 0.0 108.294 169.628 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 47.6 t30 -71.75 -42.66 66.97 Favored 'General case' 0 N--CA 1.471 0.578 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 170.864 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 1.1 m -52.02 141.45 18.07 Favored 'General case' 0 N--CA 1.453 -0.319 0 C-N-CA 125.696 1.598 . . . . 0.0 110.616 -171.331 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 3.9 m 66.91 -66.65 0.18 Allowed 'General case' 0 C--N 1.327 -0.383 0 C-N-CA 126.315 1.846 . . . . 0.0 114.525 -173.459 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 8.9 tpp180 -82.78 -46.93 12.51 Favored 'General case' 0 N--CA 1.471 0.576 0 N-CA-C 116.464 2.024 . . . . 0.0 116.464 -167.59 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 3.6 m -89.78 4.69 48.95 Favored 'General case' 0 N--CA 1.471 0.596 0 N-CA-C 114.81 1.411 . . . . 0.0 114.81 -169.051 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 28.2 pt20 -68.83 -47.64 65.54 Favored 'General case' 0 C--O 1.224 -0.289 0 O-C-N 120.959 -1.088 . . . . 0.0 113.364 -171.035 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 2.4 tpt -88.06 -34.63 17.9 Favored 'General case' 0 N--CA 1.47 0.527 0 N-CA-C 113.659 0.985 . . . . 0.0 113.659 -169.309 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -61.03 -44.95 96.64 Favored 'General case' 0 N--CA 1.471 0.605 0 N-CA-C 112.88 0.696 . . . . 0.0 112.88 -169.082 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 1.9 pp20? -64.96 -34.51 78.59 Favored 'General case' 0 N--CA 1.464 0.255 0 O-C-N 121.96 -0.463 . . . . 0.0 109.834 176.522 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -52.11 -56.47 16.64 Favored Glycine 0 C--N 1.34 0.753 0 C-N-CA 125.182 1.372 . . . . 0.0 110.623 175.539 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 13.5 m-85 -68.52 -29.89 68.58 Favored 'General case' 0 CA--C 1.508 -0.657 0 O-C-N 121.521 -0.987 . . . . 0.0 112.512 -179.964 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -69.73 -31.93 70.19 Favored 'General case' 0 N--CA 1.452 -0.341 0 CA-C-N 119.52 1.055 . . . . 0.0 111.603 -174.766 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -68.19 -25.56 65.3 Favored 'General case' 0 N--CA 1.474 0.758 0 CA-C-N 119.541 1.064 . . . . 0.0 111.651 172.566 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 3.2 m -82.42 -56.46 3.87 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 124.959 1.304 . . . . 0.0 110.139 -177.592 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 70.7 mt -75.33 -36.42 61.05 Favored 'General case' 0 C--N 1.331 -0.215 0 C-N-CA 124.298 1.039 . . . . 0.0 110.055 -173.83 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -89.96 6.12 82.92 Favored Glycine 0 C--N 1.339 0.715 0 C-N-CA 124.855 1.217 . . . . 0.0 113.152 -177.017 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -50.74 125.28 12.86 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 124.739 1.215 . . . . 0.0 110.321 -175.635 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 76.54 -5.41 45.38 Favored Glycine 0 CA--C 1.534 1.229 0 CA-C-O 118.782 -1.01 . . . . 0.0 114.437 179.41 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 63.2 mttm -107.5 -51.89 2.84 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-N 119.322 1.561 . . . . 0.0 110.226 -179.762 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 26.1 pt -136.36 147.74 27.66 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.295 0 C-N-CA 123.913 0.885 . . . . 0.0 110.066 -169.31 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -109.89 104.26 13.16 Favored 'General case' 0 N--CA 1.463 0.198 0 C-N-CA 125.082 1.353 . . . . 0.0 108.885 -169.871 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 14.6 p -81.09 142.02 14.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 119.51 1.05 . . . . 0.0 109.192 177.003 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 11.6 m -132.15 -49.63 0.94 Allowed 'General case' 0 N--CA 1.455 -0.212 0 C-N-CA 124.216 1.006 . . . . 0.0 110.22 175.633 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 48.1 m 62.69 -27.03 0.06 Allowed 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 127.439 2.296 . . . . 0.0 117.14 176.49 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 5.6 m 54.37 -135.78 1.4 Allowed 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 124.765 1.226 . . . . 0.0 110.804 169.752 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -172.65 170.25 43.35 Favored Glycine 0 C--N 1.336 0.574 0 N-CA-C 108.331 -1.907 . . . . 0.0 108.331 178.289 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 34.2 mt -118.28 -43.31 2.73 Favored 'General case' 0 N--CA 1.451 -0.398 0 C-N-CA 125.353 1.461 . . . . 0.0 109.084 179.833 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 36.6 mt-10 -140.45 -59.3 0.53 Allowed 'General case' 0 C--O 1.233 0.192 0 N-CA-C 101.687 -3.449 . . . . 0.0 101.687 169.605 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 17.1 m 57.39 177.88 0.05 OUTLIER 'General case' 0 N--CA 1.447 -0.582 0 C-N-CA 127.291 2.236 . . . . 0.0 116.702 167.263 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 4.4 m -162.51 175.38 11.52 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 128.233 2.613 . . . . 0.0 106.089 -169.491 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 11.4 ptt180 -91.72 174.08 7.54 Favored 'General case' 0 N--CA 1.469 0.503 0 O-C-N 121.022 -1.049 . . . . 0.0 109.607 178.618 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 15.9 m -74.94 176.11 0.67 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.64 0 C-N-CA 123.701 0.8 . . . . 0.0 111.219 -176.415 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 26.0 m-70 -88.02 152.2 50.47 Favored Pre-proline 0 CA--C 1.54 0.596 0 C-N-CA 123.8 0.84 . . . . 0.0 109.995 -175.999 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -63.47 -47.29 7.79 Favored 'Trans proline' 0 C--N 1.347 0.49 0 C-N-CA 122.956 2.438 . . . . 0.0 112.612 -172.636 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 4.4 m -68.21 -25.83 65.41 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-O 119.247 -0.406 . . . . 0.0 110.3 -178.391 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -56.91 -53.4 58.37 Favored 'General case' 0 CA--C 1.51 -0.595 0 N-CA-C 108.99 -0.744 . . . . 0.0 108.99 175.048 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 63.9 mt -60.51 -38.09 76.99 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 N-CA-C 109.054 -0.721 . . . . 0.0 109.054 -172.562 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -63.86 -46.74 83.63 Favored 'General case' 0 CA--C 1.536 0.425 0 CA-C-N 119.041 0.837 . . . . 0.0 111.007 179.869 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 37.6 mmt -71.18 -34.7 71.16 Favored 'General case' 0 CA--C 1.539 0.523 0 CA-C-O 123.546 1.641 . . . . 0.0 110.366 -178.376 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -74.82 -31.61 61.73 Favored 'General case' 0 N--CA 1.443 -0.825 0 N-CA-C 106.886 -1.524 . . . . 0.0 106.886 -177.796 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 -70.76 -20.41 62.63 Favored 'General case' 0 N--CA 1.45 -0.453 0 C-N-CA 124.347 1.059 . . . . 0.0 110.305 169.661 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 77.3 mt-10 -62.55 -38.76 91.28 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-N 119.958 1.254 . . . . 0.0 109.306 169.244 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 17.1 m -86.92 10.25 1.6 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.724 0 N-CA-C 113.168 0.803 . . . . 0.0 113.168 169.933 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 70.55 15.48 73.17 Favored Glycine 0 CA--C 1.532 1.114 0 C-N-CA 124.621 1.105 . . . . 0.0 113.803 177.115 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 4.8 mt -91.6 143.54 11.08 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.259 0 C-N-CA 124.425 1.09 . . . . 0.0 111.372 -172.707 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 3.4 t70 -90.84 131.84 36.24 Favored 'General case' 0 C--O 1.234 0.247 0 C-N-CA 126.04 1.736 . . . . 0.0 108.851 169.352 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 7.2 pt -140.41 -27.03 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.874 0 C-N-CA 124.661 1.184 . . . . 0.0 110.371 168.863 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -38.78 138.26 0.55 Allowed 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 128.31 2.644 . . . . 0.0 111.453 168.964 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 62.72 34.67 90.34 Favored Glycine 0 CA--C 1.533 1.21 0 CA-C-O 119.661 -0.522 . . . . 0.0 112.655 175.002 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 5.4 tt0 -57.24 -35.74 70.07 Favored 'General case' 0 C--N 1.344 0.346 0 C-N-CA 123.781 0.832 . . . . 0.0 112.83 -175.422 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -69.07 139.34 54.84 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 124.56 1.144 . . . . 0.0 110.518 -169.611 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 9.9 p -141.43 -67.78 0.4 Allowed 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 123.605 0.762 . . . . 0.0 110.624 -170.622 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -147.33 155.93 46.17 Favored Pre-proline 0 C--O 1.239 0.513 0 C-N-CA 125.484 1.513 . . . . 0.0 108.798 -176.852 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -66.06 152.54 81.03 Favored 'Trans proline' 0 N--CA 1.455 -0.782 0 C-N-CA 121.991 1.794 . . . . 0.0 109.617 171.224 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 3.8 tt -62.58 -23.57 32.92 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.545 0 C-N-CA 123.745 0.818 . . . . 0.0 110.811 -177.626 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 24.0 tt0 -67.7 -25.08 65.49 Favored 'General case' 0 N--CA 1.438 -1.075 0 C-N-CA 126.546 1.938 . . . . 0.0 110.658 -179.111 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 9.0 t-20 -63.43 -23.64 67.49 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 124.567 1.147 . . . . 0.0 112.103 176.385 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 40.5 m-85 -106.03 -168.39 1.43 Allowed 'General case' 0 C--O 1.236 0.363 0 C-N-CA 126.573 1.949 . . . . 0.0 109.305 -176.394 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 55.5 t-20 -139.44 139.74 37.13 Favored 'General case' 0 N--CA 1.447 -0.616 0 N-CA-C 106.836 -1.542 . . . . 0.0 106.836 169.251 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -71.45 -25.31 62.25 Favored 'General case' 0 N--CA 1.434 -1.236 0 C-N-CA 119.749 -0.78 . . . . 0.0 109.516 -178.821 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 35.5 t70 -64.8 -24.84 67.68 Favored 'General case' 0 N--CA 1.445 -0.686 0 O-C-N 123.505 0.503 . . . . 0.0 112.022 -179.575 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -78.05 -29.01 49.08 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 123.38 0.672 . . . . 0.0 111.426 174.411 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 13.1 m-85 -79.24 166.06 22.57 Favored 'General case' 0 N--CA 1.451 -0.394 0 C-N-CA 125.582 1.553 . . . . 0.0 111.126 178.855 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -118.25 -34.41 4.09 Favored 'General case' 0 N--CA 1.466 0.348 0 C-N-CA 123.022 0.529 . . . . 0.0 111.446 -179.985 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -143.35 136.02 24.57 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.595 0 CA-C-O 121.865 0.841 . . . . 0.0 110.234 -172.151 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 98.9 t -144.02 126.36 11.17 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.593 0 N-CA-C 106.249 -1.76 . . . . 0.0 106.249 -178.583 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.55 HD12 ' HB2' ' A' ' 97' ' ' GLU . 12.6 mm -104.6 124.37 59.13 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.521 0 N-CA-C 105.846 -1.909 . . . . 0.0 105.846 176.108 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 37.0 m -93.46 98.25 11.08 Favored 'General case' 0 N--CA 1.443 -0.807 0 N-CA-C 105.057 -2.201 . . . . 0.0 105.057 169.576 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 85.8 mt -68.54 -2.97 10.03 Favored 'General case' 0 N--CA 1.467 0.391 0 O-C-N 121.51 -0.744 . . . . 0.0 112.283 -176.709 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 64.0 m -138.65 128.4 24.99 Favored 'General case' 0 N--CA 1.443 -0.812 0 N-CA-C 106.134 -1.802 . . . . 0.0 106.134 169.397 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 50.71 -144.4 11.96 Favored Glycine 0 CA--C 1.532 1.133 0 C-N-CA 125.272 1.415 . . . . 0.0 113.515 173.425 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 16.2 m -112.23 -111.52 0.34 Allowed 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 124.652 1.181 . . . . 0.0 107.993 178.832 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -80.61 69.37 3.2 Favored Glycine 0 CA--C 1.527 0.83 0 N-CA-C 109.682 -1.367 . . . . 0.0 109.682 171.087 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 1.3 m -60.04 -50.51 79.9 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.598 0 CA-C-N 117.528 0.664 . . . . 0.0 111.688 -171.689 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 1.5 t30 -154.69 52.48 0.64 Allowed 'General case' 0 N--CA 1.467 0.404 0 N-CA-C 103.845 -2.65 . . . . 0.0 103.845 169.327 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -147.42 139.6 14.09 Favored Pre-proline 0 CA--C 1.536 0.442 0 C-N-CA 125.622 1.569 . . . . 0.0 108.297 -168.36 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -65.96 144.21 75.6 Favored 'Trans proline' 0 C--N 1.351 0.692 0 C-N-CA 121.338 1.358 . . . . 0.0 112.577 -174.669 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_endo -66.48 -26.09 47.71 Favored 'Trans proline' 0 N--CA 1.461 -0.405 0 C-N-CA 122.314 2.009 . . . . 0.0 113.242 -169.848 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 -55.91 -22.46 25.96 Favored 'General case' 0 CA--C 1.537 0.474 0 CA-C-N 118.898 0.772 . . . . 0.0 111.926 178.426 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 85.5 m95 -74.67 -43.64 54.24 Favored 'General case' 0 N--CA 1.445 -0.687 0 C-N-CA 123.504 0.722 . . . . 0.0 112.179 -179.339 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 15.2 m -70.46 -32.98 51.84 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.438 0 CA-C-O 118.398 -0.81 . . . . 0.0 110.109 176.854 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 82.3 p -82.06 29.83 0.4 Allowed 'General case' 0 CA--C 1.538 0.504 0 CA-C-N 120.23 1.377 . . . . 0.0 114.019 -170.01 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 93.0 mm-40 -79.09 -173.78 3.76 Favored 'General case' 0 CA--C 1.539 0.52 0 O-C-N 121.731 -0.605 . . . . 0.0 110.543 172.107 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 29.0 mm-40 -65.04 -14.71 61.12 Favored 'General case' 0 CA--C 1.54 0.577 0 N-CA-C 112.531 0.567 . . . . 0.0 112.531 -169.757 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 6.4 tt -143.72 137.36 24.74 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.496 0 C-N-CA 125.664 1.586 . . . . 0.0 107.177 170.934 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 16.2 t80 -116.98 132.32 56.73 Favored 'General case' 0 CA--C 1.535 0.399 0 N-CA-C 105.385 -2.08 . . . . 0.0 105.385 169.381 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 97' ' ' GLU . . . . . 0.55 ' HB2' HD12 ' A' ' 77' ' ' ILE . 11.6 mm-40 -142.13 162.83 34.49 Favored 'General case' 0 C--O 1.237 0.418 0 C-N-CA 124.546 1.139 . . . . 0.0 108.522 176.288 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 3.0 t70 -173.96 127.9 0.38 Allowed 'General case' 0 C--O 1.236 0.393 0 C-N-CA 127.11 2.164 . . . . 0.0 107.758 -169.255 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 5.4 m0 -148.65 142.58 25.79 Favored 'General case' 0 N--CA 1.456 -0.133 0 C-N-CA 123.571 0.749 . . . . 0.0 109.019 -170.488 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 86.4 mt-30 -84.21 83.24 8.04 Favored 'General case' 0 CA--C 1.533 0.3 0 N-CA-C 108.399 -0.963 . . . . 0.0 108.399 174.46 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 9.6 mp -67.42 129.05 38.67 Favored 'General case' 0 N--CA 1.466 0.352 0 N-CA-C 106.148 -1.797 . . . . 0.0 106.148 171.132 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 32.4 mt-10 -71.29 -20.83 62.16 Favored 'General case' 0 CA--C 1.536 0.417 0 N-CA-C 113.563 0.949 . . . . 0.0 113.563 -169.279 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 1.6 t70 62.29 124.09 0.02 OUTLIER Pre-proline 0 CA--C 1.552 1.047 0 C-N-CA 127.039 2.136 . . . . 0.0 114.212 -179.7 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 23.7 Cg_endo -88.48 -3.67 6.64 Favored 'Trans proline' 0 N--CA 1.454 -0.809 0 C-N-CA 122.689 2.259 . . . . 0.0 114.488 -178.93 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -53.42 126.51 21.61 Favored 'General case' 0 C--O 1.238 0.457 0 CA-C-N 120.793 1.633 . . . . 0.0 111.152 -172.374 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 71.74 -1.64 28.98 Favored Glycine 0 CA--C 1.534 1.271 0 CA-C-O 118.918 -0.934 . . . . 0.0 113.729 177.238 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 8.2 mt-30 -89.7 171.51 9.6 Favored 'General case' 0 CA--C 1.543 0.689 0 CA-C-N 118.807 1.304 . . . . 0.0 109.159 174.796 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 15.6 m -69.11 163.52 24.61 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 123.658 0.783 . . . . 0.0 111.063 -179.301 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 43.2 mt -63.88 -26.37 68.58 Favored 'General case' 0 N--CA 1.472 0.638 0 O-C-N 121.231 -0.918 . . . . 0.0 112.019 -175.026 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 5.4 pt-20 -56.41 -34.85 67.15 Favored 'General case' 0 N--CA 1.461 0.12 0 C-N-CA 123.322 0.649 . . . . 0.0 111.26 171.935 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 21.4 t -76.82 -41.77 32.9 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.395 0 CA-C-O 118.28 -0.866 . . . . 0.0 109.066 -178.139 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 61.8 m-85 -55.02 -49.6 71.15 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-N 120.002 1.274 . . . . 0.0 109.66 170.384 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 96.2 mtt180 -67.67 -33.14 74.34 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 123.056 0.542 . . . . 0.0 111.214 -175.778 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 3.2 m -65.55 -50.16 66.19 Favored 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 124.222 1.009 . . . . 0.0 109.712 170.977 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 90.1 t -70.25 -26.9 30.24 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.309 0 CA-C-O 118.426 -0.797 . . . . 0.0 109.109 -171.442 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 20.5 mtm105 -56.5 -50.15 72.63 Favored 'General case' 0 C--O 1.223 -0.309 0 CA-C-N 119.462 1.028 . . . . 0.0 109.239 169.569 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -62.09 -46.59 93.7 Favored Glycine 0 CA--C 1.528 0.884 0 CA-C-O 119.539 -0.59 . . . . 0.0 111.898 178.676 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 89.8 mt-30 -57.14 -51.69 68.28 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-N 117.854 0.827 . . . . 0.0 110.268 -179.784 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 95.9 t -68.68 -42.35 83.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-O 118.445 -0.788 . . . . 0.0 109.615 -175.574 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -54.51 -47.24 73.31 Favored 'General case' 0 C--O 1.223 -0.341 0 N-CA-C 108.62 -0.881 . . . . 0.0 108.62 178.355 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 39.9 tt0 -64.91 -42.49 94.7 Favored 'General case' 0 N--CA 1.449 -0.523 0 C-N-CA 122.953 0.501 . . . . 0.0 111.325 -176.358 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 44.4 mtt-85 -65.64 -45.61 82.35 Favored 'General case' 0 N--CA 1.469 0.485 0 O-C-N 121.302 -0.874 . . . . 0.0 111.766 177.19 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 61.3 t -64.94 -37.23 79.7 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.723 0 N-CA-C 109.143 -0.688 . . . . 0.0 109.143 178.092 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 20.9 mt-10 -60.66 -44.58 96.28 Favored 'General case' 0 C--O 1.226 -0.182 0 O-C-N 120.743 -1.223 . . . . 0.0 109.857 174.911 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 27.8 t-20 -65.12 -40.54 94.63 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 123.021 0.528 . . . . 0.0 111.054 -177.925 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 29.3 tp -58.7 -49.58 77.07 Favored 'General case' 0 CA--C 1.53 0.195 0 C-N-CA 124.864 1.266 . . . . 0.0 110.85 173.292 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 63.6 mt -64.72 -46.66 91.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 N-CA-C 107.925 -1.139 . . . . 0.0 107.925 -177.969 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -58.17 -31.82 67.63 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 123.436 0.695 . . . . 0.0 112.109 -178.882 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . 0.258 18.5 ptpt -82.51 -37.89 24.61 Favored 'General case' 0 C--N 1.344 0.341 0 CA-C-O 117.782 -1.104 . . . . 0.0 112.512 177.099 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 12.1 pt -84.08 -38.74 14.15 Favored 'Isoleucine or valine' 0 C--O 1.236 0.35 0 CA-C-N 120.373 1.442 . . . . 0.0 113.967 -176.261 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 68.2 m . . . . . 0 C--O 1.252 1.219 0 C-N-CA 125.644 1.578 . . . . 0.0 110.141 -169.876 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.498 1.964 0 N-CA-C 110.583 -0.155 . . . . 0.0 110.583 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 26.1 mttm -79.77 117.48 20.7 Favored 'General case' 0 N--CA 1.474 0.749 0 N-CA-C 105.71 -1.959 . . . . 0.0 105.71 171.53 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 85.0 mttt -81.84 143.4 31.76 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-N 119.935 1.243 . . . . 0.0 108.499 176.904 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 2.2 t -132.54 145.07 35.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 O-C-N 124.347 1.029 . . . . 0.0 111.058 -169.341 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 12.4 mtt -137.06 145.33 43.85 Favored 'General case' 0 C--N 1.329 -0.291 0 C-N-CA 125.327 1.451 . . . . 0.0 108.957 168.48 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 54.5 m-85 -133.91 117.46 16.8 Favored 'General case' 0 CA--C 1.518 -0.281 0 N-CA-C 104.903 -2.258 . . . . 0.0 104.903 169.915 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 2.2 p -151.67 155.26 7.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-O 121.248 0.547 . . . . 0.0 109.842 -168.848 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 39.9 t -140.94 159.32 42.45 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 105.119 -2.178 . . . . 0.0 105.119 169.266 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 64.8 pttt -56.68 143.92 34.37 Favored 'General case' 0 N--CA 1.467 0.394 0 N-CA-C 109.036 -0.727 . . . . 0.0 109.036 171.838 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 96.6 mtt180 51.44 73.9 0.28 Allowed 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 124.665 1.186 . . . . 0.0 110.136 -169.824 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 10.4 t30 -31.63 -46.41 0.11 Allowed 'General case' 0 N--CA 1.482 1.141 0 C-N-CA 127.523 2.329 . . . . 0.0 115.33 -172.4 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 2.1 m -50.96 -37.79 46.71 Favored 'General case' 0 N--CA 1.45 -0.447 0 C-N-CA 124.164 0.985 . . . . 0.0 111.419 -175.515 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 21.9 m -72.17 122.15 20.52 Favored 'General case' 0 N--CA 1.449 -0.51 0 CA-C-N 119.094 0.861 . . . . 0.0 109.767 173.906 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . 0.334 0.1 OUTLIER 56.01 -24.02 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 130.914 3.686 . . . . 0.0 117.248 177.182 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -74.92 -11.53 60.15 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-N 121.102 1.774 . . . . 0.0 111.417 175.416 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 25.2 pt20 -75.04 30.47 0.09 Allowed 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 125.756 1.622 . . . . 0.0 113.725 174.856 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 17' ' ' MET . . . . . 0.425 ' SD ' ' CD2' ' A' ' 21' ' ' PHE . 0.0 OUTLIER -152.62 -54.24 0.12 Allowed 'General case' 0 C--N 1.329 -0.284 0 O-C-N 120.29 -1.506 . . . . 0.0 112.06 174.837 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -59.44 -47.77 84.21 Favored 'General case' 0 N--CA 1.474 0.725 0 N-CA-C 114.313 1.227 . . . . 0.0 114.313 -169.009 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -65.05 -30.99 71.99 Favored 'General case' 0 N--CA 1.463 0.182 0 O-C-N 121.88 -0.512 . . . . 0.0 110.058 177.7 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -55.15 -59.13 10.93 Favored Glycine 0 C--N 1.337 0.605 0 C-N-CA 125.312 1.434 . . . . 0.0 110.588 173.222 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 21' ' ' PHE . . . . . 0.425 ' CD2' ' SD ' ' A' ' 17' ' ' MET . 3.3 m-85 -61.98 -32.54 73.0 Favored 'General case' 0 CA--C 1.511 -0.532 0 CA-C-N 118.377 1.088 . . . . 0.0 112.906 175.806 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -63.91 -36.47 84.05 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 119.146 0.884 . . . . 0.0 111.123 -172.418 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -69.03 -24.43 64.19 Favored 'General case' 0 N--CA 1.47 0.571 0 CA-C-N 119.164 0.893 . . . . 0.0 112.274 176.803 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 1.5 m -80.15 -53.22 6.89 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 125.305 1.442 . . . . 0.0 110.45 177.733 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 80.9 mt -74.24 -37.82 63.68 Favored 'General case' 0 N--CA 1.464 0.249 0 C-N-CA 123.648 0.779 . . . . 0.0 110.266 -173.124 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -96.39 14.07 64.81 Favored Glycine 0 CA--C 1.527 0.815 0 C-N-CA 125.175 1.369 . . . . 0.0 112.98 -176.767 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -51.52 123.57 10.18 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 124.743 1.217 . . . . 0.0 110.49 -174.809 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 76.11 -7.89 26.97 Favored Glycine 0 CA--C 1.536 1.356 0 C-N-CA 124.293 0.949 . . . . 0.0 114.382 179.797 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 62.9 mttm -97.62 -49.19 4.96 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-N 119.283 1.541 . . . . 0.0 110.298 179.854 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 17.1 pt -137.28 152.52 27.83 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.328 0 C-N-CA 124.137 0.975 . . . . 0.0 110.067 -169.264 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -112.02 98.66 7.5 Favored 'General case' 0 CA--C 1.521 -0.153 0 C-N-CA 124.584 1.153 . . . . 0.0 109.187 -169.738 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 13.0 p -87.8 134.4 28.0 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.487 0 O-C-N 121.823 -0.548 . . . . 0.0 109.666 178.966 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 20.1 m -150.51 92.45 1.85 Allowed 'General case' 0 N--CA 1.456 -0.143 0 N-CA-C 105.19 -2.152 . . . . 0.0 105.19 172.413 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 53.4 m -95.49 87.01 4.63 Favored 'General case' 0 C--O 1.237 0.396 0 C-N-CA 120.066 -0.654 . . . . 0.0 110.63 -170.057 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 58.8 m -61.19 165.85 4.14 Favored 'General case' 0 CA--C 1.539 0.522 0 CA-C-N 115.322 -0.854 . . . . 0.0 110.07 169.018 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -138.96 -173.84 13.18 Favored Glycine 0 CA--C 1.525 0.702 0 N-CA-C 106.807 -2.517 . . . . 0.0 106.807 -177.721 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 6.4 mt -123.71 -83.51 0.65 Allowed 'General case' 0 N--CA 1.45 -0.465 0 C-N-CA 124.298 1.039 . . . . 0.0 109.048 -169.952 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 3.3 tt0 -69.02 -27.17 65.44 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 122.823 0.449 . . . . 0.0 111.574 176.673 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 1.3 m -144.18 179.45 7.21 Favored 'General case' 0 N--CA 1.463 0.176 0 C-N-CA 126.187 1.795 . . . . 0.0 107.747 177.032 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 3.7 m -166.05 -18.66 0.02 OUTLIER 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 125.301 1.44 . . . . 0.0 112.145 -169.725 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 7.8 ttt180 -100.37 -162.1 0.92 Allowed 'General case' 0 N--CA 1.473 0.709 0 CA-C-N 119.637 1.108 . . . . 0.0 110.207 176.046 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 27.4 m -134.95 173.68 14.1 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.449 0 C-N-CA 125.421 1.489 . . . . 0.0 111.376 -169.988 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 96.7 m-70 -83.65 156.45 65.01 Favored Pre-proline 0 CA--C 1.543 0.698 0 C-N-CA 124.804 1.242 . . . . 0.0 110.299 173.816 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -62.16 -51.47 3.58 Favored 'Trans proline' 0 C--N 1.349 0.575 0 C-N-CA 123.845 3.03 . . . . 0.0 113.426 -173.425 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 6.8 m -65.85 -24.95 66.99 Favored 'General case' 0 CA--C 1.534 0.328 0 O-C-N 121.902 -0.499 . . . . 0.0 110.936 -172.845 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -55.52 -53.31 57.95 Favored 'General case' 0 CA--C 1.508 -0.672 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 173.261 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 69.8 mt -59.83 -40.71 83.43 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.369 0 N-CA-C 108.475 -0.935 . . . . 0.0 108.475 -170.352 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -62.75 -46.76 86.58 Favored 'General case' 0 N--CA 1.449 -0.518 0 CA-C-N 118.488 0.586 . . . . 0.0 111.004 179.924 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 27.9 mmt -67.64 -39.78 84.61 Favored 'General case' 0 C--O 1.238 0.473 0 CA-C-O 122.789 1.281 . . . . 0.0 110.839 -178.65 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 1.2 mmt -74.31 -35.2 63.66 Favored 'General case' 0 N--CA 1.444 -0.772 0 N-CA-C 106.711 -1.588 . . . . 0.0 106.711 -174.875 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 41.7 tt0 -69.98 -23.94 63.24 Favored 'General case' 0 N--CA 1.447 -0.583 0 O-C-N 121.179 -0.951 . . . . 0.0 110.219 173.672 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 10.2 mm-40 -65.74 -29.49 70.01 Favored 'General case' 0 N--CA 1.452 -0.341 0 CA-C-N 118.762 0.71 . . . . 0.0 110.241 173.251 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . 0.29 9.0 m -98.22 16.95 2.85 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.858 0 N-CA-C 112.758 0.651 . . . . 0.0 112.758 169.35 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 84.33 16.21 67.27 Favored Glycine 0 CA--C 1.534 1.275 0 C-N-CA 125.366 1.46 . . . . 0.0 114.636 169.935 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 8.2 mm -97.52 151.59 4.25 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.329 0 C-N-CA 124.736 1.214 . . . . 0.0 111.121 -170.52 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -112.52 126.95 55.89 Favored 'General case' 0 C--O 1.233 0.189 0 N-CA-C 106.051 -1.833 . . . . 0.0 106.051 168.222 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 3.6 pt -128.93 -24.51 1.24 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.481 0 C-N-CA 125.751 1.62 . . . . 0.0 110.353 170.312 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -39.51 -40.38 0.84 Allowed 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 128.177 2.591 . . . . 0.0 112.789 169.163 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -91.24 19.62 45.63 Favored Glycine 0 CA--C 1.531 1.069 0 C-N-CA 125.446 1.498 . . . . 0.0 113.763 -179.166 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 21.2 mt-30 -61.84 -27.62 68.91 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-N 120.152 1.976 . . . . 0.0 112.84 179.78 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -61.92 129.39 40.72 Favored 'General case' 0 N--CA 1.445 -0.678 0 N-CA-C 109.683 -0.488 . . . . 0.0 109.683 -171.562 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 8.5 p -141.61 -70.44 0.36 Allowed 'General case' 0 C--O 1.235 0.31 0 C-N-CA 123.817 0.847 . . . . 0.0 109.452 -173.269 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -157.66 161.34 29.26 Favored Pre-proline 0 CA--C 1.552 1.037 0 C-N-CA 124.952 1.301 . . . . 0.0 109.913 -174.66 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -67.84 28.92 0.13 Allowed 'Trans proline' 0 CA--C 1.552 1.381 0 C-N-CA 125.247 3.964 . . . . 0.0 116.694 173.126 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . 0.256 1.1 tt 64.43 -26.21 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.541 0.619 0 C-N-CA 129.529 3.132 . . . . 0.0 113.989 -169.583 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -68.79 -30.19 68.72 Favored 'General case' 0 N--CA 1.429 -1.516 0 C-N-CA 128.005 2.522 . . . . 0.0 115.407 -169.304 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 26.0 m-80 -68.72 -17.44 64.06 Favored 'General case' 0 C--O 1.236 0.35 0 CA-C-N 118.359 0.527 . . . . 0.0 112.192 -176.419 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 69.8 m-85 -104.76 160.98 14.55 Favored 'General case' 0 CA--C 1.513 -0.447 0 C-N-CA 124.726 1.211 . . . . 0.0 112.015 -176.854 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 48.1 t-20 -95.65 134.13 38.92 Favored 'General case' 0 N--CA 1.439 -0.989 0 N-CA-C 106.107 -1.812 . . . . 0.0 106.107 168.156 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -72.57 -27.67 62.34 Favored 'General case' 0 N--CA 1.436 -1.172 0 N-CA-C 108.845 -0.798 . . . . 0.0 108.845 179.629 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 36.6 t70 -67.0 -21.04 65.97 Favored 'General case' 0 N--CA 1.447 -0.585 0 N-CA-C 111.73 0.27 . . . . 0.0 111.73 -179.168 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 35.7 t70 -72.63 -29.24 63.3 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 122.974 0.509 . . . . 0.0 111.611 175.782 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 17.2 m-85 -77.27 144.51 38.1 Favored 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 123.981 0.912 . . . . 0.0 110.316 179.18 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -93.93 -32.1 14.02 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.724 177.555 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 21.7 t -137.34 130.8 44.15 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.467 0 C-N-CA 123.824 0.85 . . . . 0.0 109.841 -171.307 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 53.7 t -145.48 139.58 21.84 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.419 0 N-CA-C 106.28 -1.748 . . . . 0.0 106.28 174.851 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 36.6 mm -130.63 123.62 55.26 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.537 0 N-CA-C 107.238 -1.393 . . . . 0.0 107.238 -169.859 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 55.3 m -90.49 115.37 27.59 Favored 'General case' 0 N--CA 1.444 -0.732 0 N-CA-C 106.562 -1.644 . . . . 0.0 106.562 169.225 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 68.7 mt -77.72 -7.54 56.66 Favored 'General case' 0 C--N 1.332 -0.191 0 C-N-CA 123.769 0.827 . . . . 0.0 111.418 179.88 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 31.9 p -139.72 132.75 29.5 Favored 'General case' 0 N--CA 1.443 -0.817 0 N-CA-C 106.81 -1.552 . . . . 0.0 106.81 169.632 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 50.68 -155.85 2.84 Favored Glycine 0 CA--C 1.539 1.547 0 C-N-CA 125.579 1.561 . . . . 0.0 115.713 170.067 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 17.4 m -134.52 139.24 45.29 Favored 'General case' 0 C--O 1.235 0.306 0 C-N-CA 125.897 1.679 . . . . 0.0 107.153 177.232 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 74.36 -75.44 1.18 Allowed Glycine 0 C--N 1.335 0.517 0 N-CA-C 110.324 -1.11 . . . . 0.0 110.324 -174.28 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . 0.299 34.7 m 48.12 36.22 0.27 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.792 0 C-N-CA 125.973 1.709 . . . . 0.0 113.401 176.647 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 10.6 t-20 69.99 -0.15 2.86 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 127.679 2.392 . . . . 0.0 113.318 179.061 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.407 ' HA ' ' HD3' ' A' ' 87' ' ' PRO . 0.0 OUTLIER -77.03 148.09 78.01 Favored Pre-proline 0 CA--C 1.548 0.882 0 N-CA-C 107.749 -1.204 . . . . 0.0 107.749 169.524 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 87' ' ' PRO . . . . . 0.407 ' HD3' ' HA ' ' A' ' 86' ' ' LEU . 34.1 Cg_exo -65.99 142.17 67.38 Favored 'Trans proline' 0 CA--C 1.544 1.013 0 C-N-CA 121.452 1.435 . . . . 0.0 113.0 -174.165 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -67.33 -20.17 49.03 Favored 'Trans proline' 0 C--N 1.344 0.336 0 C-N-CA 123.379 2.719 . . . . 0.0 114.267 -170.592 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 5.4 pm0 -63.04 -18.77 63.71 Favored 'General case' 0 CA--C 1.54 0.562 0 CA-C-N 121.371 1.896 . . . . 0.0 111.547 174.75 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 97.8 m95 -88.33 -5.93 58.03 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 125.414 1.486 . . . . 0.0 112.799 173.728 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 39.9 t -94.23 -9.03 9.66 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.62 0 C-N-CA 124.769 1.228 . . . . 0.0 109.137 173.325 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 73.3 p -119.77 36.94 4.34 Favored 'General case' 0 C--O 1.237 0.404 0 N-CA-C 116.134 1.901 . . . . 0.0 116.134 -169.305 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 12.2 mp0 -71.42 173.71 7.53 Favored 'General case' 0 CA--C 1.535 0.384 0 O-C-N 121.718 -0.614 . . . . 0.0 111.568 173.852 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 33.9 mm-40 -59.93 -28.81 67.93 Favored 'General case' 0 CA--C 1.536 0.432 0 N-CA-C 109.807 -0.442 . . . . 0.0 109.807 177.012 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 4.3 tt -133.62 116.98 25.65 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.56 0 N-CA-C 105.489 -2.041 . . . . 0.0 105.489 168.729 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 62.1 t80 -108.98 145.3 35.73 Favored 'General case' 0 C--O 1.237 0.443 0 N-CA-C 104.534 -2.395 . . . . 0.0 104.534 168.28 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 21.7 mm-40 -134.86 139.74 45.28 Favored 'General case' 0 C--O 1.236 0.379 0 CA-C-N 119.161 0.891 . . . . 0.0 108.691 169.859 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -106.93 113.29 26.69 Favored 'General case' 0 C--O 1.239 0.551 0 N-CA-C 105.609 -1.997 . . . . 0.0 105.609 169.883 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 9.2 m95 -117.47 166.52 12.24 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 124.405 1.082 . . . . 0.0 108.118 169.756 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 24.0 mm-40 -128.33 78.1 1.81 Allowed 'General case' 0 CA--C 1.534 0.36 0 N-CA-C 107.257 -1.386 . . . . 0.0 107.257 174.326 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -77.04 148.46 36.15 Favored 'General case' 0 N--CA 1.467 0.399 0 N-CA-C 109.192 -0.67 . . . . 0.0 109.192 -179.505 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -81.09 168.25 18.83 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 124.514 1.126 . . . . 0.0 108.724 169.765 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -134.14 133.71 22.18 Favored Pre-proline 0 CA--C 1.534 0.334 0 C-N-CA 124.022 0.929 . . . . 0.0 110.975 178.085 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 40.2 Cg_endo -89.87 -2.41 5.65 Favored 'Trans proline' 0 CA--C 1.539 0.772 0 C-N-CA 122.911 2.407 . . . . 0.0 115.22 -174.349 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 24.4 t70 -60.25 128.32 36.14 Favored 'General case' 0 C--O 1.238 0.484 0 CA-C-N 121.347 1.885 . . . . 0.0 110.357 -177.861 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 72.94 -0.3 46.61 Favored Glycine 0 CA--C 1.533 1.163 0 CA-C-O 119.216 -0.769 . . . . 0.0 113.605 179.474 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 17.1 mm-40 -86.2 172.82 10.23 Favored 'General case' 0 C--O 1.238 0.454 0 CA-C-N 118.65 1.225 . . . . 0.0 109.738 174.335 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 16.0 m -69.17 159.53 32.81 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 123.768 0.827 . . . . 0.0 110.868 171.778 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 33.1 tp -56.61 -30.58 63.41 Favored 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 126.153 1.781 . . . . 0.0 113.071 -176.302 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 6.7 pt-20 -56.49 -34.28 66.79 Favored 'General case' 0 CA--C 1.528 0.106 0 C-N-CA 123.817 0.847 . . . . 0.0 111.331 175.563 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 5.1 t -77.61 -39.81 27.44 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.39 0 CA-C-O 118.125 -0.941 . . . . 0.0 110.414 -174.987 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 63.9 m-85 -56.5 -47.98 78.15 Favored 'General case' 0 N--CA 1.473 0.708 0 CA-C-N 120.368 1.44 . . . . 0.0 109.454 170.152 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 86.3 mtt180 -60.87 -42.69 98.38 Favored 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 123.259 0.624 . . . . 0.0 110.909 179.794 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 6.0 m -67.51 -49.42 63.51 Favored 'General case' 0 N--CA 1.447 -0.595 0 C-N-CA 124.696 1.199 . . . . 0.0 110.311 -179.865 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 73.0 t -68.96 -30.02 45.34 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.234 0 CA-C-O 117.813 -1.089 . . . . 0.0 110.223 -169.787 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 32.5 mtm105 -56.84 -47.1 81.11 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-N 120.011 1.278 . . . . 0.0 110.357 169.89 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -62.94 -49.05 75.63 Favored Glycine 0 CA--C 1.527 0.816 0 CA-C-N 118.438 0.563 . . . . 0.0 111.773 179.272 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 17.5 mt-30 -62.01 -44.18 97.27 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-N 117.698 0.749 . . . . 0.0 110.22 -177.914 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 54.6 t -66.19 -45.15 90.88 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.245 0 CA-C-O 118.183 -0.913 . . . . 0.0 109.684 -177.96 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -52.74 -47.79 67.16 Favored 'General case' 0 CA--C 1.516 -0.361 0 CA-C-N 119.094 0.861 . . . . 0.0 109.013 -177.957 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 39.9 tt0 -62.72 -42.79 99.83 Favored 'General case' 0 N--CA 1.447 -0.584 0 O-C-N 123.569 0.543 . . . . 0.0 111.029 -176.052 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 44.7 mtt-85 -67.06 -41.45 86.42 Favored 'General case' 0 N--CA 1.468 0.455 0 O-C-N 121.381 -0.824 . . . . 0.0 111.57 177.85 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 54.0 t -68.92 -38.46 78.61 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.429 0 N-CA-C 109.372 -0.603 . . . . 0.0 109.372 179.463 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 22.1 mt-10 -60.06 -42.09 93.74 Favored 'General case' 0 C--O 1.226 -0.166 0 O-C-N 121.414 -0.804 . . . . 0.0 110.247 174.923 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 29.1 t-20 -64.56 -45.25 87.88 Favored 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 122.735 0.414 . . . . 0.0 111.145 -179.7 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 2.1 tm? -57.19 -49.28 76.49 Favored 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 124.625 1.17 . . . . 0.0 109.992 175.815 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 75.8 mt -63.21 -47.71 91.0 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.141 0 N-CA-C 108.558 -0.904 . . . . 0.0 108.558 -179.797 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -58.61 -28.74 65.9 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 123.254 0.621 . . . . 0.0 112.411 178.908 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 88.9 mttt -70.18 -55.39 9.46 Favored 'General case' 0 C--O 1.234 0.243 0 CA-C-N 119.257 0.935 . . . . 0.0 110.567 172.495 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 16.2 pt -77.03 -38.28 27.71 Favored 'Isoleucine or valine' 0 C--O 1.234 0.25 0 N-CA-C 114.91 1.448 . . . . 0.0 114.91 -169.085 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 74.5 m . . . . . 0 C--O 1.254 1.296 0 C-N-CA 125.882 1.673 . . . . 0.0 109.52 -169.774 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 19.8 ptm . . . . . 0 N--CA 1.497 1.924 0 N-CA-C 110.821 -0.066 . . . . 0.0 110.821 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 2' ' ' LYS . . . . . 0.506 ' HB2' HG22 ' A' ' 30' ' ' ILE . 16.3 mttm -73.59 125.96 29.18 Favored 'General case' 0 N--CA 1.482 1.131 0 N-CA-C 107.88 -1.156 . . . . 0.0 107.88 -172.006 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 69.6 mttt -94.13 137.26 33.52 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-N 120.062 1.301 . . . . 0.0 108.376 174.087 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.441 HG21 HD12 ' A' ' 30' ' ' ILE . 15.0 t -119.84 151.28 22.39 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 C-N-CA 127.121 2.169 . . . . 0.0 106.473 -169.939 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 31.9 mtt -134.65 147.14 50.09 Favored 'General case' 0 C--N 1.321 -0.64 0 C-N-CA 124.164 0.986 . . . . 0.0 108.705 168.782 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 45.6 m-85 -131.67 122.85 26.64 Favored 'General case' 0 CA--C 1.516 -0.336 0 N-CA-C 102.218 -3.252 . . . . 0.0 102.218 169.226 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 1.3 p -148.4 141.81 18.74 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.263 0 CA-C-O 121.764 0.793 . . . . 0.0 112.151 -168.41 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 46.3 t -136.29 173.86 11.25 Favored 'General case' 0 CA--C 1.547 0.846 0 C-N-CA 127.807 2.443 . . . . 0.0 105.269 169.019 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 87.6 tttt -51.59 -46.92 63.71 Favored 'General case' 0 N--CA 1.475 0.813 0 O-C-N 120.975 -1.078 . . . . 0.0 113.433 -169.368 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 19.6 ttt180 -130.11 147.47 51.85 Favored 'General case' 0 N--CA 1.468 0.461 0 CA-C-N 118.995 0.816 . . . . 0.0 109.118 -178.319 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 64.3 t30 -58.94 -30.33 67.79 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 123.964 0.906 . . . . 0.0 113.354 -175.589 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -56.31 -55.27 35.46 Favored 'General case' 0 C--O 1.236 0.378 0 C-N-CA 124.069 0.948 . . . . 0.0 109.992 -171.428 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 9.2 m -91.02 151.2 21.13 Favored 'General case' 0 N--CA 1.452 -0.37 0 C-N-CA 123.659 0.784 . . . . 0.0 110.797 -176.353 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 5.4 mmm180 67.32 -50.5 0.49 Allowed 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 128.462 2.705 . . . . 0.0 113.323 170.228 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 7.3 m -76.92 49.94 0.68 Allowed 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 125.677 1.591 . . . . 0.0 111.704 -179.351 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 4.5 pt20 -123.52 12.73 9.36 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 126.109 1.763 . . . . 0.0 112.148 -175.669 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -160.96 -40.37 0.05 OUTLIER 'General case' 0 C--O 1.224 -0.265 0 N-CA-C 113.973 1.101 . . . . 0.0 113.973 176.935 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -66.62 -52.45 44.99 Favored 'General case' 0 N--CA 1.475 0.797 0 CA-C-N 120.657 1.571 . . . . 0.0 112.164 -169.56 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -56.42 -38.3 71.39 Favored 'General case' 0 N--CA 1.446 -0.653 0 C-N-CA 124.029 0.931 . . . . 0.0 110.645 169.942 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -57.11 -52.6 50.4 Favored Glycine 0 CA--C 1.526 0.754 0 C-N-CA 124.722 1.153 . . . . 0.0 111.209 175.902 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 1.3 m-85 -65.0 -32.07 73.61 Favored 'General case' 0 CA--C 1.51 -0.582 0 O-C-N 120.94 -1.329 . . . . 0.0 111.907 175.723 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -71.05 -41.23 71.04 Favored 'General case' 0 N--CA 1.445 -0.688 0 CA-C-O 118.156 -0.926 . . . . 0.0 110.739 -174.607 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.15 -33.3 75.18 Favored 'General case' 0 N--CA 1.471 0.582 0 CA-C-N 119.617 1.099 . . . . 0.0 109.886 173.591 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 10.6 m -68.9 -54.05 17.66 Favored 'General case' 0 N--CA 1.442 -0.842 0 C-N-CA 123.171 0.588 . . . . 0.0 110.364 -175.046 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 39.9 mt -77.8 -37.3 49.06 Favored 'General case' 0 C--N 1.329 -0.285 0 C-N-CA 124.946 1.298 . . . . 0.0 111.034 -172.941 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -101.08 8.29 57.42 Favored Glycine 0 CA--C 1.526 0.761 0 CA-C-O 118.033 -1.426 . . . . 0.0 114.303 -169.734 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -40.92 -48.91 3.21 Favored 'General case' 0 N--CA 1.468 0.437 0 C-N-CA 125.798 1.639 . . . . 0.0 114.882 -169.443 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -89.94 -2.09 75.47 Favored Glycine 0 CA--C 1.531 1.074 0 CA-C-O 118.836 -0.98 . . . . 0.0 114.469 -173.506 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 13.8 ptpt -124.88 -28.29 3.51 Favored 'General case' 0 N--CA 1.472 0.651 0 CA-C-N 118.915 1.357 . . . . 0.0 113.145 -173.626 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.506 HG22 ' HB2' ' A' ' 2' ' ' LYS . 14.8 pt -143.65 150.15 17.47 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.437 0 CA-C-N 119.657 1.117 . . . . 0.0 111.47 -174.218 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -98.54 158.17 15.77 Favored 'General case' 0 N--CA 1.465 0.302 0 C-N-CA 125.575 1.55 . . . . 0.0 108.543 172.182 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 22.6 t -139.66 133.35 37.23 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 N-CA-C 107.547 -1.279 . . . . 0.0 107.547 -175.976 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 34.5 m -138.49 107.42 5.99 Favored 'General case' 0 N--CA 1.447 -0.594 0 N-CA-C 106.042 -1.836 . . . . 0.0 106.042 175.345 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 2.4 p -80.65 99.48 8.18 Favored 'General case' 0 C--N 1.327 -0.386 0 C-N-CA 119.843 -0.743 . . . . 0.0 109.064 174.501 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 25.7 p -72.16 -177.47 2.11 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 123.956 0.903 . . . . 0.0 110.827 175.254 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -173.17 171.88 44.76 Favored Glycine 0 CA--C 1.522 0.504 0 N-CA-C 106.457 -2.657 . . . . 0.0 106.457 -179.297 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 18.4 mt -106.43 -20.05 13.5 Favored 'General case' 0 C--N 1.325 -0.489 0 C-N-CA 124.804 1.241 . . . . 0.0 110.072 174.633 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 36.9 mt-10 -131.87 162.84 29.64 Favored 'General case' 0 N--CA 1.448 -0.538 0 C-N-CA 127.683 2.393 . . . . 0.0 106.948 169.207 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 78.9 p -145.2 155.99 43.59 Favored 'General case' 0 N--CA 1.451 -0.409 0 CA-C-O 122.844 1.307 . . . . 0.0 114.499 179.615 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 4.3 m -168.89 -179.85 3.86 Favored 'General case' 0 N--CA 1.451 -0.41 0 C-N-CA 131.118 3.767 . . . . 0.0 103.966 -170.028 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 25.6 ttp180 -86.9 171.69 10.62 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 107.079 -1.452 . . . . 0.0 107.079 169.142 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 11.2 m -68.58 165.47 2.3 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.808 0 CA-C-N 115.796 -0.638 . . . . 0.0 109.973 178.409 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 55.1 m170 -62.96 152.43 83.51 Favored Pre-proline 0 CA--C 1.549 0.917 0 C-N-CA 123.161 0.584 . . . . 0.0 112.537 177.675 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -70.45 -55.62 0.15 Allowed 'Trans proline' 0 C--N 1.352 0.711 0 C-N-CA 123.382 2.722 . . . . 0.0 114.388 -169.909 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 26.9 m -65.8 -22.75 66.59 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-N 119.256 0.934 . . . . 0.0 110.071 -175.973 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -52.41 -52.3 54.52 Favored 'General case' 0 CA--C 1.509 -0.603 0 CA-C-O 118.815 -0.612 . . . . 0.0 110.585 169.957 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 85.3 mt -58.69 -41.32 81.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 -172.292 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -63.96 -49.32 72.99 Favored 'General case' 0 N--CA 1.45 -0.455 0 CA-C-N 118.079 0.399 . . . . 0.0 111.113 178.477 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 49' ' ' MET . . . . . 0.437 ' HG3' ' CG ' ' A' ' 112' ' ' PHE . 24.3 mmt -65.33 -35.81 82.12 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-O 122.638 1.208 . . . . 0.0 111.445 -178.627 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -79.22 -33.09 44.01 Favored 'General case' 0 N--CA 1.44 -0.944 0 N-CA-C 107.584 -1.265 . . . . 0.0 107.584 -173.47 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 42.0 tt0 -68.25 -26.76 65.84 Favored 'General case' 0 N--CA 1.445 -0.713 0 C-N-CA 123.307 0.643 . . . . 0.0 109.86 170.614 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 14.7 mm-40 -68.25 -28.57 67.33 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-N 118.816 0.734 . . . . 0.0 110.654 174.241 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . 0.276 4.6 p -93.07 11.81 3.14 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.907 0 CA-C-N 118.658 0.663 . . . . 0.0 111.375 169.201 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 77.33 17.53 79.23 Favored Glycine 0 CA--C 1.53 1.029 0 C-N-CA 124.516 1.055 . . . . 0.0 114.003 173.071 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 12.5 mt -109.58 131.3 60.85 Favored 'Isoleucine or valine' 0 C--O 1.232 0.134 0 CA-C-N 118.884 1.342 . . . . 0.0 109.921 -177.947 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 8.1 t70 -87.28 121.04 29.19 Favored 'General case' 0 C--O 1.236 0.375 0 N-CA-C 106.783 -1.562 . . . . 0.0 106.783 169.061 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 10.1 pt -110.39 -26.68 3.09 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.487 0 C-N-CA 123.097 0.559 . . . . 0.0 110.105 169.126 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -32.67 -46.42 0.14 Allowed 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 130.146 3.378 . . . . 0.0 114.279 173.073 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -73.75 -3.59 63.85 Favored Glycine 0 CA--C 1.534 1.221 0 CA-C-O 118.82 -0.989 . . . . 0.0 114.126 -176.27 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 13.3 mt-30 -79.25 114.53 18.26 Favored 'General case' 0 CA--C 1.511 -0.55 0 CA-C-N 119.353 1.577 . . . . 0.0 111.468 -176.216 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -150.22 148.33 28.77 Favored 'General case' 0 N--CA 1.434 -1.248 0 N-CA-C 105.257 -2.127 . . . . 0.0 105.257 167.328 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 18.8 m -150.81 156.7 41.78 Favored 'General case' 0 N--CA 1.447 -0.607 0 N-CA-C 108.373 -0.973 . . . . 0.0 108.373 -169.677 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -67.98 163.45 50.4 Favored Pre-proline 0 CA--C 1.542 0.646 0 C-N-CA 124.682 1.193 . . . . 0.0 109.464 169.422 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -60.73 151.65 75.08 Favored 'Trans proline' 0 N--CA 1.456 -0.685 0 C-N-CA 122.043 1.829 . . . . 0.0 110.31 172.126 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 13.9 tt -58.61 -26.24 30.69 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.453 0 C-N-CA 124.031 0.932 . . . . 0.0 112.212 -174.475 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 23.1 tt0 -67.21 -25.34 66.07 Favored 'General case' 0 N--CA 1.434 -1.241 0 C-N-CA 125.68 1.592 . . . . 0.0 110.682 -177.052 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 12.9 t-20 -63.21 -31.51 72.67 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 124.984 1.314 . . . . 0.0 112.221 -178.888 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 8.5 m-85 -96.69 -167.69 1.6 Allowed 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 124.904 1.281 . . . . 0.0 110.333 -175.46 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 54.9 t-20 -137.35 136.95 38.39 Favored 'General case' 0 CA--C 1.515 -0.402 0 N-CA-C 107.27 -1.382 . . . . 0.0 107.27 169.188 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.46 ' HB3' ' HG2' ' A' ' 89' ' ' GLU . . . -73.54 -24.91 60.19 Favored 'General case' 0 N--CA 1.436 -1.128 0 N-CA-C 109.408 -0.59 . . . . 0.0 109.408 -176.547 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 36.0 t70 -66.34 -23.97 66.44 Favored 'General case' 0 N--CA 1.443 -0.804 0 O-C-N 123.751 0.657 . . . . 0.0 111.82 -179.618 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -75.96 -28.82 58.05 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 123.097 0.559 . . . . 0.0 111.348 175.541 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 18.8 m-85 -83.58 168.61 16.22 Favored 'General case' 0 N--CA 1.45 -0.47 0 C-N-CA 125.897 1.679 . . . . 0.0 110.368 177.939 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -114.97 -36.26 4.5 Favored 'General case' 0 N--CA 1.465 0.321 0 C-N-CA 123.126 0.57 . . . . 0.0 111.281 178.595 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -140.58 139.09 35.57 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.361 0 C-N-CA 123.42 0.688 . . . . 0.0 109.621 -171.499 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 83.4 t -140.48 140.0 34.72 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.319 0 N-CA-C 106.381 -1.711 . . . . 0.0 106.381 -177.692 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 37.3 mm -131.41 127.86 60.44 Favored 'Isoleucine or valine' 0 C--O 1.237 0.441 0 N-CA-C 106.743 -1.577 . . . . 0.0 106.743 -174.921 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 13.6 m -86.59 130.83 34.34 Favored 'General case' 0 N--CA 1.441 -0.905 0 N-CA-C 106.647 -1.612 . . . . 0.0 106.647 168.927 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 85.0 mt -93.94 -7.25 43.53 Favored 'General case' 0 C--N 1.331 -0.226 0 C-N-CA 123.465 0.706 . . . . 0.0 109.726 169.751 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 18.0 p -161.58 158.67 26.65 Favored 'General case' 0 N--CA 1.444 -0.73 0 C-N-CA 124.881 1.272 . . . . 0.0 108.768 169.454 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 65.76 -161.39 43.4 Favored Glycine 0 CA--C 1.535 1.285 0 N-CA-C 115.178 0.831 . . . . 0.0 115.178 169.345 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 15.1 m -142.59 -161.2 1.2 Allowed 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 126.841 2.057 . . . . 0.0 107.626 -172.39 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -72.76 61.41 1.64 Allowed Glycine 0 CA--C 1.535 1.315 0 O-C-N 120.921 -1.112 . . . . 0.0 111.667 172.28 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 6.7 m -78.21 -55.86 9.03 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.508 0 C-N-CA 124.235 1.014 . . . . 0.0 110.82 -170.001 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 46.4 t30 -143.9 48.85 1.39 Allowed 'General case' 0 N--CA 1.467 0.383 0 N-CA-C 104.416 -2.438 . . . . 0.0 104.416 169.551 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 6.0 tt -144.15 119.33 6.09 Favored Pre-proline 0 CA--C 1.535 0.386 0 N-CA-C 104.75 -2.315 . . . . 0.0 104.75 -168.443 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 76.4 Cg_exo -60.13 138.07 79.35 Favored 'Trans proline' 0 C--N 1.349 0.579 0 C-N-CA 121.823 1.682 . . . . 0.0 112.316 -170.194 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 66.9 Cg_endo -68.85 -14.57 39.16 Favored 'Trans proline' 0 N--CA 1.459 -0.516 0 C-N-CA 122.0 1.8 . . . . 0.0 113.084 -174.776 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 89' ' ' GLU . . . . . 0.46 ' HG2' ' HB3' ' A' ' 70' ' ' ALA . 14.0 tt0 -58.08 -25.48 61.34 Favored 'General case' 0 N--CA 1.439 -1.019 0 C-N-CA 125.713 1.605 . . . . 0.0 110.887 171.565 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 99.7 m95 -78.87 -41.38 30.02 Favored 'General case' 0 N--CA 1.456 -0.134 0 C-N-CA 123.722 0.809 . . . . 0.0 111.804 173.035 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 2.0 m -79.46 0.02 3.47 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.638 0 C-N-CA 123.321 0.648 . . . . 0.0 112.326 -175.153 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . 0.254 1.4 t -133.11 34.98 3.53 Favored 'General case' 0 CA--C 1.546 0.797 0 O-C-N 121.519 -0.738 . . . . 0.0 112.565 -175.731 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 89.4 mm-40 -71.66 -178.66 2.3 Favored 'General case' 0 CA--C 1.543 0.703 0 O-C-N 121.208 -0.933 . . . . 0.0 110.052 169.199 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 31.1 mm-40 -57.22 -28.83 63.23 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 123.181 0.592 . . . . 0.0 111.923 -169.348 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 5.3 tt -136.72 138.63 46.06 Favored 'Isoleucine or valine' 0 C--O 1.239 0.519 0 N-CA-C 104.383 -2.451 . . . . 0.0 104.383 168.406 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 70.9 t80 -132.33 142.46 49.35 Favored 'General case' 0 N--CA 1.448 -0.564 0 N-CA-C 106.407 -1.701 . . . . 0.0 106.407 169.491 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 19.9 mm-40 -141.64 152.1 43.66 Favored 'General case' 0 C--O 1.237 0.397 0 N-CA-C 106.652 -1.61 . . . . 0.0 106.652 171.351 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -125.4 127.66 46.92 Favored 'General case' 0 C--O 1.239 0.5 0 N-CA-C 107.244 -1.391 . . . . 0.0 107.244 169.204 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 4.6 m95 -116.05 158.17 23.56 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 124.192 0.997 . . . . 0.0 110.452 -173.328 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 19.9 pt20 -122.06 39.56 3.85 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 124.553 1.141 . . . . 0.0 111.258 -177.054 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -64.36 133.08 51.91 Favored 'General case' 0 N--CA 1.466 0.359 0 N-CA-C 107.764 -1.199 . . . . 0.0 107.764 173.492 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 3.2 mp0 -64.59 152.09 42.95 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 123.943 0.897 . . . . 0.0 110.037 173.049 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -91.01 113.64 58.85 Favored Pre-proline 0 C--O 1.236 0.377 0 N-CA-C 105.603 -1.999 . . . . 0.0 105.603 168.349 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 104' ' ' PRO . . . . . 0.439 ' HG2' ' CE1' ' A' ' 112' ' ' PHE . 78.6 Cg_endo -76.25 -8.73 18.78 Favored 'Trans proline' 0 N--CA 1.453 -0.868 0 C-N-CA 121.804 1.669 . . . . 0.0 114.189 -172.819 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -66.79 -41.2 88.01 Favored 'General case' 0 C--O 1.235 0.299 0 CA-C-N 120.45 1.477 . . . . 0.0 113.293 -169.309 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -79.3 6.96 55.65 Favored Glycine 0 CA--C 1.533 1.179 0 CA-C-O 118.823 -0.987 . . . . 0.0 113.663 -176.082 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 24.3 pt20 -148.53 -165.59 2.32 Favored 'General case' 0 CA--C 1.54 0.582 0 CA-C-N 118.932 1.366 . . . . 0.0 111.141 -169.874 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 2.1 m -69.3 156.65 38.42 Favored 'General case' 0 CA--C 1.533 0.324 0 N-CA-C 116.164 1.912 . . . . 0.0 116.164 -168.365 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 35.0 tp -57.33 -30.34 64.71 Favored 'General case' 0 N--CA 1.465 0.305 0 C-N-CA 126.28 1.832 . . . . 0.0 112.475 173.544 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 40.4 tt0 -58.62 -34.92 71.71 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 123.601 0.76 . . . . 0.0 110.62 173.978 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 3.4 t -76.0 -38.23 35.2 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.378 0 CA-C-O 118.12 -0.943 . . . . 0.0 109.676 -178.939 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 112' ' ' PHE . . . . . 0.439 ' CE1' ' HG2' ' A' ' 104' ' ' PRO . 27.0 m-85 -57.03 -50.14 73.66 Favored 'General case' 0 N--CA 1.475 0.793 0 CA-C-N 120.733 1.606 . . . . 0.0 110.256 169.904 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 85.7 mtt180 -60.5 -39.54 88.07 Favored 'General case' 0 N--CA 1.468 0.457 0 C-N-CA 123.358 0.663 . . . . 0.0 110.849 -179.161 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 16.3 m -68.28 -50.58 52.73 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 124.657 1.183 . . . . 0.0 110.726 176.565 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 55.2 t -67.6 -33.87 64.69 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.197 0 CA-C-O 117.498 -1.239 . . . . 0.0 110.856 -169.423 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 31.1 mtm105 -57.54 -41.77 81.62 Favored 'General case' 0 CA--C 1.539 0.534 0 CA-C-N 120.335 1.425 . . . . 0.0 110.273 173.598 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -67.02 -50.34 47.27 Favored Glycine 0 CA--C 1.529 0.92 0 C-N-CA 123.926 0.774 . . . . 0.0 111.878 177.577 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 25.4 mt-30 -54.95 -47.59 74.3 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-N 117.752 0.776 . . . . 0.0 110.211 178.377 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 53.7 t -64.83 -48.79 82.96 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.432 0 CA-C-O 118.329 -0.843 . . . . 0.0 109.967 -177.101 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 62.6 tttm -55.96 -45.65 78.83 Favored 'General case' 0 CA--C 1.519 -0.22 0 CA-C-N 119.114 0.87 . . . . 0.0 109.107 -174.429 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -64.88 -43.93 91.31 Favored 'General case' 0 N--CA 1.443 -0.781 0 C-N-CA 123.019 0.528 . . . . 0.0 110.776 -177.12 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 57.8 mtt-85 -68.0 -42.94 79.95 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-N 118.639 0.654 . . . . 0.0 111.695 179.578 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 98.5 t -66.55 -44.11 90.29 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.374 0 N-CA-C 108.433 -0.951 . . . . 0.0 108.433 179.406 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 21.3 mt-10 -61.39 -42.73 99.19 Favored 'General case' 0 C--N 1.338 0.092 0 CA-C-N 119.892 1.224 . . . . 0.0 110.39 178.861 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 29.6 t-20 -62.22 -44.56 96.29 Favored 'General case' 0 C--O 1.225 -0.189 0 C-N-CA 122.861 0.464 . . . . 0.0 110.827 178.239 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 45.7 tp -60.1 -47.24 86.74 Favored 'General case' 0 N--CA 1.454 -0.246 0 C-N-CA 124.239 1.016 . . . . 0.0 111.052 177.5 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 79.7 mt -61.69 -45.83 97.83 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.256 0 N-CA-C 108.026 -1.101 . . . . 0.0 108.026 178.191 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -62.04 -29.3 70.19 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 123.262 0.625 . . . . 0.0 112.239 178.28 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 89.9 mttt -68.59 -56.55 7.89 Favored 'General case' 0 C--N 1.342 0.248 0 CA-C-N 119.16 0.891 . . . . 0.0 110.096 171.711 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 15.8 pt -73.93 -40.35 52.51 Favored 'Isoleucine or valine' 0 C--O 1.235 0.338 0 N-CA-C 114.213 1.19 . . . . 0.0 114.213 -169.308 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 75.0 m . . . . . 0 C--O 1.253 1.262 0 C-N-CA 126.144 1.777 . . . . 0.0 109.408 -169.74 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 9.7 ptm . . . . . 0 N--CA 1.497 1.913 0 N-CA-C 110.711 -0.107 . . . . 0.0 110.711 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 2' ' ' LYS . . . . . 0.417 ' HB2' HG22 ' A' ' 30' ' ' ILE . 18.1 mttm -76.06 124.0 26.7 Favored 'General case' 0 N--CA 1.481 1.095 0 N-CA-C 107.701 -1.222 . . . . 0.0 107.701 -172.499 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 87.1 mttt -92.64 135.01 34.46 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-N 119.689 1.131 . . . . 0.0 108.343 176.692 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 1.7 t -118.81 150.31 21.11 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 C-N-CA 126.852 2.061 . . . . 0.0 108.848 -169.161 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 6.2 mtt -139.41 148.15 42.4 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 125.617 1.567 . . . . 0.0 109.286 169.352 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 91.0 m-85 -132.78 105.75 7.34 Favored 'General case' 0 C--O 1.225 -0.193 0 N-CA-C 104.769 -2.308 . . . . 0.0 104.769 172.131 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 22.1 t -131.82 138.88 51.76 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.221 0 CA-C-O 121.898 0.856 . . . . 0.0 111.211 -168.745 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 37.9 t -154.41 156.08 36.17 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 127.47 2.308 . . . . 0.0 105.236 169.27 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 65.6 pttt -65.37 -21.74 66.72 Favored 'General case' 0 N--CA 1.472 0.64 0 N-CA-C 114.69 1.367 . . . . 0.0 114.69 -170.427 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 7.9 tpp180 -126.94 78.05 1.77 Allowed 'General case' 0 N--CA 1.47 0.54 0 CA-C-N 119.814 1.188 . . . . 0.0 110.058 -173.9 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 34.9 t30 -43.18 -48.33 6.44 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 125.159 1.384 . . . . 0.0 112.222 176.379 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -51.53 -32.14 26.76 Favored 'General case' 0 C--O 1.232 0.147 0 C-N-CA 126.617 1.967 . . . . 0.0 112.998 -175.66 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 8.8 m -125.01 17.52 8.5 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 123.795 0.838 . . . . 0.0 111.805 -173.198 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 10.2 tpt180 -151.81 -55.86 0.14 Allowed 'General case' 0 C--N 1.348 0.528 0 N-CA-C 115.727 1.751 . . . . 0.0 115.727 179.33 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 3.3 m -65.66 -55.01 19.78 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 119.61 1.095 . . . . 0.0 112.195 -168.509 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER 43.8 -111.12 0.19 Allowed 'General case' 0 N--CA 1.452 -0.368 0 C-N-CA 126.328 1.851 . . . . 0.0 111.453 169.106 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -78.53 -8.38 58.51 Favored 'General case' 0 C--O 1.224 -0.246 0 N-CA-C 114.29 1.218 . . . . 0.0 114.29 -170.629 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -62.78 -58.95 5.66 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-N 120.131 1.332 . . . . 0.0 111.138 -169.751 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -68.11 -32.1 72.16 Favored 'General case' 0 CA--C 1.541 0.597 0 O-C-N 121.722 -0.611 . . . . 0.0 109.542 175.627 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -48.63 -56.65 9.35 Favored Glycine 0 C--N 1.346 1.113 0 C-N-CA 125.38 1.467 . . . . 0.0 111.637 176.23 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 13.9 m-85 -74.54 -28.3 60.9 Favored 'General case' 0 CA--C 1.508 -0.663 0 CA-C-N 118.77 1.285 . . . . 0.0 112.928 179.322 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -66.25 -31.0 71.55 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 119.323 0.965 . . . . 0.0 111.554 -172.451 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 7.5 ptpt -63.5 -33.06 74.75 Favored 'General case' 0 N--CA 1.477 0.908 0 CA-C-N 119.432 1.015 . . . . 0.0 112.036 171.067 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 5.9 m -78.72 -55.17 5.38 Favored 'General case' 0 N--CA 1.446 -0.626 0 C-N-CA 125.187 1.395 . . . . 0.0 110.245 -175.202 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 79.3 mt -73.4 -34.32 65.45 Favored 'General case' 0 C--N 1.33 -0.248 0 C-N-CA 123.971 0.909 . . . . 0.0 110.339 -174.753 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -91.08 2.85 79.88 Favored Glycine 0 CA--C 1.527 0.822 0 CA-C-O 118.362 -1.243 . . . . 0.0 113.709 -176.494 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -49.92 123.0 7.31 Favored 'General case' 0 CA--C 1.533 0.31 0 CA-C-N 118.796 1.298 . . . . 0.0 110.904 -172.074 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 76.78 -14.11 7.73 Favored Glycine 0 CA--C 1.533 1.195 0 C-N-CA 124.676 1.132 . . . . 0.0 114.353 179.631 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 53.6 mttm -94.15 -46.41 7.12 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-N 119.212 1.506 . . . . 0.0 110.393 178.918 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.417 HG22 ' HB2' ' A' ' 2' ' ' LYS . 24.7 pt -142.15 152.39 18.41 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.427 0 C-N-CA 124.301 1.04 . . . . 0.0 109.95 -169.408 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -112.87 109.01 18.19 Favored 'General case' 0 N--CA 1.464 0.235 0 C-N-CA 125.035 1.334 . . . . 0.0 108.694 -174.036 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 11.1 p -86.27 139.16 17.79 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.401 0 CA-C-N 119.702 1.137 . . . . 0.0 109.867 177.71 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 3.9 m -144.55 107.7 4.55 Favored 'General case' 0 N--CA 1.445 -0.69 0 N-CA-C 104.77 -2.308 . . . . 0.0 104.77 172.191 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 66.2 m -105.63 75.47 1.14 Allowed 'General case' 0 C--N 1.329 -0.32 0 O-C-N 120.933 -1.105 . . . . 0.0 108.827 178.48 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 2.0 m -60.46 -45.55 93.29 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 125.388 1.475 . . . . 0.0 112.054 -169.891 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 89.65 161.73 37.74 Favored Glycine 0 C--N 1.335 0.508 0 CA-C-O 122.038 0.799 . . . . 0.0 112.159 170.905 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 5.6 mt -131.49 142.67 50.01 Favored 'General case' 0 N--CA 1.442 -0.845 0 C-N-CA 128.079 2.552 . . . . 0.0 104.548 174.533 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 33.2 mt-10 57.42 -89.77 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.385 0 N-CA-C 108.134 -1.061 . . . . 0.0 108.134 -169.516 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 69.3 m 64.52 169.63 0.18 Allowed 'General case' 0 N--CA 1.445 -0.721 0 C-N-CA 127.269 2.228 . . . . 0.0 115.615 169.184 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 59.9 m -157.47 177.29 11.59 Favored 'General case' 0 N--CA 1.446 -0.646 0 C-N-CA 128.269 2.627 . . . . 0.0 105.984 -168.847 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 14.4 ttt85 -82.12 -178.77 7.15 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 107.963 -1.125 . . . . 0.0 107.963 169.377 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 17.6 m -81.41 170.17 1.48 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.729 0 C-N-CA 123.789 0.836 . . . . 0.0 109.766 -178.675 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 74.0 t60 -73.0 139.22 79.59 Favored Pre-proline 0 CA--C 1.545 0.763 0 CA-C-O 118.163 -0.922 . . . . 0.0 108.631 172.207 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -58.35 -48.3 16.16 Favored 'Trans proline' 0 C--N 1.348 0.507 0 C-N-CA 123.093 2.529 . . . . 0.0 113.833 -174.193 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 25.2 m -65.58 -18.82 65.6 Favored 'General case' 0 CA--C 1.535 0.387 0 CA-C-N 118.258 0.481 . . . . 0.0 110.937 -179.294 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.404 ' HB1' HD11 ' A' ' 57' ' ' ILE . . . -60.28 -50.64 72.82 Favored 'General case' 0 CA--C 1.51 -0.562 0 O-C-N 121.458 -0.776 . . . . 0.0 108.996 175.018 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 72.5 mt -57.98 -41.57 80.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 N-CA-C 108.352 -0.981 . . . . 0.0 108.352 -173.112 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -63.56 -46.48 85.72 Favored 'General case' 0 N--CA 1.452 -0.352 0 CA-C-N 117.631 0.196 . . . . 0.0 110.856 -179.05 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 28.4 mmt -68.02 -36.38 79.85 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-O 122.439 1.114 . . . . 0.0 110.841 -179.819 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -74.6 -31.93 62.19 Favored 'General case' 0 N--CA 1.444 -0.753 0 N-CA-C 106.887 -1.523 . . . . 0.0 106.887 -175.698 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 40.8 tt0 -72.3 -21.89 61.28 Favored 'General case' 0 N--CA 1.446 -0.651 0 C-N-CA 124.311 1.045 . . . . 0.0 110.157 172.495 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 21.6 mm-40 -67.53 -30.63 70.34 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-N 119.272 0.942 . . . . 0.0 110.017 169.962 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . 0.291 5.5 p -89.86 8.74 3.21 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.993 0 CA-C-N 118.802 0.728 . . . . 0.0 111.467 168.839 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 77.29 21.75 72.36 Favored Glycine 0 CA--C 1.532 1.11 0 O-C-N 120.818 -1.176 . . . . 0.0 113.799 174.953 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 25.2 mt -118.71 144.71 26.17 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.239 0 C-N-CA 125.314 1.445 . . . . 0.0 110.005 -174.15 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 20.6 t70 -108.03 147.59 30.93 Favored 'General case' 0 C--O 1.234 0.282 0 N-CA-C 108.375 -0.972 . . . . 0.0 108.375 168.74 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.404 HD11 ' HB1' ' A' ' 46' ' ' ALA . 13.5 pt -132.29 -12.57 1.48 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.707 0 C-N-CA 125.895 1.678 . . . . 0.0 111.529 170.565 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 5.4 t -45.77 -46.73 15.42 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-N 120.333 1.424 . . . . 0.0 111.688 170.845 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -78.51 29.51 1.99 Allowed Glycine 0 CA--C 1.533 1.207 0 C-N-CA 124.966 1.269 . . . . 0.0 114.147 -177.621 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 1.7 tt0 -63.5 -37.37 87.04 Favored 'General case' 0 C--N 1.344 0.36 0 CA-C-N 119.728 1.764 . . . . 0.0 113.213 -175.046 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 12.4 t -81.22 161.36 24.01 Favored 'General case' 0 C--O 1.238 0.451 0 CA-C-O 122.047 0.927 . . . . 0.0 110.352 -169.534 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 4.2 m -168.34 -51.42 0.02 OUTLIER 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 125.919 1.687 . . . . 0.0 109.175 178.197 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -154.39 154.97 30.32 Favored Pre-proline 0 C--O 1.237 0.41 0 C-N-CA 124.988 1.315 . . . . 0.0 108.208 -179.672 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 98.9 Cg_endo -66.86 159.13 53.07 Favored 'Trans proline' 0 N--CA 1.457 -0.659 0 C-N-CA 123.111 2.541 . . . . 0.0 110.508 171.421 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 5.6 tt -60.11 -26.01 35.01 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.477 0 O-C-N 121.577 -0.702 . . . . 0.0 111.63 179.681 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 15.8 mt-10 -65.66 -25.46 67.36 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 124.555 1.142 . . . . 0.0 110.593 -175.121 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 4.4 t-20 -65.84 -20.96 66.43 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 124.666 1.186 . . . . 0.0 112.459 177.985 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 77.0 m-85 -106.42 -173.49 2.31 Favored 'General case' 0 C--O 1.236 0.356 0 C-N-CA 126.37 1.868 . . . . 0.0 110.1 -174.95 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 53.2 t-20 -135.78 139.71 43.72 Favored 'General case' 0 N--CA 1.448 -0.542 0 N-CA-C 107.857 -1.164 . . . . 0.0 107.857 169.123 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -72.44 -26.16 61.73 Favored 'General case' 0 N--CA 1.433 -1.31 0 N-CA-C 109.283 -0.636 . . . . 0.0 109.283 -178.102 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -65.56 -24.39 67.08 Favored 'General case' 0 N--CA 1.447 -0.596 0 O-C-N 123.639 0.587 . . . . 0.0 112.002 -179.652 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -78.42 -28.43 46.79 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 123.297 0.639 . . . . 0.0 111.635 174.848 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 11.4 m-85 -81.13 167.44 19.68 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 125.536 1.534 . . . . 0.0 111.151 179.877 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -116.86 -39.98 3.21 Favored 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 123.099 0.56 . . . . 0.0 111.243 -179.081 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -136.13 133.62 50.28 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.453 0 CA-C-O 121.841 0.829 . . . . 0.0 109.498 -172.43 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 70.5 t -142.01 130.0 21.32 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.585 0 N-CA-C 106.199 -1.778 . . . . 0.0 106.199 -177.83 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 38.0 mm -118.9 125.42 74.46 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.575 0 N-CA-C 106.387 -1.708 . . . . 0.0 106.387 -173.233 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 56.0 m -84.0 145.06 28.72 Favored 'General case' 0 N--CA 1.446 -0.655 0 N-CA-C 106.061 -1.829 . . . . 0.0 106.061 168.601 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 93.1 mt -111.61 5.35 19.3 Favored 'General case' 0 C--N 1.328 -0.344 0 O-C-N 121.637 -0.664 . . . . 0.0 110.785 171.74 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 10.8 p -155.47 147.25 23.22 Favored 'General case' 0 N--CA 1.447 -0.584 0 C-N-CA 124.537 1.135 . . . . 0.0 108.566 168.898 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 53.4 -156.56 5.5 Favored Glycine 0 CA--C 1.537 1.426 0 C-N-CA 125.204 1.383 . . . . 0.0 115.22 169.604 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 48.0 m -145.83 127.12 14.85 Favored 'General case' 0 CA--C 1.532 0.271 0 N-CA-C 105.902 -1.888 . . . . 0.0 105.902 174.913 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 58.59 44.43 95.55 Favored Glycine 0 CA--C 1.53 1.013 0 N-CA-C 109.711 -1.356 . . . . 0.0 109.711 -171.378 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . 0.279 4.0 p -75.37 64.46 0.16 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.842 0 C-N-CA 125.916 1.686 . . . . 0.0 112.213 -168.834 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 56.5 t30 56.84 52.89 8.81 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 125.874 1.67 . . . . 0.0 107.83 -169.569 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -143.83 138.59 15.29 Favored Pre-proline 0 CA--C 1.538 0.489 0 C-N-CA 126.102 1.761 . . . . 0.0 108.743 -168.748 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 33.2 Cg_exo -64.93 139.47 62.05 Favored 'Trans proline' 0 CA--C 1.54 0.81 0 C-N-CA 122.221 1.947 . . . . 0.0 111.576 176.463 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -66.21 -24.9 50.72 Favored 'Trans proline' 0 N--CA 1.457 -0.657 0 C-N-CA 122.585 2.19 . . . . 0.0 114.476 -169.649 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 5.0 pm0 -61.46 -18.08 57.36 Favored 'General case' 0 CA--C 1.537 0.453 0 CA-C-N 121.251 1.841 . . . . 0.0 111.898 178.413 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 99.4 m95 -77.91 -38.84 44.71 Favored 'General case' 0 N--CA 1.451 -0.393 0 O-C-N 121.702 -0.624 . . . . 0.0 111.396 174.093 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -79.33 -5.12 7.72 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.456 0 O-C-N 121.869 -0.519 . . . . 0.0 111.672 -177.827 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 81.5 p -114.39 18.42 16.9 Favored 'General case' 0 C--O 1.238 0.453 0 N-CA-C 114.411 1.264 . . . . 0.0 114.411 -175.633 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 91.6 mm-40 -68.18 173.99 4.27 Favored 'General case' 0 CA--C 1.541 0.628 0 CA-C-N 119.025 0.83 . . . . 0.0 111.858 179.324 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 28.7 mm-40 -53.22 -31.57 43.79 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 124.362 1.065 . . . . 0.0 112.735 -169.0 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 4.8 tt -131.35 124.83 55.77 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.51 0 N-CA-C 104.305 -2.48 . . . . 0.0 104.305 168.39 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 4.1 t80 -113.55 133.39 55.28 Favored 'General case' 0 C--O 1.237 0.444 0 N-CA-C 104.722 -2.325 . . . . 0.0 104.722 169.186 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 14.4 mm-40 -137.66 152.07 48.93 Favored 'General case' 0 C--O 1.238 0.495 0 N-CA-C 106.57 -1.641 . . . . 0.0 106.57 169.723 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -130.94 134.82 47.1 Favored 'General case' 0 C--O 1.237 0.419 0 N-CA-C 107.411 -1.329 . . . . 0.0 107.411 169.263 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 6.6 m95 -121.08 138.95 53.94 Favored 'General case' 0 C--O 1.234 0.25 0 C-N-CA 123.059 0.543 . . . . 0.0 109.767 -174.82 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 4.8 tp-100 -82.72 63.33 6.79 Favored 'General case' 0 CA--C 1.535 0.395 0 N-CA-C 107.361 -1.348 . . . . 0.0 107.361 169.907 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 1.6 tp -67.38 127.53 33.03 Favored 'General case' 0 C--N 1.34 0.165 0 N-CA-C 108.955 -0.757 . . . . 0.0 108.955 -173.352 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -76.89 159.05 30.33 Favored 'General case' 0 N--CA 1.449 -0.508 0 N-CA-C 107.045 -1.465 . . . . 0.0 107.045 169.572 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 20.0 t70 -149.07 137.65 11.96 Favored Pre-proline 0 CA--C 1.536 0.419 0 CA-C-O 118.596 -0.716 . . . . 0.0 111.209 -171.584 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 20.8 Cg_endo -91.7 9.53 2.82 Favored 'Trans proline' 0 CA--C 1.548 1.217 0 C-N-CA 123.424 2.749 . . . . 0.0 114.808 -172.193 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -53.27 128.44 28.16 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-N 120.596 1.544 . . . . 0.0 111.361 177.811 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 64.0 25.16 69.18 Favored Glycine 0 CA--C 1.532 1.126 0 CA-C-O 118.741 -1.033 . . . . 0.0 115.458 169.223 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 6.9 pt20 -142.1 -168.48 2.71 Favored 'General case' 0 CA--C 1.536 0.434 0 CA-C-N 118.891 1.345 . . . . 0.0 111.343 -177.911 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 2.6 m -68.51 156.0 38.84 Favored 'General case' 0 CA--C 1.532 0.274 0 N-CA-C 116.149 1.907 . . . . 0.0 116.149 -168.401 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 42.9 tp -54.97 -33.68 62.63 Favored 'General case' 0 N--CA 1.465 0.307 0 C-N-CA 126.997 2.119 . . . . 0.0 111.785 175.211 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 40.8 tt0 -58.49 -35.43 72.2 Favored 'General case' 0 CA--C 1.529 0.172 0 C-N-CA 123.806 0.843 . . . . 0.0 110.702 176.399 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 4.2 t -74.98 -40.47 45.39 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.291 0 CA-C-O 118.434 -0.793 . . . . 0.0 109.652 -177.216 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 89.9 m-85 -57.12 -49.64 75.29 Favored 'General case' 0 N--CA 1.471 0.621 0 CA-C-N 119.927 1.24 . . . . 0.0 109.568 171.837 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 89.4 mtt180 -61.61 -40.0 93.27 Favored 'General case' 0 N--CA 1.467 0.385 0 C-N-CA 122.871 0.468 . . . . 0.0 110.993 -178.592 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 7.6 m -66.32 -56.27 11.96 Favored 'General case' 0 N--CA 1.447 -0.608 0 C-N-CA 124.507 1.123 . . . . 0.0 109.514 177.996 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 83.8 t -68.33 -34.06 63.92 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.343 0 CA-C-O 118.683 -0.675 . . . . 0.0 110.057 -169.643 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 47.1 ttp85 -57.82 -43.23 85.59 Favored 'General case' 0 CA--C 1.538 0.489 0 CA-C-N 119.275 0.943 . . . . 0.0 109.883 173.173 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -64.54 -53.4 35.62 Favored Glycine 0 CA--C 1.53 0.987 0 CA-C-N 118.318 0.508 . . . . 0.0 111.842 175.273 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 12.6 mt-30 -61.01 -43.34 99.03 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-N 117.884 0.842 . . . . 0.0 110.837 -174.859 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 76.8 t -70.5 -38.85 75.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 118.085 -0.959 . . . . 0.0 109.966 -174.951 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 84.0 tttt -54.73 -46.81 74.29 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 119.279 0.945 . . . . 0.0 108.673 175.789 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -65.98 -42.51 89.75 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 122.933 0.493 . . . . 0.0 111.398 -176.604 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 43.6 mtt-85 -61.49 -46.62 89.22 Favored 'General case' 0 N--CA 1.472 0.635 0 O-C-N 121.336 -0.852 . . . . 0.0 111.514 176.524 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 98.4 t -65.28 -39.87 86.77 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.637 0 N-CA-C 109.08 -0.711 . . . . 0.0 109.08 179.354 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 29.7 mt-10 -59.42 -44.48 92.87 Favored 'General case' 0 N--CA 1.462 0.172 0 CA-C-N 119.789 1.177 . . . . 0.0 110.787 176.667 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 46.7 t30 -62.98 -45.2 93.54 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 123.329 0.652 . . . . 0.0 110.551 -177.649 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 22.0 tp -58.0 -47.91 81.61 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 124.112 0.965 . . . . 0.0 111.006 175.382 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 81.0 mt -63.09 -46.09 96.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 N-CA-C 108.329 -0.989 . . . . 0.0 108.329 179.664 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -59.91 -27.83 67.08 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 123.25 0.62 . . . . 0.0 112.214 177.901 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 90.5 mttt -69.72 -56.99 5.69 Favored 'General case' 0 C--N 1.343 0.284 0 CA-C-N 119.322 0.964 . . . . 0.0 110.184 171.706 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 18.2 pt -75.71 -38.44 37.66 Favored 'Isoleucine or valine' 0 C--O 1.235 0.326 0 N-CA-C 114.645 1.35 . . . . 0.0 114.645 -169.283 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 73.7 m . . . . . 0 C--O 1.252 1.237 0 C-N-CA 126.199 1.799 . . . . 0.0 109.128 -169.805 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 6.3 ptm . . . . . 0 N--CA 1.497 1.878 0 N-CA-C 110.807 -0.071 . . . . 0.0 110.807 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 2' ' ' LYS . . . . . 0.457 ' HB2' HG22 ' A' ' 30' ' ' ILE . 10.6 mtmm -71.69 130.14 40.41 Favored 'General case' 0 N--CA 1.476 0.874 0 N-CA-C 107.507 -1.294 . . . . 0.0 107.507 -178.936 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 66.7 mttt -103.74 138.32 40.53 Favored 'General case' 0 CA--C 1.511 -0.526 0 N-CA-C 107.912 -1.144 . . . . 0.0 107.912 171.046 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.419 HG21 HD12 ' A' ' 30' ' ' ILE . 4.0 t -116.25 152.84 17.93 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.787 0 C-N-CA 126.522 1.929 . . . . 0.0 108.169 -169.878 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 5.1 mtt -135.78 148.17 48.66 Favored 'General case' 0 C--N 1.323 -0.562 0 C-N-CA 126.512 1.925 . . . . 0.0 107.951 168.88 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -135.19 109.22 8.2 Favored 'General case' 0 CA--C 1.512 -0.51 0 N-CA-C 104.161 -2.533 . . . . 0.0 104.161 175.909 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 72.4 t -132.73 149.52 32.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-O 121.378 0.608 . . . . 0.0 110.0 -168.454 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 32.7 t -135.85 -174.43 3.66 Favored 'General case' 0 CA--C 1.548 0.866 0 C-N-CA 128.134 2.573 . . . . 0.0 105.952 172.814 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 64.3 tttp -54.45 -39.93 67.88 Favored 'General case' 0 N--CA 1.479 1.008 0 O-C-N 121.26 -0.9 . . . . 0.0 111.505 177.777 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 33.3 mtp85 -132.3 158.35 42.1 Favored 'General case' 0 N--CA 1.468 0.47 0 C-N-CA 124.644 1.177 . . . . 0.0 108.449 174.6 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -63.27 -24.97 68.1 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 122.948 0.499 . . . . 0.0 112.093 170.212 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -48.93 -44.46 40.51 Favored 'General case' 0 CA--C 1.53 0.197 0 C-N-CA 126.105 1.762 . . . . 0.0 113.627 -169.31 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 13.5 m -120.03 144.36 47.59 Favored 'General case' 0 N--CA 1.454 -0.27 0 C-N-CA 123.111 0.564 . . . . 0.0 109.733 -169.386 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . 0.37 0.0 OUTLIER 56.32 -40.68 0.03 OUTLIER 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 130.3 3.44 . . . . 0.0 115.061 -178.746 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 2.0 m -61.8 -24.19 66.7 Favored 'General case' 0 CA--C 1.539 0.524 0 O-C-N 120.358 -1.464 . . . . 0.0 109.663 169.293 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 16' ' ' GLN . . . . . 0.432 ' O ' HD13 ' A' ' 57' ' ' ILE . 22.0 pt20 -67.18 10.81 0.13 Allowed 'General case' 0 CA--C 1.546 0.823 0 C-N-CA 125.638 1.575 . . . . 0.0 113.401 169.414 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -139.18 -51.64 0.54 Allowed 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 125.158 1.383 . . . . 0.0 111.577 173.599 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -57.8 -47.43 82.6 Favored 'General case' 0 N--CA 1.472 0.669 0 N-CA-C 114.934 1.457 . . . . 0.0 114.934 -169.003 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 1.9 pp20? -63.5 -30.61 71.71 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-N 117.981 0.355 . . . . 0.0 110.109 178.36 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -51.81 -67.32 2.07 Favored Glycine 0 C--N 1.34 0.805 0 C-N-CA 126.399 1.952 . . . . 0.0 110.885 173.376 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 12.8 m-85 -62.53 -31.01 71.71 Favored 'General case' 0 N--CA 1.469 0.514 0 CA-C-N 118.25 1.025 . . . . 0.0 113.294 179.67 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -67.36 -35.79 80.07 Favored 'General case' 0 N--CA 1.45 -0.454 0 CA-C-N 119.07 0.85 . . . . 0.0 111.549 -176.226 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -67.35 -27.28 67.0 Favored 'General case' 0 CA--C 1.541 0.624 0 CA-C-N 119.426 1.012 . . . . 0.0 111.431 174.201 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 2.8 m -77.2 -56.17 4.8 Favored 'General case' 0 N--CA 1.451 -0.397 0 C-N-CA 125.443 1.497 . . . . 0.0 110.571 -178.601 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 54.9 mt -75.54 -38.35 59.37 Favored 'General case' 0 C--N 1.33 -0.245 0 C-N-CA 124.098 0.959 . . . . 0.0 109.497 -174.484 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -82.24 3.78 79.68 Favored Glycine 0 CA--C 1.524 0.628 0 C-N-CA 125.154 1.359 . . . . 0.0 113.447 -179.65 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -54.39 127.28 26.73 Favored 'General case' 0 CA--C 1.531 0.219 0 CA-C-N 118.881 1.34 . . . . 0.0 109.691 -177.328 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 73.38 5.41 67.18 Favored Glycine 0 CA--C 1.533 1.168 0 CA-C-O 118.775 -1.014 . . . . 0.0 114.273 -178.8 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 46.3 mttp -121.22 -51.32 2.1 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-N 119.104 1.452 . . . . 0.0 110.943 -176.508 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.457 HG22 ' HB2' ' A' ' 2' ' ' LYS . 19.2 pt -139.71 148.12 23.39 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.453 0 C-N-CA 123.88 0.872 . . . . 0.0 109.567 -169.495 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -94.67 158.75 15.38 Favored 'General case' 0 C--O 1.224 -0.266 0 C-N-CA 124.851 1.26 . . . . 0.0 108.522 178.06 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 21.7 t -140.54 130.71 28.07 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 N-CA-C 107.172 -1.418 . . . . 0.0 107.172 -176.474 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 24.4 m -141.0 109.77 6.04 Favored 'General case' 0 N--CA 1.446 -0.645 0 N-CA-C 105.122 -2.177 . . . . 0.0 105.122 172.684 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 69.3 m -110.81 85.0 2.03 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.869 0.842 . . . . 0.0 110.079 -177.439 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 4.8 m -72.48 -170.09 0.61 Allowed 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 126.651 1.98 . . . . 0.0 110.748 176.749 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -165.74 -168.2 27.53 Favored Glycine 0 C--N 1.337 0.604 0 N-CA-C 108.01 -2.036 . . . . 0.0 108.01 177.949 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 16.9 mt -127.25 -8.41 5.86 Favored 'General case' 0 C--N 1.332 -0.177 0 C-N-CA 124.657 1.183 . . . . 0.0 112.773 -171.946 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 20.9 mt-10 -142.52 -71.53 0.32 Allowed 'General case' 0 CA--C 1.535 0.366 0 N-CA-C 107.427 -1.323 . . . . 0.0 107.427 -178.023 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . 0.25 53.8 m 63.17 158.58 0.07 Allowed 'General case' 0 N--CA 1.465 0.296 0 C-N-CA 127.259 2.223 . . . . 0.0 116.586 169.675 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 69.6 m -152.74 1.62 0.3 Allowed 'General case' 0 CA--C 1.538 0.484 0 N-CA-C 115.747 1.758 . . . . 0.0 115.747 -167.532 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 1.5 ttt180 66.51 168.51 0.23 Allowed 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 125.251 1.42 . . . . 0.0 109.802 -167.439 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 5.1 m -83.79 172.33 1.07 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.315 0 C-N-CA 123.528 0.731 . . . . 0.0 110.978 -169.19 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 91.1 m-70 -88.65 150.55 46.36 Favored Pre-proline 0 CA--C 1.537 0.443 0 C-N-CA 123.188 0.595 . . . . 0.0 109.949 178.133 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 39.5 Cg_endo -63.72 -46.44 8.95 Favored 'Trans proline' 0 C--N 1.347 0.485 0 C-N-CA 122.855 2.37 . . . . 0.0 112.341 -170.338 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 6.0 m -66.17 -25.94 67.19 Favored 'General case' 0 CA--C 1.531 0.242 0 CA-C-O 119.016 -0.516 . . . . 0.0 110.256 -179.112 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -58.69 -54.12 50.61 Favored 'General case' 0 CA--C 1.51 -0.581 0 CA-C-N 119.086 0.857 . . . . 0.0 109.109 176.27 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 38.1 mt -59.7 -42.8 89.78 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.427 0 N-CA-C 108.193 -1.04 . . . . 0.0 108.193 -174.654 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -59.23 -44.86 92.31 Favored 'General case' 0 CA--C 1.532 0.269 0 CA-C-N 118.421 0.555 . . . . 0.0 110.623 -178.775 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 26.4 mmt -70.9 -37.58 72.98 Favored 'General case' 0 C--O 1.239 0.503 0 CA-C-O 122.158 0.98 . . . . 0.0 111.128 -179.161 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -69.91 -32.96 71.54 Favored 'General case' 0 N--CA 1.443 -0.778 0 N-CA-C 106.649 -1.612 . . . . 0.0 106.649 179.781 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 18.6 mm-40 -73.29 -16.59 61.38 Favored 'General case' 0 N--CA 1.444 -0.752 0 O-C-N 120.79 -1.194 . . . . 0.0 111.278 171.757 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 22.6 mm-40 -66.28 -35.1 79.53 Favored 'General case' 0 C--N 1.341 0.221 0 CA-C-N 119.847 1.203 . . . . 0.0 109.095 169.552 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 16.8 m -90.07 11.59 2.09 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.766 0 N-CA-C 112.2 0.445 . . . . 0.0 112.2 169.311 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 73.21 23.52 77.36 Favored Glycine 0 CA--C 1.534 1.234 0 C-N-CA 124.487 1.042 . . . . 0.0 113.345 174.67 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 8.6 mt -107.83 135.53 46.19 Favored 'Isoleucine or valine' 0 C--O 1.232 0.152 0 C-N-CA 125.419 1.488 . . . . 0.0 110.197 -174.994 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -95.57 140.01 31.02 Favored 'General case' 0 C--O 1.236 0.365 0 C-N-CA 123.508 0.723 . . . . 0.0 109.514 169.791 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.494 HG13 ' H ' ' A' ' 58' ' ' SER . 3.6 pt -119.72 -66.94 1.2 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.607 0 C-N-CA 124.773 1.229 . . . . 0.0 108.393 171.043 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 58' ' ' SER . . . . . 0.494 ' H ' HG13 ' A' ' 57' ' ' ILE . 95.2 p 30.59 -98.54 0.01 OUTLIER 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 128.961 2.905 . . . . 0.0 114.225 174.897 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -76.35 53.96 3.16 Favored Glycine 0 CA--C 1.528 0.876 0 C-N-CA 127.273 2.368 . . . . 0.0 112.703 -175.773 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 5.6 mt-30 -65.44 -29.9 70.63 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 123.203 0.601 . . . . 0.0 110.297 169.744 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -60.28 128.19 35.52 Favored 'General case' 0 N--CA 1.446 -0.639 0 C-N-CA 126.037 1.735 . . . . 0.0 109.19 -169.795 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 75.5 m -147.63 -169.94 3.44 Favored 'General case' 0 N--CA 1.447 -0.587 0 C-N-CA 126.332 1.853 . . . . 0.0 106.605 -169.635 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -57.38 154.59 22.24 Favored Pre-proline 0 C--O 1.241 0.613 0 O-C-N 121.854 -0.529 . . . . 0.0 109.903 169.355 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 64.4 Cg_endo -61.2 152.61 70.77 Favored 'Trans proline' 0 N--CA 1.456 -0.691 0 C-N-CA 121.918 1.745 . . . . 0.0 109.488 171.613 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 7.9 tt -60.09 -26.53 36.48 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.497 0 O-C-N 121.794 -0.566 . . . . 0.0 111.015 -176.682 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 25.4 tt0 -67.52 -26.33 66.28 Favored 'General case' 0 N--CA 1.435 -1.215 0 C-N-CA 125.398 1.479 . . . . 0.0 110.65 -176.625 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 11.3 t-20 -64.72 -31.16 72.26 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 124.416 1.087 . . . . 0.0 111.731 176.945 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 79.4 m-85 -86.58 168.13 13.94 Favored 'General case' 0 C--O 1.237 0.429 0 C-N-CA 124.946 1.298 . . . . 0.0 111.612 -174.695 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 46.4 t-20 -106.26 132.05 52.77 Favored 'General case' 0 N--CA 1.444 -0.738 0 N-CA-C 107.298 -1.371 . . . . 0.0 107.298 168.676 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -73.6 -24.69 60.08 Favored 'General case' 0 N--CA 1.437 -1.092 0 N-CA-C 109.339 -0.615 . . . . 0.0 109.339 -178.77 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 36.1 t70 -65.85 -21.76 66.49 Favored 'General case' 0 N--CA 1.447 -0.595 0 O-C-N 123.477 0.486 . . . . 0.0 112.096 -179.617 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -73.29 -29.31 62.63 Favored 'General case' 0 C--N 1.344 0.367 0 CA-C-O 121.222 0.534 . . . . 0.0 111.795 176.164 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 32.7 m-85 -84.25 165.84 18.0 Favored 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 125.744 1.618 . . . . 0.0 110.166 179.703 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 20.4 t70 -113.13 -35.84 5.25 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.72 176.903 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -142.24 135.94 28.5 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.826 0 CA-C-O 121.792 0.806 . . . . 0.0 110.496 -169.305 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 73.3 t -142.16 131.07 22.32 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.729 0 N-CA-C 106.178 -1.786 . . . . 0.0 106.178 -174.097 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 41.4 mm -117.93 125.5 74.23 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.443 0 N-CA-C 106.387 -1.709 . . . . 0.0 106.387 -171.712 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 41.3 m -95.19 108.69 20.83 Favored 'General case' 0 N--CA 1.447 -0.597 0 N-CA-C 106.675 -1.602 . . . . 0.0 106.675 169.889 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 90.0 mt -74.63 -13.37 60.63 Favored 'General case' 0 N--CA 1.464 0.254 0 C-N-CA 123.175 0.59 . . . . 0.0 111.661 -178.943 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 45.4 m -142.19 89.89 2.21 Favored 'General case' 0 N--CA 1.452 -0.367 0 C-N-CA 124.981 1.312 . . . . 0.0 109.073 -169.824 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 64.33 -154.7 47.51 Favored Glycine 0 CA--C 1.534 1.221 0 N-CA-C 111.585 -0.606 . . . . 0.0 111.585 178.418 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 2.9 p -161.77 152.81 18.11 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 124.587 1.155 . . . . 0.0 109.651 179.365 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 61.43 31.0 75.85 Favored Glycine 0 CA--C 1.531 1.069 0 N-CA-C 111.619 -0.592 . . . . 0.0 111.619 -178.534 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 28.5 m -70.69 -38.76 74.34 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.543 0 C-N-CA 123.087 0.555 . . . . 0.0 112.118 -169.366 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 21.4 t-20 179.66 -40.86 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 127.795 2.438 . . . . 0.0 107.573 176.712 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 3.6 tt -37.59 137.93 0.64 Allowed Pre-proline 0 CA--C 1.548 0.878 0 C-N-CA 128.788 2.835 . . . . 0.0 112.562 170.963 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 87' ' ' PRO . . . . . 0.439 ' HA ' ' HD3' ' A' ' 88' ' ' PRO . 53.2 Cg_exo -65.32 148.83 88.7 Favored 'Trans proline' 0 C--N 1.355 0.886 0 C-N-CA 121.734 1.623 . . . . 0.0 115.635 -169.399 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 88' ' ' PRO . . . . . 0.439 ' HD3' ' HA ' ' A' ' 87' ' ' PRO . 50.6 Cg_exo -64.04 -33.44 62.26 Favored 'Trans proline' 0 C--N 1.351 0.672 0 C-N-CA 122.394 2.062 . . . . 0.0 115.788 -170.981 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 5.1 pm0 -61.45 -14.41 28.34 Favored 'General case' 0 CA--C 1.538 0.49 0 CA-C-N 120.27 1.395 . . . . 0.0 112.46 -175.876 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 98.0 m95 -79.67 -45.94 18.08 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 124.008 0.923 . . . . 0.0 110.904 176.711 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 16.1 m -80.18 -1.32 4.58 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.366 0 C-N-CA 123.955 0.902 . . . . 0.0 112.25 179.975 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 74.9 p -109.62 18.76 19.94 Favored 'General case' 0 C--O 1.238 0.454 0 CA-C-N 119.672 1.124 . . . . 0.0 113.655 175.544 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 88.0 mm-40 -66.66 172.24 4.41 Favored 'General case' 0 CA--C 1.542 0.635 0 CA-C-N 118.842 0.746 . . . . 0.0 111.783 177.0 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 31.7 mm-40 -54.85 -31.97 60.14 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 123.869 0.868 . . . . 0.0 112.272 -169.033 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 1.9 tt -129.0 126.32 64.37 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.543 0 N-CA-C 103.817 -2.66 . . . . 0.0 103.817 168.412 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 7.3 t80 -110.47 139.04 46.08 Favored 'General case' 0 N--CA 1.448 -0.549 0 N-CA-C 105.955 -1.869 . . . . 0.0 105.955 170.104 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 12.8 mm-40 -134.8 145.09 48.03 Favored 'General case' 0 C--O 1.237 0.435 0 N-CA-C 107.137 -1.431 . . . . 0.0 107.137 169.774 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -129.11 125.78 37.9 Favored 'General case' 0 C--O 1.239 0.515 0 C-N-CA 126.375 1.87 . . . . 0.0 106.235 178.117 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 34.6 m95 -135.43 179.31 6.41 Favored 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 124.585 1.154 . . . . 0.0 108.865 179.987 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 6.4 tp-100 -141.24 72.22 1.38 Allowed 'General case' 0 CA--C 1.535 0.376 0 N-CA-C 106.274 -1.75 . . . . 0.0 106.274 169.643 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -67.03 146.01 54.78 Favored 'General case' 0 N--CA 1.469 0.488 0 N-CA-C 108.448 -0.945 . . . . 0.0 108.448 178.506 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 34.4 mt-10 -78.66 169.68 17.85 Favored 'General case' 0 C--N 1.328 -0.369 0 C-N-CA 123.975 0.91 . . . . 0.0 109.318 170.891 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -141.35 138.59 17.76 Favored Pre-proline 0 CA--C 1.539 0.549 0 C-N-CA 124.331 1.052 . . . . 0.0 110.27 179.27 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_endo -85.47 0.58 8.57 Favored 'Trans proline' 0 CA--C 1.543 0.927 0 C-N-CA 123.248 2.632 . . . . 0.0 115.771 -174.063 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 7.1 t70 -53.66 124.0 13.86 Favored 'General case' 0 C--O 1.237 0.416 0 CA-C-N 121.077 1.762 . . . . 0.0 110.849 -179.063 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 72.33 4.71 61.02 Favored Glycine 0 CA--C 1.533 1.168 0 CA-C-O 118.961 -0.911 . . . . 0.0 113.749 178.188 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 7.1 mt-30 -103.0 167.25 9.96 Favored 'General case' 0 CA--C 1.539 0.557 0 CA-C-N 118.658 1.229 . . . . 0.0 110.014 178.594 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 16.4 m -71.91 167.38 20.18 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 124.09 0.956 . . . . 0.0 111.636 -178.928 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 73.8 mt -59.62 -26.51 65.54 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 124.379 1.072 . . . . 0.0 112.402 -176.454 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 5.9 pt-20 -56.25 -34.93 66.84 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-N 118.738 0.699 . . . . 0.0 111.11 174.184 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 14.0 t -77.93 -42.51 28.31 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.316 0 CA-C-O 118.664 -0.684 . . . . 0.0 109.913 -177.238 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 68.3 m-85 -56.84 -43.5 81.19 Favored 'General case' 0 N--CA 1.474 0.77 0 CA-C-N 119.639 1.109 . . . . 0.0 109.569 171.07 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 94.1 mtt180 -66.25 -42.33 88.7 Favored 'General case' 0 N--CA 1.472 0.655 0 O-C-N 121.305 -0.872 . . . . 0.0 110.804 179.485 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 4.1 m -65.75 -49.72 67.36 Favored 'General case' 0 N--CA 1.45 -0.427 0 C-N-CA 124.606 1.162 . . . . 0.0 110.312 179.394 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 77.2 t -70.43 -30.58 43.46 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.202 0 CA-C-O 117.807 -1.092 . . . . 0.0 110.587 -169.501 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 74.5 mtm-85 -59.09 -45.36 91.05 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 120.192 1.36 . . . . 0.0 109.799 170.508 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -62.16 -51.68 55.05 Favored Glycine 0 CA--C 1.528 0.88 0 CA-C-N 118.946 0.794 . . . . 0.0 112.1 178.093 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 15.7 mt-30 -58.94 -45.4 90.53 Favored 'General case' 0 N--CA 1.469 0.475 0 CA-C-N 117.936 0.868 . . . . 0.0 110.779 -178.852 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 55.3 t -67.04 -47.22 82.72 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.344 0 N-CA-C 109.202 -0.666 . . . . 0.0 109.202 -177.987 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 84.3 tttt -55.52 -45.67 77.11 Favored 'General case' 0 C--O 1.224 -0.262 0 N-CA-C 109.185 -0.672 . . . . 0.0 109.185 -176.635 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 10.1 tp10 -62.83 -44.2 96.79 Favored 'General case' 0 N--CA 1.45 -0.427 0 C-N-CA 123.145 0.578 . . . . 0.0 110.757 -176.268 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 48.6 mtt-85 -68.51 -42.97 77.81 Favored 'General case' 0 N--CA 1.468 0.443 0 O-C-N 121.32 -0.863 . . . . 0.0 111.025 178.987 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 95.4 t -64.17 -38.98 83.87 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.513 0 CA-C-O 119.138 -0.458 . . . . 0.0 109.884 178.305 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 27.8 mt-10 -61.72 -44.85 96.13 Favored 'General case' 0 C--O 1.227 -0.128 0 CA-C-N 119.993 1.27 . . . . 0.0 110.177 176.014 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 28.3 t-20 -63.02 -42.12 99.71 Favored 'General case' 0 CA--C 1.53 0.208 0 C-N-CA 122.915 0.486 . . . . 0.0 111.049 -177.801 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 28.7 tp -58.04 -49.63 76.21 Favored 'General case' 0 N--CA 1.451 -0.399 0 C-N-CA 125.203 1.401 . . . . 0.0 110.742 174.17 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 81.6 mt -66.41 -43.99 90.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 N-CA-C 108.146 -1.057 . . . . 0.0 108.146 -177.057 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -59.23 -32.92 70.41 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 123.198 0.599 . . . . 0.0 112.098 -179.486 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 18.6 ptpt -80.87 -37.79 29.25 Favored 'General case' 0 C--N 1.344 0.351 0 CA-C-O 117.929 -1.034 . . . . 0.0 112.32 177.344 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 13.1 pt -84.85 -34.38 9.05 Favored 'Isoleucine or valine' 0 C--O 1.236 0.356 0 CA-C-N 119.962 1.255 . . . . 0.0 114.045 -175.184 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 74.3 m . . . . . 0 C--O 1.252 1.195 0 C-N-CA 125.372 1.469 . . . . 0.0 109.462 -169.837 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.4 ptt? . . . . . 0 N--CA 1.496 1.854 0 N-CA-C 111.776 0.287 . . . . 0.0 111.776 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' LYS . . . . . 0.426 ' HB2' HG22 ' A' ' 30' ' ' ILE . 11.0 mtmm -59.91 128.4 36.71 Favored 'General case' 0 N--CA 1.475 0.8 0 N-CA-C 107.816 -1.179 . . . . 0.0 107.816 -178.872 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 66.0 mttt -103.14 136.12 43.52 Favored 'General case' 0 CA--C 1.513 -0.465 0 N-CA-C 107.745 -1.205 . . . . 0.0 107.745 171.528 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.44 HG21 HD12 ' A' ' 30' ' ' ILE . 3.7 t -113.73 152.73 15.38 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.622 0 C-N-CA 126.144 1.777 . . . . 0.0 107.111 -171.479 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 2.7 mtt -137.14 145.08 43.37 Favored 'General case' 0 C--N 1.323 -0.55 0 C-N-CA 126.433 1.893 . . . . 0.0 108.341 169.525 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 60.0 m-85 -128.6 89.01 2.82 Favored 'General case' 0 CA--C 1.528 0.109 0 N-CA-C 105.234 -2.136 . . . . 0.0 105.234 170.769 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 44.0 t -128.57 108.62 17.73 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.217 0 CA-C-O 121.409 0.623 . . . . 0.0 111.72 -168.741 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 33.9 t -101.64 164.57 11.68 Favored 'General case' 0 CA--C 1.543 0.682 0 N-CA-C 105.392 -2.077 . . . . 0.0 105.392 167.812 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 61.7 pttt -72.0 148.36 45.99 Favored 'General case' 0 CA--C 1.53 0.206 0 O-C-N 121.133 -0.979 . . . . 0.0 108.809 169.529 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 2.8 mpt_? 60.07 168.75 0.08 Allowed 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 125.63 1.572 . . . . 0.0 110.939 -170.443 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -138.4 -14.04 1.31 Allowed 'General case' 0 N--CA 1.468 0.433 0 N-CA-C 112.882 0.697 . . . . 0.0 112.882 -176.117 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 2.0 m -59.96 -30.71 69.28 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-N 118.681 0.673 . . . . 0.0 109.988 178.564 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 7.3 p -136.15 151.56 49.9 Favored 'General case' 0 N--CA 1.45 -0.455 0 C-N-CA 127.046 2.138 . . . . 0.0 105.652 168.738 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 2.0 mmm-85 58.77 176.12 0.07 Allowed 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 125.767 1.627 . . . . 0.0 110.026 -169.527 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 6.6 m 51.03 37.7 18.54 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 123.378 0.671 . . . . 0.0 111.557 -174.906 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 24.3 pt20 -143.21 155.09 44.45 Favored 'General case' 0 N--CA 1.444 -0.744 0 N-CA-C 106.476 -1.676 . . . . 0.0 106.476 174.401 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER 66.79 -39.58 0.35 Allowed 'General case' 0 C--N 1.326 -0.423 0 C-N-CA 127.091 2.156 . . . . 0.0 114.851 179.141 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -65.9 -48.14 72.45 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-N 120.834 1.652 . . . . 0.0 110.591 -176.315 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -64.37 -40.68 96.32 Favored 'General case' 0 C--N 1.324 -0.519 0 C-N-CA 123.651 0.78 . . . . 0.0 111.258 174.546 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -59.23 -45.44 95.37 Favored Glycine 0 CA--C 1.526 0.779 0 N-CA-C 111.622 -0.591 . . . . 0.0 111.622 176.476 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 1.5 m-85 -69.36 -33.44 73.08 Favored 'General case' 0 CA--C 1.51 -0.588 0 O-C-N 121.414 -1.051 . . . . 0.0 111.262 177.483 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -70.28 -37.83 74.94 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 119.098 0.863 . . . . 0.0 110.336 -178.105 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -53.06 -45.02 67.89 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 123.928 0.891 . . . . 0.0 109.146 169.55 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 14.7 m -70.48 -57.2 5.04 Favored 'General case' 0 N--CA 1.448 -0.562 0 C-N-CA 124.15 0.98 . . . . 0.0 111.279 -174.467 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 37.6 mt -74.65 -34.41 62.72 Favored 'General case' 0 C--N 1.332 -0.167 0 C-N-CA 125.108 1.363 . . . . 0.0 110.814 -171.71 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -92.05 1.21 73.64 Favored Glycine 0 CA--C 1.528 0.874 0 C-N-CA 125.162 1.363 . . . . 0.0 113.291 -175.898 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -49.27 127.81 15.58 Favored 'General case' 0 CA--C 1.534 0.335 0 CA-C-N 118.991 1.395 . . . . 0.0 110.565 -179.176 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 76.11 -9.8 17.67 Favored Glycine 0 CA--C 1.535 1.298 0 C-N-CA 124.412 1.006 . . . . 0.0 114.121 179.743 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 63.1 mttm -99.65 -47.51 5.06 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 119.177 1.489 . . . . 0.0 110.307 175.22 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.44 HD12 HG21 ' A' ' 4' ' ' VAL . 22.0 pt -144.0 155.38 15.63 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.26 0 C-N-CA 124.443 1.097 . . . . 0.0 110.819 -169.155 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -98.48 155.46 17.25 Favored 'General case' 0 C--O 1.224 -0.269 0 C-N-CA 125.344 1.458 . . . . 0.0 108.566 179.673 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 21.9 t -139.53 130.97 33.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 N-CA-C 106.969 -1.493 . . . . 0.0 106.969 -178.317 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 24.7 m -140.36 114.02 8.77 Favored 'General case' 0 N--CA 1.446 -0.664 0 N-CA-C 104.36 -2.459 . . . . 0.0 104.36 172.095 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 55.0 m -112.32 91.22 3.58 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 107.862 -1.162 . . . . 0.0 107.862 173.16 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 3.0 p -67.06 -59.12 3.73 Favored 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 126.478 1.911 . . . . 0.0 111.579 -174.372 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 107.15 164.49 22.08 Favored Glycine 0 CA--C 1.527 0.787 0 C-N-CA 124.463 1.03 . . . . 0.0 112.331 176.651 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 6.1 mt -131.86 138.85 48.61 Favored 'General case' 0 CA--C 1.508 -0.667 0 C-N-CA 127.362 2.265 . . . . 0.0 105.447 170.166 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 28.4 mt-10 53.72 20.46 2.24 Favored 'General case' 0 N--CA 1.48 1.029 0 CA-C-O 122.443 1.116 . . . . 0.0 111.735 179.178 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 3.7 p -78.13 165.41 24.0 Favored 'General case' 0 N--CA 1.435 -1.185 0 N-CA-C 116.481 2.03 . . . . 0.0 116.481 -166.854 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 37.3 p -147.07 -165.52 2.27 Favored 'General case' 0 N--CA 1.433 -1.278 0 C-N-CA 128.956 2.903 . . . . 0.0 106.289 -168.716 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -75.81 161.24 29.19 Favored 'General case' 0 N--CA 1.456 -0.153 0 CA-C-O 122.128 0.965 . . . . 0.0 109.182 169.343 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 2.3 m -66.87 173.28 0.63 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.709 0 CA-C-N 114.35 -1.295 . . . . 0.0 108.37 169.655 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 81.1 t60 -70.76 137.85 85.52 Favored Pre-proline 0 CA--C 1.544 0.73 0 O-C-N 121.187 -0.946 . . . . 0.0 110.4 -178.319 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 16.4 Cg_endo -56.44 -50.55 11.58 Favored 'Trans proline' 0 C--N 1.349 0.571 0 C-N-CA 123.077 2.518 . . . . 0.0 113.106 -177.433 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 23.5 m -69.35 -21.94 63.78 Favored 'General case' 0 CA--C 1.537 0.45 0 O-C-N 121.846 -0.534 . . . . 0.0 110.739 -177.296 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -61.18 -47.62 85.34 Favored 'General case' 0 CA--C 1.505 -0.774 0 N-CA-C 108.771 -0.825 . . . . 0.0 108.771 174.189 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 55.9 mt -58.7 -42.89 86.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 N-CA-C 108.345 -0.983 . . . . 0.0 108.345 -174.212 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -61.93 -47.43 84.92 Favored 'General case' 0 N--CA 1.453 -0.287 0 CA-C-N 118.395 0.543 . . . . 0.0 110.988 -179.898 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 27.4 mmt -66.5 -34.48 78.01 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-O 122.343 1.068 . . . . 0.0 110.7 179.853 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -78.36 -35.59 47.24 Favored 'General case' 0 N--CA 1.441 -0.875 0 N-CA-C 107.247 -1.39 . . . . 0.0 107.247 -172.924 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 33.9 mt-10 -70.42 -22.78 62.68 Favored 'General case' 0 N--CA 1.442 -0.851 0 C-N-CA 123.703 0.801 . . . . 0.0 110.229 171.757 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 14.7 mm-40 -69.23 -29.32 67.22 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-N 119.28 0.945 . . . . 0.0 110.62 171.448 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . 0.278 7.8 p -90.74 8.54 3.74 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.002 0 CA-C-N 118.768 0.713 . . . . 0.0 110.738 168.876 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 81.07 20.91 64.01 Favored Glycine 0 CA--C 1.532 1.114 0 C-N-CA 124.732 1.158 . . . . 0.0 114.055 173.463 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 16.7 mt -117.45 134.02 62.36 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.306 0 C-N-CA 124.49 1.116 . . . . 0.0 110.884 -172.251 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 3.3 t70 -89.4 139.11 30.84 Favored 'General case' 0 N--CA 1.464 0.258 0 N-CA-C 108.08 -1.082 . . . . 0.0 108.08 169.18 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 8.8 pt -129.92 -31.97 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.543 0 C-N-CA 124.587 1.155 . . . . 0.0 110.908 172.362 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -38.41 -42.52 0.74 Allowed 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 128.233 2.613 . . . . 0.0 113.698 169.388 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -70.58 1.63 20.41 Favored Glycine 0 CA--C 1.534 1.27 0 C-N-CA 124.518 1.056 . . . . 0.0 115.18 -174.121 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 16.6 mt-30 -60.46 -34.17 73.63 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 119.512 1.656 . . . . 0.0 114.457 -178.506 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -57.49 118.25 4.99 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-O 121.435 0.636 . . . . 0.0 110.765 -169.041 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 49.2 m -152.05 -167.63 2.83 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 127.857 2.463 . . . . 0.0 106.763 -169.537 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -59.52 153.21 51.57 Favored Pre-proline 0 CA--C 1.54 0.562 0 O-C-N 121.795 -0.566 . . . . 0.0 110.49 169.653 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -64.43 158.26 50.29 Favored 'Trans proline' 0 C--N 1.349 0.56 0 C-N-CA 123.13 2.553 . . . . 0.0 110.514 171.751 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 13.0 tt -59.72 -27.05 36.94 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.289 0 O-C-N 121.783 -0.573 . . . . 0.0 111.33 -178.762 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 15.7 mt-10 -65.98 -26.24 67.46 Favored 'General case' 0 C--O 1.234 0.24 0 C-N-CA 124.185 0.994 . . . . 0.0 110.409 -175.175 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 5.9 t-20 -66.48 -26.52 67.22 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 124.646 1.179 . . . . 0.0 111.769 177.13 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 96.3 m-85 -96.26 170.76 9.03 Favored 'General case' 0 C--O 1.235 0.32 0 C-N-CA 125.632 1.573 . . . . 0.0 110.927 -177.909 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 19.0 p-10 -116.79 137.43 52.2 Favored 'General case' 0 N--CA 1.436 -1.129 0 C-N-CA 125.075 1.35 . . . . 0.0 110.889 168.966 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -77.11 -22.18 53.09 Favored 'General case' 0 N--CA 1.433 -1.302 0 N-CA-C 109.82 -0.437 . . . . 0.0 109.82 -171.181 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -64.16 -21.92 66.74 Favored 'General case' 0 N--CA 1.443 -0.799 0 O-C-N 123.881 0.738 . . . . 0.0 111.79 -179.239 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 37.8 t70 -75.77 -27.72 58.14 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 122.973 0.509 . . . . 0.0 112.146 175.02 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 32.1 m-85 -85.93 170.11 12.63 Favored 'General case' 0 N--CA 1.451 -0.402 0 C-N-CA 126.271 1.828 . . . . 0.0 111.031 -179.319 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -119.01 -34.24 3.95 Favored 'General case' 0 N--CA 1.466 0.332 0 C-N-CA 123.117 0.567 . . . . 0.0 111.753 177.569 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -145.51 138.04 20.8 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.489 0 CA-C-O 121.324 0.583 . . . . 0.0 109.834 -170.216 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 95.5 t -144.87 126.09 8.51 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.515 0 N-CA-C 106.254 -1.758 . . . . 0.0 106.254 -173.782 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.518 HD12 ' HB2' ' A' ' 97' ' ' GLU . 4.5 mm -101.87 132.39 47.9 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.599 0 N-CA-C 105.803 -1.925 . . . . 0.0 105.803 173.609 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 55.8 m -93.04 -16.09 25.41 Favored 'General case' 0 CA--C 1.535 0.37 0 N-CA-C 113.288 0.848 . . . . 0.0 113.288 178.81 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 24.4 mt 57.06 -12.27 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.613 0 N-CA-C 118.218 2.673 . . . . 0.0 118.218 171.079 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 26.5 p -149.58 33.87 0.7 Allowed 'General case' 0 CA--C 1.537 0.454 0 CA-C-N 122.303 2.319 . . . . 0.0 112.816 -178.072 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 130.85 -165.49 22.9 Favored Glycine 0 CA--C 1.525 0.665 0 C-N-CA 125.498 1.523 . . . . 0.0 110.675 179.485 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 8.4 p -102.72 -53.39 2.87 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 124.762 1.225 . . . . 0.0 110.116 177.012 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -65.52 -53.93 29.13 Favored Glycine 0 C--N 1.341 0.84 0 N-CA-C 111.201 -0.76 . . . . 0.0 111.201 -175.394 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . 0.313 98.5 t 55.94 10.36 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.551 1.01 0 C-N-CA 126.749 2.02 . . . . 0.0 114.919 169.592 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 64.1 t30 53.38 44.57 29.86 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 124.839 1.256 . . . . 0.0 109.398 -169.592 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -126.31 142.63 43.39 Favored Pre-proline 0 CA--C 1.539 0.552 0 C-N-CA 127.242 2.217 . . . . 0.0 108.22 -169.317 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 30.1 Cg_exo -65.93 143.04 71.36 Favored 'Trans proline' 0 C--N 1.352 0.75 0 C-N-CA 121.396 1.397 . . . . 0.0 111.45 -178.749 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -65.4 -28.31 54.53 Favored 'Trans proline' 0 N--CA 1.462 -0.377 0 C-N-CA 122.054 1.836 . . . . 0.0 114.273 -169.191 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -58.09 -19.39 31.73 Favored 'General case' 0 CA--C 1.538 0.483 0 CA-C-N 119.436 1.016 . . . . 0.0 112.488 179.873 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 95.0 m95 -78.88 -40.62 31.88 Favored 'General case' 0 N--CA 1.446 -0.642 0 C-N-CA 123.52 0.728 . . . . 0.0 112.263 -177.15 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 2.9 m -71.25 -34.11 53.06 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.445 0 CA-C-O 118.722 -0.656 . . . . 0.0 110.117 174.29 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 76.6 p -81.99 23.69 0.68 Allowed 'General case' 0 C--O 1.236 0.356 0 CA-C-N 120.046 1.293 . . . . 0.0 113.893 -170.159 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 94.3 mm-40 -72.79 179.03 3.84 Favored 'General case' 0 N--CA 1.446 -0.634 0 O-C-N 121.703 -0.623 . . . . 0.0 110.319 172.343 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 30.7 mm-40 -62.3 -19.79 63.65 Favored 'General case' 0 CA--C 1.538 0.489 0 N-CA-C 112.829 0.677 . . . . 0.0 112.829 -169.398 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 2.1 tt -142.14 124.12 13.28 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.354 0 C-N-CA 126.338 1.855 . . . . 0.0 106.698 173.547 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 7.0 t80 -97.29 132.23 43.23 Favored 'General case' 0 CA--C 1.535 0.397 0 N-CA-C 105.158 -2.164 . . . . 0.0 105.158 169.022 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 97' ' ' GLU . . . . . 0.518 ' HB2' HD12 ' A' ' 77' ' ' ILE . 7.9 mm-40 -138.46 160.27 39.98 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-O 121.792 0.806 . . . . 0.0 109.434 172.034 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 8.9 t70 -179.92 134.98 0.11 Allowed 'General case' 0 C--N 1.325 -0.482 0 C-N-CA 127.085 2.154 . . . . 0.0 106.509 -169.57 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 99' ' ' TRP . . . . . 0.465 ' CZ3' HG21 ' A' ' 77' ' ' ILE . 5.0 m-90 -145.58 154.23 41.94 Favored 'General case' 0 C--O 1.234 0.238 0 N-CA-C 109.325 -0.62 . . . . 0.0 109.325 -172.043 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 15.2 pt20 -79.58 50.24 1.11 Allowed 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 124.216 1.006 . . . . 0.0 110.118 171.474 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 1.1 mt -65.43 121.92 15.99 Favored 'General case' 0 C--N 1.34 0.181 0 N-CA-C 107.672 -1.232 . . . . 0.0 107.672 178.141 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 -73.02 160.35 32.21 Favored 'General case' 0 CA--C 1.537 0.465 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 173.826 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -137.26 137.21 21.95 Favored Pre-proline 0 C--O 1.237 0.413 0 C-N-CA 124.296 1.039 . . . . 0.0 109.835 -169.698 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 22.7 Cg_endo -88.66 6.16 4.84 Favored 'Trans proline' 0 CA--C 1.544 0.994 0 C-N-CA 122.817 2.344 . . . . 0.0 113.736 -170.517 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 4.6 t70 -47.01 111.53 0.41 Allowed 'General case' 0 C--O 1.236 0.389 0 CA-C-N 120.356 1.434 . . . . 0.0 111.857 -179.973 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 67.65 7.91 49.84 Favored Glycine 0 CA--C 1.535 1.307 0 C-N-CA 124.348 0.975 . . . . 0.0 114.3 177.853 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 6.7 mt-30 -91.2 173.6 7.84 Favored 'General case' 0 CA--C 1.541 0.626 0 CA-C-N 118.777 1.289 . . . . 0.0 110.518 -178.649 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 15.6 m -74.16 166.55 23.23 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 124.432 1.093 . . . . 0.0 111.555 179.978 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -57.35 -31.78 66.08 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 125.06 1.344 . . . . 0.0 112.084 -176.85 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 6.2 pt-20 -56.82 -35.17 68.48 Favored 'General case' 0 N--CA 1.463 0.196 0 C-N-CA 123.195 0.598 . . . . 0.0 111.377 176.404 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 15.6 t -76.9 -41.42 32.11 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.31 0 CA-C-O 118.412 -0.804 . . . . 0.0 109.416 -176.883 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 84.1 m-85 -57.25 -48.91 77.64 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-N 119.89 1.223 . . . . 0.0 110.413 171.606 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 94.9 mtt180 -60.81 -41.77 96.32 Favored 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 123.322 0.649 . . . . 0.0 110.972 179.766 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 5.2 m -63.5 -47.62 80.96 Favored 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 124.629 1.171 . . . . 0.0 110.196 176.25 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 73.1 t -68.92 -35.11 67.68 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.335 0 CA-C-O 117.955 -1.022 . . . . 0.0 109.7 -172.402 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 27.2 mtm105 -57.68 -48.24 80.08 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 120.205 1.366 . . . . 0.0 110.094 174.128 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -63.36 -48.84 75.24 Favored Glycine 0 CA--C 1.53 0.999 0 CA-C-N 118.38 0.536 . . . . 0.0 111.852 179.003 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 14.3 mm-40 -55.79 -54.1 48.56 Favored 'General case' 0 N--CA 1.464 0.259 0 C-N-CA 123.677 0.791 . . . . 0.0 109.93 179.556 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 95.6 t -65.34 -43.46 94.92 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-O 118.168 -0.92 . . . . 0.0 109.821 -173.559 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 61.5 tttm -53.45 -44.5 68.91 Favored 'General case' 0 C--O 1.225 -0.191 0 N-CA-C 108.828 -0.804 . . . . 0.0 108.828 178.479 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -69.53 -45.4 68.92 Favored 'General case' 0 N--CA 1.448 -0.575 0 CA-C-O 119.12 -0.467 . . . . 0.0 111.627 -176.394 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 1.5 mmt-85 -59.41 -44.85 92.77 Favored 'General case' 0 N--CA 1.478 0.969 0 CA-C-N 119.26 0.936 . . . . 0.0 110.257 176.487 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 88.6 t -68.63 -40.76 82.23 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.445 0 N-CA-C 109.193 -0.669 . . . . 0.0 109.193 -176.555 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 23.6 mt-10 -60.61 -40.45 91.9 Favored 'General case' 0 C--O 1.226 -0.151 0 CA-C-N 119.645 1.111 . . . . 0.0 110.21 176.129 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 25.0 t-20 -65.69 -43.2 89.95 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 123.082 0.553 . . . . 0.0 111.442 -179.579 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 1.4 tm? -58.75 -47.76 83.53 Favored 'General case' 0 C--O 1.225 -0.191 0 C-N-CA 126.112 1.765 . . . . 0.0 110.689 174.509 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 85.5 mt -65.91 -48.37 82.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 N-CA-C 108.697 -0.853 . . . . 0.0 108.697 179.16 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -56.54 -33.86 66.5 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-N 118.488 0.586 . . . . 0.0 112.264 -177.31 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 17.6 ptpt -80.4 -36.06 34.37 Favored 'General case' 0 C--N 1.342 0.279 0 CA-C-O 117.952 -1.023 . . . . 0.0 112.552 178.543 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 14.0 pt -85.22 -34.56 8.88 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.376 0 CA-C-N 119.973 1.261 . . . . 0.0 114.08 -177.353 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 75.1 m . . . . . 0 C--O 1.254 1.322 0 C-N-CA 125.706 1.602 . . . . 0.0 109.398 -169.884 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.497 1.882 0 N-CA-C 110.37 -0.233 . . . . 0.0 110.37 . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 26.6 mttm -81.66 121.01 25.82 Favored 'General case' 0 N--CA 1.478 0.956 0 N-CA-C 106.776 -1.565 . . . . 0.0 106.776 173.501 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 37.0 ttmt -87.17 128.6 35.13 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 107.396 -1.335 . . . . 0.0 107.396 -179.366 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 1.7 t -117.17 150.8 19.12 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 C-N-CA 125.715 1.606 . . . . 0.0 109.61 -168.865 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 46.4 ttm -141.23 148.21 39.54 Favored 'General case' 0 C--N 1.329 -0.319 0 C-N-CA 125.474 1.51 . . . . 0.0 108.786 169.699 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 87.1 m-85 -136.29 128.7 30.25 Favored 'General case' 0 C--N 1.332 -0.175 0 N-CA-C 104.072 -2.566 . . . . 0.0 104.072 175.005 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 2.2 p -157.17 156.39 4.41 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.437 0 CA-C-N 119.147 0.885 . . . . 0.0 110.837 -168.947 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 48.0 t -140.63 177.58 7.93 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 126.966 2.106 . . . . 0.0 106.652 169.04 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 40.7 ttmt -49.86 -40.99 44.33 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 124.707 1.203 . . . . 0.0 111.742 -177.064 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 99.1 mtt180 -134.17 169.23 17.48 Favored 'General case' 0 N--CA 1.466 0.325 0 C-N-CA 125.478 1.511 . . . . 0.0 107.898 169.906 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 55.1 t-20 -70.8 -39.91 72.82 Favored 'General case' 0 N--CA 1.47 0.53 0 N-CA-C 109.702 -0.481 . . . . 0.0 109.702 173.405 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 3.6 m -51.85 139.15 22.56 Favored 'General case' 0 C--O 1.237 0.397 0 C-N-CA 124.849 1.26 . . . . 0.0 111.084 -178.339 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 4.6 m 60.99 17.13 7.63 Favored 'General case' 0 CA--C 1.542 0.648 0 N-CA-C 115.076 1.51 . . . . 0.0 115.076 171.852 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -156.13 -55.37 0.09 Allowed 'General case' 0 N--CA 1.471 0.605 0 CA-C-N 121.05 1.75 . . . . 0.0 114.886 169.842 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 3.3 m -77.92 15.6 0.85 Allowed 'General case' 0 N--CA 1.468 0.431 0 N-CA-C 115.654 1.724 . . . . 0.0 115.654 -168.254 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 6.0 pt20 -66.15 -43.26 87.54 Favored 'General case' 0 C--O 1.22 -0.453 0 CA-C-N 120.247 1.385 . . . . 0.0 113.302 -169.989 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 1.4 tpt -108.55 -19.83 13.31 Favored 'General case' 0 N--CA 1.47 0.526 0 N-CA-C 114.487 1.291 . . . . 0.0 114.487 -168.571 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -66.65 -50.29 63.41 Favored 'General case' 0 N--CA 1.475 0.792 0 CA-C-N 119.149 0.886 . . . . 0.0 111.846 -170.498 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -63.29 -32.42 73.83 Favored 'General case' 0 N--CA 1.467 0.38 0 N-CA-C 109.492 -0.559 . . . . 0.0 109.492 173.008 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -51.43 -65.7 2.98 Favored Glycine 0 C--N 1.345 1.03 0 C-N-CA 124.569 1.081 . . . . 0.0 111.347 174.471 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 13.6 m-85 -65.72 -29.38 69.9 Favored 'General case' 0 CA--C 1.506 -0.746 0 CA-C-N 118.588 1.194 . . . . 0.0 112.477 -176.882 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -67.45 -30.11 69.75 Favored 'General case' 0 N--CA 1.446 -0.638 0 CA-C-O 117.98 -1.01 . . . . 0.0 111.737 -177.624 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 2.1 ptmt -70.72 -27.89 64.31 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-N 120.248 1.385 . . . . 0.0 111.342 174.132 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 12.8 m -77.52 -57.16 3.97 Favored 'General case' 0 N--CA 1.448 -0.541 0 C-N-CA 125.538 1.535 . . . . 0.0 110.954 179.774 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 57.2 mt -72.84 -36.9 67.57 Favored 'General case' 0 N--CA 1.464 0.228 0 C-N-CA 124.019 0.927 . . . . 0.0 109.76 -175.703 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -81.21 0.74 87.08 Favored Glycine 0 CA--C 1.525 0.68 0 C-N-CA 124.812 1.196 . . . . 0.0 113.2 179.907 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -54.96 135.71 48.29 Favored 'General case' 0 C--O 1.236 0.372 0 CA-C-N 119.186 1.493 . . . . 0.0 109.395 179.172 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 72.49 5.81 64.44 Favored Glycine 0 CA--C 1.534 1.248 0 CA-C-O 118.332 -1.26 . . . . 0.0 114.597 178.393 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 9.2 ptpp? -137.81 -44.33 0.53 Allowed 'General case' 0 N--CA 1.475 0.777 0 CA-C-N 119.731 1.765 . . . . 0.0 112.937 -178.595 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 24.0 pt -138.49 152.81 25.44 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.794 0 CA-C-N 119.978 1.263 . . . . 0.0 110.138 -173.082 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -118.47 106.32 12.57 Favored 'General case' 0 C--O 1.227 -0.105 0 C-N-CA 124.62 1.168 . . . . 0.0 110.009 -169.738 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 4.6 t -79.62 134.4 27.74 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.399 0 N-CA-C 109.178 -0.675 . . . . 0.0 109.178 177.833 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 22.2 m -140.62 87.4 2.12 Favored 'General case' 0 N--CA 1.449 -0.5 0 N-CA-C 105.493 -2.04 . . . . 0.0 105.493 169.663 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 38.6 m -95.0 82.91 3.86 Favored 'General case' 0 N--CA 1.448 -0.557 0 CA-C-O 121.917 0.865 . . . . 0.0 111.223 -169.809 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -64.26 172.0 2.74 Favored 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 125.715 1.606 . . . . 0.0 110.3 169.874 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -157.75 -167.86 19.33 Favored Glycine 0 C--N 1.338 0.664 0 N-CA-C 108.575 -1.81 . . . . 0.0 108.575 -173.297 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 3.0 mt -136.96 131.27 32.75 Favored 'General case' 0 N--CA 1.44 -0.932 0 N-CA-C 104.468 -2.419 . . . . 0.0 104.468 -172.272 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 28.7 mt-10 65.47 -61.55 0.24 Allowed 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 126.754 2.022 . . . . 0.0 111.041 -169.714 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 75.4 m 65.31 158.63 0.1 Allowed 'General case' 0 N--CA 1.438 -1.026 0 C-N-CA 129.313 3.045 . . . . 0.0 115.917 171.133 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 49.7 p -161.9 170.94 18.53 Favored 'General case' 0 N--CA 1.431 -1.375 0 CA-C-N 111.039 -2.801 . . . . 0.0 106.932 -168.838 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 5.7 ttt180 -92.28 167.05 12.28 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.657 0.742 . . . . 0.0 109.31 175.721 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 18.8 m -73.07 171.88 1.13 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.622 0 CA-C-N 114.711 -1.131 . . . . 0.0 109.853 178.647 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 92.2 m-70 -82.99 150.28 61.2 Favored Pre-proline 0 CA--C 1.539 0.526 0 C-N-CA 123.416 0.687 . . . . 0.0 110.479 -176.889 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -62.7 -45.63 13.32 Favored 'Trans proline' 0 C--N 1.347 0.496 0 C-N-CA 122.982 2.455 . . . . 0.0 112.383 -172.675 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 6.1 m -68.49 -25.94 65.22 Favored 'General case' 0 CA--C 1.534 0.33 0 O-C-N 121.881 -0.512 . . . . 0.0 110.22 -179.146 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -58.51 -52.8 64.12 Favored 'General case' 0 CA--C 1.507 -0.691 0 N-CA-C 108.766 -0.827 . . . . 0.0 108.766 171.356 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 81.5 mt -59.27 -41.09 82.96 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.342 0 N-CA-C 108.471 -0.937 . . . . 0.0 108.471 -173.176 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -63.1 -49.75 73.21 Favored 'General case' 0 CA--C 1.534 0.363 0 CA-C-N 118.503 0.592 . . . . 0.0 111.331 179.718 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 29.4 mmt -65.89 -36.63 83.96 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-O 122.933 1.349 . . . . 0.0 111.106 -179.698 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -78.45 -30.44 47.46 Favored 'General case' 0 N--CA 1.439 -0.993 0 N-CA-C 106.803 -1.554 . . . . 0.0 106.803 -172.754 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 4.8 mm-40 -73.75 -20.51 60.48 Favored 'General case' 0 N--CA 1.445 -0.712 0 O-C-N 121.355 -0.841 . . . . 0.0 110.642 169.749 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 18.0 mm-40 -66.83 -30.67 70.91 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-N 119.713 1.142 . . . . 0.0 110.038 170.0 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 15.4 m -91.92 10.56 3.25 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.814 0 CA-C-N 118.703 0.683 . . . . 0.0 111.427 168.635 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 76.66 22.87 71.39 Favored Glycine 0 CA--C 1.531 1.059 0 C-N-CA 124.962 1.267 . . . . 0.0 113.554 172.24 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 8.1 mt -111.7 129.64 66.73 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.222 0 CA-C-N 118.485 1.142 . . . . 0.0 111.033 -173.659 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -86.31 126.09 34.08 Favored 'General case' 0 C--O 1.232 0.177 0 N-CA-C 107.371 -1.344 . . . . 0.0 107.371 168.822 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 6.5 pt -122.48 -22.22 3.17 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.645 0 C-N-CA 125.219 1.408 . . . . 0.0 109.894 169.659 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -36.86 -41.04 0.31 Allowed 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 129.367 3.067 . . . . 0.0 113.633 169.376 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -82.05 14.0 35.14 Favored Glycine 0 CA--C 1.532 1.119 0 C-N-CA 124.943 1.258 . . . . 0.0 114.801 -176.551 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -63.71 -30.18 71.31 Favored 'General case' 0 C--N 1.343 0.309 0 CA-C-N 119.667 1.733 . . . . 0.0 114.099 -170.533 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -61.91 122.88 16.55 Favored 'General case' 0 CA--C 1.535 0.379 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 -169.797 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 67.3 m -145.91 -175.28 4.68 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 125.92 1.688 . . . . 0.0 107.864 -169.261 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -57.3 155.22 19.0 Favored Pre-proline 0 CA--C 1.539 0.543 0 C-N-CA 124.162 0.985 . . . . 0.0 111.572 173.131 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -65.42 155.81 66.76 Favored 'Trans proline' 0 N--CA 1.456 -0.703 0 C-N-CA 122.529 2.152 . . . . 0.0 110.095 171.053 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 7.8 tt -58.97 -28.24 37.97 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.486 0 C-N-CA 124.02 0.928 . . . . 0.0 110.979 -178.713 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 14.5 mt-10 -68.08 -25.55 65.39 Favored 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 125.329 1.452 . . . . 0.0 110.399 -173.883 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 7.4 t-20 -62.04 -22.81 66.04 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 124.926 1.29 . . . . 0.0 111.969 177.149 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 88.7 m-85 -109.0 -176.71 3.11 Favored 'General case' 0 C--O 1.235 0.33 0 C-N-CA 125.697 1.599 . . . . 0.0 111.528 -172.109 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 55.2 t-20 -130.07 137.79 50.39 Favored 'General case' 0 N--CA 1.442 -0.866 0 N-CA-C 106.183 -1.784 . . . . 0.0 106.183 169.315 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -73.35 -24.5 60.35 Favored 'General case' 0 N--CA 1.432 -1.35 0 CA-C-N 118.539 0.609 . . . . 0.0 109.734 -178.826 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 35.8 t70 -63.94 -22.4 66.9 Favored 'General case' 0 N--CA 1.446 -0.636 0 O-C-N 123.627 0.579 . . . . 0.0 111.333 179.327 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -73.85 -29.77 62.3 Favored 'General case' 0 N--CA 1.452 -0.332 0 C-N-CA 123.762 0.825 . . . . 0.0 111.431 175.246 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 17.8 m-85 -79.33 159.53 27.14 Favored 'General case' 0 N--CA 1.446 -0.629 0 C-N-CA 124.518 1.127 . . . . 0.0 110.302 177.681 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 23.6 t70 -99.53 -38.61 8.7 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.241 171.218 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -139.26 137.6 41.21 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.359 0 C-N-CA 123.857 0.863 . . . . 0.0 109.634 -170.551 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 89.7 t -143.1 142.46 25.82 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.745 0 N-CA-C 106.435 -1.691 . . . . 0.0 106.435 -178.574 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.526 HD12 ' HB2' ' A' ' 97' ' ' GLU . 28.9 mm -137.09 132.7 47.06 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.568 0 N-CA-C 107.133 -1.432 . . . . 0.0 107.133 -171.32 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 57.8 m -95.92 166.36 11.82 Favored 'General case' 0 N--CA 1.445 -0.716 0 N-CA-C 108.146 -1.057 . . . . 0.0 108.146 168.691 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 53.6 mt -134.61 18.57 3.59 Favored 'General case' 0 CA--C 1.531 0.239 0 O-C-N 121.364 -0.835 . . . . 0.0 110.752 -178.638 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 25.1 p -168.86 -0.22 0.02 OUTLIER 'General case' 0 CA--C 1.543 0.674 0 N-CA-C 115.584 1.698 . . . . 0.0 115.584 -176.357 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 162.6 -175.12 39.04 Favored Glycine 0 CA--C 1.526 0.769 0 CA-C-N 120.89 1.677 . . . . 0.0 112.607 179.83 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 17.9 m -128.65 127.01 41.35 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 125.065 1.346 . . . . 0.0 107.888 -176.243 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 83' ' ' GLY . . . . . 0.409 ' H ' HG11 ' A' ' 91' ' ' VAL . . . 58.06 34.26 72.19 Favored Glycine 0 CA--C 1.533 1.2 0 N-CA-C 110.624 -0.99 . . . . 0.0 110.624 -170.414 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . 0.286 7.7 p -80.3 69.17 0.5 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.657 0 C-N-CA 125.332 1.453 . . . . 0.0 110.437 -169.263 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 56.2 t30 55.67 49.22 16.83 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 127.146 2.178 . . . . 0.0 109.103 -173.553 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -154.27 143.98 15.34 Favored Pre-proline 0 CA--C 1.541 0.611 0 C-N-CA 126.918 2.087 . . . . 0.0 106.596 -169.237 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_exo -69.56 145.86 59.64 Favored 'Trans proline' 0 C--N 1.352 0.737 0 CA-C-N 120.912 1.361 . . . . 0.0 113.059 -173.246 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -73.18 -22.52 19.04 Favored 'Trans proline' 0 N--CA 1.461 -0.391 0 C-N-CA 122.209 1.939 . . . . 0.0 113.795 -170.754 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -57.85 -23.48 53.02 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-N 120.072 1.305 . . . . 0.0 111.627 177.378 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 99.6 m95 -72.05 -43.48 64.87 Favored 'General case' 0 N--CA 1.449 -0.478 0 C-N-CA 123.493 0.717 . . . . 0.0 111.252 176.235 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.409 HG11 ' H ' ' A' ' 83' ' ' GLY . 4.9 m -78.1 -1.33 3.95 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.627 0 N-CA-C 112.582 0.586 . . . . 0.0 112.582 -179.094 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 63.3 p -115.9 22.33 13.11 Favored 'General case' 0 CA--C 1.538 0.514 0 N-CA-C 115.462 1.652 . . . . 0.0 115.462 -178.412 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 92.3 mm-40 -71.03 179.46 2.75 Favored 'General case' 0 CA--C 1.54 0.573 0 O-C-N 121.27 -0.894 . . . . 0.0 111.875 175.015 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 30.1 mm-40 -54.84 -28.47 49.99 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 124.146 0.978 . . . . 0.0 112.733 -169.085 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 6.8 tt -135.12 139.66 46.66 Favored 'Isoleucine or valine' 0 C--O 1.238 0.497 0 N-CA-C 104.569 -2.382 . . . . 0.0 104.569 168.477 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 47.6 t80 -126.57 140.43 52.44 Favored 'General case' 0 N--CA 1.447 -0.608 0 N-CA-C 106.383 -1.71 . . . . 0.0 106.383 169.567 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 97' ' ' GLU . . . . . 0.526 ' HB2' HD12 ' A' ' 77' ' ' ILE . 44.0 mm-40 -142.08 163.86 31.73 Favored 'General case' 0 C--O 1.235 0.336 0 N-CA-C 107.409 -1.33 . . . . 0.0 107.409 169.88 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -167.51 131.63 1.82 Allowed 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 125.443 1.497 . . . . 0.0 107.46 -173.65 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 4.3 m-90 -150.65 143.44 24.58 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 107.897 -1.149 . . . . 0.0 107.897 -169.598 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 24.8 tt0 -84.81 82.28 8.51 Favored 'General case' 0 CA--C 1.537 0.48 0 N-CA-C 107.689 -1.226 . . . . 0.0 107.689 173.44 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -69.34 140.98 54.34 Favored 'General case' 0 N--CA 1.464 0.234 0 N-CA-C 108.667 -0.864 . . . . 0.0 108.667 172.719 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -73.68 157.2 37.0 Favored 'General case' 0 CA--C 1.537 0.449 0 N-CA-C 107.036 -1.468 . . . . 0.0 107.036 168.683 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -129.45 130.68 23.31 Favored Pre-proline 0 C--O 1.236 0.386 0 C-N-CA 123.77 0.828 . . . . 0.0 109.095 176.886 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_endo -86.14 -8.39 7.73 Favored 'Trans proline' 0 CA--C 1.54 0.821 0 C-N-CA 123.17 2.58 . . . . 0.0 115.245 -169.992 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -50.03 -51.04 45.38 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-N 120.171 1.351 . . . . 0.0 113.723 -169.093 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -84.21 9.26 64.39 Favored Glycine 0 CA--C 1.531 1.038 0 CA-C-O 118.368 -1.24 . . . . 0.0 113.953 -172.725 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 25.9 pt20 -148.04 -164.19 1.95 Allowed 'General case' 0 CA--C 1.544 0.712 0 CA-C-N 119.385 1.592 . . . . 0.0 112.531 -169.585 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 1.5 m -69.01 159.09 33.48 Favored 'General case' 0 CA--C 1.535 0.372 0 N-CA-C 117.567 2.432 . . . . 0.0 117.567 -167.726 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 56.5 tp -54.44 -34.69 61.91 Favored 'General case' 0 N--CA 1.465 0.32 0 C-N-CA 126.94 2.096 . . . . 0.0 111.713 170.124 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -62.12 -32.34 72.91 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 122.819 0.448 . . . . 0.0 110.773 177.498 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 5.3 t -76.42 -37.74 31.29 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.362 0 CA-C-O 117.894 -1.051 . . . . 0.0 109.892 177.649 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 54.0 m-85 -57.01 -47.97 79.59 Favored 'General case' 0 N--CA 1.474 0.767 0 CA-C-N 120.728 1.604 . . . . 0.0 109.579 171.155 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 75.3 mtt180 -59.23 -43.96 92.33 Favored 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 123.333 0.653 . . . . 0.0 110.858 178.152 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 17.1 m -64.44 -48.89 73.62 Favored 'General case' 0 N--CA 1.446 -0.663 0 C-N-CA 124.192 0.997 . . . . 0.0 110.396 178.606 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 64.9 t -70.39 -29.9 40.84 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.301 0 CA-C-N 119.019 0.827 . . . . 0.0 109.945 -169.937 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 30.7 mtm105 -57.04 -47.91 79.8 Favored 'General case' 0 C--O 1.226 -0.181 0 CA-C-N 119.404 1.002 . . . . 0.0 109.583 169.859 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -62.06 -48.52 82.63 Favored Glycine 0 CA--C 1.529 0.961 0 CA-C-O 119.258 -0.745 . . . . 0.0 112.0 177.697 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 86.1 mt-30 -55.66 -52.93 62.17 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-O 122.017 0.913 . . . . 0.0 110.104 -178.83 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 98.1 t -67.5 -44.9 86.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 115.102 -0.954 . . . . 0.0 109.596 -175.32 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 62.6 tttm -55.04 -46.34 75.31 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 119.435 1.016 . . . . 0.0 109.197 -179.041 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -67.64 -43.44 80.35 Favored 'General case' 0 N--CA 1.449 -0.524 0 C-N-CA 122.873 0.469 . . . . 0.0 111.366 -176.271 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 44.9 mtt-85 -66.63 -42.23 87.08 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-N 118.867 0.758 . . . . 0.0 111.082 178.047 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 81.1 t -64.99 -41.48 92.23 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.532 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 177.736 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 21.2 mt-10 -59.69 -41.36 90.52 Favored 'General case' 0 C--N 1.34 0.162 0 CA-C-N 119.768 1.167 . . . . 0.0 110.641 176.971 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 29.1 t-20 -62.54 -45.01 94.92 Favored 'General case' 0 CA--C 1.534 0.336 0 CA-C-N 118.166 0.439 . . . . 0.0 111.139 -179.635 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 1.5 tm? -58.45 -49.49 77.12 Favored 'General case' 0 CA--C 1.53 0.192 0 C-N-CA 124.26 1.024 . . . . 0.0 110.277 177.091 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 94.8 mt -63.87 -43.02 97.69 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.276 0 C-N-CA 123.887 0.875 . . . . 0.0 108.86 -179.518 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -62.56 -28.14 69.67 Favored 'General case' 0 CA--C 1.534 0.355 0 CA-C-N 118.902 0.774 . . . . 0.0 112.074 179.956 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 89.7 mttt -69.57 -54.52 13.68 Favored 'General case' 0 C--N 1.341 0.235 0 CA-C-N 118.769 0.713 . . . . 0.0 110.358 172.646 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 19.3 pt -77.64 -38.19 25.34 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.362 0 N-CA-C 114.586 1.328 . . . . 0.0 114.586 -169.395 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 74.7 m . . . . . 0 C--O 1.252 1.209 0 C-N-CA 126.162 1.785 . . . . 0.0 109.629 -169.748 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 8.0 ptm . . . . . 0 N--CA 1.497 1.898 0 N-CA-C 110.468 -0.197 . . . . 0.0 110.468 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' LYS . . . . . 0.455 ' HB2' HG22 ' A' ' 30' ' ' ILE . 15.7 mttm -74.64 128.46 35.62 Favored 'General case' 0 N--CA 1.478 0.971 0 N-CA-C 107.83 -1.174 . . . . 0.0 107.83 -174.912 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 72.9 mttt -97.4 138.1 35.37 Favored 'General case' 0 CA--C 1.511 -0.522 0 CA-C-N 120.198 1.363 . . . . 0.0 108.26 172.432 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.461 HG21 HD12 ' A' ' 30' ' ' ILE . 12.1 t -119.31 152.22 21.72 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.678 0 C-N-CA 126.231 1.812 . . . . 0.0 106.66 -169.995 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 15.8 mtt -135.27 146.45 48.57 Favored 'General case' 0 C--N 1.322 -0.623 0 C-N-CA 124.897 1.279 . . . . 0.0 108.167 168.792 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 86.5 m-85 -133.74 125.47 28.63 Favored 'General case' 0 CA--C 1.516 -0.361 0 N-CA-C 103.921 -2.622 . . . . 0.0 103.921 171.332 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 1.3 p -150.03 142.61 17.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 118.975 0.807 . . . . 0.0 110.382 -169.014 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 20.9 t -125.1 -174.96 3.17 Favored 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 127.379 2.272 . . . . 0.0 106.552 169.597 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 39.0 ttpt -60.45 -42.16 95.59 Favored 'General case' 0 N--CA 1.472 0.65 0 O-C-N 120.822 -1.174 . . . . 0.0 111.508 -177.33 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 94.0 mtt180 -123.79 163.92 20.22 Favored 'General case' 0 N--CA 1.467 0.423 0 C-N-CA 123.764 0.826 . . . . 0.0 109.48 176.421 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -77.01 -27.75 54.75 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 122.41 0.284 . . . . 0.0 111.28 -179.511 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 1.3 m -69.16 -23.58 63.96 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 124.133 0.973 . . . . 0.0 113.385 -169.657 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 6.8 t -128.55 136.3 50.56 Favored 'General case' 0 C--N 1.339 0.143 0 N-CA-C 108.274 -1.01 . . . . 0.0 108.274 -174.612 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 9.1 mpt_? 61.72 -42.94 0.15 Allowed 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 128.533 2.733 . . . . 0.0 114.45 -176.549 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -75.08 41.13 0.16 Allowed 'General case' 0 CA--C 1.542 0.635 0 CA-C-N 120.268 1.394 . . . . 0.0 111.463 177.286 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 20.2 pt20 -135.11 154.16 51.76 Favored 'General case' 0 N--CA 1.441 -0.892 0 C-N-CA 127.455 2.302 . . . . 0.0 104.819 169.593 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER 66.41 -33.91 0.2 Allowed 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 126.216 1.806 . . . . 0.0 114.681 -178.648 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -64.62 -49.97 68.96 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 121.514 1.961 . . . . 0.0 109.865 179.671 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 4.5 pm0 -61.53 -37.8 85.06 Favored 'General case' 0 N--CA 1.453 -0.293 0 C-N-CA 124.42 1.088 . . . . 0.0 110.74 172.445 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -60.54 -55.31 30.67 Favored Glycine 0 C--N 1.337 0.627 0 N-CA-C 109.457 -1.457 . . . . 0.0 109.457 -176.926 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 6.3 m-85 -63.65 -33.23 75.16 Favored 'General case' 0 CA--C 1.509 -0.634 0 O-C-N 122.143 -0.622 . . . . 0.0 111.887 177.417 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -67.49 -38.2 83.99 Favored 'General case' 0 N--CA 1.445 -0.706 0 C-N-CA 119.839 -0.744 . . . . 0.0 110.926 -178.08 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.06 -37.58 87.96 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-N 118.701 0.682 . . . . 0.0 110.077 173.45 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 13.0 m -66.99 -55.39 14.66 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 123.675 0.79 . . . . 0.0 112.244 179.887 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 40.1 mt -76.28 -35.68 58.78 Favored 'General case' 0 C--N 1.327 -0.376 0 C-N-CA 124.636 1.175 . . . . 0.0 110.09 -171.158 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -94.39 12.17 69.27 Favored Glycine 0 CA--C 1.525 0.666 0 C-N-CA 125.233 1.397 . . . . 0.0 112.848 -178.778 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -51.01 122.2 7.17 Favored 'General case' 0 CA--C 1.533 0.29 0 CA-C-N 119.011 1.406 . . . . 0.0 110.623 -173.813 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 78.89 -16.26 8.81 Favored Glycine 0 CA--C 1.535 1.313 0 C-N-CA 124.791 1.186 . . . . 0.0 114.21 -179.519 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 59.7 mttt -89.68 -42.5 11.32 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-N 119.398 1.599 . . . . 0.0 110.806 179.152 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.461 HD12 HG21 ' A' ' 4' ' ' VAL . 12.4 pt -140.71 149.97 20.95 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.33 0 C-N-CA 123.543 0.737 . . . . 0.0 111.263 -169.031 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -95.51 157.89 15.69 Favored 'General case' 0 C--O 1.224 -0.243 0 C-N-CA 125.6 1.56 . . . . 0.0 108.039 172.584 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 20.0 t -139.74 135.19 38.89 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 N-CA-C 107.189 -1.412 . . . . 0.0 107.189 -175.413 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 14.0 m -142.76 106.87 4.72 Favored 'General case' 0 N--CA 1.446 -0.663 0 N-CA-C 107.401 -1.333 . . . . 0.0 107.401 177.896 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 58.9 m -90.15 99.63 12.61 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 107.986 -1.116 . . . . 0.0 107.986 169.501 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 11.1 p -68.56 -63.03 1.14 Allowed 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 124.296 1.038 . . . . 0.0 110.461 -178.587 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 94.05 136.09 7.99 Favored Glycine 0 N--CA 1.446 -0.646 0 N-CA-C 107.713 -2.155 . . . . 0.0 107.713 -172.373 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 10.2 mt -68.74 -31.05 69.82 Favored 'General case' 0 CA--C 1.533 0.315 0 N-CA-C 108.538 -0.912 . . . . 0.0 108.538 170.183 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 26.6 mt-10 -137.25 156.1 48.7 Favored 'General case' 0 N--CA 1.444 -0.727 0 C-N-CA 129.119 2.968 . . . . 0.0 104.855 168.752 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 78.5 p -142.46 155.05 45.04 Favored 'General case' 0 N--CA 1.446 -0.646 0 N-CA-C 115.465 1.654 . . . . 0.0 115.465 -174.407 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 51.1 m -163.17 179.25 7.59 Favored 'General case' 0 N--CA 1.447 -0.577 0 C-N-CA 131.257 3.823 . . . . 0.0 104.796 -169.337 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 16.4 ttt180 -81.56 179.16 7.95 Favored 'General case' 0 N--CA 1.469 0.487 0 N-CA-C 108.411 -0.959 . . . . 0.0 108.411 169.486 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 4.1 m -81.16 176.4 0.68 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.575 0 C-N-CA 124.864 1.266 . . . . 0.0 109.445 176.805 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 76.1 t60 -78.59 140.97 59.91 Favored Pre-proline 0 CA--C 1.545 0.772 0 CA-C-O 118.58 -0.724 . . . . 0.0 110.104 -178.403 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 20.4 Cg_endo -60.59 -50.3 7.06 Favored 'Trans proline' 0 C--N 1.348 0.525 0 C-N-CA 123.084 2.523 . . . . 0.0 113.592 -173.787 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 23.1 m -65.91 -21.52 66.45 Favored 'General case' 0 CA--C 1.533 0.324 0 CA-C-N 118.807 0.731 . . . . 0.0 110.813 -178.29 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -58.79 -45.03 90.79 Favored 'General case' 0 C--O 1.215 -0.733 0 O-C-N 121.386 -0.821 . . . . 0.0 109.453 174.576 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 62.6 mt -60.51 -43.72 94.95 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 N-CA-C 108.303 -0.999 . . . . 0.0 108.303 -173.598 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -64.9 -44.47 89.48 Favored 'General case' 0 CA--C 1.536 0.442 0 CA-C-O 121.282 0.563 . . . . 0.0 110.857 -179.632 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 33.6 mmt -66.33 -39.3 89.14 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-O 123.455 1.598 . . . . 0.0 110.779 -179.972 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -76.21 -29.8 57.75 Favored 'General case' 0 N--CA 1.44 -0.952 0 N-CA-C 106.296 -1.742 . . . . 0.0 106.296 -174.882 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 -70.27 -20.48 63.04 Favored 'General case' 0 N--CA 1.444 -0.765 0 C-N-CA 123.91 0.884 . . . . 0.0 110.438 169.525 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 59.0 mt-10 -64.55 -38.03 89.59 Favored 'General case' 0 C--N 1.345 0.375 0 CA-C-N 120.237 1.381 . . . . 0.0 108.787 169.405 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . 0.311 5.3 p -84.92 8.21 1.65 Allowed 'Isoleucine or valine' 0 CA--C 1.548 0.87 0 N-CA-C 112.272 0.471 . . . . 0.0 112.272 171.442 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 75.05 16.68 80.45 Favored Glycine 0 CA--C 1.533 1.19 0 C-N-CA 124.493 1.044 . . . . 0.0 113.523 175.494 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 43.9 mt -108.85 137.62 39.89 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.229 0 C-N-CA 124.487 1.115 . . . . 0.0 108.921 -177.016 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 21.1 t0 -102.22 145.34 29.56 Favored 'General case' 0 N--CA 1.462 0.153 0 CA-C-O 121.103 0.478 . . . . 0.0 110.208 169.69 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 11.2 pt -138.36 -15.11 0.53 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.633 0 C-N-CA 127.548 2.339 . . . . 0.0 111.325 178.223 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 13.0 t -39.39 -43.12 1.16 Allowed 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 125.883 1.673 . . . . 0.0 113.527 171.584 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -76.37 6.13 39.35 Favored Glycine 0 CA--C 1.532 1.111 0 CA-C-O 118.635 -1.092 . . . . 0.0 114.36 -175.01 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -68.57 130.18 42.09 Favored 'General case' 0 N--CA 1.448 -0.559 0 CA-C-N 119.736 1.768 . . . . 0.0 110.203 -178.43 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 5.2 t -168.18 161.3 12.31 Favored 'General case' 0 N--CA 1.44 -0.95 0 N-CA-C 106.067 -1.827 . . . . 0.0 106.067 167.047 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 15.0 m -173.87 161.38 3.76 Favored 'General case' 0 C--N 1.322 -0.598 0 C-N-CA 127.438 2.295 . . . . 0.0 106.746 -178.396 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -65.91 161.49 53.99 Favored Pre-proline 0 CA--C 1.542 0.652 0 CA-C-N 115.184 -0.917 . . . . 0.0 108.854 169.002 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -59.39 150.6 74.08 Favored 'Trans proline' 0 N--CA 1.457 -0.627 0 C-N-CA 121.545 1.497 . . . . 0.0 109.802 172.444 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 16.8 tt -57.3 -26.34 25.67 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.278 0 C-N-CA 123.433 0.693 . . . . 0.0 112.181 -174.681 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 11.6 mt-10 -65.42 -27.71 68.72 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 123.212 0.605 . . . . 0.0 110.453 -176.637 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 10.0 t-20 -65.23 -30.04 70.89 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 125.484 1.514 . . . . 0.0 111.71 178.662 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 78.0 m-85 -88.47 176.51 7.14 Favored 'General case' 0 C--O 1.236 0.374 0 C-N-CA 125.012 1.325 . . . . 0.0 111.543 -173.962 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 51.9 t-20 -126.56 129.06 47.84 Favored 'General case' 0 N--CA 1.447 -0.621 0 N-CA-C 107.278 -1.379 . . . . 0.0 107.278 169.136 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -73.11 -21.23 60.78 Favored 'General case' 0 N--CA 1.436 -1.139 0 N-CA-C 109.936 -0.394 . . . . 0.0 109.936 -177.208 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 36.0 t70 -65.06 -25.76 67.95 Favored 'General case' 0 N--CA 1.441 -0.897 0 O-C-N 123.617 0.573 . . . . 0.0 111.583 -179.446 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -74.76 -28.37 60.73 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 122.976 0.51 . . . . 0.0 111.477 176.022 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 18.1 m-85 -84.43 163.58 19.4 Favored 'General case' 0 N--CA 1.45 -0.443 0 C-N-CA 125.784 1.634 . . . . 0.0 110.585 -179.419 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 19.8 t70 -108.01 -36.91 6.21 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.624 178.591 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -142.7 139.4 28.33 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.31 0 CA-C-O 121.657 0.741 . . . . 0.0 110.316 -170.797 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 96.9 t -141.15 140.68 32.0 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.407 0 N-CA-C 106.631 -1.618 . . . . 0.0 106.631 -175.634 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 45.3 mm -132.7 121.41 44.77 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.429 0 N-CA-C 106.619 -1.623 . . . . 0.0 106.619 -173.913 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 67.4 m -91.31 115.13 27.78 Favored 'General case' 0 N--CA 1.449 -0.5 0 N-CA-C 106.657 -1.608 . . . . 0.0 106.657 169.359 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 69.7 mt -77.04 -13.75 59.91 Favored 'General case' 0 N--CA 1.466 0.343 0 C-N-CA 124.245 1.018 . . . . 0.0 111.693 -177.536 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 65.2 m -140.87 88.64 2.2 Favored 'General case' 0 N--CA 1.452 -0.328 0 C-N-CA 125.288 1.435 . . . . 0.0 108.478 -169.724 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 63.66 -155.57 44.36 Favored Glycine 0 CA--C 1.528 0.893 0 N-CA-C 110.562 -1.015 . . . . 0.0 110.562 -175.852 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 4.7 p -150.82 148.56 28.64 Favored 'General case' 0 C--O 1.236 0.363 0 C-N-CA 124.527 1.131 . . . . 0.0 109.166 179.64 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 62.48 28.92 72.02 Favored Glycine 0 CA--C 1.532 1.153 0 CA-C-O 119.696 -0.502 . . . . 0.0 112.189 -179.495 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 12.7 m -80.06 67.59 0.44 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.587 0 C-N-CA 124.661 1.185 . . . . 0.0 110.63 -170.007 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 1.3 t30 58.0 56.06 4.89 Favored 'General case' 0 N--CA 1.468 0.432 0 C-N-CA 126.298 1.839 . . . . 0.0 108.201 -173.714 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.407 ' HA ' ' HD3' ' A' ' 87' ' ' PRO . 0.4 OUTLIER -142.67 142.26 22.44 Favored Pre-proline 0 CA--C 1.541 0.613 0 C-N-CA 126.215 1.806 . . . . 0.0 108.425 -169.086 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 87' ' ' PRO . . . . . 0.407 ' HD3' ' HA ' ' A' ' 86' ' ' LEU . 35.2 Cg_exo -67.46 146.43 74.41 Favored 'Trans proline' 0 CA--C 1.54 0.779 0 C-N-CA 121.693 1.595 . . . . 0.0 113.518 -176.95 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 88' ' ' PRO . . . . . 0.432 ' O ' HG22 ' A' ' 92' ' ' THR . 69.8 Cg_endo -72.43 -18.46 26.13 Favored 'Trans proline' 0 N--CA 1.46 -0.451 0 C-N-CA 122.535 2.157 . . . . 0.0 113.751 -171.975 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -57.07 -24.78 56.36 Favored 'General case' 0 CA--C 1.538 0.491 0 CA-C-N 119.944 1.247 . . . . 0.0 111.19 173.98 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 95.1 m95 -81.8 -31.35 31.83 Favored 'General case' 0 N--CA 1.451 -0.389 0 C-N-CA 124.088 0.955 . . . . 0.0 112.251 178.546 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 2.7 m -80.83 -6.5 9.73 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.362 0 CA-C-N 118.748 0.704 . . . . 0.0 112.245 178.022 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 92' ' ' THR . . . . . 0.432 HG22 ' O ' ' A' ' 88' ' ' PRO . 5.4 t -137.04 77.08 1.62 Allowed 'General case' 0 CA--C 1.542 0.654 0 CA-C-O 122.768 1.271 . . . . 0.0 111.655 -175.329 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 91.0 mm-40 -114.33 -171.68 1.96 Allowed 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 125.064 1.346 . . . . 0.0 108.115 168.694 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 35.1 mm-40 -58.76 -28.03 65.52 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-N 118.9 0.773 . . . . 0.0 111.194 -172.348 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 5.3 tt -141.37 143.63 27.44 Favored 'Isoleucine or valine' 0 C--O 1.24 0.567 0 N-CA-C 104.737 -2.32 . . . . 0.0 104.737 168.346 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 63.9 t80 -133.8 145.65 49.96 Favored 'General case' 0 N--CA 1.447 -0.581 0 N-CA-C 105.905 -1.887 . . . . 0.0 105.905 169.286 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 24.1 mm-40 -136.26 145.48 45.63 Favored 'General case' 0 C--O 1.237 0.434 0 N-CA-C 107.903 -1.147 . . . . 0.0 107.903 171.685 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -115.9 135.79 53.65 Favored 'General case' 0 C--O 1.238 0.451 0 N-CA-C 107.146 -1.428 . . . . 0.0 107.146 169.703 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 30.2 m95 -138.68 178.77 6.9 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 124.462 1.105 . . . . 0.0 108.796 178.963 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 30.6 tt0 -138.5 77.39 1.62 Allowed 'General case' 0 CA--C 1.532 0.285 0 N-CA-C 106.013 -1.847 . . . . 0.0 106.013 169.467 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -68.26 144.09 55.01 Favored 'General case' 0 N--CA 1.466 0.37 0 N-CA-C 108.656 -0.868 . . . . 0.0 108.656 177.877 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -81.18 166.66 20.43 Favored 'General case' 0 N--CA 1.452 -0.363 0 N-CA-C 107.576 -1.268 . . . . 0.0 107.576 169.457 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -142.32 135.23 13.92 Favored Pre-proline 0 CA--C 1.535 0.385 0 O-C-N 121.803 -0.56 . . . . 0.0 111.193 179.076 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -84.21 2.47 8.15 Favored 'Trans proline' 0 CA--C 1.545 1.042 0 C-N-CA 123.416 2.744 . . . . 0.0 114.958 -172.3 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 2.9 t70 -45.29 122.77 3.63 Favored 'General case' 0 C--O 1.238 0.484 0 CA-C-N 120.121 1.328 . . . . 0.0 111.521 176.634 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 70.9 13.73 72.54 Favored Glycine 0 CA--C 1.533 1.171 0 CA-C-O 118.335 -1.258 . . . . 0.0 114.724 170.18 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 29.6 pt20 -130.14 -172.32 2.75 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-N 119.444 1.622 . . . . 0.0 111.165 175.889 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 3.3 m -68.83 156.85 37.66 Favored 'General case' 0 CA--C 1.535 0.374 0 N-CA-C 116.25 1.944 . . . . 0.0 116.25 -168.0 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -63.73 -27.42 69.19 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 125.017 1.327 . . . . 0.0 111.155 179.645 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 7.7 tp10 -60.17 -35.12 74.63 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-N 118.171 0.442 . . . . 0.0 110.164 173.346 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 3.4 t -74.08 -42.62 52.08 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.301 0 CA-C-O 118.234 -0.889 . . . . 0.0 109.154 179.018 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 61.1 m-85 -53.78 -50.28 66.41 Favored 'General case' 0 N--CA 1.472 0.645 0 CA-C-N 120.042 1.292 . . . . 0.0 109.644 171.599 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 95.5 mtt180 -67.5 -34.97 78.21 Favored 'General case' 0 N--CA 1.465 0.296 0 O-C-N 121.795 -0.566 . . . . 0.0 111.237 -175.46 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 6.6 m -62.77 -49.9 73.15 Favored 'General case' 0 N--CA 1.448 -0.56 0 C-N-CA 123.984 0.913 . . . . 0.0 109.547 171.292 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 96.7 t -70.06 -26.72 30.38 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.296 0 CA-C-O 117.485 -1.245 . . . . 0.0 109.897 -171.092 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 85.4 mtm-85 -57.29 -48.41 78.97 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-N 120.407 1.458 . . . . 0.0 109.58 169.58 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -63.18 -48.67 77.71 Favored Glycine 0 CA--C 1.53 1.012 0 CA-C-N 118.464 0.575 . . . . 0.0 111.877 178.912 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 17.8 mt-30 -61.51 -46.69 88.94 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-N 118.073 0.937 . . . . 0.0 110.895 -178.3 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 67.4 t -64.89 -46.21 92.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-O 118.504 -0.76 . . . . 0.0 109.27 -179.585 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 87.4 tttt -54.23 -48.22 71.32 Favored 'General case' 0 C--O 1.22 -0.457 0 CA-C-N 118.921 0.782 . . . . 0.0 109.018 -178.462 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 40.4 tt0 -64.12 -42.62 96.77 Favored 'General case' 0 N--CA 1.45 -0.471 0 O-C-N 123.252 0.345 . . . . 0.0 110.865 -173.385 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 52.9 mtt-85 -67.34 -43.31 81.86 Favored 'General case' 0 N--CA 1.468 0.445 0 O-C-N 121.656 -0.653 . . . . 0.0 111.02 177.987 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 77.2 t -65.55 -41.15 90.15 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.395 0 N-CA-C 109.734 -0.469 . . . . 0.0 109.734 179.378 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 26.3 mt-10 -59.02 -44.82 91.77 Favored 'General case' 0 N--CA 1.455 -0.221 0 CA-C-N 119.17 0.895 . . . . 0.0 109.971 177.271 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 29.2 t-20 -62.06 -43.31 99.1 Favored 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 122.575 0.35 . . . . 0.0 110.933 -178.323 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 1.8 tm? -59.36 -49.04 79.34 Favored 'General case' 0 N--CA 1.455 -0.201 0 C-N-CA 124.042 0.937 . . . . 0.0 110.529 176.726 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 96.4 mt -64.91 -42.81 95.81 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.258 0 C-N-CA 124.108 0.963 . . . . 0.0 108.933 -178.844 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -61.5 -30.22 70.48 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 123.347 0.659 . . . . 0.0 111.639 177.951 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 91.5 mttt -69.25 -55.75 9.62 Favored 'General case' 0 C--N 1.343 0.313 0 CA-C-N 118.933 0.788 . . . . 0.0 110.229 172.862 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 20.8 pt -74.52 -41.26 49.09 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.291 0 N-CA-C 114.017 1.117 . . . . 0.0 114.017 -169.523 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 72.5 m . . . . . 0 C--O 1.253 1.268 0 C-N-CA 126.226 1.81 . . . . 0.0 108.995 -169.558 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 9.9 ptm . . . . . 0 N--CA 1.498 1.939 0 N-CA-C 110.64 -0.133 . . . . 0.0 110.64 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 33.8 mttm -74.62 119.76 19.24 Favored 'General case' 0 N--CA 1.479 0.985 0 O-C-N 121.127 -0.983 . . . . 0.0 108.397 -170.711 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 90.2 mttt -85.33 135.15 34.02 Favored 'General case' 0 CA--C 1.515 -0.403 0 N-CA-C 108.07 -1.085 . . . . 0.0 108.07 174.894 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 1.6 t -121.81 147.13 25.98 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 C-N-CA 125.529 1.532 . . . . 0.0 109.37 -168.849 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 13.3 mtt -134.66 146.39 49.47 Favored 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 125.659 1.584 . . . . 0.0 109.544 169.399 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 41.2 m-85 -135.58 113.51 11.14 Favored 'General case' 0 N--CA 1.454 -0.274 0 N-CA-C 106.339 -1.726 . . . . 0.0 106.339 169.41 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 3.2 p -157.25 146.36 10.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 N-CA-C 109.029 -0.73 . . . . 0.0 109.029 -169.963 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 25.5 t -157.73 145.75 18.87 Favored 'General case' 0 C--N 1.328 -0.326 0 N-CA-C 105.593 -2.003 . . . . 0.0 105.593 168.839 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 5.6 tmtt? 51.81 -85.58 0.01 OUTLIER 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 126.078 1.751 . . . . 0.0 112.145 178.552 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 11.8 ptp180 -142.17 -178.82 5.9 Favored 'General case' 0 C--O 1.225 -0.198 0 CA-C-N 119.589 1.086 . . . . 0.0 111.09 178.706 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 1.7 t30 -57.49 -35.26 69.98 Favored 'General case' 0 N--CA 1.467 0.412 0 C-N-CA 124.416 1.086 . . . . 0.0 111.666 -179.21 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -70.95 -23.45 62.23 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 124.456 1.102 . . . . 0.0 113.05 -175.194 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 3.8 m -70.4 -159.61 0.04 OUTLIER 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 126.272 1.829 . . . . 0.0 111.994 -169.673 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 2.8 mpp_? -51.8 -25.52 7.87 Favored 'General case' 0 N--CA 1.481 1.112 0 O-C-N 119.808 -1.808 . . . . 0.0 112.34 175.638 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 1.4 m -41.89 -29.44 0.21 Allowed 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 126.74 2.016 . . . . 0.0 112.856 169.622 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 5.1 pt20 -54.47 -35.87 63.52 Favored 'General case' 0 C--O 1.22 -0.497 0 CA-C-O 117.491 -1.242 . . . . 0.0 113.218 178.328 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -105.66 -51.64 2.96 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-N 120.678 1.581 . . . . 0.0 114.727 -168.592 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -63.72 -34.8 78.68 Favored 'General case' 0 N--CA 1.471 0.61 0 N-CA-C 114.248 1.203 . . . . 0.0 114.248 -168.456 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 2.4 pp20? -64.95 -34.13 77.69 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-N 119.003 0.82 . . . . 0.0 110.103 172.783 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -51.29 -62.79 5.14 Favored Glycine 0 C--N 1.338 0.652 0 C-N-CA 125.847 1.689 . . . . 0.0 110.419 174.287 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 9.2 m-85 -63.13 -33.31 75.18 Favored 'General case' 0 CA--C 1.507 -0.7 0 CA-C-N 118.684 1.242 . . . . 0.0 113.434 179.985 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -67.42 -30.47 70.23 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 119.592 1.087 . . . . 0.0 111.376 -173.644 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 1.1 ptmt -70.32 -20.92 62.97 Favored 'General case' 0 CA--C 1.539 0.522 0 CA-C-N 119.288 0.949 . . . . 0.0 111.784 174.366 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 2.9 m -85.37 -57.39 3.09 Favored 'General case' 0 N--CA 1.45 -0.475 0 C-N-CA 125.537 1.535 . . . . 0.0 110.633 176.931 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 75.3 mt -73.98 -36.76 64.59 Favored 'General case' 0 N--CA 1.463 0.224 0 C-N-CA 123.989 0.915 . . . . 0.0 110.297 -172.617 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -93.36 8.9 74.95 Favored Glycine 0 CA--C 1.525 0.662 0 CA-C-O 118.486 -1.174 . . . . 0.0 112.813 -177.202 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -51.33 123.69 10.2 Favored 'General case' 0 CA--C 1.534 0.327 0 C-N-CA 124.806 1.242 . . . . 0.0 110.507 -174.962 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 76.48 -9.81 19.9 Favored Glycine 0 CA--C 1.533 1.17 0 CA-C-O 118.721 -1.044 . . . . 0.0 114.274 179.906 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 85.4 mttt -97.19 -49.66 4.88 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-N 119.478 1.639 . . . . 0.0 110.518 178.666 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 39.8 pt -137.57 147.64 26.29 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.537 0 C-N-CA 124.056 0.942 . . . . 0.0 108.772 -169.881 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -107.47 102.6 11.86 Favored 'General case' 0 C--O 1.225 -0.193 0 C-N-CA 124.949 1.3 . . . . 0.0 110.065 -169.582 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 6.2 t -85.69 125.19 40.55 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 N-CA-C 108.619 -0.882 . . . . 0.0 108.619 -179.531 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 23.4 m -151.85 97.71 2.38 Favored 'General case' 0 N--CA 1.453 -0.321 0 N-CA-C 103.957 -2.608 . . . . 0.0 103.957 173.105 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 18.0 m -94.99 1.12 55.16 Favored 'General case' 0 CA--C 1.535 0.386 0 N-CA-C 115.019 1.489 . . . . 0.0 115.019 -169.153 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 1.5 m 52.88 -147.52 0.47 Allowed 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 123.747 0.819 . . . . 0.0 110.767 -179.663 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -164.27 167.15 38.08 Favored Glycine 0 CA--C 1.525 0.69 0 N-CA-C 109.7 -1.36 . . . . 0.0 109.7 169.973 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 3.2 mt -133.64 143.72 48.77 Favored 'General case' 0 N--CA 1.446 -0.657 0 C-N-CA 127.67 2.388 . . . . 0.0 104.952 170.02 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 50.7 mt-10 65.46 -59.78 0.27 Allowed 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 127.227 2.211 . . . . 0.0 111.293 -173.755 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 65.1 m 67.11 152.78 0.08 Allowed 'General case' 0 N--CA 1.44 -0.935 0 C-N-CA 129.463 3.105 . . . . 0.0 115.894 170.043 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 15.2 m -177.62 -173.75 0.43 Allowed 'General case' 0 CA--C 1.545 0.764 1 C-N-CA 132.107 4.163 . . . . 0.0 102.607 -169.457 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 7.5 ttt180 -105.53 169.02 8.71 Favored 'General case' 0 N--CA 1.469 0.515 0 O-C-N 120.584 -1.323 . . . . 0.0 108.663 169.678 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 11.4 m -69.68 165.62 2.47 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.71 0 CA-C-N 115.649 -0.705 . . . . 0.0 109.415 175.827 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 90.3 m-70 -79.12 151.62 75.91 Favored Pre-proline 0 CA--C 1.537 0.446 0 CA-C-O 119.314 -0.374 . . . . 0.0 111.511 -174.89 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 39.9 Cg_endo -62.21 -46.12 13.57 Favored 'Trans proline' 0 C--N 1.346 0.43 0 C-N-CA 123.175 2.583 . . . . 0.0 111.772 -174.583 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 4.4 m -66.93 -28.24 68.13 Favored 'General case' 0 CA--C 1.531 0.25 0 O-C-N 121.949 -0.47 . . . . 0.0 110.02 -179.953 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -57.62 -54.56 45.52 Favored 'General case' 0 CA--C 1.511 -0.545 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 173.03 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 63.4 mt -59.55 -40.05 80.96 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.357 0 N-CA-C 108.607 -0.886 . . . . 0.0 108.607 -174.987 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -61.65 -43.49 98.75 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-N 119.004 0.82 . . . . 0.0 111.633 179.8 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 38.0 mmt -75.48 -36.52 60.62 Favored 'General case' 0 C--O 1.235 0.315 0 CA-C-O 122.806 1.289 . . . . 0.0 110.488 -177.285 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -71.58 -28.89 64.13 Favored 'General case' 0 N--CA 1.446 -0.643 0 N-CA-C 107.509 -1.293 . . . . 0.0 107.509 178.604 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 41.2 tt0 -73.78 -19.18 60.84 Favored 'General case' 0 N--CA 1.446 -0.63 0 C-N-CA 125.069 1.347 . . . . 0.0 110.563 169.958 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 76.1 mt-10 -64.09 -34.71 78.65 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-N 120.234 1.379 . . . . 0.0 108.681 169.146 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . 0.302 10.0 p -89.8 10.11 2.57 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.931 0 N-CA-C 112.434 0.531 . . . . 0.0 112.434 169.582 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 71.89 15.77 76.22 Favored Glycine 0 CA--C 1.533 1.162 0 O-C-N 120.761 -1.212 . . . . 0.0 113.767 175.926 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 22.3 mt -96.07 142.46 13.79 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.288 0 CA-C-N 118.42 1.11 . . . . 0.0 110.462 -175.473 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 8.9 t70 -91.78 129.66 37.7 Favored 'General case' 0 C--O 1.236 0.392 0 N-CA-C 108.192 -1.04 . . . . 0.0 108.192 169.574 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 10.1 pt -124.91 -27.21 1.52 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.657 0 C-N-CA 124.567 1.147 . . . . 0.0 110.166 169.7 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -37.12 -40.92 0.34 Allowed 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 129.746 3.218 . . . . 0.0 113.909 169.11 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -83.2 13.04 47.52 Favored Glycine 0 CA--C 1.534 1.251 0 C-N-CA 125.443 1.497 . . . . 0.0 114.566 -177.47 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 1.2 mt-30 -60.98 -34.84 75.41 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 119.607 1.703 . . . . 0.0 113.026 -176.026 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -70.3 131.89 44.86 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 123.539 0.736 . . . . 0.0 109.142 -170.677 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 26.0 m -158.29 -61.17 0.08 Allowed 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 123.463 0.705 . . . . 0.0 110.568 -179.526 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -150.98 153.31 32.93 Favored Pre-proline 0 N--CA 1.467 0.422 0 C-N-CA 123.424 0.69 . . . . 0.0 109.815 -175.007 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 96.4 Cg_endo -66.94 155.59 70.11 Favored 'Trans proline' 0 N--CA 1.454 -0.819 0 C-N-CA 122.53 2.153 . . . . 0.0 110.008 171.588 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 7.1 tt -59.94 -26.0 34.42 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.513 0 C-N-CA 123.326 0.65 . . . . 0.0 111.324 -179.242 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 14.8 mt-10 -67.71 -25.25 65.57 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 124.867 1.267 . . . . 0.0 110.636 -175.096 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 7.0 t-20 -63.89 -22.72 67.05 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 124.69 1.196 . . . . 0.0 112.047 177.648 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 70.0 m-85 -105.75 -174.1 2.46 Favored 'General case' 0 C--O 1.234 0.269 0 C-N-CA 126.424 1.889 . . . . 0.0 109.923 -175.89 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 54.3 t-20 -137.69 140.86 41.02 Favored 'General case' 0 N--CA 1.446 -0.654 0 N-CA-C 107.667 -1.235 . . . . 0.0 107.667 169.407 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -74.07 -25.13 59.65 Favored 'General case' 0 N--CA 1.435 -1.181 0 N-CA-C 109.19 -0.67 . . . . 0.0 109.19 -178.559 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -63.01 -24.35 67.88 Favored 'General case' 0 N--CA 1.447 -0.584 0 O-C-N 123.441 0.463 . . . . 0.0 111.643 178.937 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -77.71 -27.69 50.72 Favored 'General case' 0 C--O 1.236 0.361 0 C-N-CA 123.808 0.843 . . . . 0.0 112.37 175.991 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 11.6 m-85 -81.02 172.21 14.02 Favored 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 125.853 1.661 . . . . 0.0 112.099 -177.47 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 24.1 t70 -120.98 -37.72 2.93 Favored 'General case' 0 N--CA 1.464 0.234 0 C-N-CA 123.68 0.792 . . . . 0.0 111.678 175.824 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -139.38 136.76 41.05 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.328 0 CA-C-N 118.432 0.56 . . . . 0.0 110.498 -170.144 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 77.2 t -147.5 128.81 5.96 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.537 0 N-CA-C 106.516 -1.661 . . . . 0.0 106.516 -176.062 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.597 HD12 ' HB2' ' A' ' 97' ' ' GLU . 12.0 mm -109.17 128.09 65.36 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.473 0 N-CA-C 106.862 -1.533 . . . . 0.0 106.862 177.732 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 60.5 m -94.71 101.24 13.08 Favored 'General case' 0 N--CA 1.446 -0.671 0 N-CA-C 104.508 -2.404 . . . . 0.0 104.508 169.292 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 30.0 mt -66.73 -4.94 10.15 Favored 'General case' 0 N--CA 1.471 0.576 0 N-CA-C 113.931 1.085 . . . . 0.0 113.931 -169.775 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -151.04 151.82 32.58 Favored 'General case' 0 N--CA 1.45 -0.46 0 N-CA-C 106.335 -1.728 . . . . 0.0 106.335 168.744 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 54.75 -140.77 37.28 Favored Glycine 0 CA--C 1.533 1.166 0 C-N-CA 123.851 0.738 . . . . 0.0 111.701 174.647 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 16.0 m -132.71 -76.65 0.49 Allowed 'General case' 0 CA--C 1.529 0.163 0 N-CA-C 108.603 -0.888 . . . . 0.0 108.603 175.783 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -78.34 -40.45 19.55 Favored Glycine 0 C--N 1.34 0.793 0 CA-C-O 118.85 -0.972 . . . . 0.0 112.05 -179.156 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . 0.351 16.2 m 47.48 -94.27 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.547 0.838 0 C-N-CA 125.56 1.544 . . . . 0.0 112.629 -178.757 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 58.7 t30 -141.82 45.07 1.7 Allowed 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 124.653 1.181 . . . . 0.0 109.365 171.557 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 1.2 tt -136.25 140.58 33.24 Favored Pre-proline 0 CA--C 1.547 0.837 0 C-N-CA 126.591 1.956 . . . . 0.0 109.384 -169.517 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -67.96 149.98 77.79 Favored 'Trans proline' 0 CA--C 1.541 0.873 0 C-N-CA 121.649 1.566 . . . . 0.0 113.668 -172.173 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -69.37 -27.66 28.07 Favored 'Trans proline' 0 N--CA 1.461 -0.423 0 C-N-CA 122.622 2.214 . . . . 0.0 115.502 -169.587 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 4.3 pm0 -61.91 -17.05 55.34 Favored 'General case' 0 CA--C 1.539 0.557 0 CA-C-N 121.432 1.924 . . . . 0.0 111.954 178.684 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 99.6 m95 -78.01 -42.04 33.86 Favored 'General case' 0 N--CA 1.447 -0.583 0 C-N-CA 123.8 0.84 . . . . 0.0 110.933 175.424 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 1.6 m -74.49 -7.72 10.46 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.26 0 C-N-CA 123.469 0.708 . . . . 0.0 111.97 -179.317 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 74.4 p -109.15 18.47 20.53 Favored 'General case' 0 C--O 1.238 0.49 0 N-CA-C 113.837 1.051 . . . . 0.0 113.837 -178.132 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 91.9 mm-40 -68.56 171.03 8.11 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-N 118.539 0.609 . . . . 0.0 111.644 176.912 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 32.8 mm-40 -56.03 -30.23 61.57 Favored 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 123.995 0.918 . . . . 0.0 112.929 -168.83 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 4.0 tt -130.54 114.73 29.04 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.345 0 N-CA-C 105.018 -2.216 . . . . 0.0 105.018 169.014 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 22.5 t80 -100.65 134.41 43.66 Favored 'General case' 0 C--O 1.236 0.392 0 N-CA-C 105.63 -1.989 . . . . 0.0 105.63 169.388 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 97' ' ' GLU . . . . . 0.597 ' HB2' HD12 ' A' ' 77' ' ' ILE . 11.4 mm-40 -142.69 164.21 30.71 Favored 'General case' 0 C--N 1.329 -0.289 0 C-N-CA 124.451 1.1 . . . . 0.0 109.18 179.247 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 2.3 t70 -170.02 129.87 0.95 Allowed 'General case' 0 C--O 1.237 0.445 0 C-N-CA 128.192 2.597 . . . . 0.0 106.618 -169.954 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 99' ' ' TRP . . . . . 0.465 ' CZ3' HG21 ' A' ' 77' ' ' ILE . 10.0 m0 -140.8 147.91 39.79 Favored 'General case' 0 C--O 1.234 0.242 0 C-N-CA 123.33 0.652 . . . . 0.0 111.836 -169.814 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 18.4 mp0 -74.06 111.64 9.42 Favored 'General case' 0 C--O 1.234 0.285 0 N-CA-C 105.294 -2.114 . . . . 0.0 105.294 169.345 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.464 HD13 HG22 ' A' ' 119' ' ' VAL . 44.3 mt -146.03 128.34 15.83 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 104.323 -2.473 . . . . 0.0 104.323 178.604 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 61.4 mm-40 -76.99 156.07 32.16 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-N 119.197 0.908 . . . . 0.0 110.044 179.417 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 55.6 t0 -100.39 111.37 62.48 Favored Pre-proline 0 N--CA 1.448 -0.567 0 N-CA-C 105.612 -1.996 . . . . 0.0 105.612 168.882 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 96.3 Cg_endo -73.75 -0.08 8.92 Favored 'Trans proline' 0 CA--C 1.541 0.843 0 C-N-CA 122.913 2.408 . . . . 0.0 113.643 -175.834 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -47.61 128.96 13.37 Favored 'General case' 0 C--O 1.237 0.445 0 CA-C-N 119.468 1.031 . . . . 0.0 111.268 173.748 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 70.99 12.17 71.04 Favored Glycine 0 CA--C 1.53 1.017 0 CA-C-O 118.523 -1.154 . . . . 0.0 114.236 169.953 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 29.5 pt20 -133.15 -172.83 3.04 Favored 'General case' 0 CA--C 1.536 0.414 0 CA-C-N 119.029 1.415 . . . . 0.0 110.763 176.282 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 3.2 m -68.59 156.55 37.88 Favored 'General case' 0 CA--C 1.532 0.256 0 N-CA-C 116.161 1.912 . . . . 0.0 116.161 -167.964 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 48.7 mt -60.47 -28.49 68.38 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 125.05 1.34 . . . . 0.0 111.146 174.758 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 40.1 tt0 -58.19 -37.22 74.32 Favored 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 122.919 0.487 . . . . 0.0 110.34 173.168 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 3.5 t -75.12 -43.95 44.09 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.31 0 CA-C-O 117.866 -1.064 . . . . 0.0 109.34 179.195 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 59.9 m-85 -53.67 -47.45 70.38 Favored 'General case' 0 N--CA 1.474 0.759 0 CA-C-N 120.399 1.454 . . . . 0.0 110.404 172.873 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 92.5 mtt180 -72.88 -35.17 67.1 Favored 'General case' 0 N--CA 1.466 0.344 0 O-C-N 121.612 -0.68 . . . . 0.0 111.428 -175.785 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 4.0 m -60.77 -49.67 76.56 Favored 'General case' 0 N--CA 1.448 -0.551 0 N-CA-C 109.003 -0.74 . . . . 0.0 109.003 171.103 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 75.0 t -65.02 -38.4 82.68 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.415 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 -176.647 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 52.5 ttp85 -57.37 -44.88 84.79 Favored 'General case' 0 CA--C 1.539 0.528 0 CA-C-N 118.734 0.697 . . . . 0.0 110.234 176.244 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -65.65 -50.02 56.61 Favored Glycine 0 CA--C 1.532 1.146 0 CA-C-N 118.609 0.641 . . . . 0.0 112.143 174.915 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 40.8 mm-40 -58.69 -48.78 79.94 Favored 'General case' 0 N--CA 1.464 0.252 0 C-N-CA 123.776 0.83 . . . . 0.0 110.454 -176.215 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 119' ' ' VAL . . . . . 0.464 HG22 HD13 ' A' ' 101' ' ' LEU . 87.7 t -66.27 -40.31 86.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-O 118.234 -0.889 . . . . 0.0 110.236 -175.724 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 57.2 tttm -54.28 -45.12 72.39 Favored 'General case' 0 N--CA 1.462 0.139 0 CA-C-N 119.374 0.988 . . . . 0.0 109.075 177.669 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -67.71 -43.03 81.02 Favored 'General case' 0 CA--C 1.54 0.595 0 CA-C-O 119.154 -0.451 . . . . 0.0 111.658 -177.631 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 29.0 mmt180 -58.53 -47.4 84.3 Favored 'General case' 0 N--CA 1.477 0.886 0 CA-C-N 119.31 0.959 . . . . 0.0 110.845 175.373 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 77.0 t -69.43 -37.59 75.5 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.536 0 CA-C-O 118.673 -0.679 . . . . 0.0 109.25 -176.361 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 28.4 mt-10 -59.0 -44.42 91.65 Favored 'General case' 0 C--N 1.339 0.149 0 CA-C-N 120.089 1.313 . . . . 0.0 110.047 173.315 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 29.1 t-20 -62.41 -44.32 96.72 Favored 'General case' 0 CA--C 1.53 0.174 0 C-N-CA 122.661 0.384 . . . . 0.0 110.918 -179.431 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 39.1 tp -57.91 -48.44 79.89 Favored 'General case' 0 N--CA 1.454 -0.25 0 C-N-CA 124.166 0.986 . . . . 0.0 110.944 176.76 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 62.4 mt -65.47 -45.15 93.66 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.266 0 N-CA-C 107.705 -1.22 . . . . 0.0 107.705 -178.407 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -59.27 -29.08 67.31 Favored 'General case' 0 CA--C 1.54 0.592 0 CA-C-O 118.855 -0.593 . . . . 0.0 112.124 177.114 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 94.5 mttt -70.05 -57.29 5.15 Favored 'General case' 0 C--N 1.343 0.321 0 CA-C-N 119.09 0.859 . . . . 0.0 110.604 172.379 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 9.5 pt -80.79 -42.84 20.8 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.334 0 N-CA-C 115.659 1.726 . . . . 0.0 115.659 -168.497 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 51.0 m . . . . . 0 C--O 1.251 1.184 0 C-N-CA 124.979 1.312 . . . . 0.0 110.387 -169.861 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 11.8 ptm . . . . . 0 N--CA 1.497 1.919 0 N-CA-C 110.57 -0.159 . . . . 0.0 110.57 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' LYS . . . . . 0.416 ' HB2' HG22 ' A' ' 30' ' ' ILE . 25.3 mttm -75.55 120.84 21.52 Favored 'General case' 0 N--CA 1.479 1.018 0 N-CA-C 107.907 -1.145 . . . . 0.0 107.907 -171.806 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 89.8 mttt -89.38 134.85 33.9 Favored 'General case' 0 CA--C 1.515 -0.367 0 N-CA-C 108.069 -1.085 . . . . 0.0 108.069 177.548 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 1.5 t -119.69 149.59 22.3 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.619 0 C-N-CA 126.997 2.119 . . . . 0.0 108.789 -169.229 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 26.5 mtt -137.32 145.96 44.03 Favored 'General case' 0 C--N 1.325 -0.493 0 C-N-CA 124.849 1.26 . . . . 0.0 108.484 168.686 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 49.3 m-85 -138.12 132.48 32.05 Favored 'General case' 0 C--O 1.234 0.249 0 N-CA-C 105.661 -1.978 . . . . 0.0 105.661 171.132 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 2.1 p -163.13 143.86 2.62 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.189 0 CA-C-N 118.459 0.572 . . . . 0.0 111.035 -170.023 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 45.2 t -136.34 177.97 7.42 Favored 'General case' 0 CA--C 1.547 0.861 0 C-N-CA 127.758 2.423 . . . . 0.0 105.877 168.367 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 27.1 ttpp -59.58 -22.6 61.99 Favored 'General case' 0 N--CA 1.474 0.748 0 N-CA-C 113.874 1.064 . . . . 0.0 113.874 -169.804 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 84.9 mmt-85 -138.24 155.78 48.31 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-N 119.755 1.162 . . . . 0.0 107.871 169.886 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 46.6 t30 -71.09 -35.44 71.83 Favored 'General case' 0 CA--C 1.535 0.384 0 CA-C-O 121.279 0.561 . . . . 0.0 109.839 173.377 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 1.2 m -61.34 -25.26 67.02 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 125.012 1.325 . . . . 0.0 112.928 -174.993 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 14.2 m -138.37 125.28 21.17 Favored 'General case' 0 N--CA 1.455 -0.199 0 C-N-CA 123.46 0.704 . . . . 0.0 109.481 -172.73 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' ARG . . . . . 0.449 ' H ' ' CG ' ' A' ' 103' ' ' ASP 0.259 27.2 ttt180 59.57 31.05 20.72 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 126.878 2.071 . . . . 0.0 112.831 175.775 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 20.4 m -131.71 -122.18 0.2 Allowed 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 103.363 -2.829 . . . . 0.0 103.363 168.783 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . 0.352 17.7 pt20 54.79 -57.9 0.02 OUTLIER 'General case' 0 N--CA 1.452 -0.33 0 C-N-CA 129.507 3.123 . . . . 0.0 115.951 171.995 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 5.4 tpt -107.34 -16.79 14.3 Favored 'General case' 0 N--CA 1.45 -0.447 0 N-CA-C 116.588 2.07 . . . . 0.0 116.588 -169.659 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -65.63 -45.39 83.25 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 120.182 1.356 . . . . 0.0 109.027 174.189 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 2.8 pm0 -66.55 -37.25 84.57 Favored 'General case' 0 N--CA 1.45 -0.427 0 C-N-CA 124.818 1.247 . . . . 0.0 110.439 170.034 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -61.98 -45.35 96.31 Favored Glycine 0 C--N 1.339 0.746 0 C-N-CA 124.37 0.986 . . . . 0.0 111.997 -178.536 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 24.9 m-85 -73.82 -31.13 63.08 Favored 'General case' 0 CA--C 1.509 -0.597 0 CA-C-N 119.056 1.428 . . . . 0.0 113.717 170.981 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -65.49 -34.17 77.65 Favored 'General case' 0 C--O 1.225 -0.203 0 CA-C-N 120.531 1.514 . . . . 0.0 111.333 -172.493 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 17.1 ptpt -61.66 -27.72 68.88 Favored 'General case' 0 N--CA 1.475 0.795 0 CA-C-N 119.026 0.83 . . . . 0.0 112.392 170.945 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 2.1 m -84.27 -56.34 3.7 Favored 'General case' 0 N--CA 1.451 -0.382 0 C-N-CA 125.291 1.436 . . . . 0.0 109.817 -178.099 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 75.7 mt -72.72 -36.44 67.8 Favored 'General case' 0 CA--C 1.529 0.138 0 C-N-CA 124.068 0.947 . . . . 0.0 110.021 -173.232 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -96.7 9.26 66.32 Favored Glycine 0 CA--C 1.526 0.771 0 C-N-CA 125.159 1.361 . . . . 0.0 112.943 -175.737 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -48.83 122.88 6.16 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 124.989 1.316 . . . . 0.0 110.71 -175.41 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 77.33 -11.78 16.11 Favored Glycine 0 CA--C 1.533 1.203 0 C-N-CA 124.404 1.002 . . . . 0.0 114.589 178.953 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 63.7 mttm -96.68 -46.11 6.42 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-N 119.265 1.532 . . . . 0.0 110.571 179.908 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.416 HG22 ' HB2' ' A' ' 2' ' ' LYS . 29.6 pt -138.62 147.64 25.07 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.58 0 C-N-CA 123.547 0.739 . . . . 0.0 110.087 -169.577 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -107.77 107.82 18.76 Favored 'General case' 0 N--CA 1.467 0.389 0 C-N-CA 125.196 1.398 . . . . 0.0 109.679 -171.471 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 8.3 t -78.44 139.53 18.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 119.152 0.887 . . . . 0.0 109.117 176.385 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 4.2 m -139.79 115.78 10.32 Favored 'General case' 0 N--CA 1.436 -1.145 0 N-CA-C 105.176 -2.157 . . . . 0.0 105.176 169.899 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 4.5 m -90.34 45.3 1.25 Allowed 'General case' 0 C--N 1.32 -0.679 0 O-C-N 121.416 -0.803 . . . . 0.0 112.399 -170.831 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 2.6 m -67.15 165.35 16.16 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 124.484 1.114 . . . . 0.0 111.801 -178.577 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -177.1 -177.09 45.76 Favored Glycine 0 N--CA 1.444 -0.77 0 N-CA-C 106.081 -2.808 . . . . 0.0 106.081 -170.22 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 19.1 mt -104.76 -14.88 15.4 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 117.754 0.777 . . . . 0.0 111.152 179.047 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -144.12 155.26 43.87 Favored 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 128.227 2.611 . . . . 0.0 105.388 168.984 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 1.9 m -164.25 169.8 17.1 Favored 'General case' 0 N--CA 1.449 -0.485 0 CA-C-O 122.277 1.037 . . . . 0.0 110.994 175.379 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 62.7 p -153.14 -172.37 4.22 Favored 'General case' 0 N--CA 1.439 -1.023 0 C-N-CA 126.385 1.874 . . . . 0.0 107.304 -169.182 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 7.5 ttt180 -91.62 168.98 11.11 Favored 'General case' 0 C--N 1.331 -0.237 0 O-C-N 121.19 -0.943 . . . . 0.0 109.587 170.473 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 19.8 m -71.28 170.55 1.27 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.805 0 C-N-CA 123.543 0.737 . . . . 0.0 109.585 -178.824 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 74.1 t60 -71.44 138.71 83.8 Favored Pre-proline 0 CA--C 1.546 0.818 0 CA-C-O 118.391 -0.814 . . . . 0.0 109.274 172.989 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -59.29 -49.46 10.76 Favored 'Trans proline' 0 C--N 1.349 0.556 0 C-N-CA 123.231 2.621 . . . . 0.0 113.899 -173.654 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 22.6 m -66.13 -17.18 64.55 Favored 'General case' 0 CA--C 1.539 0.521 0 CA-C-N 118.842 0.746 . . . . 0.0 111.168 -178.471 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.472 ' HB1' HD11 ' A' ' 57' ' ' ILE . . . -60.62 -49.0 79.3 Favored 'General case' 0 C--O 1.215 -0.715 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 173.253 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 52.4 mt -58.49 -41.05 80.69 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 N-CA-C 108.288 -1.005 . . . . 0.0 108.288 -173.44 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -66.27 -50.76 62.6 Favored 'General case' 0 N--CA 1.45 -0.434 0 CA-C-N 118.229 0.468 . . . . 0.0 111.597 -179.99 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 31.9 mmt -69.15 -34.2 74.62 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-O 122.825 1.297 . . . . 0.0 111.087 -177.047 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 20.8 mmt -77.81 -28.66 50.42 Favored 'General case' 0 N--CA 1.441 -0.899 0 O-C-N 120.784 -1.197 . . . . 0.0 108.277 -177.355 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 -70.87 -23.32 62.28 Favored 'General case' 0 N--CA 1.449 -0.479 0 O-C-N 121.372 -0.83 . . . . 0.0 109.692 169.652 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 18.2 mm-40 -68.14 -30.66 69.85 Favored 'General case' 0 CA--C 1.531 0.242 0 CA-C-N 119.203 0.91 . . . . 0.0 110.443 170.984 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . 0.286 3.1 p -87.64 9.43 2.04 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.918 0 CA-C-N 118.807 0.73 . . . . 0.0 111.264 169.205 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 81.41 17.69 70.66 Favored Glycine 0 CA--C 1.531 1.057 0 C-N-CA 124.667 1.127 . . . . 0.0 113.75 172.449 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 39.5 mt -116.28 139.35 43.39 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.295 0 CA-C-N 119.107 1.453 . . . . 0.0 110.625 -176.618 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -100.73 136.16 41.04 Favored 'General case' 0 C--O 1.235 0.319 0 N-CA-C 109.236 -0.653 . . . . 0.0 109.236 169.141 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.472 HD11 ' HB1' ' A' ' 46' ' ' ALA . 15.8 pt -128.36 -13.43 3.01 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.499 0 C-N-CA 125.439 1.496 . . . . 0.0 112.414 176.172 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 93.2 p -44.38 -38.21 3.84 Favored 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 125.467 1.507 . . . . 0.0 114.552 176.143 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -87.12 2.86 87.05 Favored Glycine 0 CA--C 1.529 0.912 0 CA-C-O 118.81 -0.995 . . . . 0.0 114.091 -172.92 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 26.8 mt-30 -75.81 120.11 20.73 Favored 'General case' 0 CA--C 1.514 -0.44 0 CA-C-N 119.615 1.708 . . . . 0.0 111.28 -170.182 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 7.7 t -162.13 167.0 24.95 Favored 'General case' 0 N--CA 1.436 -1.132 0 N-CA-C 106.671 -1.603 . . . . 0.0 106.671 167.391 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 40.4 m -154.32 164.38 38.67 Favored 'General case' 0 N--CA 1.448 -0.558 0 C-N-CA 126.195 1.798 . . . . 0.0 107.236 -177.548 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -60.18 163.25 8.53 Favored Pre-proline 0 CA--C 1.54 0.586 0 C-N-CA 124.514 1.125 . . . . 0.0 110.704 169.973 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -61.36 151.19 81.12 Favored 'Trans proline' 0 N--CA 1.456 -0.692 0 C-N-CA 121.584 1.523 . . . . 0.0 109.478 172.565 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 5.6 tt -61.59 -24.23 33.22 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.536 0 O-C-N 121.648 -0.658 . . . . 0.0 111.254 -173.289 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 12.3 mt-10 -67.59 -25.52 65.81 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 125.352 1.461 . . . . 0.0 110.803 -177.064 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 12.2 t-20 -63.07 -26.12 68.69 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 125.006 1.322 . . . . 0.0 111.904 178.612 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 39.2 m-85 -105.07 -169.68 1.64 Allowed 'General case' 0 C--O 1.236 0.37 0 C-N-CA 126.464 1.906 . . . . 0.0 109.762 -176.357 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 55.3 t-20 -135.98 138.81 42.66 Favored 'General case' 0 N--CA 1.445 -0.688 0 N-CA-C 106.526 -1.657 . . . . 0.0 106.526 168.753 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.536 ' HB2' ' CD2' ' A' ' 90' ' ' TRP . . . -72.18 -27.16 62.39 Favored 'General case' 0 N--CA 1.431 -1.379 0 N-CA-C 108.576 -0.898 . . . . 0.0 108.576 -178.768 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 35.8 t70 -67.04 -20.93 65.92 Favored 'General case' 0 N--CA 1.443 -0.778 0 C-N-CA 120.728 -0.389 . . . . 0.0 111.388 -177.55 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 35.2 t70 -80.13 -29.74 38.93 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 124.278 1.031 . . . . 0.0 111.697 173.672 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 11.2 m-85 -77.51 168.59 19.74 Favored 'General case' 0 C--O 1.237 0.446 0 C-N-CA 125.176 1.39 . . . . 0.0 110.926 177.551 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -119.29 -38.56 3.01 Favored 'General case' 0 C--O 1.235 0.309 0 C-N-CA 123.098 0.559 . . . . 0.0 111.491 178.728 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -139.32 134.62 40.44 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.494 0 CA-C-O 121.565 0.698 . . . . 0.0 110.196 -169.921 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 57.0 t -142.5 139.66 28.86 Favored 'Isoleucine or valine' 0 C--O 1.236 0.369 0 N-CA-C 106.082 -1.822 . . . . 0.0 106.082 -179.85 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.533 HD12 ' HB2' ' A' ' 97' ' ' GLU . 23.8 mm -125.63 122.07 61.51 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.572 0 N-CA-C 105.859 -1.904 . . . . 0.0 105.859 -177.388 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 36.0 m -95.4 97.06 9.54 Favored 'General case' 0 N--CA 1.447 -0.586 0 N-CA-C 106.019 -1.845 . . . . 0.0 106.019 169.731 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 67.6 mt -63.04 -18.6 63.53 Favored 'General case' 0 N--CA 1.463 0.207 0 C-N-CA 122.756 0.422 . . . . 0.0 111.092 -178.629 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 14.3 p -152.78 166.55 31.87 Favored 'General case' 0 N--CA 1.448 -0.54 0 N-CA-C 106.7 -1.593 . . . . 0.0 106.7 168.847 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 73.36 -165.52 54.79 Favored Glycine 0 CA--C 1.533 1.194 0 CA-C-O 121.381 0.434 . . . . 0.0 113.053 172.764 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 34.9 p -151.88 -168.21 3.01 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 125.548 1.539 . . . . 0.0 109.318 -169.873 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -73.36 60.74 1.91 Allowed Glycine 0 CA--C 1.534 1.277 0 C-N-CA 124.449 1.023 . . . . 0.0 110.644 170.743 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 7.3 p -72.66 -55.11 14.09 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.398 0 C-N-CA 124.987 1.315 . . . . 0.0 110.823 -169.87 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 36.7 p-10 -135.99 24.93 3.32 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 127.12 2.168 . . . . 0.0 108.6 170.053 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 2.8 tt -116.15 135.52 22.82 Favored Pre-proline 0 CA--C 1.537 0.446 0 C-N-CA 127.076 2.15 . . . . 0.0 107.881 -169.491 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 87' ' ' PRO . . . . . 0.45 ' HA ' ' HD3' ' A' ' 88' ' ' PRO . 51.4 Cg_exo -63.55 141.96 82.33 Favored 'Trans proline' 0 CA--C 1.541 0.84 0 CA-C-N 120.518 1.221 . . . . 0.0 114.78 -169.313 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 88' ' ' PRO . . . . . 0.45 ' HD3' ' HA ' ' A' ' 87' ' ' PRO . 75.4 Cg_exo -60.33 -33.97 93.96 Favored 'Trans proline' 0 C--N 1.35 0.614 0 C-N-CA 122.1 1.867 . . . . 0.0 115.106 -171.425 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 4.0 pm0 -62.41 -13.62 31.6 Favored 'General case' 0 CA--C 1.536 0.435 0 CA-C-N 119.817 1.189 . . . . 0.0 112.349 -177.721 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 90' ' ' TRP . . . . . 0.536 ' CD2' ' HB2' ' A' ' 70' ' ' ALA . 99.1 m95 -80.51 -32.31 36.95 Favored 'General case' 0 CA--C 1.53 0.191 0 CA-C-N 118.61 0.641 . . . . 0.0 111.825 173.83 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 25.1 m -96.3 -3.52 10.27 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.472 0 C-N-CA 124.913 1.285 . . . . 0.0 112.822 -179.309 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . 0.263 6.5 t -130.99 65.54 1.55 Allowed 'General case' 0 CA--C 1.541 0.604 0 CA-C-O 123.465 1.602 . . . . 0.0 108.132 169.634 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 32.9 mm-40 -80.56 -175.85 5.43 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 125.668 1.587 . . . . 0.0 109.603 169.516 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 36.4 mm-40 -63.06 -28.25 69.96 Favored 'General case' 0 CA--C 1.54 0.563 0 O-C-N 121.869 -0.52 . . . . 0.0 110.118 175.121 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 3.8 tt -141.01 134.58 31.89 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.358 0 C-N-CA 126.69 1.996 . . . . 0.0 105.675 169.319 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 57.0 t80 -126.11 137.57 53.61 Favored 'General case' 0 N--CA 1.448 -0.543 0 N-CA-C 107.556 -1.276 . . . . 0.0 107.556 169.789 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 97' ' ' GLU . . . . . 0.533 ' HB2' HD12 ' A' ' 77' ' ' ILE . 8.5 mm-40 -138.11 167.03 22.67 Favored 'General case' 0 C--O 1.236 0.372 0 CA-C-O 122.248 1.023 . . . . 0.0 109.223 175.186 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -168.74 133.0 1.51 Allowed 'General case' 0 C--N 1.325 -0.488 0 C-N-CA 129.267 3.027 . . . . 0.0 105.606 -170.121 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 8.2 m0 -142.87 147.66 35.72 Favored 'General case' 0 C--O 1.232 0.18 0 C-N-CA 123.126 0.57 . . . . 0.0 110.136 -169.833 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 84.6 mt-30 -83.59 52.69 2.31 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 124.301 1.041 . . . . 0.0 108.914 172.362 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.454 HD13 HG22 ' A' ' 119' ' ' VAL . 16.3 mt -70.59 123.42 21.8 Favored 'General case' 0 C--N 1.339 0.113 0 N-CA-C 107.546 -1.279 . . . . 0.0 107.546 176.328 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 5.6 pt-20 -71.87 163.6 27.55 Favored 'General case' 0 CA--C 1.54 0.564 0 N-CA-C 109.139 -0.689 . . . . 0.0 109.139 169.759 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 103' ' ' ASP . . . . . 0.449 ' CG ' ' H ' ' A' ' 14' ' ' ARG . 13.7 t70 -138.66 139.61 24.92 Favored Pre-proline 0 CA--C 1.538 0.489 0 C-N-CA 124.132 0.973 . . . . 0.0 110.158 -173.198 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 39.5 Cg_endo -86.68 0.01 7.95 Favored 'Trans proline' 0 CA--C 1.543 0.96 0 C-N-CA 122.716 2.277 . . . . 0.0 114.651 -170.436 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -48.59 118.96 2.77 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-N 120.43 1.468 . . . . 0.0 111.221 -177.903 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 72.21 14.15 76.63 Favored Glycine 0 CA--C 1.534 1.249 0 CA-C-O 118.193 -1.337 . . . . 0.0 114.544 172.538 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 16.6 pt20 -128.23 172.26 11.19 Favored 'General case' 0 CA--C 1.541 0.605 0 CA-C-N 119.455 1.628 . . . . 0.0 111.827 176.448 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 9.9 m -65.78 165.18 13.25 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 125.851 1.66 . . . . 0.0 115.133 -168.644 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -60.68 -26.68 67.28 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 125.678 1.591 . . . . 0.0 112.614 -173.993 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 -56.07 -35.14 66.65 Favored 'General case' 0 N--CA 1.461 0.113 0 CA-C-N 118.687 0.676 . . . . 0.0 111.105 173.054 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 4.1 t -77.18 -40.98 30.41 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.558 0 CA-C-O 118.214 -0.898 . . . . 0.0 109.733 -178.036 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 83.6 m-85 -57.5 -46.44 83.75 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-N 120.29 1.404 . . . . 0.0 109.93 171.926 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 91.4 mtt180 -62.94 -41.35 99.46 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 123.274 0.629 . . . . 0.0 110.915 -179.906 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 8.7 m -63.13 -48.56 77.98 Favored 'General case' 0 N--CA 1.449 -0.522 0 C-N-CA 124.704 1.202 . . . . 0.0 110.178 175.525 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 75.4 t -68.72 -31.65 51.73 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.28 0 CA-C-O 118.481 -0.771 . . . . 0.0 109.703 -172.679 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 34.7 mtm105 -57.7 -50.16 74.11 Favored 'General case' 0 C--O 1.226 -0.15 0 CA-C-N 119.521 1.055 . . . . 0.0 110.497 171.399 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -60.74 -51.48 58.35 Favored Glycine 0 CA--C 1.529 0.955 0 N-CA-C 111.22 -0.752 . . . . 0.0 111.22 178.755 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 15.1 mm-40 -58.24 -52.15 66.76 Favored 'General case' 0 N--CA 1.464 0.235 0 C-N-CA 123.911 0.885 . . . . 0.0 110.658 -176.269 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 119' ' ' VAL . . . . . 0.454 HG22 HD13 ' A' ' 101' ' ' LEU . 69.4 t -74.47 -39.48 47.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-O 118.357 -0.83 . . . . 0.0 110.339 -171.91 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 59.8 tttm -54.79 -44.7 73.99 Favored 'General case' 0 CA--C 1.517 -0.29 0 CA-C-N 119.134 0.879 . . . . 0.0 108.871 175.798 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 45.1 tt0 -64.79 -42.99 94.64 Favored 'General case' 0 CA--C 1.542 0.642 0 CA-C-O 118.75 -0.643 . . . . 0.0 111.363 -177.862 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 63.2 mmt-85 -62.87 -47.63 82.51 Favored 'General case' 0 N--CA 1.478 0.972 0 CA-C-N 119.967 1.258 . . . . 0.0 110.822 176.161 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 60.2 t -69.09 -37.44 76.79 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.438 0 N-CA-C 108.774 -0.824 . . . . 0.0 108.774 -174.675 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 15.8 mt-10 -61.07 -45.22 95.63 Favored 'General case' 0 CA--C 1.52 -0.185 0 CA-C-N 119.269 0.941 . . . . 0.0 110.076 174.111 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 28.4 t-20 -64.22 -40.97 97.14 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 123.008 0.523 . . . . 0.0 111.218 -178.332 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 53.0 tp -58.86 -49.94 75.86 Favored 'General case' 0 C--O 1.226 -0.14 0 C-N-CA 125.285 1.434 . . . . 0.0 110.909 173.77 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 56.7 mt -64.59 -46.87 91.23 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 N-CA-C 107.997 -1.112 . . . . 0.0 107.997 -178.748 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -58.65 -32.45 69.09 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 123.424 0.69 . . . . 0.0 112.102 -178.151 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 18.6 ptpt -81.53 -36.56 29.01 Favored 'General case' 0 C--N 1.345 0.37 0 CA-C-O 117.824 -1.084 . . . . 0.0 112.596 177.105 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 10.4 pt -84.81 -41.27 15.76 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.322 0 CA-C-N 120.124 1.329 . . . . 0.0 113.741 -176.225 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 67.4 m . . . . . 0 C--O 1.254 1.302 0 C-N-CA 126.065 1.746 . . . . 0.0 109.873 -169.927 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 8.5 ptm . . . . . 0 N--CA 1.498 1.965 0 N-CA-C 110.523 -0.177 . . . . 0.0 110.523 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' LYS . . . . . 0.41 ' HB2' HG22 ' A' ' 30' ' ' ILE . 23.4 mttm -74.62 125.07 27.87 Favored 'General case' 0 N--CA 1.479 1.005 0 N-CA-C 107.103 -1.443 . . . . 0.0 107.103 -174.516 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 70.0 mttt -97.97 136.4 38.31 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-N 120.236 1.38 . . . . 0.0 108.027 173.771 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.428 HG21 HD12 ' A' ' 30' ' ' ILE . 11.6 t -116.31 152.47 18.03 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.551 0 C-N-CA 127.233 2.213 . . . . 0.0 108.199 -169.56 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 17.7 mtt -137.19 144.11 42.7 Favored 'General case' 0 C--N 1.324 -0.541 0 C-N-CA 124.926 1.29 . . . . 0.0 108.057 168.67 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 92.1 m-85 -125.26 113.89 18.22 Favored 'General case' 0 CA--C 1.516 -0.329 0 N-CA-C 102.839 -3.023 . . . . 0.0 102.839 170.05 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 1.2 p -141.0 137.21 34.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 121.289 0.566 . . . . 0.0 111.531 -168.051 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 44.0 t -165.82 152.93 10.08 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 128.639 2.775 . . . . 0.0 104.94 171.767 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 40.2 mtmt -75.47 163.3 27.55 Favored 'General case' 0 N--CA 1.47 0.569 0 O-C-N 121.655 -0.653 . . . . 0.0 111.421 -170.038 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 28.5 mmt85 53.41 70.39 0.6 Allowed 'General case' 0 N--CA 1.465 0.285 0 C-N-CA 126.801 2.041 . . . . 0.0 110.888 -176.28 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 2.4 t-20 -44.4 -20.07 0.03 OUTLIER 'General case' 0 N--CA 1.487 1.386 0 C-N-CA 127.839 2.455 . . . . 0.0 114.955 176.828 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 3.3 m -50.47 -27.82 7.23 Favored 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 124.269 1.028 . . . . 0.0 111.407 168.954 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 10.3 m -131.63 140.32 49.35 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 126.876 2.071 . . . . 0.0 107.889 172.078 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 5.5 mpt_? 59.16 165.2 0.05 OUTLIER 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 126.536 1.934 . . . . 0.0 112.631 -173.022 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 54.7 m 52.2 39.65 27.31 Favored 'General case' 0 CA--C 1.536 0.42 0 CA-C-N 115.207 -0.906 . . . . 0.0 110.334 -169.525 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 26.1 pt20 -135.48 33.07 3.03 Favored 'General case' 0 C--O 1.223 -0.294 0 O-C-N 120.543 -1.348 . . . . 0.0 109.636 174.414 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' MET . . . . . 0.405 ' HE2' ' HG3' ' A' ' 50' ' ' MET . 0.0 OUTLIER -163.88 -50.2 0.03 OUTLIER 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 124.149 0.979 . . . . 0.0 109.848 -177.762 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -67.73 -45.21 75.68 Favored 'General case' 0 C--N 1.343 0.285 0 N-CA-C 112.584 0.586 . . . . 0.0 112.584 -169.465 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' GLU . . . . . 0.518 ' H ' ' CD ' ' A' ' 19' ' ' GLU . 0.7 OUTLIER -66.86 -34.88 78.78 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 109.489 -0.56 . . . . 0.0 109.489 174.516 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -47.97 -66.71 1.87 Allowed Glycine 0 CA--C 1.527 0.791 0 N-CA-C 110.094 -1.202 . . . . 0.0 110.094 169.909 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 3.7 m-85 -59.62 -34.36 72.68 Favored 'General case' 0 CA--C 1.509 -0.602 0 O-C-N 121.547 -0.973 . . . . 0.0 113.444 178.091 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -66.63 -32.57 73.99 Favored 'General case' 0 N--CA 1.447 -0.61 0 C-N-CA 119.943 -0.703 . . . . 0.0 109.954 -174.032 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -65.9 -33.73 76.5 Favored 'General case' 0 CA--C 1.533 0.327 0 CA-C-N 118.395 0.543 . . . . 0.0 110.675 174.797 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 7.4 m -75.06 -55.69 5.49 Favored 'General case' 0 N--CA 1.448 -0.528 0 C-N-CA 125.453 1.501 . . . . 0.0 110.354 -176.752 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 40.1 mt -75.08 -38.63 61.2 Favored 'General case' 0 C--N 1.331 -0.22 0 C-N-CA 124.302 1.041 . . . . 0.0 109.467 -174.025 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -84.97 5.16 83.8 Favored Glycine 0 CA--C 1.526 0.78 0 C-N-CA 125.487 1.518 . . . . 0.0 113.629 -177.959 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -53.24 128.56 28.48 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-N 118.807 1.303 . . . . 0.0 109.802 -178.983 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 74.2 6.63 75.24 Favored Glycine 0 CA--C 1.536 1.35 0 C-N-CA 124.567 1.08 . . . . 0.0 114.313 -178.388 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 42.7 mttp -124.94 -50.42 1.7 Allowed 'General case' 0 N--CA 1.47 0.534 0 CA-C-N 118.927 1.364 . . . . 0.0 110.986 -175.0 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.428 HD12 HG21 ' A' ' 4' ' ' VAL . 19.3 pt -139.25 147.58 24.39 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.497 0 C-N-CA 123.642 0.777 . . . . 0.0 110.278 -169.244 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -96.01 159.48 14.95 Favored 'General case' 0 C--O 1.221 -0.417 0 C-N-CA 125.833 1.653 . . . . 0.0 108.109 175.578 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 12.2 t -142.44 135.68 27.43 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 N-CA-C 107.961 -1.125 . . . . 0.0 107.961 -173.416 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 4.1 m -148.38 103.04 3.39 Favored 'General case' 0 N--CA 1.446 -0.65 0 C-N-CA 124.665 1.186 . . . . 0.0 107.952 -177.218 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 60.2 m -89.6 71.43 7.87 Favored 'General case' 0 C--O 1.234 0.247 0 O-C-N 120.942 -1.099 . . . . 0.0 111.92 177.608 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 2.1 m -69.14 176.6 3.14 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 124.819 1.248 . . . . 0.0 110.696 170.763 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -167.07 -167.85 28.38 Favored Glycine 0 C--N 1.339 0.698 0 N-CA-C 108.082 -2.007 . . . . 0.0 108.082 179.691 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 18.2 mt -124.44 2.59 8.39 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 124.607 1.163 . . . . 0.0 111.691 -179.755 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 -145.36 -155.5 0.62 Allowed 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 129.185 2.994 . . . . 0.0 105.463 174.969 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 5.8 m 70.4 176.69 0.28 Allowed 'General case' 0 C--O 1.235 0.338 0 C-N-CA 125.38 1.472 . . . . 0.0 114.891 169.41 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 17.1 m -143.9 -72.87 0.28 Allowed 'General case' 0 N--CA 1.452 -0.354 0 CA-C-N 113.491 -1.686 . . . . 0.0 109.769 -169.236 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 6.0 ttt180 -152.3 172.1 16.96 Favored 'General case' 0 N--CA 1.467 0.415 0 C-N-CA 123.952 0.901 . . . . 0.0 111.15 -175.406 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 3.5 m -73.5 168.7 1.85 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.57 0 C-N-CA 124.534 1.134 . . . . 0.0 109.842 176.657 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -94.23 160.03 32.87 Favored Pre-proline 0 CA--C 1.544 0.718 0 N-CA-C 112.697 0.629 . . . . 0.0 112.697 -177.815 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -61.26 -53.55 2.37 Favored 'Trans proline' 0 C--N 1.352 0.742 0 C-N-CA 124.018 3.145 . . . . 0.0 113.777 -169.261 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 4.9 m -66.06 -26.6 67.58 Favored 'General case' 0 CA--C 1.532 0.278 0 O-C-N 121.893 -0.505 . . . . 0.0 110.358 -174.324 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -54.27 -53.19 56.97 Favored 'General case' 0 CA--C 1.509 -0.609 0 N-CA-C 108.75 -0.834 . . . . 0.0 108.75 174.745 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 58.9 mt -60.79 -41.08 87.2 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.468 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 -171.482 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -62.58 -40.97 98.59 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-N 118.431 0.56 . . . . 0.0 110.802 -179.009 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' MET . . . . . 0.426 ' HG3' ' CG ' ' A' ' 112' ' ' PHE . 38.4 mmt -74.06 -35.9 64.31 Favored 'General case' 0 C--O 1.235 0.321 0 CA-C-O 122.388 1.089 . . . . 0.0 110.338 -178.853 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 50' ' ' MET . . . . . 0.405 ' HG3' ' HE2' ' A' ' 17' ' ' MET . 0.2 OUTLIER -73.02 -31.33 64.39 Favored 'General case' 0 N--CA 1.442 -0.863 0 N-CA-C 106.806 -1.553 . . . . 0.0 106.806 -178.916 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 -70.52 -21.08 62.77 Favored 'General case' 0 N--CA 1.445 -0.719 0 C-N-CA 124.703 1.201 . . . . 0.0 111.061 170.273 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 77.7 mt-10 -63.84 -37.88 89.04 Favored 'General case' 0 C--N 1.344 0.361 0 CA-C-N 120.137 1.335 . . . . 0.0 109.107 169.457 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . 0.303 7.7 p -88.28 12.68 1.34 Allowed 'Isoleucine or valine' 0 CA--C 1.548 0.897 0 CA-C-O 121.082 0.468 . . . . 0.0 112.204 171.076 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 72.02 17.24 76.98 Favored Glycine 0 CA--C 1.533 1.212 0 O-C-N 120.723 -1.235 . . . . 0.0 113.869 174.791 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 5.7 mt -100.36 145.57 10.7 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.191 0 C-N-CA 125.154 1.382 . . . . 0.0 111.494 -174.221 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -96.77 137.13 36.32 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 125.297 1.439 . . . . 0.0 108.874 169.625 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 4.6 pt -134.0 -28.83 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.46 0 C-N-CA 125.441 1.496 . . . . 0.0 109.382 169.529 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -39.86 -37.67 0.58 Allowed 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 128.475 2.71 . . . . 0.0 113.509 169.563 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -66.72 -12.25 59.01 Favored Glycine 0 CA--C 1.537 1.423 0 C-N-CA 124.481 1.039 . . . . 0.0 114.379 179.213 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 28.7 mt-30 -70.73 156.43 39.51 Favored 'General case' 0 N--CA 1.45 -0.438 0 CA-C-N 118.965 1.382 . . . . 0.0 110.297 174.382 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 1.4 p -150.31 151.07 32.34 Favored 'General case' 0 N--CA 1.431 -1.421 0 N-CA-C 104.717 -2.327 . . . . 0.0 104.717 168.448 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 63.2 m -92.47 75.82 5.15 Favored 'General case' 0 N--CA 1.45 -0.44 0 N-CA-C 107.831 -1.174 . . . . 0.0 107.831 -174.117 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -62.96 153.13 81.67 Favored Pre-proline 0 C--O 1.241 0.642 0 N-CA-C 108.947 -0.761 . . . . 0.0 108.947 171.161 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 26.4 Cg_exo -57.55 134.36 62.78 Favored 'Trans proline' 0 N--CA 1.447 -1.209 0 N-CA-C 107.841 -1.638 . . . . 0.0 107.841 169.376 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 8.3 tt -61.22 -23.8 31.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 O-C-N 121.482 -0.762 . . . . 0.0 109.596 171.021 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 21.5 tt0 -69.61 -22.9 63.46 Favored 'General case' 0 N--CA 1.434 -1.273 0 C-N-CA 127.375 2.27 . . . . 0.0 110.789 -179.995 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 8.2 t-20 -60.32 -17.59 43.92 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 124.665 1.186 . . . . 0.0 111.68 174.313 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 4.4 m-85 -128.31 178.34 6.32 Favored 'General case' 0 C--O 1.235 0.34 0 C-N-CA 127.115 2.166 . . . . 0.0 108.54 -179.873 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 13.9 p-10 -128.32 143.61 51.04 Favored 'General case' 0 N--CA 1.438 -1.035 0 C-N-CA 124.716 1.206 . . . . 0.0 110.428 169.236 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.575 ' HB2' ' CD2' ' A' ' 90' ' ' TRP . . . -77.36 -25.27 50.85 Favored 'General case' 0 N--CA 1.432 -1.347 0 N-CA-C 109.143 -0.688 . . . . 0.0 109.143 -170.712 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 35.6 t70 -64.61 -19.79 65.89 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 120.41 -0.516 . . . . 0.0 111.214 -178.903 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -83.96 -31.04 25.77 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 124.427 1.091 . . . . 0.0 112.321 172.215 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 11.1 m-85 -72.85 170.31 14.98 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 124.89 1.276 . . . . 0.0 110.287 173.23 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -120.43 -35.85 3.33 Favored 'General case' 0 C--O 1.236 0.39 0 C-N-CA 123.047 0.539 . . . . 0.0 111.67 179.905 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -141.51 135.31 30.82 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.691 0 CA-C-O 121.839 0.828 . . . . 0.0 110.454 -169.705 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 76.3 t -143.0 138.38 27.16 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.278 0 N-CA-C 106.629 -1.619 . . . . 0.0 106.629 -177.496 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 41.6 mm -127.16 117.28 46.96 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.581 0 N-CA-C 106.12 -1.807 . . . . 0.0 106.12 -170.516 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 67.1 m -94.96 91.61 6.47 Favored 'General case' 0 N--CA 1.449 -0.519 0 N-CA-C 105.546 -2.02 . . . . 0.0 105.546 169.445 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . 0.251 0.3 OUTLIER -75.3 -6.55 50.44 Favored 'General case' 0 CA--C 1.536 0.442 0 CA-C-N 115.605 -0.725 . . . . 0.0 112.908 -175.267 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 6.4 p -166.14 167.38 16.34 Favored 'General case' 0 C--O 1.236 0.344 0 C-N-CA 127.398 2.279 . . . . 0.0 107.549 168.247 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 77.79 -81.3 1.27 Allowed Glycine 0 CA--C 1.526 0.746 0 N-CA-C 110.632 -0.987 . . . . 0.0 110.632 174.573 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 4.9 m 67.79 -53.2 0.51 Allowed 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 127.659 2.383 . . . . 0.0 113.738 178.429 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -81.47 57.79 4.89 Favored Glycine 0 CA--C 1.528 0.902 0 C-N-CA 124.774 1.178 . . . . 0.0 110.511 170.741 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 27.7 m -99.5 14.71 4.51 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.71 0 C-N-CA 124.082 0.953 . . . . 0.0 113.068 -169.881 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 47.4 t30 58.64 69.65 0.71 Allowed 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 126.1 1.76 . . . . 0.0 109.258 -175.865 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.405 ' HA ' ' HD3' ' A' ' 87' ' ' PRO . 0.3 OUTLIER -139.36 148.61 57.36 Favored Pre-proline 0 CA--C 1.546 0.81 0 C-N-CA 126.146 1.778 . . . . 0.0 109.276 -168.949 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 87' ' ' PRO . . . . . 0.405 ' HD3' ' HA ' ' A' ' 86' ' ' LEU . 51.7 Cg_exo -62.99 149.43 91.61 Favored 'Trans proline' 0 C--N 1.356 0.957 0 C-N-CA 121.47 1.447 . . . . 0.0 114.501 -169.643 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_endo -66.83 -34.9 29.17 Favored 'Trans proline' 0 N--CA 1.459 -0.522 0 C-N-CA 122.649 2.232 . . . . 0.0 114.583 -169.212 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 89' ' ' GLU . . . . . 0.446 ' HG3' ' HB3' ' A' ' 70' ' ' ALA . 11.8 pt-20 -64.16 -11.91 35.0 Favored 'General case' 0 CA--C 1.54 0.57 0 CA-C-N 119.85 1.205 . . . . 0.0 112.157 -176.62 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 90' ' ' TRP . . . . . 0.575 ' CD2' ' HB2' ' A' ' 70' ' ' ALA . 98.0 m95 -80.96 -35.53 32.07 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 123.481 0.712 . . . . 0.0 111.941 173.932 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 18.8 m -92.34 -4.59 10.78 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.551 0 C-N-CA 125.047 1.339 . . . . 0.0 112.697 -179.694 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 4.0 t -132.92 85.61 2.24 Favored 'General case' 0 CA--C 1.539 0.54 0 CA-C-O 123.24 1.495 . . . . 0.0 107.159 169.725 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 30.4 mm-40 -103.02 -174.11 2.47 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 127.806 2.442 . . . . 0.0 108.943 173.889 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 38.3 mm-40 -64.55 -28.62 69.77 Favored 'General case' 0 CA--C 1.539 0.544 0 O-C-N 121.82 -0.55 . . . . 0.0 110.036 172.653 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 4.0 tt -142.39 130.21 20.38 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.409 0 N-CA-C 105.692 -1.966 . . . . 0.0 105.692 169.338 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 70.3 t80 -122.87 142.37 50.85 Favored 'General case' 0 N--CA 1.448 -0.537 0 N-CA-C 105.868 -1.901 . . . . 0.0 105.868 169.062 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 10.5 mm-40 -132.77 138.9 47.31 Favored 'General case' 0 C--O 1.236 0.369 0 N-CA-C 107.809 -1.182 . . . . 0.0 107.809 174.025 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 8.0 t70 -108.36 118.91 37.99 Favored 'General case' 0 N--CA 1.45 -0.443 0 N-CA-C 106.455 -1.683 . . . . 0.0 106.455 169.855 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 10.5 m95 -115.68 170.44 8.44 Favored 'General case' 0 CA--C 1.533 0.318 0 N-CA-C 108.73 -0.841 . . . . 0.0 108.73 170.308 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 47.8 mt-30 -129.76 57.99 1.66 Allowed 'General case' 0 CA--C 1.534 0.362 0 N-CA-C 106.823 -1.547 . . . . 0.0 106.823 169.86 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.423 HD13 HG22 ' A' ' 119' ' ' VAL . 4.5 mt -67.76 139.48 56.66 Favored 'General case' 0 N--CA 1.463 0.217 0 N-CA-C 108.197 -1.038 . . . . 0.0 108.197 -179.694 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -74.65 170.61 15.46 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 125.056 1.343 . . . . 0.0 109.083 174.408 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -143.0 138.01 15.43 Favored Pre-proline 0 N--CA 1.452 -0.35 0 C-N-CA 123.199 0.599 . . . . 0.0 110.833 176.856 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 29.2 Cg_endo -86.35 -2.88 8.59 Favored 'Trans proline' 0 CA--C 1.54 0.807 0 C-N-CA 123.302 2.668 . . . . 0.0 115.318 -172.586 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -56.78 130.88 47.51 Favored 'General case' 0 C--O 1.237 0.432 0 CA-C-N 120.356 1.435 . . . . 0.0 110.571 -174.209 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 72.41 9.4 73.16 Favored Glycine 0 CA--C 1.534 1.233 0 CA-C-O 118.399 -1.223 . . . . 0.0 114.146 174.215 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 30.0 pt20 -126.44 -167.65 1.75 Allowed 'General case' 0 CA--C 1.537 0.453 0 CA-C-N 119.253 1.526 . . . . 0.0 110.799 172.326 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 1.9 m -66.93 154.74 40.3 Favored 'General case' 0 CA--C 1.532 0.268 0 N-CA-C 116.144 1.905 . . . . 0.0 116.144 -167.96 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 9.0 tp -57.61 -34.61 69.45 Favored 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 126.255 1.822 . . . . 0.0 111.201 177.487 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 -59.22 -34.66 72.45 Favored 'General case' 0 CA--C 1.531 0.213 0 C-N-CA 124.297 1.039 . . . . 0.0 110.721 175.839 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 3.5 t -73.18 -40.46 57.82 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.283 0 CA-C-O 118.207 -0.901 . . . . 0.0 109.456 -178.477 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 112' ' ' PHE . . . . . 0.426 ' CG ' ' HG3' ' A' ' 49' ' ' MET . 81.1 m-85 -56.56 -50.01 73.17 Favored 'General case' 0 N--CA 1.471 0.612 0 CA-C-N 120.248 1.385 . . . . 0.0 109.376 172.482 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 91.6 mtt180 -66.25 -33.19 75.18 Favored 'General case' 0 CA--C 1.535 0.378 0 CA-C-O 119.348 -0.358 . . . . 0.0 111.515 -177.009 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 6.2 m -67.37 -49.86 62.18 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 124.224 1.01 . . . . 0.0 109.971 173.107 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 80.1 t -69.8 -26.89 31.39 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.232 0 CA-C-O 117.675 -1.155 . . . . 0.0 109.399 -170.938 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 31.5 mtm105 -56.63 -47.5 79.57 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-N 120.31 1.414 . . . . 0.0 109.746 169.791 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -63.48 -49.12 72.24 Favored Glycine 0 CA--C 1.532 1.135 0 CA-C-N 118.949 0.795 . . . . 0.0 112.241 179.445 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 16.8 mt-30 -57.78 -46.37 84.69 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-N 117.565 0.682 . . . . 0.0 110.67 179.277 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 119' ' ' VAL . . . . . 0.423 HG22 HD13 ' A' ' 101' ' ' LEU . 65.8 t -70.42 -41.2 78.29 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.474 0 CA-C-O 118.585 -0.722 . . . . 0.0 110.405 -176.675 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 57.7 tttm -54.54 -46.48 73.61 Favored 'General case' 0 CA--C 1.517 -0.301 0 CA-C-N 119.381 0.991 . . . . 0.0 109.178 179.917 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -64.19 -42.79 96.51 Favored 'General case' 0 N--CA 1.448 -0.539 0 C-N-CA 123.002 0.521 . . . . 0.0 110.68 -176.758 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 37.8 mmt180 -63.16 -46.54 86.69 Favored 'General case' 0 N--CA 1.47 0.541 0 O-C-N 121.808 -0.557 . . . . 0.0 110.824 178.047 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 86.1 t -70.02 -39.03 76.86 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.436 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 -176.834 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 17.2 mt-10 -60.82 -43.8 97.75 Favored 'General case' 0 C--O 1.227 -0.105 0 CA-C-N 119.392 0.996 . . . . 0.0 110.316 175.509 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 28.8 t-20 -63.71 -43.68 95.88 Favored 'General case' 0 CA--C 1.53 0.206 0 C-N-CA 122.968 0.507 . . . . 0.0 111.115 -178.011 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 45.7 tp -58.09 -49.47 76.81 Favored 'General case' 0 N--CA 1.453 -0.322 0 C-N-CA 125.525 1.53 . . . . 0.0 111.151 174.374 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 73.1 mt -64.58 -46.03 93.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 N-CA-C 108.261 -1.014 . . . . 0.0 108.261 -178.895 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -59.74 -30.8 69.08 Favored 'General case' 0 CA--C 1.536 0.438 0 CA-C-O 118.734 -0.651 . . . . 0.0 112.157 -178.084 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 19.1 ptpt -82.45 -37.65 25.11 Favored 'General case' 0 C--N 1.344 0.35 0 CA-C-O 118.033 -0.984 . . . . 0.0 112.346 176.797 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 12.7 pt -81.69 -41.68 18.77 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.328 0 CA-C-N 120.072 1.305 . . . . 0.0 113.354 -176.737 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 74.5 m . . . . . 0 C--O 1.252 1.232 0 C-N-CA 125.882 1.673 . . . . 0.0 109.607 -169.848 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 11.6 ptm . . . . . 0 N--CA 1.497 1.897 0 N-CA-C 110.744 -0.095 . . . . 0.0 110.744 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' LYS . . . . . 0.402 ' HB2' HG22 ' A' ' 30' ' ' ILE . 26.1 mttm -76.08 118.71 19.12 Favored 'General case' 0 N--CA 1.48 1.064 0 O-C-N 120.875 -1.141 . . . . 0.0 108.196 -170.262 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 90.9 mttt -86.08 136.03 33.39 Favored 'General case' 0 CA--C 1.513 -0.454 0 N-CA-C 107.935 -1.135 . . . . 0.0 107.935 177.223 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 1.8 t -122.45 150.82 26.16 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 C-N-CA 125.752 1.621 . . . . 0.0 109.45 -168.936 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 13.6 mtt -139.35 147.52 41.65 Favored 'General case' 0 C--N 1.327 -0.376 0 C-N-CA 125.677 1.591 . . . . 0.0 108.462 168.963 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 70.2 m-85 -134.51 121.98 21.78 Favored 'General case' 0 N--CA 1.456 -0.161 0 N-CA-C 105.246 -2.131 . . . . 0.0 105.246 170.502 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 1.5 p -152.35 146.28 15.33 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.244 0 CA-C-N 118.954 0.797 . . . . 0.0 111.422 -168.932 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 43.7 t -132.99 -175.73 3.88 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 126.709 2.004 . . . . 0.0 106.226 169.225 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 20.2 ptpt -58.53 -25.44 62.45 Favored 'General case' 0 N--CA 1.471 0.601 0 N-CA-C 114.104 1.15 . . . . 0.0 114.104 -171.308 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 48.3 ttt85 -140.39 159.29 42.52 Favored 'General case' 0 N--CA 1.467 0.417 0 C-N-CA 124.264 1.026 . . . . 0.0 109.054 176.428 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 6.4 t30 -72.06 -34.86 69.06 Favored 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 123.779 0.832 . . . . 0.0 112.963 -176.556 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -64.75 -55.95 16.68 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 123.197 0.599 . . . . 0.0 111.215 -169.116 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 11.1 m -88.73 146.48 25.01 Favored 'General case' 0 N--CA 1.455 -0.196 0 C-N-CA 123.549 0.74 . . . . 0.0 109.624 -176.652 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 6.4 mmm180 68.33 -57.49 0.48 Allowed 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 127.424 2.29 . . . . 0.0 111.488 176.993 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 2.5 m -69.62 -9.95 56.25 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 124.702 1.201 . . . . 0.0 113.97 -172.146 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 29.3 pt20 -64.9 -42.67 94.56 Favored 'General case' 0 C--O 1.223 -0.332 0 CA-C-O 117.732 -1.127 . . . . 0.0 113.587 -175.292 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 2.2 tpt -94.72 -36.26 11.8 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-N 120.046 1.294 . . . . 0.0 114.102 -169.199 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -62.78 -42.97 99.94 Favored 'General case' 0 N--CA 1.474 0.737 0 N-CA-C 113.526 0.936 . . . . 0.0 113.526 -168.929 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -64.46 -33.49 76.0 Favored 'General case' 0 N--CA 1.472 0.645 0 CA-C-N 118.674 0.67 . . . . 0.0 109.366 175.6 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -51.94 -57.57 12.5 Favored Glycine 0 C--N 1.342 0.888 0 C-N-CA 125.422 1.487 . . . . 0.0 110.439 175.647 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 13.5 m-85 -70.8 -31.89 68.79 Favored 'General case' 0 CA--C 1.505 -0.757 0 O-C-N 121.647 -0.914 . . . . 0.0 112.724 -179.172 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -68.94 -34.41 75.31 Favored 'General case' 0 N--CA 1.449 -0.521 0 C-N-CA 119.305 -0.958 . . . . 0.0 111.155 -174.761 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 2.4 ptmt -65.39 -25.88 67.75 Favored 'General case' 0 N--CA 1.471 0.621 0 CA-C-N 119.085 0.857 . . . . 0.0 111.717 172.952 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 8.8 m -83.21 -57.07 3.42 Favored 'General case' 0 N--CA 1.444 -0.728 0 C-N-CA 125.198 1.399 . . . . 0.0 109.538 -173.96 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 55.5 mt -74.9 -36.34 62.23 Favored 'General case' 0 C--N 1.331 -0.204 0 C-N-CA 124.753 1.221 . . . . 0.0 110.213 -175.005 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -93.34 9.4 74.49 Favored Glycine 0 C--N 1.338 0.675 0 C-N-CA 124.988 1.28 . . . . 0.0 113.068 -176.161 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -50.89 122.73 7.85 Favored 'General case' 0 CA--C 1.534 0.327 0 C-N-CA 124.841 1.257 . . . . 0.0 110.524 -175.257 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 76.54 -8.76 25.29 Favored Glycine 0 CA--C 1.534 1.264 0 C-N-CA 124.371 0.986 . . . . 0.0 114.426 179.652 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 60.2 mttm -98.67 -46.67 5.61 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 119.19 1.495 . . . . 0.0 110.403 179.254 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.402 HG22 ' HB2' ' A' ' 2' ' ' LYS . 24.3 pt -139.24 149.25 23.14 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.585 0 C-N-CA 123.632 0.773 . . . . 0.0 109.388 -169.76 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -113.09 106.41 14.64 Favored 'General case' 0 N--CA 1.463 0.187 0 C-N-CA 125.132 1.373 . . . . 0.0 109.272 -169.899 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 2.5 t -84.64 137.68 20.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 119.316 0.962 . . . . 0.0 109.742 -179.449 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 14.5 m -145.32 91.7 2.16 Favored 'General case' 0 N--CA 1.446 -0.669 0 N-CA-C 106.037 -1.838 . . . . 0.0 106.037 170.368 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 45.0 m -89.28 68.93 8.13 Favored 'General case' 0 CA--C 1.532 0.273 0 O-C-N 121.287 -0.883 . . . . 0.0 111.017 -171.363 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 11.9 m -61.89 164.72 6.1 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 125.895 1.678 . . . . 0.0 110.715 170.198 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -158.6 -167.64 19.67 Favored Glycine 0 C--N 1.337 0.638 0 N-CA-C 107.752 -2.139 . . . . 0.0 107.752 -170.057 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 17.3 mt -123.96 -3.72 8.1 Favored 'General case' 0 C--N 1.327 -0.376 0 C-N-CA 124.113 0.965 . . . . 0.0 111.592 -179.405 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 36.7 mt-10 -142.63 154.15 44.12 Favored 'General case' 0 C--O 1.238 0.499 0 C-N-CA 128.052 2.541 . . . . 0.0 106.511 169.297 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 60.7 p -148.53 160.78 42.75 Favored 'General case' 0 N--CA 1.446 -0.66 0 CA-C-O 122.555 1.169 . . . . 0.0 113.795 -179.693 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 93.0 p -164.45 -144.45 0.08 Allowed 'General case' 0 N--CA 1.443 -0.817 0 CA-C-N 112.531 -2.122 . . . . 0.0 105.94 -168.841 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 9.2 ttt180 -136.31 173.0 12.18 Favored 'General case' 0 C--O 1.232 0.134 0 N-CA-C 106.311 -1.737 . . . . 0.0 106.311 168.368 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 5.6 m -81.89 175.16 0.77 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.609 0 C-N-CA 122.918 0.487 . . . . 0.0 110.038 -178.845 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 97.0 m-70 -90.98 150.33 41.66 Favored Pre-proline 0 CA--C 1.542 0.669 0 CA-C-O 119.3 -0.381 . . . . 0.0 111.686 -174.916 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -63.4 -45.64 11.37 Favored 'Trans proline' 0 C--N 1.349 0.59 0 C-N-CA 122.76 2.306 . . . . 0.0 113.31 -171.216 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' THR . . . . . 0.407 ' HB ' ' CZ ' ' A' ' 112' ' ' PHE . 5.8 m -69.0 -22.74 64.06 Favored 'General case' 0 CA--C 1.54 0.558 0 O-C-N 121.681 -0.637 . . . . 0.0 110.364 -178.321 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -61.11 -56.68 18.1 Favored 'General case' 0 CA--C 1.509 -0.632 0 N-CA-C 108.197 -1.038 . . . . 0.0 108.197 169.85 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 75.9 mt -56.8 -38.76 60.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 N-CA-C 108.427 -0.953 . . . . 0.0 108.427 -175.229 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -62.47 -50.48 71.27 Favored 'General case' 0 N--CA 1.452 -0.332 0 CA-C-N 118.87 0.759 . . . . 0.0 111.827 -178.845 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 35.9 mmt -72.18 -31.78 66.23 Favored 'General case' 0 N--CA 1.472 0.648 0 CA-C-O 122.584 1.183 . . . . 0.0 110.806 -179.112 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -72.21 -33.13 67.37 Favored 'General case' 0 N--CA 1.443 -0.801 0 N-CA-C 106.855 -1.535 . . . . 0.0 106.855 -177.911 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 41.3 tt0 -74.7 -19.94 60.05 Favored 'General case' 0 N--CA 1.446 -0.67 0 O-C-N 120.925 -1.109 . . . . 0.0 110.525 172.441 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 20.3 mm-40 -64.49 -33.33 75.63 Favored 'General case' 0 CA--C 1.532 0.265 0 CA-C-N 119.576 1.08 . . . . 0.0 109.982 169.771 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 16.4 m -91.17 12.31 2.17 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.736 0 N-CA-C 112.275 0.472 . . . . 0.0 112.275 169.192 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 73.08 13.67 79.25 Favored Glycine 0 CA--C 1.531 1.089 0 C-N-CA 124.53 1.062 . . . . 0.0 113.695 174.675 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 17.2 mt -91.23 143.95 10.17 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.239 0 C-N-CA 124.438 1.095 . . . . 0.0 110.001 -177.476 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 7.2 t70 -104.49 124.6 49.56 Favored 'General case' 0 C--O 1.235 0.298 0 N-CA-C 106.628 -1.619 . . . . 0.0 106.628 168.902 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 5.8 pt -120.06 -21.81 4.02 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.697 0 C-N-CA 124.686 1.195 . . . . 0.0 109.526 169.073 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -38.67 -35.91 0.22 Allowed 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 129.252 3.021 . . . . 0.0 113.778 169.326 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -72.46 -9.75 74.0 Favored Glycine 0 CA--C 1.535 1.321 0 C-N-CA 124.649 1.118 . . . . 0.0 114.229 179.963 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 26.2 mt-30 -68.1 140.08 56.21 Favored 'General case' 0 N--CA 1.451 -0.401 0 CA-C-N 119.753 1.777 . . . . 0.0 110.265 176.764 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 1.2 m -155.94 -51.88 0.08 Allowed 'General case' 0 N--CA 1.438 -1.046 0 N-CA-C 104.119 -2.548 . . . . 0.0 104.119 168.412 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 3.9 m 68.9 160.03 0.18 Allowed 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 126.677 1.991 . . . . 0.0 114.071 169.095 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -95.32 163.61 21.23 Favored Pre-proline 0 C--O 1.241 0.621 0 C-N-CA 124.968 1.307 . . . . 0.0 109.754 -172.833 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -62.05 136.24 59.77 Favored 'Trans proline' 0 N--CA 1.449 -1.095 0 N-CA-C 108.203 -1.499 . . . . 0.0 108.203 169.762 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 8.1 tt -61.6 -19.15 20.3 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.498 0 C-N-CA 124.248 1.019 . . . . 0.0 111.03 -177.958 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 12.1 mt-10 -67.29 -25.48 66.06 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 125.533 1.533 . . . . 0.0 110.391 -179.748 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 15.4 t-20 -71.82 1.29 7.21 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 124.702 1.201 . . . . 0.0 113.112 -179.632 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 42.5 m-85 -130.74 -174.18 3.29 Favored 'General case' 0 C--O 1.236 0.388 0 C-N-CA 126.585 1.954 . . . . 0.0 109.136 -177.707 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 57.1 t-20 -135.05 140.19 45.38 Favored 'General case' 0 N--CA 1.446 -0.628 0 N-CA-C 107.397 -1.335 . . . . 0.0 107.397 169.382 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -72.22 -25.13 61.53 Favored 'General case' 0 N--CA 1.435 -1.207 0 N-CA-C 109.08 -0.711 . . . . 0.0 109.08 -178.157 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 35.1 t70 -63.71 -24.76 67.91 Favored 'General case' 0 N--CA 1.447 -0.609 0 O-C-N 123.254 0.346 . . . . 0.0 111.868 -179.132 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -78.08 -28.32 48.73 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 123.52 0.728 . . . . 0.0 111.925 176.036 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 14.7 m-85 -80.38 170.96 15.67 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 125.805 1.642 . . . . 0.0 111.695 -178.568 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 22.9 t70 -119.63 -39.07 2.9 Favored 'General case' 0 N--CA 1.464 0.272 0 C-N-CA 123.185 0.594 . . . . 0.0 111.599 177.318 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -139.32 133.96 39.73 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.494 0 CA-C-O 121.98 0.895 . . . . 0.0 110.639 -170.204 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 70.4 t -142.69 133.45 23.77 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.632 0 N-CA-C 105.746 -1.946 . . . . 0.0 105.746 -176.382 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 33.6 mm -124.94 122.09 62.59 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.527 0 N-CA-C 106.448 -1.686 . . . . 0.0 106.448 -171.603 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 58.7 m -87.09 122.59 31.12 Favored 'General case' 0 N--CA 1.441 -0.884 0 N-CA-C 105.204 -2.147 . . . . 0.0 105.204 169.0 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 69.3 mt -83.92 3.39 34.25 Favored 'General case' 0 C--N 1.327 -0.37 0 O-C-N 121.711 -0.618 . . . . 0.0 110.341 175.153 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 29.7 p -160.82 141.57 11.56 Favored 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 124.838 1.255 . . . . 0.0 108.249 169.728 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 57.97 -162.2 9.71 Favored Glycine 0 CA--C 1.534 1.223 0 C-N-CA 124.581 1.086 . . . . 0.0 114.523 170.26 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 10.9 p -152.17 147.75 26.8 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 125.367 1.467 . . . . 0.0 107.536 170.303 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 59.1 44.2 96.5 Favored Glycine 0 CA--C 1.533 1.176 0 N-CA-C 111.145 -0.782 . . . . 0.0 111.145 -178.107 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 29.8 m -79.8 52.53 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.545 0.775 0 C-N-CA 124.845 1.258 . . . . 0.0 112.799 -169.589 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 17.5 t-20 56.06 53.09 9.51 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 126.295 1.838 . . . . 0.0 108.827 -175.275 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -147.74 147.17 26.5 Favored Pre-proline 0 CA--C 1.54 0.579 0 C-N-CA 126.913 2.085 . . . . 0.0 107.34 -169.28 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_exo -64.24 138.34 60.68 Favored 'Trans proline' 0 CA--C 1.542 0.892 0 CA-C-N 120.692 1.283 . . . . 0.0 112.693 -171.878 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -67.15 -28.37 40.77 Favored 'Trans proline' 0 N--CA 1.458 -0.567 0 C-N-CA 122.667 2.245 . . . . 0.0 114.425 -169.393 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 5.1 pm0 -62.13 -15.92 48.95 Favored 'General case' 0 CA--C 1.536 0.42 0 CA-C-N 120.404 1.456 . . . . 0.0 112.53 -178.275 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 96.4 m95 -73.38 -49.36 27.62 Favored 'General case' 0 N--CA 1.451 -0.394 0 C-N-CA 123.242 0.617 . . . . 0.0 110.848 174.371 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 28.6 m -79.87 -0.29 3.79 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.359 0 C-N-CA 123.615 0.766 . . . . 0.0 112.717 -178.446 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 57.7 p -113.33 25.32 11.42 Favored 'General case' 0 C--O 1.237 0.409 0 CA-C-N 119.547 1.067 . . . . 0.0 113.155 174.033 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 76.2 mm-40 -66.57 174.22 2.94 Favored 'General case' 0 CA--C 1.539 0.528 0 CA-C-N 118.611 0.641 . . . . 0.0 112.084 176.251 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 32.7 mm-40 -54.57 -29.44 51.25 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 124.038 0.935 . . . . 0.0 111.723 -169.765 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 3.3 tt -133.7 130.63 56.36 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.672 0 N-CA-C 104.041 -2.577 . . . . 0.0 104.041 168.388 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 44.1 t80 -120.86 142.03 50.03 Favored 'General case' 0 N--CA 1.448 -0.546 0 N-CA-C 105.921 -1.881 . . . . 0.0 105.921 169.221 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 20.6 mm-40 -139.79 144.49 37.39 Favored 'General case' 0 C--O 1.236 0.373 0 N-CA-C 107.624 -1.25 . . . . 0.0 107.624 170.112 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 6.0 t0 -110.56 107.69 17.39 Favored 'General case' 0 C--O 1.238 0.484 0 N-CA-C 105.168 -2.16 . . . . 0.0 105.168 169.093 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -99.53 125.37 45.29 Favored 'General case' 0 N--CA 1.454 -0.269 0 C-N-CA 123.377 0.671 . . . . 0.0 109.546 -173.301 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 34.2 mm-40 -89.05 116.98 27.73 Favored 'General case' 0 N--CA 1.456 -0.163 0 N-CA-C 105.416 -2.068 . . . . 0.0 105.416 168.823 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.517 HD13 HG22 ' A' ' 119' ' ' VAL . 28.9 mt -142.95 127.69 18.17 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 104.638 -2.356 . . . . 0.0 104.638 -179.738 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 26.5 mm-40 -63.48 157.77 22.59 Favored 'General case' 0 CA--C 1.534 0.333 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 172.722 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -117.13 135.03 22.98 Favored Pre-proline 0 N--CA 1.45 -0.426 0 C-N-CA 124.526 1.13 . . . . 0.0 108.105 169.687 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -89.09 -8.68 4.72 Favored 'Trans proline' 0 N--CA 1.453 -0.882 0 C-N-CA 122.285 1.99 . . . . 0.0 114.674 -170.138 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -50.7 -51.4 49.97 Favored 'General case' 0 N--CA 1.472 0.672 0 CA-C-N 120.554 1.525 . . . . 0.0 113.14 -169.31 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -84.31 11.84 56.93 Favored Glycine 0 CA--C 1.532 1.147 0 CA-C-O 118.702 -1.055 . . . . 0.0 113.396 -176.49 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 9.8 mt-30 -130.98 176.45 8.23 Favored 'General case' 0 CA--C 1.542 0.664 0 CA-C-N 118.847 1.324 . . . . 0.0 110.654 -169.683 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 13.9 m -78.23 169.7 17.83 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 124.604 1.161 . . . . 0.0 112.242 -173.592 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 34.4 tp -55.19 -33.93 63.45 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 125.86 1.664 . . . . 0.0 113.058 -178.11 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 5.9 pt-20 -56.99 -34.71 68.41 Favored 'General case' 0 N--CA 1.463 0.208 0 C-N-CA 123.483 0.713 . . . . 0.0 111.608 174.782 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 16.0 t -76.63 -38.52 30.96 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.525 0 CA-C-O 118.02 -0.991 . . . . 0.0 109.801 -176.874 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 112' ' ' PHE . . . . . 0.407 ' CZ ' ' HB ' ' A' ' 45' ' ' THR . 85.2 m-85 -57.02 -48.13 79.23 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-N 120.377 1.444 . . . . 0.0 109.547 171.545 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 85.6 mtt180 -63.72 -39.46 94.35 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 122.916 0.486 . . . . 0.0 111.247 -179.613 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 5.7 m -67.34 -49.6 63.37 Favored 'General case' 0 N--CA 1.452 -0.339 0 C-N-CA 124.203 1.001 . . . . 0.0 110.226 177.975 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 59.2 t -65.56 -35.13 74.52 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.306 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 -173.697 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 58.7 ttp85 -56.42 -45.18 80.84 Favored 'General case' 0 CA--C 1.537 0.475 0 CA-C-N 118.499 0.59 . . . . 0.0 109.76 174.077 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -64.18 -51.63 51.24 Favored Glycine 0 CA--C 1.53 1.006 0 CA-C-N 118.346 0.521 . . . . 0.0 112.208 175.922 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 9.4 mt-30 -61.52 -43.21 99.27 Favored 'General case' 0 N--CA 1.468 0.428 0 CA-C-N 118.258 1.029 . . . . 0.0 110.713 -175.364 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 119' ' ' VAL . . . . . 0.517 HG22 HD13 ' A' ' 101' ' ' LEU . 95.6 t -70.58 -40.66 77.48 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.377 0 CA-C-O 118.399 -0.81 . . . . 0.0 109.265 -176.011 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 58.2 tttm -54.94 -45.85 74.88 Favored 'General case' 0 CA--C 1.518 -0.276 0 CA-C-N 119.275 0.943 . . . . 0.0 109.093 174.906 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 41.5 tt0 -66.84 -43.16 84.43 Favored 'General case' 0 N--CA 1.45 -0.446 0 C-N-CA 122.761 0.424 . . . . 0.0 111.043 -173.794 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 36.3 mtt-85 -66.21 -40.75 90.56 Favored 'General case' 0 N--CA 1.471 0.599 0 O-C-N 121.413 -0.804 . . . . 0.0 111.722 176.857 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 90.2 t -68.77 -37.61 77.7 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.499 0 N-CA-C 108.952 -0.758 . . . . 0.0 108.952 179.289 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 13.4 mt-10 -60.01 -43.8 94.99 Favored 'General case' 0 C--O 1.226 -0.174 0 CA-C-N 119.308 0.958 . . . . 0.0 110.064 174.13 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 29.2 t-20 -63.02 -45.27 93.13 Favored 'General case' 0 CA--C 1.53 0.204 0 CA-C-N 118.124 0.42 . . . . 0.0 111.103 -179.489 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 38.6 tp -57.75 -49.11 77.66 Favored 'General case' 0 N--CA 1.452 -0.364 0 C-N-CA 124.684 1.194 . . . . 0.0 110.489 176.715 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 70.0 mt -63.49 -46.78 94.23 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 N-CA-C 108.12 -1.067 . . . . 0.0 108.12 -179.408 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -59.13 -29.64 67.54 Favored 'General case' 0 CA--C 1.535 0.377 0 CA-C-O 118.325 -0.845 . . . . 0.0 112.251 -178.426 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . 0.25 19.3 ptpt -83.17 -39.05 21.52 Favored 'General case' 0 C--N 1.343 0.323 0 CA-C-O 117.863 -1.065 . . . . 0.0 112.616 175.421 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 12.6 pt -82.46 -40.19 16.72 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.362 0 CA-C-N 120.207 1.367 . . . . 0.0 113.497 -175.166 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 70.8 m . . . . . 0 C--O 1.253 1.24 0 C-N-CA 125.692 1.597 . . . . 0.0 109.848 -170.05 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 9.8 ptm . . . . . 0 N--CA 1.496 1.872 0 N-CA-C 110.622 -0.14 . . . . 0.0 110.622 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 27.5 mttm -75.09 121.25 21.75 Favored 'General case' 0 N--CA 1.48 1.045 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 -171.24 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 91.6 mttt -88.15 134.75 33.69 Favored 'General case' 0 CA--C 1.512 -0.491 0 N-CA-C 108.075 -1.083 . . . . 0.0 108.075 177.201 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 1.9 t -123.35 147.93 27.49 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.648 0 C-N-CA 126.574 1.95 . . . . 0.0 108.89 -168.994 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 34.3 mtt -137.02 150.5 48.14 Favored 'General case' 0 C--N 1.325 -0.493 0 C-N-CA 124.671 1.189 . . . . 0.0 108.215 168.049 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 35.7 m-85 -129.29 129.54 45.03 Favored 'General case' 0 CA--C 1.515 -0.397 0 N-CA-C 103.833 -2.654 . . . . 0.0 103.833 169.715 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 1.1 p -152.78 136.39 8.17 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.366 0 CA-C-O 121.352 0.596 . . . . 0.0 109.587 -169.276 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 49.9 t -122.08 174.66 6.79 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 127.317 2.247 . . . . 0.0 107.182 169.661 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 51.5 tttm -63.78 -32.28 73.73 Favored 'General case' 0 CA--C 1.539 0.531 0 O-C-N 121.226 -0.921 . . . . 0.0 111.303 179.275 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 74.4 mtm-85 -108.63 162.94 13.68 Favored 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 124.815 1.246 . . . . 0.0 108.003 169.615 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 7.3 t30 -70.55 -54.77 10.8 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-O 121.366 0.603 . . . . 0.0 110.296 172.625 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 12.4 m -89.75 46.39 1.36 Allowed 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 123.499 0.72 . . . . 0.0 111.454 -168.953 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 50.6 m -139.78 118.17 12.12 Favored 'General case' 0 N--CA 1.448 -0.548 0 N-CA-C 106.81 -1.552 . . . . 0.0 106.81 170.073 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 79.2 mtt180 64.96 -26.88 0.09 Allowed 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 129.02 2.928 . . . . 0.0 115.218 176.537 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 1.2 m -76.67 -140.79 0.02 OUTLIER 'General case' 0 CA--C 1.549 0.916 0 N-CA-C 104.658 -2.349 . . . . 0.0 104.658 168.036 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 22.5 pt20 49.43 26.44 1.65 Allowed 'General case' 0 N--CA 1.475 0.813 0 CA-C-N 121.047 1.749 . . . . 0.0 112.455 178.311 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' MET . . . . . 0.428 ' HG2' ' CE ' ' A' ' 50' ' ' MET . 0.0 OUTLIER -171.42 -49.34 0.02 OUTLIER 'General case' 0 N--CA 1.446 -0.663 0 C-N-CA 127.748 2.419 . . . . 0.0 108.515 -175.102 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 18' ' ' ALA . . . . . 0.407 ' HA ' ' CG1' ' A' ' 119' ' ' VAL . . . -71.88 -45.94 59.53 Favored 'General case' 0 C--N 1.343 0.321 0 C-N-CA 123.448 0.699 . . . . 0.0 112.749 -169.562 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -63.71 -35.58 81.02 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 169.493 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -49.75 -66.06 2.5 Favored Glycine 0 C--N 1.341 0.811 0 C-N-CA 126.021 1.772 . . . . 0.0 110.745 174.851 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 2.5 m-85 -59.75 -27.67 66.7 Favored 'General case' 0 CA--C 1.512 -0.497 0 O-C-N 121.103 -1.234 . . . . 0.0 112.519 178.492 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -71.65 -32.8 68.31 Favored 'General case' 0 N--CA 1.447 -0.599 0 CA-C-O 117.71 -1.138 . . . . 0.0 112.117 -176.526 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.29 -30.44 70.3 Favored 'General case' 0 N--CA 1.476 0.848 0 CA-C-N 120.517 1.508 . . . . 0.0 110.903 172.065 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 18.8 m -75.92 -56.63 4.49 Favored 'General case' 0 N--CA 1.448 -0.54 0 C-N-CA 124.638 1.175 . . . . 0.0 111.078 -176.864 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 71.9 mt -78.56 -38.06 41.25 Favored 'General case' 0 C--N 1.33 -0.267 0 C-N-CA 124.3 1.04 . . . . 0.0 109.807 -173.771 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -80.54 2.75 76.98 Favored Glycine 0 CA--C 1.527 0.811 0 C-N-CA 124.838 1.209 . . . . 0.0 112.971 179.929 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -53.35 129.74 32.85 Favored 'General case' 0 C--O 1.236 0.389 0 CA-C-N 118.462 1.131 . . . . 0.0 109.301 179.809 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 75.44 5.32 77.33 Favored Glycine 0 CA--C 1.536 1.397 0 C-N-CA 124.378 0.99 . . . . 0.0 114.464 -178.606 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 41.0 mttp -128.23 -52.32 1.29 Allowed 'General case' 0 N--CA 1.472 0.671 0 CA-C-N 119.087 1.444 . . . . 0.0 111.373 -172.375 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 29.5 pt -140.02 147.43 23.67 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.502 0 C-N-CA 123.57 0.748 . . . . 0.0 109.59 -169.407 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -105.32 104.85 14.66 Favored 'General case' 0 N--CA 1.464 0.261 0 C-N-CA 124.889 1.275 . . . . 0.0 109.035 -172.825 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 9.8 p -80.24 137.47 21.48 Favored 'Isoleucine or valine' 0 C--O 1.236 0.357 0 CA-C-N 119.126 0.876 . . . . 0.0 109.431 173.86 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 6.6 m -134.56 117.9 16.67 Favored 'General case' 0 N--CA 1.434 -1.264 0 N-CA-C 104.686 -2.339 . . . . 0.0 104.686 173.766 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 2.4 m -89.74 39.62 0.96 Allowed 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 113.01 0.744 . . . . 0.0 113.01 -169.643 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 1.5 m -65.19 159.68 23.05 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 124.515 1.126 . . . . 0.0 111.077 178.549 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -177.64 -165.85 33.35 Favored Glycine 0 C--N 1.337 0.618 0 N-CA-C 108.678 -1.769 . . . . 0.0 108.678 -175.542 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 12.4 mt -132.49 160.59 36.04 Favored 'General case' 0 N--CA 1.445 -0.679 0 C-N-CA 126.547 1.939 . . . . 0.0 107.773 177.473 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 21.5 mt-10 56.13 18.04 3.02 Favored 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 124.627 1.171 . . . . 0.0 112.885 178.639 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 13.7 p -76.35 163.53 26.91 Favored 'General case' 0 N--CA 1.435 -1.179 0 N-CA-C 115.054 1.501 . . . . 0.0 115.054 -167.841 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 8.0 m -153.82 177.21 11.25 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 129.15 2.98 . . . . 0.0 105.98 -169.735 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 53.6 ttt180 -88.9 153.13 21.29 Favored 'General case' 0 CA--C 1.533 0.297 0 O-C-N 121.07 -1.019 . . . . 0.0 109.737 -177.505 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 1.9 p -44.72 149.54 0.25 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.439 0 C-N-CA 128.035 2.534 . . . . 0.0 112.568 169.987 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 23.0 m170 -88.69 152.81 49.59 Favored Pre-proline 0 CA--C 1.543 0.7 0 C-N-CA 123.274 0.63 . . . . 0.0 111.2 -179.563 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -59.08 -52.98 4.1 Favored 'Trans proline' 0 C--N 1.351 0.665 0 C-N-CA 124.149 3.233 . . . . 0.0 114.204 -169.091 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 7.3 m -67.37 -24.58 65.71 Favored 'General case' 0 CA--C 1.537 0.445 0 CA-C-O 119.215 -0.421 . . . . 0.0 110.651 -171.407 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -56.8 -53.8 53.7 Favored 'General case' 0 CA--C 1.511 -0.548 0 N-CA-C 109.177 -0.675 . . . . 0.0 109.177 173.231 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 52.1 mt -60.6 -38.59 78.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 -170.424 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -62.92 -49.13 75.98 Favored 'General case' 0 N--CA 1.454 -0.243 0 CA-C-N 118.595 0.634 . . . . 0.0 111.244 178.957 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 30.2 mmt -67.46 -37.14 82.48 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-O 122.779 1.276 . . . . 0.0 110.968 179.964 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' MET . . . . . 0.428 ' CE ' ' HG2' ' A' ' 17' ' ' MET . 0.0 OUTLIER -74.3 -31.61 62.55 Favored 'General case' 0 N--CA 1.443 -0.779 0 N-CA-C 107.2 -1.408 . . . . 0.0 107.2 -176.08 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 40.2 tt0 -72.07 -20.84 61.6 Favored 'General case' 0 N--CA 1.449 -0.52 0 O-C-N 121.211 -0.931 . . . . 0.0 110.788 170.699 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 20.6 mm-40 -66.01 -32.23 73.59 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-N 119.571 1.078 . . . . 0.0 109.89 169.912 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 15.7 m -91.97 13.63 1.98 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.835 0 CA-C-N 118.361 0.528 . . . . 0.0 112.036 169.037 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 75.82 15.97 80.97 Favored Glycine 0 CA--C 1.532 1.123 0 C-N-CA 124.99 1.281 . . . . 0.0 113.981 173.006 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 3.5 mt -99.54 140.8 18.04 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.113 0 C-N-CA 124.588 1.155 . . . . 0.0 111.201 -171.613 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 3.0 t70 -97.04 130.72 44.31 Favored 'General case' 0 CA--C 1.528 0.12 0 C-N-CA 125.421 1.489 . . . . 0.0 108.886 169.857 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 6.5 pt -132.58 -31.27 0.55 Allowed 'Isoleucine or valine' 0 C--O 1.216 -0.689 0 C-N-CA 125.78 1.632 . . . . 0.0 109.501 169.673 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -15.76 -36.37 0.0 OUTLIER 'General case' 0 CA--C 1.545 0.763 1 C-N-CA 131.768 4.027 . . . . 0.0 118.5 169.992 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -110.25 37.2 3.86 Favored Glycine 0 CA--C 1.534 1.251 0 C-N-CA 125.921 1.724 . . . . 0.0 113.858 -179.507 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 6.3 mt-30 -59.88 -30.48 69.02 Favored 'General case' 0 N--CA 1.474 0.75 0 CA-C-N 119.63 1.715 . . . . 0.0 114.232 -174.719 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -57.8 123.73 16.74 Favored 'General case' 0 C--O 1.236 0.342 0 C-N-CA 124.043 0.937 . . . . 0.0 109.135 -169.421 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 75.2 m -145.96 177.28 9.06 Favored 'General case' 0 N--CA 1.443 -0.802 0 C-N-CA 126.452 1.901 . . . . 0.0 107.019 -169.369 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -59.26 153.95 44.48 Favored Pre-proline 0 C--O 1.239 0.543 0 C-N-CA 123.691 0.796 . . . . 0.0 111.49 175.756 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -63.48 154.16 70.34 Favored 'Trans proline' 0 N--CA 1.454 -0.826 0 C-N-CA 122.49 2.127 . . . . 0.0 109.84 170.879 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 3.2 tt -61.95 -24.41 34.32 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.522 0 O-C-N 121.701 -0.624 . . . . 0.0 111.212 -175.764 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 12.6 mt-10 -65.96 -26.23 67.48 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 124.751 1.22 . . . . 0.0 110.81 -177.377 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 7.6 t-20 -63.12 -23.89 67.65 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 124.673 1.189 . . . . 0.0 111.942 179.085 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 75.0 m-85 -104.62 -174.68 2.59 Favored 'General case' 0 C--O 1.236 0.367 0 C-N-CA 126.19 1.796 . . . . 0.0 110.357 -174.819 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 56.3 t-20 -135.82 132.83 37.16 Favored 'General case' 0 N--CA 1.443 -0.819 0 N-CA-C 106.176 -1.787 . . . . 0.0 106.176 168.855 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -75.0 -19.75 59.95 Favored 'General case' 0 N--CA 1.431 -1.38 0 C-N-CA 120.125 -0.63 . . . . 0.0 109.389 -176.585 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 35.5 t70 -65.03 -24.71 67.57 Favored 'General case' 0 N--CA 1.442 -0.829 0 O-C-N 122.211 -0.305 . . . . 0.0 111.235 179.127 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -77.0 -28.81 55.18 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 123.773 0.829 . . . . 0.0 111.779 173.872 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 11.6 m-85 -77.35 168.21 20.41 Favored 'General case' 0 N--CA 1.451 -0.42 0 C-N-CA 125.261 1.424 . . . . 0.0 111.342 178.863 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -117.28 -39.21 3.22 Favored 'General case' 0 C--O 1.234 0.266 0 C-N-CA 123.213 0.605 . . . . 0.0 111.249 177.256 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -138.2 135.02 44.73 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.693 0 CA-C-O 122.021 0.915 . . . . 0.0 109.943 -169.887 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 75.6 t -142.09 133.89 26.65 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.451 0 N-CA-C 105.905 -1.887 . . . . 0.0 105.905 176.708 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 39.7 mm -117.78 102.82 13.89 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.78 0 N-CA-C 105.253 -2.129 . . . . 0.0 105.253 -170.437 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 47.2 m -101.34 70.61 1.32 Allowed 'General case' 0 N--CA 1.439 -1.014 0 N-CA-C 106.458 -1.682 . . . . 0.0 106.458 -172.947 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -71.22 23.33 0.04 OUTLIER 'General case' 0 CA--C 1.542 0.655 0 N-CA-C 114.136 1.162 . . . . 0.0 114.136 -170.075 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 74.9 m -146.3 55.64 1.16 Allowed 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 125.823 1.649 . . . . 0.0 109.996 172.33 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 81.34 -167.0 48.55 Favored Glycine 0 CA--C 1.531 1.034 0 O-C-N 121.363 -0.835 . . . . 0.0 112.663 176.981 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 15.0 p -151.68 150.19 29.96 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 123.649 0.779 . . . . 0.0 110.375 -169.952 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 61.26 28.25 68.91 Favored Glycine 0 CA--C 1.531 1.036 0 C-N-CA 123.208 0.433 . . . . 0.0 112.081 -179.014 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 32.8 m -71.45 -34.43 53.25 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.612 0 CA-C-N 117.479 0.64 . . . . 0.0 111.719 -169.303 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 21.2 t-20 -178.13 -43.02 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 128.792 2.837 . . . . 0.0 106.14 174.318 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.437 ' HA ' ' HD3' ' A' ' 87' ' ' PRO . 3.0 tt -44.09 139.68 3.03 Favored Pre-proline 0 CA--C 1.547 0.859 0 C-N-CA 128.202 2.601 . . . . 0.0 111.295 169.659 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 87' ' ' PRO . . . . . 0.437 ' HD3' ' HA ' ' A' ' 86' ' ' LEU . 51.8 Cg_exo -65.17 150.98 86.99 Favored 'Trans proline' 0 C--N 1.356 0.936 0 C-N-CA 121.974 1.782 . . . . 0.0 115.658 -169.727 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 88' ' ' PRO . . . . . 0.431 ' HD3' ' HA ' ' A' ' 87' ' ' PRO . 51.2 Cg_exo -64.51 -30.47 61.63 Favored 'Trans proline' 0 C--N 1.349 0.594 0 C-N-CA 122.491 2.127 . . . . 0.0 114.972 -174.661 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -56.35 -21.05 22.05 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-N 119.49 1.041 . . . . 0.0 112.739 -177.026 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 99.4 m95 -80.06 -28.75 39.16 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 124.948 1.299 . . . . 0.0 112.188 -179.56 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 16.1 m -100.67 -4.35 9.29 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.41 0 C-N-CA 124.946 1.299 . . . . 0.0 112.019 179.623 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 59.8 p -103.27 30.37 4.95 Favored 'General case' 0 CA--C 1.535 0.39 0 CA-C-N 119.325 0.966 . . . . 0.0 112.449 175.644 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 46.1 mm-40 -72.33 175.06 6.47 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 123.344 0.658 . . . . 0.0 111.275 -175.354 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 36.2 mm-40 -61.54 -26.05 67.69 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-O 120.832 0.348 . . . . 0.0 110.513 179.758 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 4.1 tt -136.54 124.49 34.3 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.523 0 N-CA-C 104.997 -2.223 . . . . 0.0 104.997 169.169 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 20.9 t80 -103.49 135.01 45.89 Favored 'General case' 0 CA--C 1.538 0.49 0 N-CA-C 105.755 -1.943 . . . . 0.0 105.755 169.581 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 15.6 mm-40 -136.26 162.25 33.51 Favored 'General case' 0 C--O 1.235 0.291 0 N-CA-C 108.552 -0.907 . . . . 0.0 108.552 170.294 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 5.2 t0 -178.79 126.95 0.1 Allowed 'General case' 0 C--N 1.326 -0.439 0 C-N-CA 126.869 2.068 . . . . 0.0 105.643 -169.519 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 6.6 m0 -143.42 149.0 37.01 Favored 'General case' 0 C--N 1.333 -0.136 0 C-N-CA 122.616 0.366 . . . . 0.0 110.788 -170.933 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 1.9 tp-100 -82.73 54.04 2.56 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 124.338 1.055 . . . . 0.0 109.508 175.909 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 1.1 mp -64.28 147.13 53.16 Favored 'General case' 0 C--N 1.34 0.184 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 178.209 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 69.2 mm-40 -77.8 166.4 22.97 Favored 'General case' 0 CA--C 1.536 0.413 0 N-CA-C 108.229 -1.026 . . . . 0.0 108.229 169.496 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -135.08 137.74 27.69 Favored Pre-proline 0 CA--C 1.536 0.426 0 C-N-CA 124.161 0.984 . . . . 0.0 109.334 171.86 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 21.4 Cg_endo -92.94 3.77 3.43 Favored 'Trans proline' 0 N--CA 1.452 -0.944 0 C-N-CA 122.318 2.012 . . . . 0.0 114.781 -171.661 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -55.81 120.88 8.04 Favored 'General case' 0 C--O 1.237 0.399 0 CA-C-N 120.398 1.454 . . . . 0.0 110.841 -174.571 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 68.65 5.48 45.04 Favored Glycine 0 CA--C 1.534 1.274 0 CA-C-O 118.873 -0.96 . . . . 0.0 114.151 179.902 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 7.0 mt-30 -97.12 167.74 10.87 Favored 'General case' 0 CA--C 1.537 0.47 0 CA-C-N 118.882 1.341 . . . . 0.0 109.864 179.428 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 15.6 m -69.95 165.98 20.57 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 124.097 0.959 . . . . 0.0 111.754 179.762 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 64.7 mt -60.29 -26.77 66.76 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 123.924 0.89 . . . . 0.0 112.452 -175.594 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 5.8 pt-20 -56.29 -35.27 67.32 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 118.773 0.715 . . . . 0.0 111.162 173.934 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 11.9 t -77.27 -41.09 30.14 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.309 0 CA-C-O 118.203 -0.903 . . . . 0.0 109.823 -178.951 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 62.7 m-85 -57.21 -45.67 83.6 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-N 120.323 1.419 . . . . 0.0 109.596 172.091 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 92.4 mtt180 -63.77 -44.11 94.41 Favored 'General case' 0 N--CA 1.468 0.455 0 C-N-CA 123.395 0.678 . . . . 0.0 110.8 -179.789 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 5.3 m -60.9 -46.76 89.37 Favored 'General case' 0 N--CA 1.449 -0.475 0 C-N-CA 124.642 1.177 . . . . 0.0 109.998 176.281 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 69.4 t -70.09 -37.86 73.33 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.494 0 CA-C-O 117.704 -1.141 . . . . 0.0 109.116 -173.39 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 41.1 mtm105 -57.22 -43.36 82.75 Favored 'General case' 0 C--O 1.224 -0.275 0 CA-C-N 120.113 1.324 . . . . 0.0 110.131 172.859 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -63.67 -54.35 31.99 Favored Glycine 0 CA--C 1.53 1.022 0 CA-C-N 118.672 0.669 . . . . 0.0 111.766 179.128 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 49.8 mm-40 -52.69 -51.23 61.2 Favored 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 124.696 1.198 . . . . 0.0 110.049 177.838 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 119' ' ' VAL . . . . . 0.407 ' CG1' ' HA ' ' A' ' 18' ' ' ALA . 59.6 t -63.8 -50.22 78.64 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.666 0 CA-C-O 118.397 -0.811 . . . . 0.0 109.782 -176.172 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 86.7 tttt -56.38 -46.81 79.91 Favored 'General case' 0 CA--C 1.512 -0.483 0 N-CA-C 108.219 -1.03 . . . . 0.0 108.219 -175.059 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 40.2 tt0 -64.11 -42.88 96.71 Favored 'General case' 0 N--CA 1.446 -0.668 0 C-N-CA 122.945 0.498 . . . . 0.0 111.112 -175.561 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 25.4 mtt180 -74.61 -38.73 62.5 Favored 'General case' 0 N--CA 1.467 0.395 0 O-C-N 121.047 -1.033 . . . . 0.0 111.666 -178.046 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 85.2 t -65.29 -40.33 88.2 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.634 0 N-CA-C 108.441 -0.948 . . . . 0.0 108.441 174.676 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 4.2 mm-40 -60.54 -46.74 89.07 Favored 'General case' 0 C--O 1.227 -0.125 0 CA-C-N 119.489 1.041 . . . . 0.0 109.798 176.028 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 27.7 t-20 -64.36 -40.64 96.25 Favored 'General case' 0 CA--C 1.529 0.17 0 C-N-CA 123.039 0.536 . . . . 0.0 110.952 -176.471 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 24.2 tp -58.19 -50.13 74.6 Favored 'General case' 0 N--CA 1.451 -0.399 0 C-N-CA 124.875 1.27 . . . . 0.0 110.784 173.186 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 75.3 mt -66.12 -44.89 91.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 N-CA-C 107.808 -1.182 . . . . 0.0 107.808 -177.081 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -58.92 -33.93 71.13 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 123.315 0.646 . . . . 0.0 112.182 -179.796 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 17.8 ptpt -79.73 -38.95 32.21 Favored 'General case' 0 C--N 1.345 0.4 0 CA-C-O 117.926 -1.035 . . . . 0.0 112.101 177.634 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 11.1 pt -83.98 -40.6 15.82 Favored 'Isoleucine or valine' 0 C--O 1.234 0.271 0 CA-C-N 119.997 1.271 . . . . 0.0 113.699 -174.794 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 67.7 m . . . . . 0 C--O 1.254 1.333 0 C-N-CA 125.436 1.494 . . . . 0.0 110.06 -169.807 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 9.9 ptm . . . . . 0 N--CA 1.497 1.902 0 N-CA-C 110.837 -0.06 . . . . 0.0 110.837 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' LYS . . . . . 0.43 ' HB2' HG22 ' A' ' 30' ' ' ILE . 20.9 mttm -73.95 122.76 23.08 Favored 'General case' 0 N--CA 1.478 0.967 0 O-C-N 120.961 -1.087 . . . . 0.0 108.329 -171.083 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 93.7 mttt -89.23 134.92 33.84 Favored 'General case' 0 CA--C 1.515 -0.371 0 N-CA-C 108.156 -1.053 . . . . 0.0 108.156 176.403 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 1.9 t -122.26 149.98 25.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 C-N-CA 125.764 1.626 . . . . 0.0 109.655 -169.021 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 28.3 mtt -141.02 148.31 40.06 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 125.548 1.539 . . . . 0.0 108.31 168.667 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 65.4 m-85 -132.21 113.02 12.77 Favored 'General case' 0 N--CA 1.453 -0.318 0 N-CA-C 103.919 -2.623 . . . . 0.0 103.919 169.983 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 19.7 t -140.69 127.02 20.95 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 N-CA-C 107.07 -1.455 . . . . 0.0 107.07 -169.248 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 44.3 t -91.7 -152.07 0.29 Allowed 'General case' 0 CA--C 1.546 0.814 0 N-CA-C 105.621 -1.992 . . . . 0.0 105.621 169.239 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 64.0 tttp -58.95 -35.24 72.8 Favored 'General case' 0 N--CA 1.473 0.693 0 O-C-N 119.852 -1.78 . . . . 0.0 109.187 169.348 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 79.7 mtt180 -134.06 176.93 8.14 Favored 'General case' 0 N--CA 1.465 0.302 0 C-N-CA 125.462 1.505 . . . . 0.0 108.999 177.662 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 51.5 t30 -70.64 -15.35 62.73 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 123.387 0.675 . . . . 0.0 111.296 169.651 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 1.8 m -57.04 169.68 0.51 Allowed 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 126.682 1.993 . . . . 0.0 112.443 174.72 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 5.1 m 62.51 -92.51 0.03 OUTLIER 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 125.974 1.71 . . . . 0.0 113.885 169.549 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -92.68 -36.65 12.83 Favored 'General case' 0 N--CA 1.476 0.855 0 CA-C-N 119.851 1.205 . . . . 0.0 112.34 -174.247 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 1.2 m -59.72 -37.28 78.46 Favored 'General case' 0 N--CA 1.47 0.574 0 O-C-N 121.516 -0.74 . . . . 0.0 112.344 -169.659 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 22.2 pt20 -47.82 -46.09 30.5 Favored 'General case' 0 C--N 1.341 0.212 0 C-N-CA 125.008 1.323 . . . . 0.0 111.299 176.028 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -84.45 -38.59 19.97 Favored 'General case' 0 C--O 1.226 -0.183 0 CA-C-N 118.999 0.818 . . . . 0.0 111.139 -175.685 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -61.66 -47.88 83.36 Favored 'General case' 0 C--N 1.332 -0.16 0 C-N-CA 122.126 0.171 . . . . 0.0 111.307 -174.421 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 1.2 pp20? -71.01 -29.37 65.29 Favored 'General case' 0 C--O 1.235 0.309 0 C-N-CA 119.928 -0.709 . . . . 0.0 109.928 176.113 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -49.01 -62.54 4.54 Favored Glycine 0 C--N 1.34 0.805 0 C-N-CA 126.418 1.961 . . . . 0.0 110.457 173.917 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 9.7 m-85 -65.84 -31.21 72.03 Favored 'General case' 0 CA--C 1.512 -0.491 0 CA-C-N 119.35 1.575 . . . . 0.0 114.14 175.922 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -65.22 -33.05 75.09 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 119.56 1.073 . . . . 0.0 111.918 -169.823 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 5.9 ptpt -63.22 -33.79 76.25 Favored 'General case' 0 N--CA 1.476 0.846 0 CA-C-N 119.561 1.073 . . . . 0.0 111.646 173.312 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 6.6 m -75.31 -54.71 6.62 Favored 'General case' 0 N--CA 1.448 -0.528 0 C-N-CA 125.179 1.392 . . . . 0.0 110.002 -177.672 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 87.8 mt -73.41 -35.95 65.92 Favored 'General case' 0 CA--C 1.53 0.205 0 C-N-CA 123.667 0.787 . . . . 0.0 110.533 -173.509 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -93.43 6.27 74.77 Favored Glycine 0 CA--C 1.526 0.762 0 C-N-CA 125.117 1.342 . . . . 0.0 113.499 -175.757 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -48.72 123.92 7.61 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 125.06 1.344 . . . . 0.0 110.94 -173.389 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 77.9 -14.62 9.99 Favored Glycine 0 CA--C 1.536 1.368 0 C-N-CA 124.655 1.122 . . . . 0.0 114.472 178.406 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 61.9 mttm -95.39 -45.04 7.29 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-N 119.372 1.586 . . . . 0.0 110.48 179.655 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.43 HG22 ' HB2' ' A' ' 2' ' ' LYS . 25.7 pt -140.29 153.14 21.87 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.37 0 C-N-CA 123.776 0.83 . . . . 0.0 110.215 -169.534 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -113.15 104.98 12.9 Favored 'General case' 0 C--O 1.226 -0.162 0 C-N-CA 125.209 1.404 . . . . 0.0 108.611 -173.258 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 14.9 p -88.97 133.01 32.32 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.307 0 CA-C-N 118.988 0.813 . . . . 0.0 109.248 175.756 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 15.1 m -152.36 95.54 2.05 Favored 'General case' 0 N--CA 1.456 -0.157 0 N-CA-C 105.302 -2.111 . . . . 0.0 105.302 172.351 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 48.3 m -92.31 72.39 5.3 Favored 'General case' 0 C--O 1.232 0.184 0 CA-C-O 121.741 0.781 . . . . 0.0 111.03 -169.844 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 3.7 m -60.31 165.74 3.39 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 125.482 1.513 . . . . 0.0 109.925 170.066 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -161.1 -160.73 10.96 Favored Glycine 0 C--N 1.337 0.622 0 N-CA-C 109.209 -1.557 . . . . 0.0 109.209 -169.686 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 10.6 mt -133.56 -62.23 0.79 Allowed 'General case' 0 N--CA 1.45 -0.455 0 C-N-CA 123.329 0.651 . . . . 0.0 110.13 -169.731 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -80.44 -21.01 42.55 Favored 'General case' 0 CA--C 1.537 0.481 0 C-N-CA 124.013 0.925 . . . . 0.0 111.382 174.825 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 43.0 m -60.82 166.18 3.54 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 128.196 2.598 . . . . 0.0 116.086 -169.306 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 60.9 p -145.69 -96.68 0.09 Allowed 'General case' 0 N--CA 1.448 -0.529 0 CA-C-N 113.439 -1.71 . . . . 0.0 111.685 -168.604 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 6.4 ttt180 -140.97 179.67 6.59 Favored 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 125.366 1.466 . . . . 0.0 109.316 178.052 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 3.5 m -85.68 178.72 0.53 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.788 0 C-N-CA 123.701 0.8 . . . . 0.0 110.234 -174.442 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 18.4 m-70 -89.05 153.85 49.33 Favored Pre-proline 0 CA--C 1.546 0.801 0 C-N-CA 123.505 0.722 . . . . 0.0 110.825 -177.974 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 33.1 Cg_endo -65.72 -54.29 0.59 Allowed 'Trans proline' 0 C--N 1.349 0.554 0 C-N-CA 123.109 2.539 . . . . 0.0 113.033 -174.004 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 8.7 m -67.74 -24.46 65.36 Favored 'General case' 0 CA--C 1.535 0.381 0 O-C-N 121.97 -0.456 . . . . 0.0 110.337 -176.702 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -55.56 -52.03 65.11 Favored 'General case' 0 CA--C 1.509 -0.623 0 CA-C-O 119.198 -0.429 . . . . 0.0 109.862 173.266 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 37.3 mt -58.87 -42.32 85.4 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 N-CA-C 108.466 -0.939 . . . . 0.0 108.466 -172.778 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -62.21 -47.13 85.82 Favored 'General case' 0 N--CA 1.448 -0.534 0 CA-C-N 118.23 0.468 . . . . 0.0 110.724 -179.443 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' MET . . . . . 0.4 ' HG3' ' CG ' ' A' ' 112' ' ' PHE . 30.7 mmt -72.56 -33.7 66.99 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-O 122.251 1.024 . . . . 0.0 111.415 -177.144 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -74.49 -31.52 62.22 Favored 'General case' 0 N--CA 1.443 -0.821 0 N-CA-C 107.316 -1.364 . . . . 0.0 107.316 -179.144 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 41.6 tt0 -72.91 -22.77 60.68 Favored 'General case' 0 N--CA 1.444 -0.73 0 O-C-N 121.341 -0.849 . . . . 0.0 110.087 172.418 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 16.9 mm-40 -67.32 -29.71 69.36 Favored 'General case' 0 CA--C 1.532 0.28 0 CA-C-N 119.179 0.9 . . . . 0.0 110.334 171.392 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . 0.279 5.3 p -90.83 11.17 2.49 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.927 0 CA-C-N 118.552 0.615 . . . . 0.0 111.289 169.183 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 77.82 17.64 78.34 Favored Glycine 0 CA--C 1.531 1.034 0 C-N-CA 124.677 1.132 . . . . 0.0 113.65 173.773 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 6.9 mt -108.9 138.11 37.63 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.186 0 CA-C-N 118.723 1.262 . . . . 0.0 110.454 -175.374 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 4.3 t70 -90.07 138.36 31.57 Favored 'General case' 0 C--O 1.234 0.275 0 C-N-CA 123.929 0.891 . . . . 0.0 108.773 169.301 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 13.7 pt -130.5 -30.38 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.438 0 C-N-CA 124.67 1.188 . . . . 0.0 110.182 169.492 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -42.18 -35.87 1.06 Allowed 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 127.471 2.308 . . . . 0.0 114.253 169.035 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -65.55 -13.54 58.77 Favored Glycine 0 CA--C 1.53 1.02 0 C-N-CA 124.031 0.824 . . . . 0.0 113.506 -179.862 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 28.0 mt-30 -72.28 154.33 41.04 Favored 'General case' 0 N--CA 1.442 -0.84 0 CA-C-N 118.753 1.276 . . . . 0.0 111.372 172.589 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 2.4 p -152.11 161.7 42.23 Favored 'General case' 0 N--CA 1.433 -1.312 0 C-N-CA 129.826 3.25 . . . . 0.0 103.605 167.702 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 49.9 m -112.72 97.01 6.29 Favored 'General case' 0 C--O 1.234 0.287 0 N-CA-C 108.76 -0.83 . . . . 0.0 108.76 -170.444 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -68.84 152.85 96.56 Favored Pre-proline 0 C--O 1.241 0.646 0 N-CA-C 107.558 -1.275 . . . . 0.0 107.558 169.183 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -59.78 135.74 65.71 Favored 'Trans proline' 0 N--CA 1.449 -1.129 0 C-N-CA 121.531 1.487 . . . . 0.0 108.447 170.168 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 2.1 tt -61.77 -19.13 20.59 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.622 0 C-N-CA 123.703 0.801 . . . . 0.0 110.767 -179.445 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 12.8 mt-10 -66.32 -24.37 66.52 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 126.089 1.756 . . . . 0.0 110.669 179.418 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 13.3 t-20 -69.25 -0.45 6.16 Favored 'General case' 0 CA--C 1.546 0.798 0 C-N-CA 124.822 1.249 . . . . 0.0 112.603 176.346 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 14.0 m-85 -137.22 -170.95 2.84 Favored 'General case' 0 C--O 1.236 0.392 0 C-N-CA 127.604 2.362 . . . . 0.0 108.245 -179.155 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 57.0 t-20 -141.08 141.87 34.21 Favored 'General case' 0 N--CA 1.45 -0.46 0 N-CA-C 107.657 -1.238 . . . . 0.0 107.657 169.577 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.544 ' HB2' ' CD2' ' A' ' 90' ' ' TRP . . . -71.8 -28.85 63.88 Favored 'General case' 0 N--CA 1.434 -1.267 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 178.98 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 36.6 t70 -65.86 -20.98 66.42 Favored 'General case' 0 CA--C 1.546 0.799 0 C-N-CA 120.582 -0.447 . . . . 0.0 111.015 -177.806 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -80.18 -28.91 38.64 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 124.677 1.191 . . . . 0.0 111.79 173.999 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 8.0 m-85 -77.57 169.84 17.61 Favored 'General case' 0 C--O 1.238 0.465 0 C-N-CA 125.152 1.381 . . . . 0.0 111.8 179.956 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 23.5 t70 -118.3 -39.98 2.99 Favored 'General case' 0 C--O 1.235 0.33 0 C-N-CA 123.437 0.695 . . . . 0.0 111.606 178.593 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -139.44 134.49 39.73 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.395 0 CA-C-O 121.393 0.616 . . . . 0.0 110.113 -170.111 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 70.5 t -145.52 129.7 11.81 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.495 0 N-CA-C 105.554 -2.017 . . . . 0.0 105.554 179.424 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.615 HD12 ' HB2' ' A' ' 97' ' ' GLU . 11.6 mm -104.85 130.55 55.7 Favored 'Isoleucine or valine' 0 C--O 1.236 0.392 0 N-CA-C 106.759 -1.571 . . . . 0.0 106.759 176.484 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 37.5 m -96.87 91.2 5.53 Favored 'General case' 0 N--CA 1.446 -0.672 0 N-CA-C 104.677 -2.342 . . . . 0.0 104.677 169.028 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 33.9 mt -61.62 -12.86 17.8 Favored 'General case' 0 N--CA 1.465 0.314 0 C-N-CA 123.399 0.68 . . . . 0.0 112.748 -175.368 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 56.7 m -143.54 134.65 25.67 Favored 'General case' 0 N--CA 1.445 -0.696 0 N-CA-C 106.075 -1.824 . . . . 0.0 106.075 179.194 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 57.03 -146.3 36.17 Favored Glycine 0 CA--C 1.533 1.195 0 C-N-CA 123.452 0.548 . . . . 0.0 111.826 178.929 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 19.6 p -127.23 -93.56 0.47 Allowed 'General case' 0 CA--C 1.529 0.172 0 C-N-CA 124.052 0.941 . . . . 0.0 108.822 174.163 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -72.85 -27.5 68.81 Favored Glycine 0 C--N 1.337 0.602 0 CA-C-O 118.898 -0.945 . . . . 0.0 112.482 -178.442 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.441 HG23 ' H ' ' A' ' 85' ' ' ASN 0.325 16.0 m 47.18 -94.04 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.545 0.754 0 C-N-CA 126.404 1.882 . . . . 0.0 112.602 179.452 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 85' ' ' ASN . . . . . 0.441 ' H ' HG23 ' A' ' 84' ' ' VAL . 53.0 t30 -142.91 45.4 1.58 Allowed 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 126.105 1.762 . . . . 0.0 108.068 178.408 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.412 ' HA ' ' HD3' ' A' ' 87' ' ' PRO . 0.3 OUTLIER -143.14 147.08 39.4 Favored Pre-proline 0 CA--C 1.548 0.88 0 C-N-CA 125.408 1.483 . . . . 0.0 110.624 -168.89 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 87' ' ' PRO . . . . . 0.412 ' HD3' ' HA ' ' A' ' 86' ' ' LEU . 51.8 Cg_exo -64.67 150.3 88.4 Favored 'Trans proline' 0 C--N 1.357 1.005 0 C-N-CA 122.08 1.853 . . . . 0.0 114.498 -170.973 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -67.19 -33.52 30.79 Favored 'Trans proline' 0 N--CA 1.458 -0.616 0 C-N-CA 122.795 2.33 . . . . 0.0 116.014 -169.204 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 3.1 pm0 -63.33 -15.26 56.84 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-N 121.573 1.988 . . . . 0.0 112.045 -178.719 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 90' ' ' TRP . . . . . 0.544 ' CD2' ' HB2' ' A' ' 70' ' ' ALA . 98.2 m95 -76.51 -22.95 53.76 Favored 'General case' 0 N--CA 1.452 -0.341 0 CA-C-O 118.835 -0.602 . . . . 0.0 111.953 174.597 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 28.3 m -104.46 -6.85 9.63 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.488 0 C-N-CA 124.832 1.253 . . . . 0.0 113.163 178.023 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . 0.271 9.3 t -112.73 70.62 0.72 Allowed 'General case' 0 CA--C 1.537 0.454 0 CA-C-O 123.441 1.591 . . . . 0.0 107.539 168.899 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 60.4 mm-40 -100.67 179.46 4.41 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 126.545 1.938 . . . . 0.0 109.084 175.067 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 37.7 mm-40 -64.95 -24.18 67.44 Favored 'General case' 0 CA--C 1.539 0.543 0 O-C-N 121.743 -0.598 . . . . 0.0 110.94 179.892 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 6.9 tt -139.63 130.08 31.33 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.354 0 N-CA-C 105.807 -1.923 . . . . 0.0 105.807 169.329 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 36.8 t80 -113.36 135.54 53.75 Favored 'General case' 0 CA--C 1.536 0.41 0 N-CA-C 105.713 -1.958 . . . . 0.0 105.713 169.643 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 97' ' ' GLU . . . . . 0.615 ' HB2' HD12 ' A' ' 77' ' ' ILE . 11.1 mm-40 -142.44 163.29 33.23 Favored 'General case' 0 C--O 1.232 0.165 0 C-N-CA 124.311 1.044 . . . . 0.0 109.524 179.666 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 2.7 t70 -172.46 129.64 0.56 Allowed 'General case' 0 C--O 1.237 0.422 0 C-N-CA 127.594 2.358 . . . . 0.0 107.07 -169.366 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 99' ' ' TRP . . . . . 0.523 ' CZ3' HG21 ' A' ' 77' ' ' ILE . 5.9 m0 -144.58 153.5 41.87 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-O 120.99 0.424 . . . . 0.0 111.936 -170.637 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 2.3 mp0 -87.48 51.87 2.34 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 124.527 1.131 . . . . 0.0 109.456 175.789 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -67.42 134.59 51.7 Favored 'General case' 0 C--N 1.339 0.136 0 N-CA-C 106.5 -1.667 . . . . 0.0 106.5 169.823 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 6.4 pt-20 -83.18 171.55 13.56 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 123.488 0.715 . . . . 0.0 110.192 175.448 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -131.6 133.27 24.1 Favored Pre-proline 0 C--O 1.238 0.459 0 C-N-CA 125.849 1.66 . . . . 0.0 109.804 -169.805 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 10.6 Cg_endo -97.93 2.5 1.41 Allowed 'Trans proline' 0 N--CA 1.451 -1.004 0 C-N-CA 123.003 2.469 . . . . 0.0 113.538 -174.799 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 8.0 t70 -50.61 115.84 1.66 Allowed 'General case' 0 CA--C 1.538 0.518 0 CA-C-N 120.486 1.494 . . . . 0.0 110.787 -174.113 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 67.47 5.5 36.68 Favored Glycine 0 CA--C 1.537 1.434 0 CA-C-O 119.014 -0.881 . . . . 0.0 114.61 178.172 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 5.6 mt-30 -87.32 172.46 9.84 Favored 'General case' 0 CA--C 1.54 0.583 0 CA-C-N 118.998 1.399 . . . . 0.0 109.869 178.495 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 15.5 m -68.95 161.19 29.37 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 123.854 0.862 . . . . 0.0 110.559 176.897 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 28.1 mt -63.36 -24.42 67.84 Favored 'General case' 0 N--CA 1.47 0.561 0 O-C-N 121.491 -0.756 . . . . 0.0 112.499 -173.02 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 6.0 pt-20 -55.19 -35.49 64.89 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 118.875 0.761 . . . . 0.0 111.189 172.346 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 10.9 t -76.82 -42.08 33.02 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.398 0 CA-C-O 118.433 -0.794 . . . . 0.0 109.189 -178.811 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 112' ' ' PHE . . . . . 0.4 ' CG ' ' HG3' ' A' ' 49' ' ' MET . 55.4 m-85 -57.24 -45.36 83.99 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-N 120.222 1.374 . . . . 0.0 110.296 172.529 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 90.9 mtt180 -63.27 -43.82 96.86 Favored 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 123.327 0.651 . . . . 0.0 110.584 179.548 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 4.2 m -62.14 -45.6 92.7 Favored 'General case' 0 N--CA 1.448 -0.542 0 C-N-CA 124.518 1.127 . . . . 0.0 110.275 177.168 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 60.2 t -67.21 -39.34 82.82 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.404 0 CA-C-O 118.593 -0.718 . . . . 0.0 109.25 -174.892 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 44.0 mtm105 -57.41 -42.89 83.2 Favored 'General case' 0 CA--C 1.536 0.431 0 CA-C-N 119.31 0.959 . . . . 0.0 110.397 174.913 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -63.37 -54.13 34.4 Favored Glycine 0 CA--C 1.533 1.158 0 CA-C-O 119.576 -0.569 . . . . 0.0 112.08 177.548 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 13.3 mm-40 -51.65 -51.52 55.11 Favored 'General case' 0 N--CA 1.468 0.47 0 C-N-CA 124.66 1.184 . . . . 0.0 110.204 178.215 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 86.1 t -67.74 -48.17 76.95 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 115.186 -0.916 . . . . 0.0 109.684 -173.114 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 62.0 tttm -55.06 -47.51 74.74 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 119.388 0.995 . . . . 0.0 109.711 -175.033 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -64.68 -43.32 93.93 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 122.917 0.487 . . . . 0.0 111.214 -175.469 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 20.8 mtt180 -75.1 -33.97 61.67 Favored 'General case' 0 N--CA 1.469 0.511 0 O-C-N 121.277 -0.889 . . . . 0.0 111.623 -178.179 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 59.5 t -67.34 -39.8 83.51 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.419 0 N-CA-C 108.62 -0.882 . . . . 0.0 108.62 173.674 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 22.8 mt-10 -59.45 -43.05 93.27 Favored 'General case' 0 N--CA 1.462 0.157 0 CA-C-N 119.938 1.245 . . . . 0.0 110.403 174.112 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 29.2 t-20 -63.55 -43.39 97.19 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 123.151 0.58 . . . . 0.0 111.371 -178.918 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 1.9 tm? -59.1 -47.22 86.06 Favored 'General case' 0 N--CA 1.456 -0.152 0 C-N-CA 125.063 1.345 . . . . 0.0 110.947 175.253 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 84.8 mt -65.17 -46.09 92.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 N-CA-C 108.302 -0.999 . . . . 0.0 108.302 179.985 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -59.23 -29.62 67.65 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 123.431 0.692 . . . . 0.0 112.073 177.099 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 69.1 mttt -69.09 -55.21 11.43 Favored 'General case' 0 C--N 1.343 0.311 0 CA-C-N 119.033 0.833 . . . . 0.0 110.385 172.707 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 17.1 pt -78.7 -36.76 19.87 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.335 0 N-CA-C 114.854 1.427 . . . . 0.0 114.854 -169.609 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 75.3 m . . . . . 0 C--O 1.253 1.26 0 C-N-CA 126.185 1.794 . . . . 0.0 109.117 -169.898 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 12.3 ptm . . . . . 0 N--CA 1.497 1.877 0 CA-C-O 120.17 0.033 . . . . 0.0 110.987 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 26.7 mttm -71.08 127.49 32.75 Favored 'General case' 0 N--CA 1.478 0.945 0 N-CA-C 107.682 -1.229 . . . . 0.0 107.682 -174.496 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 72.7 mttt -97.91 133.71 42.03 Favored 'General case' 0 CA--C 1.512 -0.502 0 CA-C-N 119.785 1.175 . . . . 0.0 108.059 172.199 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.474 HG21 HD12 ' A' ' 30' ' ' ILE . 11.7 t -113.21 151.21 15.12 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.605 0 C-N-CA 127.237 2.215 . . . . 0.0 106.568 -170.916 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 52.3 ttm -146.43 141.94 27.65 Favored 'General case' 0 C--N 1.32 -0.676 0 C-N-CA 125.544 1.538 . . . . 0.0 108.708 174.751 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 47.4 m-85 -131.63 103.72 6.54 Favored 'General case' 0 CA--C 1.519 -0.233 0 N-CA-C 106.088 -1.819 . . . . 0.0 106.088 175.216 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 11.0 t -134.83 137.84 50.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 118.629 0.65 . . . . 0.0 110.812 -168.912 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 44.8 t -121.08 -171.66 2.24 Favored 'General case' 0 CA--C 1.548 0.875 0 N-CA-C 104.594 -2.373 . . . . 0.0 104.594 168.53 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 60.2 mtpt -57.18 -67.62 0.3 Allowed 'General case' 0 N--CA 1.471 0.617 0 CA-C-N 120.007 1.276 . . . . 0.0 111.365 -171.191 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 29.3 ttm-85 -111.8 132.83 54.41 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-N 119.47 1.032 . . . . 0.0 108.221 -178.759 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 12.6 t30 -54.56 -34.84 62.53 Favored 'General case' 0 N--CA 1.478 0.943 0 N-CA-C 114.177 1.177 . . . . 0.0 114.177 -169.665 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 5.7 m -57.94 -20.56 38.5 Favored 'General case' 0 CA--C 1.537 0.464 0 N-CA-C 114.242 1.201 . . . . 0.0 114.242 -170.373 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 21.2 m -134.13 151.79 51.53 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 124.513 1.125 . . . . 0.0 109.652 176.828 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 90.5 mtm-85 55.01 40.78 32.15 Favored 'General case' 0 N--CA 1.467 0.414 0 C-N-CA 126.024 1.729 . . . . 0.0 112.346 175.845 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 13.6 m -136.43 -73.78 0.44 Allowed 'General case' 0 CA--C 1.534 0.353 0 N-CA-C 104.052 -2.573 . . . . 0.0 104.052 169.044 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER 40.89 -109.81 0.11 Allowed 'General case' 0 N--CA 1.454 -0.244 0 C-N-CA 127.607 2.363 . . . . 0.0 112.135 168.017 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -76.54 -14.55 60.01 Favored 'General case' 0 CA--C 1.518 -0.261 0 N-CA-C 113.819 1.044 . . . . 0.0 113.819 -169.964 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -63.86 -50.58 68.27 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 119.608 1.094 . . . . 0.0 111.415 -169.135 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -66.82 -38.07 85.74 Favored 'General case' 0 N--CA 1.467 0.405 0 N-CA-C 109.573 -0.529 . . . . 0.0 109.573 173.39 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -55.69 -55.71 27.43 Favored Glycine 0 C--N 1.338 0.645 0 N-CA-C 110.881 -0.888 . . . . 0.0 110.881 -176.959 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 4.8 m-85 -65.9 -32.17 73.52 Favored 'General case' 0 CA--C 1.506 -0.718 0 CA-C-O 118.587 -0.72 . . . . 0.0 111.787 178.484 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -68.84 -32.92 72.95 Favored 'General case' 0 N--CA 1.446 -0.674 0 CA-C-N 118.965 0.802 . . . . 0.0 110.72 -178.051 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.74 -36.97 86.03 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-N 119.504 1.047 . . . . 0.0 110.066 172.256 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 19.0 m -70.09 -56.89 5.76 Favored 'General case' 0 N--CA 1.45 -0.429 0 C-N-CA 124.236 1.014 . . . . 0.0 112.26 -179.939 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 41.7 mt -75.19 -38.23 60.89 Favored 'General case' 0 N--CA 1.466 0.359 0 C-N-CA 124.809 1.244 . . . . 0.0 109.891 -173.513 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -82.51 4.13 79.38 Favored Glycine 0 CA--C 1.526 0.756 0 C-N-CA 125.585 1.564 . . . . 0.0 113.19 179.796 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -53.79 133.22 42.41 Favored 'General case' 0 C--O 1.236 0.358 0 CA-C-N 118.793 1.297 . . . . 0.0 109.279 178.913 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 70.19 8.57 62.18 Favored Glycine 0 CA--C 1.533 1.196 0 CA-C-O 118.444 -1.198 . . . . 0.0 114.969 177.837 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 9.8 ptpp? -137.01 -36.59 0.67 Allowed 'General case' 0 N--CA 1.473 0.724 0 CA-C-N 119.744 1.772 . . . . 0.0 113.079 179.727 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.474 HD12 HG21 ' A' ' 4' ' ' VAL . 17.6 pt -141.22 148.73 21.06 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.568 0 CA-C-N 119.807 1.185 . . . . 0.0 109.723 -177.477 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -95.26 158.22 15.55 Favored 'General case' 0 N--CA 1.467 0.412 0 C-N-CA 125.322 1.449 . . . . 0.0 108.181 176.81 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 21.7 t -141.34 134.19 30.0 Favored 'Isoleucine or valine' 0 C--O 1.236 0.374 0 N-CA-C 107.872 -1.159 . . . . 0.0 107.872 -176.421 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 26.7 m -147.23 113.41 5.86 Favored 'General case' 0 N--CA 1.44 -0.964 0 N-CA-C 106.751 -1.574 . . . . 0.0 106.751 171.711 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 50.3 m -99.65 97.8 8.72 Favored 'General case' 0 N--CA 1.449 -0.516 0 N-CA-C 108.423 -0.955 . . . . 0.0 108.423 169.578 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 7.7 p -68.07 -66.46 0.56 Allowed 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 125.566 1.546 . . . . 0.0 111.322 -175.952 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 110.17 135.07 6.96 Favored Glycine 0 CA--C 1.523 0.581 0 N-CA-C 108.428 -1.869 . . . . 0.0 108.428 -171.436 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 5.9 mt -70.71 -36.96 73.48 Favored 'General case' 0 CA--C 1.529 0.15 0 N-CA-C 109.003 -0.74 . . . . 0.0 109.003 171.31 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 34.4 mt-10 -126.77 160.97 29.3 Favored 'General case' 0 N--CA 1.445 -0.702 0 C-N-CA 129.624 3.17 . . . . 0.0 105.691 169.259 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 54.6 p -150.86 145.51 25.72 Favored 'General case' 0 N--CA 1.445 -0.715 0 N-CA-C 114.003 1.112 . . . . 0.0 114.003 -173.192 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 3.1 m -147.3 -82.94 0.12 Allowed 'General case' 0 N--CA 1.452 -0.351 0 CA-C-N 113.117 -1.856 . . . . 0.0 108.271 -173.119 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 5.8 ttp180 -159.22 -154.01 0.39 Allowed 'General case' 0 N--CA 1.466 0.339 0 N-CA-C 109.33 -0.619 . . . . 0.0 109.33 -179.29 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 2.9 p -133.12 148.79 31.19 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.7 0 C-N-CA 128.2 2.6 . . . . 0.0 105.529 177.988 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 81.5 t60 -73.38 136.97 78.16 Favored Pre-proline 0 CA--C 1.544 0.725 0 CA-C-O 118.646 -0.692 . . . . 0.0 110.5 -169.759 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 28.6 Cg_endo -60.75 -49.1 9.23 Favored 'Trans proline' 0 C--N 1.35 0.626 0 C-N-CA 123.181 2.587 . . . . 0.0 112.962 -172.918 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 18.5 m -67.05 -20.13 65.79 Favored 'General case' 0 CA--C 1.536 0.416 0 O-C-N 121.95 -0.469 . . . . 0.0 110.526 -177.881 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -59.52 -52.32 66.08 Favored 'General case' 0 CA--C 1.506 -0.737 0 N-CA-C 108.838 -0.801 . . . . 0.0 108.838 173.87 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 60.0 mt -56.89 -42.27 78.05 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 N-CA-C 108.729 -0.841 . . . . 0.0 108.729 -171.621 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -64.23 -47.95 77.7 Favored 'General case' 0 N--CA 1.45 -0.429 0 CA-C-N 117.826 0.285 . . . . 0.0 111.509 -179.798 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 38.9 mmt -69.26 -35.37 76.02 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-O 122.747 1.261 . . . . 0.0 110.76 -178.521 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -73.26 -33.05 65.06 Favored 'General case' 0 N--CA 1.443 -0.82 0 N-CA-C 106.887 -1.523 . . . . 0.0 106.887 -177.662 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 6.6 tp10 -70.24 -20.29 63.08 Favored 'General case' 0 N--CA 1.449 -0.522 0 C-N-CA 123.645 0.778 . . . . 0.0 110.775 170.807 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 81.5 mt-10 -64.26 -38.65 91.8 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-N 119.773 1.17 . . . . 0.0 109.353 169.666 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . 0.306 9.7 p -83.43 7.35 1.55 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.771 0 CA-C-O 120.805 0.336 . . . . 0.0 111.81 171.252 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 74.45 23.57 75.15 Favored Glycine 0 CA--C 1.531 1.071 0 O-C-N 120.838 -1.164 . . . . 0.0 113.028 175.981 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 38.4 mt -117.12 131.88 68.52 Favored 'Isoleucine or valine' 0 C--N 1.338 0.068 0 C-N-CA 124.831 1.252 . . . . 0.0 108.584 -176.552 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 34.6 t0 -101.59 146.39 27.75 Favored 'General case' 0 C--O 1.235 0.318 0 CA-C-O 121.028 0.442 . . . . 0.0 110.238 170.794 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 12.2 pt -135.98 -9.6 0.84 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.461 0 C-N-CA 127.081 2.152 . . . . 0.0 110.836 176.145 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 7.7 t -43.31 131.82 4.6 Favored 'General case' 0 CA--C 1.542 0.663 0 CA-C-N 120.249 1.386 . . . . 0.0 109.325 168.971 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 71.92 38.37 60.24 Favored Glycine 0 CA--C 1.532 1.114 0 CA-C-O 118.917 -0.935 . . . . 0.0 113.082 -177.299 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 29.9 mt-30 -56.25 -40.94 74.95 Favored 'General case' 0 N--CA 1.473 0.679 0 CA-C-N 118.888 1.344 . . . . 0.0 110.478 169.995 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -66.17 134.59 53.06 Favored 'General case' 0 N--CA 1.447 -0.592 0 C-N-CA 124.177 0.991 . . . . 0.0 109.413 -170.0 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 2.9 p -140.2 -68.77 0.41 Allowed 'General case' 0 C--O 1.233 0.226 0 C-N-CA 124.018 0.927 . . . . 0.0 108.929 -169.657 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -148.54 154.6 41.45 Favored Pre-proline 0 C--O 1.238 0.484 0 C-N-CA 126.021 1.728 . . . . 0.0 107.478 174.595 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -62.71 151.81 81.7 Favored 'Trans proline' 0 N--CA 1.456 -0.734 0 C-N-CA 121.831 1.687 . . . . 0.0 109.34 170.027 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 18.2 tt -56.19 -28.78 26.17 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.439 0 C-N-CA 123.25 0.62 . . . . 0.0 111.741 -178.687 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 11.4 mt-10 -66.72 -26.69 67.12 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 124.563 1.145 . . . . 0.0 110.689 -174.83 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 11.2 t-20 -63.6 -30.97 72.0 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 124.833 1.253 . . . . 0.0 111.611 178.424 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 94.1 m-85 -92.12 -178.11 4.88 Favored 'General case' 0 C--O 1.235 0.328 0 C-N-CA 125.269 1.428 . . . . 0.0 111.139 -176.61 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 54.6 t-20 -124.11 137.77 54.52 Favored 'General case' 0 N--CA 1.443 -0.79 0 N-CA-C 106.756 -1.572 . . . . 0.0 106.756 168.654 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.457 ' HB2' ' CD2' ' A' ' 90' ' ' TRP . . . -73.58 -24.4 60.07 Favored 'General case' 0 N--CA 1.433 -1.29 0 N-CA-C 109.187 -0.671 . . . . 0.0 109.187 -178.048 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 36.1 t70 -67.32 -20.56 65.62 Favored 'General case' 0 N--CA 1.447 -0.618 0 C-N-CA 121.221 -0.192 . . . . 0.0 111.474 -178.611 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 37.1 t70 -75.75 -29.07 58.73 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 123.526 0.73 . . . . 0.0 111.61 175.186 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 33.0 m-85 -80.17 167.24 20.6 Favored 'General case' 0 N--CA 1.45 -0.433 0 C-N-CA 125.058 1.343 . . . . 0.0 110.613 176.558 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 24.2 t70 -117.29 -35.4 4.04 Favored 'General case' 0 C--O 1.237 0.401 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.169 175.241 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -140.04 134.77 36.99 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.697 0 CA-C-O 121.922 0.868 . . . . 0.0 108.676 -173.399 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 88.7 t -143.36 137.72 25.9 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.604 0 N-CA-C 105.786 -1.931 . . . . 0.0 105.786 178.929 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.658 HD12 ' HB2' ' A' ' 97' ' ' GLU . 20.6 mm -112.75 127.3 70.06 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.727 0 N-CA-C 105.781 -1.933 . . . . 0.0 105.781 177.188 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 70.6 m -89.32 99.83 12.74 Favored 'General case' 0 N--CA 1.441 -0.918 0 N-CA-C 104.196 -2.52 . . . . 0.0 104.196 169.225 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 38.3 mt -69.56 -2.04 10.38 Favored 'General case' 0 N--CA 1.464 0.244 0 O-C-N 121.484 -0.76 . . . . 0.0 112.386 -178.578 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 85.4 m -139.58 135.05 32.96 Favored 'General case' 0 N--CA 1.441 -0.887 0 N-CA-C 106.988 -1.486 . . . . 0.0 106.988 170.149 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 48.43 -142.18 8.59 Favored Glycine 0 CA--C 1.535 1.301 0 C-N-CA 125.148 1.356 . . . . 0.0 113.148 175.123 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 13.2 m -127.48 -85.64 0.59 Allowed 'General case' 0 CA--C 1.529 0.165 0 N-CA-C 107.585 -1.265 . . . . 0.0 107.585 175.993 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -84.55 66.66 3.84 Favored Glycine 0 C--N 1.338 0.694 0 N-CA-C 110.145 -1.182 . . . . 0.0 110.145 175.226 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 6.5 m -77.78 65.28 0.26 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.575 0 C-N-CA 124.071 0.948 . . . . 0.0 110.891 -178.094 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 52.1 t30 54.36 54.05 10.0 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 126.4 1.88 . . . . 0.0 108.249 -172.611 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -133.14 142.32 44.03 Favored Pre-proline 0 CA--C 1.539 0.544 0 C-N-CA 126.604 1.962 . . . . 0.0 108.506 -168.867 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -66.97 135.38 37.53 Favored 'Trans proline' 0 CA--C 1.541 0.857 0 C-N-CA 121.798 1.665 . . . . 0.0 110.611 176.6 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 42.1 Cg_endo -63.24 -23.99 72.4 Favored 'Trans proline' 0 N--CA 1.461 -0.439 0 C-N-CA 122.746 2.297 . . . . 0.0 114.315 -169.721 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 5.7 pm0 -56.21 -21.67 24.67 Favored 'General case' 0 CA--C 1.539 0.521 0 CA-C-N 119.529 1.059 . . . . 0.0 112.133 175.95 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 90' ' ' TRP . . . . . 0.457 ' CD2' ' HB2' ' A' ' 70' ' ' ALA . 99.3 m95 -82.64 -21.78 34.91 Favored 'General case' 0 N--CA 1.454 -0.251 0 N-CA-C 113.13 0.789 . . . . 0.0 113.13 179.979 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 5.5 m -92.94 -34.86 6.19 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.351 0 CA-C-N 120.117 1.326 . . . . 0.0 110.998 172.518 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . 0.266 6.3 t -87.22 46.01 1.33 Allowed 'General case' 0 CA--C 1.548 0.869 0 CA-C-O 123.409 1.576 . . . . 0.0 110.497 -174.85 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 68.6 mm-40 -79.0 -178.81 6.3 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 126.851 2.061 . . . . 0.0 109.218 171.338 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 35.1 mm-40 -67.22 -18.38 65.21 Favored 'General case' 0 CA--C 1.539 0.554 0 O-C-N 121.572 -0.705 . . . . 0.0 111.87 -178.629 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 7.4 tt -143.2 135.03 24.02 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.381 0 C-N-CA 125.642 1.577 . . . . 0.0 106.88 170.035 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 32.4 t80 -110.21 135.26 51.25 Favored 'General case' 0 CA--C 1.535 0.373 0 N-CA-C 106.186 -1.783 . . . . 0.0 106.186 169.386 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 97' ' ' GLU . . . . . 0.658 ' HB2' HD12 ' A' ' 77' ' ' ILE . 31.2 mm-40 -144.73 164.09 32.04 Favored 'General case' 0 C--O 1.238 0.452 0 C-N-CA 123.971 0.908 . . . . 0.0 108.689 170.21 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -169.87 130.67 1.02 Allowed 'General case' 0 N--CA 1.45 -0.458 0 C-N-CA 127.969 2.508 . . . . 0.0 106.889 -170.585 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 99' ' ' TRP . . . . . 0.411 ' CZ3' HG21 ' A' ' 77' ' ' ILE . 5.1 m-90 -150.14 141.21 23.01 Favored 'General case' 0 N--CA 1.453 -0.315 0 N-CA-C 107.947 -1.131 . . . . 0.0 107.947 -171.231 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 63.0 tt0 -82.26 77.98 8.99 Favored 'General case' 0 CA--C 1.536 0.416 0 N-CA-C 108.219 -1.03 . . . . 0.0 108.219 179.095 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 10.1 mp -71.51 119.1 15.18 Favored 'General case' 0 N--CA 1.462 0.157 0 N-CA-C 107.023 -1.473 . . . . 0.0 107.023 171.056 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -79.35 112.91 17.05 Favored 'General case' 0 N--CA 1.449 -0.524 0 N-CA-C 106.085 -1.821 . . . . 0.0 106.085 170.069 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 11.2 t70 -76.32 133.99 70.87 Favored Pre-proline 0 C--O 1.239 0.501 0 CA-C-O 118.928 -0.558 . . . . 0.0 109.833 -177.021 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -78.7 3.13 7.55 Favored 'Trans proline' 0 CA--C 1.545 1.071 0 C-N-CA 123.01 2.473 . . . . 0.0 113.971 -177.435 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 2.1 t70 -36.7 112.68 0.2 Allowed 'General case' 0 C--O 1.239 0.538 0 C-N-CA 126.196 1.798 . . . . 0.0 111.778 171.876 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 68.58 5.31 43.64 Favored Glycine 0 CA--C 1.537 1.462 0 CA-C-O 118.813 -0.993 . . . . 0.0 115.038 175.172 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 33.7 mm-40 -80.47 174.37 11.67 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-N 119.41 1.605 . . . . 0.0 110.45 178.412 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 15.3 m -68.96 156.9 37.77 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 123.729 0.811 . . . . 0.0 109.9 169.683 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -65.15 -26.25 68.09 Favored 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 123.429 0.692 . . . . 0.0 111.641 -172.29 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 6.9 pt-20 -56.33 -34.85 66.95 Favored 'General case' 0 N--CA 1.462 0.164 0 C-N-CA 123.29 0.636 . . . . 0.0 111.279 173.072 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 13.2 t -76.89 -45.59 31.05 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.362 0 CA-C-O 118.27 -0.871 . . . . 0.0 108.987 -176.724 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 67.2 m-85 -50.62 -50.45 54.15 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-N 119.691 1.132 . . . . 0.0 110.211 169.643 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 94.5 mtt180 -69.4 -34.6 74.74 Favored 'General case' 0 N--CA 1.466 0.349 0 O-C-N 121.887 -0.508 . . . . 0.0 110.901 -173.291 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 2.7 m -61.56 -49.64 75.86 Favored 'General case' 0 N--CA 1.45 -0.452 0 C-N-CA 124.162 0.985 . . . . 0.0 109.407 169.947 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 81.7 t -70.35 -27.18 30.83 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.182 0 CA-C-O 118.417 -0.801 . . . . 0.0 109.761 -170.972 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 14.2 mtm105 -56.72 -48.98 76.54 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-N 119.644 1.111 . . . . 0.0 109.646 169.956 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -63.02 -48.18 82.56 Favored Glycine 0 CA--C 1.527 0.784 0 N-CA-C 111.614 -0.594 . . . . 0.0 111.614 179.235 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 9.9 mt-30 -62.29 -45.41 93.37 Favored 'General case' 0 C--N 1.342 0.24 0 CA-C-N 117.676 0.738 . . . . 0.0 110.952 -177.209 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 86.9 t -67.75 -42.32 86.09 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.189 0 CA-C-O 118.229 -0.891 . . . . 0.0 110.557 -178.911 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 59.1 tttm -53.81 -46.6 71.15 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 119.307 0.958 . . . . 0.0 109.337 179.908 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -65.19 -43.52 91.37 Favored 'General case' 0 N--CA 1.45 -0.464 0 C-N-CA 122.964 0.506 . . . . 0.0 111.139 -175.97 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 49.4 mtt-85 -65.5 -44.54 86.7 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-N 118.719 0.69 . . . . 0.0 111.303 178.554 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 98.0 t -66.15 -40.19 86.41 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.472 0 N-CA-C 109.204 -0.665 . . . . 0.0 109.204 179.024 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 16.6 mt-10 -60.25 -42.52 95.5 Favored 'General case' 0 N--CA 1.46 0.047 0 CA-C-N 119.751 1.16 . . . . 0.0 110.488 176.153 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 29.0 t-20 -62.68 -44.67 95.66 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 122.712 0.405 . . . . 0.0 110.998 178.977 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 34.8 tp -58.08 -49.2 77.75 Favored 'General case' 0 N--CA 1.455 -0.208 0 C-N-CA 124.26 1.024 . . . . 0.0 110.772 176.992 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 89.8 mt -63.55 -44.62 98.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 N-CA-C 108.043 -1.095 . . . . 0.0 108.043 -179.524 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -61.07 -28.37 69.03 Favored 'General case' 0 CA--C 1.54 0.58 0 CA-C-N 118.654 0.661 . . . . 0.0 112.19 177.545 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 93.5 mttt -70.03 -56.13 7.76 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-N 119.391 0.996 . . . . 0.0 110.69 171.183 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 14.9 pt -78.13 -44.41 27.59 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.424 0 N-CA-C 114.969 1.47 . . . . 0.0 114.969 -168.925 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 69.8 m . . . . . 0 C--O 1.252 1.217 0 C-N-CA 126.011 1.724 . . . . 0.0 109.945 -169.772 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.497 1.906 0 N-CA-C 110.365 -0.235 . . . . 0.0 110.365 . . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 31.2 mttm -79.1 118.64 21.25 Favored 'General case' 0 N--CA 1.474 0.742 0 N-CA-C 105.787 -1.931 . . . . 0.0 105.787 171.84 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 89.2 mttt -86.06 134.11 33.85 Favored 'General case' 0 CA--C 1.513 -0.464 0 N-CA-C 107.69 -1.226 . . . . 0.0 107.69 178.465 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 1.5 t -119.8 148.82 22.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 C-N-CA 125.535 1.534 . . . . 0.0 109.0 -169.006 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 3.2 mtt -135.88 146.82 47.81 Favored 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 125.872 1.669 . . . . 0.0 108.434 169.255 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 90.6 m-85 -132.5 95.42 3.62 Favored 'General case' 0 N--CA 1.457 -0.099 0 N-CA-C 105.165 -2.161 . . . . 0.0 105.165 171.495 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 42.3 t -131.29 129.98 62.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 N-CA-C 109.675 -0.491 . . . . 0.0 109.675 -169.049 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 41.1 t -99.07 -177.76 3.72 Favored 'General case' 0 CA--C 1.547 0.857 0 C-N-CA 125.754 1.622 . . . . 0.0 106.922 169.101 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -56.48 -39.2 72.82 Favored 'General case' 0 N--CA 1.478 0.932 0 O-C-N 120.587 -1.32 . . . . 0.0 111.292 -176.532 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 79.1 mtp180 -119.89 168.65 10.9 Favored 'General case' 0 N--CA 1.465 0.308 0 N-CA-C 107.106 -1.442 . . . . 0.0 107.106 169.156 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 29.1 t30 -65.13 -28.61 69.55 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 120.563 -0.455 . . . . 0.0 110.784 169.601 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 1.5 m -56.15 124.15 16.9 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 125.165 1.386 . . . . 0.0 110.548 179.644 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 8.5 m 65.72 150.2 0.05 OUTLIER 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 126.256 1.822 . . . . 0.0 113.302 178.872 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 1.5 mmm180 68.34 -58.33 0.47 Allowed 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 127.455 2.302 . . . . 0.0 111.869 177.12 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 1.7 m -63.83 -17.15 62.83 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 125.436 1.495 . . . . 0.0 112.719 -175.214 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 21.7 pt20 -62.17 -63.01 1.38 Allowed 'General case' 0 C--N 1.343 0.289 0 CA-C-N 119.285 0.948 . . . . 0.0 111.585 176.7 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 1.1 tpt -78.56 -32.57 47.85 Favored 'General case' 0 N--CA 1.465 0.291 0 O-C-N 121.56 -0.713 . . . . 0.0 112.209 -169.61 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -64.58 -51.38 63.03 Favored 'General case' 0 N--CA 1.469 0.488 0 N-CA-C 112.346 0.499 . . . . 0.0 112.346 -170.955 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -65.68 -31.45 72.47 Favored 'General case' 0 N--CA 1.469 0.491 0 O-C-N 121.505 -0.747 . . . . 0.0 110.198 172.811 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -49.12 -55.42 12.14 Favored Glycine 0 C--N 1.342 0.895 0 C-N-CA 125.89 1.709 . . . . 0.0 110.518 175.149 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 8.8 m-85 -73.99 -29.74 62.13 Favored 'General case' 0 CA--C 1.508 -0.655 0 CA-C-N 119.072 1.436 . . . . 0.0 113.811 178.806 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -67.85 -31.7 71.71 Favored 'General case' 0 N--CA 1.451 -0.408 0 C-N-CA 119.459 -0.896 . . . . 0.0 111.318 -169.989 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 6.7 ptpt -62.06 -34.35 76.1 Favored 'General case' 0 N--CA 1.476 0.835 0 CA-C-N 119.252 0.933 . . . . 0.0 111.498 172.108 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 12.2 m -76.46 -55.42 5.55 Favored 'General case' 0 N--CA 1.447 -0.601 0 C-N-CA 125.373 1.469 . . . . 0.0 110.183 -175.939 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 75.3 mt -74.74 -35.63 62.63 Favored 'General case' 0 CA--C 1.531 0.213 0 C-N-CA 123.455 0.702 . . . . 0.0 110.328 -174.022 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -93.04 6.81 76.45 Favored Glycine 0 CA--C 1.526 0.722 0 C-N-CA 125.118 1.342 . . . . 0.0 113.285 -175.317 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -49.67 125.45 11.57 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 125.113 1.365 . . . . 0.0 110.881 -175.105 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 76.33 -8.1 27.35 Favored Glycine 0 CA--C 1.535 1.343 0 C-N-CA 124.452 1.025 . . . . 0.0 114.287 178.801 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 64.3 mttm -102.83 -49.93 3.67 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-N 119.421 1.61 . . . . 0.0 110.384 -179.711 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 25.3 pt -136.2 149.09 27.27 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.385 0 C-N-CA 123.669 0.788 . . . . 0.0 110.34 -169.37 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -111.58 104.47 12.87 Favored 'General case' 0 C--O 1.227 -0.123 0 C-N-CA 124.962 1.305 . . . . 0.0 109.844 -169.332 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 6.5 t -87.02 132.08 33.33 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 C-N-CA 123.471 0.708 . . . . 0.0 109.669 -175.957 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 20.5 m -144.96 110.81 5.42 Favored 'General case' 0 N--CA 1.446 -0.658 0 N-CA-C 104.623 -2.362 . . . . 0.0 104.623 169.963 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 51.8 m -107.18 81.53 1.55 Allowed 'General case' 0 N--CA 1.463 0.205 0 CA-C-N 119.611 1.096 . . . . 0.0 108.233 179.661 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 3.8 m -61.16 -39.79 91.43 Favored 'General case' 0 CA--C 1.532 0.274 0 N-CA-C 114.289 1.218 . . . . 0.0 114.289 -169.261 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 92.91 137.81 8.36 Favored Glycine 0 C--N 1.338 0.671 0 N-CA-C 109.107 -1.597 . . . . 0.0 109.107 176.912 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 15.5 mt -74.51 -34.01 62.94 Favored 'General case' 0 C--N 1.331 -0.199 0 C-N-CA 124.108 0.963 . . . . 0.0 108.794 176.774 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 26.3 mt-10 -141.33 156.79 45.81 Favored 'General case' 0 N--CA 1.443 -0.805 0 C-N-CA 128.28 2.632 . . . . 0.0 105.984 168.926 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 60.9 p -109.79 148.33 31.66 Favored 'General case' 0 N--CA 1.441 -0.922 0 CA-C-O 123.106 1.431 . . . . 0.0 112.937 -175.116 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 17.1 m -170.35 162.13 8.34 Favored 'General case' 0 N--CA 1.447 -0.608 0 C-N-CA 129.389 3.076 . . . . 0.0 103.752 -169.856 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 41' ' ' ARG . . . . . 0.433 ' HG3' ' H ' ' A' ' 42' ' ' VAL . 6.9 tpt180 -92.14 -155.93 0.44 Allowed 'General case' 0 N--CA 1.467 0.416 0 O-C-N 121.053 -1.029 . . . . 0.0 109.656 -173.039 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.433 ' H ' ' HG3' ' A' ' 41' ' ' ARG . 0.6 OUTLIER -131.87 156.67 42.75 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 C-N-CA 129.009 2.924 . . . . 0.0 107.064 -169.446 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 62.4 m80 -85.79 144.53 39.71 Favored Pre-proline 0 N--CA 1.468 0.459 0 N-CA-C 112.317 0.488 . . . . 0.0 112.317 -169.071 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -65.06 -45.07 8.44 Favored 'Trans proline' 0 C--N 1.348 0.546 0 C-N-CA 122.904 2.403 . . . . 0.0 111.834 -176.172 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 6.5 m -69.57 -28.06 65.66 Favored 'General case' 0 CA--C 1.531 0.233 0 CA-C-O 118.977 -0.535 . . . . 0.0 110.002 179.575 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -60.46 -54.33 46.86 Favored 'General case' 0 CA--C 1.507 -0.691 0 N-CA-C 107.882 -1.155 . . . . 0.0 107.882 171.183 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 56.7 mt -58.1 -40.21 76.11 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 N-CA-C 108.657 -0.868 . . . . 0.0 108.657 -173.828 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -63.37 -49.3 74.39 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-N 118.555 0.616 . . . . 0.0 111.61 179.046 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 28.1 mmt -66.23 -36.5 83.2 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-O 122.98 1.371 . . . . 0.0 110.895 -179.712 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -78.25 -30.82 48.85 Favored 'General case' 0 N--CA 1.441 -0.875 0 N-CA-C 107.416 -1.327 . . . . 0.0 107.416 -173.335 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 41.2 tt0 -71.95 -22.14 61.5 Favored 'General case' 0 N--CA 1.447 -0.598 0 C-N-CA 123.815 0.846 . . . . 0.0 110.228 169.986 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 16.8 mm-40 -68.19 -30.73 69.89 Favored 'General case' 0 CA--C 1.534 0.361 0 CA-C-N 119.487 1.039 . . . . 0.0 110.23 171.62 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . 0.276 9.3 p -89.34 10.0 2.43 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.035 0 CA-C-N 118.514 0.597 . . . . 0.0 111.114 168.914 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 78.18 16.28 79.89 Favored Glycine 0 CA--C 1.532 1.121 0 C-N-CA 124.956 1.265 . . . . 0.0 113.76 173.8 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 13.5 mt -102.2 141.35 18.57 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.237 0 C-N-CA 124.453 1.101 . . . . 0.0 110.555 -173.574 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -94.71 137.29 33.99 Favored 'General case' 0 C--O 1.235 0.312 0 C-N-CA 124.417 1.087 . . . . 0.0 108.26 169.817 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 7.0 pt -138.04 -30.0 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.544 0 C-N-CA 124.543 1.137 . . . . 0.0 110.538 170.095 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -23.53 -38.32 0.0 OUTLIER 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 130.054 3.341 . . . . 0.0 117.045 169.563 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -98.64 31.26 8.32 Favored Glycine 0 CA--C 1.536 1.383 0 C-N-CA 125.543 1.544 . . . . 0.0 115.349 -175.205 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 12.7 mt-30 -62.0 -31.42 71.79 Favored 'General case' 0 N--CA 1.476 0.846 0 CA-C-N 120.088 1.944 . . . . 0.0 113.956 -174.336 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -70.34 122.16 19.04 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 123.059 0.544 . . . . 0.0 110.517 -169.158 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 74.9 m -151.91 -167.9 2.91 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 127.03 2.132 . . . . 0.0 107.417 -171.292 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -51.58 143.55 20.0 Favored Pre-proline 0 CA--C 1.539 0.528 0 C-N-CA 123.967 0.907 . . . . 0.0 110.402 170.51 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 84.5 Cg_endo -70.92 160.73 48.43 Favored 'Trans proline' 0 N--CA 1.456 -0.683 0 C-N-CA 122.883 2.389 . . . . 0.0 110.326 172.941 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 11.9 tt -60.86 -20.45 21.74 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.447 0 C-N-CA 123.889 0.876 . . . . 0.0 112.246 -179.878 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 25.9 tt0 -66.5 -28.6 68.69 Favored 'General case' 0 N--CA 1.434 -1.256 0 C-N-CA 124.768 1.227 . . . . 0.0 110.516 -176.558 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 74.9 m-20 -80.54 -1.44 41.96 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 124.305 1.042 . . . . 0.0 112.387 179.115 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 85.5 m-85 -110.76 177.19 4.75 Favored 'General case' 0 C--O 1.234 0.278 0 C-N-CA 125.698 1.599 . . . . 0.0 110.925 179.204 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 50.4 t-20 -128.66 135.76 49.72 Favored 'General case' 0 N--CA 1.448 -0.532 0 N-CA-C 108.175 -1.046 . . . . 0.0 108.175 169.297 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.589 ' HB2' ' CD2' ' A' ' 90' ' ' TRP . . . -73.28 -24.63 60.45 Favored 'General case' 0 N--CA 1.435 -1.184 0 N-CA-C 109.25 -0.648 . . . . 0.0 109.25 -178.473 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 35.5 t70 -66.2 -21.78 66.32 Favored 'General case' 0 N--CA 1.445 -0.696 0 C-N-CA 120.644 -0.422 . . . . 0.0 111.091 -177.59 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 35.2 t70 -77.42 -27.95 52.48 Favored 'General case' 0 C--N 1.345 0.393 0 C-N-CA 123.617 0.767 . . . . 0.0 111.584 174.144 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 14.1 m-85 -80.17 167.55 20.21 Favored 'General case' 0 C--O 1.239 0.53 0 C-N-CA 125.39 1.476 . . . . 0.0 111.392 -179.552 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -117.03 -39.18 3.26 Favored 'General case' 0 C--O 1.235 0.312 0 C-N-CA 123.338 0.655 . . . . 0.0 111.668 177.953 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -138.01 133.56 44.38 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.406 0 C-N-CA 123.866 0.866 . . . . 0.0 109.881 -170.871 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 66.6 t -140.79 125.63 18.55 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.402 0 N-CA-C 105.72 -1.956 . . . . 0.0 105.72 178.306 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.557 HD12 ' HB2' ' A' ' 97' ' ' GLU . 7.5 mm -96.24 125.26 49.15 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.545 0 N-CA-C 105.333 -2.099 . . . . 0.0 105.333 170.071 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 59.6 m -93.36 91.81 7.37 Favored 'General case' 0 N--CA 1.443 -0.811 0 N-CA-C 104.123 -2.547 . . . . 0.0 104.123 169.662 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 23.0 mt -63.08 -12.68 28.54 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-O 118.321 -0.847 . . . . 0.0 112.771 -173.206 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 39.3 m -142.94 126.53 16.88 Favored 'General case' 0 N--CA 1.445 -0.684 0 N-CA-C 106.634 -1.617 . . . . 0.0 106.634 174.43 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 58.44 -148.55 37.51 Favored Glycine 0 CA--C 1.534 1.227 0 C-N-CA 123.613 0.625 . . . . 0.0 112.183 177.488 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 14.0 p -139.2 -79.11 0.33 Allowed 'General case' 0 CA--C 1.529 0.165 0 C-N-CA 124.173 0.989 . . . . 0.0 108.727 175.865 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -79.24 53.24 4.16 Favored Glycine 0 CA--C 1.526 0.756 0 C-N-CA 125.498 1.523 . . . . 0.0 112.096 -178.429 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 16.3 m -81.21 60.83 0.2 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.71 0 C-N-CA 124.868 1.267 . . . . 0.0 110.802 -173.984 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 50.1 t30 56.2 59.74 3.54 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 125.944 1.698 . . . . 0.0 108.374 -172.41 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -136.69 143.14 41.63 Favored Pre-proline 0 CA--C 1.544 0.729 0 C-N-CA 126.223 1.809 . . . . 0.0 108.845 -168.925 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_exo -67.13 136.77 41.89 Favored 'Trans proline' 0 CA--C 1.542 0.909 0 C-N-CA 122.555 2.17 . . . . 0.0 111.353 172.973 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 42.4 Cg_endo -63.66 -25.84 69.0 Favored 'Trans proline' 0 N--CA 1.46 -0.474 0 C-N-CA 122.778 2.319 . . . . 0.0 114.821 -169.663 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 6.4 pm0 -57.42 -20.61 31.19 Favored 'General case' 0 CA--C 1.539 0.528 0 CA-C-N 120.149 1.341 . . . . 0.0 112.272 177.345 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 90' ' ' TRP . . . . . 0.589 ' CD2' ' HB2' ' A' ' 70' ' ' ALA . 99.9 m95 -79.28 -23.41 43.61 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-O 118.726 -0.654 . . . . 0.0 112.629 178.657 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 6.5 m -104.67 -8.87 9.77 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.156 0 C-N-CA 124.669 1.188 . . . . 0.0 113.03 -179.818 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . 0.266 6.6 t -111.57 45.58 1.2 Allowed 'General case' 0 CA--C 1.544 0.713 0 CA-C-O 123.142 1.448 . . . . 0.0 110.104 172.299 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 56.2 mm-40 -73.47 177.42 5.3 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 124.919 1.288 . . . . 0.0 109.73 169.936 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 34.9 mm-40 -65.49 -21.73 66.66 Favored 'General case' 0 CA--C 1.538 0.503 0 O-C-N 121.844 -0.535 . . . . 0.0 111.225 -179.626 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 4.6 tt -140.26 131.14 30.33 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.334 0 C-N-CA 126.241 1.816 . . . . 0.0 106.439 169.871 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 35.2 t80 -109.57 136.36 49.07 Favored 'General case' 0 CA--C 1.539 0.528 0 N-CA-C 106.272 -1.751 . . . . 0.0 106.272 169.487 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 97' ' ' GLU . . . . . 0.557 ' HB2' HD12 ' A' ' 77' ' ' ILE . 10.7 mm-40 -142.2 162.55 35.18 Favored 'General case' 0 C--O 1.234 0.287 0 C-N-CA 124.429 1.091 . . . . 0.0 108.871 175.83 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 2.5 t70 -175.27 129.62 0.28 Allowed 'General case' 0 C--O 1.236 0.368 0 C-N-CA 127.014 2.126 . . . . 0.0 106.918 -169.802 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 99' ' ' TRP . . . . . 0.53 ' CZ3' HG21 ' A' ' 77' ' ' ILE . 6.5 m0 -143.69 140.47 30.05 Favored 'General case' 0 CA--C 1.522 -0.119 0 C-N-CA 122.826 0.45 . . . . 0.0 110.057 -171.853 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 31.3 mm-40 -84.57 59.79 5.69 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-O 121.653 0.739 . . . . 0.0 109.159 171.786 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.47 HD13 HG22 ' A' ' 119' ' ' VAL . 16.6 mt -64.68 138.67 58.53 Favored 'General case' 0 CA--C 1.529 0.14 0 N-CA-C 108.233 -1.025 . . . . 0.0 108.233 172.471 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 34.3 mm-40 -68.65 161.15 28.78 Favored 'General case' 0 N--CA 1.451 -0.397 0 N-CA-C 108.265 -1.013 . . . . 0.0 108.265 168.901 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -130.97 131.45 23.24 Favored Pre-proline 0 N--CA 1.45 -0.456 0 N-CA-C 107.341 -1.355 . . . . 0.0 107.341 169.352 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 67.9 Cg_endo -78.9 -3.9 13.57 Favored 'Trans proline' 0 CA--C 1.545 1.043 0 C-N-CA 122.125 1.883 . . . . 0.0 114.729 -169.867 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -51.26 129.38 24.5 Favored 'General case' 0 CA--C 1.537 0.443 0 CA-C-N 119.996 1.271 . . . . 0.0 111.05 177.606 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 72.71 11.1 77.39 Favored Glycine 0 CA--C 1.533 1.206 0 CA-C-O 118.758 -1.023 . . . . 0.0 114.127 171.942 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 29.7 pt20 -136.66 -171.12 2.84 Favored 'General case' 0 CA--C 1.542 0.659 0 CA-C-N 118.991 1.395 . . . . 0.0 111.302 176.245 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 1.9 m -68.34 158.3 33.8 Favored 'General case' 0 CA--C 1.533 0.327 0 N-CA-C 117.641 2.46 . . . . 0.0 117.641 -167.563 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 55.7 tp -54.42 -34.16 60.83 Favored 'General case' 0 C--N 1.344 0.33 0 C-N-CA 126.917 2.087 . . . . 0.0 111.451 170.144 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 29.5 tp10 -64.73 -29.32 70.3 Favored 'General case' 0 C--N 1.331 -0.235 0 O-C-N 122.028 -0.42 . . . . 0.0 110.796 177.491 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 4.1 t -76.83 -37.1 27.25 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.385 0 CA-C-O 117.866 -1.064 . . . . 0.0 110.21 175.471 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 59.3 m-85 -56.21 -49.36 74.31 Favored 'General case' 0 N--CA 1.474 0.727 0 CA-C-N 120.738 1.608 . . . . 0.0 109.656 170.121 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 77.0 mtt180 -58.99 -44.07 91.54 Favored 'General case' 0 N--CA 1.468 0.432 0 C-N-CA 123.501 0.72 . . . . 0.0 110.691 178.319 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 18.5 m -65.5 -49.24 69.76 Favored 'General case' 0 N--CA 1.445 -0.714 0 C-N-CA 124.261 1.025 . . . . 0.0 110.07 -179.962 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 63.8 t -67.69 -35.84 74.06 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.191 0 CA-C-N 119.42 1.009 . . . . 0.0 109.353 -172.128 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 45.8 ttp85 -58.23 -39.9 80.28 Favored 'General case' 0 CA--C 1.539 0.553 0 CA-C-N 118.405 0.548 . . . . 0.0 109.808 173.585 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -66.81 -53.41 27.51 Favored Glycine 0 CA--C 1.533 1.218 0 C-N-CA 123.698 0.666 . . . . 0.0 112.566 172.809 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 72.2 mt-30 -55.08 -48.35 73.64 Favored 'General case' 0 N--CA 1.469 0.5 0 CA-C-O 122.184 0.992 . . . . 0.0 110.0 -176.137 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 119' ' ' VAL . . . . . 0.47 HG22 HD13 ' A' ' 101' ' ' LEU . 97.0 t -74.48 -37.01 43.45 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.439 0 CA-C-O 117.738 -1.125 . . . . 0.0 109.786 -171.563 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -55.47 -46.58 76.83 Favored 'General case' 0 C--O 1.224 -0.288 0 CA-C-N 120.112 1.324 . . . . 0.0 108.585 172.198 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 41.5 tt0 -66.43 -43.04 86.79 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 122.458 0.303 . . . . 0.0 111.205 -175.121 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 38.5 mmt180 -62.44 -45.55 92.58 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-N 119.069 0.85 . . . . 0.0 111.01 176.18 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 97.2 t -69.14 -37.68 76.92 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.578 0 N-CA-C 109.196 -0.668 . . . . 0.0 109.196 -177.219 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 20.2 mt-10 -59.85 -44.79 93.92 Favored 'General case' 0 N--CA 1.457 -0.12 0 CA-C-N 119.346 0.975 . . . . 0.0 110.09 173.556 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 25.9 t-20 -65.02 -42.24 94.57 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 123.169 0.588 . . . . 0.0 111.641 -178.487 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 1.6 tm? -58.31 -48.39 80.67 Favored 'General case' 0 C--O 1.228 -0.068 0 C-N-CA 126.323 1.849 . . . . 0.0 110.752 174.035 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 63.4 mt -66.04 -47.75 83.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 N-CA-C 108.658 -0.867 . . . . 0.0 108.658 179.598 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -58.52 -31.21 67.7 Favored 'General case' 0 CA--C 1.535 0.381 0 CA-C-O 118.849 -0.596 . . . . 0.0 112.145 -176.851 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 17.3 ptpt -81.59 -39.62 24.26 Favored 'General case' 0 C--N 1.344 0.364 0 CA-C-O 117.786 -1.102 . . . . 0.0 112.486 176.53 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 11.8 pt -81.67 -37.42 15.24 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.287 0 CA-C-N 119.931 1.242 . . . . 0.0 113.725 -176.039 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 72.4 m . . . . . 0 C--O 1.253 1.288 0 C-N-CA 125.638 1.575 . . . . 0.0 109.764 -169.985 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.499 1.985 0 N-CA-C 110.411 -0.218 . . . . 0.0 110.411 . . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 32.9 mttm -81.43 118.92 23.09 Favored 'General case' 0 N--CA 1.476 0.849 0 N-CA-C 106.541 -1.652 . . . . 0.0 106.541 173.348 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 93.0 mttt -80.86 133.84 35.65 Favored 'General case' 0 CA--C 1.507 -0.692 0 CA-C-N 119.785 1.175 . . . . 0.0 108.398 175.691 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 1.5 t -118.36 145.48 24.27 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.589 0 C-N-CA 125.914 1.686 . . . . 0.0 106.796 -172.843 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 26.6 ttm -136.53 145.1 44.66 Favored 'General case' 0 C--N 1.318 -0.777 0 C-N-CA 125.143 1.377 . . . . 0.0 108.265 169.764 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 91.5 m-85 -137.93 121.62 17.46 Favored 'General case' 0 CA--C 1.516 -0.339 0 N-CA-C 104.673 -2.343 . . . . 0.0 104.673 177.445 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 2.6 p -153.58 154.16 7.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-O 122.338 1.066 . . . . 0.0 111.745 -169.178 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 42.7 t -144.77 165.18 28.82 Favored 'General case' 0 CA--C 1.538 0.486 0 N-CA-C 104.506 -2.405 . . . . 0.0 104.506 168.981 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 22.9 pttp -61.47 130.17 44.73 Favored 'General case' 0 N--CA 1.467 0.378 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 172.515 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 59.2 136.58 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 128.211 2.604 . . . . 0.0 114.114 -170.373 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 20.4 t30 -56.05 -35.0 66.43 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 125.106 1.362 . . . . 0.0 111.885 176.526 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 1.6 p -70.3 -8.06 47.41 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 125.398 1.479 . . . . 0.0 113.243 -175.802 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 38.5 m -76.01 -88.15 0.04 OUTLIER 'General case' 0 CA--C 1.54 0.568 0 CA-C-N 119.292 0.951 . . . . 0.0 110.259 178.638 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 10.6 mpt_? -115.5 6.83 14.79 Favored 'General case' 0 N--CA 1.475 0.801 0 CA-C-N 120.349 1.431 . . . . 0.0 113.041 179.227 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 1.4 m -91.92 47.44 1.35 Allowed 'General case' 0 CA--C 1.541 0.601 0 O-C-N 121.327 -0.858 . . . . 0.0 110.918 -175.449 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -118.37 9.01 12.31 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 125.967 1.707 . . . . 0.0 112.596 170.941 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 1.1 tpt -159.87 -39.48 0.05 Allowed 'General case' 0 N--CA 1.457 -0.119 0 N-CA-C 115.443 1.646 . . . . 0.0 115.443 -176.916 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -69.55 -46.72 65.77 Favored 'General case' 0 N--CA 1.471 0.597 0 CA-C-N 120.947 1.703 . . . . 0.0 111.703 -169.482 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' GLU . . . . . 0.45 ' CD ' HE22 ' A' ' 60' ' ' GLN . 0.0 OUTLIER -57.35 -42.28 81.69 Favored 'General case' 0 C--N 1.325 -0.473 0 C-N-CA 124.321 1.049 . . . . 0.0 110.731 170.837 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -61.59 -45.59 96.02 Favored Glycine 0 CA--C 1.524 0.653 0 C-N-CA 123.84 0.733 . . . . 0.0 111.798 176.924 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -66.85 -35.93 81.17 Favored 'General case' 0 CA--C 1.514 -0.431 0 O-C-N 121.216 -1.167 . . . . 0.0 111.918 178.278 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -70.86 -36.3 72.77 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 119.662 1.119 . . . . 0.0 110.555 179.688 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -52.52 -42.66 64.54 Favored 'General case' 0 N--CA 1.467 0.392 0 C-N-CA 123.864 0.866 . . . . 0.0 109.009 169.207 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 22.4 m -75.15 -59.29 2.81 Favored 'General case' 0 N--CA 1.446 -0.653 0 C-N-CA 124.303 1.041 . . . . 0.0 111.397 -173.872 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 34.6 mt -73.82 -33.87 64.35 Favored 'General case' 0 C--N 1.332 -0.191 0 C-N-CA 125.083 1.353 . . . . 0.0 110.949 -170.567 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -102.76 6.77 52.43 Favored Glycine 0 CA--C 1.525 0.668 0 CA-C-O 117.901 -1.5 . . . . 0.0 113.521 -172.585 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -41.15 -52.77 3.25 Favored 'General case' 0 N--CA 1.466 0.363 0 C-N-CA 126.254 1.821 . . . . 0.0 114.819 -169.714 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -88.81 7.12 82.83 Favored Glycine 0 CA--C 1.531 1.048 0 CA-C-O 119.186 -0.785 . . . . 0.0 113.573 -175.547 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 70.0 mttt -124.73 -49.35 1.76 Allowed 'General case' 0 N--CA 1.467 0.395 0 CA-C-N 118.511 1.155 . . . . 0.0 111.937 -169.27 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 27.1 pt -137.96 150.93 25.07 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.401 0 C-N-CA 124.732 1.213 . . . . 0.0 110.415 -168.911 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -111.17 105.77 14.58 Favored 'General case' 0 C--O 1.226 -0.146 0 C-N-CA 125.013 1.325 . . . . 0.0 109.971 -169.526 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 11.4 t -78.93 127.9 38.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 177.374 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 18.7 m -144.31 92.94 2.37 Favored 'General case' 0 N--CA 1.449 -0.503 0 N-CA-C 103.615 -2.735 . . . . 0.0 103.615 169.677 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 58.1 m -89.33 -1.32 58.02 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 115.764 1.764 . . . . 0.0 115.764 -168.759 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 28.4 p 49.05 -130.08 1.92 Allowed 'General case' 0 CA--C 1.546 0.815 0 C-N-CA 124.451 1.1 . . . . 0.0 111.333 -178.842 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 173.5 153.98 10.17 Favored Glycine 0 CA--C 1.53 0.978 0 C-N-CA 124.951 1.262 . . . . 0.0 111.027 170.06 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 4.3 mt -111.89 103.95 12.21 Favored 'General case' 0 N--CA 1.444 -0.755 1 N-CA-C 100.071 -4.048 . . . . 0.0 100.071 169.16 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 35.2 mt-10 64.05 170.36 0.17 Allowed 'General case' 0 C--O 1.238 0.458 0 O-C-N 125.371 1.669 . . . . 0.0 110.241 -167.583 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 59.1 p -146.9 158.79 44.01 Favored 'General case' 0 N--CA 1.448 -0.558 0 CA-C-O 122.628 1.204 . . . . 0.0 113.701 -178.457 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 4.1 m -170.81 166.96 7.72 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 129.801 3.24 . . . . 0.0 104.222 -171.892 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -87.94 -159.61 0.55 Allowed 'General case' 0 N--CA 1.468 0.459 0 O-C-N 120.845 -1.159 . . . . 0.0 108.72 176.209 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.517 HG21 HD12 ' A' ' 57' ' ' ILE . 1.5 p -127.17 157.84 38.51 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.782 0 C-N-CA 126.418 1.887 . . . . 0.0 107.73 179.933 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -85.84 153.04 57.48 Favored Pre-proline 0 CA--C 1.538 0.517 0 C-N-CA 124.67 1.188 . . . . 0.0 111.366 -169.452 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 55.1 Cg_endo -63.84 -41.34 24.26 Favored 'Trans proline' 0 C--N 1.347 0.495 0 C-N-CA 123.474 2.783 . . . . 0.0 112.415 -174.039 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 7.3 m -69.79 -29.63 66.98 Favored 'General case' 0 CA--C 1.53 0.188 0 CA-C-O 118.649 -0.691 . . . . 0.0 110.319 -176.839 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -62.99 -50.6 70.13 Favored 'General case' 0 C--O 1.215 -0.712 0 CA-C-N 119.659 1.118 . . . . 0.0 108.413 171.094 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 75.1 mt -58.38 -40.09 76.89 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.447 0 CA-C-N 118.982 0.81 . . . . 0.0 108.851 -176.462 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -64.7 -49.63 70.15 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-N 118.915 0.779 . . . . 0.0 112.354 178.255 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 38.6 mmt -69.35 -36.48 76.92 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-O 122.739 1.257 . . . . 0.0 110.543 -177.564 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -71.69 -32.05 67.41 Favored 'General case' 0 N--CA 1.444 -0.763 0 N-CA-C 106.369 -1.715 . . . . 0.0 106.369 -178.761 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 40.5 tt0 -72.02 -19.57 61.83 Favored 'General case' 0 CA--C 1.54 0.572 0 O-C-N 121.122 -0.986 . . . . 0.0 110.999 169.882 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 75.5 mt-10 -64.19 -37.11 86.31 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-N 120.176 1.353 . . . . 0.0 109.859 169.605 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 11.9 m -85.94 12.12 1.05 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.675 0 N-CA-C 112.759 0.651 . . . . 0.0 112.759 169.968 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 72.4 14.23 77.2 Favored Glycine 0 CA--C 1.532 1.155 0 C-N-CA 124.488 1.042 . . . . 0.0 113.476 176.154 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 10.5 mt -93.35 137.73 21.88 Favored 'Isoleucine or valine' 0 C--O 1.233 0.199 0 CA-C-N 118.498 1.149 . . . . 0.0 109.613 -177.053 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 12.9 t0 -101.87 132.93 47.37 Favored 'General case' 0 C--O 1.233 0.236 0 N-CA-C 107.566 -1.272 . . . . 0.0 107.566 169.343 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.517 HD12 HG21 ' A' ' 42' ' ' VAL . 0.6 OUTLIER -118.72 -70.64 0.78 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.37 0 C-N-CA 125.528 1.531 . . . . 0.0 107.319 177.321 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 97.2 p 40.33 -97.78 0.02 OUTLIER 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 127.169 2.187 . . . . 0.0 114.349 170.152 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -74.79 58.0 2.6 Favored Glycine 0 CA--C 1.531 1.067 0 C-N-CA 126.99 2.233 . . . . 0.0 111.705 178.947 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 60' ' ' GLN . . . . . 0.45 HE22 ' CD ' ' A' ' 19' ' ' GLU . 12.5 mm100 -66.89 -30.31 70.43 Favored 'General case' 0 C--O 1.233 0.232 0 C-N-CA 125.051 1.34 . . . . 0.0 111.69 -179.868 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 1.1 p -62.68 133.66 55.17 Favored 'General case' 0 N--CA 1.444 -0.746 0 C-N-CA 124.934 1.294 . . . . 0.0 109.435 -169.369 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 57.7 m -146.14 -179.21 6.57 Favored 'General case' 0 N--CA 1.446 -0.666 0 C-N-CA 125.999 1.72 . . . . 0.0 107.493 -169.307 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -56.61 152.74 24.19 Favored Pre-proline 0 CA--C 1.536 0.427 0 C-N-CA 123.87 0.868 . . . . 0.0 111.446 175.064 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 89.3 Cg_endo -65.59 158.24 54.25 Favored 'Trans proline' 0 N--CA 1.453 -0.856 0 C-N-CA 122.574 2.183 . . . . 0.0 110.345 172.965 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 14.0 tt -58.52 -26.81 31.97 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.411 0 C-N-CA 124.013 0.925 . . . . 0.0 111.622 179.133 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 15.1 mt-10 -67.94 -26.55 66.02 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 124.255 1.022 . . . . 0.0 110.356 -174.524 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 5.4 t-20 -64.31 -22.16 66.86 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 125.197 1.399 . . . . 0.0 112.208 177.728 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -108.67 178.57 4.44 Favored 'General case' 0 C--O 1.235 0.339 0 C-N-CA 126.024 1.729 . . . . 0.0 111.209 -173.797 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 57.5 t-20 -133.25 137.36 46.05 Favored 'General case' 0 N--CA 1.444 -0.745 0 N-CA-C 107.144 -1.428 . . . . 0.0 107.144 168.988 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -74.86 -23.84 58.48 Favored 'General case' 0 N--CA 1.437 -1.112 0 N-CA-C 109.456 -0.572 . . . . 0.0 109.456 -176.985 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -61.62 -24.74 66.9 Favored 'General case' 0 N--CA 1.447 -0.604 0 O-C-N 123.331 0.395 . . . . 0.0 111.579 178.831 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -76.57 -27.64 55.93 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 123.578 0.751 . . . . 0.0 112.081 177.133 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 11.7 m-85 -78.75 164.01 24.91 Favored 'General case' 0 N--CA 1.45 -0.442 0 C-N-CA 125.187 1.395 . . . . 0.0 111.465 -177.043 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -105.4 -39.29 6.19 Favored 'General case' 0 N--CA 1.462 0.13 0 CA-C-N 115.557 -0.747 . . . . 0.0 110.41 171.436 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -139.19 138.91 40.57 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.441 0 CA-C-O 122.449 1.118 . . . . 0.0 110.188 -171.333 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 42.6 t -140.21 145.03 26.75 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.855 0 N-CA-C 106.411 -1.7 . . . . 0.0 106.411 179.936 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.435 HD12 ' HB2' ' A' ' 97' ' ' GLU . 24.1 mm -141.71 137.36 31.65 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.865 0 N-CA-C 106.496 -1.668 . . . . 0.0 106.496 -170.69 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 50.3 m -101.43 163.84 12.07 Favored 'General case' 0 N--CA 1.445 -0.691 0 N-CA-C 107.625 -1.25 . . . . 0.0 107.625 168.861 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 51.3 mt -132.66 18.84 4.26 Favored 'General case' 0 CA--C 1.533 0.292 0 O-C-N 121.14 -0.975 . . . . 0.0 111.048 -174.53 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 28.1 p -169.21 -5.12 0.02 OUTLIER 'General case' 0 CA--C 1.541 0.603 0 N-CA-C 115.433 1.642 . . . . 0.0 115.433 -173.986 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 167.78 175.0 37.24 Favored Glycine 0 CA--C 1.529 0.927 0 CA-C-N 120.54 1.518 . . . . 0.0 111.292 -177.081 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 40.2 m -117.31 124.34 48.73 Favored 'General case' 0 C--O 1.233 0.229 0 C-N-CA 124.444 1.098 . . . . 0.0 108.101 -177.046 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 62.55 28.74 71.83 Favored Glycine 0 CA--C 1.531 1.044 0 N-CA-C 111.343 -0.703 . . . . 0.0 111.343 -174.822 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . 0.267 7.2 p -80.2 74.41 0.74 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.512 0 C-N-CA 125.006 1.322 . . . . 0.0 109.988 -169.459 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 1.1 t30 60.07 54.08 4.3 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 126.711 2.005 . . . . 0.0 108.012 -176.476 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.409 ' HA ' ' HD3' ' A' ' 87' ' ' PRO . 0.9 OUTLIER -152.12 138.4 11.79 Favored Pre-proline 0 CA--C 1.539 0.55 0 C-N-CA 125.803 1.641 . . . . 0.0 107.621 -169.341 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 87' ' ' PRO . . . . . 0.417 ' HA ' ' HD3' ' A' ' 88' ' ' PRO . 31.8 Cg_exo -69.84 146.6 60.2 Favored 'Trans proline' 0 CA--C 1.546 1.08 0 C-N-CA 121.494 1.463 . . . . 0.0 114.139 -175.77 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 88' ' ' PRO . . . . . 0.417 ' HD3' ' HA ' ' A' ' 87' ' ' PRO . 51.8 Cg_exo -63.7 -25.95 68.65 Favored 'Trans proline' 0 C--N 1.349 0.581 0 C-N-CA 122.667 2.244 . . . . 0.0 115.945 -174.085 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 5.7 pm0 -61.53 -14.84 32.85 Favored 'General case' 0 CA--C 1.543 0.707 0 CA-C-N 121.024 1.738 . . . . 0.0 111.809 175.982 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 90.8 m95 -91.81 -21.7 20.53 Favored 'General case' 0 N--CA 1.451 -0.409 0 C-N-CA 124.509 1.123 . . . . 0.0 113.07 173.793 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 2.9 m -78.64 -5.01 7.39 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.36 0 CA-C-N 120.129 1.331 . . . . 0.0 111.326 171.377 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 60.3 p -107.95 -118.14 0.26 Allowed 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 123.081 0.552 . . . . 0.0 111.492 -176.747 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 70.5 mm-40 55.96 -171.13 0.07 Allowed 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 125.563 1.545 . . . . 0.0 111.47 -168.787 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 37.0 mm-40 -70.25 -23.11 62.85 Favored 'General case' 0 CA--C 1.537 0.474 0 O-C-N 121.479 -0.763 . . . . 0.0 112.316 -169.466 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 9.5 tt -147.83 141.64 19.3 Favored 'Isoleucine or valine' 0 C--O 1.238 0.46 0 C-N-CA 125.103 1.361 . . . . 0.0 107.607 169.761 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 73.3 t80 -128.22 139.41 52.47 Favored 'General case' 0 N--CA 1.446 -0.661 0 N-CA-C 106.277 -1.749 . . . . 0.0 106.277 168.867 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 97' ' ' GLU . . . . . 0.435 ' HB2' HD12 ' A' ' 77' ' ' ILE . 29.3 mm-40 -139.32 166.26 25.02 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 107.246 -1.39 . . . . 0.0 107.246 170.003 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -165.33 137.29 4.17 Favored 'General case' 0 C--N 1.323 -0.568 0 C-N-CA 126.074 1.75 . . . . 0.0 106.334 -176.642 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 6.9 m0 -143.12 144.77 32.35 Favored 'General case' 0 N--CA 1.451 -0.377 0 C-N-CA 122.875 0.47 . . . . 0.0 110.201 -169.332 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 20.0 tt0 -83.33 57.42 3.98 Favored 'General case' 0 CA--C 1.537 0.451 0 N-CA-C 108.179 -1.045 . . . . 0.0 108.179 171.054 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.455 HD13 HG22 ' A' ' 119' ' ' VAL . 19.4 mt -65.74 138.47 57.97 Favored 'General case' 0 C--O 1.235 0.321 0 N-CA-C 107.155 -1.424 . . . . 0.0 107.155 173.459 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 23.5 mm-40 -67.22 151.52 47.38 Favored 'General case' 0 N--CA 1.451 -0.41 0 CA-C-O 121.574 0.702 . . . . 0.0 109.511 172.033 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -112.41 117.97 46.33 Favored Pre-proline 0 N--CA 1.45 -0.468 0 N-CA-C 106.098 -1.816 . . . . 0.0 106.098 170.447 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_endo -80.82 -1.52 11.29 Favored 'Trans proline' 0 N--CA 1.448 -1.183 0 C-N-CA 122.98 2.453 . . . . 0.0 113.412 -173.217 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -53.4 120.07 5.61 Favored 'General case' 0 CA--C 1.536 0.429 0 CA-C-N 120.473 1.488 . . . . 0.0 110.864 -175.917 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 70.2 0.65 30.08 Favored Glycine 0 CA--C 1.534 1.245 0 CA-C-O 118.765 -1.019 . . . . 0.0 114.562 179.518 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 12.9 mt-30 -85.3 171.89 11.54 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-N 119.156 1.478 . . . . 0.0 109.638 174.096 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 15.0 m -69.2 162.33 27.32 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 123.91 0.884 . . . . 0.0 111.322 178.71 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 13.3 tp -59.04 -30.93 68.4 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 124.615 1.166 . . . . 0.0 112.43 -173.779 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 5.3 pt-20 -56.57 -34.92 67.61 Favored 'General case' 0 C--O 1.226 -0.166 0 C-N-CA 124.768 1.227 . . . . 0.0 111.775 174.778 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 32.2 t -75.03 -42.19 45.54 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.422 0 CA-C-O 117.813 -1.089 . . . . 0.0 109.164 -176.798 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 89.7 m-85 -56.52 -49.94 73.27 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-N 120.329 1.422 . . . . 0.0 109.666 172.621 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 86.8 mtt180 -66.84 -34.6 78.17 Favored 'General case' 0 N--CA 1.467 0.409 0 O-C-N 122.037 -0.414 . . . . 0.0 111.761 -176.358 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 3.5 m -62.24 -48.59 79.29 Favored 'General case' 0 N--CA 1.451 -0.404 0 C-N-CA 124.681 1.192 . . . . 0.0 109.413 170.357 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 45.7 t -63.62 -33.44 61.63 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.243 0 CA-C-O 118.265 -0.874 . . . . 0.0 110.0 -174.627 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 13.1 mtm105 -56.58 -49.8 73.83 Favored 'General case' 0 C--O 1.225 -0.226 0 CA-C-N 119.303 0.956 . . . . 0.0 110.071 172.188 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -62.3 -48.55 81.69 Favored Glycine 0 CA--C 1.526 0.731 0 CA-C-O 119.103 -0.832 . . . . 0.0 111.216 179.55 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 69.8 mt-30 -55.24 -53.23 58.63 Favored 'General case' 0 C--N 1.343 0.296 0 CA-C-O 122.091 0.948 . . . . 0.0 109.364 -179.802 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 119' ' ' VAL . . . . . 0.455 HG22 HD13 ' A' ' 101' ' ' LEU . 73.8 t -71.44 -39.97 71.91 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-O 117.875 -1.06 . . . . 0.0 110.605 -170.608 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 87.2 tttt -55.6 -47.46 76.47 Favored 'General case' 0 C--O 1.223 -0.321 0 CA-C-N 119.411 1.005 . . . . 0.0 108.316 176.792 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -66.22 -43.01 87.89 Favored 'General case' 0 N--CA 1.45 -0.465 0 C-N-CA 122.438 0.295 . . . . 0.0 111.078 -174.838 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 40.2 mmt180 -63.02 -46.6 86.85 Favored 'General case' 0 N--CA 1.471 0.611 0 O-C-N 121.563 -0.711 . . . . 0.0 110.837 177.831 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 78.2 t -67.31 -41.73 86.81 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.665 0 C-N-CA 123.08 0.552 . . . . 0.0 109.618 -178.897 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 31.3 mt-10 -60.23 -43.74 95.81 Favored 'General case' 0 CA--C 1.52 -0.191 0 CA-C-N 119.595 1.089 . . . . 0.0 110.011 177.651 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 29.0 t-20 -62.38 -45.03 94.97 Favored 'General case' 0 N--CA 1.454 -0.243 0 C-N-CA 122.776 0.43 . . . . 0.0 110.668 179.789 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 28.5 tp -59.44 -47.69 84.49 Favored 'General case' 0 N--CA 1.453 -0.277 0 C-N-CA 123.859 0.864 . . . . 0.0 111.102 177.579 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 85.0 mt -63.09 -46.59 95.71 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.175 0 N-CA-C 107.845 -1.169 . . . . 0.0 107.845 179.504 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -59.79 -28.8 67.74 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-N 118.457 0.571 . . . . 0.0 112.335 178.682 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 92.1 mttt -69.37 -57.17 5.63 Favored 'General case' 0 C--N 1.344 0.349 0 CA-C-N 119.219 0.918 . . . . 0.0 110.629 171.751 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 13.6 pt -77.29 -38.46 27.03 Favored 'Isoleucine or valine' 0 C--O 1.235 0.305 0 N-CA-C 115.095 1.517 . . . . 0.0 115.095 -168.823 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 69.5 m . . . . . 0 C--O 1.252 1.219 0 C-N-CA 125.694 1.597 . . . . 0.0 109.334 -169.79 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.496 1.839 0 N-CA-C 110.535 -0.172 . . . . 0.0 110.535 . . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 30.8 mttm -80.18 116.65 20.39 Favored 'General case' 0 N--CA 1.475 0.799 0 N-CA-C 106.109 -1.811 . . . . 0.0 106.109 173.66 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 92.2 mttt -81.89 131.88 35.26 Favored 'General case' 0 CA--C 1.505 -0.777 0 CA-C-N 119.566 1.075 . . . . 0.0 108.399 177.45 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 1.4 t -116.61 146.82 20.53 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 O-C-N 125.515 1.76 . . . . 0.0 107.131 -170.821 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 35.3 ttm -138.27 147.27 43.47 Favored 'General case' 0 C--N 1.32 -0.676 0 C-N-CA 125.194 1.398 . . . . 0.0 107.864 170.709 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' PHE . . . . . 0.403 ' CE2' HG13 ' A' ' 77' ' ' ILE . 67.2 m-85 -136.26 119.82 17.07 Favored 'General case' 0 CA--C 1.516 -0.339 0 N-CA-C 105.509 -2.034 . . . . 0.0 105.509 177.526 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 2.0 p -151.45 129.81 2.75 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.386 0 N-CA-C 108.656 -0.868 . . . . 0.0 108.656 -169.427 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -110.77 -178.58 3.52 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 125.764 1.626 . . . . 0.0 106.921 169.754 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 85.1 tttt -70.88 -26.98 63.48 Favored 'General case' 0 N--CA 1.472 0.659 0 O-C-N 121.131 -0.981 . . . . 0.0 112.306 -171.821 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 37.8 ttp180 -136.47 160.7 37.98 Favored 'General case' 0 N--CA 1.467 0.392 0 C-N-CA 124.269 1.028 . . . . 0.0 109.077 -169.545 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -68.96 -38.82 79.64 Favored 'General case' 0 N--CA 1.47 0.571 0 CA-C-N 118.613 0.642 . . . . 0.0 110.596 175.748 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 2.9 p -84.13 66.87 9.49 Favored 'General case' 0 C--O 1.234 0.284 0 C-N-CA 125.863 1.665 . . . . 0.0 108.565 -177.863 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 40.6 p -155.15 -167.02 2.43 Favored 'General case' 0 N--CA 1.451 -0.382 0 CA-C-O 121.789 0.804 . . . . 0.0 109.903 -172.946 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 76.0 mtt180 -54.17 -23.29 13.81 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 126.033 1.733 . . . . 0.0 111.986 169.987 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 28.7 m -51.01 -26.05 5.58 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-N 119.84 1.2 . . . . 0.0 112.991 178.1 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 6.5 pt20 -69.1 -26.99 65.19 Favored 'General case' 0 C--O 1.221 -0.432 0 N-CA-C 114.925 1.454 . . . . 0.0 114.925 -172.554 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 2.1 tpt -115.43 -32.26 5.65 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-N 120.72 1.6 . . . . 0.0 115.033 -169.31 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -68.48 -43.7 76.35 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-N 119.723 1.147 . . . . 0.0 113.083 -169.204 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 1.5 pp20? -63.75 -34.07 77.07 Favored 'General case' 0 N--CA 1.473 0.688 0 CA-C-N 119.267 0.94 . . . . 0.0 109.541 171.997 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -50.8 -49.66 40.44 Favored Glycine 0 C--O 1.219 -0.839 0 C-N-CA 125.259 1.409 . . . . 0.0 111.011 176.057 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 5.6 m-85 -75.98 -31.76 59.14 Favored 'General case' 0 CA--C 1.511 -0.541 0 CA-C-N 118.928 1.364 . . . . 0.0 113.899 178.258 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -68.03 -32.8 73.42 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 119.421 1.009 . . . . 0.0 111.58 -170.174 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 4.7 ptpt -61.07 -29.21 69.61 Favored 'General case' 0 N--CA 1.473 0.697 0 CA-C-N 118.546 0.612 . . . . 0.0 111.643 172.407 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 15.1 m -82.66 -56.93 3.56 Favored 'General case' 0 N--CA 1.443 -0.793 0 C-N-CA 124.965 1.306 . . . . 0.0 109.819 -177.399 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 76.3 mt -73.49 -36.58 65.8 Favored 'General case' 0 C--N 1.331 -0.207 0 C-N-CA 123.35 0.66 . . . . 0.0 110.947 -170.359 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -103.87 13.16 53.17 Favored Glycine 0 CA--C 1.525 0.687 0 CA-C-O 118.068 -1.407 . . . . 0.0 113.044 -174.072 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -41.66 -53.95 3.41 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 126.345 1.858 . . . . 0.0 114.707 -169.229 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -91.31 10.08 75.78 Favored Glycine 0 CA--C 1.53 1.027 0 CA-C-O 119.216 -0.769 . . . . 0.0 113.525 -176.201 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 50.5 mttm -124.13 -50.86 1.79 Allowed 'General case' 0 N--CA 1.467 0.411 0 CA-C-N 118.435 1.117 . . . . 0.0 112.028 -169.21 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 28.3 pt -136.54 150.36 27.32 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.338 0 C-N-CA 124.222 1.009 . . . . 0.0 110.137 -169.011 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -110.27 102.48 11.14 Favored 'General case' 0 C--O 1.228 -0.048 0 C-N-CA 124.911 1.284 . . . . 0.0 109.47 -169.549 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 9.6 p -84.93 130.28 36.32 Favored 'Isoleucine or valine' 0 C--O 1.235 0.309 0 CA-C-N 118.686 0.675 . . . . 0.0 109.658 -179.982 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 19.1 m -145.14 115.46 7.55 Favored 'General case' 0 N--CA 1.448 -0.548 0 N-CA-C 104.342 -2.466 . . . . 0.0 104.342 170.519 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 48.2 m -112.47 8.0 19.22 Favored 'General case' 0 N--CA 1.466 0.325 0 N-CA-C 115.434 1.642 . . . . 0.0 115.434 -174.391 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 1.5 m 52.96 -133.73 1.78 Allowed 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 123.568 0.747 . . . . 0.0 111.114 169.679 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -171.14 154.7 23.08 Favored Glycine 0 N--CA 1.444 -0.777 0 N-CA-C 108.16 -1.976 . . . . 0.0 108.16 170.047 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 55.8 mt -103.08 -51.02 3.35 Favored 'General case' 0 N--CA 1.451 -0.404 0 C-N-CA 124.057 0.943 . . . . 0.0 108.864 171.755 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 25.7 mt-10 -130.58 72.0 1.48 Allowed 'General case' 0 CA--C 1.514 -0.428 0 CA-C-O 124.124 1.916 . . . . 0.0 107.069 169.663 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 10.7 m 57.33 -31.39 0.03 OUTLIER 'General case' 0 C--N 1.321 -0.649 0 C-N-CA 131.446 3.898 . . . . 0.0 117.422 -174.976 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 60.9 m 60.67 23.25 13.09 Favored 'General case' 0 CA--C 1.54 0.573 0 N-CA-C 115.9 1.815 . . . . 0.0 115.9 168.35 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 11.3 ttt180 -71.86 -178.98 2.5 Favored 'General case' 0 CA--C 1.539 0.519 0 N-CA-C 107.558 -1.275 . . . . 0.0 107.558 169.017 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 11.5 m -123.95 -172.32 0.75 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.642 0 C-N-CA 124.437 1.095 . . . . 0.0 111.279 -169.187 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 96.1 m-70 -112.45 156.32 42.41 Favored Pre-proline 0 CA--C 1.536 0.422 0 C-N-CA 125.184 1.394 . . . . 0.0 111.009 -171.984 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -57.2 -48.49 17.65 Favored 'Trans proline' 0 C--N 1.347 0.49 0 C-N-CA 124.012 3.141 . . . . 0.0 112.628 -174.014 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 2.7 m -67.9 -29.64 68.79 Favored 'General case' 0 CA--C 1.531 0.227 0 CA-C-O 118.849 -0.596 . . . . 0.0 110.156 -176.876 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -59.61 -56.09 26.33 Favored 'General case' 0 CA--C 1.505 -0.763 0 N-CA-C 108.137 -1.06 . . . . 0.0 108.137 171.164 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 56.2 mt -59.61 -39.07 78.51 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.396 0 N-CA-C 108.52 -0.918 . . . . 0.0 108.52 -173.043 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -62.32 -49.58 75.05 Favored 'General case' 0 N--CA 1.452 -0.358 0 CA-C-N 119.181 0.9 . . . . 0.0 111.138 -179.838 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 38.9 mmt -71.46 -34.25 70.06 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-O 122.756 1.265 . . . . 0.0 110.161 -177.226 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -73.31 -31.27 63.92 Favored 'General case' 0 N--CA 1.44 -0.925 0 N-CA-C 107.393 -1.336 . . . . 0.0 107.393 -178.634 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 4.9 mm-40 -72.88 -17.5 61.52 Favored 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 124.101 0.96 . . . . 0.0 110.985 169.704 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 78.5 mt-10 -65.11 -36.84 85.55 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 119.844 1.202 . . . . 0.0 108.762 168.932 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . 0.302 8.5 p -86.46 7.5 2.33 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.991 0 CA-C-O 120.789 0.328 . . . . 0.0 111.608 169.742 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 71.41 23.31 78.2 Favored Glycine 0 CA--C 1.532 1.147 0 C-N-CA 124.994 1.283 . . . . 0.0 113.266 175.773 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 5.4 mt -103.7 136.65 35.71 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.226 0 C-N-CA 124.273 1.029 . . . . 0.0 111.975 -172.225 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -78.11 137.28 38.12 Favored 'General case' 0 CA--C 1.529 0.155 0 CA-C-N 114.507 -1.224 . . . . 0.0 109.043 168.972 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 8.1 pt -143.35 -27.56 0.17 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.39 0 C-N-CA 125.062 1.345 . . . . 0.0 108.951 168.209 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -40.21 -41.17 1.25 Allowed 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 129.459 3.104 . . . . 0.0 113.113 169.443 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -87.25 20.52 25.68 Favored Glycine 0 CA--C 1.533 1.171 0 C-N-CA 125.225 1.393 . . . . 0.0 114.38 -177.422 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -60.08 -35.14 74.54 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-N 119.812 1.806 . . . . 0.0 112.489 -178.161 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -66.97 133.01 49.12 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 123.981 0.912 . . . . 0.0 109.817 -171.067 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 13.7 p -151.23 -68.97 0.18 Allowed 'General case' 0 C--O 1.235 0.307 0 C-N-CA 123.356 0.663 . . . . 0.0 109.962 -177.761 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -151.3 155.77 34.74 Favored Pre-proline 0 C--O 1.236 0.376 0 C-N-CA 125.807 1.643 . . . . 0.0 108.57 -177.126 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -64.39 156.3 60.98 Favored 'Trans proline' 0 N--CA 1.456 -0.686 0 C-N-CA 122.234 1.956 . . . . 0.0 110.208 171.46 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 11.3 tt -57.55 -28.41 31.59 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.499 0 C-N-CA 123.137 0.575 . . . . 0.0 111.536 178.826 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 23.1 tt0 -66.04 -25.23 66.95 Favored 'General case' 0 N--CA 1.437 -1.083 0 C-N-CA 126.335 1.854 . . . . 0.0 110.715 -175.588 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 6.1 t-20 -64.11 -21.22 66.45 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 124.287 1.035 . . . . 0.0 112.126 176.82 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 77.6 m-85 -110.88 -176.0 2.86 Favored 'General case' 0 C--O 1.235 0.306 0 C-N-CA 126.025 1.73 . . . . 0.0 110.802 -174.487 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 61.5 t-20 -136.68 141.2 43.12 Favored 'General case' 0 N--CA 1.445 -0.697 0 N-CA-C 107.206 -1.405 . . . . 0.0 107.206 169.366 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -72.2 -25.2 61.58 Favored 'General case' 0 N--CA 1.433 -1.295 0 CA-C-N 118.44 0.564 . . . . 0.0 109.701 -178.901 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 35.6 t70 -63.04 -24.16 67.78 Favored 'General case' 0 N--CA 1.447 -0.607 0 O-C-N 123.549 0.531 . . . . 0.0 111.634 -179.417 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -74.94 -28.11 60.46 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 123.159 0.584 . . . . 0.0 111.868 175.626 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 12.3 m-85 -81.51 164.47 21.96 Favored 'General case' 0 N--CA 1.448 -0.556 0 C-N-CA 125.353 1.461 . . . . 0.0 111.357 -177.21 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -107.16 -37.9 6.15 Favored 'General case' 0 N--CA 1.462 0.138 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.776 173.583 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -139.28 138.71 40.39 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.504 0 CA-C-O 121.731 0.776 . . . . 0.0 110.17 -170.615 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 57.9 t -141.42 130.6 24.15 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.659 0 N-CA-C 106.22 -1.77 . . . . 0.0 106.22 178.033 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.538 HD12 ' HB2' ' A' ' 97' ' ' GLU . 27.4 mm -106.0 128.12 60.57 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.76 0 N-CA-C 105.325 -2.102 . . . . 0.0 105.325 176.537 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 28.9 m -109.93 75.72 0.95 Allowed 'General case' 0 N--CA 1.437 -1.112 0 N-CA-C 105.455 -2.054 . . . . 0.0 105.455 -176.336 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 59.9 mt -53.03 -17.06 1.27 Allowed 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 125.768 1.627 . . . . 0.0 115.102 -169.1 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 12.7 m -112.14 -7.92 14.03 Favored 'General case' 0 CA--C 1.541 0.597 0 CA-C-N 119.866 1.212 . . . . 0.0 114.2 -177.477 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 142.89 -132.91 5.28 Favored Glycine 0 C--N 1.338 0.692 0 CA-C-N 120.635 1.562 . . . . 0.0 111.543 -178.041 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 13.0 m -125.15 -28.13 3.45 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 123.554 0.742 . . . . 0.0 112.314 -169.901 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -76.14 -62.93 2.5 Favored Glycine 0 C--N 1.343 0.925 0 N-CA-C 109.45 -1.46 . . . . 0.0 109.45 173.171 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . 0.321 10.9 t 56.81 18.96 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.55 0.962 0 C-N-CA 125.39 1.476 . . . . 0.0 112.693 170.602 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 64.9 t30 45.33 37.79 3.1 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 125.56 1.544 . . . . 0.0 112.385 -172.089 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -136.45 158.73 72.82 Favored Pre-proline 0 CA--C 1.541 0.62 0 C-N-CA 123.63 0.772 . . . . 0.0 111.849 179.766 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 80.4 Cg_exo -54.99 131.14 44.64 Favored 'Trans proline' 0 C--N 1.352 0.732 0 C-N-CA 123.22 2.613 . . . . 0.0 110.953 175.04 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 49.3 Cg_endo -62.06 -19.45 66.33 Favored 'Trans proline' 0 C--N 1.348 0.512 0 C-N-CA 122.089 1.86 . . . . 0.0 112.138 -177.997 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 2.2 pt-20 -51.13 -26.56 6.81 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 126.136 1.775 . . . . 0.0 112.569 172.739 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 83.4 m95 -74.52 -40.9 61.47 Favored 'General case' 0 N--CA 1.455 -0.2 0 C-N-CA 123.803 0.841 . . . . 0.0 111.844 175.371 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 14.0 t -66.15 -37.12 79.06 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.5 0 C-N-CA 123.901 0.88 . . . . 0.0 108.931 179.374 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 68.8 p -84.39 25.52 0.86 Allowed 'General case' 0 C--O 1.237 0.438 0 N-CA-C 114.851 1.426 . . . . 0.0 114.851 -168.826 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 91.3 mm-40 -74.44 -179.12 3.83 Favored 'General case' 0 CA--C 1.54 0.583 0 CA-C-N 118.385 0.539 . . . . 0.0 110.877 171.706 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 25.6 mm-40 -61.73 -17.87 57.48 Favored 'General case' 0 CA--C 1.54 0.566 0 N-CA-C 113.421 0.897 . . . . 0.0 113.421 -169.027 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 4.6 tt -140.6 133.61 32.59 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.513 0 N-CA-C 106.849 -1.537 . . . . 0.0 106.849 170.026 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -109.57 135.4 50.62 Favored 'General case' 0 CA--C 1.537 0.467 0 N-CA-C 105.04 -2.208 . . . . 0.0 105.04 169.149 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 97' ' ' GLU . . . . . 0.538 ' HB2' HD12 ' A' ' 77' ' ' ILE . 12.8 mm-40 -138.67 163.6 31.69 Favored 'General case' 0 C--O 1.233 0.185 0 C-N-CA 124.542 1.137 . . . . 0.0 107.982 171.26 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -173.57 127.96 0.42 Allowed 'General case' 0 C--O 1.238 0.482 0 C-N-CA 126.944 2.098 . . . . 0.0 105.374 -169.571 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 99' ' ' TRP . . . . . 0.402 ' CZ3' HG21 ' A' ' 77' ' ' ILE . 7.5 m0 -143.13 142.48 31.5 Favored 'General case' 0 N--CA 1.469 0.519 0 N-CA-C 112.751 0.648 . . . . 0.0 112.751 -169.669 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 7.3 pt20 -81.52 50.5 1.49 Allowed 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 125.107 1.363 . . . . 0.0 111.183 174.66 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.497 HD13 HG22 ' A' ' 119' ' ' VAL . 41.7 mt -64.51 140.91 58.92 Favored 'General case' 0 N--CA 1.464 0.269 0 N-CA-C 107.707 -1.22 . . . . 0.0 107.707 172.856 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 27.8 mm-40 -67.15 142.01 57.18 Favored 'General case' 0 CA--C 1.533 0.324 0 CA-C-N 119.681 1.128 . . . . 0.0 109.035 169.938 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 1.5 t0 -97.35 116.07 65.85 Favored Pre-proline 0 N--CA 1.448 -0.526 0 N-CA-C 105.435 -2.061 . . . . 0.0 105.435 169.224 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 49.7 Cg_endo -83.94 -5.4 10.53 Favored 'Trans proline' 0 N--CA 1.451 -1.004 0 C-N-CA 122.815 2.344 . . . . 0.0 112.963 -174.949 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -58.86 127.42 32.12 Favored 'General case' 0 C--O 1.236 0.384 0 CA-C-N 120.204 1.366 . . . . 0.0 109.742 -178.882 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 74.4 0.4 57.7 Favored Glycine 0 CA--C 1.537 1.414 0 CA-C-O 118.618 -1.101 . . . . 0.0 114.013 -178.687 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 13.0 mt-30 -97.3 169.14 9.97 Favored 'General case' 0 CA--C 1.54 0.581 0 CA-C-N 119.09 1.445 . . . . 0.0 109.841 173.386 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 15.0 m -70.64 164.85 24.1 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 124.442 1.097 . . . . 0.0 111.554 -179.608 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 38.2 mt -61.93 -27.04 68.55 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 123.596 0.758 . . . . 0.0 112.115 -175.654 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 5.0 pt-20 -56.76 -36.09 69.38 Favored 'General case' 0 CA--C 1.53 0.198 0 C-N-CA 123.274 0.63 . . . . 0.0 111.228 173.413 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 24.8 t -76.44 -44.37 35.21 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.298 0 CA-C-O 117.786 -1.102 . . . . 0.0 108.837 -178.73 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 59.1 m-85 -55.05 -47.88 74.22 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-N 120.488 1.495 . . . . 0.0 110.364 173.272 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 93.7 mtt180 -70.01 -35.22 74.2 Favored 'General case' 0 CA--C 1.534 0.337 0 O-C-N 121.705 -0.622 . . . . 0.0 110.97 -175.801 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 2.6 m -60.81 -47.35 86.73 Favored 'General case' 0 N--CA 1.454 -0.262 0 C-N-CA 123.922 0.889 . . . . 0.0 109.175 169.812 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 44.4 t -65.31 -31.66 54.86 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.263 0 CA-C-O 118.481 -0.771 . . . . 0.0 109.867 -174.211 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 19.2 mtm105 -57.31 -46.37 83.26 Favored 'General case' 0 CA--C 1.535 0.382 0 CA-C-N 119.41 1.004 . . . . 0.0 110.375 172.507 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -62.57 -50.69 62.07 Favored Glycine 0 CA--C 1.529 0.907 0 CA-C-O 119.543 -0.587 . . . . 0.0 111.636 175.649 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 70.7 mt-30 -57.03 -49.63 75.23 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-O 121.889 0.852 . . . . 0.0 110.414 -176.865 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 119' ' ' VAL . . . . . 0.497 HG22 HD13 ' A' ' 101' ' ' LEU . 58.4 t -74.89 -37.74 42.31 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-O 117.998 -1.001 . . . . 0.0 110.336 -172.062 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -54.77 -45.19 74.21 Favored 'General case' 0 C--O 1.224 -0.247 0 CA-C-N 119.892 1.224 . . . . 0.0 108.839 173.617 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 40.6 tt0 -67.16 -42.81 83.69 Favored 'General case' 0 N--CA 1.448 -0.571 0 C-N-CA 122.977 0.511 . . . . 0.0 111.267 -175.425 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 35.3 mmt180 -63.89 -45.69 88.24 Favored 'General case' 0 N--CA 1.473 0.689 0 CA-C-N 119.084 0.856 . . . . 0.0 111.304 176.881 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 77.5 t -68.37 -37.48 77.96 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.828 0 N-CA-C 108.71 -0.848 . . . . 0.0 108.71 -177.981 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 4.8 mm-40 -59.22 -46.26 88.93 Favored 'General case' 0 C--N 1.34 0.18 0 CA-C-N 119.426 1.012 . . . . 0.0 110.429 172.647 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 27.1 t-20 -64.89 -40.16 94.66 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 123.143 0.577 . . . . 0.0 111.182 -176.87 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 27.9 tp -58.99 -49.83 76.41 Favored 'General case' 0 CA--C 1.53 0.176 0 C-N-CA 125.105 1.362 . . . . 0.0 110.906 172.901 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 51.7 mt -64.57 -46.13 93.47 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 N-CA-C 107.829 -1.175 . . . . 0.0 107.829 -178.059 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -58.98 -30.96 68.35 Favored 'General case' 0 N--CA 1.452 -0.364 0 CA-C-O 118.52 -0.753 . . . . 0.0 112.284 -178.557 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 17.6 ptpt -84.25 -39.81 18.82 Favored 'General case' 0 C--N 1.345 0.375 0 CA-C-O 117.845 -1.074 . . . . 0.0 112.561 177.003 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 11.8 pt -82.55 -35.94 13.09 Favored 'Isoleucine or valine' 0 C--O 1.235 0.309 0 CA-C-N 120.094 1.315 . . . . 0.0 113.814 -175.133 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 65.1 m . . . . . 0 C--O 1.253 1.243 0 C-N-CA 125.134 1.374 . . . . 0.0 109.732 -169.814 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.0 mmt . . . . . 0 N--CA 1.495 1.805 0 N-CA-C 111.195 0.072 . . . . 0.0 111.195 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 30.0 mttm -83.75 112.34 19.99 Favored 'General case' 0 N--CA 1.475 0.818 0 N-CA-C 105.044 -2.206 . . . . 0.0 105.044 169.495 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 91.9 mttt -82.46 133.87 35.21 Favored 'General case' 0 CA--C 1.512 -0.481 0 CA-C-N 119.869 1.213 . . . . 0.0 107.94 179.758 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 1.8 t -120.05 147.14 23.93 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 C-N-CA 125.512 1.525 . . . . 0.0 108.867 -169.077 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 11.1 mtt -134.55 147.22 50.23 Favored 'General case' 0 C--N 1.326 -0.423 0 C-N-CA 125.731 1.613 . . . . 0.0 109.856 169.432 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 62.0 m-85 -135.54 116.72 14.45 Favored 'General case' 0 C--N 1.334 -0.084 0 N-CA-C 105.878 -1.897 . . . . 0.0 105.878 169.684 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 2.6 p -155.04 157.12 4.42 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.367 0 CA-C-O 121.127 0.489 . . . . 0.0 110.269 -168.991 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 52.3 t -152.43 174.89 13.3 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 127.482 2.313 . . . . 0.0 105.932 169.547 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 65.7 pttt -62.7 144.46 56.34 Favored 'General case' 0 N--CA 1.469 0.488 0 O-C-N 121.213 -0.93 . . . . 0.0 109.867 171.598 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 62.8 mtp85 57.78 170.34 0.05 OUTLIER 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 126.468 1.907 . . . . 0.0 113.171 -173.501 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -118.53 0.21 11.52 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 124.066 0.946 . . . . 0.0 111.462 170.113 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 1.4 m -64.19 -37.78 88.69 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 124.137 0.975 . . . . 0.0 110.147 -174.328 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 24.1 p -136.8 153.38 50.83 Favored 'General case' 0 C--O 1.236 0.391 0 C-N-CA 126.657 1.983 . . . . 0.0 106.532 169.718 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 8.0 mpt_? 56.68 -176.05 0.06 Allowed 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 125.391 1.476 . . . . 0.0 110.003 -169.288 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 3.9 m 48.45 46.44 20.64 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 124.069 0.948 . . . . 0.0 110.245 -169.756 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 21.4 pt20 -151.93 157.28 41.58 Favored 'General case' 0 N--CA 1.444 -0.732 0 N-CA-C 106.175 -1.787 . . . . 0.0 106.175 169.997 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER 64.47 -36.07 0.18 Allowed 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 128.124 2.569 . . . . 0.0 115.746 179.326 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -71.51 -48.76 46.8 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-N 121.431 1.923 . . . . 0.0 110.141 -176.827 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -62.66 -39.0 92.53 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 123.113 0.565 . . . . 0.0 110.447 170.012 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -55.73 -43.43 86.67 Favored Glycine 0 C--N 1.343 0.918 0 C-N-CA 123.924 0.773 . . . . 0.0 112.543 174.822 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 2.1 m-85 -74.72 -32.31 62.11 Favored 'General case' 0 CA--C 1.51 -0.573 0 CA-C-N 119.599 1.7 . . . . 0.0 112.227 177.253 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -67.37 -34.19 76.78 Favored 'General case' 0 N--CA 1.453 -0.313 0 CA-C-N 118.839 0.745 . . . . 0.0 111.257 -172.853 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 17.9 ptpt -62.71 -28.16 69.76 Favored 'General case' 0 N--CA 1.475 0.794 0 CA-C-N 119.224 0.92 . . . . 0.0 111.975 170.827 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 2.1 m -83.78 -56.16 3.86 Favored 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 124.573 1.149 . . . . 0.0 110.369 -177.483 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 72.4 mt -73.33 -34.34 65.61 Favored 'General case' 0 C--N 1.331 -0.206 0 C-N-CA 123.861 0.864 . . . . 0.0 110.186 -173.856 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -97.98 11.34 64.14 Favored Glycine 0 CA--C 1.525 0.667 0 C-N-CA 125.487 1.518 . . . . 0.0 112.82 -177.112 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -50.25 122.8 7.37 Favored 'General case' 0 CA--C 1.535 0.391 0 CA-C-N 118.754 1.277 . . . . 0.0 110.406 -177.121 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 74.67 -2.85 46.23 Favored Glycine 0 CA--C 1.536 1.348 0 CA-C-O 118.764 -1.02 . . . . 0.0 114.39 179.216 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 64.4 mttm -103.89 -42.23 5.65 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-N 119.316 1.558 . . . . 0.0 111.319 178.918 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 17.2 pt -141.97 152.84 18.68 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.657 0 C-N-CA 125.068 1.347 . . . . 0.0 109.671 -171.012 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -113.69 103.42 11.21 Favored 'General case' 0 N--CA 1.467 0.4 0 C-N-CA 125.242 1.417 . . . . 0.0 109.877 -170.752 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 3.8 t -86.22 127.9 39.87 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 O-C-N 121.299 -0.875 . . . . 0.0 108.695 -178.517 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 24.6 m -151.46 98.67 2.54 Favored 'General case' 0 C--O 1.223 -0.341 0 N-CA-C 104.843 -2.28 . . . . 0.0 104.843 173.659 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 20.2 m -97.53 5.06 50.13 Favored 'General case' 0 N--CA 1.467 0.388 0 N-CA-C 114.7 1.37 . . . . 0.0 114.7 -169.693 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 4.6 m 53.12 -133.95 1.74 Allowed 'General case' 0 CA--C 1.548 0.873 0 C-N-CA 124.02 0.928 . . . . 0.0 111.458 175.318 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -177.75 170.79 43.27 Favored Glycine 0 CA--C 1.526 0.728 0 N-CA-C 107.121 -2.392 . . . . 0.0 107.121 179.447 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 24.8 mt -113.34 -43.17 3.38 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 118.481 1.14 . . . . 0.0 109.707 179.327 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -141.83 -59.51 0.47 Allowed 'General case' 0 C--N 1.332 -0.175 0 N-CA-C 102.404 -3.184 . . . . 0.0 102.404 169.743 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 15.9 m 58.93 175.58 0.07 Allowed 'General case' 0 N--CA 1.446 -0.649 0 C-N-CA 127.167 2.187 . . . . 0.0 115.772 167.553 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 4.4 m -165.75 178.98 6.23 Favored 'General case' 0 C--O 1.238 0.499 0 C-N-CA 129.464 3.105 . . . . 0.0 104.442 -169.645 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -65.9 163.17 17.55 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-O 122.491 1.139 . . . . 0.0 110.581 172.26 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 4.3 m -67.34 175.32 0.51 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.71 0 CA-C-N 113.305 -1.771 . . . . 0.0 109.3 169.849 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 49.8 t-80 -72.62 139.55 80.91 Favored Pre-proline 0 CA--C 1.545 0.786 0 CA-C-O 118.474 -0.774 . . . . 0.0 109.549 -176.638 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 21.8 Cg_endo -60.74 -48.1 11.72 Favored 'Trans proline' 0 C--N 1.348 0.552 0 C-N-CA 122.645 2.23 . . . . 0.0 113.019 -172.301 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 4.9 m -65.47 -23.41 66.9 Favored 'General case' 0 CA--C 1.536 0.425 0 O-C-N 121.727 -0.608 . . . . 0.0 110.899 179.374 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -58.89 -46.52 87.64 Favored 'General case' 0 C--O 1.216 -0.707 0 CA-C-N 119.146 0.884 . . . . 0.0 108.723 176.835 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 38.6 mt -61.11 -40.18 84.87 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 N-CA-C 108.89 -0.781 . . . . 0.0 108.89 -174.489 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -65.71 -45.1 84.01 Favored 'General case' 0 CA--C 1.534 0.338 0 CA-C-N 118.39 0.541 . . . . 0.0 110.946 -179.864 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 33.0 mmt -68.25 -36.77 79.95 Favored 'General case' 0 CA--C 1.536 0.414 0 CA-C-O 123.295 1.522 . . . . 0.0 110.006 -179.106 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -76.96 -30.39 56.0 Favored 'General case' 0 N--CA 1.44 -0.933 0 N-CA-C 106.632 -1.618 . . . . 0.0 106.632 -175.675 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 40.6 tt0 -69.69 -21.13 63.53 Favored 'General case' 0 N--CA 1.445 -0.686 0 C-N-CA 124.1 0.96 . . . . 0.0 110.049 169.672 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 54.8 mt-10 -63.65 -39.02 93.3 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-N 119.85 1.205 . . . . 0.0 108.963 169.206 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . 0.32 6.2 p -84.7 8.42 1.56 Allowed 'Isoleucine or valine' 0 CA--C 1.549 0.922 0 N-CA-C 112.005 0.372 . . . . 0.0 112.005 171.628 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 79.46 20.15 69.79 Favored Glycine 0 CA--C 1.53 1.01 0 C-N-CA 125.009 1.29 . . . . 0.0 113.563 174.318 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 22.8 mt -116.54 145.97 21.58 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.261 0 C-N-CA 124.861 1.265 . . . . 0.0 110.547 -171.528 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -116.73 149.02 40.56 Favored 'General case' 0 N--CA 1.463 0.214 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 168.94 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 3.3 pt -138.34 -18.78 0.47 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.376 0 C-N-CA 128.058 2.543 . . . . 0.0 111.197 -174.529 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 1.6 t -47.2 -39.87 14.89 Favored 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 124.11 0.964 . . . . 0.0 112.023 169.929 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -68.97 6.26 4.0 Favored Glycine 0 CA--C 1.535 1.306 0 C-N-CA 124.958 1.266 . . . . 0.0 115.318 -176.977 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 2.2 mt-30 -61.33 -33.35 73.47 Favored 'General case' 0 C--N 1.342 0.24 0 CA-C-N 119.605 1.702 . . . . 0.0 113.355 179.191 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -59.77 119.75 8.25 Favored 'General case' 0 C--O 1.236 0.385 0 C-N-CA 123.596 0.758 . . . . 0.0 109.736 -169.412 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 56.1 m -148.84 -169.71 3.44 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 126.358 1.863 . . . . 0.0 108.229 -169.149 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -54.75 154.6 9.1 Favored Pre-proline 0 C--O 1.239 0.524 0 C-N-CA 124.407 1.083 . . . . 0.0 111.613 169.925 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 98.2 Cg_endo -66.08 157.06 61.55 Favored 'Trans proline' 0 N--CA 1.454 -0.82 0 C-N-CA 122.328 2.018 . . . . 0.0 110.225 171.175 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 14.0 tt -61.19 -26.46 39.31 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.328 0 C-N-CA 124.229 1.011 . . . . 0.0 110.979 -178.789 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 13.6 mt-10 -68.03 -24.93 65.15 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 124.556 1.142 . . . . 0.0 110.619 -175.673 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 6.8 t-20 -62.93 -19.14 63.95 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 124.821 1.249 . . . . 0.0 112.153 177.477 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 13.3 m-85 -120.8 174.01 6.87 Favored 'General case' 0 C--O 1.237 0.412 0 C-N-CA 126.484 1.914 . . . . 0.0 109.318 -178.286 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 29.9 p-10 -125.09 149.29 47.99 Favored 'General case' 0 N--CA 1.437 -1.124 0 C-N-CA 124.681 1.192 . . . . 0.0 110.942 168.936 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -75.64 -22.23 56.97 Favored 'General case' 0 N--CA 1.435 -1.223 0 N-CA-C 109.603 -0.518 . . . . 0.0 109.603 -169.901 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 34.7 t70 -64.7 -23.66 67.32 Favored 'General case' 0 N--CA 1.444 -0.774 0 O-C-N 123.666 0.603 . . . . 0.0 111.804 -178.828 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -76.61 -29.44 56.5 Favored 'General case' 0 CA--C 1.533 0.323 0 O-C-N 121.893 -0.505 . . . . 0.0 111.928 173.993 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 21.0 m-85 -78.7 167.73 20.79 Favored 'General case' 0 N--CA 1.448 -0.532 0 C-N-CA 125.116 1.366 . . . . 0.0 110.949 179.597 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -115.63 -40.06 3.43 Favored 'General case' 0 N--CA 1.466 0.353 0 C-N-CA 122.893 0.477 . . . . 0.0 111.223 178.962 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -138.04 136.16 45.03 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.497 0 CA-C-O 121.8 0.81 . . . . 0.0 109.315 -171.324 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 72.1 t -143.84 136.56 23.75 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.68 0 N-CA-C 106.126 -1.805 . . . . 0.0 106.126 -176.869 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 40.9 mm -129.18 127.3 65.45 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.609 0 N-CA-C 107.325 -1.361 . . . . 0.0 107.325 -169.916 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 15.0 m -87.37 131.19 34.37 Favored 'General case' 0 N--CA 1.436 -1.159 0 N-CA-C 105.96 -1.867 . . . . 0.0 105.96 168.235 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 90.6 mt -88.71 -11.67 44.5 Favored 'General case' 0 C--N 1.331 -0.208 0 O-C-N 122.026 -0.421 . . . . 0.0 110.617 172.004 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -167.23 148.85 5.81 Favored 'General case' 0 N--CA 1.447 -0.618 0 C-N-CA 126.633 1.973 . . . . 0.0 107.339 168.385 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 72.37 167.79 10.51 Favored Glycine 0 CA--C 1.535 1.338 0 C-N-CA 124.849 1.214 . . . . 0.0 114.452 174.009 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 41.9 m -141.38 111.09 6.51 Favored 'General case' 0 CA--C 1.532 0.262 0 N-CA-C 107.454 -1.313 . . . . 0.0 107.454 178.936 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 60.23 30.94 71.96 Favored Glycine 0 CA--C 1.535 1.304 0 N-CA-C 111.567 -0.613 . . . . 0.0 111.567 -174.747 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 10.4 p -67.4 -51.71 49.52 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.563 0 C-N-CA 123.882 0.873 . . . . 0.0 111.493 -169.182 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 16.1 t-20 -154.4 41.61 0.49 Allowed 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 125.32 1.448 . . . . 0.0 107.128 173.04 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 2.3 tt -147.59 141.12 15.39 Favored Pre-proline 0 CA--C 1.542 0.641 0 C-N-CA 125.934 1.693 . . . . 0.0 107.85 -169.351 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 32.9 Cg_exo -68.18 149.94 76.57 Favored 'Trans proline' 0 C--N 1.355 0.885 0 CA-C-N 120.742 1.301 . . . . 0.0 114.272 -169.837 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -69.53 -29.05 25.58 Favored 'Trans proline' 0 C--N 1.347 0.455 0 C-N-CA 122.464 2.11 . . . . 0.0 114.292 -169.873 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -61.22 -18.36 57.93 Favored 'General case' 0 CA--C 1.538 0.492 0 CA-C-N 119.738 1.154 . . . . 0.0 112.081 -178.866 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 97.9 m95 -75.83 -49.37 18.2 Favored 'General case' 0 N--CA 1.449 -0.522 0 C-N-CA 123.628 0.771 . . . . 0.0 110.583 177.739 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 33.5 m -77.02 1.07 2.2 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.44 0 C-N-CA 123.13 0.572 . . . . 0.0 112.421 -178.647 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 81.3 p -111.47 19.57 18.06 Favored 'General case' 0 CA--C 1.537 0.458 0 N-CA-C 114.302 1.223 . . . . 0.0 114.302 175.464 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 87.4 mm-40 -67.54 174.61 3.33 Favored 'General case' 0 CA--C 1.539 0.544 0 CA-C-N 119.16 0.891 . . . . 0.0 112.445 178.158 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 29.7 mm-40 -51.91 -32.23 31.87 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 124.711 1.204 . . . . 0.0 112.334 -169.056 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 5.3 tt -131.71 130.85 62.24 Favored 'Isoleucine or valine' 0 C--O 1.24 0.557 0 N-CA-C 103.92 -2.622 . . . . 0.0 103.92 168.017 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 40.9 t80 -120.47 141.18 50.42 Favored 'General case' 0 N--CA 1.444 -0.738 0 N-CA-C 106.061 -1.829 . . . . 0.0 106.061 169.27 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 31.2 mm-40 -139.68 144.8 37.76 Favored 'General case' 0 C--O 1.237 0.408 0 N-CA-C 106.204 -1.776 . . . . 0.0 106.204 169.632 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 7.1 t0 -119.8 103.45 9.37 Favored 'General case' 0 C--O 1.237 0.443 0 N-CA-C 104.746 -2.316 . . . . 0.0 104.746 169.247 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 4.2 m95 -86.15 134.22 33.81 Favored 'General case' 0 N--CA 1.453 -0.278 0 CA-C-O 120.683 0.278 . . . . 0.0 110.928 -169.62 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 66.5 tt0 -81.89 99.71 9.21 Favored 'General case' 0 C--O 1.236 0.383 0 N-CA-C 103.568 -2.753 . . . . 0.0 103.568 168.712 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.401 HD13 HG22 ' A' ' 119' ' ' VAL . 11.1 mt -129.62 133.17 46.99 Favored 'General case' 0 CA--C 1.52 -0.196 0 N-CA-C 107.477 -1.305 . . . . 0.0 107.477 178.622 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 -76.74 165.0 25.33 Favored 'General case' 0 N--CA 1.452 -0.366 0 C-N-CA 124.902 1.281 . . . . 0.0 108.323 169.803 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 15.3 t70 -140.66 139.72 20.71 Favored Pre-proline 0 CA--C 1.536 0.439 0 C-N-CA 123.872 0.869 . . . . 0.0 110.142 -177.511 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 42.4 Cg_endo -84.83 0.92 8.82 Favored 'Trans proline' 0 CA--C 1.544 0.977 0 C-N-CA 123.149 2.566 . . . . 0.0 114.405 -172.8 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 3.2 t70 -48.76 120.0 3.52 Favored 'General case' 0 N--CA 1.468 0.428 0 CA-C-N 120.517 1.508 . . . . 0.0 110.926 177.623 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 67.87 4.73 35.49 Favored Glycine 0 CA--C 1.536 1.383 0 CA-C-O 118.723 -1.043 . . . . 0.0 114.777 179.076 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 6.3 mt-30 -94.45 171.14 8.99 Favored 'General case' 0 CA--C 1.538 0.509 0 CA-C-N 119.31 1.555 . . . . 0.0 110.424 -178.612 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 14.6 m -68.47 159.61 31.36 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 124.321 1.048 . . . . 0.0 110.599 178.083 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 13.8 tp -60.06 -32.0 70.52 Favored 'General case' 0 N--CA 1.467 0.417 0 C-N-CA 123.888 0.875 . . . . 0.0 112.127 -170.055 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 5.3 pt-20 -53.85 -35.76 61.86 Favored 'General case' 0 N--CA 1.467 0.418 0 C-N-CA 126.016 1.726 . . . . 0.0 112.137 176.095 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 38.3 t -70.81 -37.86 70.37 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.258 0 N-CA-C 109.083 -0.71 . . . . 0.0 109.083 -174.008 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 91.8 m-85 -56.74 -50.35 72.5 Favored 'General case' 0 N--CA 1.462 0.126 0 CA-C-N 119.346 0.975 . . . . 0.0 110.806 172.563 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -66.34 -38.09 86.86 Favored 'General case' 0 N--CA 1.473 0.699 0 N-CA-C 109.766 -0.457 . . . . 0.0 109.766 -174.992 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 4.0 m -60.85 -49.64 76.66 Favored 'General case' 0 N--CA 1.451 -0.42 0 C-N-CA 124.704 1.201 . . . . 0.0 109.984 173.681 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 76.7 t -69.59 -25.84 29.62 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.229 0 CA-C-O 117.812 -1.089 . . . . 0.0 109.944 -171.829 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 11.9 mtm105 -57.15 -49.07 77.07 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 120.142 1.337 . . . . 0.0 109.729 169.839 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -63.35 -48.47 78.54 Favored Glycine 0 CA--C 1.527 0.84 0 CA-C-N 118.608 0.64 . . . . 0.0 111.951 -179.52 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 12.8 mt-30 -60.74 -46.15 91.52 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-N 117.719 0.759 . . . . 0.0 110.77 -179.188 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 119' ' ' VAL . . . . . 0.401 HG22 HD13 ' A' ' 101' ' ' LEU . 82.6 t -70.68 -40.67 77.27 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-O 118.424 -0.798 . . . . 0.0 110.297 -175.84 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 85.9 tttt -52.69 -47.26 67.33 Favored 'General case' 0 C--O 1.223 -0.322 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 175.688 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 40.2 tt0 -64.58 -42.63 95.49 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-O 119.245 -0.407 . . . . 0.0 111.253 -175.134 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 35.3 mmt180 -60.21 -47.46 85.86 Favored 'General case' 0 N--CA 1.472 0.635 0 CA-C-N 118.882 0.765 . . . . 0.0 110.434 175.893 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 89.8 t -69.94 -37.78 73.7 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.525 0 N-CA-C 109.563 -0.532 . . . . 0.0 109.563 -175.274 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 35.4 mt-10 -59.96 -44.44 94.42 Favored 'General case' 0 C--O 1.227 -0.097 0 CA-C-N 119.657 1.117 . . . . 0.0 110.049 174.165 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 28.7 t-20 -63.26 -44.55 94.84 Favored 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 122.693 0.397 . . . . 0.0 110.834 -178.564 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 41.8 tp -58.73 -48.53 80.85 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 124.335 1.054 . . . . 0.0 111.104 175.97 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 65.4 mt -62.79 -47.1 94.48 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.149 0 N-CA-C 107.865 -1.161 . . . . 0.0 107.865 -179.999 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -58.85 -27.65 65.34 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 123.095 0.558 . . . . 0.0 112.436 178.11 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 89.4 mttt -72.03 -57.43 4.29 Favored 'General case' 0 C--N 1.343 0.325 0 CA-C-N 119.153 0.888 . . . . 0.0 110.616 171.604 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 13.2 pt -76.14 -36.23 30.31 Favored 'Isoleucine or valine' 0 C--O 1.235 0.293 0 N-CA-C 115.184 1.55 . . . . 0.0 115.184 -168.943 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 69.2 m . . . . . 0 C--O 1.252 1.229 0 C-N-CA 125.707 1.603 . . . . 0.0 109.606 -169.881 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 19.5 mmm . . . . . 0 N--CA 1.499 1.997 0 N-CA-C 110.936 -0.024 . . . . 0.0 110.936 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 31.0 mttm -79.43 117.81 20.73 Favored 'General case' 0 N--CA 1.477 0.895 0 N-CA-C 105.407 -2.071 . . . . 0.0 105.407 169.545 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 74.5 mttt -83.43 133.67 34.91 Favored 'General case' 0 CA--C 1.514 -0.414 0 CA-C-N 120.252 1.387 . . . . 0.0 107.997 179.324 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 1.5 t -118.78 147.94 21.98 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.583 0 C-N-CA 126.725 2.01 . . . . 0.0 106.711 -169.635 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 49.7 ttm -142.8 142.04 31.78 Favored 'General case' 0 C--N 1.325 -0.484 0 C-N-CA 123.71 0.804 . . . . 0.0 109.343 172.191 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 97.0 m-85 -132.64 122.06 24.12 Favored 'General case' 0 CA--C 1.511 -0.551 0 N-CA-C 104.987 -2.227 . . . . 0.0 104.987 179.855 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 1.6 p -154.07 119.78 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.397 0 C-N-CA 119.566 -0.854 . . . . 0.0 109.412 -169.515 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 51.1 t -98.75 178.43 4.98 Favored 'General case' 0 CA--C 1.541 0.623 0 N-CA-C 106.971 -1.492 . . . . 0.0 106.971 168.915 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -52.4 -42.19 63.83 Favored 'General case' 0 N--CA 1.473 0.707 0 O-C-N 121.624 -0.673 . . . . 0.0 110.803 178.662 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 66.2 mtp180 -108.94 145.45 35.41 Favored 'General case' 0 CA--C 1.521 -0.156 0 N-CA-C 108.978 -0.749 . . . . 0.0 108.978 169.852 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 7.4 t30 -55.04 -38.01 67.42 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 124.363 1.065 . . . . 0.0 111.112 169.372 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 1.4 m -68.71 -15.0 63.38 Favored 'General case' 0 CA--C 1.533 0.307 0 N-CA-C 114.667 1.358 . . . . 0.0 114.667 -169.557 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 52.3 m -124.69 139.43 53.86 Favored 'General case' 0 C--O 1.223 -0.309 0 C-N-CA 123.97 0.908 . . . . 0.0 110.311 -169.09 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 6.4 mpt_? 59.14 -60.97 0.04 OUTLIER 'General case' 0 N--CA 1.481 1.112 0 C-N-CA 127.605 2.362 . . . . 0.0 114.066 -174.737 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -44.72 -36.91 3.39 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 126.499 1.919 . . . . 0.0 109.624 170.001 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 23.8 tt0 -25.63 -61.91 0.07 Allowed 'General case' 0 C--O 1.22 -0.486 0 C-N-CA 130.686 3.595 . . . . 0.0 111.772 168.848 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -98.68 -29.87 12.78 Favored 'General case' 0 CA--C 1.516 -0.345 0 CA-C-N 119.719 1.145 . . . . 0.0 113.434 177.501 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -61.09 -48.55 81.18 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 111.993 0.368 . . . . 0.0 111.993 -169.321 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -68.74 -30.62 69.28 Favored 'General case' 0 N--CA 1.463 0.177 0 C-N-CA 120.237 -0.585 . . . . 0.0 109.645 176.767 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -54.81 -57.3 18.55 Favored Glycine 0 C--N 1.34 0.781 0 C-N-CA 125.405 1.478 . . . . 0.0 110.099 176.812 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 8.7 m-85 -67.89 -32.18 72.48 Favored 'General case' 0 CA--C 1.503 -0.835 0 O-C-N 121.659 -0.906 . . . . 0.0 111.981 179.982 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -65.82 -34.74 78.85 Favored 'General case' 0 N--CA 1.447 -0.585 0 C-N-CA 119.431 -0.908 . . . . 0.0 111.141 -175.452 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -68.1 -24.23 65.01 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-N 119.436 1.016 . . . . 0.0 112.036 175.037 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 2.1 m -82.11 -56.12 4.13 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 125.223 1.409 . . . . 0.0 110.438 -179.993 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 72.3 mt -76.37 -34.97 58.91 Favored 'General case' 0 C--N 1.329 -0.283 0 C-N-CA 124.631 1.172 . . . . 0.0 110.258 -172.529 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -92.57 7.13 77.69 Favored Glycine 0 CA--C 1.526 0.758 0 C-N-CA 125.282 1.42 . . . . 0.0 113.198 -177.292 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -52.52 124.18 12.93 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 124.448 1.099 . . . . 0.0 110.002 -176.01 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 75.44 1.95 66.74 Favored Glycine 0 CA--C 1.535 1.288 0 CA-C-O 118.835 -0.981 . . . . 0.0 114.406 179.074 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 64.0 mttm -113.36 -43.06 3.39 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-N 119.294 1.547 . . . . 0.0 111.359 178.828 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 20.4 pt -140.94 151.41 20.2 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.604 0 C-N-CA 123.805 0.842 . . . . 0.0 110.388 -169.36 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -108.66 103.25 12.31 Favored 'General case' 0 N--CA 1.467 0.393 0 C-N-CA 125.37 1.468 . . . . 0.0 109.646 -173.209 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 20.8 t -81.31 135.84 24.28 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 179.604 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 4.8 m -140.68 111.51 6.99 Favored 'General case' 0 N--CA 1.445 -0.678 0 N-CA-C 104.492 -2.41 . . . . 0.0 104.492 169.513 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 75.0 m -114.31 91.97 3.81 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 107.64 -1.245 . . . . 0.0 107.64 178.739 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 5.0 p -63.69 -62.38 1.7 Allowed 'General case' 0 C--O 1.233 0.215 0 C-N-CA 126.408 1.883 . . . . 0.0 112.044 -173.071 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 107.88 137.63 8.36 Favored Glycine 0 CA--C 1.527 0.786 0 N-CA-C 109.157 -1.577 . . . . 0.0 109.157 -174.425 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 12.8 mt -80.08 -40.44 27.6 Favored 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 124.395 1.078 . . . . 0.0 108.874 170.207 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 33.5 mt-10 -139.87 170.16 16.38 Favored 'General case' 0 C--O 1.239 0.523 0 C-N-CA 128.143 2.577 . . . . 0.0 107.629 172.914 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 13.2 m 64.75 -168.17 0.21 Allowed 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 124.837 1.255 . . . . 0.0 112.315 -177.487 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 36.8 p -162.55 -47.66 0.04 OUTLIER 'General case' 0 C--O 1.232 0.184 0 N-CA-C 112.442 0.534 . . . . 0.0 112.442 -167.067 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 2.0 ttp-105 -108.87 -167.5 1.23 Allowed 'General case' 0 CA--C 1.52 -0.19 0 C-N-CA 125.498 1.519 . . . . 0.0 109.227 177.766 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 34.2 m -127.32 168.94 19.53 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 C-N-CA 125.506 1.523 . . . . 0.0 109.838 -171.757 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 37.4 m80 -71.59 148.1 92.67 Favored Pre-proline 0 CA--C 1.548 0.889 0 C-N-CA 123.313 0.645 . . . . 0.0 109.694 177.975 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -62.39 -50.74 4.14 Favored 'Trans proline' 0 C--N 1.348 0.529 0 C-N-CA 123.818 3.012 . . . . 0.0 114.806 -168.632 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 11.5 m -63.88 -22.69 67.03 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-N 118.211 0.459 . . . . 0.0 110.61 -175.678 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.415 ' HB1' HD11 ' A' ' 57' ' ' ILE . . . -55.12 -55.33 32.32 Favored 'General case' 0 CA--C 1.511 -0.546 0 C-N-CA 122.765 0.426 . . . . 0.0 109.911 174.152 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 56.3 mt -60.54 -38.04 76.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 N-CA-C 108.554 -0.906 . . . . 0.0 108.554 -170.635 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -62.94 -48.19 79.98 Favored 'General case' 0 N--CA 1.451 -0.379 0 CA-C-N 118.471 0.578 . . . . 0.0 111.07 177.778 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 27.8 mmt -66.73 -36.54 82.71 Favored 'General case' 0 C--O 1.238 0.488 0 CA-C-O 122.78 1.276 . . . . 0.0 111.071 -179.748 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -75.98 -31.23 58.88 Favored 'General case' 0 N--CA 1.441 -0.878 0 N-CA-C 107.183 -1.414 . . . . 0.0 107.183 -174.777 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 41.0 tt0 -71.28 -21.77 62.04 Favored 'General case' 0 N--CA 1.446 -0.63 0 C-N-CA 124.138 0.975 . . . . 0.0 110.426 171.031 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 20.0 mm-40 -67.57 -31.0 70.77 Favored 'General case' 0 CA--C 1.534 0.359 0 CA-C-N 119.508 1.049 . . . . 0.0 110.141 170.814 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . 0.28 7.2 p -90.39 8.62 3.53 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.983 0 CA-C-N 118.633 0.652 . . . . 0.0 111.482 169.062 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 75.73 18.59 79.6 Favored Glycine 0 CA--C 1.533 1.162 0 C-N-CA 124.678 1.133 . . . . 0.0 113.746 174.908 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 21.6 mt -111.35 134.81 52.5 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.23 0 C-N-CA 124.559 1.143 . . . . 0.0 109.379 -177.234 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 28.7 t0 -99.52 141.53 32.19 Favored 'General case' 0 C--O 1.235 0.323 0 N-CA-C 108.288 -1.005 . . . . 0.0 108.288 168.952 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.415 HD11 ' HB1' ' A' ' 46' ' ' ALA . 8.8 pt -131.15 -15.67 1.58 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.503 0 C-N-CA 126.335 1.854 . . . . 0.0 111.298 -174.135 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 1.2 t -57.2 163.48 2.14 Favored 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 124.544 1.138 . . . . 0.0 109.86 168.342 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 57.73 32.6 65.82 Favored Glycine 0 CA--C 1.532 1.106 0 C-N-CA 123.543 0.592 . . . . 0.0 112.129 179.177 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 4.3 tt0 -65.5 -39.41 91.82 Favored 'General case' 0 C--N 1.341 0.214 0 N-CA-C 113.957 1.095 . . . . 0.0 113.957 -169.135 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 7.0 t -76.19 177.82 6.9 Favored 'General case' 0 N--CA 1.449 -0.518 0 CA-C-O 122.557 1.17 . . . . 0.0 110.555 -169.646 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 13.3 p -155.72 -54.1 0.09 Allowed 'General case' 0 C--N 1.324 -0.515 0 C-N-CA 125.213 1.405 . . . . 0.0 108.327 -171.25 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -151.88 155.89 33.95 Favored Pre-proline 0 C--O 1.239 0.521 0 C-N-CA 127.628 2.371 . . . . 0.0 106.173 169.955 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -59.84 148.81 86.85 Favored 'Trans proline' 0 N--CA 1.457 -0.654 0 C-N-CA 121.801 1.668 . . . . 0.0 108.991 169.411 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 20.6 tt -55.24 -29.62 23.44 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.352 0 C-N-CA 123.12 0.568 . . . . 0.0 112.364 -174.181 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 9.0 mt-10 -65.73 -29.62 70.17 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 123.233 0.613 . . . . 0.0 111.026 -173.234 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 88.3 m-20 -77.93 -8.98 58.84 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 124.002 0.921 . . . . 0.0 112.273 -177.796 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 61.8 m-85 -95.53 162.24 13.72 Favored 'General case' 0 C--O 1.236 0.352 0 C-N-CA 124.286 1.034 . . . . 0.0 111.321 176.836 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 40.9 t-20 -99.47 127.32 45.52 Favored 'General case' 0 N--CA 1.447 -0.62 0 N-CA-C 107.431 -1.322 . . . . 0.0 107.431 168.875 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.415 ' HB2' ' CE2' ' A' ' 90' ' ' TRP . . . -73.3 -26.28 61.01 Favored 'General case' 0 N--CA 1.434 -1.266 0 N-CA-C 109.466 -0.568 . . . . 0.0 109.466 -178.252 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -63.85 -22.47 66.93 Favored 'General case' 0 N--CA 1.443 -0.798 0 CA-C-N 116.528 -0.306 . . . . 0.0 111.582 -178.347 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -74.02 -24.64 59.58 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 123.058 0.543 . . . . 0.0 111.991 178.851 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 34.4 m-85 -85.85 145.67 27.09 Favored 'General case' 0 N--CA 1.451 -0.394 0 C-N-CA 124.974 1.31 . . . . 0.0 111.5 -176.534 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 27.3 t70 -98.66 -32.69 11.28 Favored 'General case' 0 N--CA 1.466 0.357 0 C-N-CA 123.506 0.722 . . . . 0.0 111.032 -179.844 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -140.19 134.66 36.13 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.393 0 C-N-CA 124.376 1.071 . . . . 0.0 109.119 -175.792 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 94.2 t -144.1 139.49 24.77 Favored 'Isoleucine or valine' 0 C--O 1.237 0.396 0 N-CA-C 107.165 -1.42 . . . . 0.0 107.165 -178.822 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.598 HD12 ' HB2' ' A' ' 97' ' ' GLU . 19.0 mm -123.06 124.4 70.11 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.601 0 N-CA-C 106.589 -1.634 . . . . 0.0 106.589 -179.357 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 28.2 m -95.4 105.87 17.88 Favored 'General case' 0 N--CA 1.448 -0.555 0 N-CA-C 103.66 -2.718 . . . . 0.0 103.66 169.321 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 29.4 mt -76.21 -4.76 43.58 Favored 'General case' 0 N--CA 1.463 0.219 0 N-CA-C 114.273 1.212 . . . . 0.0 114.273 -169.364 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 73.2 m -146.13 71.77 1.27 Allowed 'General case' 0 N--CA 1.451 -0.391 0 CA-C-N 118.795 0.725 . . . . 0.0 109.168 -169.761 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 91.05 178.79 43.18 Favored Glycine 0 CA--C 1.53 0.979 0 C-N-CA 124.484 1.04 . . . . 0.0 111.031 -177.009 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 15.0 p -89.79 -92.95 0.12 Allowed 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 123.643 0.777 . . . . 0.0 111.087 -169.533 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -79.52 -41.67 12.85 Favored Glycine 0 C--N 1.338 0.665 0 CA-C-O 119.058 -0.856 . . . . 0.0 111.06 176.885 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . 0.317 4.7 m 44.13 -94.41 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.543 0.698 0 C-N-CA 126.063 1.745 . . . . 0.0 113.704 174.833 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 57.3 t30 -141.13 43.42 1.79 Allowed 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 125.129 1.372 . . . . 0.0 109.111 177.131 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -133.72 139.27 33.1 Favored Pre-proline 0 CA--C 1.541 0.623 0 C-N-CA 127.247 2.219 . . . . 0.0 107.316 -171.642 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 39.6 Cg_exo -65.36 137.84 52.91 Favored 'Trans proline' 0 CA--C 1.539 0.748 0 C-N-CA 121.386 1.391 . . . . 0.0 111.965 -176.124 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 65.1 Cg_endo -68.88 -15.53 40.44 Favored 'Trans proline' 0 N--CA 1.46 -0.472 0 C-N-CA 122.616 2.211 . . . . 0.0 113.513 -173.644 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -59.54 -14.74 14.21 Favored 'General case' 0 CA--C 1.541 0.625 0 CA-C-N 120.315 1.416 . . . . 0.0 111.966 170.425 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 90' ' ' TRP . . . . . 0.415 ' CE2' ' HB2' ' A' ' 70' ' ' ALA . 99.8 m95 -96.56 -11.36 25.49 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 125.215 1.406 . . . . 0.0 113.563 174.683 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.403 ' HA ' ' CD1' ' A' ' 96' ' ' PHE . 3.9 m -92.42 0.75 9.42 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.355 0 CA-C-N 120.261 1.392 . . . . 0.0 111.477 174.745 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 63.6 p -117.88 15.66 14.32 Favored 'General case' 0 C--O 1.237 0.406 0 N-CA-C 116.872 2.175 . . . . 0.0 116.872 -169.455 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 17.6 mp0 -66.51 173.87 3.1 Favored 'General case' 0 CA--C 1.54 0.587 0 CA-C-N 118.852 0.751 . . . . 0.0 111.016 176.284 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 33.3 mm-40 -56.67 -27.06 57.98 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 123.691 0.796 . . . . 0.0 111.268 -172.353 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 5.0 tt -133.8 131.24 56.41 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.528 0 N-CA-C 104.958 -2.238 . . . . 0.0 104.958 168.361 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 96' ' ' PHE . . . . . 0.403 ' CD1' ' HA ' ' A' ' 91' ' ' VAL . 40.5 t80 -117.99 135.99 53.81 Favored 'General case' 0 N--CA 1.449 -0.486 0 N-CA-C 106.706 -1.59 . . . . 0.0 106.706 169.739 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 97' ' ' GLU . . . . . 0.598 ' HB2' HD12 ' A' ' 77' ' ' ILE . 16.4 mm-40 -142.09 165.81 26.44 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-O 121.963 0.887 . . . . 0.0 110.116 174.881 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 3.7 t0 -168.1 134.16 1.95 Allowed 'General case' 0 C--O 1.239 0.516 0 C-N-CA 129.71 3.204 . . . . 0.0 106.108 -172.76 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 6.2 m-90 -144.8 149.04 34.77 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 123.847 0.859 . . . . 0.0 109.72 -171.269 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 7.4 tp-100 -82.56 57.36 3.69 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-O 121.809 0.814 . . . . 0.0 109.589 177.889 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.515 HD13 HG22 ' A' ' 119' ' ' VAL . 66.6 mt -79.22 152.66 30.5 Favored 'General case' 0 CA--C 1.53 0.179 0 N-CA-C 106.526 -1.657 . . . . 0.0 106.526 169.62 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 5.6 pt-20 -119.24 164.55 15.46 Favored 'General case' 0 N--CA 1.456 -0.141 0 C-N-CA 124.936 1.294 . . . . 0.0 110.436 178.623 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 64.4 t0 -97.42 121.28 58.91 Favored Pre-proline 0 CA--C 1.539 0.542 0 C-N-CA 123.739 0.815 . . . . 0.0 108.842 171.375 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 90.2 Cg_endo -70.48 -5.0 15.65 Favored 'Trans proline' 0 CA--C 1.544 1.02 0 C-N-CA 123.792 2.995 . . . . 0.0 113.765 176.18 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -43.28 123.23 2.85 Favored 'General case' 0 C--O 1.238 0.453 0 C-N-CA 126.249 1.82 . . . . 0.0 111.367 -179.506 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 69.5 2.79 36.89 Favored Glycine 0 CA--C 1.533 1.19 0 CA-C-O 118.612 -1.105 . . . . 0.0 114.98 169.759 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 28.8 pt20 -111.62 -167.06 1.13 Allowed 'General case' 0 CA--C 1.536 0.433 0 CA-C-N 119.021 1.41 . . . . 0.0 109.737 171.928 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 2.3 m -68.45 154.43 41.84 Favored 'General case' 0 N--CA 1.453 -0.303 0 N-CA-C 115.699 1.74 . . . . 0.0 115.699 -168.261 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 36.0 tp -55.76 -33.39 64.27 Favored 'General case' 0 N--CA 1.465 0.317 0 C-N-CA 126.349 1.86 . . . . 0.0 111.784 173.722 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -58.12 -34.67 70.47 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 123.544 0.738 . . . . 0.0 110.529 174.711 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 2.8 t -76.47 -40.52 34.53 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.299 0 CA-C-O 118.284 -0.865 . . . . 0.0 109.96 -178.912 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 61.9 m-85 -56.47 -47.27 79.55 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-N 120.122 1.328 . . . . 0.0 109.538 171.4 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 86.7 mtt180 -62.99 -43.16 99.55 Favored 'General case' 0 N--CA 1.466 0.351 0 C-N-CA 122.982 0.513 . . . . 0.0 110.972 179.43 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 6.9 m -64.25 -50.12 69.19 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 124.266 1.027 . . . . 0.0 109.955 179.347 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 75.8 t -68.68 -37.46 77.59 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.365 0 CA-C-N 118.796 0.725 . . . . 0.0 109.056 -173.564 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 46.1 ttp85 -58.22 -44.39 88.17 Favored 'General case' 0 CA--C 1.538 0.483 0 CA-C-N 119.117 0.871 . . . . 0.0 110.329 174.706 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -64.83 -50.24 59.34 Favored Glycine 0 CA--C 1.531 1.07 0 CA-C-N 118.543 0.611 . . . . 0.0 112.204 176.137 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 39.1 mm-40 -58.02 -50.99 71.51 Favored 'General case' 0 N--CA 1.465 0.324 0 C-N-CA 124.213 1.005 . . . . 0.0 110.278 -177.838 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 119' ' ' VAL . . . . . 0.515 HG22 HD13 ' A' ' 101' ' ' LEU . 98.3 t -67.56 -38.38 80.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-O 118.211 -0.899 . . . . 0.0 110.344 -174.054 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 57.1 tttm -55.0 -44.75 74.8 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 119.451 1.023 . . . . 0.0 109.338 175.551 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -68.48 -43.33 77.16 Favored 'General case' 0 N--CA 1.447 -0.621 0 CA-C-O 119.053 -0.498 . . . . 0.0 111.293 -176.204 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 1.8 mmt-85 -60.34 -46.83 88.51 Favored 'General case' 0 N--CA 1.476 0.841 0 CA-C-N 119.363 0.983 . . . . 0.0 110.604 176.262 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 98.4 t -69.41 -38.57 77.43 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.487 0 N-CA-C 109.101 -0.703 . . . . 0.0 109.101 -177.172 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 15.3 mt-10 -60.38 -45.63 92.86 Favored 'General case' 0 CA--C 1.52 -0.202 0 CA-C-N 119.884 1.22 . . . . 0.0 110.122 175.022 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 29.4 t-20 -62.53 -41.51 98.91 Favored 'General case' 0 CA--C 1.531 0.223 0 C-N-CA 123.25 0.62 . . . . 0.0 110.712 -179.85 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 58.7 tp -60.78 -48.45 81.73 Favored 'General case' 0 N--CA 1.456 -0.148 0 C-N-CA 123.819 0.848 . . . . 0.0 111.261 176.424 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 76.1 mt -63.49 -45.72 97.09 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.292 0 N-CA-C 107.646 -1.242 . . . . 0.0 107.646 179.91 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -59.19 -28.31 66.51 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 123.135 0.574 . . . . 0.0 112.405 177.009 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 72.3 mttt -71.87 -54.22 10.77 Favored 'General case' 0 C--N 1.343 0.309 0 CA-C-N 119.129 0.877 . . . . 0.0 110.726 172.772 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 14.1 pt -79.44 -38.43 19.74 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.332 0 N-CA-C 114.667 1.358 . . . . 0.0 114.667 -169.215 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 73.3 m . . . . . 0 C--O 1.253 1.266 0 C-N-CA 125.967 1.707 . . . . 0.0 109.742 -169.982 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.496 1.834 0 N-CA-C 110.234 -0.284 . . . . 0.0 110.234 . . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 34.3 mttm -76.56 117.16 17.92 Favored 'General case' 0 N--CA 1.477 0.883 0 N-CA-C 106.021 -1.844 . . . . 0.0 106.021 172.295 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 88.8 mttt -84.92 135.11 34.2 Favored 'General case' 0 CA--C 1.515 -0.387 0 N-CA-C 107.695 -1.224 . . . . 0.0 107.695 179.47 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 1.8 t -120.81 149.51 23.69 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 C-N-CA 125.9 1.68 . . . . 0.0 109.511 -168.493 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 25.9 mtt -139.57 147.47 41.2 Favored 'General case' 0 C--N 1.324 -0.523 0 C-N-CA 124.534 1.133 . . . . 0.0 109.111 169.27 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 72.0 m-85 -133.06 114.33 13.81 Favored 'General case' 0 CA--C 1.517 -0.32 0 N-CA-C 104.343 -2.465 . . . . 0.0 104.343 172.133 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 2.4 p -151.39 137.2 11.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 118.563 0.62 . . . . 0.0 109.758 -169.352 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 19.9 t -117.24 178.43 4.37 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 126.225 1.81 . . . . 0.0 106.323 169.6 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 39.7 ttpt -55.05 -35.08 64.11 Favored 'General case' 0 N--CA 1.475 0.819 0 O-C-N 121.148 -0.97 . . . . 0.0 111.479 179.638 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 33.3 ptt180 -123.55 160.27 27.38 Favored 'General case' 0 N--CA 1.463 0.212 0 C-N-CA 124.868 1.267 . . . . 0.0 108.294 169.628 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 47.6 t30 -71.75 -42.66 66.97 Favored 'General case' 0 N--CA 1.471 0.578 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 170.864 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 1.1 m -52.02 141.45 18.07 Favored 'General case' 0 N--CA 1.453 -0.319 0 C-N-CA 125.696 1.598 . . . . 0.0 110.616 -171.331 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 3.9 m 66.91 -66.65 0.18 Allowed 'General case' 0 C--N 1.327 -0.383 0 C-N-CA 126.315 1.846 . . . . 0.0 114.525 -173.459 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 8.9 tpp180 -82.78 -46.93 12.51 Favored 'General case' 0 N--CA 1.471 0.576 0 N-CA-C 116.464 2.024 . . . . 0.0 116.464 -167.59 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 3.6 m -89.78 4.69 48.95 Favored 'General case' 0 N--CA 1.471 0.596 0 N-CA-C 114.81 1.411 . . . . 0.0 114.81 -169.051 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 28.2 pt20 -68.83 -47.64 65.54 Favored 'General case' 0 C--O 1.224 -0.289 0 O-C-N 120.959 -1.088 . . . . 0.0 113.364 -171.035 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 2.4 tpt -88.06 -34.63 17.9 Favored 'General case' 0 N--CA 1.47 0.527 0 N-CA-C 113.659 0.985 . . . . 0.0 113.659 -169.309 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -61.03 -44.95 96.64 Favored 'General case' 0 N--CA 1.471 0.605 0 N-CA-C 112.88 0.696 . . . . 0.0 112.88 -169.082 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 1.9 pp20? -64.96 -34.51 78.59 Favored 'General case' 0 N--CA 1.464 0.255 0 O-C-N 121.96 -0.463 . . . . 0.0 109.834 176.522 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -52.11 -56.47 16.64 Favored Glycine 0 C--N 1.34 0.753 0 C-N-CA 125.182 1.372 . . . . 0.0 110.623 175.539 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 13.5 m-85 -68.52 -29.89 68.58 Favored 'General case' 0 CA--C 1.508 -0.657 0 O-C-N 121.521 -0.987 . . . . 0.0 112.512 -179.964 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -69.73 -31.93 70.19 Favored 'General case' 0 N--CA 1.452 -0.341 0 CA-C-N 119.52 1.055 . . . . 0.0 111.603 -174.766 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -68.19 -25.56 65.3 Favored 'General case' 0 N--CA 1.474 0.758 0 CA-C-N 119.541 1.064 . . . . 0.0 111.651 172.566 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 3.2 m -82.42 -56.46 3.87 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 124.959 1.304 . . . . 0.0 110.139 -177.592 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 70.7 mt -75.33 -36.42 61.05 Favored 'General case' 0 C--N 1.331 -0.215 0 C-N-CA 124.298 1.039 . . . . 0.0 110.055 -173.83 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -89.96 6.12 82.92 Favored Glycine 0 C--N 1.339 0.715 0 C-N-CA 124.855 1.217 . . . . 0.0 113.152 -177.017 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -50.74 125.28 12.86 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 124.739 1.215 . . . . 0.0 110.321 -175.635 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 76.54 -5.41 45.38 Favored Glycine 0 CA--C 1.534 1.229 0 CA-C-O 118.782 -1.01 . . . . 0.0 114.437 179.41 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 63.2 mttm -107.5 -51.89 2.84 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-N 119.322 1.561 . . . . 0.0 110.226 -179.762 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 26.1 pt -136.36 147.74 27.66 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.295 0 C-N-CA 123.913 0.885 . . . . 0.0 110.066 -169.31 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -109.89 104.26 13.16 Favored 'General case' 0 N--CA 1.463 0.198 0 C-N-CA 125.082 1.353 . . . . 0.0 108.885 -169.871 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 14.6 p -81.09 142.02 14.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 119.51 1.05 . . . . 0.0 109.192 177.003 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 11.6 m -132.15 -49.63 0.94 Allowed 'General case' 0 N--CA 1.455 -0.212 0 C-N-CA 124.216 1.006 . . . . 0.0 110.22 175.633 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 48.1 m 62.69 -27.03 0.06 Allowed 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 127.439 2.296 . . . . 0.0 117.14 176.49 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 5.6 m 54.37 -135.78 1.4 Allowed 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 124.765 1.226 . . . . 0.0 110.804 169.752 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -172.65 170.25 43.35 Favored Glycine 0 C--N 1.336 0.574 0 N-CA-C 108.331 -1.907 . . . . 0.0 108.331 178.289 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 34.2 mt -118.28 -43.31 2.73 Favored 'General case' 0 N--CA 1.451 -0.398 0 C-N-CA 125.353 1.461 . . . . 0.0 109.084 179.833 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 36.6 mt-10 -140.45 -59.3 0.53 Allowed 'General case' 0 C--O 1.233 0.192 0 N-CA-C 101.687 -3.449 . . . . 0.0 101.687 169.605 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 17.1 m 57.39 177.88 0.05 OUTLIER 'General case' 0 N--CA 1.447 -0.582 0 C-N-CA 127.291 2.236 . . . . 0.0 116.702 167.263 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 4.4 m -162.51 175.38 11.52 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 128.233 2.613 . . . . 0.0 106.089 -169.491 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 11.4 ptt180 -91.72 174.08 7.54 Favored 'General case' 0 N--CA 1.469 0.503 0 O-C-N 121.022 -1.049 . . . . 0.0 109.607 178.618 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 15.9 m -74.94 176.11 0.67 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.64 0 C-N-CA 123.701 0.8 . . . . 0.0 111.219 -176.415 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 26.0 m-70 -88.02 152.2 50.47 Favored Pre-proline 0 CA--C 1.54 0.596 0 C-N-CA 123.8 0.84 . . . . 0.0 109.995 -175.999 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -63.47 -47.29 7.79 Favored 'Trans proline' 0 C--N 1.347 0.49 0 C-N-CA 122.956 2.438 . . . . 0.0 112.612 -172.636 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 4.4 m -68.21 -25.83 65.41 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-O 119.247 -0.406 . . . . 0.0 110.3 -178.391 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -56.91 -53.4 58.37 Favored 'General case' 0 CA--C 1.51 -0.595 0 N-CA-C 108.99 -0.744 . . . . 0.0 108.99 175.048 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 63.9 mt -60.51 -38.09 76.99 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 N-CA-C 109.054 -0.721 . . . . 0.0 109.054 -172.562 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -63.86 -46.74 83.63 Favored 'General case' 0 CA--C 1.536 0.425 0 CA-C-N 119.041 0.837 . . . . 0.0 111.007 179.869 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 37.6 mmt -71.18 -34.7 71.16 Favored 'General case' 0 CA--C 1.539 0.523 0 CA-C-O 123.546 1.641 . . . . 0.0 110.366 -178.376 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -74.82 -31.61 61.73 Favored 'General case' 0 N--CA 1.443 -0.825 0 N-CA-C 106.886 -1.524 . . . . 0.0 106.886 -177.796 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 -70.76 -20.41 62.63 Favored 'General case' 0 N--CA 1.45 -0.453 0 C-N-CA 124.347 1.059 . . . . 0.0 110.305 169.661 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 77.3 mt-10 -62.55 -38.76 91.28 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-N 119.958 1.254 . . . . 0.0 109.306 169.244 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 17.1 m -86.92 10.25 1.6 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.724 0 N-CA-C 113.168 0.803 . . . . 0.0 113.168 169.933 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 70.55 15.48 73.17 Favored Glycine 0 CA--C 1.532 1.114 0 C-N-CA 124.621 1.105 . . . . 0.0 113.803 177.115 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 4.8 mt -91.6 143.54 11.08 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.259 0 C-N-CA 124.425 1.09 . . . . 0.0 111.372 -172.707 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 3.4 t70 -90.84 131.84 36.24 Favored 'General case' 0 C--O 1.234 0.247 0 C-N-CA 126.04 1.736 . . . . 0.0 108.851 169.352 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 7.2 pt -140.41 -27.03 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.874 0 C-N-CA 124.661 1.184 . . . . 0.0 110.371 168.863 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -38.78 138.26 0.55 Allowed 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 128.31 2.644 . . . . 0.0 111.453 168.964 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 62.72 34.67 90.34 Favored Glycine 0 CA--C 1.533 1.21 0 CA-C-O 119.661 -0.522 . . . . 0.0 112.655 175.002 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 5.4 tt0 -57.24 -35.74 70.07 Favored 'General case' 0 C--N 1.344 0.346 0 C-N-CA 123.781 0.832 . . . . 0.0 112.83 -175.422 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -69.07 139.34 54.84 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 124.56 1.144 . . . . 0.0 110.518 -169.611 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 9.9 p -141.43 -67.78 0.4 Allowed 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 123.605 0.762 . . . . 0.0 110.624 -170.622 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -147.33 155.93 46.17 Favored Pre-proline 0 C--O 1.239 0.513 0 C-N-CA 125.484 1.513 . . . . 0.0 108.798 -176.852 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -66.06 152.54 81.03 Favored 'Trans proline' 0 N--CA 1.455 -0.782 0 C-N-CA 121.991 1.794 . . . . 0.0 109.617 171.224 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 3.8 tt -62.58 -23.57 32.92 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.545 0 C-N-CA 123.745 0.818 . . . . 0.0 110.811 -177.626 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 24.0 tt0 -67.7 -25.08 65.49 Favored 'General case' 0 N--CA 1.438 -1.075 0 C-N-CA 126.546 1.938 . . . . 0.0 110.658 -179.111 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 9.0 t-20 -63.43 -23.64 67.49 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 124.567 1.147 . . . . 0.0 112.103 176.385 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 40.5 m-85 -106.03 -168.39 1.43 Allowed 'General case' 0 C--O 1.236 0.363 0 C-N-CA 126.573 1.949 . . . . 0.0 109.305 -176.394 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 55.5 t-20 -139.44 139.74 37.13 Favored 'General case' 0 N--CA 1.447 -0.616 0 N-CA-C 106.836 -1.542 . . . . 0.0 106.836 169.251 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -71.45 -25.31 62.25 Favored 'General case' 0 N--CA 1.434 -1.236 0 C-N-CA 119.749 -0.78 . . . . 0.0 109.516 -178.821 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 35.5 t70 -64.8 -24.84 67.68 Favored 'General case' 0 N--CA 1.445 -0.686 0 O-C-N 123.505 0.503 . . . . 0.0 112.022 -179.575 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -78.05 -29.01 49.08 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 123.38 0.672 . . . . 0.0 111.426 174.411 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 13.1 m-85 -79.24 166.06 22.57 Favored 'General case' 0 N--CA 1.451 -0.394 0 C-N-CA 125.582 1.553 . . . . 0.0 111.126 178.855 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -118.25 -34.41 4.09 Favored 'General case' 0 N--CA 1.466 0.348 0 C-N-CA 123.022 0.529 . . . . 0.0 111.446 -179.985 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -143.35 136.02 24.57 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.595 0 CA-C-O 121.865 0.841 . . . . 0.0 110.234 -172.151 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 98.9 t -144.02 126.36 11.17 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.593 0 N-CA-C 106.249 -1.76 . . . . 0.0 106.249 -178.583 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.55 HD12 ' HB2' ' A' ' 97' ' ' GLU . 12.6 mm -104.6 124.37 59.13 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.521 0 N-CA-C 105.846 -1.909 . . . . 0.0 105.846 176.108 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 37.0 m -93.46 98.25 11.08 Favored 'General case' 0 N--CA 1.443 -0.807 0 N-CA-C 105.057 -2.201 . . . . 0.0 105.057 169.576 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 85.8 mt -68.54 -2.97 10.03 Favored 'General case' 0 N--CA 1.467 0.391 0 O-C-N 121.51 -0.744 . . . . 0.0 112.283 -176.709 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 64.0 m -138.65 128.4 24.99 Favored 'General case' 0 N--CA 1.443 -0.812 0 N-CA-C 106.134 -1.802 . . . . 0.0 106.134 169.397 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 50.71 -144.4 11.96 Favored Glycine 0 CA--C 1.532 1.133 0 C-N-CA 125.272 1.415 . . . . 0.0 113.515 173.425 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 16.2 m -112.23 -111.52 0.34 Allowed 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 124.652 1.181 . . . . 0.0 107.993 178.832 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -80.61 69.37 3.2 Favored Glycine 0 CA--C 1.527 0.83 0 N-CA-C 109.682 -1.367 . . . . 0.0 109.682 171.087 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 1.3 m -60.04 -50.51 79.9 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.598 0 CA-C-N 117.528 0.664 . . . . 0.0 111.688 -171.689 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 1.5 t30 -154.69 52.48 0.64 Allowed 'General case' 0 N--CA 1.467 0.404 0 N-CA-C 103.845 -2.65 . . . . 0.0 103.845 169.327 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -147.42 139.6 14.09 Favored Pre-proline 0 CA--C 1.536 0.442 0 C-N-CA 125.622 1.569 . . . . 0.0 108.297 -168.36 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -65.96 144.21 75.6 Favored 'Trans proline' 0 C--N 1.351 0.692 0 C-N-CA 121.338 1.358 . . . . 0.0 112.577 -174.669 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_endo -66.48 -26.09 47.71 Favored 'Trans proline' 0 N--CA 1.461 -0.405 0 C-N-CA 122.314 2.009 . . . . 0.0 113.242 -169.848 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 -55.91 -22.46 25.96 Favored 'General case' 0 CA--C 1.537 0.474 0 CA-C-N 118.898 0.772 . . . . 0.0 111.926 178.426 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 85.5 m95 -74.67 -43.64 54.24 Favored 'General case' 0 N--CA 1.445 -0.687 0 C-N-CA 123.504 0.722 . . . . 0.0 112.179 -179.339 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 15.2 m -70.46 -32.98 51.84 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.438 0 CA-C-O 118.398 -0.81 . . . . 0.0 110.109 176.854 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 82.3 p -82.06 29.83 0.4 Allowed 'General case' 0 CA--C 1.538 0.504 0 CA-C-N 120.23 1.377 . . . . 0.0 114.019 -170.01 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 93.0 mm-40 -79.09 -173.78 3.76 Favored 'General case' 0 CA--C 1.539 0.52 0 O-C-N 121.731 -0.605 . . . . 0.0 110.543 172.107 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 29.0 mm-40 -65.04 -14.71 61.12 Favored 'General case' 0 CA--C 1.54 0.577 0 N-CA-C 112.531 0.567 . . . . 0.0 112.531 -169.757 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 6.4 tt -143.72 137.36 24.74 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.496 0 C-N-CA 125.664 1.586 . . . . 0.0 107.177 170.934 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 16.2 t80 -116.98 132.32 56.73 Favored 'General case' 0 CA--C 1.535 0.399 0 N-CA-C 105.385 -2.08 . . . . 0.0 105.385 169.381 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 97' ' ' GLU . . . . . 0.55 ' HB2' HD12 ' A' ' 77' ' ' ILE . 11.6 mm-40 -142.13 162.83 34.49 Favored 'General case' 0 C--O 1.237 0.418 0 C-N-CA 124.546 1.139 . . . . 0.0 108.522 176.288 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 3.0 t70 -173.96 127.9 0.38 Allowed 'General case' 0 C--O 1.236 0.393 0 C-N-CA 127.11 2.164 . . . . 0.0 107.758 -169.255 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 5.4 m0 -148.65 142.58 25.79 Favored 'General case' 0 N--CA 1.456 -0.133 0 C-N-CA 123.571 0.749 . . . . 0.0 109.019 -170.488 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 86.4 mt-30 -84.21 83.24 8.04 Favored 'General case' 0 CA--C 1.533 0.3 0 N-CA-C 108.399 -0.963 . . . . 0.0 108.399 174.46 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 9.6 mp -67.42 129.05 38.67 Favored 'General case' 0 N--CA 1.466 0.352 0 N-CA-C 106.148 -1.797 . . . . 0.0 106.148 171.132 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 32.4 mt-10 -71.29 -20.83 62.16 Favored 'General case' 0 CA--C 1.536 0.417 0 N-CA-C 113.563 0.949 . . . . 0.0 113.563 -169.279 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 1.6 t70 62.29 124.09 0.02 OUTLIER Pre-proline 0 CA--C 1.552 1.047 0 C-N-CA 127.039 2.136 . . . . 0.0 114.212 -179.7 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 23.7 Cg_endo -88.48 -3.67 6.64 Favored 'Trans proline' 0 N--CA 1.454 -0.809 0 C-N-CA 122.689 2.259 . . . . 0.0 114.488 -178.93 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -53.42 126.51 21.61 Favored 'General case' 0 C--O 1.238 0.457 0 CA-C-N 120.793 1.633 . . . . 0.0 111.152 -172.374 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 71.74 -1.64 28.98 Favored Glycine 0 CA--C 1.534 1.271 0 CA-C-O 118.918 -0.934 . . . . 0.0 113.729 177.238 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 8.2 mt-30 -89.7 171.51 9.6 Favored 'General case' 0 CA--C 1.543 0.689 0 CA-C-N 118.807 1.304 . . . . 0.0 109.159 174.796 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 15.6 m -69.11 163.52 24.61 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 123.658 0.783 . . . . 0.0 111.063 -179.301 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 43.2 mt -63.88 -26.37 68.58 Favored 'General case' 0 N--CA 1.472 0.638 0 O-C-N 121.231 -0.918 . . . . 0.0 112.019 -175.026 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 5.4 pt-20 -56.41 -34.85 67.15 Favored 'General case' 0 N--CA 1.461 0.12 0 C-N-CA 123.322 0.649 . . . . 0.0 111.26 171.935 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 21.4 t -76.82 -41.77 32.9 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.395 0 CA-C-O 118.28 -0.866 . . . . 0.0 109.066 -178.139 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 61.8 m-85 -55.02 -49.6 71.15 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-N 120.002 1.274 . . . . 0.0 109.66 170.384 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 96.2 mtt180 -67.67 -33.14 74.34 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 123.056 0.542 . . . . 0.0 111.214 -175.778 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 3.2 m -65.55 -50.16 66.19 Favored 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 124.222 1.009 . . . . 0.0 109.712 170.977 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 90.1 t -70.25 -26.9 30.24 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.309 0 CA-C-O 118.426 -0.797 . . . . 0.0 109.109 -171.442 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 20.5 mtm105 -56.5 -50.15 72.63 Favored 'General case' 0 C--O 1.223 -0.309 0 CA-C-N 119.462 1.028 . . . . 0.0 109.239 169.569 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -62.09 -46.59 93.7 Favored Glycine 0 CA--C 1.528 0.884 0 CA-C-O 119.539 -0.59 . . . . 0.0 111.898 178.676 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 89.8 mt-30 -57.14 -51.69 68.28 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-N 117.854 0.827 . . . . 0.0 110.268 -179.784 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 95.9 t -68.68 -42.35 83.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-O 118.445 -0.788 . . . . 0.0 109.615 -175.574 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -54.51 -47.24 73.31 Favored 'General case' 0 C--O 1.223 -0.341 0 N-CA-C 108.62 -0.881 . . . . 0.0 108.62 178.355 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 39.9 tt0 -64.91 -42.49 94.7 Favored 'General case' 0 N--CA 1.449 -0.523 0 C-N-CA 122.953 0.501 . . . . 0.0 111.325 -176.358 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 44.4 mtt-85 -65.64 -45.61 82.35 Favored 'General case' 0 N--CA 1.469 0.485 0 O-C-N 121.302 -0.874 . . . . 0.0 111.766 177.19 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 61.3 t -64.94 -37.23 79.7 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.723 0 N-CA-C 109.143 -0.688 . . . . 0.0 109.143 178.092 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 20.9 mt-10 -60.66 -44.58 96.28 Favored 'General case' 0 C--O 1.226 -0.182 0 O-C-N 120.743 -1.223 . . . . 0.0 109.857 174.911 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 27.8 t-20 -65.12 -40.54 94.63 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 123.021 0.528 . . . . 0.0 111.054 -177.925 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 29.3 tp -58.7 -49.58 77.07 Favored 'General case' 0 CA--C 1.53 0.195 0 C-N-CA 124.864 1.266 . . . . 0.0 110.85 173.292 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 63.6 mt -64.72 -46.66 91.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 N-CA-C 107.925 -1.139 . . . . 0.0 107.925 -177.969 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -58.17 -31.82 67.63 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 123.436 0.695 . . . . 0.0 112.109 -178.882 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . 0.258 18.5 ptpt -82.51 -37.89 24.61 Favored 'General case' 0 C--N 1.344 0.341 0 CA-C-O 117.782 -1.104 . . . . 0.0 112.512 177.099 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 12.1 pt -84.08 -38.74 14.15 Favored 'Isoleucine or valine' 0 C--O 1.236 0.35 0 CA-C-N 120.373 1.442 . . . . 0.0 113.967 -176.261 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 68.2 m . . . . . 0 C--O 1.252 1.219 0 C-N-CA 125.644 1.578 . . . . 0.0 110.141 -169.876 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.498 1.964 0 N-CA-C 110.583 -0.155 . . . . 0.0 110.583 . . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 26.1 mttm -79.77 117.48 20.7 Favored 'General case' 0 N--CA 1.474 0.749 0 N-CA-C 105.71 -1.959 . . . . 0.0 105.71 171.53 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 85.0 mttt -81.84 143.4 31.76 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-N 119.935 1.243 . . . . 0.0 108.499 176.904 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 2.2 t -132.54 145.07 35.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 O-C-N 124.347 1.029 . . . . 0.0 111.058 -169.341 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 12.4 mtt -137.06 145.33 43.85 Favored 'General case' 0 C--N 1.329 -0.291 0 C-N-CA 125.327 1.451 . . . . 0.0 108.957 168.48 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 54.5 m-85 -133.91 117.46 16.8 Favored 'General case' 0 CA--C 1.518 -0.281 0 N-CA-C 104.903 -2.258 . . . . 0.0 104.903 169.915 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 2.2 p -151.67 155.26 7.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-O 121.248 0.547 . . . . 0.0 109.842 -168.848 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 39.9 t -140.94 159.32 42.45 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 105.119 -2.178 . . . . 0.0 105.119 169.266 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 64.8 pttt -56.68 143.92 34.37 Favored 'General case' 0 N--CA 1.467 0.394 0 N-CA-C 109.036 -0.727 . . . . 0.0 109.036 171.838 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 96.6 mtt180 51.44 73.9 0.28 Allowed 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 124.665 1.186 . . . . 0.0 110.136 -169.824 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 10.4 t30 -31.63 -46.41 0.11 Allowed 'General case' 0 N--CA 1.482 1.141 0 C-N-CA 127.523 2.329 . . . . 0.0 115.33 -172.4 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 2.1 m -50.96 -37.79 46.71 Favored 'General case' 0 N--CA 1.45 -0.447 0 C-N-CA 124.164 0.985 . . . . 0.0 111.419 -175.515 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 21.9 m -72.17 122.15 20.52 Favored 'General case' 0 N--CA 1.449 -0.51 0 CA-C-N 119.094 0.861 . . . . 0.0 109.767 173.906 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . 0.334 0.1 OUTLIER 56.01 -24.02 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 130.914 3.686 . . . . 0.0 117.248 177.182 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -74.92 -11.53 60.15 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-N 121.102 1.774 . . . . 0.0 111.417 175.416 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 25.2 pt20 -75.04 30.47 0.09 Allowed 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 125.756 1.622 . . . . 0.0 113.725 174.856 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 17' ' ' MET . . . . . 0.425 ' SD ' ' CD2' ' A' ' 21' ' ' PHE . 0.0 OUTLIER -152.62 -54.24 0.12 Allowed 'General case' 0 C--N 1.329 -0.284 0 O-C-N 120.29 -1.506 . . . . 0.0 112.06 174.837 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -59.44 -47.77 84.21 Favored 'General case' 0 N--CA 1.474 0.725 0 N-CA-C 114.313 1.227 . . . . 0.0 114.313 -169.009 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -65.05 -30.99 71.99 Favored 'General case' 0 N--CA 1.463 0.182 0 O-C-N 121.88 -0.512 . . . . 0.0 110.058 177.7 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -55.15 -59.13 10.93 Favored Glycine 0 C--N 1.337 0.605 0 C-N-CA 125.312 1.434 . . . . 0.0 110.588 173.222 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 21' ' ' PHE . . . . . 0.425 ' CD2' ' SD ' ' A' ' 17' ' ' MET . 3.3 m-85 -61.98 -32.54 73.0 Favored 'General case' 0 CA--C 1.511 -0.532 0 CA-C-N 118.377 1.088 . . . . 0.0 112.906 175.806 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -63.91 -36.47 84.05 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 119.146 0.884 . . . . 0.0 111.123 -172.418 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -69.03 -24.43 64.19 Favored 'General case' 0 N--CA 1.47 0.571 0 CA-C-N 119.164 0.893 . . . . 0.0 112.274 176.803 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 1.5 m -80.15 -53.22 6.89 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 125.305 1.442 . . . . 0.0 110.45 177.733 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 80.9 mt -74.24 -37.82 63.68 Favored 'General case' 0 N--CA 1.464 0.249 0 C-N-CA 123.648 0.779 . . . . 0.0 110.266 -173.124 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -96.39 14.07 64.81 Favored Glycine 0 CA--C 1.527 0.815 0 C-N-CA 125.175 1.369 . . . . 0.0 112.98 -176.767 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -51.52 123.57 10.18 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 124.743 1.217 . . . . 0.0 110.49 -174.809 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 76.11 -7.89 26.97 Favored Glycine 0 CA--C 1.536 1.356 0 C-N-CA 124.293 0.949 . . . . 0.0 114.382 179.797 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 62.9 mttm -97.62 -49.19 4.96 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-N 119.283 1.541 . . . . 0.0 110.298 179.854 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 17.1 pt -137.28 152.52 27.83 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.328 0 C-N-CA 124.137 0.975 . . . . 0.0 110.067 -169.264 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -112.02 98.66 7.5 Favored 'General case' 0 CA--C 1.521 -0.153 0 C-N-CA 124.584 1.153 . . . . 0.0 109.187 -169.738 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 13.0 p -87.8 134.4 28.0 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.487 0 O-C-N 121.823 -0.548 . . . . 0.0 109.666 178.966 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 20.1 m -150.51 92.45 1.85 Allowed 'General case' 0 N--CA 1.456 -0.143 0 N-CA-C 105.19 -2.152 . . . . 0.0 105.19 172.413 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 53.4 m -95.49 87.01 4.63 Favored 'General case' 0 C--O 1.237 0.396 0 C-N-CA 120.066 -0.654 . . . . 0.0 110.63 -170.057 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 58.8 m -61.19 165.85 4.14 Favored 'General case' 0 CA--C 1.539 0.522 0 CA-C-N 115.322 -0.854 . . . . 0.0 110.07 169.018 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -138.96 -173.84 13.18 Favored Glycine 0 CA--C 1.525 0.702 0 N-CA-C 106.807 -2.517 . . . . 0.0 106.807 -177.721 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 6.4 mt -123.71 -83.51 0.65 Allowed 'General case' 0 N--CA 1.45 -0.465 0 C-N-CA 124.298 1.039 . . . . 0.0 109.048 -169.952 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 3.3 tt0 -69.02 -27.17 65.44 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 122.823 0.449 . . . . 0.0 111.574 176.673 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 1.3 m -144.18 179.45 7.21 Favored 'General case' 0 N--CA 1.463 0.176 0 C-N-CA 126.187 1.795 . . . . 0.0 107.747 177.032 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 3.7 m -166.05 -18.66 0.02 OUTLIER 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 125.301 1.44 . . . . 0.0 112.145 -169.725 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 7.8 ttt180 -100.37 -162.1 0.92 Allowed 'General case' 0 N--CA 1.473 0.709 0 CA-C-N 119.637 1.108 . . . . 0.0 110.207 176.046 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 27.4 m -134.95 173.68 14.1 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.449 0 C-N-CA 125.421 1.489 . . . . 0.0 111.376 -169.988 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 96.7 m-70 -83.65 156.45 65.01 Favored Pre-proline 0 CA--C 1.543 0.698 0 C-N-CA 124.804 1.242 . . . . 0.0 110.299 173.816 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -62.16 -51.47 3.58 Favored 'Trans proline' 0 C--N 1.349 0.575 0 C-N-CA 123.845 3.03 . . . . 0.0 113.426 -173.425 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 6.8 m -65.85 -24.95 66.99 Favored 'General case' 0 CA--C 1.534 0.328 0 O-C-N 121.902 -0.499 . . . . 0.0 110.936 -172.845 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -55.52 -53.31 57.95 Favored 'General case' 0 CA--C 1.508 -0.672 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 173.261 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 69.8 mt -59.83 -40.71 83.43 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.369 0 N-CA-C 108.475 -0.935 . . . . 0.0 108.475 -170.352 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -62.75 -46.76 86.58 Favored 'General case' 0 N--CA 1.449 -0.518 0 CA-C-N 118.488 0.586 . . . . 0.0 111.004 179.924 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 27.9 mmt -67.64 -39.78 84.61 Favored 'General case' 0 C--O 1.238 0.473 0 CA-C-O 122.789 1.281 . . . . 0.0 110.839 -178.65 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 1.2 mmt -74.31 -35.2 63.66 Favored 'General case' 0 N--CA 1.444 -0.772 0 N-CA-C 106.711 -1.588 . . . . 0.0 106.711 -174.875 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 41.7 tt0 -69.98 -23.94 63.24 Favored 'General case' 0 N--CA 1.447 -0.583 0 O-C-N 121.179 -0.951 . . . . 0.0 110.219 173.672 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 10.2 mm-40 -65.74 -29.49 70.01 Favored 'General case' 0 N--CA 1.452 -0.341 0 CA-C-N 118.762 0.71 . . . . 0.0 110.241 173.251 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . 0.29 9.0 m -98.22 16.95 2.85 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.858 0 N-CA-C 112.758 0.651 . . . . 0.0 112.758 169.35 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 84.33 16.21 67.27 Favored Glycine 0 CA--C 1.534 1.275 0 C-N-CA 125.366 1.46 . . . . 0.0 114.636 169.935 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 8.2 mm -97.52 151.59 4.25 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.329 0 C-N-CA 124.736 1.214 . . . . 0.0 111.121 -170.52 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -112.52 126.95 55.89 Favored 'General case' 0 C--O 1.233 0.189 0 N-CA-C 106.051 -1.833 . . . . 0.0 106.051 168.222 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 3.6 pt -128.93 -24.51 1.24 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.481 0 C-N-CA 125.751 1.62 . . . . 0.0 110.353 170.312 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -39.51 -40.38 0.84 Allowed 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 128.177 2.591 . . . . 0.0 112.789 169.163 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -91.24 19.62 45.63 Favored Glycine 0 CA--C 1.531 1.069 0 C-N-CA 125.446 1.498 . . . . 0.0 113.763 -179.166 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 21.2 mt-30 -61.84 -27.62 68.91 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-N 120.152 1.976 . . . . 0.0 112.84 179.78 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -61.92 129.39 40.72 Favored 'General case' 0 N--CA 1.445 -0.678 0 N-CA-C 109.683 -0.488 . . . . 0.0 109.683 -171.562 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 8.5 p -141.61 -70.44 0.36 Allowed 'General case' 0 C--O 1.235 0.31 0 C-N-CA 123.817 0.847 . . . . 0.0 109.452 -173.269 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -157.66 161.34 29.26 Favored Pre-proline 0 CA--C 1.552 1.037 0 C-N-CA 124.952 1.301 . . . . 0.0 109.913 -174.66 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -67.84 28.92 0.13 Allowed 'Trans proline' 0 CA--C 1.552 1.381 0 C-N-CA 125.247 3.964 . . . . 0.0 116.694 173.126 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . 0.256 1.1 tt 64.43 -26.21 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.541 0.619 0 C-N-CA 129.529 3.132 . . . . 0.0 113.989 -169.583 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -68.79 -30.19 68.72 Favored 'General case' 0 N--CA 1.429 -1.516 0 C-N-CA 128.005 2.522 . . . . 0.0 115.407 -169.304 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 26.0 m-80 -68.72 -17.44 64.06 Favored 'General case' 0 C--O 1.236 0.35 0 CA-C-N 118.359 0.527 . . . . 0.0 112.192 -176.419 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 69.8 m-85 -104.76 160.98 14.55 Favored 'General case' 0 CA--C 1.513 -0.447 0 C-N-CA 124.726 1.211 . . . . 0.0 112.015 -176.854 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 48.1 t-20 -95.65 134.13 38.92 Favored 'General case' 0 N--CA 1.439 -0.989 0 N-CA-C 106.107 -1.812 . . . . 0.0 106.107 168.156 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -72.57 -27.67 62.34 Favored 'General case' 0 N--CA 1.436 -1.172 0 N-CA-C 108.845 -0.798 . . . . 0.0 108.845 179.629 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 36.6 t70 -67.0 -21.04 65.97 Favored 'General case' 0 N--CA 1.447 -0.585 0 N-CA-C 111.73 0.27 . . . . 0.0 111.73 -179.168 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 35.7 t70 -72.63 -29.24 63.3 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 122.974 0.509 . . . . 0.0 111.611 175.782 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 17.2 m-85 -77.27 144.51 38.1 Favored 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 123.981 0.912 . . . . 0.0 110.316 179.18 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -93.93 -32.1 14.02 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.724 177.555 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 21.7 t -137.34 130.8 44.15 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.467 0 C-N-CA 123.824 0.85 . . . . 0.0 109.841 -171.307 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 53.7 t -145.48 139.58 21.84 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.419 0 N-CA-C 106.28 -1.748 . . . . 0.0 106.28 174.851 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 36.6 mm -130.63 123.62 55.26 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.537 0 N-CA-C 107.238 -1.393 . . . . 0.0 107.238 -169.859 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 55.3 m -90.49 115.37 27.59 Favored 'General case' 0 N--CA 1.444 -0.732 0 N-CA-C 106.562 -1.644 . . . . 0.0 106.562 169.225 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 68.7 mt -77.72 -7.54 56.66 Favored 'General case' 0 C--N 1.332 -0.191 0 C-N-CA 123.769 0.827 . . . . 0.0 111.418 179.88 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 31.9 p -139.72 132.75 29.5 Favored 'General case' 0 N--CA 1.443 -0.817 0 N-CA-C 106.81 -1.552 . . . . 0.0 106.81 169.632 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 50.68 -155.85 2.84 Favored Glycine 0 CA--C 1.539 1.547 0 C-N-CA 125.579 1.561 . . . . 0.0 115.713 170.067 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 17.4 m -134.52 139.24 45.29 Favored 'General case' 0 C--O 1.235 0.306 0 C-N-CA 125.897 1.679 . . . . 0.0 107.153 177.232 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 74.36 -75.44 1.18 Allowed Glycine 0 C--N 1.335 0.517 0 N-CA-C 110.324 -1.11 . . . . 0.0 110.324 -174.28 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . 0.299 34.7 m 48.12 36.22 0.27 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.792 0 C-N-CA 125.973 1.709 . . . . 0.0 113.401 176.647 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 10.6 t-20 69.99 -0.15 2.86 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 127.679 2.392 . . . . 0.0 113.318 179.061 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.407 ' HA ' ' HD3' ' A' ' 87' ' ' PRO . 0.0 OUTLIER -77.03 148.09 78.01 Favored Pre-proline 0 CA--C 1.548 0.882 0 N-CA-C 107.749 -1.204 . . . . 0.0 107.749 169.524 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 87' ' ' PRO . . . . . 0.407 ' HD3' ' HA ' ' A' ' 86' ' ' LEU . 34.1 Cg_exo -65.99 142.17 67.38 Favored 'Trans proline' 0 CA--C 1.544 1.013 0 C-N-CA 121.452 1.435 . . . . 0.0 113.0 -174.165 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -67.33 -20.17 49.03 Favored 'Trans proline' 0 C--N 1.344 0.336 0 C-N-CA 123.379 2.719 . . . . 0.0 114.267 -170.592 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 5.4 pm0 -63.04 -18.77 63.71 Favored 'General case' 0 CA--C 1.54 0.562 0 CA-C-N 121.371 1.896 . . . . 0.0 111.547 174.75 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 97.8 m95 -88.33 -5.93 58.03 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 125.414 1.486 . . . . 0.0 112.799 173.728 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 39.9 t -94.23 -9.03 9.66 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.62 0 C-N-CA 124.769 1.228 . . . . 0.0 109.137 173.325 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 73.3 p -119.77 36.94 4.34 Favored 'General case' 0 C--O 1.237 0.404 0 N-CA-C 116.134 1.901 . . . . 0.0 116.134 -169.305 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 12.2 mp0 -71.42 173.71 7.53 Favored 'General case' 0 CA--C 1.535 0.384 0 O-C-N 121.718 -0.614 . . . . 0.0 111.568 173.852 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 33.9 mm-40 -59.93 -28.81 67.93 Favored 'General case' 0 CA--C 1.536 0.432 0 N-CA-C 109.807 -0.442 . . . . 0.0 109.807 177.012 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 4.3 tt -133.62 116.98 25.65 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.56 0 N-CA-C 105.489 -2.041 . . . . 0.0 105.489 168.729 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 62.1 t80 -108.98 145.3 35.73 Favored 'General case' 0 C--O 1.237 0.443 0 N-CA-C 104.534 -2.395 . . . . 0.0 104.534 168.28 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 21.7 mm-40 -134.86 139.74 45.28 Favored 'General case' 0 C--O 1.236 0.379 0 CA-C-N 119.161 0.891 . . . . 0.0 108.691 169.859 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -106.93 113.29 26.69 Favored 'General case' 0 C--O 1.239 0.551 0 N-CA-C 105.609 -1.997 . . . . 0.0 105.609 169.883 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 9.2 m95 -117.47 166.52 12.24 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 124.405 1.082 . . . . 0.0 108.118 169.756 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 24.0 mm-40 -128.33 78.1 1.81 Allowed 'General case' 0 CA--C 1.534 0.36 0 N-CA-C 107.257 -1.386 . . . . 0.0 107.257 174.326 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -77.04 148.46 36.15 Favored 'General case' 0 N--CA 1.467 0.399 0 N-CA-C 109.192 -0.67 . . . . 0.0 109.192 -179.505 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -81.09 168.25 18.83 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 124.514 1.126 . . . . 0.0 108.724 169.765 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -134.14 133.71 22.18 Favored Pre-proline 0 CA--C 1.534 0.334 0 C-N-CA 124.022 0.929 . . . . 0.0 110.975 178.085 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 40.2 Cg_endo -89.87 -2.41 5.65 Favored 'Trans proline' 0 CA--C 1.539 0.772 0 C-N-CA 122.911 2.407 . . . . 0.0 115.22 -174.349 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 24.4 t70 -60.25 128.32 36.14 Favored 'General case' 0 C--O 1.238 0.484 0 CA-C-N 121.347 1.885 . . . . 0.0 110.357 -177.861 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 72.94 -0.3 46.61 Favored Glycine 0 CA--C 1.533 1.163 0 CA-C-O 119.216 -0.769 . . . . 0.0 113.605 179.474 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 17.1 mm-40 -86.2 172.82 10.23 Favored 'General case' 0 C--O 1.238 0.454 0 CA-C-N 118.65 1.225 . . . . 0.0 109.738 174.335 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 16.0 m -69.17 159.53 32.81 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 123.768 0.827 . . . . 0.0 110.868 171.778 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 33.1 tp -56.61 -30.58 63.41 Favored 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 126.153 1.781 . . . . 0.0 113.071 -176.302 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 6.7 pt-20 -56.49 -34.28 66.79 Favored 'General case' 0 CA--C 1.528 0.106 0 C-N-CA 123.817 0.847 . . . . 0.0 111.331 175.563 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 5.1 t -77.61 -39.81 27.44 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.39 0 CA-C-O 118.125 -0.941 . . . . 0.0 110.414 -174.987 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 63.9 m-85 -56.5 -47.98 78.15 Favored 'General case' 0 N--CA 1.473 0.708 0 CA-C-N 120.368 1.44 . . . . 0.0 109.454 170.152 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 86.3 mtt180 -60.87 -42.69 98.38 Favored 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 123.259 0.624 . . . . 0.0 110.909 179.794 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 6.0 m -67.51 -49.42 63.51 Favored 'General case' 0 N--CA 1.447 -0.595 0 C-N-CA 124.696 1.199 . . . . 0.0 110.311 -179.865 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 73.0 t -68.96 -30.02 45.34 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.234 0 CA-C-O 117.813 -1.089 . . . . 0.0 110.223 -169.787 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 32.5 mtm105 -56.84 -47.1 81.11 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-N 120.011 1.278 . . . . 0.0 110.357 169.89 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -62.94 -49.05 75.63 Favored Glycine 0 CA--C 1.527 0.816 0 CA-C-N 118.438 0.563 . . . . 0.0 111.773 179.272 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 17.5 mt-30 -62.01 -44.18 97.27 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-N 117.698 0.749 . . . . 0.0 110.22 -177.914 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 54.6 t -66.19 -45.15 90.88 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.245 0 CA-C-O 118.183 -0.913 . . . . 0.0 109.684 -177.96 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -52.74 -47.79 67.16 Favored 'General case' 0 CA--C 1.516 -0.361 0 CA-C-N 119.094 0.861 . . . . 0.0 109.013 -177.957 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 39.9 tt0 -62.72 -42.79 99.83 Favored 'General case' 0 N--CA 1.447 -0.584 0 O-C-N 123.569 0.543 . . . . 0.0 111.029 -176.052 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 44.7 mtt-85 -67.06 -41.45 86.42 Favored 'General case' 0 N--CA 1.468 0.455 0 O-C-N 121.381 -0.824 . . . . 0.0 111.57 177.85 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 54.0 t -68.92 -38.46 78.61 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.429 0 N-CA-C 109.372 -0.603 . . . . 0.0 109.372 179.463 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 22.1 mt-10 -60.06 -42.09 93.74 Favored 'General case' 0 C--O 1.226 -0.166 0 O-C-N 121.414 -0.804 . . . . 0.0 110.247 174.923 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 29.1 t-20 -64.56 -45.25 87.88 Favored 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 122.735 0.414 . . . . 0.0 111.145 -179.7 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 2.1 tm? -57.19 -49.28 76.49 Favored 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 124.625 1.17 . . . . 0.0 109.992 175.815 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 75.8 mt -63.21 -47.71 91.0 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.141 0 N-CA-C 108.558 -0.904 . . . . 0.0 108.558 -179.797 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -58.61 -28.74 65.9 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 123.254 0.621 . . . . 0.0 112.411 178.908 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 88.9 mttt -70.18 -55.39 9.46 Favored 'General case' 0 C--O 1.234 0.243 0 CA-C-N 119.257 0.935 . . . . 0.0 110.567 172.495 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 16.2 pt -77.03 -38.28 27.71 Favored 'Isoleucine or valine' 0 C--O 1.234 0.25 0 N-CA-C 114.91 1.448 . . . . 0.0 114.91 -169.085 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 74.5 m . . . . . 0 C--O 1.254 1.296 0 C-N-CA 125.882 1.673 . . . . 0.0 109.52 -169.774 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 19.8 ptm . . . . . 0 N--CA 1.497 1.924 0 N-CA-C 110.821 -0.066 . . . . 0.0 110.821 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' LYS . . . . . 0.506 ' HB2' HG22 ' A' ' 30' ' ' ILE . 16.3 mttm -73.59 125.96 29.18 Favored 'General case' 0 N--CA 1.482 1.131 0 N-CA-C 107.88 -1.156 . . . . 0.0 107.88 -172.006 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 69.6 mttt -94.13 137.26 33.52 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-N 120.062 1.301 . . . . 0.0 108.376 174.087 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.441 HG21 HD12 ' A' ' 30' ' ' ILE . 15.0 t -119.84 151.28 22.39 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 C-N-CA 127.121 2.169 . . . . 0.0 106.473 -169.939 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 31.9 mtt -134.65 147.14 50.09 Favored 'General case' 0 C--N 1.321 -0.64 0 C-N-CA 124.164 0.986 . . . . 0.0 108.705 168.782 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 45.6 m-85 -131.67 122.85 26.64 Favored 'General case' 0 CA--C 1.516 -0.336 0 N-CA-C 102.218 -3.252 . . . . 0.0 102.218 169.226 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 1.3 p -148.4 141.81 18.74 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.263 0 CA-C-O 121.764 0.793 . . . . 0.0 112.151 -168.41 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 46.3 t -136.29 173.86 11.25 Favored 'General case' 0 CA--C 1.547 0.846 0 C-N-CA 127.807 2.443 . . . . 0.0 105.269 169.019 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 87.6 tttt -51.59 -46.92 63.71 Favored 'General case' 0 N--CA 1.475 0.813 0 O-C-N 120.975 -1.078 . . . . 0.0 113.433 -169.368 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 19.6 ttt180 -130.11 147.47 51.85 Favored 'General case' 0 N--CA 1.468 0.461 0 CA-C-N 118.995 0.816 . . . . 0.0 109.118 -178.319 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 64.3 t30 -58.94 -30.33 67.79 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 123.964 0.906 . . . . 0.0 113.354 -175.589 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -56.31 -55.27 35.46 Favored 'General case' 0 C--O 1.236 0.378 0 C-N-CA 124.069 0.948 . . . . 0.0 109.992 -171.428 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 9.2 m -91.02 151.2 21.13 Favored 'General case' 0 N--CA 1.452 -0.37 0 C-N-CA 123.659 0.784 . . . . 0.0 110.797 -176.353 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 5.4 mmm180 67.32 -50.5 0.49 Allowed 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 128.462 2.705 . . . . 0.0 113.323 170.228 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 7.3 m -76.92 49.94 0.68 Allowed 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 125.677 1.591 . . . . 0.0 111.704 -179.351 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 4.5 pt20 -123.52 12.73 9.36 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 126.109 1.763 . . . . 0.0 112.148 -175.669 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -160.96 -40.37 0.05 OUTLIER 'General case' 0 C--O 1.224 -0.265 0 N-CA-C 113.973 1.101 . . . . 0.0 113.973 176.935 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -66.62 -52.45 44.99 Favored 'General case' 0 N--CA 1.475 0.797 0 CA-C-N 120.657 1.571 . . . . 0.0 112.164 -169.56 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -56.42 -38.3 71.39 Favored 'General case' 0 N--CA 1.446 -0.653 0 C-N-CA 124.029 0.931 . . . . 0.0 110.645 169.942 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -57.11 -52.6 50.4 Favored Glycine 0 CA--C 1.526 0.754 0 C-N-CA 124.722 1.153 . . . . 0.0 111.209 175.902 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 1.3 m-85 -65.0 -32.07 73.61 Favored 'General case' 0 CA--C 1.51 -0.582 0 O-C-N 120.94 -1.329 . . . . 0.0 111.907 175.723 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -71.05 -41.23 71.04 Favored 'General case' 0 N--CA 1.445 -0.688 0 CA-C-O 118.156 -0.926 . . . . 0.0 110.739 -174.607 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.15 -33.3 75.18 Favored 'General case' 0 N--CA 1.471 0.582 0 CA-C-N 119.617 1.099 . . . . 0.0 109.886 173.591 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 10.6 m -68.9 -54.05 17.66 Favored 'General case' 0 N--CA 1.442 -0.842 0 C-N-CA 123.171 0.588 . . . . 0.0 110.364 -175.046 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 39.9 mt -77.8 -37.3 49.06 Favored 'General case' 0 C--N 1.329 -0.285 0 C-N-CA 124.946 1.298 . . . . 0.0 111.034 -172.941 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -101.08 8.29 57.42 Favored Glycine 0 CA--C 1.526 0.761 0 CA-C-O 118.033 -1.426 . . . . 0.0 114.303 -169.734 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -40.92 -48.91 3.21 Favored 'General case' 0 N--CA 1.468 0.437 0 C-N-CA 125.798 1.639 . . . . 0.0 114.882 -169.443 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -89.94 -2.09 75.47 Favored Glycine 0 CA--C 1.531 1.074 0 CA-C-O 118.836 -0.98 . . . . 0.0 114.469 -173.506 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 13.8 ptpt -124.88 -28.29 3.51 Favored 'General case' 0 N--CA 1.472 0.651 0 CA-C-N 118.915 1.357 . . . . 0.0 113.145 -173.626 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.506 HG22 ' HB2' ' A' ' 2' ' ' LYS . 14.8 pt -143.65 150.15 17.47 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.437 0 CA-C-N 119.657 1.117 . . . . 0.0 111.47 -174.218 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -98.54 158.17 15.77 Favored 'General case' 0 N--CA 1.465 0.302 0 C-N-CA 125.575 1.55 . . . . 0.0 108.543 172.182 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 22.6 t -139.66 133.35 37.23 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 N-CA-C 107.547 -1.279 . . . . 0.0 107.547 -175.976 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 34.5 m -138.49 107.42 5.99 Favored 'General case' 0 N--CA 1.447 -0.594 0 N-CA-C 106.042 -1.836 . . . . 0.0 106.042 175.345 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 2.4 p -80.65 99.48 8.18 Favored 'General case' 0 C--N 1.327 -0.386 0 C-N-CA 119.843 -0.743 . . . . 0.0 109.064 174.501 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 25.7 p -72.16 -177.47 2.11 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 123.956 0.903 . . . . 0.0 110.827 175.254 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -173.17 171.88 44.76 Favored Glycine 0 CA--C 1.522 0.504 0 N-CA-C 106.457 -2.657 . . . . 0.0 106.457 -179.297 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 18.4 mt -106.43 -20.05 13.5 Favored 'General case' 0 C--N 1.325 -0.489 0 C-N-CA 124.804 1.241 . . . . 0.0 110.072 174.633 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 36.9 mt-10 -131.87 162.84 29.64 Favored 'General case' 0 N--CA 1.448 -0.538 0 C-N-CA 127.683 2.393 . . . . 0.0 106.948 169.207 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 78.9 p -145.2 155.99 43.59 Favored 'General case' 0 N--CA 1.451 -0.409 0 CA-C-O 122.844 1.307 . . . . 0.0 114.499 179.615 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 4.3 m -168.89 -179.85 3.86 Favored 'General case' 0 N--CA 1.451 -0.41 0 C-N-CA 131.118 3.767 . . . . 0.0 103.966 -170.028 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 25.6 ttp180 -86.9 171.69 10.62 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 107.079 -1.452 . . . . 0.0 107.079 169.142 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 11.2 m -68.58 165.47 2.3 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.808 0 CA-C-N 115.796 -0.638 . . . . 0.0 109.973 178.409 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 55.1 m170 -62.96 152.43 83.51 Favored Pre-proline 0 CA--C 1.549 0.917 0 C-N-CA 123.161 0.584 . . . . 0.0 112.537 177.675 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -70.45 -55.62 0.15 Allowed 'Trans proline' 0 C--N 1.352 0.711 0 C-N-CA 123.382 2.722 . . . . 0.0 114.388 -169.909 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 26.9 m -65.8 -22.75 66.59 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-N 119.256 0.934 . . . . 0.0 110.071 -175.973 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -52.41 -52.3 54.52 Favored 'General case' 0 CA--C 1.509 -0.603 0 CA-C-O 118.815 -0.612 . . . . 0.0 110.585 169.957 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 85.3 mt -58.69 -41.32 81.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 -172.292 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -63.96 -49.32 72.99 Favored 'General case' 0 N--CA 1.45 -0.455 0 CA-C-N 118.079 0.399 . . . . 0.0 111.113 178.477 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 49' ' ' MET . . . . . 0.437 ' HG3' ' CG ' ' A' ' 112' ' ' PHE . 24.3 mmt -65.33 -35.81 82.12 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-O 122.638 1.208 . . . . 0.0 111.445 -178.627 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -79.22 -33.09 44.01 Favored 'General case' 0 N--CA 1.44 -0.944 0 N-CA-C 107.584 -1.265 . . . . 0.0 107.584 -173.47 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 42.0 tt0 -68.25 -26.76 65.84 Favored 'General case' 0 N--CA 1.445 -0.713 0 C-N-CA 123.307 0.643 . . . . 0.0 109.86 170.614 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 14.7 mm-40 -68.25 -28.57 67.33 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-N 118.816 0.734 . . . . 0.0 110.654 174.241 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . 0.276 4.6 p -93.07 11.81 3.14 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.907 0 CA-C-N 118.658 0.663 . . . . 0.0 111.375 169.201 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 77.33 17.53 79.23 Favored Glycine 0 CA--C 1.53 1.029 0 C-N-CA 124.516 1.055 . . . . 0.0 114.003 173.071 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 12.5 mt -109.58 131.3 60.85 Favored 'Isoleucine or valine' 0 C--O 1.232 0.134 0 CA-C-N 118.884 1.342 . . . . 0.0 109.921 -177.947 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 8.1 t70 -87.28 121.04 29.19 Favored 'General case' 0 C--O 1.236 0.375 0 N-CA-C 106.783 -1.562 . . . . 0.0 106.783 169.061 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 10.1 pt -110.39 -26.68 3.09 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.487 0 C-N-CA 123.097 0.559 . . . . 0.0 110.105 169.126 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -32.67 -46.42 0.14 Allowed 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 130.146 3.378 . . . . 0.0 114.279 173.073 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -73.75 -3.59 63.85 Favored Glycine 0 CA--C 1.534 1.221 0 CA-C-O 118.82 -0.989 . . . . 0.0 114.126 -176.27 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 13.3 mt-30 -79.25 114.53 18.26 Favored 'General case' 0 CA--C 1.511 -0.55 0 CA-C-N 119.353 1.577 . . . . 0.0 111.468 -176.216 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -150.22 148.33 28.77 Favored 'General case' 0 N--CA 1.434 -1.248 0 N-CA-C 105.257 -2.127 . . . . 0.0 105.257 167.328 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 18.8 m -150.81 156.7 41.78 Favored 'General case' 0 N--CA 1.447 -0.607 0 N-CA-C 108.373 -0.973 . . . . 0.0 108.373 -169.677 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -67.98 163.45 50.4 Favored Pre-proline 0 CA--C 1.542 0.646 0 C-N-CA 124.682 1.193 . . . . 0.0 109.464 169.422 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -60.73 151.65 75.08 Favored 'Trans proline' 0 N--CA 1.456 -0.685 0 C-N-CA 122.043 1.829 . . . . 0.0 110.31 172.126 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 13.9 tt -58.61 -26.24 30.69 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.453 0 C-N-CA 124.031 0.932 . . . . 0.0 112.212 -174.475 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 23.1 tt0 -67.21 -25.34 66.07 Favored 'General case' 0 N--CA 1.434 -1.241 0 C-N-CA 125.68 1.592 . . . . 0.0 110.682 -177.052 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 12.9 t-20 -63.21 -31.51 72.67 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 124.984 1.314 . . . . 0.0 112.221 -178.888 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 8.5 m-85 -96.69 -167.69 1.6 Allowed 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 124.904 1.281 . . . . 0.0 110.333 -175.46 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 54.9 t-20 -137.35 136.95 38.39 Favored 'General case' 0 CA--C 1.515 -0.402 0 N-CA-C 107.27 -1.382 . . . . 0.0 107.27 169.188 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.46 ' HB3' ' HG2' ' A' ' 89' ' ' GLU . . . -73.54 -24.91 60.19 Favored 'General case' 0 N--CA 1.436 -1.128 0 N-CA-C 109.408 -0.59 . . . . 0.0 109.408 -176.547 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 36.0 t70 -66.34 -23.97 66.44 Favored 'General case' 0 N--CA 1.443 -0.804 0 O-C-N 123.751 0.657 . . . . 0.0 111.82 -179.618 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -75.96 -28.82 58.05 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 123.097 0.559 . . . . 0.0 111.348 175.541 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 18.8 m-85 -83.58 168.61 16.22 Favored 'General case' 0 N--CA 1.45 -0.47 0 C-N-CA 125.897 1.679 . . . . 0.0 110.368 177.939 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -114.97 -36.26 4.5 Favored 'General case' 0 N--CA 1.465 0.321 0 C-N-CA 123.126 0.57 . . . . 0.0 111.281 178.595 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -140.58 139.09 35.57 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.361 0 C-N-CA 123.42 0.688 . . . . 0.0 109.621 -171.499 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 83.4 t -140.48 140.0 34.72 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.319 0 N-CA-C 106.381 -1.711 . . . . 0.0 106.381 -177.692 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 37.3 mm -131.41 127.86 60.44 Favored 'Isoleucine or valine' 0 C--O 1.237 0.441 0 N-CA-C 106.743 -1.577 . . . . 0.0 106.743 -174.921 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 13.6 m -86.59 130.83 34.34 Favored 'General case' 0 N--CA 1.441 -0.905 0 N-CA-C 106.647 -1.612 . . . . 0.0 106.647 168.927 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 85.0 mt -93.94 -7.25 43.53 Favored 'General case' 0 C--N 1.331 -0.226 0 C-N-CA 123.465 0.706 . . . . 0.0 109.726 169.751 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 18.0 p -161.58 158.67 26.65 Favored 'General case' 0 N--CA 1.444 -0.73 0 C-N-CA 124.881 1.272 . . . . 0.0 108.768 169.454 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 65.76 -161.39 43.4 Favored Glycine 0 CA--C 1.535 1.285 0 N-CA-C 115.178 0.831 . . . . 0.0 115.178 169.345 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 15.1 m -142.59 -161.2 1.2 Allowed 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 126.841 2.057 . . . . 0.0 107.626 -172.39 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -72.76 61.41 1.64 Allowed Glycine 0 CA--C 1.535 1.315 0 O-C-N 120.921 -1.112 . . . . 0.0 111.667 172.28 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 6.7 m -78.21 -55.86 9.03 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.508 0 C-N-CA 124.235 1.014 . . . . 0.0 110.82 -170.001 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 46.4 t30 -143.9 48.85 1.39 Allowed 'General case' 0 N--CA 1.467 0.383 0 N-CA-C 104.416 -2.438 . . . . 0.0 104.416 169.551 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 6.0 tt -144.15 119.33 6.09 Favored Pre-proline 0 CA--C 1.535 0.386 0 N-CA-C 104.75 -2.315 . . . . 0.0 104.75 -168.443 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 76.4 Cg_exo -60.13 138.07 79.35 Favored 'Trans proline' 0 C--N 1.349 0.579 0 C-N-CA 121.823 1.682 . . . . 0.0 112.316 -170.194 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 66.9 Cg_endo -68.85 -14.57 39.16 Favored 'Trans proline' 0 N--CA 1.459 -0.516 0 C-N-CA 122.0 1.8 . . . . 0.0 113.084 -174.776 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 89' ' ' GLU . . . . . 0.46 ' HG2' ' HB3' ' A' ' 70' ' ' ALA . 14.0 tt0 -58.08 -25.48 61.34 Favored 'General case' 0 N--CA 1.439 -1.019 0 C-N-CA 125.713 1.605 . . . . 0.0 110.887 171.565 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 99.7 m95 -78.87 -41.38 30.02 Favored 'General case' 0 N--CA 1.456 -0.134 0 C-N-CA 123.722 0.809 . . . . 0.0 111.804 173.035 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 2.0 m -79.46 0.02 3.47 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.638 0 C-N-CA 123.321 0.648 . . . . 0.0 112.326 -175.153 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . 0.254 1.4 t -133.11 34.98 3.53 Favored 'General case' 0 CA--C 1.546 0.797 0 O-C-N 121.519 -0.738 . . . . 0.0 112.565 -175.731 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 89.4 mm-40 -71.66 -178.66 2.3 Favored 'General case' 0 CA--C 1.543 0.703 0 O-C-N 121.208 -0.933 . . . . 0.0 110.052 169.199 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 31.1 mm-40 -57.22 -28.83 63.23 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 123.181 0.592 . . . . 0.0 111.923 -169.348 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 5.3 tt -136.72 138.63 46.06 Favored 'Isoleucine or valine' 0 C--O 1.239 0.519 0 N-CA-C 104.383 -2.451 . . . . 0.0 104.383 168.406 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 70.9 t80 -132.33 142.46 49.35 Favored 'General case' 0 N--CA 1.448 -0.564 0 N-CA-C 106.407 -1.701 . . . . 0.0 106.407 169.491 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 19.9 mm-40 -141.64 152.1 43.66 Favored 'General case' 0 C--O 1.237 0.397 0 N-CA-C 106.652 -1.61 . . . . 0.0 106.652 171.351 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -125.4 127.66 46.92 Favored 'General case' 0 C--O 1.239 0.5 0 N-CA-C 107.244 -1.391 . . . . 0.0 107.244 169.204 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 4.6 m95 -116.05 158.17 23.56 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 124.192 0.997 . . . . 0.0 110.452 -173.328 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 19.9 pt20 -122.06 39.56 3.85 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 124.553 1.141 . . . . 0.0 111.258 -177.054 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -64.36 133.08 51.91 Favored 'General case' 0 N--CA 1.466 0.359 0 N-CA-C 107.764 -1.199 . . . . 0.0 107.764 173.492 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 3.2 mp0 -64.59 152.09 42.95 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 123.943 0.897 . . . . 0.0 110.037 173.049 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -91.01 113.64 58.85 Favored Pre-proline 0 C--O 1.236 0.377 0 N-CA-C 105.603 -1.999 . . . . 0.0 105.603 168.349 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 104' ' ' PRO . . . . . 0.439 ' HG2' ' CE1' ' A' ' 112' ' ' PHE . 78.6 Cg_endo -76.25 -8.73 18.78 Favored 'Trans proline' 0 N--CA 1.453 -0.868 0 C-N-CA 121.804 1.669 . . . . 0.0 114.189 -172.819 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -66.79 -41.2 88.01 Favored 'General case' 0 C--O 1.235 0.299 0 CA-C-N 120.45 1.477 . . . . 0.0 113.293 -169.309 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -79.3 6.96 55.65 Favored Glycine 0 CA--C 1.533 1.179 0 CA-C-O 118.823 -0.987 . . . . 0.0 113.663 -176.082 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 24.3 pt20 -148.53 -165.59 2.32 Favored 'General case' 0 CA--C 1.54 0.582 0 CA-C-N 118.932 1.366 . . . . 0.0 111.141 -169.874 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 2.1 m -69.3 156.65 38.42 Favored 'General case' 0 CA--C 1.533 0.324 0 N-CA-C 116.164 1.912 . . . . 0.0 116.164 -168.365 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 35.0 tp -57.33 -30.34 64.71 Favored 'General case' 0 N--CA 1.465 0.305 0 C-N-CA 126.28 1.832 . . . . 0.0 112.475 173.544 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 40.4 tt0 -58.62 -34.92 71.71 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 123.601 0.76 . . . . 0.0 110.62 173.978 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 3.4 t -76.0 -38.23 35.2 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.378 0 CA-C-O 118.12 -0.943 . . . . 0.0 109.676 -178.939 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 112' ' ' PHE . . . . . 0.439 ' CE1' ' HG2' ' A' ' 104' ' ' PRO . 27.0 m-85 -57.03 -50.14 73.66 Favored 'General case' 0 N--CA 1.475 0.793 0 CA-C-N 120.733 1.606 . . . . 0.0 110.256 169.904 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 85.7 mtt180 -60.5 -39.54 88.07 Favored 'General case' 0 N--CA 1.468 0.457 0 C-N-CA 123.358 0.663 . . . . 0.0 110.849 -179.161 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 16.3 m -68.28 -50.58 52.73 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 124.657 1.183 . . . . 0.0 110.726 176.565 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 55.2 t -67.6 -33.87 64.69 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.197 0 CA-C-O 117.498 -1.239 . . . . 0.0 110.856 -169.423 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 31.1 mtm105 -57.54 -41.77 81.62 Favored 'General case' 0 CA--C 1.539 0.534 0 CA-C-N 120.335 1.425 . . . . 0.0 110.273 173.598 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -67.02 -50.34 47.27 Favored Glycine 0 CA--C 1.529 0.92 0 C-N-CA 123.926 0.774 . . . . 0.0 111.878 177.577 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 25.4 mt-30 -54.95 -47.59 74.3 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-N 117.752 0.776 . . . . 0.0 110.211 178.377 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 53.7 t -64.83 -48.79 82.96 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.432 0 CA-C-O 118.329 -0.843 . . . . 0.0 109.967 -177.101 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 62.6 tttm -55.96 -45.65 78.83 Favored 'General case' 0 CA--C 1.519 -0.22 0 CA-C-N 119.114 0.87 . . . . 0.0 109.107 -174.429 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -64.88 -43.93 91.31 Favored 'General case' 0 N--CA 1.443 -0.781 0 C-N-CA 123.019 0.528 . . . . 0.0 110.776 -177.12 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 57.8 mtt-85 -68.0 -42.94 79.95 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-N 118.639 0.654 . . . . 0.0 111.695 179.578 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 98.5 t -66.55 -44.11 90.29 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.374 0 N-CA-C 108.433 -0.951 . . . . 0.0 108.433 179.406 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 21.3 mt-10 -61.39 -42.73 99.19 Favored 'General case' 0 C--N 1.338 0.092 0 CA-C-N 119.892 1.224 . . . . 0.0 110.39 178.861 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 29.6 t-20 -62.22 -44.56 96.29 Favored 'General case' 0 C--O 1.225 -0.189 0 C-N-CA 122.861 0.464 . . . . 0.0 110.827 178.239 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 45.7 tp -60.1 -47.24 86.74 Favored 'General case' 0 N--CA 1.454 -0.246 0 C-N-CA 124.239 1.016 . . . . 0.0 111.052 177.5 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 79.7 mt -61.69 -45.83 97.83 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.256 0 N-CA-C 108.026 -1.101 . . . . 0.0 108.026 178.191 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -62.04 -29.3 70.19 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 123.262 0.625 . . . . 0.0 112.239 178.28 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 89.9 mttt -68.59 -56.55 7.89 Favored 'General case' 0 C--N 1.342 0.248 0 CA-C-N 119.16 0.891 . . . . 0.0 110.096 171.711 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 15.8 pt -73.93 -40.35 52.51 Favored 'Isoleucine or valine' 0 C--O 1.235 0.338 0 N-CA-C 114.213 1.19 . . . . 0.0 114.213 -169.308 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 75.0 m . . . . . 0 C--O 1.253 1.262 0 C-N-CA 126.144 1.777 . . . . 0.0 109.408 -169.74 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 9.7 ptm . . . . . 0 N--CA 1.497 1.913 0 N-CA-C 110.711 -0.107 . . . . 0.0 110.711 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' LYS . . . . . 0.417 ' HB2' HG22 ' A' ' 30' ' ' ILE . 18.1 mttm -76.06 124.0 26.7 Favored 'General case' 0 N--CA 1.481 1.095 0 N-CA-C 107.701 -1.222 . . . . 0.0 107.701 -172.499 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 87.1 mttt -92.64 135.01 34.46 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-N 119.689 1.131 . . . . 0.0 108.343 176.692 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 1.7 t -118.81 150.31 21.11 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 C-N-CA 126.852 2.061 . . . . 0.0 108.848 -169.161 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 6.2 mtt -139.41 148.15 42.4 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 125.617 1.567 . . . . 0.0 109.286 169.352 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 91.0 m-85 -132.78 105.75 7.34 Favored 'General case' 0 C--O 1.225 -0.193 0 N-CA-C 104.769 -2.308 . . . . 0.0 104.769 172.131 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 22.1 t -131.82 138.88 51.76 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.221 0 CA-C-O 121.898 0.856 . . . . 0.0 111.211 -168.745 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 37.9 t -154.41 156.08 36.17 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 127.47 2.308 . . . . 0.0 105.236 169.27 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 65.6 pttt -65.37 -21.74 66.72 Favored 'General case' 0 N--CA 1.472 0.64 0 N-CA-C 114.69 1.367 . . . . 0.0 114.69 -170.427 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 7.9 tpp180 -126.94 78.05 1.77 Allowed 'General case' 0 N--CA 1.47 0.54 0 CA-C-N 119.814 1.188 . . . . 0.0 110.058 -173.9 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 34.9 t30 -43.18 -48.33 6.44 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 125.159 1.384 . . . . 0.0 112.222 176.379 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -51.53 -32.14 26.76 Favored 'General case' 0 C--O 1.232 0.147 0 C-N-CA 126.617 1.967 . . . . 0.0 112.998 -175.66 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 8.8 m -125.01 17.52 8.5 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 123.795 0.838 . . . . 0.0 111.805 -173.198 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 10.2 tpt180 -151.81 -55.86 0.14 Allowed 'General case' 0 C--N 1.348 0.528 0 N-CA-C 115.727 1.751 . . . . 0.0 115.727 179.33 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 3.3 m -65.66 -55.01 19.78 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 119.61 1.095 . . . . 0.0 112.195 -168.509 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER 43.8 -111.12 0.19 Allowed 'General case' 0 N--CA 1.452 -0.368 0 C-N-CA 126.328 1.851 . . . . 0.0 111.453 169.106 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -78.53 -8.38 58.51 Favored 'General case' 0 C--O 1.224 -0.246 0 N-CA-C 114.29 1.218 . . . . 0.0 114.29 -170.629 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -62.78 -58.95 5.66 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-N 120.131 1.332 . . . . 0.0 111.138 -169.751 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -68.11 -32.1 72.16 Favored 'General case' 0 CA--C 1.541 0.597 0 O-C-N 121.722 -0.611 . . . . 0.0 109.542 175.627 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -48.63 -56.65 9.35 Favored Glycine 0 C--N 1.346 1.113 0 C-N-CA 125.38 1.467 . . . . 0.0 111.637 176.23 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 13.9 m-85 -74.54 -28.3 60.9 Favored 'General case' 0 CA--C 1.508 -0.663 0 CA-C-N 118.77 1.285 . . . . 0.0 112.928 179.322 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -66.25 -31.0 71.55 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 119.323 0.965 . . . . 0.0 111.554 -172.451 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 7.5 ptpt -63.5 -33.06 74.75 Favored 'General case' 0 N--CA 1.477 0.908 0 CA-C-N 119.432 1.015 . . . . 0.0 112.036 171.067 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 5.9 m -78.72 -55.17 5.38 Favored 'General case' 0 N--CA 1.446 -0.626 0 C-N-CA 125.187 1.395 . . . . 0.0 110.245 -175.202 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 79.3 mt -73.4 -34.32 65.45 Favored 'General case' 0 C--N 1.33 -0.248 0 C-N-CA 123.971 0.909 . . . . 0.0 110.339 -174.753 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -91.08 2.85 79.88 Favored Glycine 0 CA--C 1.527 0.822 0 CA-C-O 118.362 -1.243 . . . . 0.0 113.709 -176.494 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -49.92 123.0 7.31 Favored 'General case' 0 CA--C 1.533 0.31 0 CA-C-N 118.796 1.298 . . . . 0.0 110.904 -172.074 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 76.78 -14.11 7.73 Favored Glycine 0 CA--C 1.533 1.195 0 C-N-CA 124.676 1.132 . . . . 0.0 114.353 179.631 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 53.6 mttm -94.15 -46.41 7.12 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-N 119.212 1.506 . . . . 0.0 110.393 178.918 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.417 HG22 ' HB2' ' A' ' 2' ' ' LYS . 24.7 pt -142.15 152.39 18.41 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.427 0 C-N-CA 124.301 1.04 . . . . 0.0 109.95 -169.408 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -112.87 109.01 18.19 Favored 'General case' 0 N--CA 1.464 0.235 0 C-N-CA 125.035 1.334 . . . . 0.0 108.694 -174.036 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 11.1 p -86.27 139.16 17.79 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.401 0 CA-C-N 119.702 1.137 . . . . 0.0 109.867 177.71 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 3.9 m -144.55 107.7 4.55 Favored 'General case' 0 N--CA 1.445 -0.69 0 N-CA-C 104.77 -2.308 . . . . 0.0 104.77 172.191 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 66.2 m -105.63 75.47 1.14 Allowed 'General case' 0 C--N 1.329 -0.32 0 O-C-N 120.933 -1.105 . . . . 0.0 108.827 178.48 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 2.0 m -60.46 -45.55 93.29 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 125.388 1.475 . . . . 0.0 112.054 -169.891 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 89.65 161.73 37.74 Favored Glycine 0 C--N 1.335 0.508 0 CA-C-O 122.038 0.799 . . . . 0.0 112.159 170.905 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 5.6 mt -131.49 142.67 50.01 Favored 'General case' 0 N--CA 1.442 -0.845 0 C-N-CA 128.079 2.552 . . . . 0.0 104.548 174.533 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 33.2 mt-10 57.42 -89.77 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.385 0 N-CA-C 108.134 -1.061 . . . . 0.0 108.134 -169.516 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 69.3 m 64.52 169.63 0.18 Allowed 'General case' 0 N--CA 1.445 -0.721 0 C-N-CA 127.269 2.228 . . . . 0.0 115.615 169.184 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 59.9 m -157.47 177.29 11.59 Favored 'General case' 0 N--CA 1.446 -0.646 0 C-N-CA 128.269 2.627 . . . . 0.0 105.984 -168.847 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 14.4 ttt85 -82.12 -178.77 7.15 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 107.963 -1.125 . . . . 0.0 107.963 169.377 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 17.6 m -81.41 170.17 1.48 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.729 0 C-N-CA 123.789 0.836 . . . . 0.0 109.766 -178.675 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 74.0 t60 -73.0 139.22 79.59 Favored Pre-proline 0 CA--C 1.545 0.763 0 CA-C-O 118.163 -0.922 . . . . 0.0 108.631 172.207 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -58.35 -48.3 16.16 Favored 'Trans proline' 0 C--N 1.348 0.507 0 C-N-CA 123.093 2.529 . . . . 0.0 113.833 -174.193 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 25.2 m -65.58 -18.82 65.6 Favored 'General case' 0 CA--C 1.535 0.387 0 CA-C-N 118.258 0.481 . . . . 0.0 110.937 -179.294 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.404 ' HB1' HD11 ' A' ' 57' ' ' ILE . . . -60.28 -50.64 72.82 Favored 'General case' 0 CA--C 1.51 -0.562 0 O-C-N 121.458 -0.776 . . . . 0.0 108.996 175.018 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 72.5 mt -57.98 -41.57 80.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 N-CA-C 108.352 -0.981 . . . . 0.0 108.352 -173.112 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -63.56 -46.48 85.72 Favored 'General case' 0 N--CA 1.452 -0.352 0 CA-C-N 117.631 0.196 . . . . 0.0 110.856 -179.05 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 28.4 mmt -68.02 -36.38 79.85 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-O 122.439 1.114 . . . . 0.0 110.841 -179.819 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -74.6 -31.93 62.19 Favored 'General case' 0 N--CA 1.444 -0.753 0 N-CA-C 106.887 -1.523 . . . . 0.0 106.887 -175.698 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 40.8 tt0 -72.3 -21.89 61.28 Favored 'General case' 0 N--CA 1.446 -0.651 0 C-N-CA 124.311 1.045 . . . . 0.0 110.157 172.495 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 21.6 mm-40 -67.53 -30.63 70.34 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-N 119.272 0.942 . . . . 0.0 110.017 169.962 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . 0.291 5.5 p -89.86 8.74 3.21 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.993 0 CA-C-N 118.802 0.728 . . . . 0.0 111.467 168.839 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 77.29 21.75 72.36 Favored Glycine 0 CA--C 1.532 1.11 0 O-C-N 120.818 -1.176 . . . . 0.0 113.799 174.953 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 25.2 mt -118.71 144.71 26.17 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.239 0 C-N-CA 125.314 1.445 . . . . 0.0 110.005 -174.15 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 20.6 t70 -108.03 147.59 30.93 Favored 'General case' 0 C--O 1.234 0.282 0 N-CA-C 108.375 -0.972 . . . . 0.0 108.375 168.74 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.404 HD11 ' HB1' ' A' ' 46' ' ' ALA . 13.5 pt -132.29 -12.57 1.48 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.707 0 C-N-CA 125.895 1.678 . . . . 0.0 111.529 170.565 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 5.4 t -45.77 -46.73 15.42 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-N 120.333 1.424 . . . . 0.0 111.688 170.845 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -78.51 29.51 1.99 Allowed Glycine 0 CA--C 1.533 1.207 0 C-N-CA 124.966 1.269 . . . . 0.0 114.147 -177.621 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 1.7 tt0 -63.5 -37.37 87.04 Favored 'General case' 0 C--N 1.344 0.36 0 CA-C-N 119.728 1.764 . . . . 0.0 113.213 -175.046 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 12.4 t -81.22 161.36 24.01 Favored 'General case' 0 C--O 1.238 0.451 0 CA-C-O 122.047 0.927 . . . . 0.0 110.352 -169.534 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 4.2 m -168.34 -51.42 0.02 OUTLIER 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 125.919 1.687 . . . . 0.0 109.175 178.197 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -154.39 154.97 30.32 Favored Pre-proline 0 C--O 1.237 0.41 0 C-N-CA 124.988 1.315 . . . . 0.0 108.208 -179.672 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 98.9 Cg_endo -66.86 159.13 53.07 Favored 'Trans proline' 0 N--CA 1.457 -0.659 0 C-N-CA 123.111 2.541 . . . . 0.0 110.508 171.421 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 5.6 tt -60.11 -26.01 35.01 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.477 0 O-C-N 121.577 -0.702 . . . . 0.0 111.63 179.681 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 15.8 mt-10 -65.66 -25.46 67.36 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 124.555 1.142 . . . . 0.0 110.593 -175.121 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 4.4 t-20 -65.84 -20.96 66.43 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 124.666 1.186 . . . . 0.0 112.459 177.985 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 77.0 m-85 -106.42 -173.49 2.31 Favored 'General case' 0 C--O 1.236 0.356 0 C-N-CA 126.37 1.868 . . . . 0.0 110.1 -174.95 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 53.2 t-20 -135.78 139.71 43.72 Favored 'General case' 0 N--CA 1.448 -0.542 0 N-CA-C 107.857 -1.164 . . . . 0.0 107.857 169.123 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -72.44 -26.16 61.73 Favored 'General case' 0 N--CA 1.433 -1.31 0 N-CA-C 109.283 -0.636 . . . . 0.0 109.283 -178.102 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -65.56 -24.39 67.08 Favored 'General case' 0 N--CA 1.447 -0.596 0 O-C-N 123.639 0.587 . . . . 0.0 112.002 -179.652 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -78.42 -28.43 46.79 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 123.297 0.639 . . . . 0.0 111.635 174.848 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 11.4 m-85 -81.13 167.44 19.68 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 125.536 1.534 . . . . 0.0 111.151 179.877 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -116.86 -39.98 3.21 Favored 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 123.099 0.56 . . . . 0.0 111.243 -179.081 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -136.13 133.62 50.28 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.453 0 CA-C-O 121.841 0.829 . . . . 0.0 109.498 -172.43 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 70.5 t -142.01 130.0 21.32 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.585 0 N-CA-C 106.199 -1.778 . . . . 0.0 106.199 -177.83 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 38.0 mm -118.9 125.42 74.46 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.575 0 N-CA-C 106.387 -1.708 . . . . 0.0 106.387 -173.233 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 56.0 m -84.0 145.06 28.72 Favored 'General case' 0 N--CA 1.446 -0.655 0 N-CA-C 106.061 -1.829 . . . . 0.0 106.061 168.601 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 93.1 mt -111.61 5.35 19.3 Favored 'General case' 0 C--N 1.328 -0.344 0 O-C-N 121.637 -0.664 . . . . 0.0 110.785 171.74 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 10.8 p -155.47 147.25 23.22 Favored 'General case' 0 N--CA 1.447 -0.584 0 C-N-CA 124.537 1.135 . . . . 0.0 108.566 168.898 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 53.4 -156.56 5.5 Favored Glycine 0 CA--C 1.537 1.426 0 C-N-CA 125.204 1.383 . . . . 0.0 115.22 169.604 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 48.0 m -145.83 127.12 14.85 Favored 'General case' 0 CA--C 1.532 0.271 0 N-CA-C 105.902 -1.888 . . . . 0.0 105.902 174.913 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 58.59 44.43 95.55 Favored Glycine 0 CA--C 1.53 1.013 0 N-CA-C 109.711 -1.356 . . . . 0.0 109.711 -171.378 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . 0.279 4.0 p -75.37 64.46 0.16 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.842 0 C-N-CA 125.916 1.686 . . . . 0.0 112.213 -168.834 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 56.5 t30 56.84 52.89 8.81 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 125.874 1.67 . . . . 0.0 107.83 -169.569 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -143.83 138.59 15.29 Favored Pre-proline 0 CA--C 1.538 0.489 0 C-N-CA 126.102 1.761 . . . . 0.0 108.743 -168.748 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 33.2 Cg_exo -64.93 139.47 62.05 Favored 'Trans proline' 0 CA--C 1.54 0.81 0 C-N-CA 122.221 1.947 . . . . 0.0 111.576 176.463 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -66.21 -24.9 50.72 Favored 'Trans proline' 0 N--CA 1.457 -0.657 0 C-N-CA 122.585 2.19 . . . . 0.0 114.476 -169.649 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 5.0 pm0 -61.46 -18.08 57.36 Favored 'General case' 0 CA--C 1.537 0.453 0 CA-C-N 121.251 1.841 . . . . 0.0 111.898 178.413 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 99.4 m95 -77.91 -38.84 44.71 Favored 'General case' 0 N--CA 1.451 -0.393 0 O-C-N 121.702 -0.624 . . . . 0.0 111.396 174.093 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -79.33 -5.12 7.72 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.456 0 O-C-N 121.869 -0.519 . . . . 0.0 111.672 -177.827 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 81.5 p -114.39 18.42 16.9 Favored 'General case' 0 C--O 1.238 0.453 0 N-CA-C 114.411 1.264 . . . . 0.0 114.411 -175.633 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 91.6 mm-40 -68.18 173.99 4.27 Favored 'General case' 0 CA--C 1.541 0.628 0 CA-C-N 119.025 0.83 . . . . 0.0 111.858 179.324 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 28.7 mm-40 -53.22 -31.57 43.79 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 124.362 1.065 . . . . 0.0 112.735 -169.0 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 4.8 tt -131.35 124.83 55.77 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.51 0 N-CA-C 104.305 -2.48 . . . . 0.0 104.305 168.39 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 4.1 t80 -113.55 133.39 55.28 Favored 'General case' 0 C--O 1.237 0.444 0 N-CA-C 104.722 -2.325 . . . . 0.0 104.722 169.186 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 14.4 mm-40 -137.66 152.07 48.93 Favored 'General case' 0 C--O 1.238 0.495 0 N-CA-C 106.57 -1.641 . . . . 0.0 106.57 169.723 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -130.94 134.82 47.1 Favored 'General case' 0 C--O 1.237 0.419 0 N-CA-C 107.411 -1.329 . . . . 0.0 107.411 169.263 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 6.6 m95 -121.08 138.95 53.94 Favored 'General case' 0 C--O 1.234 0.25 0 C-N-CA 123.059 0.543 . . . . 0.0 109.767 -174.82 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 4.8 tp-100 -82.72 63.33 6.79 Favored 'General case' 0 CA--C 1.535 0.395 0 N-CA-C 107.361 -1.348 . . . . 0.0 107.361 169.907 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 1.6 tp -67.38 127.53 33.03 Favored 'General case' 0 C--N 1.34 0.165 0 N-CA-C 108.955 -0.757 . . . . 0.0 108.955 -173.352 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -76.89 159.05 30.33 Favored 'General case' 0 N--CA 1.449 -0.508 0 N-CA-C 107.045 -1.465 . . . . 0.0 107.045 169.572 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 20.0 t70 -149.07 137.65 11.96 Favored Pre-proline 0 CA--C 1.536 0.419 0 CA-C-O 118.596 -0.716 . . . . 0.0 111.209 -171.584 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 20.8 Cg_endo -91.7 9.53 2.82 Favored 'Trans proline' 0 CA--C 1.548 1.217 0 C-N-CA 123.424 2.749 . . . . 0.0 114.808 -172.193 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -53.27 128.44 28.16 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-N 120.596 1.544 . . . . 0.0 111.361 177.811 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 64.0 25.16 69.18 Favored Glycine 0 CA--C 1.532 1.126 0 CA-C-O 118.741 -1.033 . . . . 0.0 115.458 169.223 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 6.9 pt20 -142.1 -168.48 2.71 Favored 'General case' 0 CA--C 1.536 0.434 0 CA-C-N 118.891 1.345 . . . . 0.0 111.343 -177.911 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 2.6 m -68.51 156.0 38.84 Favored 'General case' 0 CA--C 1.532 0.274 0 N-CA-C 116.149 1.907 . . . . 0.0 116.149 -168.401 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 42.9 tp -54.97 -33.68 62.63 Favored 'General case' 0 N--CA 1.465 0.307 0 C-N-CA 126.997 2.119 . . . . 0.0 111.785 175.211 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 40.8 tt0 -58.49 -35.43 72.2 Favored 'General case' 0 CA--C 1.529 0.172 0 C-N-CA 123.806 0.843 . . . . 0.0 110.702 176.399 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 4.2 t -74.98 -40.47 45.39 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.291 0 CA-C-O 118.434 -0.793 . . . . 0.0 109.652 -177.216 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 89.9 m-85 -57.12 -49.64 75.29 Favored 'General case' 0 N--CA 1.471 0.621 0 CA-C-N 119.927 1.24 . . . . 0.0 109.568 171.837 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 89.4 mtt180 -61.61 -40.0 93.27 Favored 'General case' 0 N--CA 1.467 0.385 0 C-N-CA 122.871 0.468 . . . . 0.0 110.993 -178.592 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 7.6 m -66.32 -56.27 11.96 Favored 'General case' 0 N--CA 1.447 -0.608 0 C-N-CA 124.507 1.123 . . . . 0.0 109.514 177.996 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 83.8 t -68.33 -34.06 63.92 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.343 0 CA-C-O 118.683 -0.675 . . . . 0.0 110.057 -169.643 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 47.1 ttp85 -57.82 -43.23 85.59 Favored 'General case' 0 CA--C 1.538 0.489 0 CA-C-N 119.275 0.943 . . . . 0.0 109.883 173.173 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -64.54 -53.4 35.62 Favored Glycine 0 CA--C 1.53 0.987 0 CA-C-N 118.318 0.508 . . . . 0.0 111.842 175.273 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 12.6 mt-30 -61.01 -43.34 99.03 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-N 117.884 0.842 . . . . 0.0 110.837 -174.859 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 76.8 t -70.5 -38.85 75.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 118.085 -0.959 . . . . 0.0 109.966 -174.951 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 84.0 tttt -54.73 -46.81 74.29 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 119.279 0.945 . . . . 0.0 108.673 175.789 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -65.98 -42.51 89.75 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 122.933 0.493 . . . . 0.0 111.398 -176.604 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 43.6 mtt-85 -61.49 -46.62 89.22 Favored 'General case' 0 N--CA 1.472 0.635 0 O-C-N 121.336 -0.852 . . . . 0.0 111.514 176.524 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 98.4 t -65.28 -39.87 86.77 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.637 0 N-CA-C 109.08 -0.711 . . . . 0.0 109.08 179.354 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 29.7 mt-10 -59.42 -44.48 92.87 Favored 'General case' 0 N--CA 1.462 0.172 0 CA-C-N 119.789 1.177 . . . . 0.0 110.787 176.667 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 46.7 t30 -62.98 -45.2 93.54 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 123.329 0.652 . . . . 0.0 110.551 -177.649 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 22.0 tp -58.0 -47.91 81.61 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 124.112 0.965 . . . . 0.0 111.006 175.382 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 81.0 mt -63.09 -46.09 96.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 N-CA-C 108.329 -0.989 . . . . 0.0 108.329 179.664 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -59.91 -27.83 67.08 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 123.25 0.62 . . . . 0.0 112.214 177.901 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 90.5 mttt -69.72 -56.99 5.69 Favored 'General case' 0 C--N 1.343 0.284 0 CA-C-N 119.322 0.964 . . . . 0.0 110.184 171.706 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 18.2 pt -75.71 -38.44 37.66 Favored 'Isoleucine or valine' 0 C--O 1.235 0.326 0 N-CA-C 114.645 1.35 . . . . 0.0 114.645 -169.283 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 73.7 m . . . . . 0 C--O 1.252 1.237 0 C-N-CA 126.199 1.799 . . . . 0.0 109.128 -169.805 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 6.3 ptm . . . . . 0 N--CA 1.497 1.878 0 N-CA-C 110.807 -0.071 . . . . 0.0 110.807 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' LYS . . . . . 0.457 ' HB2' HG22 ' A' ' 30' ' ' ILE . 10.6 mtmm -71.69 130.14 40.41 Favored 'General case' 0 N--CA 1.476 0.874 0 N-CA-C 107.507 -1.294 . . . . 0.0 107.507 -178.936 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 66.7 mttt -103.74 138.32 40.53 Favored 'General case' 0 CA--C 1.511 -0.526 0 N-CA-C 107.912 -1.144 . . . . 0.0 107.912 171.046 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.419 HG21 HD12 ' A' ' 30' ' ' ILE . 4.0 t -116.25 152.84 17.93 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.787 0 C-N-CA 126.522 1.929 . . . . 0.0 108.169 -169.878 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 5.1 mtt -135.78 148.17 48.66 Favored 'General case' 0 C--N 1.323 -0.562 0 C-N-CA 126.512 1.925 . . . . 0.0 107.951 168.88 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -135.19 109.22 8.2 Favored 'General case' 0 CA--C 1.512 -0.51 0 N-CA-C 104.161 -2.533 . . . . 0.0 104.161 175.909 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 72.4 t -132.73 149.52 32.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-O 121.378 0.608 . . . . 0.0 110.0 -168.454 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 32.7 t -135.85 -174.43 3.66 Favored 'General case' 0 CA--C 1.548 0.866 0 C-N-CA 128.134 2.573 . . . . 0.0 105.952 172.814 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 64.3 tttp -54.45 -39.93 67.88 Favored 'General case' 0 N--CA 1.479 1.008 0 O-C-N 121.26 -0.9 . . . . 0.0 111.505 177.777 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 33.3 mtp85 -132.3 158.35 42.1 Favored 'General case' 0 N--CA 1.468 0.47 0 C-N-CA 124.644 1.177 . . . . 0.0 108.449 174.6 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -63.27 -24.97 68.1 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 122.948 0.499 . . . . 0.0 112.093 170.212 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -48.93 -44.46 40.51 Favored 'General case' 0 CA--C 1.53 0.197 0 C-N-CA 126.105 1.762 . . . . 0.0 113.627 -169.31 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 13.5 m -120.03 144.36 47.59 Favored 'General case' 0 N--CA 1.454 -0.27 0 C-N-CA 123.111 0.564 . . . . 0.0 109.733 -169.386 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . 0.37 0.0 OUTLIER 56.32 -40.68 0.03 OUTLIER 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 130.3 3.44 . . . . 0.0 115.061 -178.746 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 2.0 m -61.8 -24.19 66.7 Favored 'General case' 0 CA--C 1.539 0.524 0 O-C-N 120.358 -1.464 . . . . 0.0 109.663 169.293 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 16' ' ' GLN . . . . . 0.432 ' O ' HD13 ' A' ' 57' ' ' ILE . 22.0 pt20 -67.18 10.81 0.13 Allowed 'General case' 0 CA--C 1.546 0.823 0 C-N-CA 125.638 1.575 . . . . 0.0 113.401 169.414 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -139.18 -51.64 0.54 Allowed 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 125.158 1.383 . . . . 0.0 111.577 173.599 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -57.8 -47.43 82.6 Favored 'General case' 0 N--CA 1.472 0.669 0 N-CA-C 114.934 1.457 . . . . 0.0 114.934 -169.003 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 1.9 pp20? -63.5 -30.61 71.71 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-N 117.981 0.355 . . . . 0.0 110.109 178.36 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -51.81 -67.32 2.07 Favored Glycine 0 C--N 1.34 0.805 0 C-N-CA 126.399 1.952 . . . . 0.0 110.885 173.376 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 12.8 m-85 -62.53 -31.01 71.71 Favored 'General case' 0 N--CA 1.469 0.514 0 CA-C-N 118.25 1.025 . . . . 0.0 113.294 179.67 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -67.36 -35.79 80.07 Favored 'General case' 0 N--CA 1.45 -0.454 0 CA-C-N 119.07 0.85 . . . . 0.0 111.549 -176.226 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -67.35 -27.28 67.0 Favored 'General case' 0 CA--C 1.541 0.624 0 CA-C-N 119.426 1.012 . . . . 0.0 111.431 174.201 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 2.8 m -77.2 -56.17 4.8 Favored 'General case' 0 N--CA 1.451 -0.397 0 C-N-CA 125.443 1.497 . . . . 0.0 110.571 -178.601 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 54.9 mt -75.54 -38.35 59.37 Favored 'General case' 0 C--N 1.33 -0.245 0 C-N-CA 124.098 0.959 . . . . 0.0 109.497 -174.484 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -82.24 3.78 79.68 Favored Glycine 0 CA--C 1.524 0.628 0 C-N-CA 125.154 1.359 . . . . 0.0 113.447 -179.65 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -54.39 127.28 26.73 Favored 'General case' 0 CA--C 1.531 0.219 0 CA-C-N 118.881 1.34 . . . . 0.0 109.691 -177.328 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 73.38 5.41 67.18 Favored Glycine 0 CA--C 1.533 1.168 0 CA-C-O 118.775 -1.014 . . . . 0.0 114.273 -178.8 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 46.3 mttp -121.22 -51.32 2.1 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-N 119.104 1.452 . . . . 0.0 110.943 -176.508 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.457 HG22 ' HB2' ' A' ' 2' ' ' LYS . 19.2 pt -139.71 148.12 23.39 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.453 0 C-N-CA 123.88 0.872 . . . . 0.0 109.567 -169.495 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -94.67 158.75 15.38 Favored 'General case' 0 C--O 1.224 -0.266 0 C-N-CA 124.851 1.26 . . . . 0.0 108.522 178.06 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 21.7 t -140.54 130.71 28.07 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 N-CA-C 107.172 -1.418 . . . . 0.0 107.172 -176.474 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 24.4 m -141.0 109.77 6.04 Favored 'General case' 0 N--CA 1.446 -0.645 0 N-CA-C 105.122 -2.177 . . . . 0.0 105.122 172.684 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 69.3 m -110.81 85.0 2.03 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.869 0.842 . . . . 0.0 110.079 -177.439 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 4.8 m -72.48 -170.09 0.61 Allowed 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 126.651 1.98 . . . . 0.0 110.748 176.749 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -165.74 -168.2 27.53 Favored Glycine 0 C--N 1.337 0.604 0 N-CA-C 108.01 -2.036 . . . . 0.0 108.01 177.949 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 16.9 mt -127.25 -8.41 5.86 Favored 'General case' 0 C--N 1.332 -0.177 0 C-N-CA 124.657 1.183 . . . . 0.0 112.773 -171.946 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 20.9 mt-10 -142.52 -71.53 0.32 Allowed 'General case' 0 CA--C 1.535 0.366 0 N-CA-C 107.427 -1.323 . . . . 0.0 107.427 -178.023 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . 0.25 53.8 m 63.17 158.58 0.07 Allowed 'General case' 0 N--CA 1.465 0.296 0 C-N-CA 127.259 2.223 . . . . 0.0 116.586 169.675 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 69.6 m -152.74 1.62 0.3 Allowed 'General case' 0 CA--C 1.538 0.484 0 N-CA-C 115.747 1.758 . . . . 0.0 115.747 -167.532 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 1.5 ttt180 66.51 168.51 0.23 Allowed 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 125.251 1.42 . . . . 0.0 109.802 -167.439 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 5.1 m -83.79 172.33 1.07 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.315 0 C-N-CA 123.528 0.731 . . . . 0.0 110.978 -169.19 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 91.1 m-70 -88.65 150.55 46.36 Favored Pre-proline 0 CA--C 1.537 0.443 0 C-N-CA 123.188 0.595 . . . . 0.0 109.949 178.133 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 39.5 Cg_endo -63.72 -46.44 8.95 Favored 'Trans proline' 0 C--N 1.347 0.485 0 C-N-CA 122.855 2.37 . . . . 0.0 112.341 -170.338 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 6.0 m -66.17 -25.94 67.19 Favored 'General case' 0 CA--C 1.531 0.242 0 CA-C-O 119.016 -0.516 . . . . 0.0 110.256 -179.112 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -58.69 -54.12 50.61 Favored 'General case' 0 CA--C 1.51 -0.581 0 CA-C-N 119.086 0.857 . . . . 0.0 109.109 176.27 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 38.1 mt -59.7 -42.8 89.78 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.427 0 N-CA-C 108.193 -1.04 . . . . 0.0 108.193 -174.654 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -59.23 -44.86 92.31 Favored 'General case' 0 CA--C 1.532 0.269 0 CA-C-N 118.421 0.555 . . . . 0.0 110.623 -178.775 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 26.4 mmt -70.9 -37.58 72.98 Favored 'General case' 0 C--O 1.239 0.503 0 CA-C-O 122.158 0.98 . . . . 0.0 111.128 -179.161 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -69.91 -32.96 71.54 Favored 'General case' 0 N--CA 1.443 -0.778 0 N-CA-C 106.649 -1.612 . . . . 0.0 106.649 179.781 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 18.6 mm-40 -73.29 -16.59 61.38 Favored 'General case' 0 N--CA 1.444 -0.752 0 O-C-N 120.79 -1.194 . . . . 0.0 111.278 171.757 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 22.6 mm-40 -66.28 -35.1 79.53 Favored 'General case' 0 C--N 1.341 0.221 0 CA-C-N 119.847 1.203 . . . . 0.0 109.095 169.552 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 16.8 m -90.07 11.59 2.09 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.766 0 N-CA-C 112.2 0.445 . . . . 0.0 112.2 169.311 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 73.21 23.52 77.36 Favored Glycine 0 CA--C 1.534 1.234 0 C-N-CA 124.487 1.042 . . . . 0.0 113.345 174.67 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 8.6 mt -107.83 135.53 46.19 Favored 'Isoleucine or valine' 0 C--O 1.232 0.152 0 C-N-CA 125.419 1.488 . . . . 0.0 110.197 -174.994 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -95.57 140.01 31.02 Favored 'General case' 0 C--O 1.236 0.365 0 C-N-CA 123.508 0.723 . . . . 0.0 109.514 169.791 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.494 HG13 ' H ' ' A' ' 58' ' ' SER . 3.6 pt -119.72 -66.94 1.2 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.607 0 C-N-CA 124.773 1.229 . . . . 0.0 108.393 171.043 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 58' ' ' SER . . . . . 0.494 ' H ' HG13 ' A' ' 57' ' ' ILE . 95.2 p 30.59 -98.54 0.01 OUTLIER 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 128.961 2.905 . . . . 0.0 114.225 174.897 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -76.35 53.96 3.16 Favored Glycine 0 CA--C 1.528 0.876 0 C-N-CA 127.273 2.368 . . . . 0.0 112.703 -175.773 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 5.6 mt-30 -65.44 -29.9 70.63 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 123.203 0.601 . . . . 0.0 110.297 169.744 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -60.28 128.19 35.52 Favored 'General case' 0 N--CA 1.446 -0.639 0 C-N-CA 126.037 1.735 . . . . 0.0 109.19 -169.795 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 75.5 m -147.63 -169.94 3.44 Favored 'General case' 0 N--CA 1.447 -0.587 0 C-N-CA 126.332 1.853 . . . . 0.0 106.605 -169.635 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -57.38 154.59 22.24 Favored Pre-proline 0 C--O 1.241 0.613 0 O-C-N 121.854 -0.529 . . . . 0.0 109.903 169.355 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 64.4 Cg_endo -61.2 152.61 70.77 Favored 'Trans proline' 0 N--CA 1.456 -0.691 0 C-N-CA 121.918 1.745 . . . . 0.0 109.488 171.613 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 7.9 tt -60.09 -26.53 36.48 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.497 0 O-C-N 121.794 -0.566 . . . . 0.0 111.015 -176.682 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 25.4 tt0 -67.52 -26.33 66.28 Favored 'General case' 0 N--CA 1.435 -1.215 0 C-N-CA 125.398 1.479 . . . . 0.0 110.65 -176.625 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 11.3 t-20 -64.72 -31.16 72.26 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 124.416 1.087 . . . . 0.0 111.731 176.945 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 79.4 m-85 -86.58 168.13 13.94 Favored 'General case' 0 C--O 1.237 0.429 0 C-N-CA 124.946 1.298 . . . . 0.0 111.612 -174.695 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 46.4 t-20 -106.26 132.05 52.77 Favored 'General case' 0 N--CA 1.444 -0.738 0 N-CA-C 107.298 -1.371 . . . . 0.0 107.298 168.676 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -73.6 -24.69 60.08 Favored 'General case' 0 N--CA 1.437 -1.092 0 N-CA-C 109.339 -0.615 . . . . 0.0 109.339 -178.77 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 36.1 t70 -65.85 -21.76 66.49 Favored 'General case' 0 N--CA 1.447 -0.595 0 O-C-N 123.477 0.486 . . . . 0.0 112.096 -179.617 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -73.29 -29.31 62.63 Favored 'General case' 0 C--N 1.344 0.367 0 CA-C-O 121.222 0.534 . . . . 0.0 111.795 176.164 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 32.7 m-85 -84.25 165.84 18.0 Favored 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 125.744 1.618 . . . . 0.0 110.166 179.703 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 20.4 t70 -113.13 -35.84 5.25 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.72 176.903 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -142.24 135.94 28.5 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.826 0 CA-C-O 121.792 0.806 . . . . 0.0 110.496 -169.305 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 73.3 t -142.16 131.07 22.32 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.729 0 N-CA-C 106.178 -1.786 . . . . 0.0 106.178 -174.097 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 41.4 mm -117.93 125.5 74.23 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.443 0 N-CA-C 106.387 -1.709 . . . . 0.0 106.387 -171.712 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 41.3 m -95.19 108.69 20.83 Favored 'General case' 0 N--CA 1.447 -0.597 0 N-CA-C 106.675 -1.602 . . . . 0.0 106.675 169.889 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 90.0 mt -74.63 -13.37 60.63 Favored 'General case' 0 N--CA 1.464 0.254 0 C-N-CA 123.175 0.59 . . . . 0.0 111.661 -178.943 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 45.4 m -142.19 89.89 2.21 Favored 'General case' 0 N--CA 1.452 -0.367 0 C-N-CA 124.981 1.312 . . . . 0.0 109.073 -169.824 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 64.33 -154.7 47.51 Favored Glycine 0 CA--C 1.534 1.221 0 N-CA-C 111.585 -0.606 . . . . 0.0 111.585 178.418 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 2.9 p -161.77 152.81 18.11 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 124.587 1.155 . . . . 0.0 109.651 179.365 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 61.43 31.0 75.85 Favored Glycine 0 CA--C 1.531 1.069 0 N-CA-C 111.619 -0.592 . . . . 0.0 111.619 -178.534 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 28.5 m -70.69 -38.76 74.34 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.543 0 C-N-CA 123.087 0.555 . . . . 0.0 112.118 -169.366 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 21.4 t-20 179.66 -40.86 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 127.795 2.438 . . . . 0.0 107.573 176.712 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 3.6 tt -37.59 137.93 0.64 Allowed Pre-proline 0 CA--C 1.548 0.878 0 C-N-CA 128.788 2.835 . . . . 0.0 112.562 170.963 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 87' ' ' PRO . . . . . 0.439 ' HA ' ' HD3' ' A' ' 88' ' ' PRO . 53.2 Cg_exo -65.32 148.83 88.7 Favored 'Trans proline' 0 C--N 1.355 0.886 0 C-N-CA 121.734 1.623 . . . . 0.0 115.635 -169.399 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 88' ' ' PRO . . . . . 0.439 ' HD3' ' HA ' ' A' ' 87' ' ' PRO . 50.6 Cg_exo -64.04 -33.44 62.26 Favored 'Trans proline' 0 C--N 1.351 0.672 0 C-N-CA 122.394 2.062 . . . . 0.0 115.788 -170.981 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 5.1 pm0 -61.45 -14.41 28.34 Favored 'General case' 0 CA--C 1.538 0.49 0 CA-C-N 120.27 1.395 . . . . 0.0 112.46 -175.876 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 98.0 m95 -79.67 -45.94 18.08 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 124.008 0.923 . . . . 0.0 110.904 176.711 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 16.1 m -80.18 -1.32 4.58 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.366 0 C-N-CA 123.955 0.902 . . . . 0.0 112.25 179.975 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 74.9 p -109.62 18.76 19.94 Favored 'General case' 0 C--O 1.238 0.454 0 CA-C-N 119.672 1.124 . . . . 0.0 113.655 175.544 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 88.0 mm-40 -66.66 172.24 4.41 Favored 'General case' 0 CA--C 1.542 0.635 0 CA-C-N 118.842 0.746 . . . . 0.0 111.783 177.0 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 31.7 mm-40 -54.85 -31.97 60.14 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 123.869 0.868 . . . . 0.0 112.272 -169.033 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 1.9 tt -129.0 126.32 64.37 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.543 0 N-CA-C 103.817 -2.66 . . . . 0.0 103.817 168.412 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 7.3 t80 -110.47 139.04 46.08 Favored 'General case' 0 N--CA 1.448 -0.549 0 N-CA-C 105.955 -1.869 . . . . 0.0 105.955 170.104 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 12.8 mm-40 -134.8 145.09 48.03 Favored 'General case' 0 C--O 1.237 0.435 0 N-CA-C 107.137 -1.431 . . . . 0.0 107.137 169.774 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -129.11 125.78 37.9 Favored 'General case' 0 C--O 1.239 0.515 0 C-N-CA 126.375 1.87 . . . . 0.0 106.235 178.117 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 34.6 m95 -135.43 179.31 6.41 Favored 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 124.585 1.154 . . . . 0.0 108.865 179.987 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 6.4 tp-100 -141.24 72.22 1.38 Allowed 'General case' 0 CA--C 1.535 0.376 0 N-CA-C 106.274 -1.75 . . . . 0.0 106.274 169.643 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -67.03 146.01 54.78 Favored 'General case' 0 N--CA 1.469 0.488 0 N-CA-C 108.448 -0.945 . . . . 0.0 108.448 178.506 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 34.4 mt-10 -78.66 169.68 17.85 Favored 'General case' 0 C--N 1.328 -0.369 0 C-N-CA 123.975 0.91 . . . . 0.0 109.318 170.891 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -141.35 138.59 17.76 Favored Pre-proline 0 CA--C 1.539 0.549 0 C-N-CA 124.331 1.052 . . . . 0.0 110.27 179.27 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_endo -85.47 0.58 8.57 Favored 'Trans proline' 0 CA--C 1.543 0.927 0 C-N-CA 123.248 2.632 . . . . 0.0 115.771 -174.063 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 7.1 t70 -53.66 124.0 13.86 Favored 'General case' 0 C--O 1.237 0.416 0 CA-C-N 121.077 1.762 . . . . 0.0 110.849 -179.063 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 72.33 4.71 61.02 Favored Glycine 0 CA--C 1.533 1.168 0 CA-C-O 118.961 -0.911 . . . . 0.0 113.749 178.188 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 7.1 mt-30 -103.0 167.25 9.96 Favored 'General case' 0 CA--C 1.539 0.557 0 CA-C-N 118.658 1.229 . . . . 0.0 110.014 178.594 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 16.4 m -71.91 167.38 20.18 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 124.09 0.956 . . . . 0.0 111.636 -178.928 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 73.8 mt -59.62 -26.51 65.54 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 124.379 1.072 . . . . 0.0 112.402 -176.454 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 5.9 pt-20 -56.25 -34.93 66.84 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-N 118.738 0.699 . . . . 0.0 111.11 174.184 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 14.0 t -77.93 -42.51 28.31 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.316 0 CA-C-O 118.664 -0.684 . . . . 0.0 109.913 -177.238 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 68.3 m-85 -56.84 -43.5 81.19 Favored 'General case' 0 N--CA 1.474 0.77 0 CA-C-N 119.639 1.109 . . . . 0.0 109.569 171.07 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 94.1 mtt180 -66.25 -42.33 88.7 Favored 'General case' 0 N--CA 1.472 0.655 0 O-C-N 121.305 -0.872 . . . . 0.0 110.804 179.485 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 4.1 m -65.75 -49.72 67.36 Favored 'General case' 0 N--CA 1.45 -0.427 0 C-N-CA 124.606 1.162 . . . . 0.0 110.312 179.394 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 77.2 t -70.43 -30.58 43.46 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.202 0 CA-C-O 117.807 -1.092 . . . . 0.0 110.587 -169.501 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 74.5 mtm-85 -59.09 -45.36 91.05 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 120.192 1.36 . . . . 0.0 109.799 170.508 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -62.16 -51.68 55.05 Favored Glycine 0 CA--C 1.528 0.88 0 CA-C-N 118.946 0.794 . . . . 0.0 112.1 178.093 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 15.7 mt-30 -58.94 -45.4 90.53 Favored 'General case' 0 N--CA 1.469 0.475 0 CA-C-N 117.936 0.868 . . . . 0.0 110.779 -178.852 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 55.3 t -67.04 -47.22 82.72 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.344 0 N-CA-C 109.202 -0.666 . . . . 0.0 109.202 -177.987 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 84.3 tttt -55.52 -45.67 77.11 Favored 'General case' 0 C--O 1.224 -0.262 0 N-CA-C 109.185 -0.672 . . . . 0.0 109.185 -176.635 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 10.1 tp10 -62.83 -44.2 96.79 Favored 'General case' 0 N--CA 1.45 -0.427 0 C-N-CA 123.145 0.578 . . . . 0.0 110.757 -176.268 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 48.6 mtt-85 -68.51 -42.97 77.81 Favored 'General case' 0 N--CA 1.468 0.443 0 O-C-N 121.32 -0.863 . . . . 0.0 111.025 178.987 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 95.4 t -64.17 -38.98 83.87 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.513 0 CA-C-O 119.138 -0.458 . . . . 0.0 109.884 178.305 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 27.8 mt-10 -61.72 -44.85 96.13 Favored 'General case' 0 C--O 1.227 -0.128 0 CA-C-N 119.993 1.27 . . . . 0.0 110.177 176.014 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 28.3 t-20 -63.02 -42.12 99.71 Favored 'General case' 0 CA--C 1.53 0.208 0 C-N-CA 122.915 0.486 . . . . 0.0 111.049 -177.801 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 28.7 tp -58.04 -49.63 76.21 Favored 'General case' 0 N--CA 1.451 -0.399 0 C-N-CA 125.203 1.401 . . . . 0.0 110.742 174.17 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 81.6 mt -66.41 -43.99 90.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 N-CA-C 108.146 -1.057 . . . . 0.0 108.146 -177.057 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -59.23 -32.92 70.41 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 123.198 0.599 . . . . 0.0 112.098 -179.486 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 18.6 ptpt -80.87 -37.79 29.25 Favored 'General case' 0 C--N 1.344 0.351 0 CA-C-O 117.929 -1.034 . . . . 0.0 112.32 177.344 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 13.1 pt -84.85 -34.38 9.05 Favored 'Isoleucine or valine' 0 C--O 1.236 0.356 0 CA-C-N 119.962 1.255 . . . . 0.0 114.045 -175.184 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 74.3 m . . . . . 0 C--O 1.252 1.195 0 C-N-CA 125.372 1.469 . . . . 0.0 109.462 -169.837 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.4 ptt? . . . . . 0 N--CA 1.496 1.854 0 N-CA-C 111.776 0.287 . . . . 0.0 111.776 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . 0.426 ' HB2' HG22 ' A' ' 30' ' ' ILE . 11.0 mtmm -59.91 128.4 36.71 Favored 'General case' 0 N--CA 1.475 0.8 0 N-CA-C 107.816 -1.179 . . . . 0.0 107.816 -178.872 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 66.0 mttt -103.14 136.12 43.52 Favored 'General case' 0 CA--C 1.513 -0.465 0 N-CA-C 107.745 -1.205 . . . . 0.0 107.745 171.528 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.44 HG21 HD12 ' A' ' 30' ' ' ILE . 3.7 t -113.73 152.73 15.38 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.622 0 C-N-CA 126.144 1.777 . . . . 0.0 107.111 -171.479 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 2.7 mtt -137.14 145.08 43.37 Favored 'General case' 0 C--N 1.323 -0.55 0 C-N-CA 126.433 1.893 . . . . 0.0 108.341 169.525 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 60.0 m-85 -128.6 89.01 2.82 Favored 'General case' 0 CA--C 1.528 0.109 0 N-CA-C 105.234 -2.136 . . . . 0.0 105.234 170.769 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 44.0 t -128.57 108.62 17.73 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.217 0 CA-C-O 121.409 0.623 . . . . 0.0 111.72 -168.741 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 33.9 t -101.64 164.57 11.68 Favored 'General case' 0 CA--C 1.543 0.682 0 N-CA-C 105.392 -2.077 . . . . 0.0 105.392 167.812 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 61.7 pttt -72.0 148.36 45.99 Favored 'General case' 0 CA--C 1.53 0.206 0 O-C-N 121.133 -0.979 . . . . 0.0 108.809 169.529 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 2.8 mpt_? 60.07 168.75 0.08 Allowed 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 125.63 1.572 . . . . 0.0 110.939 -170.443 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -138.4 -14.04 1.31 Allowed 'General case' 0 N--CA 1.468 0.433 0 N-CA-C 112.882 0.697 . . . . 0.0 112.882 -176.117 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 2.0 m -59.96 -30.71 69.28 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-N 118.681 0.673 . . . . 0.0 109.988 178.564 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 7.3 p -136.15 151.56 49.9 Favored 'General case' 0 N--CA 1.45 -0.455 0 C-N-CA 127.046 2.138 . . . . 0.0 105.652 168.738 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 2.0 mmm-85 58.77 176.12 0.07 Allowed 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 125.767 1.627 . . . . 0.0 110.026 -169.527 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 6.6 m 51.03 37.7 18.54 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 123.378 0.671 . . . . 0.0 111.557 -174.906 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 24.3 pt20 -143.21 155.09 44.45 Favored 'General case' 0 N--CA 1.444 -0.744 0 N-CA-C 106.476 -1.676 . . . . 0.0 106.476 174.401 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER 66.79 -39.58 0.35 Allowed 'General case' 0 C--N 1.326 -0.423 0 C-N-CA 127.091 2.156 . . . . 0.0 114.851 179.141 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -65.9 -48.14 72.45 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-N 120.834 1.652 . . . . 0.0 110.591 -176.315 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -64.37 -40.68 96.32 Favored 'General case' 0 C--N 1.324 -0.519 0 C-N-CA 123.651 0.78 . . . . 0.0 111.258 174.546 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -59.23 -45.44 95.37 Favored Glycine 0 CA--C 1.526 0.779 0 N-CA-C 111.622 -0.591 . . . . 0.0 111.622 176.476 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 1.5 m-85 -69.36 -33.44 73.08 Favored 'General case' 0 CA--C 1.51 -0.588 0 O-C-N 121.414 -1.051 . . . . 0.0 111.262 177.483 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -70.28 -37.83 74.94 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 119.098 0.863 . . . . 0.0 110.336 -178.105 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -53.06 -45.02 67.89 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 123.928 0.891 . . . . 0.0 109.146 169.55 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 14.7 m -70.48 -57.2 5.04 Favored 'General case' 0 N--CA 1.448 -0.562 0 C-N-CA 124.15 0.98 . . . . 0.0 111.279 -174.467 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 37.6 mt -74.65 -34.41 62.72 Favored 'General case' 0 C--N 1.332 -0.167 0 C-N-CA 125.108 1.363 . . . . 0.0 110.814 -171.71 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -92.05 1.21 73.64 Favored Glycine 0 CA--C 1.528 0.874 0 C-N-CA 125.162 1.363 . . . . 0.0 113.291 -175.898 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -49.27 127.81 15.58 Favored 'General case' 0 CA--C 1.534 0.335 0 CA-C-N 118.991 1.395 . . . . 0.0 110.565 -179.176 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 76.11 -9.8 17.67 Favored Glycine 0 CA--C 1.535 1.298 0 C-N-CA 124.412 1.006 . . . . 0.0 114.121 179.743 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 63.1 mttm -99.65 -47.51 5.06 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 119.177 1.489 . . . . 0.0 110.307 175.22 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.44 HD12 HG21 ' A' ' 4' ' ' VAL . 22.0 pt -144.0 155.38 15.63 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.26 0 C-N-CA 124.443 1.097 . . . . 0.0 110.819 -169.155 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -98.48 155.46 17.25 Favored 'General case' 0 C--O 1.224 -0.269 0 C-N-CA 125.344 1.458 . . . . 0.0 108.566 179.673 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 21.9 t -139.53 130.97 33.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 N-CA-C 106.969 -1.493 . . . . 0.0 106.969 -178.317 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 24.7 m -140.36 114.02 8.77 Favored 'General case' 0 N--CA 1.446 -0.664 0 N-CA-C 104.36 -2.459 . . . . 0.0 104.36 172.095 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 55.0 m -112.32 91.22 3.58 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 107.862 -1.162 . . . . 0.0 107.862 173.16 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 3.0 p -67.06 -59.12 3.73 Favored 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 126.478 1.911 . . . . 0.0 111.579 -174.372 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 107.15 164.49 22.08 Favored Glycine 0 CA--C 1.527 0.787 0 C-N-CA 124.463 1.03 . . . . 0.0 112.331 176.651 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 6.1 mt -131.86 138.85 48.61 Favored 'General case' 0 CA--C 1.508 -0.667 0 C-N-CA 127.362 2.265 . . . . 0.0 105.447 170.166 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 28.4 mt-10 53.72 20.46 2.24 Favored 'General case' 0 N--CA 1.48 1.029 0 CA-C-O 122.443 1.116 . . . . 0.0 111.735 179.178 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 3.7 p -78.13 165.41 24.0 Favored 'General case' 0 N--CA 1.435 -1.185 0 N-CA-C 116.481 2.03 . . . . 0.0 116.481 -166.854 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 37.3 p -147.07 -165.52 2.27 Favored 'General case' 0 N--CA 1.433 -1.278 0 C-N-CA 128.956 2.903 . . . . 0.0 106.289 -168.716 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -75.81 161.24 29.19 Favored 'General case' 0 N--CA 1.456 -0.153 0 CA-C-O 122.128 0.965 . . . . 0.0 109.182 169.343 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 2.3 m -66.87 173.28 0.63 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.709 0 CA-C-N 114.35 -1.295 . . . . 0.0 108.37 169.655 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 81.1 t60 -70.76 137.85 85.52 Favored Pre-proline 0 CA--C 1.544 0.73 0 O-C-N 121.187 -0.946 . . . . 0.0 110.4 -178.319 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 16.4 Cg_endo -56.44 -50.55 11.58 Favored 'Trans proline' 0 C--N 1.349 0.571 0 C-N-CA 123.077 2.518 . . . . 0.0 113.106 -177.433 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 23.5 m -69.35 -21.94 63.78 Favored 'General case' 0 CA--C 1.537 0.45 0 O-C-N 121.846 -0.534 . . . . 0.0 110.739 -177.296 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -61.18 -47.62 85.34 Favored 'General case' 0 CA--C 1.505 -0.774 0 N-CA-C 108.771 -0.825 . . . . 0.0 108.771 174.189 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 55.9 mt -58.7 -42.89 86.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 N-CA-C 108.345 -0.983 . . . . 0.0 108.345 -174.212 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -61.93 -47.43 84.92 Favored 'General case' 0 N--CA 1.453 -0.287 0 CA-C-N 118.395 0.543 . . . . 0.0 110.988 -179.898 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 27.4 mmt -66.5 -34.48 78.01 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-O 122.343 1.068 . . . . 0.0 110.7 179.853 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -78.36 -35.59 47.24 Favored 'General case' 0 N--CA 1.441 -0.875 0 N-CA-C 107.247 -1.39 . . . . 0.0 107.247 -172.924 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 33.9 mt-10 -70.42 -22.78 62.68 Favored 'General case' 0 N--CA 1.442 -0.851 0 C-N-CA 123.703 0.801 . . . . 0.0 110.229 171.757 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 14.7 mm-40 -69.23 -29.32 67.22 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-N 119.28 0.945 . . . . 0.0 110.62 171.448 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . 0.278 7.8 p -90.74 8.54 3.74 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.002 0 CA-C-N 118.768 0.713 . . . . 0.0 110.738 168.876 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 81.07 20.91 64.01 Favored Glycine 0 CA--C 1.532 1.114 0 C-N-CA 124.732 1.158 . . . . 0.0 114.055 173.463 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 16.7 mt -117.45 134.02 62.36 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.306 0 C-N-CA 124.49 1.116 . . . . 0.0 110.884 -172.251 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 3.3 t70 -89.4 139.11 30.84 Favored 'General case' 0 N--CA 1.464 0.258 0 N-CA-C 108.08 -1.082 . . . . 0.0 108.08 169.18 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 8.8 pt -129.92 -31.97 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.543 0 C-N-CA 124.587 1.155 . . . . 0.0 110.908 172.362 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -38.41 -42.52 0.74 Allowed 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 128.233 2.613 . . . . 0.0 113.698 169.388 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -70.58 1.63 20.41 Favored Glycine 0 CA--C 1.534 1.27 0 C-N-CA 124.518 1.056 . . . . 0.0 115.18 -174.121 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 16.6 mt-30 -60.46 -34.17 73.63 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 119.512 1.656 . . . . 0.0 114.457 -178.506 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -57.49 118.25 4.99 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-O 121.435 0.636 . . . . 0.0 110.765 -169.041 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 49.2 m -152.05 -167.63 2.83 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 127.857 2.463 . . . . 0.0 106.763 -169.537 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -59.52 153.21 51.57 Favored Pre-proline 0 CA--C 1.54 0.562 0 O-C-N 121.795 -0.566 . . . . 0.0 110.49 169.653 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -64.43 158.26 50.29 Favored 'Trans proline' 0 C--N 1.349 0.56 0 C-N-CA 123.13 2.553 . . . . 0.0 110.514 171.751 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 13.0 tt -59.72 -27.05 36.94 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.289 0 O-C-N 121.783 -0.573 . . . . 0.0 111.33 -178.762 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 15.7 mt-10 -65.98 -26.24 67.46 Favored 'General case' 0 C--O 1.234 0.24 0 C-N-CA 124.185 0.994 . . . . 0.0 110.409 -175.175 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 5.9 t-20 -66.48 -26.52 67.22 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 124.646 1.179 . . . . 0.0 111.769 177.13 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 96.3 m-85 -96.26 170.76 9.03 Favored 'General case' 0 C--O 1.235 0.32 0 C-N-CA 125.632 1.573 . . . . 0.0 110.927 -177.909 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 19.0 p-10 -116.79 137.43 52.2 Favored 'General case' 0 N--CA 1.436 -1.129 0 C-N-CA 125.075 1.35 . . . . 0.0 110.889 168.966 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -77.11 -22.18 53.09 Favored 'General case' 0 N--CA 1.433 -1.302 0 N-CA-C 109.82 -0.437 . . . . 0.0 109.82 -171.181 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -64.16 -21.92 66.74 Favored 'General case' 0 N--CA 1.443 -0.799 0 O-C-N 123.881 0.738 . . . . 0.0 111.79 -179.239 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 37.8 t70 -75.77 -27.72 58.14 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 122.973 0.509 . . . . 0.0 112.146 175.02 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 32.1 m-85 -85.93 170.11 12.63 Favored 'General case' 0 N--CA 1.451 -0.402 0 C-N-CA 126.271 1.828 . . . . 0.0 111.031 -179.319 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -119.01 -34.24 3.95 Favored 'General case' 0 N--CA 1.466 0.332 0 C-N-CA 123.117 0.567 . . . . 0.0 111.753 177.569 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -145.51 138.04 20.8 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.489 0 CA-C-O 121.324 0.583 . . . . 0.0 109.834 -170.216 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 95.5 t -144.87 126.09 8.51 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.515 0 N-CA-C 106.254 -1.758 . . . . 0.0 106.254 -173.782 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.518 HD12 ' HB2' ' A' ' 97' ' ' GLU . 4.5 mm -101.87 132.39 47.9 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.599 0 N-CA-C 105.803 -1.925 . . . . 0.0 105.803 173.609 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 55.8 m -93.04 -16.09 25.41 Favored 'General case' 0 CA--C 1.535 0.37 0 N-CA-C 113.288 0.848 . . . . 0.0 113.288 178.81 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 24.4 mt 57.06 -12.27 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.613 0 N-CA-C 118.218 2.673 . . . . 0.0 118.218 171.079 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 26.5 p -149.58 33.87 0.7 Allowed 'General case' 0 CA--C 1.537 0.454 0 CA-C-N 122.303 2.319 . . . . 0.0 112.816 -178.072 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 130.85 -165.49 22.9 Favored Glycine 0 CA--C 1.525 0.665 0 C-N-CA 125.498 1.523 . . . . 0.0 110.675 179.485 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 8.4 p -102.72 -53.39 2.87 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 124.762 1.225 . . . . 0.0 110.116 177.012 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -65.52 -53.93 29.13 Favored Glycine 0 C--N 1.341 0.84 0 N-CA-C 111.201 -0.76 . . . . 0.0 111.201 -175.394 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . 0.313 98.5 t 55.94 10.36 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.551 1.01 0 C-N-CA 126.749 2.02 . . . . 0.0 114.919 169.592 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 64.1 t30 53.38 44.57 29.86 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 124.839 1.256 . . . . 0.0 109.398 -169.592 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -126.31 142.63 43.39 Favored Pre-proline 0 CA--C 1.539 0.552 0 C-N-CA 127.242 2.217 . . . . 0.0 108.22 -169.317 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 30.1 Cg_exo -65.93 143.04 71.36 Favored 'Trans proline' 0 C--N 1.352 0.75 0 C-N-CA 121.396 1.397 . . . . 0.0 111.45 -178.749 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -65.4 -28.31 54.53 Favored 'Trans proline' 0 N--CA 1.462 -0.377 0 C-N-CA 122.054 1.836 . . . . 0.0 114.273 -169.191 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -58.09 -19.39 31.73 Favored 'General case' 0 CA--C 1.538 0.483 0 CA-C-N 119.436 1.016 . . . . 0.0 112.488 179.873 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 95.0 m95 -78.88 -40.62 31.88 Favored 'General case' 0 N--CA 1.446 -0.642 0 C-N-CA 123.52 0.728 . . . . 0.0 112.263 -177.15 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 2.9 m -71.25 -34.11 53.06 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.445 0 CA-C-O 118.722 -0.656 . . . . 0.0 110.117 174.29 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 76.6 p -81.99 23.69 0.68 Allowed 'General case' 0 C--O 1.236 0.356 0 CA-C-N 120.046 1.293 . . . . 0.0 113.893 -170.159 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 94.3 mm-40 -72.79 179.03 3.84 Favored 'General case' 0 N--CA 1.446 -0.634 0 O-C-N 121.703 -0.623 . . . . 0.0 110.319 172.343 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 30.7 mm-40 -62.3 -19.79 63.65 Favored 'General case' 0 CA--C 1.538 0.489 0 N-CA-C 112.829 0.677 . . . . 0.0 112.829 -169.398 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 2.1 tt -142.14 124.12 13.28 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.354 0 C-N-CA 126.338 1.855 . . . . 0.0 106.698 173.547 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 7.0 t80 -97.29 132.23 43.23 Favored 'General case' 0 CA--C 1.535 0.397 0 N-CA-C 105.158 -2.164 . . . . 0.0 105.158 169.022 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . 0.518 ' HB2' HD12 ' A' ' 77' ' ' ILE . 7.9 mm-40 -138.46 160.27 39.98 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-O 121.792 0.806 . . . . 0.0 109.434 172.034 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 8.9 t70 -179.92 134.98 0.11 Allowed 'General case' 0 C--N 1.325 -0.482 0 C-N-CA 127.085 2.154 . . . . 0.0 106.509 -169.57 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' TRP . . . . . 0.465 ' CZ3' HG21 ' A' ' 77' ' ' ILE . 5.0 m-90 -145.58 154.23 41.94 Favored 'General case' 0 C--O 1.234 0.238 0 N-CA-C 109.325 -0.62 . . . . 0.0 109.325 -172.043 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 15.2 pt20 -79.58 50.24 1.11 Allowed 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 124.216 1.006 . . . . 0.0 110.118 171.474 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 1.1 mt -65.43 121.92 15.99 Favored 'General case' 0 C--N 1.34 0.181 0 N-CA-C 107.672 -1.232 . . . . 0.0 107.672 178.141 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 -73.02 160.35 32.21 Favored 'General case' 0 CA--C 1.537 0.465 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 173.826 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -137.26 137.21 21.95 Favored Pre-proline 0 C--O 1.237 0.413 0 C-N-CA 124.296 1.039 . . . . 0.0 109.835 -169.698 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 22.7 Cg_endo -88.66 6.16 4.84 Favored 'Trans proline' 0 CA--C 1.544 0.994 0 C-N-CA 122.817 2.344 . . . . 0.0 113.736 -170.517 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 4.6 t70 -47.01 111.53 0.41 Allowed 'General case' 0 C--O 1.236 0.389 0 CA-C-N 120.356 1.434 . . . . 0.0 111.857 -179.973 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 67.65 7.91 49.84 Favored Glycine 0 CA--C 1.535 1.307 0 C-N-CA 124.348 0.975 . . . . 0.0 114.3 177.853 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 6.7 mt-30 -91.2 173.6 7.84 Favored 'General case' 0 CA--C 1.541 0.626 0 CA-C-N 118.777 1.289 . . . . 0.0 110.518 -178.649 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 15.6 m -74.16 166.55 23.23 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 124.432 1.093 . . . . 0.0 111.555 179.978 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -57.35 -31.78 66.08 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 125.06 1.344 . . . . 0.0 112.084 -176.85 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 6.2 pt-20 -56.82 -35.17 68.48 Favored 'General case' 0 N--CA 1.463 0.196 0 C-N-CA 123.195 0.598 . . . . 0.0 111.377 176.404 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 15.6 t -76.9 -41.42 32.11 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.31 0 CA-C-O 118.412 -0.804 . . . . 0.0 109.416 -176.883 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 84.1 m-85 -57.25 -48.91 77.64 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-N 119.89 1.223 . . . . 0.0 110.413 171.606 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 94.9 mtt180 -60.81 -41.77 96.32 Favored 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 123.322 0.649 . . . . 0.0 110.972 179.766 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 5.2 m -63.5 -47.62 80.96 Favored 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 124.629 1.171 . . . . 0.0 110.196 176.25 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 73.1 t -68.92 -35.11 67.68 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.335 0 CA-C-O 117.955 -1.022 . . . . 0.0 109.7 -172.402 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 27.2 mtm105 -57.68 -48.24 80.08 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 120.205 1.366 . . . . 0.0 110.094 174.128 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -63.36 -48.84 75.24 Favored Glycine 0 CA--C 1.53 0.999 0 CA-C-N 118.38 0.536 . . . . 0.0 111.852 179.003 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 14.3 mm-40 -55.79 -54.1 48.56 Favored 'General case' 0 N--CA 1.464 0.259 0 C-N-CA 123.677 0.791 . . . . 0.0 109.93 179.556 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 95.6 t -65.34 -43.46 94.92 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-O 118.168 -0.92 . . . . 0.0 109.821 -173.559 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 61.5 tttm -53.45 -44.5 68.91 Favored 'General case' 0 C--O 1.225 -0.191 0 N-CA-C 108.828 -0.804 . . . . 0.0 108.828 178.479 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -69.53 -45.4 68.92 Favored 'General case' 0 N--CA 1.448 -0.575 0 CA-C-O 119.12 -0.467 . . . . 0.0 111.627 -176.394 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 1.5 mmt-85 -59.41 -44.85 92.77 Favored 'General case' 0 N--CA 1.478 0.969 0 CA-C-N 119.26 0.936 . . . . 0.0 110.257 176.487 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 88.6 t -68.63 -40.76 82.23 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.445 0 N-CA-C 109.193 -0.669 . . . . 0.0 109.193 -176.555 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 23.6 mt-10 -60.61 -40.45 91.9 Favored 'General case' 0 C--O 1.226 -0.151 0 CA-C-N 119.645 1.111 . . . . 0.0 110.21 176.129 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 25.0 t-20 -65.69 -43.2 89.95 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 123.082 0.553 . . . . 0.0 111.442 -179.579 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 1.4 tm? -58.75 -47.76 83.53 Favored 'General case' 0 C--O 1.225 -0.191 0 C-N-CA 126.112 1.765 . . . . 0.0 110.689 174.509 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 85.5 mt -65.91 -48.37 82.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 N-CA-C 108.697 -0.853 . . . . 0.0 108.697 179.16 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -56.54 -33.86 66.5 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-N 118.488 0.586 . . . . 0.0 112.264 -177.31 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 17.6 ptpt -80.4 -36.06 34.37 Favored 'General case' 0 C--N 1.342 0.279 0 CA-C-O 117.952 -1.023 . . . . 0.0 112.552 178.543 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 14.0 pt -85.22 -34.56 8.88 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.376 0 CA-C-N 119.973 1.261 . . . . 0.0 114.08 -177.353 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 75.1 m . . . . . 0 C--O 1.254 1.322 0 C-N-CA 125.706 1.602 . . . . 0.0 109.398 -169.884 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.497 1.882 0 N-CA-C 110.37 -0.233 . . . . 0.0 110.37 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 26.6 mttm -81.66 121.01 25.82 Favored 'General case' 0 N--CA 1.478 0.956 0 N-CA-C 106.776 -1.565 . . . . 0.0 106.776 173.501 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 37.0 ttmt -87.17 128.6 35.13 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 107.396 -1.335 . . . . 0.0 107.396 -179.366 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 1.7 t -117.17 150.8 19.12 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 C-N-CA 125.715 1.606 . . . . 0.0 109.61 -168.865 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 46.4 ttm -141.23 148.21 39.54 Favored 'General case' 0 C--N 1.329 -0.319 0 C-N-CA 125.474 1.51 . . . . 0.0 108.786 169.699 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 87.1 m-85 -136.29 128.7 30.25 Favored 'General case' 0 C--N 1.332 -0.175 0 N-CA-C 104.072 -2.566 . . . . 0.0 104.072 175.005 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 2.2 p -157.17 156.39 4.41 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.437 0 CA-C-N 119.147 0.885 . . . . 0.0 110.837 -168.947 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 48.0 t -140.63 177.58 7.93 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 126.966 2.106 . . . . 0.0 106.652 169.04 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 40.7 ttmt -49.86 -40.99 44.33 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 124.707 1.203 . . . . 0.0 111.742 -177.064 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 99.1 mtt180 -134.17 169.23 17.48 Favored 'General case' 0 N--CA 1.466 0.325 0 C-N-CA 125.478 1.511 . . . . 0.0 107.898 169.906 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 55.1 t-20 -70.8 -39.91 72.82 Favored 'General case' 0 N--CA 1.47 0.53 0 N-CA-C 109.702 -0.481 . . . . 0.0 109.702 173.405 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 3.6 m -51.85 139.15 22.56 Favored 'General case' 0 C--O 1.237 0.397 0 C-N-CA 124.849 1.26 . . . . 0.0 111.084 -178.339 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 4.6 m 60.99 17.13 7.63 Favored 'General case' 0 CA--C 1.542 0.648 0 N-CA-C 115.076 1.51 . . . . 0.0 115.076 171.852 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -156.13 -55.37 0.09 Allowed 'General case' 0 N--CA 1.471 0.605 0 CA-C-N 121.05 1.75 . . . . 0.0 114.886 169.842 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 3.3 m -77.92 15.6 0.85 Allowed 'General case' 0 N--CA 1.468 0.431 0 N-CA-C 115.654 1.724 . . . . 0.0 115.654 -168.254 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 6.0 pt20 -66.15 -43.26 87.54 Favored 'General case' 0 C--O 1.22 -0.453 0 CA-C-N 120.247 1.385 . . . . 0.0 113.302 -169.989 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 1.4 tpt -108.55 -19.83 13.31 Favored 'General case' 0 N--CA 1.47 0.526 0 N-CA-C 114.487 1.291 . . . . 0.0 114.487 -168.571 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -66.65 -50.29 63.41 Favored 'General case' 0 N--CA 1.475 0.792 0 CA-C-N 119.149 0.886 . . . . 0.0 111.846 -170.498 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -63.29 -32.42 73.83 Favored 'General case' 0 N--CA 1.467 0.38 0 N-CA-C 109.492 -0.559 . . . . 0.0 109.492 173.008 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -51.43 -65.7 2.98 Favored Glycine 0 C--N 1.345 1.03 0 C-N-CA 124.569 1.081 . . . . 0.0 111.347 174.471 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 13.6 m-85 -65.72 -29.38 69.9 Favored 'General case' 0 CA--C 1.506 -0.746 0 CA-C-N 118.588 1.194 . . . . 0.0 112.477 -176.882 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -67.45 -30.11 69.75 Favored 'General case' 0 N--CA 1.446 -0.638 0 CA-C-O 117.98 -1.01 . . . . 0.0 111.737 -177.624 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 2.1 ptmt -70.72 -27.89 64.31 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-N 120.248 1.385 . . . . 0.0 111.342 174.132 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 12.8 m -77.52 -57.16 3.97 Favored 'General case' 0 N--CA 1.448 -0.541 0 C-N-CA 125.538 1.535 . . . . 0.0 110.954 179.774 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 57.2 mt -72.84 -36.9 67.57 Favored 'General case' 0 N--CA 1.464 0.228 0 C-N-CA 124.019 0.927 . . . . 0.0 109.76 -175.703 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -81.21 0.74 87.08 Favored Glycine 0 CA--C 1.525 0.68 0 C-N-CA 124.812 1.196 . . . . 0.0 113.2 179.907 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -54.96 135.71 48.29 Favored 'General case' 0 C--O 1.236 0.372 0 CA-C-N 119.186 1.493 . . . . 0.0 109.395 179.172 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 72.49 5.81 64.44 Favored Glycine 0 CA--C 1.534 1.248 0 CA-C-O 118.332 -1.26 . . . . 0.0 114.597 178.393 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 9.2 ptpp? -137.81 -44.33 0.53 Allowed 'General case' 0 N--CA 1.475 0.777 0 CA-C-N 119.731 1.765 . . . . 0.0 112.937 -178.595 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 24.0 pt -138.49 152.81 25.44 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.794 0 CA-C-N 119.978 1.263 . . . . 0.0 110.138 -173.082 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -118.47 106.32 12.57 Favored 'General case' 0 C--O 1.227 -0.105 0 C-N-CA 124.62 1.168 . . . . 0.0 110.009 -169.738 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 4.6 t -79.62 134.4 27.74 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.399 0 N-CA-C 109.178 -0.675 . . . . 0.0 109.178 177.833 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 22.2 m -140.62 87.4 2.12 Favored 'General case' 0 N--CA 1.449 -0.5 0 N-CA-C 105.493 -2.04 . . . . 0.0 105.493 169.663 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 38.6 m -95.0 82.91 3.86 Favored 'General case' 0 N--CA 1.448 -0.557 0 CA-C-O 121.917 0.865 . . . . 0.0 111.223 -169.809 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -64.26 172.0 2.74 Favored 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 125.715 1.606 . . . . 0.0 110.3 169.874 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -157.75 -167.86 19.33 Favored Glycine 0 C--N 1.338 0.664 0 N-CA-C 108.575 -1.81 . . . . 0.0 108.575 -173.297 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 3.0 mt -136.96 131.27 32.75 Favored 'General case' 0 N--CA 1.44 -0.932 0 N-CA-C 104.468 -2.419 . . . . 0.0 104.468 -172.272 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 28.7 mt-10 65.47 -61.55 0.24 Allowed 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 126.754 2.022 . . . . 0.0 111.041 -169.714 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 75.4 m 65.31 158.63 0.1 Allowed 'General case' 0 N--CA 1.438 -1.026 0 C-N-CA 129.313 3.045 . . . . 0.0 115.917 171.133 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 49.7 p -161.9 170.94 18.53 Favored 'General case' 0 N--CA 1.431 -1.375 0 CA-C-N 111.039 -2.801 . . . . 0.0 106.932 -168.838 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 5.7 ttt180 -92.28 167.05 12.28 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.657 0.742 . . . . 0.0 109.31 175.721 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 18.8 m -73.07 171.88 1.13 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.622 0 CA-C-N 114.711 -1.131 . . . . 0.0 109.853 178.647 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 92.2 m-70 -82.99 150.28 61.2 Favored Pre-proline 0 CA--C 1.539 0.526 0 C-N-CA 123.416 0.687 . . . . 0.0 110.479 -176.889 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -62.7 -45.63 13.32 Favored 'Trans proline' 0 C--N 1.347 0.496 0 C-N-CA 122.982 2.455 . . . . 0.0 112.383 -172.675 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 6.1 m -68.49 -25.94 65.22 Favored 'General case' 0 CA--C 1.534 0.33 0 O-C-N 121.881 -0.512 . . . . 0.0 110.22 -179.146 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -58.51 -52.8 64.12 Favored 'General case' 0 CA--C 1.507 -0.691 0 N-CA-C 108.766 -0.827 . . . . 0.0 108.766 171.356 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 81.5 mt -59.27 -41.09 82.96 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.342 0 N-CA-C 108.471 -0.937 . . . . 0.0 108.471 -173.176 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -63.1 -49.75 73.21 Favored 'General case' 0 CA--C 1.534 0.363 0 CA-C-N 118.503 0.592 . . . . 0.0 111.331 179.718 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 29.4 mmt -65.89 -36.63 83.96 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-O 122.933 1.349 . . . . 0.0 111.106 -179.698 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -78.45 -30.44 47.46 Favored 'General case' 0 N--CA 1.439 -0.993 0 N-CA-C 106.803 -1.554 . . . . 0.0 106.803 -172.754 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 4.8 mm-40 -73.75 -20.51 60.48 Favored 'General case' 0 N--CA 1.445 -0.712 0 O-C-N 121.355 -0.841 . . . . 0.0 110.642 169.749 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 18.0 mm-40 -66.83 -30.67 70.91 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-N 119.713 1.142 . . . . 0.0 110.038 170.0 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 15.4 m -91.92 10.56 3.25 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.814 0 CA-C-N 118.703 0.683 . . . . 0.0 111.427 168.635 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 76.66 22.87 71.39 Favored Glycine 0 CA--C 1.531 1.059 0 C-N-CA 124.962 1.267 . . . . 0.0 113.554 172.24 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 8.1 mt -111.7 129.64 66.73 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.222 0 CA-C-N 118.485 1.142 . . . . 0.0 111.033 -173.659 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -86.31 126.09 34.08 Favored 'General case' 0 C--O 1.232 0.177 0 N-CA-C 107.371 -1.344 . . . . 0.0 107.371 168.822 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 6.5 pt -122.48 -22.22 3.17 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.645 0 C-N-CA 125.219 1.408 . . . . 0.0 109.894 169.659 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -36.86 -41.04 0.31 Allowed 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 129.367 3.067 . . . . 0.0 113.633 169.376 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -82.05 14.0 35.14 Favored Glycine 0 CA--C 1.532 1.119 0 C-N-CA 124.943 1.258 . . . . 0.0 114.801 -176.551 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -63.71 -30.18 71.31 Favored 'General case' 0 C--N 1.343 0.309 0 CA-C-N 119.667 1.733 . . . . 0.0 114.099 -170.533 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -61.91 122.88 16.55 Favored 'General case' 0 CA--C 1.535 0.379 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 -169.797 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 67.3 m -145.91 -175.28 4.68 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 125.92 1.688 . . . . 0.0 107.864 -169.261 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -57.3 155.22 19.0 Favored Pre-proline 0 CA--C 1.539 0.543 0 C-N-CA 124.162 0.985 . . . . 0.0 111.572 173.131 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -65.42 155.81 66.76 Favored 'Trans proline' 0 N--CA 1.456 -0.703 0 C-N-CA 122.529 2.152 . . . . 0.0 110.095 171.053 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 7.8 tt -58.97 -28.24 37.97 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.486 0 C-N-CA 124.02 0.928 . . . . 0.0 110.979 -178.713 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 14.5 mt-10 -68.08 -25.55 65.39 Favored 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 125.329 1.452 . . . . 0.0 110.399 -173.883 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 7.4 t-20 -62.04 -22.81 66.04 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 124.926 1.29 . . . . 0.0 111.969 177.149 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 88.7 m-85 -109.0 -176.71 3.11 Favored 'General case' 0 C--O 1.235 0.33 0 C-N-CA 125.697 1.599 . . . . 0.0 111.528 -172.109 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 55.2 t-20 -130.07 137.79 50.39 Favored 'General case' 0 N--CA 1.442 -0.866 0 N-CA-C 106.183 -1.784 . . . . 0.0 106.183 169.315 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -73.35 -24.5 60.35 Favored 'General case' 0 N--CA 1.432 -1.35 0 CA-C-N 118.539 0.609 . . . . 0.0 109.734 -178.826 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 35.8 t70 -63.94 -22.4 66.9 Favored 'General case' 0 N--CA 1.446 -0.636 0 O-C-N 123.627 0.579 . . . . 0.0 111.333 179.327 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -73.85 -29.77 62.3 Favored 'General case' 0 N--CA 1.452 -0.332 0 C-N-CA 123.762 0.825 . . . . 0.0 111.431 175.246 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 17.8 m-85 -79.33 159.53 27.14 Favored 'General case' 0 N--CA 1.446 -0.629 0 C-N-CA 124.518 1.127 . . . . 0.0 110.302 177.681 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 23.6 t70 -99.53 -38.61 8.7 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.241 171.218 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -139.26 137.6 41.21 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.359 0 C-N-CA 123.857 0.863 . . . . 0.0 109.634 -170.551 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 89.7 t -143.1 142.46 25.82 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.745 0 N-CA-C 106.435 -1.691 . . . . 0.0 106.435 -178.574 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.526 HD12 ' HB2' ' A' ' 97' ' ' GLU . 28.9 mm -137.09 132.7 47.06 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.568 0 N-CA-C 107.133 -1.432 . . . . 0.0 107.133 -171.32 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 57.8 m -95.92 166.36 11.82 Favored 'General case' 0 N--CA 1.445 -0.716 0 N-CA-C 108.146 -1.057 . . . . 0.0 108.146 168.691 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 53.6 mt -134.61 18.57 3.59 Favored 'General case' 0 CA--C 1.531 0.239 0 O-C-N 121.364 -0.835 . . . . 0.0 110.752 -178.638 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 25.1 p -168.86 -0.22 0.02 OUTLIER 'General case' 0 CA--C 1.543 0.674 0 N-CA-C 115.584 1.698 . . . . 0.0 115.584 -176.357 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 162.6 -175.12 39.04 Favored Glycine 0 CA--C 1.526 0.769 0 CA-C-N 120.89 1.677 . . . . 0.0 112.607 179.83 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 17.9 m -128.65 127.01 41.35 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 125.065 1.346 . . . . 0.0 107.888 -176.243 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . 0.409 ' H ' HG11 ' A' ' 91' ' ' VAL . . . 58.06 34.26 72.19 Favored Glycine 0 CA--C 1.533 1.2 0 N-CA-C 110.624 -0.99 . . . . 0.0 110.624 -170.414 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . 0.286 7.7 p -80.3 69.17 0.5 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.657 0 C-N-CA 125.332 1.453 . . . . 0.0 110.437 -169.263 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 56.2 t30 55.67 49.22 16.83 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 127.146 2.178 . . . . 0.0 109.103 -173.553 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -154.27 143.98 15.34 Favored Pre-proline 0 CA--C 1.541 0.611 0 C-N-CA 126.918 2.087 . . . . 0.0 106.596 -169.237 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_exo -69.56 145.86 59.64 Favored 'Trans proline' 0 C--N 1.352 0.737 0 CA-C-N 120.912 1.361 . . . . 0.0 113.059 -173.246 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -73.18 -22.52 19.04 Favored 'Trans proline' 0 N--CA 1.461 -0.391 0 C-N-CA 122.209 1.939 . . . . 0.0 113.795 -170.754 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -57.85 -23.48 53.02 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-N 120.072 1.305 . . . . 0.0 111.627 177.378 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 99.6 m95 -72.05 -43.48 64.87 Favored 'General case' 0 N--CA 1.449 -0.478 0 C-N-CA 123.493 0.717 . . . . 0.0 111.252 176.235 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.409 HG11 ' H ' ' A' ' 83' ' ' GLY . 4.9 m -78.1 -1.33 3.95 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.627 0 N-CA-C 112.582 0.586 . . . . 0.0 112.582 -179.094 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 63.3 p -115.9 22.33 13.11 Favored 'General case' 0 CA--C 1.538 0.514 0 N-CA-C 115.462 1.652 . . . . 0.0 115.462 -178.412 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 92.3 mm-40 -71.03 179.46 2.75 Favored 'General case' 0 CA--C 1.54 0.573 0 O-C-N 121.27 -0.894 . . . . 0.0 111.875 175.015 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 30.1 mm-40 -54.84 -28.47 49.99 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 124.146 0.978 . . . . 0.0 112.733 -169.085 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 6.8 tt -135.12 139.66 46.66 Favored 'Isoleucine or valine' 0 C--O 1.238 0.497 0 N-CA-C 104.569 -2.382 . . . . 0.0 104.569 168.477 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 47.6 t80 -126.57 140.43 52.44 Favored 'General case' 0 N--CA 1.447 -0.608 0 N-CA-C 106.383 -1.71 . . . . 0.0 106.383 169.567 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . 0.526 ' HB2' HD12 ' A' ' 77' ' ' ILE . 44.0 mm-40 -142.08 163.86 31.73 Favored 'General case' 0 C--O 1.235 0.336 0 N-CA-C 107.409 -1.33 . . . . 0.0 107.409 169.88 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -167.51 131.63 1.82 Allowed 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 125.443 1.497 . . . . 0.0 107.46 -173.65 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 4.3 m-90 -150.65 143.44 24.58 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 107.897 -1.149 . . . . 0.0 107.897 -169.598 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 24.8 tt0 -84.81 82.28 8.51 Favored 'General case' 0 CA--C 1.537 0.48 0 N-CA-C 107.689 -1.226 . . . . 0.0 107.689 173.44 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -69.34 140.98 54.34 Favored 'General case' 0 N--CA 1.464 0.234 0 N-CA-C 108.667 -0.864 . . . . 0.0 108.667 172.719 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -73.68 157.2 37.0 Favored 'General case' 0 CA--C 1.537 0.449 0 N-CA-C 107.036 -1.468 . . . . 0.0 107.036 168.683 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -129.45 130.68 23.31 Favored Pre-proline 0 C--O 1.236 0.386 0 C-N-CA 123.77 0.828 . . . . 0.0 109.095 176.886 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_endo -86.14 -8.39 7.73 Favored 'Trans proline' 0 CA--C 1.54 0.821 0 C-N-CA 123.17 2.58 . . . . 0.0 115.245 -169.992 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -50.03 -51.04 45.38 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-N 120.171 1.351 . . . . 0.0 113.723 -169.093 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -84.21 9.26 64.39 Favored Glycine 0 CA--C 1.531 1.038 0 CA-C-O 118.368 -1.24 . . . . 0.0 113.953 -172.725 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 25.9 pt20 -148.04 -164.19 1.95 Allowed 'General case' 0 CA--C 1.544 0.712 0 CA-C-N 119.385 1.592 . . . . 0.0 112.531 -169.585 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 1.5 m -69.01 159.09 33.48 Favored 'General case' 0 CA--C 1.535 0.372 0 N-CA-C 117.567 2.432 . . . . 0.0 117.567 -167.726 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 56.5 tp -54.44 -34.69 61.91 Favored 'General case' 0 N--CA 1.465 0.32 0 C-N-CA 126.94 2.096 . . . . 0.0 111.713 170.124 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -62.12 -32.34 72.91 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 122.819 0.448 . . . . 0.0 110.773 177.498 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 5.3 t -76.42 -37.74 31.29 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.362 0 CA-C-O 117.894 -1.051 . . . . 0.0 109.892 177.649 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 54.0 m-85 -57.01 -47.97 79.59 Favored 'General case' 0 N--CA 1.474 0.767 0 CA-C-N 120.728 1.604 . . . . 0.0 109.579 171.155 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 75.3 mtt180 -59.23 -43.96 92.33 Favored 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 123.333 0.653 . . . . 0.0 110.858 178.152 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 17.1 m -64.44 -48.89 73.62 Favored 'General case' 0 N--CA 1.446 -0.663 0 C-N-CA 124.192 0.997 . . . . 0.0 110.396 178.606 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 64.9 t -70.39 -29.9 40.84 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.301 0 CA-C-N 119.019 0.827 . . . . 0.0 109.945 -169.937 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 30.7 mtm105 -57.04 -47.91 79.8 Favored 'General case' 0 C--O 1.226 -0.181 0 CA-C-N 119.404 1.002 . . . . 0.0 109.583 169.859 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -62.06 -48.52 82.63 Favored Glycine 0 CA--C 1.529 0.961 0 CA-C-O 119.258 -0.745 . . . . 0.0 112.0 177.697 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 86.1 mt-30 -55.66 -52.93 62.17 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-O 122.017 0.913 . . . . 0.0 110.104 -178.83 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 98.1 t -67.5 -44.9 86.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 115.102 -0.954 . . . . 0.0 109.596 -175.32 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 62.6 tttm -55.04 -46.34 75.31 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 119.435 1.016 . . . . 0.0 109.197 -179.041 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -67.64 -43.44 80.35 Favored 'General case' 0 N--CA 1.449 -0.524 0 C-N-CA 122.873 0.469 . . . . 0.0 111.366 -176.271 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 44.9 mtt-85 -66.63 -42.23 87.08 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-N 118.867 0.758 . . . . 0.0 111.082 178.047 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 81.1 t -64.99 -41.48 92.23 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.532 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 177.736 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 21.2 mt-10 -59.69 -41.36 90.52 Favored 'General case' 0 C--N 1.34 0.162 0 CA-C-N 119.768 1.167 . . . . 0.0 110.641 176.971 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 29.1 t-20 -62.54 -45.01 94.92 Favored 'General case' 0 CA--C 1.534 0.336 0 CA-C-N 118.166 0.439 . . . . 0.0 111.139 -179.635 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 1.5 tm? -58.45 -49.49 77.12 Favored 'General case' 0 CA--C 1.53 0.192 0 C-N-CA 124.26 1.024 . . . . 0.0 110.277 177.091 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 94.8 mt -63.87 -43.02 97.69 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.276 0 C-N-CA 123.887 0.875 . . . . 0.0 108.86 -179.518 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -62.56 -28.14 69.67 Favored 'General case' 0 CA--C 1.534 0.355 0 CA-C-N 118.902 0.774 . . . . 0.0 112.074 179.956 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 89.7 mttt -69.57 -54.52 13.68 Favored 'General case' 0 C--N 1.341 0.235 0 CA-C-N 118.769 0.713 . . . . 0.0 110.358 172.646 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 19.3 pt -77.64 -38.19 25.34 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.362 0 N-CA-C 114.586 1.328 . . . . 0.0 114.586 -169.395 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 74.7 m . . . . . 0 C--O 1.252 1.209 0 C-N-CA 126.162 1.785 . . . . 0.0 109.629 -169.748 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 8.0 ptm . . . . . 0 N--CA 1.497 1.898 0 N-CA-C 110.468 -0.197 . . . . 0.0 110.468 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . 0.455 ' HB2' HG22 ' A' ' 30' ' ' ILE . 15.7 mttm -74.64 128.46 35.62 Favored 'General case' 0 N--CA 1.478 0.971 0 N-CA-C 107.83 -1.174 . . . . 0.0 107.83 -174.912 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 72.9 mttt -97.4 138.1 35.37 Favored 'General case' 0 CA--C 1.511 -0.522 0 CA-C-N 120.198 1.363 . . . . 0.0 108.26 172.432 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.461 HG21 HD12 ' A' ' 30' ' ' ILE . 12.1 t -119.31 152.22 21.72 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.678 0 C-N-CA 126.231 1.812 . . . . 0.0 106.66 -169.995 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 15.8 mtt -135.27 146.45 48.57 Favored 'General case' 0 C--N 1.322 -0.623 0 C-N-CA 124.897 1.279 . . . . 0.0 108.167 168.792 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 86.5 m-85 -133.74 125.47 28.63 Favored 'General case' 0 CA--C 1.516 -0.361 0 N-CA-C 103.921 -2.622 . . . . 0.0 103.921 171.332 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 1.3 p -150.03 142.61 17.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 118.975 0.807 . . . . 0.0 110.382 -169.014 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 20.9 t -125.1 -174.96 3.17 Favored 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 127.379 2.272 . . . . 0.0 106.552 169.597 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 39.0 ttpt -60.45 -42.16 95.59 Favored 'General case' 0 N--CA 1.472 0.65 0 O-C-N 120.822 -1.174 . . . . 0.0 111.508 -177.33 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 94.0 mtt180 -123.79 163.92 20.22 Favored 'General case' 0 N--CA 1.467 0.423 0 C-N-CA 123.764 0.826 . . . . 0.0 109.48 176.421 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -77.01 -27.75 54.75 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 122.41 0.284 . . . . 0.0 111.28 -179.511 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 1.3 m -69.16 -23.58 63.96 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 124.133 0.973 . . . . 0.0 113.385 -169.657 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 6.8 t -128.55 136.3 50.56 Favored 'General case' 0 C--N 1.339 0.143 0 N-CA-C 108.274 -1.01 . . . . 0.0 108.274 -174.612 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 9.1 mpt_? 61.72 -42.94 0.15 Allowed 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 128.533 2.733 . . . . 0.0 114.45 -176.549 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -75.08 41.13 0.16 Allowed 'General case' 0 CA--C 1.542 0.635 0 CA-C-N 120.268 1.394 . . . . 0.0 111.463 177.286 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 20.2 pt20 -135.11 154.16 51.76 Favored 'General case' 0 N--CA 1.441 -0.892 0 C-N-CA 127.455 2.302 . . . . 0.0 104.819 169.593 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER 66.41 -33.91 0.2 Allowed 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 126.216 1.806 . . . . 0.0 114.681 -178.648 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -64.62 -49.97 68.96 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 121.514 1.961 . . . . 0.0 109.865 179.671 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 4.5 pm0 -61.53 -37.8 85.06 Favored 'General case' 0 N--CA 1.453 -0.293 0 C-N-CA 124.42 1.088 . . . . 0.0 110.74 172.445 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -60.54 -55.31 30.67 Favored Glycine 0 C--N 1.337 0.627 0 N-CA-C 109.457 -1.457 . . . . 0.0 109.457 -176.926 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 6.3 m-85 -63.65 -33.23 75.16 Favored 'General case' 0 CA--C 1.509 -0.634 0 O-C-N 122.143 -0.622 . . . . 0.0 111.887 177.417 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -67.49 -38.2 83.99 Favored 'General case' 0 N--CA 1.445 -0.706 0 C-N-CA 119.839 -0.744 . . . . 0.0 110.926 -178.08 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.06 -37.58 87.96 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-N 118.701 0.682 . . . . 0.0 110.077 173.45 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 13.0 m -66.99 -55.39 14.66 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 123.675 0.79 . . . . 0.0 112.244 179.887 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 40.1 mt -76.28 -35.68 58.78 Favored 'General case' 0 C--N 1.327 -0.376 0 C-N-CA 124.636 1.175 . . . . 0.0 110.09 -171.158 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -94.39 12.17 69.27 Favored Glycine 0 CA--C 1.525 0.666 0 C-N-CA 125.233 1.397 . . . . 0.0 112.848 -178.778 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -51.01 122.2 7.17 Favored 'General case' 0 CA--C 1.533 0.29 0 CA-C-N 119.011 1.406 . . . . 0.0 110.623 -173.813 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 78.89 -16.26 8.81 Favored Glycine 0 CA--C 1.535 1.313 0 C-N-CA 124.791 1.186 . . . . 0.0 114.21 -179.519 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 59.7 mttt -89.68 -42.5 11.32 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-N 119.398 1.599 . . . . 0.0 110.806 179.152 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.461 HD12 HG21 ' A' ' 4' ' ' VAL . 12.4 pt -140.71 149.97 20.95 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.33 0 C-N-CA 123.543 0.737 . . . . 0.0 111.263 -169.031 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -95.51 157.89 15.69 Favored 'General case' 0 C--O 1.224 -0.243 0 C-N-CA 125.6 1.56 . . . . 0.0 108.039 172.584 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 20.0 t -139.74 135.19 38.89 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 N-CA-C 107.189 -1.412 . . . . 0.0 107.189 -175.413 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 14.0 m -142.76 106.87 4.72 Favored 'General case' 0 N--CA 1.446 -0.663 0 N-CA-C 107.401 -1.333 . . . . 0.0 107.401 177.896 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 58.9 m -90.15 99.63 12.61 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 107.986 -1.116 . . . . 0.0 107.986 169.501 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 11.1 p -68.56 -63.03 1.14 Allowed 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 124.296 1.038 . . . . 0.0 110.461 -178.587 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 94.05 136.09 7.99 Favored Glycine 0 N--CA 1.446 -0.646 0 N-CA-C 107.713 -2.155 . . . . 0.0 107.713 -172.373 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 10.2 mt -68.74 -31.05 69.82 Favored 'General case' 0 CA--C 1.533 0.315 0 N-CA-C 108.538 -0.912 . . . . 0.0 108.538 170.183 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 26.6 mt-10 -137.25 156.1 48.7 Favored 'General case' 0 N--CA 1.444 -0.727 0 C-N-CA 129.119 2.968 . . . . 0.0 104.855 168.752 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 78.5 p -142.46 155.05 45.04 Favored 'General case' 0 N--CA 1.446 -0.646 0 N-CA-C 115.465 1.654 . . . . 0.0 115.465 -174.407 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 51.1 m -163.17 179.25 7.59 Favored 'General case' 0 N--CA 1.447 -0.577 0 C-N-CA 131.257 3.823 . . . . 0.0 104.796 -169.337 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 16.4 ttt180 -81.56 179.16 7.95 Favored 'General case' 0 N--CA 1.469 0.487 0 N-CA-C 108.411 -0.959 . . . . 0.0 108.411 169.486 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 4.1 m -81.16 176.4 0.68 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.575 0 C-N-CA 124.864 1.266 . . . . 0.0 109.445 176.805 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 76.1 t60 -78.59 140.97 59.91 Favored Pre-proline 0 CA--C 1.545 0.772 0 CA-C-O 118.58 -0.724 . . . . 0.0 110.104 -178.403 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 20.4 Cg_endo -60.59 -50.3 7.06 Favored 'Trans proline' 0 C--N 1.348 0.525 0 C-N-CA 123.084 2.523 . . . . 0.0 113.592 -173.787 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 23.1 m -65.91 -21.52 66.45 Favored 'General case' 0 CA--C 1.533 0.324 0 CA-C-N 118.807 0.731 . . . . 0.0 110.813 -178.29 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -58.79 -45.03 90.79 Favored 'General case' 0 C--O 1.215 -0.733 0 O-C-N 121.386 -0.821 . . . . 0.0 109.453 174.576 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 62.6 mt -60.51 -43.72 94.95 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 N-CA-C 108.303 -0.999 . . . . 0.0 108.303 -173.598 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -64.9 -44.47 89.48 Favored 'General case' 0 CA--C 1.536 0.442 0 CA-C-O 121.282 0.563 . . . . 0.0 110.857 -179.632 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 33.6 mmt -66.33 -39.3 89.14 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-O 123.455 1.598 . . . . 0.0 110.779 -179.972 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -76.21 -29.8 57.75 Favored 'General case' 0 N--CA 1.44 -0.952 0 N-CA-C 106.296 -1.742 . . . . 0.0 106.296 -174.882 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 -70.27 -20.48 63.04 Favored 'General case' 0 N--CA 1.444 -0.765 0 C-N-CA 123.91 0.884 . . . . 0.0 110.438 169.525 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 59.0 mt-10 -64.55 -38.03 89.59 Favored 'General case' 0 C--N 1.345 0.375 0 CA-C-N 120.237 1.381 . . . . 0.0 108.787 169.405 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . 0.311 5.3 p -84.92 8.21 1.65 Allowed 'Isoleucine or valine' 0 CA--C 1.548 0.87 0 N-CA-C 112.272 0.471 . . . . 0.0 112.272 171.442 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 75.05 16.68 80.45 Favored Glycine 0 CA--C 1.533 1.19 0 C-N-CA 124.493 1.044 . . . . 0.0 113.523 175.494 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 43.9 mt -108.85 137.62 39.89 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.229 0 C-N-CA 124.487 1.115 . . . . 0.0 108.921 -177.016 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 21.1 t0 -102.22 145.34 29.56 Favored 'General case' 0 N--CA 1.462 0.153 0 CA-C-O 121.103 0.478 . . . . 0.0 110.208 169.69 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 11.2 pt -138.36 -15.11 0.53 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.633 0 C-N-CA 127.548 2.339 . . . . 0.0 111.325 178.223 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 13.0 t -39.39 -43.12 1.16 Allowed 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 125.883 1.673 . . . . 0.0 113.527 171.584 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -76.37 6.13 39.35 Favored Glycine 0 CA--C 1.532 1.111 0 CA-C-O 118.635 -1.092 . . . . 0.0 114.36 -175.01 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -68.57 130.18 42.09 Favored 'General case' 0 N--CA 1.448 -0.559 0 CA-C-N 119.736 1.768 . . . . 0.0 110.203 -178.43 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 5.2 t -168.18 161.3 12.31 Favored 'General case' 0 N--CA 1.44 -0.95 0 N-CA-C 106.067 -1.827 . . . . 0.0 106.067 167.047 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 15.0 m -173.87 161.38 3.76 Favored 'General case' 0 C--N 1.322 -0.598 0 C-N-CA 127.438 2.295 . . . . 0.0 106.746 -178.396 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -65.91 161.49 53.99 Favored Pre-proline 0 CA--C 1.542 0.652 0 CA-C-N 115.184 -0.917 . . . . 0.0 108.854 169.002 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -59.39 150.6 74.08 Favored 'Trans proline' 0 N--CA 1.457 -0.627 0 C-N-CA 121.545 1.497 . . . . 0.0 109.802 172.444 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 16.8 tt -57.3 -26.34 25.67 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.278 0 C-N-CA 123.433 0.693 . . . . 0.0 112.181 -174.681 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 11.6 mt-10 -65.42 -27.71 68.72 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 123.212 0.605 . . . . 0.0 110.453 -176.637 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 10.0 t-20 -65.23 -30.04 70.89 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 125.484 1.514 . . . . 0.0 111.71 178.662 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 78.0 m-85 -88.47 176.51 7.14 Favored 'General case' 0 C--O 1.236 0.374 0 C-N-CA 125.012 1.325 . . . . 0.0 111.543 -173.962 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 51.9 t-20 -126.56 129.06 47.84 Favored 'General case' 0 N--CA 1.447 -0.621 0 N-CA-C 107.278 -1.379 . . . . 0.0 107.278 169.136 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -73.11 -21.23 60.78 Favored 'General case' 0 N--CA 1.436 -1.139 0 N-CA-C 109.936 -0.394 . . . . 0.0 109.936 -177.208 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 36.0 t70 -65.06 -25.76 67.95 Favored 'General case' 0 N--CA 1.441 -0.897 0 O-C-N 123.617 0.573 . . . . 0.0 111.583 -179.446 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -74.76 -28.37 60.73 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 122.976 0.51 . . . . 0.0 111.477 176.022 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 18.1 m-85 -84.43 163.58 19.4 Favored 'General case' 0 N--CA 1.45 -0.443 0 C-N-CA 125.784 1.634 . . . . 0.0 110.585 -179.419 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 19.8 t70 -108.01 -36.91 6.21 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.624 178.591 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -142.7 139.4 28.33 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.31 0 CA-C-O 121.657 0.741 . . . . 0.0 110.316 -170.797 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 96.9 t -141.15 140.68 32.0 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.407 0 N-CA-C 106.631 -1.618 . . . . 0.0 106.631 -175.634 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 45.3 mm -132.7 121.41 44.77 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.429 0 N-CA-C 106.619 -1.623 . . . . 0.0 106.619 -173.913 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 67.4 m -91.31 115.13 27.78 Favored 'General case' 0 N--CA 1.449 -0.5 0 N-CA-C 106.657 -1.608 . . . . 0.0 106.657 169.359 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 69.7 mt -77.04 -13.75 59.91 Favored 'General case' 0 N--CA 1.466 0.343 0 C-N-CA 124.245 1.018 . . . . 0.0 111.693 -177.536 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 65.2 m -140.87 88.64 2.2 Favored 'General case' 0 N--CA 1.452 -0.328 0 C-N-CA 125.288 1.435 . . . . 0.0 108.478 -169.724 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 63.66 -155.57 44.36 Favored Glycine 0 CA--C 1.528 0.893 0 N-CA-C 110.562 -1.015 . . . . 0.0 110.562 -175.852 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 4.7 p -150.82 148.56 28.64 Favored 'General case' 0 C--O 1.236 0.363 0 C-N-CA 124.527 1.131 . . . . 0.0 109.166 179.64 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 62.48 28.92 72.02 Favored Glycine 0 CA--C 1.532 1.153 0 CA-C-O 119.696 -0.502 . . . . 0.0 112.189 -179.495 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 12.7 m -80.06 67.59 0.44 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.587 0 C-N-CA 124.661 1.185 . . . . 0.0 110.63 -170.007 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 1.3 t30 58.0 56.06 4.89 Favored 'General case' 0 N--CA 1.468 0.432 0 C-N-CA 126.298 1.839 . . . . 0.0 108.201 -173.714 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.407 ' HA ' ' HD3' ' A' ' 87' ' ' PRO . 0.4 OUTLIER -142.67 142.26 22.44 Favored Pre-proline 0 CA--C 1.541 0.613 0 C-N-CA 126.215 1.806 . . . . 0.0 108.425 -169.086 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . 0.407 ' HD3' ' HA ' ' A' ' 86' ' ' LEU . 35.2 Cg_exo -67.46 146.43 74.41 Favored 'Trans proline' 0 CA--C 1.54 0.779 0 C-N-CA 121.693 1.595 . . . . 0.0 113.518 -176.95 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . 0.432 ' O ' HG22 ' A' ' 92' ' ' THR . 69.8 Cg_endo -72.43 -18.46 26.13 Favored 'Trans proline' 0 N--CA 1.46 -0.451 0 C-N-CA 122.535 2.157 . . . . 0.0 113.751 -171.975 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -57.07 -24.78 56.36 Favored 'General case' 0 CA--C 1.538 0.491 0 CA-C-N 119.944 1.247 . . . . 0.0 111.19 173.98 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 95.1 m95 -81.8 -31.35 31.83 Favored 'General case' 0 N--CA 1.451 -0.389 0 C-N-CA 124.088 0.955 . . . . 0.0 112.251 178.546 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 2.7 m -80.83 -6.5 9.73 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.362 0 CA-C-N 118.748 0.704 . . . . 0.0 112.245 178.022 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . 0.432 HG22 ' O ' ' A' ' 88' ' ' PRO . 5.4 t -137.04 77.08 1.62 Allowed 'General case' 0 CA--C 1.542 0.654 0 CA-C-O 122.768 1.271 . . . . 0.0 111.655 -175.329 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 91.0 mm-40 -114.33 -171.68 1.96 Allowed 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 125.064 1.346 . . . . 0.0 108.115 168.694 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 35.1 mm-40 -58.76 -28.03 65.52 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-N 118.9 0.773 . . . . 0.0 111.194 -172.348 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 5.3 tt -141.37 143.63 27.44 Favored 'Isoleucine or valine' 0 C--O 1.24 0.567 0 N-CA-C 104.737 -2.32 . . . . 0.0 104.737 168.346 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 63.9 t80 -133.8 145.65 49.96 Favored 'General case' 0 N--CA 1.447 -0.581 0 N-CA-C 105.905 -1.887 . . . . 0.0 105.905 169.286 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 24.1 mm-40 -136.26 145.48 45.63 Favored 'General case' 0 C--O 1.237 0.434 0 N-CA-C 107.903 -1.147 . . . . 0.0 107.903 171.685 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -115.9 135.79 53.65 Favored 'General case' 0 C--O 1.238 0.451 0 N-CA-C 107.146 -1.428 . . . . 0.0 107.146 169.703 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 30.2 m95 -138.68 178.77 6.9 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 124.462 1.105 . . . . 0.0 108.796 178.963 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 30.6 tt0 -138.5 77.39 1.62 Allowed 'General case' 0 CA--C 1.532 0.285 0 N-CA-C 106.013 -1.847 . . . . 0.0 106.013 169.467 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -68.26 144.09 55.01 Favored 'General case' 0 N--CA 1.466 0.37 0 N-CA-C 108.656 -0.868 . . . . 0.0 108.656 177.877 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -81.18 166.66 20.43 Favored 'General case' 0 N--CA 1.452 -0.363 0 N-CA-C 107.576 -1.268 . . . . 0.0 107.576 169.457 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -142.32 135.23 13.92 Favored Pre-proline 0 CA--C 1.535 0.385 0 O-C-N 121.803 -0.56 . . . . 0.0 111.193 179.076 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -84.21 2.47 8.15 Favored 'Trans proline' 0 CA--C 1.545 1.042 0 C-N-CA 123.416 2.744 . . . . 0.0 114.958 -172.3 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 2.9 t70 -45.29 122.77 3.63 Favored 'General case' 0 C--O 1.238 0.484 0 CA-C-N 120.121 1.328 . . . . 0.0 111.521 176.634 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 70.9 13.73 72.54 Favored Glycine 0 CA--C 1.533 1.171 0 CA-C-O 118.335 -1.258 . . . . 0.0 114.724 170.18 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 29.6 pt20 -130.14 -172.32 2.75 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-N 119.444 1.622 . . . . 0.0 111.165 175.889 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 3.3 m -68.83 156.85 37.66 Favored 'General case' 0 CA--C 1.535 0.374 0 N-CA-C 116.25 1.944 . . . . 0.0 116.25 -168.0 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -63.73 -27.42 69.19 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 125.017 1.327 . . . . 0.0 111.155 179.645 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 7.7 tp10 -60.17 -35.12 74.63 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-N 118.171 0.442 . . . . 0.0 110.164 173.346 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 3.4 t -74.08 -42.62 52.08 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.301 0 CA-C-O 118.234 -0.889 . . . . 0.0 109.154 179.018 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 61.1 m-85 -53.78 -50.28 66.41 Favored 'General case' 0 N--CA 1.472 0.645 0 CA-C-N 120.042 1.292 . . . . 0.0 109.644 171.599 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 95.5 mtt180 -67.5 -34.97 78.21 Favored 'General case' 0 N--CA 1.465 0.296 0 O-C-N 121.795 -0.566 . . . . 0.0 111.237 -175.46 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 6.6 m -62.77 -49.9 73.15 Favored 'General case' 0 N--CA 1.448 -0.56 0 C-N-CA 123.984 0.913 . . . . 0.0 109.547 171.292 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 96.7 t -70.06 -26.72 30.38 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.296 0 CA-C-O 117.485 -1.245 . . . . 0.0 109.897 -171.092 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 85.4 mtm-85 -57.29 -48.41 78.97 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-N 120.407 1.458 . . . . 0.0 109.58 169.58 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -63.18 -48.67 77.71 Favored Glycine 0 CA--C 1.53 1.012 0 CA-C-N 118.464 0.575 . . . . 0.0 111.877 178.912 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 17.8 mt-30 -61.51 -46.69 88.94 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-N 118.073 0.937 . . . . 0.0 110.895 -178.3 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 67.4 t -64.89 -46.21 92.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-O 118.504 -0.76 . . . . 0.0 109.27 -179.585 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 87.4 tttt -54.23 -48.22 71.32 Favored 'General case' 0 C--O 1.22 -0.457 0 CA-C-N 118.921 0.782 . . . . 0.0 109.018 -178.462 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 40.4 tt0 -64.12 -42.62 96.77 Favored 'General case' 0 N--CA 1.45 -0.471 0 O-C-N 123.252 0.345 . . . . 0.0 110.865 -173.385 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 52.9 mtt-85 -67.34 -43.31 81.86 Favored 'General case' 0 N--CA 1.468 0.445 0 O-C-N 121.656 -0.653 . . . . 0.0 111.02 177.987 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 77.2 t -65.55 -41.15 90.15 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.395 0 N-CA-C 109.734 -0.469 . . . . 0.0 109.734 179.378 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 26.3 mt-10 -59.02 -44.82 91.77 Favored 'General case' 0 N--CA 1.455 -0.221 0 CA-C-N 119.17 0.895 . . . . 0.0 109.971 177.271 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 29.2 t-20 -62.06 -43.31 99.1 Favored 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 122.575 0.35 . . . . 0.0 110.933 -178.323 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 1.8 tm? -59.36 -49.04 79.34 Favored 'General case' 0 N--CA 1.455 -0.201 0 C-N-CA 124.042 0.937 . . . . 0.0 110.529 176.726 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 96.4 mt -64.91 -42.81 95.81 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.258 0 C-N-CA 124.108 0.963 . . . . 0.0 108.933 -178.844 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -61.5 -30.22 70.48 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 123.347 0.659 . . . . 0.0 111.639 177.951 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 91.5 mttt -69.25 -55.75 9.62 Favored 'General case' 0 C--N 1.343 0.313 0 CA-C-N 118.933 0.788 . . . . 0.0 110.229 172.862 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 20.8 pt -74.52 -41.26 49.09 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.291 0 N-CA-C 114.017 1.117 . . . . 0.0 114.017 -169.523 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 72.5 m . . . . . 0 C--O 1.253 1.268 0 C-N-CA 126.226 1.81 . . . . 0.0 108.995 -169.558 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 9.9 ptm . . . . . 0 N--CA 1.498 1.939 0 N-CA-C 110.64 -0.133 . . . . 0.0 110.64 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 33.8 mttm -74.62 119.76 19.24 Favored 'General case' 0 N--CA 1.479 0.985 0 O-C-N 121.127 -0.983 . . . . 0.0 108.397 -170.711 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 90.2 mttt -85.33 135.15 34.02 Favored 'General case' 0 CA--C 1.515 -0.403 0 N-CA-C 108.07 -1.085 . . . . 0.0 108.07 174.894 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 1.6 t -121.81 147.13 25.98 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 C-N-CA 125.529 1.532 . . . . 0.0 109.37 -168.849 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 13.3 mtt -134.66 146.39 49.47 Favored 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 125.659 1.584 . . . . 0.0 109.544 169.399 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 41.2 m-85 -135.58 113.51 11.14 Favored 'General case' 0 N--CA 1.454 -0.274 0 N-CA-C 106.339 -1.726 . . . . 0.0 106.339 169.41 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 3.2 p -157.25 146.36 10.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 N-CA-C 109.029 -0.73 . . . . 0.0 109.029 -169.963 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 25.5 t -157.73 145.75 18.87 Favored 'General case' 0 C--N 1.328 -0.326 0 N-CA-C 105.593 -2.003 . . . . 0.0 105.593 168.839 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 5.6 tmtt? 51.81 -85.58 0.01 OUTLIER 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 126.078 1.751 . . . . 0.0 112.145 178.552 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 11.8 ptp180 -142.17 -178.82 5.9 Favored 'General case' 0 C--O 1.225 -0.198 0 CA-C-N 119.589 1.086 . . . . 0.0 111.09 178.706 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 1.7 t30 -57.49 -35.26 69.98 Favored 'General case' 0 N--CA 1.467 0.412 0 C-N-CA 124.416 1.086 . . . . 0.0 111.666 -179.21 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -70.95 -23.45 62.23 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 124.456 1.102 . . . . 0.0 113.05 -175.194 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 3.8 m -70.4 -159.61 0.04 OUTLIER 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 126.272 1.829 . . . . 0.0 111.994 -169.673 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 2.8 mpp_? -51.8 -25.52 7.87 Favored 'General case' 0 N--CA 1.481 1.112 0 O-C-N 119.808 -1.808 . . . . 0.0 112.34 175.638 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 1.4 m -41.89 -29.44 0.21 Allowed 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 126.74 2.016 . . . . 0.0 112.856 169.622 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . 0.442 ' HA ' HE22 ' A' ' 60' ' ' GLN . 5.1 pt20 -54.47 -35.87 63.52 Favored 'General case' 0 C--O 1.22 -0.497 0 CA-C-O 117.491 -1.242 . . . . 0.0 113.218 178.328 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -105.66 -51.64 2.96 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-N 120.678 1.581 . . . . 0.0 114.727 -168.592 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -63.72 -34.8 78.68 Favored 'General case' 0 N--CA 1.471 0.61 0 N-CA-C 114.248 1.203 . . . . 0.0 114.248 -168.456 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 2.4 pp20? -64.95 -34.13 77.69 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-N 119.003 0.82 . . . . 0.0 110.103 172.783 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -51.29 -62.79 5.14 Favored Glycine 0 C--N 1.338 0.652 0 C-N-CA 125.847 1.689 . . . . 0.0 110.419 174.287 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 9.2 m-85 -63.13 -33.31 75.18 Favored 'General case' 0 CA--C 1.507 -0.7 0 CA-C-N 118.684 1.242 . . . . 0.0 113.434 179.985 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -67.42 -30.47 70.23 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 119.592 1.087 . . . . 0.0 111.376 -173.644 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 1.1 ptmt -70.32 -20.92 62.97 Favored 'General case' 0 CA--C 1.539 0.522 0 CA-C-N 119.288 0.949 . . . . 0.0 111.784 174.366 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 2.9 m -85.37 -57.39 3.09 Favored 'General case' 0 N--CA 1.45 -0.475 0 C-N-CA 125.537 1.535 . . . . 0.0 110.633 176.931 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 75.3 mt -73.98 -36.76 64.59 Favored 'General case' 0 N--CA 1.463 0.224 0 C-N-CA 123.989 0.915 . . . . 0.0 110.297 -172.617 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -93.36 8.9 74.95 Favored Glycine 0 CA--C 1.525 0.662 0 CA-C-O 118.486 -1.174 . . . . 0.0 112.813 -177.202 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -51.33 123.69 10.2 Favored 'General case' 0 CA--C 1.534 0.327 0 C-N-CA 124.806 1.242 . . . . 0.0 110.507 -174.962 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 76.48 -9.81 19.9 Favored Glycine 0 CA--C 1.533 1.17 0 CA-C-O 118.721 -1.044 . . . . 0.0 114.274 179.906 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 85.4 mttt -97.19 -49.66 4.88 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-N 119.478 1.639 . . . . 0.0 110.518 178.666 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 39.8 pt -137.57 147.64 26.29 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.537 0 C-N-CA 124.056 0.942 . . . . 0.0 108.772 -169.881 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -107.47 102.6 11.86 Favored 'General case' 0 C--O 1.225 -0.193 0 C-N-CA 124.949 1.3 . . . . 0.0 110.065 -169.582 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 6.2 t -85.69 125.19 40.55 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 N-CA-C 108.619 -0.882 . . . . 0.0 108.619 -179.531 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 23.4 m -151.85 97.71 2.38 Favored 'General case' 0 N--CA 1.453 -0.321 0 N-CA-C 103.957 -2.608 . . . . 0.0 103.957 173.105 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 18.0 m -94.99 1.12 55.16 Favored 'General case' 0 CA--C 1.535 0.386 0 N-CA-C 115.019 1.489 . . . . 0.0 115.019 -169.153 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 1.5 m 52.88 -147.52 0.47 Allowed 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 123.747 0.819 . . . . 0.0 110.767 -179.663 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -164.27 167.15 38.08 Favored Glycine 0 CA--C 1.525 0.69 0 N-CA-C 109.7 -1.36 . . . . 0.0 109.7 169.973 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 3.2 mt -133.64 143.72 48.77 Favored 'General case' 0 N--CA 1.446 -0.657 0 C-N-CA 127.67 2.388 . . . . 0.0 104.952 170.02 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 50.7 mt-10 65.46 -59.78 0.27 Allowed 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 127.227 2.211 . . . . 0.0 111.293 -173.755 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 65.1 m 67.11 152.78 0.08 Allowed 'General case' 0 N--CA 1.44 -0.935 0 C-N-CA 129.463 3.105 . . . . 0.0 115.894 170.043 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 15.2 m -177.62 -173.75 0.43 Allowed 'General case' 0 CA--C 1.545 0.764 1 C-N-CA 132.107 4.163 . . . . 0.0 102.607 -169.457 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 7.5 ttt180 -105.53 169.02 8.71 Favored 'General case' 0 N--CA 1.469 0.515 0 O-C-N 120.584 -1.323 . . . . 0.0 108.663 169.678 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 11.4 m -69.68 165.62 2.47 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.71 0 CA-C-N 115.649 -0.705 . . . . 0.0 109.415 175.827 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 90.3 m-70 -79.12 151.62 75.91 Favored Pre-proline 0 CA--C 1.537 0.446 0 CA-C-O 119.314 -0.374 . . . . 0.0 111.511 -174.89 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 39.9 Cg_endo -62.21 -46.12 13.57 Favored 'Trans proline' 0 C--N 1.346 0.43 0 C-N-CA 123.175 2.583 . . . . 0.0 111.772 -174.583 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 4.4 m -66.93 -28.24 68.13 Favored 'General case' 0 CA--C 1.531 0.25 0 O-C-N 121.949 -0.47 . . . . 0.0 110.02 -179.953 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -57.62 -54.56 45.52 Favored 'General case' 0 CA--C 1.511 -0.545 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 173.03 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 63.4 mt -59.55 -40.05 80.96 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.357 0 N-CA-C 108.607 -0.886 . . . . 0.0 108.607 -174.987 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -61.65 -43.49 98.75 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-N 119.004 0.82 . . . . 0.0 111.633 179.8 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 38.0 mmt -75.48 -36.52 60.62 Favored 'General case' 0 C--O 1.235 0.315 0 CA-C-O 122.806 1.289 . . . . 0.0 110.488 -177.285 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -71.58 -28.89 64.13 Favored 'General case' 0 N--CA 1.446 -0.643 0 N-CA-C 107.509 -1.293 . . . . 0.0 107.509 178.604 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 41.2 tt0 -73.78 -19.18 60.84 Favored 'General case' 0 N--CA 1.446 -0.63 0 C-N-CA 125.069 1.347 . . . . 0.0 110.563 169.958 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 76.1 mt-10 -64.09 -34.71 78.65 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-N 120.234 1.379 . . . . 0.0 108.681 169.146 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . 0.302 10.0 p -89.8 10.11 2.57 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.931 0 N-CA-C 112.434 0.531 . . . . 0.0 112.434 169.582 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 71.89 15.77 76.22 Favored Glycine 0 CA--C 1.533 1.162 0 O-C-N 120.761 -1.212 . . . . 0.0 113.767 175.926 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 22.3 mt -96.07 142.46 13.79 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.288 0 CA-C-N 118.42 1.11 . . . . 0.0 110.462 -175.473 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 8.9 t70 -91.78 129.66 37.7 Favored 'General case' 0 C--O 1.236 0.392 0 N-CA-C 108.192 -1.04 . . . . 0.0 108.192 169.574 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 10.1 pt -124.91 -27.21 1.52 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.657 0 C-N-CA 124.567 1.147 . . . . 0.0 110.166 169.7 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -37.12 -40.92 0.34 Allowed 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 129.746 3.218 . . . . 0.0 113.909 169.11 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -83.2 13.04 47.52 Favored Glycine 0 CA--C 1.534 1.251 0 C-N-CA 125.443 1.497 . . . . 0.0 114.566 -177.47 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . 0.442 HE22 ' HA ' ' A' ' 16' ' ' GLN . 0.9 OUTLIER -60.98 -34.84 75.41 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 119.607 1.703 . . . . 0.0 113.026 -176.026 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -70.3 131.89 44.86 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 123.539 0.736 . . . . 0.0 109.142 -170.677 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 26.0 m -158.29 -61.17 0.08 Allowed 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 123.463 0.705 . . . . 0.0 110.568 -179.526 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -150.98 153.31 32.93 Favored Pre-proline 0 N--CA 1.467 0.422 0 C-N-CA 123.424 0.69 . . . . 0.0 109.815 -175.007 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 96.4 Cg_endo -66.94 155.59 70.11 Favored 'Trans proline' 0 N--CA 1.454 -0.819 0 C-N-CA 122.53 2.153 . . . . 0.0 110.008 171.588 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 7.1 tt -59.94 -26.0 34.42 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.513 0 C-N-CA 123.326 0.65 . . . . 0.0 111.324 -179.242 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 14.8 mt-10 -67.71 -25.25 65.57 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 124.867 1.267 . . . . 0.0 110.636 -175.096 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 7.0 t-20 -63.89 -22.72 67.05 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 124.69 1.196 . . . . 0.0 112.047 177.648 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 70.0 m-85 -105.75 -174.1 2.46 Favored 'General case' 0 C--O 1.234 0.269 0 C-N-CA 126.424 1.889 . . . . 0.0 109.923 -175.89 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 54.3 t-20 -137.69 140.86 41.02 Favored 'General case' 0 N--CA 1.446 -0.654 0 N-CA-C 107.667 -1.235 . . . . 0.0 107.667 169.407 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -74.07 -25.13 59.65 Favored 'General case' 0 N--CA 1.435 -1.181 0 N-CA-C 109.19 -0.67 . . . . 0.0 109.19 -178.559 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -63.01 -24.35 67.88 Favored 'General case' 0 N--CA 1.447 -0.584 0 O-C-N 123.441 0.463 . . . . 0.0 111.643 178.937 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -77.71 -27.69 50.72 Favored 'General case' 0 C--O 1.236 0.361 0 C-N-CA 123.808 0.843 . . . . 0.0 112.37 175.991 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 11.6 m-85 -81.02 172.21 14.02 Favored 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 125.853 1.661 . . . . 0.0 112.099 -177.47 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 24.1 t70 -120.98 -37.72 2.93 Favored 'General case' 0 N--CA 1.464 0.234 0 C-N-CA 123.68 0.792 . . . . 0.0 111.678 175.824 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -139.38 136.76 41.05 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.328 0 CA-C-N 118.432 0.56 . . . . 0.0 110.498 -170.144 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 77.2 t -147.5 128.81 5.96 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.537 0 N-CA-C 106.516 -1.661 . . . . 0.0 106.516 -176.062 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.597 HD12 ' HB2' ' A' ' 97' ' ' GLU . 12.0 mm -109.17 128.09 65.36 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.473 0 N-CA-C 106.862 -1.533 . . . . 0.0 106.862 177.732 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 60.5 m -94.71 101.24 13.08 Favored 'General case' 0 N--CA 1.446 -0.671 0 N-CA-C 104.508 -2.404 . . . . 0.0 104.508 169.292 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 30.0 mt -66.73 -4.94 10.15 Favored 'General case' 0 N--CA 1.471 0.576 0 N-CA-C 113.931 1.085 . . . . 0.0 113.931 -169.775 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -151.04 151.82 32.58 Favored 'General case' 0 N--CA 1.45 -0.46 0 N-CA-C 106.335 -1.728 . . . . 0.0 106.335 168.744 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 54.75 -140.77 37.28 Favored Glycine 0 CA--C 1.533 1.166 0 C-N-CA 123.851 0.738 . . . . 0.0 111.701 174.647 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 16.0 m -132.71 -76.65 0.49 Allowed 'General case' 0 CA--C 1.529 0.163 0 N-CA-C 108.603 -0.888 . . . . 0.0 108.603 175.783 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -78.34 -40.45 19.55 Favored Glycine 0 C--N 1.34 0.793 0 CA-C-O 118.85 -0.972 . . . . 0.0 112.05 -179.156 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . 0.351 16.2 m 47.48 -94.27 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.547 0.838 0 C-N-CA 125.56 1.544 . . . . 0.0 112.629 -178.757 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 58.7 t30 -141.82 45.07 1.7 Allowed 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 124.653 1.181 . . . . 0.0 109.365 171.557 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 1.2 tt -136.25 140.58 33.24 Favored Pre-proline 0 CA--C 1.547 0.837 0 C-N-CA 126.591 1.956 . . . . 0.0 109.384 -169.517 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -67.96 149.98 77.79 Favored 'Trans proline' 0 CA--C 1.541 0.873 0 C-N-CA 121.649 1.566 . . . . 0.0 113.668 -172.173 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -69.37 -27.66 28.07 Favored 'Trans proline' 0 N--CA 1.461 -0.423 0 C-N-CA 122.622 2.214 . . . . 0.0 115.502 -169.587 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 4.3 pm0 -61.91 -17.05 55.34 Favored 'General case' 0 CA--C 1.539 0.557 0 CA-C-N 121.432 1.924 . . . . 0.0 111.954 178.684 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 99.6 m95 -78.01 -42.04 33.86 Favored 'General case' 0 N--CA 1.447 -0.583 0 C-N-CA 123.8 0.84 . . . . 0.0 110.933 175.424 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 1.6 m -74.49 -7.72 10.46 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.26 0 C-N-CA 123.469 0.708 . . . . 0.0 111.97 -179.317 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 74.4 p -109.15 18.47 20.53 Favored 'General case' 0 C--O 1.238 0.49 0 N-CA-C 113.837 1.051 . . . . 0.0 113.837 -178.132 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 91.9 mm-40 -68.56 171.03 8.11 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-N 118.539 0.609 . . . . 0.0 111.644 176.912 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 32.8 mm-40 -56.03 -30.23 61.57 Favored 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 123.995 0.918 . . . . 0.0 112.929 -168.83 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 4.0 tt -130.54 114.73 29.04 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.345 0 N-CA-C 105.018 -2.216 . . . . 0.0 105.018 169.014 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 22.5 t80 -100.65 134.41 43.66 Favored 'General case' 0 C--O 1.236 0.392 0 N-CA-C 105.63 -1.989 . . . . 0.0 105.63 169.388 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . 0.597 ' HB2' HD12 ' A' ' 77' ' ' ILE . 11.4 mm-40 -142.69 164.21 30.71 Favored 'General case' 0 C--N 1.329 -0.289 0 C-N-CA 124.451 1.1 . . . . 0.0 109.18 179.247 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 2.3 t70 -170.02 129.87 0.95 Allowed 'General case' 0 C--O 1.237 0.445 0 C-N-CA 128.192 2.597 . . . . 0.0 106.618 -169.954 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' TRP . . . . . 0.465 ' CZ3' HG21 ' A' ' 77' ' ' ILE . 10.0 m0 -140.8 147.91 39.79 Favored 'General case' 0 C--O 1.234 0.242 0 C-N-CA 123.33 0.652 . . . . 0.0 111.836 -169.814 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 18.4 mp0 -74.06 111.64 9.42 Favored 'General case' 0 C--O 1.234 0.285 0 N-CA-C 105.294 -2.114 . . . . 0.0 105.294 169.345 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.464 HD13 HG22 ' A' ' 119' ' ' VAL . 44.3 mt -146.03 128.34 15.83 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 104.323 -2.473 . . . . 0.0 104.323 178.604 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 61.4 mm-40 -76.99 156.07 32.16 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-N 119.197 0.908 . . . . 0.0 110.044 179.417 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 55.6 t0 -100.39 111.37 62.48 Favored Pre-proline 0 N--CA 1.448 -0.567 0 N-CA-C 105.612 -1.996 . . . . 0.0 105.612 168.882 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 96.3 Cg_endo -73.75 -0.08 8.92 Favored 'Trans proline' 0 CA--C 1.541 0.843 0 C-N-CA 122.913 2.408 . . . . 0.0 113.643 -175.834 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -47.61 128.96 13.37 Favored 'General case' 0 C--O 1.237 0.445 0 CA-C-N 119.468 1.031 . . . . 0.0 111.268 173.748 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 70.99 12.17 71.04 Favored Glycine 0 CA--C 1.53 1.017 0 CA-C-O 118.523 -1.154 . . . . 0.0 114.236 169.953 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 29.5 pt20 -133.15 -172.83 3.04 Favored 'General case' 0 CA--C 1.536 0.414 0 CA-C-N 119.029 1.415 . . . . 0.0 110.763 176.282 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 3.2 m -68.59 156.55 37.88 Favored 'General case' 0 CA--C 1.532 0.256 0 N-CA-C 116.161 1.912 . . . . 0.0 116.161 -167.964 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 48.7 mt -60.47 -28.49 68.38 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 125.05 1.34 . . . . 0.0 111.146 174.758 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 40.1 tt0 -58.19 -37.22 74.32 Favored 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 122.919 0.487 . . . . 0.0 110.34 173.168 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 3.5 t -75.12 -43.95 44.09 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.31 0 CA-C-O 117.866 -1.064 . . . . 0.0 109.34 179.195 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 59.9 m-85 -53.67 -47.45 70.38 Favored 'General case' 0 N--CA 1.474 0.759 0 CA-C-N 120.399 1.454 . . . . 0.0 110.404 172.873 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 92.5 mtt180 -72.88 -35.17 67.1 Favored 'General case' 0 N--CA 1.466 0.344 0 O-C-N 121.612 -0.68 . . . . 0.0 111.428 -175.785 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 4.0 m -60.77 -49.67 76.56 Favored 'General case' 0 N--CA 1.448 -0.551 0 N-CA-C 109.003 -0.74 . . . . 0.0 109.003 171.103 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 75.0 t -65.02 -38.4 82.68 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.415 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 -176.647 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 52.5 ttp85 -57.37 -44.88 84.79 Favored 'General case' 0 CA--C 1.539 0.528 0 CA-C-N 118.734 0.697 . . . . 0.0 110.234 176.244 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -65.65 -50.02 56.61 Favored Glycine 0 CA--C 1.532 1.146 0 CA-C-N 118.609 0.641 . . . . 0.0 112.143 174.915 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 40.8 mm-40 -58.69 -48.78 79.94 Favored 'General case' 0 N--CA 1.464 0.252 0 C-N-CA 123.776 0.83 . . . . 0.0 110.454 -176.215 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . 0.464 HG22 HD13 ' A' ' 101' ' ' LEU . 87.7 t -66.27 -40.31 86.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-O 118.234 -0.889 . . . . 0.0 110.236 -175.724 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 57.2 tttm -54.28 -45.12 72.39 Favored 'General case' 0 N--CA 1.462 0.139 0 CA-C-N 119.374 0.988 . . . . 0.0 109.075 177.669 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -67.71 -43.03 81.02 Favored 'General case' 0 CA--C 1.54 0.595 0 CA-C-O 119.154 -0.451 . . . . 0.0 111.658 -177.631 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 29.0 mmt180 -58.53 -47.4 84.3 Favored 'General case' 0 N--CA 1.477 0.886 0 CA-C-N 119.31 0.959 . . . . 0.0 110.845 175.373 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 77.0 t -69.43 -37.59 75.5 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.536 0 CA-C-O 118.673 -0.679 . . . . 0.0 109.25 -176.361 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 28.4 mt-10 -59.0 -44.42 91.65 Favored 'General case' 0 C--N 1.339 0.149 0 CA-C-N 120.089 1.313 . . . . 0.0 110.047 173.315 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 29.1 t-20 -62.41 -44.32 96.72 Favored 'General case' 0 CA--C 1.53 0.174 0 C-N-CA 122.661 0.384 . . . . 0.0 110.918 -179.431 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 39.1 tp -57.91 -48.44 79.89 Favored 'General case' 0 N--CA 1.454 -0.25 0 C-N-CA 124.166 0.986 . . . . 0.0 110.944 176.76 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 62.4 mt -65.47 -45.15 93.66 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.266 0 N-CA-C 107.705 -1.22 . . . . 0.0 107.705 -178.407 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -59.27 -29.08 67.31 Favored 'General case' 0 CA--C 1.54 0.592 0 CA-C-O 118.855 -0.593 . . . . 0.0 112.124 177.114 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 94.5 mttt -70.05 -57.29 5.15 Favored 'General case' 0 C--N 1.343 0.321 0 CA-C-N 119.09 0.859 . . . . 0.0 110.604 172.379 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 9.5 pt -80.79 -42.84 20.8 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.334 0 N-CA-C 115.659 1.726 . . . . 0.0 115.659 -168.497 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 51.0 m . . . . . 0 C--O 1.251 1.184 0 C-N-CA 124.979 1.312 . . . . 0.0 110.387 -169.861 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 11.8 ptm . . . . . 0 N--CA 1.497 1.919 0 N-CA-C 110.57 -0.159 . . . . 0.0 110.57 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . 0.416 ' HB2' HG22 ' A' ' 30' ' ' ILE . 25.3 mttm -75.55 120.84 21.52 Favored 'General case' 0 N--CA 1.479 1.018 0 N-CA-C 107.907 -1.145 . . . . 0.0 107.907 -171.806 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 89.8 mttt -89.38 134.85 33.9 Favored 'General case' 0 CA--C 1.515 -0.367 0 N-CA-C 108.069 -1.085 . . . . 0.0 108.069 177.548 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 1.5 t -119.69 149.59 22.3 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.619 0 C-N-CA 126.997 2.119 . . . . 0.0 108.789 -169.229 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 26.5 mtt -137.32 145.96 44.03 Favored 'General case' 0 C--N 1.325 -0.493 0 C-N-CA 124.849 1.26 . . . . 0.0 108.484 168.686 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 49.3 m-85 -138.12 132.48 32.05 Favored 'General case' 0 C--O 1.234 0.249 0 N-CA-C 105.661 -1.978 . . . . 0.0 105.661 171.132 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 2.1 p -163.13 143.86 2.62 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.189 0 CA-C-N 118.459 0.572 . . . . 0.0 111.035 -170.023 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 45.2 t -136.34 177.97 7.42 Favored 'General case' 0 CA--C 1.547 0.861 0 C-N-CA 127.758 2.423 . . . . 0.0 105.877 168.367 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 27.1 ttpp -59.58 -22.6 61.99 Favored 'General case' 0 N--CA 1.474 0.748 0 N-CA-C 113.874 1.064 . . . . 0.0 113.874 -169.804 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 84.9 mmt-85 -138.24 155.78 48.31 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-N 119.755 1.162 . . . . 0.0 107.871 169.886 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 46.6 t30 -71.09 -35.44 71.83 Favored 'General case' 0 CA--C 1.535 0.384 0 CA-C-O 121.279 0.561 . . . . 0.0 109.839 173.377 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 1.2 m -61.34 -25.26 67.02 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 125.012 1.325 . . . . 0.0 112.928 -174.993 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 14.2 m -138.37 125.28 21.17 Favored 'General case' 0 N--CA 1.455 -0.199 0 C-N-CA 123.46 0.704 . . . . 0.0 109.481 -172.73 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . 0.449 ' H ' ' CG ' ' A' ' 103' ' ' ASP 0.259 27.2 ttt180 59.57 31.05 20.72 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 126.878 2.071 . . . . 0.0 112.831 175.775 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 20.4 m -131.71 -122.18 0.2 Allowed 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 103.363 -2.829 . . . . 0.0 103.363 168.783 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . 0.352 17.7 pt20 54.79 -57.9 0.02 OUTLIER 'General case' 0 N--CA 1.452 -0.33 0 C-N-CA 129.507 3.123 . . . . 0.0 115.951 171.995 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 5.4 tpt -107.34 -16.79 14.3 Favored 'General case' 0 N--CA 1.45 -0.447 0 N-CA-C 116.588 2.07 . . . . 0.0 116.588 -169.659 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -65.63 -45.39 83.25 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 120.182 1.356 . . . . 0.0 109.027 174.189 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 2.8 pm0 -66.55 -37.25 84.57 Favored 'General case' 0 N--CA 1.45 -0.427 0 C-N-CA 124.818 1.247 . . . . 0.0 110.439 170.034 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -61.98 -45.35 96.31 Favored Glycine 0 C--N 1.339 0.746 0 C-N-CA 124.37 0.986 . . . . 0.0 111.997 -178.536 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 24.9 m-85 -73.82 -31.13 63.08 Favored 'General case' 0 CA--C 1.509 -0.597 0 CA-C-N 119.056 1.428 . . . . 0.0 113.717 170.981 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -65.49 -34.17 77.65 Favored 'General case' 0 C--O 1.225 -0.203 0 CA-C-N 120.531 1.514 . . . . 0.0 111.333 -172.493 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 17.1 ptpt -61.66 -27.72 68.88 Favored 'General case' 0 N--CA 1.475 0.795 0 CA-C-N 119.026 0.83 . . . . 0.0 112.392 170.945 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 2.1 m -84.27 -56.34 3.7 Favored 'General case' 0 N--CA 1.451 -0.382 0 C-N-CA 125.291 1.436 . . . . 0.0 109.817 -178.099 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 75.7 mt -72.72 -36.44 67.8 Favored 'General case' 0 CA--C 1.529 0.138 0 C-N-CA 124.068 0.947 . . . . 0.0 110.021 -173.232 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -96.7 9.26 66.32 Favored Glycine 0 CA--C 1.526 0.771 0 C-N-CA 125.159 1.361 . . . . 0.0 112.943 -175.737 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -48.83 122.88 6.16 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 124.989 1.316 . . . . 0.0 110.71 -175.41 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 77.33 -11.78 16.11 Favored Glycine 0 CA--C 1.533 1.203 0 C-N-CA 124.404 1.002 . . . . 0.0 114.589 178.953 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 63.7 mttm -96.68 -46.11 6.42 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-N 119.265 1.532 . . . . 0.0 110.571 179.908 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.416 HG22 ' HB2' ' A' ' 2' ' ' LYS . 29.6 pt -138.62 147.64 25.07 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.58 0 C-N-CA 123.547 0.739 . . . . 0.0 110.087 -169.577 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -107.77 107.82 18.76 Favored 'General case' 0 N--CA 1.467 0.389 0 C-N-CA 125.196 1.398 . . . . 0.0 109.679 -171.471 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 8.3 t -78.44 139.53 18.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 119.152 0.887 . . . . 0.0 109.117 176.385 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 4.2 m -139.79 115.78 10.32 Favored 'General case' 0 N--CA 1.436 -1.145 0 N-CA-C 105.176 -2.157 . . . . 0.0 105.176 169.899 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 4.5 m -90.34 45.3 1.25 Allowed 'General case' 0 C--N 1.32 -0.679 0 O-C-N 121.416 -0.803 . . . . 0.0 112.399 -170.831 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 2.6 m -67.15 165.35 16.16 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 124.484 1.114 . . . . 0.0 111.801 -178.577 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -177.1 -177.09 45.76 Favored Glycine 0 N--CA 1.444 -0.77 0 N-CA-C 106.081 -2.808 . . . . 0.0 106.081 -170.22 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 19.1 mt -104.76 -14.88 15.4 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 117.754 0.777 . . . . 0.0 111.152 179.047 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -144.12 155.26 43.87 Favored 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 128.227 2.611 . . . . 0.0 105.388 168.984 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 1.9 m -164.25 169.8 17.1 Favored 'General case' 0 N--CA 1.449 -0.485 0 CA-C-O 122.277 1.037 . . . . 0.0 110.994 175.379 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 62.7 p -153.14 -172.37 4.22 Favored 'General case' 0 N--CA 1.439 -1.023 0 C-N-CA 126.385 1.874 . . . . 0.0 107.304 -169.182 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 7.5 ttt180 -91.62 168.98 11.11 Favored 'General case' 0 C--N 1.331 -0.237 0 O-C-N 121.19 -0.943 . . . . 0.0 109.587 170.473 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 19.8 m -71.28 170.55 1.27 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.805 0 C-N-CA 123.543 0.737 . . . . 0.0 109.585 -178.824 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 74.1 t60 -71.44 138.71 83.8 Favored Pre-proline 0 CA--C 1.546 0.818 0 CA-C-O 118.391 -0.814 . . . . 0.0 109.274 172.989 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -59.29 -49.46 10.76 Favored 'Trans proline' 0 C--N 1.349 0.556 0 C-N-CA 123.231 2.621 . . . . 0.0 113.899 -173.654 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 22.6 m -66.13 -17.18 64.55 Favored 'General case' 0 CA--C 1.539 0.521 0 CA-C-N 118.842 0.746 . . . . 0.0 111.168 -178.471 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.472 ' HB1' HD11 ' A' ' 57' ' ' ILE . . . -60.62 -49.0 79.3 Favored 'General case' 0 C--O 1.215 -0.715 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 173.253 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 52.4 mt -58.49 -41.05 80.69 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 N-CA-C 108.288 -1.005 . . . . 0.0 108.288 -173.44 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -66.27 -50.76 62.6 Favored 'General case' 0 N--CA 1.45 -0.434 0 CA-C-N 118.229 0.468 . . . . 0.0 111.597 -179.99 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 31.9 mmt -69.15 -34.2 74.62 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-O 122.825 1.297 . . . . 0.0 111.087 -177.047 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 20.8 mmt -77.81 -28.66 50.42 Favored 'General case' 0 N--CA 1.441 -0.899 0 O-C-N 120.784 -1.197 . . . . 0.0 108.277 -177.355 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 -70.87 -23.32 62.28 Favored 'General case' 0 N--CA 1.449 -0.479 0 O-C-N 121.372 -0.83 . . . . 0.0 109.692 169.652 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 18.2 mm-40 -68.14 -30.66 69.85 Favored 'General case' 0 CA--C 1.531 0.242 0 CA-C-N 119.203 0.91 . . . . 0.0 110.443 170.984 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . 0.286 3.1 p -87.64 9.43 2.04 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.918 0 CA-C-N 118.807 0.73 . . . . 0.0 111.264 169.205 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 81.41 17.69 70.66 Favored Glycine 0 CA--C 1.531 1.057 0 C-N-CA 124.667 1.127 . . . . 0.0 113.75 172.449 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 39.5 mt -116.28 139.35 43.39 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.295 0 CA-C-N 119.107 1.453 . . . . 0.0 110.625 -176.618 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -100.73 136.16 41.04 Favored 'General case' 0 C--O 1.235 0.319 0 N-CA-C 109.236 -0.653 . . . . 0.0 109.236 169.141 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.472 HD11 ' HB1' ' A' ' 46' ' ' ALA . 15.8 pt -128.36 -13.43 3.01 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.499 0 C-N-CA 125.439 1.496 . . . . 0.0 112.414 176.172 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 93.2 p -44.38 -38.21 3.84 Favored 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 125.467 1.507 . . . . 0.0 114.552 176.143 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -87.12 2.86 87.05 Favored Glycine 0 CA--C 1.529 0.912 0 CA-C-O 118.81 -0.995 . . . . 0.0 114.091 -172.92 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 26.8 mt-30 -75.81 120.11 20.73 Favored 'General case' 0 CA--C 1.514 -0.44 0 CA-C-N 119.615 1.708 . . . . 0.0 111.28 -170.182 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 7.7 t -162.13 167.0 24.95 Favored 'General case' 0 N--CA 1.436 -1.132 0 N-CA-C 106.671 -1.603 . . . . 0.0 106.671 167.391 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 40.4 m -154.32 164.38 38.67 Favored 'General case' 0 N--CA 1.448 -0.558 0 C-N-CA 126.195 1.798 . . . . 0.0 107.236 -177.548 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -60.18 163.25 8.53 Favored Pre-proline 0 CA--C 1.54 0.586 0 C-N-CA 124.514 1.125 . . . . 0.0 110.704 169.973 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -61.36 151.19 81.12 Favored 'Trans proline' 0 N--CA 1.456 -0.692 0 C-N-CA 121.584 1.523 . . . . 0.0 109.478 172.565 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 5.6 tt -61.59 -24.23 33.22 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.536 0 O-C-N 121.648 -0.658 . . . . 0.0 111.254 -173.289 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 12.3 mt-10 -67.59 -25.52 65.81 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 125.352 1.461 . . . . 0.0 110.803 -177.064 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 12.2 t-20 -63.07 -26.12 68.69 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 125.006 1.322 . . . . 0.0 111.904 178.612 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 39.2 m-85 -105.07 -169.68 1.64 Allowed 'General case' 0 C--O 1.236 0.37 0 C-N-CA 126.464 1.906 . . . . 0.0 109.762 -176.357 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 55.3 t-20 -135.98 138.81 42.66 Favored 'General case' 0 N--CA 1.445 -0.688 0 N-CA-C 106.526 -1.657 . . . . 0.0 106.526 168.753 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.536 ' HB2' ' CD2' ' A' ' 90' ' ' TRP . . . -72.18 -27.16 62.39 Favored 'General case' 0 N--CA 1.431 -1.379 0 N-CA-C 108.576 -0.898 . . . . 0.0 108.576 -178.768 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 35.8 t70 -67.04 -20.93 65.92 Favored 'General case' 0 N--CA 1.443 -0.778 0 C-N-CA 120.728 -0.389 . . . . 0.0 111.388 -177.55 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 35.2 t70 -80.13 -29.74 38.93 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 124.278 1.031 . . . . 0.0 111.697 173.672 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 11.2 m-85 -77.51 168.59 19.74 Favored 'General case' 0 C--O 1.237 0.446 0 C-N-CA 125.176 1.39 . . . . 0.0 110.926 177.551 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -119.29 -38.56 3.01 Favored 'General case' 0 C--O 1.235 0.309 0 C-N-CA 123.098 0.559 . . . . 0.0 111.491 178.728 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -139.32 134.62 40.44 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.494 0 CA-C-O 121.565 0.698 . . . . 0.0 110.196 -169.921 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 57.0 t -142.5 139.66 28.86 Favored 'Isoleucine or valine' 0 C--O 1.236 0.369 0 N-CA-C 106.082 -1.822 . . . . 0.0 106.082 -179.85 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.533 HD12 ' HB2' ' A' ' 97' ' ' GLU . 23.8 mm -125.63 122.07 61.51 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.572 0 N-CA-C 105.859 -1.904 . . . . 0.0 105.859 -177.388 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 36.0 m -95.4 97.06 9.54 Favored 'General case' 0 N--CA 1.447 -0.586 0 N-CA-C 106.019 -1.845 . . . . 0.0 106.019 169.731 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 67.6 mt -63.04 -18.6 63.53 Favored 'General case' 0 N--CA 1.463 0.207 0 C-N-CA 122.756 0.422 . . . . 0.0 111.092 -178.629 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 14.3 p -152.78 166.55 31.87 Favored 'General case' 0 N--CA 1.448 -0.54 0 N-CA-C 106.7 -1.593 . . . . 0.0 106.7 168.847 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 73.36 -165.52 54.79 Favored Glycine 0 CA--C 1.533 1.194 0 CA-C-O 121.381 0.434 . . . . 0.0 113.053 172.764 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 34.9 p -151.88 -168.21 3.01 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 125.548 1.539 . . . . 0.0 109.318 -169.873 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -73.36 60.74 1.91 Allowed Glycine 0 CA--C 1.534 1.277 0 C-N-CA 124.449 1.023 . . . . 0.0 110.644 170.743 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 7.3 p -72.66 -55.11 14.09 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.398 0 C-N-CA 124.987 1.315 . . . . 0.0 110.823 -169.87 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 36.7 p-10 -135.99 24.93 3.32 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 127.12 2.168 . . . . 0.0 108.6 170.053 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 2.8 tt -116.15 135.52 22.82 Favored Pre-proline 0 CA--C 1.537 0.446 0 C-N-CA 127.076 2.15 . . . . 0.0 107.881 -169.491 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . 0.45 ' HA ' ' HD3' ' A' ' 88' ' ' PRO . 51.4 Cg_exo -63.55 141.96 82.33 Favored 'Trans proline' 0 CA--C 1.541 0.84 0 CA-C-N 120.518 1.221 . . . . 0.0 114.78 -169.313 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . 0.45 ' HD3' ' HA ' ' A' ' 87' ' ' PRO . 75.4 Cg_exo -60.33 -33.97 93.96 Favored 'Trans proline' 0 C--N 1.35 0.614 0 C-N-CA 122.1 1.867 . . . . 0.0 115.106 -171.425 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 4.0 pm0 -62.41 -13.62 31.6 Favored 'General case' 0 CA--C 1.536 0.435 0 CA-C-N 119.817 1.189 . . . . 0.0 112.349 -177.721 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' TRP . . . . . 0.536 ' CD2' ' HB2' ' A' ' 70' ' ' ALA . 99.1 m95 -80.51 -32.31 36.95 Favored 'General case' 0 CA--C 1.53 0.191 0 CA-C-N 118.61 0.641 . . . . 0.0 111.825 173.83 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 25.1 m -96.3 -3.52 10.27 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.472 0 C-N-CA 124.913 1.285 . . . . 0.0 112.822 -179.309 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . 0.263 6.5 t -130.99 65.54 1.55 Allowed 'General case' 0 CA--C 1.541 0.604 0 CA-C-O 123.465 1.602 . . . . 0.0 108.132 169.634 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 32.9 mm-40 -80.56 -175.85 5.43 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 125.668 1.587 . . . . 0.0 109.603 169.516 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 36.4 mm-40 -63.06 -28.25 69.96 Favored 'General case' 0 CA--C 1.54 0.563 0 O-C-N 121.869 -0.52 . . . . 0.0 110.118 175.121 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 3.8 tt -141.01 134.58 31.89 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.358 0 C-N-CA 126.69 1.996 . . . . 0.0 105.675 169.319 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 57.0 t80 -126.11 137.57 53.61 Favored 'General case' 0 N--CA 1.448 -0.543 0 N-CA-C 107.556 -1.276 . . . . 0.0 107.556 169.789 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . 0.533 ' HB2' HD12 ' A' ' 77' ' ' ILE . 8.5 mm-40 -138.11 167.03 22.67 Favored 'General case' 0 C--O 1.236 0.372 0 CA-C-O 122.248 1.023 . . . . 0.0 109.223 175.186 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -168.74 133.0 1.51 Allowed 'General case' 0 C--N 1.325 -0.488 0 C-N-CA 129.267 3.027 . . . . 0.0 105.606 -170.121 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 8.2 m0 -142.87 147.66 35.72 Favored 'General case' 0 C--O 1.232 0.18 0 C-N-CA 123.126 0.57 . . . . 0.0 110.136 -169.833 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 84.6 mt-30 -83.59 52.69 2.31 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 124.301 1.041 . . . . 0.0 108.914 172.362 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.454 HD13 HG22 ' A' ' 119' ' ' VAL . 16.3 mt -70.59 123.42 21.8 Favored 'General case' 0 C--N 1.339 0.113 0 N-CA-C 107.546 -1.279 . . . . 0.0 107.546 176.328 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 5.6 pt-20 -71.87 163.6 27.55 Favored 'General case' 0 CA--C 1.54 0.564 0 N-CA-C 109.139 -0.689 . . . . 0.0 109.139 169.759 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . 0.449 ' CG ' ' H ' ' A' ' 14' ' ' ARG . 13.7 t70 -138.66 139.61 24.92 Favored Pre-proline 0 CA--C 1.538 0.489 0 C-N-CA 124.132 0.973 . . . . 0.0 110.158 -173.198 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 39.5 Cg_endo -86.68 0.01 7.95 Favored 'Trans proline' 0 CA--C 1.543 0.96 0 C-N-CA 122.716 2.277 . . . . 0.0 114.651 -170.436 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -48.59 118.96 2.77 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-N 120.43 1.468 . . . . 0.0 111.221 -177.903 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 72.21 14.15 76.63 Favored Glycine 0 CA--C 1.534 1.249 0 CA-C-O 118.193 -1.337 . . . . 0.0 114.544 172.538 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 16.6 pt20 -128.23 172.26 11.19 Favored 'General case' 0 CA--C 1.541 0.605 0 CA-C-N 119.455 1.628 . . . . 0.0 111.827 176.448 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 9.9 m -65.78 165.18 13.25 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 125.851 1.66 . . . . 0.0 115.133 -168.644 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -60.68 -26.68 67.28 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 125.678 1.591 . . . . 0.0 112.614 -173.993 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 -56.07 -35.14 66.65 Favored 'General case' 0 N--CA 1.461 0.113 0 CA-C-N 118.687 0.676 . . . . 0.0 111.105 173.054 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 4.1 t -77.18 -40.98 30.41 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.558 0 CA-C-O 118.214 -0.898 . . . . 0.0 109.733 -178.036 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 83.6 m-85 -57.5 -46.44 83.75 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-N 120.29 1.404 . . . . 0.0 109.93 171.926 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 91.4 mtt180 -62.94 -41.35 99.46 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 123.274 0.629 . . . . 0.0 110.915 -179.906 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 8.7 m -63.13 -48.56 77.98 Favored 'General case' 0 N--CA 1.449 -0.522 0 C-N-CA 124.704 1.202 . . . . 0.0 110.178 175.525 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 75.4 t -68.72 -31.65 51.73 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.28 0 CA-C-O 118.481 -0.771 . . . . 0.0 109.703 -172.679 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 34.7 mtm105 -57.7 -50.16 74.11 Favored 'General case' 0 C--O 1.226 -0.15 0 CA-C-N 119.521 1.055 . . . . 0.0 110.497 171.399 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -60.74 -51.48 58.35 Favored Glycine 0 CA--C 1.529 0.955 0 N-CA-C 111.22 -0.752 . . . . 0.0 111.22 178.755 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 15.1 mm-40 -58.24 -52.15 66.76 Favored 'General case' 0 N--CA 1.464 0.235 0 C-N-CA 123.911 0.885 . . . . 0.0 110.658 -176.269 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . 0.454 HG22 HD13 ' A' ' 101' ' ' LEU . 69.4 t -74.47 -39.48 47.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-O 118.357 -0.83 . . . . 0.0 110.339 -171.91 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 59.8 tttm -54.79 -44.7 73.99 Favored 'General case' 0 CA--C 1.517 -0.29 0 CA-C-N 119.134 0.879 . . . . 0.0 108.871 175.798 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 45.1 tt0 -64.79 -42.99 94.64 Favored 'General case' 0 CA--C 1.542 0.642 0 CA-C-O 118.75 -0.643 . . . . 0.0 111.363 -177.862 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 63.2 mmt-85 -62.87 -47.63 82.51 Favored 'General case' 0 N--CA 1.478 0.972 0 CA-C-N 119.967 1.258 . . . . 0.0 110.822 176.161 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 60.2 t -69.09 -37.44 76.79 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.438 0 N-CA-C 108.774 -0.824 . . . . 0.0 108.774 -174.675 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 15.8 mt-10 -61.07 -45.22 95.63 Favored 'General case' 0 CA--C 1.52 -0.185 0 CA-C-N 119.269 0.941 . . . . 0.0 110.076 174.111 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 28.4 t-20 -64.22 -40.97 97.14 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 123.008 0.523 . . . . 0.0 111.218 -178.332 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 53.0 tp -58.86 -49.94 75.86 Favored 'General case' 0 C--O 1.226 -0.14 0 C-N-CA 125.285 1.434 . . . . 0.0 110.909 173.77 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 56.7 mt -64.59 -46.87 91.23 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 N-CA-C 107.997 -1.112 . . . . 0.0 107.997 -178.748 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -58.65 -32.45 69.09 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 123.424 0.69 . . . . 0.0 112.102 -178.151 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 18.6 ptpt -81.53 -36.56 29.01 Favored 'General case' 0 C--N 1.345 0.37 0 CA-C-O 117.824 -1.084 . . . . 0.0 112.596 177.105 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 10.4 pt -84.81 -41.27 15.76 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.322 0 CA-C-N 120.124 1.329 . . . . 0.0 113.741 -176.225 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 67.4 m . . . . . 0 C--O 1.254 1.302 0 C-N-CA 126.065 1.746 . . . . 0.0 109.873 -169.927 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 8.5 ptm . . . . . 0 N--CA 1.498 1.965 0 N-CA-C 110.523 -0.177 . . . . 0.0 110.523 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . 0.41 ' HB2' HG22 ' A' ' 30' ' ' ILE . 23.4 mttm -74.62 125.07 27.87 Favored 'General case' 0 N--CA 1.479 1.005 0 N-CA-C 107.103 -1.443 . . . . 0.0 107.103 -174.516 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 70.0 mttt -97.97 136.4 38.31 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-N 120.236 1.38 . . . . 0.0 108.027 173.771 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.428 HG21 HD12 ' A' ' 30' ' ' ILE . 11.6 t -116.31 152.47 18.03 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.551 0 C-N-CA 127.233 2.213 . . . . 0.0 108.199 -169.56 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 17.7 mtt -137.19 144.11 42.7 Favored 'General case' 0 C--N 1.324 -0.541 0 C-N-CA 124.926 1.29 . . . . 0.0 108.057 168.67 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 92.1 m-85 -125.26 113.89 18.22 Favored 'General case' 0 CA--C 1.516 -0.329 0 N-CA-C 102.839 -3.023 . . . . 0.0 102.839 170.05 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 1.2 p -141.0 137.21 34.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 121.289 0.566 . . . . 0.0 111.531 -168.051 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 44.0 t -165.82 152.93 10.08 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 128.639 2.775 . . . . 0.0 104.94 171.767 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 40.2 mtmt -75.47 163.3 27.55 Favored 'General case' 0 N--CA 1.47 0.569 0 O-C-N 121.655 -0.653 . . . . 0.0 111.421 -170.038 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 28.5 mmt85 53.41 70.39 0.6 Allowed 'General case' 0 N--CA 1.465 0.285 0 C-N-CA 126.801 2.041 . . . . 0.0 110.888 -176.28 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 2.4 t-20 -44.4 -20.07 0.03 OUTLIER 'General case' 0 N--CA 1.487 1.386 0 C-N-CA 127.839 2.455 . . . . 0.0 114.955 176.828 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 3.3 m -50.47 -27.82 7.23 Favored 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 124.269 1.028 . . . . 0.0 111.407 168.954 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 10.3 m -131.63 140.32 49.35 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 126.876 2.071 . . . . 0.0 107.889 172.078 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 5.5 mpt_? 59.16 165.2 0.05 OUTLIER 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 126.536 1.934 . . . . 0.0 112.631 -173.022 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 54.7 m 52.2 39.65 27.31 Favored 'General case' 0 CA--C 1.536 0.42 0 CA-C-N 115.207 -0.906 . . . . 0.0 110.334 -169.525 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 26.1 pt20 -135.48 33.07 3.03 Favored 'General case' 0 C--O 1.223 -0.294 0 O-C-N 120.543 -1.348 . . . . 0.0 109.636 174.414 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' MET . . . . . 0.405 ' HE2' ' HG3' ' A' ' 50' ' ' MET . 0.0 OUTLIER -163.88 -50.2 0.03 OUTLIER 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 124.149 0.979 . . . . 0.0 109.848 -177.762 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -67.73 -45.21 75.68 Favored 'General case' 0 C--N 1.343 0.285 0 N-CA-C 112.584 0.586 . . . . 0.0 112.584 -169.465 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . 0.518 ' H ' ' CD ' ' A' ' 19' ' ' GLU . 0.7 OUTLIER -66.86 -34.88 78.78 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 109.489 -0.56 . . . . 0.0 109.489 174.516 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -47.97 -66.71 1.87 Allowed Glycine 0 CA--C 1.527 0.791 0 N-CA-C 110.094 -1.202 . . . . 0.0 110.094 169.909 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 3.7 m-85 -59.62 -34.36 72.68 Favored 'General case' 0 CA--C 1.509 -0.602 0 O-C-N 121.547 -0.973 . . . . 0.0 113.444 178.091 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -66.63 -32.57 73.99 Favored 'General case' 0 N--CA 1.447 -0.61 0 C-N-CA 119.943 -0.703 . . . . 0.0 109.954 -174.032 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -65.9 -33.73 76.5 Favored 'General case' 0 CA--C 1.533 0.327 0 CA-C-N 118.395 0.543 . . . . 0.0 110.675 174.797 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 7.4 m -75.06 -55.69 5.49 Favored 'General case' 0 N--CA 1.448 -0.528 0 C-N-CA 125.453 1.501 . . . . 0.0 110.354 -176.752 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 40.1 mt -75.08 -38.63 61.2 Favored 'General case' 0 C--N 1.331 -0.22 0 C-N-CA 124.302 1.041 . . . . 0.0 109.467 -174.025 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -84.97 5.16 83.8 Favored Glycine 0 CA--C 1.526 0.78 0 C-N-CA 125.487 1.518 . . . . 0.0 113.629 -177.959 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -53.24 128.56 28.48 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-N 118.807 1.303 . . . . 0.0 109.802 -178.983 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 74.2 6.63 75.24 Favored Glycine 0 CA--C 1.536 1.35 0 C-N-CA 124.567 1.08 . . . . 0.0 114.313 -178.388 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 42.7 mttp -124.94 -50.42 1.7 Allowed 'General case' 0 N--CA 1.47 0.534 0 CA-C-N 118.927 1.364 . . . . 0.0 110.986 -175.0 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.428 HD12 HG21 ' A' ' 4' ' ' VAL . 19.3 pt -139.25 147.58 24.39 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.497 0 C-N-CA 123.642 0.777 . . . . 0.0 110.278 -169.244 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -96.01 159.48 14.95 Favored 'General case' 0 C--O 1.221 -0.417 0 C-N-CA 125.833 1.653 . . . . 0.0 108.109 175.578 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 12.2 t -142.44 135.68 27.43 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 N-CA-C 107.961 -1.125 . . . . 0.0 107.961 -173.416 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 4.1 m -148.38 103.04 3.39 Favored 'General case' 0 N--CA 1.446 -0.65 0 C-N-CA 124.665 1.186 . . . . 0.0 107.952 -177.218 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 60.2 m -89.6 71.43 7.87 Favored 'General case' 0 C--O 1.234 0.247 0 O-C-N 120.942 -1.099 . . . . 0.0 111.92 177.608 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 2.1 m -69.14 176.6 3.14 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 124.819 1.248 . . . . 0.0 110.696 170.763 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -167.07 -167.85 28.38 Favored Glycine 0 C--N 1.339 0.698 0 N-CA-C 108.082 -2.007 . . . . 0.0 108.082 179.691 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 18.2 mt -124.44 2.59 8.39 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 124.607 1.163 . . . . 0.0 111.691 -179.755 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 -145.36 -155.5 0.62 Allowed 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 129.185 2.994 . . . . 0.0 105.463 174.969 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 5.8 m 70.4 176.69 0.28 Allowed 'General case' 0 C--O 1.235 0.338 0 C-N-CA 125.38 1.472 . . . . 0.0 114.891 169.41 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 17.1 m -143.9 -72.87 0.28 Allowed 'General case' 0 N--CA 1.452 -0.354 0 CA-C-N 113.491 -1.686 . . . . 0.0 109.769 -169.236 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 6.0 ttt180 -152.3 172.1 16.96 Favored 'General case' 0 N--CA 1.467 0.415 0 C-N-CA 123.952 0.901 . . . . 0.0 111.15 -175.406 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 3.5 m -73.5 168.7 1.85 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.57 0 C-N-CA 124.534 1.134 . . . . 0.0 109.842 176.657 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -94.23 160.03 32.87 Favored Pre-proline 0 CA--C 1.544 0.718 0 N-CA-C 112.697 0.629 . . . . 0.0 112.697 -177.815 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -61.26 -53.55 2.37 Favored 'Trans proline' 0 C--N 1.352 0.742 0 C-N-CA 124.018 3.145 . . . . 0.0 113.777 -169.261 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 4.9 m -66.06 -26.6 67.58 Favored 'General case' 0 CA--C 1.532 0.278 0 O-C-N 121.893 -0.505 . . . . 0.0 110.358 -174.324 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -54.27 -53.19 56.97 Favored 'General case' 0 CA--C 1.509 -0.609 0 N-CA-C 108.75 -0.834 . . . . 0.0 108.75 174.745 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 58.9 mt -60.79 -41.08 87.2 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.468 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 -171.482 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -62.58 -40.97 98.59 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-N 118.431 0.56 . . . . 0.0 110.802 -179.009 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' MET . . . . . 0.426 ' HG3' ' CG ' ' A' ' 112' ' ' PHE . 38.4 mmt -74.06 -35.9 64.31 Favored 'General case' 0 C--O 1.235 0.321 0 CA-C-O 122.388 1.089 . . . . 0.0 110.338 -178.853 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' MET . . . . . 0.405 ' HG3' ' HE2' ' A' ' 17' ' ' MET . 0.2 OUTLIER -73.02 -31.33 64.39 Favored 'General case' 0 N--CA 1.442 -0.863 0 N-CA-C 106.806 -1.553 . . . . 0.0 106.806 -178.916 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 -70.52 -21.08 62.77 Favored 'General case' 0 N--CA 1.445 -0.719 0 C-N-CA 124.703 1.201 . . . . 0.0 111.061 170.273 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 77.7 mt-10 -63.84 -37.88 89.04 Favored 'General case' 0 C--N 1.344 0.361 0 CA-C-N 120.137 1.335 . . . . 0.0 109.107 169.457 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . 0.303 7.7 p -88.28 12.68 1.34 Allowed 'Isoleucine or valine' 0 CA--C 1.548 0.897 0 CA-C-O 121.082 0.468 . . . . 0.0 112.204 171.076 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 72.02 17.24 76.98 Favored Glycine 0 CA--C 1.533 1.212 0 O-C-N 120.723 -1.235 . . . . 0.0 113.869 174.791 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 5.7 mt -100.36 145.57 10.7 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.191 0 C-N-CA 125.154 1.382 . . . . 0.0 111.494 -174.221 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -96.77 137.13 36.32 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 125.297 1.439 . . . . 0.0 108.874 169.625 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 4.6 pt -134.0 -28.83 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.46 0 C-N-CA 125.441 1.496 . . . . 0.0 109.382 169.529 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -39.86 -37.67 0.58 Allowed 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 128.475 2.71 . . . . 0.0 113.509 169.563 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -66.72 -12.25 59.01 Favored Glycine 0 CA--C 1.537 1.423 0 C-N-CA 124.481 1.039 . . . . 0.0 114.379 179.213 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 28.7 mt-30 -70.73 156.43 39.51 Favored 'General case' 0 N--CA 1.45 -0.438 0 CA-C-N 118.965 1.382 . . . . 0.0 110.297 174.382 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 1.4 p -150.31 151.07 32.34 Favored 'General case' 0 N--CA 1.431 -1.421 0 N-CA-C 104.717 -2.327 . . . . 0.0 104.717 168.448 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 63.2 m -92.47 75.82 5.15 Favored 'General case' 0 N--CA 1.45 -0.44 0 N-CA-C 107.831 -1.174 . . . . 0.0 107.831 -174.117 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -62.96 153.13 81.67 Favored Pre-proline 0 C--O 1.241 0.642 0 N-CA-C 108.947 -0.761 . . . . 0.0 108.947 171.161 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 26.4 Cg_exo -57.55 134.36 62.78 Favored 'Trans proline' 0 N--CA 1.447 -1.209 0 N-CA-C 107.841 -1.638 . . . . 0.0 107.841 169.376 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 8.3 tt -61.22 -23.8 31.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 O-C-N 121.482 -0.762 . . . . 0.0 109.596 171.021 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 21.5 tt0 -69.61 -22.9 63.46 Favored 'General case' 0 N--CA 1.434 -1.273 0 C-N-CA 127.375 2.27 . . . . 0.0 110.789 -179.995 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 8.2 t-20 -60.32 -17.59 43.92 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 124.665 1.186 . . . . 0.0 111.68 174.313 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 4.4 m-85 -128.31 178.34 6.32 Favored 'General case' 0 C--O 1.235 0.34 0 C-N-CA 127.115 2.166 . . . . 0.0 108.54 -179.873 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 13.9 p-10 -128.32 143.61 51.04 Favored 'General case' 0 N--CA 1.438 -1.035 0 C-N-CA 124.716 1.206 . . . . 0.0 110.428 169.236 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.575 ' HB2' ' CD2' ' A' ' 90' ' ' TRP . . . -77.36 -25.27 50.85 Favored 'General case' 0 N--CA 1.432 -1.347 0 N-CA-C 109.143 -0.688 . . . . 0.0 109.143 -170.712 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 35.6 t70 -64.61 -19.79 65.89 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 120.41 -0.516 . . . . 0.0 111.214 -178.903 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -83.96 -31.04 25.77 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 124.427 1.091 . . . . 0.0 112.321 172.215 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 11.1 m-85 -72.85 170.31 14.98 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 124.89 1.276 . . . . 0.0 110.287 173.23 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -120.43 -35.85 3.33 Favored 'General case' 0 C--O 1.236 0.39 0 C-N-CA 123.047 0.539 . . . . 0.0 111.67 179.905 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -141.51 135.31 30.82 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.691 0 CA-C-O 121.839 0.828 . . . . 0.0 110.454 -169.705 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 76.3 t -143.0 138.38 27.16 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.278 0 N-CA-C 106.629 -1.619 . . . . 0.0 106.629 -177.496 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 41.6 mm -127.16 117.28 46.96 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.581 0 N-CA-C 106.12 -1.807 . . . . 0.0 106.12 -170.516 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 67.1 m -94.96 91.61 6.47 Favored 'General case' 0 N--CA 1.449 -0.519 0 N-CA-C 105.546 -2.02 . . . . 0.0 105.546 169.445 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . 0.251 0.3 OUTLIER -75.3 -6.55 50.44 Favored 'General case' 0 CA--C 1.536 0.442 0 CA-C-N 115.605 -0.725 . . . . 0.0 112.908 -175.267 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 6.4 p -166.14 167.38 16.34 Favored 'General case' 0 C--O 1.236 0.344 0 C-N-CA 127.398 2.279 . . . . 0.0 107.549 168.247 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 77.79 -81.3 1.27 Allowed Glycine 0 CA--C 1.526 0.746 0 N-CA-C 110.632 -0.987 . . . . 0.0 110.632 174.573 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 4.9 m 67.79 -53.2 0.51 Allowed 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 127.659 2.383 . . . . 0.0 113.738 178.429 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -81.47 57.79 4.89 Favored Glycine 0 CA--C 1.528 0.902 0 C-N-CA 124.774 1.178 . . . . 0.0 110.511 170.741 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 27.7 m -99.5 14.71 4.51 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.71 0 C-N-CA 124.082 0.953 . . . . 0.0 113.068 -169.881 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 47.4 t30 58.64 69.65 0.71 Allowed 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 126.1 1.76 . . . . 0.0 109.258 -175.865 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.405 ' HA ' ' HD3' ' A' ' 87' ' ' PRO . 0.3 OUTLIER -139.36 148.61 57.36 Favored Pre-proline 0 CA--C 1.546 0.81 0 C-N-CA 126.146 1.778 . . . . 0.0 109.276 -168.949 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . 0.405 ' HD3' ' HA ' ' A' ' 86' ' ' LEU . 51.7 Cg_exo -62.99 149.43 91.61 Favored 'Trans proline' 0 C--N 1.356 0.957 0 C-N-CA 121.47 1.447 . . . . 0.0 114.501 -169.643 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_endo -66.83 -34.9 29.17 Favored 'Trans proline' 0 N--CA 1.459 -0.522 0 C-N-CA 122.649 2.232 . . . . 0.0 114.583 -169.212 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . 0.446 ' HG3' ' HB3' ' A' ' 70' ' ' ALA . 11.8 pt-20 -64.16 -11.91 35.0 Favored 'General case' 0 CA--C 1.54 0.57 0 CA-C-N 119.85 1.205 . . . . 0.0 112.157 -176.62 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' TRP . . . . . 0.575 ' CD2' ' HB2' ' A' ' 70' ' ' ALA . 98.0 m95 -80.96 -35.53 32.07 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 123.481 0.712 . . . . 0.0 111.941 173.932 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 18.8 m -92.34 -4.59 10.78 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.551 0 C-N-CA 125.047 1.339 . . . . 0.0 112.697 -179.694 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 4.0 t -132.92 85.61 2.24 Favored 'General case' 0 CA--C 1.539 0.54 0 CA-C-O 123.24 1.495 . . . . 0.0 107.159 169.725 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 30.4 mm-40 -103.02 -174.11 2.47 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 127.806 2.442 . . . . 0.0 108.943 173.889 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 38.3 mm-40 -64.55 -28.62 69.77 Favored 'General case' 0 CA--C 1.539 0.544 0 O-C-N 121.82 -0.55 . . . . 0.0 110.036 172.653 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 4.0 tt -142.39 130.21 20.38 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.409 0 N-CA-C 105.692 -1.966 . . . . 0.0 105.692 169.338 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 70.3 t80 -122.87 142.37 50.85 Favored 'General case' 0 N--CA 1.448 -0.537 0 N-CA-C 105.868 -1.901 . . . . 0.0 105.868 169.062 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 10.5 mm-40 -132.77 138.9 47.31 Favored 'General case' 0 C--O 1.236 0.369 0 N-CA-C 107.809 -1.182 . . . . 0.0 107.809 174.025 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 8.0 t70 -108.36 118.91 37.99 Favored 'General case' 0 N--CA 1.45 -0.443 0 N-CA-C 106.455 -1.683 . . . . 0.0 106.455 169.855 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 10.5 m95 -115.68 170.44 8.44 Favored 'General case' 0 CA--C 1.533 0.318 0 N-CA-C 108.73 -0.841 . . . . 0.0 108.73 170.308 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 47.8 mt-30 -129.76 57.99 1.66 Allowed 'General case' 0 CA--C 1.534 0.362 0 N-CA-C 106.823 -1.547 . . . . 0.0 106.823 169.86 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.423 HD13 HG22 ' A' ' 119' ' ' VAL . 4.5 mt -67.76 139.48 56.66 Favored 'General case' 0 N--CA 1.463 0.217 0 N-CA-C 108.197 -1.038 . . . . 0.0 108.197 -179.694 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -74.65 170.61 15.46 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 125.056 1.343 . . . . 0.0 109.083 174.408 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -143.0 138.01 15.43 Favored Pre-proline 0 N--CA 1.452 -0.35 0 C-N-CA 123.199 0.599 . . . . 0.0 110.833 176.856 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 29.2 Cg_endo -86.35 -2.88 8.59 Favored 'Trans proline' 0 CA--C 1.54 0.807 0 C-N-CA 123.302 2.668 . . . . 0.0 115.318 -172.586 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -56.78 130.88 47.51 Favored 'General case' 0 C--O 1.237 0.432 0 CA-C-N 120.356 1.435 . . . . 0.0 110.571 -174.209 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 72.41 9.4 73.16 Favored Glycine 0 CA--C 1.534 1.233 0 CA-C-O 118.399 -1.223 . . . . 0.0 114.146 174.215 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 30.0 pt20 -126.44 -167.65 1.75 Allowed 'General case' 0 CA--C 1.537 0.453 0 CA-C-N 119.253 1.526 . . . . 0.0 110.799 172.326 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 1.9 m -66.93 154.74 40.3 Favored 'General case' 0 CA--C 1.532 0.268 0 N-CA-C 116.144 1.905 . . . . 0.0 116.144 -167.96 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 9.0 tp -57.61 -34.61 69.45 Favored 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 126.255 1.822 . . . . 0.0 111.201 177.487 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 -59.22 -34.66 72.45 Favored 'General case' 0 CA--C 1.531 0.213 0 C-N-CA 124.297 1.039 . . . . 0.0 110.721 175.839 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 3.5 t -73.18 -40.46 57.82 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.283 0 CA-C-O 118.207 -0.901 . . . . 0.0 109.456 -178.477 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . 0.426 ' CG ' ' HG3' ' A' ' 49' ' ' MET . 81.1 m-85 -56.56 -50.01 73.17 Favored 'General case' 0 N--CA 1.471 0.612 0 CA-C-N 120.248 1.385 . . . . 0.0 109.376 172.482 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 91.6 mtt180 -66.25 -33.19 75.18 Favored 'General case' 0 CA--C 1.535 0.378 0 CA-C-O 119.348 -0.358 . . . . 0.0 111.515 -177.009 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 6.2 m -67.37 -49.86 62.18 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 124.224 1.01 . . . . 0.0 109.971 173.107 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 80.1 t -69.8 -26.89 31.39 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.232 0 CA-C-O 117.675 -1.155 . . . . 0.0 109.399 -170.938 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 31.5 mtm105 -56.63 -47.5 79.57 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-N 120.31 1.414 . . . . 0.0 109.746 169.791 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -63.48 -49.12 72.24 Favored Glycine 0 CA--C 1.532 1.135 0 CA-C-N 118.949 0.795 . . . . 0.0 112.241 179.445 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 16.8 mt-30 -57.78 -46.37 84.69 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-N 117.565 0.682 . . . . 0.0 110.67 179.277 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . 0.423 HG22 HD13 ' A' ' 101' ' ' LEU . 65.8 t -70.42 -41.2 78.29 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.474 0 CA-C-O 118.585 -0.722 . . . . 0.0 110.405 -176.675 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 57.7 tttm -54.54 -46.48 73.61 Favored 'General case' 0 CA--C 1.517 -0.301 0 CA-C-N 119.381 0.991 . . . . 0.0 109.178 179.917 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -64.19 -42.79 96.51 Favored 'General case' 0 N--CA 1.448 -0.539 0 C-N-CA 123.002 0.521 . . . . 0.0 110.68 -176.758 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 37.8 mmt180 -63.16 -46.54 86.69 Favored 'General case' 0 N--CA 1.47 0.541 0 O-C-N 121.808 -0.557 . . . . 0.0 110.824 178.047 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 86.1 t -70.02 -39.03 76.86 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.436 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 -176.834 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 17.2 mt-10 -60.82 -43.8 97.75 Favored 'General case' 0 C--O 1.227 -0.105 0 CA-C-N 119.392 0.996 . . . . 0.0 110.316 175.509 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 28.8 t-20 -63.71 -43.68 95.88 Favored 'General case' 0 CA--C 1.53 0.206 0 C-N-CA 122.968 0.507 . . . . 0.0 111.115 -178.011 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 45.7 tp -58.09 -49.47 76.81 Favored 'General case' 0 N--CA 1.453 -0.322 0 C-N-CA 125.525 1.53 . . . . 0.0 111.151 174.374 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 73.1 mt -64.58 -46.03 93.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 N-CA-C 108.261 -1.014 . . . . 0.0 108.261 -178.895 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -59.74 -30.8 69.08 Favored 'General case' 0 CA--C 1.536 0.438 0 CA-C-O 118.734 -0.651 . . . . 0.0 112.157 -178.084 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 19.1 ptpt -82.45 -37.65 25.11 Favored 'General case' 0 C--N 1.344 0.35 0 CA-C-O 118.033 -0.984 . . . . 0.0 112.346 176.797 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 12.7 pt -81.69 -41.68 18.77 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.328 0 CA-C-N 120.072 1.305 . . . . 0.0 113.354 -176.737 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 74.5 m . . . . . 0 C--O 1.252 1.232 0 C-N-CA 125.882 1.673 . . . . 0.0 109.607 -169.848 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 11.6 ptm . . . . . 0 N--CA 1.497 1.897 0 N-CA-C 110.744 -0.095 . . . . 0.0 110.744 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . 0.402 ' HB2' HG22 ' A' ' 30' ' ' ILE . 26.1 mttm -76.08 118.71 19.12 Favored 'General case' 0 N--CA 1.48 1.064 0 O-C-N 120.875 -1.141 . . . . 0.0 108.196 -170.262 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 90.9 mttt -86.08 136.03 33.39 Favored 'General case' 0 CA--C 1.513 -0.454 0 N-CA-C 107.935 -1.135 . . . . 0.0 107.935 177.223 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 1.8 t -122.45 150.82 26.16 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 C-N-CA 125.752 1.621 . . . . 0.0 109.45 -168.936 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 13.6 mtt -139.35 147.52 41.65 Favored 'General case' 0 C--N 1.327 -0.376 0 C-N-CA 125.677 1.591 . . . . 0.0 108.462 168.963 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 70.2 m-85 -134.51 121.98 21.78 Favored 'General case' 0 N--CA 1.456 -0.161 0 N-CA-C 105.246 -2.131 . . . . 0.0 105.246 170.502 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 1.5 p -152.35 146.28 15.33 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.244 0 CA-C-N 118.954 0.797 . . . . 0.0 111.422 -168.932 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 43.7 t -132.99 -175.73 3.88 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 126.709 2.004 . . . . 0.0 106.226 169.225 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 20.2 ptpt -58.53 -25.44 62.45 Favored 'General case' 0 N--CA 1.471 0.601 0 N-CA-C 114.104 1.15 . . . . 0.0 114.104 -171.308 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 48.3 ttt85 -140.39 159.29 42.52 Favored 'General case' 0 N--CA 1.467 0.417 0 C-N-CA 124.264 1.026 . . . . 0.0 109.054 176.428 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 6.4 t30 -72.06 -34.86 69.06 Favored 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 123.779 0.832 . . . . 0.0 112.963 -176.556 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -64.75 -55.95 16.68 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 123.197 0.599 . . . . 0.0 111.215 -169.116 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 11.1 m -88.73 146.48 25.01 Favored 'General case' 0 N--CA 1.455 -0.196 0 C-N-CA 123.549 0.74 . . . . 0.0 109.624 -176.652 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 6.4 mmm180 68.33 -57.49 0.48 Allowed 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 127.424 2.29 . . . . 0.0 111.488 176.993 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 2.5 m -69.62 -9.95 56.25 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 124.702 1.201 . . . . 0.0 113.97 -172.146 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 29.3 pt20 -64.9 -42.67 94.56 Favored 'General case' 0 C--O 1.223 -0.332 0 CA-C-O 117.732 -1.127 . . . . 0.0 113.587 -175.292 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 2.2 tpt -94.72 -36.26 11.8 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-N 120.046 1.294 . . . . 0.0 114.102 -169.199 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -62.78 -42.97 99.94 Favored 'General case' 0 N--CA 1.474 0.737 0 N-CA-C 113.526 0.936 . . . . 0.0 113.526 -168.929 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -64.46 -33.49 76.0 Favored 'General case' 0 N--CA 1.472 0.645 0 CA-C-N 118.674 0.67 . . . . 0.0 109.366 175.6 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -51.94 -57.57 12.5 Favored Glycine 0 C--N 1.342 0.888 0 C-N-CA 125.422 1.487 . . . . 0.0 110.439 175.647 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 13.5 m-85 -70.8 -31.89 68.79 Favored 'General case' 0 CA--C 1.505 -0.757 0 O-C-N 121.647 -0.914 . . . . 0.0 112.724 -179.172 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -68.94 -34.41 75.31 Favored 'General case' 0 N--CA 1.449 -0.521 0 C-N-CA 119.305 -0.958 . . . . 0.0 111.155 -174.761 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 2.4 ptmt -65.39 -25.88 67.75 Favored 'General case' 0 N--CA 1.471 0.621 0 CA-C-N 119.085 0.857 . . . . 0.0 111.717 172.952 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 8.8 m -83.21 -57.07 3.42 Favored 'General case' 0 N--CA 1.444 -0.728 0 C-N-CA 125.198 1.399 . . . . 0.0 109.538 -173.96 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 55.5 mt -74.9 -36.34 62.23 Favored 'General case' 0 C--N 1.331 -0.204 0 C-N-CA 124.753 1.221 . . . . 0.0 110.213 -175.005 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -93.34 9.4 74.49 Favored Glycine 0 C--N 1.338 0.675 0 C-N-CA 124.988 1.28 . . . . 0.0 113.068 -176.161 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -50.89 122.73 7.85 Favored 'General case' 0 CA--C 1.534 0.327 0 C-N-CA 124.841 1.257 . . . . 0.0 110.524 -175.257 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 76.54 -8.76 25.29 Favored Glycine 0 CA--C 1.534 1.264 0 C-N-CA 124.371 0.986 . . . . 0.0 114.426 179.652 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 60.2 mttm -98.67 -46.67 5.61 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 119.19 1.495 . . . . 0.0 110.403 179.254 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.402 HG22 ' HB2' ' A' ' 2' ' ' LYS . 24.3 pt -139.24 149.25 23.14 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.585 0 C-N-CA 123.632 0.773 . . . . 0.0 109.388 -169.76 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -113.09 106.41 14.64 Favored 'General case' 0 N--CA 1.463 0.187 0 C-N-CA 125.132 1.373 . . . . 0.0 109.272 -169.899 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 2.5 t -84.64 137.68 20.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 119.316 0.962 . . . . 0.0 109.742 -179.449 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 14.5 m -145.32 91.7 2.16 Favored 'General case' 0 N--CA 1.446 -0.669 0 N-CA-C 106.037 -1.838 . . . . 0.0 106.037 170.368 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 45.0 m -89.28 68.93 8.13 Favored 'General case' 0 CA--C 1.532 0.273 0 O-C-N 121.287 -0.883 . . . . 0.0 111.017 -171.363 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 11.9 m -61.89 164.72 6.1 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 125.895 1.678 . . . . 0.0 110.715 170.198 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -158.6 -167.64 19.67 Favored Glycine 0 C--N 1.337 0.638 0 N-CA-C 107.752 -2.139 . . . . 0.0 107.752 -170.057 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 17.3 mt -123.96 -3.72 8.1 Favored 'General case' 0 C--N 1.327 -0.376 0 C-N-CA 124.113 0.965 . . . . 0.0 111.592 -179.405 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 36.7 mt-10 -142.63 154.15 44.12 Favored 'General case' 0 C--O 1.238 0.499 0 C-N-CA 128.052 2.541 . . . . 0.0 106.511 169.297 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 60.7 p -148.53 160.78 42.75 Favored 'General case' 0 N--CA 1.446 -0.66 0 CA-C-O 122.555 1.169 . . . . 0.0 113.795 -179.693 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 93.0 p -164.45 -144.45 0.08 Allowed 'General case' 0 N--CA 1.443 -0.817 0 CA-C-N 112.531 -2.122 . . . . 0.0 105.94 -168.841 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 9.2 ttt180 -136.31 173.0 12.18 Favored 'General case' 0 C--O 1.232 0.134 0 N-CA-C 106.311 -1.737 . . . . 0.0 106.311 168.368 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 5.6 m -81.89 175.16 0.77 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.609 0 C-N-CA 122.918 0.487 . . . . 0.0 110.038 -178.845 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 97.0 m-70 -90.98 150.33 41.66 Favored Pre-proline 0 CA--C 1.542 0.669 0 CA-C-O 119.3 -0.381 . . . . 0.0 111.686 -174.916 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -63.4 -45.64 11.37 Favored 'Trans proline' 0 C--N 1.349 0.59 0 C-N-CA 122.76 2.306 . . . . 0.0 113.31 -171.216 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . 0.407 ' HB ' ' CZ ' ' A' ' 112' ' ' PHE . 5.8 m -69.0 -22.74 64.06 Favored 'General case' 0 CA--C 1.54 0.558 0 O-C-N 121.681 -0.637 . . . . 0.0 110.364 -178.321 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -61.11 -56.68 18.1 Favored 'General case' 0 CA--C 1.509 -0.632 0 N-CA-C 108.197 -1.038 . . . . 0.0 108.197 169.85 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 75.9 mt -56.8 -38.76 60.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 N-CA-C 108.427 -0.953 . . . . 0.0 108.427 -175.229 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -62.47 -50.48 71.27 Favored 'General case' 0 N--CA 1.452 -0.332 0 CA-C-N 118.87 0.759 . . . . 0.0 111.827 -178.845 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 35.9 mmt -72.18 -31.78 66.23 Favored 'General case' 0 N--CA 1.472 0.648 0 CA-C-O 122.584 1.183 . . . . 0.0 110.806 -179.112 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -72.21 -33.13 67.37 Favored 'General case' 0 N--CA 1.443 -0.801 0 N-CA-C 106.855 -1.535 . . . . 0.0 106.855 -177.911 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 41.3 tt0 -74.7 -19.94 60.05 Favored 'General case' 0 N--CA 1.446 -0.67 0 O-C-N 120.925 -1.109 . . . . 0.0 110.525 172.441 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 20.3 mm-40 -64.49 -33.33 75.63 Favored 'General case' 0 CA--C 1.532 0.265 0 CA-C-N 119.576 1.08 . . . . 0.0 109.982 169.771 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 16.4 m -91.17 12.31 2.17 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.736 0 N-CA-C 112.275 0.472 . . . . 0.0 112.275 169.192 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 73.08 13.67 79.25 Favored Glycine 0 CA--C 1.531 1.089 0 C-N-CA 124.53 1.062 . . . . 0.0 113.695 174.675 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 17.2 mt -91.23 143.95 10.17 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.239 0 C-N-CA 124.438 1.095 . . . . 0.0 110.001 -177.476 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 7.2 t70 -104.49 124.6 49.56 Favored 'General case' 0 C--O 1.235 0.298 0 N-CA-C 106.628 -1.619 . . . . 0.0 106.628 168.902 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 5.8 pt -120.06 -21.81 4.02 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.697 0 C-N-CA 124.686 1.195 . . . . 0.0 109.526 169.073 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -38.67 -35.91 0.22 Allowed 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 129.252 3.021 . . . . 0.0 113.778 169.326 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -72.46 -9.75 74.0 Favored Glycine 0 CA--C 1.535 1.321 0 C-N-CA 124.649 1.118 . . . . 0.0 114.229 179.963 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 26.2 mt-30 -68.1 140.08 56.21 Favored 'General case' 0 N--CA 1.451 -0.401 0 CA-C-N 119.753 1.777 . . . . 0.0 110.265 176.764 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 1.2 m -155.94 -51.88 0.08 Allowed 'General case' 0 N--CA 1.438 -1.046 0 N-CA-C 104.119 -2.548 . . . . 0.0 104.119 168.412 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 3.9 m 68.9 160.03 0.18 Allowed 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 126.677 1.991 . . . . 0.0 114.071 169.095 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -95.32 163.61 21.23 Favored Pre-proline 0 C--O 1.241 0.621 0 C-N-CA 124.968 1.307 . . . . 0.0 109.754 -172.833 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -62.05 136.24 59.77 Favored 'Trans proline' 0 N--CA 1.449 -1.095 0 N-CA-C 108.203 -1.499 . . . . 0.0 108.203 169.762 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 8.1 tt -61.6 -19.15 20.3 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.498 0 C-N-CA 124.248 1.019 . . . . 0.0 111.03 -177.958 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 12.1 mt-10 -67.29 -25.48 66.06 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 125.533 1.533 . . . . 0.0 110.391 -179.748 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 15.4 t-20 -71.82 1.29 7.21 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 124.702 1.201 . . . . 0.0 113.112 -179.632 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 42.5 m-85 -130.74 -174.18 3.29 Favored 'General case' 0 C--O 1.236 0.388 0 C-N-CA 126.585 1.954 . . . . 0.0 109.136 -177.707 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 57.1 t-20 -135.05 140.19 45.38 Favored 'General case' 0 N--CA 1.446 -0.628 0 N-CA-C 107.397 -1.335 . . . . 0.0 107.397 169.382 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -72.22 -25.13 61.53 Favored 'General case' 0 N--CA 1.435 -1.207 0 N-CA-C 109.08 -0.711 . . . . 0.0 109.08 -178.157 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 35.1 t70 -63.71 -24.76 67.91 Favored 'General case' 0 N--CA 1.447 -0.609 0 O-C-N 123.254 0.346 . . . . 0.0 111.868 -179.132 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -78.08 -28.32 48.73 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 123.52 0.728 . . . . 0.0 111.925 176.036 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 14.7 m-85 -80.38 170.96 15.67 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 125.805 1.642 . . . . 0.0 111.695 -178.568 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 22.9 t70 -119.63 -39.07 2.9 Favored 'General case' 0 N--CA 1.464 0.272 0 C-N-CA 123.185 0.594 . . . . 0.0 111.599 177.318 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -139.32 133.96 39.73 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.494 0 CA-C-O 121.98 0.895 . . . . 0.0 110.639 -170.204 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 70.4 t -142.69 133.45 23.77 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.632 0 N-CA-C 105.746 -1.946 . . . . 0.0 105.746 -176.382 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 33.6 mm -124.94 122.09 62.59 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.527 0 N-CA-C 106.448 -1.686 . . . . 0.0 106.448 -171.603 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 58.7 m -87.09 122.59 31.12 Favored 'General case' 0 N--CA 1.441 -0.884 0 N-CA-C 105.204 -2.147 . . . . 0.0 105.204 169.0 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 69.3 mt -83.92 3.39 34.25 Favored 'General case' 0 C--N 1.327 -0.37 0 O-C-N 121.711 -0.618 . . . . 0.0 110.341 175.153 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 29.7 p -160.82 141.57 11.56 Favored 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 124.838 1.255 . . . . 0.0 108.249 169.728 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 57.97 -162.2 9.71 Favored Glycine 0 CA--C 1.534 1.223 0 C-N-CA 124.581 1.086 . . . . 0.0 114.523 170.26 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 10.9 p -152.17 147.75 26.8 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 125.367 1.467 . . . . 0.0 107.536 170.303 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 59.1 44.2 96.5 Favored Glycine 0 CA--C 1.533 1.176 0 N-CA-C 111.145 -0.782 . . . . 0.0 111.145 -178.107 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 29.8 m -79.8 52.53 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.545 0.775 0 C-N-CA 124.845 1.258 . . . . 0.0 112.799 -169.589 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 17.5 t-20 56.06 53.09 9.51 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 126.295 1.838 . . . . 0.0 108.827 -175.275 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -147.74 147.17 26.5 Favored Pre-proline 0 CA--C 1.54 0.579 0 C-N-CA 126.913 2.085 . . . . 0.0 107.34 -169.28 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_exo -64.24 138.34 60.68 Favored 'Trans proline' 0 CA--C 1.542 0.892 0 CA-C-N 120.692 1.283 . . . . 0.0 112.693 -171.878 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -67.15 -28.37 40.77 Favored 'Trans proline' 0 N--CA 1.458 -0.567 0 C-N-CA 122.667 2.245 . . . . 0.0 114.425 -169.393 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 5.1 pm0 -62.13 -15.92 48.95 Favored 'General case' 0 CA--C 1.536 0.42 0 CA-C-N 120.404 1.456 . . . . 0.0 112.53 -178.275 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 96.4 m95 -73.38 -49.36 27.62 Favored 'General case' 0 N--CA 1.451 -0.394 0 C-N-CA 123.242 0.617 . . . . 0.0 110.848 174.371 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 28.6 m -79.87 -0.29 3.79 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.359 0 C-N-CA 123.615 0.766 . . . . 0.0 112.717 -178.446 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 57.7 p -113.33 25.32 11.42 Favored 'General case' 0 C--O 1.237 0.409 0 CA-C-N 119.547 1.067 . . . . 0.0 113.155 174.033 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 76.2 mm-40 -66.57 174.22 2.94 Favored 'General case' 0 CA--C 1.539 0.528 0 CA-C-N 118.611 0.641 . . . . 0.0 112.084 176.251 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 32.7 mm-40 -54.57 -29.44 51.25 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 124.038 0.935 . . . . 0.0 111.723 -169.765 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 3.3 tt -133.7 130.63 56.36 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.672 0 N-CA-C 104.041 -2.577 . . . . 0.0 104.041 168.388 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 44.1 t80 -120.86 142.03 50.03 Favored 'General case' 0 N--CA 1.448 -0.546 0 N-CA-C 105.921 -1.881 . . . . 0.0 105.921 169.221 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 20.6 mm-40 -139.79 144.49 37.39 Favored 'General case' 0 C--O 1.236 0.373 0 N-CA-C 107.624 -1.25 . . . . 0.0 107.624 170.112 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 6.0 t0 -110.56 107.69 17.39 Favored 'General case' 0 C--O 1.238 0.484 0 N-CA-C 105.168 -2.16 . . . . 0.0 105.168 169.093 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -99.53 125.37 45.29 Favored 'General case' 0 N--CA 1.454 -0.269 0 C-N-CA 123.377 0.671 . . . . 0.0 109.546 -173.301 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 34.2 mm-40 -89.05 116.98 27.73 Favored 'General case' 0 N--CA 1.456 -0.163 0 N-CA-C 105.416 -2.068 . . . . 0.0 105.416 168.823 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.517 HD13 HG22 ' A' ' 119' ' ' VAL . 28.9 mt -142.95 127.69 18.17 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 104.638 -2.356 . . . . 0.0 104.638 -179.738 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 26.5 mm-40 -63.48 157.77 22.59 Favored 'General case' 0 CA--C 1.534 0.333 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 172.722 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -117.13 135.03 22.98 Favored Pre-proline 0 N--CA 1.45 -0.426 0 C-N-CA 124.526 1.13 . . . . 0.0 108.105 169.687 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -89.09 -8.68 4.72 Favored 'Trans proline' 0 N--CA 1.453 -0.882 0 C-N-CA 122.285 1.99 . . . . 0.0 114.674 -170.138 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -50.7 -51.4 49.97 Favored 'General case' 0 N--CA 1.472 0.672 0 CA-C-N 120.554 1.525 . . . . 0.0 113.14 -169.31 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -84.31 11.84 56.93 Favored Glycine 0 CA--C 1.532 1.147 0 CA-C-O 118.702 -1.055 . . . . 0.0 113.396 -176.49 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 9.8 mt-30 -130.98 176.45 8.23 Favored 'General case' 0 CA--C 1.542 0.664 0 CA-C-N 118.847 1.324 . . . . 0.0 110.654 -169.683 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 13.9 m -78.23 169.7 17.83 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 124.604 1.161 . . . . 0.0 112.242 -173.592 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 34.4 tp -55.19 -33.93 63.45 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 125.86 1.664 . . . . 0.0 113.058 -178.11 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 5.9 pt-20 -56.99 -34.71 68.41 Favored 'General case' 0 N--CA 1.463 0.208 0 C-N-CA 123.483 0.713 . . . . 0.0 111.608 174.782 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 16.0 t -76.63 -38.52 30.96 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.525 0 CA-C-O 118.02 -0.991 . . . . 0.0 109.801 -176.874 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . 0.407 ' CZ ' ' HB ' ' A' ' 45' ' ' THR . 85.2 m-85 -57.02 -48.13 79.23 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-N 120.377 1.444 . . . . 0.0 109.547 171.545 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 85.6 mtt180 -63.72 -39.46 94.35 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 122.916 0.486 . . . . 0.0 111.247 -179.613 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 5.7 m -67.34 -49.6 63.37 Favored 'General case' 0 N--CA 1.452 -0.339 0 C-N-CA 124.203 1.001 . . . . 0.0 110.226 177.975 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 59.2 t -65.56 -35.13 74.52 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.306 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 -173.697 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 58.7 ttp85 -56.42 -45.18 80.84 Favored 'General case' 0 CA--C 1.537 0.475 0 CA-C-N 118.499 0.59 . . . . 0.0 109.76 174.077 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -64.18 -51.63 51.24 Favored Glycine 0 CA--C 1.53 1.006 0 CA-C-N 118.346 0.521 . . . . 0.0 112.208 175.922 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 9.4 mt-30 -61.52 -43.21 99.27 Favored 'General case' 0 N--CA 1.468 0.428 0 CA-C-N 118.258 1.029 . . . . 0.0 110.713 -175.364 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . 0.517 HG22 HD13 ' A' ' 101' ' ' LEU . 95.6 t -70.58 -40.66 77.48 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.377 0 CA-C-O 118.399 -0.81 . . . . 0.0 109.265 -176.011 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 58.2 tttm -54.94 -45.85 74.88 Favored 'General case' 0 CA--C 1.518 -0.276 0 CA-C-N 119.275 0.943 . . . . 0.0 109.093 174.906 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 41.5 tt0 -66.84 -43.16 84.43 Favored 'General case' 0 N--CA 1.45 -0.446 0 C-N-CA 122.761 0.424 . . . . 0.0 111.043 -173.794 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 36.3 mtt-85 -66.21 -40.75 90.56 Favored 'General case' 0 N--CA 1.471 0.599 0 O-C-N 121.413 -0.804 . . . . 0.0 111.722 176.857 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 90.2 t -68.77 -37.61 77.7 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.499 0 N-CA-C 108.952 -0.758 . . . . 0.0 108.952 179.289 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 13.4 mt-10 -60.01 -43.8 94.99 Favored 'General case' 0 C--O 1.226 -0.174 0 CA-C-N 119.308 0.958 . . . . 0.0 110.064 174.13 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 29.2 t-20 -63.02 -45.27 93.13 Favored 'General case' 0 CA--C 1.53 0.204 0 CA-C-N 118.124 0.42 . . . . 0.0 111.103 -179.489 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 38.6 tp -57.75 -49.11 77.66 Favored 'General case' 0 N--CA 1.452 -0.364 0 C-N-CA 124.684 1.194 . . . . 0.0 110.489 176.715 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 70.0 mt -63.49 -46.78 94.23 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 N-CA-C 108.12 -1.067 . . . . 0.0 108.12 -179.408 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -59.13 -29.64 67.54 Favored 'General case' 0 CA--C 1.535 0.377 0 CA-C-O 118.325 -0.845 . . . . 0.0 112.251 -178.426 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . 0.25 19.3 ptpt -83.17 -39.05 21.52 Favored 'General case' 0 C--N 1.343 0.323 0 CA-C-O 117.863 -1.065 . . . . 0.0 112.616 175.421 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 12.6 pt -82.46 -40.19 16.72 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.362 0 CA-C-N 120.207 1.367 . . . . 0.0 113.497 -175.166 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 70.8 m . . . . . 0 C--O 1.253 1.24 0 C-N-CA 125.692 1.597 . . . . 0.0 109.848 -170.05 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 9.8 ptm . . . . . 0 N--CA 1.496 1.872 0 N-CA-C 110.622 -0.14 . . . . 0.0 110.622 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 27.5 mttm -75.09 121.25 21.75 Favored 'General case' 0 N--CA 1.48 1.045 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 -171.24 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 91.6 mttt -88.15 134.75 33.69 Favored 'General case' 0 CA--C 1.512 -0.491 0 N-CA-C 108.075 -1.083 . . . . 0.0 108.075 177.201 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 1.9 t -123.35 147.93 27.49 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.648 0 C-N-CA 126.574 1.95 . . . . 0.0 108.89 -168.994 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 34.3 mtt -137.02 150.5 48.14 Favored 'General case' 0 C--N 1.325 -0.493 0 C-N-CA 124.671 1.189 . . . . 0.0 108.215 168.049 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 35.7 m-85 -129.29 129.54 45.03 Favored 'General case' 0 CA--C 1.515 -0.397 0 N-CA-C 103.833 -2.654 . . . . 0.0 103.833 169.715 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 1.1 p -152.78 136.39 8.17 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.366 0 CA-C-O 121.352 0.596 . . . . 0.0 109.587 -169.276 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 49.9 t -122.08 174.66 6.79 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 127.317 2.247 . . . . 0.0 107.182 169.661 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 51.5 tttm -63.78 -32.28 73.73 Favored 'General case' 0 CA--C 1.539 0.531 0 O-C-N 121.226 -0.921 . . . . 0.0 111.303 179.275 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 74.4 mtm-85 -108.63 162.94 13.68 Favored 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 124.815 1.246 . . . . 0.0 108.003 169.615 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 7.3 t30 -70.55 -54.77 10.8 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-O 121.366 0.603 . . . . 0.0 110.296 172.625 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 12.4 m -89.75 46.39 1.36 Allowed 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 123.499 0.72 . . . . 0.0 111.454 -168.953 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 50.6 m -139.78 118.17 12.12 Favored 'General case' 0 N--CA 1.448 -0.548 0 N-CA-C 106.81 -1.552 . . . . 0.0 106.81 170.073 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 79.2 mtt180 64.96 -26.88 0.09 Allowed 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 129.02 2.928 . . . . 0.0 115.218 176.537 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 1.2 m -76.67 -140.79 0.02 OUTLIER 'General case' 0 CA--C 1.549 0.916 0 N-CA-C 104.658 -2.349 . . . . 0.0 104.658 168.036 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 22.5 pt20 49.43 26.44 1.65 Allowed 'General case' 0 N--CA 1.475 0.813 0 CA-C-N 121.047 1.749 . . . . 0.0 112.455 178.311 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' MET . . . . . 0.428 ' HG2' ' CE ' ' A' ' 50' ' ' MET . 0.0 OUTLIER -171.42 -49.34 0.02 OUTLIER 'General case' 0 N--CA 1.446 -0.663 0 C-N-CA 127.748 2.419 . . . . 0.0 108.515 -175.102 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . 0.407 ' HA ' ' CG1' ' A' ' 119' ' ' VAL . . . -71.88 -45.94 59.53 Favored 'General case' 0 C--N 1.343 0.321 0 C-N-CA 123.448 0.699 . . . . 0.0 112.749 -169.562 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -63.71 -35.58 81.02 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 169.493 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -49.75 -66.06 2.5 Favored Glycine 0 C--N 1.341 0.811 0 C-N-CA 126.021 1.772 . . . . 0.0 110.745 174.851 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 2.5 m-85 -59.75 -27.67 66.7 Favored 'General case' 0 CA--C 1.512 -0.497 0 O-C-N 121.103 -1.234 . . . . 0.0 112.519 178.492 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -71.65 -32.8 68.31 Favored 'General case' 0 N--CA 1.447 -0.599 0 CA-C-O 117.71 -1.138 . . . . 0.0 112.117 -176.526 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.29 -30.44 70.3 Favored 'General case' 0 N--CA 1.476 0.848 0 CA-C-N 120.517 1.508 . . . . 0.0 110.903 172.065 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 18.8 m -75.92 -56.63 4.49 Favored 'General case' 0 N--CA 1.448 -0.54 0 C-N-CA 124.638 1.175 . . . . 0.0 111.078 -176.864 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 71.9 mt -78.56 -38.06 41.25 Favored 'General case' 0 C--N 1.33 -0.267 0 C-N-CA 124.3 1.04 . . . . 0.0 109.807 -173.771 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -80.54 2.75 76.98 Favored Glycine 0 CA--C 1.527 0.811 0 C-N-CA 124.838 1.209 . . . . 0.0 112.971 179.929 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -53.35 129.74 32.85 Favored 'General case' 0 C--O 1.236 0.389 0 CA-C-N 118.462 1.131 . . . . 0.0 109.301 179.809 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 75.44 5.32 77.33 Favored Glycine 0 CA--C 1.536 1.397 0 C-N-CA 124.378 0.99 . . . . 0.0 114.464 -178.606 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 41.0 mttp -128.23 -52.32 1.29 Allowed 'General case' 0 N--CA 1.472 0.671 0 CA-C-N 119.087 1.444 . . . . 0.0 111.373 -172.375 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 29.5 pt -140.02 147.43 23.67 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.502 0 C-N-CA 123.57 0.748 . . . . 0.0 109.59 -169.407 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -105.32 104.85 14.66 Favored 'General case' 0 N--CA 1.464 0.261 0 C-N-CA 124.889 1.275 . . . . 0.0 109.035 -172.825 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 9.8 p -80.24 137.47 21.48 Favored 'Isoleucine or valine' 0 C--O 1.236 0.357 0 CA-C-N 119.126 0.876 . . . . 0.0 109.431 173.86 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 6.6 m -134.56 117.9 16.67 Favored 'General case' 0 N--CA 1.434 -1.264 0 N-CA-C 104.686 -2.339 . . . . 0.0 104.686 173.766 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 2.4 m -89.74 39.62 0.96 Allowed 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 113.01 0.744 . . . . 0.0 113.01 -169.643 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 1.5 m -65.19 159.68 23.05 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 124.515 1.126 . . . . 0.0 111.077 178.549 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -177.64 -165.85 33.35 Favored Glycine 0 C--N 1.337 0.618 0 N-CA-C 108.678 -1.769 . . . . 0.0 108.678 -175.542 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 12.4 mt -132.49 160.59 36.04 Favored 'General case' 0 N--CA 1.445 -0.679 0 C-N-CA 126.547 1.939 . . . . 0.0 107.773 177.473 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 21.5 mt-10 56.13 18.04 3.02 Favored 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 124.627 1.171 . . . . 0.0 112.885 178.639 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 13.7 p -76.35 163.53 26.91 Favored 'General case' 0 N--CA 1.435 -1.179 0 N-CA-C 115.054 1.501 . . . . 0.0 115.054 -167.841 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 8.0 m -153.82 177.21 11.25 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 129.15 2.98 . . . . 0.0 105.98 -169.735 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 53.6 ttt180 -88.9 153.13 21.29 Favored 'General case' 0 CA--C 1.533 0.297 0 O-C-N 121.07 -1.019 . . . . 0.0 109.737 -177.505 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 1.9 p -44.72 149.54 0.25 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.439 0 C-N-CA 128.035 2.534 . . . . 0.0 112.568 169.987 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 23.0 m170 -88.69 152.81 49.59 Favored Pre-proline 0 CA--C 1.543 0.7 0 C-N-CA 123.274 0.63 . . . . 0.0 111.2 -179.563 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -59.08 -52.98 4.1 Favored 'Trans proline' 0 C--N 1.351 0.665 0 C-N-CA 124.149 3.233 . . . . 0.0 114.204 -169.091 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 7.3 m -67.37 -24.58 65.71 Favored 'General case' 0 CA--C 1.537 0.445 0 CA-C-O 119.215 -0.421 . . . . 0.0 110.651 -171.407 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -56.8 -53.8 53.7 Favored 'General case' 0 CA--C 1.511 -0.548 0 N-CA-C 109.177 -0.675 . . . . 0.0 109.177 173.231 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 52.1 mt -60.6 -38.59 78.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 -170.424 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -62.92 -49.13 75.98 Favored 'General case' 0 N--CA 1.454 -0.243 0 CA-C-N 118.595 0.634 . . . . 0.0 111.244 178.957 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 30.2 mmt -67.46 -37.14 82.48 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-O 122.779 1.276 . . . . 0.0 110.968 179.964 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' MET . . . . . 0.428 ' CE ' ' HG2' ' A' ' 17' ' ' MET . 0.0 OUTLIER -74.3 -31.61 62.55 Favored 'General case' 0 N--CA 1.443 -0.779 0 N-CA-C 107.2 -1.408 . . . . 0.0 107.2 -176.08 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 40.2 tt0 -72.07 -20.84 61.6 Favored 'General case' 0 N--CA 1.449 -0.52 0 O-C-N 121.211 -0.931 . . . . 0.0 110.788 170.699 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 20.6 mm-40 -66.01 -32.23 73.59 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-N 119.571 1.078 . . . . 0.0 109.89 169.912 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 15.7 m -91.97 13.63 1.98 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.835 0 CA-C-N 118.361 0.528 . . . . 0.0 112.036 169.037 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 75.82 15.97 80.97 Favored Glycine 0 CA--C 1.532 1.123 0 C-N-CA 124.99 1.281 . . . . 0.0 113.981 173.006 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 3.5 mt -99.54 140.8 18.04 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.113 0 C-N-CA 124.588 1.155 . . . . 0.0 111.201 -171.613 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 3.0 t70 -97.04 130.72 44.31 Favored 'General case' 0 CA--C 1.528 0.12 0 C-N-CA 125.421 1.489 . . . . 0.0 108.886 169.857 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 6.5 pt -132.58 -31.27 0.55 Allowed 'Isoleucine or valine' 0 C--O 1.216 -0.689 0 C-N-CA 125.78 1.632 . . . . 0.0 109.501 169.673 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -15.76 -36.37 0.0 OUTLIER 'General case' 0 CA--C 1.545 0.763 1 C-N-CA 131.768 4.027 . . . . 0.0 118.5 169.992 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -110.25 37.2 3.86 Favored Glycine 0 CA--C 1.534 1.251 0 C-N-CA 125.921 1.724 . . . . 0.0 113.858 -179.507 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 6.3 mt-30 -59.88 -30.48 69.02 Favored 'General case' 0 N--CA 1.474 0.75 0 CA-C-N 119.63 1.715 . . . . 0.0 114.232 -174.719 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -57.8 123.73 16.74 Favored 'General case' 0 C--O 1.236 0.342 0 C-N-CA 124.043 0.937 . . . . 0.0 109.135 -169.421 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 75.2 m -145.96 177.28 9.06 Favored 'General case' 0 N--CA 1.443 -0.802 0 C-N-CA 126.452 1.901 . . . . 0.0 107.019 -169.369 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -59.26 153.95 44.48 Favored Pre-proline 0 C--O 1.239 0.543 0 C-N-CA 123.691 0.796 . . . . 0.0 111.49 175.756 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -63.48 154.16 70.34 Favored 'Trans proline' 0 N--CA 1.454 -0.826 0 C-N-CA 122.49 2.127 . . . . 0.0 109.84 170.879 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 3.2 tt -61.95 -24.41 34.32 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.522 0 O-C-N 121.701 -0.624 . . . . 0.0 111.212 -175.764 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 12.6 mt-10 -65.96 -26.23 67.48 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 124.751 1.22 . . . . 0.0 110.81 -177.377 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 7.6 t-20 -63.12 -23.89 67.65 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 124.673 1.189 . . . . 0.0 111.942 179.085 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 75.0 m-85 -104.62 -174.68 2.59 Favored 'General case' 0 C--O 1.236 0.367 0 C-N-CA 126.19 1.796 . . . . 0.0 110.357 -174.819 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 56.3 t-20 -135.82 132.83 37.16 Favored 'General case' 0 N--CA 1.443 -0.819 0 N-CA-C 106.176 -1.787 . . . . 0.0 106.176 168.855 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -75.0 -19.75 59.95 Favored 'General case' 0 N--CA 1.431 -1.38 0 C-N-CA 120.125 -0.63 . . . . 0.0 109.389 -176.585 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 35.5 t70 -65.03 -24.71 67.57 Favored 'General case' 0 N--CA 1.442 -0.829 0 O-C-N 122.211 -0.305 . . . . 0.0 111.235 179.127 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -77.0 -28.81 55.18 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 123.773 0.829 . . . . 0.0 111.779 173.872 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 11.6 m-85 -77.35 168.21 20.41 Favored 'General case' 0 N--CA 1.451 -0.42 0 C-N-CA 125.261 1.424 . . . . 0.0 111.342 178.863 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -117.28 -39.21 3.22 Favored 'General case' 0 C--O 1.234 0.266 0 C-N-CA 123.213 0.605 . . . . 0.0 111.249 177.256 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -138.2 135.02 44.73 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.693 0 CA-C-O 122.021 0.915 . . . . 0.0 109.943 -169.887 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 75.6 t -142.09 133.89 26.65 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.451 0 N-CA-C 105.905 -1.887 . . . . 0.0 105.905 176.708 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 39.7 mm -117.78 102.82 13.89 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.78 0 N-CA-C 105.253 -2.129 . . . . 0.0 105.253 -170.437 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 47.2 m -101.34 70.61 1.32 Allowed 'General case' 0 N--CA 1.439 -1.014 0 N-CA-C 106.458 -1.682 . . . . 0.0 106.458 -172.947 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -71.22 23.33 0.04 OUTLIER 'General case' 0 CA--C 1.542 0.655 0 N-CA-C 114.136 1.162 . . . . 0.0 114.136 -170.075 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 74.9 m -146.3 55.64 1.16 Allowed 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 125.823 1.649 . . . . 0.0 109.996 172.33 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 81.34 -167.0 48.55 Favored Glycine 0 CA--C 1.531 1.034 0 O-C-N 121.363 -0.835 . . . . 0.0 112.663 176.981 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 15.0 p -151.68 150.19 29.96 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 123.649 0.779 . . . . 0.0 110.375 -169.952 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 61.26 28.25 68.91 Favored Glycine 0 CA--C 1.531 1.036 0 C-N-CA 123.208 0.433 . . . . 0.0 112.081 -179.014 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 32.8 m -71.45 -34.43 53.25 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.612 0 CA-C-N 117.479 0.64 . . . . 0.0 111.719 -169.303 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 21.2 t-20 -178.13 -43.02 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 128.792 2.837 . . . . 0.0 106.14 174.318 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.437 ' HA ' ' HD3' ' A' ' 87' ' ' PRO . 3.0 tt -44.09 139.68 3.03 Favored Pre-proline 0 CA--C 1.547 0.859 0 C-N-CA 128.202 2.601 . . . . 0.0 111.295 169.659 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . 0.437 ' HD3' ' HA ' ' A' ' 86' ' ' LEU . 51.8 Cg_exo -65.17 150.98 86.99 Favored 'Trans proline' 0 C--N 1.356 0.936 0 C-N-CA 121.974 1.782 . . . . 0.0 115.658 -169.727 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . 0.431 ' HD3' ' HA ' ' A' ' 87' ' ' PRO . 51.2 Cg_exo -64.51 -30.47 61.63 Favored 'Trans proline' 0 C--N 1.349 0.594 0 C-N-CA 122.491 2.127 . . . . 0.0 114.972 -174.661 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -56.35 -21.05 22.05 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-N 119.49 1.041 . . . . 0.0 112.739 -177.026 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 99.4 m95 -80.06 -28.75 39.16 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 124.948 1.299 . . . . 0.0 112.188 -179.56 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 16.1 m -100.67 -4.35 9.29 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.41 0 C-N-CA 124.946 1.299 . . . . 0.0 112.019 179.623 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 59.8 p -103.27 30.37 4.95 Favored 'General case' 0 CA--C 1.535 0.39 0 CA-C-N 119.325 0.966 . . . . 0.0 112.449 175.644 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 46.1 mm-40 -72.33 175.06 6.47 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 123.344 0.658 . . . . 0.0 111.275 -175.354 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 36.2 mm-40 -61.54 -26.05 67.69 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-O 120.832 0.348 . . . . 0.0 110.513 179.758 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 4.1 tt -136.54 124.49 34.3 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.523 0 N-CA-C 104.997 -2.223 . . . . 0.0 104.997 169.169 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 20.9 t80 -103.49 135.01 45.89 Favored 'General case' 0 CA--C 1.538 0.49 0 N-CA-C 105.755 -1.943 . . . . 0.0 105.755 169.581 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 15.6 mm-40 -136.26 162.25 33.51 Favored 'General case' 0 C--O 1.235 0.291 0 N-CA-C 108.552 -0.907 . . . . 0.0 108.552 170.294 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 5.2 t0 -178.79 126.95 0.1 Allowed 'General case' 0 C--N 1.326 -0.439 0 C-N-CA 126.869 2.068 . . . . 0.0 105.643 -169.519 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 6.6 m0 -143.42 149.0 37.01 Favored 'General case' 0 C--N 1.333 -0.136 0 C-N-CA 122.616 0.366 . . . . 0.0 110.788 -170.933 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 1.9 tp-100 -82.73 54.04 2.56 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 124.338 1.055 . . . . 0.0 109.508 175.909 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 1.1 mp -64.28 147.13 53.16 Favored 'General case' 0 C--N 1.34 0.184 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 178.209 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 69.2 mm-40 -77.8 166.4 22.97 Favored 'General case' 0 CA--C 1.536 0.413 0 N-CA-C 108.229 -1.026 . . . . 0.0 108.229 169.496 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -135.08 137.74 27.69 Favored Pre-proline 0 CA--C 1.536 0.426 0 C-N-CA 124.161 0.984 . . . . 0.0 109.334 171.86 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 21.4 Cg_endo -92.94 3.77 3.43 Favored 'Trans proline' 0 N--CA 1.452 -0.944 0 C-N-CA 122.318 2.012 . . . . 0.0 114.781 -171.661 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -55.81 120.88 8.04 Favored 'General case' 0 C--O 1.237 0.399 0 CA-C-N 120.398 1.454 . . . . 0.0 110.841 -174.571 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 68.65 5.48 45.04 Favored Glycine 0 CA--C 1.534 1.274 0 CA-C-O 118.873 -0.96 . . . . 0.0 114.151 179.902 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 7.0 mt-30 -97.12 167.74 10.87 Favored 'General case' 0 CA--C 1.537 0.47 0 CA-C-N 118.882 1.341 . . . . 0.0 109.864 179.428 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 15.6 m -69.95 165.98 20.57 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 124.097 0.959 . . . . 0.0 111.754 179.762 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 64.7 mt -60.29 -26.77 66.76 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 123.924 0.89 . . . . 0.0 112.452 -175.594 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 5.8 pt-20 -56.29 -35.27 67.32 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 118.773 0.715 . . . . 0.0 111.162 173.934 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 11.9 t -77.27 -41.09 30.14 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.309 0 CA-C-O 118.203 -0.903 . . . . 0.0 109.823 -178.951 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 62.7 m-85 -57.21 -45.67 83.6 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-N 120.323 1.419 . . . . 0.0 109.596 172.091 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 92.4 mtt180 -63.77 -44.11 94.41 Favored 'General case' 0 N--CA 1.468 0.455 0 C-N-CA 123.395 0.678 . . . . 0.0 110.8 -179.789 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 5.3 m -60.9 -46.76 89.37 Favored 'General case' 0 N--CA 1.449 -0.475 0 C-N-CA 124.642 1.177 . . . . 0.0 109.998 176.281 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 69.4 t -70.09 -37.86 73.33 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.494 0 CA-C-O 117.704 -1.141 . . . . 0.0 109.116 -173.39 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 41.1 mtm105 -57.22 -43.36 82.75 Favored 'General case' 0 C--O 1.224 -0.275 0 CA-C-N 120.113 1.324 . . . . 0.0 110.131 172.859 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -63.67 -54.35 31.99 Favored Glycine 0 CA--C 1.53 1.022 0 CA-C-N 118.672 0.669 . . . . 0.0 111.766 179.128 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 49.8 mm-40 -52.69 -51.23 61.2 Favored 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 124.696 1.198 . . . . 0.0 110.049 177.838 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . 0.407 ' CG1' ' HA ' ' A' ' 18' ' ' ALA . 59.6 t -63.8 -50.22 78.64 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.666 0 CA-C-O 118.397 -0.811 . . . . 0.0 109.782 -176.172 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 86.7 tttt -56.38 -46.81 79.91 Favored 'General case' 0 CA--C 1.512 -0.483 0 N-CA-C 108.219 -1.03 . . . . 0.0 108.219 -175.059 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 40.2 tt0 -64.11 -42.88 96.71 Favored 'General case' 0 N--CA 1.446 -0.668 0 C-N-CA 122.945 0.498 . . . . 0.0 111.112 -175.561 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 25.4 mtt180 -74.61 -38.73 62.5 Favored 'General case' 0 N--CA 1.467 0.395 0 O-C-N 121.047 -1.033 . . . . 0.0 111.666 -178.046 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 85.2 t -65.29 -40.33 88.2 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.634 0 N-CA-C 108.441 -0.948 . . . . 0.0 108.441 174.676 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 4.2 mm-40 -60.54 -46.74 89.07 Favored 'General case' 0 C--O 1.227 -0.125 0 CA-C-N 119.489 1.041 . . . . 0.0 109.798 176.028 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 27.7 t-20 -64.36 -40.64 96.25 Favored 'General case' 0 CA--C 1.529 0.17 0 C-N-CA 123.039 0.536 . . . . 0.0 110.952 -176.471 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 24.2 tp -58.19 -50.13 74.6 Favored 'General case' 0 N--CA 1.451 -0.399 0 C-N-CA 124.875 1.27 . . . . 0.0 110.784 173.186 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 75.3 mt -66.12 -44.89 91.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 N-CA-C 107.808 -1.182 . . . . 0.0 107.808 -177.081 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -58.92 -33.93 71.13 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 123.315 0.646 . . . . 0.0 112.182 -179.796 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 17.8 ptpt -79.73 -38.95 32.21 Favored 'General case' 0 C--N 1.345 0.4 0 CA-C-O 117.926 -1.035 . . . . 0.0 112.101 177.634 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 11.1 pt -83.98 -40.6 15.82 Favored 'Isoleucine or valine' 0 C--O 1.234 0.271 0 CA-C-N 119.997 1.271 . . . . 0.0 113.699 -174.794 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 67.7 m . . . . . 0 C--O 1.254 1.333 0 C-N-CA 125.436 1.494 . . . . 0.0 110.06 -169.807 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 9.9 ptm . . . . . 0 N--CA 1.497 1.902 0 N-CA-C 110.837 -0.06 . . . . 0.0 110.837 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . 0.43 ' HB2' HG22 ' A' ' 30' ' ' ILE . 20.9 mttm -73.95 122.76 23.08 Favored 'General case' 0 N--CA 1.478 0.967 0 O-C-N 120.961 -1.087 . . . . 0.0 108.329 -171.083 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 93.7 mttt -89.23 134.92 33.84 Favored 'General case' 0 CA--C 1.515 -0.371 0 N-CA-C 108.156 -1.053 . . . . 0.0 108.156 176.403 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 1.9 t -122.26 149.98 25.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 C-N-CA 125.764 1.626 . . . . 0.0 109.655 -169.021 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 28.3 mtt -141.02 148.31 40.06 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 125.548 1.539 . . . . 0.0 108.31 168.667 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 65.4 m-85 -132.21 113.02 12.77 Favored 'General case' 0 N--CA 1.453 -0.318 0 N-CA-C 103.919 -2.623 . . . . 0.0 103.919 169.983 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 19.7 t -140.69 127.02 20.95 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 N-CA-C 107.07 -1.455 . . . . 0.0 107.07 -169.248 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 44.3 t -91.7 -152.07 0.29 Allowed 'General case' 0 CA--C 1.546 0.814 0 N-CA-C 105.621 -1.992 . . . . 0.0 105.621 169.239 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 64.0 tttp -58.95 -35.24 72.8 Favored 'General case' 0 N--CA 1.473 0.693 0 O-C-N 119.852 -1.78 . . . . 0.0 109.187 169.348 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 79.7 mtt180 -134.06 176.93 8.14 Favored 'General case' 0 N--CA 1.465 0.302 0 C-N-CA 125.462 1.505 . . . . 0.0 108.999 177.662 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 51.5 t30 -70.64 -15.35 62.73 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 123.387 0.675 . . . . 0.0 111.296 169.651 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 1.8 m -57.04 169.68 0.51 Allowed 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 126.682 1.993 . . . . 0.0 112.443 174.72 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 5.1 m 62.51 -92.51 0.03 OUTLIER 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 125.974 1.71 . . . . 0.0 113.885 169.549 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -92.68 -36.65 12.83 Favored 'General case' 0 N--CA 1.476 0.855 0 CA-C-N 119.851 1.205 . . . . 0.0 112.34 -174.247 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 1.2 m -59.72 -37.28 78.46 Favored 'General case' 0 N--CA 1.47 0.574 0 O-C-N 121.516 -0.74 . . . . 0.0 112.344 -169.659 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 22.2 pt20 -47.82 -46.09 30.5 Favored 'General case' 0 C--N 1.341 0.212 0 C-N-CA 125.008 1.323 . . . . 0.0 111.299 176.028 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -84.45 -38.59 19.97 Favored 'General case' 0 C--O 1.226 -0.183 0 CA-C-N 118.999 0.818 . . . . 0.0 111.139 -175.685 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -61.66 -47.88 83.36 Favored 'General case' 0 C--N 1.332 -0.16 0 C-N-CA 122.126 0.171 . . . . 0.0 111.307 -174.421 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 1.2 pp20? -71.01 -29.37 65.29 Favored 'General case' 0 C--O 1.235 0.309 0 C-N-CA 119.928 -0.709 . . . . 0.0 109.928 176.113 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -49.01 -62.54 4.54 Favored Glycine 0 C--N 1.34 0.805 0 C-N-CA 126.418 1.961 . . . . 0.0 110.457 173.917 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 9.7 m-85 -65.84 -31.21 72.03 Favored 'General case' 0 CA--C 1.512 -0.491 0 CA-C-N 119.35 1.575 . . . . 0.0 114.14 175.922 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -65.22 -33.05 75.09 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 119.56 1.073 . . . . 0.0 111.918 -169.823 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 5.9 ptpt -63.22 -33.79 76.25 Favored 'General case' 0 N--CA 1.476 0.846 0 CA-C-N 119.561 1.073 . . . . 0.0 111.646 173.312 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 6.6 m -75.31 -54.71 6.62 Favored 'General case' 0 N--CA 1.448 -0.528 0 C-N-CA 125.179 1.392 . . . . 0.0 110.002 -177.672 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 87.8 mt -73.41 -35.95 65.92 Favored 'General case' 0 CA--C 1.53 0.205 0 C-N-CA 123.667 0.787 . . . . 0.0 110.533 -173.509 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -93.43 6.27 74.77 Favored Glycine 0 CA--C 1.526 0.762 0 C-N-CA 125.117 1.342 . . . . 0.0 113.499 -175.757 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -48.72 123.92 7.61 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 125.06 1.344 . . . . 0.0 110.94 -173.389 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 77.9 -14.62 9.99 Favored Glycine 0 CA--C 1.536 1.368 0 C-N-CA 124.655 1.122 . . . . 0.0 114.472 178.406 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 61.9 mttm -95.39 -45.04 7.29 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-N 119.372 1.586 . . . . 0.0 110.48 179.655 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.43 HG22 ' HB2' ' A' ' 2' ' ' LYS . 25.7 pt -140.29 153.14 21.87 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.37 0 C-N-CA 123.776 0.83 . . . . 0.0 110.215 -169.534 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -113.15 104.98 12.9 Favored 'General case' 0 C--O 1.226 -0.162 0 C-N-CA 125.209 1.404 . . . . 0.0 108.611 -173.258 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 14.9 p -88.97 133.01 32.32 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.307 0 CA-C-N 118.988 0.813 . . . . 0.0 109.248 175.756 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 15.1 m -152.36 95.54 2.05 Favored 'General case' 0 N--CA 1.456 -0.157 0 N-CA-C 105.302 -2.111 . . . . 0.0 105.302 172.351 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 48.3 m -92.31 72.39 5.3 Favored 'General case' 0 C--O 1.232 0.184 0 CA-C-O 121.741 0.781 . . . . 0.0 111.03 -169.844 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 3.7 m -60.31 165.74 3.39 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 125.482 1.513 . . . . 0.0 109.925 170.066 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -161.1 -160.73 10.96 Favored Glycine 0 C--N 1.337 0.622 0 N-CA-C 109.209 -1.557 . . . . 0.0 109.209 -169.686 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 10.6 mt -133.56 -62.23 0.79 Allowed 'General case' 0 N--CA 1.45 -0.455 0 C-N-CA 123.329 0.651 . . . . 0.0 110.13 -169.731 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -80.44 -21.01 42.55 Favored 'General case' 0 CA--C 1.537 0.481 0 C-N-CA 124.013 0.925 . . . . 0.0 111.382 174.825 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 43.0 m -60.82 166.18 3.54 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 128.196 2.598 . . . . 0.0 116.086 -169.306 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 60.9 p -145.69 -96.68 0.09 Allowed 'General case' 0 N--CA 1.448 -0.529 0 CA-C-N 113.439 -1.71 . . . . 0.0 111.685 -168.604 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 6.4 ttt180 -140.97 179.67 6.59 Favored 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 125.366 1.466 . . . . 0.0 109.316 178.052 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 3.5 m -85.68 178.72 0.53 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.788 0 C-N-CA 123.701 0.8 . . . . 0.0 110.234 -174.442 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 18.4 m-70 -89.05 153.85 49.33 Favored Pre-proline 0 CA--C 1.546 0.801 0 C-N-CA 123.505 0.722 . . . . 0.0 110.825 -177.974 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 33.1 Cg_endo -65.72 -54.29 0.59 Allowed 'Trans proline' 0 C--N 1.349 0.554 0 C-N-CA 123.109 2.539 . . . . 0.0 113.033 -174.004 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 8.7 m -67.74 -24.46 65.36 Favored 'General case' 0 CA--C 1.535 0.381 0 O-C-N 121.97 -0.456 . . . . 0.0 110.337 -176.702 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -55.56 -52.03 65.11 Favored 'General case' 0 CA--C 1.509 -0.623 0 CA-C-O 119.198 -0.429 . . . . 0.0 109.862 173.266 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 37.3 mt -58.87 -42.32 85.4 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 N-CA-C 108.466 -0.939 . . . . 0.0 108.466 -172.778 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -62.21 -47.13 85.82 Favored 'General case' 0 N--CA 1.448 -0.534 0 CA-C-N 118.23 0.468 . . . . 0.0 110.724 -179.443 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' MET . . . . . 0.4 ' HG3' ' CG ' ' A' ' 112' ' ' PHE . 30.7 mmt -72.56 -33.7 66.99 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-O 122.251 1.024 . . . . 0.0 111.415 -177.144 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -74.49 -31.52 62.22 Favored 'General case' 0 N--CA 1.443 -0.821 0 N-CA-C 107.316 -1.364 . . . . 0.0 107.316 -179.144 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 41.6 tt0 -72.91 -22.77 60.68 Favored 'General case' 0 N--CA 1.444 -0.73 0 O-C-N 121.341 -0.849 . . . . 0.0 110.087 172.418 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 16.9 mm-40 -67.32 -29.71 69.36 Favored 'General case' 0 CA--C 1.532 0.28 0 CA-C-N 119.179 0.9 . . . . 0.0 110.334 171.392 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . 0.279 5.3 p -90.83 11.17 2.49 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.927 0 CA-C-N 118.552 0.615 . . . . 0.0 111.289 169.183 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 77.82 17.64 78.34 Favored Glycine 0 CA--C 1.531 1.034 0 C-N-CA 124.677 1.132 . . . . 0.0 113.65 173.773 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 6.9 mt -108.9 138.11 37.63 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.186 0 CA-C-N 118.723 1.262 . . . . 0.0 110.454 -175.374 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 4.3 t70 -90.07 138.36 31.57 Favored 'General case' 0 C--O 1.234 0.275 0 C-N-CA 123.929 0.891 . . . . 0.0 108.773 169.301 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 13.7 pt -130.5 -30.38 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.438 0 C-N-CA 124.67 1.188 . . . . 0.0 110.182 169.492 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -42.18 -35.87 1.06 Allowed 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 127.471 2.308 . . . . 0.0 114.253 169.035 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -65.55 -13.54 58.77 Favored Glycine 0 CA--C 1.53 1.02 0 C-N-CA 124.031 0.824 . . . . 0.0 113.506 -179.862 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 28.0 mt-30 -72.28 154.33 41.04 Favored 'General case' 0 N--CA 1.442 -0.84 0 CA-C-N 118.753 1.276 . . . . 0.0 111.372 172.589 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 2.4 p -152.11 161.7 42.23 Favored 'General case' 0 N--CA 1.433 -1.312 0 C-N-CA 129.826 3.25 . . . . 0.0 103.605 167.702 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 49.9 m -112.72 97.01 6.29 Favored 'General case' 0 C--O 1.234 0.287 0 N-CA-C 108.76 -0.83 . . . . 0.0 108.76 -170.444 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -68.84 152.85 96.56 Favored Pre-proline 0 C--O 1.241 0.646 0 N-CA-C 107.558 -1.275 . . . . 0.0 107.558 169.183 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -59.78 135.74 65.71 Favored 'Trans proline' 0 N--CA 1.449 -1.129 0 C-N-CA 121.531 1.487 . . . . 0.0 108.447 170.168 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 2.1 tt -61.77 -19.13 20.59 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.622 0 C-N-CA 123.703 0.801 . . . . 0.0 110.767 -179.445 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 12.8 mt-10 -66.32 -24.37 66.52 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 126.089 1.756 . . . . 0.0 110.669 179.418 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 13.3 t-20 -69.25 -0.45 6.16 Favored 'General case' 0 CA--C 1.546 0.798 0 C-N-CA 124.822 1.249 . . . . 0.0 112.603 176.346 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 14.0 m-85 -137.22 -170.95 2.84 Favored 'General case' 0 C--O 1.236 0.392 0 C-N-CA 127.604 2.362 . . . . 0.0 108.245 -179.155 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 57.0 t-20 -141.08 141.87 34.21 Favored 'General case' 0 N--CA 1.45 -0.46 0 N-CA-C 107.657 -1.238 . . . . 0.0 107.657 169.577 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.544 ' HB2' ' CD2' ' A' ' 90' ' ' TRP . . . -71.8 -28.85 63.88 Favored 'General case' 0 N--CA 1.434 -1.267 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 178.98 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 36.6 t70 -65.86 -20.98 66.42 Favored 'General case' 0 CA--C 1.546 0.799 0 C-N-CA 120.582 -0.447 . . . . 0.0 111.015 -177.806 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -80.18 -28.91 38.64 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 124.677 1.191 . . . . 0.0 111.79 173.999 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 8.0 m-85 -77.57 169.84 17.61 Favored 'General case' 0 C--O 1.238 0.465 0 C-N-CA 125.152 1.381 . . . . 0.0 111.8 179.956 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 23.5 t70 -118.3 -39.98 2.99 Favored 'General case' 0 C--O 1.235 0.33 0 C-N-CA 123.437 0.695 . . . . 0.0 111.606 178.593 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -139.44 134.49 39.73 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.395 0 CA-C-O 121.393 0.616 . . . . 0.0 110.113 -170.111 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 70.5 t -145.52 129.7 11.81 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.495 0 N-CA-C 105.554 -2.017 . . . . 0.0 105.554 179.424 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.615 HD12 ' HB2' ' A' ' 97' ' ' GLU . 11.6 mm -104.85 130.55 55.7 Favored 'Isoleucine or valine' 0 C--O 1.236 0.392 0 N-CA-C 106.759 -1.571 . . . . 0.0 106.759 176.484 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 37.5 m -96.87 91.2 5.53 Favored 'General case' 0 N--CA 1.446 -0.672 0 N-CA-C 104.677 -2.342 . . . . 0.0 104.677 169.028 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 33.9 mt -61.62 -12.86 17.8 Favored 'General case' 0 N--CA 1.465 0.314 0 C-N-CA 123.399 0.68 . . . . 0.0 112.748 -175.368 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 56.7 m -143.54 134.65 25.67 Favored 'General case' 0 N--CA 1.445 -0.696 0 N-CA-C 106.075 -1.824 . . . . 0.0 106.075 179.194 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 57.03 -146.3 36.17 Favored Glycine 0 CA--C 1.533 1.195 0 C-N-CA 123.452 0.548 . . . . 0.0 111.826 178.929 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 19.6 p -127.23 -93.56 0.47 Allowed 'General case' 0 CA--C 1.529 0.172 0 C-N-CA 124.052 0.941 . . . . 0.0 108.822 174.163 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -72.85 -27.5 68.81 Favored Glycine 0 C--N 1.337 0.602 0 CA-C-O 118.898 -0.945 . . . . 0.0 112.482 -178.442 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.441 HG23 ' H ' ' A' ' 85' ' ' ASN 0.325 16.0 m 47.18 -94.04 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.545 0.754 0 C-N-CA 126.404 1.882 . . . . 0.0 112.602 179.452 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . 0.441 ' H ' HG23 ' A' ' 84' ' ' VAL . 53.0 t30 -142.91 45.4 1.58 Allowed 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 126.105 1.762 . . . . 0.0 108.068 178.408 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.412 ' HA ' ' HD3' ' A' ' 87' ' ' PRO . 0.3 OUTLIER -143.14 147.08 39.4 Favored Pre-proline 0 CA--C 1.548 0.88 0 C-N-CA 125.408 1.483 . . . . 0.0 110.624 -168.89 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . 0.412 ' HD3' ' HA ' ' A' ' 86' ' ' LEU . 51.8 Cg_exo -64.67 150.3 88.4 Favored 'Trans proline' 0 C--N 1.357 1.005 0 C-N-CA 122.08 1.853 . . . . 0.0 114.498 -170.973 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -67.19 -33.52 30.79 Favored 'Trans proline' 0 N--CA 1.458 -0.616 0 C-N-CA 122.795 2.33 . . . . 0.0 116.014 -169.204 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 3.1 pm0 -63.33 -15.26 56.84 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-N 121.573 1.988 . . . . 0.0 112.045 -178.719 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' TRP . . . . . 0.544 ' CD2' ' HB2' ' A' ' 70' ' ' ALA . 98.2 m95 -76.51 -22.95 53.76 Favored 'General case' 0 N--CA 1.452 -0.341 0 CA-C-O 118.835 -0.602 . . . . 0.0 111.953 174.597 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 28.3 m -104.46 -6.85 9.63 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.488 0 C-N-CA 124.832 1.253 . . . . 0.0 113.163 178.023 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . 0.271 9.3 t -112.73 70.62 0.72 Allowed 'General case' 0 CA--C 1.537 0.454 0 CA-C-O 123.441 1.591 . . . . 0.0 107.539 168.899 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 60.4 mm-40 -100.67 179.46 4.41 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 126.545 1.938 . . . . 0.0 109.084 175.067 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 37.7 mm-40 -64.95 -24.18 67.44 Favored 'General case' 0 CA--C 1.539 0.543 0 O-C-N 121.743 -0.598 . . . . 0.0 110.94 179.892 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 6.9 tt -139.63 130.08 31.33 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.354 0 N-CA-C 105.807 -1.923 . . . . 0.0 105.807 169.329 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 36.8 t80 -113.36 135.54 53.75 Favored 'General case' 0 CA--C 1.536 0.41 0 N-CA-C 105.713 -1.958 . . . . 0.0 105.713 169.643 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . 0.615 ' HB2' HD12 ' A' ' 77' ' ' ILE . 11.1 mm-40 -142.44 163.29 33.23 Favored 'General case' 0 C--O 1.232 0.165 0 C-N-CA 124.311 1.044 . . . . 0.0 109.524 179.666 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 2.7 t70 -172.46 129.64 0.56 Allowed 'General case' 0 C--O 1.237 0.422 0 C-N-CA 127.594 2.358 . . . . 0.0 107.07 -169.366 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' TRP . . . . . 0.523 ' CZ3' HG21 ' A' ' 77' ' ' ILE . 5.9 m0 -144.58 153.5 41.87 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-O 120.99 0.424 . . . . 0.0 111.936 -170.637 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 2.3 mp0 -87.48 51.87 2.34 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 124.527 1.131 . . . . 0.0 109.456 175.789 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -67.42 134.59 51.7 Favored 'General case' 0 C--N 1.339 0.136 0 N-CA-C 106.5 -1.667 . . . . 0.0 106.5 169.823 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 6.4 pt-20 -83.18 171.55 13.56 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 123.488 0.715 . . . . 0.0 110.192 175.448 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -131.6 133.27 24.1 Favored Pre-proline 0 C--O 1.238 0.459 0 C-N-CA 125.849 1.66 . . . . 0.0 109.804 -169.805 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 10.6 Cg_endo -97.93 2.5 1.41 Allowed 'Trans proline' 0 N--CA 1.451 -1.004 0 C-N-CA 123.003 2.469 . . . . 0.0 113.538 -174.799 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 8.0 t70 -50.61 115.84 1.66 Allowed 'General case' 0 CA--C 1.538 0.518 0 CA-C-N 120.486 1.494 . . . . 0.0 110.787 -174.113 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 67.47 5.5 36.68 Favored Glycine 0 CA--C 1.537 1.434 0 CA-C-O 119.014 -0.881 . . . . 0.0 114.61 178.172 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 5.6 mt-30 -87.32 172.46 9.84 Favored 'General case' 0 CA--C 1.54 0.583 0 CA-C-N 118.998 1.399 . . . . 0.0 109.869 178.495 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 15.5 m -68.95 161.19 29.37 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 123.854 0.862 . . . . 0.0 110.559 176.897 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 28.1 mt -63.36 -24.42 67.84 Favored 'General case' 0 N--CA 1.47 0.561 0 O-C-N 121.491 -0.756 . . . . 0.0 112.499 -173.02 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 6.0 pt-20 -55.19 -35.49 64.89 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 118.875 0.761 . . . . 0.0 111.189 172.346 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 10.9 t -76.82 -42.08 33.02 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.398 0 CA-C-O 118.433 -0.794 . . . . 0.0 109.189 -178.811 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . 0.4 ' CG ' ' HG3' ' A' ' 49' ' ' MET . 55.4 m-85 -57.24 -45.36 83.99 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-N 120.222 1.374 . . . . 0.0 110.296 172.529 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 90.9 mtt180 -63.27 -43.82 96.86 Favored 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 123.327 0.651 . . . . 0.0 110.584 179.548 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 4.2 m -62.14 -45.6 92.7 Favored 'General case' 0 N--CA 1.448 -0.542 0 C-N-CA 124.518 1.127 . . . . 0.0 110.275 177.168 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 60.2 t -67.21 -39.34 82.82 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.404 0 CA-C-O 118.593 -0.718 . . . . 0.0 109.25 -174.892 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 44.0 mtm105 -57.41 -42.89 83.2 Favored 'General case' 0 CA--C 1.536 0.431 0 CA-C-N 119.31 0.959 . . . . 0.0 110.397 174.913 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -63.37 -54.13 34.4 Favored Glycine 0 CA--C 1.533 1.158 0 CA-C-O 119.576 -0.569 . . . . 0.0 112.08 177.548 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 13.3 mm-40 -51.65 -51.52 55.11 Favored 'General case' 0 N--CA 1.468 0.47 0 C-N-CA 124.66 1.184 . . . . 0.0 110.204 178.215 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 86.1 t -67.74 -48.17 76.95 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 115.186 -0.916 . . . . 0.0 109.684 -173.114 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 62.0 tttm -55.06 -47.51 74.74 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 119.388 0.995 . . . . 0.0 109.711 -175.033 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -64.68 -43.32 93.93 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 122.917 0.487 . . . . 0.0 111.214 -175.469 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 20.8 mtt180 -75.1 -33.97 61.67 Favored 'General case' 0 N--CA 1.469 0.511 0 O-C-N 121.277 -0.889 . . . . 0.0 111.623 -178.179 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 59.5 t -67.34 -39.8 83.51 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.419 0 N-CA-C 108.62 -0.882 . . . . 0.0 108.62 173.674 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 22.8 mt-10 -59.45 -43.05 93.27 Favored 'General case' 0 N--CA 1.462 0.157 0 CA-C-N 119.938 1.245 . . . . 0.0 110.403 174.112 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 29.2 t-20 -63.55 -43.39 97.19 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 123.151 0.58 . . . . 0.0 111.371 -178.918 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 1.9 tm? -59.1 -47.22 86.06 Favored 'General case' 0 N--CA 1.456 -0.152 0 C-N-CA 125.063 1.345 . . . . 0.0 110.947 175.253 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 84.8 mt -65.17 -46.09 92.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 N-CA-C 108.302 -0.999 . . . . 0.0 108.302 179.985 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -59.23 -29.62 67.65 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 123.431 0.692 . . . . 0.0 112.073 177.099 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 69.1 mttt -69.09 -55.21 11.43 Favored 'General case' 0 C--N 1.343 0.311 0 CA-C-N 119.033 0.833 . . . . 0.0 110.385 172.707 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 17.1 pt -78.7 -36.76 19.87 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.335 0 N-CA-C 114.854 1.427 . . . . 0.0 114.854 -169.609 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 75.3 m . . . . . 0 C--O 1.253 1.26 0 C-N-CA 126.185 1.794 . . . . 0.0 109.117 -169.898 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 12.3 ptm . . . . . 0 N--CA 1.497 1.877 0 CA-C-O 120.17 0.033 . . . . 0.0 110.987 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 26.7 mttm -71.08 127.49 32.75 Favored 'General case' 0 N--CA 1.478 0.945 0 N-CA-C 107.682 -1.229 . . . . 0.0 107.682 -174.496 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 72.7 mttt -97.91 133.71 42.03 Favored 'General case' 0 CA--C 1.512 -0.502 0 CA-C-N 119.785 1.175 . . . . 0.0 108.059 172.199 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.474 HG21 HD12 ' A' ' 30' ' ' ILE . 11.7 t -113.21 151.21 15.12 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.605 0 C-N-CA 127.237 2.215 . . . . 0.0 106.568 -170.916 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 52.3 ttm -146.43 141.94 27.65 Favored 'General case' 0 C--N 1.32 -0.676 0 C-N-CA 125.544 1.538 . . . . 0.0 108.708 174.751 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 47.4 m-85 -131.63 103.72 6.54 Favored 'General case' 0 CA--C 1.519 -0.233 0 N-CA-C 106.088 -1.819 . . . . 0.0 106.088 175.216 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 11.0 t -134.83 137.84 50.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 118.629 0.65 . . . . 0.0 110.812 -168.912 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 44.8 t -121.08 -171.66 2.24 Favored 'General case' 0 CA--C 1.548 0.875 0 N-CA-C 104.594 -2.373 . . . . 0.0 104.594 168.53 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 60.2 mtpt -57.18 -67.62 0.3 Allowed 'General case' 0 N--CA 1.471 0.617 0 CA-C-N 120.007 1.276 . . . . 0.0 111.365 -171.191 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 29.3 ttm-85 -111.8 132.83 54.41 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-N 119.47 1.032 . . . . 0.0 108.221 -178.759 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 12.6 t30 -54.56 -34.84 62.53 Favored 'General case' 0 N--CA 1.478 0.943 0 N-CA-C 114.177 1.177 . . . . 0.0 114.177 -169.665 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 5.7 m -57.94 -20.56 38.5 Favored 'General case' 0 CA--C 1.537 0.464 0 N-CA-C 114.242 1.201 . . . . 0.0 114.242 -170.373 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 21.2 m -134.13 151.79 51.53 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 124.513 1.125 . . . . 0.0 109.652 176.828 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 90.5 mtm-85 55.01 40.78 32.15 Favored 'General case' 0 N--CA 1.467 0.414 0 C-N-CA 126.024 1.729 . . . . 0.0 112.346 175.845 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 13.6 m -136.43 -73.78 0.44 Allowed 'General case' 0 CA--C 1.534 0.353 0 N-CA-C 104.052 -2.573 . . . . 0.0 104.052 169.044 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER 40.89 -109.81 0.11 Allowed 'General case' 0 N--CA 1.454 -0.244 0 C-N-CA 127.607 2.363 . . . . 0.0 112.135 168.017 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -76.54 -14.55 60.01 Favored 'General case' 0 CA--C 1.518 -0.261 0 N-CA-C 113.819 1.044 . . . . 0.0 113.819 -169.964 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -63.86 -50.58 68.27 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 119.608 1.094 . . . . 0.0 111.415 -169.135 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -66.82 -38.07 85.74 Favored 'General case' 0 N--CA 1.467 0.405 0 N-CA-C 109.573 -0.529 . . . . 0.0 109.573 173.39 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -55.69 -55.71 27.43 Favored Glycine 0 C--N 1.338 0.645 0 N-CA-C 110.881 -0.888 . . . . 0.0 110.881 -176.959 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 4.8 m-85 -65.9 -32.17 73.52 Favored 'General case' 0 CA--C 1.506 -0.718 0 CA-C-O 118.587 -0.72 . . . . 0.0 111.787 178.484 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -68.84 -32.92 72.95 Favored 'General case' 0 N--CA 1.446 -0.674 0 CA-C-N 118.965 0.802 . . . . 0.0 110.72 -178.051 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.74 -36.97 86.03 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-N 119.504 1.047 . . . . 0.0 110.066 172.256 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 19.0 m -70.09 -56.89 5.76 Favored 'General case' 0 N--CA 1.45 -0.429 0 C-N-CA 124.236 1.014 . . . . 0.0 112.26 -179.939 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 41.7 mt -75.19 -38.23 60.89 Favored 'General case' 0 N--CA 1.466 0.359 0 C-N-CA 124.809 1.244 . . . . 0.0 109.891 -173.513 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -82.51 4.13 79.38 Favored Glycine 0 CA--C 1.526 0.756 0 C-N-CA 125.585 1.564 . . . . 0.0 113.19 179.796 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -53.79 133.22 42.41 Favored 'General case' 0 C--O 1.236 0.358 0 CA-C-N 118.793 1.297 . . . . 0.0 109.279 178.913 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 70.19 8.57 62.18 Favored Glycine 0 CA--C 1.533 1.196 0 CA-C-O 118.444 -1.198 . . . . 0.0 114.969 177.837 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 9.8 ptpp? -137.01 -36.59 0.67 Allowed 'General case' 0 N--CA 1.473 0.724 0 CA-C-N 119.744 1.772 . . . . 0.0 113.079 179.727 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.474 HD12 HG21 ' A' ' 4' ' ' VAL . 17.6 pt -141.22 148.73 21.06 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.568 0 CA-C-N 119.807 1.185 . . . . 0.0 109.723 -177.477 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -95.26 158.22 15.55 Favored 'General case' 0 N--CA 1.467 0.412 0 C-N-CA 125.322 1.449 . . . . 0.0 108.181 176.81 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 21.7 t -141.34 134.19 30.0 Favored 'Isoleucine or valine' 0 C--O 1.236 0.374 0 N-CA-C 107.872 -1.159 . . . . 0.0 107.872 -176.421 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 26.7 m -147.23 113.41 5.86 Favored 'General case' 0 N--CA 1.44 -0.964 0 N-CA-C 106.751 -1.574 . . . . 0.0 106.751 171.711 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 50.3 m -99.65 97.8 8.72 Favored 'General case' 0 N--CA 1.449 -0.516 0 N-CA-C 108.423 -0.955 . . . . 0.0 108.423 169.578 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 7.7 p -68.07 -66.46 0.56 Allowed 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 125.566 1.546 . . . . 0.0 111.322 -175.952 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 110.17 135.07 6.96 Favored Glycine 0 CA--C 1.523 0.581 0 N-CA-C 108.428 -1.869 . . . . 0.0 108.428 -171.436 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 5.9 mt -70.71 -36.96 73.48 Favored 'General case' 0 CA--C 1.529 0.15 0 N-CA-C 109.003 -0.74 . . . . 0.0 109.003 171.31 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 34.4 mt-10 -126.77 160.97 29.3 Favored 'General case' 0 N--CA 1.445 -0.702 0 C-N-CA 129.624 3.17 . . . . 0.0 105.691 169.259 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 54.6 p -150.86 145.51 25.72 Favored 'General case' 0 N--CA 1.445 -0.715 0 N-CA-C 114.003 1.112 . . . . 0.0 114.003 -173.192 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 3.1 m -147.3 -82.94 0.12 Allowed 'General case' 0 N--CA 1.452 -0.351 0 CA-C-N 113.117 -1.856 . . . . 0.0 108.271 -173.119 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 5.8 ttp180 -159.22 -154.01 0.39 Allowed 'General case' 0 N--CA 1.466 0.339 0 N-CA-C 109.33 -0.619 . . . . 0.0 109.33 -179.29 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 2.9 p -133.12 148.79 31.19 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.7 0 C-N-CA 128.2 2.6 . . . . 0.0 105.529 177.988 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 81.5 t60 -73.38 136.97 78.16 Favored Pre-proline 0 CA--C 1.544 0.725 0 CA-C-O 118.646 -0.692 . . . . 0.0 110.5 -169.759 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 28.6 Cg_endo -60.75 -49.1 9.23 Favored 'Trans proline' 0 C--N 1.35 0.626 0 C-N-CA 123.181 2.587 . . . . 0.0 112.962 -172.918 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 18.5 m -67.05 -20.13 65.79 Favored 'General case' 0 CA--C 1.536 0.416 0 O-C-N 121.95 -0.469 . . . . 0.0 110.526 -177.881 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -59.52 -52.32 66.08 Favored 'General case' 0 CA--C 1.506 -0.737 0 N-CA-C 108.838 -0.801 . . . . 0.0 108.838 173.87 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 60.0 mt -56.89 -42.27 78.05 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 N-CA-C 108.729 -0.841 . . . . 0.0 108.729 -171.621 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -64.23 -47.95 77.7 Favored 'General case' 0 N--CA 1.45 -0.429 0 CA-C-N 117.826 0.285 . . . . 0.0 111.509 -179.798 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 38.9 mmt -69.26 -35.37 76.02 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-O 122.747 1.261 . . . . 0.0 110.76 -178.521 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -73.26 -33.05 65.06 Favored 'General case' 0 N--CA 1.443 -0.82 0 N-CA-C 106.887 -1.523 . . . . 0.0 106.887 -177.662 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 6.6 tp10 -70.24 -20.29 63.08 Favored 'General case' 0 N--CA 1.449 -0.522 0 C-N-CA 123.645 0.778 . . . . 0.0 110.775 170.807 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 81.5 mt-10 -64.26 -38.65 91.8 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-N 119.773 1.17 . . . . 0.0 109.353 169.666 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . 0.306 9.7 p -83.43 7.35 1.55 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.771 0 CA-C-O 120.805 0.336 . . . . 0.0 111.81 171.252 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 74.45 23.57 75.15 Favored Glycine 0 CA--C 1.531 1.071 0 O-C-N 120.838 -1.164 . . . . 0.0 113.028 175.981 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 38.4 mt -117.12 131.88 68.52 Favored 'Isoleucine or valine' 0 C--N 1.338 0.068 0 C-N-CA 124.831 1.252 . . . . 0.0 108.584 -176.552 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 34.6 t0 -101.59 146.39 27.75 Favored 'General case' 0 C--O 1.235 0.318 0 CA-C-O 121.028 0.442 . . . . 0.0 110.238 170.794 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 12.2 pt -135.98 -9.6 0.84 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.461 0 C-N-CA 127.081 2.152 . . . . 0.0 110.836 176.145 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 7.7 t -43.31 131.82 4.6 Favored 'General case' 0 CA--C 1.542 0.663 0 CA-C-N 120.249 1.386 . . . . 0.0 109.325 168.971 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 71.92 38.37 60.24 Favored Glycine 0 CA--C 1.532 1.114 0 CA-C-O 118.917 -0.935 . . . . 0.0 113.082 -177.299 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 29.9 mt-30 -56.25 -40.94 74.95 Favored 'General case' 0 N--CA 1.473 0.679 0 CA-C-N 118.888 1.344 . . . . 0.0 110.478 169.995 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -66.17 134.59 53.06 Favored 'General case' 0 N--CA 1.447 -0.592 0 C-N-CA 124.177 0.991 . . . . 0.0 109.413 -170.0 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 2.9 p -140.2 -68.77 0.41 Allowed 'General case' 0 C--O 1.233 0.226 0 C-N-CA 124.018 0.927 . . . . 0.0 108.929 -169.657 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -148.54 154.6 41.45 Favored Pre-proline 0 C--O 1.238 0.484 0 C-N-CA 126.021 1.728 . . . . 0.0 107.478 174.595 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -62.71 151.81 81.7 Favored 'Trans proline' 0 N--CA 1.456 -0.734 0 C-N-CA 121.831 1.687 . . . . 0.0 109.34 170.027 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 18.2 tt -56.19 -28.78 26.17 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.439 0 C-N-CA 123.25 0.62 . . . . 0.0 111.741 -178.687 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 11.4 mt-10 -66.72 -26.69 67.12 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 124.563 1.145 . . . . 0.0 110.689 -174.83 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 11.2 t-20 -63.6 -30.97 72.0 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 124.833 1.253 . . . . 0.0 111.611 178.424 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 94.1 m-85 -92.12 -178.11 4.88 Favored 'General case' 0 C--O 1.235 0.328 0 C-N-CA 125.269 1.428 . . . . 0.0 111.139 -176.61 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 54.6 t-20 -124.11 137.77 54.52 Favored 'General case' 0 N--CA 1.443 -0.79 0 N-CA-C 106.756 -1.572 . . . . 0.0 106.756 168.654 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.457 ' HB2' ' CD2' ' A' ' 90' ' ' TRP . . . -73.58 -24.4 60.07 Favored 'General case' 0 N--CA 1.433 -1.29 0 N-CA-C 109.187 -0.671 . . . . 0.0 109.187 -178.048 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 36.1 t70 -67.32 -20.56 65.62 Favored 'General case' 0 N--CA 1.447 -0.618 0 C-N-CA 121.221 -0.192 . . . . 0.0 111.474 -178.611 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 37.1 t70 -75.75 -29.07 58.73 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 123.526 0.73 . . . . 0.0 111.61 175.186 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 33.0 m-85 -80.17 167.24 20.6 Favored 'General case' 0 N--CA 1.45 -0.433 0 C-N-CA 125.058 1.343 . . . . 0.0 110.613 176.558 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 24.2 t70 -117.29 -35.4 4.04 Favored 'General case' 0 C--O 1.237 0.401 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.169 175.241 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -140.04 134.77 36.99 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.697 0 CA-C-O 121.922 0.868 . . . . 0.0 108.676 -173.399 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 88.7 t -143.36 137.72 25.9 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.604 0 N-CA-C 105.786 -1.931 . . . . 0.0 105.786 178.929 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.658 HD12 ' HB2' ' A' ' 97' ' ' GLU . 20.6 mm -112.75 127.3 70.06 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.727 0 N-CA-C 105.781 -1.933 . . . . 0.0 105.781 177.188 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 70.6 m -89.32 99.83 12.74 Favored 'General case' 0 N--CA 1.441 -0.918 0 N-CA-C 104.196 -2.52 . . . . 0.0 104.196 169.225 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 38.3 mt -69.56 -2.04 10.38 Favored 'General case' 0 N--CA 1.464 0.244 0 O-C-N 121.484 -0.76 . . . . 0.0 112.386 -178.578 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 85.4 m -139.58 135.05 32.96 Favored 'General case' 0 N--CA 1.441 -0.887 0 N-CA-C 106.988 -1.486 . . . . 0.0 106.988 170.149 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 48.43 -142.18 8.59 Favored Glycine 0 CA--C 1.535 1.301 0 C-N-CA 125.148 1.356 . . . . 0.0 113.148 175.123 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 13.2 m -127.48 -85.64 0.59 Allowed 'General case' 0 CA--C 1.529 0.165 0 N-CA-C 107.585 -1.265 . . . . 0.0 107.585 175.993 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -84.55 66.66 3.84 Favored Glycine 0 C--N 1.338 0.694 0 N-CA-C 110.145 -1.182 . . . . 0.0 110.145 175.226 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 6.5 m -77.78 65.28 0.26 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.575 0 C-N-CA 124.071 0.948 . . . . 0.0 110.891 -178.094 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 52.1 t30 54.36 54.05 10.0 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 126.4 1.88 . . . . 0.0 108.249 -172.611 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -133.14 142.32 44.03 Favored Pre-proline 0 CA--C 1.539 0.544 0 C-N-CA 126.604 1.962 . . . . 0.0 108.506 -168.867 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -66.97 135.38 37.53 Favored 'Trans proline' 0 CA--C 1.541 0.857 0 C-N-CA 121.798 1.665 . . . . 0.0 110.611 176.6 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 42.1 Cg_endo -63.24 -23.99 72.4 Favored 'Trans proline' 0 N--CA 1.461 -0.439 0 C-N-CA 122.746 2.297 . . . . 0.0 114.315 -169.721 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 5.7 pm0 -56.21 -21.67 24.67 Favored 'General case' 0 CA--C 1.539 0.521 0 CA-C-N 119.529 1.059 . . . . 0.0 112.133 175.95 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' TRP . . . . . 0.457 ' CD2' ' HB2' ' A' ' 70' ' ' ALA . 99.3 m95 -82.64 -21.78 34.91 Favored 'General case' 0 N--CA 1.454 -0.251 0 N-CA-C 113.13 0.789 . . . . 0.0 113.13 179.979 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 5.5 m -92.94 -34.86 6.19 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.351 0 CA-C-N 120.117 1.326 . . . . 0.0 110.998 172.518 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . 0.266 6.3 t -87.22 46.01 1.33 Allowed 'General case' 0 CA--C 1.548 0.869 0 CA-C-O 123.409 1.576 . . . . 0.0 110.497 -174.85 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 68.6 mm-40 -79.0 -178.81 6.3 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 126.851 2.061 . . . . 0.0 109.218 171.338 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 35.1 mm-40 -67.22 -18.38 65.21 Favored 'General case' 0 CA--C 1.539 0.554 0 O-C-N 121.572 -0.705 . . . . 0.0 111.87 -178.629 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 7.4 tt -143.2 135.03 24.02 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.381 0 C-N-CA 125.642 1.577 . . . . 0.0 106.88 170.035 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 32.4 t80 -110.21 135.26 51.25 Favored 'General case' 0 CA--C 1.535 0.373 0 N-CA-C 106.186 -1.783 . . . . 0.0 106.186 169.386 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . 0.658 ' HB2' HD12 ' A' ' 77' ' ' ILE . 31.2 mm-40 -144.73 164.09 32.04 Favored 'General case' 0 C--O 1.238 0.452 0 C-N-CA 123.971 0.908 . . . . 0.0 108.689 170.21 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -169.87 130.67 1.02 Allowed 'General case' 0 N--CA 1.45 -0.458 0 C-N-CA 127.969 2.508 . . . . 0.0 106.889 -170.585 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' TRP . . . . . 0.411 ' CZ3' HG21 ' A' ' 77' ' ' ILE . 5.1 m-90 -150.14 141.21 23.01 Favored 'General case' 0 N--CA 1.453 -0.315 0 N-CA-C 107.947 -1.131 . . . . 0.0 107.947 -171.231 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 63.0 tt0 -82.26 77.98 8.99 Favored 'General case' 0 CA--C 1.536 0.416 0 N-CA-C 108.219 -1.03 . . . . 0.0 108.219 179.095 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 10.1 mp -71.51 119.1 15.18 Favored 'General case' 0 N--CA 1.462 0.157 0 N-CA-C 107.023 -1.473 . . . . 0.0 107.023 171.056 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -79.35 112.91 17.05 Favored 'General case' 0 N--CA 1.449 -0.524 0 N-CA-C 106.085 -1.821 . . . . 0.0 106.085 170.069 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 11.2 t70 -76.32 133.99 70.87 Favored Pre-proline 0 C--O 1.239 0.501 0 CA-C-O 118.928 -0.558 . . . . 0.0 109.833 -177.021 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -78.7 3.13 7.55 Favored 'Trans proline' 0 CA--C 1.545 1.071 0 C-N-CA 123.01 2.473 . . . . 0.0 113.971 -177.435 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 2.1 t70 -36.7 112.68 0.2 Allowed 'General case' 0 C--O 1.239 0.538 0 C-N-CA 126.196 1.798 . . . . 0.0 111.778 171.876 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 68.58 5.31 43.64 Favored Glycine 0 CA--C 1.537 1.462 0 CA-C-O 118.813 -0.993 . . . . 0.0 115.038 175.172 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 33.7 mm-40 -80.47 174.37 11.67 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-N 119.41 1.605 . . . . 0.0 110.45 178.412 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 15.3 m -68.96 156.9 37.77 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 123.729 0.811 . . . . 0.0 109.9 169.683 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -65.15 -26.25 68.09 Favored 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 123.429 0.692 . . . . 0.0 111.641 -172.29 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 6.9 pt-20 -56.33 -34.85 66.95 Favored 'General case' 0 N--CA 1.462 0.164 0 C-N-CA 123.29 0.636 . . . . 0.0 111.279 173.072 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 13.2 t -76.89 -45.59 31.05 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.362 0 CA-C-O 118.27 -0.871 . . . . 0.0 108.987 -176.724 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 67.2 m-85 -50.62 -50.45 54.15 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-N 119.691 1.132 . . . . 0.0 110.211 169.643 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 94.5 mtt180 -69.4 -34.6 74.74 Favored 'General case' 0 N--CA 1.466 0.349 0 O-C-N 121.887 -0.508 . . . . 0.0 110.901 -173.291 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 2.7 m -61.56 -49.64 75.86 Favored 'General case' 0 N--CA 1.45 -0.452 0 C-N-CA 124.162 0.985 . . . . 0.0 109.407 169.947 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 81.7 t -70.35 -27.18 30.83 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.182 0 CA-C-O 118.417 -0.801 . . . . 0.0 109.761 -170.972 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 14.2 mtm105 -56.72 -48.98 76.54 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-N 119.644 1.111 . . . . 0.0 109.646 169.956 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -63.02 -48.18 82.56 Favored Glycine 0 CA--C 1.527 0.784 0 N-CA-C 111.614 -0.594 . . . . 0.0 111.614 179.235 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 9.9 mt-30 -62.29 -45.41 93.37 Favored 'General case' 0 C--N 1.342 0.24 0 CA-C-N 117.676 0.738 . . . . 0.0 110.952 -177.209 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 86.9 t -67.75 -42.32 86.09 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.189 0 CA-C-O 118.229 -0.891 . . . . 0.0 110.557 -178.911 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 59.1 tttm -53.81 -46.6 71.15 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 119.307 0.958 . . . . 0.0 109.337 179.908 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -65.19 -43.52 91.37 Favored 'General case' 0 N--CA 1.45 -0.464 0 C-N-CA 122.964 0.506 . . . . 0.0 111.139 -175.97 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 49.4 mtt-85 -65.5 -44.54 86.7 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-N 118.719 0.69 . . . . 0.0 111.303 178.554 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 98.0 t -66.15 -40.19 86.41 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.472 0 N-CA-C 109.204 -0.665 . . . . 0.0 109.204 179.024 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 16.6 mt-10 -60.25 -42.52 95.5 Favored 'General case' 0 N--CA 1.46 0.047 0 CA-C-N 119.751 1.16 . . . . 0.0 110.488 176.153 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 29.0 t-20 -62.68 -44.67 95.66 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 122.712 0.405 . . . . 0.0 110.998 178.977 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 34.8 tp -58.08 -49.2 77.75 Favored 'General case' 0 N--CA 1.455 -0.208 0 C-N-CA 124.26 1.024 . . . . 0.0 110.772 176.992 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 89.8 mt -63.55 -44.62 98.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 N-CA-C 108.043 -1.095 . . . . 0.0 108.043 -179.524 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -61.07 -28.37 69.03 Favored 'General case' 0 CA--C 1.54 0.58 0 CA-C-N 118.654 0.661 . . . . 0.0 112.19 177.545 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 93.5 mttt -70.03 -56.13 7.76 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-N 119.391 0.996 . . . . 0.0 110.69 171.183 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 14.9 pt -78.13 -44.41 27.59 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.424 0 N-CA-C 114.969 1.47 . . . . 0.0 114.969 -168.925 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 69.8 m . . . . . 0 C--O 1.252 1.217 0 C-N-CA 126.011 1.724 . . . . 0.0 109.945 -169.772 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.497 1.906 0 N-CA-C 110.365 -0.235 . . . . 0.0 110.365 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 31.2 mttm -79.1 118.64 21.25 Favored 'General case' 0 N--CA 1.474 0.742 0 N-CA-C 105.787 -1.931 . . . . 0.0 105.787 171.84 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 89.2 mttt -86.06 134.11 33.85 Favored 'General case' 0 CA--C 1.513 -0.464 0 N-CA-C 107.69 -1.226 . . . . 0.0 107.69 178.465 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 1.5 t -119.8 148.82 22.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 C-N-CA 125.535 1.534 . . . . 0.0 109.0 -169.006 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 3.2 mtt -135.88 146.82 47.81 Favored 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 125.872 1.669 . . . . 0.0 108.434 169.255 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 90.6 m-85 -132.5 95.42 3.62 Favored 'General case' 0 N--CA 1.457 -0.099 0 N-CA-C 105.165 -2.161 . . . . 0.0 105.165 171.495 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 42.3 t -131.29 129.98 62.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 N-CA-C 109.675 -0.491 . . . . 0.0 109.675 -169.049 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 41.1 t -99.07 -177.76 3.72 Favored 'General case' 0 CA--C 1.547 0.857 0 C-N-CA 125.754 1.622 . . . . 0.0 106.922 169.101 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -56.48 -39.2 72.82 Favored 'General case' 0 N--CA 1.478 0.932 0 O-C-N 120.587 -1.32 . . . . 0.0 111.292 -176.532 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 79.1 mtp180 -119.89 168.65 10.9 Favored 'General case' 0 N--CA 1.465 0.308 0 N-CA-C 107.106 -1.442 . . . . 0.0 107.106 169.156 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 29.1 t30 -65.13 -28.61 69.55 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 120.563 -0.455 . . . . 0.0 110.784 169.601 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 1.5 m -56.15 124.15 16.9 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 125.165 1.386 . . . . 0.0 110.548 179.644 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 8.5 m 65.72 150.2 0.05 OUTLIER 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 126.256 1.822 . . . . 0.0 113.302 178.872 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 1.5 mmm180 68.34 -58.33 0.47 Allowed 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 127.455 2.302 . . . . 0.0 111.869 177.12 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 1.7 m -63.83 -17.15 62.83 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 125.436 1.495 . . . . 0.0 112.719 -175.214 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 21.7 pt20 -62.17 -63.01 1.38 Allowed 'General case' 0 C--N 1.343 0.289 0 CA-C-N 119.285 0.948 . . . . 0.0 111.585 176.7 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 1.1 tpt -78.56 -32.57 47.85 Favored 'General case' 0 N--CA 1.465 0.291 0 O-C-N 121.56 -0.713 . . . . 0.0 112.209 -169.61 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -64.58 -51.38 63.03 Favored 'General case' 0 N--CA 1.469 0.488 0 N-CA-C 112.346 0.499 . . . . 0.0 112.346 -170.955 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -65.68 -31.45 72.47 Favored 'General case' 0 N--CA 1.469 0.491 0 O-C-N 121.505 -0.747 . . . . 0.0 110.198 172.811 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -49.12 -55.42 12.14 Favored Glycine 0 C--N 1.342 0.895 0 C-N-CA 125.89 1.709 . . . . 0.0 110.518 175.149 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 8.8 m-85 -73.99 -29.74 62.13 Favored 'General case' 0 CA--C 1.508 -0.655 0 CA-C-N 119.072 1.436 . . . . 0.0 113.811 178.806 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -67.85 -31.7 71.71 Favored 'General case' 0 N--CA 1.451 -0.408 0 C-N-CA 119.459 -0.896 . . . . 0.0 111.318 -169.989 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 6.7 ptpt -62.06 -34.35 76.1 Favored 'General case' 0 N--CA 1.476 0.835 0 CA-C-N 119.252 0.933 . . . . 0.0 111.498 172.108 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 12.2 m -76.46 -55.42 5.55 Favored 'General case' 0 N--CA 1.447 -0.601 0 C-N-CA 125.373 1.469 . . . . 0.0 110.183 -175.939 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 75.3 mt -74.74 -35.63 62.63 Favored 'General case' 0 CA--C 1.531 0.213 0 C-N-CA 123.455 0.702 . . . . 0.0 110.328 -174.022 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -93.04 6.81 76.45 Favored Glycine 0 CA--C 1.526 0.722 0 C-N-CA 125.118 1.342 . . . . 0.0 113.285 -175.317 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -49.67 125.45 11.57 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 125.113 1.365 . . . . 0.0 110.881 -175.105 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 76.33 -8.1 27.35 Favored Glycine 0 CA--C 1.535 1.343 0 C-N-CA 124.452 1.025 . . . . 0.0 114.287 178.801 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 64.3 mttm -102.83 -49.93 3.67 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-N 119.421 1.61 . . . . 0.0 110.384 -179.711 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 25.3 pt -136.2 149.09 27.27 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.385 0 C-N-CA 123.669 0.788 . . . . 0.0 110.34 -169.37 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -111.58 104.47 12.87 Favored 'General case' 0 C--O 1.227 -0.123 0 C-N-CA 124.962 1.305 . . . . 0.0 109.844 -169.332 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 6.5 t -87.02 132.08 33.33 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 C-N-CA 123.471 0.708 . . . . 0.0 109.669 -175.957 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 20.5 m -144.96 110.81 5.42 Favored 'General case' 0 N--CA 1.446 -0.658 0 N-CA-C 104.623 -2.362 . . . . 0.0 104.623 169.963 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 51.8 m -107.18 81.53 1.55 Allowed 'General case' 0 N--CA 1.463 0.205 0 CA-C-N 119.611 1.096 . . . . 0.0 108.233 179.661 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 3.8 m -61.16 -39.79 91.43 Favored 'General case' 0 CA--C 1.532 0.274 0 N-CA-C 114.289 1.218 . . . . 0.0 114.289 -169.261 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 92.91 137.81 8.36 Favored Glycine 0 C--N 1.338 0.671 0 N-CA-C 109.107 -1.597 . . . . 0.0 109.107 176.912 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 15.5 mt -74.51 -34.01 62.94 Favored 'General case' 0 C--N 1.331 -0.199 0 C-N-CA 124.108 0.963 . . . . 0.0 108.794 176.774 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 26.3 mt-10 -141.33 156.79 45.81 Favored 'General case' 0 N--CA 1.443 -0.805 0 C-N-CA 128.28 2.632 . . . . 0.0 105.984 168.926 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 60.9 p -109.79 148.33 31.66 Favored 'General case' 0 N--CA 1.441 -0.922 0 CA-C-O 123.106 1.431 . . . . 0.0 112.937 -175.116 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 17.1 m -170.35 162.13 8.34 Favored 'General case' 0 N--CA 1.447 -0.608 0 C-N-CA 129.389 3.076 . . . . 0.0 103.752 -169.856 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . 0.433 ' HG3' ' H ' ' A' ' 42' ' ' VAL . 6.9 tpt180 -92.14 -155.93 0.44 Allowed 'General case' 0 N--CA 1.467 0.416 0 O-C-N 121.053 -1.029 . . . . 0.0 109.656 -173.039 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.433 ' H ' ' HG3' ' A' ' 41' ' ' ARG . 0.6 OUTLIER -131.87 156.67 42.75 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 C-N-CA 129.009 2.924 . . . . 0.0 107.064 -169.446 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 62.4 m80 -85.79 144.53 39.71 Favored Pre-proline 0 N--CA 1.468 0.459 0 N-CA-C 112.317 0.488 . . . . 0.0 112.317 -169.071 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -65.06 -45.07 8.44 Favored 'Trans proline' 0 C--N 1.348 0.546 0 C-N-CA 122.904 2.403 . . . . 0.0 111.834 -176.172 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 6.5 m -69.57 -28.06 65.66 Favored 'General case' 0 CA--C 1.531 0.233 0 CA-C-O 118.977 -0.535 . . . . 0.0 110.002 179.575 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -60.46 -54.33 46.86 Favored 'General case' 0 CA--C 1.507 -0.691 0 N-CA-C 107.882 -1.155 . . . . 0.0 107.882 171.183 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 56.7 mt -58.1 -40.21 76.11 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 N-CA-C 108.657 -0.868 . . . . 0.0 108.657 -173.828 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -63.37 -49.3 74.39 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-N 118.555 0.616 . . . . 0.0 111.61 179.046 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 28.1 mmt -66.23 -36.5 83.2 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-O 122.98 1.371 . . . . 0.0 110.895 -179.712 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -78.25 -30.82 48.85 Favored 'General case' 0 N--CA 1.441 -0.875 0 N-CA-C 107.416 -1.327 . . . . 0.0 107.416 -173.335 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 41.2 tt0 -71.95 -22.14 61.5 Favored 'General case' 0 N--CA 1.447 -0.598 0 C-N-CA 123.815 0.846 . . . . 0.0 110.228 169.986 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 16.8 mm-40 -68.19 -30.73 69.89 Favored 'General case' 0 CA--C 1.534 0.361 0 CA-C-N 119.487 1.039 . . . . 0.0 110.23 171.62 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . 0.276 9.3 p -89.34 10.0 2.43 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.035 0 CA-C-N 118.514 0.597 . . . . 0.0 111.114 168.914 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 78.18 16.28 79.89 Favored Glycine 0 CA--C 1.532 1.121 0 C-N-CA 124.956 1.265 . . . . 0.0 113.76 173.8 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 13.5 mt -102.2 141.35 18.57 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.237 0 C-N-CA 124.453 1.101 . . . . 0.0 110.555 -173.574 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -94.71 137.29 33.99 Favored 'General case' 0 C--O 1.235 0.312 0 C-N-CA 124.417 1.087 . . . . 0.0 108.26 169.817 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 7.0 pt -138.04 -30.0 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.544 0 C-N-CA 124.543 1.137 . . . . 0.0 110.538 170.095 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -23.53 -38.32 0.0 OUTLIER 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 130.054 3.341 . . . . 0.0 117.045 169.563 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -98.64 31.26 8.32 Favored Glycine 0 CA--C 1.536 1.383 0 C-N-CA 125.543 1.544 . . . . 0.0 115.349 -175.205 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 12.7 mt-30 -62.0 -31.42 71.79 Favored 'General case' 0 N--CA 1.476 0.846 0 CA-C-N 120.088 1.944 . . . . 0.0 113.956 -174.336 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -70.34 122.16 19.04 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 123.059 0.544 . . . . 0.0 110.517 -169.158 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 74.9 m -151.91 -167.9 2.91 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 127.03 2.132 . . . . 0.0 107.417 -171.292 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -51.58 143.55 20.0 Favored Pre-proline 0 CA--C 1.539 0.528 0 C-N-CA 123.967 0.907 . . . . 0.0 110.402 170.51 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 84.5 Cg_endo -70.92 160.73 48.43 Favored 'Trans proline' 0 N--CA 1.456 -0.683 0 C-N-CA 122.883 2.389 . . . . 0.0 110.326 172.941 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 11.9 tt -60.86 -20.45 21.74 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.447 0 C-N-CA 123.889 0.876 . . . . 0.0 112.246 -179.878 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 25.9 tt0 -66.5 -28.6 68.69 Favored 'General case' 0 N--CA 1.434 -1.256 0 C-N-CA 124.768 1.227 . . . . 0.0 110.516 -176.558 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 74.9 m-20 -80.54 -1.44 41.96 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 124.305 1.042 . . . . 0.0 112.387 179.115 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 85.5 m-85 -110.76 177.19 4.75 Favored 'General case' 0 C--O 1.234 0.278 0 C-N-CA 125.698 1.599 . . . . 0.0 110.925 179.204 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 50.4 t-20 -128.66 135.76 49.72 Favored 'General case' 0 N--CA 1.448 -0.532 0 N-CA-C 108.175 -1.046 . . . . 0.0 108.175 169.297 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.589 ' HB2' ' CD2' ' A' ' 90' ' ' TRP . . . -73.28 -24.63 60.45 Favored 'General case' 0 N--CA 1.435 -1.184 0 N-CA-C 109.25 -0.648 . . . . 0.0 109.25 -178.473 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 35.5 t70 -66.2 -21.78 66.32 Favored 'General case' 0 N--CA 1.445 -0.696 0 C-N-CA 120.644 -0.422 . . . . 0.0 111.091 -177.59 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 35.2 t70 -77.42 -27.95 52.48 Favored 'General case' 0 C--N 1.345 0.393 0 C-N-CA 123.617 0.767 . . . . 0.0 111.584 174.144 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 14.1 m-85 -80.17 167.55 20.21 Favored 'General case' 0 C--O 1.239 0.53 0 C-N-CA 125.39 1.476 . . . . 0.0 111.392 -179.552 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -117.03 -39.18 3.26 Favored 'General case' 0 C--O 1.235 0.312 0 C-N-CA 123.338 0.655 . . . . 0.0 111.668 177.953 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -138.01 133.56 44.38 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.406 0 C-N-CA 123.866 0.866 . . . . 0.0 109.881 -170.871 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 66.6 t -140.79 125.63 18.55 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.402 0 N-CA-C 105.72 -1.956 . . . . 0.0 105.72 178.306 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.557 HD12 ' HB2' ' A' ' 97' ' ' GLU . 7.5 mm -96.24 125.26 49.15 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.545 0 N-CA-C 105.333 -2.099 . . . . 0.0 105.333 170.071 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 59.6 m -93.36 91.81 7.37 Favored 'General case' 0 N--CA 1.443 -0.811 0 N-CA-C 104.123 -2.547 . . . . 0.0 104.123 169.662 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 23.0 mt -63.08 -12.68 28.54 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-O 118.321 -0.847 . . . . 0.0 112.771 -173.206 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 39.3 m -142.94 126.53 16.88 Favored 'General case' 0 N--CA 1.445 -0.684 0 N-CA-C 106.634 -1.617 . . . . 0.0 106.634 174.43 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 58.44 -148.55 37.51 Favored Glycine 0 CA--C 1.534 1.227 0 C-N-CA 123.613 0.625 . . . . 0.0 112.183 177.488 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 14.0 p -139.2 -79.11 0.33 Allowed 'General case' 0 CA--C 1.529 0.165 0 C-N-CA 124.173 0.989 . . . . 0.0 108.727 175.865 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -79.24 53.24 4.16 Favored Glycine 0 CA--C 1.526 0.756 0 C-N-CA 125.498 1.523 . . . . 0.0 112.096 -178.429 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 16.3 m -81.21 60.83 0.2 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.71 0 C-N-CA 124.868 1.267 . . . . 0.0 110.802 -173.984 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 50.1 t30 56.2 59.74 3.54 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 125.944 1.698 . . . . 0.0 108.374 -172.41 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -136.69 143.14 41.63 Favored Pre-proline 0 CA--C 1.544 0.729 0 C-N-CA 126.223 1.809 . . . . 0.0 108.845 -168.925 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_exo -67.13 136.77 41.89 Favored 'Trans proline' 0 CA--C 1.542 0.909 0 C-N-CA 122.555 2.17 . . . . 0.0 111.353 172.973 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 42.4 Cg_endo -63.66 -25.84 69.0 Favored 'Trans proline' 0 N--CA 1.46 -0.474 0 C-N-CA 122.778 2.319 . . . . 0.0 114.821 -169.663 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 6.4 pm0 -57.42 -20.61 31.19 Favored 'General case' 0 CA--C 1.539 0.528 0 CA-C-N 120.149 1.341 . . . . 0.0 112.272 177.345 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' TRP . . . . . 0.589 ' CD2' ' HB2' ' A' ' 70' ' ' ALA . 99.9 m95 -79.28 -23.41 43.61 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-O 118.726 -0.654 . . . . 0.0 112.629 178.657 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 6.5 m -104.67 -8.87 9.77 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.156 0 C-N-CA 124.669 1.188 . . . . 0.0 113.03 -179.818 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . 0.266 6.6 t -111.57 45.58 1.2 Allowed 'General case' 0 CA--C 1.544 0.713 0 CA-C-O 123.142 1.448 . . . . 0.0 110.104 172.299 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 56.2 mm-40 -73.47 177.42 5.3 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 124.919 1.288 . . . . 0.0 109.73 169.936 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 34.9 mm-40 -65.49 -21.73 66.66 Favored 'General case' 0 CA--C 1.538 0.503 0 O-C-N 121.844 -0.535 . . . . 0.0 111.225 -179.626 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 4.6 tt -140.26 131.14 30.33 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.334 0 C-N-CA 126.241 1.816 . . . . 0.0 106.439 169.871 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 35.2 t80 -109.57 136.36 49.07 Favored 'General case' 0 CA--C 1.539 0.528 0 N-CA-C 106.272 -1.751 . . . . 0.0 106.272 169.487 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . 0.557 ' HB2' HD12 ' A' ' 77' ' ' ILE . 10.7 mm-40 -142.2 162.55 35.18 Favored 'General case' 0 C--O 1.234 0.287 0 C-N-CA 124.429 1.091 . . . . 0.0 108.871 175.83 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 2.5 t70 -175.27 129.62 0.28 Allowed 'General case' 0 C--O 1.236 0.368 0 C-N-CA 127.014 2.126 . . . . 0.0 106.918 -169.802 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 99' ' ' TRP . . . . . 0.53 ' CZ3' HG21 ' A' ' 77' ' ' ILE . 6.5 m0 -143.69 140.47 30.05 Favored 'General case' 0 CA--C 1.522 -0.119 0 C-N-CA 122.826 0.45 . . . . 0.0 110.057 -171.853 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 31.3 mm-40 -84.57 59.79 5.69 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-O 121.653 0.739 . . . . 0.0 109.159 171.786 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.47 HD13 HG22 ' A' ' 119' ' ' VAL . 16.6 mt -64.68 138.67 58.53 Favored 'General case' 0 CA--C 1.529 0.14 0 N-CA-C 108.233 -1.025 . . . . 0.0 108.233 172.471 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 34.3 mm-40 -68.65 161.15 28.78 Favored 'General case' 0 N--CA 1.451 -0.397 0 N-CA-C 108.265 -1.013 . . . . 0.0 108.265 168.901 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -130.97 131.45 23.24 Favored Pre-proline 0 N--CA 1.45 -0.456 0 N-CA-C 107.341 -1.355 . . . . 0.0 107.341 169.352 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 67.9 Cg_endo -78.9 -3.9 13.57 Favored 'Trans proline' 0 CA--C 1.545 1.043 0 C-N-CA 122.125 1.883 . . . . 0.0 114.729 -169.867 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -51.26 129.38 24.5 Favored 'General case' 0 CA--C 1.537 0.443 0 CA-C-N 119.996 1.271 . . . . 0.0 111.05 177.606 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 72.71 11.1 77.39 Favored Glycine 0 CA--C 1.533 1.206 0 CA-C-O 118.758 -1.023 . . . . 0.0 114.127 171.942 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 29.7 pt20 -136.66 -171.12 2.84 Favored 'General case' 0 CA--C 1.542 0.659 0 CA-C-N 118.991 1.395 . . . . 0.0 111.302 176.245 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 1.9 m -68.34 158.3 33.8 Favored 'General case' 0 CA--C 1.533 0.327 0 N-CA-C 117.641 2.46 . . . . 0.0 117.641 -167.563 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 55.7 tp -54.42 -34.16 60.83 Favored 'General case' 0 C--N 1.344 0.33 0 C-N-CA 126.917 2.087 . . . . 0.0 111.451 170.144 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 29.5 tp10 -64.73 -29.32 70.3 Favored 'General case' 0 C--N 1.331 -0.235 0 O-C-N 122.028 -0.42 . . . . 0.0 110.796 177.491 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 4.1 t -76.83 -37.1 27.25 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.385 0 CA-C-O 117.866 -1.064 . . . . 0.0 110.21 175.471 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 59.3 m-85 -56.21 -49.36 74.31 Favored 'General case' 0 N--CA 1.474 0.727 0 CA-C-N 120.738 1.608 . . . . 0.0 109.656 170.121 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 77.0 mtt180 -58.99 -44.07 91.54 Favored 'General case' 0 N--CA 1.468 0.432 0 C-N-CA 123.501 0.72 . . . . 0.0 110.691 178.319 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 18.5 m -65.5 -49.24 69.76 Favored 'General case' 0 N--CA 1.445 -0.714 0 C-N-CA 124.261 1.025 . . . . 0.0 110.07 -179.962 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 63.8 t -67.69 -35.84 74.06 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.191 0 CA-C-N 119.42 1.009 . . . . 0.0 109.353 -172.128 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 45.8 ttp85 -58.23 -39.9 80.28 Favored 'General case' 0 CA--C 1.539 0.553 0 CA-C-N 118.405 0.548 . . . . 0.0 109.808 173.585 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -66.81 -53.41 27.51 Favored Glycine 0 CA--C 1.533 1.218 0 C-N-CA 123.698 0.666 . . . . 0.0 112.566 172.809 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 72.2 mt-30 -55.08 -48.35 73.64 Favored 'General case' 0 N--CA 1.469 0.5 0 CA-C-O 122.184 0.992 . . . . 0.0 110.0 -176.137 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . 0.47 HG22 HD13 ' A' ' 101' ' ' LEU . 97.0 t -74.48 -37.01 43.45 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.439 0 CA-C-O 117.738 -1.125 . . . . 0.0 109.786 -171.563 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -55.47 -46.58 76.83 Favored 'General case' 0 C--O 1.224 -0.288 0 CA-C-N 120.112 1.324 . . . . 0.0 108.585 172.198 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 41.5 tt0 -66.43 -43.04 86.79 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 122.458 0.303 . . . . 0.0 111.205 -175.121 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 38.5 mmt180 -62.44 -45.55 92.58 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-N 119.069 0.85 . . . . 0.0 111.01 176.18 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 97.2 t -69.14 -37.68 76.92 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.578 0 N-CA-C 109.196 -0.668 . . . . 0.0 109.196 -177.219 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 20.2 mt-10 -59.85 -44.79 93.92 Favored 'General case' 0 N--CA 1.457 -0.12 0 CA-C-N 119.346 0.975 . . . . 0.0 110.09 173.556 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 25.9 t-20 -65.02 -42.24 94.57 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 123.169 0.588 . . . . 0.0 111.641 -178.487 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 1.6 tm? -58.31 -48.39 80.67 Favored 'General case' 0 C--O 1.228 -0.068 0 C-N-CA 126.323 1.849 . . . . 0.0 110.752 174.035 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 63.4 mt -66.04 -47.75 83.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 N-CA-C 108.658 -0.867 . . . . 0.0 108.658 179.598 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -58.52 -31.21 67.7 Favored 'General case' 0 CA--C 1.535 0.381 0 CA-C-O 118.849 -0.596 . . . . 0.0 112.145 -176.851 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 17.3 ptpt -81.59 -39.62 24.26 Favored 'General case' 0 C--N 1.344 0.364 0 CA-C-O 117.786 -1.102 . . . . 0.0 112.486 176.53 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 11.8 pt -81.67 -37.42 15.24 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.287 0 CA-C-N 119.931 1.242 . . . . 0.0 113.725 -176.039 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 72.4 m . . . . . 0 C--O 1.253 1.288 0 C-N-CA 125.638 1.575 . . . . 0.0 109.764 -169.985 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.499 1.985 0 N-CA-C 110.411 -0.218 . . . . 0.0 110.411 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 32.9 mttm -81.43 118.92 23.09 Favored 'General case' 0 N--CA 1.476 0.849 0 N-CA-C 106.541 -1.652 . . . . 0.0 106.541 173.348 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 93.0 mttt -80.86 133.84 35.65 Favored 'General case' 0 CA--C 1.507 -0.692 0 CA-C-N 119.785 1.175 . . . . 0.0 108.398 175.691 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 1.5 t -118.36 145.48 24.27 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.589 0 C-N-CA 125.914 1.686 . . . . 0.0 106.796 -172.843 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 26.6 ttm -136.53 145.1 44.66 Favored 'General case' 0 C--N 1.318 -0.777 0 C-N-CA 125.143 1.377 . . . . 0.0 108.265 169.764 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 91.5 m-85 -137.93 121.62 17.46 Favored 'General case' 0 CA--C 1.516 -0.339 0 N-CA-C 104.673 -2.343 . . . . 0.0 104.673 177.445 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 2.6 p -153.58 154.16 7.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-O 122.338 1.066 . . . . 0.0 111.745 -169.178 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 42.7 t -144.77 165.18 28.82 Favored 'General case' 0 CA--C 1.538 0.486 0 N-CA-C 104.506 -2.405 . . . . 0.0 104.506 168.981 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 22.9 pttp -61.47 130.17 44.73 Favored 'General case' 0 N--CA 1.467 0.378 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 172.515 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 59.2 136.58 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 128.211 2.604 . . . . 0.0 114.114 -170.373 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 20.4 t30 -56.05 -35.0 66.43 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 125.106 1.362 . . . . 0.0 111.885 176.526 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 1.6 p -70.3 -8.06 47.41 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 125.398 1.479 . . . . 0.0 113.243 -175.802 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 38.5 m -76.01 -88.15 0.04 OUTLIER 'General case' 0 CA--C 1.54 0.568 0 CA-C-N 119.292 0.951 . . . . 0.0 110.259 178.638 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 10.6 mpt_? -115.5 6.83 14.79 Favored 'General case' 0 N--CA 1.475 0.801 0 CA-C-N 120.349 1.431 . . . . 0.0 113.041 179.227 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 1.4 m -91.92 47.44 1.35 Allowed 'General case' 0 CA--C 1.541 0.601 0 O-C-N 121.327 -0.858 . . . . 0.0 110.918 -175.449 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -118.37 9.01 12.31 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 125.967 1.707 . . . . 0.0 112.596 170.941 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 1.1 tpt -159.87 -39.48 0.05 Allowed 'General case' 0 N--CA 1.457 -0.119 0 N-CA-C 115.443 1.646 . . . . 0.0 115.443 -176.916 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -69.55 -46.72 65.77 Favored 'General case' 0 N--CA 1.471 0.597 0 CA-C-N 120.947 1.703 . . . . 0.0 111.703 -169.482 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . 0.45 ' CD ' HE22 ' A' ' 60' ' ' GLN . 0.0 OUTLIER -57.35 -42.28 81.69 Favored 'General case' 0 C--N 1.325 -0.473 0 C-N-CA 124.321 1.049 . . . . 0.0 110.731 170.837 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -61.59 -45.59 96.02 Favored Glycine 0 CA--C 1.524 0.653 0 C-N-CA 123.84 0.733 . . . . 0.0 111.798 176.924 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -66.85 -35.93 81.17 Favored 'General case' 0 CA--C 1.514 -0.431 0 O-C-N 121.216 -1.167 . . . . 0.0 111.918 178.278 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -70.86 -36.3 72.77 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 119.662 1.119 . . . . 0.0 110.555 179.688 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -52.52 -42.66 64.54 Favored 'General case' 0 N--CA 1.467 0.392 0 C-N-CA 123.864 0.866 . . . . 0.0 109.009 169.207 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 22.4 m -75.15 -59.29 2.81 Favored 'General case' 0 N--CA 1.446 -0.653 0 C-N-CA 124.303 1.041 . . . . 0.0 111.397 -173.872 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 34.6 mt -73.82 -33.87 64.35 Favored 'General case' 0 C--N 1.332 -0.191 0 C-N-CA 125.083 1.353 . . . . 0.0 110.949 -170.567 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -102.76 6.77 52.43 Favored Glycine 0 CA--C 1.525 0.668 0 CA-C-O 117.901 -1.5 . . . . 0.0 113.521 -172.585 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -41.15 -52.77 3.25 Favored 'General case' 0 N--CA 1.466 0.363 0 C-N-CA 126.254 1.821 . . . . 0.0 114.819 -169.714 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -88.81 7.12 82.83 Favored Glycine 0 CA--C 1.531 1.048 0 CA-C-O 119.186 -0.785 . . . . 0.0 113.573 -175.547 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 70.0 mttt -124.73 -49.35 1.76 Allowed 'General case' 0 N--CA 1.467 0.395 0 CA-C-N 118.511 1.155 . . . . 0.0 111.937 -169.27 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 27.1 pt -137.96 150.93 25.07 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.401 0 C-N-CA 124.732 1.213 . . . . 0.0 110.415 -168.911 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -111.17 105.77 14.58 Favored 'General case' 0 C--O 1.226 -0.146 0 C-N-CA 125.013 1.325 . . . . 0.0 109.971 -169.526 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 11.4 t -78.93 127.9 38.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 177.374 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 18.7 m -144.31 92.94 2.37 Favored 'General case' 0 N--CA 1.449 -0.503 0 N-CA-C 103.615 -2.735 . . . . 0.0 103.615 169.677 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 58.1 m -89.33 -1.32 58.02 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 115.764 1.764 . . . . 0.0 115.764 -168.759 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 28.4 p 49.05 -130.08 1.92 Allowed 'General case' 0 CA--C 1.546 0.815 0 C-N-CA 124.451 1.1 . . . . 0.0 111.333 -178.842 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 173.5 153.98 10.17 Favored Glycine 0 CA--C 1.53 0.978 0 C-N-CA 124.951 1.262 . . . . 0.0 111.027 170.06 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 4.3 mt -111.89 103.95 12.21 Favored 'General case' 0 N--CA 1.444 -0.755 1 N-CA-C 100.071 -4.048 . . . . 0.0 100.071 169.16 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 35.2 mt-10 64.05 170.36 0.17 Allowed 'General case' 0 C--O 1.238 0.458 0 O-C-N 125.371 1.669 . . . . 0.0 110.241 -167.583 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 59.1 p -146.9 158.79 44.01 Favored 'General case' 0 N--CA 1.448 -0.558 0 CA-C-O 122.628 1.204 . . . . 0.0 113.701 -178.457 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 4.1 m -170.81 166.96 7.72 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 129.801 3.24 . . . . 0.0 104.222 -171.892 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -87.94 -159.61 0.55 Allowed 'General case' 0 N--CA 1.468 0.459 0 O-C-N 120.845 -1.159 . . . . 0.0 108.72 176.209 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.517 HG21 HD12 ' A' ' 57' ' ' ILE . 1.5 p -127.17 157.84 38.51 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.782 0 C-N-CA 126.418 1.887 . . . . 0.0 107.73 179.933 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -85.84 153.04 57.48 Favored Pre-proline 0 CA--C 1.538 0.517 0 C-N-CA 124.67 1.188 . . . . 0.0 111.366 -169.452 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 55.1 Cg_endo -63.84 -41.34 24.26 Favored 'Trans proline' 0 C--N 1.347 0.495 0 C-N-CA 123.474 2.783 . . . . 0.0 112.415 -174.039 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 7.3 m -69.79 -29.63 66.98 Favored 'General case' 0 CA--C 1.53 0.188 0 CA-C-O 118.649 -0.691 . . . . 0.0 110.319 -176.839 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -62.99 -50.6 70.13 Favored 'General case' 0 C--O 1.215 -0.712 0 CA-C-N 119.659 1.118 . . . . 0.0 108.413 171.094 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 75.1 mt -58.38 -40.09 76.89 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.447 0 CA-C-N 118.982 0.81 . . . . 0.0 108.851 -176.462 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -64.7 -49.63 70.15 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-N 118.915 0.779 . . . . 0.0 112.354 178.255 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 38.6 mmt -69.35 -36.48 76.92 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-O 122.739 1.257 . . . . 0.0 110.543 -177.564 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -71.69 -32.05 67.41 Favored 'General case' 0 N--CA 1.444 -0.763 0 N-CA-C 106.369 -1.715 . . . . 0.0 106.369 -178.761 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 40.5 tt0 -72.02 -19.57 61.83 Favored 'General case' 0 CA--C 1.54 0.572 0 O-C-N 121.122 -0.986 . . . . 0.0 110.999 169.882 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 75.5 mt-10 -64.19 -37.11 86.31 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-N 120.176 1.353 . . . . 0.0 109.859 169.605 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 11.9 m -85.94 12.12 1.05 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.675 0 N-CA-C 112.759 0.651 . . . . 0.0 112.759 169.968 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 72.4 14.23 77.2 Favored Glycine 0 CA--C 1.532 1.155 0 C-N-CA 124.488 1.042 . . . . 0.0 113.476 176.154 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 10.5 mt -93.35 137.73 21.88 Favored 'Isoleucine or valine' 0 C--O 1.233 0.199 0 CA-C-N 118.498 1.149 . . . . 0.0 109.613 -177.053 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 12.9 t0 -101.87 132.93 47.37 Favored 'General case' 0 C--O 1.233 0.236 0 N-CA-C 107.566 -1.272 . . . . 0.0 107.566 169.343 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.517 HD12 HG21 ' A' ' 42' ' ' VAL . 0.6 OUTLIER -118.72 -70.64 0.78 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.37 0 C-N-CA 125.528 1.531 . . . . 0.0 107.319 177.321 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 97.2 p 40.33 -97.78 0.02 OUTLIER 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 127.169 2.187 . . . . 0.0 114.349 170.152 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -74.79 58.0 2.6 Favored Glycine 0 CA--C 1.531 1.067 0 C-N-CA 126.99 2.233 . . . . 0.0 111.705 178.947 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . 0.45 HE22 ' CD ' ' A' ' 19' ' ' GLU . 12.5 mm100 -66.89 -30.31 70.43 Favored 'General case' 0 C--O 1.233 0.232 0 C-N-CA 125.051 1.34 . . . . 0.0 111.69 -179.868 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 1.1 p -62.68 133.66 55.17 Favored 'General case' 0 N--CA 1.444 -0.746 0 C-N-CA 124.934 1.294 . . . . 0.0 109.435 -169.369 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 57.7 m -146.14 -179.21 6.57 Favored 'General case' 0 N--CA 1.446 -0.666 0 C-N-CA 125.999 1.72 . . . . 0.0 107.493 -169.307 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -56.61 152.74 24.19 Favored Pre-proline 0 CA--C 1.536 0.427 0 C-N-CA 123.87 0.868 . . . . 0.0 111.446 175.064 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 89.3 Cg_endo -65.59 158.24 54.25 Favored 'Trans proline' 0 N--CA 1.453 -0.856 0 C-N-CA 122.574 2.183 . . . . 0.0 110.345 172.965 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 14.0 tt -58.52 -26.81 31.97 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.411 0 C-N-CA 124.013 0.925 . . . . 0.0 111.622 179.133 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 15.1 mt-10 -67.94 -26.55 66.02 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 124.255 1.022 . . . . 0.0 110.356 -174.524 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 5.4 t-20 -64.31 -22.16 66.86 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 125.197 1.399 . . . . 0.0 112.208 177.728 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -108.67 178.57 4.44 Favored 'General case' 0 C--O 1.235 0.339 0 C-N-CA 126.024 1.729 . . . . 0.0 111.209 -173.797 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 57.5 t-20 -133.25 137.36 46.05 Favored 'General case' 0 N--CA 1.444 -0.745 0 N-CA-C 107.144 -1.428 . . . . 0.0 107.144 168.988 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -74.86 -23.84 58.48 Favored 'General case' 0 N--CA 1.437 -1.112 0 N-CA-C 109.456 -0.572 . . . . 0.0 109.456 -176.985 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -61.62 -24.74 66.9 Favored 'General case' 0 N--CA 1.447 -0.604 0 O-C-N 123.331 0.395 . . . . 0.0 111.579 178.831 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -76.57 -27.64 55.93 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 123.578 0.751 . . . . 0.0 112.081 177.133 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 11.7 m-85 -78.75 164.01 24.91 Favored 'General case' 0 N--CA 1.45 -0.442 0 C-N-CA 125.187 1.395 . . . . 0.0 111.465 -177.043 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -105.4 -39.29 6.19 Favored 'General case' 0 N--CA 1.462 0.13 0 CA-C-N 115.557 -0.747 . . . . 0.0 110.41 171.436 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -139.19 138.91 40.57 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.441 0 CA-C-O 122.449 1.118 . . . . 0.0 110.188 -171.333 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 42.6 t -140.21 145.03 26.75 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.855 0 N-CA-C 106.411 -1.7 . . . . 0.0 106.411 179.936 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.435 HD12 ' HB2' ' A' ' 97' ' ' GLU . 24.1 mm -141.71 137.36 31.65 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.865 0 N-CA-C 106.496 -1.668 . . . . 0.0 106.496 -170.69 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 50.3 m -101.43 163.84 12.07 Favored 'General case' 0 N--CA 1.445 -0.691 0 N-CA-C 107.625 -1.25 . . . . 0.0 107.625 168.861 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 51.3 mt -132.66 18.84 4.26 Favored 'General case' 0 CA--C 1.533 0.292 0 O-C-N 121.14 -0.975 . . . . 0.0 111.048 -174.53 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 28.1 p -169.21 -5.12 0.02 OUTLIER 'General case' 0 CA--C 1.541 0.603 0 N-CA-C 115.433 1.642 . . . . 0.0 115.433 -173.986 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 167.78 175.0 37.24 Favored Glycine 0 CA--C 1.529 0.927 0 CA-C-N 120.54 1.518 . . . . 0.0 111.292 -177.081 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 40.2 m -117.31 124.34 48.73 Favored 'General case' 0 C--O 1.233 0.229 0 C-N-CA 124.444 1.098 . . . . 0.0 108.101 -177.046 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 62.55 28.74 71.83 Favored Glycine 0 CA--C 1.531 1.044 0 N-CA-C 111.343 -0.703 . . . . 0.0 111.343 -174.822 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . 0.267 7.2 p -80.2 74.41 0.74 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.512 0 C-N-CA 125.006 1.322 . . . . 0.0 109.988 -169.459 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 1.1 t30 60.07 54.08 4.3 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 126.711 2.005 . . . . 0.0 108.012 -176.476 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.409 ' HA ' ' HD3' ' A' ' 87' ' ' PRO . 0.9 OUTLIER -152.12 138.4 11.79 Favored Pre-proline 0 CA--C 1.539 0.55 0 C-N-CA 125.803 1.641 . . . . 0.0 107.621 -169.341 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . 0.417 ' HA ' ' HD3' ' A' ' 88' ' ' PRO . 31.8 Cg_exo -69.84 146.6 60.2 Favored 'Trans proline' 0 CA--C 1.546 1.08 0 C-N-CA 121.494 1.463 . . . . 0.0 114.139 -175.77 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . 0.417 ' HD3' ' HA ' ' A' ' 87' ' ' PRO . 51.8 Cg_exo -63.7 -25.95 68.65 Favored 'Trans proline' 0 C--N 1.349 0.581 0 C-N-CA 122.667 2.244 . . . . 0.0 115.945 -174.085 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 5.7 pm0 -61.53 -14.84 32.85 Favored 'General case' 0 CA--C 1.543 0.707 0 CA-C-N 121.024 1.738 . . . . 0.0 111.809 175.982 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 90.8 m95 -91.81 -21.7 20.53 Favored 'General case' 0 N--CA 1.451 -0.409 0 C-N-CA 124.509 1.123 . . . . 0.0 113.07 173.793 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 2.9 m -78.64 -5.01 7.39 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.36 0 CA-C-N 120.129 1.331 . . . . 0.0 111.326 171.377 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 60.3 p -107.95 -118.14 0.26 Allowed 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 123.081 0.552 . . . . 0.0 111.492 -176.747 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 70.5 mm-40 55.96 -171.13 0.07 Allowed 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 125.563 1.545 . . . . 0.0 111.47 -168.787 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 37.0 mm-40 -70.25 -23.11 62.85 Favored 'General case' 0 CA--C 1.537 0.474 0 O-C-N 121.479 -0.763 . . . . 0.0 112.316 -169.466 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 9.5 tt -147.83 141.64 19.3 Favored 'Isoleucine or valine' 0 C--O 1.238 0.46 0 C-N-CA 125.103 1.361 . . . . 0.0 107.607 169.761 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 73.3 t80 -128.22 139.41 52.47 Favored 'General case' 0 N--CA 1.446 -0.661 0 N-CA-C 106.277 -1.749 . . . . 0.0 106.277 168.867 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . 0.435 ' HB2' HD12 ' A' ' 77' ' ' ILE . 29.3 mm-40 -139.32 166.26 25.02 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 107.246 -1.39 . . . . 0.0 107.246 170.003 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -165.33 137.29 4.17 Favored 'General case' 0 C--N 1.323 -0.568 0 C-N-CA 126.074 1.75 . . . . 0.0 106.334 -176.642 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 6.9 m0 -143.12 144.77 32.35 Favored 'General case' 0 N--CA 1.451 -0.377 0 C-N-CA 122.875 0.47 . . . . 0.0 110.201 -169.332 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 20.0 tt0 -83.33 57.42 3.98 Favored 'General case' 0 CA--C 1.537 0.451 0 N-CA-C 108.179 -1.045 . . . . 0.0 108.179 171.054 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.455 HD13 HG22 ' A' ' 119' ' ' VAL . 19.4 mt -65.74 138.47 57.97 Favored 'General case' 0 C--O 1.235 0.321 0 N-CA-C 107.155 -1.424 . . . . 0.0 107.155 173.459 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 23.5 mm-40 -67.22 151.52 47.38 Favored 'General case' 0 N--CA 1.451 -0.41 0 CA-C-O 121.574 0.702 . . . . 0.0 109.511 172.033 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -112.41 117.97 46.33 Favored Pre-proline 0 N--CA 1.45 -0.468 0 N-CA-C 106.098 -1.816 . . . . 0.0 106.098 170.447 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_endo -80.82 -1.52 11.29 Favored 'Trans proline' 0 N--CA 1.448 -1.183 0 C-N-CA 122.98 2.453 . . . . 0.0 113.412 -173.217 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -53.4 120.07 5.61 Favored 'General case' 0 CA--C 1.536 0.429 0 CA-C-N 120.473 1.488 . . . . 0.0 110.864 -175.917 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 70.2 0.65 30.08 Favored Glycine 0 CA--C 1.534 1.245 0 CA-C-O 118.765 -1.019 . . . . 0.0 114.562 179.518 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 12.9 mt-30 -85.3 171.89 11.54 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-N 119.156 1.478 . . . . 0.0 109.638 174.096 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 15.0 m -69.2 162.33 27.32 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 123.91 0.884 . . . . 0.0 111.322 178.71 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 13.3 tp -59.04 -30.93 68.4 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 124.615 1.166 . . . . 0.0 112.43 -173.779 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 5.3 pt-20 -56.57 -34.92 67.61 Favored 'General case' 0 C--O 1.226 -0.166 0 C-N-CA 124.768 1.227 . . . . 0.0 111.775 174.778 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 32.2 t -75.03 -42.19 45.54 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.422 0 CA-C-O 117.813 -1.089 . . . . 0.0 109.164 -176.798 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 89.7 m-85 -56.52 -49.94 73.27 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-N 120.329 1.422 . . . . 0.0 109.666 172.621 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 86.8 mtt180 -66.84 -34.6 78.17 Favored 'General case' 0 N--CA 1.467 0.409 0 O-C-N 122.037 -0.414 . . . . 0.0 111.761 -176.358 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 3.5 m -62.24 -48.59 79.29 Favored 'General case' 0 N--CA 1.451 -0.404 0 C-N-CA 124.681 1.192 . . . . 0.0 109.413 170.357 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 45.7 t -63.62 -33.44 61.63 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.243 0 CA-C-O 118.265 -0.874 . . . . 0.0 110.0 -174.627 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 13.1 mtm105 -56.58 -49.8 73.83 Favored 'General case' 0 C--O 1.225 -0.226 0 CA-C-N 119.303 0.956 . . . . 0.0 110.071 172.188 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -62.3 -48.55 81.69 Favored Glycine 0 CA--C 1.526 0.731 0 CA-C-O 119.103 -0.832 . . . . 0.0 111.216 179.55 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 69.8 mt-30 -55.24 -53.23 58.63 Favored 'General case' 0 C--N 1.343 0.296 0 CA-C-O 122.091 0.948 . . . . 0.0 109.364 -179.802 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . 0.455 HG22 HD13 ' A' ' 101' ' ' LEU . 73.8 t -71.44 -39.97 71.91 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-O 117.875 -1.06 . . . . 0.0 110.605 -170.608 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 87.2 tttt -55.6 -47.46 76.47 Favored 'General case' 0 C--O 1.223 -0.321 0 CA-C-N 119.411 1.005 . . . . 0.0 108.316 176.792 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -66.22 -43.01 87.89 Favored 'General case' 0 N--CA 1.45 -0.465 0 C-N-CA 122.438 0.295 . . . . 0.0 111.078 -174.838 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 40.2 mmt180 -63.02 -46.6 86.85 Favored 'General case' 0 N--CA 1.471 0.611 0 O-C-N 121.563 -0.711 . . . . 0.0 110.837 177.831 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 78.2 t -67.31 -41.73 86.81 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.665 0 C-N-CA 123.08 0.552 . . . . 0.0 109.618 -178.897 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 31.3 mt-10 -60.23 -43.74 95.81 Favored 'General case' 0 CA--C 1.52 -0.191 0 CA-C-N 119.595 1.089 . . . . 0.0 110.011 177.651 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 29.0 t-20 -62.38 -45.03 94.97 Favored 'General case' 0 N--CA 1.454 -0.243 0 C-N-CA 122.776 0.43 . . . . 0.0 110.668 179.789 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 28.5 tp -59.44 -47.69 84.49 Favored 'General case' 0 N--CA 1.453 -0.277 0 C-N-CA 123.859 0.864 . . . . 0.0 111.102 177.579 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 85.0 mt -63.09 -46.59 95.71 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.175 0 N-CA-C 107.845 -1.169 . . . . 0.0 107.845 179.504 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -59.79 -28.8 67.74 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-N 118.457 0.571 . . . . 0.0 112.335 178.682 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 92.1 mttt -69.37 -57.17 5.63 Favored 'General case' 0 C--N 1.344 0.349 0 CA-C-N 119.219 0.918 . . . . 0.0 110.629 171.751 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 13.6 pt -77.29 -38.46 27.03 Favored 'Isoleucine or valine' 0 C--O 1.235 0.305 0 N-CA-C 115.095 1.517 . . . . 0.0 115.095 -168.823 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 69.5 m . . . . . 0 C--O 1.252 1.219 0 C-N-CA 125.694 1.597 . . . . 0.0 109.334 -169.79 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.496 1.839 0 N-CA-C 110.535 -0.172 . . . . 0.0 110.535 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 30.8 mttm -80.18 116.65 20.39 Favored 'General case' 0 N--CA 1.475 0.799 0 N-CA-C 106.109 -1.811 . . . . 0.0 106.109 173.66 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 92.2 mttt -81.89 131.88 35.26 Favored 'General case' 0 CA--C 1.505 -0.777 0 CA-C-N 119.566 1.075 . . . . 0.0 108.399 177.45 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 1.4 t -116.61 146.82 20.53 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 O-C-N 125.515 1.76 . . . . 0.0 107.131 -170.821 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 35.3 ttm -138.27 147.27 43.47 Favored 'General case' 0 C--N 1.32 -0.676 0 C-N-CA 125.194 1.398 . . . . 0.0 107.864 170.709 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . 0.403 ' CE2' HG13 ' A' ' 77' ' ' ILE . 67.2 m-85 -136.26 119.82 17.07 Favored 'General case' 0 CA--C 1.516 -0.339 0 N-CA-C 105.509 -2.034 . . . . 0.0 105.509 177.526 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 2.0 p -151.45 129.81 2.75 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.386 0 N-CA-C 108.656 -0.868 . . . . 0.0 108.656 -169.427 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -110.77 -178.58 3.52 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 125.764 1.626 . . . . 0.0 106.921 169.754 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 85.1 tttt -70.88 -26.98 63.48 Favored 'General case' 0 N--CA 1.472 0.659 0 O-C-N 121.131 -0.981 . . . . 0.0 112.306 -171.821 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 37.8 ttp180 -136.47 160.7 37.98 Favored 'General case' 0 N--CA 1.467 0.392 0 C-N-CA 124.269 1.028 . . . . 0.0 109.077 -169.545 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -68.96 -38.82 79.64 Favored 'General case' 0 N--CA 1.47 0.571 0 CA-C-N 118.613 0.642 . . . . 0.0 110.596 175.748 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 2.9 p -84.13 66.87 9.49 Favored 'General case' 0 C--O 1.234 0.284 0 C-N-CA 125.863 1.665 . . . . 0.0 108.565 -177.863 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 40.6 p -155.15 -167.02 2.43 Favored 'General case' 0 N--CA 1.451 -0.382 0 CA-C-O 121.789 0.804 . . . . 0.0 109.903 -172.946 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 76.0 mtt180 -54.17 -23.29 13.81 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 126.033 1.733 . . . . 0.0 111.986 169.987 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 28.7 m -51.01 -26.05 5.58 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-N 119.84 1.2 . . . . 0.0 112.991 178.1 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 6.5 pt20 -69.1 -26.99 65.19 Favored 'General case' 0 C--O 1.221 -0.432 0 N-CA-C 114.925 1.454 . . . . 0.0 114.925 -172.554 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 2.1 tpt -115.43 -32.26 5.65 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-N 120.72 1.6 . . . . 0.0 115.033 -169.31 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -68.48 -43.7 76.35 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-N 119.723 1.147 . . . . 0.0 113.083 -169.204 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 1.5 pp20? -63.75 -34.07 77.07 Favored 'General case' 0 N--CA 1.473 0.688 0 CA-C-N 119.267 0.94 . . . . 0.0 109.541 171.997 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -50.8 -49.66 40.44 Favored Glycine 0 C--O 1.219 -0.839 0 C-N-CA 125.259 1.409 . . . . 0.0 111.011 176.057 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 5.6 m-85 -75.98 -31.76 59.14 Favored 'General case' 0 CA--C 1.511 -0.541 0 CA-C-N 118.928 1.364 . . . . 0.0 113.899 178.258 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -68.03 -32.8 73.42 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 119.421 1.009 . . . . 0.0 111.58 -170.174 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 4.7 ptpt -61.07 -29.21 69.61 Favored 'General case' 0 N--CA 1.473 0.697 0 CA-C-N 118.546 0.612 . . . . 0.0 111.643 172.407 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 15.1 m -82.66 -56.93 3.56 Favored 'General case' 0 N--CA 1.443 -0.793 0 C-N-CA 124.965 1.306 . . . . 0.0 109.819 -177.399 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 76.3 mt -73.49 -36.58 65.8 Favored 'General case' 0 C--N 1.331 -0.207 0 C-N-CA 123.35 0.66 . . . . 0.0 110.947 -170.359 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -103.87 13.16 53.17 Favored Glycine 0 CA--C 1.525 0.687 0 CA-C-O 118.068 -1.407 . . . . 0.0 113.044 -174.072 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -41.66 -53.95 3.41 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 126.345 1.858 . . . . 0.0 114.707 -169.229 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -91.31 10.08 75.78 Favored Glycine 0 CA--C 1.53 1.027 0 CA-C-O 119.216 -0.769 . . . . 0.0 113.525 -176.201 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 50.5 mttm -124.13 -50.86 1.79 Allowed 'General case' 0 N--CA 1.467 0.411 0 CA-C-N 118.435 1.117 . . . . 0.0 112.028 -169.21 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 28.3 pt -136.54 150.36 27.32 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.338 0 C-N-CA 124.222 1.009 . . . . 0.0 110.137 -169.011 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -110.27 102.48 11.14 Favored 'General case' 0 C--O 1.228 -0.048 0 C-N-CA 124.911 1.284 . . . . 0.0 109.47 -169.549 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 9.6 p -84.93 130.28 36.32 Favored 'Isoleucine or valine' 0 C--O 1.235 0.309 0 CA-C-N 118.686 0.675 . . . . 0.0 109.658 -179.982 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 19.1 m -145.14 115.46 7.55 Favored 'General case' 0 N--CA 1.448 -0.548 0 N-CA-C 104.342 -2.466 . . . . 0.0 104.342 170.519 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 48.2 m -112.47 8.0 19.22 Favored 'General case' 0 N--CA 1.466 0.325 0 N-CA-C 115.434 1.642 . . . . 0.0 115.434 -174.391 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 1.5 m 52.96 -133.73 1.78 Allowed 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 123.568 0.747 . . . . 0.0 111.114 169.679 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -171.14 154.7 23.08 Favored Glycine 0 N--CA 1.444 -0.777 0 N-CA-C 108.16 -1.976 . . . . 0.0 108.16 170.047 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 55.8 mt -103.08 -51.02 3.35 Favored 'General case' 0 N--CA 1.451 -0.404 0 C-N-CA 124.057 0.943 . . . . 0.0 108.864 171.755 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 25.7 mt-10 -130.58 72.0 1.48 Allowed 'General case' 0 CA--C 1.514 -0.428 0 CA-C-O 124.124 1.916 . . . . 0.0 107.069 169.663 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 10.7 m 57.33 -31.39 0.03 OUTLIER 'General case' 0 C--N 1.321 -0.649 0 C-N-CA 131.446 3.898 . . . . 0.0 117.422 -174.976 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 60.9 m 60.67 23.25 13.09 Favored 'General case' 0 CA--C 1.54 0.573 0 N-CA-C 115.9 1.815 . . . . 0.0 115.9 168.35 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 11.3 ttt180 -71.86 -178.98 2.5 Favored 'General case' 0 CA--C 1.539 0.519 0 N-CA-C 107.558 -1.275 . . . . 0.0 107.558 169.017 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 11.5 m -123.95 -172.32 0.75 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.642 0 C-N-CA 124.437 1.095 . . . . 0.0 111.279 -169.187 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 96.1 m-70 -112.45 156.32 42.41 Favored Pre-proline 0 CA--C 1.536 0.422 0 C-N-CA 125.184 1.394 . . . . 0.0 111.009 -171.984 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -57.2 -48.49 17.65 Favored 'Trans proline' 0 C--N 1.347 0.49 0 C-N-CA 124.012 3.141 . . . . 0.0 112.628 -174.014 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 2.7 m -67.9 -29.64 68.79 Favored 'General case' 0 CA--C 1.531 0.227 0 CA-C-O 118.849 -0.596 . . . . 0.0 110.156 -176.876 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -59.61 -56.09 26.33 Favored 'General case' 0 CA--C 1.505 -0.763 0 N-CA-C 108.137 -1.06 . . . . 0.0 108.137 171.164 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 56.2 mt -59.61 -39.07 78.51 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.396 0 N-CA-C 108.52 -0.918 . . . . 0.0 108.52 -173.043 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -62.32 -49.58 75.05 Favored 'General case' 0 N--CA 1.452 -0.358 0 CA-C-N 119.181 0.9 . . . . 0.0 111.138 -179.838 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 38.9 mmt -71.46 -34.25 70.06 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-O 122.756 1.265 . . . . 0.0 110.161 -177.226 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -73.31 -31.27 63.92 Favored 'General case' 0 N--CA 1.44 -0.925 0 N-CA-C 107.393 -1.336 . . . . 0.0 107.393 -178.634 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 4.9 mm-40 -72.88 -17.5 61.52 Favored 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 124.101 0.96 . . . . 0.0 110.985 169.704 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 78.5 mt-10 -65.11 -36.84 85.55 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 119.844 1.202 . . . . 0.0 108.762 168.932 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . 0.302 8.5 p -86.46 7.5 2.33 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.991 0 CA-C-O 120.789 0.328 . . . . 0.0 111.608 169.742 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 71.41 23.31 78.2 Favored Glycine 0 CA--C 1.532 1.147 0 C-N-CA 124.994 1.283 . . . . 0.0 113.266 175.773 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 5.4 mt -103.7 136.65 35.71 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.226 0 C-N-CA 124.273 1.029 . . . . 0.0 111.975 -172.225 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -78.11 137.28 38.12 Favored 'General case' 0 CA--C 1.529 0.155 0 CA-C-N 114.507 -1.224 . . . . 0.0 109.043 168.972 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 8.1 pt -143.35 -27.56 0.17 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.39 0 C-N-CA 125.062 1.345 . . . . 0.0 108.951 168.209 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -40.21 -41.17 1.25 Allowed 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 129.459 3.104 . . . . 0.0 113.113 169.443 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -87.25 20.52 25.68 Favored Glycine 0 CA--C 1.533 1.171 0 C-N-CA 125.225 1.393 . . . . 0.0 114.38 -177.422 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -60.08 -35.14 74.54 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-N 119.812 1.806 . . . . 0.0 112.489 -178.161 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -66.97 133.01 49.12 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 123.981 0.912 . . . . 0.0 109.817 -171.067 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 13.7 p -151.23 -68.97 0.18 Allowed 'General case' 0 C--O 1.235 0.307 0 C-N-CA 123.356 0.663 . . . . 0.0 109.962 -177.761 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -151.3 155.77 34.74 Favored Pre-proline 0 C--O 1.236 0.376 0 C-N-CA 125.807 1.643 . . . . 0.0 108.57 -177.126 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -64.39 156.3 60.98 Favored 'Trans proline' 0 N--CA 1.456 -0.686 0 C-N-CA 122.234 1.956 . . . . 0.0 110.208 171.46 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 11.3 tt -57.55 -28.41 31.59 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.499 0 C-N-CA 123.137 0.575 . . . . 0.0 111.536 178.826 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 23.1 tt0 -66.04 -25.23 66.95 Favored 'General case' 0 N--CA 1.437 -1.083 0 C-N-CA 126.335 1.854 . . . . 0.0 110.715 -175.588 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 6.1 t-20 -64.11 -21.22 66.45 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 124.287 1.035 . . . . 0.0 112.126 176.82 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 77.6 m-85 -110.88 -176.0 2.86 Favored 'General case' 0 C--O 1.235 0.306 0 C-N-CA 126.025 1.73 . . . . 0.0 110.802 -174.487 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 61.5 t-20 -136.68 141.2 43.12 Favored 'General case' 0 N--CA 1.445 -0.697 0 N-CA-C 107.206 -1.405 . . . . 0.0 107.206 169.366 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -72.2 -25.2 61.58 Favored 'General case' 0 N--CA 1.433 -1.295 0 CA-C-N 118.44 0.564 . . . . 0.0 109.701 -178.901 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 35.6 t70 -63.04 -24.16 67.78 Favored 'General case' 0 N--CA 1.447 -0.607 0 O-C-N 123.549 0.531 . . . . 0.0 111.634 -179.417 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -74.94 -28.11 60.46 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 123.159 0.584 . . . . 0.0 111.868 175.626 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 12.3 m-85 -81.51 164.47 21.96 Favored 'General case' 0 N--CA 1.448 -0.556 0 C-N-CA 125.353 1.461 . . . . 0.0 111.357 -177.21 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -107.16 -37.9 6.15 Favored 'General case' 0 N--CA 1.462 0.138 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.776 173.583 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -139.28 138.71 40.39 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.504 0 CA-C-O 121.731 0.776 . . . . 0.0 110.17 -170.615 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 57.9 t -141.42 130.6 24.15 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.659 0 N-CA-C 106.22 -1.77 . . . . 0.0 106.22 178.033 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.538 HD12 ' HB2' ' A' ' 97' ' ' GLU . 27.4 mm -106.0 128.12 60.57 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.76 0 N-CA-C 105.325 -2.102 . . . . 0.0 105.325 176.537 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 28.9 m -109.93 75.72 0.95 Allowed 'General case' 0 N--CA 1.437 -1.112 0 N-CA-C 105.455 -2.054 . . . . 0.0 105.455 -176.336 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 59.9 mt -53.03 -17.06 1.27 Allowed 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 125.768 1.627 . . . . 0.0 115.102 -169.1 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 12.7 m -112.14 -7.92 14.03 Favored 'General case' 0 CA--C 1.541 0.597 0 CA-C-N 119.866 1.212 . . . . 0.0 114.2 -177.477 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 142.89 -132.91 5.28 Favored Glycine 0 C--N 1.338 0.692 0 CA-C-N 120.635 1.562 . . . . 0.0 111.543 -178.041 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 13.0 m -125.15 -28.13 3.45 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 123.554 0.742 . . . . 0.0 112.314 -169.901 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -76.14 -62.93 2.5 Favored Glycine 0 C--N 1.343 0.925 0 N-CA-C 109.45 -1.46 . . . . 0.0 109.45 173.171 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . 0.321 10.9 t 56.81 18.96 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.55 0.962 0 C-N-CA 125.39 1.476 . . . . 0.0 112.693 170.602 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 64.9 t30 45.33 37.79 3.1 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 125.56 1.544 . . . . 0.0 112.385 -172.089 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -136.45 158.73 72.82 Favored Pre-proline 0 CA--C 1.541 0.62 0 C-N-CA 123.63 0.772 . . . . 0.0 111.849 179.766 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 80.4 Cg_exo -54.99 131.14 44.64 Favored 'Trans proline' 0 C--N 1.352 0.732 0 C-N-CA 123.22 2.613 . . . . 0.0 110.953 175.04 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 49.3 Cg_endo -62.06 -19.45 66.33 Favored 'Trans proline' 0 C--N 1.348 0.512 0 C-N-CA 122.089 1.86 . . . . 0.0 112.138 -177.997 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 2.2 pt-20 -51.13 -26.56 6.81 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 126.136 1.775 . . . . 0.0 112.569 172.739 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 83.4 m95 -74.52 -40.9 61.47 Favored 'General case' 0 N--CA 1.455 -0.2 0 C-N-CA 123.803 0.841 . . . . 0.0 111.844 175.371 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 14.0 t -66.15 -37.12 79.06 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.5 0 C-N-CA 123.901 0.88 . . . . 0.0 108.931 179.374 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 68.8 p -84.39 25.52 0.86 Allowed 'General case' 0 C--O 1.237 0.438 0 N-CA-C 114.851 1.426 . . . . 0.0 114.851 -168.826 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 91.3 mm-40 -74.44 -179.12 3.83 Favored 'General case' 0 CA--C 1.54 0.583 0 CA-C-N 118.385 0.539 . . . . 0.0 110.877 171.706 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 25.6 mm-40 -61.73 -17.87 57.48 Favored 'General case' 0 CA--C 1.54 0.566 0 N-CA-C 113.421 0.897 . . . . 0.0 113.421 -169.027 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 4.6 tt -140.6 133.61 32.59 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.513 0 N-CA-C 106.849 -1.537 . . . . 0.0 106.849 170.026 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -109.57 135.4 50.62 Favored 'General case' 0 CA--C 1.537 0.467 0 N-CA-C 105.04 -2.208 . . . . 0.0 105.04 169.149 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . 0.538 ' HB2' HD12 ' A' ' 77' ' ' ILE . 12.8 mm-40 -138.67 163.6 31.69 Favored 'General case' 0 C--O 1.233 0.185 0 C-N-CA 124.542 1.137 . . . . 0.0 107.982 171.26 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -173.57 127.96 0.42 Allowed 'General case' 0 C--O 1.238 0.482 0 C-N-CA 126.944 2.098 . . . . 0.0 105.374 -169.571 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 99' ' ' TRP . . . . . 0.402 ' CZ3' HG21 ' A' ' 77' ' ' ILE . 7.5 m0 -143.13 142.48 31.5 Favored 'General case' 0 N--CA 1.469 0.519 0 N-CA-C 112.751 0.648 . . . . 0.0 112.751 -169.669 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 7.3 pt20 -81.52 50.5 1.49 Allowed 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 125.107 1.363 . . . . 0.0 111.183 174.66 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.497 HD13 HG22 ' A' ' 119' ' ' VAL . 41.7 mt -64.51 140.91 58.92 Favored 'General case' 0 N--CA 1.464 0.269 0 N-CA-C 107.707 -1.22 . . . . 0.0 107.707 172.856 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 27.8 mm-40 -67.15 142.01 57.18 Favored 'General case' 0 CA--C 1.533 0.324 0 CA-C-N 119.681 1.128 . . . . 0.0 109.035 169.938 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 1.5 t0 -97.35 116.07 65.85 Favored Pre-proline 0 N--CA 1.448 -0.526 0 N-CA-C 105.435 -2.061 . . . . 0.0 105.435 169.224 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 49.7 Cg_endo -83.94 -5.4 10.53 Favored 'Trans proline' 0 N--CA 1.451 -1.004 0 C-N-CA 122.815 2.344 . . . . 0.0 112.963 -174.949 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -58.86 127.42 32.12 Favored 'General case' 0 C--O 1.236 0.384 0 CA-C-N 120.204 1.366 . . . . 0.0 109.742 -178.882 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 74.4 0.4 57.7 Favored Glycine 0 CA--C 1.537 1.414 0 CA-C-O 118.618 -1.101 . . . . 0.0 114.013 -178.687 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 13.0 mt-30 -97.3 169.14 9.97 Favored 'General case' 0 CA--C 1.54 0.581 0 CA-C-N 119.09 1.445 . . . . 0.0 109.841 173.386 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 15.0 m -70.64 164.85 24.1 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 124.442 1.097 . . . . 0.0 111.554 -179.608 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 38.2 mt -61.93 -27.04 68.55 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 123.596 0.758 . . . . 0.0 112.115 -175.654 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 5.0 pt-20 -56.76 -36.09 69.38 Favored 'General case' 0 CA--C 1.53 0.198 0 C-N-CA 123.274 0.63 . . . . 0.0 111.228 173.413 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 24.8 t -76.44 -44.37 35.21 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.298 0 CA-C-O 117.786 -1.102 . . . . 0.0 108.837 -178.73 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 59.1 m-85 -55.05 -47.88 74.22 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-N 120.488 1.495 . . . . 0.0 110.364 173.272 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 93.7 mtt180 -70.01 -35.22 74.2 Favored 'General case' 0 CA--C 1.534 0.337 0 O-C-N 121.705 -0.622 . . . . 0.0 110.97 -175.801 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 2.6 m -60.81 -47.35 86.73 Favored 'General case' 0 N--CA 1.454 -0.262 0 C-N-CA 123.922 0.889 . . . . 0.0 109.175 169.812 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 44.4 t -65.31 -31.66 54.86 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.263 0 CA-C-O 118.481 -0.771 . . . . 0.0 109.867 -174.211 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 19.2 mtm105 -57.31 -46.37 83.26 Favored 'General case' 0 CA--C 1.535 0.382 0 CA-C-N 119.41 1.004 . . . . 0.0 110.375 172.507 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -62.57 -50.69 62.07 Favored Glycine 0 CA--C 1.529 0.907 0 CA-C-O 119.543 -0.587 . . . . 0.0 111.636 175.649 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 70.7 mt-30 -57.03 -49.63 75.23 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-O 121.889 0.852 . . . . 0.0 110.414 -176.865 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . 0.497 HG22 HD13 ' A' ' 101' ' ' LEU . 58.4 t -74.89 -37.74 42.31 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-O 117.998 -1.001 . . . . 0.0 110.336 -172.062 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -54.77 -45.19 74.21 Favored 'General case' 0 C--O 1.224 -0.247 0 CA-C-N 119.892 1.224 . . . . 0.0 108.839 173.617 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 40.6 tt0 -67.16 -42.81 83.69 Favored 'General case' 0 N--CA 1.448 -0.571 0 C-N-CA 122.977 0.511 . . . . 0.0 111.267 -175.425 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 35.3 mmt180 -63.89 -45.69 88.24 Favored 'General case' 0 N--CA 1.473 0.689 0 CA-C-N 119.084 0.856 . . . . 0.0 111.304 176.881 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 77.5 t -68.37 -37.48 77.96 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.828 0 N-CA-C 108.71 -0.848 . . . . 0.0 108.71 -177.981 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 4.8 mm-40 -59.22 -46.26 88.93 Favored 'General case' 0 C--N 1.34 0.18 0 CA-C-N 119.426 1.012 . . . . 0.0 110.429 172.647 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 27.1 t-20 -64.89 -40.16 94.66 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 123.143 0.577 . . . . 0.0 111.182 -176.87 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 27.9 tp -58.99 -49.83 76.41 Favored 'General case' 0 CA--C 1.53 0.176 0 C-N-CA 125.105 1.362 . . . . 0.0 110.906 172.901 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 51.7 mt -64.57 -46.13 93.47 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 N-CA-C 107.829 -1.175 . . . . 0.0 107.829 -178.059 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -58.98 -30.96 68.35 Favored 'General case' 0 N--CA 1.452 -0.364 0 CA-C-O 118.52 -0.753 . . . . 0.0 112.284 -178.557 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 17.6 ptpt -84.25 -39.81 18.82 Favored 'General case' 0 C--N 1.345 0.375 0 CA-C-O 117.845 -1.074 . . . . 0.0 112.561 177.003 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 11.8 pt -82.55 -35.94 13.09 Favored 'Isoleucine or valine' 0 C--O 1.235 0.309 0 CA-C-N 120.094 1.315 . . . . 0.0 113.814 -175.133 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 65.1 m . . . . . 0 C--O 1.253 1.243 0 C-N-CA 125.134 1.374 . . . . 0.0 109.732 -169.814 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.0 mmt . . . . . 0 N--CA 1.495 1.805 0 N-CA-C 111.195 0.072 . . . . 0.0 111.195 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 30.0 mttm -83.75 112.34 19.99 Favored 'General case' 0 N--CA 1.475 0.818 0 N-CA-C 105.044 -2.206 . . . . 0.0 105.044 169.495 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 91.9 mttt -82.46 133.87 35.21 Favored 'General case' 0 CA--C 1.512 -0.481 0 CA-C-N 119.869 1.213 . . . . 0.0 107.94 179.758 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 1.8 t -120.05 147.14 23.93 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 C-N-CA 125.512 1.525 . . . . 0.0 108.867 -169.077 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 11.1 mtt -134.55 147.22 50.23 Favored 'General case' 0 C--N 1.326 -0.423 0 C-N-CA 125.731 1.613 . . . . 0.0 109.856 169.432 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 62.0 m-85 -135.54 116.72 14.45 Favored 'General case' 0 C--N 1.334 -0.084 0 N-CA-C 105.878 -1.897 . . . . 0.0 105.878 169.684 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 2.6 p -155.04 157.12 4.42 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.367 0 CA-C-O 121.127 0.489 . . . . 0.0 110.269 -168.991 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 52.3 t -152.43 174.89 13.3 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 127.482 2.313 . . . . 0.0 105.932 169.547 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 65.7 pttt -62.7 144.46 56.34 Favored 'General case' 0 N--CA 1.469 0.488 0 O-C-N 121.213 -0.93 . . . . 0.0 109.867 171.598 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 62.8 mtp85 57.78 170.34 0.05 OUTLIER 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 126.468 1.907 . . . . 0.0 113.171 -173.501 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -118.53 0.21 11.52 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 124.066 0.946 . . . . 0.0 111.462 170.113 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 1.4 m -64.19 -37.78 88.69 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 124.137 0.975 . . . . 0.0 110.147 -174.328 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 24.1 p -136.8 153.38 50.83 Favored 'General case' 0 C--O 1.236 0.391 0 C-N-CA 126.657 1.983 . . . . 0.0 106.532 169.718 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 8.0 mpt_? 56.68 -176.05 0.06 Allowed 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 125.391 1.476 . . . . 0.0 110.003 -169.288 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 3.9 m 48.45 46.44 20.64 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 124.069 0.948 . . . . 0.0 110.245 -169.756 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 21.4 pt20 -151.93 157.28 41.58 Favored 'General case' 0 N--CA 1.444 -0.732 0 N-CA-C 106.175 -1.787 . . . . 0.0 106.175 169.997 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER 64.47 -36.07 0.18 Allowed 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 128.124 2.569 . . . . 0.0 115.746 179.326 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -71.51 -48.76 46.8 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-N 121.431 1.923 . . . . 0.0 110.141 -176.827 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -62.66 -39.0 92.53 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 123.113 0.565 . . . . 0.0 110.447 170.012 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -55.73 -43.43 86.67 Favored Glycine 0 C--N 1.343 0.918 0 C-N-CA 123.924 0.773 . . . . 0.0 112.543 174.822 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 2.1 m-85 -74.72 -32.31 62.11 Favored 'General case' 0 CA--C 1.51 -0.573 0 CA-C-N 119.599 1.7 . . . . 0.0 112.227 177.253 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -67.37 -34.19 76.78 Favored 'General case' 0 N--CA 1.453 -0.313 0 CA-C-N 118.839 0.745 . . . . 0.0 111.257 -172.853 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 17.9 ptpt -62.71 -28.16 69.76 Favored 'General case' 0 N--CA 1.475 0.794 0 CA-C-N 119.224 0.92 . . . . 0.0 111.975 170.827 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 2.1 m -83.78 -56.16 3.86 Favored 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 124.573 1.149 . . . . 0.0 110.369 -177.483 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 72.4 mt -73.33 -34.34 65.61 Favored 'General case' 0 C--N 1.331 -0.206 0 C-N-CA 123.861 0.864 . . . . 0.0 110.186 -173.856 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -97.98 11.34 64.14 Favored Glycine 0 CA--C 1.525 0.667 0 C-N-CA 125.487 1.518 . . . . 0.0 112.82 -177.112 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -50.25 122.8 7.37 Favored 'General case' 0 CA--C 1.535 0.391 0 CA-C-N 118.754 1.277 . . . . 0.0 110.406 -177.121 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 74.67 -2.85 46.23 Favored Glycine 0 CA--C 1.536 1.348 0 CA-C-O 118.764 -1.02 . . . . 0.0 114.39 179.216 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 64.4 mttm -103.89 -42.23 5.65 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-N 119.316 1.558 . . . . 0.0 111.319 178.918 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 17.2 pt -141.97 152.84 18.68 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.657 0 C-N-CA 125.068 1.347 . . . . 0.0 109.671 -171.012 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -113.69 103.42 11.21 Favored 'General case' 0 N--CA 1.467 0.4 0 C-N-CA 125.242 1.417 . . . . 0.0 109.877 -170.752 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 3.8 t -86.22 127.9 39.87 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 O-C-N 121.299 -0.875 . . . . 0.0 108.695 -178.517 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 24.6 m -151.46 98.67 2.54 Favored 'General case' 0 C--O 1.223 -0.341 0 N-CA-C 104.843 -2.28 . . . . 0.0 104.843 173.659 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 20.2 m -97.53 5.06 50.13 Favored 'General case' 0 N--CA 1.467 0.388 0 N-CA-C 114.7 1.37 . . . . 0.0 114.7 -169.693 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 4.6 m 53.12 -133.95 1.74 Allowed 'General case' 0 CA--C 1.548 0.873 0 C-N-CA 124.02 0.928 . . . . 0.0 111.458 175.318 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -177.75 170.79 43.27 Favored Glycine 0 CA--C 1.526 0.728 0 N-CA-C 107.121 -2.392 . . . . 0.0 107.121 179.447 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 24.8 mt -113.34 -43.17 3.38 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 118.481 1.14 . . . . 0.0 109.707 179.327 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -141.83 -59.51 0.47 Allowed 'General case' 0 C--N 1.332 -0.175 0 N-CA-C 102.404 -3.184 . . . . 0.0 102.404 169.743 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 15.9 m 58.93 175.58 0.07 Allowed 'General case' 0 N--CA 1.446 -0.649 0 C-N-CA 127.167 2.187 . . . . 0.0 115.772 167.553 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 4.4 m -165.75 178.98 6.23 Favored 'General case' 0 C--O 1.238 0.499 0 C-N-CA 129.464 3.105 . . . . 0.0 104.442 -169.645 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -65.9 163.17 17.55 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-O 122.491 1.139 . . . . 0.0 110.581 172.26 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 4.3 m -67.34 175.32 0.51 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.71 0 CA-C-N 113.305 -1.771 . . . . 0.0 109.3 169.849 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 49.8 t-80 -72.62 139.55 80.91 Favored Pre-proline 0 CA--C 1.545 0.786 0 CA-C-O 118.474 -0.774 . . . . 0.0 109.549 -176.638 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 21.8 Cg_endo -60.74 -48.1 11.72 Favored 'Trans proline' 0 C--N 1.348 0.552 0 C-N-CA 122.645 2.23 . . . . 0.0 113.019 -172.301 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 4.9 m -65.47 -23.41 66.9 Favored 'General case' 0 CA--C 1.536 0.425 0 O-C-N 121.727 -0.608 . . . . 0.0 110.899 179.374 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -58.89 -46.52 87.64 Favored 'General case' 0 C--O 1.216 -0.707 0 CA-C-N 119.146 0.884 . . . . 0.0 108.723 176.835 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 38.6 mt -61.11 -40.18 84.87 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 N-CA-C 108.89 -0.781 . . . . 0.0 108.89 -174.489 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -65.71 -45.1 84.01 Favored 'General case' 0 CA--C 1.534 0.338 0 CA-C-N 118.39 0.541 . . . . 0.0 110.946 -179.864 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 33.0 mmt -68.25 -36.77 79.95 Favored 'General case' 0 CA--C 1.536 0.414 0 CA-C-O 123.295 1.522 . . . . 0.0 110.006 -179.106 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -76.96 -30.39 56.0 Favored 'General case' 0 N--CA 1.44 -0.933 0 N-CA-C 106.632 -1.618 . . . . 0.0 106.632 -175.675 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 40.6 tt0 -69.69 -21.13 63.53 Favored 'General case' 0 N--CA 1.445 -0.686 0 C-N-CA 124.1 0.96 . . . . 0.0 110.049 169.672 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 54.8 mt-10 -63.65 -39.02 93.3 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-N 119.85 1.205 . . . . 0.0 108.963 169.206 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . 0.32 6.2 p -84.7 8.42 1.56 Allowed 'Isoleucine or valine' 0 CA--C 1.549 0.922 0 N-CA-C 112.005 0.372 . . . . 0.0 112.005 171.628 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 79.46 20.15 69.79 Favored Glycine 0 CA--C 1.53 1.01 0 C-N-CA 125.009 1.29 . . . . 0.0 113.563 174.318 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 22.8 mt -116.54 145.97 21.58 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.261 0 C-N-CA 124.861 1.265 . . . . 0.0 110.547 -171.528 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -116.73 149.02 40.56 Favored 'General case' 0 N--CA 1.463 0.214 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 168.94 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 3.3 pt -138.34 -18.78 0.47 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.376 0 C-N-CA 128.058 2.543 . . . . 0.0 111.197 -174.529 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 1.6 t -47.2 -39.87 14.89 Favored 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 124.11 0.964 . . . . 0.0 112.023 169.929 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -68.97 6.26 4.0 Favored Glycine 0 CA--C 1.535 1.306 0 C-N-CA 124.958 1.266 . . . . 0.0 115.318 -176.977 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 2.2 mt-30 -61.33 -33.35 73.47 Favored 'General case' 0 C--N 1.342 0.24 0 CA-C-N 119.605 1.702 . . . . 0.0 113.355 179.191 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -59.77 119.75 8.25 Favored 'General case' 0 C--O 1.236 0.385 0 C-N-CA 123.596 0.758 . . . . 0.0 109.736 -169.412 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 56.1 m -148.84 -169.71 3.44 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 126.358 1.863 . . . . 0.0 108.229 -169.149 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -54.75 154.6 9.1 Favored Pre-proline 0 C--O 1.239 0.524 0 C-N-CA 124.407 1.083 . . . . 0.0 111.613 169.925 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 98.2 Cg_endo -66.08 157.06 61.55 Favored 'Trans proline' 0 N--CA 1.454 -0.82 0 C-N-CA 122.328 2.018 . . . . 0.0 110.225 171.175 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 14.0 tt -61.19 -26.46 39.31 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.328 0 C-N-CA 124.229 1.011 . . . . 0.0 110.979 -178.789 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 13.6 mt-10 -68.03 -24.93 65.15 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 124.556 1.142 . . . . 0.0 110.619 -175.673 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 6.8 t-20 -62.93 -19.14 63.95 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 124.821 1.249 . . . . 0.0 112.153 177.477 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 13.3 m-85 -120.8 174.01 6.87 Favored 'General case' 0 C--O 1.237 0.412 0 C-N-CA 126.484 1.914 . . . . 0.0 109.318 -178.286 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 29.9 p-10 -125.09 149.29 47.99 Favored 'General case' 0 N--CA 1.437 -1.124 0 C-N-CA 124.681 1.192 . . . . 0.0 110.942 168.936 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -75.64 -22.23 56.97 Favored 'General case' 0 N--CA 1.435 -1.223 0 N-CA-C 109.603 -0.518 . . . . 0.0 109.603 -169.901 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 34.7 t70 -64.7 -23.66 67.32 Favored 'General case' 0 N--CA 1.444 -0.774 0 O-C-N 123.666 0.603 . . . . 0.0 111.804 -178.828 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -76.61 -29.44 56.5 Favored 'General case' 0 CA--C 1.533 0.323 0 O-C-N 121.893 -0.505 . . . . 0.0 111.928 173.993 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 21.0 m-85 -78.7 167.73 20.79 Favored 'General case' 0 N--CA 1.448 -0.532 0 C-N-CA 125.116 1.366 . . . . 0.0 110.949 179.597 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -115.63 -40.06 3.43 Favored 'General case' 0 N--CA 1.466 0.353 0 C-N-CA 122.893 0.477 . . . . 0.0 111.223 178.962 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -138.04 136.16 45.03 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.497 0 CA-C-O 121.8 0.81 . . . . 0.0 109.315 -171.324 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 72.1 t -143.84 136.56 23.75 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.68 0 N-CA-C 106.126 -1.805 . . . . 0.0 106.126 -176.869 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 40.9 mm -129.18 127.3 65.45 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.609 0 N-CA-C 107.325 -1.361 . . . . 0.0 107.325 -169.916 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 15.0 m -87.37 131.19 34.37 Favored 'General case' 0 N--CA 1.436 -1.159 0 N-CA-C 105.96 -1.867 . . . . 0.0 105.96 168.235 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 90.6 mt -88.71 -11.67 44.5 Favored 'General case' 0 C--N 1.331 -0.208 0 O-C-N 122.026 -0.421 . . . . 0.0 110.617 172.004 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -167.23 148.85 5.81 Favored 'General case' 0 N--CA 1.447 -0.618 0 C-N-CA 126.633 1.973 . . . . 0.0 107.339 168.385 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 72.37 167.79 10.51 Favored Glycine 0 CA--C 1.535 1.338 0 C-N-CA 124.849 1.214 . . . . 0.0 114.452 174.009 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 41.9 m -141.38 111.09 6.51 Favored 'General case' 0 CA--C 1.532 0.262 0 N-CA-C 107.454 -1.313 . . . . 0.0 107.454 178.936 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 60.23 30.94 71.96 Favored Glycine 0 CA--C 1.535 1.304 0 N-CA-C 111.567 -0.613 . . . . 0.0 111.567 -174.747 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 10.4 p -67.4 -51.71 49.52 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.563 0 C-N-CA 123.882 0.873 . . . . 0.0 111.493 -169.182 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 16.1 t-20 -154.4 41.61 0.49 Allowed 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 125.32 1.448 . . . . 0.0 107.128 173.04 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 2.3 tt -147.59 141.12 15.39 Favored Pre-proline 0 CA--C 1.542 0.641 0 C-N-CA 125.934 1.693 . . . . 0.0 107.85 -169.351 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 32.9 Cg_exo -68.18 149.94 76.57 Favored 'Trans proline' 0 C--N 1.355 0.885 0 CA-C-N 120.742 1.301 . . . . 0.0 114.272 -169.837 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -69.53 -29.05 25.58 Favored 'Trans proline' 0 C--N 1.347 0.455 0 C-N-CA 122.464 2.11 . . . . 0.0 114.292 -169.873 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -61.22 -18.36 57.93 Favored 'General case' 0 CA--C 1.538 0.492 0 CA-C-N 119.738 1.154 . . . . 0.0 112.081 -178.866 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 97.9 m95 -75.83 -49.37 18.2 Favored 'General case' 0 N--CA 1.449 -0.522 0 C-N-CA 123.628 0.771 . . . . 0.0 110.583 177.739 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 33.5 m -77.02 1.07 2.2 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.44 0 C-N-CA 123.13 0.572 . . . . 0.0 112.421 -178.647 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 81.3 p -111.47 19.57 18.06 Favored 'General case' 0 CA--C 1.537 0.458 0 N-CA-C 114.302 1.223 . . . . 0.0 114.302 175.464 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 87.4 mm-40 -67.54 174.61 3.33 Favored 'General case' 0 CA--C 1.539 0.544 0 CA-C-N 119.16 0.891 . . . . 0.0 112.445 178.158 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 29.7 mm-40 -51.91 -32.23 31.87 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 124.711 1.204 . . . . 0.0 112.334 -169.056 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 5.3 tt -131.71 130.85 62.24 Favored 'Isoleucine or valine' 0 C--O 1.24 0.557 0 N-CA-C 103.92 -2.622 . . . . 0.0 103.92 168.017 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 40.9 t80 -120.47 141.18 50.42 Favored 'General case' 0 N--CA 1.444 -0.738 0 N-CA-C 106.061 -1.829 . . . . 0.0 106.061 169.27 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 31.2 mm-40 -139.68 144.8 37.76 Favored 'General case' 0 C--O 1.237 0.408 0 N-CA-C 106.204 -1.776 . . . . 0.0 106.204 169.632 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 7.1 t0 -119.8 103.45 9.37 Favored 'General case' 0 C--O 1.237 0.443 0 N-CA-C 104.746 -2.316 . . . . 0.0 104.746 169.247 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 4.2 m95 -86.15 134.22 33.81 Favored 'General case' 0 N--CA 1.453 -0.278 0 CA-C-O 120.683 0.278 . . . . 0.0 110.928 -169.62 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 66.5 tt0 -81.89 99.71 9.21 Favored 'General case' 0 C--O 1.236 0.383 0 N-CA-C 103.568 -2.753 . . . . 0.0 103.568 168.712 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.401 HD13 HG22 ' A' ' 119' ' ' VAL . 11.1 mt -129.62 133.17 46.99 Favored 'General case' 0 CA--C 1.52 -0.196 0 N-CA-C 107.477 -1.305 . . . . 0.0 107.477 178.622 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 -76.74 165.0 25.33 Favored 'General case' 0 N--CA 1.452 -0.366 0 C-N-CA 124.902 1.281 . . . . 0.0 108.323 169.803 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 15.3 t70 -140.66 139.72 20.71 Favored Pre-proline 0 CA--C 1.536 0.439 0 C-N-CA 123.872 0.869 . . . . 0.0 110.142 -177.511 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 42.4 Cg_endo -84.83 0.92 8.82 Favored 'Trans proline' 0 CA--C 1.544 0.977 0 C-N-CA 123.149 2.566 . . . . 0.0 114.405 -172.8 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 3.2 t70 -48.76 120.0 3.52 Favored 'General case' 0 N--CA 1.468 0.428 0 CA-C-N 120.517 1.508 . . . . 0.0 110.926 177.623 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 67.87 4.73 35.49 Favored Glycine 0 CA--C 1.536 1.383 0 CA-C-O 118.723 -1.043 . . . . 0.0 114.777 179.076 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 6.3 mt-30 -94.45 171.14 8.99 Favored 'General case' 0 CA--C 1.538 0.509 0 CA-C-N 119.31 1.555 . . . . 0.0 110.424 -178.612 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 14.6 m -68.47 159.61 31.36 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 124.321 1.048 . . . . 0.0 110.599 178.083 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 13.8 tp -60.06 -32.0 70.52 Favored 'General case' 0 N--CA 1.467 0.417 0 C-N-CA 123.888 0.875 . . . . 0.0 112.127 -170.055 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 5.3 pt-20 -53.85 -35.76 61.86 Favored 'General case' 0 N--CA 1.467 0.418 0 C-N-CA 126.016 1.726 . . . . 0.0 112.137 176.095 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 38.3 t -70.81 -37.86 70.37 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.258 0 N-CA-C 109.083 -0.71 . . . . 0.0 109.083 -174.008 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 91.8 m-85 -56.74 -50.35 72.5 Favored 'General case' 0 N--CA 1.462 0.126 0 CA-C-N 119.346 0.975 . . . . 0.0 110.806 172.563 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -66.34 -38.09 86.86 Favored 'General case' 0 N--CA 1.473 0.699 0 N-CA-C 109.766 -0.457 . . . . 0.0 109.766 -174.992 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 4.0 m -60.85 -49.64 76.66 Favored 'General case' 0 N--CA 1.451 -0.42 0 C-N-CA 124.704 1.201 . . . . 0.0 109.984 173.681 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 76.7 t -69.59 -25.84 29.62 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.229 0 CA-C-O 117.812 -1.089 . . . . 0.0 109.944 -171.829 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 11.9 mtm105 -57.15 -49.07 77.07 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 120.142 1.337 . . . . 0.0 109.729 169.839 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -63.35 -48.47 78.54 Favored Glycine 0 CA--C 1.527 0.84 0 CA-C-N 118.608 0.64 . . . . 0.0 111.951 -179.52 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 12.8 mt-30 -60.74 -46.15 91.52 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-N 117.719 0.759 . . . . 0.0 110.77 -179.188 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . 0.401 HG22 HD13 ' A' ' 101' ' ' LEU . 82.6 t -70.68 -40.67 77.27 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-O 118.424 -0.798 . . . . 0.0 110.297 -175.84 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 85.9 tttt -52.69 -47.26 67.33 Favored 'General case' 0 C--O 1.223 -0.322 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 175.688 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 40.2 tt0 -64.58 -42.63 95.49 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-O 119.245 -0.407 . . . . 0.0 111.253 -175.134 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 35.3 mmt180 -60.21 -47.46 85.86 Favored 'General case' 0 N--CA 1.472 0.635 0 CA-C-N 118.882 0.765 . . . . 0.0 110.434 175.893 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 89.8 t -69.94 -37.78 73.7 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.525 0 N-CA-C 109.563 -0.532 . . . . 0.0 109.563 -175.274 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 35.4 mt-10 -59.96 -44.44 94.42 Favored 'General case' 0 C--O 1.227 -0.097 0 CA-C-N 119.657 1.117 . . . . 0.0 110.049 174.165 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 28.7 t-20 -63.26 -44.55 94.84 Favored 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 122.693 0.397 . . . . 0.0 110.834 -178.564 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 41.8 tp -58.73 -48.53 80.85 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 124.335 1.054 . . . . 0.0 111.104 175.97 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 65.4 mt -62.79 -47.1 94.48 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.149 0 N-CA-C 107.865 -1.161 . . . . 0.0 107.865 -179.999 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -58.85 -27.65 65.34 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 123.095 0.558 . . . . 0.0 112.436 178.11 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 89.4 mttt -72.03 -57.43 4.29 Favored 'General case' 0 C--N 1.343 0.325 0 CA-C-N 119.153 0.888 . . . . 0.0 110.616 171.604 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 13.2 pt -76.14 -36.23 30.31 Favored 'Isoleucine or valine' 0 C--O 1.235 0.293 0 N-CA-C 115.184 1.55 . . . . 0.0 115.184 -168.943 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 69.2 m . . . . . 0 C--O 1.252 1.229 0 C-N-CA 125.707 1.603 . . . . 0.0 109.606 -169.881 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 19.5 mmm . . . . . 0 N--CA 1.499 1.997 0 N-CA-C 110.936 -0.024 . . . . 0.0 110.936 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 31.0 mttm -79.43 117.81 20.73 Favored 'General case' 0 N--CA 1.477 0.895 0 N-CA-C 105.407 -2.071 . . . . 0.0 105.407 169.545 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 74.5 mttt -83.43 133.67 34.91 Favored 'General case' 0 CA--C 1.514 -0.414 0 CA-C-N 120.252 1.387 . . . . 0.0 107.997 179.324 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 1.5 t -118.78 147.94 21.98 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.583 0 C-N-CA 126.725 2.01 . . . . 0.0 106.711 -169.635 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 49.7 ttm -142.8 142.04 31.78 Favored 'General case' 0 C--N 1.325 -0.484 0 C-N-CA 123.71 0.804 . . . . 0.0 109.343 172.191 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 97.0 m-85 -132.64 122.06 24.12 Favored 'General case' 0 CA--C 1.511 -0.551 0 N-CA-C 104.987 -2.227 . . . . 0.0 104.987 179.855 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 1.6 p -154.07 119.78 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.397 0 C-N-CA 119.566 -0.854 . . . . 0.0 109.412 -169.515 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 51.1 t -98.75 178.43 4.98 Favored 'General case' 0 CA--C 1.541 0.623 0 N-CA-C 106.971 -1.492 . . . . 0.0 106.971 168.915 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -52.4 -42.19 63.83 Favored 'General case' 0 N--CA 1.473 0.707 0 O-C-N 121.624 -0.673 . . . . 0.0 110.803 178.662 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 66.2 mtp180 -108.94 145.45 35.41 Favored 'General case' 0 CA--C 1.521 -0.156 0 N-CA-C 108.978 -0.749 . . . . 0.0 108.978 169.852 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 7.4 t30 -55.04 -38.01 67.42 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 124.363 1.065 . . . . 0.0 111.112 169.372 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 1.4 m -68.71 -15.0 63.38 Favored 'General case' 0 CA--C 1.533 0.307 0 N-CA-C 114.667 1.358 . . . . 0.0 114.667 -169.557 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 52.3 m -124.69 139.43 53.86 Favored 'General case' 0 C--O 1.223 -0.309 0 C-N-CA 123.97 0.908 . . . . 0.0 110.311 -169.09 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 6.4 mpt_? 59.14 -60.97 0.04 OUTLIER 'General case' 0 N--CA 1.481 1.112 0 C-N-CA 127.605 2.362 . . . . 0.0 114.066 -174.737 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -44.72 -36.91 3.39 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 126.499 1.919 . . . . 0.0 109.624 170.001 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 23.8 tt0 -25.63 -61.91 0.07 Allowed 'General case' 0 C--O 1.22 -0.486 0 C-N-CA 130.686 3.595 . . . . 0.0 111.772 168.848 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -98.68 -29.87 12.78 Favored 'General case' 0 CA--C 1.516 -0.345 0 CA-C-N 119.719 1.145 . . . . 0.0 113.434 177.501 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -61.09 -48.55 81.18 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 111.993 0.368 . . . . 0.0 111.993 -169.321 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -68.74 -30.62 69.28 Favored 'General case' 0 N--CA 1.463 0.177 0 C-N-CA 120.237 -0.585 . . . . 0.0 109.645 176.767 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -54.81 -57.3 18.55 Favored Glycine 0 C--N 1.34 0.781 0 C-N-CA 125.405 1.478 . . . . 0.0 110.099 176.812 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 8.7 m-85 -67.89 -32.18 72.48 Favored 'General case' 0 CA--C 1.503 -0.835 0 O-C-N 121.659 -0.906 . . . . 0.0 111.981 179.982 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -65.82 -34.74 78.85 Favored 'General case' 0 N--CA 1.447 -0.585 0 C-N-CA 119.431 -0.908 . . . . 0.0 111.141 -175.452 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -68.1 -24.23 65.01 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-N 119.436 1.016 . . . . 0.0 112.036 175.037 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 2.1 m -82.11 -56.12 4.13 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 125.223 1.409 . . . . 0.0 110.438 -179.993 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 72.3 mt -76.37 -34.97 58.91 Favored 'General case' 0 C--N 1.329 -0.283 0 C-N-CA 124.631 1.172 . . . . 0.0 110.258 -172.529 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -92.57 7.13 77.69 Favored Glycine 0 CA--C 1.526 0.758 0 C-N-CA 125.282 1.42 . . . . 0.0 113.198 -177.292 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -52.52 124.18 12.93 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 124.448 1.099 . . . . 0.0 110.002 -176.01 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 75.44 1.95 66.74 Favored Glycine 0 CA--C 1.535 1.288 0 CA-C-O 118.835 -0.981 . . . . 0.0 114.406 179.074 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 64.0 mttm -113.36 -43.06 3.39 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-N 119.294 1.547 . . . . 0.0 111.359 178.828 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 20.4 pt -140.94 151.41 20.2 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.604 0 C-N-CA 123.805 0.842 . . . . 0.0 110.388 -169.36 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -108.66 103.25 12.31 Favored 'General case' 0 N--CA 1.467 0.393 0 C-N-CA 125.37 1.468 . . . . 0.0 109.646 -173.209 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 20.8 t -81.31 135.84 24.28 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 179.604 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 4.8 m -140.68 111.51 6.99 Favored 'General case' 0 N--CA 1.445 -0.678 0 N-CA-C 104.492 -2.41 . . . . 0.0 104.492 169.513 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 75.0 m -114.31 91.97 3.81 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 107.64 -1.245 . . . . 0.0 107.64 178.739 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 5.0 p -63.69 -62.38 1.7 Allowed 'General case' 0 C--O 1.233 0.215 0 C-N-CA 126.408 1.883 . . . . 0.0 112.044 -173.071 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 107.88 137.63 8.36 Favored Glycine 0 CA--C 1.527 0.786 0 N-CA-C 109.157 -1.577 . . . . 0.0 109.157 -174.425 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 12.8 mt -80.08 -40.44 27.6 Favored 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 124.395 1.078 . . . . 0.0 108.874 170.207 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 33.5 mt-10 -139.87 170.16 16.38 Favored 'General case' 0 C--O 1.239 0.523 0 C-N-CA 128.143 2.577 . . . . 0.0 107.629 172.914 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 13.2 m 64.75 -168.17 0.21 Allowed 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 124.837 1.255 . . . . 0.0 112.315 -177.487 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 36.8 p -162.55 -47.66 0.04 OUTLIER 'General case' 0 C--O 1.232 0.184 0 N-CA-C 112.442 0.534 . . . . 0.0 112.442 -167.067 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 2.0 ttp-105 -108.87 -167.5 1.23 Allowed 'General case' 0 CA--C 1.52 -0.19 0 C-N-CA 125.498 1.519 . . . . 0.0 109.227 177.766 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 34.2 m -127.32 168.94 19.53 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 C-N-CA 125.506 1.523 . . . . 0.0 109.838 -171.757 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 37.4 m80 -71.59 148.1 92.67 Favored Pre-proline 0 CA--C 1.548 0.889 0 C-N-CA 123.313 0.645 . . . . 0.0 109.694 177.975 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -62.39 -50.74 4.14 Favored 'Trans proline' 0 C--N 1.348 0.529 0 C-N-CA 123.818 3.012 . . . . 0.0 114.806 -168.632 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 11.5 m -63.88 -22.69 67.03 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-N 118.211 0.459 . . . . 0.0 110.61 -175.678 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.415 ' HB1' HD11 ' A' ' 57' ' ' ILE . . . -55.12 -55.33 32.32 Favored 'General case' 0 CA--C 1.511 -0.546 0 C-N-CA 122.765 0.426 . . . . 0.0 109.911 174.152 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 56.3 mt -60.54 -38.04 76.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 N-CA-C 108.554 -0.906 . . . . 0.0 108.554 -170.635 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -62.94 -48.19 79.98 Favored 'General case' 0 N--CA 1.451 -0.379 0 CA-C-N 118.471 0.578 . . . . 0.0 111.07 177.778 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 27.8 mmt -66.73 -36.54 82.71 Favored 'General case' 0 C--O 1.238 0.488 0 CA-C-O 122.78 1.276 . . . . 0.0 111.071 -179.748 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -75.98 -31.23 58.88 Favored 'General case' 0 N--CA 1.441 -0.878 0 N-CA-C 107.183 -1.414 . . . . 0.0 107.183 -174.777 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 41.0 tt0 -71.28 -21.77 62.04 Favored 'General case' 0 N--CA 1.446 -0.63 0 C-N-CA 124.138 0.975 . . . . 0.0 110.426 171.031 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 20.0 mm-40 -67.57 -31.0 70.77 Favored 'General case' 0 CA--C 1.534 0.359 0 CA-C-N 119.508 1.049 . . . . 0.0 110.141 170.814 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . 0.28 7.2 p -90.39 8.62 3.53 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.983 0 CA-C-N 118.633 0.652 . . . . 0.0 111.482 169.062 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 75.73 18.59 79.6 Favored Glycine 0 CA--C 1.533 1.162 0 C-N-CA 124.678 1.133 . . . . 0.0 113.746 174.908 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 21.6 mt -111.35 134.81 52.5 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.23 0 C-N-CA 124.559 1.143 . . . . 0.0 109.379 -177.234 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 28.7 t0 -99.52 141.53 32.19 Favored 'General case' 0 C--O 1.235 0.323 0 N-CA-C 108.288 -1.005 . . . . 0.0 108.288 168.952 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.415 HD11 ' HB1' ' A' ' 46' ' ' ALA . 8.8 pt -131.15 -15.67 1.58 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.503 0 C-N-CA 126.335 1.854 . . . . 0.0 111.298 -174.135 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 1.2 t -57.2 163.48 2.14 Favored 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 124.544 1.138 . . . . 0.0 109.86 168.342 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 57.73 32.6 65.82 Favored Glycine 0 CA--C 1.532 1.106 0 C-N-CA 123.543 0.592 . . . . 0.0 112.129 179.177 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 4.3 tt0 -65.5 -39.41 91.82 Favored 'General case' 0 C--N 1.341 0.214 0 N-CA-C 113.957 1.095 . . . . 0.0 113.957 -169.135 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 7.0 t -76.19 177.82 6.9 Favored 'General case' 0 N--CA 1.449 -0.518 0 CA-C-O 122.557 1.17 . . . . 0.0 110.555 -169.646 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 13.3 p -155.72 -54.1 0.09 Allowed 'General case' 0 C--N 1.324 -0.515 0 C-N-CA 125.213 1.405 . . . . 0.0 108.327 -171.25 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -151.88 155.89 33.95 Favored Pre-proline 0 C--O 1.239 0.521 0 C-N-CA 127.628 2.371 . . . . 0.0 106.173 169.955 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -59.84 148.81 86.85 Favored 'Trans proline' 0 N--CA 1.457 -0.654 0 C-N-CA 121.801 1.668 . . . . 0.0 108.991 169.411 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 20.6 tt -55.24 -29.62 23.44 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.352 0 C-N-CA 123.12 0.568 . . . . 0.0 112.364 -174.181 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 9.0 mt-10 -65.73 -29.62 70.17 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 123.233 0.613 . . . . 0.0 111.026 -173.234 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 88.3 m-20 -77.93 -8.98 58.84 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 124.002 0.921 . . . . 0.0 112.273 -177.796 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 61.8 m-85 -95.53 162.24 13.72 Favored 'General case' 0 C--O 1.236 0.352 0 C-N-CA 124.286 1.034 . . . . 0.0 111.321 176.836 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 40.9 t-20 -99.47 127.32 45.52 Favored 'General case' 0 N--CA 1.447 -0.62 0 N-CA-C 107.431 -1.322 . . . . 0.0 107.431 168.875 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.415 ' HB2' ' CE2' ' A' ' 90' ' ' TRP . . . -73.3 -26.28 61.01 Favored 'General case' 0 N--CA 1.434 -1.266 0 N-CA-C 109.466 -0.568 . . . . 0.0 109.466 -178.252 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -63.85 -22.47 66.93 Favored 'General case' 0 N--CA 1.443 -0.798 0 CA-C-N 116.528 -0.306 . . . . 0.0 111.582 -178.347 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -74.02 -24.64 59.58 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 123.058 0.543 . . . . 0.0 111.991 178.851 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 34.4 m-85 -85.85 145.67 27.09 Favored 'General case' 0 N--CA 1.451 -0.394 0 C-N-CA 124.974 1.31 . . . . 0.0 111.5 -176.534 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 27.3 t70 -98.66 -32.69 11.28 Favored 'General case' 0 N--CA 1.466 0.357 0 C-N-CA 123.506 0.722 . . . . 0.0 111.032 -179.844 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -140.19 134.66 36.13 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.393 0 C-N-CA 124.376 1.071 . . . . 0.0 109.119 -175.792 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 94.2 t -144.1 139.49 24.77 Favored 'Isoleucine or valine' 0 C--O 1.237 0.396 0 N-CA-C 107.165 -1.42 . . . . 0.0 107.165 -178.822 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.598 HD12 ' HB2' ' A' ' 97' ' ' GLU . 19.0 mm -123.06 124.4 70.11 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.601 0 N-CA-C 106.589 -1.634 . . . . 0.0 106.589 -179.357 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 28.2 m -95.4 105.87 17.88 Favored 'General case' 0 N--CA 1.448 -0.555 0 N-CA-C 103.66 -2.718 . . . . 0.0 103.66 169.321 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 29.4 mt -76.21 -4.76 43.58 Favored 'General case' 0 N--CA 1.463 0.219 0 N-CA-C 114.273 1.212 . . . . 0.0 114.273 -169.364 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 73.2 m -146.13 71.77 1.27 Allowed 'General case' 0 N--CA 1.451 -0.391 0 CA-C-N 118.795 0.725 . . . . 0.0 109.168 -169.761 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 91.05 178.79 43.18 Favored Glycine 0 CA--C 1.53 0.979 0 C-N-CA 124.484 1.04 . . . . 0.0 111.031 -177.009 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 15.0 p -89.79 -92.95 0.12 Allowed 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 123.643 0.777 . . . . 0.0 111.087 -169.533 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -79.52 -41.67 12.85 Favored Glycine 0 C--N 1.338 0.665 0 CA-C-O 119.058 -0.856 . . . . 0.0 111.06 176.885 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . 0.317 4.7 m 44.13 -94.41 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.543 0.698 0 C-N-CA 126.063 1.745 . . . . 0.0 113.704 174.833 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 57.3 t30 -141.13 43.42 1.79 Allowed 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 125.129 1.372 . . . . 0.0 109.111 177.131 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -133.72 139.27 33.1 Favored Pre-proline 0 CA--C 1.541 0.623 0 C-N-CA 127.247 2.219 . . . . 0.0 107.316 -171.642 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 39.6 Cg_exo -65.36 137.84 52.91 Favored 'Trans proline' 0 CA--C 1.539 0.748 0 C-N-CA 121.386 1.391 . . . . 0.0 111.965 -176.124 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 65.1 Cg_endo -68.88 -15.53 40.44 Favored 'Trans proline' 0 N--CA 1.46 -0.472 0 C-N-CA 122.616 2.211 . . . . 0.0 113.513 -173.644 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -59.54 -14.74 14.21 Favored 'General case' 0 CA--C 1.541 0.625 0 CA-C-N 120.315 1.416 . . . . 0.0 111.966 170.425 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' TRP . . . . . 0.415 ' CE2' ' HB2' ' A' ' 70' ' ' ALA . 99.8 m95 -96.56 -11.36 25.49 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 125.215 1.406 . . . . 0.0 113.563 174.683 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.403 ' HA ' ' CD1' ' A' ' 96' ' ' PHE . 3.9 m -92.42 0.75 9.42 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.355 0 CA-C-N 120.261 1.392 . . . . 0.0 111.477 174.745 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 63.6 p -117.88 15.66 14.32 Favored 'General case' 0 C--O 1.237 0.406 0 N-CA-C 116.872 2.175 . . . . 0.0 116.872 -169.455 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 17.6 mp0 -66.51 173.87 3.1 Favored 'General case' 0 CA--C 1.54 0.587 0 CA-C-N 118.852 0.751 . . . . 0.0 111.016 176.284 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 33.3 mm-40 -56.67 -27.06 57.98 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 123.691 0.796 . . . . 0.0 111.268 -172.353 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 5.0 tt -133.8 131.24 56.41 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.528 0 N-CA-C 104.958 -2.238 . . . . 0.0 104.958 168.361 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 96' ' ' PHE . . . . . 0.403 ' CD1' ' HA ' ' A' ' 91' ' ' VAL . 40.5 t80 -117.99 135.99 53.81 Favored 'General case' 0 N--CA 1.449 -0.486 0 N-CA-C 106.706 -1.59 . . . . 0.0 106.706 169.739 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . 0.598 ' HB2' HD12 ' A' ' 77' ' ' ILE . 16.4 mm-40 -142.09 165.81 26.44 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-O 121.963 0.887 . . . . 0.0 110.116 174.881 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 3.7 t0 -168.1 134.16 1.95 Allowed 'General case' 0 C--O 1.239 0.516 0 C-N-CA 129.71 3.204 . . . . 0.0 106.108 -172.76 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 6.2 m-90 -144.8 149.04 34.77 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 123.847 0.859 . . . . 0.0 109.72 -171.269 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 7.4 tp-100 -82.56 57.36 3.69 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-O 121.809 0.814 . . . . 0.0 109.589 177.889 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.515 HD13 HG22 ' A' ' 119' ' ' VAL . 66.6 mt -79.22 152.66 30.5 Favored 'General case' 0 CA--C 1.53 0.179 0 N-CA-C 106.526 -1.657 . . . . 0.0 106.526 169.62 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 5.6 pt-20 -119.24 164.55 15.46 Favored 'General case' 0 N--CA 1.456 -0.141 0 C-N-CA 124.936 1.294 . . . . 0.0 110.436 178.623 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 64.4 t0 -97.42 121.28 58.91 Favored Pre-proline 0 CA--C 1.539 0.542 0 C-N-CA 123.739 0.815 . . . . 0.0 108.842 171.375 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 90.2 Cg_endo -70.48 -5.0 15.65 Favored 'Trans proline' 0 CA--C 1.544 1.02 0 C-N-CA 123.792 2.995 . . . . 0.0 113.765 176.18 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -43.28 123.23 2.85 Favored 'General case' 0 C--O 1.238 0.453 0 C-N-CA 126.249 1.82 . . . . 0.0 111.367 -179.506 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 69.5 2.79 36.89 Favored Glycine 0 CA--C 1.533 1.19 0 CA-C-O 118.612 -1.105 . . . . 0.0 114.98 169.759 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 28.8 pt20 -111.62 -167.06 1.13 Allowed 'General case' 0 CA--C 1.536 0.433 0 CA-C-N 119.021 1.41 . . . . 0.0 109.737 171.928 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 2.3 m -68.45 154.43 41.84 Favored 'General case' 0 N--CA 1.453 -0.303 0 N-CA-C 115.699 1.74 . . . . 0.0 115.699 -168.261 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 36.0 tp -55.76 -33.39 64.27 Favored 'General case' 0 N--CA 1.465 0.317 0 C-N-CA 126.349 1.86 . . . . 0.0 111.784 173.722 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -58.12 -34.67 70.47 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 123.544 0.738 . . . . 0.0 110.529 174.711 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 2.8 t -76.47 -40.52 34.53 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.299 0 CA-C-O 118.284 -0.865 . . . . 0.0 109.96 -178.912 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 61.9 m-85 -56.47 -47.27 79.55 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-N 120.122 1.328 . . . . 0.0 109.538 171.4 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 86.7 mtt180 -62.99 -43.16 99.55 Favored 'General case' 0 N--CA 1.466 0.351 0 C-N-CA 122.982 0.513 . . . . 0.0 110.972 179.43 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 6.9 m -64.25 -50.12 69.19 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 124.266 1.027 . . . . 0.0 109.955 179.347 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 75.8 t -68.68 -37.46 77.59 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.365 0 CA-C-N 118.796 0.725 . . . . 0.0 109.056 -173.564 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 46.1 ttp85 -58.22 -44.39 88.17 Favored 'General case' 0 CA--C 1.538 0.483 0 CA-C-N 119.117 0.871 . . . . 0.0 110.329 174.706 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -64.83 -50.24 59.34 Favored Glycine 0 CA--C 1.531 1.07 0 CA-C-N 118.543 0.611 . . . . 0.0 112.204 176.137 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 39.1 mm-40 -58.02 -50.99 71.51 Favored 'General case' 0 N--CA 1.465 0.324 0 C-N-CA 124.213 1.005 . . . . 0.0 110.278 -177.838 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . 0.515 HG22 HD13 ' A' ' 101' ' ' LEU . 98.3 t -67.56 -38.38 80.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-O 118.211 -0.899 . . . . 0.0 110.344 -174.054 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 57.1 tttm -55.0 -44.75 74.8 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 119.451 1.023 . . . . 0.0 109.338 175.551 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -68.48 -43.33 77.16 Favored 'General case' 0 N--CA 1.447 -0.621 0 CA-C-O 119.053 -0.498 . . . . 0.0 111.293 -176.204 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 1.8 mmt-85 -60.34 -46.83 88.51 Favored 'General case' 0 N--CA 1.476 0.841 0 CA-C-N 119.363 0.983 . . . . 0.0 110.604 176.262 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 98.4 t -69.41 -38.57 77.43 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.487 0 N-CA-C 109.101 -0.703 . . . . 0.0 109.101 -177.172 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 15.3 mt-10 -60.38 -45.63 92.86 Favored 'General case' 0 CA--C 1.52 -0.202 0 CA-C-N 119.884 1.22 . . . . 0.0 110.122 175.022 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 29.4 t-20 -62.53 -41.51 98.91 Favored 'General case' 0 CA--C 1.531 0.223 0 C-N-CA 123.25 0.62 . . . . 0.0 110.712 -179.85 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 58.7 tp -60.78 -48.45 81.73 Favored 'General case' 0 N--CA 1.456 -0.148 0 C-N-CA 123.819 0.848 . . . . 0.0 111.261 176.424 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 76.1 mt -63.49 -45.72 97.09 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.292 0 N-CA-C 107.646 -1.242 . . . . 0.0 107.646 179.91 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -59.19 -28.31 66.51 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 123.135 0.574 . . . . 0.0 112.405 177.009 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 72.3 mttt -71.87 -54.22 10.77 Favored 'General case' 0 C--N 1.343 0.309 0 CA-C-N 119.129 0.877 . . . . 0.0 110.726 172.772 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 14.1 pt -79.44 -38.43 19.74 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.332 0 N-CA-C 114.667 1.358 . . . . 0.0 114.667 -169.215 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 73.3 m . . . . . 0 C--O 1.253 1.266 0 C-N-CA 125.967 1.707 . . . . 0.0 109.742 -169.982 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.496 1.834 0 N-CA-C 110.234 -0.284 . . . . 0.0 110.234 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 34.3 mttm -76.56 117.16 17.92 Favored 'General case' 0 N--CA 1.477 0.883 0 N-CA-C 106.021 -1.844 . . . . 0.0 106.021 172.295 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 88.8 mttt -84.92 135.11 34.2 Favored 'General case' 0 CA--C 1.515 -0.387 0 N-CA-C 107.695 -1.224 . . . . 0.0 107.695 179.47 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 1.8 t -120.81 149.51 23.69 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 C-N-CA 125.9 1.68 . . . . 0.0 109.511 -168.493 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 25.9 mtt -139.57 147.47 41.2 Favored 'General case' 0 C--N 1.324 -0.523 0 C-N-CA 124.534 1.133 . . . . 0.0 109.111 169.27 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 72.0 m-85 -133.06 114.33 13.81 Favored 'General case' 0 CA--C 1.517 -0.32 0 N-CA-C 104.343 -2.465 . . . . 0.0 104.343 172.133 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 2.4 p -151.39 137.2 11.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 118.563 0.62 . . . . 0.0 109.758 -169.352 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 19.9 t -117.24 178.43 4.37 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 126.225 1.81 . . . . 0.0 106.323 169.6 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 39.7 ttpt -55.05 -35.08 64.11 Favored 'General case' 0 N--CA 1.475 0.819 0 O-C-N 121.148 -0.97 . . . . 0.0 111.479 179.638 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 33.3 ptt180 -123.55 160.27 27.38 Favored 'General case' 0 N--CA 1.463 0.212 0 C-N-CA 124.868 1.267 . . . . 0.0 108.294 169.628 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 47.6 t30 -71.75 -42.66 66.97 Favored 'General case' 0 N--CA 1.471 0.578 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 170.864 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 1.1 m -52.02 141.45 18.07 Favored 'General case' 0 N--CA 1.453 -0.319 0 C-N-CA 125.696 1.598 . . . . 0.0 110.616 -171.331 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 3.9 m 66.91 -66.65 0.18 Allowed 'General case' 0 C--N 1.327 -0.383 0 C-N-CA 126.315 1.846 . . . . 0.0 114.525 -173.459 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 8.9 tpp180 -82.78 -46.93 12.51 Favored 'General case' 0 N--CA 1.471 0.576 0 N-CA-C 116.464 2.024 . . . . 0.0 116.464 -167.59 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 3.6 m -89.78 4.69 48.95 Favored 'General case' 0 N--CA 1.471 0.596 0 N-CA-C 114.81 1.411 . . . . 0.0 114.81 -169.051 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 28.2 pt20 -68.83 -47.64 65.54 Favored 'General case' 0 C--O 1.224 -0.289 0 O-C-N 120.959 -1.088 . . . . 0.0 113.364 -171.035 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 2.4 tpt -88.06 -34.63 17.9 Favored 'General case' 0 N--CA 1.47 0.527 0 N-CA-C 113.659 0.985 . . . . 0.0 113.659 -169.309 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -61.03 -44.95 96.64 Favored 'General case' 0 N--CA 1.471 0.605 0 N-CA-C 112.88 0.696 . . . . 0.0 112.88 -169.082 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 1.9 pp20? -64.96 -34.51 78.59 Favored 'General case' 0 N--CA 1.464 0.255 0 O-C-N 121.96 -0.463 . . . . 0.0 109.834 176.522 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -52.11 -56.47 16.64 Favored Glycine 0 C--N 1.34 0.753 0 C-N-CA 125.182 1.372 . . . . 0.0 110.623 175.539 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 13.5 m-85 -68.52 -29.89 68.58 Favored 'General case' 0 CA--C 1.508 -0.657 0 O-C-N 121.521 -0.987 . . . . 0.0 112.512 -179.964 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -69.73 -31.93 70.19 Favored 'General case' 0 N--CA 1.452 -0.341 0 CA-C-N 119.52 1.055 . . . . 0.0 111.603 -174.766 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -68.19 -25.56 65.3 Favored 'General case' 0 N--CA 1.474 0.758 0 CA-C-N 119.541 1.064 . . . . 0.0 111.651 172.566 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 3.2 m -82.42 -56.46 3.87 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 124.959 1.304 . . . . 0.0 110.139 -177.592 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 70.7 mt -75.33 -36.42 61.05 Favored 'General case' 0 C--N 1.331 -0.215 0 C-N-CA 124.298 1.039 . . . . 0.0 110.055 -173.83 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -89.96 6.12 82.92 Favored Glycine 0 C--N 1.339 0.715 0 C-N-CA 124.855 1.217 . . . . 0.0 113.152 -177.017 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -50.74 125.28 12.86 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 124.739 1.215 . . . . 0.0 110.321 -175.635 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 76.54 -5.41 45.38 Favored Glycine 0 CA--C 1.534 1.229 0 CA-C-O 118.782 -1.01 . . . . 0.0 114.437 179.41 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 63.2 mttm -107.5 -51.89 2.84 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-N 119.322 1.561 . . . . 0.0 110.226 -179.762 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 26.1 pt -136.36 147.74 27.66 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.295 0 C-N-CA 123.913 0.885 . . . . 0.0 110.066 -169.31 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -109.89 104.26 13.16 Favored 'General case' 0 N--CA 1.463 0.198 0 C-N-CA 125.082 1.353 . . . . 0.0 108.885 -169.871 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 14.6 p -81.09 142.02 14.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 119.51 1.05 . . . . 0.0 109.192 177.003 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 11.6 m -132.15 -49.63 0.94 Allowed 'General case' 0 N--CA 1.455 -0.212 0 C-N-CA 124.216 1.006 . . . . 0.0 110.22 175.633 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 48.1 m 62.69 -27.03 0.06 Allowed 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 127.439 2.296 . . . . 0.0 117.14 176.49 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 5.6 m 54.37 -135.78 1.4 Allowed 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 124.765 1.226 . . . . 0.0 110.804 169.752 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -172.65 170.25 43.35 Favored Glycine 0 C--N 1.336 0.574 0 N-CA-C 108.331 -1.907 . . . . 0.0 108.331 178.289 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 34.2 mt -118.28 -43.31 2.73 Favored 'General case' 0 N--CA 1.451 -0.398 0 C-N-CA 125.353 1.461 . . . . 0.0 109.084 179.833 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 36.6 mt-10 -140.45 -59.3 0.53 Allowed 'General case' 0 C--O 1.233 0.192 0 N-CA-C 101.687 -3.449 . . . . 0.0 101.687 169.605 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 17.1 m 57.39 177.88 0.05 OUTLIER 'General case' 0 N--CA 1.447 -0.582 0 C-N-CA 127.291 2.236 . . . . 0.0 116.702 167.263 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 4.4 m -162.51 175.38 11.52 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 128.233 2.613 . . . . 0.0 106.089 -169.491 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 11.4 ptt180 -91.72 174.08 7.54 Favored 'General case' 0 N--CA 1.469 0.503 0 O-C-N 121.022 -1.049 . . . . 0.0 109.607 178.618 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 15.9 m -74.94 176.11 0.67 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.64 0 C-N-CA 123.701 0.8 . . . . 0.0 111.219 -176.415 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 26.0 m-70 -88.02 152.2 50.47 Favored Pre-proline 0 CA--C 1.54 0.596 0 C-N-CA 123.8 0.84 . . . . 0.0 109.995 -175.999 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -63.47 -47.29 7.79 Favored 'Trans proline' 0 C--N 1.347 0.49 0 C-N-CA 122.956 2.438 . . . . 0.0 112.612 -172.636 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 4.4 m -68.21 -25.83 65.41 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-O 119.247 -0.406 . . . . 0.0 110.3 -178.391 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -56.91 -53.4 58.37 Favored 'General case' 0 CA--C 1.51 -0.595 0 N-CA-C 108.99 -0.744 . . . . 0.0 108.99 175.048 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 63.9 mt -60.51 -38.09 76.99 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 N-CA-C 109.054 -0.721 . . . . 0.0 109.054 -172.562 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -63.86 -46.74 83.63 Favored 'General case' 0 CA--C 1.536 0.425 0 CA-C-N 119.041 0.837 . . . . 0.0 111.007 179.869 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 37.6 mmt -71.18 -34.7 71.16 Favored 'General case' 0 CA--C 1.539 0.523 0 CA-C-O 123.546 1.641 . . . . 0.0 110.366 -178.376 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -74.82 -31.61 61.73 Favored 'General case' 0 N--CA 1.443 -0.825 0 N-CA-C 106.886 -1.524 . . . . 0.0 106.886 -177.796 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 -70.76 -20.41 62.63 Favored 'General case' 0 N--CA 1.45 -0.453 0 C-N-CA 124.347 1.059 . . . . 0.0 110.305 169.661 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 77.3 mt-10 -62.55 -38.76 91.28 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-N 119.958 1.254 . . . . 0.0 109.306 169.244 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 17.1 m -86.92 10.25 1.6 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.724 0 N-CA-C 113.168 0.803 . . . . 0.0 113.168 169.933 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 70.55 15.48 73.17 Favored Glycine 0 CA--C 1.532 1.114 0 C-N-CA 124.621 1.105 . . . . 0.0 113.803 177.115 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 4.8 mt -91.6 143.54 11.08 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.259 0 C-N-CA 124.425 1.09 . . . . 0.0 111.372 -172.707 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 3.4 t70 -90.84 131.84 36.24 Favored 'General case' 0 C--O 1.234 0.247 0 C-N-CA 126.04 1.736 . . . . 0.0 108.851 169.352 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 7.2 pt -140.41 -27.03 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.874 0 C-N-CA 124.661 1.184 . . . . 0.0 110.371 168.863 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -38.78 138.26 0.55 Allowed 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 128.31 2.644 . . . . 0.0 111.453 168.964 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 62.72 34.67 90.34 Favored Glycine 0 CA--C 1.533 1.21 0 CA-C-O 119.661 -0.522 . . . . 0.0 112.655 175.002 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 5.4 tt0 -57.24 -35.74 70.07 Favored 'General case' 0 C--N 1.344 0.346 0 C-N-CA 123.781 0.832 . . . . 0.0 112.83 -175.422 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -69.07 139.34 54.84 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 124.56 1.144 . . . . 0.0 110.518 -169.611 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 9.9 p -141.43 -67.78 0.4 Allowed 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 123.605 0.762 . . . . 0.0 110.624 -170.622 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -147.33 155.93 46.17 Favored Pre-proline 0 C--O 1.239 0.513 0 C-N-CA 125.484 1.513 . . . . 0.0 108.798 -176.852 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -66.06 152.54 81.03 Favored 'Trans proline' 0 N--CA 1.455 -0.782 0 C-N-CA 121.991 1.794 . . . . 0.0 109.617 171.224 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 3.8 tt -62.58 -23.57 32.92 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.545 0 C-N-CA 123.745 0.818 . . . . 0.0 110.811 -177.626 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 24.0 tt0 -67.7 -25.08 65.49 Favored 'General case' 0 N--CA 1.438 -1.075 0 C-N-CA 126.546 1.938 . . . . 0.0 110.658 -179.111 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 9.0 t-20 -63.43 -23.64 67.49 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 124.567 1.147 . . . . 0.0 112.103 176.385 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 40.5 m-85 -106.03 -168.39 1.43 Allowed 'General case' 0 C--O 1.236 0.363 0 C-N-CA 126.573 1.949 . . . . 0.0 109.305 -176.394 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 55.5 t-20 -139.44 139.74 37.13 Favored 'General case' 0 N--CA 1.447 -0.616 0 N-CA-C 106.836 -1.542 . . . . 0.0 106.836 169.251 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -71.45 -25.31 62.25 Favored 'General case' 0 N--CA 1.434 -1.236 0 C-N-CA 119.749 -0.78 . . . . 0.0 109.516 -178.821 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 35.5 t70 -64.8 -24.84 67.68 Favored 'General case' 0 N--CA 1.445 -0.686 0 O-C-N 123.505 0.503 . . . . 0.0 112.022 -179.575 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -78.05 -29.01 49.08 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 123.38 0.672 . . . . 0.0 111.426 174.411 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 13.1 m-85 -79.24 166.06 22.57 Favored 'General case' 0 N--CA 1.451 -0.394 0 C-N-CA 125.582 1.553 . . . . 0.0 111.126 178.855 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -118.25 -34.41 4.09 Favored 'General case' 0 N--CA 1.466 0.348 0 C-N-CA 123.022 0.529 . . . . 0.0 111.446 -179.985 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -143.35 136.02 24.57 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.595 0 CA-C-O 121.865 0.841 . . . . 0.0 110.234 -172.151 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 98.9 t -144.02 126.36 11.17 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.593 0 N-CA-C 106.249 -1.76 . . . . 0.0 106.249 -178.583 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.55 HD12 ' HB2' ' A' ' 97' ' ' GLU . 12.6 mm -104.6 124.37 59.13 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.521 0 N-CA-C 105.846 -1.909 . . . . 0.0 105.846 176.108 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 37.0 m -93.46 98.25 11.08 Favored 'General case' 0 N--CA 1.443 -0.807 0 N-CA-C 105.057 -2.201 . . . . 0.0 105.057 169.576 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 85.8 mt -68.54 -2.97 10.03 Favored 'General case' 0 N--CA 1.467 0.391 0 O-C-N 121.51 -0.744 . . . . 0.0 112.283 -176.709 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 64.0 m -138.65 128.4 24.99 Favored 'General case' 0 N--CA 1.443 -0.812 0 N-CA-C 106.134 -1.802 . . . . 0.0 106.134 169.397 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 50.71 -144.4 11.96 Favored Glycine 0 CA--C 1.532 1.133 0 C-N-CA 125.272 1.415 . . . . 0.0 113.515 173.425 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 16.2 m -112.23 -111.52 0.34 Allowed 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 124.652 1.181 . . . . 0.0 107.993 178.832 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -80.61 69.37 3.2 Favored Glycine 0 CA--C 1.527 0.83 0 N-CA-C 109.682 -1.367 . . . . 0.0 109.682 171.087 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 1.3 m -60.04 -50.51 79.9 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.598 0 CA-C-N 117.528 0.664 . . . . 0.0 111.688 -171.689 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 1.5 t30 -154.69 52.48 0.64 Allowed 'General case' 0 N--CA 1.467 0.404 0 N-CA-C 103.845 -2.65 . . . . 0.0 103.845 169.327 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -147.42 139.6 14.09 Favored Pre-proline 0 CA--C 1.536 0.442 0 C-N-CA 125.622 1.569 . . . . 0.0 108.297 -168.36 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -65.96 144.21 75.6 Favored 'Trans proline' 0 C--N 1.351 0.692 0 C-N-CA 121.338 1.358 . . . . 0.0 112.577 -174.669 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_endo -66.48 -26.09 47.71 Favored 'Trans proline' 0 N--CA 1.461 -0.405 0 C-N-CA 122.314 2.009 . . . . 0.0 113.242 -169.848 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 -55.91 -22.46 25.96 Favored 'General case' 0 CA--C 1.537 0.474 0 CA-C-N 118.898 0.772 . . . . 0.0 111.926 178.426 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 85.5 m95 -74.67 -43.64 54.24 Favored 'General case' 0 N--CA 1.445 -0.687 0 C-N-CA 123.504 0.722 . . . . 0.0 112.179 -179.339 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 15.2 m -70.46 -32.98 51.84 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.438 0 CA-C-O 118.398 -0.81 . . . . 0.0 110.109 176.854 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 82.3 p -82.06 29.83 0.4 Allowed 'General case' 0 CA--C 1.538 0.504 0 CA-C-N 120.23 1.377 . . . . 0.0 114.019 -170.01 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 93.0 mm-40 -79.09 -173.78 3.76 Favored 'General case' 0 CA--C 1.539 0.52 0 O-C-N 121.731 -0.605 . . . . 0.0 110.543 172.107 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 29.0 mm-40 -65.04 -14.71 61.12 Favored 'General case' 0 CA--C 1.54 0.577 0 N-CA-C 112.531 0.567 . . . . 0.0 112.531 -169.757 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 6.4 tt -143.72 137.36 24.74 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.496 0 C-N-CA 125.664 1.586 . . . . 0.0 107.177 170.934 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 16.2 t80 -116.98 132.32 56.73 Favored 'General case' 0 CA--C 1.535 0.399 0 N-CA-C 105.385 -2.08 . . . . 0.0 105.385 169.381 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . 0.55 ' HB2' HD12 ' A' ' 77' ' ' ILE . 11.6 mm-40 -142.13 162.83 34.49 Favored 'General case' 0 C--O 1.237 0.418 0 C-N-CA 124.546 1.139 . . . . 0.0 108.522 176.288 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 3.0 t70 -173.96 127.9 0.38 Allowed 'General case' 0 C--O 1.236 0.393 0 C-N-CA 127.11 2.164 . . . . 0.0 107.758 -169.255 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 5.4 m0 -148.65 142.58 25.79 Favored 'General case' 0 N--CA 1.456 -0.133 0 C-N-CA 123.571 0.749 . . . . 0.0 109.019 -170.488 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 86.4 mt-30 -84.21 83.24 8.04 Favored 'General case' 0 CA--C 1.533 0.3 0 N-CA-C 108.399 -0.963 . . . . 0.0 108.399 174.46 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 9.6 mp -67.42 129.05 38.67 Favored 'General case' 0 N--CA 1.466 0.352 0 N-CA-C 106.148 -1.797 . . . . 0.0 106.148 171.132 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 32.4 mt-10 -71.29 -20.83 62.16 Favored 'General case' 0 CA--C 1.536 0.417 0 N-CA-C 113.563 0.949 . . . . 0.0 113.563 -169.279 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 1.6 t70 62.29 124.09 0.02 OUTLIER Pre-proline 0 CA--C 1.552 1.047 0 C-N-CA 127.039 2.136 . . . . 0.0 114.212 -179.7 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 23.7 Cg_endo -88.48 -3.67 6.64 Favored 'Trans proline' 0 N--CA 1.454 -0.809 0 C-N-CA 122.689 2.259 . . . . 0.0 114.488 -178.93 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -53.42 126.51 21.61 Favored 'General case' 0 C--O 1.238 0.457 0 CA-C-N 120.793 1.633 . . . . 0.0 111.152 -172.374 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 71.74 -1.64 28.98 Favored Glycine 0 CA--C 1.534 1.271 0 CA-C-O 118.918 -0.934 . . . . 0.0 113.729 177.238 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 8.2 mt-30 -89.7 171.51 9.6 Favored 'General case' 0 CA--C 1.543 0.689 0 CA-C-N 118.807 1.304 . . . . 0.0 109.159 174.796 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 15.6 m -69.11 163.52 24.61 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 123.658 0.783 . . . . 0.0 111.063 -179.301 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 43.2 mt -63.88 -26.37 68.58 Favored 'General case' 0 N--CA 1.472 0.638 0 O-C-N 121.231 -0.918 . . . . 0.0 112.019 -175.026 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 5.4 pt-20 -56.41 -34.85 67.15 Favored 'General case' 0 N--CA 1.461 0.12 0 C-N-CA 123.322 0.649 . . . . 0.0 111.26 171.935 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 21.4 t -76.82 -41.77 32.9 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.395 0 CA-C-O 118.28 -0.866 . . . . 0.0 109.066 -178.139 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 61.8 m-85 -55.02 -49.6 71.15 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-N 120.002 1.274 . . . . 0.0 109.66 170.384 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 96.2 mtt180 -67.67 -33.14 74.34 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 123.056 0.542 . . . . 0.0 111.214 -175.778 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 3.2 m -65.55 -50.16 66.19 Favored 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 124.222 1.009 . . . . 0.0 109.712 170.977 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 90.1 t -70.25 -26.9 30.24 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.309 0 CA-C-O 118.426 -0.797 . . . . 0.0 109.109 -171.442 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 20.5 mtm105 -56.5 -50.15 72.63 Favored 'General case' 0 C--O 1.223 -0.309 0 CA-C-N 119.462 1.028 . . . . 0.0 109.239 169.569 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -62.09 -46.59 93.7 Favored Glycine 0 CA--C 1.528 0.884 0 CA-C-O 119.539 -0.59 . . . . 0.0 111.898 178.676 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 89.8 mt-30 -57.14 -51.69 68.28 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-N 117.854 0.827 . . . . 0.0 110.268 -179.784 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 95.9 t -68.68 -42.35 83.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-O 118.445 -0.788 . . . . 0.0 109.615 -175.574 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -54.51 -47.24 73.31 Favored 'General case' 0 C--O 1.223 -0.341 0 N-CA-C 108.62 -0.881 . . . . 0.0 108.62 178.355 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 39.9 tt0 -64.91 -42.49 94.7 Favored 'General case' 0 N--CA 1.449 -0.523 0 C-N-CA 122.953 0.501 . . . . 0.0 111.325 -176.358 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 44.4 mtt-85 -65.64 -45.61 82.35 Favored 'General case' 0 N--CA 1.469 0.485 0 O-C-N 121.302 -0.874 . . . . 0.0 111.766 177.19 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 61.3 t -64.94 -37.23 79.7 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.723 0 N-CA-C 109.143 -0.688 . . . . 0.0 109.143 178.092 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 20.9 mt-10 -60.66 -44.58 96.28 Favored 'General case' 0 C--O 1.226 -0.182 0 O-C-N 120.743 -1.223 . . . . 0.0 109.857 174.911 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 27.8 t-20 -65.12 -40.54 94.63 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 123.021 0.528 . . . . 0.0 111.054 -177.925 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 29.3 tp -58.7 -49.58 77.07 Favored 'General case' 0 CA--C 1.53 0.195 0 C-N-CA 124.864 1.266 . . . . 0.0 110.85 173.292 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 63.6 mt -64.72 -46.66 91.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 N-CA-C 107.925 -1.139 . . . . 0.0 107.925 -177.969 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -58.17 -31.82 67.63 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 123.436 0.695 . . . . 0.0 112.109 -178.882 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . 0.258 18.5 ptpt -82.51 -37.89 24.61 Favored 'General case' 0 C--N 1.344 0.341 0 CA-C-O 117.782 -1.104 . . . . 0.0 112.512 177.099 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 12.1 pt -84.08 -38.74 14.15 Favored 'Isoleucine or valine' 0 C--O 1.236 0.35 0 CA-C-N 120.373 1.442 . . . . 0.0 113.967 -176.261 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 68.2 m . . . . . 0 C--O 1.252 1.219 0 C-N-CA 125.644 1.578 . . . . 0.0 110.141 -169.876 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.498 1.964 0 N-CA-C 110.583 -0.155 . . . . 0.0 110.583 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 26.1 mttm -79.77 117.48 20.7 Favored 'General case' 0 N--CA 1.474 0.749 0 N-CA-C 105.71 -1.959 . . . . 0.0 105.71 171.53 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 85.0 mttt -81.84 143.4 31.76 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-N 119.935 1.243 . . . . 0.0 108.499 176.904 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 2.2 t -132.54 145.07 35.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 O-C-N 124.347 1.029 . . . . 0.0 111.058 -169.341 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 12.4 mtt -137.06 145.33 43.85 Favored 'General case' 0 C--N 1.329 -0.291 0 C-N-CA 125.327 1.451 . . . . 0.0 108.957 168.48 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 54.5 m-85 -133.91 117.46 16.8 Favored 'General case' 0 CA--C 1.518 -0.281 0 N-CA-C 104.903 -2.258 . . . . 0.0 104.903 169.915 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 2.2 p -151.67 155.26 7.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-O 121.248 0.547 . . . . 0.0 109.842 -168.848 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 39.9 t -140.94 159.32 42.45 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 105.119 -2.178 . . . . 0.0 105.119 169.266 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 64.8 pttt -56.68 143.92 34.37 Favored 'General case' 0 N--CA 1.467 0.394 0 N-CA-C 109.036 -0.727 . . . . 0.0 109.036 171.838 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 96.6 mtt180 51.44 73.9 0.28 Allowed 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 124.665 1.186 . . . . 0.0 110.136 -169.824 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 10.4 t30 -31.63 -46.41 0.11 Allowed 'General case' 0 N--CA 1.482 1.141 0 C-N-CA 127.523 2.329 . . . . 0.0 115.33 -172.4 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 2.1 m -50.96 -37.79 46.71 Favored 'General case' 0 N--CA 1.45 -0.447 0 C-N-CA 124.164 0.985 . . . . 0.0 111.419 -175.515 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 21.9 m -72.17 122.15 20.52 Favored 'General case' 0 N--CA 1.449 -0.51 0 CA-C-N 119.094 0.861 . . . . 0.0 109.767 173.906 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . 0.334 0.1 OUTLIER 56.01 -24.02 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 130.914 3.686 . . . . 0.0 117.248 177.182 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -74.92 -11.53 60.15 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-N 121.102 1.774 . . . . 0.0 111.417 175.416 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 25.2 pt20 -75.04 30.47 0.09 Allowed 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 125.756 1.622 . . . . 0.0 113.725 174.856 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' MET . . . . . 0.425 ' SD ' ' CD2' ' A' ' 21' ' ' PHE . 0.0 OUTLIER -152.62 -54.24 0.12 Allowed 'General case' 0 C--N 1.329 -0.284 0 O-C-N 120.29 -1.506 . . . . 0.0 112.06 174.837 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -59.44 -47.77 84.21 Favored 'General case' 0 N--CA 1.474 0.725 0 N-CA-C 114.313 1.227 . . . . 0.0 114.313 -169.009 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -65.05 -30.99 71.99 Favored 'General case' 0 N--CA 1.463 0.182 0 O-C-N 121.88 -0.512 . . . . 0.0 110.058 177.7 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -55.15 -59.13 10.93 Favored Glycine 0 C--N 1.337 0.605 0 C-N-CA 125.312 1.434 . . . . 0.0 110.588 173.222 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . 0.425 ' CD2' ' SD ' ' A' ' 17' ' ' MET . 3.3 m-85 -61.98 -32.54 73.0 Favored 'General case' 0 CA--C 1.511 -0.532 0 CA-C-N 118.377 1.088 . . . . 0.0 112.906 175.806 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -63.91 -36.47 84.05 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 119.146 0.884 . . . . 0.0 111.123 -172.418 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -69.03 -24.43 64.19 Favored 'General case' 0 N--CA 1.47 0.571 0 CA-C-N 119.164 0.893 . . . . 0.0 112.274 176.803 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 1.5 m -80.15 -53.22 6.89 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 125.305 1.442 . . . . 0.0 110.45 177.733 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 80.9 mt -74.24 -37.82 63.68 Favored 'General case' 0 N--CA 1.464 0.249 0 C-N-CA 123.648 0.779 . . . . 0.0 110.266 -173.124 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -96.39 14.07 64.81 Favored Glycine 0 CA--C 1.527 0.815 0 C-N-CA 125.175 1.369 . . . . 0.0 112.98 -176.767 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -51.52 123.57 10.18 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 124.743 1.217 . . . . 0.0 110.49 -174.809 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 76.11 -7.89 26.97 Favored Glycine 0 CA--C 1.536 1.356 0 C-N-CA 124.293 0.949 . . . . 0.0 114.382 179.797 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 62.9 mttm -97.62 -49.19 4.96 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-N 119.283 1.541 . . . . 0.0 110.298 179.854 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 17.1 pt -137.28 152.52 27.83 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.328 0 C-N-CA 124.137 0.975 . . . . 0.0 110.067 -169.264 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -112.02 98.66 7.5 Favored 'General case' 0 CA--C 1.521 -0.153 0 C-N-CA 124.584 1.153 . . . . 0.0 109.187 -169.738 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 13.0 p -87.8 134.4 28.0 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.487 0 O-C-N 121.823 -0.548 . . . . 0.0 109.666 178.966 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 20.1 m -150.51 92.45 1.85 Allowed 'General case' 0 N--CA 1.456 -0.143 0 N-CA-C 105.19 -2.152 . . . . 0.0 105.19 172.413 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 53.4 m -95.49 87.01 4.63 Favored 'General case' 0 C--O 1.237 0.396 0 C-N-CA 120.066 -0.654 . . . . 0.0 110.63 -170.057 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 58.8 m -61.19 165.85 4.14 Favored 'General case' 0 CA--C 1.539 0.522 0 CA-C-N 115.322 -0.854 . . . . 0.0 110.07 169.018 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -138.96 -173.84 13.18 Favored Glycine 0 CA--C 1.525 0.702 0 N-CA-C 106.807 -2.517 . . . . 0.0 106.807 -177.721 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 6.4 mt -123.71 -83.51 0.65 Allowed 'General case' 0 N--CA 1.45 -0.465 0 C-N-CA 124.298 1.039 . . . . 0.0 109.048 -169.952 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 3.3 tt0 -69.02 -27.17 65.44 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 122.823 0.449 . . . . 0.0 111.574 176.673 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 1.3 m -144.18 179.45 7.21 Favored 'General case' 0 N--CA 1.463 0.176 0 C-N-CA 126.187 1.795 . . . . 0.0 107.747 177.032 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 3.7 m -166.05 -18.66 0.02 OUTLIER 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 125.301 1.44 . . . . 0.0 112.145 -169.725 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 7.8 ttt180 -100.37 -162.1 0.92 Allowed 'General case' 0 N--CA 1.473 0.709 0 CA-C-N 119.637 1.108 . . . . 0.0 110.207 176.046 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 27.4 m -134.95 173.68 14.1 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.449 0 C-N-CA 125.421 1.489 . . . . 0.0 111.376 -169.988 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 96.7 m-70 -83.65 156.45 65.01 Favored Pre-proline 0 CA--C 1.543 0.698 0 C-N-CA 124.804 1.242 . . . . 0.0 110.299 173.816 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -62.16 -51.47 3.58 Favored 'Trans proline' 0 C--N 1.349 0.575 0 C-N-CA 123.845 3.03 . . . . 0.0 113.426 -173.425 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 6.8 m -65.85 -24.95 66.99 Favored 'General case' 0 CA--C 1.534 0.328 0 O-C-N 121.902 -0.499 . . . . 0.0 110.936 -172.845 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -55.52 -53.31 57.95 Favored 'General case' 0 CA--C 1.508 -0.672 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 173.261 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 69.8 mt -59.83 -40.71 83.43 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.369 0 N-CA-C 108.475 -0.935 . . . . 0.0 108.475 -170.352 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -62.75 -46.76 86.58 Favored 'General case' 0 N--CA 1.449 -0.518 0 CA-C-N 118.488 0.586 . . . . 0.0 111.004 179.924 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 27.9 mmt -67.64 -39.78 84.61 Favored 'General case' 0 C--O 1.238 0.473 0 CA-C-O 122.789 1.281 . . . . 0.0 110.839 -178.65 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 1.2 mmt -74.31 -35.2 63.66 Favored 'General case' 0 N--CA 1.444 -0.772 0 N-CA-C 106.711 -1.588 . . . . 0.0 106.711 -174.875 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 41.7 tt0 -69.98 -23.94 63.24 Favored 'General case' 0 N--CA 1.447 -0.583 0 O-C-N 121.179 -0.951 . . . . 0.0 110.219 173.672 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 10.2 mm-40 -65.74 -29.49 70.01 Favored 'General case' 0 N--CA 1.452 -0.341 0 CA-C-N 118.762 0.71 . . . . 0.0 110.241 173.251 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . 0.29 9.0 m -98.22 16.95 2.85 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.858 0 N-CA-C 112.758 0.651 . . . . 0.0 112.758 169.35 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 84.33 16.21 67.27 Favored Glycine 0 CA--C 1.534 1.275 0 C-N-CA 125.366 1.46 . . . . 0.0 114.636 169.935 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 8.2 mm -97.52 151.59 4.25 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.329 0 C-N-CA 124.736 1.214 . . . . 0.0 111.121 -170.52 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -112.52 126.95 55.89 Favored 'General case' 0 C--O 1.233 0.189 0 N-CA-C 106.051 -1.833 . . . . 0.0 106.051 168.222 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 3.6 pt -128.93 -24.51 1.24 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.481 0 C-N-CA 125.751 1.62 . . . . 0.0 110.353 170.312 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -39.51 -40.38 0.84 Allowed 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 128.177 2.591 . . . . 0.0 112.789 169.163 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -91.24 19.62 45.63 Favored Glycine 0 CA--C 1.531 1.069 0 C-N-CA 125.446 1.498 . . . . 0.0 113.763 -179.166 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 21.2 mt-30 -61.84 -27.62 68.91 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-N 120.152 1.976 . . . . 0.0 112.84 179.78 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -61.92 129.39 40.72 Favored 'General case' 0 N--CA 1.445 -0.678 0 N-CA-C 109.683 -0.488 . . . . 0.0 109.683 -171.562 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 8.5 p -141.61 -70.44 0.36 Allowed 'General case' 0 C--O 1.235 0.31 0 C-N-CA 123.817 0.847 . . . . 0.0 109.452 -173.269 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -157.66 161.34 29.26 Favored Pre-proline 0 CA--C 1.552 1.037 0 C-N-CA 124.952 1.301 . . . . 0.0 109.913 -174.66 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -67.84 28.92 0.13 Allowed 'Trans proline' 0 CA--C 1.552 1.381 0 C-N-CA 125.247 3.964 . . . . 0.0 116.694 173.126 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . 0.256 1.1 tt 64.43 -26.21 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.541 0.619 0 C-N-CA 129.529 3.132 . . . . 0.0 113.989 -169.583 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -68.79 -30.19 68.72 Favored 'General case' 0 N--CA 1.429 -1.516 0 C-N-CA 128.005 2.522 . . . . 0.0 115.407 -169.304 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 26.0 m-80 -68.72 -17.44 64.06 Favored 'General case' 0 C--O 1.236 0.35 0 CA-C-N 118.359 0.527 . . . . 0.0 112.192 -176.419 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 69.8 m-85 -104.76 160.98 14.55 Favored 'General case' 0 CA--C 1.513 -0.447 0 C-N-CA 124.726 1.211 . . . . 0.0 112.015 -176.854 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 48.1 t-20 -95.65 134.13 38.92 Favored 'General case' 0 N--CA 1.439 -0.989 0 N-CA-C 106.107 -1.812 . . . . 0.0 106.107 168.156 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -72.57 -27.67 62.34 Favored 'General case' 0 N--CA 1.436 -1.172 0 N-CA-C 108.845 -0.798 . . . . 0.0 108.845 179.629 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 36.6 t70 -67.0 -21.04 65.97 Favored 'General case' 0 N--CA 1.447 -0.585 0 N-CA-C 111.73 0.27 . . . . 0.0 111.73 -179.168 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 35.7 t70 -72.63 -29.24 63.3 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 122.974 0.509 . . . . 0.0 111.611 175.782 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 17.2 m-85 -77.27 144.51 38.1 Favored 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 123.981 0.912 . . . . 0.0 110.316 179.18 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -93.93 -32.1 14.02 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.724 177.555 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 21.7 t -137.34 130.8 44.15 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.467 0 C-N-CA 123.824 0.85 . . . . 0.0 109.841 -171.307 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 53.7 t -145.48 139.58 21.84 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.419 0 N-CA-C 106.28 -1.748 . . . . 0.0 106.28 174.851 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 36.6 mm -130.63 123.62 55.26 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.537 0 N-CA-C 107.238 -1.393 . . . . 0.0 107.238 -169.859 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 55.3 m -90.49 115.37 27.59 Favored 'General case' 0 N--CA 1.444 -0.732 0 N-CA-C 106.562 -1.644 . . . . 0.0 106.562 169.225 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 68.7 mt -77.72 -7.54 56.66 Favored 'General case' 0 C--N 1.332 -0.191 0 C-N-CA 123.769 0.827 . . . . 0.0 111.418 179.88 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 31.9 p -139.72 132.75 29.5 Favored 'General case' 0 N--CA 1.443 -0.817 0 N-CA-C 106.81 -1.552 . . . . 0.0 106.81 169.632 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 50.68 -155.85 2.84 Favored Glycine 0 CA--C 1.539 1.547 0 C-N-CA 125.579 1.561 . . . . 0.0 115.713 170.067 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 17.4 m -134.52 139.24 45.29 Favored 'General case' 0 C--O 1.235 0.306 0 C-N-CA 125.897 1.679 . . . . 0.0 107.153 177.232 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 74.36 -75.44 1.18 Allowed Glycine 0 C--N 1.335 0.517 0 N-CA-C 110.324 -1.11 . . . . 0.0 110.324 -174.28 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . 0.299 34.7 m 48.12 36.22 0.27 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.792 0 C-N-CA 125.973 1.709 . . . . 0.0 113.401 176.647 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 10.6 t-20 69.99 -0.15 2.86 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 127.679 2.392 . . . . 0.0 113.318 179.061 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.407 ' HA ' ' HD3' ' A' ' 87' ' ' PRO . 0.0 OUTLIER -77.03 148.09 78.01 Favored Pre-proline 0 CA--C 1.548 0.882 0 N-CA-C 107.749 -1.204 . . . . 0.0 107.749 169.524 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . 0.407 ' HD3' ' HA ' ' A' ' 86' ' ' LEU . 34.1 Cg_exo -65.99 142.17 67.38 Favored 'Trans proline' 0 CA--C 1.544 1.013 0 C-N-CA 121.452 1.435 . . . . 0.0 113.0 -174.165 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -67.33 -20.17 49.03 Favored 'Trans proline' 0 C--N 1.344 0.336 0 C-N-CA 123.379 2.719 . . . . 0.0 114.267 -170.592 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 5.4 pm0 -63.04 -18.77 63.71 Favored 'General case' 0 CA--C 1.54 0.562 0 CA-C-N 121.371 1.896 . . . . 0.0 111.547 174.75 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 97.8 m95 -88.33 -5.93 58.03 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 125.414 1.486 . . . . 0.0 112.799 173.728 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 39.9 t -94.23 -9.03 9.66 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.62 0 C-N-CA 124.769 1.228 . . . . 0.0 109.137 173.325 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 73.3 p -119.77 36.94 4.34 Favored 'General case' 0 C--O 1.237 0.404 0 N-CA-C 116.134 1.901 . . . . 0.0 116.134 -169.305 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 12.2 mp0 -71.42 173.71 7.53 Favored 'General case' 0 CA--C 1.535 0.384 0 O-C-N 121.718 -0.614 . . . . 0.0 111.568 173.852 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 33.9 mm-40 -59.93 -28.81 67.93 Favored 'General case' 0 CA--C 1.536 0.432 0 N-CA-C 109.807 -0.442 . . . . 0.0 109.807 177.012 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 4.3 tt -133.62 116.98 25.65 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.56 0 N-CA-C 105.489 -2.041 . . . . 0.0 105.489 168.729 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 62.1 t80 -108.98 145.3 35.73 Favored 'General case' 0 C--O 1.237 0.443 0 N-CA-C 104.534 -2.395 . . . . 0.0 104.534 168.28 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 21.7 mm-40 -134.86 139.74 45.28 Favored 'General case' 0 C--O 1.236 0.379 0 CA-C-N 119.161 0.891 . . . . 0.0 108.691 169.859 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -106.93 113.29 26.69 Favored 'General case' 0 C--O 1.239 0.551 0 N-CA-C 105.609 -1.997 . . . . 0.0 105.609 169.883 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 9.2 m95 -117.47 166.52 12.24 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 124.405 1.082 . . . . 0.0 108.118 169.756 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 24.0 mm-40 -128.33 78.1 1.81 Allowed 'General case' 0 CA--C 1.534 0.36 0 N-CA-C 107.257 -1.386 . . . . 0.0 107.257 174.326 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -77.04 148.46 36.15 Favored 'General case' 0 N--CA 1.467 0.399 0 N-CA-C 109.192 -0.67 . . . . 0.0 109.192 -179.505 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -81.09 168.25 18.83 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 124.514 1.126 . . . . 0.0 108.724 169.765 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -134.14 133.71 22.18 Favored Pre-proline 0 CA--C 1.534 0.334 0 C-N-CA 124.022 0.929 . . . . 0.0 110.975 178.085 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 40.2 Cg_endo -89.87 -2.41 5.65 Favored 'Trans proline' 0 CA--C 1.539 0.772 0 C-N-CA 122.911 2.407 . . . . 0.0 115.22 -174.349 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 24.4 t70 -60.25 128.32 36.14 Favored 'General case' 0 C--O 1.238 0.484 0 CA-C-N 121.347 1.885 . . . . 0.0 110.357 -177.861 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 72.94 -0.3 46.61 Favored Glycine 0 CA--C 1.533 1.163 0 CA-C-O 119.216 -0.769 . . . . 0.0 113.605 179.474 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 17.1 mm-40 -86.2 172.82 10.23 Favored 'General case' 0 C--O 1.238 0.454 0 CA-C-N 118.65 1.225 . . . . 0.0 109.738 174.335 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 16.0 m -69.17 159.53 32.81 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 123.768 0.827 . . . . 0.0 110.868 171.778 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 33.1 tp -56.61 -30.58 63.41 Favored 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 126.153 1.781 . . . . 0.0 113.071 -176.302 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 6.7 pt-20 -56.49 -34.28 66.79 Favored 'General case' 0 CA--C 1.528 0.106 0 C-N-CA 123.817 0.847 . . . . 0.0 111.331 175.563 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 5.1 t -77.61 -39.81 27.44 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.39 0 CA-C-O 118.125 -0.941 . . . . 0.0 110.414 -174.987 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 63.9 m-85 -56.5 -47.98 78.15 Favored 'General case' 0 N--CA 1.473 0.708 0 CA-C-N 120.368 1.44 . . . . 0.0 109.454 170.152 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 86.3 mtt180 -60.87 -42.69 98.38 Favored 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 123.259 0.624 . . . . 0.0 110.909 179.794 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 6.0 m -67.51 -49.42 63.51 Favored 'General case' 0 N--CA 1.447 -0.595 0 C-N-CA 124.696 1.199 . . . . 0.0 110.311 -179.865 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 73.0 t -68.96 -30.02 45.34 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.234 0 CA-C-O 117.813 -1.089 . . . . 0.0 110.223 -169.787 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 32.5 mtm105 -56.84 -47.1 81.11 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-N 120.011 1.278 . . . . 0.0 110.357 169.89 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -62.94 -49.05 75.63 Favored Glycine 0 CA--C 1.527 0.816 0 CA-C-N 118.438 0.563 . . . . 0.0 111.773 179.272 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 17.5 mt-30 -62.01 -44.18 97.27 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-N 117.698 0.749 . . . . 0.0 110.22 -177.914 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 54.6 t -66.19 -45.15 90.88 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.245 0 CA-C-O 118.183 -0.913 . . . . 0.0 109.684 -177.96 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -52.74 -47.79 67.16 Favored 'General case' 0 CA--C 1.516 -0.361 0 CA-C-N 119.094 0.861 . . . . 0.0 109.013 -177.957 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 39.9 tt0 -62.72 -42.79 99.83 Favored 'General case' 0 N--CA 1.447 -0.584 0 O-C-N 123.569 0.543 . . . . 0.0 111.029 -176.052 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 44.7 mtt-85 -67.06 -41.45 86.42 Favored 'General case' 0 N--CA 1.468 0.455 0 O-C-N 121.381 -0.824 . . . . 0.0 111.57 177.85 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 54.0 t -68.92 -38.46 78.61 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.429 0 N-CA-C 109.372 -0.603 . . . . 0.0 109.372 179.463 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 22.1 mt-10 -60.06 -42.09 93.74 Favored 'General case' 0 C--O 1.226 -0.166 0 O-C-N 121.414 -0.804 . . . . 0.0 110.247 174.923 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 29.1 t-20 -64.56 -45.25 87.88 Favored 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 122.735 0.414 . . . . 0.0 111.145 -179.7 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 2.1 tm? -57.19 -49.28 76.49 Favored 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 124.625 1.17 . . . . 0.0 109.992 175.815 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 75.8 mt -63.21 -47.71 91.0 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.141 0 N-CA-C 108.558 -0.904 . . . . 0.0 108.558 -179.797 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -58.61 -28.74 65.9 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 123.254 0.621 . . . . 0.0 112.411 178.908 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 88.9 mttt -70.18 -55.39 9.46 Favored 'General case' 0 C--O 1.234 0.243 0 CA-C-N 119.257 0.935 . . . . 0.0 110.567 172.495 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 16.2 pt -77.03 -38.28 27.71 Favored 'Isoleucine or valine' 0 C--O 1.234 0.25 0 N-CA-C 114.91 1.448 . . . . 0.0 114.91 -169.085 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 74.5 m . . . . . 0 C--O 1.254 1.296 0 C-N-CA 125.882 1.673 . . . . 0.0 109.52 -169.774 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 19.8 ptm . . . . . 0 N--CA 1.497 1.924 0 N-CA-C 110.821 -0.066 . . . . 0.0 110.821 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . 0.506 ' HB2' HG22 ' A' ' 30' ' ' ILE . 16.3 mttm -73.59 125.96 29.18 Favored 'General case' 0 N--CA 1.482 1.131 0 N-CA-C 107.88 -1.156 . . . . 0.0 107.88 -172.006 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 69.6 mttt -94.13 137.26 33.52 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-N 120.062 1.301 . . . . 0.0 108.376 174.087 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.441 HG21 HD12 ' A' ' 30' ' ' ILE . 15.0 t -119.84 151.28 22.39 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 C-N-CA 127.121 2.169 . . . . 0.0 106.473 -169.939 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 31.9 mtt -134.65 147.14 50.09 Favored 'General case' 0 C--N 1.321 -0.64 0 C-N-CA 124.164 0.986 . . . . 0.0 108.705 168.782 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 45.6 m-85 -131.67 122.85 26.64 Favored 'General case' 0 CA--C 1.516 -0.336 0 N-CA-C 102.218 -3.252 . . . . 0.0 102.218 169.226 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 1.3 p -148.4 141.81 18.74 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.263 0 CA-C-O 121.764 0.793 . . . . 0.0 112.151 -168.41 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 46.3 t -136.29 173.86 11.25 Favored 'General case' 0 CA--C 1.547 0.846 0 C-N-CA 127.807 2.443 . . . . 0.0 105.269 169.019 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 87.6 tttt -51.59 -46.92 63.71 Favored 'General case' 0 N--CA 1.475 0.813 0 O-C-N 120.975 -1.078 . . . . 0.0 113.433 -169.368 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 19.6 ttt180 -130.11 147.47 51.85 Favored 'General case' 0 N--CA 1.468 0.461 0 CA-C-N 118.995 0.816 . . . . 0.0 109.118 -178.319 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 64.3 t30 -58.94 -30.33 67.79 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 123.964 0.906 . . . . 0.0 113.354 -175.589 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -56.31 -55.27 35.46 Favored 'General case' 0 C--O 1.236 0.378 0 C-N-CA 124.069 0.948 . . . . 0.0 109.992 -171.428 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 9.2 m -91.02 151.2 21.13 Favored 'General case' 0 N--CA 1.452 -0.37 0 C-N-CA 123.659 0.784 . . . . 0.0 110.797 -176.353 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 5.4 mmm180 67.32 -50.5 0.49 Allowed 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 128.462 2.705 . . . . 0.0 113.323 170.228 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 7.3 m -76.92 49.94 0.68 Allowed 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 125.677 1.591 . . . . 0.0 111.704 -179.351 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 4.5 pt20 -123.52 12.73 9.36 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 126.109 1.763 . . . . 0.0 112.148 -175.669 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -160.96 -40.37 0.05 OUTLIER 'General case' 0 C--O 1.224 -0.265 0 N-CA-C 113.973 1.101 . . . . 0.0 113.973 176.935 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -66.62 -52.45 44.99 Favored 'General case' 0 N--CA 1.475 0.797 0 CA-C-N 120.657 1.571 . . . . 0.0 112.164 -169.56 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -56.42 -38.3 71.39 Favored 'General case' 0 N--CA 1.446 -0.653 0 C-N-CA 124.029 0.931 . . . . 0.0 110.645 169.942 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -57.11 -52.6 50.4 Favored Glycine 0 CA--C 1.526 0.754 0 C-N-CA 124.722 1.153 . . . . 0.0 111.209 175.902 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 1.3 m-85 -65.0 -32.07 73.61 Favored 'General case' 0 CA--C 1.51 -0.582 0 O-C-N 120.94 -1.329 . . . . 0.0 111.907 175.723 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -71.05 -41.23 71.04 Favored 'General case' 0 N--CA 1.445 -0.688 0 CA-C-O 118.156 -0.926 . . . . 0.0 110.739 -174.607 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.15 -33.3 75.18 Favored 'General case' 0 N--CA 1.471 0.582 0 CA-C-N 119.617 1.099 . . . . 0.0 109.886 173.591 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 10.6 m -68.9 -54.05 17.66 Favored 'General case' 0 N--CA 1.442 -0.842 0 C-N-CA 123.171 0.588 . . . . 0.0 110.364 -175.046 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 39.9 mt -77.8 -37.3 49.06 Favored 'General case' 0 C--N 1.329 -0.285 0 C-N-CA 124.946 1.298 . . . . 0.0 111.034 -172.941 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -101.08 8.29 57.42 Favored Glycine 0 CA--C 1.526 0.761 0 CA-C-O 118.033 -1.426 . . . . 0.0 114.303 -169.734 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -40.92 -48.91 3.21 Favored 'General case' 0 N--CA 1.468 0.437 0 C-N-CA 125.798 1.639 . . . . 0.0 114.882 -169.443 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -89.94 -2.09 75.47 Favored Glycine 0 CA--C 1.531 1.074 0 CA-C-O 118.836 -0.98 . . . . 0.0 114.469 -173.506 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 13.8 ptpt -124.88 -28.29 3.51 Favored 'General case' 0 N--CA 1.472 0.651 0 CA-C-N 118.915 1.357 . . . . 0.0 113.145 -173.626 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.506 HG22 ' HB2' ' A' ' 2' ' ' LYS . 14.8 pt -143.65 150.15 17.47 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.437 0 CA-C-N 119.657 1.117 . . . . 0.0 111.47 -174.218 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -98.54 158.17 15.77 Favored 'General case' 0 N--CA 1.465 0.302 0 C-N-CA 125.575 1.55 . . . . 0.0 108.543 172.182 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 22.6 t -139.66 133.35 37.23 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 N-CA-C 107.547 -1.279 . . . . 0.0 107.547 -175.976 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 34.5 m -138.49 107.42 5.99 Favored 'General case' 0 N--CA 1.447 -0.594 0 N-CA-C 106.042 -1.836 . . . . 0.0 106.042 175.345 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 2.4 p -80.65 99.48 8.18 Favored 'General case' 0 C--N 1.327 -0.386 0 C-N-CA 119.843 -0.743 . . . . 0.0 109.064 174.501 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 25.7 p -72.16 -177.47 2.11 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 123.956 0.903 . . . . 0.0 110.827 175.254 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -173.17 171.88 44.76 Favored Glycine 0 CA--C 1.522 0.504 0 N-CA-C 106.457 -2.657 . . . . 0.0 106.457 -179.297 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 18.4 mt -106.43 -20.05 13.5 Favored 'General case' 0 C--N 1.325 -0.489 0 C-N-CA 124.804 1.241 . . . . 0.0 110.072 174.633 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 36.9 mt-10 -131.87 162.84 29.64 Favored 'General case' 0 N--CA 1.448 -0.538 0 C-N-CA 127.683 2.393 . . . . 0.0 106.948 169.207 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 78.9 p -145.2 155.99 43.59 Favored 'General case' 0 N--CA 1.451 -0.409 0 CA-C-O 122.844 1.307 . . . . 0.0 114.499 179.615 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 4.3 m -168.89 -179.85 3.86 Favored 'General case' 0 N--CA 1.451 -0.41 0 C-N-CA 131.118 3.767 . . . . 0.0 103.966 -170.028 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 25.6 ttp180 -86.9 171.69 10.62 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 107.079 -1.452 . . . . 0.0 107.079 169.142 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 11.2 m -68.58 165.47 2.3 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.808 0 CA-C-N 115.796 -0.638 . . . . 0.0 109.973 178.409 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 55.1 m170 -62.96 152.43 83.51 Favored Pre-proline 0 CA--C 1.549 0.917 0 C-N-CA 123.161 0.584 . . . . 0.0 112.537 177.675 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -70.45 -55.62 0.15 Allowed 'Trans proline' 0 C--N 1.352 0.711 0 C-N-CA 123.382 2.722 . . . . 0.0 114.388 -169.909 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 26.9 m -65.8 -22.75 66.59 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-N 119.256 0.934 . . . . 0.0 110.071 -175.973 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -52.41 -52.3 54.52 Favored 'General case' 0 CA--C 1.509 -0.603 0 CA-C-O 118.815 -0.612 . . . . 0.0 110.585 169.957 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 85.3 mt -58.69 -41.32 81.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 -172.292 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -63.96 -49.32 72.99 Favored 'General case' 0 N--CA 1.45 -0.455 0 CA-C-N 118.079 0.399 . . . . 0.0 111.113 178.477 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' MET . . . . . 0.437 ' HG3' ' CG ' ' A' ' 112' ' ' PHE . 24.3 mmt -65.33 -35.81 82.12 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-O 122.638 1.208 . . . . 0.0 111.445 -178.627 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -79.22 -33.09 44.01 Favored 'General case' 0 N--CA 1.44 -0.944 0 N-CA-C 107.584 -1.265 . . . . 0.0 107.584 -173.47 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 42.0 tt0 -68.25 -26.76 65.84 Favored 'General case' 0 N--CA 1.445 -0.713 0 C-N-CA 123.307 0.643 . . . . 0.0 109.86 170.614 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 14.7 mm-40 -68.25 -28.57 67.33 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-N 118.816 0.734 . . . . 0.0 110.654 174.241 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . 0.276 4.6 p -93.07 11.81 3.14 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.907 0 CA-C-N 118.658 0.663 . . . . 0.0 111.375 169.201 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 77.33 17.53 79.23 Favored Glycine 0 CA--C 1.53 1.029 0 C-N-CA 124.516 1.055 . . . . 0.0 114.003 173.071 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 12.5 mt -109.58 131.3 60.85 Favored 'Isoleucine or valine' 0 C--O 1.232 0.134 0 CA-C-N 118.884 1.342 . . . . 0.0 109.921 -177.947 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 8.1 t70 -87.28 121.04 29.19 Favored 'General case' 0 C--O 1.236 0.375 0 N-CA-C 106.783 -1.562 . . . . 0.0 106.783 169.061 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 10.1 pt -110.39 -26.68 3.09 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.487 0 C-N-CA 123.097 0.559 . . . . 0.0 110.105 169.126 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -32.67 -46.42 0.14 Allowed 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 130.146 3.378 . . . . 0.0 114.279 173.073 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -73.75 -3.59 63.85 Favored Glycine 0 CA--C 1.534 1.221 0 CA-C-O 118.82 -0.989 . . . . 0.0 114.126 -176.27 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 13.3 mt-30 -79.25 114.53 18.26 Favored 'General case' 0 CA--C 1.511 -0.55 0 CA-C-N 119.353 1.577 . . . . 0.0 111.468 -176.216 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -150.22 148.33 28.77 Favored 'General case' 0 N--CA 1.434 -1.248 0 N-CA-C 105.257 -2.127 . . . . 0.0 105.257 167.328 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 18.8 m -150.81 156.7 41.78 Favored 'General case' 0 N--CA 1.447 -0.607 0 N-CA-C 108.373 -0.973 . . . . 0.0 108.373 -169.677 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -67.98 163.45 50.4 Favored Pre-proline 0 CA--C 1.542 0.646 0 C-N-CA 124.682 1.193 . . . . 0.0 109.464 169.422 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -60.73 151.65 75.08 Favored 'Trans proline' 0 N--CA 1.456 -0.685 0 C-N-CA 122.043 1.829 . . . . 0.0 110.31 172.126 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 13.9 tt -58.61 -26.24 30.69 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.453 0 C-N-CA 124.031 0.932 . . . . 0.0 112.212 -174.475 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 23.1 tt0 -67.21 -25.34 66.07 Favored 'General case' 0 N--CA 1.434 -1.241 0 C-N-CA 125.68 1.592 . . . . 0.0 110.682 -177.052 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 12.9 t-20 -63.21 -31.51 72.67 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 124.984 1.314 . . . . 0.0 112.221 -178.888 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 8.5 m-85 -96.69 -167.69 1.6 Allowed 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 124.904 1.281 . . . . 0.0 110.333 -175.46 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 54.9 t-20 -137.35 136.95 38.39 Favored 'General case' 0 CA--C 1.515 -0.402 0 N-CA-C 107.27 -1.382 . . . . 0.0 107.27 169.188 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.46 ' HB3' ' HG2' ' A' ' 89' ' ' GLU . . . -73.54 -24.91 60.19 Favored 'General case' 0 N--CA 1.436 -1.128 0 N-CA-C 109.408 -0.59 . . . . 0.0 109.408 -176.547 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 36.0 t70 -66.34 -23.97 66.44 Favored 'General case' 0 N--CA 1.443 -0.804 0 O-C-N 123.751 0.657 . . . . 0.0 111.82 -179.618 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -75.96 -28.82 58.05 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 123.097 0.559 . . . . 0.0 111.348 175.541 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 18.8 m-85 -83.58 168.61 16.22 Favored 'General case' 0 N--CA 1.45 -0.47 0 C-N-CA 125.897 1.679 . . . . 0.0 110.368 177.939 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -114.97 -36.26 4.5 Favored 'General case' 0 N--CA 1.465 0.321 0 C-N-CA 123.126 0.57 . . . . 0.0 111.281 178.595 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -140.58 139.09 35.57 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.361 0 C-N-CA 123.42 0.688 . . . . 0.0 109.621 -171.499 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 83.4 t -140.48 140.0 34.72 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.319 0 N-CA-C 106.381 -1.711 . . . . 0.0 106.381 -177.692 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 37.3 mm -131.41 127.86 60.44 Favored 'Isoleucine or valine' 0 C--O 1.237 0.441 0 N-CA-C 106.743 -1.577 . . . . 0.0 106.743 -174.921 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 13.6 m -86.59 130.83 34.34 Favored 'General case' 0 N--CA 1.441 -0.905 0 N-CA-C 106.647 -1.612 . . . . 0.0 106.647 168.927 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 85.0 mt -93.94 -7.25 43.53 Favored 'General case' 0 C--N 1.331 -0.226 0 C-N-CA 123.465 0.706 . . . . 0.0 109.726 169.751 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 18.0 p -161.58 158.67 26.65 Favored 'General case' 0 N--CA 1.444 -0.73 0 C-N-CA 124.881 1.272 . . . . 0.0 108.768 169.454 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 65.76 -161.39 43.4 Favored Glycine 0 CA--C 1.535 1.285 0 N-CA-C 115.178 0.831 . . . . 0.0 115.178 169.345 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 15.1 m -142.59 -161.2 1.2 Allowed 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 126.841 2.057 . . . . 0.0 107.626 -172.39 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -72.76 61.41 1.64 Allowed Glycine 0 CA--C 1.535 1.315 0 O-C-N 120.921 -1.112 . . . . 0.0 111.667 172.28 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 6.7 m -78.21 -55.86 9.03 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.508 0 C-N-CA 124.235 1.014 . . . . 0.0 110.82 -170.001 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 46.4 t30 -143.9 48.85 1.39 Allowed 'General case' 0 N--CA 1.467 0.383 0 N-CA-C 104.416 -2.438 . . . . 0.0 104.416 169.551 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 6.0 tt -144.15 119.33 6.09 Favored Pre-proline 0 CA--C 1.535 0.386 0 N-CA-C 104.75 -2.315 . . . . 0.0 104.75 -168.443 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 76.4 Cg_exo -60.13 138.07 79.35 Favored 'Trans proline' 0 C--N 1.349 0.579 0 C-N-CA 121.823 1.682 . . . . 0.0 112.316 -170.194 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 66.9 Cg_endo -68.85 -14.57 39.16 Favored 'Trans proline' 0 N--CA 1.459 -0.516 0 C-N-CA 122.0 1.8 . . . . 0.0 113.084 -174.776 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . 0.46 ' HG2' ' HB3' ' A' ' 70' ' ' ALA . 14.0 tt0 -58.08 -25.48 61.34 Favored 'General case' 0 N--CA 1.439 -1.019 0 C-N-CA 125.713 1.605 . . . . 0.0 110.887 171.565 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 99.7 m95 -78.87 -41.38 30.02 Favored 'General case' 0 N--CA 1.456 -0.134 0 C-N-CA 123.722 0.809 . . . . 0.0 111.804 173.035 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 2.0 m -79.46 0.02 3.47 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.638 0 C-N-CA 123.321 0.648 . . . . 0.0 112.326 -175.153 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . 0.254 1.4 t -133.11 34.98 3.53 Favored 'General case' 0 CA--C 1.546 0.797 0 O-C-N 121.519 -0.738 . . . . 0.0 112.565 -175.731 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 89.4 mm-40 -71.66 -178.66 2.3 Favored 'General case' 0 CA--C 1.543 0.703 0 O-C-N 121.208 -0.933 . . . . 0.0 110.052 169.199 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 31.1 mm-40 -57.22 -28.83 63.23 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 123.181 0.592 . . . . 0.0 111.923 -169.348 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 5.3 tt -136.72 138.63 46.06 Favored 'Isoleucine or valine' 0 C--O 1.239 0.519 0 N-CA-C 104.383 -2.451 . . . . 0.0 104.383 168.406 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 70.9 t80 -132.33 142.46 49.35 Favored 'General case' 0 N--CA 1.448 -0.564 0 N-CA-C 106.407 -1.701 . . . . 0.0 106.407 169.491 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 19.9 mm-40 -141.64 152.1 43.66 Favored 'General case' 0 C--O 1.237 0.397 0 N-CA-C 106.652 -1.61 . . . . 0.0 106.652 171.351 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -125.4 127.66 46.92 Favored 'General case' 0 C--O 1.239 0.5 0 N-CA-C 107.244 -1.391 . . . . 0.0 107.244 169.204 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 4.6 m95 -116.05 158.17 23.56 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 124.192 0.997 . . . . 0.0 110.452 -173.328 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 19.9 pt20 -122.06 39.56 3.85 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 124.553 1.141 . . . . 0.0 111.258 -177.054 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -64.36 133.08 51.91 Favored 'General case' 0 N--CA 1.466 0.359 0 N-CA-C 107.764 -1.199 . . . . 0.0 107.764 173.492 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 3.2 mp0 -64.59 152.09 42.95 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 123.943 0.897 . . . . 0.0 110.037 173.049 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -91.01 113.64 58.85 Favored Pre-proline 0 C--O 1.236 0.377 0 N-CA-C 105.603 -1.999 . . . . 0.0 105.603 168.349 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 104' ' ' PRO . . . . . 0.439 ' HG2' ' CE1' ' A' ' 112' ' ' PHE . 78.6 Cg_endo -76.25 -8.73 18.78 Favored 'Trans proline' 0 N--CA 1.453 -0.868 0 C-N-CA 121.804 1.669 . . . . 0.0 114.189 -172.819 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -66.79 -41.2 88.01 Favored 'General case' 0 C--O 1.235 0.299 0 CA-C-N 120.45 1.477 . . . . 0.0 113.293 -169.309 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -79.3 6.96 55.65 Favored Glycine 0 CA--C 1.533 1.179 0 CA-C-O 118.823 -0.987 . . . . 0.0 113.663 -176.082 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 24.3 pt20 -148.53 -165.59 2.32 Favored 'General case' 0 CA--C 1.54 0.582 0 CA-C-N 118.932 1.366 . . . . 0.0 111.141 -169.874 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 2.1 m -69.3 156.65 38.42 Favored 'General case' 0 CA--C 1.533 0.324 0 N-CA-C 116.164 1.912 . . . . 0.0 116.164 -168.365 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 35.0 tp -57.33 -30.34 64.71 Favored 'General case' 0 N--CA 1.465 0.305 0 C-N-CA 126.28 1.832 . . . . 0.0 112.475 173.544 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 40.4 tt0 -58.62 -34.92 71.71 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 123.601 0.76 . . . . 0.0 110.62 173.978 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 3.4 t -76.0 -38.23 35.2 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.378 0 CA-C-O 118.12 -0.943 . . . . 0.0 109.676 -178.939 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . 0.439 ' CE1' ' HG2' ' A' ' 104' ' ' PRO . 27.0 m-85 -57.03 -50.14 73.66 Favored 'General case' 0 N--CA 1.475 0.793 0 CA-C-N 120.733 1.606 . . . . 0.0 110.256 169.904 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 85.7 mtt180 -60.5 -39.54 88.07 Favored 'General case' 0 N--CA 1.468 0.457 0 C-N-CA 123.358 0.663 . . . . 0.0 110.849 -179.161 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 16.3 m -68.28 -50.58 52.73 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 124.657 1.183 . . . . 0.0 110.726 176.565 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 55.2 t -67.6 -33.87 64.69 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.197 0 CA-C-O 117.498 -1.239 . . . . 0.0 110.856 -169.423 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 31.1 mtm105 -57.54 -41.77 81.62 Favored 'General case' 0 CA--C 1.539 0.534 0 CA-C-N 120.335 1.425 . . . . 0.0 110.273 173.598 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -67.02 -50.34 47.27 Favored Glycine 0 CA--C 1.529 0.92 0 C-N-CA 123.926 0.774 . . . . 0.0 111.878 177.577 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 25.4 mt-30 -54.95 -47.59 74.3 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-N 117.752 0.776 . . . . 0.0 110.211 178.377 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 53.7 t -64.83 -48.79 82.96 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.432 0 CA-C-O 118.329 -0.843 . . . . 0.0 109.967 -177.101 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 62.6 tttm -55.96 -45.65 78.83 Favored 'General case' 0 CA--C 1.519 -0.22 0 CA-C-N 119.114 0.87 . . . . 0.0 109.107 -174.429 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -64.88 -43.93 91.31 Favored 'General case' 0 N--CA 1.443 -0.781 0 C-N-CA 123.019 0.528 . . . . 0.0 110.776 -177.12 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 57.8 mtt-85 -68.0 -42.94 79.95 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-N 118.639 0.654 . . . . 0.0 111.695 179.578 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 98.5 t -66.55 -44.11 90.29 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.374 0 N-CA-C 108.433 -0.951 . . . . 0.0 108.433 179.406 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 21.3 mt-10 -61.39 -42.73 99.19 Favored 'General case' 0 C--N 1.338 0.092 0 CA-C-N 119.892 1.224 . . . . 0.0 110.39 178.861 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 29.6 t-20 -62.22 -44.56 96.29 Favored 'General case' 0 C--O 1.225 -0.189 0 C-N-CA 122.861 0.464 . . . . 0.0 110.827 178.239 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 45.7 tp -60.1 -47.24 86.74 Favored 'General case' 0 N--CA 1.454 -0.246 0 C-N-CA 124.239 1.016 . . . . 0.0 111.052 177.5 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 79.7 mt -61.69 -45.83 97.83 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.256 0 N-CA-C 108.026 -1.101 . . . . 0.0 108.026 178.191 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -62.04 -29.3 70.19 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 123.262 0.625 . . . . 0.0 112.239 178.28 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 89.9 mttt -68.59 -56.55 7.89 Favored 'General case' 0 C--N 1.342 0.248 0 CA-C-N 119.16 0.891 . . . . 0.0 110.096 171.711 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 15.8 pt -73.93 -40.35 52.51 Favored 'Isoleucine or valine' 0 C--O 1.235 0.338 0 N-CA-C 114.213 1.19 . . . . 0.0 114.213 -169.308 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 75.0 m . . . . . 0 C--O 1.253 1.262 0 C-N-CA 126.144 1.777 . . . . 0.0 109.408 -169.74 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 9.7 ptm . . . . . 0 N--CA 1.497 1.913 0 N-CA-C 110.711 -0.107 . . . . 0.0 110.711 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . 0.417 ' HB2' HG22 ' A' ' 30' ' ' ILE . 18.1 mttm -76.06 124.0 26.7 Favored 'General case' 0 N--CA 1.481 1.095 0 N-CA-C 107.701 -1.222 . . . . 0.0 107.701 -172.499 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 87.1 mttt -92.64 135.01 34.46 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-N 119.689 1.131 . . . . 0.0 108.343 176.692 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 1.7 t -118.81 150.31 21.11 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 C-N-CA 126.852 2.061 . . . . 0.0 108.848 -169.161 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 6.2 mtt -139.41 148.15 42.4 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 125.617 1.567 . . . . 0.0 109.286 169.352 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 91.0 m-85 -132.78 105.75 7.34 Favored 'General case' 0 C--O 1.225 -0.193 0 N-CA-C 104.769 -2.308 . . . . 0.0 104.769 172.131 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 22.1 t -131.82 138.88 51.76 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.221 0 CA-C-O 121.898 0.856 . . . . 0.0 111.211 -168.745 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 37.9 t -154.41 156.08 36.17 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 127.47 2.308 . . . . 0.0 105.236 169.27 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 65.6 pttt -65.37 -21.74 66.72 Favored 'General case' 0 N--CA 1.472 0.64 0 N-CA-C 114.69 1.367 . . . . 0.0 114.69 -170.427 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 7.9 tpp180 -126.94 78.05 1.77 Allowed 'General case' 0 N--CA 1.47 0.54 0 CA-C-N 119.814 1.188 . . . . 0.0 110.058 -173.9 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 34.9 t30 -43.18 -48.33 6.44 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 125.159 1.384 . . . . 0.0 112.222 176.379 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -51.53 -32.14 26.76 Favored 'General case' 0 C--O 1.232 0.147 0 C-N-CA 126.617 1.967 . . . . 0.0 112.998 -175.66 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 8.8 m -125.01 17.52 8.5 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 123.795 0.838 . . . . 0.0 111.805 -173.198 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 10.2 tpt180 -151.81 -55.86 0.14 Allowed 'General case' 0 C--N 1.348 0.528 0 N-CA-C 115.727 1.751 . . . . 0.0 115.727 179.33 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 3.3 m -65.66 -55.01 19.78 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 119.61 1.095 . . . . 0.0 112.195 -168.509 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER 43.8 -111.12 0.19 Allowed 'General case' 0 N--CA 1.452 -0.368 0 C-N-CA 126.328 1.851 . . . . 0.0 111.453 169.106 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -78.53 -8.38 58.51 Favored 'General case' 0 C--O 1.224 -0.246 0 N-CA-C 114.29 1.218 . . . . 0.0 114.29 -170.629 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -62.78 -58.95 5.66 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-N 120.131 1.332 . . . . 0.0 111.138 -169.751 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -68.11 -32.1 72.16 Favored 'General case' 0 CA--C 1.541 0.597 0 O-C-N 121.722 -0.611 . . . . 0.0 109.542 175.627 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -48.63 -56.65 9.35 Favored Glycine 0 C--N 1.346 1.113 0 C-N-CA 125.38 1.467 . . . . 0.0 111.637 176.23 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 13.9 m-85 -74.54 -28.3 60.9 Favored 'General case' 0 CA--C 1.508 -0.663 0 CA-C-N 118.77 1.285 . . . . 0.0 112.928 179.322 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -66.25 -31.0 71.55 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 119.323 0.965 . . . . 0.0 111.554 -172.451 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 7.5 ptpt -63.5 -33.06 74.75 Favored 'General case' 0 N--CA 1.477 0.908 0 CA-C-N 119.432 1.015 . . . . 0.0 112.036 171.067 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 5.9 m -78.72 -55.17 5.38 Favored 'General case' 0 N--CA 1.446 -0.626 0 C-N-CA 125.187 1.395 . . . . 0.0 110.245 -175.202 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 79.3 mt -73.4 -34.32 65.45 Favored 'General case' 0 C--N 1.33 -0.248 0 C-N-CA 123.971 0.909 . . . . 0.0 110.339 -174.753 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -91.08 2.85 79.88 Favored Glycine 0 CA--C 1.527 0.822 0 CA-C-O 118.362 -1.243 . . . . 0.0 113.709 -176.494 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -49.92 123.0 7.31 Favored 'General case' 0 CA--C 1.533 0.31 0 CA-C-N 118.796 1.298 . . . . 0.0 110.904 -172.074 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 76.78 -14.11 7.73 Favored Glycine 0 CA--C 1.533 1.195 0 C-N-CA 124.676 1.132 . . . . 0.0 114.353 179.631 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 53.6 mttm -94.15 -46.41 7.12 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-N 119.212 1.506 . . . . 0.0 110.393 178.918 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.417 HG22 ' HB2' ' A' ' 2' ' ' LYS . 24.7 pt -142.15 152.39 18.41 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.427 0 C-N-CA 124.301 1.04 . . . . 0.0 109.95 -169.408 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -112.87 109.01 18.19 Favored 'General case' 0 N--CA 1.464 0.235 0 C-N-CA 125.035 1.334 . . . . 0.0 108.694 -174.036 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 11.1 p -86.27 139.16 17.79 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.401 0 CA-C-N 119.702 1.137 . . . . 0.0 109.867 177.71 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 3.9 m -144.55 107.7 4.55 Favored 'General case' 0 N--CA 1.445 -0.69 0 N-CA-C 104.77 -2.308 . . . . 0.0 104.77 172.191 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 66.2 m -105.63 75.47 1.14 Allowed 'General case' 0 C--N 1.329 -0.32 0 O-C-N 120.933 -1.105 . . . . 0.0 108.827 178.48 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 2.0 m -60.46 -45.55 93.29 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 125.388 1.475 . . . . 0.0 112.054 -169.891 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 89.65 161.73 37.74 Favored Glycine 0 C--N 1.335 0.508 0 CA-C-O 122.038 0.799 . . . . 0.0 112.159 170.905 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 5.6 mt -131.49 142.67 50.01 Favored 'General case' 0 N--CA 1.442 -0.845 0 C-N-CA 128.079 2.552 . . . . 0.0 104.548 174.533 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 33.2 mt-10 57.42 -89.77 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.385 0 N-CA-C 108.134 -1.061 . . . . 0.0 108.134 -169.516 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 69.3 m 64.52 169.63 0.18 Allowed 'General case' 0 N--CA 1.445 -0.721 0 C-N-CA 127.269 2.228 . . . . 0.0 115.615 169.184 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 59.9 m -157.47 177.29 11.59 Favored 'General case' 0 N--CA 1.446 -0.646 0 C-N-CA 128.269 2.627 . . . . 0.0 105.984 -168.847 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 14.4 ttt85 -82.12 -178.77 7.15 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 107.963 -1.125 . . . . 0.0 107.963 169.377 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 17.6 m -81.41 170.17 1.48 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.729 0 C-N-CA 123.789 0.836 . . . . 0.0 109.766 -178.675 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 74.0 t60 -73.0 139.22 79.59 Favored Pre-proline 0 CA--C 1.545 0.763 0 CA-C-O 118.163 -0.922 . . . . 0.0 108.631 172.207 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -58.35 -48.3 16.16 Favored 'Trans proline' 0 C--N 1.348 0.507 0 C-N-CA 123.093 2.529 . . . . 0.0 113.833 -174.193 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 25.2 m -65.58 -18.82 65.6 Favored 'General case' 0 CA--C 1.535 0.387 0 CA-C-N 118.258 0.481 . . . . 0.0 110.937 -179.294 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.404 ' HB1' HD11 ' A' ' 57' ' ' ILE . . . -60.28 -50.64 72.82 Favored 'General case' 0 CA--C 1.51 -0.562 0 O-C-N 121.458 -0.776 . . . . 0.0 108.996 175.018 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 72.5 mt -57.98 -41.57 80.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 N-CA-C 108.352 -0.981 . . . . 0.0 108.352 -173.112 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -63.56 -46.48 85.72 Favored 'General case' 0 N--CA 1.452 -0.352 0 CA-C-N 117.631 0.196 . . . . 0.0 110.856 -179.05 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 28.4 mmt -68.02 -36.38 79.85 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-O 122.439 1.114 . . . . 0.0 110.841 -179.819 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -74.6 -31.93 62.19 Favored 'General case' 0 N--CA 1.444 -0.753 0 N-CA-C 106.887 -1.523 . . . . 0.0 106.887 -175.698 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 40.8 tt0 -72.3 -21.89 61.28 Favored 'General case' 0 N--CA 1.446 -0.651 0 C-N-CA 124.311 1.045 . . . . 0.0 110.157 172.495 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 21.6 mm-40 -67.53 -30.63 70.34 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-N 119.272 0.942 . . . . 0.0 110.017 169.962 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . 0.291 5.5 p -89.86 8.74 3.21 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.993 0 CA-C-N 118.802 0.728 . . . . 0.0 111.467 168.839 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 77.29 21.75 72.36 Favored Glycine 0 CA--C 1.532 1.11 0 O-C-N 120.818 -1.176 . . . . 0.0 113.799 174.953 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 25.2 mt -118.71 144.71 26.17 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.239 0 C-N-CA 125.314 1.445 . . . . 0.0 110.005 -174.15 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 20.6 t70 -108.03 147.59 30.93 Favored 'General case' 0 C--O 1.234 0.282 0 N-CA-C 108.375 -0.972 . . . . 0.0 108.375 168.74 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.404 HD11 ' HB1' ' A' ' 46' ' ' ALA . 13.5 pt -132.29 -12.57 1.48 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.707 0 C-N-CA 125.895 1.678 . . . . 0.0 111.529 170.565 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 5.4 t -45.77 -46.73 15.42 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-N 120.333 1.424 . . . . 0.0 111.688 170.845 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -78.51 29.51 1.99 Allowed Glycine 0 CA--C 1.533 1.207 0 C-N-CA 124.966 1.269 . . . . 0.0 114.147 -177.621 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 1.7 tt0 -63.5 -37.37 87.04 Favored 'General case' 0 C--N 1.344 0.36 0 CA-C-N 119.728 1.764 . . . . 0.0 113.213 -175.046 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 12.4 t -81.22 161.36 24.01 Favored 'General case' 0 C--O 1.238 0.451 0 CA-C-O 122.047 0.927 . . . . 0.0 110.352 -169.534 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 4.2 m -168.34 -51.42 0.02 OUTLIER 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 125.919 1.687 . . . . 0.0 109.175 178.197 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -154.39 154.97 30.32 Favored Pre-proline 0 C--O 1.237 0.41 0 C-N-CA 124.988 1.315 . . . . 0.0 108.208 -179.672 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 98.9 Cg_endo -66.86 159.13 53.07 Favored 'Trans proline' 0 N--CA 1.457 -0.659 0 C-N-CA 123.111 2.541 . . . . 0.0 110.508 171.421 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 5.6 tt -60.11 -26.01 35.01 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.477 0 O-C-N 121.577 -0.702 . . . . 0.0 111.63 179.681 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 15.8 mt-10 -65.66 -25.46 67.36 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 124.555 1.142 . . . . 0.0 110.593 -175.121 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 4.4 t-20 -65.84 -20.96 66.43 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 124.666 1.186 . . . . 0.0 112.459 177.985 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 77.0 m-85 -106.42 -173.49 2.31 Favored 'General case' 0 C--O 1.236 0.356 0 C-N-CA 126.37 1.868 . . . . 0.0 110.1 -174.95 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 53.2 t-20 -135.78 139.71 43.72 Favored 'General case' 0 N--CA 1.448 -0.542 0 N-CA-C 107.857 -1.164 . . . . 0.0 107.857 169.123 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -72.44 -26.16 61.73 Favored 'General case' 0 N--CA 1.433 -1.31 0 N-CA-C 109.283 -0.636 . . . . 0.0 109.283 -178.102 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -65.56 -24.39 67.08 Favored 'General case' 0 N--CA 1.447 -0.596 0 O-C-N 123.639 0.587 . . . . 0.0 112.002 -179.652 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -78.42 -28.43 46.79 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 123.297 0.639 . . . . 0.0 111.635 174.848 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 11.4 m-85 -81.13 167.44 19.68 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 125.536 1.534 . . . . 0.0 111.151 179.877 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -116.86 -39.98 3.21 Favored 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 123.099 0.56 . . . . 0.0 111.243 -179.081 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -136.13 133.62 50.28 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.453 0 CA-C-O 121.841 0.829 . . . . 0.0 109.498 -172.43 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 70.5 t -142.01 130.0 21.32 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.585 0 N-CA-C 106.199 -1.778 . . . . 0.0 106.199 -177.83 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 38.0 mm -118.9 125.42 74.46 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.575 0 N-CA-C 106.387 -1.708 . . . . 0.0 106.387 -173.233 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 56.0 m -84.0 145.06 28.72 Favored 'General case' 0 N--CA 1.446 -0.655 0 N-CA-C 106.061 -1.829 . . . . 0.0 106.061 168.601 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 93.1 mt -111.61 5.35 19.3 Favored 'General case' 0 C--N 1.328 -0.344 0 O-C-N 121.637 -0.664 . . . . 0.0 110.785 171.74 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 10.8 p -155.47 147.25 23.22 Favored 'General case' 0 N--CA 1.447 -0.584 0 C-N-CA 124.537 1.135 . . . . 0.0 108.566 168.898 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 53.4 -156.56 5.5 Favored Glycine 0 CA--C 1.537 1.426 0 C-N-CA 125.204 1.383 . . . . 0.0 115.22 169.604 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 48.0 m -145.83 127.12 14.85 Favored 'General case' 0 CA--C 1.532 0.271 0 N-CA-C 105.902 -1.888 . . . . 0.0 105.902 174.913 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 58.59 44.43 95.55 Favored Glycine 0 CA--C 1.53 1.013 0 N-CA-C 109.711 -1.356 . . . . 0.0 109.711 -171.378 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . 0.279 4.0 p -75.37 64.46 0.16 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.842 0 C-N-CA 125.916 1.686 . . . . 0.0 112.213 -168.834 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 56.5 t30 56.84 52.89 8.81 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 125.874 1.67 . . . . 0.0 107.83 -169.569 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -143.83 138.59 15.29 Favored Pre-proline 0 CA--C 1.538 0.489 0 C-N-CA 126.102 1.761 . . . . 0.0 108.743 -168.748 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 33.2 Cg_exo -64.93 139.47 62.05 Favored 'Trans proline' 0 CA--C 1.54 0.81 0 C-N-CA 122.221 1.947 . . . . 0.0 111.576 176.463 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -66.21 -24.9 50.72 Favored 'Trans proline' 0 N--CA 1.457 -0.657 0 C-N-CA 122.585 2.19 . . . . 0.0 114.476 -169.649 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 5.0 pm0 -61.46 -18.08 57.36 Favored 'General case' 0 CA--C 1.537 0.453 0 CA-C-N 121.251 1.841 . . . . 0.0 111.898 178.413 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 99.4 m95 -77.91 -38.84 44.71 Favored 'General case' 0 N--CA 1.451 -0.393 0 O-C-N 121.702 -0.624 . . . . 0.0 111.396 174.093 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -79.33 -5.12 7.72 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.456 0 O-C-N 121.869 -0.519 . . . . 0.0 111.672 -177.827 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 81.5 p -114.39 18.42 16.9 Favored 'General case' 0 C--O 1.238 0.453 0 N-CA-C 114.411 1.264 . . . . 0.0 114.411 -175.633 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 91.6 mm-40 -68.18 173.99 4.27 Favored 'General case' 0 CA--C 1.541 0.628 0 CA-C-N 119.025 0.83 . . . . 0.0 111.858 179.324 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 28.7 mm-40 -53.22 -31.57 43.79 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 124.362 1.065 . . . . 0.0 112.735 -169.0 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 4.8 tt -131.35 124.83 55.77 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.51 0 N-CA-C 104.305 -2.48 . . . . 0.0 104.305 168.39 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 4.1 t80 -113.55 133.39 55.28 Favored 'General case' 0 C--O 1.237 0.444 0 N-CA-C 104.722 -2.325 . . . . 0.0 104.722 169.186 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 14.4 mm-40 -137.66 152.07 48.93 Favored 'General case' 0 C--O 1.238 0.495 0 N-CA-C 106.57 -1.641 . . . . 0.0 106.57 169.723 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -130.94 134.82 47.1 Favored 'General case' 0 C--O 1.237 0.419 0 N-CA-C 107.411 -1.329 . . . . 0.0 107.411 169.263 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 6.6 m95 -121.08 138.95 53.94 Favored 'General case' 0 C--O 1.234 0.25 0 C-N-CA 123.059 0.543 . . . . 0.0 109.767 -174.82 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 4.8 tp-100 -82.72 63.33 6.79 Favored 'General case' 0 CA--C 1.535 0.395 0 N-CA-C 107.361 -1.348 . . . . 0.0 107.361 169.907 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 1.6 tp -67.38 127.53 33.03 Favored 'General case' 0 C--N 1.34 0.165 0 N-CA-C 108.955 -0.757 . . . . 0.0 108.955 -173.352 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -76.89 159.05 30.33 Favored 'General case' 0 N--CA 1.449 -0.508 0 N-CA-C 107.045 -1.465 . . . . 0.0 107.045 169.572 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 20.0 t70 -149.07 137.65 11.96 Favored Pre-proline 0 CA--C 1.536 0.419 0 CA-C-O 118.596 -0.716 . . . . 0.0 111.209 -171.584 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 20.8 Cg_endo -91.7 9.53 2.82 Favored 'Trans proline' 0 CA--C 1.548 1.217 0 C-N-CA 123.424 2.749 . . . . 0.0 114.808 -172.193 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -53.27 128.44 28.16 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-N 120.596 1.544 . . . . 0.0 111.361 177.811 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 64.0 25.16 69.18 Favored Glycine 0 CA--C 1.532 1.126 0 CA-C-O 118.741 -1.033 . . . . 0.0 115.458 169.223 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 6.9 pt20 -142.1 -168.48 2.71 Favored 'General case' 0 CA--C 1.536 0.434 0 CA-C-N 118.891 1.345 . . . . 0.0 111.343 -177.911 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 2.6 m -68.51 156.0 38.84 Favored 'General case' 0 CA--C 1.532 0.274 0 N-CA-C 116.149 1.907 . . . . 0.0 116.149 -168.401 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 42.9 tp -54.97 -33.68 62.63 Favored 'General case' 0 N--CA 1.465 0.307 0 C-N-CA 126.997 2.119 . . . . 0.0 111.785 175.211 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 40.8 tt0 -58.49 -35.43 72.2 Favored 'General case' 0 CA--C 1.529 0.172 0 C-N-CA 123.806 0.843 . . . . 0.0 110.702 176.399 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 4.2 t -74.98 -40.47 45.39 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.291 0 CA-C-O 118.434 -0.793 . . . . 0.0 109.652 -177.216 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 89.9 m-85 -57.12 -49.64 75.29 Favored 'General case' 0 N--CA 1.471 0.621 0 CA-C-N 119.927 1.24 . . . . 0.0 109.568 171.837 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 89.4 mtt180 -61.61 -40.0 93.27 Favored 'General case' 0 N--CA 1.467 0.385 0 C-N-CA 122.871 0.468 . . . . 0.0 110.993 -178.592 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 7.6 m -66.32 -56.27 11.96 Favored 'General case' 0 N--CA 1.447 -0.608 0 C-N-CA 124.507 1.123 . . . . 0.0 109.514 177.996 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 83.8 t -68.33 -34.06 63.92 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.343 0 CA-C-O 118.683 -0.675 . . . . 0.0 110.057 -169.643 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 47.1 ttp85 -57.82 -43.23 85.59 Favored 'General case' 0 CA--C 1.538 0.489 0 CA-C-N 119.275 0.943 . . . . 0.0 109.883 173.173 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -64.54 -53.4 35.62 Favored Glycine 0 CA--C 1.53 0.987 0 CA-C-N 118.318 0.508 . . . . 0.0 111.842 175.273 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 12.6 mt-30 -61.01 -43.34 99.03 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-N 117.884 0.842 . . . . 0.0 110.837 -174.859 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 76.8 t -70.5 -38.85 75.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 118.085 -0.959 . . . . 0.0 109.966 -174.951 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 84.0 tttt -54.73 -46.81 74.29 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 119.279 0.945 . . . . 0.0 108.673 175.789 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -65.98 -42.51 89.75 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 122.933 0.493 . . . . 0.0 111.398 -176.604 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 43.6 mtt-85 -61.49 -46.62 89.22 Favored 'General case' 0 N--CA 1.472 0.635 0 O-C-N 121.336 -0.852 . . . . 0.0 111.514 176.524 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 98.4 t -65.28 -39.87 86.77 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.637 0 N-CA-C 109.08 -0.711 . . . . 0.0 109.08 179.354 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 29.7 mt-10 -59.42 -44.48 92.87 Favored 'General case' 0 N--CA 1.462 0.172 0 CA-C-N 119.789 1.177 . . . . 0.0 110.787 176.667 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 46.7 t30 -62.98 -45.2 93.54 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 123.329 0.652 . . . . 0.0 110.551 -177.649 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 22.0 tp -58.0 -47.91 81.61 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 124.112 0.965 . . . . 0.0 111.006 175.382 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 81.0 mt -63.09 -46.09 96.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 N-CA-C 108.329 -0.989 . . . . 0.0 108.329 179.664 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -59.91 -27.83 67.08 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 123.25 0.62 . . . . 0.0 112.214 177.901 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 90.5 mttt -69.72 -56.99 5.69 Favored 'General case' 0 C--N 1.343 0.284 0 CA-C-N 119.322 0.964 . . . . 0.0 110.184 171.706 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 18.2 pt -75.71 -38.44 37.66 Favored 'Isoleucine or valine' 0 C--O 1.235 0.326 0 N-CA-C 114.645 1.35 . . . . 0.0 114.645 -169.283 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 73.7 m . . . . . 0 C--O 1.252 1.237 0 C-N-CA 126.199 1.799 . . . . 0.0 109.128 -169.805 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 6.3 ptm . . . . . 0 N--CA 1.497 1.878 0 N-CA-C 110.807 -0.071 . . . . 0.0 110.807 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . 0.457 ' HB2' HG22 ' A' ' 30' ' ' ILE . 10.6 mtmm -71.69 130.14 40.41 Favored 'General case' 0 N--CA 1.476 0.874 0 N-CA-C 107.507 -1.294 . . . . 0.0 107.507 -178.936 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 66.7 mttt -103.74 138.32 40.53 Favored 'General case' 0 CA--C 1.511 -0.526 0 N-CA-C 107.912 -1.144 . . . . 0.0 107.912 171.046 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.419 HG21 HD12 ' A' ' 30' ' ' ILE . 4.0 t -116.25 152.84 17.93 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.787 0 C-N-CA 126.522 1.929 . . . . 0.0 108.169 -169.878 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 5.1 mtt -135.78 148.17 48.66 Favored 'General case' 0 C--N 1.323 -0.562 0 C-N-CA 126.512 1.925 . . . . 0.0 107.951 168.88 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -135.19 109.22 8.2 Favored 'General case' 0 CA--C 1.512 -0.51 0 N-CA-C 104.161 -2.533 . . . . 0.0 104.161 175.909 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 72.4 t -132.73 149.52 32.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-O 121.378 0.608 . . . . 0.0 110.0 -168.454 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 32.7 t -135.85 -174.43 3.66 Favored 'General case' 0 CA--C 1.548 0.866 0 C-N-CA 128.134 2.573 . . . . 0.0 105.952 172.814 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 64.3 tttp -54.45 -39.93 67.88 Favored 'General case' 0 N--CA 1.479 1.008 0 O-C-N 121.26 -0.9 . . . . 0.0 111.505 177.777 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 33.3 mtp85 -132.3 158.35 42.1 Favored 'General case' 0 N--CA 1.468 0.47 0 C-N-CA 124.644 1.177 . . . . 0.0 108.449 174.6 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -63.27 -24.97 68.1 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 122.948 0.499 . . . . 0.0 112.093 170.212 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -48.93 -44.46 40.51 Favored 'General case' 0 CA--C 1.53 0.197 0 C-N-CA 126.105 1.762 . . . . 0.0 113.627 -169.31 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 13.5 m -120.03 144.36 47.59 Favored 'General case' 0 N--CA 1.454 -0.27 0 C-N-CA 123.111 0.564 . . . . 0.0 109.733 -169.386 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . 0.37 0.0 OUTLIER 56.32 -40.68 0.03 OUTLIER 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 130.3 3.44 . . . . 0.0 115.061 -178.746 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 2.0 m -61.8 -24.19 66.7 Favored 'General case' 0 CA--C 1.539 0.524 0 O-C-N 120.358 -1.464 . . . . 0.0 109.663 169.293 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . 0.432 ' O ' HD13 ' A' ' 57' ' ' ILE . 22.0 pt20 -67.18 10.81 0.13 Allowed 'General case' 0 CA--C 1.546 0.823 0 C-N-CA 125.638 1.575 . . . . 0.0 113.401 169.414 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -139.18 -51.64 0.54 Allowed 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 125.158 1.383 . . . . 0.0 111.577 173.599 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -57.8 -47.43 82.6 Favored 'General case' 0 N--CA 1.472 0.669 0 N-CA-C 114.934 1.457 . . . . 0.0 114.934 -169.003 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 1.9 pp20? -63.5 -30.61 71.71 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-N 117.981 0.355 . . . . 0.0 110.109 178.36 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -51.81 -67.32 2.07 Favored Glycine 0 C--N 1.34 0.805 0 C-N-CA 126.399 1.952 . . . . 0.0 110.885 173.376 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 12.8 m-85 -62.53 -31.01 71.71 Favored 'General case' 0 N--CA 1.469 0.514 0 CA-C-N 118.25 1.025 . . . . 0.0 113.294 179.67 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -67.36 -35.79 80.07 Favored 'General case' 0 N--CA 1.45 -0.454 0 CA-C-N 119.07 0.85 . . . . 0.0 111.549 -176.226 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -67.35 -27.28 67.0 Favored 'General case' 0 CA--C 1.541 0.624 0 CA-C-N 119.426 1.012 . . . . 0.0 111.431 174.201 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 2.8 m -77.2 -56.17 4.8 Favored 'General case' 0 N--CA 1.451 -0.397 0 C-N-CA 125.443 1.497 . . . . 0.0 110.571 -178.601 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 54.9 mt -75.54 -38.35 59.37 Favored 'General case' 0 C--N 1.33 -0.245 0 C-N-CA 124.098 0.959 . . . . 0.0 109.497 -174.484 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -82.24 3.78 79.68 Favored Glycine 0 CA--C 1.524 0.628 0 C-N-CA 125.154 1.359 . . . . 0.0 113.447 -179.65 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -54.39 127.28 26.73 Favored 'General case' 0 CA--C 1.531 0.219 0 CA-C-N 118.881 1.34 . . . . 0.0 109.691 -177.328 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 73.38 5.41 67.18 Favored Glycine 0 CA--C 1.533 1.168 0 CA-C-O 118.775 -1.014 . . . . 0.0 114.273 -178.8 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 46.3 mttp -121.22 -51.32 2.1 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-N 119.104 1.452 . . . . 0.0 110.943 -176.508 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.457 HG22 ' HB2' ' A' ' 2' ' ' LYS . 19.2 pt -139.71 148.12 23.39 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.453 0 C-N-CA 123.88 0.872 . . . . 0.0 109.567 -169.495 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -94.67 158.75 15.38 Favored 'General case' 0 C--O 1.224 -0.266 0 C-N-CA 124.851 1.26 . . . . 0.0 108.522 178.06 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 21.7 t -140.54 130.71 28.07 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 N-CA-C 107.172 -1.418 . . . . 0.0 107.172 -176.474 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 24.4 m -141.0 109.77 6.04 Favored 'General case' 0 N--CA 1.446 -0.645 0 N-CA-C 105.122 -2.177 . . . . 0.0 105.122 172.684 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 69.3 m -110.81 85.0 2.03 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.869 0.842 . . . . 0.0 110.079 -177.439 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 4.8 m -72.48 -170.09 0.61 Allowed 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 126.651 1.98 . . . . 0.0 110.748 176.749 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -165.74 -168.2 27.53 Favored Glycine 0 C--N 1.337 0.604 0 N-CA-C 108.01 -2.036 . . . . 0.0 108.01 177.949 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 16.9 mt -127.25 -8.41 5.86 Favored 'General case' 0 C--N 1.332 -0.177 0 C-N-CA 124.657 1.183 . . . . 0.0 112.773 -171.946 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 20.9 mt-10 -142.52 -71.53 0.32 Allowed 'General case' 0 CA--C 1.535 0.366 0 N-CA-C 107.427 -1.323 . . . . 0.0 107.427 -178.023 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . 0.25 53.8 m 63.17 158.58 0.07 Allowed 'General case' 0 N--CA 1.465 0.296 0 C-N-CA 127.259 2.223 . . . . 0.0 116.586 169.675 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 69.6 m -152.74 1.62 0.3 Allowed 'General case' 0 CA--C 1.538 0.484 0 N-CA-C 115.747 1.758 . . . . 0.0 115.747 -167.532 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 1.5 ttt180 66.51 168.51 0.23 Allowed 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 125.251 1.42 . . . . 0.0 109.802 -167.439 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 5.1 m -83.79 172.33 1.07 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.315 0 C-N-CA 123.528 0.731 . . . . 0.0 110.978 -169.19 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 91.1 m-70 -88.65 150.55 46.36 Favored Pre-proline 0 CA--C 1.537 0.443 0 C-N-CA 123.188 0.595 . . . . 0.0 109.949 178.133 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 39.5 Cg_endo -63.72 -46.44 8.95 Favored 'Trans proline' 0 C--N 1.347 0.485 0 C-N-CA 122.855 2.37 . . . . 0.0 112.341 -170.338 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 6.0 m -66.17 -25.94 67.19 Favored 'General case' 0 CA--C 1.531 0.242 0 CA-C-O 119.016 -0.516 . . . . 0.0 110.256 -179.112 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -58.69 -54.12 50.61 Favored 'General case' 0 CA--C 1.51 -0.581 0 CA-C-N 119.086 0.857 . . . . 0.0 109.109 176.27 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 38.1 mt -59.7 -42.8 89.78 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.427 0 N-CA-C 108.193 -1.04 . . . . 0.0 108.193 -174.654 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -59.23 -44.86 92.31 Favored 'General case' 0 CA--C 1.532 0.269 0 CA-C-N 118.421 0.555 . . . . 0.0 110.623 -178.775 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 26.4 mmt -70.9 -37.58 72.98 Favored 'General case' 0 C--O 1.239 0.503 0 CA-C-O 122.158 0.98 . . . . 0.0 111.128 -179.161 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -69.91 -32.96 71.54 Favored 'General case' 0 N--CA 1.443 -0.778 0 N-CA-C 106.649 -1.612 . . . . 0.0 106.649 179.781 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 18.6 mm-40 -73.29 -16.59 61.38 Favored 'General case' 0 N--CA 1.444 -0.752 0 O-C-N 120.79 -1.194 . . . . 0.0 111.278 171.757 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 22.6 mm-40 -66.28 -35.1 79.53 Favored 'General case' 0 C--N 1.341 0.221 0 CA-C-N 119.847 1.203 . . . . 0.0 109.095 169.552 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 16.8 m -90.07 11.59 2.09 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.766 0 N-CA-C 112.2 0.445 . . . . 0.0 112.2 169.311 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 73.21 23.52 77.36 Favored Glycine 0 CA--C 1.534 1.234 0 C-N-CA 124.487 1.042 . . . . 0.0 113.345 174.67 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 8.6 mt -107.83 135.53 46.19 Favored 'Isoleucine or valine' 0 C--O 1.232 0.152 0 C-N-CA 125.419 1.488 . . . . 0.0 110.197 -174.994 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -95.57 140.01 31.02 Favored 'General case' 0 C--O 1.236 0.365 0 C-N-CA 123.508 0.723 . . . . 0.0 109.514 169.791 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.494 HG13 ' H ' ' A' ' 58' ' ' SER . 3.6 pt -119.72 -66.94 1.2 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.607 0 C-N-CA 124.773 1.229 . . . . 0.0 108.393 171.043 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . 0.494 ' H ' HG13 ' A' ' 57' ' ' ILE . 95.2 p 30.59 -98.54 0.01 OUTLIER 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 128.961 2.905 . . . . 0.0 114.225 174.897 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -76.35 53.96 3.16 Favored Glycine 0 CA--C 1.528 0.876 0 C-N-CA 127.273 2.368 . . . . 0.0 112.703 -175.773 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 5.6 mt-30 -65.44 -29.9 70.63 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 123.203 0.601 . . . . 0.0 110.297 169.744 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -60.28 128.19 35.52 Favored 'General case' 0 N--CA 1.446 -0.639 0 C-N-CA 126.037 1.735 . . . . 0.0 109.19 -169.795 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 75.5 m -147.63 -169.94 3.44 Favored 'General case' 0 N--CA 1.447 -0.587 0 C-N-CA 126.332 1.853 . . . . 0.0 106.605 -169.635 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -57.38 154.59 22.24 Favored Pre-proline 0 C--O 1.241 0.613 0 O-C-N 121.854 -0.529 . . . . 0.0 109.903 169.355 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 64.4 Cg_endo -61.2 152.61 70.77 Favored 'Trans proline' 0 N--CA 1.456 -0.691 0 C-N-CA 121.918 1.745 . . . . 0.0 109.488 171.613 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 7.9 tt -60.09 -26.53 36.48 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.497 0 O-C-N 121.794 -0.566 . . . . 0.0 111.015 -176.682 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 25.4 tt0 -67.52 -26.33 66.28 Favored 'General case' 0 N--CA 1.435 -1.215 0 C-N-CA 125.398 1.479 . . . . 0.0 110.65 -176.625 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 11.3 t-20 -64.72 -31.16 72.26 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 124.416 1.087 . . . . 0.0 111.731 176.945 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 79.4 m-85 -86.58 168.13 13.94 Favored 'General case' 0 C--O 1.237 0.429 0 C-N-CA 124.946 1.298 . . . . 0.0 111.612 -174.695 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 46.4 t-20 -106.26 132.05 52.77 Favored 'General case' 0 N--CA 1.444 -0.738 0 N-CA-C 107.298 -1.371 . . . . 0.0 107.298 168.676 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -73.6 -24.69 60.08 Favored 'General case' 0 N--CA 1.437 -1.092 0 N-CA-C 109.339 -0.615 . . . . 0.0 109.339 -178.77 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 36.1 t70 -65.85 -21.76 66.49 Favored 'General case' 0 N--CA 1.447 -0.595 0 O-C-N 123.477 0.486 . . . . 0.0 112.096 -179.617 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -73.29 -29.31 62.63 Favored 'General case' 0 C--N 1.344 0.367 0 CA-C-O 121.222 0.534 . . . . 0.0 111.795 176.164 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 32.7 m-85 -84.25 165.84 18.0 Favored 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 125.744 1.618 . . . . 0.0 110.166 179.703 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 20.4 t70 -113.13 -35.84 5.25 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.72 176.903 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -142.24 135.94 28.5 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.826 0 CA-C-O 121.792 0.806 . . . . 0.0 110.496 -169.305 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 73.3 t -142.16 131.07 22.32 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.729 0 N-CA-C 106.178 -1.786 . . . . 0.0 106.178 -174.097 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 41.4 mm -117.93 125.5 74.23 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.443 0 N-CA-C 106.387 -1.709 . . . . 0.0 106.387 -171.712 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 41.3 m -95.19 108.69 20.83 Favored 'General case' 0 N--CA 1.447 -0.597 0 N-CA-C 106.675 -1.602 . . . . 0.0 106.675 169.889 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 90.0 mt -74.63 -13.37 60.63 Favored 'General case' 0 N--CA 1.464 0.254 0 C-N-CA 123.175 0.59 . . . . 0.0 111.661 -178.943 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 45.4 m -142.19 89.89 2.21 Favored 'General case' 0 N--CA 1.452 -0.367 0 C-N-CA 124.981 1.312 . . . . 0.0 109.073 -169.824 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 64.33 -154.7 47.51 Favored Glycine 0 CA--C 1.534 1.221 0 N-CA-C 111.585 -0.606 . . . . 0.0 111.585 178.418 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 2.9 p -161.77 152.81 18.11 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 124.587 1.155 . . . . 0.0 109.651 179.365 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 61.43 31.0 75.85 Favored Glycine 0 CA--C 1.531 1.069 0 N-CA-C 111.619 -0.592 . . . . 0.0 111.619 -178.534 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 28.5 m -70.69 -38.76 74.34 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.543 0 C-N-CA 123.087 0.555 . . . . 0.0 112.118 -169.366 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 21.4 t-20 179.66 -40.86 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 127.795 2.438 . . . . 0.0 107.573 176.712 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 3.6 tt -37.59 137.93 0.64 Allowed Pre-proline 0 CA--C 1.548 0.878 0 C-N-CA 128.788 2.835 . . . . 0.0 112.562 170.963 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . 0.439 ' HA ' ' HD3' ' A' ' 88' ' ' PRO . 53.2 Cg_exo -65.32 148.83 88.7 Favored 'Trans proline' 0 C--N 1.355 0.886 0 C-N-CA 121.734 1.623 . . . . 0.0 115.635 -169.399 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . 0.439 ' HD3' ' HA ' ' A' ' 87' ' ' PRO . 50.6 Cg_exo -64.04 -33.44 62.26 Favored 'Trans proline' 0 C--N 1.351 0.672 0 C-N-CA 122.394 2.062 . . . . 0.0 115.788 -170.981 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 5.1 pm0 -61.45 -14.41 28.34 Favored 'General case' 0 CA--C 1.538 0.49 0 CA-C-N 120.27 1.395 . . . . 0.0 112.46 -175.876 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 98.0 m95 -79.67 -45.94 18.08 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 124.008 0.923 . . . . 0.0 110.904 176.711 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 16.1 m -80.18 -1.32 4.58 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.366 0 C-N-CA 123.955 0.902 . . . . 0.0 112.25 179.975 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 74.9 p -109.62 18.76 19.94 Favored 'General case' 0 C--O 1.238 0.454 0 CA-C-N 119.672 1.124 . . . . 0.0 113.655 175.544 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 88.0 mm-40 -66.66 172.24 4.41 Favored 'General case' 0 CA--C 1.542 0.635 0 CA-C-N 118.842 0.746 . . . . 0.0 111.783 177.0 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 31.7 mm-40 -54.85 -31.97 60.14 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 123.869 0.868 . . . . 0.0 112.272 -169.033 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 1.9 tt -129.0 126.32 64.37 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.543 0 N-CA-C 103.817 -2.66 . . . . 0.0 103.817 168.412 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 7.3 t80 -110.47 139.04 46.08 Favored 'General case' 0 N--CA 1.448 -0.549 0 N-CA-C 105.955 -1.869 . . . . 0.0 105.955 170.104 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 12.8 mm-40 -134.8 145.09 48.03 Favored 'General case' 0 C--O 1.237 0.435 0 N-CA-C 107.137 -1.431 . . . . 0.0 107.137 169.774 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -129.11 125.78 37.9 Favored 'General case' 0 C--O 1.239 0.515 0 C-N-CA 126.375 1.87 . . . . 0.0 106.235 178.117 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 34.6 m95 -135.43 179.31 6.41 Favored 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 124.585 1.154 . . . . 0.0 108.865 179.987 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 6.4 tp-100 -141.24 72.22 1.38 Allowed 'General case' 0 CA--C 1.535 0.376 0 N-CA-C 106.274 -1.75 . . . . 0.0 106.274 169.643 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -67.03 146.01 54.78 Favored 'General case' 0 N--CA 1.469 0.488 0 N-CA-C 108.448 -0.945 . . . . 0.0 108.448 178.506 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 34.4 mt-10 -78.66 169.68 17.85 Favored 'General case' 0 C--N 1.328 -0.369 0 C-N-CA 123.975 0.91 . . . . 0.0 109.318 170.891 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -141.35 138.59 17.76 Favored Pre-proline 0 CA--C 1.539 0.549 0 C-N-CA 124.331 1.052 . . . . 0.0 110.27 179.27 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_endo -85.47 0.58 8.57 Favored 'Trans proline' 0 CA--C 1.543 0.927 0 C-N-CA 123.248 2.632 . . . . 0.0 115.771 -174.063 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 7.1 t70 -53.66 124.0 13.86 Favored 'General case' 0 C--O 1.237 0.416 0 CA-C-N 121.077 1.762 . . . . 0.0 110.849 -179.063 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 72.33 4.71 61.02 Favored Glycine 0 CA--C 1.533 1.168 0 CA-C-O 118.961 -0.911 . . . . 0.0 113.749 178.188 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 7.1 mt-30 -103.0 167.25 9.96 Favored 'General case' 0 CA--C 1.539 0.557 0 CA-C-N 118.658 1.229 . . . . 0.0 110.014 178.594 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 16.4 m -71.91 167.38 20.18 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 124.09 0.956 . . . . 0.0 111.636 -178.928 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 73.8 mt -59.62 -26.51 65.54 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 124.379 1.072 . . . . 0.0 112.402 -176.454 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 5.9 pt-20 -56.25 -34.93 66.84 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-N 118.738 0.699 . . . . 0.0 111.11 174.184 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 14.0 t -77.93 -42.51 28.31 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.316 0 CA-C-O 118.664 -0.684 . . . . 0.0 109.913 -177.238 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 68.3 m-85 -56.84 -43.5 81.19 Favored 'General case' 0 N--CA 1.474 0.77 0 CA-C-N 119.639 1.109 . . . . 0.0 109.569 171.07 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 94.1 mtt180 -66.25 -42.33 88.7 Favored 'General case' 0 N--CA 1.472 0.655 0 O-C-N 121.305 -0.872 . . . . 0.0 110.804 179.485 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 4.1 m -65.75 -49.72 67.36 Favored 'General case' 0 N--CA 1.45 -0.427 0 C-N-CA 124.606 1.162 . . . . 0.0 110.312 179.394 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 77.2 t -70.43 -30.58 43.46 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.202 0 CA-C-O 117.807 -1.092 . . . . 0.0 110.587 -169.501 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 74.5 mtm-85 -59.09 -45.36 91.05 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 120.192 1.36 . . . . 0.0 109.799 170.508 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -62.16 -51.68 55.05 Favored Glycine 0 CA--C 1.528 0.88 0 CA-C-N 118.946 0.794 . . . . 0.0 112.1 178.093 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 15.7 mt-30 -58.94 -45.4 90.53 Favored 'General case' 0 N--CA 1.469 0.475 0 CA-C-N 117.936 0.868 . . . . 0.0 110.779 -178.852 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 55.3 t -67.04 -47.22 82.72 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.344 0 N-CA-C 109.202 -0.666 . . . . 0.0 109.202 -177.987 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 84.3 tttt -55.52 -45.67 77.11 Favored 'General case' 0 C--O 1.224 -0.262 0 N-CA-C 109.185 -0.672 . . . . 0.0 109.185 -176.635 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 10.1 tp10 -62.83 -44.2 96.79 Favored 'General case' 0 N--CA 1.45 -0.427 0 C-N-CA 123.145 0.578 . . . . 0.0 110.757 -176.268 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 48.6 mtt-85 -68.51 -42.97 77.81 Favored 'General case' 0 N--CA 1.468 0.443 0 O-C-N 121.32 -0.863 . . . . 0.0 111.025 178.987 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 95.4 t -64.17 -38.98 83.87 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.513 0 CA-C-O 119.138 -0.458 . . . . 0.0 109.884 178.305 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 27.8 mt-10 -61.72 -44.85 96.13 Favored 'General case' 0 C--O 1.227 -0.128 0 CA-C-N 119.993 1.27 . . . . 0.0 110.177 176.014 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 28.3 t-20 -63.02 -42.12 99.71 Favored 'General case' 0 CA--C 1.53 0.208 0 C-N-CA 122.915 0.486 . . . . 0.0 111.049 -177.801 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 28.7 tp -58.04 -49.63 76.21 Favored 'General case' 0 N--CA 1.451 -0.399 0 C-N-CA 125.203 1.401 . . . . 0.0 110.742 174.17 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 81.6 mt -66.41 -43.99 90.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 N-CA-C 108.146 -1.057 . . . . 0.0 108.146 -177.057 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -59.23 -32.92 70.41 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 123.198 0.599 . . . . 0.0 112.098 -179.486 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 18.6 ptpt -80.87 -37.79 29.25 Favored 'General case' 0 C--N 1.344 0.351 0 CA-C-O 117.929 -1.034 . . . . 0.0 112.32 177.344 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 13.1 pt -84.85 -34.38 9.05 Favored 'Isoleucine or valine' 0 C--O 1.236 0.356 0 CA-C-N 119.962 1.255 . . . . 0.0 114.045 -175.184 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 74.3 m . . . . . 0 C--O 1.252 1.195 0 C-N-CA 125.372 1.469 . . . . 0.0 109.462 -169.837 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.4 ptt? . . . . . 0 N--CA 1.496 1.854 0 N-CA-C 111.776 0.287 . . . . 0.0 111.776 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . 0.426 ' HB2' HG22 ' A' ' 30' ' ' ILE . 11.0 mtmm -59.91 128.4 36.71 Favored 'General case' 0 N--CA 1.475 0.8 0 N-CA-C 107.816 -1.179 . . . . 0.0 107.816 -178.872 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 66.0 mttt -103.14 136.12 43.52 Favored 'General case' 0 CA--C 1.513 -0.465 0 N-CA-C 107.745 -1.205 . . . . 0.0 107.745 171.528 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.44 HG21 HD12 ' A' ' 30' ' ' ILE . 3.7 t -113.73 152.73 15.38 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.622 0 C-N-CA 126.144 1.777 . . . . 0.0 107.111 -171.479 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 2.7 mtt -137.14 145.08 43.37 Favored 'General case' 0 C--N 1.323 -0.55 0 C-N-CA 126.433 1.893 . . . . 0.0 108.341 169.525 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 60.0 m-85 -128.6 89.01 2.82 Favored 'General case' 0 CA--C 1.528 0.109 0 N-CA-C 105.234 -2.136 . . . . 0.0 105.234 170.769 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 44.0 t -128.57 108.62 17.73 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.217 0 CA-C-O 121.409 0.623 . . . . 0.0 111.72 -168.741 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 33.9 t -101.64 164.57 11.68 Favored 'General case' 0 CA--C 1.543 0.682 0 N-CA-C 105.392 -2.077 . . . . 0.0 105.392 167.812 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 61.7 pttt -72.0 148.36 45.99 Favored 'General case' 0 CA--C 1.53 0.206 0 O-C-N 121.133 -0.979 . . . . 0.0 108.809 169.529 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 2.8 mpt_? 60.07 168.75 0.08 Allowed 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 125.63 1.572 . . . . 0.0 110.939 -170.443 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -138.4 -14.04 1.31 Allowed 'General case' 0 N--CA 1.468 0.433 0 N-CA-C 112.882 0.697 . . . . 0.0 112.882 -176.117 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 2.0 m -59.96 -30.71 69.28 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-N 118.681 0.673 . . . . 0.0 109.988 178.564 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 7.3 p -136.15 151.56 49.9 Favored 'General case' 0 N--CA 1.45 -0.455 0 C-N-CA 127.046 2.138 . . . . 0.0 105.652 168.738 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 2.0 mmm-85 58.77 176.12 0.07 Allowed 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 125.767 1.627 . . . . 0.0 110.026 -169.527 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 6.6 m 51.03 37.7 18.54 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 123.378 0.671 . . . . 0.0 111.557 -174.906 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 24.3 pt20 -143.21 155.09 44.45 Favored 'General case' 0 N--CA 1.444 -0.744 0 N-CA-C 106.476 -1.676 . . . . 0.0 106.476 174.401 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER 66.79 -39.58 0.35 Allowed 'General case' 0 C--N 1.326 -0.423 0 C-N-CA 127.091 2.156 . . . . 0.0 114.851 179.141 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -65.9 -48.14 72.45 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-N 120.834 1.652 . . . . 0.0 110.591 -176.315 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -64.37 -40.68 96.32 Favored 'General case' 0 C--N 1.324 -0.519 0 C-N-CA 123.651 0.78 . . . . 0.0 111.258 174.546 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -59.23 -45.44 95.37 Favored Glycine 0 CA--C 1.526 0.779 0 N-CA-C 111.622 -0.591 . . . . 0.0 111.622 176.476 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 1.5 m-85 -69.36 -33.44 73.08 Favored 'General case' 0 CA--C 1.51 -0.588 0 O-C-N 121.414 -1.051 . . . . 0.0 111.262 177.483 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -70.28 -37.83 74.94 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 119.098 0.863 . . . . 0.0 110.336 -178.105 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -53.06 -45.02 67.89 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 123.928 0.891 . . . . 0.0 109.146 169.55 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 14.7 m -70.48 -57.2 5.04 Favored 'General case' 0 N--CA 1.448 -0.562 0 C-N-CA 124.15 0.98 . . . . 0.0 111.279 -174.467 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 37.6 mt -74.65 -34.41 62.72 Favored 'General case' 0 C--N 1.332 -0.167 0 C-N-CA 125.108 1.363 . . . . 0.0 110.814 -171.71 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -92.05 1.21 73.64 Favored Glycine 0 CA--C 1.528 0.874 0 C-N-CA 125.162 1.363 . . . . 0.0 113.291 -175.898 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -49.27 127.81 15.58 Favored 'General case' 0 CA--C 1.534 0.335 0 CA-C-N 118.991 1.395 . . . . 0.0 110.565 -179.176 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 76.11 -9.8 17.67 Favored Glycine 0 CA--C 1.535 1.298 0 C-N-CA 124.412 1.006 . . . . 0.0 114.121 179.743 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 63.1 mttm -99.65 -47.51 5.06 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 119.177 1.489 . . . . 0.0 110.307 175.22 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.44 HD12 HG21 ' A' ' 4' ' ' VAL . 22.0 pt -144.0 155.38 15.63 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.26 0 C-N-CA 124.443 1.097 . . . . 0.0 110.819 -169.155 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -98.48 155.46 17.25 Favored 'General case' 0 C--O 1.224 -0.269 0 C-N-CA 125.344 1.458 . . . . 0.0 108.566 179.673 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 21.9 t -139.53 130.97 33.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 N-CA-C 106.969 -1.493 . . . . 0.0 106.969 -178.317 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 24.7 m -140.36 114.02 8.77 Favored 'General case' 0 N--CA 1.446 -0.664 0 N-CA-C 104.36 -2.459 . . . . 0.0 104.36 172.095 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 55.0 m -112.32 91.22 3.58 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 107.862 -1.162 . . . . 0.0 107.862 173.16 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 3.0 p -67.06 -59.12 3.73 Favored 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 126.478 1.911 . . . . 0.0 111.579 -174.372 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 107.15 164.49 22.08 Favored Glycine 0 CA--C 1.527 0.787 0 C-N-CA 124.463 1.03 . . . . 0.0 112.331 176.651 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 6.1 mt -131.86 138.85 48.61 Favored 'General case' 0 CA--C 1.508 -0.667 0 C-N-CA 127.362 2.265 . . . . 0.0 105.447 170.166 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 28.4 mt-10 53.72 20.46 2.24 Favored 'General case' 0 N--CA 1.48 1.029 0 CA-C-O 122.443 1.116 . . . . 0.0 111.735 179.178 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 3.7 p -78.13 165.41 24.0 Favored 'General case' 0 N--CA 1.435 -1.185 0 N-CA-C 116.481 2.03 . . . . 0.0 116.481 -166.854 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 37.3 p -147.07 -165.52 2.27 Favored 'General case' 0 N--CA 1.433 -1.278 0 C-N-CA 128.956 2.903 . . . . 0.0 106.289 -168.716 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -75.81 161.24 29.19 Favored 'General case' 0 N--CA 1.456 -0.153 0 CA-C-O 122.128 0.965 . . . . 0.0 109.182 169.343 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 2.3 m -66.87 173.28 0.63 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.709 0 CA-C-N 114.35 -1.295 . . . . 0.0 108.37 169.655 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 81.1 t60 -70.76 137.85 85.52 Favored Pre-proline 0 CA--C 1.544 0.73 0 O-C-N 121.187 -0.946 . . . . 0.0 110.4 -178.319 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 16.4 Cg_endo -56.44 -50.55 11.58 Favored 'Trans proline' 0 C--N 1.349 0.571 0 C-N-CA 123.077 2.518 . . . . 0.0 113.106 -177.433 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 23.5 m -69.35 -21.94 63.78 Favored 'General case' 0 CA--C 1.537 0.45 0 O-C-N 121.846 -0.534 . . . . 0.0 110.739 -177.296 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -61.18 -47.62 85.34 Favored 'General case' 0 CA--C 1.505 -0.774 0 N-CA-C 108.771 -0.825 . . . . 0.0 108.771 174.189 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 55.9 mt -58.7 -42.89 86.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 N-CA-C 108.345 -0.983 . . . . 0.0 108.345 -174.212 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -61.93 -47.43 84.92 Favored 'General case' 0 N--CA 1.453 -0.287 0 CA-C-N 118.395 0.543 . . . . 0.0 110.988 -179.898 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 27.4 mmt -66.5 -34.48 78.01 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-O 122.343 1.068 . . . . 0.0 110.7 179.853 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -78.36 -35.59 47.24 Favored 'General case' 0 N--CA 1.441 -0.875 0 N-CA-C 107.247 -1.39 . . . . 0.0 107.247 -172.924 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 33.9 mt-10 -70.42 -22.78 62.68 Favored 'General case' 0 N--CA 1.442 -0.851 0 C-N-CA 123.703 0.801 . . . . 0.0 110.229 171.757 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 14.7 mm-40 -69.23 -29.32 67.22 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-N 119.28 0.945 . . . . 0.0 110.62 171.448 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . 0.278 7.8 p -90.74 8.54 3.74 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.002 0 CA-C-N 118.768 0.713 . . . . 0.0 110.738 168.876 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 81.07 20.91 64.01 Favored Glycine 0 CA--C 1.532 1.114 0 C-N-CA 124.732 1.158 . . . . 0.0 114.055 173.463 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 16.7 mt -117.45 134.02 62.36 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.306 0 C-N-CA 124.49 1.116 . . . . 0.0 110.884 -172.251 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 3.3 t70 -89.4 139.11 30.84 Favored 'General case' 0 N--CA 1.464 0.258 0 N-CA-C 108.08 -1.082 . . . . 0.0 108.08 169.18 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 8.8 pt -129.92 -31.97 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.543 0 C-N-CA 124.587 1.155 . . . . 0.0 110.908 172.362 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -38.41 -42.52 0.74 Allowed 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 128.233 2.613 . . . . 0.0 113.698 169.388 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -70.58 1.63 20.41 Favored Glycine 0 CA--C 1.534 1.27 0 C-N-CA 124.518 1.056 . . . . 0.0 115.18 -174.121 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 16.6 mt-30 -60.46 -34.17 73.63 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 119.512 1.656 . . . . 0.0 114.457 -178.506 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -57.49 118.25 4.99 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-O 121.435 0.636 . . . . 0.0 110.765 -169.041 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 49.2 m -152.05 -167.63 2.83 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 127.857 2.463 . . . . 0.0 106.763 -169.537 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -59.52 153.21 51.57 Favored Pre-proline 0 CA--C 1.54 0.562 0 O-C-N 121.795 -0.566 . . . . 0.0 110.49 169.653 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -64.43 158.26 50.29 Favored 'Trans proline' 0 C--N 1.349 0.56 0 C-N-CA 123.13 2.553 . . . . 0.0 110.514 171.751 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 13.0 tt -59.72 -27.05 36.94 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.289 0 O-C-N 121.783 -0.573 . . . . 0.0 111.33 -178.762 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 15.7 mt-10 -65.98 -26.24 67.46 Favored 'General case' 0 C--O 1.234 0.24 0 C-N-CA 124.185 0.994 . . . . 0.0 110.409 -175.175 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 5.9 t-20 -66.48 -26.52 67.22 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 124.646 1.179 . . . . 0.0 111.769 177.13 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 96.3 m-85 -96.26 170.76 9.03 Favored 'General case' 0 C--O 1.235 0.32 0 C-N-CA 125.632 1.573 . . . . 0.0 110.927 -177.909 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 19.0 p-10 -116.79 137.43 52.2 Favored 'General case' 0 N--CA 1.436 -1.129 0 C-N-CA 125.075 1.35 . . . . 0.0 110.889 168.966 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -77.11 -22.18 53.09 Favored 'General case' 0 N--CA 1.433 -1.302 0 N-CA-C 109.82 -0.437 . . . . 0.0 109.82 -171.181 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -64.16 -21.92 66.74 Favored 'General case' 0 N--CA 1.443 -0.799 0 O-C-N 123.881 0.738 . . . . 0.0 111.79 -179.239 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 37.8 t70 -75.77 -27.72 58.14 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 122.973 0.509 . . . . 0.0 112.146 175.02 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 32.1 m-85 -85.93 170.11 12.63 Favored 'General case' 0 N--CA 1.451 -0.402 0 C-N-CA 126.271 1.828 . . . . 0.0 111.031 -179.319 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -119.01 -34.24 3.95 Favored 'General case' 0 N--CA 1.466 0.332 0 C-N-CA 123.117 0.567 . . . . 0.0 111.753 177.569 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -145.51 138.04 20.8 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.489 0 CA-C-O 121.324 0.583 . . . . 0.0 109.834 -170.216 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 95.5 t -144.87 126.09 8.51 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.515 0 N-CA-C 106.254 -1.758 . . . . 0.0 106.254 -173.782 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.518 HD12 ' HB2' ' A' ' 97' ' ' GLU . 4.5 mm -101.87 132.39 47.9 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.599 0 N-CA-C 105.803 -1.925 . . . . 0.0 105.803 173.609 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 55.8 m -93.04 -16.09 25.41 Favored 'General case' 0 CA--C 1.535 0.37 0 N-CA-C 113.288 0.848 . . . . 0.0 113.288 178.81 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 24.4 mt 57.06 -12.27 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.613 0 N-CA-C 118.218 2.673 . . . . 0.0 118.218 171.079 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 26.5 p -149.58 33.87 0.7 Allowed 'General case' 0 CA--C 1.537 0.454 0 CA-C-N 122.303 2.319 . . . . 0.0 112.816 -178.072 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 130.85 -165.49 22.9 Favored Glycine 0 CA--C 1.525 0.665 0 C-N-CA 125.498 1.523 . . . . 0.0 110.675 179.485 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 8.4 p -102.72 -53.39 2.87 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 124.762 1.225 . . . . 0.0 110.116 177.012 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -65.52 -53.93 29.13 Favored Glycine 0 C--N 1.341 0.84 0 N-CA-C 111.201 -0.76 . . . . 0.0 111.201 -175.394 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . 0.313 98.5 t 55.94 10.36 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.551 1.01 0 C-N-CA 126.749 2.02 . . . . 0.0 114.919 169.592 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 64.1 t30 53.38 44.57 29.86 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 124.839 1.256 . . . . 0.0 109.398 -169.592 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -126.31 142.63 43.39 Favored Pre-proline 0 CA--C 1.539 0.552 0 C-N-CA 127.242 2.217 . . . . 0.0 108.22 -169.317 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 30.1 Cg_exo -65.93 143.04 71.36 Favored 'Trans proline' 0 C--N 1.352 0.75 0 C-N-CA 121.396 1.397 . . . . 0.0 111.45 -178.749 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -65.4 -28.31 54.53 Favored 'Trans proline' 0 N--CA 1.462 -0.377 0 C-N-CA 122.054 1.836 . . . . 0.0 114.273 -169.191 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -58.09 -19.39 31.73 Favored 'General case' 0 CA--C 1.538 0.483 0 CA-C-N 119.436 1.016 . . . . 0.0 112.488 179.873 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 95.0 m95 -78.88 -40.62 31.88 Favored 'General case' 0 N--CA 1.446 -0.642 0 C-N-CA 123.52 0.728 . . . . 0.0 112.263 -177.15 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 2.9 m -71.25 -34.11 53.06 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.445 0 CA-C-O 118.722 -0.656 . . . . 0.0 110.117 174.29 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 76.6 p -81.99 23.69 0.68 Allowed 'General case' 0 C--O 1.236 0.356 0 CA-C-N 120.046 1.293 . . . . 0.0 113.893 -170.159 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 94.3 mm-40 -72.79 179.03 3.84 Favored 'General case' 0 N--CA 1.446 -0.634 0 O-C-N 121.703 -0.623 . . . . 0.0 110.319 172.343 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 30.7 mm-40 -62.3 -19.79 63.65 Favored 'General case' 0 CA--C 1.538 0.489 0 N-CA-C 112.829 0.677 . . . . 0.0 112.829 -169.398 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 2.1 tt -142.14 124.12 13.28 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.354 0 C-N-CA 126.338 1.855 . . . . 0.0 106.698 173.547 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 7.0 t80 -97.29 132.23 43.23 Favored 'General case' 0 CA--C 1.535 0.397 0 N-CA-C 105.158 -2.164 . . . . 0.0 105.158 169.022 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . 0.518 ' HB2' HD12 ' A' ' 77' ' ' ILE . 7.9 mm-40 -138.46 160.27 39.98 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-O 121.792 0.806 . . . . 0.0 109.434 172.034 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 8.9 t70 -179.92 134.98 0.11 Allowed 'General case' 0 C--N 1.325 -0.482 0 C-N-CA 127.085 2.154 . . . . 0.0 106.509 -169.57 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' TRP . . . . . 0.465 ' CZ3' HG21 ' A' ' 77' ' ' ILE . 5.0 m-90 -145.58 154.23 41.94 Favored 'General case' 0 C--O 1.234 0.238 0 N-CA-C 109.325 -0.62 . . . . 0.0 109.325 -172.043 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 15.2 pt20 -79.58 50.24 1.11 Allowed 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 124.216 1.006 . . . . 0.0 110.118 171.474 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 1.1 mt -65.43 121.92 15.99 Favored 'General case' 0 C--N 1.34 0.181 0 N-CA-C 107.672 -1.232 . . . . 0.0 107.672 178.141 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 -73.02 160.35 32.21 Favored 'General case' 0 CA--C 1.537 0.465 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 173.826 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -137.26 137.21 21.95 Favored Pre-proline 0 C--O 1.237 0.413 0 C-N-CA 124.296 1.039 . . . . 0.0 109.835 -169.698 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 22.7 Cg_endo -88.66 6.16 4.84 Favored 'Trans proline' 0 CA--C 1.544 0.994 0 C-N-CA 122.817 2.344 . . . . 0.0 113.736 -170.517 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 4.6 t70 -47.01 111.53 0.41 Allowed 'General case' 0 C--O 1.236 0.389 0 CA-C-N 120.356 1.434 . . . . 0.0 111.857 -179.973 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 67.65 7.91 49.84 Favored Glycine 0 CA--C 1.535 1.307 0 C-N-CA 124.348 0.975 . . . . 0.0 114.3 177.853 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 6.7 mt-30 -91.2 173.6 7.84 Favored 'General case' 0 CA--C 1.541 0.626 0 CA-C-N 118.777 1.289 . . . . 0.0 110.518 -178.649 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 15.6 m -74.16 166.55 23.23 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 124.432 1.093 . . . . 0.0 111.555 179.978 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -57.35 -31.78 66.08 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 125.06 1.344 . . . . 0.0 112.084 -176.85 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 6.2 pt-20 -56.82 -35.17 68.48 Favored 'General case' 0 N--CA 1.463 0.196 0 C-N-CA 123.195 0.598 . . . . 0.0 111.377 176.404 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 15.6 t -76.9 -41.42 32.11 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.31 0 CA-C-O 118.412 -0.804 . . . . 0.0 109.416 -176.883 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 84.1 m-85 -57.25 -48.91 77.64 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-N 119.89 1.223 . . . . 0.0 110.413 171.606 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 94.9 mtt180 -60.81 -41.77 96.32 Favored 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 123.322 0.649 . . . . 0.0 110.972 179.766 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 5.2 m -63.5 -47.62 80.96 Favored 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 124.629 1.171 . . . . 0.0 110.196 176.25 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 73.1 t -68.92 -35.11 67.68 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.335 0 CA-C-O 117.955 -1.022 . . . . 0.0 109.7 -172.402 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 27.2 mtm105 -57.68 -48.24 80.08 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 120.205 1.366 . . . . 0.0 110.094 174.128 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -63.36 -48.84 75.24 Favored Glycine 0 CA--C 1.53 0.999 0 CA-C-N 118.38 0.536 . . . . 0.0 111.852 179.003 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 14.3 mm-40 -55.79 -54.1 48.56 Favored 'General case' 0 N--CA 1.464 0.259 0 C-N-CA 123.677 0.791 . . . . 0.0 109.93 179.556 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 95.6 t -65.34 -43.46 94.92 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-O 118.168 -0.92 . . . . 0.0 109.821 -173.559 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 61.5 tttm -53.45 -44.5 68.91 Favored 'General case' 0 C--O 1.225 -0.191 0 N-CA-C 108.828 -0.804 . . . . 0.0 108.828 178.479 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -69.53 -45.4 68.92 Favored 'General case' 0 N--CA 1.448 -0.575 0 CA-C-O 119.12 -0.467 . . . . 0.0 111.627 -176.394 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 1.5 mmt-85 -59.41 -44.85 92.77 Favored 'General case' 0 N--CA 1.478 0.969 0 CA-C-N 119.26 0.936 . . . . 0.0 110.257 176.487 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 88.6 t -68.63 -40.76 82.23 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.445 0 N-CA-C 109.193 -0.669 . . . . 0.0 109.193 -176.555 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 23.6 mt-10 -60.61 -40.45 91.9 Favored 'General case' 0 C--O 1.226 -0.151 0 CA-C-N 119.645 1.111 . . . . 0.0 110.21 176.129 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 25.0 t-20 -65.69 -43.2 89.95 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 123.082 0.553 . . . . 0.0 111.442 -179.579 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 1.4 tm? -58.75 -47.76 83.53 Favored 'General case' 0 C--O 1.225 -0.191 0 C-N-CA 126.112 1.765 . . . . 0.0 110.689 174.509 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 85.5 mt -65.91 -48.37 82.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 N-CA-C 108.697 -0.853 . . . . 0.0 108.697 179.16 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -56.54 -33.86 66.5 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-N 118.488 0.586 . . . . 0.0 112.264 -177.31 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 17.6 ptpt -80.4 -36.06 34.37 Favored 'General case' 0 C--N 1.342 0.279 0 CA-C-O 117.952 -1.023 . . . . 0.0 112.552 178.543 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 14.0 pt -85.22 -34.56 8.88 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.376 0 CA-C-N 119.973 1.261 . . . . 0.0 114.08 -177.353 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 75.1 m . . . . . 0 C--O 1.254 1.322 0 C-N-CA 125.706 1.602 . . . . 0.0 109.398 -169.884 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.497 1.882 0 N-CA-C 110.37 -0.233 . . . . 0.0 110.37 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 26.6 mttm -81.66 121.01 25.82 Favored 'General case' 0 N--CA 1.478 0.956 0 N-CA-C 106.776 -1.565 . . . . 0.0 106.776 173.501 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 37.0 ttmt -87.17 128.6 35.13 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 107.396 -1.335 . . . . 0.0 107.396 -179.366 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 1.7 t -117.17 150.8 19.12 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 C-N-CA 125.715 1.606 . . . . 0.0 109.61 -168.865 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 46.4 ttm -141.23 148.21 39.54 Favored 'General case' 0 C--N 1.329 -0.319 0 C-N-CA 125.474 1.51 . . . . 0.0 108.786 169.699 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 87.1 m-85 -136.29 128.7 30.25 Favored 'General case' 0 C--N 1.332 -0.175 0 N-CA-C 104.072 -2.566 . . . . 0.0 104.072 175.005 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 2.2 p -157.17 156.39 4.41 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.437 0 CA-C-N 119.147 0.885 . . . . 0.0 110.837 -168.947 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 48.0 t -140.63 177.58 7.93 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 126.966 2.106 . . . . 0.0 106.652 169.04 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 40.7 ttmt -49.86 -40.99 44.33 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 124.707 1.203 . . . . 0.0 111.742 -177.064 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 99.1 mtt180 -134.17 169.23 17.48 Favored 'General case' 0 N--CA 1.466 0.325 0 C-N-CA 125.478 1.511 . . . . 0.0 107.898 169.906 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 55.1 t-20 -70.8 -39.91 72.82 Favored 'General case' 0 N--CA 1.47 0.53 0 N-CA-C 109.702 -0.481 . . . . 0.0 109.702 173.405 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 3.6 m -51.85 139.15 22.56 Favored 'General case' 0 C--O 1.237 0.397 0 C-N-CA 124.849 1.26 . . . . 0.0 111.084 -178.339 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 4.6 m 60.99 17.13 7.63 Favored 'General case' 0 CA--C 1.542 0.648 0 N-CA-C 115.076 1.51 . . . . 0.0 115.076 171.852 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -156.13 -55.37 0.09 Allowed 'General case' 0 N--CA 1.471 0.605 0 CA-C-N 121.05 1.75 . . . . 0.0 114.886 169.842 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 3.3 m -77.92 15.6 0.85 Allowed 'General case' 0 N--CA 1.468 0.431 0 N-CA-C 115.654 1.724 . . . . 0.0 115.654 -168.254 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 6.0 pt20 -66.15 -43.26 87.54 Favored 'General case' 0 C--O 1.22 -0.453 0 CA-C-N 120.247 1.385 . . . . 0.0 113.302 -169.989 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 1.4 tpt -108.55 -19.83 13.31 Favored 'General case' 0 N--CA 1.47 0.526 0 N-CA-C 114.487 1.291 . . . . 0.0 114.487 -168.571 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -66.65 -50.29 63.41 Favored 'General case' 0 N--CA 1.475 0.792 0 CA-C-N 119.149 0.886 . . . . 0.0 111.846 -170.498 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -63.29 -32.42 73.83 Favored 'General case' 0 N--CA 1.467 0.38 0 N-CA-C 109.492 -0.559 . . . . 0.0 109.492 173.008 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -51.43 -65.7 2.98 Favored Glycine 0 C--N 1.345 1.03 0 C-N-CA 124.569 1.081 . . . . 0.0 111.347 174.471 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 13.6 m-85 -65.72 -29.38 69.9 Favored 'General case' 0 CA--C 1.506 -0.746 0 CA-C-N 118.588 1.194 . . . . 0.0 112.477 -176.882 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -67.45 -30.11 69.75 Favored 'General case' 0 N--CA 1.446 -0.638 0 CA-C-O 117.98 -1.01 . . . . 0.0 111.737 -177.624 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 2.1 ptmt -70.72 -27.89 64.31 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-N 120.248 1.385 . . . . 0.0 111.342 174.132 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 12.8 m -77.52 -57.16 3.97 Favored 'General case' 0 N--CA 1.448 -0.541 0 C-N-CA 125.538 1.535 . . . . 0.0 110.954 179.774 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 57.2 mt -72.84 -36.9 67.57 Favored 'General case' 0 N--CA 1.464 0.228 0 C-N-CA 124.019 0.927 . . . . 0.0 109.76 -175.703 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -81.21 0.74 87.08 Favored Glycine 0 CA--C 1.525 0.68 0 C-N-CA 124.812 1.196 . . . . 0.0 113.2 179.907 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -54.96 135.71 48.29 Favored 'General case' 0 C--O 1.236 0.372 0 CA-C-N 119.186 1.493 . . . . 0.0 109.395 179.172 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 72.49 5.81 64.44 Favored Glycine 0 CA--C 1.534 1.248 0 CA-C-O 118.332 -1.26 . . . . 0.0 114.597 178.393 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 9.2 ptpp? -137.81 -44.33 0.53 Allowed 'General case' 0 N--CA 1.475 0.777 0 CA-C-N 119.731 1.765 . . . . 0.0 112.937 -178.595 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 24.0 pt -138.49 152.81 25.44 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.794 0 CA-C-N 119.978 1.263 . . . . 0.0 110.138 -173.082 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -118.47 106.32 12.57 Favored 'General case' 0 C--O 1.227 -0.105 0 C-N-CA 124.62 1.168 . . . . 0.0 110.009 -169.738 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 4.6 t -79.62 134.4 27.74 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.399 0 N-CA-C 109.178 -0.675 . . . . 0.0 109.178 177.833 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 22.2 m -140.62 87.4 2.12 Favored 'General case' 0 N--CA 1.449 -0.5 0 N-CA-C 105.493 -2.04 . . . . 0.0 105.493 169.663 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 38.6 m -95.0 82.91 3.86 Favored 'General case' 0 N--CA 1.448 -0.557 0 CA-C-O 121.917 0.865 . . . . 0.0 111.223 -169.809 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -64.26 172.0 2.74 Favored 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 125.715 1.606 . . . . 0.0 110.3 169.874 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -157.75 -167.86 19.33 Favored Glycine 0 C--N 1.338 0.664 0 N-CA-C 108.575 -1.81 . . . . 0.0 108.575 -173.297 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 3.0 mt -136.96 131.27 32.75 Favored 'General case' 0 N--CA 1.44 -0.932 0 N-CA-C 104.468 -2.419 . . . . 0.0 104.468 -172.272 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 28.7 mt-10 65.47 -61.55 0.24 Allowed 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 126.754 2.022 . . . . 0.0 111.041 -169.714 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 75.4 m 65.31 158.63 0.1 Allowed 'General case' 0 N--CA 1.438 -1.026 0 C-N-CA 129.313 3.045 . . . . 0.0 115.917 171.133 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 49.7 p -161.9 170.94 18.53 Favored 'General case' 0 N--CA 1.431 -1.375 0 CA-C-N 111.039 -2.801 . . . . 0.0 106.932 -168.838 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 5.7 ttt180 -92.28 167.05 12.28 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.657 0.742 . . . . 0.0 109.31 175.721 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 18.8 m -73.07 171.88 1.13 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.622 0 CA-C-N 114.711 -1.131 . . . . 0.0 109.853 178.647 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 92.2 m-70 -82.99 150.28 61.2 Favored Pre-proline 0 CA--C 1.539 0.526 0 C-N-CA 123.416 0.687 . . . . 0.0 110.479 -176.889 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -62.7 -45.63 13.32 Favored 'Trans proline' 0 C--N 1.347 0.496 0 C-N-CA 122.982 2.455 . . . . 0.0 112.383 -172.675 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 6.1 m -68.49 -25.94 65.22 Favored 'General case' 0 CA--C 1.534 0.33 0 O-C-N 121.881 -0.512 . . . . 0.0 110.22 -179.146 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -58.51 -52.8 64.12 Favored 'General case' 0 CA--C 1.507 -0.691 0 N-CA-C 108.766 -0.827 . . . . 0.0 108.766 171.356 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 81.5 mt -59.27 -41.09 82.96 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.342 0 N-CA-C 108.471 -0.937 . . . . 0.0 108.471 -173.176 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -63.1 -49.75 73.21 Favored 'General case' 0 CA--C 1.534 0.363 0 CA-C-N 118.503 0.592 . . . . 0.0 111.331 179.718 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 29.4 mmt -65.89 -36.63 83.96 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-O 122.933 1.349 . . . . 0.0 111.106 -179.698 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -78.45 -30.44 47.46 Favored 'General case' 0 N--CA 1.439 -0.993 0 N-CA-C 106.803 -1.554 . . . . 0.0 106.803 -172.754 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 4.8 mm-40 -73.75 -20.51 60.48 Favored 'General case' 0 N--CA 1.445 -0.712 0 O-C-N 121.355 -0.841 . . . . 0.0 110.642 169.749 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 18.0 mm-40 -66.83 -30.67 70.91 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-N 119.713 1.142 . . . . 0.0 110.038 170.0 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 15.4 m -91.92 10.56 3.25 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.814 0 CA-C-N 118.703 0.683 . . . . 0.0 111.427 168.635 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 76.66 22.87 71.39 Favored Glycine 0 CA--C 1.531 1.059 0 C-N-CA 124.962 1.267 . . . . 0.0 113.554 172.24 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 8.1 mt -111.7 129.64 66.73 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.222 0 CA-C-N 118.485 1.142 . . . . 0.0 111.033 -173.659 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -86.31 126.09 34.08 Favored 'General case' 0 C--O 1.232 0.177 0 N-CA-C 107.371 -1.344 . . . . 0.0 107.371 168.822 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 6.5 pt -122.48 -22.22 3.17 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.645 0 C-N-CA 125.219 1.408 . . . . 0.0 109.894 169.659 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -36.86 -41.04 0.31 Allowed 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 129.367 3.067 . . . . 0.0 113.633 169.376 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -82.05 14.0 35.14 Favored Glycine 0 CA--C 1.532 1.119 0 C-N-CA 124.943 1.258 . . . . 0.0 114.801 -176.551 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -63.71 -30.18 71.31 Favored 'General case' 0 C--N 1.343 0.309 0 CA-C-N 119.667 1.733 . . . . 0.0 114.099 -170.533 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -61.91 122.88 16.55 Favored 'General case' 0 CA--C 1.535 0.379 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 -169.797 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 67.3 m -145.91 -175.28 4.68 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 125.92 1.688 . . . . 0.0 107.864 -169.261 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -57.3 155.22 19.0 Favored Pre-proline 0 CA--C 1.539 0.543 0 C-N-CA 124.162 0.985 . . . . 0.0 111.572 173.131 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -65.42 155.81 66.76 Favored 'Trans proline' 0 N--CA 1.456 -0.703 0 C-N-CA 122.529 2.152 . . . . 0.0 110.095 171.053 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 7.8 tt -58.97 -28.24 37.97 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.486 0 C-N-CA 124.02 0.928 . . . . 0.0 110.979 -178.713 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 14.5 mt-10 -68.08 -25.55 65.39 Favored 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 125.329 1.452 . . . . 0.0 110.399 -173.883 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 7.4 t-20 -62.04 -22.81 66.04 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 124.926 1.29 . . . . 0.0 111.969 177.149 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 88.7 m-85 -109.0 -176.71 3.11 Favored 'General case' 0 C--O 1.235 0.33 0 C-N-CA 125.697 1.599 . . . . 0.0 111.528 -172.109 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 55.2 t-20 -130.07 137.79 50.39 Favored 'General case' 0 N--CA 1.442 -0.866 0 N-CA-C 106.183 -1.784 . . . . 0.0 106.183 169.315 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -73.35 -24.5 60.35 Favored 'General case' 0 N--CA 1.432 -1.35 0 CA-C-N 118.539 0.609 . . . . 0.0 109.734 -178.826 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 35.8 t70 -63.94 -22.4 66.9 Favored 'General case' 0 N--CA 1.446 -0.636 0 O-C-N 123.627 0.579 . . . . 0.0 111.333 179.327 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -73.85 -29.77 62.3 Favored 'General case' 0 N--CA 1.452 -0.332 0 C-N-CA 123.762 0.825 . . . . 0.0 111.431 175.246 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 17.8 m-85 -79.33 159.53 27.14 Favored 'General case' 0 N--CA 1.446 -0.629 0 C-N-CA 124.518 1.127 . . . . 0.0 110.302 177.681 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 23.6 t70 -99.53 -38.61 8.7 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.241 171.218 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -139.26 137.6 41.21 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.359 0 C-N-CA 123.857 0.863 . . . . 0.0 109.634 -170.551 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 89.7 t -143.1 142.46 25.82 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.745 0 N-CA-C 106.435 -1.691 . . . . 0.0 106.435 -178.574 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.526 HD12 ' HB2' ' A' ' 97' ' ' GLU . 28.9 mm -137.09 132.7 47.06 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.568 0 N-CA-C 107.133 -1.432 . . . . 0.0 107.133 -171.32 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 57.8 m -95.92 166.36 11.82 Favored 'General case' 0 N--CA 1.445 -0.716 0 N-CA-C 108.146 -1.057 . . . . 0.0 108.146 168.691 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 53.6 mt -134.61 18.57 3.59 Favored 'General case' 0 CA--C 1.531 0.239 0 O-C-N 121.364 -0.835 . . . . 0.0 110.752 -178.638 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 25.1 p -168.86 -0.22 0.02 OUTLIER 'General case' 0 CA--C 1.543 0.674 0 N-CA-C 115.584 1.698 . . . . 0.0 115.584 -176.357 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 162.6 -175.12 39.04 Favored Glycine 0 CA--C 1.526 0.769 0 CA-C-N 120.89 1.677 . . . . 0.0 112.607 179.83 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 17.9 m -128.65 127.01 41.35 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 125.065 1.346 . . . . 0.0 107.888 -176.243 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . 0.409 ' H ' HG11 ' A' ' 91' ' ' VAL . . . 58.06 34.26 72.19 Favored Glycine 0 CA--C 1.533 1.2 0 N-CA-C 110.624 -0.99 . . . . 0.0 110.624 -170.414 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . 0.286 7.7 p -80.3 69.17 0.5 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.657 0 C-N-CA 125.332 1.453 . . . . 0.0 110.437 -169.263 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 56.2 t30 55.67 49.22 16.83 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 127.146 2.178 . . . . 0.0 109.103 -173.553 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -154.27 143.98 15.34 Favored Pre-proline 0 CA--C 1.541 0.611 0 C-N-CA 126.918 2.087 . . . . 0.0 106.596 -169.237 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_exo -69.56 145.86 59.64 Favored 'Trans proline' 0 C--N 1.352 0.737 0 CA-C-N 120.912 1.361 . . . . 0.0 113.059 -173.246 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -73.18 -22.52 19.04 Favored 'Trans proline' 0 N--CA 1.461 -0.391 0 C-N-CA 122.209 1.939 . . . . 0.0 113.795 -170.754 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -57.85 -23.48 53.02 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-N 120.072 1.305 . . . . 0.0 111.627 177.378 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 99.6 m95 -72.05 -43.48 64.87 Favored 'General case' 0 N--CA 1.449 -0.478 0 C-N-CA 123.493 0.717 . . . . 0.0 111.252 176.235 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.409 HG11 ' H ' ' A' ' 83' ' ' GLY . 4.9 m -78.1 -1.33 3.95 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.627 0 N-CA-C 112.582 0.586 . . . . 0.0 112.582 -179.094 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 63.3 p -115.9 22.33 13.11 Favored 'General case' 0 CA--C 1.538 0.514 0 N-CA-C 115.462 1.652 . . . . 0.0 115.462 -178.412 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 92.3 mm-40 -71.03 179.46 2.75 Favored 'General case' 0 CA--C 1.54 0.573 0 O-C-N 121.27 -0.894 . . . . 0.0 111.875 175.015 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 30.1 mm-40 -54.84 -28.47 49.99 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 124.146 0.978 . . . . 0.0 112.733 -169.085 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 6.8 tt -135.12 139.66 46.66 Favored 'Isoleucine or valine' 0 C--O 1.238 0.497 0 N-CA-C 104.569 -2.382 . . . . 0.0 104.569 168.477 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 47.6 t80 -126.57 140.43 52.44 Favored 'General case' 0 N--CA 1.447 -0.608 0 N-CA-C 106.383 -1.71 . . . . 0.0 106.383 169.567 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . 0.526 ' HB2' HD12 ' A' ' 77' ' ' ILE . 44.0 mm-40 -142.08 163.86 31.73 Favored 'General case' 0 C--O 1.235 0.336 0 N-CA-C 107.409 -1.33 . . . . 0.0 107.409 169.88 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -167.51 131.63 1.82 Allowed 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 125.443 1.497 . . . . 0.0 107.46 -173.65 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 4.3 m-90 -150.65 143.44 24.58 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 107.897 -1.149 . . . . 0.0 107.897 -169.598 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 24.8 tt0 -84.81 82.28 8.51 Favored 'General case' 0 CA--C 1.537 0.48 0 N-CA-C 107.689 -1.226 . . . . 0.0 107.689 173.44 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -69.34 140.98 54.34 Favored 'General case' 0 N--CA 1.464 0.234 0 N-CA-C 108.667 -0.864 . . . . 0.0 108.667 172.719 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -73.68 157.2 37.0 Favored 'General case' 0 CA--C 1.537 0.449 0 N-CA-C 107.036 -1.468 . . . . 0.0 107.036 168.683 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -129.45 130.68 23.31 Favored Pre-proline 0 C--O 1.236 0.386 0 C-N-CA 123.77 0.828 . . . . 0.0 109.095 176.886 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_endo -86.14 -8.39 7.73 Favored 'Trans proline' 0 CA--C 1.54 0.821 0 C-N-CA 123.17 2.58 . . . . 0.0 115.245 -169.992 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -50.03 -51.04 45.38 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-N 120.171 1.351 . . . . 0.0 113.723 -169.093 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -84.21 9.26 64.39 Favored Glycine 0 CA--C 1.531 1.038 0 CA-C-O 118.368 -1.24 . . . . 0.0 113.953 -172.725 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 25.9 pt20 -148.04 -164.19 1.95 Allowed 'General case' 0 CA--C 1.544 0.712 0 CA-C-N 119.385 1.592 . . . . 0.0 112.531 -169.585 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 1.5 m -69.01 159.09 33.48 Favored 'General case' 0 CA--C 1.535 0.372 0 N-CA-C 117.567 2.432 . . . . 0.0 117.567 -167.726 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 56.5 tp -54.44 -34.69 61.91 Favored 'General case' 0 N--CA 1.465 0.32 0 C-N-CA 126.94 2.096 . . . . 0.0 111.713 170.124 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -62.12 -32.34 72.91 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 122.819 0.448 . . . . 0.0 110.773 177.498 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 5.3 t -76.42 -37.74 31.29 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.362 0 CA-C-O 117.894 -1.051 . . . . 0.0 109.892 177.649 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 54.0 m-85 -57.01 -47.97 79.59 Favored 'General case' 0 N--CA 1.474 0.767 0 CA-C-N 120.728 1.604 . . . . 0.0 109.579 171.155 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 75.3 mtt180 -59.23 -43.96 92.33 Favored 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 123.333 0.653 . . . . 0.0 110.858 178.152 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 17.1 m -64.44 -48.89 73.62 Favored 'General case' 0 N--CA 1.446 -0.663 0 C-N-CA 124.192 0.997 . . . . 0.0 110.396 178.606 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 64.9 t -70.39 -29.9 40.84 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.301 0 CA-C-N 119.019 0.827 . . . . 0.0 109.945 -169.937 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 30.7 mtm105 -57.04 -47.91 79.8 Favored 'General case' 0 C--O 1.226 -0.181 0 CA-C-N 119.404 1.002 . . . . 0.0 109.583 169.859 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -62.06 -48.52 82.63 Favored Glycine 0 CA--C 1.529 0.961 0 CA-C-O 119.258 -0.745 . . . . 0.0 112.0 177.697 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 86.1 mt-30 -55.66 -52.93 62.17 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-O 122.017 0.913 . . . . 0.0 110.104 -178.83 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 98.1 t -67.5 -44.9 86.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 115.102 -0.954 . . . . 0.0 109.596 -175.32 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 62.6 tttm -55.04 -46.34 75.31 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 119.435 1.016 . . . . 0.0 109.197 -179.041 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -67.64 -43.44 80.35 Favored 'General case' 0 N--CA 1.449 -0.524 0 C-N-CA 122.873 0.469 . . . . 0.0 111.366 -176.271 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 44.9 mtt-85 -66.63 -42.23 87.08 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-N 118.867 0.758 . . . . 0.0 111.082 178.047 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 81.1 t -64.99 -41.48 92.23 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.532 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 177.736 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 21.2 mt-10 -59.69 -41.36 90.52 Favored 'General case' 0 C--N 1.34 0.162 0 CA-C-N 119.768 1.167 . . . . 0.0 110.641 176.971 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 29.1 t-20 -62.54 -45.01 94.92 Favored 'General case' 0 CA--C 1.534 0.336 0 CA-C-N 118.166 0.439 . . . . 0.0 111.139 -179.635 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 1.5 tm? -58.45 -49.49 77.12 Favored 'General case' 0 CA--C 1.53 0.192 0 C-N-CA 124.26 1.024 . . . . 0.0 110.277 177.091 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 94.8 mt -63.87 -43.02 97.69 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.276 0 C-N-CA 123.887 0.875 . . . . 0.0 108.86 -179.518 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -62.56 -28.14 69.67 Favored 'General case' 0 CA--C 1.534 0.355 0 CA-C-N 118.902 0.774 . . . . 0.0 112.074 179.956 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 89.7 mttt -69.57 -54.52 13.68 Favored 'General case' 0 C--N 1.341 0.235 0 CA-C-N 118.769 0.713 . . . . 0.0 110.358 172.646 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 19.3 pt -77.64 -38.19 25.34 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.362 0 N-CA-C 114.586 1.328 . . . . 0.0 114.586 -169.395 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 74.7 m . . . . . 0 C--O 1.252 1.209 0 C-N-CA 126.162 1.785 . . . . 0.0 109.629 -169.748 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 8.0 ptm . . . . . 0 N--CA 1.497 1.898 0 N-CA-C 110.468 -0.197 . . . . 0.0 110.468 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . 0.455 ' HB2' HG22 ' A' ' 30' ' ' ILE . 15.7 mttm -74.64 128.46 35.62 Favored 'General case' 0 N--CA 1.478 0.971 0 N-CA-C 107.83 -1.174 . . . . 0.0 107.83 -174.912 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 72.9 mttt -97.4 138.1 35.37 Favored 'General case' 0 CA--C 1.511 -0.522 0 CA-C-N 120.198 1.363 . . . . 0.0 108.26 172.432 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.461 HG21 HD12 ' A' ' 30' ' ' ILE . 12.1 t -119.31 152.22 21.72 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.678 0 C-N-CA 126.231 1.812 . . . . 0.0 106.66 -169.995 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 15.8 mtt -135.27 146.45 48.57 Favored 'General case' 0 C--N 1.322 -0.623 0 C-N-CA 124.897 1.279 . . . . 0.0 108.167 168.792 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 86.5 m-85 -133.74 125.47 28.63 Favored 'General case' 0 CA--C 1.516 -0.361 0 N-CA-C 103.921 -2.622 . . . . 0.0 103.921 171.332 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 1.3 p -150.03 142.61 17.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 118.975 0.807 . . . . 0.0 110.382 -169.014 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 20.9 t -125.1 -174.96 3.17 Favored 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 127.379 2.272 . . . . 0.0 106.552 169.597 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 39.0 ttpt -60.45 -42.16 95.59 Favored 'General case' 0 N--CA 1.472 0.65 0 O-C-N 120.822 -1.174 . . . . 0.0 111.508 -177.33 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 94.0 mtt180 -123.79 163.92 20.22 Favored 'General case' 0 N--CA 1.467 0.423 0 C-N-CA 123.764 0.826 . . . . 0.0 109.48 176.421 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -77.01 -27.75 54.75 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 122.41 0.284 . . . . 0.0 111.28 -179.511 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 1.3 m -69.16 -23.58 63.96 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 124.133 0.973 . . . . 0.0 113.385 -169.657 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 6.8 t -128.55 136.3 50.56 Favored 'General case' 0 C--N 1.339 0.143 0 N-CA-C 108.274 -1.01 . . . . 0.0 108.274 -174.612 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 9.1 mpt_? 61.72 -42.94 0.15 Allowed 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 128.533 2.733 . . . . 0.0 114.45 -176.549 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -75.08 41.13 0.16 Allowed 'General case' 0 CA--C 1.542 0.635 0 CA-C-N 120.268 1.394 . . . . 0.0 111.463 177.286 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 20.2 pt20 -135.11 154.16 51.76 Favored 'General case' 0 N--CA 1.441 -0.892 0 C-N-CA 127.455 2.302 . . . . 0.0 104.819 169.593 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER 66.41 -33.91 0.2 Allowed 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 126.216 1.806 . . . . 0.0 114.681 -178.648 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -64.62 -49.97 68.96 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 121.514 1.961 . . . . 0.0 109.865 179.671 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 4.5 pm0 -61.53 -37.8 85.06 Favored 'General case' 0 N--CA 1.453 -0.293 0 C-N-CA 124.42 1.088 . . . . 0.0 110.74 172.445 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -60.54 -55.31 30.67 Favored Glycine 0 C--N 1.337 0.627 0 N-CA-C 109.457 -1.457 . . . . 0.0 109.457 -176.926 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 6.3 m-85 -63.65 -33.23 75.16 Favored 'General case' 0 CA--C 1.509 -0.634 0 O-C-N 122.143 -0.622 . . . . 0.0 111.887 177.417 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -67.49 -38.2 83.99 Favored 'General case' 0 N--CA 1.445 -0.706 0 C-N-CA 119.839 -0.744 . . . . 0.0 110.926 -178.08 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.06 -37.58 87.96 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-N 118.701 0.682 . . . . 0.0 110.077 173.45 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 13.0 m -66.99 -55.39 14.66 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 123.675 0.79 . . . . 0.0 112.244 179.887 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 40.1 mt -76.28 -35.68 58.78 Favored 'General case' 0 C--N 1.327 -0.376 0 C-N-CA 124.636 1.175 . . . . 0.0 110.09 -171.158 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -94.39 12.17 69.27 Favored Glycine 0 CA--C 1.525 0.666 0 C-N-CA 125.233 1.397 . . . . 0.0 112.848 -178.778 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -51.01 122.2 7.17 Favored 'General case' 0 CA--C 1.533 0.29 0 CA-C-N 119.011 1.406 . . . . 0.0 110.623 -173.813 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 78.89 -16.26 8.81 Favored Glycine 0 CA--C 1.535 1.313 0 C-N-CA 124.791 1.186 . . . . 0.0 114.21 -179.519 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 59.7 mttt -89.68 -42.5 11.32 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-N 119.398 1.599 . . . . 0.0 110.806 179.152 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.461 HD12 HG21 ' A' ' 4' ' ' VAL . 12.4 pt -140.71 149.97 20.95 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.33 0 C-N-CA 123.543 0.737 . . . . 0.0 111.263 -169.031 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -95.51 157.89 15.69 Favored 'General case' 0 C--O 1.224 -0.243 0 C-N-CA 125.6 1.56 . . . . 0.0 108.039 172.584 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 20.0 t -139.74 135.19 38.89 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 N-CA-C 107.189 -1.412 . . . . 0.0 107.189 -175.413 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 14.0 m -142.76 106.87 4.72 Favored 'General case' 0 N--CA 1.446 -0.663 0 N-CA-C 107.401 -1.333 . . . . 0.0 107.401 177.896 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 58.9 m -90.15 99.63 12.61 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 107.986 -1.116 . . . . 0.0 107.986 169.501 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 11.1 p -68.56 -63.03 1.14 Allowed 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 124.296 1.038 . . . . 0.0 110.461 -178.587 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 94.05 136.09 7.99 Favored Glycine 0 N--CA 1.446 -0.646 0 N-CA-C 107.713 -2.155 . . . . 0.0 107.713 -172.373 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 10.2 mt -68.74 -31.05 69.82 Favored 'General case' 0 CA--C 1.533 0.315 0 N-CA-C 108.538 -0.912 . . . . 0.0 108.538 170.183 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 26.6 mt-10 -137.25 156.1 48.7 Favored 'General case' 0 N--CA 1.444 -0.727 0 C-N-CA 129.119 2.968 . . . . 0.0 104.855 168.752 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 78.5 p -142.46 155.05 45.04 Favored 'General case' 0 N--CA 1.446 -0.646 0 N-CA-C 115.465 1.654 . . . . 0.0 115.465 -174.407 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 51.1 m -163.17 179.25 7.59 Favored 'General case' 0 N--CA 1.447 -0.577 0 C-N-CA 131.257 3.823 . . . . 0.0 104.796 -169.337 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 16.4 ttt180 -81.56 179.16 7.95 Favored 'General case' 0 N--CA 1.469 0.487 0 N-CA-C 108.411 -0.959 . . . . 0.0 108.411 169.486 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 4.1 m -81.16 176.4 0.68 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.575 0 C-N-CA 124.864 1.266 . . . . 0.0 109.445 176.805 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 76.1 t60 -78.59 140.97 59.91 Favored Pre-proline 0 CA--C 1.545 0.772 0 CA-C-O 118.58 -0.724 . . . . 0.0 110.104 -178.403 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 20.4 Cg_endo -60.59 -50.3 7.06 Favored 'Trans proline' 0 C--N 1.348 0.525 0 C-N-CA 123.084 2.523 . . . . 0.0 113.592 -173.787 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 23.1 m -65.91 -21.52 66.45 Favored 'General case' 0 CA--C 1.533 0.324 0 CA-C-N 118.807 0.731 . . . . 0.0 110.813 -178.29 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -58.79 -45.03 90.79 Favored 'General case' 0 C--O 1.215 -0.733 0 O-C-N 121.386 -0.821 . . . . 0.0 109.453 174.576 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 62.6 mt -60.51 -43.72 94.95 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 N-CA-C 108.303 -0.999 . . . . 0.0 108.303 -173.598 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -64.9 -44.47 89.48 Favored 'General case' 0 CA--C 1.536 0.442 0 CA-C-O 121.282 0.563 . . . . 0.0 110.857 -179.632 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 33.6 mmt -66.33 -39.3 89.14 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-O 123.455 1.598 . . . . 0.0 110.779 -179.972 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -76.21 -29.8 57.75 Favored 'General case' 0 N--CA 1.44 -0.952 0 N-CA-C 106.296 -1.742 . . . . 0.0 106.296 -174.882 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 -70.27 -20.48 63.04 Favored 'General case' 0 N--CA 1.444 -0.765 0 C-N-CA 123.91 0.884 . . . . 0.0 110.438 169.525 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 59.0 mt-10 -64.55 -38.03 89.59 Favored 'General case' 0 C--N 1.345 0.375 0 CA-C-N 120.237 1.381 . . . . 0.0 108.787 169.405 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . 0.311 5.3 p -84.92 8.21 1.65 Allowed 'Isoleucine or valine' 0 CA--C 1.548 0.87 0 N-CA-C 112.272 0.471 . . . . 0.0 112.272 171.442 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 75.05 16.68 80.45 Favored Glycine 0 CA--C 1.533 1.19 0 C-N-CA 124.493 1.044 . . . . 0.0 113.523 175.494 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 43.9 mt -108.85 137.62 39.89 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.229 0 C-N-CA 124.487 1.115 . . . . 0.0 108.921 -177.016 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 21.1 t0 -102.22 145.34 29.56 Favored 'General case' 0 N--CA 1.462 0.153 0 CA-C-O 121.103 0.478 . . . . 0.0 110.208 169.69 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 11.2 pt -138.36 -15.11 0.53 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.633 0 C-N-CA 127.548 2.339 . . . . 0.0 111.325 178.223 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 13.0 t -39.39 -43.12 1.16 Allowed 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 125.883 1.673 . . . . 0.0 113.527 171.584 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -76.37 6.13 39.35 Favored Glycine 0 CA--C 1.532 1.111 0 CA-C-O 118.635 -1.092 . . . . 0.0 114.36 -175.01 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -68.57 130.18 42.09 Favored 'General case' 0 N--CA 1.448 -0.559 0 CA-C-N 119.736 1.768 . . . . 0.0 110.203 -178.43 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 5.2 t -168.18 161.3 12.31 Favored 'General case' 0 N--CA 1.44 -0.95 0 N-CA-C 106.067 -1.827 . . . . 0.0 106.067 167.047 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 15.0 m -173.87 161.38 3.76 Favored 'General case' 0 C--N 1.322 -0.598 0 C-N-CA 127.438 2.295 . . . . 0.0 106.746 -178.396 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -65.91 161.49 53.99 Favored Pre-proline 0 CA--C 1.542 0.652 0 CA-C-N 115.184 -0.917 . . . . 0.0 108.854 169.002 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -59.39 150.6 74.08 Favored 'Trans proline' 0 N--CA 1.457 -0.627 0 C-N-CA 121.545 1.497 . . . . 0.0 109.802 172.444 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 16.8 tt -57.3 -26.34 25.67 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.278 0 C-N-CA 123.433 0.693 . . . . 0.0 112.181 -174.681 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 11.6 mt-10 -65.42 -27.71 68.72 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 123.212 0.605 . . . . 0.0 110.453 -176.637 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 10.0 t-20 -65.23 -30.04 70.89 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 125.484 1.514 . . . . 0.0 111.71 178.662 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 78.0 m-85 -88.47 176.51 7.14 Favored 'General case' 0 C--O 1.236 0.374 0 C-N-CA 125.012 1.325 . . . . 0.0 111.543 -173.962 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 51.9 t-20 -126.56 129.06 47.84 Favored 'General case' 0 N--CA 1.447 -0.621 0 N-CA-C 107.278 -1.379 . . . . 0.0 107.278 169.136 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -73.11 -21.23 60.78 Favored 'General case' 0 N--CA 1.436 -1.139 0 N-CA-C 109.936 -0.394 . . . . 0.0 109.936 -177.208 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 36.0 t70 -65.06 -25.76 67.95 Favored 'General case' 0 N--CA 1.441 -0.897 0 O-C-N 123.617 0.573 . . . . 0.0 111.583 -179.446 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -74.76 -28.37 60.73 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 122.976 0.51 . . . . 0.0 111.477 176.022 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 18.1 m-85 -84.43 163.58 19.4 Favored 'General case' 0 N--CA 1.45 -0.443 0 C-N-CA 125.784 1.634 . . . . 0.0 110.585 -179.419 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 19.8 t70 -108.01 -36.91 6.21 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.624 178.591 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -142.7 139.4 28.33 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.31 0 CA-C-O 121.657 0.741 . . . . 0.0 110.316 -170.797 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 96.9 t -141.15 140.68 32.0 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.407 0 N-CA-C 106.631 -1.618 . . . . 0.0 106.631 -175.634 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 45.3 mm -132.7 121.41 44.77 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.429 0 N-CA-C 106.619 -1.623 . . . . 0.0 106.619 -173.913 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 67.4 m -91.31 115.13 27.78 Favored 'General case' 0 N--CA 1.449 -0.5 0 N-CA-C 106.657 -1.608 . . . . 0.0 106.657 169.359 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 69.7 mt -77.04 -13.75 59.91 Favored 'General case' 0 N--CA 1.466 0.343 0 C-N-CA 124.245 1.018 . . . . 0.0 111.693 -177.536 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 65.2 m -140.87 88.64 2.2 Favored 'General case' 0 N--CA 1.452 -0.328 0 C-N-CA 125.288 1.435 . . . . 0.0 108.478 -169.724 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 63.66 -155.57 44.36 Favored Glycine 0 CA--C 1.528 0.893 0 N-CA-C 110.562 -1.015 . . . . 0.0 110.562 -175.852 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 4.7 p -150.82 148.56 28.64 Favored 'General case' 0 C--O 1.236 0.363 0 C-N-CA 124.527 1.131 . . . . 0.0 109.166 179.64 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 62.48 28.92 72.02 Favored Glycine 0 CA--C 1.532 1.153 0 CA-C-O 119.696 -0.502 . . . . 0.0 112.189 -179.495 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 12.7 m -80.06 67.59 0.44 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.587 0 C-N-CA 124.661 1.185 . . . . 0.0 110.63 -170.007 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 1.3 t30 58.0 56.06 4.89 Favored 'General case' 0 N--CA 1.468 0.432 0 C-N-CA 126.298 1.839 . . . . 0.0 108.201 -173.714 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.407 ' HA ' ' HD3' ' A' ' 87' ' ' PRO . 0.4 OUTLIER -142.67 142.26 22.44 Favored Pre-proline 0 CA--C 1.541 0.613 0 C-N-CA 126.215 1.806 . . . . 0.0 108.425 -169.086 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . 0.407 ' HD3' ' HA ' ' A' ' 86' ' ' LEU . 35.2 Cg_exo -67.46 146.43 74.41 Favored 'Trans proline' 0 CA--C 1.54 0.779 0 C-N-CA 121.693 1.595 . . . . 0.0 113.518 -176.95 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . 0.432 ' O ' HG22 ' A' ' 92' ' ' THR . 69.8 Cg_endo -72.43 -18.46 26.13 Favored 'Trans proline' 0 N--CA 1.46 -0.451 0 C-N-CA 122.535 2.157 . . . . 0.0 113.751 -171.975 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -57.07 -24.78 56.36 Favored 'General case' 0 CA--C 1.538 0.491 0 CA-C-N 119.944 1.247 . . . . 0.0 111.19 173.98 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 95.1 m95 -81.8 -31.35 31.83 Favored 'General case' 0 N--CA 1.451 -0.389 0 C-N-CA 124.088 0.955 . . . . 0.0 112.251 178.546 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 2.7 m -80.83 -6.5 9.73 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.362 0 CA-C-N 118.748 0.704 . . . . 0.0 112.245 178.022 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . 0.432 HG22 ' O ' ' A' ' 88' ' ' PRO . 5.4 t -137.04 77.08 1.62 Allowed 'General case' 0 CA--C 1.542 0.654 0 CA-C-O 122.768 1.271 . . . . 0.0 111.655 -175.329 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 91.0 mm-40 -114.33 -171.68 1.96 Allowed 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 125.064 1.346 . . . . 0.0 108.115 168.694 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 35.1 mm-40 -58.76 -28.03 65.52 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-N 118.9 0.773 . . . . 0.0 111.194 -172.348 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 5.3 tt -141.37 143.63 27.44 Favored 'Isoleucine or valine' 0 C--O 1.24 0.567 0 N-CA-C 104.737 -2.32 . . . . 0.0 104.737 168.346 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 63.9 t80 -133.8 145.65 49.96 Favored 'General case' 0 N--CA 1.447 -0.581 0 N-CA-C 105.905 -1.887 . . . . 0.0 105.905 169.286 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 24.1 mm-40 -136.26 145.48 45.63 Favored 'General case' 0 C--O 1.237 0.434 0 N-CA-C 107.903 -1.147 . . . . 0.0 107.903 171.685 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -115.9 135.79 53.65 Favored 'General case' 0 C--O 1.238 0.451 0 N-CA-C 107.146 -1.428 . . . . 0.0 107.146 169.703 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 30.2 m95 -138.68 178.77 6.9 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 124.462 1.105 . . . . 0.0 108.796 178.963 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 30.6 tt0 -138.5 77.39 1.62 Allowed 'General case' 0 CA--C 1.532 0.285 0 N-CA-C 106.013 -1.847 . . . . 0.0 106.013 169.467 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -68.26 144.09 55.01 Favored 'General case' 0 N--CA 1.466 0.37 0 N-CA-C 108.656 -0.868 . . . . 0.0 108.656 177.877 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -81.18 166.66 20.43 Favored 'General case' 0 N--CA 1.452 -0.363 0 N-CA-C 107.576 -1.268 . . . . 0.0 107.576 169.457 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -142.32 135.23 13.92 Favored Pre-proline 0 CA--C 1.535 0.385 0 O-C-N 121.803 -0.56 . . . . 0.0 111.193 179.076 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -84.21 2.47 8.15 Favored 'Trans proline' 0 CA--C 1.545 1.042 0 C-N-CA 123.416 2.744 . . . . 0.0 114.958 -172.3 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 2.9 t70 -45.29 122.77 3.63 Favored 'General case' 0 C--O 1.238 0.484 0 CA-C-N 120.121 1.328 . . . . 0.0 111.521 176.634 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 70.9 13.73 72.54 Favored Glycine 0 CA--C 1.533 1.171 0 CA-C-O 118.335 -1.258 . . . . 0.0 114.724 170.18 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 29.6 pt20 -130.14 -172.32 2.75 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-N 119.444 1.622 . . . . 0.0 111.165 175.889 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 3.3 m -68.83 156.85 37.66 Favored 'General case' 0 CA--C 1.535 0.374 0 N-CA-C 116.25 1.944 . . . . 0.0 116.25 -168.0 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -63.73 -27.42 69.19 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 125.017 1.327 . . . . 0.0 111.155 179.645 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 7.7 tp10 -60.17 -35.12 74.63 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-N 118.171 0.442 . . . . 0.0 110.164 173.346 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 3.4 t -74.08 -42.62 52.08 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.301 0 CA-C-O 118.234 -0.889 . . . . 0.0 109.154 179.018 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 61.1 m-85 -53.78 -50.28 66.41 Favored 'General case' 0 N--CA 1.472 0.645 0 CA-C-N 120.042 1.292 . . . . 0.0 109.644 171.599 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 95.5 mtt180 -67.5 -34.97 78.21 Favored 'General case' 0 N--CA 1.465 0.296 0 O-C-N 121.795 -0.566 . . . . 0.0 111.237 -175.46 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 6.6 m -62.77 -49.9 73.15 Favored 'General case' 0 N--CA 1.448 -0.56 0 C-N-CA 123.984 0.913 . . . . 0.0 109.547 171.292 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 96.7 t -70.06 -26.72 30.38 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.296 0 CA-C-O 117.485 -1.245 . . . . 0.0 109.897 -171.092 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 85.4 mtm-85 -57.29 -48.41 78.97 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-N 120.407 1.458 . . . . 0.0 109.58 169.58 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -63.18 -48.67 77.71 Favored Glycine 0 CA--C 1.53 1.012 0 CA-C-N 118.464 0.575 . . . . 0.0 111.877 178.912 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 17.8 mt-30 -61.51 -46.69 88.94 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-N 118.073 0.937 . . . . 0.0 110.895 -178.3 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 67.4 t -64.89 -46.21 92.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-O 118.504 -0.76 . . . . 0.0 109.27 -179.585 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 87.4 tttt -54.23 -48.22 71.32 Favored 'General case' 0 C--O 1.22 -0.457 0 CA-C-N 118.921 0.782 . . . . 0.0 109.018 -178.462 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 40.4 tt0 -64.12 -42.62 96.77 Favored 'General case' 0 N--CA 1.45 -0.471 0 O-C-N 123.252 0.345 . . . . 0.0 110.865 -173.385 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 52.9 mtt-85 -67.34 -43.31 81.86 Favored 'General case' 0 N--CA 1.468 0.445 0 O-C-N 121.656 -0.653 . . . . 0.0 111.02 177.987 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 77.2 t -65.55 -41.15 90.15 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.395 0 N-CA-C 109.734 -0.469 . . . . 0.0 109.734 179.378 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 26.3 mt-10 -59.02 -44.82 91.77 Favored 'General case' 0 N--CA 1.455 -0.221 0 CA-C-N 119.17 0.895 . . . . 0.0 109.971 177.271 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 29.2 t-20 -62.06 -43.31 99.1 Favored 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 122.575 0.35 . . . . 0.0 110.933 -178.323 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 1.8 tm? -59.36 -49.04 79.34 Favored 'General case' 0 N--CA 1.455 -0.201 0 C-N-CA 124.042 0.937 . . . . 0.0 110.529 176.726 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 96.4 mt -64.91 -42.81 95.81 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.258 0 C-N-CA 124.108 0.963 . . . . 0.0 108.933 -178.844 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -61.5 -30.22 70.48 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 123.347 0.659 . . . . 0.0 111.639 177.951 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 91.5 mttt -69.25 -55.75 9.62 Favored 'General case' 0 C--N 1.343 0.313 0 CA-C-N 118.933 0.788 . . . . 0.0 110.229 172.862 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 20.8 pt -74.52 -41.26 49.09 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.291 0 N-CA-C 114.017 1.117 . . . . 0.0 114.017 -169.523 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 72.5 m . . . . . 0 C--O 1.253 1.268 0 C-N-CA 126.226 1.81 . . . . 0.0 108.995 -169.558 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 9.9 ptm . . . . . 0 N--CA 1.498 1.939 0 N-CA-C 110.64 -0.133 . . . . 0.0 110.64 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 33.8 mttm -74.62 119.76 19.24 Favored 'General case' 0 N--CA 1.479 0.985 0 O-C-N 121.127 -0.983 . . . . 0.0 108.397 -170.711 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 90.2 mttt -85.33 135.15 34.02 Favored 'General case' 0 CA--C 1.515 -0.403 0 N-CA-C 108.07 -1.085 . . . . 0.0 108.07 174.894 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 1.6 t -121.81 147.13 25.98 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 C-N-CA 125.529 1.532 . . . . 0.0 109.37 -168.849 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 13.3 mtt -134.66 146.39 49.47 Favored 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 125.659 1.584 . . . . 0.0 109.544 169.399 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 41.2 m-85 -135.58 113.51 11.14 Favored 'General case' 0 N--CA 1.454 -0.274 0 N-CA-C 106.339 -1.726 . . . . 0.0 106.339 169.41 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 3.2 p -157.25 146.36 10.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 N-CA-C 109.029 -0.73 . . . . 0.0 109.029 -169.963 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 25.5 t -157.73 145.75 18.87 Favored 'General case' 0 C--N 1.328 -0.326 0 N-CA-C 105.593 -2.003 . . . . 0.0 105.593 168.839 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 5.6 tmtt? 51.81 -85.58 0.01 OUTLIER 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 126.078 1.751 . . . . 0.0 112.145 178.552 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 11.8 ptp180 -142.17 -178.82 5.9 Favored 'General case' 0 C--O 1.225 -0.198 0 CA-C-N 119.589 1.086 . . . . 0.0 111.09 178.706 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 1.7 t30 -57.49 -35.26 69.98 Favored 'General case' 0 N--CA 1.467 0.412 0 C-N-CA 124.416 1.086 . . . . 0.0 111.666 -179.21 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -70.95 -23.45 62.23 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 124.456 1.102 . . . . 0.0 113.05 -175.194 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 3.8 m -70.4 -159.61 0.04 OUTLIER 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 126.272 1.829 . . . . 0.0 111.994 -169.673 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 2.8 mpp_? -51.8 -25.52 7.87 Favored 'General case' 0 N--CA 1.481 1.112 0 O-C-N 119.808 -1.808 . . . . 0.0 112.34 175.638 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 1.4 m -41.89 -29.44 0.21 Allowed 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 126.74 2.016 . . . . 0.0 112.856 169.622 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . 0.442 ' HA ' HE22 ' A' ' 60' ' ' GLN . 5.1 pt20 -54.47 -35.87 63.52 Favored 'General case' 0 C--O 1.22 -0.497 0 CA-C-O 117.491 -1.242 . . . . 0.0 113.218 178.328 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -105.66 -51.64 2.96 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-N 120.678 1.581 . . . . 0.0 114.727 -168.592 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -63.72 -34.8 78.68 Favored 'General case' 0 N--CA 1.471 0.61 0 N-CA-C 114.248 1.203 . . . . 0.0 114.248 -168.456 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 2.4 pp20? -64.95 -34.13 77.69 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-N 119.003 0.82 . . . . 0.0 110.103 172.783 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -51.29 -62.79 5.14 Favored Glycine 0 C--N 1.338 0.652 0 C-N-CA 125.847 1.689 . . . . 0.0 110.419 174.287 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 9.2 m-85 -63.13 -33.31 75.18 Favored 'General case' 0 CA--C 1.507 -0.7 0 CA-C-N 118.684 1.242 . . . . 0.0 113.434 179.985 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -67.42 -30.47 70.23 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 119.592 1.087 . . . . 0.0 111.376 -173.644 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 1.1 ptmt -70.32 -20.92 62.97 Favored 'General case' 0 CA--C 1.539 0.522 0 CA-C-N 119.288 0.949 . . . . 0.0 111.784 174.366 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 2.9 m -85.37 -57.39 3.09 Favored 'General case' 0 N--CA 1.45 -0.475 0 C-N-CA 125.537 1.535 . . . . 0.0 110.633 176.931 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 75.3 mt -73.98 -36.76 64.59 Favored 'General case' 0 N--CA 1.463 0.224 0 C-N-CA 123.989 0.915 . . . . 0.0 110.297 -172.617 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -93.36 8.9 74.95 Favored Glycine 0 CA--C 1.525 0.662 0 CA-C-O 118.486 -1.174 . . . . 0.0 112.813 -177.202 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -51.33 123.69 10.2 Favored 'General case' 0 CA--C 1.534 0.327 0 C-N-CA 124.806 1.242 . . . . 0.0 110.507 -174.962 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 76.48 -9.81 19.9 Favored Glycine 0 CA--C 1.533 1.17 0 CA-C-O 118.721 -1.044 . . . . 0.0 114.274 179.906 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 85.4 mttt -97.19 -49.66 4.88 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-N 119.478 1.639 . . . . 0.0 110.518 178.666 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 39.8 pt -137.57 147.64 26.29 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.537 0 C-N-CA 124.056 0.942 . . . . 0.0 108.772 -169.881 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -107.47 102.6 11.86 Favored 'General case' 0 C--O 1.225 -0.193 0 C-N-CA 124.949 1.3 . . . . 0.0 110.065 -169.582 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 6.2 t -85.69 125.19 40.55 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 N-CA-C 108.619 -0.882 . . . . 0.0 108.619 -179.531 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 23.4 m -151.85 97.71 2.38 Favored 'General case' 0 N--CA 1.453 -0.321 0 N-CA-C 103.957 -2.608 . . . . 0.0 103.957 173.105 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 18.0 m -94.99 1.12 55.16 Favored 'General case' 0 CA--C 1.535 0.386 0 N-CA-C 115.019 1.489 . . . . 0.0 115.019 -169.153 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 1.5 m 52.88 -147.52 0.47 Allowed 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 123.747 0.819 . . . . 0.0 110.767 -179.663 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -164.27 167.15 38.08 Favored Glycine 0 CA--C 1.525 0.69 0 N-CA-C 109.7 -1.36 . . . . 0.0 109.7 169.973 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 3.2 mt -133.64 143.72 48.77 Favored 'General case' 0 N--CA 1.446 -0.657 0 C-N-CA 127.67 2.388 . . . . 0.0 104.952 170.02 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 50.7 mt-10 65.46 -59.78 0.27 Allowed 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 127.227 2.211 . . . . 0.0 111.293 -173.755 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 65.1 m 67.11 152.78 0.08 Allowed 'General case' 0 N--CA 1.44 -0.935 0 C-N-CA 129.463 3.105 . . . . 0.0 115.894 170.043 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 15.2 m -177.62 -173.75 0.43 Allowed 'General case' 0 CA--C 1.545 0.764 1 C-N-CA 132.107 4.163 . . . . 0.0 102.607 -169.457 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 7.5 ttt180 -105.53 169.02 8.71 Favored 'General case' 0 N--CA 1.469 0.515 0 O-C-N 120.584 -1.323 . . . . 0.0 108.663 169.678 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 11.4 m -69.68 165.62 2.47 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.71 0 CA-C-N 115.649 -0.705 . . . . 0.0 109.415 175.827 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 90.3 m-70 -79.12 151.62 75.91 Favored Pre-proline 0 CA--C 1.537 0.446 0 CA-C-O 119.314 -0.374 . . . . 0.0 111.511 -174.89 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 39.9 Cg_endo -62.21 -46.12 13.57 Favored 'Trans proline' 0 C--N 1.346 0.43 0 C-N-CA 123.175 2.583 . . . . 0.0 111.772 -174.583 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 4.4 m -66.93 -28.24 68.13 Favored 'General case' 0 CA--C 1.531 0.25 0 O-C-N 121.949 -0.47 . . . . 0.0 110.02 -179.953 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -57.62 -54.56 45.52 Favored 'General case' 0 CA--C 1.511 -0.545 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 173.03 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 63.4 mt -59.55 -40.05 80.96 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.357 0 N-CA-C 108.607 -0.886 . . . . 0.0 108.607 -174.987 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -61.65 -43.49 98.75 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-N 119.004 0.82 . . . . 0.0 111.633 179.8 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 38.0 mmt -75.48 -36.52 60.62 Favored 'General case' 0 C--O 1.235 0.315 0 CA-C-O 122.806 1.289 . . . . 0.0 110.488 -177.285 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -71.58 -28.89 64.13 Favored 'General case' 0 N--CA 1.446 -0.643 0 N-CA-C 107.509 -1.293 . . . . 0.0 107.509 178.604 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 41.2 tt0 -73.78 -19.18 60.84 Favored 'General case' 0 N--CA 1.446 -0.63 0 C-N-CA 125.069 1.347 . . . . 0.0 110.563 169.958 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 76.1 mt-10 -64.09 -34.71 78.65 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-N 120.234 1.379 . . . . 0.0 108.681 169.146 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . 0.302 10.0 p -89.8 10.11 2.57 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.931 0 N-CA-C 112.434 0.531 . . . . 0.0 112.434 169.582 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 71.89 15.77 76.22 Favored Glycine 0 CA--C 1.533 1.162 0 O-C-N 120.761 -1.212 . . . . 0.0 113.767 175.926 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 22.3 mt -96.07 142.46 13.79 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.288 0 CA-C-N 118.42 1.11 . . . . 0.0 110.462 -175.473 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 8.9 t70 -91.78 129.66 37.7 Favored 'General case' 0 C--O 1.236 0.392 0 N-CA-C 108.192 -1.04 . . . . 0.0 108.192 169.574 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 10.1 pt -124.91 -27.21 1.52 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.657 0 C-N-CA 124.567 1.147 . . . . 0.0 110.166 169.7 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -37.12 -40.92 0.34 Allowed 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 129.746 3.218 . . . . 0.0 113.909 169.11 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -83.2 13.04 47.52 Favored Glycine 0 CA--C 1.534 1.251 0 C-N-CA 125.443 1.497 . . . . 0.0 114.566 -177.47 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . 0.442 HE22 ' HA ' ' A' ' 16' ' ' GLN . 0.9 OUTLIER -60.98 -34.84 75.41 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 119.607 1.703 . . . . 0.0 113.026 -176.026 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -70.3 131.89 44.86 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 123.539 0.736 . . . . 0.0 109.142 -170.677 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 26.0 m -158.29 -61.17 0.08 Allowed 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 123.463 0.705 . . . . 0.0 110.568 -179.526 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -150.98 153.31 32.93 Favored Pre-proline 0 N--CA 1.467 0.422 0 C-N-CA 123.424 0.69 . . . . 0.0 109.815 -175.007 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 96.4 Cg_endo -66.94 155.59 70.11 Favored 'Trans proline' 0 N--CA 1.454 -0.819 0 C-N-CA 122.53 2.153 . . . . 0.0 110.008 171.588 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 7.1 tt -59.94 -26.0 34.42 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.513 0 C-N-CA 123.326 0.65 . . . . 0.0 111.324 -179.242 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 14.8 mt-10 -67.71 -25.25 65.57 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 124.867 1.267 . . . . 0.0 110.636 -175.096 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 7.0 t-20 -63.89 -22.72 67.05 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 124.69 1.196 . . . . 0.0 112.047 177.648 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 70.0 m-85 -105.75 -174.1 2.46 Favored 'General case' 0 C--O 1.234 0.269 0 C-N-CA 126.424 1.889 . . . . 0.0 109.923 -175.89 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 54.3 t-20 -137.69 140.86 41.02 Favored 'General case' 0 N--CA 1.446 -0.654 0 N-CA-C 107.667 -1.235 . . . . 0.0 107.667 169.407 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -74.07 -25.13 59.65 Favored 'General case' 0 N--CA 1.435 -1.181 0 N-CA-C 109.19 -0.67 . . . . 0.0 109.19 -178.559 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -63.01 -24.35 67.88 Favored 'General case' 0 N--CA 1.447 -0.584 0 O-C-N 123.441 0.463 . . . . 0.0 111.643 178.937 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -77.71 -27.69 50.72 Favored 'General case' 0 C--O 1.236 0.361 0 C-N-CA 123.808 0.843 . . . . 0.0 112.37 175.991 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 11.6 m-85 -81.02 172.21 14.02 Favored 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 125.853 1.661 . . . . 0.0 112.099 -177.47 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 24.1 t70 -120.98 -37.72 2.93 Favored 'General case' 0 N--CA 1.464 0.234 0 C-N-CA 123.68 0.792 . . . . 0.0 111.678 175.824 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -139.38 136.76 41.05 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.328 0 CA-C-N 118.432 0.56 . . . . 0.0 110.498 -170.144 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 77.2 t -147.5 128.81 5.96 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.537 0 N-CA-C 106.516 -1.661 . . . . 0.0 106.516 -176.062 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.597 HD12 ' HB2' ' A' ' 97' ' ' GLU . 12.0 mm -109.17 128.09 65.36 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.473 0 N-CA-C 106.862 -1.533 . . . . 0.0 106.862 177.732 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 60.5 m -94.71 101.24 13.08 Favored 'General case' 0 N--CA 1.446 -0.671 0 N-CA-C 104.508 -2.404 . . . . 0.0 104.508 169.292 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 30.0 mt -66.73 -4.94 10.15 Favored 'General case' 0 N--CA 1.471 0.576 0 N-CA-C 113.931 1.085 . . . . 0.0 113.931 -169.775 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -151.04 151.82 32.58 Favored 'General case' 0 N--CA 1.45 -0.46 0 N-CA-C 106.335 -1.728 . . . . 0.0 106.335 168.744 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 54.75 -140.77 37.28 Favored Glycine 0 CA--C 1.533 1.166 0 C-N-CA 123.851 0.738 . . . . 0.0 111.701 174.647 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 16.0 m -132.71 -76.65 0.49 Allowed 'General case' 0 CA--C 1.529 0.163 0 N-CA-C 108.603 -0.888 . . . . 0.0 108.603 175.783 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -78.34 -40.45 19.55 Favored Glycine 0 C--N 1.34 0.793 0 CA-C-O 118.85 -0.972 . . . . 0.0 112.05 -179.156 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . 0.351 16.2 m 47.48 -94.27 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.547 0.838 0 C-N-CA 125.56 1.544 . . . . 0.0 112.629 -178.757 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 58.7 t30 -141.82 45.07 1.7 Allowed 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 124.653 1.181 . . . . 0.0 109.365 171.557 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 1.2 tt -136.25 140.58 33.24 Favored Pre-proline 0 CA--C 1.547 0.837 0 C-N-CA 126.591 1.956 . . . . 0.0 109.384 -169.517 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -67.96 149.98 77.79 Favored 'Trans proline' 0 CA--C 1.541 0.873 0 C-N-CA 121.649 1.566 . . . . 0.0 113.668 -172.173 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -69.37 -27.66 28.07 Favored 'Trans proline' 0 N--CA 1.461 -0.423 0 C-N-CA 122.622 2.214 . . . . 0.0 115.502 -169.587 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 4.3 pm0 -61.91 -17.05 55.34 Favored 'General case' 0 CA--C 1.539 0.557 0 CA-C-N 121.432 1.924 . . . . 0.0 111.954 178.684 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 99.6 m95 -78.01 -42.04 33.86 Favored 'General case' 0 N--CA 1.447 -0.583 0 C-N-CA 123.8 0.84 . . . . 0.0 110.933 175.424 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 1.6 m -74.49 -7.72 10.46 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.26 0 C-N-CA 123.469 0.708 . . . . 0.0 111.97 -179.317 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 74.4 p -109.15 18.47 20.53 Favored 'General case' 0 C--O 1.238 0.49 0 N-CA-C 113.837 1.051 . . . . 0.0 113.837 -178.132 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 91.9 mm-40 -68.56 171.03 8.11 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-N 118.539 0.609 . . . . 0.0 111.644 176.912 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 32.8 mm-40 -56.03 -30.23 61.57 Favored 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 123.995 0.918 . . . . 0.0 112.929 -168.83 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 4.0 tt -130.54 114.73 29.04 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.345 0 N-CA-C 105.018 -2.216 . . . . 0.0 105.018 169.014 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 22.5 t80 -100.65 134.41 43.66 Favored 'General case' 0 C--O 1.236 0.392 0 N-CA-C 105.63 -1.989 . . . . 0.0 105.63 169.388 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . 0.597 ' HB2' HD12 ' A' ' 77' ' ' ILE . 11.4 mm-40 -142.69 164.21 30.71 Favored 'General case' 0 C--N 1.329 -0.289 0 C-N-CA 124.451 1.1 . . . . 0.0 109.18 179.247 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 2.3 t70 -170.02 129.87 0.95 Allowed 'General case' 0 C--O 1.237 0.445 0 C-N-CA 128.192 2.597 . . . . 0.0 106.618 -169.954 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' TRP . . . . . 0.465 ' CZ3' HG21 ' A' ' 77' ' ' ILE . 10.0 m0 -140.8 147.91 39.79 Favored 'General case' 0 C--O 1.234 0.242 0 C-N-CA 123.33 0.652 . . . . 0.0 111.836 -169.814 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 18.4 mp0 -74.06 111.64 9.42 Favored 'General case' 0 C--O 1.234 0.285 0 N-CA-C 105.294 -2.114 . . . . 0.0 105.294 169.345 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.464 HD13 HG22 ' A' ' 119' ' ' VAL . 44.3 mt -146.03 128.34 15.83 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 104.323 -2.473 . . . . 0.0 104.323 178.604 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 61.4 mm-40 -76.99 156.07 32.16 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-N 119.197 0.908 . . . . 0.0 110.044 179.417 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 55.6 t0 -100.39 111.37 62.48 Favored Pre-proline 0 N--CA 1.448 -0.567 0 N-CA-C 105.612 -1.996 . . . . 0.0 105.612 168.882 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 96.3 Cg_endo -73.75 -0.08 8.92 Favored 'Trans proline' 0 CA--C 1.541 0.843 0 C-N-CA 122.913 2.408 . . . . 0.0 113.643 -175.834 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -47.61 128.96 13.37 Favored 'General case' 0 C--O 1.237 0.445 0 CA-C-N 119.468 1.031 . . . . 0.0 111.268 173.748 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 70.99 12.17 71.04 Favored Glycine 0 CA--C 1.53 1.017 0 CA-C-O 118.523 -1.154 . . . . 0.0 114.236 169.953 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 29.5 pt20 -133.15 -172.83 3.04 Favored 'General case' 0 CA--C 1.536 0.414 0 CA-C-N 119.029 1.415 . . . . 0.0 110.763 176.282 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 3.2 m -68.59 156.55 37.88 Favored 'General case' 0 CA--C 1.532 0.256 0 N-CA-C 116.161 1.912 . . . . 0.0 116.161 -167.964 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 48.7 mt -60.47 -28.49 68.38 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 125.05 1.34 . . . . 0.0 111.146 174.758 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 40.1 tt0 -58.19 -37.22 74.32 Favored 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 122.919 0.487 . . . . 0.0 110.34 173.168 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 3.5 t -75.12 -43.95 44.09 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.31 0 CA-C-O 117.866 -1.064 . . . . 0.0 109.34 179.195 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 59.9 m-85 -53.67 -47.45 70.38 Favored 'General case' 0 N--CA 1.474 0.759 0 CA-C-N 120.399 1.454 . . . . 0.0 110.404 172.873 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 92.5 mtt180 -72.88 -35.17 67.1 Favored 'General case' 0 N--CA 1.466 0.344 0 O-C-N 121.612 -0.68 . . . . 0.0 111.428 -175.785 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 4.0 m -60.77 -49.67 76.56 Favored 'General case' 0 N--CA 1.448 -0.551 0 N-CA-C 109.003 -0.74 . . . . 0.0 109.003 171.103 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 75.0 t -65.02 -38.4 82.68 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.415 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 -176.647 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 52.5 ttp85 -57.37 -44.88 84.79 Favored 'General case' 0 CA--C 1.539 0.528 0 CA-C-N 118.734 0.697 . . . . 0.0 110.234 176.244 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -65.65 -50.02 56.61 Favored Glycine 0 CA--C 1.532 1.146 0 CA-C-N 118.609 0.641 . . . . 0.0 112.143 174.915 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 40.8 mm-40 -58.69 -48.78 79.94 Favored 'General case' 0 N--CA 1.464 0.252 0 C-N-CA 123.776 0.83 . . . . 0.0 110.454 -176.215 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . 0.464 HG22 HD13 ' A' ' 101' ' ' LEU . 87.7 t -66.27 -40.31 86.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-O 118.234 -0.889 . . . . 0.0 110.236 -175.724 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 57.2 tttm -54.28 -45.12 72.39 Favored 'General case' 0 N--CA 1.462 0.139 0 CA-C-N 119.374 0.988 . . . . 0.0 109.075 177.669 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -67.71 -43.03 81.02 Favored 'General case' 0 CA--C 1.54 0.595 0 CA-C-O 119.154 -0.451 . . . . 0.0 111.658 -177.631 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 29.0 mmt180 -58.53 -47.4 84.3 Favored 'General case' 0 N--CA 1.477 0.886 0 CA-C-N 119.31 0.959 . . . . 0.0 110.845 175.373 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 77.0 t -69.43 -37.59 75.5 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.536 0 CA-C-O 118.673 -0.679 . . . . 0.0 109.25 -176.361 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 28.4 mt-10 -59.0 -44.42 91.65 Favored 'General case' 0 C--N 1.339 0.149 0 CA-C-N 120.089 1.313 . . . . 0.0 110.047 173.315 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 29.1 t-20 -62.41 -44.32 96.72 Favored 'General case' 0 CA--C 1.53 0.174 0 C-N-CA 122.661 0.384 . . . . 0.0 110.918 -179.431 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 39.1 tp -57.91 -48.44 79.89 Favored 'General case' 0 N--CA 1.454 -0.25 0 C-N-CA 124.166 0.986 . . . . 0.0 110.944 176.76 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 62.4 mt -65.47 -45.15 93.66 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.266 0 N-CA-C 107.705 -1.22 . . . . 0.0 107.705 -178.407 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -59.27 -29.08 67.31 Favored 'General case' 0 CA--C 1.54 0.592 0 CA-C-O 118.855 -0.593 . . . . 0.0 112.124 177.114 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 94.5 mttt -70.05 -57.29 5.15 Favored 'General case' 0 C--N 1.343 0.321 0 CA-C-N 119.09 0.859 . . . . 0.0 110.604 172.379 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 9.5 pt -80.79 -42.84 20.8 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.334 0 N-CA-C 115.659 1.726 . . . . 0.0 115.659 -168.497 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 51.0 m . . . . . 0 C--O 1.251 1.184 0 C-N-CA 124.979 1.312 . . . . 0.0 110.387 -169.861 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 11.8 ptm . . . . . 0 N--CA 1.497 1.919 0 N-CA-C 110.57 -0.159 . . . . 0.0 110.57 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . 0.416 ' HB2' HG22 ' A' ' 30' ' ' ILE . 25.3 mttm -75.55 120.84 21.52 Favored 'General case' 0 N--CA 1.479 1.018 0 N-CA-C 107.907 -1.145 . . . . 0.0 107.907 -171.806 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 89.8 mttt -89.38 134.85 33.9 Favored 'General case' 0 CA--C 1.515 -0.367 0 N-CA-C 108.069 -1.085 . . . . 0.0 108.069 177.548 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 1.5 t -119.69 149.59 22.3 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.619 0 C-N-CA 126.997 2.119 . . . . 0.0 108.789 -169.229 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 26.5 mtt -137.32 145.96 44.03 Favored 'General case' 0 C--N 1.325 -0.493 0 C-N-CA 124.849 1.26 . . . . 0.0 108.484 168.686 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 49.3 m-85 -138.12 132.48 32.05 Favored 'General case' 0 C--O 1.234 0.249 0 N-CA-C 105.661 -1.978 . . . . 0.0 105.661 171.132 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 2.1 p -163.13 143.86 2.62 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.189 0 CA-C-N 118.459 0.572 . . . . 0.0 111.035 -170.023 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 45.2 t -136.34 177.97 7.42 Favored 'General case' 0 CA--C 1.547 0.861 0 C-N-CA 127.758 2.423 . . . . 0.0 105.877 168.367 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 27.1 ttpp -59.58 -22.6 61.99 Favored 'General case' 0 N--CA 1.474 0.748 0 N-CA-C 113.874 1.064 . . . . 0.0 113.874 -169.804 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 84.9 mmt-85 -138.24 155.78 48.31 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-N 119.755 1.162 . . . . 0.0 107.871 169.886 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 46.6 t30 -71.09 -35.44 71.83 Favored 'General case' 0 CA--C 1.535 0.384 0 CA-C-O 121.279 0.561 . . . . 0.0 109.839 173.377 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 1.2 m -61.34 -25.26 67.02 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 125.012 1.325 . . . . 0.0 112.928 -174.993 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 14.2 m -138.37 125.28 21.17 Favored 'General case' 0 N--CA 1.455 -0.199 0 C-N-CA 123.46 0.704 . . . . 0.0 109.481 -172.73 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . 0.449 ' H ' ' CG ' ' A' ' 103' ' ' ASP 0.259 27.2 ttt180 59.57 31.05 20.72 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 126.878 2.071 . . . . 0.0 112.831 175.775 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 20.4 m -131.71 -122.18 0.2 Allowed 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 103.363 -2.829 . . . . 0.0 103.363 168.783 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . 0.352 17.7 pt20 54.79 -57.9 0.02 OUTLIER 'General case' 0 N--CA 1.452 -0.33 0 C-N-CA 129.507 3.123 . . . . 0.0 115.951 171.995 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 5.4 tpt -107.34 -16.79 14.3 Favored 'General case' 0 N--CA 1.45 -0.447 0 N-CA-C 116.588 2.07 . . . . 0.0 116.588 -169.659 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -65.63 -45.39 83.25 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 120.182 1.356 . . . . 0.0 109.027 174.189 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 2.8 pm0 -66.55 -37.25 84.57 Favored 'General case' 0 N--CA 1.45 -0.427 0 C-N-CA 124.818 1.247 . . . . 0.0 110.439 170.034 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -61.98 -45.35 96.31 Favored Glycine 0 C--N 1.339 0.746 0 C-N-CA 124.37 0.986 . . . . 0.0 111.997 -178.536 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 24.9 m-85 -73.82 -31.13 63.08 Favored 'General case' 0 CA--C 1.509 -0.597 0 CA-C-N 119.056 1.428 . . . . 0.0 113.717 170.981 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -65.49 -34.17 77.65 Favored 'General case' 0 C--O 1.225 -0.203 0 CA-C-N 120.531 1.514 . . . . 0.0 111.333 -172.493 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 17.1 ptpt -61.66 -27.72 68.88 Favored 'General case' 0 N--CA 1.475 0.795 0 CA-C-N 119.026 0.83 . . . . 0.0 112.392 170.945 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 2.1 m -84.27 -56.34 3.7 Favored 'General case' 0 N--CA 1.451 -0.382 0 C-N-CA 125.291 1.436 . . . . 0.0 109.817 -178.099 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 75.7 mt -72.72 -36.44 67.8 Favored 'General case' 0 CA--C 1.529 0.138 0 C-N-CA 124.068 0.947 . . . . 0.0 110.021 -173.232 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -96.7 9.26 66.32 Favored Glycine 0 CA--C 1.526 0.771 0 C-N-CA 125.159 1.361 . . . . 0.0 112.943 -175.737 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -48.83 122.88 6.16 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 124.989 1.316 . . . . 0.0 110.71 -175.41 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 77.33 -11.78 16.11 Favored Glycine 0 CA--C 1.533 1.203 0 C-N-CA 124.404 1.002 . . . . 0.0 114.589 178.953 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 63.7 mttm -96.68 -46.11 6.42 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-N 119.265 1.532 . . . . 0.0 110.571 179.908 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.416 HG22 ' HB2' ' A' ' 2' ' ' LYS . 29.6 pt -138.62 147.64 25.07 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.58 0 C-N-CA 123.547 0.739 . . . . 0.0 110.087 -169.577 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -107.77 107.82 18.76 Favored 'General case' 0 N--CA 1.467 0.389 0 C-N-CA 125.196 1.398 . . . . 0.0 109.679 -171.471 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 8.3 t -78.44 139.53 18.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 119.152 0.887 . . . . 0.0 109.117 176.385 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 4.2 m -139.79 115.78 10.32 Favored 'General case' 0 N--CA 1.436 -1.145 0 N-CA-C 105.176 -2.157 . . . . 0.0 105.176 169.899 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 4.5 m -90.34 45.3 1.25 Allowed 'General case' 0 C--N 1.32 -0.679 0 O-C-N 121.416 -0.803 . . . . 0.0 112.399 -170.831 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 2.6 m -67.15 165.35 16.16 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 124.484 1.114 . . . . 0.0 111.801 -178.577 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -177.1 -177.09 45.76 Favored Glycine 0 N--CA 1.444 -0.77 0 N-CA-C 106.081 -2.808 . . . . 0.0 106.081 -170.22 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 19.1 mt -104.76 -14.88 15.4 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 117.754 0.777 . . . . 0.0 111.152 179.047 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -144.12 155.26 43.87 Favored 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 128.227 2.611 . . . . 0.0 105.388 168.984 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 1.9 m -164.25 169.8 17.1 Favored 'General case' 0 N--CA 1.449 -0.485 0 CA-C-O 122.277 1.037 . . . . 0.0 110.994 175.379 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 62.7 p -153.14 -172.37 4.22 Favored 'General case' 0 N--CA 1.439 -1.023 0 C-N-CA 126.385 1.874 . . . . 0.0 107.304 -169.182 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 7.5 ttt180 -91.62 168.98 11.11 Favored 'General case' 0 C--N 1.331 -0.237 0 O-C-N 121.19 -0.943 . . . . 0.0 109.587 170.473 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 19.8 m -71.28 170.55 1.27 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.805 0 C-N-CA 123.543 0.737 . . . . 0.0 109.585 -178.824 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 74.1 t60 -71.44 138.71 83.8 Favored Pre-proline 0 CA--C 1.546 0.818 0 CA-C-O 118.391 -0.814 . . . . 0.0 109.274 172.989 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -59.29 -49.46 10.76 Favored 'Trans proline' 0 C--N 1.349 0.556 0 C-N-CA 123.231 2.621 . . . . 0.0 113.899 -173.654 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 22.6 m -66.13 -17.18 64.55 Favored 'General case' 0 CA--C 1.539 0.521 0 CA-C-N 118.842 0.746 . . . . 0.0 111.168 -178.471 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.472 ' HB1' HD11 ' A' ' 57' ' ' ILE . . . -60.62 -49.0 79.3 Favored 'General case' 0 C--O 1.215 -0.715 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 173.253 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 52.4 mt -58.49 -41.05 80.69 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 N-CA-C 108.288 -1.005 . . . . 0.0 108.288 -173.44 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -66.27 -50.76 62.6 Favored 'General case' 0 N--CA 1.45 -0.434 0 CA-C-N 118.229 0.468 . . . . 0.0 111.597 -179.99 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 31.9 mmt -69.15 -34.2 74.62 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-O 122.825 1.297 . . . . 0.0 111.087 -177.047 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 20.8 mmt -77.81 -28.66 50.42 Favored 'General case' 0 N--CA 1.441 -0.899 0 O-C-N 120.784 -1.197 . . . . 0.0 108.277 -177.355 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 -70.87 -23.32 62.28 Favored 'General case' 0 N--CA 1.449 -0.479 0 O-C-N 121.372 -0.83 . . . . 0.0 109.692 169.652 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 18.2 mm-40 -68.14 -30.66 69.85 Favored 'General case' 0 CA--C 1.531 0.242 0 CA-C-N 119.203 0.91 . . . . 0.0 110.443 170.984 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . 0.286 3.1 p -87.64 9.43 2.04 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.918 0 CA-C-N 118.807 0.73 . . . . 0.0 111.264 169.205 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 81.41 17.69 70.66 Favored Glycine 0 CA--C 1.531 1.057 0 C-N-CA 124.667 1.127 . . . . 0.0 113.75 172.449 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 39.5 mt -116.28 139.35 43.39 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.295 0 CA-C-N 119.107 1.453 . . . . 0.0 110.625 -176.618 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -100.73 136.16 41.04 Favored 'General case' 0 C--O 1.235 0.319 0 N-CA-C 109.236 -0.653 . . . . 0.0 109.236 169.141 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.472 HD11 ' HB1' ' A' ' 46' ' ' ALA . 15.8 pt -128.36 -13.43 3.01 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.499 0 C-N-CA 125.439 1.496 . . . . 0.0 112.414 176.172 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 93.2 p -44.38 -38.21 3.84 Favored 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 125.467 1.507 . . . . 0.0 114.552 176.143 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -87.12 2.86 87.05 Favored Glycine 0 CA--C 1.529 0.912 0 CA-C-O 118.81 -0.995 . . . . 0.0 114.091 -172.92 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 26.8 mt-30 -75.81 120.11 20.73 Favored 'General case' 0 CA--C 1.514 -0.44 0 CA-C-N 119.615 1.708 . . . . 0.0 111.28 -170.182 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 7.7 t -162.13 167.0 24.95 Favored 'General case' 0 N--CA 1.436 -1.132 0 N-CA-C 106.671 -1.603 . . . . 0.0 106.671 167.391 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 40.4 m -154.32 164.38 38.67 Favored 'General case' 0 N--CA 1.448 -0.558 0 C-N-CA 126.195 1.798 . . . . 0.0 107.236 -177.548 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -60.18 163.25 8.53 Favored Pre-proline 0 CA--C 1.54 0.586 0 C-N-CA 124.514 1.125 . . . . 0.0 110.704 169.973 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -61.36 151.19 81.12 Favored 'Trans proline' 0 N--CA 1.456 -0.692 0 C-N-CA 121.584 1.523 . . . . 0.0 109.478 172.565 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 5.6 tt -61.59 -24.23 33.22 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.536 0 O-C-N 121.648 -0.658 . . . . 0.0 111.254 -173.289 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 12.3 mt-10 -67.59 -25.52 65.81 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 125.352 1.461 . . . . 0.0 110.803 -177.064 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 12.2 t-20 -63.07 -26.12 68.69 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 125.006 1.322 . . . . 0.0 111.904 178.612 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 39.2 m-85 -105.07 -169.68 1.64 Allowed 'General case' 0 C--O 1.236 0.37 0 C-N-CA 126.464 1.906 . . . . 0.0 109.762 -176.357 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 55.3 t-20 -135.98 138.81 42.66 Favored 'General case' 0 N--CA 1.445 -0.688 0 N-CA-C 106.526 -1.657 . . . . 0.0 106.526 168.753 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.536 ' HB2' ' CD2' ' A' ' 90' ' ' TRP . . . -72.18 -27.16 62.39 Favored 'General case' 0 N--CA 1.431 -1.379 0 N-CA-C 108.576 -0.898 . . . . 0.0 108.576 -178.768 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 35.8 t70 -67.04 -20.93 65.92 Favored 'General case' 0 N--CA 1.443 -0.778 0 C-N-CA 120.728 -0.389 . . . . 0.0 111.388 -177.55 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 35.2 t70 -80.13 -29.74 38.93 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 124.278 1.031 . . . . 0.0 111.697 173.672 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 11.2 m-85 -77.51 168.59 19.74 Favored 'General case' 0 C--O 1.237 0.446 0 C-N-CA 125.176 1.39 . . . . 0.0 110.926 177.551 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -119.29 -38.56 3.01 Favored 'General case' 0 C--O 1.235 0.309 0 C-N-CA 123.098 0.559 . . . . 0.0 111.491 178.728 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -139.32 134.62 40.44 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.494 0 CA-C-O 121.565 0.698 . . . . 0.0 110.196 -169.921 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 57.0 t -142.5 139.66 28.86 Favored 'Isoleucine or valine' 0 C--O 1.236 0.369 0 N-CA-C 106.082 -1.822 . . . . 0.0 106.082 -179.85 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.533 HD12 ' HB2' ' A' ' 97' ' ' GLU . 23.8 mm -125.63 122.07 61.51 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.572 0 N-CA-C 105.859 -1.904 . . . . 0.0 105.859 -177.388 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 36.0 m -95.4 97.06 9.54 Favored 'General case' 0 N--CA 1.447 -0.586 0 N-CA-C 106.019 -1.845 . . . . 0.0 106.019 169.731 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 67.6 mt -63.04 -18.6 63.53 Favored 'General case' 0 N--CA 1.463 0.207 0 C-N-CA 122.756 0.422 . . . . 0.0 111.092 -178.629 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 14.3 p -152.78 166.55 31.87 Favored 'General case' 0 N--CA 1.448 -0.54 0 N-CA-C 106.7 -1.593 . . . . 0.0 106.7 168.847 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 73.36 -165.52 54.79 Favored Glycine 0 CA--C 1.533 1.194 0 CA-C-O 121.381 0.434 . . . . 0.0 113.053 172.764 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 34.9 p -151.88 -168.21 3.01 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 125.548 1.539 . . . . 0.0 109.318 -169.873 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -73.36 60.74 1.91 Allowed Glycine 0 CA--C 1.534 1.277 0 C-N-CA 124.449 1.023 . . . . 0.0 110.644 170.743 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 7.3 p -72.66 -55.11 14.09 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.398 0 C-N-CA 124.987 1.315 . . . . 0.0 110.823 -169.87 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 36.7 p-10 -135.99 24.93 3.32 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 127.12 2.168 . . . . 0.0 108.6 170.053 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 2.8 tt -116.15 135.52 22.82 Favored Pre-proline 0 CA--C 1.537 0.446 0 C-N-CA 127.076 2.15 . . . . 0.0 107.881 -169.491 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . 0.45 ' HA ' ' HD3' ' A' ' 88' ' ' PRO . 51.4 Cg_exo -63.55 141.96 82.33 Favored 'Trans proline' 0 CA--C 1.541 0.84 0 CA-C-N 120.518 1.221 . . . . 0.0 114.78 -169.313 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . 0.45 ' HD3' ' HA ' ' A' ' 87' ' ' PRO . 75.4 Cg_exo -60.33 -33.97 93.96 Favored 'Trans proline' 0 C--N 1.35 0.614 0 C-N-CA 122.1 1.867 . . . . 0.0 115.106 -171.425 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 4.0 pm0 -62.41 -13.62 31.6 Favored 'General case' 0 CA--C 1.536 0.435 0 CA-C-N 119.817 1.189 . . . . 0.0 112.349 -177.721 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' TRP . . . . . 0.536 ' CD2' ' HB2' ' A' ' 70' ' ' ALA . 99.1 m95 -80.51 -32.31 36.95 Favored 'General case' 0 CA--C 1.53 0.191 0 CA-C-N 118.61 0.641 . . . . 0.0 111.825 173.83 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 25.1 m -96.3 -3.52 10.27 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.472 0 C-N-CA 124.913 1.285 . . . . 0.0 112.822 -179.309 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . 0.263 6.5 t -130.99 65.54 1.55 Allowed 'General case' 0 CA--C 1.541 0.604 0 CA-C-O 123.465 1.602 . . . . 0.0 108.132 169.634 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 32.9 mm-40 -80.56 -175.85 5.43 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 125.668 1.587 . . . . 0.0 109.603 169.516 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 36.4 mm-40 -63.06 -28.25 69.96 Favored 'General case' 0 CA--C 1.54 0.563 0 O-C-N 121.869 -0.52 . . . . 0.0 110.118 175.121 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 3.8 tt -141.01 134.58 31.89 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.358 0 C-N-CA 126.69 1.996 . . . . 0.0 105.675 169.319 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 57.0 t80 -126.11 137.57 53.61 Favored 'General case' 0 N--CA 1.448 -0.543 0 N-CA-C 107.556 -1.276 . . . . 0.0 107.556 169.789 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . 0.533 ' HB2' HD12 ' A' ' 77' ' ' ILE . 8.5 mm-40 -138.11 167.03 22.67 Favored 'General case' 0 C--O 1.236 0.372 0 CA-C-O 122.248 1.023 . . . . 0.0 109.223 175.186 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -168.74 133.0 1.51 Allowed 'General case' 0 C--N 1.325 -0.488 0 C-N-CA 129.267 3.027 . . . . 0.0 105.606 -170.121 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 8.2 m0 -142.87 147.66 35.72 Favored 'General case' 0 C--O 1.232 0.18 0 C-N-CA 123.126 0.57 . . . . 0.0 110.136 -169.833 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 84.6 mt-30 -83.59 52.69 2.31 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 124.301 1.041 . . . . 0.0 108.914 172.362 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.454 HD13 HG22 ' A' ' 119' ' ' VAL . 16.3 mt -70.59 123.42 21.8 Favored 'General case' 0 C--N 1.339 0.113 0 N-CA-C 107.546 -1.279 . . . . 0.0 107.546 176.328 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 5.6 pt-20 -71.87 163.6 27.55 Favored 'General case' 0 CA--C 1.54 0.564 0 N-CA-C 109.139 -0.689 . . . . 0.0 109.139 169.759 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . 0.449 ' CG ' ' H ' ' A' ' 14' ' ' ARG . 13.7 t70 -138.66 139.61 24.92 Favored Pre-proline 0 CA--C 1.538 0.489 0 C-N-CA 124.132 0.973 . . . . 0.0 110.158 -173.198 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 39.5 Cg_endo -86.68 0.01 7.95 Favored 'Trans proline' 0 CA--C 1.543 0.96 0 C-N-CA 122.716 2.277 . . . . 0.0 114.651 -170.436 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -48.59 118.96 2.77 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-N 120.43 1.468 . . . . 0.0 111.221 -177.903 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 72.21 14.15 76.63 Favored Glycine 0 CA--C 1.534 1.249 0 CA-C-O 118.193 -1.337 . . . . 0.0 114.544 172.538 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 16.6 pt20 -128.23 172.26 11.19 Favored 'General case' 0 CA--C 1.541 0.605 0 CA-C-N 119.455 1.628 . . . . 0.0 111.827 176.448 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 9.9 m -65.78 165.18 13.25 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 125.851 1.66 . . . . 0.0 115.133 -168.644 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -60.68 -26.68 67.28 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 125.678 1.591 . . . . 0.0 112.614 -173.993 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 -56.07 -35.14 66.65 Favored 'General case' 0 N--CA 1.461 0.113 0 CA-C-N 118.687 0.676 . . . . 0.0 111.105 173.054 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 4.1 t -77.18 -40.98 30.41 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.558 0 CA-C-O 118.214 -0.898 . . . . 0.0 109.733 -178.036 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 83.6 m-85 -57.5 -46.44 83.75 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-N 120.29 1.404 . . . . 0.0 109.93 171.926 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 91.4 mtt180 -62.94 -41.35 99.46 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 123.274 0.629 . . . . 0.0 110.915 -179.906 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 8.7 m -63.13 -48.56 77.98 Favored 'General case' 0 N--CA 1.449 -0.522 0 C-N-CA 124.704 1.202 . . . . 0.0 110.178 175.525 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 75.4 t -68.72 -31.65 51.73 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.28 0 CA-C-O 118.481 -0.771 . . . . 0.0 109.703 -172.679 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 34.7 mtm105 -57.7 -50.16 74.11 Favored 'General case' 0 C--O 1.226 -0.15 0 CA-C-N 119.521 1.055 . . . . 0.0 110.497 171.399 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -60.74 -51.48 58.35 Favored Glycine 0 CA--C 1.529 0.955 0 N-CA-C 111.22 -0.752 . . . . 0.0 111.22 178.755 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 15.1 mm-40 -58.24 -52.15 66.76 Favored 'General case' 0 N--CA 1.464 0.235 0 C-N-CA 123.911 0.885 . . . . 0.0 110.658 -176.269 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . 0.454 HG22 HD13 ' A' ' 101' ' ' LEU . 69.4 t -74.47 -39.48 47.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-O 118.357 -0.83 . . . . 0.0 110.339 -171.91 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 59.8 tttm -54.79 -44.7 73.99 Favored 'General case' 0 CA--C 1.517 -0.29 0 CA-C-N 119.134 0.879 . . . . 0.0 108.871 175.798 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 45.1 tt0 -64.79 -42.99 94.64 Favored 'General case' 0 CA--C 1.542 0.642 0 CA-C-O 118.75 -0.643 . . . . 0.0 111.363 -177.862 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 63.2 mmt-85 -62.87 -47.63 82.51 Favored 'General case' 0 N--CA 1.478 0.972 0 CA-C-N 119.967 1.258 . . . . 0.0 110.822 176.161 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 60.2 t -69.09 -37.44 76.79 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.438 0 N-CA-C 108.774 -0.824 . . . . 0.0 108.774 -174.675 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 15.8 mt-10 -61.07 -45.22 95.63 Favored 'General case' 0 CA--C 1.52 -0.185 0 CA-C-N 119.269 0.941 . . . . 0.0 110.076 174.111 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 28.4 t-20 -64.22 -40.97 97.14 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 123.008 0.523 . . . . 0.0 111.218 -178.332 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 53.0 tp -58.86 -49.94 75.86 Favored 'General case' 0 C--O 1.226 -0.14 0 C-N-CA 125.285 1.434 . . . . 0.0 110.909 173.77 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 56.7 mt -64.59 -46.87 91.23 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 N-CA-C 107.997 -1.112 . . . . 0.0 107.997 -178.748 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -58.65 -32.45 69.09 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 123.424 0.69 . . . . 0.0 112.102 -178.151 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 18.6 ptpt -81.53 -36.56 29.01 Favored 'General case' 0 C--N 1.345 0.37 0 CA-C-O 117.824 -1.084 . . . . 0.0 112.596 177.105 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 10.4 pt -84.81 -41.27 15.76 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.322 0 CA-C-N 120.124 1.329 . . . . 0.0 113.741 -176.225 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 67.4 m . . . . . 0 C--O 1.254 1.302 0 C-N-CA 126.065 1.746 . . . . 0.0 109.873 -169.927 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 8.5 ptm . . . . . 0 N--CA 1.498 1.965 0 N-CA-C 110.523 -0.177 . . . . 0.0 110.523 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . 0.41 ' HB2' HG22 ' A' ' 30' ' ' ILE . 23.4 mttm -74.62 125.07 27.87 Favored 'General case' 0 N--CA 1.479 1.005 0 N-CA-C 107.103 -1.443 . . . . 0.0 107.103 -174.516 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 70.0 mttt -97.97 136.4 38.31 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-N 120.236 1.38 . . . . 0.0 108.027 173.771 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.428 HG21 HD12 ' A' ' 30' ' ' ILE . 11.6 t -116.31 152.47 18.03 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.551 0 C-N-CA 127.233 2.213 . . . . 0.0 108.199 -169.56 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 17.7 mtt -137.19 144.11 42.7 Favored 'General case' 0 C--N 1.324 -0.541 0 C-N-CA 124.926 1.29 . . . . 0.0 108.057 168.67 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 92.1 m-85 -125.26 113.89 18.22 Favored 'General case' 0 CA--C 1.516 -0.329 0 N-CA-C 102.839 -3.023 . . . . 0.0 102.839 170.05 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 1.2 p -141.0 137.21 34.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 121.289 0.566 . . . . 0.0 111.531 -168.051 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 44.0 t -165.82 152.93 10.08 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 128.639 2.775 . . . . 0.0 104.94 171.767 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 40.2 mtmt -75.47 163.3 27.55 Favored 'General case' 0 N--CA 1.47 0.569 0 O-C-N 121.655 -0.653 . . . . 0.0 111.421 -170.038 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 28.5 mmt85 53.41 70.39 0.6 Allowed 'General case' 0 N--CA 1.465 0.285 0 C-N-CA 126.801 2.041 . . . . 0.0 110.888 -176.28 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 2.4 t-20 -44.4 -20.07 0.03 OUTLIER 'General case' 0 N--CA 1.487 1.386 0 C-N-CA 127.839 2.455 . . . . 0.0 114.955 176.828 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 3.3 m -50.47 -27.82 7.23 Favored 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 124.269 1.028 . . . . 0.0 111.407 168.954 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 10.3 m -131.63 140.32 49.35 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 126.876 2.071 . . . . 0.0 107.889 172.078 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 5.5 mpt_? 59.16 165.2 0.05 OUTLIER 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 126.536 1.934 . . . . 0.0 112.631 -173.022 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 54.7 m 52.2 39.65 27.31 Favored 'General case' 0 CA--C 1.536 0.42 0 CA-C-N 115.207 -0.906 . . . . 0.0 110.334 -169.525 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 26.1 pt20 -135.48 33.07 3.03 Favored 'General case' 0 C--O 1.223 -0.294 0 O-C-N 120.543 -1.348 . . . . 0.0 109.636 174.414 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' MET . . . . . 0.405 ' HE2' ' HG3' ' A' ' 50' ' ' MET . 0.0 OUTLIER -163.88 -50.2 0.03 OUTLIER 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 124.149 0.979 . . . . 0.0 109.848 -177.762 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -67.73 -45.21 75.68 Favored 'General case' 0 C--N 1.343 0.285 0 N-CA-C 112.584 0.586 . . . . 0.0 112.584 -169.465 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . 0.518 ' H ' ' CD ' ' A' ' 19' ' ' GLU . 0.7 OUTLIER -66.86 -34.88 78.78 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 109.489 -0.56 . . . . 0.0 109.489 174.516 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -47.97 -66.71 1.87 Allowed Glycine 0 CA--C 1.527 0.791 0 N-CA-C 110.094 -1.202 . . . . 0.0 110.094 169.909 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 3.7 m-85 -59.62 -34.36 72.68 Favored 'General case' 0 CA--C 1.509 -0.602 0 O-C-N 121.547 -0.973 . . . . 0.0 113.444 178.091 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -66.63 -32.57 73.99 Favored 'General case' 0 N--CA 1.447 -0.61 0 C-N-CA 119.943 -0.703 . . . . 0.0 109.954 -174.032 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -65.9 -33.73 76.5 Favored 'General case' 0 CA--C 1.533 0.327 0 CA-C-N 118.395 0.543 . . . . 0.0 110.675 174.797 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 7.4 m -75.06 -55.69 5.49 Favored 'General case' 0 N--CA 1.448 -0.528 0 C-N-CA 125.453 1.501 . . . . 0.0 110.354 -176.752 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 40.1 mt -75.08 -38.63 61.2 Favored 'General case' 0 C--N 1.331 -0.22 0 C-N-CA 124.302 1.041 . . . . 0.0 109.467 -174.025 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -84.97 5.16 83.8 Favored Glycine 0 CA--C 1.526 0.78 0 C-N-CA 125.487 1.518 . . . . 0.0 113.629 -177.959 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -53.24 128.56 28.48 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-N 118.807 1.303 . . . . 0.0 109.802 -178.983 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 74.2 6.63 75.24 Favored Glycine 0 CA--C 1.536 1.35 0 C-N-CA 124.567 1.08 . . . . 0.0 114.313 -178.388 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 42.7 mttp -124.94 -50.42 1.7 Allowed 'General case' 0 N--CA 1.47 0.534 0 CA-C-N 118.927 1.364 . . . . 0.0 110.986 -175.0 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.428 HD12 HG21 ' A' ' 4' ' ' VAL . 19.3 pt -139.25 147.58 24.39 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.497 0 C-N-CA 123.642 0.777 . . . . 0.0 110.278 -169.244 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -96.01 159.48 14.95 Favored 'General case' 0 C--O 1.221 -0.417 0 C-N-CA 125.833 1.653 . . . . 0.0 108.109 175.578 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 12.2 t -142.44 135.68 27.43 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 N-CA-C 107.961 -1.125 . . . . 0.0 107.961 -173.416 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 4.1 m -148.38 103.04 3.39 Favored 'General case' 0 N--CA 1.446 -0.65 0 C-N-CA 124.665 1.186 . . . . 0.0 107.952 -177.218 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 60.2 m -89.6 71.43 7.87 Favored 'General case' 0 C--O 1.234 0.247 0 O-C-N 120.942 -1.099 . . . . 0.0 111.92 177.608 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 2.1 m -69.14 176.6 3.14 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 124.819 1.248 . . . . 0.0 110.696 170.763 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -167.07 -167.85 28.38 Favored Glycine 0 C--N 1.339 0.698 0 N-CA-C 108.082 -2.007 . . . . 0.0 108.082 179.691 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 18.2 mt -124.44 2.59 8.39 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 124.607 1.163 . . . . 0.0 111.691 -179.755 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 -145.36 -155.5 0.62 Allowed 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 129.185 2.994 . . . . 0.0 105.463 174.969 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 5.8 m 70.4 176.69 0.28 Allowed 'General case' 0 C--O 1.235 0.338 0 C-N-CA 125.38 1.472 . . . . 0.0 114.891 169.41 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 17.1 m -143.9 -72.87 0.28 Allowed 'General case' 0 N--CA 1.452 -0.354 0 CA-C-N 113.491 -1.686 . . . . 0.0 109.769 -169.236 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 6.0 ttt180 -152.3 172.1 16.96 Favored 'General case' 0 N--CA 1.467 0.415 0 C-N-CA 123.952 0.901 . . . . 0.0 111.15 -175.406 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 3.5 m -73.5 168.7 1.85 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.57 0 C-N-CA 124.534 1.134 . . . . 0.0 109.842 176.657 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -94.23 160.03 32.87 Favored Pre-proline 0 CA--C 1.544 0.718 0 N-CA-C 112.697 0.629 . . . . 0.0 112.697 -177.815 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -61.26 -53.55 2.37 Favored 'Trans proline' 0 C--N 1.352 0.742 0 C-N-CA 124.018 3.145 . . . . 0.0 113.777 -169.261 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 4.9 m -66.06 -26.6 67.58 Favored 'General case' 0 CA--C 1.532 0.278 0 O-C-N 121.893 -0.505 . . . . 0.0 110.358 -174.324 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -54.27 -53.19 56.97 Favored 'General case' 0 CA--C 1.509 -0.609 0 N-CA-C 108.75 -0.834 . . . . 0.0 108.75 174.745 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 58.9 mt -60.79 -41.08 87.2 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.468 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 -171.482 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -62.58 -40.97 98.59 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-N 118.431 0.56 . . . . 0.0 110.802 -179.009 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' MET . . . . . 0.426 ' HG3' ' CG ' ' A' ' 112' ' ' PHE . 38.4 mmt -74.06 -35.9 64.31 Favored 'General case' 0 C--O 1.235 0.321 0 CA-C-O 122.388 1.089 . . . . 0.0 110.338 -178.853 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' MET . . . . . 0.405 ' HG3' ' HE2' ' A' ' 17' ' ' MET . 0.2 OUTLIER -73.02 -31.33 64.39 Favored 'General case' 0 N--CA 1.442 -0.863 0 N-CA-C 106.806 -1.553 . . . . 0.0 106.806 -178.916 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 -70.52 -21.08 62.77 Favored 'General case' 0 N--CA 1.445 -0.719 0 C-N-CA 124.703 1.201 . . . . 0.0 111.061 170.273 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 77.7 mt-10 -63.84 -37.88 89.04 Favored 'General case' 0 C--N 1.344 0.361 0 CA-C-N 120.137 1.335 . . . . 0.0 109.107 169.457 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . 0.303 7.7 p -88.28 12.68 1.34 Allowed 'Isoleucine or valine' 0 CA--C 1.548 0.897 0 CA-C-O 121.082 0.468 . . . . 0.0 112.204 171.076 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 72.02 17.24 76.98 Favored Glycine 0 CA--C 1.533 1.212 0 O-C-N 120.723 -1.235 . . . . 0.0 113.869 174.791 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 5.7 mt -100.36 145.57 10.7 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.191 0 C-N-CA 125.154 1.382 . . . . 0.0 111.494 -174.221 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -96.77 137.13 36.32 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 125.297 1.439 . . . . 0.0 108.874 169.625 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 4.6 pt -134.0 -28.83 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.46 0 C-N-CA 125.441 1.496 . . . . 0.0 109.382 169.529 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -39.86 -37.67 0.58 Allowed 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 128.475 2.71 . . . . 0.0 113.509 169.563 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -66.72 -12.25 59.01 Favored Glycine 0 CA--C 1.537 1.423 0 C-N-CA 124.481 1.039 . . . . 0.0 114.379 179.213 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 28.7 mt-30 -70.73 156.43 39.51 Favored 'General case' 0 N--CA 1.45 -0.438 0 CA-C-N 118.965 1.382 . . . . 0.0 110.297 174.382 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 1.4 p -150.31 151.07 32.34 Favored 'General case' 0 N--CA 1.431 -1.421 0 N-CA-C 104.717 -2.327 . . . . 0.0 104.717 168.448 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 63.2 m -92.47 75.82 5.15 Favored 'General case' 0 N--CA 1.45 -0.44 0 N-CA-C 107.831 -1.174 . . . . 0.0 107.831 -174.117 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -62.96 153.13 81.67 Favored Pre-proline 0 C--O 1.241 0.642 0 N-CA-C 108.947 -0.761 . . . . 0.0 108.947 171.161 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 26.4 Cg_exo -57.55 134.36 62.78 Favored 'Trans proline' 0 N--CA 1.447 -1.209 0 N-CA-C 107.841 -1.638 . . . . 0.0 107.841 169.376 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 8.3 tt -61.22 -23.8 31.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 O-C-N 121.482 -0.762 . . . . 0.0 109.596 171.021 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 21.5 tt0 -69.61 -22.9 63.46 Favored 'General case' 0 N--CA 1.434 -1.273 0 C-N-CA 127.375 2.27 . . . . 0.0 110.789 -179.995 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 8.2 t-20 -60.32 -17.59 43.92 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 124.665 1.186 . . . . 0.0 111.68 174.313 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 4.4 m-85 -128.31 178.34 6.32 Favored 'General case' 0 C--O 1.235 0.34 0 C-N-CA 127.115 2.166 . . . . 0.0 108.54 -179.873 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 13.9 p-10 -128.32 143.61 51.04 Favored 'General case' 0 N--CA 1.438 -1.035 0 C-N-CA 124.716 1.206 . . . . 0.0 110.428 169.236 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.575 ' HB2' ' CD2' ' A' ' 90' ' ' TRP . . . -77.36 -25.27 50.85 Favored 'General case' 0 N--CA 1.432 -1.347 0 N-CA-C 109.143 -0.688 . . . . 0.0 109.143 -170.712 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 35.6 t70 -64.61 -19.79 65.89 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 120.41 -0.516 . . . . 0.0 111.214 -178.903 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -83.96 -31.04 25.77 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 124.427 1.091 . . . . 0.0 112.321 172.215 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 11.1 m-85 -72.85 170.31 14.98 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 124.89 1.276 . . . . 0.0 110.287 173.23 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -120.43 -35.85 3.33 Favored 'General case' 0 C--O 1.236 0.39 0 C-N-CA 123.047 0.539 . . . . 0.0 111.67 179.905 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -141.51 135.31 30.82 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.691 0 CA-C-O 121.839 0.828 . . . . 0.0 110.454 -169.705 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 76.3 t -143.0 138.38 27.16 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.278 0 N-CA-C 106.629 -1.619 . . . . 0.0 106.629 -177.496 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 41.6 mm -127.16 117.28 46.96 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.581 0 N-CA-C 106.12 -1.807 . . . . 0.0 106.12 -170.516 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 67.1 m -94.96 91.61 6.47 Favored 'General case' 0 N--CA 1.449 -0.519 0 N-CA-C 105.546 -2.02 . . . . 0.0 105.546 169.445 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . 0.251 0.3 OUTLIER -75.3 -6.55 50.44 Favored 'General case' 0 CA--C 1.536 0.442 0 CA-C-N 115.605 -0.725 . . . . 0.0 112.908 -175.267 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 6.4 p -166.14 167.38 16.34 Favored 'General case' 0 C--O 1.236 0.344 0 C-N-CA 127.398 2.279 . . . . 0.0 107.549 168.247 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 77.79 -81.3 1.27 Allowed Glycine 0 CA--C 1.526 0.746 0 N-CA-C 110.632 -0.987 . . . . 0.0 110.632 174.573 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 4.9 m 67.79 -53.2 0.51 Allowed 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 127.659 2.383 . . . . 0.0 113.738 178.429 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -81.47 57.79 4.89 Favored Glycine 0 CA--C 1.528 0.902 0 C-N-CA 124.774 1.178 . . . . 0.0 110.511 170.741 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 27.7 m -99.5 14.71 4.51 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.71 0 C-N-CA 124.082 0.953 . . . . 0.0 113.068 -169.881 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 47.4 t30 58.64 69.65 0.71 Allowed 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 126.1 1.76 . . . . 0.0 109.258 -175.865 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.405 ' HA ' ' HD3' ' A' ' 87' ' ' PRO . 0.3 OUTLIER -139.36 148.61 57.36 Favored Pre-proline 0 CA--C 1.546 0.81 0 C-N-CA 126.146 1.778 . . . . 0.0 109.276 -168.949 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . 0.405 ' HD3' ' HA ' ' A' ' 86' ' ' LEU . 51.7 Cg_exo -62.99 149.43 91.61 Favored 'Trans proline' 0 C--N 1.356 0.957 0 C-N-CA 121.47 1.447 . . . . 0.0 114.501 -169.643 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_endo -66.83 -34.9 29.17 Favored 'Trans proline' 0 N--CA 1.459 -0.522 0 C-N-CA 122.649 2.232 . . . . 0.0 114.583 -169.212 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . 0.446 ' HG3' ' HB3' ' A' ' 70' ' ' ALA . 11.8 pt-20 -64.16 -11.91 35.0 Favored 'General case' 0 CA--C 1.54 0.57 0 CA-C-N 119.85 1.205 . . . . 0.0 112.157 -176.62 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' TRP . . . . . 0.575 ' CD2' ' HB2' ' A' ' 70' ' ' ALA . 98.0 m95 -80.96 -35.53 32.07 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 123.481 0.712 . . . . 0.0 111.941 173.932 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 18.8 m -92.34 -4.59 10.78 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.551 0 C-N-CA 125.047 1.339 . . . . 0.0 112.697 -179.694 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 4.0 t -132.92 85.61 2.24 Favored 'General case' 0 CA--C 1.539 0.54 0 CA-C-O 123.24 1.495 . . . . 0.0 107.159 169.725 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 30.4 mm-40 -103.02 -174.11 2.47 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 127.806 2.442 . . . . 0.0 108.943 173.889 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 38.3 mm-40 -64.55 -28.62 69.77 Favored 'General case' 0 CA--C 1.539 0.544 0 O-C-N 121.82 -0.55 . . . . 0.0 110.036 172.653 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 4.0 tt -142.39 130.21 20.38 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.409 0 N-CA-C 105.692 -1.966 . . . . 0.0 105.692 169.338 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 70.3 t80 -122.87 142.37 50.85 Favored 'General case' 0 N--CA 1.448 -0.537 0 N-CA-C 105.868 -1.901 . . . . 0.0 105.868 169.062 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 10.5 mm-40 -132.77 138.9 47.31 Favored 'General case' 0 C--O 1.236 0.369 0 N-CA-C 107.809 -1.182 . . . . 0.0 107.809 174.025 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 8.0 t70 -108.36 118.91 37.99 Favored 'General case' 0 N--CA 1.45 -0.443 0 N-CA-C 106.455 -1.683 . . . . 0.0 106.455 169.855 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 10.5 m95 -115.68 170.44 8.44 Favored 'General case' 0 CA--C 1.533 0.318 0 N-CA-C 108.73 -0.841 . . . . 0.0 108.73 170.308 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 47.8 mt-30 -129.76 57.99 1.66 Allowed 'General case' 0 CA--C 1.534 0.362 0 N-CA-C 106.823 -1.547 . . . . 0.0 106.823 169.86 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.423 HD13 HG22 ' A' ' 119' ' ' VAL . 4.5 mt -67.76 139.48 56.66 Favored 'General case' 0 N--CA 1.463 0.217 0 N-CA-C 108.197 -1.038 . . . . 0.0 108.197 -179.694 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -74.65 170.61 15.46 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 125.056 1.343 . . . . 0.0 109.083 174.408 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -143.0 138.01 15.43 Favored Pre-proline 0 N--CA 1.452 -0.35 0 C-N-CA 123.199 0.599 . . . . 0.0 110.833 176.856 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 29.2 Cg_endo -86.35 -2.88 8.59 Favored 'Trans proline' 0 CA--C 1.54 0.807 0 C-N-CA 123.302 2.668 . . . . 0.0 115.318 -172.586 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -56.78 130.88 47.51 Favored 'General case' 0 C--O 1.237 0.432 0 CA-C-N 120.356 1.435 . . . . 0.0 110.571 -174.209 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 72.41 9.4 73.16 Favored Glycine 0 CA--C 1.534 1.233 0 CA-C-O 118.399 -1.223 . . . . 0.0 114.146 174.215 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 30.0 pt20 -126.44 -167.65 1.75 Allowed 'General case' 0 CA--C 1.537 0.453 0 CA-C-N 119.253 1.526 . . . . 0.0 110.799 172.326 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 1.9 m -66.93 154.74 40.3 Favored 'General case' 0 CA--C 1.532 0.268 0 N-CA-C 116.144 1.905 . . . . 0.0 116.144 -167.96 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 9.0 tp -57.61 -34.61 69.45 Favored 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 126.255 1.822 . . . . 0.0 111.201 177.487 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 -59.22 -34.66 72.45 Favored 'General case' 0 CA--C 1.531 0.213 0 C-N-CA 124.297 1.039 . . . . 0.0 110.721 175.839 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 3.5 t -73.18 -40.46 57.82 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.283 0 CA-C-O 118.207 -0.901 . . . . 0.0 109.456 -178.477 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . 0.426 ' CG ' ' HG3' ' A' ' 49' ' ' MET . 81.1 m-85 -56.56 -50.01 73.17 Favored 'General case' 0 N--CA 1.471 0.612 0 CA-C-N 120.248 1.385 . . . . 0.0 109.376 172.482 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 91.6 mtt180 -66.25 -33.19 75.18 Favored 'General case' 0 CA--C 1.535 0.378 0 CA-C-O 119.348 -0.358 . . . . 0.0 111.515 -177.009 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 6.2 m -67.37 -49.86 62.18 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 124.224 1.01 . . . . 0.0 109.971 173.107 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 80.1 t -69.8 -26.89 31.39 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.232 0 CA-C-O 117.675 -1.155 . . . . 0.0 109.399 -170.938 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 31.5 mtm105 -56.63 -47.5 79.57 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-N 120.31 1.414 . . . . 0.0 109.746 169.791 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -63.48 -49.12 72.24 Favored Glycine 0 CA--C 1.532 1.135 0 CA-C-N 118.949 0.795 . . . . 0.0 112.241 179.445 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 16.8 mt-30 -57.78 -46.37 84.69 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-N 117.565 0.682 . . . . 0.0 110.67 179.277 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . 0.423 HG22 HD13 ' A' ' 101' ' ' LEU . 65.8 t -70.42 -41.2 78.29 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.474 0 CA-C-O 118.585 -0.722 . . . . 0.0 110.405 -176.675 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 57.7 tttm -54.54 -46.48 73.61 Favored 'General case' 0 CA--C 1.517 -0.301 0 CA-C-N 119.381 0.991 . . . . 0.0 109.178 179.917 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -64.19 -42.79 96.51 Favored 'General case' 0 N--CA 1.448 -0.539 0 C-N-CA 123.002 0.521 . . . . 0.0 110.68 -176.758 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 37.8 mmt180 -63.16 -46.54 86.69 Favored 'General case' 0 N--CA 1.47 0.541 0 O-C-N 121.808 -0.557 . . . . 0.0 110.824 178.047 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 86.1 t -70.02 -39.03 76.86 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.436 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 -176.834 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 17.2 mt-10 -60.82 -43.8 97.75 Favored 'General case' 0 C--O 1.227 -0.105 0 CA-C-N 119.392 0.996 . . . . 0.0 110.316 175.509 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 28.8 t-20 -63.71 -43.68 95.88 Favored 'General case' 0 CA--C 1.53 0.206 0 C-N-CA 122.968 0.507 . . . . 0.0 111.115 -178.011 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 45.7 tp -58.09 -49.47 76.81 Favored 'General case' 0 N--CA 1.453 -0.322 0 C-N-CA 125.525 1.53 . . . . 0.0 111.151 174.374 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 73.1 mt -64.58 -46.03 93.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 N-CA-C 108.261 -1.014 . . . . 0.0 108.261 -178.895 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -59.74 -30.8 69.08 Favored 'General case' 0 CA--C 1.536 0.438 0 CA-C-O 118.734 -0.651 . . . . 0.0 112.157 -178.084 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 19.1 ptpt -82.45 -37.65 25.11 Favored 'General case' 0 C--N 1.344 0.35 0 CA-C-O 118.033 -0.984 . . . . 0.0 112.346 176.797 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 12.7 pt -81.69 -41.68 18.77 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.328 0 CA-C-N 120.072 1.305 . . . . 0.0 113.354 -176.737 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 74.5 m . . . . . 0 C--O 1.252 1.232 0 C-N-CA 125.882 1.673 . . . . 0.0 109.607 -169.848 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 11.6 ptm . . . . . 0 N--CA 1.497 1.897 0 N-CA-C 110.744 -0.095 . . . . 0.0 110.744 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . 0.402 ' HB2' HG22 ' A' ' 30' ' ' ILE . 26.1 mttm -76.08 118.71 19.12 Favored 'General case' 0 N--CA 1.48 1.064 0 O-C-N 120.875 -1.141 . . . . 0.0 108.196 -170.262 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 90.9 mttt -86.08 136.03 33.39 Favored 'General case' 0 CA--C 1.513 -0.454 0 N-CA-C 107.935 -1.135 . . . . 0.0 107.935 177.223 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 1.8 t -122.45 150.82 26.16 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 C-N-CA 125.752 1.621 . . . . 0.0 109.45 -168.936 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 13.6 mtt -139.35 147.52 41.65 Favored 'General case' 0 C--N 1.327 -0.376 0 C-N-CA 125.677 1.591 . . . . 0.0 108.462 168.963 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 70.2 m-85 -134.51 121.98 21.78 Favored 'General case' 0 N--CA 1.456 -0.161 0 N-CA-C 105.246 -2.131 . . . . 0.0 105.246 170.502 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 1.5 p -152.35 146.28 15.33 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.244 0 CA-C-N 118.954 0.797 . . . . 0.0 111.422 -168.932 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 43.7 t -132.99 -175.73 3.88 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 126.709 2.004 . . . . 0.0 106.226 169.225 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 20.2 ptpt -58.53 -25.44 62.45 Favored 'General case' 0 N--CA 1.471 0.601 0 N-CA-C 114.104 1.15 . . . . 0.0 114.104 -171.308 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 48.3 ttt85 -140.39 159.29 42.52 Favored 'General case' 0 N--CA 1.467 0.417 0 C-N-CA 124.264 1.026 . . . . 0.0 109.054 176.428 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 6.4 t30 -72.06 -34.86 69.06 Favored 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 123.779 0.832 . . . . 0.0 112.963 -176.556 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -64.75 -55.95 16.68 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 123.197 0.599 . . . . 0.0 111.215 -169.116 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 11.1 m -88.73 146.48 25.01 Favored 'General case' 0 N--CA 1.455 -0.196 0 C-N-CA 123.549 0.74 . . . . 0.0 109.624 -176.652 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 6.4 mmm180 68.33 -57.49 0.48 Allowed 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 127.424 2.29 . . . . 0.0 111.488 176.993 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 2.5 m -69.62 -9.95 56.25 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 124.702 1.201 . . . . 0.0 113.97 -172.146 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 29.3 pt20 -64.9 -42.67 94.56 Favored 'General case' 0 C--O 1.223 -0.332 0 CA-C-O 117.732 -1.127 . . . . 0.0 113.587 -175.292 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 2.2 tpt -94.72 -36.26 11.8 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-N 120.046 1.294 . . . . 0.0 114.102 -169.199 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -62.78 -42.97 99.94 Favored 'General case' 0 N--CA 1.474 0.737 0 N-CA-C 113.526 0.936 . . . . 0.0 113.526 -168.929 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -64.46 -33.49 76.0 Favored 'General case' 0 N--CA 1.472 0.645 0 CA-C-N 118.674 0.67 . . . . 0.0 109.366 175.6 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -51.94 -57.57 12.5 Favored Glycine 0 C--N 1.342 0.888 0 C-N-CA 125.422 1.487 . . . . 0.0 110.439 175.647 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 13.5 m-85 -70.8 -31.89 68.79 Favored 'General case' 0 CA--C 1.505 -0.757 0 O-C-N 121.647 -0.914 . . . . 0.0 112.724 -179.172 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -68.94 -34.41 75.31 Favored 'General case' 0 N--CA 1.449 -0.521 0 C-N-CA 119.305 -0.958 . . . . 0.0 111.155 -174.761 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 2.4 ptmt -65.39 -25.88 67.75 Favored 'General case' 0 N--CA 1.471 0.621 0 CA-C-N 119.085 0.857 . . . . 0.0 111.717 172.952 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 8.8 m -83.21 -57.07 3.42 Favored 'General case' 0 N--CA 1.444 -0.728 0 C-N-CA 125.198 1.399 . . . . 0.0 109.538 -173.96 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 55.5 mt -74.9 -36.34 62.23 Favored 'General case' 0 C--N 1.331 -0.204 0 C-N-CA 124.753 1.221 . . . . 0.0 110.213 -175.005 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -93.34 9.4 74.49 Favored Glycine 0 C--N 1.338 0.675 0 C-N-CA 124.988 1.28 . . . . 0.0 113.068 -176.161 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -50.89 122.73 7.85 Favored 'General case' 0 CA--C 1.534 0.327 0 C-N-CA 124.841 1.257 . . . . 0.0 110.524 -175.257 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 76.54 -8.76 25.29 Favored Glycine 0 CA--C 1.534 1.264 0 C-N-CA 124.371 0.986 . . . . 0.0 114.426 179.652 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 60.2 mttm -98.67 -46.67 5.61 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 119.19 1.495 . . . . 0.0 110.403 179.254 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.402 HG22 ' HB2' ' A' ' 2' ' ' LYS . 24.3 pt -139.24 149.25 23.14 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.585 0 C-N-CA 123.632 0.773 . . . . 0.0 109.388 -169.76 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -113.09 106.41 14.64 Favored 'General case' 0 N--CA 1.463 0.187 0 C-N-CA 125.132 1.373 . . . . 0.0 109.272 -169.899 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 2.5 t -84.64 137.68 20.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 119.316 0.962 . . . . 0.0 109.742 -179.449 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 14.5 m -145.32 91.7 2.16 Favored 'General case' 0 N--CA 1.446 -0.669 0 N-CA-C 106.037 -1.838 . . . . 0.0 106.037 170.368 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 45.0 m -89.28 68.93 8.13 Favored 'General case' 0 CA--C 1.532 0.273 0 O-C-N 121.287 -0.883 . . . . 0.0 111.017 -171.363 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 11.9 m -61.89 164.72 6.1 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 125.895 1.678 . . . . 0.0 110.715 170.198 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -158.6 -167.64 19.67 Favored Glycine 0 C--N 1.337 0.638 0 N-CA-C 107.752 -2.139 . . . . 0.0 107.752 -170.057 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 17.3 mt -123.96 -3.72 8.1 Favored 'General case' 0 C--N 1.327 -0.376 0 C-N-CA 124.113 0.965 . . . . 0.0 111.592 -179.405 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 36.7 mt-10 -142.63 154.15 44.12 Favored 'General case' 0 C--O 1.238 0.499 0 C-N-CA 128.052 2.541 . . . . 0.0 106.511 169.297 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 60.7 p -148.53 160.78 42.75 Favored 'General case' 0 N--CA 1.446 -0.66 0 CA-C-O 122.555 1.169 . . . . 0.0 113.795 -179.693 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 93.0 p -164.45 -144.45 0.08 Allowed 'General case' 0 N--CA 1.443 -0.817 0 CA-C-N 112.531 -2.122 . . . . 0.0 105.94 -168.841 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 9.2 ttt180 -136.31 173.0 12.18 Favored 'General case' 0 C--O 1.232 0.134 0 N-CA-C 106.311 -1.737 . . . . 0.0 106.311 168.368 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 5.6 m -81.89 175.16 0.77 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.609 0 C-N-CA 122.918 0.487 . . . . 0.0 110.038 -178.845 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 97.0 m-70 -90.98 150.33 41.66 Favored Pre-proline 0 CA--C 1.542 0.669 0 CA-C-O 119.3 -0.381 . . . . 0.0 111.686 -174.916 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -63.4 -45.64 11.37 Favored 'Trans proline' 0 C--N 1.349 0.59 0 C-N-CA 122.76 2.306 . . . . 0.0 113.31 -171.216 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . 0.407 ' HB ' ' CZ ' ' A' ' 112' ' ' PHE . 5.8 m -69.0 -22.74 64.06 Favored 'General case' 0 CA--C 1.54 0.558 0 O-C-N 121.681 -0.637 . . . . 0.0 110.364 -178.321 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -61.11 -56.68 18.1 Favored 'General case' 0 CA--C 1.509 -0.632 0 N-CA-C 108.197 -1.038 . . . . 0.0 108.197 169.85 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 75.9 mt -56.8 -38.76 60.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 N-CA-C 108.427 -0.953 . . . . 0.0 108.427 -175.229 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -62.47 -50.48 71.27 Favored 'General case' 0 N--CA 1.452 -0.332 0 CA-C-N 118.87 0.759 . . . . 0.0 111.827 -178.845 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 35.9 mmt -72.18 -31.78 66.23 Favored 'General case' 0 N--CA 1.472 0.648 0 CA-C-O 122.584 1.183 . . . . 0.0 110.806 -179.112 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -72.21 -33.13 67.37 Favored 'General case' 0 N--CA 1.443 -0.801 0 N-CA-C 106.855 -1.535 . . . . 0.0 106.855 -177.911 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 41.3 tt0 -74.7 -19.94 60.05 Favored 'General case' 0 N--CA 1.446 -0.67 0 O-C-N 120.925 -1.109 . . . . 0.0 110.525 172.441 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 20.3 mm-40 -64.49 -33.33 75.63 Favored 'General case' 0 CA--C 1.532 0.265 0 CA-C-N 119.576 1.08 . . . . 0.0 109.982 169.771 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 16.4 m -91.17 12.31 2.17 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.736 0 N-CA-C 112.275 0.472 . . . . 0.0 112.275 169.192 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 73.08 13.67 79.25 Favored Glycine 0 CA--C 1.531 1.089 0 C-N-CA 124.53 1.062 . . . . 0.0 113.695 174.675 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 17.2 mt -91.23 143.95 10.17 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.239 0 C-N-CA 124.438 1.095 . . . . 0.0 110.001 -177.476 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 7.2 t70 -104.49 124.6 49.56 Favored 'General case' 0 C--O 1.235 0.298 0 N-CA-C 106.628 -1.619 . . . . 0.0 106.628 168.902 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 5.8 pt -120.06 -21.81 4.02 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.697 0 C-N-CA 124.686 1.195 . . . . 0.0 109.526 169.073 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -38.67 -35.91 0.22 Allowed 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 129.252 3.021 . . . . 0.0 113.778 169.326 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -72.46 -9.75 74.0 Favored Glycine 0 CA--C 1.535 1.321 0 C-N-CA 124.649 1.118 . . . . 0.0 114.229 179.963 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 26.2 mt-30 -68.1 140.08 56.21 Favored 'General case' 0 N--CA 1.451 -0.401 0 CA-C-N 119.753 1.777 . . . . 0.0 110.265 176.764 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 1.2 m -155.94 -51.88 0.08 Allowed 'General case' 0 N--CA 1.438 -1.046 0 N-CA-C 104.119 -2.548 . . . . 0.0 104.119 168.412 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 3.9 m 68.9 160.03 0.18 Allowed 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 126.677 1.991 . . . . 0.0 114.071 169.095 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -95.32 163.61 21.23 Favored Pre-proline 0 C--O 1.241 0.621 0 C-N-CA 124.968 1.307 . . . . 0.0 109.754 -172.833 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -62.05 136.24 59.77 Favored 'Trans proline' 0 N--CA 1.449 -1.095 0 N-CA-C 108.203 -1.499 . . . . 0.0 108.203 169.762 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 8.1 tt -61.6 -19.15 20.3 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.498 0 C-N-CA 124.248 1.019 . . . . 0.0 111.03 -177.958 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 12.1 mt-10 -67.29 -25.48 66.06 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 125.533 1.533 . . . . 0.0 110.391 -179.748 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 15.4 t-20 -71.82 1.29 7.21 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 124.702 1.201 . . . . 0.0 113.112 -179.632 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 42.5 m-85 -130.74 -174.18 3.29 Favored 'General case' 0 C--O 1.236 0.388 0 C-N-CA 126.585 1.954 . . . . 0.0 109.136 -177.707 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 57.1 t-20 -135.05 140.19 45.38 Favored 'General case' 0 N--CA 1.446 -0.628 0 N-CA-C 107.397 -1.335 . . . . 0.0 107.397 169.382 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -72.22 -25.13 61.53 Favored 'General case' 0 N--CA 1.435 -1.207 0 N-CA-C 109.08 -0.711 . . . . 0.0 109.08 -178.157 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 35.1 t70 -63.71 -24.76 67.91 Favored 'General case' 0 N--CA 1.447 -0.609 0 O-C-N 123.254 0.346 . . . . 0.0 111.868 -179.132 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -78.08 -28.32 48.73 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 123.52 0.728 . . . . 0.0 111.925 176.036 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 14.7 m-85 -80.38 170.96 15.67 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 125.805 1.642 . . . . 0.0 111.695 -178.568 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 22.9 t70 -119.63 -39.07 2.9 Favored 'General case' 0 N--CA 1.464 0.272 0 C-N-CA 123.185 0.594 . . . . 0.0 111.599 177.318 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -139.32 133.96 39.73 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.494 0 CA-C-O 121.98 0.895 . . . . 0.0 110.639 -170.204 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 70.4 t -142.69 133.45 23.77 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.632 0 N-CA-C 105.746 -1.946 . . . . 0.0 105.746 -176.382 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 33.6 mm -124.94 122.09 62.59 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.527 0 N-CA-C 106.448 -1.686 . . . . 0.0 106.448 -171.603 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 58.7 m -87.09 122.59 31.12 Favored 'General case' 0 N--CA 1.441 -0.884 0 N-CA-C 105.204 -2.147 . . . . 0.0 105.204 169.0 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 69.3 mt -83.92 3.39 34.25 Favored 'General case' 0 C--N 1.327 -0.37 0 O-C-N 121.711 -0.618 . . . . 0.0 110.341 175.153 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 29.7 p -160.82 141.57 11.56 Favored 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 124.838 1.255 . . . . 0.0 108.249 169.728 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 57.97 -162.2 9.71 Favored Glycine 0 CA--C 1.534 1.223 0 C-N-CA 124.581 1.086 . . . . 0.0 114.523 170.26 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 10.9 p -152.17 147.75 26.8 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 125.367 1.467 . . . . 0.0 107.536 170.303 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 59.1 44.2 96.5 Favored Glycine 0 CA--C 1.533 1.176 0 N-CA-C 111.145 -0.782 . . . . 0.0 111.145 -178.107 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 29.8 m -79.8 52.53 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.545 0.775 0 C-N-CA 124.845 1.258 . . . . 0.0 112.799 -169.589 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 17.5 t-20 56.06 53.09 9.51 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 126.295 1.838 . . . . 0.0 108.827 -175.275 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -147.74 147.17 26.5 Favored Pre-proline 0 CA--C 1.54 0.579 0 C-N-CA 126.913 2.085 . . . . 0.0 107.34 -169.28 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_exo -64.24 138.34 60.68 Favored 'Trans proline' 0 CA--C 1.542 0.892 0 CA-C-N 120.692 1.283 . . . . 0.0 112.693 -171.878 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -67.15 -28.37 40.77 Favored 'Trans proline' 0 N--CA 1.458 -0.567 0 C-N-CA 122.667 2.245 . . . . 0.0 114.425 -169.393 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 5.1 pm0 -62.13 -15.92 48.95 Favored 'General case' 0 CA--C 1.536 0.42 0 CA-C-N 120.404 1.456 . . . . 0.0 112.53 -178.275 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 96.4 m95 -73.38 -49.36 27.62 Favored 'General case' 0 N--CA 1.451 -0.394 0 C-N-CA 123.242 0.617 . . . . 0.0 110.848 174.371 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 28.6 m -79.87 -0.29 3.79 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.359 0 C-N-CA 123.615 0.766 . . . . 0.0 112.717 -178.446 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 57.7 p -113.33 25.32 11.42 Favored 'General case' 0 C--O 1.237 0.409 0 CA-C-N 119.547 1.067 . . . . 0.0 113.155 174.033 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 76.2 mm-40 -66.57 174.22 2.94 Favored 'General case' 0 CA--C 1.539 0.528 0 CA-C-N 118.611 0.641 . . . . 0.0 112.084 176.251 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 32.7 mm-40 -54.57 -29.44 51.25 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 124.038 0.935 . . . . 0.0 111.723 -169.765 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 3.3 tt -133.7 130.63 56.36 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.672 0 N-CA-C 104.041 -2.577 . . . . 0.0 104.041 168.388 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 44.1 t80 -120.86 142.03 50.03 Favored 'General case' 0 N--CA 1.448 -0.546 0 N-CA-C 105.921 -1.881 . . . . 0.0 105.921 169.221 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 20.6 mm-40 -139.79 144.49 37.39 Favored 'General case' 0 C--O 1.236 0.373 0 N-CA-C 107.624 -1.25 . . . . 0.0 107.624 170.112 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 6.0 t0 -110.56 107.69 17.39 Favored 'General case' 0 C--O 1.238 0.484 0 N-CA-C 105.168 -2.16 . . . . 0.0 105.168 169.093 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -99.53 125.37 45.29 Favored 'General case' 0 N--CA 1.454 -0.269 0 C-N-CA 123.377 0.671 . . . . 0.0 109.546 -173.301 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 34.2 mm-40 -89.05 116.98 27.73 Favored 'General case' 0 N--CA 1.456 -0.163 0 N-CA-C 105.416 -2.068 . . . . 0.0 105.416 168.823 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.517 HD13 HG22 ' A' ' 119' ' ' VAL . 28.9 mt -142.95 127.69 18.17 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 104.638 -2.356 . . . . 0.0 104.638 -179.738 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 26.5 mm-40 -63.48 157.77 22.59 Favored 'General case' 0 CA--C 1.534 0.333 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 172.722 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -117.13 135.03 22.98 Favored Pre-proline 0 N--CA 1.45 -0.426 0 C-N-CA 124.526 1.13 . . . . 0.0 108.105 169.687 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -89.09 -8.68 4.72 Favored 'Trans proline' 0 N--CA 1.453 -0.882 0 C-N-CA 122.285 1.99 . . . . 0.0 114.674 -170.138 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -50.7 -51.4 49.97 Favored 'General case' 0 N--CA 1.472 0.672 0 CA-C-N 120.554 1.525 . . . . 0.0 113.14 -169.31 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -84.31 11.84 56.93 Favored Glycine 0 CA--C 1.532 1.147 0 CA-C-O 118.702 -1.055 . . . . 0.0 113.396 -176.49 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 9.8 mt-30 -130.98 176.45 8.23 Favored 'General case' 0 CA--C 1.542 0.664 0 CA-C-N 118.847 1.324 . . . . 0.0 110.654 -169.683 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 13.9 m -78.23 169.7 17.83 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 124.604 1.161 . . . . 0.0 112.242 -173.592 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 34.4 tp -55.19 -33.93 63.45 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 125.86 1.664 . . . . 0.0 113.058 -178.11 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 5.9 pt-20 -56.99 -34.71 68.41 Favored 'General case' 0 N--CA 1.463 0.208 0 C-N-CA 123.483 0.713 . . . . 0.0 111.608 174.782 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 16.0 t -76.63 -38.52 30.96 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.525 0 CA-C-O 118.02 -0.991 . . . . 0.0 109.801 -176.874 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . 0.407 ' CZ ' ' HB ' ' A' ' 45' ' ' THR . 85.2 m-85 -57.02 -48.13 79.23 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-N 120.377 1.444 . . . . 0.0 109.547 171.545 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 85.6 mtt180 -63.72 -39.46 94.35 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 122.916 0.486 . . . . 0.0 111.247 -179.613 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 5.7 m -67.34 -49.6 63.37 Favored 'General case' 0 N--CA 1.452 -0.339 0 C-N-CA 124.203 1.001 . . . . 0.0 110.226 177.975 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 59.2 t -65.56 -35.13 74.52 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.306 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 -173.697 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 58.7 ttp85 -56.42 -45.18 80.84 Favored 'General case' 0 CA--C 1.537 0.475 0 CA-C-N 118.499 0.59 . . . . 0.0 109.76 174.077 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -64.18 -51.63 51.24 Favored Glycine 0 CA--C 1.53 1.006 0 CA-C-N 118.346 0.521 . . . . 0.0 112.208 175.922 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 9.4 mt-30 -61.52 -43.21 99.27 Favored 'General case' 0 N--CA 1.468 0.428 0 CA-C-N 118.258 1.029 . . . . 0.0 110.713 -175.364 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . 0.517 HG22 HD13 ' A' ' 101' ' ' LEU . 95.6 t -70.58 -40.66 77.48 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.377 0 CA-C-O 118.399 -0.81 . . . . 0.0 109.265 -176.011 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 58.2 tttm -54.94 -45.85 74.88 Favored 'General case' 0 CA--C 1.518 -0.276 0 CA-C-N 119.275 0.943 . . . . 0.0 109.093 174.906 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 41.5 tt0 -66.84 -43.16 84.43 Favored 'General case' 0 N--CA 1.45 -0.446 0 C-N-CA 122.761 0.424 . . . . 0.0 111.043 -173.794 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 36.3 mtt-85 -66.21 -40.75 90.56 Favored 'General case' 0 N--CA 1.471 0.599 0 O-C-N 121.413 -0.804 . . . . 0.0 111.722 176.857 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 90.2 t -68.77 -37.61 77.7 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.499 0 N-CA-C 108.952 -0.758 . . . . 0.0 108.952 179.289 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 13.4 mt-10 -60.01 -43.8 94.99 Favored 'General case' 0 C--O 1.226 -0.174 0 CA-C-N 119.308 0.958 . . . . 0.0 110.064 174.13 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 29.2 t-20 -63.02 -45.27 93.13 Favored 'General case' 0 CA--C 1.53 0.204 0 CA-C-N 118.124 0.42 . . . . 0.0 111.103 -179.489 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 38.6 tp -57.75 -49.11 77.66 Favored 'General case' 0 N--CA 1.452 -0.364 0 C-N-CA 124.684 1.194 . . . . 0.0 110.489 176.715 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 70.0 mt -63.49 -46.78 94.23 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 N-CA-C 108.12 -1.067 . . . . 0.0 108.12 -179.408 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -59.13 -29.64 67.54 Favored 'General case' 0 CA--C 1.535 0.377 0 CA-C-O 118.325 -0.845 . . . . 0.0 112.251 -178.426 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . 0.25 19.3 ptpt -83.17 -39.05 21.52 Favored 'General case' 0 C--N 1.343 0.323 0 CA-C-O 117.863 -1.065 . . . . 0.0 112.616 175.421 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 12.6 pt -82.46 -40.19 16.72 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.362 0 CA-C-N 120.207 1.367 . . . . 0.0 113.497 -175.166 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 70.8 m . . . . . 0 C--O 1.253 1.24 0 C-N-CA 125.692 1.597 . . . . 0.0 109.848 -170.05 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 9.8 ptm . . . . . 0 N--CA 1.496 1.872 0 N-CA-C 110.622 -0.14 . . . . 0.0 110.622 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 27.5 mttm -75.09 121.25 21.75 Favored 'General case' 0 N--CA 1.48 1.045 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 -171.24 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 91.6 mttt -88.15 134.75 33.69 Favored 'General case' 0 CA--C 1.512 -0.491 0 N-CA-C 108.075 -1.083 . . . . 0.0 108.075 177.201 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 1.9 t -123.35 147.93 27.49 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.648 0 C-N-CA 126.574 1.95 . . . . 0.0 108.89 -168.994 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 34.3 mtt -137.02 150.5 48.14 Favored 'General case' 0 C--N 1.325 -0.493 0 C-N-CA 124.671 1.189 . . . . 0.0 108.215 168.049 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 35.7 m-85 -129.29 129.54 45.03 Favored 'General case' 0 CA--C 1.515 -0.397 0 N-CA-C 103.833 -2.654 . . . . 0.0 103.833 169.715 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 1.1 p -152.78 136.39 8.17 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.366 0 CA-C-O 121.352 0.596 . . . . 0.0 109.587 -169.276 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 49.9 t -122.08 174.66 6.79 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 127.317 2.247 . . . . 0.0 107.182 169.661 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 51.5 tttm -63.78 -32.28 73.73 Favored 'General case' 0 CA--C 1.539 0.531 0 O-C-N 121.226 -0.921 . . . . 0.0 111.303 179.275 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 74.4 mtm-85 -108.63 162.94 13.68 Favored 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 124.815 1.246 . . . . 0.0 108.003 169.615 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 7.3 t30 -70.55 -54.77 10.8 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-O 121.366 0.603 . . . . 0.0 110.296 172.625 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 12.4 m -89.75 46.39 1.36 Allowed 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 123.499 0.72 . . . . 0.0 111.454 -168.953 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 50.6 m -139.78 118.17 12.12 Favored 'General case' 0 N--CA 1.448 -0.548 0 N-CA-C 106.81 -1.552 . . . . 0.0 106.81 170.073 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 79.2 mtt180 64.96 -26.88 0.09 Allowed 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 129.02 2.928 . . . . 0.0 115.218 176.537 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 1.2 m -76.67 -140.79 0.02 OUTLIER 'General case' 0 CA--C 1.549 0.916 0 N-CA-C 104.658 -2.349 . . . . 0.0 104.658 168.036 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 22.5 pt20 49.43 26.44 1.65 Allowed 'General case' 0 N--CA 1.475 0.813 0 CA-C-N 121.047 1.749 . . . . 0.0 112.455 178.311 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' MET . . . . . 0.428 ' HG2' ' CE ' ' A' ' 50' ' ' MET . 0.0 OUTLIER -171.42 -49.34 0.02 OUTLIER 'General case' 0 N--CA 1.446 -0.663 0 C-N-CA 127.748 2.419 . . . . 0.0 108.515 -175.102 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . 0.407 ' HA ' ' CG1' ' A' ' 119' ' ' VAL . . . -71.88 -45.94 59.53 Favored 'General case' 0 C--N 1.343 0.321 0 C-N-CA 123.448 0.699 . . . . 0.0 112.749 -169.562 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -63.71 -35.58 81.02 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 169.493 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -49.75 -66.06 2.5 Favored Glycine 0 C--N 1.341 0.811 0 C-N-CA 126.021 1.772 . . . . 0.0 110.745 174.851 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 2.5 m-85 -59.75 -27.67 66.7 Favored 'General case' 0 CA--C 1.512 -0.497 0 O-C-N 121.103 -1.234 . . . . 0.0 112.519 178.492 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -71.65 -32.8 68.31 Favored 'General case' 0 N--CA 1.447 -0.599 0 CA-C-O 117.71 -1.138 . . . . 0.0 112.117 -176.526 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.29 -30.44 70.3 Favored 'General case' 0 N--CA 1.476 0.848 0 CA-C-N 120.517 1.508 . . . . 0.0 110.903 172.065 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 18.8 m -75.92 -56.63 4.49 Favored 'General case' 0 N--CA 1.448 -0.54 0 C-N-CA 124.638 1.175 . . . . 0.0 111.078 -176.864 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 71.9 mt -78.56 -38.06 41.25 Favored 'General case' 0 C--N 1.33 -0.267 0 C-N-CA 124.3 1.04 . . . . 0.0 109.807 -173.771 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -80.54 2.75 76.98 Favored Glycine 0 CA--C 1.527 0.811 0 C-N-CA 124.838 1.209 . . . . 0.0 112.971 179.929 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -53.35 129.74 32.85 Favored 'General case' 0 C--O 1.236 0.389 0 CA-C-N 118.462 1.131 . . . . 0.0 109.301 179.809 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 75.44 5.32 77.33 Favored Glycine 0 CA--C 1.536 1.397 0 C-N-CA 124.378 0.99 . . . . 0.0 114.464 -178.606 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 41.0 mttp -128.23 -52.32 1.29 Allowed 'General case' 0 N--CA 1.472 0.671 0 CA-C-N 119.087 1.444 . . . . 0.0 111.373 -172.375 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 29.5 pt -140.02 147.43 23.67 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.502 0 C-N-CA 123.57 0.748 . . . . 0.0 109.59 -169.407 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -105.32 104.85 14.66 Favored 'General case' 0 N--CA 1.464 0.261 0 C-N-CA 124.889 1.275 . . . . 0.0 109.035 -172.825 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 9.8 p -80.24 137.47 21.48 Favored 'Isoleucine or valine' 0 C--O 1.236 0.357 0 CA-C-N 119.126 0.876 . . . . 0.0 109.431 173.86 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 6.6 m -134.56 117.9 16.67 Favored 'General case' 0 N--CA 1.434 -1.264 0 N-CA-C 104.686 -2.339 . . . . 0.0 104.686 173.766 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 2.4 m -89.74 39.62 0.96 Allowed 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 113.01 0.744 . . . . 0.0 113.01 -169.643 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 1.5 m -65.19 159.68 23.05 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 124.515 1.126 . . . . 0.0 111.077 178.549 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -177.64 -165.85 33.35 Favored Glycine 0 C--N 1.337 0.618 0 N-CA-C 108.678 -1.769 . . . . 0.0 108.678 -175.542 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 12.4 mt -132.49 160.59 36.04 Favored 'General case' 0 N--CA 1.445 -0.679 0 C-N-CA 126.547 1.939 . . . . 0.0 107.773 177.473 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 21.5 mt-10 56.13 18.04 3.02 Favored 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 124.627 1.171 . . . . 0.0 112.885 178.639 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 13.7 p -76.35 163.53 26.91 Favored 'General case' 0 N--CA 1.435 -1.179 0 N-CA-C 115.054 1.501 . . . . 0.0 115.054 -167.841 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 8.0 m -153.82 177.21 11.25 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 129.15 2.98 . . . . 0.0 105.98 -169.735 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 53.6 ttt180 -88.9 153.13 21.29 Favored 'General case' 0 CA--C 1.533 0.297 0 O-C-N 121.07 -1.019 . . . . 0.0 109.737 -177.505 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 1.9 p -44.72 149.54 0.25 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.439 0 C-N-CA 128.035 2.534 . . . . 0.0 112.568 169.987 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 23.0 m170 -88.69 152.81 49.59 Favored Pre-proline 0 CA--C 1.543 0.7 0 C-N-CA 123.274 0.63 . . . . 0.0 111.2 -179.563 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -59.08 -52.98 4.1 Favored 'Trans proline' 0 C--N 1.351 0.665 0 C-N-CA 124.149 3.233 . . . . 0.0 114.204 -169.091 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 7.3 m -67.37 -24.58 65.71 Favored 'General case' 0 CA--C 1.537 0.445 0 CA-C-O 119.215 -0.421 . . . . 0.0 110.651 -171.407 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -56.8 -53.8 53.7 Favored 'General case' 0 CA--C 1.511 -0.548 0 N-CA-C 109.177 -0.675 . . . . 0.0 109.177 173.231 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 52.1 mt -60.6 -38.59 78.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 -170.424 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -62.92 -49.13 75.98 Favored 'General case' 0 N--CA 1.454 -0.243 0 CA-C-N 118.595 0.634 . . . . 0.0 111.244 178.957 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 30.2 mmt -67.46 -37.14 82.48 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-O 122.779 1.276 . . . . 0.0 110.968 179.964 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' MET . . . . . 0.428 ' CE ' ' HG2' ' A' ' 17' ' ' MET . 0.0 OUTLIER -74.3 -31.61 62.55 Favored 'General case' 0 N--CA 1.443 -0.779 0 N-CA-C 107.2 -1.408 . . . . 0.0 107.2 -176.08 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 40.2 tt0 -72.07 -20.84 61.6 Favored 'General case' 0 N--CA 1.449 -0.52 0 O-C-N 121.211 -0.931 . . . . 0.0 110.788 170.699 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 20.6 mm-40 -66.01 -32.23 73.59 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-N 119.571 1.078 . . . . 0.0 109.89 169.912 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 15.7 m -91.97 13.63 1.98 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.835 0 CA-C-N 118.361 0.528 . . . . 0.0 112.036 169.037 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 75.82 15.97 80.97 Favored Glycine 0 CA--C 1.532 1.123 0 C-N-CA 124.99 1.281 . . . . 0.0 113.981 173.006 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 3.5 mt -99.54 140.8 18.04 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.113 0 C-N-CA 124.588 1.155 . . . . 0.0 111.201 -171.613 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 3.0 t70 -97.04 130.72 44.31 Favored 'General case' 0 CA--C 1.528 0.12 0 C-N-CA 125.421 1.489 . . . . 0.0 108.886 169.857 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 6.5 pt -132.58 -31.27 0.55 Allowed 'Isoleucine or valine' 0 C--O 1.216 -0.689 0 C-N-CA 125.78 1.632 . . . . 0.0 109.501 169.673 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -15.76 -36.37 0.0 OUTLIER 'General case' 0 CA--C 1.545 0.763 1 C-N-CA 131.768 4.027 . . . . 0.0 118.5 169.992 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -110.25 37.2 3.86 Favored Glycine 0 CA--C 1.534 1.251 0 C-N-CA 125.921 1.724 . . . . 0.0 113.858 -179.507 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 6.3 mt-30 -59.88 -30.48 69.02 Favored 'General case' 0 N--CA 1.474 0.75 0 CA-C-N 119.63 1.715 . . . . 0.0 114.232 -174.719 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -57.8 123.73 16.74 Favored 'General case' 0 C--O 1.236 0.342 0 C-N-CA 124.043 0.937 . . . . 0.0 109.135 -169.421 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 75.2 m -145.96 177.28 9.06 Favored 'General case' 0 N--CA 1.443 -0.802 0 C-N-CA 126.452 1.901 . . . . 0.0 107.019 -169.369 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -59.26 153.95 44.48 Favored Pre-proline 0 C--O 1.239 0.543 0 C-N-CA 123.691 0.796 . . . . 0.0 111.49 175.756 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -63.48 154.16 70.34 Favored 'Trans proline' 0 N--CA 1.454 -0.826 0 C-N-CA 122.49 2.127 . . . . 0.0 109.84 170.879 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 3.2 tt -61.95 -24.41 34.32 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.522 0 O-C-N 121.701 -0.624 . . . . 0.0 111.212 -175.764 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 12.6 mt-10 -65.96 -26.23 67.48 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 124.751 1.22 . . . . 0.0 110.81 -177.377 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 7.6 t-20 -63.12 -23.89 67.65 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 124.673 1.189 . . . . 0.0 111.942 179.085 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 75.0 m-85 -104.62 -174.68 2.59 Favored 'General case' 0 C--O 1.236 0.367 0 C-N-CA 126.19 1.796 . . . . 0.0 110.357 -174.819 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 56.3 t-20 -135.82 132.83 37.16 Favored 'General case' 0 N--CA 1.443 -0.819 0 N-CA-C 106.176 -1.787 . . . . 0.0 106.176 168.855 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -75.0 -19.75 59.95 Favored 'General case' 0 N--CA 1.431 -1.38 0 C-N-CA 120.125 -0.63 . . . . 0.0 109.389 -176.585 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 35.5 t70 -65.03 -24.71 67.57 Favored 'General case' 0 N--CA 1.442 -0.829 0 O-C-N 122.211 -0.305 . . . . 0.0 111.235 179.127 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -77.0 -28.81 55.18 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 123.773 0.829 . . . . 0.0 111.779 173.872 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 11.6 m-85 -77.35 168.21 20.41 Favored 'General case' 0 N--CA 1.451 -0.42 0 C-N-CA 125.261 1.424 . . . . 0.0 111.342 178.863 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -117.28 -39.21 3.22 Favored 'General case' 0 C--O 1.234 0.266 0 C-N-CA 123.213 0.605 . . . . 0.0 111.249 177.256 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -138.2 135.02 44.73 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.693 0 CA-C-O 122.021 0.915 . . . . 0.0 109.943 -169.887 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 75.6 t -142.09 133.89 26.65 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.451 0 N-CA-C 105.905 -1.887 . . . . 0.0 105.905 176.708 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 39.7 mm -117.78 102.82 13.89 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.78 0 N-CA-C 105.253 -2.129 . . . . 0.0 105.253 -170.437 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 47.2 m -101.34 70.61 1.32 Allowed 'General case' 0 N--CA 1.439 -1.014 0 N-CA-C 106.458 -1.682 . . . . 0.0 106.458 -172.947 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -71.22 23.33 0.04 OUTLIER 'General case' 0 CA--C 1.542 0.655 0 N-CA-C 114.136 1.162 . . . . 0.0 114.136 -170.075 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 74.9 m -146.3 55.64 1.16 Allowed 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 125.823 1.649 . . . . 0.0 109.996 172.33 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 81.34 -167.0 48.55 Favored Glycine 0 CA--C 1.531 1.034 0 O-C-N 121.363 -0.835 . . . . 0.0 112.663 176.981 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 15.0 p -151.68 150.19 29.96 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 123.649 0.779 . . . . 0.0 110.375 -169.952 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 61.26 28.25 68.91 Favored Glycine 0 CA--C 1.531 1.036 0 C-N-CA 123.208 0.433 . . . . 0.0 112.081 -179.014 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 32.8 m -71.45 -34.43 53.25 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.612 0 CA-C-N 117.479 0.64 . . . . 0.0 111.719 -169.303 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 21.2 t-20 -178.13 -43.02 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 128.792 2.837 . . . . 0.0 106.14 174.318 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.437 ' HA ' ' HD3' ' A' ' 87' ' ' PRO . 3.0 tt -44.09 139.68 3.03 Favored Pre-proline 0 CA--C 1.547 0.859 0 C-N-CA 128.202 2.601 . . . . 0.0 111.295 169.659 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . 0.437 ' HD3' ' HA ' ' A' ' 86' ' ' LEU . 51.8 Cg_exo -65.17 150.98 86.99 Favored 'Trans proline' 0 C--N 1.356 0.936 0 C-N-CA 121.974 1.782 . . . . 0.0 115.658 -169.727 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . 0.431 ' HD3' ' HA ' ' A' ' 87' ' ' PRO . 51.2 Cg_exo -64.51 -30.47 61.63 Favored 'Trans proline' 0 C--N 1.349 0.594 0 C-N-CA 122.491 2.127 . . . . 0.0 114.972 -174.661 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -56.35 -21.05 22.05 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-N 119.49 1.041 . . . . 0.0 112.739 -177.026 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 99.4 m95 -80.06 -28.75 39.16 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 124.948 1.299 . . . . 0.0 112.188 -179.56 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 16.1 m -100.67 -4.35 9.29 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.41 0 C-N-CA 124.946 1.299 . . . . 0.0 112.019 179.623 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 59.8 p -103.27 30.37 4.95 Favored 'General case' 0 CA--C 1.535 0.39 0 CA-C-N 119.325 0.966 . . . . 0.0 112.449 175.644 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 46.1 mm-40 -72.33 175.06 6.47 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 123.344 0.658 . . . . 0.0 111.275 -175.354 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 36.2 mm-40 -61.54 -26.05 67.69 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-O 120.832 0.348 . . . . 0.0 110.513 179.758 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 4.1 tt -136.54 124.49 34.3 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.523 0 N-CA-C 104.997 -2.223 . . . . 0.0 104.997 169.169 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 20.9 t80 -103.49 135.01 45.89 Favored 'General case' 0 CA--C 1.538 0.49 0 N-CA-C 105.755 -1.943 . . . . 0.0 105.755 169.581 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 15.6 mm-40 -136.26 162.25 33.51 Favored 'General case' 0 C--O 1.235 0.291 0 N-CA-C 108.552 -0.907 . . . . 0.0 108.552 170.294 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 5.2 t0 -178.79 126.95 0.1 Allowed 'General case' 0 C--N 1.326 -0.439 0 C-N-CA 126.869 2.068 . . . . 0.0 105.643 -169.519 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 6.6 m0 -143.42 149.0 37.01 Favored 'General case' 0 C--N 1.333 -0.136 0 C-N-CA 122.616 0.366 . . . . 0.0 110.788 -170.933 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 1.9 tp-100 -82.73 54.04 2.56 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 124.338 1.055 . . . . 0.0 109.508 175.909 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 1.1 mp -64.28 147.13 53.16 Favored 'General case' 0 C--N 1.34 0.184 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 178.209 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 69.2 mm-40 -77.8 166.4 22.97 Favored 'General case' 0 CA--C 1.536 0.413 0 N-CA-C 108.229 -1.026 . . . . 0.0 108.229 169.496 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -135.08 137.74 27.69 Favored Pre-proline 0 CA--C 1.536 0.426 0 C-N-CA 124.161 0.984 . . . . 0.0 109.334 171.86 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 21.4 Cg_endo -92.94 3.77 3.43 Favored 'Trans proline' 0 N--CA 1.452 -0.944 0 C-N-CA 122.318 2.012 . . . . 0.0 114.781 -171.661 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -55.81 120.88 8.04 Favored 'General case' 0 C--O 1.237 0.399 0 CA-C-N 120.398 1.454 . . . . 0.0 110.841 -174.571 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 68.65 5.48 45.04 Favored Glycine 0 CA--C 1.534 1.274 0 CA-C-O 118.873 -0.96 . . . . 0.0 114.151 179.902 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 7.0 mt-30 -97.12 167.74 10.87 Favored 'General case' 0 CA--C 1.537 0.47 0 CA-C-N 118.882 1.341 . . . . 0.0 109.864 179.428 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 15.6 m -69.95 165.98 20.57 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 124.097 0.959 . . . . 0.0 111.754 179.762 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 64.7 mt -60.29 -26.77 66.76 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 123.924 0.89 . . . . 0.0 112.452 -175.594 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 5.8 pt-20 -56.29 -35.27 67.32 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 118.773 0.715 . . . . 0.0 111.162 173.934 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 11.9 t -77.27 -41.09 30.14 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.309 0 CA-C-O 118.203 -0.903 . . . . 0.0 109.823 -178.951 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 62.7 m-85 -57.21 -45.67 83.6 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-N 120.323 1.419 . . . . 0.0 109.596 172.091 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 92.4 mtt180 -63.77 -44.11 94.41 Favored 'General case' 0 N--CA 1.468 0.455 0 C-N-CA 123.395 0.678 . . . . 0.0 110.8 -179.789 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 5.3 m -60.9 -46.76 89.37 Favored 'General case' 0 N--CA 1.449 -0.475 0 C-N-CA 124.642 1.177 . . . . 0.0 109.998 176.281 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 69.4 t -70.09 -37.86 73.33 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.494 0 CA-C-O 117.704 -1.141 . . . . 0.0 109.116 -173.39 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 41.1 mtm105 -57.22 -43.36 82.75 Favored 'General case' 0 C--O 1.224 -0.275 0 CA-C-N 120.113 1.324 . . . . 0.0 110.131 172.859 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -63.67 -54.35 31.99 Favored Glycine 0 CA--C 1.53 1.022 0 CA-C-N 118.672 0.669 . . . . 0.0 111.766 179.128 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 49.8 mm-40 -52.69 -51.23 61.2 Favored 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 124.696 1.198 . . . . 0.0 110.049 177.838 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . 0.407 ' CG1' ' HA ' ' A' ' 18' ' ' ALA . 59.6 t -63.8 -50.22 78.64 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.666 0 CA-C-O 118.397 -0.811 . . . . 0.0 109.782 -176.172 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 86.7 tttt -56.38 -46.81 79.91 Favored 'General case' 0 CA--C 1.512 -0.483 0 N-CA-C 108.219 -1.03 . . . . 0.0 108.219 -175.059 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 40.2 tt0 -64.11 -42.88 96.71 Favored 'General case' 0 N--CA 1.446 -0.668 0 C-N-CA 122.945 0.498 . . . . 0.0 111.112 -175.561 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 25.4 mtt180 -74.61 -38.73 62.5 Favored 'General case' 0 N--CA 1.467 0.395 0 O-C-N 121.047 -1.033 . . . . 0.0 111.666 -178.046 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 85.2 t -65.29 -40.33 88.2 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.634 0 N-CA-C 108.441 -0.948 . . . . 0.0 108.441 174.676 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 4.2 mm-40 -60.54 -46.74 89.07 Favored 'General case' 0 C--O 1.227 -0.125 0 CA-C-N 119.489 1.041 . . . . 0.0 109.798 176.028 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 27.7 t-20 -64.36 -40.64 96.25 Favored 'General case' 0 CA--C 1.529 0.17 0 C-N-CA 123.039 0.536 . . . . 0.0 110.952 -176.471 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 24.2 tp -58.19 -50.13 74.6 Favored 'General case' 0 N--CA 1.451 -0.399 0 C-N-CA 124.875 1.27 . . . . 0.0 110.784 173.186 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 75.3 mt -66.12 -44.89 91.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 N-CA-C 107.808 -1.182 . . . . 0.0 107.808 -177.081 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -58.92 -33.93 71.13 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 123.315 0.646 . . . . 0.0 112.182 -179.796 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 17.8 ptpt -79.73 -38.95 32.21 Favored 'General case' 0 C--N 1.345 0.4 0 CA-C-O 117.926 -1.035 . . . . 0.0 112.101 177.634 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 11.1 pt -83.98 -40.6 15.82 Favored 'Isoleucine or valine' 0 C--O 1.234 0.271 0 CA-C-N 119.997 1.271 . . . . 0.0 113.699 -174.794 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 67.7 m . . . . . 0 C--O 1.254 1.333 0 C-N-CA 125.436 1.494 . . . . 0.0 110.06 -169.807 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 9.9 ptm . . . . . 0 N--CA 1.497 1.902 0 N-CA-C 110.837 -0.06 . . . . 0.0 110.837 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . 0.43 ' HB2' HG22 ' A' ' 30' ' ' ILE . 20.9 mttm -73.95 122.76 23.08 Favored 'General case' 0 N--CA 1.478 0.967 0 O-C-N 120.961 -1.087 . . . . 0.0 108.329 -171.083 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 93.7 mttt -89.23 134.92 33.84 Favored 'General case' 0 CA--C 1.515 -0.371 0 N-CA-C 108.156 -1.053 . . . . 0.0 108.156 176.403 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 1.9 t -122.26 149.98 25.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 C-N-CA 125.764 1.626 . . . . 0.0 109.655 -169.021 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 28.3 mtt -141.02 148.31 40.06 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 125.548 1.539 . . . . 0.0 108.31 168.667 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 65.4 m-85 -132.21 113.02 12.77 Favored 'General case' 0 N--CA 1.453 -0.318 0 N-CA-C 103.919 -2.623 . . . . 0.0 103.919 169.983 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 19.7 t -140.69 127.02 20.95 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 N-CA-C 107.07 -1.455 . . . . 0.0 107.07 -169.248 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 44.3 t -91.7 -152.07 0.29 Allowed 'General case' 0 CA--C 1.546 0.814 0 N-CA-C 105.621 -1.992 . . . . 0.0 105.621 169.239 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 64.0 tttp -58.95 -35.24 72.8 Favored 'General case' 0 N--CA 1.473 0.693 0 O-C-N 119.852 -1.78 . . . . 0.0 109.187 169.348 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 79.7 mtt180 -134.06 176.93 8.14 Favored 'General case' 0 N--CA 1.465 0.302 0 C-N-CA 125.462 1.505 . . . . 0.0 108.999 177.662 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 51.5 t30 -70.64 -15.35 62.73 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 123.387 0.675 . . . . 0.0 111.296 169.651 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 1.8 m -57.04 169.68 0.51 Allowed 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 126.682 1.993 . . . . 0.0 112.443 174.72 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 5.1 m 62.51 -92.51 0.03 OUTLIER 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 125.974 1.71 . . . . 0.0 113.885 169.549 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -92.68 -36.65 12.83 Favored 'General case' 0 N--CA 1.476 0.855 0 CA-C-N 119.851 1.205 . . . . 0.0 112.34 -174.247 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 1.2 m -59.72 -37.28 78.46 Favored 'General case' 0 N--CA 1.47 0.574 0 O-C-N 121.516 -0.74 . . . . 0.0 112.344 -169.659 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 22.2 pt20 -47.82 -46.09 30.5 Favored 'General case' 0 C--N 1.341 0.212 0 C-N-CA 125.008 1.323 . . . . 0.0 111.299 176.028 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -84.45 -38.59 19.97 Favored 'General case' 0 C--O 1.226 -0.183 0 CA-C-N 118.999 0.818 . . . . 0.0 111.139 -175.685 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -61.66 -47.88 83.36 Favored 'General case' 0 C--N 1.332 -0.16 0 C-N-CA 122.126 0.171 . . . . 0.0 111.307 -174.421 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 1.2 pp20? -71.01 -29.37 65.29 Favored 'General case' 0 C--O 1.235 0.309 0 C-N-CA 119.928 -0.709 . . . . 0.0 109.928 176.113 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -49.01 -62.54 4.54 Favored Glycine 0 C--N 1.34 0.805 0 C-N-CA 126.418 1.961 . . . . 0.0 110.457 173.917 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 9.7 m-85 -65.84 -31.21 72.03 Favored 'General case' 0 CA--C 1.512 -0.491 0 CA-C-N 119.35 1.575 . . . . 0.0 114.14 175.922 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -65.22 -33.05 75.09 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 119.56 1.073 . . . . 0.0 111.918 -169.823 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 5.9 ptpt -63.22 -33.79 76.25 Favored 'General case' 0 N--CA 1.476 0.846 0 CA-C-N 119.561 1.073 . . . . 0.0 111.646 173.312 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 6.6 m -75.31 -54.71 6.62 Favored 'General case' 0 N--CA 1.448 -0.528 0 C-N-CA 125.179 1.392 . . . . 0.0 110.002 -177.672 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 87.8 mt -73.41 -35.95 65.92 Favored 'General case' 0 CA--C 1.53 0.205 0 C-N-CA 123.667 0.787 . . . . 0.0 110.533 -173.509 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -93.43 6.27 74.77 Favored Glycine 0 CA--C 1.526 0.762 0 C-N-CA 125.117 1.342 . . . . 0.0 113.499 -175.757 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -48.72 123.92 7.61 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 125.06 1.344 . . . . 0.0 110.94 -173.389 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 77.9 -14.62 9.99 Favored Glycine 0 CA--C 1.536 1.368 0 C-N-CA 124.655 1.122 . . . . 0.0 114.472 178.406 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 61.9 mttm -95.39 -45.04 7.29 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-N 119.372 1.586 . . . . 0.0 110.48 179.655 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.43 HG22 ' HB2' ' A' ' 2' ' ' LYS . 25.7 pt -140.29 153.14 21.87 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.37 0 C-N-CA 123.776 0.83 . . . . 0.0 110.215 -169.534 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -113.15 104.98 12.9 Favored 'General case' 0 C--O 1.226 -0.162 0 C-N-CA 125.209 1.404 . . . . 0.0 108.611 -173.258 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 14.9 p -88.97 133.01 32.32 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.307 0 CA-C-N 118.988 0.813 . . . . 0.0 109.248 175.756 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 15.1 m -152.36 95.54 2.05 Favored 'General case' 0 N--CA 1.456 -0.157 0 N-CA-C 105.302 -2.111 . . . . 0.0 105.302 172.351 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 48.3 m -92.31 72.39 5.3 Favored 'General case' 0 C--O 1.232 0.184 0 CA-C-O 121.741 0.781 . . . . 0.0 111.03 -169.844 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 3.7 m -60.31 165.74 3.39 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 125.482 1.513 . . . . 0.0 109.925 170.066 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -161.1 -160.73 10.96 Favored Glycine 0 C--N 1.337 0.622 0 N-CA-C 109.209 -1.557 . . . . 0.0 109.209 -169.686 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 10.6 mt -133.56 -62.23 0.79 Allowed 'General case' 0 N--CA 1.45 -0.455 0 C-N-CA 123.329 0.651 . . . . 0.0 110.13 -169.731 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -80.44 -21.01 42.55 Favored 'General case' 0 CA--C 1.537 0.481 0 C-N-CA 124.013 0.925 . . . . 0.0 111.382 174.825 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 43.0 m -60.82 166.18 3.54 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 128.196 2.598 . . . . 0.0 116.086 -169.306 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 60.9 p -145.69 -96.68 0.09 Allowed 'General case' 0 N--CA 1.448 -0.529 0 CA-C-N 113.439 -1.71 . . . . 0.0 111.685 -168.604 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 6.4 ttt180 -140.97 179.67 6.59 Favored 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 125.366 1.466 . . . . 0.0 109.316 178.052 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 3.5 m -85.68 178.72 0.53 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.788 0 C-N-CA 123.701 0.8 . . . . 0.0 110.234 -174.442 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 18.4 m-70 -89.05 153.85 49.33 Favored Pre-proline 0 CA--C 1.546 0.801 0 C-N-CA 123.505 0.722 . . . . 0.0 110.825 -177.974 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 33.1 Cg_endo -65.72 -54.29 0.59 Allowed 'Trans proline' 0 C--N 1.349 0.554 0 C-N-CA 123.109 2.539 . . . . 0.0 113.033 -174.004 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 8.7 m -67.74 -24.46 65.36 Favored 'General case' 0 CA--C 1.535 0.381 0 O-C-N 121.97 -0.456 . . . . 0.0 110.337 -176.702 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -55.56 -52.03 65.11 Favored 'General case' 0 CA--C 1.509 -0.623 0 CA-C-O 119.198 -0.429 . . . . 0.0 109.862 173.266 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 37.3 mt -58.87 -42.32 85.4 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 N-CA-C 108.466 -0.939 . . . . 0.0 108.466 -172.778 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -62.21 -47.13 85.82 Favored 'General case' 0 N--CA 1.448 -0.534 0 CA-C-N 118.23 0.468 . . . . 0.0 110.724 -179.443 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' MET . . . . . 0.4 ' HG3' ' CG ' ' A' ' 112' ' ' PHE . 30.7 mmt -72.56 -33.7 66.99 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-O 122.251 1.024 . . . . 0.0 111.415 -177.144 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -74.49 -31.52 62.22 Favored 'General case' 0 N--CA 1.443 -0.821 0 N-CA-C 107.316 -1.364 . . . . 0.0 107.316 -179.144 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 41.6 tt0 -72.91 -22.77 60.68 Favored 'General case' 0 N--CA 1.444 -0.73 0 O-C-N 121.341 -0.849 . . . . 0.0 110.087 172.418 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 16.9 mm-40 -67.32 -29.71 69.36 Favored 'General case' 0 CA--C 1.532 0.28 0 CA-C-N 119.179 0.9 . . . . 0.0 110.334 171.392 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . 0.279 5.3 p -90.83 11.17 2.49 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.927 0 CA-C-N 118.552 0.615 . . . . 0.0 111.289 169.183 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 77.82 17.64 78.34 Favored Glycine 0 CA--C 1.531 1.034 0 C-N-CA 124.677 1.132 . . . . 0.0 113.65 173.773 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 6.9 mt -108.9 138.11 37.63 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.186 0 CA-C-N 118.723 1.262 . . . . 0.0 110.454 -175.374 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 4.3 t70 -90.07 138.36 31.57 Favored 'General case' 0 C--O 1.234 0.275 0 C-N-CA 123.929 0.891 . . . . 0.0 108.773 169.301 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 13.7 pt -130.5 -30.38 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.438 0 C-N-CA 124.67 1.188 . . . . 0.0 110.182 169.492 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -42.18 -35.87 1.06 Allowed 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 127.471 2.308 . . . . 0.0 114.253 169.035 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -65.55 -13.54 58.77 Favored Glycine 0 CA--C 1.53 1.02 0 C-N-CA 124.031 0.824 . . . . 0.0 113.506 -179.862 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 28.0 mt-30 -72.28 154.33 41.04 Favored 'General case' 0 N--CA 1.442 -0.84 0 CA-C-N 118.753 1.276 . . . . 0.0 111.372 172.589 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 2.4 p -152.11 161.7 42.23 Favored 'General case' 0 N--CA 1.433 -1.312 0 C-N-CA 129.826 3.25 . . . . 0.0 103.605 167.702 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 49.9 m -112.72 97.01 6.29 Favored 'General case' 0 C--O 1.234 0.287 0 N-CA-C 108.76 -0.83 . . . . 0.0 108.76 -170.444 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -68.84 152.85 96.56 Favored Pre-proline 0 C--O 1.241 0.646 0 N-CA-C 107.558 -1.275 . . . . 0.0 107.558 169.183 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -59.78 135.74 65.71 Favored 'Trans proline' 0 N--CA 1.449 -1.129 0 C-N-CA 121.531 1.487 . . . . 0.0 108.447 170.168 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 2.1 tt -61.77 -19.13 20.59 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.622 0 C-N-CA 123.703 0.801 . . . . 0.0 110.767 -179.445 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 12.8 mt-10 -66.32 -24.37 66.52 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 126.089 1.756 . . . . 0.0 110.669 179.418 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 13.3 t-20 -69.25 -0.45 6.16 Favored 'General case' 0 CA--C 1.546 0.798 0 C-N-CA 124.822 1.249 . . . . 0.0 112.603 176.346 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 14.0 m-85 -137.22 -170.95 2.84 Favored 'General case' 0 C--O 1.236 0.392 0 C-N-CA 127.604 2.362 . . . . 0.0 108.245 -179.155 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 57.0 t-20 -141.08 141.87 34.21 Favored 'General case' 0 N--CA 1.45 -0.46 0 N-CA-C 107.657 -1.238 . . . . 0.0 107.657 169.577 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.544 ' HB2' ' CD2' ' A' ' 90' ' ' TRP . . . -71.8 -28.85 63.88 Favored 'General case' 0 N--CA 1.434 -1.267 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 178.98 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 36.6 t70 -65.86 -20.98 66.42 Favored 'General case' 0 CA--C 1.546 0.799 0 C-N-CA 120.582 -0.447 . . . . 0.0 111.015 -177.806 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -80.18 -28.91 38.64 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 124.677 1.191 . . . . 0.0 111.79 173.999 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 8.0 m-85 -77.57 169.84 17.61 Favored 'General case' 0 C--O 1.238 0.465 0 C-N-CA 125.152 1.381 . . . . 0.0 111.8 179.956 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 23.5 t70 -118.3 -39.98 2.99 Favored 'General case' 0 C--O 1.235 0.33 0 C-N-CA 123.437 0.695 . . . . 0.0 111.606 178.593 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -139.44 134.49 39.73 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.395 0 CA-C-O 121.393 0.616 . . . . 0.0 110.113 -170.111 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 70.5 t -145.52 129.7 11.81 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.495 0 N-CA-C 105.554 -2.017 . . . . 0.0 105.554 179.424 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.615 HD12 ' HB2' ' A' ' 97' ' ' GLU . 11.6 mm -104.85 130.55 55.7 Favored 'Isoleucine or valine' 0 C--O 1.236 0.392 0 N-CA-C 106.759 -1.571 . . . . 0.0 106.759 176.484 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 37.5 m -96.87 91.2 5.53 Favored 'General case' 0 N--CA 1.446 -0.672 0 N-CA-C 104.677 -2.342 . . . . 0.0 104.677 169.028 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 33.9 mt -61.62 -12.86 17.8 Favored 'General case' 0 N--CA 1.465 0.314 0 C-N-CA 123.399 0.68 . . . . 0.0 112.748 -175.368 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 56.7 m -143.54 134.65 25.67 Favored 'General case' 0 N--CA 1.445 -0.696 0 N-CA-C 106.075 -1.824 . . . . 0.0 106.075 179.194 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 57.03 -146.3 36.17 Favored Glycine 0 CA--C 1.533 1.195 0 C-N-CA 123.452 0.548 . . . . 0.0 111.826 178.929 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 19.6 p -127.23 -93.56 0.47 Allowed 'General case' 0 CA--C 1.529 0.172 0 C-N-CA 124.052 0.941 . . . . 0.0 108.822 174.163 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -72.85 -27.5 68.81 Favored Glycine 0 C--N 1.337 0.602 0 CA-C-O 118.898 -0.945 . . . . 0.0 112.482 -178.442 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.441 HG23 ' H ' ' A' ' 85' ' ' ASN 0.325 16.0 m 47.18 -94.04 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.545 0.754 0 C-N-CA 126.404 1.882 . . . . 0.0 112.602 179.452 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . 0.441 ' H ' HG23 ' A' ' 84' ' ' VAL . 53.0 t30 -142.91 45.4 1.58 Allowed 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 126.105 1.762 . . . . 0.0 108.068 178.408 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.412 ' HA ' ' HD3' ' A' ' 87' ' ' PRO . 0.3 OUTLIER -143.14 147.08 39.4 Favored Pre-proline 0 CA--C 1.548 0.88 0 C-N-CA 125.408 1.483 . . . . 0.0 110.624 -168.89 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . 0.412 ' HD3' ' HA ' ' A' ' 86' ' ' LEU . 51.8 Cg_exo -64.67 150.3 88.4 Favored 'Trans proline' 0 C--N 1.357 1.005 0 C-N-CA 122.08 1.853 . . . . 0.0 114.498 -170.973 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -67.19 -33.52 30.79 Favored 'Trans proline' 0 N--CA 1.458 -0.616 0 C-N-CA 122.795 2.33 . . . . 0.0 116.014 -169.204 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 3.1 pm0 -63.33 -15.26 56.84 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-N 121.573 1.988 . . . . 0.0 112.045 -178.719 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' TRP . . . . . 0.544 ' CD2' ' HB2' ' A' ' 70' ' ' ALA . 98.2 m95 -76.51 -22.95 53.76 Favored 'General case' 0 N--CA 1.452 -0.341 0 CA-C-O 118.835 -0.602 . . . . 0.0 111.953 174.597 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 28.3 m -104.46 -6.85 9.63 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.488 0 C-N-CA 124.832 1.253 . . . . 0.0 113.163 178.023 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . 0.271 9.3 t -112.73 70.62 0.72 Allowed 'General case' 0 CA--C 1.537 0.454 0 CA-C-O 123.441 1.591 . . . . 0.0 107.539 168.899 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 60.4 mm-40 -100.67 179.46 4.41 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 126.545 1.938 . . . . 0.0 109.084 175.067 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 37.7 mm-40 -64.95 -24.18 67.44 Favored 'General case' 0 CA--C 1.539 0.543 0 O-C-N 121.743 -0.598 . . . . 0.0 110.94 179.892 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 6.9 tt -139.63 130.08 31.33 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.354 0 N-CA-C 105.807 -1.923 . . . . 0.0 105.807 169.329 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 36.8 t80 -113.36 135.54 53.75 Favored 'General case' 0 CA--C 1.536 0.41 0 N-CA-C 105.713 -1.958 . . . . 0.0 105.713 169.643 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . 0.615 ' HB2' HD12 ' A' ' 77' ' ' ILE . 11.1 mm-40 -142.44 163.29 33.23 Favored 'General case' 0 C--O 1.232 0.165 0 C-N-CA 124.311 1.044 . . . . 0.0 109.524 179.666 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 2.7 t70 -172.46 129.64 0.56 Allowed 'General case' 0 C--O 1.237 0.422 0 C-N-CA 127.594 2.358 . . . . 0.0 107.07 -169.366 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' TRP . . . . . 0.523 ' CZ3' HG21 ' A' ' 77' ' ' ILE . 5.9 m0 -144.58 153.5 41.87 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-O 120.99 0.424 . . . . 0.0 111.936 -170.637 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 2.3 mp0 -87.48 51.87 2.34 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 124.527 1.131 . . . . 0.0 109.456 175.789 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -67.42 134.59 51.7 Favored 'General case' 0 C--N 1.339 0.136 0 N-CA-C 106.5 -1.667 . . . . 0.0 106.5 169.823 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 6.4 pt-20 -83.18 171.55 13.56 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 123.488 0.715 . . . . 0.0 110.192 175.448 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -131.6 133.27 24.1 Favored Pre-proline 0 C--O 1.238 0.459 0 C-N-CA 125.849 1.66 . . . . 0.0 109.804 -169.805 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 10.6 Cg_endo -97.93 2.5 1.41 Allowed 'Trans proline' 0 N--CA 1.451 -1.004 0 C-N-CA 123.003 2.469 . . . . 0.0 113.538 -174.799 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 8.0 t70 -50.61 115.84 1.66 Allowed 'General case' 0 CA--C 1.538 0.518 0 CA-C-N 120.486 1.494 . . . . 0.0 110.787 -174.113 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 67.47 5.5 36.68 Favored Glycine 0 CA--C 1.537 1.434 0 CA-C-O 119.014 -0.881 . . . . 0.0 114.61 178.172 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 5.6 mt-30 -87.32 172.46 9.84 Favored 'General case' 0 CA--C 1.54 0.583 0 CA-C-N 118.998 1.399 . . . . 0.0 109.869 178.495 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 15.5 m -68.95 161.19 29.37 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 123.854 0.862 . . . . 0.0 110.559 176.897 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 28.1 mt -63.36 -24.42 67.84 Favored 'General case' 0 N--CA 1.47 0.561 0 O-C-N 121.491 -0.756 . . . . 0.0 112.499 -173.02 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 6.0 pt-20 -55.19 -35.49 64.89 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 118.875 0.761 . . . . 0.0 111.189 172.346 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 10.9 t -76.82 -42.08 33.02 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.398 0 CA-C-O 118.433 -0.794 . . . . 0.0 109.189 -178.811 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . 0.4 ' CG ' ' HG3' ' A' ' 49' ' ' MET . 55.4 m-85 -57.24 -45.36 83.99 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-N 120.222 1.374 . . . . 0.0 110.296 172.529 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 90.9 mtt180 -63.27 -43.82 96.86 Favored 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 123.327 0.651 . . . . 0.0 110.584 179.548 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 4.2 m -62.14 -45.6 92.7 Favored 'General case' 0 N--CA 1.448 -0.542 0 C-N-CA 124.518 1.127 . . . . 0.0 110.275 177.168 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 60.2 t -67.21 -39.34 82.82 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.404 0 CA-C-O 118.593 -0.718 . . . . 0.0 109.25 -174.892 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 44.0 mtm105 -57.41 -42.89 83.2 Favored 'General case' 0 CA--C 1.536 0.431 0 CA-C-N 119.31 0.959 . . . . 0.0 110.397 174.913 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -63.37 -54.13 34.4 Favored Glycine 0 CA--C 1.533 1.158 0 CA-C-O 119.576 -0.569 . . . . 0.0 112.08 177.548 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 13.3 mm-40 -51.65 -51.52 55.11 Favored 'General case' 0 N--CA 1.468 0.47 0 C-N-CA 124.66 1.184 . . . . 0.0 110.204 178.215 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 86.1 t -67.74 -48.17 76.95 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 115.186 -0.916 . . . . 0.0 109.684 -173.114 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 62.0 tttm -55.06 -47.51 74.74 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 119.388 0.995 . . . . 0.0 109.711 -175.033 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -64.68 -43.32 93.93 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 122.917 0.487 . . . . 0.0 111.214 -175.469 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 20.8 mtt180 -75.1 -33.97 61.67 Favored 'General case' 0 N--CA 1.469 0.511 0 O-C-N 121.277 -0.889 . . . . 0.0 111.623 -178.179 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 59.5 t -67.34 -39.8 83.51 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.419 0 N-CA-C 108.62 -0.882 . . . . 0.0 108.62 173.674 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 22.8 mt-10 -59.45 -43.05 93.27 Favored 'General case' 0 N--CA 1.462 0.157 0 CA-C-N 119.938 1.245 . . . . 0.0 110.403 174.112 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 29.2 t-20 -63.55 -43.39 97.19 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 123.151 0.58 . . . . 0.0 111.371 -178.918 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 1.9 tm? -59.1 -47.22 86.06 Favored 'General case' 0 N--CA 1.456 -0.152 0 C-N-CA 125.063 1.345 . . . . 0.0 110.947 175.253 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 84.8 mt -65.17 -46.09 92.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 N-CA-C 108.302 -0.999 . . . . 0.0 108.302 179.985 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -59.23 -29.62 67.65 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 123.431 0.692 . . . . 0.0 112.073 177.099 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 69.1 mttt -69.09 -55.21 11.43 Favored 'General case' 0 C--N 1.343 0.311 0 CA-C-N 119.033 0.833 . . . . 0.0 110.385 172.707 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 17.1 pt -78.7 -36.76 19.87 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.335 0 N-CA-C 114.854 1.427 . . . . 0.0 114.854 -169.609 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 75.3 m . . . . . 0 C--O 1.253 1.26 0 C-N-CA 126.185 1.794 . . . . 0.0 109.117 -169.898 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 12.3 ptm . . . . . 0 N--CA 1.497 1.877 0 CA-C-O 120.17 0.033 . . . . 0.0 110.987 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 26.7 mttm -71.08 127.49 32.75 Favored 'General case' 0 N--CA 1.478 0.945 0 N-CA-C 107.682 -1.229 . . . . 0.0 107.682 -174.496 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 72.7 mttt -97.91 133.71 42.03 Favored 'General case' 0 CA--C 1.512 -0.502 0 CA-C-N 119.785 1.175 . . . . 0.0 108.059 172.199 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.474 HG21 HD12 ' A' ' 30' ' ' ILE . 11.7 t -113.21 151.21 15.12 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.605 0 C-N-CA 127.237 2.215 . . . . 0.0 106.568 -170.916 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 52.3 ttm -146.43 141.94 27.65 Favored 'General case' 0 C--N 1.32 -0.676 0 C-N-CA 125.544 1.538 . . . . 0.0 108.708 174.751 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 47.4 m-85 -131.63 103.72 6.54 Favored 'General case' 0 CA--C 1.519 -0.233 0 N-CA-C 106.088 -1.819 . . . . 0.0 106.088 175.216 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 11.0 t -134.83 137.84 50.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 118.629 0.65 . . . . 0.0 110.812 -168.912 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 44.8 t -121.08 -171.66 2.24 Favored 'General case' 0 CA--C 1.548 0.875 0 N-CA-C 104.594 -2.373 . . . . 0.0 104.594 168.53 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 60.2 mtpt -57.18 -67.62 0.3 Allowed 'General case' 0 N--CA 1.471 0.617 0 CA-C-N 120.007 1.276 . . . . 0.0 111.365 -171.191 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 29.3 ttm-85 -111.8 132.83 54.41 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-N 119.47 1.032 . . . . 0.0 108.221 -178.759 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 12.6 t30 -54.56 -34.84 62.53 Favored 'General case' 0 N--CA 1.478 0.943 0 N-CA-C 114.177 1.177 . . . . 0.0 114.177 -169.665 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 5.7 m -57.94 -20.56 38.5 Favored 'General case' 0 CA--C 1.537 0.464 0 N-CA-C 114.242 1.201 . . . . 0.0 114.242 -170.373 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 21.2 m -134.13 151.79 51.53 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 124.513 1.125 . . . . 0.0 109.652 176.828 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 90.5 mtm-85 55.01 40.78 32.15 Favored 'General case' 0 N--CA 1.467 0.414 0 C-N-CA 126.024 1.729 . . . . 0.0 112.346 175.845 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 13.6 m -136.43 -73.78 0.44 Allowed 'General case' 0 CA--C 1.534 0.353 0 N-CA-C 104.052 -2.573 . . . . 0.0 104.052 169.044 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER 40.89 -109.81 0.11 Allowed 'General case' 0 N--CA 1.454 -0.244 0 C-N-CA 127.607 2.363 . . . . 0.0 112.135 168.017 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -76.54 -14.55 60.01 Favored 'General case' 0 CA--C 1.518 -0.261 0 N-CA-C 113.819 1.044 . . . . 0.0 113.819 -169.964 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -63.86 -50.58 68.27 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 119.608 1.094 . . . . 0.0 111.415 -169.135 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -66.82 -38.07 85.74 Favored 'General case' 0 N--CA 1.467 0.405 0 N-CA-C 109.573 -0.529 . . . . 0.0 109.573 173.39 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -55.69 -55.71 27.43 Favored Glycine 0 C--N 1.338 0.645 0 N-CA-C 110.881 -0.888 . . . . 0.0 110.881 -176.959 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 4.8 m-85 -65.9 -32.17 73.52 Favored 'General case' 0 CA--C 1.506 -0.718 0 CA-C-O 118.587 -0.72 . . . . 0.0 111.787 178.484 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -68.84 -32.92 72.95 Favored 'General case' 0 N--CA 1.446 -0.674 0 CA-C-N 118.965 0.802 . . . . 0.0 110.72 -178.051 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.74 -36.97 86.03 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-N 119.504 1.047 . . . . 0.0 110.066 172.256 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 19.0 m -70.09 -56.89 5.76 Favored 'General case' 0 N--CA 1.45 -0.429 0 C-N-CA 124.236 1.014 . . . . 0.0 112.26 -179.939 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 41.7 mt -75.19 -38.23 60.89 Favored 'General case' 0 N--CA 1.466 0.359 0 C-N-CA 124.809 1.244 . . . . 0.0 109.891 -173.513 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -82.51 4.13 79.38 Favored Glycine 0 CA--C 1.526 0.756 0 C-N-CA 125.585 1.564 . . . . 0.0 113.19 179.796 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -53.79 133.22 42.41 Favored 'General case' 0 C--O 1.236 0.358 0 CA-C-N 118.793 1.297 . . . . 0.0 109.279 178.913 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 70.19 8.57 62.18 Favored Glycine 0 CA--C 1.533 1.196 0 CA-C-O 118.444 -1.198 . . . . 0.0 114.969 177.837 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 9.8 ptpp? -137.01 -36.59 0.67 Allowed 'General case' 0 N--CA 1.473 0.724 0 CA-C-N 119.744 1.772 . . . . 0.0 113.079 179.727 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.474 HD12 HG21 ' A' ' 4' ' ' VAL . 17.6 pt -141.22 148.73 21.06 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.568 0 CA-C-N 119.807 1.185 . . . . 0.0 109.723 -177.477 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -95.26 158.22 15.55 Favored 'General case' 0 N--CA 1.467 0.412 0 C-N-CA 125.322 1.449 . . . . 0.0 108.181 176.81 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 21.7 t -141.34 134.19 30.0 Favored 'Isoleucine or valine' 0 C--O 1.236 0.374 0 N-CA-C 107.872 -1.159 . . . . 0.0 107.872 -176.421 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 26.7 m -147.23 113.41 5.86 Favored 'General case' 0 N--CA 1.44 -0.964 0 N-CA-C 106.751 -1.574 . . . . 0.0 106.751 171.711 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 50.3 m -99.65 97.8 8.72 Favored 'General case' 0 N--CA 1.449 -0.516 0 N-CA-C 108.423 -0.955 . . . . 0.0 108.423 169.578 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 7.7 p -68.07 -66.46 0.56 Allowed 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 125.566 1.546 . . . . 0.0 111.322 -175.952 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 110.17 135.07 6.96 Favored Glycine 0 CA--C 1.523 0.581 0 N-CA-C 108.428 -1.869 . . . . 0.0 108.428 -171.436 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 5.9 mt -70.71 -36.96 73.48 Favored 'General case' 0 CA--C 1.529 0.15 0 N-CA-C 109.003 -0.74 . . . . 0.0 109.003 171.31 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 34.4 mt-10 -126.77 160.97 29.3 Favored 'General case' 0 N--CA 1.445 -0.702 0 C-N-CA 129.624 3.17 . . . . 0.0 105.691 169.259 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 54.6 p -150.86 145.51 25.72 Favored 'General case' 0 N--CA 1.445 -0.715 0 N-CA-C 114.003 1.112 . . . . 0.0 114.003 -173.192 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 3.1 m -147.3 -82.94 0.12 Allowed 'General case' 0 N--CA 1.452 -0.351 0 CA-C-N 113.117 -1.856 . . . . 0.0 108.271 -173.119 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 5.8 ttp180 -159.22 -154.01 0.39 Allowed 'General case' 0 N--CA 1.466 0.339 0 N-CA-C 109.33 -0.619 . . . . 0.0 109.33 -179.29 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 2.9 p -133.12 148.79 31.19 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.7 0 C-N-CA 128.2 2.6 . . . . 0.0 105.529 177.988 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 81.5 t60 -73.38 136.97 78.16 Favored Pre-proline 0 CA--C 1.544 0.725 0 CA-C-O 118.646 -0.692 . . . . 0.0 110.5 -169.759 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 28.6 Cg_endo -60.75 -49.1 9.23 Favored 'Trans proline' 0 C--N 1.35 0.626 0 C-N-CA 123.181 2.587 . . . . 0.0 112.962 -172.918 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 18.5 m -67.05 -20.13 65.79 Favored 'General case' 0 CA--C 1.536 0.416 0 O-C-N 121.95 -0.469 . . . . 0.0 110.526 -177.881 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -59.52 -52.32 66.08 Favored 'General case' 0 CA--C 1.506 -0.737 0 N-CA-C 108.838 -0.801 . . . . 0.0 108.838 173.87 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 60.0 mt -56.89 -42.27 78.05 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 N-CA-C 108.729 -0.841 . . . . 0.0 108.729 -171.621 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -64.23 -47.95 77.7 Favored 'General case' 0 N--CA 1.45 -0.429 0 CA-C-N 117.826 0.285 . . . . 0.0 111.509 -179.798 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 38.9 mmt -69.26 -35.37 76.02 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-O 122.747 1.261 . . . . 0.0 110.76 -178.521 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -73.26 -33.05 65.06 Favored 'General case' 0 N--CA 1.443 -0.82 0 N-CA-C 106.887 -1.523 . . . . 0.0 106.887 -177.662 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 6.6 tp10 -70.24 -20.29 63.08 Favored 'General case' 0 N--CA 1.449 -0.522 0 C-N-CA 123.645 0.778 . . . . 0.0 110.775 170.807 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 81.5 mt-10 -64.26 -38.65 91.8 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-N 119.773 1.17 . . . . 0.0 109.353 169.666 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . 0.306 9.7 p -83.43 7.35 1.55 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.771 0 CA-C-O 120.805 0.336 . . . . 0.0 111.81 171.252 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 74.45 23.57 75.15 Favored Glycine 0 CA--C 1.531 1.071 0 O-C-N 120.838 -1.164 . . . . 0.0 113.028 175.981 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 38.4 mt -117.12 131.88 68.52 Favored 'Isoleucine or valine' 0 C--N 1.338 0.068 0 C-N-CA 124.831 1.252 . . . . 0.0 108.584 -176.552 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 34.6 t0 -101.59 146.39 27.75 Favored 'General case' 0 C--O 1.235 0.318 0 CA-C-O 121.028 0.442 . . . . 0.0 110.238 170.794 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 12.2 pt -135.98 -9.6 0.84 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.461 0 C-N-CA 127.081 2.152 . . . . 0.0 110.836 176.145 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 7.7 t -43.31 131.82 4.6 Favored 'General case' 0 CA--C 1.542 0.663 0 CA-C-N 120.249 1.386 . . . . 0.0 109.325 168.971 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 71.92 38.37 60.24 Favored Glycine 0 CA--C 1.532 1.114 0 CA-C-O 118.917 -0.935 . . . . 0.0 113.082 -177.299 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 29.9 mt-30 -56.25 -40.94 74.95 Favored 'General case' 0 N--CA 1.473 0.679 0 CA-C-N 118.888 1.344 . . . . 0.0 110.478 169.995 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -66.17 134.59 53.06 Favored 'General case' 0 N--CA 1.447 -0.592 0 C-N-CA 124.177 0.991 . . . . 0.0 109.413 -170.0 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 2.9 p -140.2 -68.77 0.41 Allowed 'General case' 0 C--O 1.233 0.226 0 C-N-CA 124.018 0.927 . . . . 0.0 108.929 -169.657 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -148.54 154.6 41.45 Favored Pre-proline 0 C--O 1.238 0.484 0 C-N-CA 126.021 1.728 . . . . 0.0 107.478 174.595 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -62.71 151.81 81.7 Favored 'Trans proline' 0 N--CA 1.456 -0.734 0 C-N-CA 121.831 1.687 . . . . 0.0 109.34 170.027 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 18.2 tt -56.19 -28.78 26.17 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.439 0 C-N-CA 123.25 0.62 . . . . 0.0 111.741 -178.687 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 11.4 mt-10 -66.72 -26.69 67.12 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 124.563 1.145 . . . . 0.0 110.689 -174.83 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 11.2 t-20 -63.6 -30.97 72.0 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 124.833 1.253 . . . . 0.0 111.611 178.424 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 94.1 m-85 -92.12 -178.11 4.88 Favored 'General case' 0 C--O 1.235 0.328 0 C-N-CA 125.269 1.428 . . . . 0.0 111.139 -176.61 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 54.6 t-20 -124.11 137.77 54.52 Favored 'General case' 0 N--CA 1.443 -0.79 0 N-CA-C 106.756 -1.572 . . . . 0.0 106.756 168.654 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.457 ' HB2' ' CD2' ' A' ' 90' ' ' TRP . . . -73.58 -24.4 60.07 Favored 'General case' 0 N--CA 1.433 -1.29 0 N-CA-C 109.187 -0.671 . . . . 0.0 109.187 -178.048 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 36.1 t70 -67.32 -20.56 65.62 Favored 'General case' 0 N--CA 1.447 -0.618 0 C-N-CA 121.221 -0.192 . . . . 0.0 111.474 -178.611 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 37.1 t70 -75.75 -29.07 58.73 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 123.526 0.73 . . . . 0.0 111.61 175.186 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 33.0 m-85 -80.17 167.24 20.6 Favored 'General case' 0 N--CA 1.45 -0.433 0 C-N-CA 125.058 1.343 . . . . 0.0 110.613 176.558 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 24.2 t70 -117.29 -35.4 4.04 Favored 'General case' 0 C--O 1.237 0.401 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.169 175.241 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -140.04 134.77 36.99 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.697 0 CA-C-O 121.922 0.868 . . . . 0.0 108.676 -173.399 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 88.7 t -143.36 137.72 25.9 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.604 0 N-CA-C 105.786 -1.931 . . . . 0.0 105.786 178.929 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.658 HD12 ' HB2' ' A' ' 97' ' ' GLU . 20.6 mm -112.75 127.3 70.06 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.727 0 N-CA-C 105.781 -1.933 . . . . 0.0 105.781 177.188 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 70.6 m -89.32 99.83 12.74 Favored 'General case' 0 N--CA 1.441 -0.918 0 N-CA-C 104.196 -2.52 . . . . 0.0 104.196 169.225 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 38.3 mt -69.56 -2.04 10.38 Favored 'General case' 0 N--CA 1.464 0.244 0 O-C-N 121.484 -0.76 . . . . 0.0 112.386 -178.578 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 85.4 m -139.58 135.05 32.96 Favored 'General case' 0 N--CA 1.441 -0.887 0 N-CA-C 106.988 -1.486 . . . . 0.0 106.988 170.149 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 48.43 -142.18 8.59 Favored Glycine 0 CA--C 1.535 1.301 0 C-N-CA 125.148 1.356 . . . . 0.0 113.148 175.123 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 13.2 m -127.48 -85.64 0.59 Allowed 'General case' 0 CA--C 1.529 0.165 0 N-CA-C 107.585 -1.265 . . . . 0.0 107.585 175.993 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -84.55 66.66 3.84 Favored Glycine 0 C--N 1.338 0.694 0 N-CA-C 110.145 -1.182 . . . . 0.0 110.145 175.226 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 6.5 m -77.78 65.28 0.26 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.575 0 C-N-CA 124.071 0.948 . . . . 0.0 110.891 -178.094 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 52.1 t30 54.36 54.05 10.0 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 126.4 1.88 . . . . 0.0 108.249 -172.611 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -133.14 142.32 44.03 Favored Pre-proline 0 CA--C 1.539 0.544 0 C-N-CA 126.604 1.962 . . . . 0.0 108.506 -168.867 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -66.97 135.38 37.53 Favored 'Trans proline' 0 CA--C 1.541 0.857 0 C-N-CA 121.798 1.665 . . . . 0.0 110.611 176.6 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 42.1 Cg_endo -63.24 -23.99 72.4 Favored 'Trans proline' 0 N--CA 1.461 -0.439 0 C-N-CA 122.746 2.297 . . . . 0.0 114.315 -169.721 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 5.7 pm0 -56.21 -21.67 24.67 Favored 'General case' 0 CA--C 1.539 0.521 0 CA-C-N 119.529 1.059 . . . . 0.0 112.133 175.95 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' TRP . . . . . 0.457 ' CD2' ' HB2' ' A' ' 70' ' ' ALA . 99.3 m95 -82.64 -21.78 34.91 Favored 'General case' 0 N--CA 1.454 -0.251 0 N-CA-C 113.13 0.789 . . . . 0.0 113.13 179.979 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 5.5 m -92.94 -34.86 6.19 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.351 0 CA-C-N 120.117 1.326 . . . . 0.0 110.998 172.518 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . 0.266 6.3 t -87.22 46.01 1.33 Allowed 'General case' 0 CA--C 1.548 0.869 0 CA-C-O 123.409 1.576 . . . . 0.0 110.497 -174.85 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 68.6 mm-40 -79.0 -178.81 6.3 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 126.851 2.061 . . . . 0.0 109.218 171.338 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 35.1 mm-40 -67.22 -18.38 65.21 Favored 'General case' 0 CA--C 1.539 0.554 0 O-C-N 121.572 -0.705 . . . . 0.0 111.87 -178.629 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 7.4 tt -143.2 135.03 24.02 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.381 0 C-N-CA 125.642 1.577 . . . . 0.0 106.88 170.035 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 32.4 t80 -110.21 135.26 51.25 Favored 'General case' 0 CA--C 1.535 0.373 0 N-CA-C 106.186 -1.783 . . . . 0.0 106.186 169.386 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . 0.658 ' HB2' HD12 ' A' ' 77' ' ' ILE . 31.2 mm-40 -144.73 164.09 32.04 Favored 'General case' 0 C--O 1.238 0.452 0 C-N-CA 123.971 0.908 . . . . 0.0 108.689 170.21 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -169.87 130.67 1.02 Allowed 'General case' 0 N--CA 1.45 -0.458 0 C-N-CA 127.969 2.508 . . . . 0.0 106.889 -170.585 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' TRP . . . . . 0.411 ' CZ3' HG21 ' A' ' 77' ' ' ILE . 5.1 m-90 -150.14 141.21 23.01 Favored 'General case' 0 N--CA 1.453 -0.315 0 N-CA-C 107.947 -1.131 . . . . 0.0 107.947 -171.231 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 63.0 tt0 -82.26 77.98 8.99 Favored 'General case' 0 CA--C 1.536 0.416 0 N-CA-C 108.219 -1.03 . . . . 0.0 108.219 179.095 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 10.1 mp -71.51 119.1 15.18 Favored 'General case' 0 N--CA 1.462 0.157 0 N-CA-C 107.023 -1.473 . . . . 0.0 107.023 171.056 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -79.35 112.91 17.05 Favored 'General case' 0 N--CA 1.449 -0.524 0 N-CA-C 106.085 -1.821 . . . . 0.0 106.085 170.069 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 11.2 t70 -76.32 133.99 70.87 Favored Pre-proline 0 C--O 1.239 0.501 0 CA-C-O 118.928 -0.558 . . . . 0.0 109.833 -177.021 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -78.7 3.13 7.55 Favored 'Trans proline' 0 CA--C 1.545 1.071 0 C-N-CA 123.01 2.473 . . . . 0.0 113.971 -177.435 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 2.1 t70 -36.7 112.68 0.2 Allowed 'General case' 0 C--O 1.239 0.538 0 C-N-CA 126.196 1.798 . . . . 0.0 111.778 171.876 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 68.58 5.31 43.64 Favored Glycine 0 CA--C 1.537 1.462 0 CA-C-O 118.813 -0.993 . . . . 0.0 115.038 175.172 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 33.7 mm-40 -80.47 174.37 11.67 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-N 119.41 1.605 . . . . 0.0 110.45 178.412 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 15.3 m -68.96 156.9 37.77 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 123.729 0.811 . . . . 0.0 109.9 169.683 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -65.15 -26.25 68.09 Favored 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 123.429 0.692 . . . . 0.0 111.641 -172.29 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 6.9 pt-20 -56.33 -34.85 66.95 Favored 'General case' 0 N--CA 1.462 0.164 0 C-N-CA 123.29 0.636 . . . . 0.0 111.279 173.072 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 13.2 t -76.89 -45.59 31.05 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.362 0 CA-C-O 118.27 -0.871 . . . . 0.0 108.987 -176.724 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 67.2 m-85 -50.62 -50.45 54.15 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-N 119.691 1.132 . . . . 0.0 110.211 169.643 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 94.5 mtt180 -69.4 -34.6 74.74 Favored 'General case' 0 N--CA 1.466 0.349 0 O-C-N 121.887 -0.508 . . . . 0.0 110.901 -173.291 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 2.7 m -61.56 -49.64 75.86 Favored 'General case' 0 N--CA 1.45 -0.452 0 C-N-CA 124.162 0.985 . . . . 0.0 109.407 169.947 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 81.7 t -70.35 -27.18 30.83 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.182 0 CA-C-O 118.417 -0.801 . . . . 0.0 109.761 -170.972 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 14.2 mtm105 -56.72 -48.98 76.54 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-N 119.644 1.111 . . . . 0.0 109.646 169.956 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -63.02 -48.18 82.56 Favored Glycine 0 CA--C 1.527 0.784 0 N-CA-C 111.614 -0.594 . . . . 0.0 111.614 179.235 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 9.9 mt-30 -62.29 -45.41 93.37 Favored 'General case' 0 C--N 1.342 0.24 0 CA-C-N 117.676 0.738 . . . . 0.0 110.952 -177.209 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 86.9 t -67.75 -42.32 86.09 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.189 0 CA-C-O 118.229 -0.891 . . . . 0.0 110.557 -178.911 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 59.1 tttm -53.81 -46.6 71.15 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 119.307 0.958 . . . . 0.0 109.337 179.908 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -65.19 -43.52 91.37 Favored 'General case' 0 N--CA 1.45 -0.464 0 C-N-CA 122.964 0.506 . . . . 0.0 111.139 -175.97 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 49.4 mtt-85 -65.5 -44.54 86.7 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-N 118.719 0.69 . . . . 0.0 111.303 178.554 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 98.0 t -66.15 -40.19 86.41 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.472 0 N-CA-C 109.204 -0.665 . . . . 0.0 109.204 179.024 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 16.6 mt-10 -60.25 -42.52 95.5 Favored 'General case' 0 N--CA 1.46 0.047 0 CA-C-N 119.751 1.16 . . . . 0.0 110.488 176.153 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 29.0 t-20 -62.68 -44.67 95.66 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 122.712 0.405 . . . . 0.0 110.998 178.977 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 34.8 tp -58.08 -49.2 77.75 Favored 'General case' 0 N--CA 1.455 -0.208 0 C-N-CA 124.26 1.024 . . . . 0.0 110.772 176.992 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 89.8 mt -63.55 -44.62 98.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 N-CA-C 108.043 -1.095 . . . . 0.0 108.043 -179.524 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -61.07 -28.37 69.03 Favored 'General case' 0 CA--C 1.54 0.58 0 CA-C-N 118.654 0.661 . . . . 0.0 112.19 177.545 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 93.5 mttt -70.03 -56.13 7.76 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-N 119.391 0.996 . . . . 0.0 110.69 171.183 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 14.9 pt -78.13 -44.41 27.59 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.424 0 N-CA-C 114.969 1.47 . . . . 0.0 114.969 -168.925 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 69.8 m . . . . . 0 C--O 1.252 1.217 0 C-N-CA 126.011 1.724 . . . . 0.0 109.945 -169.772 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.497 1.906 0 N-CA-C 110.365 -0.235 . . . . 0.0 110.365 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 31.2 mttm -79.1 118.64 21.25 Favored 'General case' 0 N--CA 1.474 0.742 0 N-CA-C 105.787 -1.931 . . . . 0.0 105.787 171.84 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 89.2 mttt -86.06 134.11 33.85 Favored 'General case' 0 CA--C 1.513 -0.464 0 N-CA-C 107.69 -1.226 . . . . 0.0 107.69 178.465 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 1.5 t -119.8 148.82 22.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 C-N-CA 125.535 1.534 . . . . 0.0 109.0 -169.006 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 3.2 mtt -135.88 146.82 47.81 Favored 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 125.872 1.669 . . . . 0.0 108.434 169.255 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 90.6 m-85 -132.5 95.42 3.62 Favored 'General case' 0 N--CA 1.457 -0.099 0 N-CA-C 105.165 -2.161 . . . . 0.0 105.165 171.495 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 42.3 t -131.29 129.98 62.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 N-CA-C 109.675 -0.491 . . . . 0.0 109.675 -169.049 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 41.1 t -99.07 -177.76 3.72 Favored 'General case' 0 CA--C 1.547 0.857 0 C-N-CA 125.754 1.622 . . . . 0.0 106.922 169.101 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -56.48 -39.2 72.82 Favored 'General case' 0 N--CA 1.478 0.932 0 O-C-N 120.587 -1.32 . . . . 0.0 111.292 -176.532 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 79.1 mtp180 -119.89 168.65 10.9 Favored 'General case' 0 N--CA 1.465 0.308 0 N-CA-C 107.106 -1.442 . . . . 0.0 107.106 169.156 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 29.1 t30 -65.13 -28.61 69.55 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 120.563 -0.455 . . . . 0.0 110.784 169.601 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 1.5 m -56.15 124.15 16.9 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 125.165 1.386 . . . . 0.0 110.548 179.644 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 8.5 m 65.72 150.2 0.05 OUTLIER 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 126.256 1.822 . . . . 0.0 113.302 178.872 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 1.5 mmm180 68.34 -58.33 0.47 Allowed 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 127.455 2.302 . . . . 0.0 111.869 177.12 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 1.7 m -63.83 -17.15 62.83 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 125.436 1.495 . . . . 0.0 112.719 -175.214 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 21.7 pt20 -62.17 -63.01 1.38 Allowed 'General case' 0 C--N 1.343 0.289 0 CA-C-N 119.285 0.948 . . . . 0.0 111.585 176.7 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 1.1 tpt -78.56 -32.57 47.85 Favored 'General case' 0 N--CA 1.465 0.291 0 O-C-N 121.56 -0.713 . . . . 0.0 112.209 -169.61 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -64.58 -51.38 63.03 Favored 'General case' 0 N--CA 1.469 0.488 0 N-CA-C 112.346 0.499 . . . . 0.0 112.346 -170.955 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -65.68 -31.45 72.47 Favored 'General case' 0 N--CA 1.469 0.491 0 O-C-N 121.505 -0.747 . . . . 0.0 110.198 172.811 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -49.12 -55.42 12.14 Favored Glycine 0 C--N 1.342 0.895 0 C-N-CA 125.89 1.709 . . . . 0.0 110.518 175.149 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 8.8 m-85 -73.99 -29.74 62.13 Favored 'General case' 0 CA--C 1.508 -0.655 0 CA-C-N 119.072 1.436 . . . . 0.0 113.811 178.806 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -67.85 -31.7 71.71 Favored 'General case' 0 N--CA 1.451 -0.408 0 C-N-CA 119.459 -0.896 . . . . 0.0 111.318 -169.989 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 6.7 ptpt -62.06 -34.35 76.1 Favored 'General case' 0 N--CA 1.476 0.835 0 CA-C-N 119.252 0.933 . . . . 0.0 111.498 172.108 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 12.2 m -76.46 -55.42 5.55 Favored 'General case' 0 N--CA 1.447 -0.601 0 C-N-CA 125.373 1.469 . . . . 0.0 110.183 -175.939 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 75.3 mt -74.74 -35.63 62.63 Favored 'General case' 0 CA--C 1.531 0.213 0 C-N-CA 123.455 0.702 . . . . 0.0 110.328 -174.022 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -93.04 6.81 76.45 Favored Glycine 0 CA--C 1.526 0.722 0 C-N-CA 125.118 1.342 . . . . 0.0 113.285 -175.317 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -49.67 125.45 11.57 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 125.113 1.365 . . . . 0.0 110.881 -175.105 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 76.33 -8.1 27.35 Favored Glycine 0 CA--C 1.535 1.343 0 C-N-CA 124.452 1.025 . . . . 0.0 114.287 178.801 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 64.3 mttm -102.83 -49.93 3.67 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-N 119.421 1.61 . . . . 0.0 110.384 -179.711 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 25.3 pt -136.2 149.09 27.27 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.385 0 C-N-CA 123.669 0.788 . . . . 0.0 110.34 -169.37 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -111.58 104.47 12.87 Favored 'General case' 0 C--O 1.227 -0.123 0 C-N-CA 124.962 1.305 . . . . 0.0 109.844 -169.332 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 6.5 t -87.02 132.08 33.33 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 C-N-CA 123.471 0.708 . . . . 0.0 109.669 -175.957 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 20.5 m -144.96 110.81 5.42 Favored 'General case' 0 N--CA 1.446 -0.658 0 N-CA-C 104.623 -2.362 . . . . 0.0 104.623 169.963 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 51.8 m -107.18 81.53 1.55 Allowed 'General case' 0 N--CA 1.463 0.205 0 CA-C-N 119.611 1.096 . . . . 0.0 108.233 179.661 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 3.8 m -61.16 -39.79 91.43 Favored 'General case' 0 CA--C 1.532 0.274 0 N-CA-C 114.289 1.218 . . . . 0.0 114.289 -169.261 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 92.91 137.81 8.36 Favored Glycine 0 C--N 1.338 0.671 0 N-CA-C 109.107 -1.597 . . . . 0.0 109.107 176.912 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 15.5 mt -74.51 -34.01 62.94 Favored 'General case' 0 C--N 1.331 -0.199 0 C-N-CA 124.108 0.963 . . . . 0.0 108.794 176.774 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 26.3 mt-10 -141.33 156.79 45.81 Favored 'General case' 0 N--CA 1.443 -0.805 0 C-N-CA 128.28 2.632 . . . . 0.0 105.984 168.926 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 60.9 p -109.79 148.33 31.66 Favored 'General case' 0 N--CA 1.441 -0.922 0 CA-C-O 123.106 1.431 . . . . 0.0 112.937 -175.116 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 17.1 m -170.35 162.13 8.34 Favored 'General case' 0 N--CA 1.447 -0.608 0 C-N-CA 129.389 3.076 . . . . 0.0 103.752 -169.856 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . 0.433 ' HG3' ' H ' ' A' ' 42' ' ' VAL . 6.9 tpt180 -92.14 -155.93 0.44 Allowed 'General case' 0 N--CA 1.467 0.416 0 O-C-N 121.053 -1.029 . . . . 0.0 109.656 -173.039 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.433 ' H ' ' HG3' ' A' ' 41' ' ' ARG . 0.6 OUTLIER -131.87 156.67 42.75 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 C-N-CA 129.009 2.924 . . . . 0.0 107.064 -169.446 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 62.4 m80 -85.79 144.53 39.71 Favored Pre-proline 0 N--CA 1.468 0.459 0 N-CA-C 112.317 0.488 . . . . 0.0 112.317 -169.071 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -65.06 -45.07 8.44 Favored 'Trans proline' 0 C--N 1.348 0.546 0 C-N-CA 122.904 2.403 . . . . 0.0 111.834 -176.172 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 6.5 m -69.57 -28.06 65.66 Favored 'General case' 0 CA--C 1.531 0.233 0 CA-C-O 118.977 -0.535 . . . . 0.0 110.002 179.575 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -60.46 -54.33 46.86 Favored 'General case' 0 CA--C 1.507 -0.691 0 N-CA-C 107.882 -1.155 . . . . 0.0 107.882 171.183 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 56.7 mt -58.1 -40.21 76.11 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 N-CA-C 108.657 -0.868 . . . . 0.0 108.657 -173.828 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -63.37 -49.3 74.39 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-N 118.555 0.616 . . . . 0.0 111.61 179.046 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 28.1 mmt -66.23 -36.5 83.2 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-O 122.98 1.371 . . . . 0.0 110.895 -179.712 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -78.25 -30.82 48.85 Favored 'General case' 0 N--CA 1.441 -0.875 0 N-CA-C 107.416 -1.327 . . . . 0.0 107.416 -173.335 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 41.2 tt0 -71.95 -22.14 61.5 Favored 'General case' 0 N--CA 1.447 -0.598 0 C-N-CA 123.815 0.846 . . . . 0.0 110.228 169.986 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 16.8 mm-40 -68.19 -30.73 69.89 Favored 'General case' 0 CA--C 1.534 0.361 0 CA-C-N 119.487 1.039 . . . . 0.0 110.23 171.62 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . 0.276 9.3 p -89.34 10.0 2.43 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.035 0 CA-C-N 118.514 0.597 . . . . 0.0 111.114 168.914 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 78.18 16.28 79.89 Favored Glycine 0 CA--C 1.532 1.121 0 C-N-CA 124.956 1.265 . . . . 0.0 113.76 173.8 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 13.5 mt -102.2 141.35 18.57 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.237 0 C-N-CA 124.453 1.101 . . . . 0.0 110.555 -173.574 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -94.71 137.29 33.99 Favored 'General case' 0 C--O 1.235 0.312 0 C-N-CA 124.417 1.087 . . . . 0.0 108.26 169.817 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 7.0 pt -138.04 -30.0 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.544 0 C-N-CA 124.543 1.137 . . . . 0.0 110.538 170.095 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -23.53 -38.32 0.0 OUTLIER 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 130.054 3.341 . . . . 0.0 117.045 169.563 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -98.64 31.26 8.32 Favored Glycine 0 CA--C 1.536 1.383 0 C-N-CA 125.543 1.544 . . . . 0.0 115.349 -175.205 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 12.7 mt-30 -62.0 -31.42 71.79 Favored 'General case' 0 N--CA 1.476 0.846 0 CA-C-N 120.088 1.944 . . . . 0.0 113.956 -174.336 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -70.34 122.16 19.04 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 123.059 0.544 . . . . 0.0 110.517 -169.158 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 74.9 m -151.91 -167.9 2.91 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 127.03 2.132 . . . . 0.0 107.417 -171.292 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -51.58 143.55 20.0 Favored Pre-proline 0 CA--C 1.539 0.528 0 C-N-CA 123.967 0.907 . . . . 0.0 110.402 170.51 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 84.5 Cg_endo -70.92 160.73 48.43 Favored 'Trans proline' 0 N--CA 1.456 -0.683 0 C-N-CA 122.883 2.389 . . . . 0.0 110.326 172.941 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 11.9 tt -60.86 -20.45 21.74 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.447 0 C-N-CA 123.889 0.876 . . . . 0.0 112.246 -179.878 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 25.9 tt0 -66.5 -28.6 68.69 Favored 'General case' 0 N--CA 1.434 -1.256 0 C-N-CA 124.768 1.227 . . . . 0.0 110.516 -176.558 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 74.9 m-20 -80.54 -1.44 41.96 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 124.305 1.042 . . . . 0.0 112.387 179.115 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 85.5 m-85 -110.76 177.19 4.75 Favored 'General case' 0 C--O 1.234 0.278 0 C-N-CA 125.698 1.599 . . . . 0.0 110.925 179.204 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 50.4 t-20 -128.66 135.76 49.72 Favored 'General case' 0 N--CA 1.448 -0.532 0 N-CA-C 108.175 -1.046 . . . . 0.0 108.175 169.297 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.589 ' HB2' ' CD2' ' A' ' 90' ' ' TRP . . . -73.28 -24.63 60.45 Favored 'General case' 0 N--CA 1.435 -1.184 0 N-CA-C 109.25 -0.648 . . . . 0.0 109.25 -178.473 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 35.5 t70 -66.2 -21.78 66.32 Favored 'General case' 0 N--CA 1.445 -0.696 0 C-N-CA 120.644 -0.422 . . . . 0.0 111.091 -177.59 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 35.2 t70 -77.42 -27.95 52.48 Favored 'General case' 0 C--N 1.345 0.393 0 C-N-CA 123.617 0.767 . . . . 0.0 111.584 174.144 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 14.1 m-85 -80.17 167.55 20.21 Favored 'General case' 0 C--O 1.239 0.53 0 C-N-CA 125.39 1.476 . . . . 0.0 111.392 -179.552 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -117.03 -39.18 3.26 Favored 'General case' 0 C--O 1.235 0.312 0 C-N-CA 123.338 0.655 . . . . 0.0 111.668 177.953 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -138.01 133.56 44.38 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.406 0 C-N-CA 123.866 0.866 . . . . 0.0 109.881 -170.871 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 66.6 t -140.79 125.63 18.55 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.402 0 N-CA-C 105.72 -1.956 . . . . 0.0 105.72 178.306 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.557 HD12 ' HB2' ' A' ' 97' ' ' GLU . 7.5 mm -96.24 125.26 49.15 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.545 0 N-CA-C 105.333 -2.099 . . . . 0.0 105.333 170.071 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 59.6 m -93.36 91.81 7.37 Favored 'General case' 0 N--CA 1.443 -0.811 0 N-CA-C 104.123 -2.547 . . . . 0.0 104.123 169.662 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 23.0 mt -63.08 -12.68 28.54 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-O 118.321 -0.847 . . . . 0.0 112.771 -173.206 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 39.3 m -142.94 126.53 16.88 Favored 'General case' 0 N--CA 1.445 -0.684 0 N-CA-C 106.634 -1.617 . . . . 0.0 106.634 174.43 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 58.44 -148.55 37.51 Favored Glycine 0 CA--C 1.534 1.227 0 C-N-CA 123.613 0.625 . . . . 0.0 112.183 177.488 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 14.0 p -139.2 -79.11 0.33 Allowed 'General case' 0 CA--C 1.529 0.165 0 C-N-CA 124.173 0.989 . . . . 0.0 108.727 175.865 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -79.24 53.24 4.16 Favored Glycine 0 CA--C 1.526 0.756 0 C-N-CA 125.498 1.523 . . . . 0.0 112.096 -178.429 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 16.3 m -81.21 60.83 0.2 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.71 0 C-N-CA 124.868 1.267 . . . . 0.0 110.802 -173.984 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 50.1 t30 56.2 59.74 3.54 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 125.944 1.698 . . . . 0.0 108.374 -172.41 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -136.69 143.14 41.63 Favored Pre-proline 0 CA--C 1.544 0.729 0 C-N-CA 126.223 1.809 . . . . 0.0 108.845 -168.925 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_exo -67.13 136.77 41.89 Favored 'Trans proline' 0 CA--C 1.542 0.909 0 C-N-CA 122.555 2.17 . . . . 0.0 111.353 172.973 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 42.4 Cg_endo -63.66 -25.84 69.0 Favored 'Trans proline' 0 N--CA 1.46 -0.474 0 C-N-CA 122.778 2.319 . . . . 0.0 114.821 -169.663 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 6.4 pm0 -57.42 -20.61 31.19 Favored 'General case' 0 CA--C 1.539 0.528 0 CA-C-N 120.149 1.341 . . . . 0.0 112.272 177.345 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' TRP . . . . . 0.589 ' CD2' ' HB2' ' A' ' 70' ' ' ALA . 99.9 m95 -79.28 -23.41 43.61 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-O 118.726 -0.654 . . . . 0.0 112.629 178.657 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 6.5 m -104.67 -8.87 9.77 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.156 0 C-N-CA 124.669 1.188 . . . . 0.0 113.03 -179.818 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . 0.266 6.6 t -111.57 45.58 1.2 Allowed 'General case' 0 CA--C 1.544 0.713 0 CA-C-O 123.142 1.448 . . . . 0.0 110.104 172.299 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 56.2 mm-40 -73.47 177.42 5.3 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 124.919 1.288 . . . . 0.0 109.73 169.936 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 34.9 mm-40 -65.49 -21.73 66.66 Favored 'General case' 0 CA--C 1.538 0.503 0 O-C-N 121.844 -0.535 . . . . 0.0 111.225 -179.626 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 4.6 tt -140.26 131.14 30.33 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.334 0 C-N-CA 126.241 1.816 . . . . 0.0 106.439 169.871 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 35.2 t80 -109.57 136.36 49.07 Favored 'General case' 0 CA--C 1.539 0.528 0 N-CA-C 106.272 -1.751 . . . . 0.0 106.272 169.487 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . 0.557 ' HB2' HD12 ' A' ' 77' ' ' ILE . 10.7 mm-40 -142.2 162.55 35.18 Favored 'General case' 0 C--O 1.234 0.287 0 C-N-CA 124.429 1.091 . . . . 0.0 108.871 175.83 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 2.5 t70 -175.27 129.62 0.28 Allowed 'General case' 0 C--O 1.236 0.368 0 C-N-CA 127.014 2.126 . . . . 0.0 106.918 -169.802 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' TRP . . . . . 0.53 ' CZ3' HG21 ' A' ' 77' ' ' ILE . 6.5 m0 -143.69 140.47 30.05 Favored 'General case' 0 CA--C 1.522 -0.119 0 C-N-CA 122.826 0.45 . . . . 0.0 110.057 -171.853 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 31.3 mm-40 -84.57 59.79 5.69 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-O 121.653 0.739 . . . . 0.0 109.159 171.786 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.47 HD13 HG22 ' A' ' 119' ' ' VAL . 16.6 mt -64.68 138.67 58.53 Favored 'General case' 0 CA--C 1.529 0.14 0 N-CA-C 108.233 -1.025 . . . . 0.0 108.233 172.471 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 34.3 mm-40 -68.65 161.15 28.78 Favored 'General case' 0 N--CA 1.451 -0.397 0 N-CA-C 108.265 -1.013 . . . . 0.0 108.265 168.901 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -130.97 131.45 23.24 Favored Pre-proline 0 N--CA 1.45 -0.456 0 N-CA-C 107.341 -1.355 . . . . 0.0 107.341 169.352 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 67.9 Cg_endo -78.9 -3.9 13.57 Favored 'Trans proline' 0 CA--C 1.545 1.043 0 C-N-CA 122.125 1.883 . . . . 0.0 114.729 -169.867 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -51.26 129.38 24.5 Favored 'General case' 0 CA--C 1.537 0.443 0 CA-C-N 119.996 1.271 . . . . 0.0 111.05 177.606 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 72.71 11.1 77.39 Favored Glycine 0 CA--C 1.533 1.206 0 CA-C-O 118.758 -1.023 . . . . 0.0 114.127 171.942 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 29.7 pt20 -136.66 -171.12 2.84 Favored 'General case' 0 CA--C 1.542 0.659 0 CA-C-N 118.991 1.395 . . . . 0.0 111.302 176.245 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 1.9 m -68.34 158.3 33.8 Favored 'General case' 0 CA--C 1.533 0.327 0 N-CA-C 117.641 2.46 . . . . 0.0 117.641 -167.563 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 55.7 tp -54.42 -34.16 60.83 Favored 'General case' 0 C--N 1.344 0.33 0 C-N-CA 126.917 2.087 . . . . 0.0 111.451 170.144 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 29.5 tp10 -64.73 -29.32 70.3 Favored 'General case' 0 C--N 1.331 -0.235 0 O-C-N 122.028 -0.42 . . . . 0.0 110.796 177.491 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 4.1 t -76.83 -37.1 27.25 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.385 0 CA-C-O 117.866 -1.064 . . . . 0.0 110.21 175.471 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 59.3 m-85 -56.21 -49.36 74.31 Favored 'General case' 0 N--CA 1.474 0.727 0 CA-C-N 120.738 1.608 . . . . 0.0 109.656 170.121 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 77.0 mtt180 -58.99 -44.07 91.54 Favored 'General case' 0 N--CA 1.468 0.432 0 C-N-CA 123.501 0.72 . . . . 0.0 110.691 178.319 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 18.5 m -65.5 -49.24 69.76 Favored 'General case' 0 N--CA 1.445 -0.714 0 C-N-CA 124.261 1.025 . . . . 0.0 110.07 -179.962 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 63.8 t -67.69 -35.84 74.06 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.191 0 CA-C-N 119.42 1.009 . . . . 0.0 109.353 -172.128 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 45.8 ttp85 -58.23 -39.9 80.28 Favored 'General case' 0 CA--C 1.539 0.553 0 CA-C-N 118.405 0.548 . . . . 0.0 109.808 173.585 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -66.81 -53.41 27.51 Favored Glycine 0 CA--C 1.533 1.218 0 C-N-CA 123.698 0.666 . . . . 0.0 112.566 172.809 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 72.2 mt-30 -55.08 -48.35 73.64 Favored 'General case' 0 N--CA 1.469 0.5 0 CA-C-O 122.184 0.992 . . . . 0.0 110.0 -176.137 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . 0.47 HG22 HD13 ' A' ' 101' ' ' LEU . 97.0 t -74.48 -37.01 43.45 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.439 0 CA-C-O 117.738 -1.125 . . . . 0.0 109.786 -171.563 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -55.47 -46.58 76.83 Favored 'General case' 0 C--O 1.224 -0.288 0 CA-C-N 120.112 1.324 . . . . 0.0 108.585 172.198 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 41.5 tt0 -66.43 -43.04 86.79 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 122.458 0.303 . . . . 0.0 111.205 -175.121 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 38.5 mmt180 -62.44 -45.55 92.58 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-N 119.069 0.85 . . . . 0.0 111.01 176.18 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 97.2 t -69.14 -37.68 76.92 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.578 0 N-CA-C 109.196 -0.668 . . . . 0.0 109.196 -177.219 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 20.2 mt-10 -59.85 -44.79 93.92 Favored 'General case' 0 N--CA 1.457 -0.12 0 CA-C-N 119.346 0.975 . . . . 0.0 110.09 173.556 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 25.9 t-20 -65.02 -42.24 94.57 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 123.169 0.588 . . . . 0.0 111.641 -178.487 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 1.6 tm? -58.31 -48.39 80.67 Favored 'General case' 0 C--O 1.228 -0.068 0 C-N-CA 126.323 1.849 . . . . 0.0 110.752 174.035 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 63.4 mt -66.04 -47.75 83.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 N-CA-C 108.658 -0.867 . . . . 0.0 108.658 179.598 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -58.52 -31.21 67.7 Favored 'General case' 0 CA--C 1.535 0.381 0 CA-C-O 118.849 -0.596 . . . . 0.0 112.145 -176.851 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 17.3 ptpt -81.59 -39.62 24.26 Favored 'General case' 0 C--N 1.344 0.364 0 CA-C-O 117.786 -1.102 . . . . 0.0 112.486 176.53 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 11.8 pt -81.67 -37.42 15.24 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.287 0 CA-C-N 119.931 1.242 . . . . 0.0 113.725 -176.039 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 72.4 m . . . . . 0 C--O 1.253 1.288 0 C-N-CA 125.638 1.575 . . . . 0.0 109.764 -169.985 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.499 1.985 0 N-CA-C 110.411 -0.218 . . . . 0.0 110.411 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 32.9 mttm -81.43 118.92 23.09 Favored 'General case' 0 N--CA 1.476 0.849 0 N-CA-C 106.541 -1.652 . . . . 0.0 106.541 173.348 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 93.0 mttt -80.86 133.84 35.65 Favored 'General case' 0 CA--C 1.507 -0.692 0 CA-C-N 119.785 1.175 . . . . 0.0 108.398 175.691 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 1.5 t -118.36 145.48 24.27 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.589 0 C-N-CA 125.914 1.686 . . . . 0.0 106.796 -172.843 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 26.6 ttm -136.53 145.1 44.66 Favored 'General case' 0 C--N 1.318 -0.777 0 C-N-CA 125.143 1.377 . . . . 0.0 108.265 169.764 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 91.5 m-85 -137.93 121.62 17.46 Favored 'General case' 0 CA--C 1.516 -0.339 0 N-CA-C 104.673 -2.343 . . . . 0.0 104.673 177.445 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 2.6 p -153.58 154.16 7.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-O 122.338 1.066 . . . . 0.0 111.745 -169.178 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 42.7 t -144.77 165.18 28.82 Favored 'General case' 0 CA--C 1.538 0.486 0 N-CA-C 104.506 -2.405 . . . . 0.0 104.506 168.981 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 22.9 pttp -61.47 130.17 44.73 Favored 'General case' 0 N--CA 1.467 0.378 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 172.515 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 59.2 136.58 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 128.211 2.604 . . . . 0.0 114.114 -170.373 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 20.4 t30 -56.05 -35.0 66.43 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 125.106 1.362 . . . . 0.0 111.885 176.526 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 1.6 p -70.3 -8.06 47.41 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 125.398 1.479 . . . . 0.0 113.243 -175.802 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 38.5 m -76.01 -88.15 0.04 OUTLIER 'General case' 0 CA--C 1.54 0.568 0 CA-C-N 119.292 0.951 . . . . 0.0 110.259 178.638 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 10.6 mpt_? -115.5 6.83 14.79 Favored 'General case' 0 N--CA 1.475 0.801 0 CA-C-N 120.349 1.431 . . . . 0.0 113.041 179.227 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 1.4 m -91.92 47.44 1.35 Allowed 'General case' 0 CA--C 1.541 0.601 0 O-C-N 121.327 -0.858 . . . . 0.0 110.918 -175.449 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -118.37 9.01 12.31 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 125.967 1.707 . . . . 0.0 112.596 170.941 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 1.1 tpt -159.87 -39.48 0.05 Allowed 'General case' 0 N--CA 1.457 -0.119 0 N-CA-C 115.443 1.646 . . . . 0.0 115.443 -176.916 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -69.55 -46.72 65.77 Favored 'General case' 0 N--CA 1.471 0.597 0 CA-C-N 120.947 1.703 . . . . 0.0 111.703 -169.482 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . 0.45 ' CD ' HE22 ' A' ' 60' ' ' GLN . 0.0 OUTLIER -57.35 -42.28 81.69 Favored 'General case' 0 C--N 1.325 -0.473 0 C-N-CA 124.321 1.049 . . . . 0.0 110.731 170.837 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -61.59 -45.59 96.02 Favored Glycine 0 CA--C 1.524 0.653 0 C-N-CA 123.84 0.733 . . . . 0.0 111.798 176.924 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -66.85 -35.93 81.17 Favored 'General case' 0 CA--C 1.514 -0.431 0 O-C-N 121.216 -1.167 . . . . 0.0 111.918 178.278 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -70.86 -36.3 72.77 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 119.662 1.119 . . . . 0.0 110.555 179.688 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -52.52 -42.66 64.54 Favored 'General case' 0 N--CA 1.467 0.392 0 C-N-CA 123.864 0.866 . . . . 0.0 109.009 169.207 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 22.4 m -75.15 -59.29 2.81 Favored 'General case' 0 N--CA 1.446 -0.653 0 C-N-CA 124.303 1.041 . . . . 0.0 111.397 -173.872 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 34.6 mt -73.82 -33.87 64.35 Favored 'General case' 0 C--N 1.332 -0.191 0 C-N-CA 125.083 1.353 . . . . 0.0 110.949 -170.567 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -102.76 6.77 52.43 Favored Glycine 0 CA--C 1.525 0.668 0 CA-C-O 117.901 -1.5 . . . . 0.0 113.521 -172.585 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -41.15 -52.77 3.25 Favored 'General case' 0 N--CA 1.466 0.363 0 C-N-CA 126.254 1.821 . . . . 0.0 114.819 -169.714 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -88.81 7.12 82.83 Favored Glycine 0 CA--C 1.531 1.048 0 CA-C-O 119.186 -0.785 . . . . 0.0 113.573 -175.547 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 70.0 mttt -124.73 -49.35 1.76 Allowed 'General case' 0 N--CA 1.467 0.395 0 CA-C-N 118.511 1.155 . . . . 0.0 111.937 -169.27 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 27.1 pt -137.96 150.93 25.07 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.401 0 C-N-CA 124.732 1.213 . . . . 0.0 110.415 -168.911 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -111.17 105.77 14.58 Favored 'General case' 0 C--O 1.226 -0.146 0 C-N-CA 125.013 1.325 . . . . 0.0 109.971 -169.526 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 11.4 t -78.93 127.9 38.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 177.374 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 18.7 m -144.31 92.94 2.37 Favored 'General case' 0 N--CA 1.449 -0.503 0 N-CA-C 103.615 -2.735 . . . . 0.0 103.615 169.677 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 58.1 m -89.33 -1.32 58.02 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 115.764 1.764 . . . . 0.0 115.764 -168.759 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 28.4 p 49.05 -130.08 1.92 Allowed 'General case' 0 CA--C 1.546 0.815 0 C-N-CA 124.451 1.1 . . . . 0.0 111.333 -178.842 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 173.5 153.98 10.17 Favored Glycine 0 CA--C 1.53 0.978 0 C-N-CA 124.951 1.262 . . . . 0.0 111.027 170.06 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 4.3 mt -111.89 103.95 12.21 Favored 'General case' 0 N--CA 1.444 -0.755 1 N-CA-C 100.071 -4.048 . . . . 0.0 100.071 169.16 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 35.2 mt-10 64.05 170.36 0.17 Allowed 'General case' 0 C--O 1.238 0.458 0 O-C-N 125.371 1.669 . . . . 0.0 110.241 -167.583 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 59.1 p -146.9 158.79 44.01 Favored 'General case' 0 N--CA 1.448 -0.558 0 CA-C-O 122.628 1.204 . . . . 0.0 113.701 -178.457 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 4.1 m -170.81 166.96 7.72 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 129.801 3.24 . . . . 0.0 104.222 -171.892 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -87.94 -159.61 0.55 Allowed 'General case' 0 N--CA 1.468 0.459 0 O-C-N 120.845 -1.159 . . . . 0.0 108.72 176.209 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.517 HG21 HD12 ' A' ' 57' ' ' ILE . 1.5 p -127.17 157.84 38.51 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.782 0 C-N-CA 126.418 1.887 . . . . 0.0 107.73 179.933 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -85.84 153.04 57.48 Favored Pre-proline 0 CA--C 1.538 0.517 0 C-N-CA 124.67 1.188 . . . . 0.0 111.366 -169.452 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 55.1 Cg_endo -63.84 -41.34 24.26 Favored 'Trans proline' 0 C--N 1.347 0.495 0 C-N-CA 123.474 2.783 . . . . 0.0 112.415 -174.039 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 7.3 m -69.79 -29.63 66.98 Favored 'General case' 0 CA--C 1.53 0.188 0 CA-C-O 118.649 -0.691 . . . . 0.0 110.319 -176.839 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -62.99 -50.6 70.13 Favored 'General case' 0 C--O 1.215 -0.712 0 CA-C-N 119.659 1.118 . . . . 0.0 108.413 171.094 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 75.1 mt -58.38 -40.09 76.89 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.447 0 CA-C-N 118.982 0.81 . . . . 0.0 108.851 -176.462 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -64.7 -49.63 70.15 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-N 118.915 0.779 . . . . 0.0 112.354 178.255 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 38.6 mmt -69.35 -36.48 76.92 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-O 122.739 1.257 . . . . 0.0 110.543 -177.564 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -71.69 -32.05 67.41 Favored 'General case' 0 N--CA 1.444 -0.763 0 N-CA-C 106.369 -1.715 . . . . 0.0 106.369 -178.761 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 40.5 tt0 -72.02 -19.57 61.83 Favored 'General case' 0 CA--C 1.54 0.572 0 O-C-N 121.122 -0.986 . . . . 0.0 110.999 169.882 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 75.5 mt-10 -64.19 -37.11 86.31 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-N 120.176 1.353 . . . . 0.0 109.859 169.605 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 11.9 m -85.94 12.12 1.05 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.675 0 N-CA-C 112.759 0.651 . . . . 0.0 112.759 169.968 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 72.4 14.23 77.2 Favored Glycine 0 CA--C 1.532 1.155 0 C-N-CA 124.488 1.042 . . . . 0.0 113.476 176.154 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 10.5 mt -93.35 137.73 21.88 Favored 'Isoleucine or valine' 0 C--O 1.233 0.199 0 CA-C-N 118.498 1.149 . . . . 0.0 109.613 -177.053 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 12.9 t0 -101.87 132.93 47.37 Favored 'General case' 0 C--O 1.233 0.236 0 N-CA-C 107.566 -1.272 . . . . 0.0 107.566 169.343 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.517 HD12 HG21 ' A' ' 42' ' ' VAL . 0.6 OUTLIER -118.72 -70.64 0.78 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.37 0 C-N-CA 125.528 1.531 . . . . 0.0 107.319 177.321 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 97.2 p 40.33 -97.78 0.02 OUTLIER 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 127.169 2.187 . . . . 0.0 114.349 170.152 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -74.79 58.0 2.6 Favored Glycine 0 CA--C 1.531 1.067 0 C-N-CA 126.99 2.233 . . . . 0.0 111.705 178.947 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . 0.45 HE22 ' CD ' ' A' ' 19' ' ' GLU . 12.5 mm100 -66.89 -30.31 70.43 Favored 'General case' 0 C--O 1.233 0.232 0 C-N-CA 125.051 1.34 . . . . 0.0 111.69 -179.868 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 1.1 p -62.68 133.66 55.17 Favored 'General case' 0 N--CA 1.444 -0.746 0 C-N-CA 124.934 1.294 . . . . 0.0 109.435 -169.369 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 57.7 m -146.14 -179.21 6.57 Favored 'General case' 0 N--CA 1.446 -0.666 0 C-N-CA 125.999 1.72 . . . . 0.0 107.493 -169.307 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -56.61 152.74 24.19 Favored Pre-proline 0 CA--C 1.536 0.427 0 C-N-CA 123.87 0.868 . . . . 0.0 111.446 175.064 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 89.3 Cg_endo -65.59 158.24 54.25 Favored 'Trans proline' 0 N--CA 1.453 -0.856 0 C-N-CA 122.574 2.183 . . . . 0.0 110.345 172.965 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 14.0 tt -58.52 -26.81 31.97 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.411 0 C-N-CA 124.013 0.925 . . . . 0.0 111.622 179.133 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 15.1 mt-10 -67.94 -26.55 66.02 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 124.255 1.022 . . . . 0.0 110.356 -174.524 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 5.4 t-20 -64.31 -22.16 66.86 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 125.197 1.399 . . . . 0.0 112.208 177.728 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -108.67 178.57 4.44 Favored 'General case' 0 C--O 1.235 0.339 0 C-N-CA 126.024 1.729 . . . . 0.0 111.209 -173.797 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 57.5 t-20 -133.25 137.36 46.05 Favored 'General case' 0 N--CA 1.444 -0.745 0 N-CA-C 107.144 -1.428 . . . . 0.0 107.144 168.988 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -74.86 -23.84 58.48 Favored 'General case' 0 N--CA 1.437 -1.112 0 N-CA-C 109.456 -0.572 . . . . 0.0 109.456 -176.985 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -61.62 -24.74 66.9 Favored 'General case' 0 N--CA 1.447 -0.604 0 O-C-N 123.331 0.395 . . . . 0.0 111.579 178.831 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -76.57 -27.64 55.93 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 123.578 0.751 . . . . 0.0 112.081 177.133 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 11.7 m-85 -78.75 164.01 24.91 Favored 'General case' 0 N--CA 1.45 -0.442 0 C-N-CA 125.187 1.395 . . . . 0.0 111.465 -177.043 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -105.4 -39.29 6.19 Favored 'General case' 0 N--CA 1.462 0.13 0 CA-C-N 115.557 -0.747 . . . . 0.0 110.41 171.436 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -139.19 138.91 40.57 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.441 0 CA-C-O 122.449 1.118 . . . . 0.0 110.188 -171.333 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 42.6 t -140.21 145.03 26.75 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.855 0 N-CA-C 106.411 -1.7 . . . . 0.0 106.411 179.936 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.435 HD12 ' HB2' ' A' ' 97' ' ' GLU . 24.1 mm -141.71 137.36 31.65 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.865 0 N-CA-C 106.496 -1.668 . . . . 0.0 106.496 -170.69 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 50.3 m -101.43 163.84 12.07 Favored 'General case' 0 N--CA 1.445 -0.691 0 N-CA-C 107.625 -1.25 . . . . 0.0 107.625 168.861 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 51.3 mt -132.66 18.84 4.26 Favored 'General case' 0 CA--C 1.533 0.292 0 O-C-N 121.14 -0.975 . . . . 0.0 111.048 -174.53 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 28.1 p -169.21 -5.12 0.02 OUTLIER 'General case' 0 CA--C 1.541 0.603 0 N-CA-C 115.433 1.642 . . . . 0.0 115.433 -173.986 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 167.78 175.0 37.24 Favored Glycine 0 CA--C 1.529 0.927 0 CA-C-N 120.54 1.518 . . . . 0.0 111.292 -177.081 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 40.2 m -117.31 124.34 48.73 Favored 'General case' 0 C--O 1.233 0.229 0 C-N-CA 124.444 1.098 . . . . 0.0 108.101 -177.046 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 62.55 28.74 71.83 Favored Glycine 0 CA--C 1.531 1.044 0 N-CA-C 111.343 -0.703 . . . . 0.0 111.343 -174.822 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . 0.267 7.2 p -80.2 74.41 0.74 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.512 0 C-N-CA 125.006 1.322 . . . . 0.0 109.988 -169.459 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 1.1 t30 60.07 54.08 4.3 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 126.711 2.005 . . . . 0.0 108.012 -176.476 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.409 ' HA ' ' HD3' ' A' ' 87' ' ' PRO . 0.9 OUTLIER -152.12 138.4 11.79 Favored Pre-proline 0 CA--C 1.539 0.55 0 C-N-CA 125.803 1.641 . . . . 0.0 107.621 -169.341 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . 0.417 ' HA ' ' HD3' ' A' ' 88' ' ' PRO . 31.8 Cg_exo -69.84 146.6 60.2 Favored 'Trans proline' 0 CA--C 1.546 1.08 0 C-N-CA 121.494 1.463 . . . . 0.0 114.139 -175.77 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . 0.417 ' HD3' ' HA ' ' A' ' 87' ' ' PRO . 51.8 Cg_exo -63.7 -25.95 68.65 Favored 'Trans proline' 0 C--N 1.349 0.581 0 C-N-CA 122.667 2.244 . . . . 0.0 115.945 -174.085 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 5.7 pm0 -61.53 -14.84 32.85 Favored 'General case' 0 CA--C 1.543 0.707 0 CA-C-N 121.024 1.738 . . . . 0.0 111.809 175.982 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 90.8 m95 -91.81 -21.7 20.53 Favored 'General case' 0 N--CA 1.451 -0.409 0 C-N-CA 124.509 1.123 . . . . 0.0 113.07 173.793 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 2.9 m -78.64 -5.01 7.39 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.36 0 CA-C-N 120.129 1.331 . . . . 0.0 111.326 171.377 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 60.3 p -107.95 -118.14 0.26 Allowed 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 123.081 0.552 . . . . 0.0 111.492 -176.747 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 70.5 mm-40 55.96 -171.13 0.07 Allowed 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 125.563 1.545 . . . . 0.0 111.47 -168.787 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 37.0 mm-40 -70.25 -23.11 62.85 Favored 'General case' 0 CA--C 1.537 0.474 0 O-C-N 121.479 -0.763 . . . . 0.0 112.316 -169.466 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 9.5 tt -147.83 141.64 19.3 Favored 'Isoleucine or valine' 0 C--O 1.238 0.46 0 C-N-CA 125.103 1.361 . . . . 0.0 107.607 169.761 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 73.3 t80 -128.22 139.41 52.47 Favored 'General case' 0 N--CA 1.446 -0.661 0 N-CA-C 106.277 -1.749 . . . . 0.0 106.277 168.867 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . 0.435 ' HB2' HD12 ' A' ' 77' ' ' ILE . 29.3 mm-40 -139.32 166.26 25.02 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 107.246 -1.39 . . . . 0.0 107.246 170.003 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -165.33 137.29 4.17 Favored 'General case' 0 C--N 1.323 -0.568 0 C-N-CA 126.074 1.75 . . . . 0.0 106.334 -176.642 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 6.9 m0 -143.12 144.77 32.35 Favored 'General case' 0 N--CA 1.451 -0.377 0 C-N-CA 122.875 0.47 . . . . 0.0 110.201 -169.332 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 20.0 tt0 -83.33 57.42 3.98 Favored 'General case' 0 CA--C 1.537 0.451 0 N-CA-C 108.179 -1.045 . . . . 0.0 108.179 171.054 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.455 HD13 HG22 ' A' ' 119' ' ' VAL . 19.4 mt -65.74 138.47 57.97 Favored 'General case' 0 C--O 1.235 0.321 0 N-CA-C 107.155 -1.424 . . . . 0.0 107.155 173.459 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 23.5 mm-40 -67.22 151.52 47.38 Favored 'General case' 0 N--CA 1.451 -0.41 0 CA-C-O 121.574 0.702 . . . . 0.0 109.511 172.033 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -112.41 117.97 46.33 Favored Pre-proline 0 N--CA 1.45 -0.468 0 N-CA-C 106.098 -1.816 . . . . 0.0 106.098 170.447 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_endo -80.82 -1.52 11.29 Favored 'Trans proline' 0 N--CA 1.448 -1.183 0 C-N-CA 122.98 2.453 . . . . 0.0 113.412 -173.217 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -53.4 120.07 5.61 Favored 'General case' 0 CA--C 1.536 0.429 0 CA-C-N 120.473 1.488 . . . . 0.0 110.864 -175.917 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 70.2 0.65 30.08 Favored Glycine 0 CA--C 1.534 1.245 0 CA-C-O 118.765 -1.019 . . . . 0.0 114.562 179.518 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 12.9 mt-30 -85.3 171.89 11.54 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-N 119.156 1.478 . . . . 0.0 109.638 174.096 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 15.0 m -69.2 162.33 27.32 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 123.91 0.884 . . . . 0.0 111.322 178.71 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 13.3 tp -59.04 -30.93 68.4 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 124.615 1.166 . . . . 0.0 112.43 -173.779 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 5.3 pt-20 -56.57 -34.92 67.61 Favored 'General case' 0 C--O 1.226 -0.166 0 C-N-CA 124.768 1.227 . . . . 0.0 111.775 174.778 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 32.2 t -75.03 -42.19 45.54 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.422 0 CA-C-O 117.813 -1.089 . . . . 0.0 109.164 -176.798 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 89.7 m-85 -56.52 -49.94 73.27 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-N 120.329 1.422 . . . . 0.0 109.666 172.621 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 86.8 mtt180 -66.84 -34.6 78.17 Favored 'General case' 0 N--CA 1.467 0.409 0 O-C-N 122.037 -0.414 . . . . 0.0 111.761 -176.358 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 3.5 m -62.24 -48.59 79.29 Favored 'General case' 0 N--CA 1.451 -0.404 0 C-N-CA 124.681 1.192 . . . . 0.0 109.413 170.357 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 45.7 t -63.62 -33.44 61.63 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.243 0 CA-C-O 118.265 -0.874 . . . . 0.0 110.0 -174.627 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 13.1 mtm105 -56.58 -49.8 73.83 Favored 'General case' 0 C--O 1.225 -0.226 0 CA-C-N 119.303 0.956 . . . . 0.0 110.071 172.188 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -62.3 -48.55 81.69 Favored Glycine 0 CA--C 1.526 0.731 0 CA-C-O 119.103 -0.832 . . . . 0.0 111.216 179.55 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 69.8 mt-30 -55.24 -53.23 58.63 Favored 'General case' 0 C--N 1.343 0.296 0 CA-C-O 122.091 0.948 . . . . 0.0 109.364 -179.802 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . 0.455 HG22 HD13 ' A' ' 101' ' ' LEU . 73.8 t -71.44 -39.97 71.91 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-O 117.875 -1.06 . . . . 0.0 110.605 -170.608 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 87.2 tttt -55.6 -47.46 76.47 Favored 'General case' 0 C--O 1.223 -0.321 0 CA-C-N 119.411 1.005 . . . . 0.0 108.316 176.792 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -66.22 -43.01 87.89 Favored 'General case' 0 N--CA 1.45 -0.465 0 C-N-CA 122.438 0.295 . . . . 0.0 111.078 -174.838 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 40.2 mmt180 -63.02 -46.6 86.85 Favored 'General case' 0 N--CA 1.471 0.611 0 O-C-N 121.563 -0.711 . . . . 0.0 110.837 177.831 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 78.2 t -67.31 -41.73 86.81 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.665 0 C-N-CA 123.08 0.552 . . . . 0.0 109.618 -178.897 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 31.3 mt-10 -60.23 -43.74 95.81 Favored 'General case' 0 CA--C 1.52 -0.191 0 CA-C-N 119.595 1.089 . . . . 0.0 110.011 177.651 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 29.0 t-20 -62.38 -45.03 94.97 Favored 'General case' 0 N--CA 1.454 -0.243 0 C-N-CA 122.776 0.43 . . . . 0.0 110.668 179.789 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 28.5 tp -59.44 -47.69 84.49 Favored 'General case' 0 N--CA 1.453 -0.277 0 C-N-CA 123.859 0.864 . . . . 0.0 111.102 177.579 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 85.0 mt -63.09 -46.59 95.71 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.175 0 N-CA-C 107.845 -1.169 . . . . 0.0 107.845 179.504 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -59.79 -28.8 67.74 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-N 118.457 0.571 . . . . 0.0 112.335 178.682 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 92.1 mttt -69.37 -57.17 5.63 Favored 'General case' 0 C--N 1.344 0.349 0 CA-C-N 119.219 0.918 . . . . 0.0 110.629 171.751 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 13.6 pt -77.29 -38.46 27.03 Favored 'Isoleucine or valine' 0 C--O 1.235 0.305 0 N-CA-C 115.095 1.517 . . . . 0.0 115.095 -168.823 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 69.5 m . . . . . 0 C--O 1.252 1.219 0 C-N-CA 125.694 1.597 . . . . 0.0 109.334 -169.79 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.496 1.839 0 N-CA-C 110.535 -0.172 . . . . 0.0 110.535 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 30.8 mttm -80.18 116.65 20.39 Favored 'General case' 0 N--CA 1.475 0.799 0 N-CA-C 106.109 -1.811 . . . . 0.0 106.109 173.66 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 92.2 mttt -81.89 131.88 35.26 Favored 'General case' 0 CA--C 1.505 -0.777 0 CA-C-N 119.566 1.075 . . . . 0.0 108.399 177.45 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 1.4 t -116.61 146.82 20.53 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 O-C-N 125.515 1.76 . . . . 0.0 107.131 -170.821 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 35.3 ttm -138.27 147.27 43.47 Favored 'General case' 0 C--N 1.32 -0.676 0 C-N-CA 125.194 1.398 . . . . 0.0 107.864 170.709 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . 0.403 ' CE2' HG13 ' A' ' 77' ' ' ILE . 67.2 m-85 -136.26 119.82 17.07 Favored 'General case' 0 CA--C 1.516 -0.339 0 N-CA-C 105.509 -2.034 . . . . 0.0 105.509 177.526 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 2.0 p -151.45 129.81 2.75 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.386 0 N-CA-C 108.656 -0.868 . . . . 0.0 108.656 -169.427 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -110.77 -178.58 3.52 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 125.764 1.626 . . . . 0.0 106.921 169.754 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 85.1 tttt -70.88 -26.98 63.48 Favored 'General case' 0 N--CA 1.472 0.659 0 O-C-N 121.131 -0.981 . . . . 0.0 112.306 -171.821 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 37.8 ttp180 -136.47 160.7 37.98 Favored 'General case' 0 N--CA 1.467 0.392 0 C-N-CA 124.269 1.028 . . . . 0.0 109.077 -169.545 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -68.96 -38.82 79.64 Favored 'General case' 0 N--CA 1.47 0.571 0 CA-C-N 118.613 0.642 . . . . 0.0 110.596 175.748 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 2.9 p -84.13 66.87 9.49 Favored 'General case' 0 C--O 1.234 0.284 0 C-N-CA 125.863 1.665 . . . . 0.0 108.565 -177.863 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 40.6 p -155.15 -167.02 2.43 Favored 'General case' 0 N--CA 1.451 -0.382 0 CA-C-O 121.789 0.804 . . . . 0.0 109.903 -172.946 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 76.0 mtt180 -54.17 -23.29 13.81 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 126.033 1.733 . . . . 0.0 111.986 169.987 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 28.7 m -51.01 -26.05 5.58 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-N 119.84 1.2 . . . . 0.0 112.991 178.1 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 6.5 pt20 -69.1 -26.99 65.19 Favored 'General case' 0 C--O 1.221 -0.432 0 N-CA-C 114.925 1.454 . . . . 0.0 114.925 -172.554 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 2.1 tpt -115.43 -32.26 5.65 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-N 120.72 1.6 . . . . 0.0 115.033 -169.31 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -68.48 -43.7 76.35 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-N 119.723 1.147 . . . . 0.0 113.083 -169.204 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 1.5 pp20? -63.75 -34.07 77.07 Favored 'General case' 0 N--CA 1.473 0.688 0 CA-C-N 119.267 0.94 . . . . 0.0 109.541 171.997 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -50.8 -49.66 40.44 Favored Glycine 0 C--O 1.219 -0.839 0 C-N-CA 125.259 1.409 . . . . 0.0 111.011 176.057 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 5.6 m-85 -75.98 -31.76 59.14 Favored 'General case' 0 CA--C 1.511 -0.541 0 CA-C-N 118.928 1.364 . . . . 0.0 113.899 178.258 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -68.03 -32.8 73.42 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 119.421 1.009 . . . . 0.0 111.58 -170.174 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 4.7 ptpt -61.07 -29.21 69.61 Favored 'General case' 0 N--CA 1.473 0.697 0 CA-C-N 118.546 0.612 . . . . 0.0 111.643 172.407 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 15.1 m -82.66 -56.93 3.56 Favored 'General case' 0 N--CA 1.443 -0.793 0 C-N-CA 124.965 1.306 . . . . 0.0 109.819 -177.399 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 76.3 mt -73.49 -36.58 65.8 Favored 'General case' 0 C--N 1.331 -0.207 0 C-N-CA 123.35 0.66 . . . . 0.0 110.947 -170.359 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -103.87 13.16 53.17 Favored Glycine 0 CA--C 1.525 0.687 0 CA-C-O 118.068 -1.407 . . . . 0.0 113.044 -174.072 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -41.66 -53.95 3.41 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 126.345 1.858 . . . . 0.0 114.707 -169.229 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -91.31 10.08 75.78 Favored Glycine 0 CA--C 1.53 1.027 0 CA-C-O 119.216 -0.769 . . . . 0.0 113.525 -176.201 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 50.5 mttm -124.13 -50.86 1.79 Allowed 'General case' 0 N--CA 1.467 0.411 0 CA-C-N 118.435 1.117 . . . . 0.0 112.028 -169.21 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 28.3 pt -136.54 150.36 27.32 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.338 0 C-N-CA 124.222 1.009 . . . . 0.0 110.137 -169.011 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -110.27 102.48 11.14 Favored 'General case' 0 C--O 1.228 -0.048 0 C-N-CA 124.911 1.284 . . . . 0.0 109.47 -169.549 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 9.6 p -84.93 130.28 36.32 Favored 'Isoleucine or valine' 0 C--O 1.235 0.309 0 CA-C-N 118.686 0.675 . . . . 0.0 109.658 -179.982 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 19.1 m -145.14 115.46 7.55 Favored 'General case' 0 N--CA 1.448 -0.548 0 N-CA-C 104.342 -2.466 . . . . 0.0 104.342 170.519 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 48.2 m -112.47 8.0 19.22 Favored 'General case' 0 N--CA 1.466 0.325 0 N-CA-C 115.434 1.642 . . . . 0.0 115.434 -174.391 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 1.5 m 52.96 -133.73 1.78 Allowed 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 123.568 0.747 . . . . 0.0 111.114 169.679 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -171.14 154.7 23.08 Favored Glycine 0 N--CA 1.444 -0.777 0 N-CA-C 108.16 -1.976 . . . . 0.0 108.16 170.047 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 55.8 mt -103.08 -51.02 3.35 Favored 'General case' 0 N--CA 1.451 -0.404 0 C-N-CA 124.057 0.943 . . . . 0.0 108.864 171.755 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 25.7 mt-10 -130.58 72.0 1.48 Allowed 'General case' 0 CA--C 1.514 -0.428 0 CA-C-O 124.124 1.916 . . . . 0.0 107.069 169.663 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 10.7 m 57.33 -31.39 0.03 OUTLIER 'General case' 0 C--N 1.321 -0.649 0 C-N-CA 131.446 3.898 . . . . 0.0 117.422 -174.976 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 60.9 m 60.67 23.25 13.09 Favored 'General case' 0 CA--C 1.54 0.573 0 N-CA-C 115.9 1.815 . . . . 0.0 115.9 168.35 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 11.3 ttt180 -71.86 -178.98 2.5 Favored 'General case' 0 CA--C 1.539 0.519 0 N-CA-C 107.558 -1.275 . . . . 0.0 107.558 169.017 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 11.5 m -123.95 -172.32 0.75 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.642 0 C-N-CA 124.437 1.095 . . . . 0.0 111.279 -169.187 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 96.1 m-70 -112.45 156.32 42.41 Favored Pre-proline 0 CA--C 1.536 0.422 0 C-N-CA 125.184 1.394 . . . . 0.0 111.009 -171.984 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -57.2 -48.49 17.65 Favored 'Trans proline' 0 C--N 1.347 0.49 0 C-N-CA 124.012 3.141 . . . . 0.0 112.628 -174.014 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 2.7 m -67.9 -29.64 68.79 Favored 'General case' 0 CA--C 1.531 0.227 0 CA-C-O 118.849 -0.596 . . . . 0.0 110.156 -176.876 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -59.61 -56.09 26.33 Favored 'General case' 0 CA--C 1.505 -0.763 0 N-CA-C 108.137 -1.06 . . . . 0.0 108.137 171.164 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 56.2 mt -59.61 -39.07 78.51 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.396 0 N-CA-C 108.52 -0.918 . . . . 0.0 108.52 -173.043 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -62.32 -49.58 75.05 Favored 'General case' 0 N--CA 1.452 -0.358 0 CA-C-N 119.181 0.9 . . . . 0.0 111.138 -179.838 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 38.9 mmt -71.46 -34.25 70.06 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-O 122.756 1.265 . . . . 0.0 110.161 -177.226 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -73.31 -31.27 63.92 Favored 'General case' 0 N--CA 1.44 -0.925 0 N-CA-C 107.393 -1.336 . . . . 0.0 107.393 -178.634 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 4.9 mm-40 -72.88 -17.5 61.52 Favored 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 124.101 0.96 . . . . 0.0 110.985 169.704 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 78.5 mt-10 -65.11 -36.84 85.55 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 119.844 1.202 . . . . 0.0 108.762 168.932 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . 0.302 8.5 p -86.46 7.5 2.33 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.991 0 CA-C-O 120.789 0.328 . . . . 0.0 111.608 169.742 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 71.41 23.31 78.2 Favored Glycine 0 CA--C 1.532 1.147 0 C-N-CA 124.994 1.283 . . . . 0.0 113.266 175.773 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 5.4 mt -103.7 136.65 35.71 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.226 0 C-N-CA 124.273 1.029 . . . . 0.0 111.975 -172.225 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -78.11 137.28 38.12 Favored 'General case' 0 CA--C 1.529 0.155 0 CA-C-N 114.507 -1.224 . . . . 0.0 109.043 168.972 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 8.1 pt -143.35 -27.56 0.17 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.39 0 C-N-CA 125.062 1.345 . . . . 0.0 108.951 168.209 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -40.21 -41.17 1.25 Allowed 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 129.459 3.104 . . . . 0.0 113.113 169.443 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -87.25 20.52 25.68 Favored Glycine 0 CA--C 1.533 1.171 0 C-N-CA 125.225 1.393 . . . . 0.0 114.38 -177.422 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -60.08 -35.14 74.54 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-N 119.812 1.806 . . . . 0.0 112.489 -178.161 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -66.97 133.01 49.12 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 123.981 0.912 . . . . 0.0 109.817 -171.067 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 13.7 p -151.23 -68.97 0.18 Allowed 'General case' 0 C--O 1.235 0.307 0 C-N-CA 123.356 0.663 . . . . 0.0 109.962 -177.761 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -151.3 155.77 34.74 Favored Pre-proline 0 C--O 1.236 0.376 0 C-N-CA 125.807 1.643 . . . . 0.0 108.57 -177.126 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -64.39 156.3 60.98 Favored 'Trans proline' 0 N--CA 1.456 -0.686 0 C-N-CA 122.234 1.956 . . . . 0.0 110.208 171.46 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 11.3 tt -57.55 -28.41 31.59 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.499 0 C-N-CA 123.137 0.575 . . . . 0.0 111.536 178.826 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 23.1 tt0 -66.04 -25.23 66.95 Favored 'General case' 0 N--CA 1.437 -1.083 0 C-N-CA 126.335 1.854 . . . . 0.0 110.715 -175.588 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 6.1 t-20 -64.11 -21.22 66.45 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 124.287 1.035 . . . . 0.0 112.126 176.82 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 77.6 m-85 -110.88 -176.0 2.86 Favored 'General case' 0 C--O 1.235 0.306 0 C-N-CA 126.025 1.73 . . . . 0.0 110.802 -174.487 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 61.5 t-20 -136.68 141.2 43.12 Favored 'General case' 0 N--CA 1.445 -0.697 0 N-CA-C 107.206 -1.405 . . . . 0.0 107.206 169.366 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -72.2 -25.2 61.58 Favored 'General case' 0 N--CA 1.433 -1.295 0 CA-C-N 118.44 0.564 . . . . 0.0 109.701 -178.901 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 35.6 t70 -63.04 -24.16 67.78 Favored 'General case' 0 N--CA 1.447 -0.607 0 O-C-N 123.549 0.531 . . . . 0.0 111.634 -179.417 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -74.94 -28.11 60.46 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 123.159 0.584 . . . . 0.0 111.868 175.626 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 12.3 m-85 -81.51 164.47 21.96 Favored 'General case' 0 N--CA 1.448 -0.556 0 C-N-CA 125.353 1.461 . . . . 0.0 111.357 -177.21 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -107.16 -37.9 6.15 Favored 'General case' 0 N--CA 1.462 0.138 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.776 173.583 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -139.28 138.71 40.39 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.504 0 CA-C-O 121.731 0.776 . . . . 0.0 110.17 -170.615 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 57.9 t -141.42 130.6 24.15 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.659 0 N-CA-C 106.22 -1.77 . . . . 0.0 106.22 178.033 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.538 HD12 ' HB2' ' A' ' 97' ' ' GLU . 27.4 mm -106.0 128.12 60.57 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.76 0 N-CA-C 105.325 -2.102 . . . . 0.0 105.325 176.537 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 28.9 m -109.93 75.72 0.95 Allowed 'General case' 0 N--CA 1.437 -1.112 0 N-CA-C 105.455 -2.054 . . . . 0.0 105.455 -176.336 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 59.9 mt -53.03 -17.06 1.27 Allowed 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 125.768 1.627 . . . . 0.0 115.102 -169.1 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 12.7 m -112.14 -7.92 14.03 Favored 'General case' 0 CA--C 1.541 0.597 0 CA-C-N 119.866 1.212 . . . . 0.0 114.2 -177.477 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 142.89 -132.91 5.28 Favored Glycine 0 C--N 1.338 0.692 0 CA-C-N 120.635 1.562 . . . . 0.0 111.543 -178.041 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 13.0 m -125.15 -28.13 3.45 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 123.554 0.742 . . . . 0.0 112.314 -169.901 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -76.14 -62.93 2.5 Favored Glycine 0 C--N 1.343 0.925 0 N-CA-C 109.45 -1.46 . . . . 0.0 109.45 173.171 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . 0.321 10.9 t 56.81 18.96 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.55 0.962 0 C-N-CA 125.39 1.476 . . . . 0.0 112.693 170.602 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 64.9 t30 45.33 37.79 3.1 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 125.56 1.544 . . . . 0.0 112.385 -172.089 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -136.45 158.73 72.82 Favored Pre-proline 0 CA--C 1.541 0.62 0 C-N-CA 123.63 0.772 . . . . 0.0 111.849 179.766 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 80.4 Cg_exo -54.99 131.14 44.64 Favored 'Trans proline' 0 C--N 1.352 0.732 0 C-N-CA 123.22 2.613 . . . . 0.0 110.953 175.04 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 49.3 Cg_endo -62.06 -19.45 66.33 Favored 'Trans proline' 0 C--N 1.348 0.512 0 C-N-CA 122.089 1.86 . . . . 0.0 112.138 -177.997 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 2.2 pt-20 -51.13 -26.56 6.81 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 126.136 1.775 . . . . 0.0 112.569 172.739 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 83.4 m95 -74.52 -40.9 61.47 Favored 'General case' 0 N--CA 1.455 -0.2 0 C-N-CA 123.803 0.841 . . . . 0.0 111.844 175.371 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 14.0 t -66.15 -37.12 79.06 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.5 0 C-N-CA 123.901 0.88 . . . . 0.0 108.931 179.374 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 68.8 p -84.39 25.52 0.86 Allowed 'General case' 0 C--O 1.237 0.438 0 N-CA-C 114.851 1.426 . . . . 0.0 114.851 -168.826 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 91.3 mm-40 -74.44 -179.12 3.83 Favored 'General case' 0 CA--C 1.54 0.583 0 CA-C-N 118.385 0.539 . . . . 0.0 110.877 171.706 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 25.6 mm-40 -61.73 -17.87 57.48 Favored 'General case' 0 CA--C 1.54 0.566 0 N-CA-C 113.421 0.897 . . . . 0.0 113.421 -169.027 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 4.6 tt -140.6 133.61 32.59 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.513 0 N-CA-C 106.849 -1.537 . . . . 0.0 106.849 170.026 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -109.57 135.4 50.62 Favored 'General case' 0 CA--C 1.537 0.467 0 N-CA-C 105.04 -2.208 . . . . 0.0 105.04 169.149 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . 0.538 ' HB2' HD12 ' A' ' 77' ' ' ILE . 12.8 mm-40 -138.67 163.6 31.69 Favored 'General case' 0 C--O 1.233 0.185 0 C-N-CA 124.542 1.137 . . . . 0.0 107.982 171.26 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -173.57 127.96 0.42 Allowed 'General case' 0 C--O 1.238 0.482 0 C-N-CA 126.944 2.098 . . . . 0.0 105.374 -169.571 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' TRP . . . . . 0.402 ' CZ3' HG21 ' A' ' 77' ' ' ILE . 7.5 m0 -143.13 142.48 31.5 Favored 'General case' 0 N--CA 1.469 0.519 0 N-CA-C 112.751 0.648 . . . . 0.0 112.751 -169.669 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 7.3 pt20 -81.52 50.5 1.49 Allowed 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 125.107 1.363 . . . . 0.0 111.183 174.66 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.497 HD13 HG22 ' A' ' 119' ' ' VAL . 41.7 mt -64.51 140.91 58.92 Favored 'General case' 0 N--CA 1.464 0.269 0 N-CA-C 107.707 -1.22 . . . . 0.0 107.707 172.856 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 27.8 mm-40 -67.15 142.01 57.18 Favored 'General case' 0 CA--C 1.533 0.324 0 CA-C-N 119.681 1.128 . . . . 0.0 109.035 169.938 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 1.5 t0 -97.35 116.07 65.85 Favored Pre-proline 0 N--CA 1.448 -0.526 0 N-CA-C 105.435 -2.061 . . . . 0.0 105.435 169.224 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 49.7 Cg_endo -83.94 -5.4 10.53 Favored 'Trans proline' 0 N--CA 1.451 -1.004 0 C-N-CA 122.815 2.344 . . . . 0.0 112.963 -174.949 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -58.86 127.42 32.12 Favored 'General case' 0 C--O 1.236 0.384 0 CA-C-N 120.204 1.366 . . . . 0.0 109.742 -178.882 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 74.4 0.4 57.7 Favored Glycine 0 CA--C 1.537 1.414 0 CA-C-O 118.618 -1.101 . . . . 0.0 114.013 -178.687 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 13.0 mt-30 -97.3 169.14 9.97 Favored 'General case' 0 CA--C 1.54 0.581 0 CA-C-N 119.09 1.445 . . . . 0.0 109.841 173.386 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 15.0 m -70.64 164.85 24.1 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 124.442 1.097 . . . . 0.0 111.554 -179.608 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 38.2 mt -61.93 -27.04 68.55 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 123.596 0.758 . . . . 0.0 112.115 -175.654 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 5.0 pt-20 -56.76 -36.09 69.38 Favored 'General case' 0 CA--C 1.53 0.198 0 C-N-CA 123.274 0.63 . . . . 0.0 111.228 173.413 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 24.8 t -76.44 -44.37 35.21 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.298 0 CA-C-O 117.786 -1.102 . . . . 0.0 108.837 -178.73 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 59.1 m-85 -55.05 -47.88 74.22 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-N 120.488 1.495 . . . . 0.0 110.364 173.272 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 93.7 mtt180 -70.01 -35.22 74.2 Favored 'General case' 0 CA--C 1.534 0.337 0 O-C-N 121.705 -0.622 . . . . 0.0 110.97 -175.801 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 2.6 m -60.81 -47.35 86.73 Favored 'General case' 0 N--CA 1.454 -0.262 0 C-N-CA 123.922 0.889 . . . . 0.0 109.175 169.812 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 44.4 t -65.31 -31.66 54.86 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.263 0 CA-C-O 118.481 -0.771 . . . . 0.0 109.867 -174.211 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 19.2 mtm105 -57.31 -46.37 83.26 Favored 'General case' 0 CA--C 1.535 0.382 0 CA-C-N 119.41 1.004 . . . . 0.0 110.375 172.507 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -62.57 -50.69 62.07 Favored Glycine 0 CA--C 1.529 0.907 0 CA-C-O 119.543 -0.587 . . . . 0.0 111.636 175.649 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 70.7 mt-30 -57.03 -49.63 75.23 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-O 121.889 0.852 . . . . 0.0 110.414 -176.865 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . 0.497 HG22 HD13 ' A' ' 101' ' ' LEU . 58.4 t -74.89 -37.74 42.31 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-O 117.998 -1.001 . . . . 0.0 110.336 -172.062 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -54.77 -45.19 74.21 Favored 'General case' 0 C--O 1.224 -0.247 0 CA-C-N 119.892 1.224 . . . . 0.0 108.839 173.617 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 40.6 tt0 -67.16 -42.81 83.69 Favored 'General case' 0 N--CA 1.448 -0.571 0 C-N-CA 122.977 0.511 . . . . 0.0 111.267 -175.425 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 35.3 mmt180 -63.89 -45.69 88.24 Favored 'General case' 0 N--CA 1.473 0.689 0 CA-C-N 119.084 0.856 . . . . 0.0 111.304 176.881 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 77.5 t -68.37 -37.48 77.96 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.828 0 N-CA-C 108.71 -0.848 . . . . 0.0 108.71 -177.981 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 4.8 mm-40 -59.22 -46.26 88.93 Favored 'General case' 0 C--N 1.34 0.18 0 CA-C-N 119.426 1.012 . . . . 0.0 110.429 172.647 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 27.1 t-20 -64.89 -40.16 94.66 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 123.143 0.577 . . . . 0.0 111.182 -176.87 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 27.9 tp -58.99 -49.83 76.41 Favored 'General case' 0 CA--C 1.53 0.176 0 C-N-CA 125.105 1.362 . . . . 0.0 110.906 172.901 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 51.7 mt -64.57 -46.13 93.47 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 N-CA-C 107.829 -1.175 . . . . 0.0 107.829 -178.059 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -58.98 -30.96 68.35 Favored 'General case' 0 N--CA 1.452 -0.364 0 CA-C-O 118.52 -0.753 . . . . 0.0 112.284 -178.557 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 17.6 ptpt -84.25 -39.81 18.82 Favored 'General case' 0 C--N 1.345 0.375 0 CA-C-O 117.845 -1.074 . . . . 0.0 112.561 177.003 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 11.8 pt -82.55 -35.94 13.09 Favored 'Isoleucine or valine' 0 C--O 1.235 0.309 0 CA-C-N 120.094 1.315 . . . . 0.0 113.814 -175.133 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 65.1 m . . . . . 0 C--O 1.253 1.243 0 C-N-CA 125.134 1.374 . . . . 0.0 109.732 -169.814 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.0 mmt . . . . . 0 N--CA 1.495 1.805 0 N-CA-C 111.195 0.072 . . . . 0.0 111.195 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 30.0 mttm -83.75 112.34 19.99 Favored 'General case' 0 N--CA 1.475 0.818 0 N-CA-C 105.044 -2.206 . . . . 0.0 105.044 169.495 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 91.9 mttt -82.46 133.87 35.21 Favored 'General case' 0 CA--C 1.512 -0.481 0 CA-C-N 119.869 1.213 . . . . 0.0 107.94 179.758 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 1.8 t -120.05 147.14 23.93 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 C-N-CA 125.512 1.525 . . . . 0.0 108.867 -169.077 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 11.1 mtt -134.55 147.22 50.23 Favored 'General case' 0 C--N 1.326 -0.423 0 C-N-CA 125.731 1.613 . . . . 0.0 109.856 169.432 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 62.0 m-85 -135.54 116.72 14.45 Favored 'General case' 0 C--N 1.334 -0.084 0 N-CA-C 105.878 -1.897 . . . . 0.0 105.878 169.684 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 2.6 p -155.04 157.12 4.42 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.367 0 CA-C-O 121.127 0.489 . . . . 0.0 110.269 -168.991 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 52.3 t -152.43 174.89 13.3 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 127.482 2.313 . . . . 0.0 105.932 169.547 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 65.7 pttt -62.7 144.46 56.34 Favored 'General case' 0 N--CA 1.469 0.488 0 O-C-N 121.213 -0.93 . . . . 0.0 109.867 171.598 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 62.8 mtp85 57.78 170.34 0.05 OUTLIER 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 126.468 1.907 . . . . 0.0 113.171 -173.501 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -118.53 0.21 11.52 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 124.066 0.946 . . . . 0.0 111.462 170.113 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 1.4 m -64.19 -37.78 88.69 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 124.137 0.975 . . . . 0.0 110.147 -174.328 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 24.1 p -136.8 153.38 50.83 Favored 'General case' 0 C--O 1.236 0.391 0 C-N-CA 126.657 1.983 . . . . 0.0 106.532 169.718 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 8.0 mpt_? 56.68 -176.05 0.06 Allowed 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 125.391 1.476 . . . . 0.0 110.003 -169.288 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 3.9 m 48.45 46.44 20.64 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 124.069 0.948 . . . . 0.0 110.245 -169.756 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 21.4 pt20 -151.93 157.28 41.58 Favored 'General case' 0 N--CA 1.444 -0.732 0 N-CA-C 106.175 -1.787 . . . . 0.0 106.175 169.997 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER 64.47 -36.07 0.18 Allowed 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 128.124 2.569 . . . . 0.0 115.746 179.326 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -71.51 -48.76 46.8 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-N 121.431 1.923 . . . . 0.0 110.141 -176.827 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -62.66 -39.0 92.53 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 123.113 0.565 . . . . 0.0 110.447 170.012 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -55.73 -43.43 86.67 Favored Glycine 0 C--N 1.343 0.918 0 C-N-CA 123.924 0.773 . . . . 0.0 112.543 174.822 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 2.1 m-85 -74.72 -32.31 62.11 Favored 'General case' 0 CA--C 1.51 -0.573 0 CA-C-N 119.599 1.7 . . . . 0.0 112.227 177.253 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -67.37 -34.19 76.78 Favored 'General case' 0 N--CA 1.453 -0.313 0 CA-C-N 118.839 0.745 . . . . 0.0 111.257 -172.853 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 17.9 ptpt -62.71 -28.16 69.76 Favored 'General case' 0 N--CA 1.475 0.794 0 CA-C-N 119.224 0.92 . . . . 0.0 111.975 170.827 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 2.1 m -83.78 -56.16 3.86 Favored 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 124.573 1.149 . . . . 0.0 110.369 -177.483 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 72.4 mt -73.33 -34.34 65.61 Favored 'General case' 0 C--N 1.331 -0.206 0 C-N-CA 123.861 0.864 . . . . 0.0 110.186 -173.856 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -97.98 11.34 64.14 Favored Glycine 0 CA--C 1.525 0.667 0 C-N-CA 125.487 1.518 . . . . 0.0 112.82 -177.112 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -50.25 122.8 7.37 Favored 'General case' 0 CA--C 1.535 0.391 0 CA-C-N 118.754 1.277 . . . . 0.0 110.406 -177.121 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 74.67 -2.85 46.23 Favored Glycine 0 CA--C 1.536 1.348 0 CA-C-O 118.764 -1.02 . . . . 0.0 114.39 179.216 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 64.4 mttm -103.89 -42.23 5.65 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-N 119.316 1.558 . . . . 0.0 111.319 178.918 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 17.2 pt -141.97 152.84 18.68 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.657 0 C-N-CA 125.068 1.347 . . . . 0.0 109.671 -171.012 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -113.69 103.42 11.21 Favored 'General case' 0 N--CA 1.467 0.4 0 C-N-CA 125.242 1.417 . . . . 0.0 109.877 -170.752 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 3.8 t -86.22 127.9 39.87 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 O-C-N 121.299 -0.875 . . . . 0.0 108.695 -178.517 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 24.6 m -151.46 98.67 2.54 Favored 'General case' 0 C--O 1.223 -0.341 0 N-CA-C 104.843 -2.28 . . . . 0.0 104.843 173.659 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 20.2 m -97.53 5.06 50.13 Favored 'General case' 0 N--CA 1.467 0.388 0 N-CA-C 114.7 1.37 . . . . 0.0 114.7 -169.693 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 4.6 m 53.12 -133.95 1.74 Allowed 'General case' 0 CA--C 1.548 0.873 0 C-N-CA 124.02 0.928 . . . . 0.0 111.458 175.318 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -177.75 170.79 43.27 Favored Glycine 0 CA--C 1.526 0.728 0 N-CA-C 107.121 -2.392 . . . . 0.0 107.121 179.447 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 24.8 mt -113.34 -43.17 3.38 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 118.481 1.14 . . . . 0.0 109.707 179.327 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -141.83 -59.51 0.47 Allowed 'General case' 0 C--N 1.332 -0.175 0 N-CA-C 102.404 -3.184 . . . . 0.0 102.404 169.743 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 15.9 m 58.93 175.58 0.07 Allowed 'General case' 0 N--CA 1.446 -0.649 0 C-N-CA 127.167 2.187 . . . . 0.0 115.772 167.553 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 4.4 m -165.75 178.98 6.23 Favored 'General case' 0 C--O 1.238 0.499 0 C-N-CA 129.464 3.105 . . . . 0.0 104.442 -169.645 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -65.9 163.17 17.55 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-O 122.491 1.139 . . . . 0.0 110.581 172.26 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 4.3 m -67.34 175.32 0.51 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.71 0 CA-C-N 113.305 -1.771 . . . . 0.0 109.3 169.849 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 49.8 t-80 -72.62 139.55 80.91 Favored Pre-proline 0 CA--C 1.545 0.786 0 CA-C-O 118.474 -0.774 . . . . 0.0 109.549 -176.638 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 21.8 Cg_endo -60.74 -48.1 11.72 Favored 'Trans proline' 0 C--N 1.348 0.552 0 C-N-CA 122.645 2.23 . . . . 0.0 113.019 -172.301 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 4.9 m -65.47 -23.41 66.9 Favored 'General case' 0 CA--C 1.536 0.425 0 O-C-N 121.727 -0.608 . . . . 0.0 110.899 179.374 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -58.89 -46.52 87.64 Favored 'General case' 0 C--O 1.216 -0.707 0 CA-C-N 119.146 0.884 . . . . 0.0 108.723 176.835 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 38.6 mt -61.11 -40.18 84.87 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 N-CA-C 108.89 -0.781 . . . . 0.0 108.89 -174.489 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -65.71 -45.1 84.01 Favored 'General case' 0 CA--C 1.534 0.338 0 CA-C-N 118.39 0.541 . . . . 0.0 110.946 -179.864 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 33.0 mmt -68.25 -36.77 79.95 Favored 'General case' 0 CA--C 1.536 0.414 0 CA-C-O 123.295 1.522 . . . . 0.0 110.006 -179.106 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -76.96 -30.39 56.0 Favored 'General case' 0 N--CA 1.44 -0.933 0 N-CA-C 106.632 -1.618 . . . . 0.0 106.632 -175.675 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 40.6 tt0 -69.69 -21.13 63.53 Favored 'General case' 0 N--CA 1.445 -0.686 0 C-N-CA 124.1 0.96 . . . . 0.0 110.049 169.672 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 54.8 mt-10 -63.65 -39.02 93.3 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-N 119.85 1.205 . . . . 0.0 108.963 169.206 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . 0.32 6.2 p -84.7 8.42 1.56 Allowed 'Isoleucine or valine' 0 CA--C 1.549 0.922 0 N-CA-C 112.005 0.372 . . . . 0.0 112.005 171.628 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 79.46 20.15 69.79 Favored Glycine 0 CA--C 1.53 1.01 0 C-N-CA 125.009 1.29 . . . . 0.0 113.563 174.318 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 22.8 mt -116.54 145.97 21.58 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.261 0 C-N-CA 124.861 1.265 . . . . 0.0 110.547 -171.528 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -116.73 149.02 40.56 Favored 'General case' 0 N--CA 1.463 0.214 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 168.94 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 3.3 pt -138.34 -18.78 0.47 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.376 0 C-N-CA 128.058 2.543 . . . . 0.0 111.197 -174.529 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 1.6 t -47.2 -39.87 14.89 Favored 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 124.11 0.964 . . . . 0.0 112.023 169.929 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -68.97 6.26 4.0 Favored Glycine 0 CA--C 1.535 1.306 0 C-N-CA 124.958 1.266 . . . . 0.0 115.318 -176.977 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 2.2 mt-30 -61.33 -33.35 73.47 Favored 'General case' 0 C--N 1.342 0.24 0 CA-C-N 119.605 1.702 . . . . 0.0 113.355 179.191 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -59.77 119.75 8.25 Favored 'General case' 0 C--O 1.236 0.385 0 C-N-CA 123.596 0.758 . . . . 0.0 109.736 -169.412 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 56.1 m -148.84 -169.71 3.44 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 126.358 1.863 . . . . 0.0 108.229 -169.149 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -54.75 154.6 9.1 Favored Pre-proline 0 C--O 1.239 0.524 0 C-N-CA 124.407 1.083 . . . . 0.0 111.613 169.925 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 98.2 Cg_endo -66.08 157.06 61.55 Favored 'Trans proline' 0 N--CA 1.454 -0.82 0 C-N-CA 122.328 2.018 . . . . 0.0 110.225 171.175 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 14.0 tt -61.19 -26.46 39.31 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.328 0 C-N-CA 124.229 1.011 . . . . 0.0 110.979 -178.789 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 13.6 mt-10 -68.03 -24.93 65.15 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 124.556 1.142 . . . . 0.0 110.619 -175.673 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 6.8 t-20 -62.93 -19.14 63.95 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 124.821 1.249 . . . . 0.0 112.153 177.477 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 13.3 m-85 -120.8 174.01 6.87 Favored 'General case' 0 C--O 1.237 0.412 0 C-N-CA 126.484 1.914 . . . . 0.0 109.318 -178.286 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 29.9 p-10 -125.09 149.29 47.99 Favored 'General case' 0 N--CA 1.437 -1.124 0 C-N-CA 124.681 1.192 . . . . 0.0 110.942 168.936 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -75.64 -22.23 56.97 Favored 'General case' 0 N--CA 1.435 -1.223 0 N-CA-C 109.603 -0.518 . . . . 0.0 109.603 -169.901 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 34.7 t70 -64.7 -23.66 67.32 Favored 'General case' 0 N--CA 1.444 -0.774 0 O-C-N 123.666 0.603 . . . . 0.0 111.804 -178.828 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -76.61 -29.44 56.5 Favored 'General case' 0 CA--C 1.533 0.323 0 O-C-N 121.893 -0.505 . . . . 0.0 111.928 173.993 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 21.0 m-85 -78.7 167.73 20.79 Favored 'General case' 0 N--CA 1.448 -0.532 0 C-N-CA 125.116 1.366 . . . . 0.0 110.949 179.597 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -115.63 -40.06 3.43 Favored 'General case' 0 N--CA 1.466 0.353 0 C-N-CA 122.893 0.477 . . . . 0.0 111.223 178.962 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -138.04 136.16 45.03 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.497 0 CA-C-O 121.8 0.81 . . . . 0.0 109.315 -171.324 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 72.1 t -143.84 136.56 23.75 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.68 0 N-CA-C 106.126 -1.805 . . . . 0.0 106.126 -176.869 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 40.9 mm -129.18 127.3 65.45 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.609 0 N-CA-C 107.325 -1.361 . . . . 0.0 107.325 -169.916 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 15.0 m -87.37 131.19 34.37 Favored 'General case' 0 N--CA 1.436 -1.159 0 N-CA-C 105.96 -1.867 . . . . 0.0 105.96 168.235 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 90.6 mt -88.71 -11.67 44.5 Favored 'General case' 0 C--N 1.331 -0.208 0 O-C-N 122.026 -0.421 . . . . 0.0 110.617 172.004 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -167.23 148.85 5.81 Favored 'General case' 0 N--CA 1.447 -0.618 0 C-N-CA 126.633 1.973 . . . . 0.0 107.339 168.385 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 72.37 167.79 10.51 Favored Glycine 0 CA--C 1.535 1.338 0 C-N-CA 124.849 1.214 . . . . 0.0 114.452 174.009 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 41.9 m -141.38 111.09 6.51 Favored 'General case' 0 CA--C 1.532 0.262 0 N-CA-C 107.454 -1.313 . . . . 0.0 107.454 178.936 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 60.23 30.94 71.96 Favored Glycine 0 CA--C 1.535 1.304 0 N-CA-C 111.567 -0.613 . . . . 0.0 111.567 -174.747 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 10.4 p -67.4 -51.71 49.52 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.563 0 C-N-CA 123.882 0.873 . . . . 0.0 111.493 -169.182 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 16.1 t-20 -154.4 41.61 0.49 Allowed 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 125.32 1.448 . . . . 0.0 107.128 173.04 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 2.3 tt -147.59 141.12 15.39 Favored Pre-proline 0 CA--C 1.542 0.641 0 C-N-CA 125.934 1.693 . . . . 0.0 107.85 -169.351 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 32.9 Cg_exo -68.18 149.94 76.57 Favored 'Trans proline' 0 C--N 1.355 0.885 0 CA-C-N 120.742 1.301 . . . . 0.0 114.272 -169.837 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -69.53 -29.05 25.58 Favored 'Trans proline' 0 C--N 1.347 0.455 0 C-N-CA 122.464 2.11 . . . . 0.0 114.292 -169.873 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -61.22 -18.36 57.93 Favored 'General case' 0 CA--C 1.538 0.492 0 CA-C-N 119.738 1.154 . . . . 0.0 112.081 -178.866 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 97.9 m95 -75.83 -49.37 18.2 Favored 'General case' 0 N--CA 1.449 -0.522 0 C-N-CA 123.628 0.771 . . . . 0.0 110.583 177.739 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 33.5 m -77.02 1.07 2.2 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.44 0 C-N-CA 123.13 0.572 . . . . 0.0 112.421 -178.647 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 81.3 p -111.47 19.57 18.06 Favored 'General case' 0 CA--C 1.537 0.458 0 N-CA-C 114.302 1.223 . . . . 0.0 114.302 175.464 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 87.4 mm-40 -67.54 174.61 3.33 Favored 'General case' 0 CA--C 1.539 0.544 0 CA-C-N 119.16 0.891 . . . . 0.0 112.445 178.158 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 29.7 mm-40 -51.91 -32.23 31.87 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 124.711 1.204 . . . . 0.0 112.334 -169.056 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 5.3 tt -131.71 130.85 62.24 Favored 'Isoleucine or valine' 0 C--O 1.24 0.557 0 N-CA-C 103.92 -2.622 . . . . 0.0 103.92 168.017 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 40.9 t80 -120.47 141.18 50.42 Favored 'General case' 0 N--CA 1.444 -0.738 0 N-CA-C 106.061 -1.829 . . . . 0.0 106.061 169.27 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 31.2 mm-40 -139.68 144.8 37.76 Favored 'General case' 0 C--O 1.237 0.408 0 N-CA-C 106.204 -1.776 . . . . 0.0 106.204 169.632 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 7.1 t0 -119.8 103.45 9.37 Favored 'General case' 0 C--O 1.237 0.443 0 N-CA-C 104.746 -2.316 . . . . 0.0 104.746 169.247 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 4.2 m95 -86.15 134.22 33.81 Favored 'General case' 0 N--CA 1.453 -0.278 0 CA-C-O 120.683 0.278 . . . . 0.0 110.928 -169.62 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 66.5 tt0 -81.89 99.71 9.21 Favored 'General case' 0 C--O 1.236 0.383 0 N-CA-C 103.568 -2.753 . . . . 0.0 103.568 168.712 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.401 HD13 HG22 ' A' ' 119' ' ' VAL . 11.1 mt -129.62 133.17 46.99 Favored 'General case' 0 CA--C 1.52 -0.196 0 N-CA-C 107.477 -1.305 . . . . 0.0 107.477 178.622 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 -76.74 165.0 25.33 Favored 'General case' 0 N--CA 1.452 -0.366 0 C-N-CA 124.902 1.281 . . . . 0.0 108.323 169.803 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 15.3 t70 -140.66 139.72 20.71 Favored Pre-proline 0 CA--C 1.536 0.439 0 C-N-CA 123.872 0.869 . . . . 0.0 110.142 -177.511 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 42.4 Cg_endo -84.83 0.92 8.82 Favored 'Trans proline' 0 CA--C 1.544 0.977 0 C-N-CA 123.149 2.566 . . . . 0.0 114.405 -172.8 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 3.2 t70 -48.76 120.0 3.52 Favored 'General case' 0 N--CA 1.468 0.428 0 CA-C-N 120.517 1.508 . . . . 0.0 110.926 177.623 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 67.87 4.73 35.49 Favored Glycine 0 CA--C 1.536 1.383 0 CA-C-O 118.723 -1.043 . . . . 0.0 114.777 179.076 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 6.3 mt-30 -94.45 171.14 8.99 Favored 'General case' 0 CA--C 1.538 0.509 0 CA-C-N 119.31 1.555 . . . . 0.0 110.424 -178.612 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 14.6 m -68.47 159.61 31.36 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 124.321 1.048 . . . . 0.0 110.599 178.083 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 13.8 tp -60.06 -32.0 70.52 Favored 'General case' 0 N--CA 1.467 0.417 0 C-N-CA 123.888 0.875 . . . . 0.0 112.127 -170.055 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 5.3 pt-20 -53.85 -35.76 61.86 Favored 'General case' 0 N--CA 1.467 0.418 0 C-N-CA 126.016 1.726 . . . . 0.0 112.137 176.095 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 38.3 t -70.81 -37.86 70.37 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.258 0 N-CA-C 109.083 -0.71 . . . . 0.0 109.083 -174.008 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 91.8 m-85 -56.74 -50.35 72.5 Favored 'General case' 0 N--CA 1.462 0.126 0 CA-C-N 119.346 0.975 . . . . 0.0 110.806 172.563 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -66.34 -38.09 86.86 Favored 'General case' 0 N--CA 1.473 0.699 0 N-CA-C 109.766 -0.457 . . . . 0.0 109.766 -174.992 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 4.0 m -60.85 -49.64 76.66 Favored 'General case' 0 N--CA 1.451 -0.42 0 C-N-CA 124.704 1.201 . . . . 0.0 109.984 173.681 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 76.7 t -69.59 -25.84 29.62 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.229 0 CA-C-O 117.812 -1.089 . . . . 0.0 109.944 -171.829 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 11.9 mtm105 -57.15 -49.07 77.07 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 120.142 1.337 . . . . 0.0 109.729 169.839 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -63.35 -48.47 78.54 Favored Glycine 0 CA--C 1.527 0.84 0 CA-C-N 118.608 0.64 . . . . 0.0 111.951 -179.52 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 12.8 mt-30 -60.74 -46.15 91.52 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-N 117.719 0.759 . . . . 0.0 110.77 -179.188 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . 0.401 HG22 HD13 ' A' ' 101' ' ' LEU . 82.6 t -70.68 -40.67 77.27 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-O 118.424 -0.798 . . . . 0.0 110.297 -175.84 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 85.9 tttt -52.69 -47.26 67.33 Favored 'General case' 0 C--O 1.223 -0.322 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 175.688 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 40.2 tt0 -64.58 -42.63 95.49 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-O 119.245 -0.407 . . . . 0.0 111.253 -175.134 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 35.3 mmt180 -60.21 -47.46 85.86 Favored 'General case' 0 N--CA 1.472 0.635 0 CA-C-N 118.882 0.765 . . . . 0.0 110.434 175.893 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 89.8 t -69.94 -37.78 73.7 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.525 0 N-CA-C 109.563 -0.532 . . . . 0.0 109.563 -175.274 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 35.4 mt-10 -59.96 -44.44 94.42 Favored 'General case' 0 C--O 1.227 -0.097 0 CA-C-N 119.657 1.117 . . . . 0.0 110.049 174.165 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 28.7 t-20 -63.26 -44.55 94.84 Favored 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 122.693 0.397 . . . . 0.0 110.834 -178.564 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 41.8 tp -58.73 -48.53 80.85 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 124.335 1.054 . . . . 0.0 111.104 175.97 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 65.4 mt -62.79 -47.1 94.48 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.149 0 N-CA-C 107.865 -1.161 . . . . 0.0 107.865 -179.999 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -58.85 -27.65 65.34 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 123.095 0.558 . . . . 0.0 112.436 178.11 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 89.4 mttt -72.03 -57.43 4.29 Favored 'General case' 0 C--N 1.343 0.325 0 CA-C-N 119.153 0.888 . . . . 0.0 110.616 171.604 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 13.2 pt -76.14 -36.23 30.31 Favored 'Isoleucine or valine' 0 C--O 1.235 0.293 0 N-CA-C 115.184 1.55 . . . . 0.0 115.184 -168.943 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 69.2 m . . . . . 0 C--O 1.252 1.229 0 C-N-CA 125.707 1.603 . . . . 0.0 109.606 -169.881 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 19.5 mmm . . . . . 0 N--CA 1.499 1.997 0 N-CA-C 110.936 -0.024 . . . . 0.0 110.936 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 31.0 mttm -79.43 117.81 20.73 Favored 'General case' 0 N--CA 1.477 0.895 0 N-CA-C 105.407 -2.071 . . . . 0.0 105.407 169.545 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 74.5 mttt -83.43 133.67 34.91 Favored 'General case' 0 CA--C 1.514 -0.414 0 CA-C-N 120.252 1.387 . . . . 0.0 107.997 179.324 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 1.5 t -118.78 147.94 21.98 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.583 0 C-N-CA 126.725 2.01 . . . . 0.0 106.711 -169.635 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 49.7 ttm -142.8 142.04 31.78 Favored 'General case' 0 C--N 1.325 -0.484 0 C-N-CA 123.71 0.804 . . . . 0.0 109.343 172.191 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 97.0 m-85 -132.64 122.06 24.12 Favored 'General case' 0 CA--C 1.511 -0.551 0 N-CA-C 104.987 -2.227 . . . . 0.0 104.987 179.855 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 1.6 p -154.07 119.78 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.397 0 C-N-CA 119.566 -0.854 . . . . 0.0 109.412 -169.515 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 51.1 t -98.75 178.43 4.98 Favored 'General case' 0 CA--C 1.541 0.623 0 N-CA-C 106.971 -1.492 . . . . 0.0 106.971 168.915 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -52.4 -42.19 63.83 Favored 'General case' 0 N--CA 1.473 0.707 0 O-C-N 121.624 -0.673 . . . . 0.0 110.803 178.662 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 66.2 mtp180 -108.94 145.45 35.41 Favored 'General case' 0 CA--C 1.521 -0.156 0 N-CA-C 108.978 -0.749 . . . . 0.0 108.978 169.852 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 7.4 t30 -55.04 -38.01 67.42 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 124.363 1.065 . . . . 0.0 111.112 169.372 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 1.4 m -68.71 -15.0 63.38 Favored 'General case' 0 CA--C 1.533 0.307 0 N-CA-C 114.667 1.358 . . . . 0.0 114.667 -169.557 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 52.3 m -124.69 139.43 53.86 Favored 'General case' 0 C--O 1.223 -0.309 0 C-N-CA 123.97 0.908 . . . . 0.0 110.311 -169.09 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 6.4 mpt_? 59.14 -60.97 0.04 OUTLIER 'General case' 0 N--CA 1.481 1.112 0 C-N-CA 127.605 2.362 . . . . 0.0 114.066 -174.737 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -44.72 -36.91 3.39 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 126.499 1.919 . . . . 0.0 109.624 170.001 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 23.8 tt0 -25.63 -61.91 0.07 Allowed 'General case' 0 C--O 1.22 -0.486 0 C-N-CA 130.686 3.595 . . . . 0.0 111.772 168.848 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -98.68 -29.87 12.78 Favored 'General case' 0 CA--C 1.516 -0.345 0 CA-C-N 119.719 1.145 . . . . 0.0 113.434 177.501 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -61.09 -48.55 81.18 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 111.993 0.368 . . . . 0.0 111.993 -169.321 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -68.74 -30.62 69.28 Favored 'General case' 0 N--CA 1.463 0.177 0 C-N-CA 120.237 -0.585 . . . . 0.0 109.645 176.767 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -54.81 -57.3 18.55 Favored Glycine 0 C--N 1.34 0.781 0 C-N-CA 125.405 1.478 . . . . 0.0 110.099 176.812 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 8.7 m-85 -67.89 -32.18 72.48 Favored 'General case' 0 CA--C 1.503 -0.835 0 O-C-N 121.659 -0.906 . . . . 0.0 111.981 179.982 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -65.82 -34.74 78.85 Favored 'General case' 0 N--CA 1.447 -0.585 0 C-N-CA 119.431 -0.908 . . . . 0.0 111.141 -175.452 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -68.1 -24.23 65.01 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-N 119.436 1.016 . . . . 0.0 112.036 175.037 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 2.1 m -82.11 -56.12 4.13 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 125.223 1.409 . . . . 0.0 110.438 -179.993 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 72.3 mt -76.37 -34.97 58.91 Favored 'General case' 0 C--N 1.329 -0.283 0 C-N-CA 124.631 1.172 . . . . 0.0 110.258 -172.529 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -92.57 7.13 77.69 Favored Glycine 0 CA--C 1.526 0.758 0 C-N-CA 125.282 1.42 . . . . 0.0 113.198 -177.292 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -52.52 124.18 12.93 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 124.448 1.099 . . . . 0.0 110.002 -176.01 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 75.44 1.95 66.74 Favored Glycine 0 CA--C 1.535 1.288 0 CA-C-O 118.835 -0.981 . . . . 0.0 114.406 179.074 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 64.0 mttm -113.36 -43.06 3.39 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-N 119.294 1.547 . . . . 0.0 111.359 178.828 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 20.4 pt -140.94 151.41 20.2 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.604 0 C-N-CA 123.805 0.842 . . . . 0.0 110.388 -169.36 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -108.66 103.25 12.31 Favored 'General case' 0 N--CA 1.467 0.393 0 C-N-CA 125.37 1.468 . . . . 0.0 109.646 -173.209 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 20.8 t -81.31 135.84 24.28 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 179.604 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 4.8 m -140.68 111.51 6.99 Favored 'General case' 0 N--CA 1.445 -0.678 0 N-CA-C 104.492 -2.41 . . . . 0.0 104.492 169.513 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 75.0 m -114.31 91.97 3.81 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 107.64 -1.245 . . . . 0.0 107.64 178.739 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 5.0 p -63.69 -62.38 1.7 Allowed 'General case' 0 C--O 1.233 0.215 0 C-N-CA 126.408 1.883 . . . . 0.0 112.044 -173.071 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 107.88 137.63 8.36 Favored Glycine 0 CA--C 1.527 0.786 0 N-CA-C 109.157 -1.577 . . . . 0.0 109.157 -174.425 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 12.8 mt -80.08 -40.44 27.6 Favored 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 124.395 1.078 . . . . 0.0 108.874 170.207 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 33.5 mt-10 -139.87 170.16 16.38 Favored 'General case' 0 C--O 1.239 0.523 0 C-N-CA 128.143 2.577 . . . . 0.0 107.629 172.914 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 13.2 m 64.75 -168.17 0.21 Allowed 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 124.837 1.255 . . . . 0.0 112.315 -177.487 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 36.8 p -162.55 -47.66 0.04 OUTLIER 'General case' 0 C--O 1.232 0.184 0 N-CA-C 112.442 0.534 . . . . 0.0 112.442 -167.067 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 2.0 ttp-105 -108.87 -167.5 1.23 Allowed 'General case' 0 CA--C 1.52 -0.19 0 C-N-CA 125.498 1.519 . . . . 0.0 109.227 177.766 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 34.2 m -127.32 168.94 19.53 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 C-N-CA 125.506 1.523 . . . . 0.0 109.838 -171.757 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 37.4 m80 -71.59 148.1 92.67 Favored Pre-proline 0 CA--C 1.548 0.889 0 C-N-CA 123.313 0.645 . . . . 0.0 109.694 177.975 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -62.39 -50.74 4.14 Favored 'Trans proline' 0 C--N 1.348 0.529 0 C-N-CA 123.818 3.012 . . . . 0.0 114.806 -168.632 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 11.5 m -63.88 -22.69 67.03 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-N 118.211 0.459 . . . . 0.0 110.61 -175.678 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.415 ' HB1' HD11 ' A' ' 57' ' ' ILE . . . -55.12 -55.33 32.32 Favored 'General case' 0 CA--C 1.511 -0.546 0 C-N-CA 122.765 0.426 . . . . 0.0 109.911 174.152 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 56.3 mt -60.54 -38.04 76.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 N-CA-C 108.554 -0.906 . . . . 0.0 108.554 -170.635 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -62.94 -48.19 79.98 Favored 'General case' 0 N--CA 1.451 -0.379 0 CA-C-N 118.471 0.578 . . . . 0.0 111.07 177.778 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 27.8 mmt -66.73 -36.54 82.71 Favored 'General case' 0 C--O 1.238 0.488 0 CA-C-O 122.78 1.276 . . . . 0.0 111.071 -179.748 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -75.98 -31.23 58.88 Favored 'General case' 0 N--CA 1.441 -0.878 0 N-CA-C 107.183 -1.414 . . . . 0.0 107.183 -174.777 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 41.0 tt0 -71.28 -21.77 62.04 Favored 'General case' 0 N--CA 1.446 -0.63 0 C-N-CA 124.138 0.975 . . . . 0.0 110.426 171.031 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 20.0 mm-40 -67.57 -31.0 70.77 Favored 'General case' 0 CA--C 1.534 0.359 0 CA-C-N 119.508 1.049 . . . . 0.0 110.141 170.814 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . 0.28 7.2 p -90.39 8.62 3.53 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.983 0 CA-C-N 118.633 0.652 . . . . 0.0 111.482 169.062 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 75.73 18.59 79.6 Favored Glycine 0 CA--C 1.533 1.162 0 C-N-CA 124.678 1.133 . . . . 0.0 113.746 174.908 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 21.6 mt -111.35 134.81 52.5 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.23 0 C-N-CA 124.559 1.143 . . . . 0.0 109.379 -177.234 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 28.7 t0 -99.52 141.53 32.19 Favored 'General case' 0 C--O 1.235 0.323 0 N-CA-C 108.288 -1.005 . . . . 0.0 108.288 168.952 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.415 HD11 ' HB1' ' A' ' 46' ' ' ALA . 8.8 pt -131.15 -15.67 1.58 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.503 0 C-N-CA 126.335 1.854 . . . . 0.0 111.298 -174.135 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 1.2 t -57.2 163.48 2.14 Favored 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 124.544 1.138 . . . . 0.0 109.86 168.342 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 57.73 32.6 65.82 Favored Glycine 0 CA--C 1.532 1.106 0 C-N-CA 123.543 0.592 . . . . 0.0 112.129 179.177 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 4.3 tt0 -65.5 -39.41 91.82 Favored 'General case' 0 C--N 1.341 0.214 0 N-CA-C 113.957 1.095 . . . . 0.0 113.957 -169.135 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 7.0 t -76.19 177.82 6.9 Favored 'General case' 0 N--CA 1.449 -0.518 0 CA-C-O 122.557 1.17 . . . . 0.0 110.555 -169.646 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 13.3 p -155.72 -54.1 0.09 Allowed 'General case' 0 C--N 1.324 -0.515 0 C-N-CA 125.213 1.405 . . . . 0.0 108.327 -171.25 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -151.88 155.89 33.95 Favored Pre-proline 0 C--O 1.239 0.521 0 C-N-CA 127.628 2.371 . . . . 0.0 106.173 169.955 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -59.84 148.81 86.85 Favored 'Trans proline' 0 N--CA 1.457 -0.654 0 C-N-CA 121.801 1.668 . . . . 0.0 108.991 169.411 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 20.6 tt -55.24 -29.62 23.44 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.352 0 C-N-CA 123.12 0.568 . . . . 0.0 112.364 -174.181 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 9.0 mt-10 -65.73 -29.62 70.17 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 123.233 0.613 . . . . 0.0 111.026 -173.234 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 88.3 m-20 -77.93 -8.98 58.84 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 124.002 0.921 . . . . 0.0 112.273 -177.796 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 61.8 m-85 -95.53 162.24 13.72 Favored 'General case' 0 C--O 1.236 0.352 0 C-N-CA 124.286 1.034 . . . . 0.0 111.321 176.836 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 40.9 t-20 -99.47 127.32 45.52 Favored 'General case' 0 N--CA 1.447 -0.62 0 N-CA-C 107.431 -1.322 . . . . 0.0 107.431 168.875 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.415 ' HB2' ' CE2' ' A' ' 90' ' ' TRP . . . -73.3 -26.28 61.01 Favored 'General case' 0 N--CA 1.434 -1.266 0 N-CA-C 109.466 -0.568 . . . . 0.0 109.466 -178.252 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -63.85 -22.47 66.93 Favored 'General case' 0 N--CA 1.443 -0.798 0 CA-C-N 116.528 -0.306 . . . . 0.0 111.582 -178.347 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -74.02 -24.64 59.58 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 123.058 0.543 . . . . 0.0 111.991 178.851 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 34.4 m-85 -85.85 145.67 27.09 Favored 'General case' 0 N--CA 1.451 -0.394 0 C-N-CA 124.974 1.31 . . . . 0.0 111.5 -176.534 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 27.3 t70 -98.66 -32.69 11.28 Favored 'General case' 0 N--CA 1.466 0.357 0 C-N-CA 123.506 0.722 . . . . 0.0 111.032 -179.844 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -140.19 134.66 36.13 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.393 0 C-N-CA 124.376 1.071 . . . . 0.0 109.119 -175.792 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 94.2 t -144.1 139.49 24.77 Favored 'Isoleucine or valine' 0 C--O 1.237 0.396 0 N-CA-C 107.165 -1.42 . . . . 0.0 107.165 -178.822 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.598 HD12 ' HB2' ' A' ' 97' ' ' GLU . 19.0 mm -123.06 124.4 70.11 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.601 0 N-CA-C 106.589 -1.634 . . . . 0.0 106.589 -179.357 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 28.2 m -95.4 105.87 17.88 Favored 'General case' 0 N--CA 1.448 -0.555 0 N-CA-C 103.66 -2.718 . . . . 0.0 103.66 169.321 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 29.4 mt -76.21 -4.76 43.58 Favored 'General case' 0 N--CA 1.463 0.219 0 N-CA-C 114.273 1.212 . . . . 0.0 114.273 -169.364 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 73.2 m -146.13 71.77 1.27 Allowed 'General case' 0 N--CA 1.451 -0.391 0 CA-C-N 118.795 0.725 . . . . 0.0 109.168 -169.761 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 91.05 178.79 43.18 Favored Glycine 0 CA--C 1.53 0.979 0 C-N-CA 124.484 1.04 . . . . 0.0 111.031 -177.009 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 15.0 p -89.79 -92.95 0.12 Allowed 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 123.643 0.777 . . . . 0.0 111.087 -169.533 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -79.52 -41.67 12.85 Favored Glycine 0 C--N 1.338 0.665 0 CA-C-O 119.058 -0.856 . . . . 0.0 111.06 176.885 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . 0.317 4.7 m 44.13 -94.41 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.543 0.698 0 C-N-CA 126.063 1.745 . . . . 0.0 113.704 174.833 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 57.3 t30 -141.13 43.42 1.79 Allowed 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 125.129 1.372 . . . . 0.0 109.111 177.131 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -133.72 139.27 33.1 Favored Pre-proline 0 CA--C 1.541 0.623 0 C-N-CA 127.247 2.219 . . . . 0.0 107.316 -171.642 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 39.6 Cg_exo -65.36 137.84 52.91 Favored 'Trans proline' 0 CA--C 1.539 0.748 0 C-N-CA 121.386 1.391 . . . . 0.0 111.965 -176.124 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 65.1 Cg_endo -68.88 -15.53 40.44 Favored 'Trans proline' 0 N--CA 1.46 -0.472 0 C-N-CA 122.616 2.211 . . . . 0.0 113.513 -173.644 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -59.54 -14.74 14.21 Favored 'General case' 0 CA--C 1.541 0.625 0 CA-C-N 120.315 1.416 . . . . 0.0 111.966 170.425 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' TRP . . . . . 0.415 ' CE2' ' HB2' ' A' ' 70' ' ' ALA . 99.8 m95 -96.56 -11.36 25.49 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 125.215 1.406 . . . . 0.0 113.563 174.683 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.403 ' HA ' ' CD1' ' A' ' 96' ' ' PHE . 3.9 m -92.42 0.75 9.42 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.355 0 CA-C-N 120.261 1.392 . . . . 0.0 111.477 174.745 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 63.6 p -117.88 15.66 14.32 Favored 'General case' 0 C--O 1.237 0.406 0 N-CA-C 116.872 2.175 . . . . 0.0 116.872 -169.455 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 17.6 mp0 -66.51 173.87 3.1 Favored 'General case' 0 CA--C 1.54 0.587 0 CA-C-N 118.852 0.751 . . . . 0.0 111.016 176.284 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 33.3 mm-40 -56.67 -27.06 57.98 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 123.691 0.796 . . . . 0.0 111.268 -172.353 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 5.0 tt -133.8 131.24 56.41 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.528 0 N-CA-C 104.958 -2.238 . . . . 0.0 104.958 168.361 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . 0.403 ' CD1' ' HA ' ' A' ' 91' ' ' VAL . 40.5 t80 -117.99 135.99 53.81 Favored 'General case' 0 N--CA 1.449 -0.486 0 N-CA-C 106.706 -1.59 . . . . 0.0 106.706 169.739 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . 0.598 ' HB2' HD12 ' A' ' 77' ' ' ILE . 16.4 mm-40 -142.09 165.81 26.44 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-O 121.963 0.887 . . . . 0.0 110.116 174.881 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 3.7 t0 -168.1 134.16 1.95 Allowed 'General case' 0 C--O 1.239 0.516 0 C-N-CA 129.71 3.204 . . . . 0.0 106.108 -172.76 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 6.2 m-90 -144.8 149.04 34.77 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 123.847 0.859 . . . . 0.0 109.72 -171.269 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 7.4 tp-100 -82.56 57.36 3.69 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-O 121.809 0.814 . . . . 0.0 109.589 177.889 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.515 HD13 HG22 ' A' ' 119' ' ' VAL . 66.6 mt -79.22 152.66 30.5 Favored 'General case' 0 CA--C 1.53 0.179 0 N-CA-C 106.526 -1.657 . . . . 0.0 106.526 169.62 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 5.6 pt-20 -119.24 164.55 15.46 Favored 'General case' 0 N--CA 1.456 -0.141 0 C-N-CA 124.936 1.294 . . . . 0.0 110.436 178.623 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 64.4 t0 -97.42 121.28 58.91 Favored Pre-proline 0 CA--C 1.539 0.542 0 C-N-CA 123.739 0.815 . . . . 0.0 108.842 171.375 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 90.2 Cg_endo -70.48 -5.0 15.65 Favored 'Trans proline' 0 CA--C 1.544 1.02 0 C-N-CA 123.792 2.995 . . . . 0.0 113.765 176.18 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -43.28 123.23 2.85 Favored 'General case' 0 C--O 1.238 0.453 0 C-N-CA 126.249 1.82 . . . . 0.0 111.367 -179.506 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 69.5 2.79 36.89 Favored Glycine 0 CA--C 1.533 1.19 0 CA-C-O 118.612 -1.105 . . . . 0.0 114.98 169.759 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 28.8 pt20 -111.62 -167.06 1.13 Allowed 'General case' 0 CA--C 1.536 0.433 0 CA-C-N 119.021 1.41 . . . . 0.0 109.737 171.928 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 2.3 m -68.45 154.43 41.84 Favored 'General case' 0 N--CA 1.453 -0.303 0 N-CA-C 115.699 1.74 . . . . 0.0 115.699 -168.261 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 36.0 tp -55.76 -33.39 64.27 Favored 'General case' 0 N--CA 1.465 0.317 0 C-N-CA 126.349 1.86 . . . . 0.0 111.784 173.722 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -58.12 -34.67 70.47 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 123.544 0.738 . . . . 0.0 110.529 174.711 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 2.8 t -76.47 -40.52 34.53 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.299 0 CA-C-O 118.284 -0.865 . . . . 0.0 109.96 -178.912 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 61.9 m-85 -56.47 -47.27 79.55 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-N 120.122 1.328 . . . . 0.0 109.538 171.4 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 86.7 mtt180 -62.99 -43.16 99.55 Favored 'General case' 0 N--CA 1.466 0.351 0 C-N-CA 122.982 0.513 . . . . 0.0 110.972 179.43 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 6.9 m -64.25 -50.12 69.19 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 124.266 1.027 . . . . 0.0 109.955 179.347 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 75.8 t -68.68 -37.46 77.59 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.365 0 CA-C-N 118.796 0.725 . . . . 0.0 109.056 -173.564 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 46.1 ttp85 -58.22 -44.39 88.17 Favored 'General case' 0 CA--C 1.538 0.483 0 CA-C-N 119.117 0.871 . . . . 0.0 110.329 174.706 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -64.83 -50.24 59.34 Favored Glycine 0 CA--C 1.531 1.07 0 CA-C-N 118.543 0.611 . . . . 0.0 112.204 176.137 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 39.1 mm-40 -58.02 -50.99 71.51 Favored 'General case' 0 N--CA 1.465 0.324 0 C-N-CA 124.213 1.005 . . . . 0.0 110.278 -177.838 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . 0.515 HG22 HD13 ' A' ' 101' ' ' LEU . 98.3 t -67.56 -38.38 80.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-O 118.211 -0.899 . . . . 0.0 110.344 -174.054 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 57.1 tttm -55.0 -44.75 74.8 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 119.451 1.023 . . . . 0.0 109.338 175.551 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -68.48 -43.33 77.16 Favored 'General case' 0 N--CA 1.447 -0.621 0 CA-C-O 119.053 -0.498 . . . . 0.0 111.293 -176.204 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 1.8 mmt-85 -60.34 -46.83 88.51 Favored 'General case' 0 N--CA 1.476 0.841 0 CA-C-N 119.363 0.983 . . . . 0.0 110.604 176.262 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 98.4 t -69.41 -38.57 77.43 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.487 0 N-CA-C 109.101 -0.703 . . . . 0.0 109.101 -177.172 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 15.3 mt-10 -60.38 -45.63 92.86 Favored 'General case' 0 CA--C 1.52 -0.202 0 CA-C-N 119.884 1.22 . . . . 0.0 110.122 175.022 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 29.4 t-20 -62.53 -41.51 98.91 Favored 'General case' 0 CA--C 1.531 0.223 0 C-N-CA 123.25 0.62 . . . . 0.0 110.712 -179.85 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 58.7 tp -60.78 -48.45 81.73 Favored 'General case' 0 N--CA 1.456 -0.148 0 C-N-CA 123.819 0.848 . . . . 0.0 111.261 176.424 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 76.1 mt -63.49 -45.72 97.09 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.292 0 N-CA-C 107.646 -1.242 . . . . 0.0 107.646 179.91 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -59.19 -28.31 66.51 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 123.135 0.574 . . . . 0.0 112.405 177.009 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 72.3 mttt -71.87 -54.22 10.77 Favored 'General case' 0 C--N 1.343 0.309 0 CA-C-N 119.129 0.877 . . . . 0.0 110.726 172.772 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 14.1 pt -79.44 -38.43 19.74 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.332 0 N-CA-C 114.667 1.358 . . . . 0.0 114.667 -169.215 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 73.3 m . . . . . 0 C--O 1.253 1.266 0 C-N-CA 125.967 1.707 . . . . 0.0 109.742 -169.982 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.496 1.834 0 N-CA-C 110.234 -0.284 . . . . 0.0 110.234 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 34.3 mttm -76.56 117.16 17.92 Favored 'General case' 0 N--CA 1.477 0.883 0 N-CA-C 106.021 -1.844 . . . . 0.0 106.021 172.295 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 88.8 mttt -84.92 135.11 34.2 Favored 'General case' 0 CA--C 1.515 -0.387 0 N-CA-C 107.695 -1.224 . . . . 0.0 107.695 179.47 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 1.8 t -120.81 149.51 23.69 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 C-N-CA 125.9 1.68 . . . . 0.0 109.511 -168.493 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 25.9 mtt -139.57 147.47 41.2 Favored 'General case' 0 C--N 1.324 -0.523 0 C-N-CA 124.534 1.133 . . . . 0.0 109.111 169.27 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 72.0 m-85 -133.06 114.33 13.81 Favored 'General case' 0 CA--C 1.517 -0.32 0 N-CA-C 104.343 -2.465 . . . . 0.0 104.343 172.133 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 2.4 p -151.39 137.2 11.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 118.563 0.62 . . . . 0.0 109.758 -169.352 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 19.9 t -117.24 178.43 4.37 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 126.225 1.81 . . . . 0.0 106.323 169.6 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 39.7 ttpt -55.05 -35.08 64.11 Favored 'General case' 0 N--CA 1.475 0.819 0 O-C-N 121.148 -0.97 . . . . 0.0 111.479 179.638 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 33.3 ptt180 -123.55 160.27 27.38 Favored 'General case' 0 N--CA 1.463 0.212 0 C-N-CA 124.868 1.267 . . . . 0.0 108.294 169.628 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 47.6 t30 -71.75 -42.66 66.97 Favored 'General case' 0 N--CA 1.471 0.578 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 170.864 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 1.1 m -52.02 141.45 18.07 Favored 'General case' 0 N--CA 1.453 -0.319 0 C-N-CA 125.696 1.598 . . . . 0.0 110.616 -171.331 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 3.9 m 66.91 -66.65 0.18 Allowed 'General case' 0 C--N 1.327 -0.383 0 C-N-CA 126.315 1.846 . . . . 0.0 114.525 -173.459 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 8.9 tpp180 -82.78 -46.93 12.51 Favored 'General case' 0 N--CA 1.471 0.576 0 N-CA-C 116.464 2.024 . . . . 0.0 116.464 -167.59 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 3.6 m -89.78 4.69 48.95 Favored 'General case' 0 N--CA 1.471 0.596 0 N-CA-C 114.81 1.411 . . . . 0.0 114.81 -169.051 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 28.2 pt20 -68.83 -47.64 65.54 Favored 'General case' 0 C--O 1.224 -0.289 0 O-C-N 120.959 -1.088 . . . . 0.0 113.364 -171.035 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 2.4 tpt -88.06 -34.63 17.9 Favored 'General case' 0 N--CA 1.47 0.527 0 N-CA-C 113.659 0.985 . . . . 0.0 113.659 -169.309 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -61.03 -44.95 96.64 Favored 'General case' 0 N--CA 1.471 0.605 0 N-CA-C 112.88 0.696 . . . . 0.0 112.88 -169.082 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 1.9 pp20? -64.96 -34.51 78.59 Favored 'General case' 0 N--CA 1.464 0.255 0 O-C-N 121.96 -0.463 . . . . 0.0 109.834 176.522 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -52.11 -56.47 16.64 Favored Glycine 0 C--N 1.34 0.753 0 C-N-CA 125.182 1.372 . . . . 0.0 110.623 175.539 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 13.5 m-85 -68.52 -29.89 68.58 Favored 'General case' 0 CA--C 1.508 -0.657 0 O-C-N 121.521 -0.987 . . . . 0.0 112.512 -179.964 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -69.73 -31.93 70.19 Favored 'General case' 0 N--CA 1.452 -0.341 0 CA-C-N 119.52 1.055 . . . . 0.0 111.603 -174.766 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -68.19 -25.56 65.3 Favored 'General case' 0 N--CA 1.474 0.758 0 CA-C-N 119.541 1.064 . . . . 0.0 111.651 172.566 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 3.2 m -82.42 -56.46 3.87 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 124.959 1.304 . . . . 0.0 110.139 -177.592 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 70.7 mt -75.33 -36.42 61.05 Favored 'General case' 0 C--N 1.331 -0.215 0 C-N-CA 124.298 1.039 . . . . 0.0 110.055 -173.83 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -89.96 6.12 82.92 Favored Glycine 0 C--N 1.339 0.715 0 C-N-CA 124.855 1.217 . . . . 0.0 113.152 -177.017 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -50.74 125.28 12.86 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 124.739 1.215 . . . . 0.0 110.321 -175.635 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 76.54 -5.41 45.38 Favored Glycine 0 CA--C 1.534 1.229 0 CA-C-O 118.782 -1.01 . . . . 0.0 114.437 179.41 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 63.2 mttm -107.5 -51.89 2.84 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-N 119.322 1.561 . . . . 0.0 110.226 -179.762 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 26.1 pt -136.36 147.74 27.66 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.295 0 C-N-CA 123.913 0.885 . . . . 0.0 110.066 -169.31 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -109.89 104.26 13.16 Favored 'General case' 0 N--CA 1.463 0.198 0 C-N-CA 125.082 1.353 . . . . 0.0 108.885 -169.871 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 14.6 p -81.09 142.02 14.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 119.51 1.05 . . . . 0.0 109.192 177.003 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 11.6 m -132.15 -49.63 0.94 Allowed 'General case' 0 N--CA 1.455 -0.212 0 C-N-CA 124.216 1.006 . . . . 0.0 110.22 175.633 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 48.1 m 62.69 -27.03 0.06 Allowed 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 127.439 2.296 . . . . 0.0 117.14 176.49 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 5.6 m 54.37 -135.78 1.4 Allowed 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 124.765 1.226 . . . . 0.0 110.804 169.752 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -172.65 170.25 43.35 Favored Glycine 0 C--N 1.336 0.574 0 N-CA-C 108.331 -1.907 . . . . 0.0 108.331 178.289 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 34.2 mt -118.28 -43.31 2.73 Favored 'General case' 0 N--CA 1.451 -0.398 0 C-N-CA 125.353 1.461 . . . . 0.0 109.084 179.833 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 36.6 mt-10 -140.45 -59.3 0.53 Allowed 'General case' 0 C--O 1.233 0.192 0 N-CA-C 101.687 -3.449 . . . . 0.0 101.687 169.605 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 17.1 m 57.39 177.88 0.05 OUTLIER 'General case' 0 N--CA 1.447 -0.582 0 C-N-CA 127.291 2.236 . . . . 0.0 116.702 167.263 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 4.4 m -162.51 175.38 11.52 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 128.233 2.613 . . . . 0.0 106.089 -169.491 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 11.4 ptt180 -91.72 174.08 7.54 Favored 'General case' 0 N--CA 1.469 0.503 0 O-C-N 121.022 -1.049 . . . . 0.0 109.607 178.618 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 15.9 m -74.94 176.11 0.67 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.64 0 C-N-CA 123.701 0.8 . . . . 0.0 111.219 -176.415 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 26.0 m-70 -88.02 152.2 50.47 Favored Pre-proline 0 CA--C 1.54 0.596 0 C-N-CA 123.8 0.84 . . . . 0.0 109.995 -175.999 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -63.47 -47.29 7.79 Favored 'Trans proline' 0 C--N 1.347 0.49 0 C-N-CA 122.956 2.438 . . . . 0.0 112.612 -172.636 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 4.4 m -68.21 -25.83 65.41 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-O 119.247 -0.406 . . . . 0.0 110.3 -178.391 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -56.91 -53.4 58.37 Favored 'General case' 0 CA--C 1.51 -0.595 0 N-CA-C 108.99 -0.744 . . . . 0.0 108.99 175.048 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 63.9 mt -60.51 -38.09 76.99 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 N-CA-C 109.054 -0.721 . . . . 0.0 109.054 -172.562 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -63.86 -46.74 83.63 Favored 'General case' 0 CA--C 1.536 0.425 0 CA-C-N 119.041 0.837 . . . . 0.0 111.007 179.869 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 37.6 mmt -71.18 -34.7 71.16 Favored 'General case' 0 CA--C 1.539 0.523 0 CA-C-O 123.546 1.641 . . . . 0.0 110.366 -178.376 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -74.82 -31.61 61.73 Favored 'General case' 0 N--CA 1.443 -0.825 0 N-CA-C 106.886 -1.524 . . . . 0.0 106.886 -177.796 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 -70.76 -20.41 62.63 Favored 'General case' 0 N--CA 1.45 -0.453 0 C-N-CA 124.347 1.059 . . . . 0.0 110.305 169.661 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 77.3 mt-10 -62.55 -38.76 91.28 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-N 119.958 1.254 . . . . 0.0 109.306 169.244 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 17.1 m -86.92 10.25 1.6 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.724 0 N-CA-C 113.168 0.803 . . . . 0.0 113.168 169.933 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 70.55 15.48 73.17 Favored Glycine 0 CA--C 1.532 1.114 0 C-N-CA 124.621 1.105 . . . . 0.0 113.803 177.115 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 4.8 mt -91.6 143.54 11.08 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.259 0 C-N-CA 124.425 1.09 . . . . 0.0 111.372 -172.707 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 3.4 t70 -90.84 131.84 36.24 Favored 'General case' 0 C--O 1.234 0.247 0 C-N-CA 126.04 1.736 . . . . 0.0 108.851 169.352 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 7.2 pt -140.41 -27.03 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.874 0 C-N-CA 124.661 1.184 . . . . 0.0 110.371 168.863 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -38.78 138.26 0.55 Allowed 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 128.31 2.644 . . . . 0.0 111.453 168.964 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 62.72 34.67 90.34 Favored Glycine 0 CA--C 1.533 1.21 0 CA-C-O 119.661 -0.522 . . . . 0.0 112.655 175.002 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 5.4 tt0 -57.24 -35.74 70.07 Favored 'General case' 0 C--N 1.344 0.346 0 C-N-CA 123.781 0.832 . . . . 0.0 112.83 -175.422 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -69.07 139.34 54.84 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 124.56 1.144 . . . . 0.0 110.518 -169.611 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 9.9 p -141.43 -67.78 0.4 Allowed 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 123.605 0.762 . . . . 0.0 110.624 -170.622 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -147.33 155.93 46.17 Favored Pre-proline 0 C--O 1.239 0.513 0 C-N-CA 125.484 1.513 . . . . 0.0 108.798 -176.852 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -66.06 152.54 81.03 Favored 'Trans proline' 0 N--CA 1.455 -0.782 0 C-N-CA 121.991 1.794 . . . . 0.0 109.617 171.224 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 3.8 tt -62.58 -23.57 32.92 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.545 0 C-N-CA 123.745 0.818 . . . . 0.0 110.811 -177.626 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 24.0 tt0 -67.7 -25.08 65.49 Favored 'General case' 0 N--CA 1.438 -1.075 0 C-N-CA 126.546 1.938 . . . . 0.0 110.658 -179.111 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 9.0 t-20 -63.43 -23.64 67.49 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 124.567 1.147 . . . . 0.0 112.103 176.385 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 40.5 m-85 -106.03 -168.39 1.43 Allowed 'General case' 0 C--O 1.236 0.363 0 C-N-CA 126.573 1.949 . . . . 0.0 109.305 -176.394 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 55.5 t-20 -139.44 139.74 37.13 Favored 'General case' 0 N--CA 1.447 -0.616 0 N-CA-C 106.836 -1.542 . . . . 0.0 106.836 169.251 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -71.45 -25.31 62.25 Favored 'General case' 0 N--CA 1.434 -1.236 0 C-N-CA 119.749 -0.78 . . . . 0.0 109.516 -178.821 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 35.5 t70 -64.8 -24.84 67.68 Favored 'General case' 0 N--CA 1.445 -0.686 0 O-C-N 123.505 0.503 . . . . 0.0 112.022 -179.575 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -78.05 -29.01 49.08 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 123.38 0.672 . . . . 0.0 111.426 174.411 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 13.1 m-85 -79.24 166.06 22.57 Favored 'General case' 0 N--CA 1.451 -0.394 0 C-N-CA 125.582 1.553 . . . . 0.0 111.126 178.855 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -118.25 -34.41 4.09 Favored 'General case' 0 N--CA 1.466 0.348 0 C-N-CA 123.022 0.529 . . . . 0.0 111.446 -179.985 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -143.35 136.02 24.57 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.595 0 CA-C-O 121.865 0.841 . . . . 0.0 110.234 -172.151 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 98.9 t -144.02 126.36 11.17 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.593 0 N-CA-C 106.249 -1.76 . . . . 0.0 106.249 -178.583 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.55 HD12 ' HB2' ' A' ' 97' ' ' GLU . 12.6 mm -104.6 124.37 59.13 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.521 0 N-CA-C 105.846 -1.909 . . . . 0.0 105.846 176.108 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 37.0 m -93.46 98.25 11.08 Favored 'General case' 0 N--CA 1.443 -0.807 0 N-CA-C 105.057 -2.201 . . . . 0.0 105.057 169.576 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 85.8 mt -68.54 -2.97 10.03 Favored 'General case' 0 N--CA 1.467 0.391 0 O-C-N 121.51 -0.744 . . . . 0.0 112.283 -176.709 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 64.0 m -138.65 128.4 24.99 Favored 'General case' 0 N--CA 1.443 -0.812 0 N-CA-C 106.134 -1.802 . . . . 0.0 106.134 169.397 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 50.71 -144.4 11.96 Favored Glycine 0 CA--C 1.532 1.133 0 C-N-CA 125.272 1.415 . . . . 0.0 113.515 173.425 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 16.2 m -112.23 -111.52 0.34 Allowed 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 124.652 1.181 . . . . 0.0 107.993 178.832 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -80.61 69.37 3.2 Favored Glycine 0 CA--C 1.527 0.83 0 N-CA-C 109.682 -1.367 . . . . 0.0 109.682 171.087 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 1.3 m -60.04 -50.51 79.9 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.598 0 CA-C-N 117.528 0.664 . . . . 0.0 111.688 -171.689 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 1.5 t30 -154.69 52.48 0.64 Allowed 'General case' 0 N--CA 1.467 0.404 0 N-CA-C 103.845 -2.65 . . . . 0.0 103.845 169.327 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -147.42 139.6 14.09 Favored Pre-proline 0 CA--C 1.536 0.442 0 C-N-CA 125.622 1.569 . . . . 0.0 108.297 -168.36 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -65.96 144.21 75.6 Favored 'Trans proline' 0 C--N 1.351 0.692 0 C-N-CA 121.338 1.358 . . . . 0.0 112.577 -174.669 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_endo -66.48 -26.09 47.71 Favored 'Trans proline' 0 N--CA 1.461 -0.405 0 C-N-CA 122.314 2.009 . . . . 0.0 113.242 -169.848 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 -55.91 -22.46 25.96 Favored 'General case' 0 CA--C 1.537 0.474 0 CA-C-N 118.898 0.772 . . . . 0.0 111.926 178.426 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 85.5 m95 -74.67 -43.64 54.24 Favored 'General case' 0 N--CA 1.445 -0.687 0 C-N-CA 123.504 0.722 . . . . 0.0 112.179 -179.339 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 15.2 m -70.46 -32.98 51.84 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.438 0 CA-C-O 118.398 -0.81 . . . . 0.0 110.109 176.854 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 82.3 p -82.06 29.83 0.4 Allowed 'General case' 0 CA--C 1.538 0.504 0 CA-C-N 120.23 1.377 . . . . 0.0 114.019 -170.01 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 93.0 mm-40 -79.09 -173.78 3.76 Favored 'General case' 0 CA--C 1.539 0.52 0 O-C-N 121.731 -0.605 . . . . 0.0 110.543 172.107 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 29.0 mm-40 -65.04 -14.71 61.12 Favored 'General case' 0 CA--C 1.54 0.577 0 N-CA-C 112.531 0.567 . . . . 0.0 112.531 -169.757 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 6.4 tt -143.72 137.36 24.74 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.496 0 C-N-CA 125.664 1.586 . . . . 0.0 107.177 170.934 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 16.2 t80 -116.98 132.32 56.73 Favored 'General case' 0 CA--C 1.535 0.399 0 N-CA-C 105.385 -2.08 . . . . 0.0 105.385 169.381 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . 0.55 ' HB2' HD12 ' A' ' 77' ' ' ILE . 11.6 mm-40 -142.13 162.83 34.49 Favored 'General case' 0 C--O 1.237 0.418 0 C-N-CA 124.546 1.139 . . . . 0.0 108.522 176.288 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 3.0 t70 -173.96 127.9 0.38 Allowed 'General case' 0 C--O 1.236 0.393 0 C-N-CA 127.11 2.164 . . . . 0.0 107.758 -169.255 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 5.4 m0 -148.65 142.58 25.79 Favored 'General case' 0 N--CA 1.456 -0.133 0 C-N-CA 123.571 0.749 . . . . 0.0 109.019 -170.488 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 86.4 mt-30 -84.21 83.24 8.04 Favored 'General case' 0 CA--C 1.533 0.3 0 N-CA-C 108.399 -0.963 . . . . 0.0 108.399 174.46 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 9.6 mp -67.42 129.05 38.67 Favored 'General case' 0 N--CA 1.466 0.352 0 N-CA-C 106.148 -1.797 . . . . 0.0 106.148 171.132 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 32.4 mt-10 -71.29 -20.83 62.16 Favored 'General case' 0 CA--C 1.536 0.417 0 N-CA-C 113.563 0.949 . . . . 0.0 113.563 -169.279 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 1.6 t70 62.29 124.09 0.02 OUTLIER Pre-proline 0 CA--C 1.552 1.047 0 C-N-CA 127.039 2.136 . . . . 0.0 114.212 -179.7 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 23.7 Cg_endo -88.48 -3.67 6.64 Favored 'Trans proline' 0 N--CA 1.454 -0.809 0 C-N-CA 122.689 2.259 . . . . 0.0 114.488 -178.93 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -53.42 126.51 21.61 Favored 'General case' 0 C--O 1.238 0.457 0 CA-C-N 120.793 1.633 . . . . 0.0 111.152 -172.374 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 71.74 -1.64 28.98 Favored Glycine 0 CA--C 1.534 1.271 0 CA-C-O 118.918 -0.934 . . . . 0.0 113.729 177.238 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 8.2 mt-30 -89.7 171.51 9.6 Favored 'General case' 0 CA--C 1.543 0.689 0 CA-C-N 118.807 1.304 . . . . 0.0 109.159 174.796 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 15.6 m -69.11 163.52 24.61 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 123.658 0.783 . . . . 0.0 111.063 -179.301 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 43.2 mt -63.88 -26.37 68.58 Favored 'General case' 0 N--CA 1.472 0.638 0 O-C-N 121.231 -0.918 . . . . 0.0 112.019 -175.026 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 5.4 pt-20 -56.41 -34.85 67.15 Favored 'General case' 0 N--CA 1.461 0.12 0 C-N-CA 123.322 0.649 . . . . 0.0 111.26 171.935 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 21.4 t -76.82 -41.77 32.9 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.395 0 CA-C-O 118.28 -0.866 . . . . 0.0 109.066 -178.139 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 61.8 m-85 -55.02 -49.6 71.15 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-N 120.002 1.274 . . . . 0.0 109.66 170.384 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 96.2 mtt180 -67.67 -33.14 74.34 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 123.056 0.542 . . . . 0.0 111.214 -175.778 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 3.2 m -65.55 -50.16 66.19 Favored 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 124.222 1.009 . . . . 0.0 109.712 170.977 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 90.1 t -70.25 -26.9 30.24 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.309 0 CA-C-O 118.426 -0.797 . . . . 0.0 109.109 -171.442 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 20.5 mtm105 -56.5 -50.15 72.63 Favored 'General case' 0 C--O 1.223 -0.309 0 CA-C-N 119.462 1.028 . . . . 0.0 109.239 169.569 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -62.09 -46.59 93.7 Favored Glycine 0 CA--C 1.528 0.884 0 CA-C-O 119.539 -0.59 . . . . 0.0 111.898 178.676 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 89.8 mt-30 -57.14 -51.69 68.28 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-N 117.854 0.827 . . . . 0.0 110.268 -179.784 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 95.9 t -68.68 -42.35 83.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-O 118.445 -0.788 . . . . 0.0 109.615 -175.574 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -54.51 -47.24 73.31 Favored 'General case' 0 C--O 1.223 -0.341 0 N-CA-C 108.62 -0.881 . . . . 0.0 108.62 178.355 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 39.9 tt0 -64.91 -42.49 94.7 Favored 'General case' 0 N--CA 1.449 -0.523 0 C-N-CA 122.953 0.501 . . . . 0.0 111.325 -176.358 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 44.4 mtt-85 -65.64 -45.61 82.35 Favored 'General case' 0 N--CA 1.469 0.485 0 O-C-N 121.302 -0.874 . . . . 0.0 111.766 177.19 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 61.3 t -64.94 -37.23 79.7 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.723 0 N-CA-C 109.143 -0.688 . . . . 0.0 109.143 178.092 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 20.9 mt-10 -60.66 -44.58 96.28 Favored 'General case' 0 C--O 1.226 -0.182 0 O-C-N 120.743 -1.223 . . . . 0.0 109.857 174.911 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 27.8 t-20 -65.12 -40.54 94.63 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 123.021 0.528 . . . . 0.0 111.054 -177.925 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 29.3 tp -58.7 -49.58 77.07 Favored 'General case' 0 CA--C 1.53 0.195 0 C-N-CA 124.864 1.266 . . . . 0.0 110.85 173.292 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 63.6 mt -64.72 -46.66 91.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 N-CA-C 107.925 -1.139 . . . . 0.0 107.925 -177.969 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -58.17 -31.82 67.63 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 123.436 0.695 . . . . 0.0 112.109 -178.882 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . 0.258 18.5 ptpt -82.51 -37.89 24.61 Favored 'General case' 0 C--N 1.344 0.341 0 CA-C-O 117.782 -1.104 . . . . 0.0 112.512 177.099 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 12.1 pt -84.08 -38.74 14.15 Favored 'Isoleucine or valine' 0 C--O 1.236 0.35 0 CA-C-N 120.373 1.442 . . . . 0.0 113.967 -176.261 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 68.2 m . . . . . 0 C--O 1.252 1.219 0 C-N-CA 125.644 1.578 . . . . 0.0 110.141 -169.876 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.498 1.964 0 N-CA-C 110.583 -0.155 . . . . 0.0 110.583 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 26.1 mttm -79.77 117.48 20.7 Favored 'General case' 0 N--CA 1.474 0.749 0 N-CA-C 105.71 -1.959 . . . . 0.0 105.71 171.53 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 85.0 mttt -81.84 143.4 31.76 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-N 119.935 1.243 . . . . 0.0 108.499 176.904 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 2.2 t -132.54 145.07 35.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 O-C-N 124.347 1.029 . . . . 0.0 111.058 -169.341 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 12.4 mtt -137.06 145.33 43.85 Favored 'General case' 0 C--N 1.329 -0.291 0 C-N-CA 125.327 1.451 . . . . 0.0 108.957 168.48 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 54.5 m-85 -133.91 117.46 16.8 Favored 'General case' 0 CA--C 1.518 -0.281 0 N-CA-C 104.903 -2.258 . . . . 0.0 104.903 169.915 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 2.2 p -151.67 155.26 7.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-O 121.248 0.547 . . . . 0.0 109.842 -168.848 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 39.9 t -140.94 159.32 42.45 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 105.119 -2.178 . . . . 0.0 105.119 169.266 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 64.8 pttt -56.68 143.92 34.37 Favored 'General case' 0 N--CA 1.467 0.394 0 N-CA-C 109.036 -0.727 . . . . 0.0 109.036 171.838 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 96.6 mtt180 51.44 73.9 0.28 Allowed 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 124.665 1.186 . . . . 0.0 110.136 -169.824 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 10.4 t30 -31.63 -46.41 0.11 Allowed 'General case' 0 N--CA 1.482 1.141 0 C-N-CA 127.523 2.329 . . . . 0.0 115.33 -172.4 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 2.1 m -50.96 -37.79 46.71 Favored 'General case' 0 N--CA 1.45 -0.447 0 C-N-CA 124.164 0.985 . . . . 0.0 111.419 -175.515 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 21.9 m -72.17 122.15 20.52 Favored 'General case' 0 N--CA 1.449 -0.51 0 CA-C-N 119.094 0.861 . . . . 0.0 109.767 173.906 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . 0.334 0.1 OUTLIER 56.01 -24.02 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 130.914 3.686 . . . . 0.0 117.248 177.182 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -74.92 -11.53 60.15 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-N 121.102 1.774 . . . . 0.0 111.417 175.416 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 25.2 pt20 -75.04 30.47 0.09 Allowed 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 125.756 1.622 . . . . 0.0 113.725 174.856 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' MET . . . . . 0.425 ' SD ' ' CD2' ' A' ' 21' ' ' PHE . 0.0 OUTLIER -152.62 -54.24 0.12 Allowed 'General case' 0 C--N 1.329 -0.284 0 O-C-N 120.29 -1.506 . . . . 0.0 112.06 174.837 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -59.44 -47.77 84.21 Favored 'General case' 0 N--CA 1.474 0.725 0 N-CA-C 114.313 1.227 . . . . 0.0 114.313 -169.009 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -65.05 -30.99 71.99 Favored 'General case' 0 N--CA 1.463 0.182 0 O-C-N 121.88 -0.512 . . . . 0.0 110.058 177.7 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -55.15 -59.13 10.93 Favored Glycine 0 C--N 1.337 0.605 0 C-N-CA 125.312 1.434 . . . . 0.0 110.588 173.222 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . 0.425 ' CD2' ' SD ' ' A' ' 17' ' ' MET . 3.3 m-85 -61.98 -32.54 73.0 Favored 'General case' 0 CA--C 1.511 -0.532 0 CA-C-N 118.377 1.088 . . . . 0.0 112.906 175.806 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -63.91 -36.47 84.05 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 119.146 0.884 . . . . 0.0 111.123 -172.418 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -69.03 -24.43 64.19 Favored 'General case' 0 N--CA 1.47 0.571 0 CA-C-N 119.164 0.893 . . . . 0.0 112.274 176.803 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 1.5 m -80.15 -53.22 6.89 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 125.305 1.442 . . . . 0.0 110.45 177.733 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 80.9 mt -74.24 -37.82 63.68 Favored 'General case' 0 N--CA 1.464 0.249 0 C-N-CA 123.648 0.779 . . . . 0.0 110.266 -173.124 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -96.39 14.07 64.81 Favored Glycine 0 CA--C 1.527 0.815 0 C-N-CA 125.175 1.369 . . . . 0.0 112.98 -176.767 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -51.52 123.57 10.18 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 124.743 1.217 . . . . 0.0 110.49 -174.809 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 76.11 -7.89 26.97 Favored Glycine 0 CA--C 1.536 1.356 0 C-N-CA 124.293 0.949 . . . . 0.0 114.382 179.797 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 62.9 mttm -97.62 -49.19 4.96 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-N 119.283 1.541 . . . . 0.0 110.298 179.854 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 17.1 pt -137.28 152.52 27.83 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.328 0 C-N-CA 124.137 0.975 . . . . 0.0 110.067 -169.264 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -112.02 98.66 7.5 Favored 'General case' 0 CA--C 1.521 -0.153 0 C-N-CA 124.584 1.153 . . . . 0.0 109.187 -169.738 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 13.0 p -87.8 134.4 28.0 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.487 0 O-C-N 121.823 -0.548 . . . . 0.0 109.666 178.966 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 20.1 m -150.51 92.45 1.85 Allowed 'General case' 0 N--CA 1.456 -0.143 0 N-CA-C 105.19 -2.152 . . . . 0.0 105.19 172.413 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 53.4 m -95.49 87.01 4.63 Favored 'General case' 0 C--O 1.237 0.396 0 C-N-CA 120.066 -0.654 . . . . 0.0 110.63 -170.057 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 58.8 m -61.19 165.85 4.14 Favored 'General case' 0 CA--C 1.539 0.522 0 CA-C-N 115.322 -0.854 . . . . 0.0 110.07 169.018 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -138.96 -173.84 13.18 Favored Glycine 0 CA--C 1.525 0.702 0 N-CA-C 106.807 -2.517 . . . . 0.0 106.807 -177.721 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 6.4 mt -123.71 -83.51 0.65 Allowed 'General case' 0 N--CA 1.45 -0.465 0 C-N-CA 124.298 1.039 . . . . 0.0 109.048 -169.952 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 3.3 tt0 -69.02 -27.17 65.44 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 122.823 0.449 . . . . 0.0 111.574 176.673 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 1.3 m -144.18 179.45 7.21 Favored 'General case' 0 N--CA 1.463 0.176 0 C-N-CA 126.187 1.795 . . . . 0.0 107.747 177.032 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 3.7 m -166.05 -18.66 0.02 OUTLIER 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 125.301 1.44 . . . . 0.0 112.145 -169.725 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 7.8 ttt180 -100.37 -162.1 0.92 Allowed 'General case' 0 N--CA 1.473 0.709 0 CA-C-N 119.637 1.108 . . . . 0.0 110.207 176.046 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 27.4 m -134.95 173.68 14.1 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.449 0 C-N-CA 125.421 1.489 . . . . 0.0 111.376 -169.988 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 96.7 m-70 -83.65 156.45 65.01 Favored Pre-proline 0 CA--C 1.543 0.698 0 C-N-CA 124.804 1.242 . . . . 0.0 110.299 173.816 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -62.16 -51.47 3.58 Favored 'Trans proline' 0 C--N 1.349 0.575 0 C-N-CA 123.845 3.03 . . . . 0.0 113.426 -173.425 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 6.8 m -65.85 -24.95 66.99 Favored 'General case' 0 CA--C 1.534 0.328 0 O-C-N 121.902 -0.499 . . . . 0.0 110.936 -172.845 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -55.52 -53.31 57.95 Favored 'General case' 0 CA--C 1.508 -0.672 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 173.261 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 69.8 mt -59.83 -40.71 83.43 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.369 0 N-CA-C 108.475 -0.935 . . . . 0.0 108.475 -170.352 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -62.75 -46.76 86.58 Favored 'General case' 0 N--CA 1.449 -0.518 0 CA-C-N 118.488 0.586 . . . . 0.0 111.004 179.924 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 27.9 mmt -67.64 -39.78 84.61 Favored 'General case' 0 C--O 1.238 0.473 0 CA-C-O 122.789 1.281 . . . . 0.0 110.839 -178.65 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 1.2 mmt -74.31 -35.2 63.66 Favored 'General case' 0 N--CA 1.444 -0.772 0 N-CA-C 106.711 -1.588 . . . . 0.0 106.711 -174.875 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 41.7 tt0 -69.98 -23.94 63.24 Favored 'General case' 0 N--CA 1.447 -0.583 0 O-C-N 121.179 -0.951 . . . . 0.0 110.219 173.672 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 10.2 mm-40 -65.74 -29.49 70.01 Favored 'General case' 0 N--CA 1.452 -0.341 0 CA-C-N 118.762 0.71 . . . . 0.0 110.241 173.251 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . 0.29 9.0 m -98.22 16.95 2.85 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.858 0 N-CA-C 112.758 0.651 . . . . 0.0 112.758 169.35 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 84.33 16.21 67.27 Favored Glycine 0 CA--C 1.534 1.275 0 C-N-CA 125.366 1.46 . . . . 0.0 114.636 169.935 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 8.2 mm -97.52 151.59 4.25 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.329 0 C-N-CA 124.736 1.214 . . . . 0.0 111.121 -170.52 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -112.52 126.95 55.89 Favored 'General case' 0 C--O 1.233 0.189 0 N-CA-C 106.051 -1.833 . . . . 0.0 106.051 168.222 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 3.6 pt -128.93 -24.51 1.24 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.481 0 C-N-CA 125.751 1.62 . . . . 0.0 110.353 170.312 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -39.51 -40.38 0.84 Allowed 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 128.177 2.591 . . . . 0.0 112.789 169.163 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -91.24 19.62 45.63 Favored Glycine 0 CA--C 1.531 1.069 0 C-N-CA 125.446 1.498 . . . . 0.0 113.763 -179.166 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 21.2 mt-30 -61.84 -27.62 68.91 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-N 120.152 1.976 . . . . 0.0 112.84 179.78 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -61.92 129.39 40.72 Favored 'General case' 0 N--CA 1.445 -0.678 0 N-CA-C 109.683 -0.488 . . . . 0.0 109.683 -171.562 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 8.5 p -141.61 -70.44 0.36 Allowed 'General case' 0 C--O 1.235 0.31 0 C-N-CA 123.817 0.847 . . . . 0.0 109.452 -173.269 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -157.66 161.34 29.26 Favored Pre-proline 0 CA--C 1.552 1.037 0 C-N-CA 124.952 1.301 . . . . 0.0 109.913 -174.66 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -67.84 28.92 0.13 Allowed 'Trans proline' 0 CA--C 1.552 1.381 0 C-N-CA 125.247 3.964 . . . . 0.0 116.694 173.126 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . 0.256 1.1 tt 64.43 -26.21 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.541 0.619 0 C-N-CA 129.529 3.132 . . . . 0.0 113.989 -169.583 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -68.79 -30.19 68.72 Favored 'General case' 0 N--CA 1.429 -1.516 0 C-N-CA 128.005 2.522 . . . . 0.0 115.407 -169.304 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 26.0 m-80 -68.72 -17.44 64.06 Favored 'General case' 0 C--O 1.236 0.35 0 CA-C-N 118.359 0.527 . . . . 0.0 112.192 -176.419 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 69.8 m-85 -104.76 160.98 14.55 Favored 'General case' 0 CA--C 1.513 -0.447 0 C-N-CA 124.726 1.211 . . . . 0.0 112.015 -176.854 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 48.1 t-20 -95.65 134.13 38.92 Favored 'General case' 0 N--CA 1.439 -0.989 0 N-CA-C 106.107 -1.812 . . . . 0.0 106.107 168.156 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -72.57 -27.67 62.34 Favored 'General case' 0 N--CA 1.436 -1.172 0 N-CA-C 108.845 -0.798 . . . . 0.0 108.845 179.629 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 36.6 t70 -67.0 -21.04 65.97 Favored 'General case' 0 N--CA 1.447 -0.585 0 N-CA-C 111.73 0.27 . . . . 0.0 111.73 -179.168 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 35.7 t70 -72.63 -29.24 63.3 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 122.974 0.509 . . . . 0.0 111.611 175.782 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 17.2 m-85 -77.27 144.51 38.1 Favored 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 123.981 0.912 . . . . 0.0 110.316 179.18 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -93.93 -32.1 14.02 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.724 177.555 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 21.7 t -137.34 130.8 44.15 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.467 0 C-N-CA 123.824 0.85 . . . . 0.0 109.841 -171.307 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 53.7 t -145.48 139.58 21.84 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.419 0 N-CA-C 106.28 -1.748 . . . . 0.0 106.28 174.851 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 36.6 mm -130.63 123.62 55.26 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.537 0 N-CA-C 107.238 -1.393 . . . . 0.0 107.238 -169.859 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 55.3 m -90.49 115.37 27.59 Favored 'General case' 0 N--CA 1.444 -0.732 0 N-CA-C 106.562 -1.644 . . . . 0.0 106.562 169.225 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 68.7 mt -77.72 -7.54 56.66 Favored 'General case' 0 C--N 1.332 -0.191 0 C-N-CA 123.769 0.827 . . . . 0.0 111.418 179.88 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 31.9 p -139.72 132.75 29.5 Favored 'General case' 0 N--CA 1.443 -0.817 0 N-CA-C 106.81 -1.552 . . . . 0.0 106.81 169.632 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 50.68 -155.85 2.84 Favored Glycine 0 CA--C 1.539 1.547 0 C-N-CA 125.579 1.561 . . . . 0.0 115.713 170.067 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 17.4 m -134.52 139.24 45.29 Favored 'General case' 0 C--O 1.235 0.306 0 C-N-CA 125.897 1.679 . . . . 0.0 107.153 177.232 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 74.36 -75.44 1.18 Allowed Glycine 0 C--N 1.335 0.517 0 N-CA-C 110.324 -1.11 . . . . 0.0 110.324 -174.28 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . 0.299 34.7 m 48.12 36.22 0.27 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.792 0 C-N-CA 125.973 1.709 . . . . 0.0 113.401 176.647 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 10.6 t-20 69.99 -0.15 2.86 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 127.679 2.392 . . . . 0.0 113.318 179.061 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.407 ' HA ' ' HD3' ' A' ' 87' ' ' PRO . 0.0 OUTLIER -77.03 148.09 78.01 Favored Pre-proline 0 CA--C 1.548 0.882 0 N-CA-C 107.749 -1.204 . . . . 0.0 107.749 169.524 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . 0.407 ' HD3' ' HA ' ' A' ' 86' ' ' LEU . 34.1 Cg_exo -65.99 142.17 67.38 Favored 'Trans proline' 0 CA--C 1.544 1.013 0 C-N-CA 121.452 1.435 . . . . 0.0 113.0 -174.165 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -67.33 -20.17 49.03 Favored 'Trans proline' 0 C--N 1.344 0.336 0 C-N-CA 123.379 2.719 . . . . 0.0 114.267 -170.592 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 5.4 pm0 -63.04 -18.77 63.71 Favored 'General case' 0 CA--C 1.54 0.562 0 CA-C-N 121.371 1.896 . . . . 0.0 111.547 174.75 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 97.8 m95 -88.33 -5.93 58.03 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 125.414 1.486 . . . . 0.0 112.799 173.728 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 39.9 t -94.23 -9.03 9.66 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.62 0 C-N-CA 124.769 1.228 . . . . 0.0 109.137 173.325 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 73.3 p -119.77 36.94 4.34 Favored 'General case' 0 C--O 1.237 0.404 0 N-CA-C 116.134 1.901 . . . . 0.0 116.134 -169.305 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 12.2 mp0 -71.42 173.71 7.53 Favored 'General case' 0 CA--C 1.535 0.384 0 O-C-N 121.718 -0.614 . . . . 0.0 111.568 173.852 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 33.9 mm-40 -59.93 -28.81 67.93 Favored 'General case' 0 CA--C 1.536 0.432 0 N-CA-C 109.807 -0.442 . . . . 0.0 109.807 177.012 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 4.3 tt -133.62 116.98 25.65 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.56 0 N-CA-C 105.489 -2.041 . . . . 0.0 105.489 168.729 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 62.1 t80 -108.98 145.3 35.73 Favored 'General case' 0 C--O 1.237 0.443 0 N-CA-C 104.534 -2.395 . . . . 0.0 104.534 168.28 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 21.7 mm-40 -134.86 139.74 45.28 Favored 'General case' 0 C--O 1.236 0.379 0 CA-C-N 119.161 0.891 . . . . 0.0 108.691 169.859 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -106.93 113.29 26.69 Favored 'General case' 0 C--O 1.239 0.551 0 N-CA-C 105.609 -1.997 . . . . 0.0 105.609 169.883 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 9.2 m95 -117.47 166.52 12.24 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 124.405 1.082 . . . . 0.0 108.118 169.756 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 24.0 mm-40 -128.33 78.1 1.81 Allowed 'General case' 0 CA--C 1.534 0.36 0 N-CA-C 107.257 -1.386 . . . . 0.0 107.257 174.326 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -77.04 148.46 36.15 Favored 'General case' 0 N--CA 1.467 0.399 0 N-CA-C 109.192 -0.67 . . . . 0.0 109.192 -179.505 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -81.09 168.25 18.83 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 124.514 1.126 . . . . 0.0 108.724 169.765 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -134.14 133.71 22.18 Favored Pre-proline 0 CA--C 1.534 0.334 0 C-N-CA 124.022 0.929 . . . . 0.0 110.975 178.085 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 40.2 Cg_endo -89.87 -2.41 5.65 Favored 'Trans proline' 0 CA--C 1.539 0.772 0 C-N-CA 122.911 2.407 . . . . 0.0 115.22 -174.349 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 24.4 t70 -60.25 128.32 36.14 Favored 'General case' 0 C--O 1.238 0.484 0 CA-C-N 121.347 1.885 . . . . 0.0 110.357 -177.861 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 72.94 -0.3 46.61 Favored Glycine 0 CA--C 1.533 1.163 0 CA-C-O 119.216 -0.769 . . . . 0.0 113.605 179.474 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 17.1 mm-40 -86.2 172.82 10.23 Favored 'General case' 0 C--O 1.238 0.454 0 CA-C-N 118.65 1.225 . . . . 0.0 109.738 174.335 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 16.0 m -69.17 159.53 32.81 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 123.768 0.827 . . . . 0.0 110.868 171.778 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 33.1 tp -56.61 -30.58 63.41 Favored 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 126.153 1.781 . . . . 0.0 113.071 -176.302 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 6.7 pt-20 -56.49 -34.28 66.79 Favored 'General case' 0 CA--C 1.528 0.106 0 C-N-CA 123.817 0.847 . . . . 0.0 111.331 175.563 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 5.1 t -77.61 -39.81 27.44 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.39 0 CA-C-O 118.125 -0.941 . . . . 0.0 110.414 -174.987 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 63.9 m-85 -56.5 -47.98 78.15 Favored 'General case' 0 N--CA 1.473 0.708 0 CA-C-N 120.368 1.44 . . . . 0.0 109.454 170.152 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 86.3 mtt180 -60.87 -42.69 98.38 Favored 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 123.259 0.624 . . . . 0.0 110.909 179.794 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 6.0 m -67.51 -49.42 63.51 Favored 'General case' 0 N--CA 1.447 -0.595 0 C-N-CA 124.696 1.199 . . . . 0.0 110.311 -179.865 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 73.0 t -68.96 -30.02 45.34 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.234 0 CA-C-O 117.813 -1.089 . . . . 0.0 110.223 -169.787 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 32.5 mtm105 -56.84 -47.1 81.11 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-N 120.011 1.278 . . . . 0.0 110.357 169.89 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -62.94 -49.05 75.63 Favored Glycine 0 CA--C 1.527 0.816 0 CA-C-N 118.438 0.563 . . . . 0.0 111.773 179.272 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 17.5 mt-30 -62.01 -44.18 97.27 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-N 117.698 0.749 . . . . 0.0 110.22 -177.914 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 54.6 t -66.19 -45.15 90.88 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.245 0 CA-C-O 118.183 -0.913 . . . . 0.0 109.684 -177.96 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -52.74 -47.79 67.16 Favored 'General case' 0 CA--C 1.516 -0.361 0 CA-C-N 119.094 0.861 . . . . 0.0 109.013 -177.957 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 39.9 tt0 -62.72 -42.79 99.83 Favored 'General case' 0 N--CA 1.447 -0.584 0 O-C-N 123.569 0.543 . . . . 0.0 111.029 -176.052 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 44.7 mtt-85 -67.06 -41.45 86.42 Favored 'General case' 0 N--CA 1.468 0.455 0 O-C-N 121.381 -0.824 . . . . 0.0 111.57 177.85 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 54.0 t -68.92 -38.46 78.61 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.429 0 N-CA-C 109.372 -0.603 . . . . 0.0 109.372 179.463 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 22.1 mt-10 -60.06 -42.09 93.74 Favored 'General case' 0 C--O 1.226 -0.166 0 O-C-N 121.414 -0.804 . . . . 0.0 110.247 174.923 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 29.1 t-20 -64.56 -45.25 87.88 Favored 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 122.735 0.414 . . . . 0.0 111.145 -179.7 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 2.1 tm? -57.19 -49.28 76.49 Favored 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 124.625 1.17 . . . . 0.0 109.992 175.815 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 75.8 mt -63.21 -47.71 91.0 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.141 0 N-CA-C 108.558 -0.904 . . . . 0.0 108.558 -179.797 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -58.61 -28.74 65.9 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 123.254 0.621 . . . . 0.0 112.411 178.908 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 88.9 mttt -70.18 -55.39 9.46 Favored 'General case' 0 C--O 1.234 0.243 0 CA-C-N 119.257 0.935 . . . . 0.0 110.567 172.495 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 16.2 pt -77.03 -38.28 27.71 Favored 'Isoleucine or valine' 0 C--O 1.234 0.25 0 N-CA-C 114.91 1.448 . . . . 0.0 114.91 -169.085 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 74.5 m . . . . . 0 C--O 1.254 1.296 0 C-N-CA 125.882 1.673 . . . . 0.0 109.52 -169.774 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 19.8 ptm . . . . . 0 N--CA 1.497 1.924 0 N-CA-C 110.821 -0.066 . . . . 0.0 110.821 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . 0.506 ' HB2' HG22 ' A' ' 30' ' ' ILE . 16.3 mttm -73.59 125.96 29.18 Favored 'General case' 0 N--CA 1.482 1.131 0 N-CA-C 107.88 -1.156 . . . . 0.0 107.88 -172.006 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 69.6 mttt -94.13 137.26 33.52 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-N 120.062 1.301 . . . . 0.0 108.376 174.087 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.441 HG21 HD12 ' A' ' 30' ' ' ILE . 15.0 t -119.84 151.28 22.39 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 C-N-CA 127.121 2.169 . . . . 0.0 106.473 -169.939 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 31.9 mtt -134.65 147.14 50.09 Favored 'General case' 0 C--N 1.321 -0.64 0 C-N-CA 124.164 0.986 . . . . 0.0 108.705 168.782 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 45.6 m-85 -131.67 122.85 26.64 Favored 'General case' 0 CA--C 1.516 -0.336 0 N-CA-C 102.218 -3.252 . . . . 0.0 102.218 169.226 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 1.3 p -148.4 141.81 18.74 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.263 0 CA-C-O 121.764 0.793 . . . . 0.0 112.151 -168.41 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 46.3 t -136.29 173.86 11.25 Favored 'General case' 0 CA--C 1.547 0.846 0 C-N-CA 127.807 2.443 . . . . 0.0 105.269 169.019 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 87.6 tttt -51.59 -46.92 63.71 Favored 'General case' 0 N--CA 1.475 0.813 0 O-C-N 120.975 -1.078 . . . . 0.0 113.433 -169.368 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 19.6 ttt180 -130.11 147.47 51.85 Favored 'General case' 0 N--CA 1.468 0.461 0 CA-C-N 118.995 0.816 . . . . 0.0 109.118 -178.319 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 64.3 t30 -58.94 -30.33 67.79 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 123.964 0.906 . . . . 0.0 113.354 -175.589 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -56.31 -55.27 35.46 Favored 'General case' 0 C--O 1.236 0.378 0 C-N-CA 124.069 0.948 . . . . 0.0 109.992 -171.428 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 9.2 m -91.02 151.2 21.13 Favored 'General case' 0 N--CA 1.452 -0.37 0 C-N-CA 123.659 0.784 . . . . 0.0 110.797 -176.353 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 5.4 mmm180 67.32 -50.5 0.49 Allowed 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 128.462 2.705 . . . . 0.0 113.323 170.228 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 7.3 m -76.92 49.94 0.68 Allowed 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 125.677 1.591 . . . . 0.0 111.704 -179.351 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 4.5 pt20 -123.52 12.73 9.36 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 126.109 1.763 . . . . 0.0 112.148 -175.669 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -160.96 -40.37 0.05 OUTLIER 'General case' 0 C--O 1.224 -0.265 0 N-CA-C 113.973 1.101 . . . . 0.0 113.973 176.935 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -66.62 -52.45 44.99 Favored 'General case' 0 N--CA 1.475 0.797 0 CA-C-N 120.657 1.571 . . . . 0.0 112.164 -169.56 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -56.42 -38.3 71.39 Favored 'General case' 0 N--CA 1.446 -0.653 0 C-N-CA 124.029 0.931 . . . . 0.0 110.645 169.942 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -57.11 -52.6 50.4 Favored Glycine 0 CA--C 1.526 0.754 0 C-N-CA 124.722 1.153 . . . . 0.0 111.209 175.902 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 1.3 m-85 -65.0 -32.07 73.61 Favored 'General case' 0 CA--C 1.51 -0.582 0 O-C-N 120.94 -1.329 . . . . 0.0 111.907 175.723 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -71.05 -41.23 71.04 Favored 'General case' 0 N--CA 1.445 -0.688 0 CA-C-O 118.156 -0.926 . . . . 0.0 110.739 -174.607 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.15 -33.3 75.18 Favored 'General case' 0 N--CA 1.471 0.582 0 CA-C-N 119.617 1.099 . . . . 0.0 109.886 173.591 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 10.6 m -68.9 -54.05 17.66 Favored 'General case' 0 N--CA 1.442 -0.842 0 C-N-CA 123.171 0.588 . . . . 0.0 110.364 -175.046 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 39.9 mt -77.8 -37.3 49.06 Favored 'General case' 0 C--N 1.329 -0.285 0 C-N-CA 124.946 1.298 . . . . 0.0 111.034 -172.941 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -101.08 8.29 57.42 Favored Glycine 0 CA--C 1.526 0.761 0 CA-C-O 118.033 -1.426 . . . . 0.0 114.303 -169.734 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -40.92 -48.91 3.21 Favored 'General case' 0 N--CA 1.468 0.437 0 C-N-CA 125.798 1.639 . . . . 0.0 114.882 -169.443 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -89.94 -2.09 75.47 Favored Glycine 0 CA--C 1.531 1.074 0 CA-C-O 118.836 -0.98 . . . . 0.0 114.469 -173.506 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 13.8 ptpt -124.88 -28.29 3.51 Favored 'General case' 0 N--CA 1.472 0.651 0 CA-C-N 118.915 1.357 . . . . 0.0 113.145 -173.626 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.506 HG22 ' HB2' ' A' ' 2' ' ' LYS . 14.8 pt -143.65 150.15 17.47 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.437 0 CA-C-N 119.657 1.117 . . . . 0.0 111.47 -174.218 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -98.54 158.17 15.77 Favored 'General case' 0 N--CA 1.465 0.302 0 C-N-CA 125.575 1.55 . . . . 0.0 108.543 172.182 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 22.6 t -139.66 133.35 37.23 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 N-CA-C 107.547 -1.279 . . . . 0.0 107.547 -175.976 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 34.5 m -138.49 107.42 5.99 Favored 'General case' 0 N--CA 1.447 -0.594 0 N-CA-C 106.042 -1.836 . . . . 0.0 106.042 175.345 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 2.4 p -80.65 99.48 8.18 Favored 'General case' 0 C--N 1.327 -0.386 0 C-N-CA 119.843 -0.743 . . . . 0.0 109.064 174.501 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 25.7 p -72.16 -177.47 2.11 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 123.956 0.903 . . . . 0.0 110.827 175.254 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -173.17 171.88 44.76 Favored Glycine 0 CA--C 1.522 0.504 0 N-CA-C 106.457 -2.657 . . . . 0.0 106.457 -179.297 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 18.4 mt -106.43 -20.05 13.5 Favored 'General case' 0 C--N 1.325 -0.489 0 C-N-CA 124.804 1.241 . . . . 0.0 110.072 174.633 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 36.9 mt-10 -131.87 162.84 29.64 Favored 'General case' 0 N--CA 1.448 -0.538 0 C-N-CA 127.683 2.393 . . . . 0.0 106.948 169.207 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 78.9 p -145.2 155.99 43.59 Favored 'General case' 0 N--CA 1.451 -0.409 0 CA-C-O 122.844 1.307 . . . . 0.0 114.499 179.615 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 4.3 m -168.89 -179.85 3.86 Favored 'General case' 0 N--CA 1.451 -0.41 0 C-N-CA 131.118 3.767 . . . . 0.0 103.966 -170.028 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 25.6 ttp180 -86.9 171.69 10.62 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 107.079 -1.452 . . . . 0.0 107.079 169.142 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 11.2 m -68.58 165.47 2.3 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.808 0 CA-C-N 115.796 -0.638 . . . . 0.0 109.973 178.409 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 55.1 m170 -62.96 152.43 83.51 Favored Pre-proline 0 CA--C 1.549 0.917 0 C-N-CA 123.161 0.584 . . . . 0.0 112.537 177.675 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -70.45 -55.62 0.15 Allowed 'Trans proline' 0 C--N 1.352 0.711 0 C-N-CA 123.382 2.722 . . . . 0.0 114.388 -169.909 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 26.9 m -65.8 -22.75 66.59 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-N 119.256 0.934 . . . . 0.0 110.071 -175.973 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -52.41 -52.3 54.52 Favored 'General case' 0 CA--C 1.509 -0.603 0 CA-C-O 118.815 -0.612 . . . . 0.0 110.585 169.957 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 85.3 mt -58.69 -41.32 81.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 -172.292 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -63.96 -49.32 72.99 Favored 'General case' 0 N--CA 1.45 -0.455 0 CA-C-N 118.079 0.399 . . . . 0.0 111.113 178.477 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' MET . . . . . 0.437 ' HG3' ' CG ' ' A' ' 112' ' ' PHE . 24.3 mmt -65.33 -35.81 82.12 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-O 122.638 1.208 . . . . 0.0 111.445 -178.627 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -79.22 -33.09 44.01 Favored 'General case' 0 N--CA 1.44 -0.944 0 N-CA-C 107.584 -1.265 . . . . 0.0 107.584 -173.47 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 42.0 tt0 -68.25 -26.76 65.84 Favored 'General case' 0 N--CA 1.445 -0.713 0 C-N-CA 123.307 0.643 . . . . 0.0 109.86 170.614 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 14.7 mm-40 -68.25 -28.57 67.33 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-N 118.816 0.734 . . . . 0.0 110.654 174.241 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . 0.276 4.6 p -93.07 11.81 3.14 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.907 0 CA-C-N 118.658 0.663 . . . . 0.0 111.375 169.201 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 77.33 17.53 79.23 Favored Glycine 0 CA--C 1.53 1.029 0 C-N-CA 124.516 1.055 . . . . 0.0 114.003 173.071 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 12.5 mt -109.58 131.3 60.85 Favored 'Isoleucine or valine' 0 C--O 1.232 0.134 0 CA-C-N 118.884 1.342 . . . . 0.0 109.921 -177.947 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 8.1 t70 -87.28 121.04 29.19 Favored 'General case' 0 C--O 1.236 0.375 0 N-CA-C 106.783 -1.562 . . . . 0.0 106.783 169.061 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 10.1 pt -110.39 -26.68 3.09 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.487 0 C-N-CA 123.097 0.559 . . . . 0.0 110.105 169.126 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -32.67 -46.42 0.14 Allowed 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 130.146 3.378 . . . . 0.0 114.279 173.073 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -73.75 -3.59 63.85 Favored Glycine 0 CA--C 1.534 1.221 0 CA-C-O 118.82 -0.989 . . . . 0.0 114.126 -176.27 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 13.3 mt-30 -79.25 114.53 18.26 Favored 'General case' 0 CA--C 1.511 -0.55 0 CA-C-N 119.353 1.577 . . . . 0.0 111.468 -176.216 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -150.22 148.33 28.77 Favored 'General case' 0 N--CA 1.434 -1.248 0 N-CA-C 105.257 -2.127 . . . . 0.0 105.257 167.328 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 18.8 m -150.81 156.7 41.78 Favored 'General case' 0 N--CA 1.447 -0.607 0 N-CA-C 108.373 -0.973 . . . . 0.0 108.373 -169.677 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -67.98 163.45 50.4 Favored Pre-proline 0 CA--C 1.542 0.646 0 C-N-CA 124.682 1.193 . . . . 0.0 109.464 169.422 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -60.73 151.65 75.08 Favored 'Trans proline' 0 N--CA 1.456 -0.685 0 C-N-CA 122.043 1.829 . . . . 0.0 110.31 172.126 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 13.9 tt -58.61 -26.24 30.69 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.453 0 C-N-CA 124.031 0.932 . . . . 0.0 112.212 -174.475 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 23.1 tt0 -67.21 -25.34 66.07 Favored 'General case' 0 N--CA 1.434 -1.241 0 C-N-CA 125.68 1.592 . . . . 0.0 110.682 -177.052 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 12.9 t-20 -63.21 -31.51 72.67 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 124.984 1.314 . . . . 0.0 112.221 -178.888 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 8.5 m-85 -96.69 -167.69 1.6 Allowed 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 124.904 1.281 . . . . 0.0 110.333 -175.46 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 54.9 t-20 -137.35 136.95 38.39 Favored 'General case' 0 CA--C 1.515 -0.402 0 N-CA-C 107.27 -1.382 . . . . 0.0 107.27 169.188 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.46 ' HB3' ' HG2' ' A' ' 89' ' ' GLU . . . -73.54 -24.91 60.19 Favored 'General case' 0 N--CA 1.436 -1.128 0 N-CA-C 109.408 -0.59 . . . . 0.0 109.408 -176.547 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 36.0 t70 -66.34 -23.97 66.44 Favored 'General case' 0 N--CA 1.443 -0.804 0 O-C-N 123.751 0.657 . . . . 0.0 111.82 -179.618 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -75.96 -28.82 58.05 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 123.097 0.559 . . . . 0.0 111.348 175.541 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 18.8 m-85 -83.58 168.61 16.22 Favored 'General case' 0 N--CA 1.45 -0.47 0 C-N-CA 125.897 1.679 . . . . 0.0 110.368 177.939 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -114.97 -36.26 4.5 Favored 'General case' 0 N--CA 1.465 0.321 0 C-N-CA 123.126 0.57 . . . . 0.0 111.281 178.595 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -140.58 139.09 35.57 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.361 0 C-N-CA 123.42 0.688 . . . . 0.0 109.621 -171.499 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 83.4 t -140.48 140.0 34.72 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.319 0 N-CA-C 106.381 -1.711 . . . . 0.0 106.381 -177.692 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 37.3 mm -131.41 127.86 60.44 Favored 'Isoleucine or valine' 0 C--O 1.237 0.441 0 N-CA-C 106.743 -1.577 . . . . 0.0 106.743 -174.921 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 13.6 m -86.59 130.83 34.34 Favored 'General case' 0 N--CA 1.441 -0.905 0 N-CA-C 106.647 -1.612 . . . . 0.0 106.647 168.927 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 85.0 mt -93.94 -7.25 43.53 Favored 'General case' 0 C--N 1.331 -0.226 0 C-N-CA 123.465 0.706 . . . . 0.0 109.726 169.751 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 18.0 p -161.58 158.67 26.65 Favored 'General case' 0 N--CA 1.444 -0.73 0 C-N-CA 124.881 1.272 . . . . 0.0 108.768 169.454 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 65.76 -161.39 43.4 Favored Glycine 0 CA--C 1.535 1.285 0 N-CA-C 115.178 0.831 . . . . 0.0 115.178 169.345 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 15.1 m -142.59 -161.2 1.2 Allowed 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 126.841 2.057 . . . . 0.0 107.626 -172.39 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -72.76 61.41 1.64 Allowed Glycine 0 CA--C 1.535 1.315 0 O-C-N 120.921 -1.112 . . . . 0.0 111.667 172.28 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 6.7 m -78.21 -55.86 9.03 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.508 0 C-N-CA 124.235 1.014 . . . . 0.0 110.82 -170.001 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 46.4 t30 -143.9 48.85 1.39 Allowed 'General case' 0 N--CA 1.467 0.383 0 N-CA-C 104.416 -2.438 . . . . 0.0 104.416 169.551 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 6.0 tt -144.15 119.33 6.09 Favored Pre-proline 0 CA--C 1.535 0.386 0 N-CA-C 104.75 -2.315 . . . . 0.0 104.75 -168.443 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 76.4 Cg_exo -60.13 138.07 79.35 Favored 'Trans proline' 0 C--N 1.349 0.579 0 C-N-CA 121.823 1.682 . . . . 0.0 112.316 -170.194 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 66.9 Cg_endo -68.85 -14.57 39.16 Favored 'Trans proline' 0 N--CA 1.459 -0.516 0 C-N-CA 122.0 1.8 . . . . 0.0 113.084 -174.776 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . 0.46 ' HG2' ' HB3' ' A' ' 70' ' ' ALA . 14.0 tt0 -58.08 -25.48 61.34 Favored 'General case' 0 N--CA 1.439 -1.019 0 C-N-CA 125.713 1.605 . . . . 0.0 110.887 171.565 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 99.7 m95 -78.87 -41.38 30.02 Favored 'General case' 0 N--CA 1.456 -0.134 0 C-N-CA 123.722 0.809 . . . . 0.0 111.804 173.035 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 2.0 m -79.46 0.02 3.47 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.638 0 C-N-CA 123.321 0.648 . . . . 0.0 112.326 -175.153 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . 0.254 1.4 t -133.11 34.98 3.53 Favored 'General case' 0 CA--C 1.546 0.797 0 O-C-N 121.519 -0.738 . . . . 0.0 112.565 -175.731 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 89.4 mm-40 -71.66 -178.66 2.3 Favored 'General case' 0 CA--C 1.543 0.703 0 O-C-N 121.208 -0.933 . . . . 0.0 110.052 169.199 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 31.1 mm-40 -57.22 -28.83 63.23 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 123.181 0.592 . . . . 0.0 111.923 -169.348 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 5.3 tt -136.72 138.63 46.06 Favored 'Isoleucine or valine' 0 C--O 1.239 0.519 0 N-CA-C 104.383 -2.451 . . . . 0.0 104.383 168.406 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 70.9 t80 -132.33 142.46 49.35 Favored 'General case' 0 N--CA 1.448 -0.564 0 N-CA-C 106.407 -1.701 . . . . 0.0 106.407 169.491 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 19.9 mm-40 -141.64 152.1 43.66 Favored 'General case' 0 C--O 1.237 0.397 0 N-CA-C 106.652 -1.61 . . . . 0.0 106.652 171.351 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -125.4 127.66 46.92 Favored 'General case' 0 C--O 1.239 0.5 0 N-CA-C 107.244 -1.391 . . . . 0.0 107.244 169.204 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 4.6 m95 -116.05 158.17 23.56 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 124.192 0.997 . . . . 0.0 110.452 -173.328 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 19.9 pt20 -122.06 39.56 3.85 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 124.553 1.141 . . . . 0.0 111.258 -177.054 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -64.36 133.08 51.91 Favored 'General case' 0 N--CA 1.466 0.359 0 N-CA-C 107.764 -1.199 . . . . 0.0 107.764 173.492 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 3.2 mp0 -64.59 152.09 42.95 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 123.943 0.897 . . . . 0.0 110.037 173.049 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -91.01 113.64 58.85 Favored Pre-proline 0 C--O 1.236 0.377 0 N-CA-C 105.603 -1.999 . . . . 0.0 105.603 168.349 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . 0.439 ' HG2' ' CE1' ' A' ' 112' ' ' PHE . 78.6 Cg_endo -76.25 -8.73 18.78 Favored 'Trans proline' 0 N--CA 1.453 -0.868 0 C-N-CA 121.804 1.669 . . . . 0.0 114.189 -172.819 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -66.79 -41.2 88.01 Favored 'General case' 0 C--O 1.235 0.299 0 CA-C-N 120.45 1.477 . . . . 0.0 113.293 -169.309 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -79.3 6.96 55.65 Favored Glycine 0 CA--C 1.533 1.179 0 CA-C-O 118.823 -0.987 . . . . 0.0 113.663 -176.082 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 24.3 pt20 -148.53 -165.59 2.32 Favored 'General case' 0 CA--C 1.54 0.582 0 CA-C-N 118.932 1.366 . . . . 0.0 111.141 -169.874 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 2.1 m -69.3 156.65 38.42 Favored 'General case' 0 CA--C 1.533 0.324 0 N-CA-C 116.164 1.912 . . . . 0.0 116.164 -168.365 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 35.0 tp -57.33 -30.34 64.71 Favored 'General case' 0 N--CA 1.465 0.305 0 C-N-CA 126.28 1.832 . . . . 0.0 112.475 173.544 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 40.4 tt0 -58.62 -34.92 71.71 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 123.601 0.76 . . . . 0.0 110.62 173.978 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 3.4 t -76.0 -38.23 35.2 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.378 0 CA-C-O 118.12 -0.943 . . . . 0.0 109.676 -178.939 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . 0.439 ' CE1' ' HG2' ' A' ' 104' ' ' PRO . 27.0 m-85 -57.03 -50.14 73.66 Favored 'General case' 0 N--CA 1.475 0.793 0 CA-C-N 120.733 1.606 . . . . 0.0 110.256 169.904 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 85.7 mtt180 -60.5 -39.54 88.07 Favored 'General case' 0 N--CA 1.468 0.457 0 C-N-CA 123.358 0.663 . . . . 0.0 110.849 -179.161 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 16.3 m -68.28 -50.58 52.73 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 124.657 1.183 . . . . 0.0 110.726 176.565 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 55.2 t -67.6 -33.87 64.69 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.197 0 CA-C-O 117.498 -1.239 . . . . 0.0 110.856 -169.423 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 31.1 mtm105 -57.54 -41.77 81.62 Favored 'General case' 0 CA--C 1.539 0.534 0 CA-C-N 120.335 1.425 . . . . 0.0 110.273 173.598 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -67.02 -50.34 47.27 Favored Glycine 0 CA--C 1.529 0.92 0 C-N-CA 123.926 0.774 . . . . 0.0 111.878 177.577 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 25.4 mt-30 -54.95 -47.59 74.3 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-N 117.752 0.776 . . . . 0.0 110.211 178.377 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 53.7 t -64.83 -48.79 82.96 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.432 0 CA-C-O 118.329 -0.843 . . . . 0.0 109.967 -177.101 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 62.6 tttm -55.96 -45.65 78.83 Favored 'General case' 0 CA--C 1.519 -0.22 0 CA-C-N 119.114 0.87 . . . . 0.0 109.107 -174.429 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -64.88 -43.93 91.31 Favored 'General case' 0 N--CA 1.443 -0.781 0 C-N-CA 123.019 0.528 . . . . 0.0 110.776 -177.12 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 57.8 mtt-85 -68.0 -42.94 79.95 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-N 118.639 0.654 . . . . 0.0 111.695 179.578 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 98.5 t -66.55 -44.11 90.29 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.374 0 N-CA-C 108.433 -0.951 . . . . 0.0 108.433 179.406 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 21.3 mt-10 -61.39 -42.73 99.19 Favored 'General case' 0 C--N 1.338 0.092 0 CA-C-N 119.892 1.224 . . . . 0.0 110.39 178.861 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 29.6 t-20 -62.22 -44.56 96.29 Favored 'General case' 0 C--O 1.225 -0.189 0 C-N-CA 122.861 0.464 . . . . 0.0 110.827 178.239 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 45.7 tp -60.1 -47.24 86.74 Favored 'General case' 0 N--CA 1.454 -0.246 0 C-N-CA 124.239 1.016 . . . . 0.0 111.052 177.5 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 79.7 mt -61.69 -45.83 97.83 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.256 0 N-CA-C 108.026 -1.101 . . . . 0.0 108.026 178.191 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -62.04 -29.3 70.19 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 123.262 0.625 . . . . 0.0 112.239 178.28 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 89.9 mttt -68.59 -56.55 7.89 Favored 'General case' 0 C--N 1.342 0.248 0 CA-C-N 119.16 0.891 . . . . 0.0 110.096 171.711 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 15.8 pt -73.93 -40.35 52.51 Favored 'Isoleucine or valine' 0 C--O 1.235 0.338 0 N-CA-C 114.213 1.19 . . . . 0.0 114.213 -169.308 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 75.0 m . . . . . 0 C--O 1.253 1.262 0 C-N-CA 126.144 1.777 . . . . 0.0 109.408 -169.74 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 9.7 ptm . . . . . 0 N--CA 1.497 1.913 0 N-CA-C 110.711 -0.107 . . . . 0.0 110.711 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . 0.417 ' HB2' HG22 ' A' ' 30' ' ' ILE . 18.1 mttm -76.06 124.0 26.7 Favored 'General case' 0 N--CA 1.481 1.095 0 N-CA-C 107.701 -1.222 . . . . 0.0 107.701 -172.499 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 87.1 mttt -92.64 135.01 34.46 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-N 119.689 1.131 . . . . 0.0 108.343 176.692 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 1.7 t -118.81 150.31 21.11 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 C-N-CA 126.852 2.061 . . . . 0.0 108.848 -169.161 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 6.2 mtt -139.41 148.15 42.4 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 125.617 1.567 . . . . 0.0 109.286 169.352 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 91.0 m-85 -132.78 105.75 7.34 Favored 'General case' 0 C--O 1.225 -0.193 0 N-CA-C 104.769 -2.308 . . . . 0.0 104.769 172.131 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 22.1 t -131.82 138.88 51.76 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.221 0 CA-C-O 121.898 0.856 . . . . 0.0 111.211 -168.745 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 37.9 t -154.41 156.08 36.17 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 127.47 2.308 . . . . 0.0 105.236 169.27 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 65.6 pttt -65.37 -21.74 66.72 Favored 'General case' 0 N--CA 1.472 0.64 0 N-CA-C 114.69 1.367 . . . . 0.0 114.69 -170.427 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 7.9 tpp180 -126.94 78.05 1.77 Allowed 'General case' 0 N--CA 1.47 0.54 0 CA-C-N 119.814 1.188 . . . . 0.0 110.058 -173.9 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 34.9 t30 -43.18 -48.33 6.44 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 125.159 1.384 . . . . 0.0 112.222 176.379 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -51.53 -32.14 26.76 Favored 'General case' 0 C--O 1.232 0.147 0 C-N-CA 126.617 1.967 . . . . 0.0 112.998 -175.66 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 8.8 m -125.01 17.52 8.5 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 123.795 0.838 . . . . 0.0 111.805 -173.198 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 10.2 tpt180 -151.81 -55.86 0.14 Allowed 'General case' 0 C--N 1.348 0.528 0 N-CA-C 115.727 1.751 . . . . 0.0 115.727 179.33 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 3.3 m -65.66 -55.01 19.78 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 119.61 1.095 . . . . 0.0 112.195 -168.509 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER 43.8 -111.12 0.19 Allowed 'General case' 0 N--CA 1.452 -0.368 0 C-N-CA 126.328 1.851 . . . . 0.0 111.453 169.106 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -78.53 -8.38 58.51 Favored 'General case' 0 C--O 1.224 -0.246 0 N-CA-C 114.29 1.218 . . . . 0.0 114.29 -170.629 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -62.78 -58.95 5.66 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-N 120.131 1.332 . . . . 0.0 111.138 -169.751 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -68.11 -32.1 72.16 Favored 'General case' 0 CA--C 1.541 0.597 0 O-C-N 121.722 -0.611 . . . . 0.0 109.542 175.627 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -48.63 -56.65 9.35 Favored Glycine 0 C--N 1.346 1.113 0 C-N-CA 125.38 1.467 . . . . 0.0 111.637 176.23 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 13.9 m-85 -74.54 -28.3 60.9 Favored 'General case' 0 CA--C 1.508 -0.663 0 CA-C-N 118.77 1.285 . . . . 0.0 112.928 179.322 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -66.25 -31.0 71.55 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 119.323 0.965 . . . . 0.0 111.554 -172.451 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 7.5 ptpt -63.5 -33.06 74.75 Favored 'General case' 0 N--CA 1.477 0.908 0 CA-C-N 119.432 1.015 . . . . 0.0 112.036 171.067 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 5.9 m -78.72 -55.17 5.38 Favored 'General case' 0 N--CA 1.446 -0.626 0 C-N-CA 125.187 1.395 . . . . 0.0 110.245 -175.202 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 79.3 mt -73.4 -34.32 65.45 Favored 'General case' 0 C--N 1.33 -0.248 0 C-N-CA 123.971 0.909 . . . . 0.0 110.339 -174.753 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -91.08 2.85 79.88 Favored Glycine 0 CA--C 1.527 0.822 0 CA-C-O 118.362 -1.243 . . . . 0.0 113.709 -176.494 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -49.92 123.0 7.31 Favored 'General case' 0 CA--C 1.533 0.31 0 CA-C-N 118.796 1.298 . . . . 0.0 110.904 -172.074 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 76.78 -14.11 7.73 Favored Glycine 0 CA--C 1.533 1.195 0 C-N-CA 124.676 1.132 . . . . 0.0 114.353 179.631 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 53.6 mttm -94.15 -46.41 7.12 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-N 119.212 1.506 . . . . 0.0 110.393 178.918 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.417 HG22 ' HB2' ' A' ' 2' ' ' LYS . 24.7 pt -142.15 152.39 18.41 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.427 0 C-N-CA 124.301 1.04 . . . . 0.0 109.95 -169.408 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -112.87 109.01 18.19 Favored 'General case' 0 N--CA 1.464 0.235 0 C-N-CA 125.035 1.334 . . . . 0.0 108.694 -174.036 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 11.1 p -86.27 139.16 17.79 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.401 0 CA-C-N 119.702 1.137 . . . . 0.0 109.867 177.71 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 3.9 m -144.55 107.7 4.55 Favored 'General case' 0 N--CA 1.445 -0.69 0 N-CA-C 104.77 -2.308 . . . . 0.0 104.77 172.191 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 66.2 m -105.63 75.47 1.14 Allowed 'General case' 0 C--N 1.329 -0.32 0 O-C-N 120.933 -1.105 . . . . 0.0 108.827 178.48 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 2.0 m -60.46 -45.55 93.29 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 125.388 1.475 . . . . 0.0 112.054 -169.891 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 89.65 161.73 37.74 Favored Glycine 0 C--N 1.335 0.508 0 CA-C-O 122.038 0.799 . . . . 0.0 112.159 170.905 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 5.6 mt -131.49 142.67 50.01 Favored 'General case' 0 N--CA 1.442 -0.845 0 C-N-CA 128.079 2.552 . . . . 0.0 104.548 174.533 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 33.2 mt-10 57.42 -89.77 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.385 0 N-CA-C 108.134 -1.061 . . . . 0.0 108.134 -169.516 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 69.3 m 64.52 169.63 0.18 Allowed 'General case' 0 N--CA 1.445 -0.721 0 C-N-CA 127.269 2.228 . . . . 0.0 115.615 169.184 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 59.9 m -157.47 177.29 11.59 Favored 'General case' 0 N--CA 1.446 -0.646 0 C-N-CA 128.269 2.627 . . . . 0.0 105.984 -168.847 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 14.4 ttt85 -82.12 -178.77 7.15 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 107.963 -1.125 . . . . 0.0 107.963 169.377 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 17.6 m -81.41 170.17 1.48 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.729 0 C-N-CA 123.789 0.836 . . . . 0.0 109.766 -178.675 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 74.0 t60 -73.0 139.22 79.59 Favored Pre-proline 0 CA--C 1.545 0.763 0 CA-C-O 118.163 -0.922 . . . . 0.0 108.631 172.207 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -58.35 -48.3 16.16 Favored 'Trans proline' 0 C--N 1.348 0.507 0 C-N-CA 123.093 2.529 . . . . 0.0 113.833 -174.193 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 25.2 m -65.58 -18.82 65.6 Favored 'General case' 0 CA--C 1.535 0.387 0 CA-C-N 118.258 0.481 . . . . 0.0 110.937 -179.294 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.404 ' HB1' HD11 ' A' ' 57' ' ' ILE . . . -60.28 -50.64 72.82 Favored 'General case' 0 CA--C 1.51 -0.562 0 O-C-N 121.458 -0.776 . . . . 0.0 108.996 175.018 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 72.5 mt -57.98 -41.57 80.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 N-CA-C 108.352 -0.981 . . . . 0.0 108.352 -173.112 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -63.56 -46.48 85.72 Favored 'General case' 0 N--CA 1.452 -0.352 0 CA-C-N 117.631 0.196 . . . . 0.0 110.856 -179.05 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 28.4 mmt -68.02 -36.38 79.85 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-O 122.439 1.114 . . . . 0.0 110.841 -179.819 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -74.6 -31.93 62.19 Favored 'General case' 0 N--CA 1.444 -0.753 0 N-CA-C 106.887 -1.523 . . . . 0.0 106.887 -175.698 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 40.8 tt0 -72.3 -21.89 61.28 Favored 'General case' 0 N--CA 1.446 -0.651 0 C-N-CA 124.311 1.045 . . . . 0.0 110.157 172.495 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 21.6 mm-40 -67.53 -30.63 70.34 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-N 119.272 0.942 . . . . 0.0 110.017 169.962 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . 0.291 5.5 p -89.86 8.74 3.21 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.993 0 CA-C-N 118.802 0.728 . . . . 0.0 111.467 168.839 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 77.29 21.75 72.36 Favored Glycine 0 CA--C 1.532 1.11 0 O-C-N 120.818 -1.176 . . . . 0.0 113.799 174.953 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 25.2 mt -118.71 144.71 26.17 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.239 0 C-N-CA 125.314 1.445 . . . . 0.0 110.005 -174.15 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 20.6 t70 -108.03 147.59 30.93 Favored 'General case' 0 C--O 1.234 0.282 0 N-CA-C 108.375 -0.972 . . . . 0.0 108.375 168.74 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.404 HD11 ' HB1' ' A' ' 46' ' ' ALA . 13.5 pt -132.29 -12.57 1.48 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.707 0 C-N-CA 125.895 1.678 . . . . 0.0 111.529 170.565 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 5.4 t -45.77 -46.73 15.42 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-N 120.333 1.424 . . . . 0.0 111.688 170.845 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -78.51 29.51 1.99 Allowed Glycine 0 CA--C 1.533 1.207 0 C-N-CA 124.966 1.269 . . . . 0.0 114.147 -177.621 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 1.7 tt0 -63.5 -37.37 87.04 Favored 'General case' 0 C--N 1.344 0.36 0 CA-C-N 119.728 1.764 . . . . 0.0 113.213 -175.046 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 12.4 t -81.22 161.36 24.01 Favored 'General case' 0 C--O 1.238 0.451 0 CA-C-O 122.047 0.927 . . . . 0.0 110.352 -169.534 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 4.2 m -168.34 -51.42 0.02 OUTLIER 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 125.919 1.687 . . . . 0.0 109.175 178.197 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -154.39 154.97 30.32 Favored Pre-proline 0 C--O 1.237 0.41 0 C-N-CA 124.988 1.315 . . . . 0.0 108.208 -179.672 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 98.9 Cg_endo -66.86 159.13 53.07 Favored 'Trans proline' 0 N--CA 1.457 -0.659 0 C-N-CA 123.111 2.541 . . . . 0.0 110.508 171.421 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 5.6 tt -60.11 -26.01 35.01 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.477 0 O-C-N 121.577 -0.702 . . . . 0.0 111.63 179.681 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 15.8 mt-10 -65.66 -25.46 67.36 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 124.555 1.142 . . . . 0.0 110.593 -175.121 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 4.4 t-20 -65.84 -20.96 66.43 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 124.666 1.186 . . . . 0.0 112.459 177.985 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 77.0 m-85 -106.42 -173.49 2.31 Favored 'General case' 0 C--O 1.236 0.356 0 C-N-CA 126.37 1.868 . . . . 0.0 110.1 -174.95 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 53.2 t-20 -135.78 139.71 43.72 Favored 'General case' 0 N--CA 1.448 -0.542 0 N-CA-C 107.857 -1.164 . . . . 0.0 107.857 169.123 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -72.44 -26.16 61.73 Favored 'General case' 0 N--CA 1.433 -1.31 0 N-CA-C 109.283 -0.636 . . . . 0.0 109.283 -178.102 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -65.56 -24.39 67.08 Favored 'General case' 0 N--CA 1.447 -0.596 0 O-C-N 123.639 0.587 . . . . 0.0 112.002 -179.652 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -78.42 -28.43 46.79 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 123.297 0.639 . . . . 0.0 111.635 174.848 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 11.4 m-85 -81.13 167.44 19.68 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 125.536 1.534 . . . . 0.0 111.151 179.877 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -116.86 -39.98 3.21 Favored 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 123.099 0.56 . . . . 0.0 111.243 -179.081 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -136.13 133.62 50.28 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.453 0 CA-C-O 121.841 0.829 . . . . 0.0 109.498 -172.43 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 70.5 t -142.01 130.0 21.32 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.585 0 N-CA-C 106.199 -1.778 . . . . 0.0 106.199 -177.83 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 38.0 mm -118.9 125.42 74.46 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.575 0 N-CA-C 106.387 -1.708 . . . . 0.0 106.387 -173.233 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 56.0 m -84.0 145.06 28.72 Favored 'General case' 0 N--CA 1.446 -0.655 0 N-CA-C 106.061 -1.829 . . . . 0.0 106.061 168.601 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 93.1 mt -111.61 5.35 19.3 Favored 'General case' 0 C--N 1.328 -0.344 0 O-C-N 121.637 -0.664 . . . . 0.0 110.785 171.74 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 10.8 p -155.47 147.25 23.22 Favored 'General case' 0 N--CA 1.447 -0.584 0 C-N-CA 124.537 1.135 . . . . 0.0 108.566 168.898 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 53.4 -156.56 5.5 Favored Glycine 0 CA--C 1.537 1.426 0 C-N-CA 125.204 1.383 . . . . 0.0 115.22 169.604 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 48.0 m -145.83 127.12 14.85 Favored 'General case' 0 CA--C 1.532 0.271 0 N-CA-C 105.902 -1.888 . . . . 0.0 105.902 174.913 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 58.59 44.43 95.55 Favored Glycine 0 CA--C 1.53 1.013 0 N-CA-C 109.711 -1.356 . . . . 0.0 109.711 -171.378 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . 0.279 4.0 p -75.37 64.46 0.16 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.842 0 C-N-CA 125.916 1.686 . . . . 0.0 112.213 -168.834 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 56.5 t30 56.84 52.89 8.81 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 125.874 1.67 . . . . 0.0 107.83 -169.569 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -143.83 138.59 15.29 Favored Pre-proline 0 CA--C 1.538 0.489 0 C-N-CA 126.102 1.761 . . . . 0.0 108.743 -168.748 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 33.2 Cg_exo -64.93 139.47 62.05 Favored 'Trans proline' 0 CA--C 1.54 0.81 0 C-N-CA 122.221 1.947 . . . . 0.0 111.576 176.463 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -66.21 -24.9 50.72 Favored 'Trans proline' 0 N--CA 1.457 -0.657 0 C-N-CA 122.585 2.19 . . . . 0.0 114.476 -169.649 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 5.0 pm0 -61.46 -18.08 57.36 Favored 'General case' 0 CA--C 1.537 0.453 0 CA-C-N 121.251 1.841 . . . . 0.0 111.898 178.413 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 99.4 m95 -77.91 -38.84 44.71 Favored 'General case' 0 N--CA 1.451 -0.393 0 O-C-N 121.702 -0.624 . . . . 0.0 111.396 174.093 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -79.33 -5.12 7.72 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.456 0 O-C-N 121.869 -0.519 . . . . 0.0 111.672 -177.827 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 81.5 p -114.39 18.42 16.9 Favored 'General case' 0 C--O 1.238 0.453 0 N-CA-C 114.411 1.264 . . . . 0.0 114.411 -175.633 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 91.6 mm-40 -68.18 173.99 4.27 Favored 'General case' 0 CA--C 1.541 0.628 0 CA-C-N 119.025 0.83 . . . . 0.0 111.858 179.324 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 28.7 mm-40 -53.22 -31.57 43.79 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 124.362 1.065 . . . . 0.0 112.735 -169.0 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 4.8 tt -131.35 124.83 55.77 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.51 0 N-CA-C 104.305 -2.48 . . . . 0.0 104.305 168.39 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 4.1 t80 -113.55 133.39 55.28 Favored 'General case' 0 C--O 1.237 0.444 0 N-CA-C 104.722 -2.325 . . . . 0.0 104.722 169.186 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 14.4 mm-40 -137.66 152.07 48.93 Favored 'General case' 0 C--O 1.238 0.495 0 N-CA-C 106.57 -1.641 . . . . 0.0 106.57 169.723 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -130.94 134.82 47.1 Favored 'General case' 0 C--O 1.237 0.419 0 N-CA-C 107.411 -1.329 . . . . 0.0 107.411 169.263 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 6.6 m95 -121.08 138.95 53.94 Favored 'General case' 0 C--O 1.234 0.25 0 C-N-CA 123.059 0.543 . . . . 0.0 109.767 -174.82 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 4.8 tp-100 -82.72 63.33 6.79 Favored 'General case' 0 CA--C 1.535 0.395 0 N-CA-C 107.361 -1.348 . . . . 0.0 107.361 169.907 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 1.6 tp -67.38 127.53 33.03 Favored 'General case' 0 C--N 1.34 0.165 0 N-CA-C 108.955 -0.757 . . . . 0.0 108.955 -173.352 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -76.89 159.05 30.33 Favored 'General case' 0 N--CA 1.449 -0.508 0 N-CA-C 107.045 -1.465 . . . . 0.0 107.045 169.572 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 20.0 t70 -149.07 137.65 11.96 Favored Pre-proline 0 CA--C 1.536 0.419 0 CA-C-O 118.596 -0.716 . . . . 0.0 111.209 -171.584 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 20.8 Cg_endo -91.7 9.53 2.82 Favored 'Trans proline' 0 CA--C 1.548 1.217 0 C-N-CA 123.424 2.749 . . . . 0.0 114.808 -172.193 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -53.27 128.44 28.16 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-N 120.596 1.544 . . . . 0.0 111.361 177.811 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 64.0 25.16 69.18 Favored Glycine 0 CA--C 1.532 1.126 0 CA-C-O 118.741 -1.033 . . . . 0.0 115.458 169.223 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 6.9 pt20 -142.1 -168.48 2.71 Favored 'General case' 0 CA--C 1.536 0.434 0 CA-C-N 118.891 1.345 . . . . 0.0 111.343 -177.911 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 2.6 m -68.51 156.0 38.84 Favored 'General case' 0 CA--C 1.532 0.274 0 N-CA-C 116.149 1.907 . . . . 0.0 116.149 -168.401 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 42.9 tp -54.97 -33.68 62.63 Favored 'General case' 0 N--CA 1.465 0.307 0 C-N-CA 126.997 2.119 . . . . 0.0 111.785 175.211 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 40.8 tt0 -58.49 -35.43 72.2 Favored 'General case' 0 CA--C 1.529 0.172 0 C-N-CA 123.806 0.843 . . . . 0.0 110.702 176.399 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 4.2 t -74.98 -40.47 45.39 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.291 0 CA-C-O 118.434 -0.793 . . . . 0.0 109.652 -177.216 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 89.9 m-85 -57.12 -49.64 75.29 Favored 'General case' 0 N--CA 1.471 0.621 0 CA-C-N 119.927 1.24 . . . . 0.0 109.568 171.837 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 89.4 mtt180 -61.61 -40.0 93.27 Favored 'General case' 0 N--CA 1.467 0.385 0 C-N-CA 122.871 0.468 . . . . 0.0 110.993 -178.592 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 7.6 m -66.32 -56.27 11.96 Favored 'General case' 0 N--CA 1.447 -0.608 0 C-N-CA 124.507 1.123 . . . . 0.0 109.514 177.996 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 83.8 t -68.33 -34.06 63.92 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.343 0 CA-C-O 118.683 -0.675 . . . . 0.0 110.057 -169.643 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 47.1 ttp85 -57.82 -43.23 85.59 Favored 'General case' 0 CA--C 1.538 0.489 0 CA-C-N 119.275 0.943 . . . . 0.0 109.883 173.173 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -64.54 -53.4 35.62 Favored Glycine 0 CA--C 1.53 0.987 0 CA-C-N 118.318 0.508 . . . . 0.0 111.842 175.273 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 12.6 mt-30 -61.01 -43.34 99.03 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-N 117.884 0.842 . . . . 0.0 110.837 -174.859 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 76.8 t -70.5 -38.85 75.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 118.085 -0.959 . . . . 0.0 109.966 -174.951 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 84.0 tttt -54.73 -46.81 74.29 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 119.279 0.945 . . . . 0.0 108.673 175.789 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -65.98 -42.51 89.75 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 122.933 0.493 . . . . 0.0 111.398 -176.604 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 43.6 mtt-85 -61.49 -46.62 89.22 Favored 'General case' 0 N--CA 1.472 0.635 0 O-C-N 121.336 -0.852 . . . . 0.0 111.514 176.524 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 98.4 t -65.28 -39.87 86.77 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.637 0 N-CA-C 109.08 -0.711 . . . . 0.0 109.08 179.354 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 29.7 mt-10 -59.42 -44.48 92.87 Favored 'General case' 0 N--CA 1.462 0.172 0 CA-C-N 119.789 1.177 . . . . 0.0 110.787 176.667 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 46.7 t30 -62.98 -45.2 93.54 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 123.329 0.652 . . . . 0.0 110.551 -177.649 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 22.0 tp -58.0 -47.91 81.61 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 124.112 0.965 . . . . 0.0 111.006 175.382 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 81.0 mt -63.09 -46.09 96.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 N-CA-C 108.329 -0.989 . . . . 0.0 108.329 179.664 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -59.91 -27.83 67.08 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 123.25 0.62 . . . . 0.0 112.214 177.901 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 90.5 mttt -69.72 -56.99 5.69 Favored 'General case' 0 C--N 1.343 0.284 0 CA-C-N 119.322 0.964 . . . . 0.0 110.184 171.706 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 18.2 pt -75.71 -38.44 37.66 Favored 'Isoleucine or valine' 0 C--O 1.235 0.326 0 N-CA-C 114.645 1.35 . . . . 0.0 114.645 -169.283 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 73.7 m . . . . . 0 C--O 1.252 1.237 0 C-N-CA 126.199 1.799 . . . . 0.0 109.128 -169.805 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 6.3 ptm . . . . . 0 N--CA 1.497 1.878 0 N-CA-C 110.807 -0.071 . . . . 0.0 110.807 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . 0.457 ' HB2' HG22 ' A' ' 30' ' ' ILE . 10.6 mtmm -71.69 130.14 40.41 Favored 'General case' 0 N--CA 1.476 0.874 0 N-CA-C 107.507 -1.294 . . . . 0.0 107.507 -178.936 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 66.7 mttt -103.74 138.32 40.53 Favored 'General case' 0 CA--C 1.511 -0.526 0 N-CA-C 107.912 -1.144 . . . . 0.0 107.912 171.046 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.419 HG21 HD12 ' A' ' 30' ' ' ILE . 4.0 t -116.25 152.84 17.93 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.787 0 C-N-CA 126.522 1.929 . . . . 0.0 108.169 -169.878 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 5.1 mtt -135.78 148.17 48.66 Favored 'General case' 0 C--N 1.323 -0.562 0 C-N-CA 126.512 1.925 . . . . 0.0 107.951 168.88 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -135.19 109.22 8.2 Favored 'General case' 0 CA--C 1.512 -0.51 0 N-CA-C 104.161 -2.533 . . . . 0.0 104.161 175.909 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 72.4 t -132.73 149.52 32.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-O 121.378 0.608 . . . . 0.0 110.0 -168.454 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 32.7 t -135.85 -174.43 3.66 Favored 'General case' 0 CA--C 1.548 0.866 0 C-N-CA 128.134 2.573 . . . . 0.0 105.952 172.814 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 64.3 tttp -54.45 -39.93 67.88 Favored 'General case' 0 N--CA 1.479 1.008 0 O-C-N 121.26 -0.9 . . . . 0.0 111.505 177.777 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 33.3 mtp85 -132.3 158.35 42.1 Favored 'General case' 0 N--CA 1.468 0.47 0 C-N-CA 124.644 1.177 . . . . 0.0 108.449 174.6 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -63.27 -24.97 68.1 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 122.948 0.499 . . . . 0.0 112.093 170.212 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -48.93 -44.46 40.51 Favored 'General case' 0 CA--C 1.53 0.197 0 C-N-CA 126.105 1.762 . . . . 0.0 113.627 -169.31 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 13.5 m -120.03 144.36 47.59 Favored 'General case' 0 N--CA 1.454 -0.27 0 C-N-CA 123.111 0.564 . . . . 0.0 109.733 -169.386 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . 0.37 0.0 OUTLIER 56.32 -40.68 0.03 OUTLIER 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 130.3 3.44 . . . . 0.0 115.061 -178.746 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 2.0 m -61.8 -24.19 66.7 Favored 'General case' 0 CA--C 1.539 0.524 0 O-C-N 120.358 -1.464 . . . . 0.0 109.663 169.293 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . 0.432 ' O ' HD13 ' A' ' 57' ' ' ILE . 22.0 pt20 -67.18 10.81 0.13 Allowed 'General case' 0 CA--C 1.546 0.823 0 C-N-CA 125.638 1.575 . . . . 0.0 113.401 169.414 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -139.18 -51.64 0.54 Allowed 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 125.158 1.383 . . . . 0.0 111.577 173.599 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -57.8 -47.43 82.6 Favored 'General case' 0 N--CA 1.472 0.669 0 N-CA-C 114.934 1.457 . . . . 0.0 114.934 -169.003 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 1.9 pp20? -63.5 -30.61 71.71 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-N 117.981 0.355 . . . . 0.0 110.109 178.36 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -51.81 -67.32 2.07 Favored Glycine 0 C--N 1.34 0.805 0 C-N-CA 126.399 1.952 . . . . 0.0 110.885 173.376 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 12.8 m-85 -62.53 -31.01 71.71 Favored 'General case' 0 N--CA 1.469 0.514 0 CA-C-N 118.25 1.025 . . . . 0.0 113.294 179.67 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -67.36 -35.79 80.07 Favored 'General case' 0 N--CA 1.45 -0.454 0 CA-C-N 119.07 0.85 . . . . 0.0 111.549 -176.226 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -67.35 -27.28 67.0 Favored 'General case' 0 CA--C 1.541 0.624 0 CA-C-N 119.426 1.012 . . . . 0.0 111.431 174.201 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 2.8 m -77.2 -56.17 4.8 Favored 'General case' 0 N--CA 1.451 -0.397 0 C-N-CA 125.443 1.497 . . . . 0.0 110.571 -178.601 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 54.9 mt -75.54 -38.35 59.37 Favored 'General case' 0 C--N 1.33 -0.245 0 C-N-CA 124.098 0.959 . . . . 0.0 109.497 -174.484 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -82.24 3.78 79.68 Favored Glycine 0 CA--C 1.524 0.628 0 C-N-CA 125.154 1.359 . . . . 0.0 113.447 -179.65 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -54.39 127.28 26.73 Favored 'General case' 0 CA--C 1.531 0.219 0 CA-C-N 118.881 1.34 . . . . 0.0 109.691 -177.328 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 73.38 5.41 67.18 Favored Glycine 0 CA--C 1.533 1.168 0 CA-C-O 118.775 -1.014 . . . . 0.0 114.273 -178.8 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 46.3 mttp -121.22 -51.32 2.1 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-N 119.104 1.452 . . . . 0.0 110.943 -176.508 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.457 HG22 ' HB2' ' A' ' 2' ' ' LYS . 19.2 pt -139.71 148.12 23.39 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.453 0 C-N-CA 123.88 0.872 . . . . 0.0 109.567 -169.495 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -94.67 158.75 15.38 Favored 'General case' 0 C--O 1.224 -0.266 0 C-N-CA 124.851 1.26 . . . . 0.0 108.522 178.06 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 21.7 t -140.54 130.71 28.07 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 N-CA-C 107.172 -1.418 . . . . 0.0 107.172 -176.474 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 24.4 m -141.0 109.77 6.04 Favored 'General case' 0 N--CA 1.446 -0.645 0 N-CA-C 105.122 -2.177 . . . . 0.0 105.122 172.684 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 69.3 m -110.81 85.0 2.03 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.869 0.842 . . . . 0.0 110.079 -177.439 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 4.8 m -72.48 -170.09 0.61 Allowed 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 126.651 1.98 . . . . 0.0 110.748 176.749 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -165.74 -168.2 27.53 Favored Glycine 0 C--N 1.337 0.604 0 N-CA-C 108.01 -2.036 . . . . 0.0 108.01 177.949 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 16.9 mt -127.25 -8.41 5.86 Favored 'General case' 0 C--N 1.332 -0.177 0 C-N-CA 124.657 1.183 . . . . 0.0 112.773 -171.946 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 20.9 mt-10 -142.52 -71.53 0.32 Allowed 'General case' 0 CA--C 1.535 0.366 0 N-CA-C 107.427 -1.323 . . . . 0.0 107.427 -178.023 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . 0.25 53.8 m 63.17 158.58 0.07 Allowed 'General case' 0 N--CA 1.465 0.296 0 C-N-CA 127.259 2.223 . . . . 0.0 116.586 169.675 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 69.6 m -152.74 1.62 0.3 Allowed 'General case' 0 CA--C 1.538 0.484 0 N-CA-C 115.747 1.758 . . . . 0.0 115.747 -167.532 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 1.5 ttt180 66.51 168.51 0.23 Allowed 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 125.251 1.42 . . . . 0.0 109.802 -167.439 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 5.1 m -83.79 172.33 1.07 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.315 0 C-N-CA 123.528 0.731 . . . . 0.0 110.978 -169.19 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 91.1 m-70 -88.65 150.55 46.36 Favored Pre-proline 0 CA--C 1.537 0.443 0 C-N-CA 123.188 0.595 . . . . 0.0 109.949 178.133 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 39.5 Cg_endo -63.72 -46.44 8.95 Favored 'Trans proline' 0 C--N 1.347 0.485 0 C-N-CA 122.855 2.37 . . . . 0.0 112.341 -170.338 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 6.0 m -66.17 -25.94 67.19 Favored 'General case' 0 CA--C 1.531 0.242 0 CA-C-O 119.016 -0.516 . . . . 0.0 110.256 -179.112 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -58.69 -54.12 50.61 Favored 'General case' 0 CA--C 1.51 -0.581 0 CA-C-N 119.086 0.857 . . . . 0.0 109.109 176.27 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 38.1 mt -59.7 -42.8 89.78 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.427 0 N-CA-C 108.193 -1.04 . . . . 0.0 108.193 -174.654 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -59.23 -44.86 92.31 Favored 'General case' 0 CA--C 1.532 0.269 0 CA-C-N 118.421 0.555 . . . . 0.0 110.623 -178.775 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 26.4 mmt -70.9 -37.58 72.98 Favored 'General case' 0 C--O 1.239 0.503 0 CA-C-O 122.158 0.98 . . . . 0.0 111.128 -179.161 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -69.91 -32.96 71.54 Favored 'General case' 0 N--CA 1.443 -0.778 0 N-CA-C 106.649 -1.612 . . . . 0.0 106.649 179.781 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 18.6 mm-40 -73.29 -16.59 61.38 Favored 'General case' 0 N--CA 1.444 -0.752 0 O-C-N 120.79 -1.194 . . . . 0.0 111.278 171.757 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 22.6 mm-40 -66.28 -35.1 79.53 Favored 'General case' 0 C--N 1.341 0.221 0 CA-C-N 119.847 1.203 . . . . 0.0 109.095 169.552 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 16.8 m -90.07 11.59 2.09 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.766 0 N-CA-C 112.2 0.445 . . . . 0.0 112.2 169.311 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 73.21 23.52 77.36 Favored Glycine 0 CA--C 1.534 1.234 0 C-N-CA 124.487 1.042 . . . . 0.0 113.345 174.67 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 8.6 mt -107.83 135.53 46.19 Favored 'Isoleucine or valine' 0 C--O 1.232 0.152 0 C-N-CA 125.419 1.488 . . . . 0.0 110.197 -174.994 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -95.57 140.01 31.02 Favored 'General case' 0 C--O 1.236 0.365 0 C-N-CA 123.508 0.723 . . . . 0.0 109.514 169.791 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.494 HG13 ' H ' ' A' ' 58' ' ' SER . 3.6 pt -119.72 -66.94 1.2 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.607 0 C-N-CA 124.773 1.229 . . . . 0.0 108.393 171.043 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . 0.494 ' H ' HG13 ' A' ' 57' ' ' ILE . 95.2 p 30.59 -98.54 0.01 OUTLIER 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 128.961 2.905 . . . . 0.0 114.225 174.897 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -76.35 53.96 3.16 Favored Glycine 0 CA--C 1.528 0.876 0 C-N-CA 127.273 2.368 . . . . 0.0 112.703 -175.773 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 5.6 mt-30 -65.44 -29.9 70.63 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 123.203 0.601 . . . . 0.0 110.297 169.744 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -60.28 128.19 35.52 Favored 'General case' 0 N--CA 1.446 -0.639 0 C-N-CA 126.037 1.735 . . . . 0.0 109.19 -169.795 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 75.5 m -147.63 -169.94 3.44 Favored 'General case' 0 N--CA 1.447 -0.587 0 C-N-CA 126.332 1.853 . . . . 0.0 106.605 -169.635 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -57.38 154.59 22.24 Favored Pre-proline 0 C--O 1.241 0.613 0 O-C-N 121.854 -0.529 . . . . 0.0 109.903 169.355 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 64.4 Cg_endo -61.2 152.61 70.77 Favored 'Trans proline' 0 N--CA 1.456 -0.691 0 C-N-CA 121.918 1.745 . . . . 0.0 109.488 171.613 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 7.9 tt -60.09 -26.53 36.48 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.497 0 O-C-N 121.794 -0.566 . . . . 0.0 111.015 -176.682 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 25.4 tt0 -67.52 -26.33 66.28 Favored 'General case' 0 N--CA 1.435 -1.215 0 C-N-CA 125.398 1.479 . . . . 0.0 110.65 -176.625 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 11.3 t-20 -64.72 -31.16 72.26 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 124.416 1.087 . . . . 0.0 111.731 176.945 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 79.4 m-85 -86.58 168.13 13.94 Favored 'General case' 0 C--O 1.237 0.429 0 C-N-CA 124.946 1.298 . . . . 0.0 111.612 -174.695 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 46.4 t-20 -106.26 132.05 52.77 Favored 'General case' 0 N--CA 1.444 -0.738 0 N-CA-C 107.298 -1.371 . . . . 0.0 107.298 168.676 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -73.6 -24.69 60.08 Favored 'General case' 0 N--CA 1.437 -1.092 0 N-CA-C 109.339 -0.615 . . . . 0.0 109.339 -178.77 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 36.1 t70 -65.85 -21.76 66.49 Favored 'General case' 0 N--CA 1.447 -0.595 0 O-C-N 123.477 0.486 . . . . 0.0 112.096 -179.617 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -73.29 -29.31 62.63 Favored 'General case' 0 C--N 1.344 0.367 0 CA-C-O 121.222 0.534 . . . . 0.0 111.795 176.164 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 32.7 m-85 -84.25 165.84 18.0 Favored 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 125.744 1.618 . . . . 0.0 110.166 179.703 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 20.4 t70 -113.13 -35.84 5.25 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.72 176.903 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -142.24 135.94 28.5 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.826 0 CA-C-O 121.792 0.806 . . . . 0.0 110.496 -169.305 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 73.3 t -142.16 131.07 22.32 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.729 0 N-CA-C 106.178 -1.786 . . . . 0.0 106.178 -174.097 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 41.4 mm -117.93 125.5 74.23 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.443 0 N-CA-C 106.387 -1.709 . . . . 0.0 106.387 -171.712 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 41.3 m -95.19 108.69 20.83 Favored 'General case' 0 N--CA 1.447 -0.597 0 N-CA-C 106.675 -1.602 . . . . 0.0 106.675 169.889 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 90.0 mt -74.63 -13.37 60.63 Favored 'General case' 0 N--CA 1.464 0.254 0 C-N-CA 123.175 0.59 . . . . 0.0 111.661 -178.943 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 45.4 m -142.19 89.89 2.21 Favored 'General case' 0 N--CA 1.452 -0.367 0 C-N-CA 124.981 1.312 . . . . 0.0 109.073 -169.824 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 64.33 -154.7 47.51 Favored Glycine 0 CA--C 1.534 1.221 0 N-CA-C 111.585 -0.606 . . . . 0.0 111.585 178.418 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 2.9 p -161.77 152.81 18.11 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 124.587 1.155 . . . . 0.0 109.651 179.365 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 61.43 31.0 75.85 Favored Glycine 0 CA--C 1.531 1.069 0 N-CA-C 111.619 -0.592 . . . . 0.0 111.619 -178.534 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 28.5 m -70.69 -38.76 74.34 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.543 0 C-N-CA 123.087 0.555 . . . . 0.0 112.118 -169.366 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 21.4 t-20 179.66 -40.86 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 127.795 2.438 . . . . 0.0 107.573 176.712 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 3.6 tt -37.59 137.93 0.64 Allowed Pre-proline 0 CA--C 1.548 0.878 0 C-N-CA 128.788 2.835 . . . . 0.0 112.562 170.963 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . 0.439 ' HA ' ' HD3' ' A' ' 88' ' ' PRO . 53.2 Cg_exo -65.32 148.83 88.7 Favored 'Trans proline' 0 C--N 1.355 0.886 0 C-N-CA 121.734 1.623 . . . . 0.0 115.635 -169.399 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . 0.439 ' HD3' ' HA ' ' A' ' 87' ' ' PRO . 50.6 Cg_exo -64.04 -33.44 62.26 Favored 'Trans proline' 0 C--N 1.351 0.672 0 C-N-CA 122.394 2.062 . . . . 0.0 115.788 -170.981 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 5.1 pm0 -61.45 -14.41 28.34 Favored 'General case' 0 CA--C 1.538 0.49 0 CA-C-N 120.27 1.395 . . . . 0.0 112.46 -175.876 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 98.0 m95 -79.67 -45.94 18.08 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 124.008 0.923 . . . . 0.0 110.904 176.711 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 16.1 m -80.18 -1.32 4.58 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.366 0 C-N-CA 123.955 0.902 . . . . 0.0 112.25 179.975 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 74.9 p -109.62 18.76 19.94 Favored 'General case' 0 C--O 1.238 0.454 0 CA-C-N 119.672 1.124 . . . . 0.0 113.655 175.544 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 88.0 mm-40 -66.66 172.24 4.41 Favored 'General case' 0 CA--C 1.542 0.635 0 CA-C-N 118.842 0.746 . . . . 0.0 111.783 177.0 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 31.7 mm-40 -54.85 -31.97 60.14 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 123.869 0.868 . . . . 0.0 112.272 -169.033 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 1.9 tt -129.0 126.32 64.37 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.543 0 N-CA-C 103.817 -2.66 . . . . 0.0 103.817 168.412 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 7.3 t80 -110.47 139.04 46.08 Favored 'General case' 0 N--CA 1.448 -0.549 0 N-CA-C 105.955 -1.869 . . . . 0.0 105.955 170.104 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 12.8 mm-40 -134.8 145.09 48.03 Favored 'General case' 0 C--O 1.237 0.435 0 N-CA-C 107.137 -1.431 . . . . 0.0 107.137 169.774 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -129.11 125.78 37.9 Favored 'General case' 0 C--O 1.239 0.515 0 C-N-CA 126.375 1.87 . . . . 0.0 106.235 178.117 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 34.6 m95 -135.43 179.31 6.41 Favored 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 124.585 1.154 . . . . 0.0 108.865 179.987 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 6.4 tp-100 -141.24 72.22 1.38 Allowed 'General case' 0 CA--C 1.535 0.376 0 N-CA-C 106.274 -1.75 . . . . 0.0 106.274 169.643 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -67.03 146.01 54.78 Favored 'General case' 0 N--CA 1.469 0.488 0 N-CA-C 108.448 -0.945 . . . . 0.0 108.448 178.506 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 34.4 mt-10 -78.66 169.68 17.85 Favored 'General case' 0 C--N 1.328 -0.369 0 C-N-CA 123.975 0.91 . . . . 0.0 109.318 170.891 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -141.35 138.59 17.76 Favored Pre-proline 0 CA--C 1.539 0.549 0 C-N-CA 124.331 1.052 . . . . 0.0 110.27 179.27 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_endo -85.47 0.58 8.57 Favored 'Trans proline' 0 CA--C 1.543 0.927 0 C-N-CA 123.248 2.632 . . . . 0.0 115.771 -174.063 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 7.1 t70 -53.66 124.0 13.86 Favored 'General case' 0 C--O 1.237 0.416 0 CA-C-N 121.077 1.762 . . . . 0.0 110.849 -179.063 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 72.33 4.71 61.02 Favored Glycine 0 CA--C 1.533 1.168 0 CA-C-O 118.961 -0.911 . . . . 0.0 113.749 178.188 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 7.1 mt-30 -103.0 167.25 9.96 Favored 'General case' 0 CA--C 1.539 0.557 0 CA-C-N 118.658 1.229 . . . . 0.0 110.014 178.594 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 16.4 m -71.91 167.38 20.18 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 124.09 0.956 . . . . 0.0 111.636 -178.928 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 73.8 mt -59.62 -26.51 65.54 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 124.379 1.072 . . . . 0.0 112.402 -176.454 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 5.9 pt-20 -56.25 -34.93 66.84 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-N 118.738 0.699 . . . . 0.0 111.11 174.184 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 14.0 t -77.93 -42.51 28.31 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.316 0 CA-C-O 118.664 -0.684 . . . . 0.0 109.913 -177.238 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 68.3 m-85 -56.84 -43.5 81.19 Favored 'General case' 0 N--CA 1.474 0.77 0 CA-C-N 119.639 1.109 . . . . 0.0 109.569 171.07 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 94.1 mtt180 -66.25 -42.33 88.7 Favored 'General case' 0 N--CA 1.472 0.655 0 O-C-N 121.305 -0.872 . . . . 0.0 110.804 179.485 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 4.1 m -65.75 -49.72 67.36 Favored 'General case' 0 N--CA 1.45 -0.427 0 C-N-CA 124.606 1.162 . . . . 0.0 110.312 179.394 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 77.2 t -70.43 -30.58 43.46 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.202 0 CA-C-O 117.807 -1.092 . . . . 0.0 110.587 -169.501 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 74.5 mtm-85 -59.09 -45.36 91.05 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 120.192 1.36 . . . . 0.0 109.799 170.508 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -62.16 -51.68 55.05 Favored Glycine 0 CA--C 1.528 0.88 0 CA-C-N 118.946 0.794 . . . . 0.0 112.1 178.093 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 15.7 mt-30 -58.94 -45.4 90.53 Favored 'General case' 0 N--CA 1.469 0.475 0 CA-C-N 117.936 0.868 . . . . 0.0 110.779 -178.852 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 55.3 t -67.04 -47.22 82.72 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.344 0 N-CA-C 109.202 -0.666 . . . . 0.0 109.202 -177.987 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 84.3 tttt -55.52 -45.67 77.11 Favored 'General case' 0 C--O 1.224 -0.262 0 N-CA-C 109.185 -0.672 . . . . 0.0 109.185 -176.635 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 10.1 tp10 -62.83 -44.2 96.79 Favored 'General case' 0 N--CA 1.45 -0.427 0 C-N-CA 123.145 0.578 . . . . 0.0 110.757 -176.268 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 48.6 mtt-85 -68.51 -42.97 77.81 Favored 'General case' 0 N--CA 1.468 0.443 0 O-C-N 121.32 -0.863 . . . . 0.0 111.025 178.987 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 95.4 t -64.17 -38.98 83.87 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.513 0 CA-C-O 119.138 -0.458 . . . . 0.0 109.884 178.305 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 27.8 mt-10 -61.72 -44.85 96.13 Favored 'General case' 0 C--O 1.227 -0.128 0 CA-C-N 119.993 1.27 . . . . 0.0 110.177 176.014 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 28.3 t-20 -63.02 -42.12 99.71 Favored 'General case' 0 CA--C 1.53 0.208 0 C-N-CA 122.915 0.486 . . . . 0.0 111.049 -177.801 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 28.7 tp -58.04 -49.63 76.21 Favored 'General case' 0 N--CA 1.451 -0.399 0 C-N-CA 125.203 1.401 . . . . 0.0 110.742 174.17 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 81.6 mt -66.41 -43.99 90.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 N-CA-C 108.146 -1.057 . . . . 0.0 108.146 -177.057 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -59.23 -32.92 70.41 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 123.198 0.599 . . . . 0.0 112.098 -179.486 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 18.6 ptpt -80.87 -37.79 29.25 Favored 'General case' 0 C--N 1.344 0.351 0 CA-C-O 117.929 -1.034 . . . . 0.0 112.32 177.344 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 13.1 pt -84.85 -34.38 9.05 Favored 'Isoleucine or valine' 0 C--O 1.236 0.356 0 CA-C-N 119.962 1.255 . . . . 0.0 114.045 -175.184 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 74.3 m . . . . . 0 C--O 1.252 1.195 0 C-N-CA 125.372 1.469 . . . . 0.0 109.462 -169.837 . . . . . . . . 0 0 . 1 stop_ save_